PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Liu, W; Tang, FL; Lin, S; Zhao, K; Mei, L; Ye, J; Xiong, WC				Liu, Wei; Tang, Fu-Lei; Lin, Sen; Zhao, Kai; Mei, Lin; Ye, Jian; Xiong, Wen-Cheng			Vps35-deficiency impairs SLC4A11 trafficking and promotes corneal dystrophy	PLOS ONE			English	Article							ENDOTHELIAL DYSTROPHY; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; ION-TRANSPORT; ALZHEIMERS-DISEASE; RETROMER COMPLEX; GOLGI RETRIEVAL; VPS35; MUTATIONS; PROTEIN	Vps35 (vacuolar protein sorting 35) is a major component of retromer that selectively promotes endosome-to-Golgi retrieval of transmembrane proteins. Dysfunction of retromer is a risk factor for the pathogenesis of Parkinson's disease (PD) and Alzheimer's disease (AD). However, Vps35/retromer's function in the eye or the contribution of Vps35-deficiency to eye degenerative disorders remains to be explored. Here we provide evidence for a critical role of Vps35 in mouse corneal dystrophy. Vps35 is expressed in mouse and human cornea. Mouse cornea from Vps35 heterozygotes (Vps35(+/-)) show features of dystrophy, such as loss of both endothelial and epithelial cell densities, disorganizations of endothelial, stroma, and epithelial cells, excrescences in the Descemet membrane, and corneal edema. Additionally, corneal epithelial cell proliferation was reduced in Vps35-deficient mice. Intriguingly, cell surface targeting of SLC4A11, a membrane transport protein (OH- /H+ /NH3 /H2O) of corneal endothelium, whose mutations have been identified in patients with corneal dystrophy, was impaired in Vps35-deficient cells and cornea. Taken together, these results suggest that SLC4A11 appears to be a Vps35/retromer cargo, and Vps35-regulation of SLC4A11 trafficking may underlie Vps35/retromer regulation of corneal dystrophy.	[Liu, Wei; Tang, Fu-Lei; Lin, Sen; Zhao, Kai; Mei, Lin; Xiong, Wen-Cheng] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Liu, Wei; Tang, Fu-Lei; Lin, Sen; Zhao, Kai; Mei, Lin; Xiong, Wen-Cheng] Augusta Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; [Liu, Wei; Lin, Sen; Ye, Jian] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Ophthalmol, Chongqing, Peoples R China; [Tang, Fu-Lei; Zhao, Kai; Mei, Lin; Xiong, Wen-Cheng] Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Army Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Xiong, WC (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA.; Xiong, WC (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA.; Ye, J (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Ophthalmol, Chongqing, Peoples R China.; Xiong, WC (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA.	yejian1979@163.com; wxiong@augusta.edu		Xiong, Wen-Cheng/0000-0001-9071-7598	National Institutes of Aging [AG045781, AG051773]	National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Aging Grants, AG045781 and AG051773 to W.-C. Xiong.	Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; de Groot REA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076971; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Dhungel N, 2015, NEURON, V85, P76, DOI 10.1016/j.neuron.2014.11.027; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P7, DOI 10.1016/bs.pmbts.2015.04.001; Frausto RF, 2014, INVEST OPHTH VIS SCI, V55, P7821, DOI 10.1167/iovs.14-15021; Gallon M, 2015, BIOCHEM SOC T, V43, P33, DOI 10.1042/BST20140290; Jiao XD, 2007, J MED GENET, V44, P64, DOI 10.1136/jmg.2006.044644; Kao LY, 2016, AM J PHYSIOL-CELL PH, V311, pC820, DOI 10.1152/ajpcell.00233.2016; Kim EK, 2015, PROG MOL BIOL TRANSL, V134, P99, DOI 10.1016/bs.pmbts.2015.05.003; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Kodaganur SG, 2013, MOL VIS, V19, P1694; Lin ZN, 2016, INT J OPHTHALMOL-CHI, V9, P904, DOI 10.18240/ijo.2016.06.20; Liu J, 2012, INVEST OPHTH VIS SCI, V53, P3270, DOI 10.1167/iovs.11-8724; Liu W, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-10; Loganathan SK, 2016, AM J PHYSIOL-CELL PH, V311, pC735, DOI 10.1152/ajpcell.00078.2016; Loganathan SK, 2016, AM J PHYSIOL-CELL PH, V310, pC161, DOI 10.1152/ajpcell.00246.2015; Lopez IA, 2009, J BIOL CHEM, V284, P26882, DOI 10.1074/jbc.M109.008102; Malik BR, 2015, HUM MOL GENET, V24, P6106, DOI 10.1093/hmg/ddv322; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Miura E, 2014, NEUROBIOL DIS, V71, P1, DOI 10.1016/j.nbd.2014.07.014; Patel SP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/475392; Pocha SM, 2011, CURR BIOL, V21, P1111, DOI 10.1016/j.cub.2011.05.007; Rovelet-Lecrux A, 2015, MOL PSYCHIATR, V20, P1046, DOI 10.1038/mp.2015.100; Roy S, 2015, CORNEA, V34, P668, DOI 10.1097/ICO.0000000000000421; Schorderet D, 2015, PROG MOL BIOL TRANSL, V134, P73, DOI 10.1016/bs.pmbts.2015.04.004; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Shei W, 2013, MOL VIS, V19, P1096; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Tang FL, 2015, CELL REP, V12, P1631, DOI 10.1016/j.celrep.2015.08.001; Tang FL, 2015, J NEUROSCI, V35, P10613, DOI 10.1523/JNEUROSCI.0042-15.2015; Tian Y, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0156-4; Tsika E, 2014, HUM MOL GENET, V23, P4621, DOI 10.1093/hmg/ddu178; Vedana G, 2016, CLIN OPHTHALMOL, V10, P321, DOI 10.2147/OPTH.S83467; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Vilas GL, 2013, HUM MOL GENET, V22, P4579, DOI 10.1093/hmg/ddt307; Vilas GL, 2012, HUM MUTAT, V33, P419, DOI 10.1002/humu.21655; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Wang CL, 2012, BIOL OPEN, V1, P1248, DOI 10.1242/bio.20122451; Wang W, 2016, J SENSORS, V2016, DOI 10.1155/2016/2646205; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Xia WF, 2013, J CELL BIOL, V200, P821, DOI 10.1083/jcb.201207154; Xiong L, 2016, EBIOMEDICINE, V9, P45, DOI 10.1016/j.ebiom.2016.05.028; Zhu AY, 2014, JAMA OPHTHALMOL, V132, P377, DOI 10.1001/jamaophthalmol.2013.7993; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	52	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184906	10.1371/journal.pone.0184906	http://dx.doi.org/10.1371/journal.pone.0184906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934248	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900060
J	Miller, C; Boegler, K; Carver, S; MacMillan, M; Bielefeldt-Ohmann, H; VandeWoude, S				Miller, Craig; Boegler, Karen; Carver, Scott; MacMillan, Martha; Bielefeldt-Ohmann, Helle; VandeWoude, Sue			Pathogenesis of oral FIV infection	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; SYSTEMIC IMMUNE ACTIVATION; CELL-FREE SIV; HIV-INFECTION; LYMPH-NODES; MICROBIAL TRANSLOCATION; GASTROINTESTINAL-TRACT; VERTICAL TRANSMISSION; COMMENSAL BACTERIA; HOMOSEXUAL-MEN	Feline immunodeficiency virus (FIV) is the feline analogue of human immunodeficiency virus (HIV) and features many hallmarks of HIV infection and pathogenesis, including the development of concurrent oral lesions. While HIV is typically transmitted via parenteral transmucosal contact, recent studies prove that oral transmission can occur, and that saliva from infected individuals contains significant amounts of HIV RNA and DNA. While it is accepted that FIV is primarily transmitted by biting, few studies have evaluated FIV oral infection kinetics and transmission mechanisms over the last 20 years. Modern quantitative analyses applied to natural FIV oral infection could significantly further our understanding of lentiviral oral disease and transmission. We therefore characterized FIV salivary viral kinetics and antibody secretions to more fully document oral viral pathogenesis. Our results demonstrate that: (i) saliva of FIV-infected cats contains infectious virus particles, FIV viral RNA at levels equivalent to circulation, and lower but significant amounts of FIV proviral DNA; (ii) the ratio of FIV RNA to DNA is significantly higher in saliva than in circulation; (iii) FIV viral load in oral lymphoid tissues (tonsil, lymph nodes) is significantly higher than mucosal tissues (buccal mucosa, salivary gland, tongue); (iv) salivary IgG antibodies increase significantly over time in FIV-infected cats, while salivary IgA levels remain static; and, (v) saliva from naive Specific Pathogen Free cats inhibits FIV growth in vitro. Collectively, these results suggest that oral lymphoid tissues serve as a site for enhanced FIV replication, resulting in accumulation of FIV particles and FIV-infected cells in saliva. Failure to induce a virus-specific oral mucosal antibody response, and/or viral capability to overcome inhibitory components in saliva may perpetuate chronic oral cavity infection. Based upon these findings, we propose a model of oral FIV pathogenesis and suggest alternative diagnostic modalities and translational approaches to study oral HIV infection.	[Miller, Craig; Boegler, Karen; MacMillan, Martha; VandeWoude, Sue] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Carver, Scott] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia	Colorado State University; University of Tasmania; University of Queensland	VandeWoude, S (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Sue.Vandewoude@colostate.edu	Carver, Scott/J-7654-2014	Carver, Scott/0000-0002-3579-7588	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI025825]; NIH Training Grants [4T32OD010437-15, 1F32DE026679-01]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI025825 (https://www.niaid.nih.gov/), and by NIH Training Grants 4T32OD010437-15 and 1F32DE026679-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreo SMS, 2004, AIDS RES HUM RETROV, V20, P349, DOI 10.1089/088922204323048087; BABA TW, 1994, AIDS RES HUM RETROV, V10, P351, DOI 10.1089/aid.1994.10.351; Baba TW, 1996, SCIENCE, V272, P1486, DOI 10.1126/science.272.5267.1486; BACH JM, 1994, AIDS RES HUM RETROV, V10, P1731, DOI 10.1089/aid.1994.10.1731; Bagley KC, 2006, CLIN VACCINE IMMUNOL, V13, P106, DOI 10.1128/CVI.13.1.106-115.2006; Baron S, 2000, J INFECT DIS, V181, P498, DOI 10.1086/315251; Baron S, 2001, AIDS RES HUM RETROV, V17, P997, DOI 10.1089/088922201300343672; Bartholomew CF, 2006, AIDS, V20, P631, DOI 10.1097/01.aids.0000210621.13825.75; BASKIN GB, 1988, VET PATHOL, V25, P456, DOI 10.1177/030098588802500609; Beczkowski PM, 2015, VET MICROBIOL, V176, P50, DOI 10.1016/j.vetmic.2014.12.023; BEEBE AM, 1994, J VIROL, V68, P3080, DOI 10.1128/JVI.68.5.3080-3091.1994; Brady LJ, 1996, ORAL MICROBIOL IMMUN, V11, P371, DOI 10.1111/j.1399-302X.1996.tb00198.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x; Casteleyn C, 2011, CLIN DEV IMMUNOLOGY, V2011; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; de Rozieres S, 2004, J VIROL, V78, P8971, DOI 10.1128/JVI.78.17.8971-8982.2004; De Rozieres S, 2008, J VIROL, V82, P7953, DOI 10.1128/JVI.00337-08; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116; DREITZ MJ, 1995, AM J VET RES, V56, P764; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Elder JH, 1998, AIDS RES HUM RETROV, V14, P797, DOI 10.1089/aid.1998.14.797; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Gilbart VL, 2004, SEX TRANSM INFECT, V80, P324, DOI 10.1136/sti.2004.009217; GROOPMAN JE, 1984, SCIENCE, V226, P447, DOI 10.1126/science.6093247; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; ISHIDA T, 1989, J AM VET MED ASSOC, V194, P221; Kenyon JC, 2011, VIRUSES-BASEL, V3, P2192, DOI 10.3390/v3112192; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Leutenegger CM, 1999, VET IMMUNOL IMMUNOP, V71, P291, DOI 10.1016/S0165-2427(99)00100-2; Levy JK, 2004, JAVMA-J AM VET MED A, V225, P1558, DOI 10.2460/javma.2004.225.1558; Li YH, 2014, J CLIN MICROBIOL, V52, P1400, DOI 10.1128/JCM.02954-13; Liem BP, 2013, J VET INTERN MED, V27, P798, DOI 10.1111/jvim.12120; Litster AL, 2014, VET J, V201, P184, DOI 10.1016/j.tvjl.2014.02.030; Liuzzi G, 1996, AIDS, V10, pF51, DOI 10.1097/00002030-199612000-00001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Magden E, 2013, VIROLOGY, V436, P284, DOI 10.1016/j.virol.2012.12.003; Mataftsi M, 2011, ORAL DIS, V17, P13, DOI 10.1111/j.1601-0825.2010.01727.x; MATTEUCCI D, 1993, J CLIN MICROBIOL, V31, P494, DOI 10.1128/JCM.31.3.494-501.1993; MCCLURE HM, 1989, VET IMMUNOL IMMUNOP, V21, P13, DOI 10.1016/0165-2427(89)90126-8; McElrath MJ, 2011, IMMUNITY, V34, P146, DOI 10.1016/j.immuni.2011.02.014; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Milush JM, 2007, J VIROL, V81, P6175, DOI 10.1128/JVI.00042-07; Norris JM, 1999, VET MICROBIOL, V65, P195, DOI 10.1016/S0378-1135(98)00290-9; Obert LA, 2002, J VIROL, V76, P6311, DOI 10.1128/JVI.76.12.6311-6322.2002; Obert LA, 2000, AIDS RES HUM RETROV, V16, P677, DOI 10.1089/088922200308909; ONEIL LL, 1995, AIDS RES HUM RETROV, V11, P171, DOI 10.1089/aid.1995.11.171; Page-Shafer K, 2002, AIDS, V16, P2350, DOI 10.1097/00002030-200211220-00022; PageShafer K, 1997, AM J EPIDEMIOL, V146, P531, DOI 10.1093/oxfordjournals.aje.a009311; PARODI AL, 1994, J COMP PATHOL, V111, P165, DOI 10.1016/S0021-9975(05)80048-9; Pedersen N, 1990, AN MOD AIDS INT TNO; Pedersen NC, 2001, VET IMMUNOL IMMUNOP, V79, P53, DOI 10.1016/S0165-2427(01)00252-5; PEDERSEN NC, 1989, VET IMMUNOL IMMUNOP, V21, P111, DOI 10.1016/0165-2427(89)90134-7; PHILLIPS TR, 1990, J VIROL, V64, P4605, DOI 10.1128/JVI.64.10.4605-4613.1990; POLI A, 1992, J CLIN MICROBIOL, V30, P2038, DOI 10.1128/JCM.30.8.2038-2041.1992; QIAGEN, 2006, PUR TOT DNA AN SAL U; QURESHI MN, 1995, J INFECT DIS, V171, P190, DOI 10.1093/infdis/171.1.190; RICHMAN KM, 1993, J ACQ IMMUN DEF SYND, V6, P402; RIDEOUT BA, 1992, VET PATHOL, V29, P391, DOI 10.1177/030098589202900504; Robinson PG, 2002, ORAL DIS, V8, P91, DOI 10.1034/j.1601-0825.2002.00019.x; Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004; Santos L C, 2001, Braz Dent J, V12, P135; SELLON RK, 1994, J VIROL, V68, P3380, DOI 10.1128/JVI.68.5.3380-3385.1994; SIEBELINK KHJ, 1990, AIDS RES HUM RETROV, V6, P1373, DOI 10.1089/aid.1990.6.1373; SIMS TJ, 1990, J DENT RES, V69, P877, DOI 10.1177/00220345900690031001; Spetz AL, 2013, J INFECT DIS, V207, P1189, DOI 10.1093/infdis/jis477; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Taniwaki SA, 2013, COMP IMMUNOL MICROB, V36, P549, DOI 10.1016/j.cimid.2013.07.001; TerWee JA, 2008, VIROLOGY, V377, P63, DOI 10.1016/j.virol.2008.03.037; Thompson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024020; Troyer RM, 2013, J VIROL, V87, P7940, DOI 10.1128/JVI.00752-13; UELAND K, 1992, VET IMMUNOL IMMUNOP, V33, P301, DOI 10.1016/0165-2427(92)90002-8; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Vidmar L, 1996, LANCET, V347, P1762, DOI 10.1016/S0140-6736(96)90838-7; Wallace JJ, 1997, AM J PUBLIC HEALTH, V87, P470, DOI 10.2105/AJPH.87.3.470; Webber LM, 2000, S AFR MED J, V90, P1004; Weese SJ, 2015, VET RES, V46, DOI 10.1186/s13567-014-0140-5; Willett BJ, 2013, CURR OPIN VIROL, V3, P670, DOI 10.1016/j.coviro.2013.08.003; Wood BA, 2013, J IMMUNOL METHODS, V396, P74, DOI 10.1016/j.jim.2013.08.001; Wood BA, 2011, CLIN VACCINE IMMUNOL, V18, P387, DOI 10.1128/CVI.00289-10; Wood LF, 2013, IMMUNOL REV, V254, P34, DOI 10.1111/imr.12078; YAMAMOTO JK, 1989, J AM VET MED ASSOC, V194, P213; YAMAMOTO JK, 1988, AM J VET RES, V49, P1246; YEUNG SCH, 1993, J PERIODONTOL, V64, P651, DOI 10.1902/jop.1993.64.7.651	92	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185138	10.1371/journal.pone.0185138	http://dx.doi.org/10.1371/journal.pone.0185138			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934316	Green Published, Green Accepted, gold			2022-12-27	WOS:000411339900102
J	Petro, B; Papachatzopoulou, A; Kiss, RM				Petro, Balint; Papachatzopoulou, Alexandra; Kiss, Rita M.			Devices and tasks involved in the objective assessment of standing dynamic balancing - A systematic literature review	PLOS ONE			English	Review							LOW-BACK-PAIN; PARKINSONS-DISEASE; POSTURAL CONTROL; MUSCLE ACTIVATION; OLDER-ADULTS; PERTURBATIONS; STABILITY; RESPONSES; RECOVERY; STROKE	Background Static balancing assessment is often complemented with dynamic balancing tasks. Numerous dynamic balancing assessment methods have been developed in recent decades with their corresponding balancing devices and tasks. Objective The aim of this systematic literature review is to identify and categorize existing objective methods of standing dynamic balancing ability assessment with an emphasis on the balancing devices and tasks being used. Data Sources Three major scientific literature databases (Science Direct, Web of Science, PLoS ONE) and additional sources were used. Study selection Studies had to use a dynamic balancing device and a task described in detail. Evaluation had to be based on objectively measureable parameters. Functional tests without instrumentation evaluated exclusively by a clinician were excluded. A total of 63 articles were included. Data extraction The data extracted during full-text assessment were: author and date; the balancing device with the balancing task and the measured parameters; the health conditions, size, age and sex of participant groups; and follow-up measurements. Data synthesis A variety of dynamic balancing assessment devices were identified and categorized as 1) Solid ground, 2) Balance board, 3) Rotating platform, 4) Horizontal translational platform, 5) Treadmill, 6) Computerized Dynamic Posturography, and 7) Other devices. The group discrimination ability of the methods was explored and the conclusions of the studies were briefly summarized. Limitations Due to the wide scope of this search, it provides an overview of balancing devices and do not represent the state-of-the-art of any single method. Conclusions The identified dynamic balancing assessment methods are offered as a catalogue of candidate methods to complement static assessments used in studies involving postural control.	[Petro, Balint; Kiss, Rita M.] Budapest Univ Technol & Econ, Dept Mechatron Opt & Mech Engn Informat, Budapest, Hungary; [Papachatzopoulou, Alexandra] Univ Thessaly, Dept Mech Engn, Volos, Greece	Budapest University of Technology & Economics; University of Thessaly	Kiss, RM (corresponding author), Budapest Univ Technol & Econ, Dept Mechatron Opt & Mech Engn Informat, Budapest, Hungary.	rikiss@mail.bme.hu	Kiss, Rita M./G-4315-2015; Petro, Balint/K-8129-2018	Kiss, Rita M./0000-0003-3607-8435; Petro, Balint/0000-0003-3920-5161	Orszagos Tudomanyos Kutatasi Alapprogramok [K083650]	Orszagos Tudomanyos Kutatasi Alapprogramok(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Orszagos Tudomanyos Kutatasi Alapprogramok. Country: HUNGARY. Grant number: K083650. URL: http.//nkfih.gov.hu/palyazatok/palyazati-archivum/otka. Receiving author: Kiss, Rita M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhbari B, 2007, PHYS THER SPORT, V8, P117, DOI 10.1016/j.ptsp.2007.03.004; Almeida GL, 2006, GAIT POSTURE, V23, P17, DOI 10.1016/j.gaitpost.2004.11.020; Arampatzis A, 2011, J BIOMECH, V44, P52, DOI 10.1016/j.jbiomech.2010.08.023; Buchanan JJ, 2003, BEHAV BRAIN RES, V143, P121, DOI 10.1016/S0166-4328(03)00038-X; Bugnariu N, 2006, ARCH GERONTOL GERIAT, V42, P73, DOI 10.1016/j.archger.2005.05.003; Cappa P, 2008, GAIT POSTURE, V28, P615, DOI 10.1016/j.gaitpost.2008.04.013; Catala MM, 2015, HUM MOVEMENT SCI, V41, P136, DOI 10.1016/j.humov.2015.03.002; Caudron S, 2014, NEUROPHYSIOL CLIN, V44, P77, DOI 10.1016/j.neucli.2013.10.134; Chagdes JR, 2013, J BIOMECH, V46, P2593, DOI 10.1016/j.jbiomech.2013.08.012; Chong RKY, 2010, NEUROPSYCHOLOGIA, V48, P2709, DOI 10.1016/j.neuropsychologia.2010.05.018; Claudino R, 2013, CLIN NEUROPHYSIOL, V124, P1628, DOI 10.1016/j.clinph.2013.02.111; Crenshaw JR, 2014, GAIT POSTURE, V40, P363, DOI 10.1016/j.gaitpost.2014.05.001; Cronin NJ, 2013, J ELECTROMYOGR KINES, V23, P1139, DOI 10.1016/j.jelekin.2013.05.012; de Kam D, 2017, GAIT POSTURE, V53, P5, DOI 10.1016/j.gaitpost.2016.12.019; De Nunzio AM, 2007, BRAIN RES BULL, V74, P258, DOI 10.1016/j.brainresbull.2007.06.020; De Ridder R, 2014, HUM MOVEMENT SCI, V33, P419, DOI 10.1016/j.humov.2013.12.008; Dettmer M, 2013, HUM MOVEMENT SCI, V32, P214, DOI 10.1016/j.humov.2012.12.002; Duncan CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165735; Elena S, 2014, PROCD SOC BEHV, V127, P260, DOI 10.1016/j.sbspro.2014.03.252; Etemadi Y, 2016, GAIT POSTURE, V44, P123, DOI 10.1016/j.gaitpost.2015.11.017; Ferber-viart C, 2007, BALANCE HLTH INDIVID, P10; Giboin LS, 2015, HUM MOVEMENT SCI, V44, P22, DOI 10.1016/j.humov.2015.08.012; Graham DF, 2014, J BIOMECH, V47, P667, DOI 10.1016/j.jbiomech.2013.11.047; Hatzitaki V, 2005, GAIT POSTURE, V22, P250, DOI 10.1016/j.gaitpost.2004.09.010; Hill KD, 2013, J CLIN GERONTOL GERI, V4, P22, DOI 10.1016/j.jcgg.2012.10.003; Honeycutt CF, 2016, J BIOMECH, V49, P3313, DOI 10.1016/j.jbiomech.2016.08.019; Horak FB, 1997, GAIT POSTURE, V6, P76, DOI 10.1016/S0966-6362(97)00018-0; Kiss RM, 2011, MED ENG PHYS, V33, P1160, DOI 10.1016/j.medengphy.2011.04.017; Ko JH, 2014, HUM MOVEMENT SCI, V38, P1, DOI 10.1016/j.humov.2014.08.005; Lee PY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162187; Mackey DC, 2006, GAIT POSTURE, V23, P59, DOI 10.1016/j.gaitpost.2004.11.009; Maranesi E, 2016, CLIN BIOMECH, V32, P236, DOI 10.1016/j.clinbiomech.2015.11.005; Marcolin G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155085; Matjacic Z, 2001, J BIOMECH, V34, P187, DOI 10.1016/S0021-9290(00)00182-2; Megrot F, 2006, NEUROSCIENCE LETT; Melzer I, 2010, CLIN BIOMECH, V25, P984, DOI 10.1016/j.clinbiomech.2010.07.007; Mergner T, 2009, J PHYSIOL-PARIS, V103, P178, DOI 10.1016/j.jphysparis.2009.08.002; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Mihelj M, 2000, GAIT POSTURE, V12, P94, DOI 10.1016/S0966-6362(00)00065-5; Moro SB, 2014, NEUROIMAGE, V85, P451, DOI 10.1016/j.neuroimage.2013.05.031; Nanhoe-Mahabier W, 2012, NEUROSCIENCE, V217, P123, DOI 10.1016/j.neuroscience.2012.03.064; Orrell AJ, 2006, GAIT POSTURE, V23, P9, DOI 10.1016/j.gaitpost.2004.11.010; Paloski WH, 2006, GAIT POSTURE, V23, P315, DOI 10.1016/j.gaitpost.2005.04.009; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Pfusterschmied J, 2013, J SCI MED SPORT, V16, P562, DOI 10.1016/j.jsams.2012.12.006; Pollock CL, 2015, CLIN NEUROPHYSIOL, V126, P1951, DOI 10.1016/j.clinph.2014.12.015; Rasool J, 2007, PHYS THER SPORT, V8, P177, DOI 10.1016/j.ptsp.2007.06.001; Rietdyk S, 1999, J BIOMECH, V32, P1149, DOI 10.1016/S0021-9290(99)00116-5; Rossi R, 2015, ACCIDENT ANAL PREV, V82, P126, DOI 10.1016/j.aap.2015.05.010; Rougier PR, 2012, GAIT POSTURE, V36, P383, DOI 10.1016/j.gaitpost.2012.03.018; Row BS, 2007, CLIN BIOMECH, V22, P155, DOI 10.1016/j.clinbiomech.2006.06.003; Sahli S, 2013, SCI SPORT, V28, P11, DOI 10.1016/j.scispo.2011.10.010; Schmid M, 2011, HUM MOVEMENT SCI, V30, P262, DOI 10.1016/j.humov.2011.02.002; Schmidt D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136551; Schulz BW, 2005, GAIT POSTURE, V22, P198, DOI 10.1016/j.gaitpost.2004.09.004; Shultz SJ, 2000, J ELECTROMYOGR KINES, V10, P159, DOI 10.1016/S1050-6411(00)00002-X; Sibley KM, 2015, ARCH PHYS MED REHAB, V96, P122, DOI 10.1016/j.apmr.2014.06.021; Silva PD, 2016, GAIT POSTURE, V44, P149, DOI 10.1016/j.gaitpost.2015.12.005; Sozzi S, 2012, NEUROSCIENCE, V212, P59, DOI 10.1016/j.neuroscience.2012.03.044; Sung PS, 2009, GAIT POSTURE, V29, P290, DOI 10.1016/j.gaitpost.2008.09.012; Valle MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142423; van Asseldonk EHF, 2006, EXP NEUROL, V201, P441, DOI 10.1016/j.expneurol.2006.04.036; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; Verbecque E, 2015, DEV MED CHILD NEUROL, V57, P521, DOI 10.1111/dmcn.12657; Visser JE, 2008, NEUROSCIENCE, V157, P798, DOI 10.1016/j.neuroscience.2008.09.051; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Welch TDJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096440; Yelnik A, 2008, NEUROPHYSIOL CLIN, V38, P439, DOI 10.1016/j.neucli.2008.09.008; Young PM, 2013, CLIN BIOMECH, V28, P927, DOI 10.1016/j.clinbiomech.2013.07.015; Zemkova E, 2016, HUM MOVEMENT SCI, V48, P142, DOI 10.1016/j.humov.2016.05.002; Zhou YT, 2017, HONG KONG PHYSIOTHER, V36, P49, DOI 10.1016/j.hkpj.2016.12.001	71	35	36	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185188	10.1371/journal.pone.0185188	http://dx.doi.org/10.1371/journal.pone.0185188			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934308	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900116
J	Zhao, SP; Li, R; Dai, W; Yu, BL; Chen, LZ; Huang, XS				Zhao, Shui-ping; Li, Rong; Dai, Wen; Yu, Bi-lian; Chen, Lu-zhu; Huang, Xian-sheng			Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPAR alpha signaling pathway	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; DENSITY-LIPOPROTEIN RECEPTOR; CORONARY-HEART-DISEASE; HMG-COA REDUCTASE; CARDIOVASCULAR-DISEASE; DYSLIPIDEMIA; ATORVASTATIN; CHOLESTEROL; MECHANISMS; EXPRESSION	Xuezhikang (XZK), an extract of Chinese red yeast rice, is recommended as an optimal choice for patients with coronary heart disease (CHD) with markedly elevated triglyceride (TG) levels. This study was designed to compare the hypotriglyceridemic effects between XZK and simvastatin. The role of apolipoprotein A5 (apoA5), a key regulator of TG metabolism and a target gene of peroxisome proliferator-activated receptor a (PPAR alpha), was to be identified in XZK-related hypotriglyceridemic actions. For these goals, hypertriglyceridemia of rats was induced by a high-fructose diet. In order to investigate the hypotriglyceridemic effects of XZK and simvastatin on these animals based on an equivalent low-density lipoprotein cholesterol (LDL-C) lowering power, we titrated their doses (XZK 80 mg/kg/d versus simvastatin 1 mg/kg/d) according to plasma LDL-C reduction of rats. Similarly, we titrated the target doses of the two agents (XZK 500 mu g/ml versus simvastatin 10 mu M) according to hepatocyte LDL receptor expressions, and then compared the effects of the two agents on TG and apoA5 of hepatocytes in vitro. Our results showed that XZK (80 mg/kg/d) had higher hypotriglyceridemic performance than simvastatin (1 mg/kg/d) on these animals albeit their equivalent LDL-C lowering power. Higher plasma apoA5 levels and hepatic apoA5 expressions were observed in rats treated with XZK (80 mg/kg/d) than simvastatin (1 mg/kg/d). Further, XZK (80 mg/kg/d) contributed to higher hepatic PPARa expressions of rats than simvastatin (1 mg/kg/d). Although the two agents led to an equivalent up-regulation of LDL receptors of hepatocytes, more TG reduction and apoA5 elevation were detected in hepatocytes treated with XZK (500 mu g/ml) than simvastatin (10 mu M). However, PPARa knockdown eliminated the above effects of XZK on hepatocytes. Therefore, our study indicates that XZK has greater hypotriglyceridemic performance than simvastatin in the setting of an equivalent LDL-C lowering power, which is attributed to more apoA5 up-regulation by this agent via the PPARa signaling pathway.	[Zhao, Shui-ping; Dai, Wen; Yu, Bi-lian; Chen, Lu-zhu; Huang, Xian-sheng] Cent S Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China; [Li, Rong] Cent S Univ, Xiangya Hosp 2, Dept Stomatol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Huang, XS (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China.	initialhxs@163.com						Baroukh N, 2004, ARTERIOSCL THROM VAS, V24, P1297, DOI 10.1161/01.ATV.0000130463.68272.1d; Brautbar A, 2011, ATHEROSCLEROSIS, V219, P737, DOI 10.1016/j.atherosclerosis.2011.08.015; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; Henneman P, 2007, ATHEROSCLEROSIS, V193, P129, DOI 10.1016/j.atherosclerosis.2006.05.030; Huang XS, 2009, BRIT J PHARMACOL, V158, P706, DOI 10.1111/j.1476-5381.2009.00350.x; KASIM SE, 1992, J LIPID RES, V33, P1; Miller M, 2008, J AM COLL CARDIOL, V51, P724, DOI 10.1016/j.jacc.2007.10.038; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Moriarty PM, 2014, J CLIN LIPIDOL, V8, P568, DOI 10.1016/j.jacl.2014.09.002; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Qiu J, 2007, NATURE, V448, P126, DOI 10.1038/448126a; REIHNER E, 1990, NEW ENGL J MED, V323, P224, DOI 10.1056/NEJM199007263230403; Roglans N, 2002, J PHARMACOL EXP THER, V302, P232, DOI 10.1124/jpet.302.1.232; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tai ES, 2008, CURR OPIN LIPIDOL, V19, P349, DOI 10.1097/MOL.0b013e328304b681; Talmud PJ, 2002, HUM MOL GENET; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; Vu-Dac N, 2003, J BIOL CHEM, V278, P17982, DOI 10.1074/jbc.M212191200; Yashiro T, 2012, ATHEROSCLEROSIS, V220, P369, DOI 10.1016/j.atherosclerosis.2011.11.006; Zhao SP, 2014, ATHEROSCLEROSIS, V235, P463, DOI 10.1016/j.atherosclerosis.2014.05.916; Zhao SP, 2004, CIRCULATION, V110, P915, DOI 10.1161/01.CIR.0000139985.81163.CE	29	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184949	10.1371/journal.pone.0184949	http://dx.doi.org/10.1371/journal.pone.0184949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934253	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900063
J	Wilke, ABB; Wilk-da-Silva, R; Marrelli, MT				Bruno Wilke, Andre Barretto; Wilk-da-Silva, Ramon; Marrelli, Mauro Toledo			Microgeographic population structuring of Aedes aegypti (Diptera: Culicidae)	PLOS ONE			English	Article							SAO-PAULO; IMMATURE MOSQUITOS; MUNICIPAL PARKS; SOFTWARE; DENGUE; FEVER; CITY; EVOLUTION; MARKERS; VECTOR	Aedes aegypti is one of the species most favored by changes in the environment caused by urbanization. Its abundance increases rapidly in the face of such changes, increasing the risk of disease transmission. Previous studies have shown that mosquito species that have adapted to anthropogenic environmental changes benefit from urbanization and undergo population expansion. In light of this, we used microsatellite markers to explore how urbanization processes may be modulating Ae. aegypti populations collected from three areas with different levels of urbanization in the city of Sao Paulo, Brazil. Specimens were collected at eleven sites in three areas with different degrees of urbanization in the city of Sao Paulo: conserved, intermediate and urbanized. Ten microsatellite loci were used to characterize the populations from these areas genetically. Our findings suggest that as urbanized areas grow and the human population density in these areas increases, Ae. aegypti populations undergo a major population expansion, which can probably be attributed to the species' adaptability to anthropogenic environmental changes. Our findings reveal a robust association between, on the one hand, urbanization processes and densification of the human population and, on the other, Ae. aegypti population structure patterns and population expansion. This indicates that this species benefits from anthropogenic effects, which are intensified by migration of the human population from rural to urban areas, increasing the risk of epidemics and disease transmission to an ever-increasing number of people.	[Bruno Wilke, Andre Barretto; Wilk-da-Silva, Ramon; Marrelli, Mauro Toledo] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Wilke, ABB (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil.	andrewilke@usp.br	Wilke, Andre B B/J-9973-2014	Wilke, Andre B B/0000-0002-6629-7666	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/15313-4, 2012/19117-2, 2015/01172-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: Grant 2013/15313-4 (www.fapesp.br) MTM; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: Grant 2012/19117-2 (www.fapesp.br) ABBW; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: Grant 2015/01172-5 (www.fapesp.br) RWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CULICIDOLOGIA MED; Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Buhaug H, 2013, GLOBAL ENVIRON CHANG, V23, P1, DOI 10.1016/j.gloenvcha.2012.10.016; Ceretti W, 2016, J ARTHROPOD-BORNE DI, V10, P102; Ceretti W, 2014, J AM MOSQUITO CONTR, V30, P268, DOI 10.2987/14-6403R.1; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Conn JE, 2006, AM J TROP MED HYG, V74, P798, DOI 10.4269/ajtmh.2006.74.798; Cornuet JM, 1996, GENETICS, V144, P2001; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1; Michel AP, 2006, GENETICS, V173, P1389, DOI 10.1534/genetics.106.059667; Mirabello L, 2006, HEREDITY, V97, P438, DOI 10.1038/sj.hdy.6800913; Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167; Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328; NATAL D, 1984, REV SAUDE PUBL, V18, P418, DOI 10.1590/S0034-89101984000500013; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Oliveira EJ, 2006, GENET MOL BIOL, V29, P294, DOI 10.1590/S1415-47572006000200018; Rodriguez-Valle M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0605-4; Rosenthal JK, 2007, ANN ACAD MED SINGAP, V36, P834; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; StatSoft I, 2012, STATISTICA DAT AN SO; Thongsripong P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002507; Piccinali RV, 2015, INFECT GENET EVOL, V34, P143, DOI 10.1016/j.meegid.2015.05.030; Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602; World Health Organization, 2012, DENG SEV DENG WHO FA	41	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185150	10.1371/journal.pone.0185150	http://dx.doi.org/10.1371/journal.pone.0185150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931078	gold, Green Published, Green Submitted			2022-12-27	WOS:000411314700073
J	Kanazawa, Y; Nakamura, K; Ishii, T; Aso, T; Yamazaki, H; Omori, K				Kanazawa, Yuji; Nakamura, Kimihiro; Ishii, Toru; Aso, Toshihiko; Yamazaki, Hiroshi; Omori, Koichi			Phonological memory in sign language relies on the visuomotor neural system outside the left hemisphere language network	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; SPOKEN LANGUAGE; PREMOTOR CORTEX; FRONTAL-CORTEX; DEAF SIGNERS; FMRI; PET; PARIETAL; SPEECH; AREAS	Sign language is an essential medium for everyday social interaction for deaf people and plays a critical role in verbal learning. In particular, language development in those people should heavily rely on the verbal short-term memory (STM) via sign language. Most previous studies compared neural activations during signed language processing in deaf signers and those during spoken language processing in hearing speakers. For sign language users, it thus remains unclear how visuospatial inputs are converted into the verbal STM operating in the left-hemisphere language network. Using functional magnetic resonance imaging, the present study investigated neural activation while bilinguals of spoken and signed language were engaged in a sequence memory span task. On each trial, participants viewed a nonsense syllable sequence presented either as written letters or as fingerspelling (4-7 syllables in length) and then held the syllable sequence for 12 s. Behavioral analysis revealed that participants relied on phonological memory while holding verbal information regardless of the type of input modality. At the neural level, this maintenance stage broadly activated the left-hemisphere language network, including the inferior frontal gyrus, supplementary motor area, superior temporal gyrus and inferior parietal lobule, for both letter and fingerspelling conditions. Interestingly, while most participants reported that they relied on phonological memory during maintenance, direct comparisons between letters and fingers revealed strikingly different patterns of neural activation during the same period. Namely, the effortful maintenance of fingerspelling inputs relative to letter inputs activated the left superior parietal lobule and dorsal premotor area, i.e., brain regions known to play a role in visuomotor analysis of hand/arm movements. These findings suggest that the dorsal visuomotor neural system subserves verbal learning via sign language by relaying gestural inputs to the classical left-hemisphere language network.	[Kanazawa, Yuji; Nakamura, Kimihiro; Ishii, Toru; Aso, Toshihiko] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Kanazawa, Yuji; Yamazaki, Hiroshi; Omori, Koichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Nakamura, Kimihiro] Univ Tsukuba, Fac Human Sci, Tsukuba, Ibaraki, Japan	Kyoto University; Kyoto University; University of Tsukuba	Nakamura, K (corresponding author), Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan.; Nakamura, K (corresponding author), Univ Tsukuba, Fac Human Sci, Tsukuba, Ibaraki, Japan.	kimihiro@human.tsukuba.ac.jp	Omori, Koichi/AAU-9017-2021; Aso, Toshihiko/C-2798-2018; YAMAZAKI, HIROSHI/AAR-5628-2021	Omori, Koichi/0000-0003-3404-5461; Aso, Toshihiko/0000-0003-4814-089X; YAMAZAKI, HIROSHI/0000-0003-0301-6350	Japan Society of Logopedics and Phoniatrics; JSPS Kakenhi [16KT0005]; Grants-in-Aid for Scientific Research [16KT0005, 15H05871] Funding Source: KAKEN	Japan Society of Logopedics and Phoniatrics(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Japan Society of Logopedics and Phoniatrics (to YK) and JSPS Kakenhi (16KT0005 to KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Masataka Nakayama (Department of Education, Kyoto University) for his assistance in devising the behavioral tasks. This work was supported by research grants from the Japan Society of Logopedics and Phoniatrics (to YK) and JSPS Kakenhi (16KT0005 to KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2000, JAPANESE NTT DATABAS; Amiez C, 2012, NEUROIMAGE, V59, P3723, DOI 10.1016/j.neuroimage.2011.10.058; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Bavelier D, 2008, CEREB CORTEX, V18, P2263, DOI 10.1093/cercor/bhm248; BELLUGI U, 1972, COGNITION, V1, P173, DOI 10.1016/0010-0277(72)90018-2; Blasi V, 2002, NEURON, V36, P159, DOI 10.1016/S0896-6273(02)00936-4; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buchsbaum B, 2005, BRAIN LANG, V95, P265, DOI 10.1016/j.bandl.2005.01.009; Cai Q, 2010, CEREB CORTEX, V20, P1153, DOI 10.1093/cercor/bhp175; Christophel TB, 2015, NEUROIMAGE, V106, P198, DOI 10.1016/j.neuroimage.2014.11.018; Corina DP, 2006, CORTEX, V42, P529, DOI 10.1016/S0010-9452(08)70393-9; Cornelissen PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005359; Crottaz-Herbette S, 2004, NEUROIMAGE, V21, P340, DOI 10.1016/j.neuroimage.2003.09.019; Ellis AW, 2009, PHILOS T R SOC B, V364, P3675, DOI 10.1098/rstb.2009.0187; Emmorey K, 2005, NEUROIMAGE, V24, P832, DOI 10.1016/j.neuroimage.2004.10.008; Emmorey K, 2007, NEUROIMAGE, V36, P202, DOI 10.1016/j.neuroimage.2007.02.040; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; HANSON VL, 1984, J EXP CHILD PSYCHOL, V37, P378, DOI 10.1016/0022-0965(84)90010-9; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hoshi E, 2007, CURR OPIN NEUROBIOL, V17, P234, DOI 10.1016/j.conb.2007.02.003; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Klein M, 2015, CEREB CORTEX, V25, P1715, DOI 10.1093/cercor/bht350; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Levanen S, 2001, CEREB CORTEX, V11, P506, DOI 10.1093/cercor/11.6.506; MacSweeney M, 2002, J COGNITIVE NEUROSCI, V14, P1064, DOI 10.1162/089892902320474517; Montgomery KJ, 2007, SOC COGN AFFECT NEUR, V2, P114, DOI 10.1093/scan/nsm004; Nakayama M, 2015, J EXP PSYCHOL LEARN, V41, P1570, DOI 10.1037/a0038825; Newman AJ, 2015, P NATL ACAD SCI USA, V112, P11684, DOI 10.1073/pnas.1510527112; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Raboyeau G, 2010, NEUROIMAGE, V49, P2850, DOI 10.1016/j.neuroimage.2009.10.007; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Ronnberg J, 2004, COGNITIVE BRAIN RES, V20, P165, DOI 10.1016/j.cogbrainres.2004.03.002; Ruchkin DS, 1997, COGNITIVE BRAIN RES, V6, P95, DOI 10.1016/S0926-6410(97)00021-9; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Schumacher EH, 1996, NEUROIMAGE, V3, P79, DOI 10.1006/nimg.1996.0009; Sehyr ZS, 2016, J DEAF STUD DEAF ED; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Tamaoka K, 2004, BEHAV RES METH INS C, V36, P531, DOI 10.3758/BF03195600; Tanaka S, 2001, NEUROREPORT, V12, P1171, DOI 10.1097/00001756-200105080-00024; Tanida Y, 2014, MOD RHEUMATOL, P1; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wheat KL, 2010, J NEUROSCI, V30, P5229, DOI 10.1523/JNEUROSCI.4448-09.2010; Wilson M, 1997, MEM COGNITION, V25, P313, DOI 10.3758/BF03211287; Xu JQ, 2013, NEUROIMAGE, V83, P991, DOI 10.1016/j.neuroimage.2013.07.055	49	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0177599	10.1371/journal.pone.0177599	http://dx.doi.org/10.1371/journal.pone.0177599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931014	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700002
J	Saigi, M; Oliva, M; Aliste, L; Calvo, M; Hormigo, G; Serra, O; Boladeras, A; Farran, L; Robles, J; Creus, G; Paules, MJ; Gornals, JB; de Lama, E; Borras, JM; Sala, N; Galan, M				Saigi, Maria; Oliva, Marc; Aliste, Luisa; Calvo, Mariona; Hormigo, Gloria; Serra, Olbia; Boladeras, Anna; Farran, Leandre; Robles, Javier; Creus, Gloria; Jose Paules, Ma; Gornals, Joan B.; de lama, Eugenia; Ma Borras, Josep; Sala, Nuria; Galan, Maica			Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre	PLOS ONE			English	Article							NEOADJUVANT RADIOCHEMOTHERAPY; ESOPHAGOGASTRIC JUNCTION; CANCER; ADENOCARCINOMA; SURVIVAL; SURGERY; CHEMOTHERAPY; MORTALITY; PATTERNS	Background Locally advanced esophageal carcinoma (LAEC) represents less than 30% of all diagnosed esophageal carcinoma worldwide. The standard of care for resectable tumours consists of preoperative chemoradiotherapy (CRT) followed by surgery. Despite the curative intent, the prognosis is still poor mainly due to relapse. A multidisciplinary approach is required in order to optimize the therapeutic strategy and follow-up. Differences in outcomes between the two main histological subtypes, adenocarcinoma (ADC) and squamous cell carcinoma (SCC), have been reported. Nevertheless, the heterogeneity in trials design and data available have hampered the achievement of clear conclusions. The purpose of this study is to report the outcomes from a cohort of patients with LAEC treated with a multidisciplinary approach and to remark the differences observed between the two main histologic subtypes and their clinical implications. Methods We retrospectively reviewed 100 patients diagnosed with LAEC that were treated with pre-operative CRT at our institution and integrated centres. Histopathological characteristics and toxicities during treatment were recorded. Patterns of recurrence at the first relapse were analysed. Survival curves were plotted using the Kaplan Meier method and multivariate Cox proportional hazards models were used. Results Among the patients who received preoperative CRT, 83% underwent surgery. The median overall survival (mOS) was 31.7 months, 26.9 months for ADC and 45.5 for SCC (p-value = 0.33). In the multivariate Cox regression analysis, ypN+ was the only factor that negatively influenced in OS (OR = 4.1, p-value = 0.022). Patterns of recurrence differed according to histologic subtype. Distant relapse was more frequent in ADC (62%), whereas locoregional relapse was higher in SCC (50%) (p-value = 0.027). Second line therapeutic strategies could be offered to 50% of those patients who relapsed. Conclusions Differences in outcomes and recurrence pattern could be observed between the two main histologic subtypes of LAEC. A better molecular characterization, adapted therapeutic regimens and follow up strategies should be adopted in order to improve survival of these patients.	[Saigi, Maria; Oliva, Marc; Calvo, Mariona; Hormigo, Gloria; Serra, Olbia; Galan, Maica] Hosp Llobregat, IDIBELL, Inst Catala Oncol, Dept Med Oncol, Barcelona, Spain; [Saigi, Maria; Oliva, Marc; Calvo, Mariona; Hormigo, Gloria; Serra, Olbia; Boladeras, Anna; Farran, Leandre; Robles, Javier; Creus, Gloria; Jose Paules, Ma; Gornals, Joan B.; de lama, Eugenia; Galan, Maica] Hosp Univ Bellvitge, Hosp Llobregat, IDIBELL, Gastroesophageal Tumours Funct Unit UTEG,Inst Cat, Barcelona, Spain; [Aliste, Luisa] Hosp Llobregat, Dept Hlth, Evaluat Unit, Canc Plan, Barcelona, Spain; [Boladeras, Anna] Hosp Llobregat, IDIBELL, Inst Catala Oncol, Dept Radiat Oncol, Barcelona, Spain; [Farran, Leandre] Hosp Univ Bellvitge, Hosp Llobregat, IDIBELL, Digest Surg Dept, Barcelona, Spain; [Robles, Javier] Hosp Univ Bellvitge, Hosp Llobregat, IDIBELL, Nucl Med Dept,Inst Diagnost Imatge, Barcelona, Spain; [Creus, Gloria] Hosp Univ Bellvitge, Hosp Llobregat, IDIBELL, Clin Nutr Unit, Barcelona, Spain; [Jose Paules, Ma] Hosp Univ Bellvitge, Hosp Llobregat, IDIBELL, Pathol Dept, Barcelona, Spain; [Gornals, Joan B.] Hosp Univ Bellvitge, Hosp Llobregat, IDIBELL, Gastroenterol Dept, Barcelona, Spain; [de lama, Eugenia] Hosp Univ Bellvitge, Hosp Llobregat, IDIBELL, Radiol Dept, Barcelona, Spain; [Ma Borras, Josep] Univ Barcelona, Hosp Llobregat, IDIBELL, Dept Clin Sci, Barcelona, Spain; [Sala, Nuria] IDIBELL, ICO, Canc Epidemiol Res Program, Unit Nutr & Canc, Barcelona, Spain; [Sala, Nuria] IDIBELL, ICO, Translat Res Lab, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Saigi, M (corresponding author), Hosp Llobregat, IDIBELL, Inst Catala Oncol, Dept Med Oncol, Barcelona, Spain.; Saigi, M (corresponding author), Hosp Univ Bellvitge, Hosp Llobregat, IDIBELL, Gastroesophageal Tumours Funct Unit UTEG,Inst Cat, Barcelona, Spain.	msaigi@iconcologia.net	Galan, Maica/AHC-9182-2022; Sala, Nuria/G-8471-2015	Sala, Nuria/0000-0003-3585-7613; Oliva Bernal, Marc/0000-0001-5352-8130; PAULES, MARIA JOSE/0000-0002-0842-3994; Borras, Josep M/0000-0001-7330-6308; Saigi, Maria/0000-0001-5815-5388	Fondo de investigaciones Sanitarias del Institute de Salud Carlos III, Spanish Ministry of Health; European Regional Development Funds (ERDF/FEDER) [ISCIII PI16/00599]	Fondo de investigaciones Sanitarias del Institute de Salud Carlos III, Spanish Ministry of Health; European Regional Development Funds (ERDF/FEDER)	This work was supported by Fondo de investigaciones Sanitarias del Institute de Salud Carlos III, Spanish Ministry of Health. Cofounded by European Regional Development Funds (ERDF/FEDER) 'a way to build Europe'. http://www.isciii.es/, ISCIII PI16/00599.	Bang YJ, 2010, LANCET, V376, P1302; Bollschweiler E, 2009, ANN ONCOL, V20, P231, DOI 10.1093/annonc/mdn622; Burtness Barbara, 2014, Am Soc Clin Oncol Educ Book, pe172, DOI 10.14694/EdBook_AM.2014.34.e172; Castro C, 2014, ANN ONCOL, V25, P283, DOI 10.1093/annonc/mdt486; Cheung P, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160251; Davies AR, 2014, J CLIN ONCOL, P1; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Teixidor LF, 2013, CIR ESPAN, V91, P517, DOI 10.1016/j.ciresp.2012.12.005; Galan M, 2015, CLIN TRANSL ONCOL, V17, P247, DOI 10.1007/s12094-014-1221-7; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Hermann RM, 2006, DIS ESOPHAGUS, V19, P329, DOI 10.1111/j.1442-2050.2006.00589.x; Kawaguchi Y, 2007, BRIT J CANCER, V97, P494, DOI 10.1038/sj.bjc.6603885; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Kubo A, 2010, NUTR RES REV, V23, P230, DOI 10.1017/S0954422410000132; Oppedijk V, 2014, J CLIN ONCOL, V32, P385, DOI 10.1200/JCO.2013.51.2186; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Secrier M, 2016, NAT GENET, V48, P1131, DOI 10.1038/ng.3659; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Siewert JR, 2005, J SURG ONCOL, V90, P139, DOI 10.1002/jso.20218; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stahl M, 2005, J CLIN ONCOL, V23, P2310, DOI 10.1200/JCO.2005.00.034; Stahl M, 2013, ANN ONCOL, V24, P51, DOI 10.1093/annonc/mdt342; Stahl M, 2009, J CLIN ONCOL, V27, P851, DOI 10.1200/JCO.2008.17.0506; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Thallinger CMR, 2011, J CLIN ONCOL, V29, P4709, DOI 10.1200/JCO.2011.36.7599; Thies S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00262; Uemura Norihisa, 2014, World J Gastrointest Pathophysiol, V5, P322, DOI 10.4291/wjgp.v5.i3.322; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088	31	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184737	10.1371/journal.pone.0184737	http://dx.doi.org/10.1371/journal.pone.0184737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931046	gold, Green Published, Green Submitted			2022-12-27	WOS:000411314700032
J	Zhang, ML; Zeng, XQ; Sanderson, SC; Byalt, VV; Sukhorukov, AP				Zhang, Ming-Li; Zeng, Xiao-Qing; Sanderson, Stewart C.; Byalt, Vyacheslav V.; Sukhorukov, Alexander P.			Insight into Central Asian flora from the Cenozoic Tianshan montane origin and radiation of Lagochilus (Lamiaceae)	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; TRIBE MENTHEAE LAMIACEAE; DIVERSIFICATION RATES; CHLOROPLAST DNA; HISTORICAL BIOGEOGRAPHY; LAMIOIDEAE LAMIACEAE; SUBFAMILY LAMIOIDEAE; PHYLOGENETIC TREES; NONCODING REGIONS; GEOGRAPHIC RANGE	The Tianshan Mountains play a significant role in the Central Asian flora and vegetation. Lagochilus has a distribution concentration in Tianshan Mountains and Central Asia. To investigate generic spatiotemporal evolution, we sampled most Lagochilus species and sequenced six cpDNA locations (rps16, psbA-trnH, matK, trnL-trnF, psbB-psbH, psbK-psbI). We employed BEAST Bayesian inference for dating, and S-DIVA, DEC, and BBM for ancestral area/biome reconstruction. Our results clearly show that the Tianshan Mountains, especially the western Ili-Kirghizia Tianshan, as well as Sunggar and Kaschgar, was the ancestral area. Ancestral biome was mainly in the montane steppe zone of valley and slope at altitudes of 1700-2700 m, and the montane desert zone of foothill and front-hill at 1000-1700 m. Here two sections Inermes and Lagochilus of the genus displayed "uphill" and "downhill" speciation process during middle and later Miocene. The origin and diversification of the genus were explained as coupled with the rapid uplift of the Tianshan Mountains starting in late Oligocene and early Miocene ca. 23.66 similar to 19.33 Ma, as well as with uplift of the Qinghai-Tibetan Plateau (QTP) and Central Asian aridification.	[Zhang, Ming-Li] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Zeng, Xiao-Qing] Cent China Normal Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Sanderson, Stewart C.] USDA, Forest Serv, Rocky Mt Res Stn, Shrub Sci Lab, Provo, UT USA; [Byalt, Vyacheslav V.] Russian Acad Sci, Komarov Bot Inst, St Petersburg, Russia; [Sukhorukov, Alexander P.] Moscow Lomonosov State Univ, Biol Fac, Moscow, Russia	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Central China Normal University; United States Department of Agriculture (USDA); United States Forest Service; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences; Lomonosov Moscow State University	Zhang, ML (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China.; Zhang, ML (corresponding author), Chinese Acad Sci, Inst Bot, Beijing, Peoples R China.	zhangml@ibcas.ac.cn	Sukhorukov, Alexander/D-2084-2013	Sukhorukov, Alexander/0000-0003-2220-826X	Chinese Academy of Sciences [ZSSD-012]; China National Key Basic Research Program [2014CB954201]; Russian Science Foundation [14-50-00029]	Chinese Academy of Sciences(Chinese Academy of Sciences); China National Key Basic Research Program(National Basic Research Program of China); Russian Science Foundation(Russian Science Foundation (RSF))	This study was funded by Biodiversity Conservation Strategy Program of Chinese Academy of Sciences (ZSSD-012), and China National Key Basic Research Program (2014CB954201). The revision of Lagochilus material in the Moscow herbaria by Alexander P. Sukhorukov was supported by the Russian Science Foundation (grant number 14-50-00029). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Hong-Hu Meng, Kai-Qing Xie and Xiao-Long Jiang for help of DNA experiment, Xiao-Guo Xiang and Jia-Li Yang for help of data processing. This study was funded by Biodiversity Conservation Strategy Program of Chinese Academy of Sciences (ZSSD-012), and China National Key Basic Research Program (2014CB954201).	ASTANOVA S B, 1984, Botanicheskii Zhurnal (St. Petersburg), V69, P1563; Bendiksby M, 2011, TAXON, V60, P471, DOI 10.1002/tax.602015; Bobrov E.G., 1965, BOT ZH, V50, P1053; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Chen H.-L, 2003, J NANJING U NATURAL, V39, P1, DOI DOI 10.3321/3.ISSN:0469-5097.2003.01.001; Doyle J. J., 1987, PHYTOCHEM B, P11; Drew BT, 2013, BOT J LINN SOC, V171, P171, DOI 10.1111/j.1095-8339.2012.01325.x; Drew BT, 2012, AM J BOT, V99, P933, DOI 10.3732/ajb.1100549; Drew BT, 2011, SYST BOT, V36, P1038, DOI 10.1600/036364411X605047; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ELIAS TS, 1983, SCIENCE, V219, P19, DOI 10.1126/science.219.4580.19; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Grubov VI, 1964, PLANTS CENTRAL ASIA, VI; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Guo Zhaojie, 2006, Dizhi Xuebao, V80, P1; Harley RM, 2004, FA GE VAS P, V7, P167; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ikramov MI, 1976, ROD LAGOCHILUS SREDN; Iljin M. M., 1937, SOVETSK BOT, V6, P95; Jamzad Z, 1989, IRANIAN J BOT, V4, P91; [焦莹 Jiao Ying], 2014, [中国新药与临床杂志, Chinese Journal of New Drugs and Clinical Remedies], V33, P204; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Kamelin RV, 1973, FLOROGENITICAL ANAL; Kar R., 1996, PALEOBOTANIST, V43, P43; Kim YI, 2011, J PLANT BIOL, V54, P396, DOI 10.1007/s12374-011-9175-6; Knorring OE, 1954, FLORA URSS, P160; Knorring OE, 1966, NOVITATES SYSTEMATIC, P197; Komarov VL, 1945, VL KOMAROV OPERA SEL, P159; Latypov A, 2011, ADM ADDICTION POLITI; Li HW, 1994, FLORA CHINA, V17, P50; Li J.J., 1998, CHINESE SCI BULL, V43, P1569, DOI DOI 10.1360/CSB1998-43-15-1569; Liu GJ, 1985, B BOT RES, V5, P127; [柳永清 Liu Yongqing], 2004, [地质学报, Acta Geologica Sinica], V78, P319; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Nylinder S, 2012, TAXON, V61, P381, DOI 10.1002/tax.612009; Ooi Kazuyuki, 1995, Journal of Japanese Botany, V70, P328; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Popov MG, 1938, PROBLEMS RELICTS FLO, VI; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qin AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056243; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2014, METHODS ECOL EVOL, V5, P701, DOI 10.1111/2041-210X.12199; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reid E, 1926, CATALOGUE CAINOZOIC; Roy T, 2015, AM J BOT, V102, P1721, DOI 10.3732/ajb.1500233; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Scheen AC, 2010, ANN MO BOT GARD, V97, P191, DOI 10.3417/2007174; Secotes C, 2015, MAP FOLIOS ATLAS NEO; Shi Y., 1999, ACTA GEOGR SIN CHIN, V54, P20; Shi YF, 1998, SCI CHINA SER D, V28, P263; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tank DC, 2015, NEW PHYTOL, V207, P454, DOI 10.1111/nph.13491; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vassilchenko IT, 1982, BOT ZH, V67, P722; Wikstrom N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126690; Willis K. J., 2002, EVOLUTION PLANTS; Wu SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138697; Wu ZY, 1977, FLORA REIPUBLICAE PO, P525; Wulff E, 1944, HIST PLANT GEOGRAPHY; Xu DH, 2000, THEOR APPL GENET, V101, P724, DOI 10.1007/s001220051537; Yu XQ, 2014, MOL PHYLOGENET EVOL, V77, P183, DOI 10.1016/j.ympev.2014.04.017; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zachos F.E., 2011, BIODIVERSITY HOTSPOT; Zhang MY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168935; Zhang ML, 2014, J INTEGR PLANT BIOL, V56, P1125, DOI 10.1111/jipb.12226; Zhang ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097582; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; Zhang ML, 2014, PHYTOTAXA, V167, P89, DOI 10.11646/phytotaxa.167.1.5; Zuckerwanik TI, 1985, BOT ZH, V70, P1183	79	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0178389	10.1371/journal.pone.0178389	http://dx.doi.org/10.1371/journal.pone.0178389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931016	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700003
J	Torres-da-Silvali, KR; Tessarin, GWL; Dias, CA; Guiati, IZ; Ervolino, E; Goncalves, A; Beneti, IM; Lovejoy, DA; Casatti, CA				Torres-da-Silvali, K. R.; Tessarin, G. W. L.; Dias, C. A.; Guiati, I. Z.; Ervolino, E.; Goncalves, A.; Beneti, I. M.; Lovejoy, D. A.; Casatti, C. A.			Teneurin-2 presence in rat and human odontoblasts	PLOS ONE			English	Article							TERMINAL-ASSOCIATED PEPTIDES; PAIR-RULE GENE; INTRACELLULAR DOMAIN; IN-SITU; EXPRESSION; DYSTROGLYCAN; PROTEINS; FAMILY; DIFFERENTIATION; ORGANIZATION	Teneurins are transmembrane proteins consisting of four paralogues (Ten-1-4), notably expressed in the central nervous system during development. All teneurins contain a bioactive peptide in their carboxyl terminal named teneurin C-terminal associated peptide (TCAP). The present study analyzed the detailed distribution of teneurin-2-like immunoreactive (Ten-2-LI) cells in developing and mature rat molar teeth, as well as in mature human dental pulps. Ten-2 and TCAP-2 genic expressions were also evaluated in rat and human dental pulps. Finally, Ten-2-LI cells were analyzed during the repair process after dentinpulp complex injury in rat lower molar teeth. For this, histological sections of rat molar teeth and human dental pulps were submitted to immunohistochemical techniques, while total RNA from developing rat teeth and mature human dental pulps were submitted to conventional RT-PCR. Ten-2-LI cells were evident in the initial bell stage of rat molar teeth development, especially in ectomesenchymal cells of the dental papilla. Ten-2-LI odontoblasts showed strong immunoreactivity in rat and human mature teeth. Ten-2 and TCAP-2 genic expressions were confirmed in rat and human dental pulps. Dentin-pulp complex injury resulted in a decrease of Ten-2-LI odontoblasts after traumatic injury. Interestingly, Ten-2-LI cells were also evident in the pulp cell-rich zone in all postoperative days. In conclusion, Ten-2-LI presence in rat and human odontoblasts was demonstrated for the first time and Ten-2/TCAP-2 genic expressions were confirmed in rat and human dental pulps. Furthermore, it was revealed that Ten-2-LI rat odontoblasts can be modulated during the regenerative process.	[Torres-da-Silvali, K. R.; Tessarin, G. W. L.; Guiati, I. Z.; Casatti, C. A.] Sao Paulo State Univ, Inst Biosci Botucatu, Botucatu, SP, Brazil; [Dias, C. A.; Guiati, I. Z.; Ervolino, E.; Goncalves, A.; Casatti, C. A.] Sao Paulo State Univ, Sch Dent Aracatuba, Basic Sci Dept, Aracatuba, SP, Brazil; [Dias, C. A.] Sao Paulo State Univ, Sch Dent Aracatuba, Restorat Dent Dept, Aracatuba, SP, Brazil; [Beneti, I. M.] Sao Paulo State Univ, Sch Dent Aracatuba, Dept Surg & Integrated Clin, Aracatuba, SP, Brazil; [Lovejoy, D. A.] Univ Toronto, Cell & Syst Biol Dept, Toronto, ON, Canada	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; University of Toronto	Casatti, CA (corresponding author), Sao Paulo State Univ, Inst Biosci Botucatu, Botucatu, SP, Brazil.; Casatti, CA (corresponding author), Sao Paulo State Univ, Sch Dent Aracatuba, Basic Sci Dept, Aracatuba, SP, Brazil.	ccasatti@foa.uneap.br	Casatti, Cláudio/AAD-1451-2019; casatti, claudio A/C-3633-2012; Ervolino, Edilson/D-1500-2018	Casatti, Cláudio/0000-0001-5650-7343; ervolino, edilson/0000-0003-4859-0583	FAPESP (Sao Paulo State Research Foundation, SP, Brazil) [2012/03067-6]; FAPESP (KRTS) [FAPESP 2012/08833-9]; FAPESP (CAD) [FAPESP 2013/0635-06]; FAPESP (IZG) [FAPESP 2013/01288-8]	FAPESP (Sao Paulo State Research Foundation, SP, Brazil); FAPESP (KRTS); FAPESP (CAD); FAPESP (IZG)	This work was supported by FAPESP (Sao Paulo State Research Foundation, SP, Brazil) for: a) research (2012/03067-6); b) fellowship (KRTS, FAPESP 2012/08833-9; c) fellowship (CAD, FAPESP 2013/0635-06); d) fellowship (IZG, FAPESP 2013/01288-8).	Al Chawaf A, 2007, NEUROSCIENCE, V144, P1241, DOI 10.1016/j.neuroscience.2006.09.062; Al Chawaf A, 2007, PEPTIDES, V28, P1406, DOI 10.1016/j.peptides.2007.05.014; Arana-Chavez VE, 2004, INT J BIOCHEM CELL B, V36, P1367, DOI 10.1016/j.biocel.2004.01.006; Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Boucard AA, 2014, J BIOL CHEM, V289, P387, DOI 10.1074/jbc.M113.504779; Chand D, 2012, NEUROSCIENCE, V219, P255, DOI 10.1016/j.neuroscience.2012.05.069; Chand D, 2014, HISTOCHEM CELL BIOL, V141, P191, DOI 10.1007/s00418-013-1154-1; Han PP, 2015, J BONE MINER RES, V30, P1160, DOI 10.1002/jbmr.2445; Harada M, 2008, HISTOCHEM CELL BIOL, V130, P773, DOI 10.1007/s00418-008-0438-3; Ida-Yonemochi H, 2013, GENE EXPR PATTERNS, V13, P293, DOI 10.1016/j.gep.2013.05.004; Ishii K, 2015, STEM CELLS, V33, P3017, DOI 10.1002/stem.2058; Koussoulakou DS, 2009, INT J BIOL SCI, V5, P226; LEVY GG, 1980, J PERIODONTOL, V51, P393, DOI 10.1902/jop.1980.51.7.393; Li ST, 2015, J CELL PHYSIOL, V230, P2164, DOI 10.1002/jcp.24945; Lossie AC, 2005, GENETICS, V169, P285, DOI 10.1534/genetics.104.034967; Lovejoy DA, 2009, ANN NY ACAD SCI, V1163, P215, DOI 10.1111/j.1749-6632.2008.03629.x; Luan XH, 2007, J HISTOCHEM CYTOCHEM, V55, P127, DOI 10.1369/jhc.6A7018.2006; Lucchini M, 2004, J DENT RES, V83, P552, DOI 10.1177/154405910408300708; Mieda M, 1999, MECH DEVELOP, V87, P223, DOI 10.1016/S0925-4773(99)00155-0; Moon CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053900; Mosca TJ, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00204, 10.3389/fncel.2015.00204]; Murakami T, 2010, J ANAT, V217, P236, DOI 10.1111/j.1469-7580.2010.01267.x; Neves VC, 2017, SCI REP; Ng T, 2012, REGUL PEPTIDES, V174, P79, DOI 10.1016/j.regpep.2011.12.003; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Otaki JM, 1999, DEV BIOL, V212, P165, DOI 10.1006/dbio.1999.9310; Qian XJ, 2004, GEN COMP ENDOCR, V137, P205, DOI 10.1016/j.ygcen.2004.02.007; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Rubin BP, 2002, DEVELOPMENT, V129, P4697; Sharpe P T, 2001, Adv Dent Res, V15, P4; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Staquet MJ, 2006, CELL TISSUE RES, V323, P457, DOI 10.1007/s00441-005-0104-1; Tada H, 2010, BIOCHEM BIOPH RES CO, V394, P1093, DOI 10.1016/j.bbrc.2010.03.135; Trubiani G, 2007, BRAIN RES, V1176, P27, DOI 10.1016/j.brainres.2007.07.087; Trzebiatowska A, 2008, MOL BIOL CELL, V19, P3898, DOI 10.1091/mbc.E08-01-0028; Tucker RP, 2012, MOL BIOL EVOL, V29, P1019, DOI 10.1093/molbev/msr271; Tucker RP, 2000, MECH DEVELOP, V98, P187, DOI 10.1016/S0925-4773(00)00444-5; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B; Vysokov NV, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00059; Wang LQ, 2005, MOL BRAIN RES, V133, P253, DOI 10.1016/j.molbrainres.2004.10.019; Woelfle R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00146, 10.3389/fnins.2015.00146]; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5	45	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184794	10.1371/journal.pone.0184794	http://dx.doi.org/10.1371/journal.pone.0184794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926618	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600042
J	Laub, KR; Marek, M; Stanchev, LD; Herrera, SA; Kanashova, T; Bourmaud, A; Dittmar, G; Pomorski, TG				laub, Katrine Rude; Marek, Magdalena; Stanchev, Lyubomir Dimitrov; Herrera, Sara Abad; Kanashova, Tamara; Bourmaud, Adele; Dittmar, Gunnar; Pomorski, Thomas Guenther			Purification and characterisation of the yeast plasma membrane ATP binding cassette transporter Pdr11p	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; STEROL UPTAKE; NUCLEOTIDE-BINDING; ABC TRANSPORTERS; P-GLYCOPROTEIN; HYDROLYSIS; CHOLESTEROL; PROTEINS; LIPIDS; CELLS	The ATP binding cassette (ABC) transporters Pdr11p and its paralog Aus1p are expressed under anaerobic growth conditions at the plasma membrane of the yeast Saccharomyces cerevisiae and are required for sterol uptake. However, the precise mechanism by which these ABC transporters facilitate sterol movement is unknown. In this study, an overexpression and purification procedure was developed with the aim to characterise the Pdr11p transporter. Engineering of Pdr11p variants fused at the C terminus with green fluorescent protein (Pdr11p-GFP) and containing a FLAG tag at the N terminus facilitated expression analysis and one-step purification, respectively. The detergent-solubilised and purified protein displayed a stable ATPase activity with a broad pH optimum near 7.4. Mutagenesis of the conserved lysine to methionine (K788M) in the Walker A motif abolished ATP hydrolysis. Remarkably, and in contrast to Aus1p, ATPase activity of Pdr11p was insensitive to orthovanadate and not specifically stimulated by phosphatidylserine upon reconstitution into lipo-somes. Our results highlight distinct differences between Pdr11p and Aus1p and create an experimental basis for further biochemical studies of both ABC transporters to elucidate their function.	[laub, Katrine Rude; Marek, Magdalena; Stanchev, Lyubomir Dimitrov; Herrera, Sara Abad; Pomorski, Thomas Guenther] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Stanchev, Lyubomir Dimitrov; Herrera, Sara Abad; Pomorski, Thomas Guenther] Ruhr Univ Bochum, Dept Mol Biochem, Bochum, Germany; [Kanashova, Tamara; Dittmar, Gunnar] Max Delbruck Ctr Mol Med, Mass Spectrometry Core Unit, Berlin, Germany; [Bourmaud, Adele; Dittmar, Gunnar] Luxembourg Inst Hlth, Proteome & Genome Res Lab, Strassen, Luxembourg; [Marek, Magdalena] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland	University of Copenhagen; Ruhr University Bochum; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Luxembourg Institute of Health; University of Lausanne	Pomorski, TG (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark.; Pomorski, TG (corresponding author), Ruhr Univ Bochum, Dept Mol Biochem, Bochum, Germany.	tgp@plen.ku.dk	Dittmar, Gunnar/C-6333-2019; Pomorski, Thomas Günther/G-4804-2014	Dittmar, Gunnar/0000-0003-3647-8623; Pomorski, Thomas Günther/0000-0002-4889-0829; Stanchev, Lyubomir Dimitrov/0000-0002-0338-8210; Bourmaud, Adele/0000-0002-0557-3639	Research Centre 'bioSYNergy' at University of Copenhagen - UCPH; Villium Fonden [022868]; FNR [FNR/P09/01]; Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	Research Centre 'bioSYNergy' at University of Copenhagen - UCPH; Villium Fonden; FNR(Luxembourg National Research Fund); Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	This work was supported by the Research Centre 'bioSYNergy' at University of Copenhagen funded by the UCPH Excellence Program for Interdisciplinary Research and the Villium Fonden (grant 022868 to TGP). AB was supported by FNR grant FNR/P09/01. TK was funded by the Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen L, 2011, APPL ENVIRON MICROB, V77, P1033, DOI 10.1128/AEM.01361-10; Alimardani P, 2004, BIOCHEM J, V381, P195, DOI 10.1042/BJ20040297; Aye ILMH, 2009, CHEM-BIOL INTERACT, V180, P327, DOI 10.1016/j.cbi.2009.04.012; Benabdelhak H, 2005, BIOCHEM J, V386, P489, DOI 10.1042/BJ20041282; Cai J, 2002, BIOCHEMISTRY-US, V41, P8058, DOI 10.1021/bi012082p; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Hirayama H, 2013, J LIPID RES, V54, P496, DOI 10.1194/jlr.M033209; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Jensen NB, 2014, FEMS YEAST RES, V14, P238, DOI 10.1111/1567-1364.12118; Ketchum CJ, 2001, J BIOL CHEM, V276, P29007, DOI 10.1074/jbc.M100810200; Kohut P, 2011, BIOCHEM BIOPH RES CO, V404, P233, DOI 10.1016/j.bbrc.2010.11.099; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Lamping E, 2010, FUNGAL GENET BIOL, V47, P127, DOI 10.1016/j.fgb.2009.10.007; Lanfermeijer FC, 1998, PROTEIN EXPRES PURIF, V12, P29, DOI 10.1006/prep.1997.0788; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Mao QC, 1999, BBA-BIOMEMBRANES, V1461, P69, DOI 10.1016/S0005-2736(99)00150-9; Marek M, 2014, FEMS YEAST RES, V14, P1223, DOI 10.1111/1567-1364.12219; Marek M, 2011, J BIOL CHEM, V286, P21835, DOI 10.1074/jbc.M111.244525; MEAD DJ, 1986, MOL GEN GENET, V205, P417, DOI 10.1007/BF00338076; Nagi M, 2013, MOL MICROBIOL, V88, P371, DOI 10.1111/mmi.12189; Nakayama H, 2007, J ANTIMICROB CHEMOTH, V60, P1264, DOI 10.1093/jac/dkm321; Neumann J, 2017, BBA-BIOMEMBRANES, V1859, P605, DOI 10.1016/j.bbamem.2016.09.023; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reiner S, 2006, MOL BIOL CELL, V17, P90, DOI 10.1091/mbc.e05-06-0515; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184236	10.1371/journal.pone.0184236	http://dx.doi.org/10.1371/journal.pone.0184236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922409	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300013
J	Murray, JW; Yin, D; Wolkoff, AW				Murray, John W.; Yin, David; Wolkoff, Allan W.			Reduction of organelle motility by removal of potassium and other solutes	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; MICROTUBULES IN-VITRO; COATED PIT FORMATION; CYTOPLASMIC DYNEIN; INTRACELLULAR POTASSIUM; MITOCHONDRIAL TRANSPORT; DEPENDENT MOVEMENT; VESICLE MOTILITY; KINESIN; CELLS	There are surprisingly few studies that describe how the composition of cell culture medium may affect the trafficking of organelles. Here we utilize time lapse multi-channel fluorescent imaging to show that short term exposure of Huh-7 cells to medium lacking potassium, sodium, or chloride strongly reduces but does not eliminate the characteristic back and forth and cell-traversing movement of fluorescent EGF (FL-EGF) containing organelles. We focused on potassium because of its relatively low abundance in media and serum and its energy requiring accumulation into cells. Upon exposure to potassium free medium, organelle motility declined steadily through 90 min and then persisted at a low level. Reduced motility was confirmed in 5 independent cell lines and for organelles of the endocytic pathway (FL-EGF and Lysotracker), autophagosomes (LC3-GFP), and mitochondria (TMRE). As has been previously established, potassium free medium also inhibited endocytosis. We expected that diminished cellular metabolism would precede loss of organelle motility. However, extracellular flux analysis showed near normal mitochondrial oxygen consumption and only a small decrease in extracellular acidification, the latter suggesting decreased glycolysis or proton efflux. Other energy dependent activities such as the accumulation of Lysotracker, TMRE, DiBAC4(3), and the exclusion of propidium iodide remained intact, as did the microtubule cytoskeleton. We took advantage of cell free in vitro motility assays and found that removal of potassium or sodium from the reconstituted cytosolic medium decreased the movement of endosomes on purified microtubules. The results indicate that although changes in proton homeostasis and cell energetics under solute depletion are not fully understood, potassium as well as sodium appear to be directly required by the motile machinery of organelles for optimal trafficking.	[Murray, John W.; Yin, David; Wolkoff, Allan W.] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Div Gastroenterol & Liver Dis, Bronx, NY 10467 USA; [Murray, John W.; Yin, David; Wolkoff, Allan W.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Murray, John W.; Wolkoff, Allan W.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Murray, JW (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Div Gastroenterol & Liver Dis, Bronx, NY 10467 USA.; Murray, JW (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.; Murray, JW (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	john.murray@einstein.yu.edu		Murray, John/0000-0002-4347-7824	National Institutes of Health Research [P30 DK041296, R01 DK098408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK023026] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Research Grants P30 DK041296 (Wolkoff), R01 DK098408 (Wolkoff, Allan W., Cuervo, Ana Maria), https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KH, 2006, J EXP BIOL, V209, P3101, DOI 10.1242/jeb.02357; ALTANKOV G, 1993, J CELL BIOL, V120, P1449, DOI 10.1083/jcb.120.6.1449; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Bananis E, 2000, J CELL BIOL, V151, P179, DOI 10.1083/jcb.151.1.179; Bananis E, 2003, J CELL SCI, V116, P2749, DOI 10.1242/jcs.00478; BRIMIJOIN S, 1979, J PHYSIOL-LONDON, V287, P303, DOI 10.1113/jphysiol.1979.sp012660; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; COHN SA, 1989, J BIOL CHEM, V264, P4290; DEBRABANDER M, 1988, CELL MOTIL CYTOSKEL, V9, P30, DOI 10.1002/cm.970090105; Dejonghe W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11710; EAGLE H, 1956, ARCH BIOCHEM BIOPHYS, V61, P356, DOI 10.1016/0003-9861(56)90358-7; ERECINSKA M, 1982, J MEMBRANE BIOL, V70, P1, DOI 10.1007/BF01871584; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035; Gerencser AA, 2008, BIOPHYS J, V95, P3079, DOI 10.1529/biophysj.108.135657; GIBBONS BH, 1985, J CELL BIOL, V101, P1281, DOI 10.1083/jcb.101.4.1281; GIBBONS IR, 1966, J BIOL CHEM, V241, P5590; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hong WL, 2016, BIOPHYS J, V111, P1287, DOI 10.1016/j.bpj.2016.08.006; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; LANG F, 1995, KIDNEY INT, V48, P1200, DOI 10.1038/ki.1995.403; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; LEDBETTER MLS, 1977, EXP CELL RES, V105, P223, DOI 10.1016/0014-4827(77)90120-3; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Macdonald JE, 2004, J AM COLL CARDIOL, V43, P155, DOI 10.1016/j.jacc.2003.06.021; MADSHUS IH, 1987, J CELL PHYSIOL, V131, P6, DOI 10.1002/jcp.1041310103; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; MCDONALD TF, 1972, EXP CELL RES, V74, P201, DOI 10.1016/0014-4827(72)90498-3; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Murray John W, 2007, Methods Mol Biol, V392, P143; Murray JW, 2008, TRAFFIC, V9, P833, DOI 10.1111/j.1600-0854.2008.00725.x; Murray JW, 2005, METHOD ENZYMOL, V403, P92, DOI 10.1016/S0076-6879(05)03009-0; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Murray JW, 2000, MOL BIOL CELL, V11, P419, DOI 10.1091/mbc.11.2.419; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; Nunes P, 2015, P NATL ACAD SCI USA, V112, pE3104, DOI 10.1073/pnas.1421290112; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Rapp S, 1996, J CELL SCI, V109, P837; Readnower RD, 2012, PHYSIOL GENOMICS, V44, P1208, DOI 10.1152/physiolgenomics.00129.2012; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; SAMUELSON AC, 1988, AM J PHYSIOL, V254, pC829, DOI 10.1152/ajpcell.1988.254.6.C829; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; SHIMIZU T, 1991, J CELL BIOL, V112, P1189, DOI 10.1083/jcb.112.6.1189; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; SWANSON JA, 1992, J CELL SCI, V103, P201; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Toomre D, 1999, J CELL SCI, V112, P21; VALE RD, 1989, J CELL BIOL, V108, P2327, DOI 10.1083/jcb.108.6.2327; Wang PJ, 2008, AM J PHYSIOL-GASTR L, V294, pG1052, DOI 10.1152/ajpgi.00584.2007; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; WOLKOFF AW, 1984, J CELL BIOL, V98, P375, DOI 10.1083/jcb.98.2.375; Xu MF, 2001, AM J PHYSIOL-HEART C, V281, pH1295, DOI 10.1152/ajpheart.2001.281.3.H1295	60	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184898	10.1371/journal.pone.0184898	http://dx.doi.org/10.1371/journal.pone.0184898			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922372	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300040
J	Taglauer, ES; Artemiuk, PA; Hanscom, SR; Lindsay, AJ; Wuebbolt, D; Breathnach, FM; Tully, EC; Khan, AR; McCaffrey, MW				Taglauer, Elizabeth S.; Artemiuk, Patrycja A.; Hanscom, Sara R.; Lindsay, Andrew J.; Wuebbolt, Danielle; Breathnach, Fionnuala M.; Tully, Elizabeth C.; Khan, Amir R.; McCaffrey, Mary W.			Rab11 family expression in the human placenta: Localization at the maternal-fetal interface	PLOS ONE			English	Article							IN-VITRO MODELS; TROPHOBLAST CELLS; PROTEINS; TRANSPORT	Rab proteins are a family of small GTPases involved in a variety of cellular processes. The Rab11 subfamily in particular directs key steps of intracellular functions involving vesicle trafficking of the endosomal recycling pathway. This Rab subfamily works through a series of effector proteins including the Rab11-FIPs (Rab11 Family-Interacting Proteins). While the Rab11 subfamily has been well characterized at the cellular level, its function within human organ systems is still being explored. In an effort to further study these proteins, we conducted a preliminary investigation of a subgroup of endosomal Rab proteins in a range of human cell lines by Western blotting. The results from this analysis indicated that Rab11a, Rab11c(Rab25) and Rab14 were expressed in a wide range of cell lines, including the human placental trophoblastic BeWo cell line. These findings encouraged us to further analyse the localization of these Rabs and their common effector protein, the Rab Coupling Protein (RCP), by immunofluorescence microscopy and to extend this work to normal human placental tissue. The placenta is a highly active exchange interface, facilitating transfer between mother and fetus during pregnancy. As Rab11 proteins are closely involved in transcytosis we hypothesized that the placenta would be an interesting human tissue model system for Rab investigation. By immunofluorescence microscopy, Rab11a, Rab11c (Rab25), Rab14 as well as their common FIP effector RCP showed prominent expression in the placental cell lines. We also identified the expression of these proteins in human placental lysates by Western blot analysis. Further, via fluorescent immunohistochemistry, we noted abundant localization of these proteins within key functional areas of primary human placental tissues, namely the outer syncytial layer of placental villous tissue and the endothelia of fetal blood vessels. Overall these findings highlight the expression of the Rab11 family within the human placenta, with novel localization at the maternal-fetal interface.	[Taglauer, Elizabeth S.] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Taglauer, Elizabeth S.; Khan, Amir R.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Artemiuk, Patrycja A.; Hanscom, Sara R.; Lindsay, Andrew J.; McCaffrey, Mary W.] Univ Coll Cork, Biosci Inst, Sch Biochem & Cell Biol, Mol Cell Biol Lab, Cork, Ireland; [Wuebbolt, Danielle] Royal Coll Surgeons Ireland, Sch Med, Dublin, Ireland; [Breathnach, Fionnuala M.; Tully, Elizabeth C.] Royal Coll Surgeons Ireland, Dept Obstet & Gynaecol, Dublin, Ireland	Harvard University; Boston Children's Hospital; Trinity College Dublin; University College Cork; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Taglauer, ES (corresponding author), Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA.; Taglauer, ES (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	elizabeth.taglauer@childrens.harvard.edu	Lindsay, Andrew J/P-9778-2017	Lindsay, Andrew J/0000-0001-9693-7022; Khan, Amir/0000-0003-1176-6952	Irish Research Council, IRCSET [GOIPD/2014/42]; Science Foundation Ireland [12/IA/1239, 09/IN.1/B2629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633] Funding Source: NIH RePORTER	Irish Research Council, IRCSET; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by Irish Research Council, IRCSET Post-Doctoral fellowship (http://www.research.ie) GOIPD/2014/42 to EST; Science Foundation Ireland (sfi.ie) Principal Investigator Award (12/IA/1239) to ARK and a Science Foundation Ireland (sfi.ie) Principal Investigator Award (09/IN.1/B2629) to MWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Gavin McManus for confocal microscopy imaging analysis at Trinity College Dublin. This work was funded by the following grants/fellowships: Irish Research Council, IRCSET Post-Doctoral fellowship GOIPD/2014/42 to ES Taglauer, Science Foundation Ireland Principal Investigator Award (09/IN.1/B2629) to MW McCaffrey and a Science Foundation Ireland Principal Investigator Award (12/IA/1239) to AR Khan.	Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Bode CJ, 2006, METH MOLEC MED, V122, P225; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Gonzalez IM, 2014, PLACENTA, V35, P442, DOI 10.1016/j.placenta.2014.04.015; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Gupta AK, 2004, CLIN CHEM, V50, P2187, DOI 10.1373/clinchem.2004.040196; Haugsten EM, 2014, TRAFFIC, V15, P665, DOI 10.1111/tra.12168; Heaton SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1445, DOI 10.1152/ajpcell.00286.2008; Ishikawa T, 2015, INT J MOL MED, V35, P1273, DOI 10.3892/ijmm.2015.2141; Jung JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044572; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Kelly EE, 2012, BIOCHEM SOC T, V40, P1337, DOI 10.1042/BST20120203; Li LP, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0070-8; Lindsay AJ, 2016, RAB COUPLING PROTEIN; Nguyen T, 2013, PLACENTA, V34, P765, DOI 10.1016/j.placenta.2013.06.003; Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023; Orendi K, 2010, REPRODUCTION, V140, P759, DOI 10.1530/REP-10-0221; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Petroff MG, 2006, METH MOLEC MED, V121, P203; Qi ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003278; Vidricaire G, 2005, J IMMUNOL, V175, P6517, DOI 10.4049/jimmunol.175.10.6517; Yan ZB, 2016, ARTERIOSCL THROM VAS, V36, P339, DOI 10.1161/ATVBAHA.115.306549	22	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184864	10.1371/journal.pone.0184864	http://dx.doi.org/10.1371/journal.pone.0184864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922401	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300037
J	Baer, J; Hartmann, F; Brinker, A				Baer, Jan; Hartmann, Frank; Brinker, Alexander			Invasion strategy and abiotic activity triggers for non-native gobiids of the River Rhine	PLOS ONE			English	Article							GOBY NEOGOBIUS MELANOSTOMUS; ROUND GOBY; GREAT-LAKES; FISH; DIFFERENTIATION; COMMUNITY; BELGIUM; DANUBE; GROWTH; GOBIES	The 24 hour activity patterns of three non-native gobiids (round goby Neogobius melanostomus, Western tubenose goby Proterorhinus semilunaris and bighead goby Ponticola kessleri) were assessed over 46 consecutive months between 2011 and 2014 from their occurrence in the cooling water intake of a nuclear power plant on the River Rhine, Germany. In total, 117717 gobiids were identified and classified. The occurrence of all three species varied strongly between sampling years, and species-specific activity triggers were identified. The activity of juveniles of all three gobiids species was positively temperature dependent while adult tubenose goby activity appeared to be negatively temperature dependent. Increasing fluvial discharge in the adjoining main river stimulated the activity of juvenile round goby but inhibited activity of adult tubenose goby. Except for adult bighead goby, activity was also structured by time of day, but with no uniform mean. Meteorological factors such as precipitation, air pressure and duration of sunshine hours had little or no influence on gobiid activity. On selected rare occasions, mainly at night, all three species exhibited pulsed swarming behaviour, with thousands of individuals recorded in the intake water. Round goby swarms exhibited both the highest intensity and the largest swarming individuals, suggesting a potential competitive advantage over tubenose and bighead goby. Electric fishing surveys in natural river stretches corroborated this observation. Negative effects on the native fish fauna were apparent only for the bullhead, Cottus gobio. The activity triggers identified offer a unique insight into the invasion mechanisms of these ecosystem-changing non-native gobiids.	[Baer, Jan; Brinker, Alexander] LAZBW, Fisheries Res Stn Baden Wurttemberg, Langenargen, Germany; [Hartmann, Frank] Regierungsprasidium Karlsruhe, Fisheries Adm, Karlsruhe, Germany		Baer, J (corresponding author), LAZBW, Fisheries Res Stn Baden Wurttemberg, Langenargen, Germany.	Jan.Baer@lazbw.bwl.de	Brinker, Alexander/ABF-4644-2020	Brinker, Alexander/0000-0002-2433-5652; Baer, Jan/0000-0001-8388-6684				Adamek Z, 2007, INT REV HYDROBIOL, V92, P554, DOI 10.1002/iroh.200510998; Baer J., 2014, ROTE LISTE BADEN WUR; Bjorklund M, 2010, BIOL INVASIONS, V12, P2609, DOI 10.1007/s10530-009-9669-z; Borcherding J, 2013, LIMNOLOGICA, V43, P49, DOI 10.1016/j.limno.2012.08.003; Brandner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073036; Bronnenhuber JE, 2011, MOL ECOL, V20, P1845, DOI 10.1111/j.1365-294X.2011.05030.x; Cammaerts R, 2012, AQUAT INVASIONS, V7, P251, DOI 10.3391/ai.2012.7.2.011; Chuang YL, 2009, J SEA RES, V61, P197, DOI 10.1016/j.seares.2009.01.001; Corkum LD, 2004, BIOL INVASIONS, V6, P173, DOI 10.1023/B:BINV.0000022136.43502.db; Coulter DP, 2011, J FRESHWATER ECOL, V26, P155, DOI 10.1080/02705060.2011.553987; Cullen P, 2003, ENVIRON BIOL FISH, V67, P349, DOI 10.1023/A:1025878830457; Dopazo SN, 2008, J GREAT LAKES RES, V34, P450, DOI 10.3394/0380-1330(2008)34[450:FAAEVA]2.0.CO;2; Dubs DOL, 1996, J GREAT LAKES RES, V22, P838, DOI 10.1016/S0380-1330(96)71005-5; Gertzen S, 2016, THESIS; Glarer H., LENGTH DAY TWILIGHT; GREGORY RS, 1993, CAN J FISH AQUAT SCI, V50, P241, DOI 10.1139/f93-027; Grul'a D, 2012, CENT EUR J BIOL, V7, P448, DOI 10.2478/s11535-012-0024-5; HADDERINGH R H, 1983, Hydrobiological Bulletin, V17, P129, DOI 10.1007/BF02280822; Janac M, 2013, ECOL FRESHW FISH, V22, P430, DOI 10.1111/eff.12037; Janac M, 2012, FUND APPL LIMNOL, V181, P73, DOI 10.1127/1863-9135/2012/0321; Jonsson N., 1991, NORD J FRESHW RES, V66, P20; Kennish M.J., 1992, ECOLOGY ESTUARIES AN; Kocovsky PM, 2011, BIOL INVASIONS, V13, P2775, DOI 10.1007/s10530-011-9962-5; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Kovac V, 2009, J APPL ICHTHYOL, V25, P33, DOI 10.1111/j.1439-0426.2009.01189.x; Krause J, 2002, LIVING GROUPS; Maes J, 1998, ESTUAR COAST SHELF S, V47, P143, DOI 10.1006/ecss.1998.0350; Manne S, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013069; Martens Andreas, 2007, Lauterbornia, V61, P145; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Plant, 2008, EKOLOGIYA, V54, P124; REUTTER J M, 1976, Ohio Journal of Science, V76, P39; Sandstrom O., 1990, 3868 SWED ENV PROT A; Scholl F, 2012, LAUTERBORNIA, V74, P111; Schreck C.B., 1990, METHODS FISH BIOL; Smith R. J. F., 1991, CYPRINID FISHES SYST, P509; Teixeira TP, 2009, MAR ENVIRON RES, V68, P188, DOI 10.1016/j.marenvres.2009.06.004; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	38	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0183769	10.1371/journal.pone.0183769	http://dx.doi.org/10.1371/journal.pone.0183769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915248	Green Submitted, gold, Green Published			2022-12-27	WOS:000410861600005
J	Ehret, C; Aid-Launais, R; Sagardoy, T; Siadous, R; Bareille, R; Rey, S; Pechev, S; Etienne, L; Kalisky, J; de Mones, E; Letourneur, D; Vilamitjana, JA				Ehret, C.; Aid-Launais, R.; Sagardoy, T.; Siadous, R.; Bareille, R.; Rey, S.; Pechev, S.; Etienne, L.; Kalisky, J.; de Mones, E.; Letourneur, D.; Vilamitjana, J. Amedee			Strontium-doped hydroxyapatite polysaccharide materials effect on ectopic bone formation	PLOS ONE			English	Article							SUBSTITUTED HYDROXYAPATITE; NANO-HYDROXYAPATITE; CALCIUM POLYPHOSPHATE; IN-VITRO; SR; SCAFFOLD; ANGIOGENESIS; BIOMATERIALS; BIOACTIVITY; DESIGN	Previous studies performed using polysaccharide-based matrices supplemented with hydroxyapatite (HA) particles showed their ability to form in subcutaneous and intramuscular sites a mineralized and osteoid tissue. Our objectives are to optimize the HA content in the matrix and to test the combination of HA with strontium (Sr-HA) to increase the matrix bioactivity. First, non-doped Sr-HA powders were combined to the matrix at three different ratios and were implanted subcutaneously for 2 and 4 weeks. Interestingly, matrices showed radiolucent properties before implantation. Quantitative analysis of micro-CT data evidenced a significant increase of mineralized tissue formed ectopically with time of implantation and allowed us to select the best ratio of HA to polysaccharides of 30% (w/w). Then, two Sr-substitution of 8% and 50% were incorporated in the HA powders (8Sr-HA and 50Sr-HA). Both Sr-HA were chemically characterized and dispersed in matrices. In vitro studies performed with human mesenchymal stem cells (MSCs) demonstrated the absence of cytotoxicity of the Sr-doped matrices whatever the amount of incorporated Sr. They also supported osteoblastic differentiation and activated the expression of one late osteoblastic marker involved in the mineralization process i.e. osteopontin. In vivo, subcutaneous implantation of these Sr-doped matrices induced osteoid tissue and blood vessels formation.	[Ehret, C.; Sagardoy, T.; Siadous, R.; Bareille, R.; Rey, S.; Kalisky, J.; de Mones, E.; Vilamitjana, J. Amedee] Univ Bordeaux, Tissue Bioengn, INSERM, U1026, Bordeaux, France; [Aid-Launais, R.; Letourneur, D.] Univ Paris Diderot, X Bichat Hosp, LVTS, Inserm U1148, F-75018 Paris, France; [Aid-Launais, R.; Letourneur, D.] Univ Paris 13, Inst Galilee, Villetaneuse, France; [Pechev, S.; Etienne, L.] Bordeaux Univ, ICMCB, Bordeaux, France; [de Mones, E.] CHU Bordeaux, Oral & Maxillofacial Dept, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; CHU Bordeaux	Vilamitjana, JA (corresponding author), Univ Bordeaux, Tissue Bioengn, INSERM, U1026, Bordeaux, France.	joelle.amedee@inserm.fr	AMEDEE, Joelle VILAMITJANA/F-3369-2013; Letourneur, Didier/H-5268-2012	EHRET, Camille/0000-0002-8346-3822; Letourneur, Didier/0000-0003-2197-9468	Fondation pour la recherche medicale [DBS20131128435]	Fondation pour la recherche medicale(Fondation pour la Recherche Medicale)	This work was supported by Fondation pour la recherche medicale, Grant number: DBS20131128435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina V, 2013, MAT SCI ENG C-MATER, V33, P1132, DOI 10.1016/j.msec.2012.12.005; Autissier A, 2010, ACTA BIOMATER, V6, P3640, DOI 10.1016/j.actbio.2010.03.004; Basha RY, 2015, MAT SCI ENG C-MATER, V57, P452, DOI 10.1016/j.msec.2015.07.016; Beachler DC, 2016, J BONE JOINT SURG AM, V98, P1064, DOI 10.2106/JBJS.15.01106; Boanini E, 2011, J MATER SCI-MATER M, V22, P2079, DOI 10.1007/s10856-011-4379-3; Boissard CIR, 2009, ACTA BIOMATER, V5, P3316, DOI 10.1016/j.actbio.2009.05.001; Boyd AR, 2015, MAT SCI ENG C-MATER, V46, P290, DOI 10.1016/j.msec.2014.10.046; Boyd AR, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5377-z; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Catros S, 2010, IRBM, V31, P226, DOI 10.1016/j.irbm.2010.04.002; Chandran S, 2016, J BIOMATER APPL, V31, P499, DOI 10.1177/0885328216647197; Chen YW, 2008, J MATER SCI-MATER M, V19, P2655, DOI 10.1007/s10856-007-3350-9; Cheng H, 2016, ACTA BIOMATER, V31, P388, DOI 10.1016/j.actbio.2015.11.046; Cox SC, 2014, MAT SCI ENG C-MATER, V35, P106, DOI 10.1016/j.msec.2013.10.015; Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039; Elgali I, 2016, ACTA BIOMATER, V29, P409, DOI 10.1016/j.actbio.2015.10.005; Fernandez-Yague MA, 2015, ADV DRUG DELIVER REV, V84, P1, DOI 10.1016/j.addr.2014.09.005; Frasnelli M, 2017, MAT SCI ENG C-MATER, V71, P653, DOI 10.1016/j.msec.2016.10.047; Fricain JC, 2013, BIOMATERIALS, V34, P2947, DOI 10.1016/j.biomaterials.2013.01.049; Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121; Gopi D, 2014, COLLOID SURFACE B, V114, P234, DOI 10.1016/j.colsurfb.2013.10.011; Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007; Gu ZP, 2013, J MATER SCI-MATER M, V24, P1251, DOI 10.1007/s10856-013-4891-8; Guerrero J, 2013, ACTA BIOMATER, V9, P8200, DOI 10.1016/j.actbio.2013.05.025; Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24; Kim K, 2007, J DRUG TARGET, V15, P241, DOI 10.1080/10611860701289818; Kondiah PJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21111580; Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006; Li YF, 2015, J APPL BIOMATER FUNC, V13, P28, DOI 10.5301/jabfm.5000168; Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056; Lindahl C, 2015, MAT SCI ENG C-MATER, V53, P322, DOI 10.1016/j.msec.2015.04.015; Lindahl C, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045018; Luo XM, 2015, ACTA BIOMATER, V26, P331, DOI 10.1016/j.actbio.2015.07.044; Marie PJ, 2010, MOL INTERV, V10, P305, DOI 10.1124/mi.10.5.7; Munarin F, 2015, INT J BIOL MACROMOL, V72, P199, DOI 10.1016/j.ijbiomac.2014.07.050; Nardone V, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/871863; Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026; Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127; Robert D, 2010, BIOMATERIALS, V31, P1586, DOI 10.1016/j.biomaterials.2009.11.014; Rosa Jucely Aparecida da, 2016, Braz. Dent. J., V27, P502, DOI 10.1590/0103-6440201600693; Roy M, 2013, BIOMATER SCI, V1; Saidak Z, 2012, PHARMACOL THERAPEUT, V136, P216, DOI 10.1016/j.pharmthera.2012.07.009; Tadier S, 2012, J BIOMED MATER RES B, V100B, P378, DOI 10.1002/jbm.b.31959; Tayton E, 2014, J BIOMED MATER RES A, V102, P2613, DOI 10.1002/jbm.a.34926; Thormann U, 2013, BIOMATERIALS, V34, P8589, DOI 10.1016/j.biomaterials.2013.07.036; Valiense H, 2016, J BIOMED MATER RES B, V104, P274, DOI 10.1002/jbm.b.33392; Vandecandelaere N, 2012, J MATER SCI-MATER M, V23, P2593, DOI 10.1007/s10856-012-4719-y; Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3124, DOI 10.1166/jbn.2014.1893; Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031	49	31	33	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184663	10.1371/journal.pone.0184663	http://dx.doi.org/10.1371/journal.pone.0184663			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910401	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200073
J	Barille, L; Le Bris, A; Meleder, V; Launeau, P; Robin, M; Louvrou, I; Ribeiro, L				Barille, Laurent; Le Bris, Anthony; Meleder, Vona; Launeau, Patrick; Robin, Marc; Louvrou, Ioanna; Ribeiro, Lourenco			Photosynthetic epibionts and endobionts of Pacific oyster shells from oyster reefs in rocky versus mudflat shores	PLOS ONE			English	Article							MICROPHYTOBENTHOS; BIOMASS; ASSEMBLAGES; EUENDOLITHS; ABUNDANCE; DYNAMICS; INVASION; DIATOMS; VECTOR; FIELD	The Pacific oyster, Crassostrea gigas (Thunberg), is the main bivalve species cultivated in the world. With global warming enabling its reproduction and larval survival at higher latitudes, this species is now recognized as invasive and creates wild oyster reefs globally. In this study, the spatial distribution of photosynthetic assemblages colonizing the shells of wild C. gigas was investigated on both a large scale (two contrasting types of reefs found in mudflats and rocky areas) and a small scale (within individual shells) using a hyperspectral imager. The microspatial distribution of all phototrophs was obtained by mapping the Normalized Difference Vegetation Index (NDVI). Second derivative (delta delta) analyses of hyperspectral images at 462, 524, 571 and 647 nm were subsequently applied to map diatoms, cyanobacteria, rhodophytes and chlorophytes, respectively. A concomitant pigment analysis was carried out by high performance liquid chromatography and completed by taxonomic observations. This study showed that there was high microalgal diversity associated with wild oyster shells and that there were differences in the structure of the phototropic assemblages depending on the type of reef. Namely, vertically-growing oysters in mudflat areas had a higher biomass of epizoic diatoms (hyperspectral proxy at delta(462) nm) and were mainly colonized by species of the genera Navicula, Nitzschia and Hippodonta, which are epipelic or motile epipsammic. The assemblages on the horizontal oysters contained more tychoplanktonic diatoms (e.g. Thalassiosira pseudonana, T. proschkinae and Plagiogrammopsis vanheurckii). Three species of boring cyanobacteria were observed for both types of reef: Mastigocoleus testarum, Leptolyngbya terrebrans, and Hyella caespistosa, but the second derivative analysis at 524 nm showed a significantly higher biomass for the horizontally-growing oysters. There was no biomass difference for the boring chlorophyte assemblages (delta delta(647) nm), with two species: Eugomontia testarum and Ostreobium quekettii observed for both types of reef. This study shows that oyster shells are an idiosyncratic but ubiquitous habitat for phototrophic assemblages. The contribution of these assemblages in terms of	[Barille, Laurent; Le Bris, Anthony; Meleder, Vona; Ribeiro, Lourenco] Univ Nantes, Inst Univ Mer & Littoral FR C 3473, Lab Mer Mol Sante EA2160, Nantes, France; [Le Bris, Anthony; Robin, Marc] Univ Nantes, Inst Univ Mer & Littoral FR C 3473, LETG Geolittomer, CNRS,UMR 6554, Nantes, France; [Launeau, Patrick] Univ Nantes, Inst Univ Mer & Littoral FR C 3473, Lab Planetol & Geodynam, CNRS,UMR 6112, Nantes, France; [Louvrou, Ioanna] Univ Athens, Dept Ecol & Systemat, Fac Biol, Athens, Greece; [Ribeiro, Lourenco] Univ Lisbon, Fac Ciencias, Marine & Environm Sci Ctr, Lisbon, Portugal	Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; National & Kapodistrian University of Athens; Universidade de Lisboa	Barille, L (corresponding author), Univ Nantes, Inst Univ Mer & Littoral FR C 3473, Lab Mer Mol Sante EA2160, Nantes, France.	laurent.barille@univ-nantes.fr	Ribeiro, Lourenço S./A-3978-2012	Ribeiro, Lourenço S./0000-0002-6585-0140; Barille, Laurent/0000-0001-5138-2684; Meleder, Vona/0000-0002-1874-1929	Ministere Francais de la Recherche et de lEnseignement Superieur; Federation de Recherche IUML FRCNRS of the University of Nantes; cluster of excellence LabexMER; IFREMER; Nantes University; Regional Council of the Pays de la Loire	Ministere Francais de la Recherche et de lEnseignement Superieur; Federation de Recherche IUML FRCNRS of the University of Nantes; cluster of excellence LabexMER; IFREMER; Nantes University; Regional Council of the Pays de la Loire(Region Pays de la Loire)	PhD grant was supported by the Ministere Francais de la Recherche et de lEnseignement Superieur and awarded by the Federation de Recherche IUML FRCNRS of the University of Nantes in collaboration with the cluster of excellence LabexMER. Anthony Lebris received the grant. COSELMAR project was supported by IFREMER and Nantes University and co-funded by the Regional Council of the Pays de la Loire. Laurent Barille received the grant.	Barille L, 2007, J EXP MAR BIOL ECOL, V343, P197, DOI 10.1016/j.jembe.2006.11.013; Barille L, 2011, REMOTE SENS ENVIRON, V115, P1034, DOI 10.1016/j.rse.2010.12.008; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Bornet ME, 1889, B SOC BOT FR, V36, pCXLVII; CAMPBELL SE, 1984, HYDROBIOLOGIA, V116, P201, DOI 10.1007/BF00027666; Chennu A, 2013, LIMNOL OCEANOGR-METH, V11, P511, DOI 10.4319/lom.2013.11.511; Cherchi A, 2012, BIOGEOSCIENCES, V9, P4607, DOI 10.5194/bg-9-4607-2012; Choe BH, 2012, ESTUAR COAST SHELF S, V97, P28, DOI 10.1016/j.ecss.2011.11.007; Cognie B, 1999, OCEANOL ACTA, V22, P441, DOI 10.1016/S0399-1784(00)88727-7; Dalelio D, 2010, ALL FLESH IS GRASS, P345; Dame RF, 1993, ROLE BIVALVE FILTER, P245; DREW KM, 1949, NATURE, V164, P748, DOI 10.1038/164748a0; Gade M, 2014, ESTUAR COAST SHELF S, V140, P32, DOI 10.1016/j.ecss.2014.01.007; Gernez P, 2014, J GEOPHYS RES-OCEANS, V119, P7277, DOI 10.1002/2014JC010055; Gillan DC, 2000, J SEA RES, V43, P83, DOI 10.1016/S1385-1101(99)00041-6; Golubic S, 1999, DIVERSITY MARINE CYA, V19, P53; Golubic S, 2003, MICROBIAL ENDOLITHS, P249; Goulletquer P, 1991, AQUACULTURE CRASSOST, P13; GRIZEL H, 1991, J CONSEIL, V47, P399; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haydar D, 2011, MAR ECOL PROG SER, V431, P1, DOI 10.3354/meps09170; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hutchinson N, 2006, AQUAT MICROB ECOL, V42, P187, DOI 10.3354/ame042187; Jeffrey S. W., 1997, PHYTOPLANKTON PIGMEN, P449; Jesus B, 2005, ESTUAR COAST SHELF S, V65, P30, DOI 10.1016/j.ecss.2005.05.005; Jesus B, 2014, REMOTE SENS ENVIRON, V140, P196, DOI 10.1016/j.rse.2013.08.040; Jesus B, 2008, J PHYCOL, V44, P1349, DOI 10.1111/j.1529-8817.2008.00583.x; Kahlert M, 2014, ENVIRON SCI-PROC IMP, V16, P2627, DOI 10.1039/c4em00326h; Kazemipour F, 2012, REMOTE SENS ENVIRON, V127, P1, DOI 10.1016/j.rse.2012.08.016; KORRINGA P., 1951, ARCH NEERLAND ZOOL, V10, P32; Kuhl M, 2008, AQUAT MICROB ECOL, V53, P99, DOI 10.3354/ame01224; Lagerheim G, 1885, OFVERS K VETENSKAPSA, V42, P21; Le Bris A, 2016, ESTUAR COAST SHELF S, V172, P1, DOI 10.1016/j.ecss.2016.01.039; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P149, DOI 10.3354/meps117149; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Marcelino VR, 2016, SCI REP-UK, V6, DOI 10.1038/srep31508; Meleder V, 2003, REMOTE SENS ENVIRON, V88, P386, DOI 10.1016/j.rse.2003.08.009; Meleder V, 2007, J PHYCOL, V43, P1177, DOI 10.1111/j.1529-8817.2007.00423.x; Meleder V, 2013, J PHOTOCH PHOTOBIO B, V129, P115, DOI 10.1016/j.jphotobiol.2013.10.005; Mineur F, 2007, BIOL CONSERV, V137, P237, DOI 10.1016/j.biocon.2007.02.001; Murphy RJ, 2009, J EXP MAR BIOL ECOL, V380, P68, DOI 10.1016/j.jembe.2009.09.002; Murphy RJ, 2006, MAR ECOL PROG SER, V312, P45, DOI 10.3354/meps312045; Murphy RJ, 2005, J EXP MAR BIOL ECOL, V325, P111, DOI 10.1016/j.jembe.2005.04.018; Pantazidou A, 2006, EUR J PHYCOL, V41, P189, DOI 10.1080/09670260600649420; Paterson DM, 1998, LIMNOL OCEANOGR, V43, P1207, DOI 10.4319/lo.1998.43.6.1207; Perkins RG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22343; Radea C, 2010, FOTTEA, V10, P129, DOI 10.5507/fot.2010.007; RAGHUKUMAR C, 1991, PHYCOLOGIA, V30, P303, DOI 10.2216/i0031-8884-30-3-303.1; Ramirez-Reinat EL, 2012, J PHYCOL, V48, P740, DOI 10.1111/j.1529-8817.2012.01157.x; Ribeiro L., 2010, THESIS U LISBON LISB; Ribeiro L, 2013, J PHYCOL, V49, P258, DOI 10.1111/jpy.12031; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Russell BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136260; Sauvage T, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0068-x; Schill SR, 2006, DEV AUTOMATED MAPPIN, P91; Schodduyn R., 1931, Bulletin de l'Institut Oceanographique Monaco, Vno. 568, P1; Seckbach J, 2010, ALL FLESH IS GRASS P, P509; Snoeijs P, 2002, J PHYCOL, V38, P265, DOI 10.1046/j.1529-8817.2002.01105.x; Spilmont N, 2011, ESTUAR COAST SHELF S, V95, P470, DOI 10.1016/j.ecss.2011.10.021; Thomas Y, 2016, J BIOGEOGR, V43, P568, DOI 10.1111/jbi.12665; Thompson RC, 1999, J MAR BIOL ASSOC UK, V79, P551, DOI 10.1017/S0025315498000678; Totti C., 2010, ALL FLESH IS GRASS, P323, DOI DOI 10.1007/978-90-481-9316-5_15; Tribollet A, 2006, J PHYCOL, V42, P292, DOI 10.1111/j.1529-8817.2006.00198.x; Troost K, 2010, J SEA RES, V64, P145, DOI 10.1016/j.seares.2010.02.004; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; WALKER S E, 1992, Palaios, V7, P236, DOI 10.2307/3514934; WILKINSON M, 1974, J EXP MAR BIOL ECOL, V16, P19, DOI 10.1016/0022-0981(74)90070-7; Witkowski A, 2000, DIATOM FLORA MARINE, P925	69	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185187	10.1371/journal.pone.0185187	http://dx.doi.org/10.1371/journal.pone.0185187			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934317	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900115
J	Branch, MR; Hepler, JR				Branch, Mary Rose; Hepler, John R.			Endogenous RGS14 is a cytoplasmic-nuclear shuttling protein that localizes to juxtanuclear membranes and chromatin-rich regions of the nucleus	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; HETEROTRIMERIC G-PROTEINS; SIGNALING 14 RGS14; G-ALPHA-I; TRANSCRIPTION FACTORIES; SYNAPTIC PLASTICITY; COUPLED RECEPTORS; MAMMALIAN-CELLS; GENE-EXPRESSION; LIVE CELLS	Regulator of G protein signaling 14 (RGS14) is a multifunctional scaffolding protein that integrates G protein and H-Ras/MAPkinase signaling pathways to regulate synaptic plasticity important for hippocampal learning and memory. However, to date, little is known about the subcellular distribution and roles of endogenous RGS14 in a neuronal cell line. Most of what is known about RGS14 cellular behavior is based on studies of tagged, recombinant RGS14 ectopically overexpressed in unnatural host cells. Here, we report for the first time a comprehensive assessment of the subcellular distribution and dynamic localization of endogenous RGS14 in rat B35 neuroblastoma cells. Using confocal imaging and 3D-structured illumination microscopy, we find that endogenous RGS14 localizes to subcellular compartments not previously recognized in studies of recombinant RGS14. RGS14 localization was observed most notably at juxtanuclear membranes encircling the nucleus, at nuclear pore complexes (NPC) on both sides of the nuclear envelope and within intranuclear membrane channels, and within both chromatin-poor and chromatin-rich regions of the nucleus in a cell cycle-dependent manner. In addition, a subset of nuclear RGS14 localized adjacent to active RNA polymerase II. Endogenous RGS14 was absent from the plasma membrane in resting cells; however, the protein could be trafficked to the plasma membrane from juxtanuclear membranes in endosomes derived from ER/Golgi, following constitutive activation of endogenous RGS14 G protein binding partners using AlF4-. Finally, our findings show that endogenous RGS14 behaves as a cytoplasmic-nuclear shuttling protein confirming what has been shown previously for recombinant RGS14. Taken together, the findings highlight possible cellular roles for RGS14 not previously recognized that are distinct from the regulation of conventional GPCR-G protein signaling, in particular undefined roles for RGS14 in the nucleus.	[Branch, Mary Rose; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Hepler, JR (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	jhepler@emory.edu		Branch, Mary Rose/0000-0002-3410-1534	National Institutes of Health [5R01NS037112, 1R21 NS087488]; Emory University Integrated Cellular Imaging Microscopy Core; Emory Neuroscience National Institute of Neurological Disorders and Stroke [5P30NS055077]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Integrated Cellular Imaging Microscopy Core; Emory Neuroscience National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01NS037112 and 1R21 NS087488 (to JRH). This research was also supported in part by the Emory University Integrated Cellular Imaging Microscopy Core and the Emory Neuroscience National Institute of Neurological Disorders and Stroke Core Facilities grant, 5P30NS055077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2008, FASEB J, V22, P2821, DOI 10.1096/fj.07-104224; Baas P. W., 2012, CENTROSOME, P309, DOI 10.1007/978-1-62703-035-9_18; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Brown NE, 2015, J BIOL CHEM, V290, P9037, DOI 10.1074/jbc.M114.634329; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Chatterjee TK, 2000, J BIOL CHEM, V275, P29660, DOI 10.1074/jbc.M000330200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Chatterjee TK, 2002, MOL CELL BIOL, V22, P4334, DOI 10.1128/MCB.22.12.4334-4345.2002; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Cho HS, 2005, J BIOL CHEM, V280, P805, DOI 10.1074/jbc.M408163200; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Cremer M, 2001, CHROMATIN CELL NUCL; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Eskiw CH, 2008, J CELL SCI, V121, P1999, DOI 10.1242/jcs.027250; Evans PR, 2014, J COMP NEUROL, V522, P186, DOI 10.1002/cne.23395; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; GOLDENTHAL KL, 1985, J HISTOCHEM CYTOCHEM, V33, P813, DOI 10.1177/33.8.3894499; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harper Jane V., 2004, V296, P157; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2003, BIOCHEMISTRY-US, V42, P811, DOI 10.1021/bi026664y; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hou CH, 2010, CELL, V140, P306, DOI 10.1016/j.cell.2010.01.036; Jagatheesan G, 1999, J CELL SCI, V112, P4651; Jourdain I, 2009, CELL MOTIL CYTOSKEL, V66, P509, DOI 10.1002/cm.20351; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lee JK, 2015, PROG MOL BIOL TRANSL, V133, P153, DOI 10.1016/bs.pmbts.2015.01.005; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Lewis TL, 2013, J CELL BIOL, V202, P837, DOI 10.1083/jcb.201305098; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Lund E, 2013, NUCLEUS-AUSTIN, V4, P424, DOI 10.4161/nucl.26865; Lyssand JS, 2007, FEBS LETT, V581, P5765, DOI 10.1016/j.febslet.2007.11.044; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Margolin W, 2012, J BACTERIOL, V194, P6369, DOI 10.1128/JB.01640-12; Markaki Y, 2010, COLD SH Q B, V75, P475, DOI 10.1101/sqb.2010.75.042; Martin-McCaffrey L, 2005, CELL CYCLE, V4, P953, DOI 10.4161/cc.4.7.1787; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; Morchoisne-Bolhy S, 2015, MOL BIOL CELL, V26, P2343, DOI 10.1091/mbc.E15-02-0060; Muralikrishna B, 2001, J CELL SCI, V114, P4001; NISHI K, 1994, J BIOL CHEM, V269, P6320; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Popken J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124619; Rose JJ, 2000, J NEUROCHEM, V75, P2103, DOI 10.1046/j.1471-4159.2000.0752103.x; Roychowdhury S, 1999, J BIOL CHEM, V274, P13485, DOI 10.1074/jbc.274.19.13485; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Stadler C, 2013, NAT METHODS, V10, P315, DOI [10.1038/NMETH.2377, 10.1038/nmeth.2377]; Stadler C, 2010, J PROTEOMICS, V73, P1067, DOI 10.1016/j.jprot.2009.10.012; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Traver S, 2004, BIOCHEM J, V379, P627, DOI 10.1042/BJ20031889; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zhang JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1099; Zhang P, 2015, LIFE SCI, V129, P35, DOI 10.1016/j.lfs.2015.02.029	65	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184497	10.1371/journal.pone.0184497	http://dx.doi.org/10.1371/journal.pone.0184497			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934222	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900031
J	Curval, LG; Franca, AD; Fernandes, HJ; Mendes, RP; de Carvalho, LR; Higa, MG; Ferreira, ED; Dorval, MEC				Curval, Larissa Gabrielle; Franca, Adriana de Oliveira; Fernandes, Henrique Jorge; Mendes, Rinaldo Poncio; de Carvalho, Lidia Raquel; Higa, Minoru German; Ferreira, Eduardo de Castro; Cavalheiros Dorval, Maria Elizabeth			Prevalence of intestinal parasites among inmates in Midwest Brazil	PLOS ONE			English	Article							DISEASES; CHILDREN; STATE; CITY	Background Intestinal parasitic infections constitute a public health issue in developing countries, with prevalence rates as high as 90%, a figure set to escalate as the socioeconomic status of affected populations deteriorates. Investigating the occurrence of these infections among inmates is critical, since this group is more vulnerable to the spread of a number of infectious illnesses. Methods This cross-sectional, analytical, quantitative study was conducted in July 2015 at prison facilities located in Midwest Brazil to estimate the prevalence of parasitic infection among inmates. For detection of parasites, 510 stool samples were examined by ether centrifugation and spontaneous sedimentation. Results Eight parasitic species were detected, with an overall prevalence of 20.2% (103/510). Giardia lamblia and Entamoeba histolytica/dispar were the most frequent pathogenic parasites. Endolimax nana was the predominant non-pathogenic species. Nearly half of the subjects (53/103; 51.4%) were positive for mixed infection. Logistic regression revealed that inmates held in closed conditions were more likely to contract parasitic infections than those held in a semi-open regime (OR = 1.97; 95% CI = 1.19-3.25; p = 0.0085). A higher prevalence of parasitic infections was observed among individuals who had received no prophylactic antiparasitic treatment in previous years (OR = 10.2; 95% CI = 5.86-17.66; p < 0.001). The other factors investigated had no direct association with the presence of intestinal parasites. Conclusion Infections caused by directly transmissible parasites were detected. Without adequate treatment and prophylactic guidance, inmates tend to remain indefinitely infected with intestinal parasites, whether while serving time in prison or after release.	[Curval, Larissa Gabrielle; Franca, Adriana de Oliveira; Higa, Minoru German; Cavalheiros Dorval, Maria Elizabeth] Univ Fed Mato Grosso do Sul, Grad Program Infect & Parasit Dis, Campo Grande, MS, Brazil; [Fernandes, Henrique Jorge] Univ Estadual Mato Grosso Sul, Dept Anim Sci, Aquidauana, MS, Brazil; [Mendes, Rinaldo Poncio] Univ Fed Mato Grosso do Sul, Sch Med, Campo Grande, MS, Brazil; [de Carvalho, Lidia Raquel] Univ Estadual Paulista, Dept Biostat, Biosci Inst Botucatu, Botucatu, SP, Brazil; [Ferreira, Eduardo de Castro] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Estadual de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista; Fundacao Oswaldo Cruz	Curval, LG (corresponding author), Univ Fed Mato Grosso do Sul, Grad Program Infect & Parasit Dis, Campo Grande, MS, Brazil.	larissagabriellecurval@gmail.com	Carvalho, L.R./C-2973-2013; Curval, Larissa Gabrielle/H-1095-2018	Carvalho, L.R./0000-0003-0575-2263; Curval, Larissa Gabrielle/0000-0003-1302-7352; Higa Junior, Minoru German/0000-0001-9794-9439; Ferreira, Eduardo/0000-0002-4073-6704; Franca, Adriana de Oliveira/0000-0002-4994-1958	Fundacao de Desenvolvimento, Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)	Fundacao de Desenvolvimento, Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	The Fundacao de Desenvolvimento, Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) is acknowledged for supporting the UFMS Graduate Program in Infectious and Parasitic Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their thanks for the support provided by Professor Maria Elizabeth Cavalheiros Dorval in granting access to the UFMS Laboratory of Clinical Parasitology Research, as well as for her valuable contribution during the analysis of biological samples. No less importantly, thanks are extended to all the subjects who volunteered to take part in this study. The Fundacao de Desenvolvimento, Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) is also acknowledged for supporting the UFMS Graduate Program in Infectious and Parasitic Diseases.	Abraham RS, 2007, REV BRAS ANAL CLIN, V39, P39; Alemu A, 2011, ASIAN PAC J TROP MED, V4, P661, DOI 10.1016/S1995-7645(11)60168-5; Amuga G, 2006, INT J NAT APPL SCI, V2, P7; Anuar TS, 2014, NATURE, V4101, P1; Assis RD, 2008, REV CEJ, V11, P74; Bica VC, 2011, REV HOSPITAL CLIN PO, V1, P3139; BLAGG W, 1955, AM J TROP MED HYG, V4, P23, DOI 10.4269/ajtmh.1955.4.23; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Pereira Maria das Graças Cabral, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P139; Basso RMC, 2008, REV SOC BRAS MED TRO, V41, P263, DOI 10.1590/S0037-86822008000300008; Campos MR, 2002, REV SAUDE PUBL, V36, P69, DOI 10.1590/S0034-89102002000100011; Colman S, 2013, AJMR, V1, P11, DOI DOI 10.15413/ajmr.2012.0103; da Costa-Macedo L M, 1998, Cad Saude Publica, V14, P851, DOI 10.1590/S0102-311X1998000400027; Dagci H, 2008, PARASITOL RES, V103, P839, DOI 10.1007/s00436-008-1065-6; de Andrade EC, 2011, EPIDEMIOL SERV SAUDE, V20, P337, DOI 10.5123/S1679-49742011000300008; de Souza EA, 2007, CAD SAUDE PUBLICA, V23, P427, DOI 10.1590/S0102-311X2007000200019; Degarege Abraham, 2010, BMC Res Notes, V3, P143, DOI 10.1186/1756-0500-3-143; dos Santos SA, 2010, CIENC SAUDE COLETIVA, V15, P899, DOI 10.1590/S1413-81232010000300033; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Ferreira H, 2006, PUBL UEPG CI BIOL SA, V12, P33; Ferreira MU, 2000, REV SAUDE PUBL, V34, P73, DOI 10.1590/S0034-89102000000700010; Guerrero AFH, 2005, ACTA AMAZONICA, V35, P487; Hoffman WA, 1934, PUERTO RICO J PUB HL, V9, P283; Holveck JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-6; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Leite Seixas Marieli Tavares, 2011, Revista de Patologia Tropical, V40, P304, DOI 10.5216/rpt.v40i4.16762; Lodo M, 2010, REV BRAS CRESCIMENTO, V20, P769; Mamman A.S., 2014, WORLD SC RES J, V2, P67; Mamo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099559; Marques S. M. T., 2005, Parasitologia Latinoamericana, V60, P78; Mehraj V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003680; [Ministerio da Saude Brasil], 2005, PLAN NAC VIG CONTR E; [Ministerio da Saude Brasil], CONS NAC HIV AIDS SI; [Ministerio da Saude Brasil], 2004, PLAN NAC SAUD SIST P; Nwosu BU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090623; OKEEFE MAUREEN L., 2010, ONE YEAR LONGITUDINA, P1; Okolie N., 2008, INTERNET J PARASITIC, V4, P1; Oliveira CLM., 2010, REV BRASILEIRA PROMO, V23, P307; Ortega YR, 1997, CLIN INFECT DIS, V25, P545, DOI 10.1086/513745; Ouattara M, 2010, PLOS NEGLECT TROP D, V4, P1; Roque FC, 2005, NEWSLAB, V69, P152; SCHAPIRO M M, 1959, Trans R Soc Trop Med Hyg, V53, P270, DOI 10.1016/0035-9203(59)90007-0; Takayanagui O M, 2001, Rev Soc Bras Med Trop, V34, P283, DOI 10.1590/S0037-86822001000300010; Teixeira JC, 2012, REV PANAM SALUD PUBL, V32, P419, DOI 10.1590/S1020-49892012001400005; Teixeira SF, 2012, REV CIENTIFICA FAMIN, V7, P37; Uecker M, 2007, RBAC, V39, P15; Uttah EC, 2012, ADV TROPICAL MED PUB, V2, P88; World Health Organization, 2009, LIB CAT IN PUBL DAT	48	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0182248	10.1371/journal.pone.0182248	http://dx.doi.org/10.1371/journal.pone.0182248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934218	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900003
J	Whatmore, AM; Dawson, C; Muchowski, J; Perrett, LL; Stubberfield, E; Koylass, M; Foster, G; Davison, NJ; Quance, C; Sidor, IF; Field, CL; Leger, JS				Whatmore, Adrian M.; Dawson, Claire; Muchowski, Jakub; Perrett, Lorraine L.; Stubberfield, Emma; Koylass, Mark; Foster, Geoffrey; Davison, Nicholas J.; Quance, Christine; Sidor, Inga F.; Field, Cara L.; Leger, Judy St.			Characterisation of North American Brucella isolates from marine mammals	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; DOLPHINS; STRAINS; INFECTION; IDENTIFICATION; NEUROBRUCELLOSIS; DIFFERENTIATION; OSTEOMYELITIS; SEALS; ST27	Extension of known ecological niches of Brucella has included the description of two novel species from marine mammals. Brucella pinnipedialis is associated predominantly with seals, while two major Brucella ceti clades, most commonly associated with porpoises or dolphins respectively, have been identified. To date there has been limited characterisation of Brucella isolates obtained from marine mammals outside Northern European waters, including North American waters. To address this gap, and extend knowledge of the global population structure and host associations of these Brucella species, 61 isolates from marine mammals inhabiting North American waters were subject to molecular and phenotypic characterisation enabling comparison with existing European isolates. The majority of isolates represent genotypes previously described in Europe although novel genotypes were identified in both B. ceti clades. Harp seals were found to carry B. pinnipedialis genotypes previously confined to hooded seals among a diverse repertoire of sequence types (STs) associated with this species. For the first time Brucella isolates were characterised from beluga whales and found to represent a number of distinct B. pinnipedialis genotypes. In addition the known host range of ST27 was extended with the identification of this ST from California sea lion samples. Finally the performance of the frequently used diagnostic tool Bruce-ladder, in differentiating B. ceti and B. pinnipedialis, was critically assessed based on improved knowledge of the global population structure of Brucella associated with marine mammals.	[Whatmore, Adrian M.; Dawson, Claire; Muchowski, Jakub; Perrett, Lorraine L.; Stubberfield, Emma; Koylass, Mark] Anim & Plant Hlth Agcy, FAO WHO Collaborating Ctr Brucellosis, OIE Brucellosis Reference Lab, Addlestone, Surrey, England; [Foster, Geoffrey; Davison, Nicholas J.] SRUC Vet Serv, Scottish Marine Anim Stranding Scheme, Inverness, Scotland; [Quance, Christine] USDA APHIS, Mycobacteria & Brucella Sect, Natl Vet Serv Labs, Ames, IA USA; [Sidor, Inga F.; Field, Cara L.] Myst Aquarium & Inst Explorat, Mystic, CT USA; [Leger, Judy St.] SeaWorld Pk & Entertainment, San Diego, CA USA; [Sidor, Inga F.] Univ New Hampshire, New Hampshire Vet Diagnost Lab, Durham, NH 03824 USA; [Field, Cara L.] Marine Mammal Ctr, Sausalito, CA USA	Animal & Plant Health Agency UK; Food & Agriculture Organization of the United Nations (FAO); United States Department of Agriculture (USDA); University System Of New Hampshire; University of New Hampshire	Whatmore, AM (corresponding author), Anim & Plant Hlth Agcy, FAO WHO Collaborating Ctr Brucellosis, OIE Brucellosis Reference Lab, Addlestone, Surrey, England.	adrian.whatmore@apha.gsi.gov.uk	Whatmore, Adrian M/C-7744-2011; St. Leger, Judy/AAD-3565-2019	Whatmore, Adrian M/0000-0003-4218-156X; St. Leger, Judy/0000-0002-6213-3429; Davison, Nicholas/0000-0001-7286-1836; Stubberfield, Emma/0000-0002-5527-1209; Sidor, Inga/0000-0001-5169-6704; Foster, Geoffrey/0000-0002-5527-758X	UK Department of the Environment, Food and Rural Affairs (Defra)	UK Department of the Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA))	Brucella research and surveillance activities at APHA are supported by the UK Department of the Environment, Food and Rural Affairs (Defra). We thank Dr Teri Rowles, the veterinarians working with captive collections and the stranded animal network partners in North America that provided material to NVSL facilitating the broad scope of this study. We declare that one author (JSL) is employed by a commercial organisation 'SeaWorld Parks and Entertainment'. This funder provider support in the form of salary for JSL but had no additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Alba P, 2013, VET MICROBIOL, V164, P158, DOI 10.1016/j.vetmic.2013.01.023; Ancora M, 2014, GENOME ANNOUNC, V2; Audic S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-200; Bricker BJ, 2000, J CLIN MICROBIOL, V38, P1258, DOI 10.1128/JCM.38.3.1258-1262.2000; Colegrove KM, 2016, DIS AQUAT ORGAN, V119, P1, DOI 10.3354/dao02969; Cvetnic Z, 2016, VET MICROBIOL, V196, P93, DOI 10.1016/j.vetmic.2016.10.013; Dawson CE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-224; EWALT DR, 1994, J VET DIAGN INVEST, V6, P448, DOI 10.1177/104063879400600408; Forbes LB, 2000, J WILDLIFE DIS, V36, P595, DOI 10.7589/0090-3558-36.3.595; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Garcia-Yoldi D, 2006, CLIN CHEM, V52, P779, DOI 10.1373/clinchem.2005.062596; Goertz CEC, 2011, J VET DIAGN INVEST, V23, P845, DOI 10.1177/1040638711407683; Goldstein T, 2009, J WILDLIFE DIS, V45, P91, DOI 10.7589/0090-3558-45.1.91; Gopaul KK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-86; Groussaud P, 2007, J MED MICROBIOL, V56, P1512, DOI 10.1099/jmm.0.47330-0; Guzman-Verri C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00003; Hernandez-Mora G, 2013, REV SCI TECH OIE, V32, P89; Hernandez-Mora G, 2008, EMERG INFECT DIS, V14, P1430, DOI 10.3201/eid1409.071056; Isidoro-Ayza M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0206-7; Jahans KL, 1997, VET MICROBIOL, V57, P373, DOI 10.1016/S0378-1135(97)00118-1; Kang SI, 2011, APPL ENVIRON MICROB, V77, P6726, DOI 10.1128/AEM.00581-11; Maquart M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-145; Maratea J, 2003, J ZOO WILDLIFE MED, V34, P256, DOI 10.1638/02-053; Mayer-Scholl A, 2010, J MICROBIOL METH, V80, P112, DOI 10.1016/j.mimet.2009.10.015; McDonald WL, 2006, J CLIN MICROBIOL, V44, P4363, DOI 10.1128/JCM.00680-06; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; Nielsen O, 2001, J WILDLIFE DIS, V37, P89, DOI 10.7589/0090-3558-37.1.89; Nymo IH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-93; Ohishi K, 2004, MICROBES INFECT, V6, P1199, DOI 10.1016/j.micinf.2004.06.006; ROSS HM, 1994, VET REC, V134, P359, DOI 10.1136/vr.134.14.359-b; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verger JM, 1988, TECHNIQUES BRUCELLOS; Wattam AR, 2014, J BACTERIOL, V196, P920, DOI 10.1128/JB.01091-13; Webber MA., 1993, FAO SPECIES IDENTIFI; Whatmore AM, 2008, EMERG INFECT DIS, V14, P517, DOI 10.3201/eid1403.070829; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05; Whatmore AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02049; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; Whatmore AM, 2005, J CLIN MICROBIOL, V43, P761, DOI 10.1128/JCM.43.2.761-769.2005; Wu QZ, 2014, J MICROBIOL METH, V100, P99, DOI 10.1016/j.mimet.2014.03.001	42	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184758	10.1371/journal.pone.0184758	http://dx.doi.org/10.1371/journal.pone.0184758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934239	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000411339900043
J	Hariri, BM; McMahon, DB; Chen, B; Adappa, ND; Palmer, JN; Kennedy, DW; Lee, RJ				Hariri, Benjamin M.; McMahon, Derek B.; Chen, Bei; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.			Plant flavones enhance antimicrobial activity of respiratory epithelial cell secretions against Pseudomonas aeruginosa	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; NITRIC-OXIDE PRODUCTION; BITTER TASTE RECEPTORS; MUCIN GENE-EXPRESSION; APICAL SURFACE FLUID; NF-KAPPA-B; ANTIBACTERIAL ACTIVITY; INHIBITORY-ACTIVITY; CHRONIC RHINOSINUSITIS; ANTIBIOTIC-RESISTANCE	Flavones are a class of natural plant secondary metabolites that have anti-inflammatory and anti-bacterial effects. Some flavones also activate the T2R14 bitter taste receptor, which is expressed in motile cilia of the sinonasal epithelium and activates innate immune nitric oxide (NO) production. Flavones may thus be potential therapeutics for respiratory infections. Our objective was to examine the anti-microbial effects of flavones on the common sinonasal pathogens Candida albicans, Staphylococcus aureus, and Pseudomonas aeruginosa, evaluating both planktonic and biofilm growth. Flavones had only very low-level antibacterial activity alone. They did not reduce biofilm formation, but did reduce production of the important P. aeruginosa inflammatory mediator and ciliotoxin pyocyanin. However, flavones exhibited synergy against P. aeruginosa in the presence of antibiotics or recombinant human lysozyme. They also enhanced the efficacy of antimicrobials secreted by cultured and primary human airway cells grown at air-liquid interface. This suggests that flavones may have anti-gram-negative potential as topical therapeutics when combined with antibiotics or in the context of innate antimicrobials secreted by the respiratory or other epithelia. This may have an additive effect when combined with T2R14-activated NO production. Additional studies are necessary to understand which flavone compounds or mixtures are the most efficacious.	[Hariri, Benjamin M.; McMahon, Derek B.; Chen, Bei; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA USA; [Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, RJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA USA.; Lee, RJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA USA.	rjl@mail.med.upenn.edu	Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686	National Institutes of Health [R03DC013862]; Cystic Fibrosis Foundation [LEER16G0]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health (R03DC013862) and Cystic Fibrosis Foundation (LEER16G0) to R.J.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Babu KS, 2006, BIOORG MED CHEM LETT, V16, P221, DOI 10.1016/j.bmcl.2005.09.009; Babu PBR, 2004, CLIN CHIM ACTA, V347, P81, DOI 10.1016/j.cccn.2004.04.006; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Berger JT, 1999, AM J RESP CELL MOL, V20, P500, DOI 10.1165/ajrcmb.20.3.3383; Bhattacharyya N, 2008, ANN OTO RHINOL LARYN, V117, P448, DOI 10.1177/000348940811700608; Bhattacharyya N, 2012, OTOLARYNG HEAD NECK, V146, P307, DOI 10.1177/0194599811426089; BOWES D, 1977, THORAX, V32, P163, DOI 10.1136/thx.32.2.163; Brook I, 2016, EUR J CLIN MICROBIOL; Caltagirone S, 2000, INT J CANCER, V87, P595, DOI 10.1002/1097-0215(20000815)87:4&lt;595::AID-IJC21&gt;3.0.CO;2-5; Chen PH, 2004, EUR ARCH OTO-RHINO-L, V261, P238, DOI 10.1007/s00405-003-0682-z; Cherry Donald K, 2002, Adv Data, P1; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Dajani R, 2005, AM J RESP CELL MOL B; Dao TT, 2004, BIOORG MED CHEM LETT, V14, P1165, DOI 10.1016/j.bmcl.2003.12.087; Dao TT, 2003, ARCH PHARM RES, V26, P581, DOI 10.1007/BF02976703; Dubin RF, 2004, AM J PHYSIOL-LUNG C, V286, pL750, DOI 10.1152/ajplung.00326.2003; Duszyk M, 2001, PFLUG ARCH EUR J PHY, V443, pS45; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; FERRIOLA PC, 1989, BIOCHEM PHARMACOL, V38, P1617, DOI 10.1016/0006-2952(89)90309-2; Gamet-Payrastre L, 1999, GEN PHARMACOL-VASC S, V32, P279, DOI 10.1016/S0306-3623(98)00220-1; Godoy JM, 2011, OTOLARYNG HEAD NECK, V145, P673, DOI 10.1177/0194599811407279; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Hariri BM, 2017, J BIOL CHEM, V292, P8484, DOI [10.1074/jbc.M116.771949, 10.1074/jbc.m116.771949]; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P261, DOI 10.2500/ajra.2016.30.4331; Harro JM, 2013, GENOME ANNOUNC, V1; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; HINGLEY ST, 1986, INFECT IMMUN, V51, P254, DOI 10.1128/IAI.51.1.254-262.1986; Jiang N, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5020027; Johnson L, 2012, J BACTERIOL, V194, P813, DOI 10.1128/JB.05230-11; Joo NS, 2004, J BIOL CHEM, V279, P38854, DOI 10.1074/jbc.M407077200; KANTHAKUMAR K, 1993, INFECT IMMUN, V61, P2848, DOI 10.1128/IAI.61.7.2848-2853.1993; Kavanaugh NL, 2014, MBIO, V5, DOI 10.1128/mBio.01911-14; Kennedy JL, 2013, AM J RHINOL ALLERGY, V27, P467, DOI 10.2500/ajra.2013.27.3960; Kim JO, 2012, PHYTOTHER RES, V26, P1784, DOI 10.1002/ptr.4650; Kingdom TT, 2004, AM J OTOLARYNG, V25, P323, DOI 10.1016/j.amjoto.2004.03.003; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; Kuroda Y, 2016, BIOSCI BIOTECH BIOCH, V80, P2014, DOI 10.1080/09168451.2016.1184558; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33221; Lee RJ, 2016, SCI AM, V314, P38; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Lee RJ, 2015, CURR OPIN ALLERGY CL, V15, P14, DOI 10.1097/ACI.0000000000000120; Lee RJ, 2014, J MOL MED, V92, P1235, DOI 10.1007/s00109-014-1222-6; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476; Lee RJ, 2013, AM J RHINOL ALLERGY, V27, P283, DOI 10.2500/ajra.2013.27.3911; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lee SH, 2002, ANN OTO RHINOL LARYN, V111, P135, DOI 10.1177/000348940211100205; Levashov PA, 2010, ANAL CHEM, V82, P2161, DOI 10.1021/ac902978u; Liu IX, 2001, J PHARM PHARMACOL, V53, P129, DOI 10.1211/0022357011775118; Lv YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Ly Nghi, 2002, Adv Data, P1; Manes RP, 2012, FACIAL PLAST SURG CL, V20, P87, DOI 10.1016/j.fsc.2011.10.010; Marcinkiewicz J, 2013, POL ARCH MED WEWN, V123, P309, DOI 10.20452/pamw.1780; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Mughal EU, 2006, BIOORGAN MED CHEM, V14, P4704, DOI 10.1016/j.bmc.2006.03.031; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Orhan DD, 2010, MICROBIOL RES, V165, P496, DOI 10.1016/j.micres.2009.09.002; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Patil RH, 2016, INFLAMMATION, V39, P138, DOI 10.1007/s10753-015-0232-z; Platz J, 2004, J IMMUNOL, V173, P1219, DOI 10.4049/jimmunol.173.2.1219; Prokhorenko IR, 2009, INT J GEN MED, V2, P33; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; Ray NF, 1999, J ALLERGY CLIN IMMUN, V103, P408, DOI 10.1016/S0091-6749(99)70464-1; Roland WSU, 2013, J AGR FOOD CHEM, V61, P10454, DOI 10.1021/jf403387p; Roland WSU, 2011, J AGR FOOD CHEM, V59, P11764, DOI 10.1021/jf202816u; Sato M, 1996, J ETHNOPHARMACOL, V54, P171, DOI 10.1016/S0378-8741(96)01464-X; Sato Y, 2004, INT J ANTIMICROB AG, V24, P226, DOI 10.1016/j.ijantimicag.2004.02.028; Schrader KK, 2010, TOXINS, V2, P1676, DOI 10.3390/toxins2071676; Schwarzer C, 2008, J BIOL CHEM, V283, P27144, DOI 10.1074/jbc.M709693200; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; Seleem D, 2016, ARCH ORAL BIOL; Seo HS, 2014, BIOMOL THER, V22, P525, DOI 10.4062/biomolther.2014.094; Settipane RA, 2013, AM J RHINOL ALLERGY, V27, pS11, DOI 10.2500/ajra.2013.27.3925; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Sikder MA, 2014, PHYTOTHER RES, V28, P62, DOI 10.1002/ptr.4954; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Tan CX, 2015, CHEM BIODIVERS, V12, P259, DOI 10.1002/cbdv.201400181; Tewfik MA, 2007, AM J RHINOL, V21, P680, DOI 10.2500/ajr.2007.21.3103; Uckoo RM, 2015, J AGR FOOD CHEM, V63, P7180, DOI 10.1021/acs.jafc.5b02445; VOSS JG, 1964, J GEN MICROBIOL, V35, P313, DOI 10.1099/00221287-35-2-313; Wang JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15963; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; Wu DL, 2008, INT J ANTIMICROB AG, V32, P421, DOI 10.1016/j.ijantimicag.2008.06.010; Yao J, 2014, IMMUNOLOGY, V143, P241, DOI 10.1111/imm.12305; Yeh CH, 2015, TOXICOL IND HEALTH, V31, P960, DOI 10.1177/0748233713485886; Yeh CH, 2014, ENVIRON TOXICOL, V29, P1162, DOI 10.1002/tox.21847; Zhang XW, 2011, PHARM BIOL, V49, P256, DOI 10.3109/13880209.2010.501803; Zhang Y, 2001, AM J RESP CELL MOL, V25, P196, DOI 10.1165/ajrcmb.25.2.4211	98	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185203	10.1371/journal.pone.0185203	http://dx.doi.org/10.1371/journal.pone.0185203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931063	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700078
J	Ungaro, A; Pech, N; Martin, JF; McCairns, RJS; Mevy, JP; Chappaz, R; Gilles, A				Ungaro, Arnaud; Pech, Nicolas; Martin, Jean-Francois; McCairns, R. J. Scott; Mevy, Jean-Philippe; Chappaz, Remi; Gilles, Andre			Challenges and advances for transcriptome assembly in non-model species	PLOS ONE			English	Article							RNA-SEQ; DE-NOVO; GENERATION; RECONSTRUCTION; STRATEGIES; GENETICS; PANTHER; LENGTH; TOOL	Analyses of high-throughput transcriptome sequences of non-model organisms are based on two main approaches: de novo assembly and genome-guided assembly using mapping to assign reads prior to assembly. Given the limits of mapping reads to a reference when it is highly divergent, as is frequently the case for non-model species, we evaluate whether using blastn would outperform mapping methods for read assignment in such situations (> 15% divergence). We demonstrate its high performance by using simulated reads of lengths corresponding to those generated by the most common sequencing platforms, and over a realistic range of genetic divergence (0% to 30% divergence). Here we focus on gene identification and not on resolving the whole set of transcripts (i.e. the complete transcriptome). For simulated datasets, the transcriptome-guided assembly based on blastn recovers 94.8% of genes irrespective of read length at 0% divergence; however, assignment rate of reads is negatively correlated with both increasing divergence level and reducing read lengths. Nevertheless, we still observe 92.6% of recovered genes at 30% divergence irrespective of read length. This analysis also produces a categorization of genes relative to their assignment, and suggests guidelines for data processing prior to analyses of comparative transcriptomics and gene expression to minimize potential inferential bias associated with incorrect transcript assignment. We also compare the performances of de novo assembly alone vs in combination with a transcriptome-guided assembly based on blastn both via simulation and empirically, using data from a cyprinid fish species and from an oak species. For any simulated scenario, the transcriptome-guided assembly using blastn outperforms the de novo approach alone, including when the divergence level is beyond the reach of traditional mapping methods. Combining de novo assembly and a related reference transcriptome for read assignment also addresses the bias/error in contigs caused by the dependence on a related reference alone. Empirical data corroborate these findings when assembling transcriptomes from the two non-model organisms: Parachondrostoma toxostoma (fish) and Quercus pubescens (plant). For the fish species, out of the 31,944 genes known from D. rerio, the guided and de novo assemblies recover respectively 20,605 and 20,032 genes but the performance of the guided assembly approach is much higher for both the contiguity and completeness metrics. For the oak, out of the 29,971 genes known from Vitis vinifera, the transcriptome-guided and de novo assemblies display similar performance, but the new guided approach detects 16,326 genes where the de novo assembly only detects 9,385 genes.	[Ungaro, Arnaud; Pech, Nicolas; McCairns, R. J. Scott; Chappaz, Remi; Gilles, Andre] Aix Marseille Univ, UMR 7263, Equipe Evolut Genome Environm, CNRS,IRD,IMBE, Marseille, France; [Martin, Jean-Francois] Montpellier SupAgro, UMR Ctr Biol Gest Populat, Montferrier Sur Lez, France; [McCairns, R. J. Scott] Agrocampus Ouest, INRA, ESE, Ecol & Ecosyst Hlth, Rennes, France; [Mevy, Jean-Philippe] Aix Marseille Univ, Equipe Divers Fonctionnement Mol Ecosyst, UMR 7263, CNRS,IRD,IMBE, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); INRAE; Institut Agro; Agrocampus Ouest; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Martin, JF (corresponding author), Montpellier SupAgro, UMR Ctr Biol Gest Populat, Montferrier Sur Lez, France.	jean-francois.martin@supagro.fr	McCairns, R.J. Scott/E-4458-2015; Martin, Jean-Francois/M-9426-2017	McCairns, R.J. Scott/0000-0002-0392-7413; Ungaro, Arnaud/0000-0002-3762-4971; MEVY, Jean-Philippe/0000-0001-5376-0810; Nicolas, Pech/0000-0002-1822-3558; Martin, Jean-Francois/0000-0001-9176-4476	EDF (Electricite de France); different departments of Electricite de France	EDF (Electricite de France)(Electricite de France (EDF)); different departments of Electricite de France	AU was supported by a PhD grant from EDF (Electricite de France). We are grateful to the different departments of Electricite de France for the financial support of the present study: EDF -Recherche et Developpement, Clamart especially Dr Mathieu Le Brun and Laurence Tissote EDF- Unite of Production Mediterranee especially Dr Julie Mosseri and EDF Centre dIngenierie Hydraulique Technolac Chambery especially Dr Agnes Barillier and Frederic Jacob. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7513; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bates D., 2014, R PACKAGE VERSION; Bushmanova E, 2016, BIOINFORMATICS, V32, P2210, DOI 10.1093/bioinformatics/btw218; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Elran R, 2014, MOL ECOL, V23, P4722, DOI 10.1111/mec.12891; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grishkevich V, 2014, GENOME RES, V24, P1497, DOI 10.1101/gr.169722.113; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hipp R Team SQLite Development, 2015, SQLITE DEV; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; Huang X, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2923-8; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jain P, 2013, PEERJ, V1, DOI 10.7717/peerj.133; Kuang YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34849; Leder EH, 2015, MOL BIOL EVOL, V32, P674, DOI 10.1093/molbev/msu328; Lu BX, 2013, SCI CHINA LIFE SCI, V56, P143, DOI 10.1007/s11427-013-4442-z; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Nikinmaa M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2974; Nikolenko SI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S7; Ockendon NF, 2016, MOL ECOL RESOUR, V16, P446, DOI 10.1111/1755-0998.12465; Palma-Silva C, 2016, MOL ECOL RESOUR, V16, P1012, DOI 10.1111/1755-0998.12504; Poelstra JW, 2015, MOL ECOL, V24, P4617, DOI 10.1111/mec.13353; Pratlong M, 2015, MOL ECOL RESOUR, V15, P1205, DOI 10.1111/1755-0998.12383; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; R Core Team, 2021, R LANGUAGE ENV STAT; Rana SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153104; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Shi XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1954; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Todd EV, 2016, MOL ECOL, V25, P1224, DOI 10.1111/mec.13526; Torre S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112487; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang S, 2016, BIOINFORMATICS; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolf JBW, 2013, MOL ECOL RESOUR, V13, P559, DOI 10.1111/1755-0998.12109; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	50	27	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185020	10.1371/journal.pone.0185020	http://dx.doi.org/10.1371/journal.pone.0185020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931057	gold, Green Published, Green Submitted			2022-12-27	WOS:000411314700058
J	Afonso, AS; Garla, R; Hazin, FHV				Afonso, Andre S.; Garla, Ricardo; Hazin, Fabio H. V.			Tiger sharks can connect equatorial habitats and fisheries across the Atlantic Ocean basin	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; APEX PREDATORY SHARKS; GALEOCERDO-CUVIER; MARINE PREDATOR; AUSTRALIA; MOVEMENTS; BEHAVIOR; GEOLOCATION; ECOSYSTEMS; MIGRATION	Increasing our knowledge about the spatial ecology of apex predators and their interactions with diverse habitats and fisheries is necessary for understanding the trophic mechanisms that underlie several aspects of marine ecosystem dynamics and for guiding informed management policies. A preliminary assessment of tiger shark (Galeocerdo cuvier) population structure off the oceanic insular system of Fernando de Noronha (FEN) and the large-scale movements performed by this species in the equatorial Atlantic Ocean was conducted using longline and handline fishing gear and satellite telemetry. A total of 25 sharks measuring 175-372 cm in total length (TL) were sampled. Most sharks were likely immature females ranging between 200 and 260 cm TL, with few individuals < 200 cm TL being caught. This contrasts greatly with the tiger shark size-distribution previously reported for coastal waters off the Brazilian mainland, where most individuals measured < 200 cm TL. Also, the movements of 8 individuals measuring 202-310 cm TL were assessed with satellite transmitters for a combined total of 757 days (mean = 94.6 days.shark(-1); SD = 65.6). These sharks exhibited a considerable variability in their horizontal movements, with three sharks showing a mostly resident behavior around FEN during the extent of the respective tracks, two sharks traveling west to the South American continent, and two sharks moving mostly along the middle of the oceanic basin, one of which ending up in the northern hemisphere. Moreover, one shark traveled east to the African continent, where it was eventually caught by fishers from Ivory Coast in less than 474 days at liberty. The present results suggest that young tiger sharks measuring < 200 cm TL make little use of insular oceanic habitats from the western South Atlantic Ocean, which agrees with a previously-hypothesized ontogenetic habitat shift from coastal to oceanic habitats experienced by juveniles of this species in this region. In addition, this study adds evidence that tiger sharks are able to connect marine trophic webs from the neritic provinces of the eastern and western margins of the Atlantic Ocean across the equatorial basin and that they may experience mortality induced by remote fisheries. All this information is extremely relevant for understanding the energetic balance of marine ecosystems as much as the exposure of this species to fishing pressure in this yet poorly-known region.	[Afonso, Andre S.; Hazin, Fabio H. V.] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil; [Garla, Ricardo] Univ Fed Rio Grande do Norte, Dept Botanifca Ecol & Zool, Natal, RN, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal do Rio Grande do Norte	Afonso, AS (corresponding author), Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil.	afonso.andre@gmail.com	Garla, Ricardo C/A-2990-2014	Afonso, Andre/0000-0001-9129-278X; Hazin, Fabio/0000-0003-3755-5379; Garla, Ricardo/0000-0002-0827-225X	Coordenagao de Aperfeigoamento de Pessoal do Ensino Superior [BJT-A049/2013]; State Government of Pernambuco; Fundo Nacional do Meio Ambiente [03/2006]; National Geographic Society Conservation Trust [C314-15]	Coordenagao de Aperfeigoamento de Pessoal do Ensino Superior; State Government of Pernambuco; Fundo Nacional do Meio Ambiente; National Geographic Society Conservation Trust(National Geographic Society)	This study was funded by the Coordenagao de Aperfeigoamento de Pessoal do Ensino Superior (http://www.capes.gov.br) (BJT-A049/2013 granted to ASA), the State Government of Pernambuco (http://www.sds.pe.gov.br), the Fundo Nacional do Meio Ambiente (http://www. mma.gov.br/fundo-national-do-meio-ambiente) (#03/2006 granted to RCG), and the National Geographic Society Conservation Trust (http:// www.nationalgeographic.com/explorers/grants programs/conservation-trust) (C314-15 granted to ASA). Precious collaborative field work and tracking data provided by Chris Fischer and Ocearch (www.ocearch.org) are deeply acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116720; Afonso AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102369; Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Baum JK, 2010, FISH RES, V102, P229, DOI 10.1016/j.fishres.2009.11.006; Bernard A, 2014, MOL ECOL IN PRESS; Bernard A, MOL ECOL IN PRESS; BRANSTETTER S, 1987, FISH B-NOAA, V85, P269; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Castro J.I., 1999, FAO FISHERIES TECHNI; Compagno LJV, 1984, FAO SPECIES CATALOGU, V4, P125; Domingo A, 2016, J FISH BIOL, V88, P1223, DOI 10.1111/jfb.12887; Driggers WB, 2008, AQUAT BIOL, V2, P161, DOI 10.3354/ab00045; Ferreira LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116916; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Francis MP, 2015, MAR BIOL, V162, P2305, DOI 10.1007/s00227-015-2756-z; Gallagher AJ, 2016, SHARK RECREATIONAL F; Galuardi B, 2010, ANALYZEPSAT R PACKAG; Graham F, 2016, DIVERS DISTRIB, V22, P534, DOI 10.1111/ddi.12425; Hammerschlag N, 2016, BEHAV ECOL SOCIOBIOL, V70, P1777, DOI 10.1007/s00265-016-2183-2; Hammerschlag N, 2015, ECOLOGY, V96, P2117, DOI 10.1890/14-2113.1; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hays GC, 2016, TRENDS ECOL EVOL, V31, P463, DOI 10.1016/j.tree.2016.02.015; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Holmes BJ, 2015, J FISH BIOL, V87, P422, DOI 10.1111/jfb.12732; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Jonsen ID, 2015, MAR BIOL; Ketchum JT, 2014, MAR BIOL, V161, P939, DOI 10.1007/s00227-014-2393-y; Kohler NE, 1998, MAR FISH REV, V60, P1; Lam CH, 2000, FISH RES, V91, P15; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Lea JSE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11202; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; Papastamatiou YP, 2015, MAR ECOL PROG SER, V521, P155, DOI 10.3354/meps11110; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Queiroz N, 2016, P NATL ACAD SCI USA, V113, P1582, DOI 10.1073/pnas.1510090113; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Simpfendorfer CA, 2014, IUCN 2013 IUCN RED L; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; STRAMMA L, 1991, J MAR RES, V49, P281, DOI 10.1357/002224091784995864; Sulikowski JA., 2016, AQUAT BIOL, V24, P175, DOI [10.3354/ab00648, DOI 10.3354/AB00648]; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081	49	18	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184763	10.1371/journal.pone.0184763	http://dx.doi.org/10.1371/journal.pone.0184763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926627	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600037
J	Du, YH; Martine, JS; Mcgee, J; Yang, YC; Liu, EY; Suns, YR; Geihs, M; Kong, XJ; Zhou, EL; Li, Y; Huang, J				Du, Yonghong; Martine, Joshua S.; Mcgee, John; Yang, Yuchen; Liu, Eric Yi; Suns, Yingrui; Geihs, Matthias; Kong, Xuejun; Zhou, Eric Lingfeng; Li, Yun; Huang, Jie			A SNP panel and online tool for checking genotype concordance through comparing QR codes	PLOS ONE			English	Article							ASSOCIATION; SEQUENCE; HEALTH	In the current precision medicine era, more and more samples get genotyped and sequenced. Both researchers and commercial companies expend significant time and resources to reduce the error rate. However, it has been reported that there is a sample mix-up rate of between 0.1% and 1%, not to mention the possibly higher mix-up rate during the down-stream genetic reporting processes. Even on the low end of this estimate, this translates to a significant number of mislabeled samples, especially over the projected one billion people that will be sequenced within the next decade. Here, we first describe a method to identify a small set of Single nucleotide polymorphisms (SNPs) that can uniquely identify a personal genome, which utilizes allele frequencies of five major continental populations reported in the 1000 genomes project and the ExAC Consortium. To make this panel more informative, we added four SNPs that are commonly used to predict ABO blood type, and another two SNPs that are capable of predicting sex. We then implement a web interface (http://qrcme.tech), nicknamed QRC (for QR code based Concordance check), which is capable of extracting the relevant ID SNPs from a raw genetic data, coding its genotype as a quick response (QR) code, and comparing QR codes to report the concordance of underlying genetic datasets. The resulting 80 fingerprinting SNPs represent a significant decrease in complexity and the number of markers used for genetic data labelling and tracking. Our method and web tool is easily accessible to both researchers and the general public who consider the accuracy of complex genetic data as a prerequisite towards precision medicine.	[Du, Yonghong] Beijing Normal Univ, Sch Stat, Beijing, Peoples R China; [Martine, Joshua S.; Yang, Yuchen; Li, Yun] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA; [Mcgee, John] Univ North Carolina Chapel Hill, NC Translat & Clin Sci Inst, Chapel Hill, NC USA; [Liu, Eric Yi; Li, Yun] Univ North Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Suns, Yingrui] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Geihs, Matthias] Tech Univ Darmstadt, Dept Comp Sci, Darmstadt, Germany; [Kong, Xuejun] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zhou, Eric Lingfeng; Li, Yun] Univ North Carolina Chapel Hill, Dept Biostat, Chapel Hill, NC 27599 USA; [Huang, Jie] Boston VA Res Inst, Boston, MA 02130 USA; [Huang, Jie] Harvard Med Sch, Brigham Womens Hosp, Div Aging, Boston, MA 02115 USA	Beijing Normal University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Boston University; Technical University of Darmstadt; Harvard University; Beth Israel Deaconess Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Li, Y (corresponding author), Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA.; Li, Y (corresponding author), Univ North Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC 27599 USA.; Li, Y (corresponding author), Univ North Carolina Chapel Hill, Dept Biostat, Chapel Hill, NC 27599 USA.; Huang, J (corresponding author), Boston VA Res Inst, Boston, MA 02130 USA.; Huang, J (corresponding author), Harvard Med Sch, Brigham Womens Hosp, Div Aging, Boston, MA 02115 USA.	yenli@med.unc.edu; jhuang@bwh.harvard.edu	Yang, Yuchen/GZK-6062-2022	Huang, Jie/0000-0002-9036-4304	Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Robert Dawson Evans Endowment of the Department of Medicine at Boston Medical Center; NIH [R01HG006292, R01 HL129132, UL1TR001111]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129132] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006292] Funding Source: NIH RePORTER	Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Robert Dawson Evans Endowment of the Department of Medicine at Boston Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The research is supported by NIH grants R01HG006292, R01 HL129132, and UL1TR001111.; We thank Dr. Alkes Price at the Harvard TH Chan School of Public Health for commenting on an earlier version of this manuscript. We acknowledge the UK Biobank for making the data available. A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The research is supported by NIH grants R01HG006292, R01 HL129132, and UL1TR001111.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Eisenstein M, 2015, NATURE, V527, pS2, DOI 10.1038/527S2a; Fradkin JE, 2016, DIABETES CARE, V39, P1080, DOI 10.2337/dc16-0541; Galichon P, 2012, NUCLEIC ACIDS RES, V40, P4774, DOI 10.1093/nar/gks169; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Hu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10247; Hwa HL, 2016, INT J LEGAL MED, V130, P81, DOI 10.1007/s00414-015-1250-y; Kim JJ, 2010, INT J LEGAL MED, V124, P125, DOI 10.1007/s00414-009-0389-9; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Lee HJ, 2017, INT J LEGAL MED, V131, P1203, DOI 10.1007/s00414-017-1564-z; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ling Hua, 2009, BMC Proc, V3 Suppl 7, pS57; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035146; Pakstis AJ, 2010, HUM GENET, V127, P315, DOI 10.1007/s00439-009-0771-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Storry J R, 2009, Immunohematology, V25, P48; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YAMAMOTO F, 1992, BIOCHEM BIOPH RES CO, V187, P366, DOI 10.1016/S0006-291X(05)81502-5	22	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0182438	10.1371/journal.pone.0182438	http://dx.doi.org/10.1371/journal.pone.0182438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926565	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600001
J	Kim, M; Ding, Y; Malcolm, P; Speeckaert, J; Siviy, CJ; Walsh, CJ; Kuindersma, S				Kim, Myunghee; Ding, Ye; Malcolm, Philippe; Speeckaert, Jozefien; Siviy, Christoper J.; Walsh, Conor J.; Kuindersma, Scott			Human-in-the-loop Bayesian optimization of wearable device parameters	PLOS ONE			English	Article							CMA EVOLUTION STRATEGY; PUSH-OFF WORK; EXOSKELETON ASSISTANCE; GLOBAL OPTIMIZATION; METABOLIC-RATE; WALKING; PROSTHESIS; REGRESSION; COST; SLOW	The increasing capabilities of exoskeletons and powered prosthetics for walking assistance have paved the way for more sophisticated and individualized control strategies. In response to this opportunity, recent work on human-in-the-loop optimization has considered the problem of automatically tuning control parameters based on realtime physiological measurements. However, the common use of metabolic cost as a performance metric creates significant experimental challenges due to its long measurement times and low signalto- noise ratio. We evaluate the use of Bayesian optimization-a family of sample-efficient, noise-tolerant, and global optimization methods-for quickly identifying near-optimal control parameters. To manage experimental complexity and provide comparisons against related work, we consider the task of minimizing metabolic cost by optimizing walking step frequencies in unaided human subjects. Compared to an existing approach based on gradient descent, Bayesian optimization identified a near-optimal step frequency with a faster time to convergence (12 minutes, p < 0.01), smaller inter-subject variability in convergence time (+/- 2 minutes, p < 0.01), and lower overall energy expenditure (p < 0.01).	[Kim, Myunghee; Ding, Ye; Malcolm, Philippe; Speeckaert, Jozefien; Siviy, Christoper J.; Walsh, Conor J.; Kuindersma, Scott] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kim, Myunghee; Ding, Ye; Malcolm, Philippe; Speeckaert, Jozefien; Siviy, Christoper J.; Walsh, Conor J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Malcolm, Philippe] Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA; [Malcolm, Philippe] Univ Nebraska, Ctr Res Human Movement Variabil, Omaha, NE 68182 USA	Harvard University; Harvard University; University of Nebraska System; University of Nebraska System	Kim, M; Walsh, CJ; Kuindersma, S (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Kim, M; Walsh, CJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	myunghee_kirn@g.harvard.edu; walsh@seas.harvard.edu; scottk@seas.harvard.edu		Siviy, Christopher/0000-0003-0789-0109; Kim, Myunghee/0000-0001-8965-6206	Defense Advanced Research Projects Agency (DARPA), Warrior Web Program [W911NF-14-C-0051]; National Science Foundation [DGE1144152]; Center for Research in Human Movement Variability of the University of Nebraska Omaha; NIH [P20GM109090]; Technology for Equitable and Assessable Medicine (TEAM) initiative at Harvard; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109090] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA), Warrior Web Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Center for Research in Human Movement Variability of the University of Nebraska Omaha; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Technology for Equitable and Assessable Medicine (TEAM) initiative at Harvard; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based on the work supported by the Defense Advanced Research Projects Agency (DARPA), Warrior Web Program (contract no. W911NF-14-C-0051), and the National Science Foundation Graduate Research Fellowship Program (grant no. DGE1144152). P.M. was supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the NIH (P20GM109090). This work was also supported in part by the Technology for Equitable and Assessable Medicine (TEAM) initiative at Harvard. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of DARPA or the NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This material is based on the work supported by the Defense Advanced Research Projects Agency (DARPA), Warrior Web Program (contract no. W911NF-14-C-0051), and the National Science Foundation Graduate Research Fellowship Program (grant no. DGE1144152). P.M. was supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the NIH (P20GM109090). This work was also supported in part by the Technology for Equitable and Assessable Medicine (TEAM) initiative at Harvard.	Asbeck AT, 2015, IEEE INT CONF ROBOT, P6197, DOI 10.1109/ICRA.2015.7140069; Ascher U, 2016, VIETNAM J MATH, V44, P49, DOI 10.1007/s10013-015-0167-6; Bae J, 2015, INT C REHAB ROBOT, P131, DOI 10.1109/ICORR.2015.7281188; BERA AK, 1981, ECON LETT, V7, P313, DOI 10.1016/0165-1765(81)90035-5; Brochu E., 2008, ADV NEURAL INFORM PR, P409; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Calandra R, 2016, ANN MATH ARTIF INTEL, V76, P5, DOI 10.1007/s10472-015-9463-9; CAMUS G, 1988, EUR J APPL PHYSIOL O, V58, P197, DOI 10.1007/BF00636626; Caputo JM, 2015, IEEE INT CONF ROBOT, P6445, DOI 10.1109/ICRA.2015.7140104; Caputo JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07213; Ding Y, 2017, IEEE T NEUR SYS REH, V25, P119, DOI 10.1109/TNSRE.2016.2523250; Ding Y, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0196-8; Eric Brochu, 2010, TUTORIAL BAYESIAN OP; Felt W., 2012, INSTANTANEUOS COST M; Felt W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135342; Galle S, 2013, GAIT POSTURE, V38, P495, DOI 10.1016/j.gaitpost.2013.01.029; Galle S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0235-0; Garde A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086427; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Hansen N, 2004, LECT NOTES COMPUT SC, V3242, P282; Hansen N, 2006, STUD FUZZ SOFT COMP, V192, P75; Huang D, 2006, J GLOBAL OPTIM, V34, P441, DOI 10.1007/s10898-005-2454-3; Jackson RW, 2017, J EXP BIOL, V220, P2082, DOI 10.1242/jeb.150011; Jones DR, 2001, J GLOBAL OPTIM, V21, P345, DOI 10.1023/A:1012771025575; Kee AJ, 2015, TRAFFIC, V16, P691, DOI 10.1111/tra.12282; Kim M., 2015, THESIS CARNEGIE MELL; Kim M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0027-3; Koller JR, 2016, ROBOTICS: SCIENCE AND SYSTEMS XII; Koller JR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0086-5; Kuindersma SR, 2013, INT J ROBOT RES, V32, P806, DOI 10.1177/0278364913476124; Kushner H.J., 1964, J BASIC ENG-T ASME, V86, P97, DOI 10.1115/1.3653121; Lee J, 2017, INT C REHAB ROBOT, P498, DOI 10.1109/ICORR.2017.8009297; Lee SJ, 2016, IEEE INT CONF ROBOT, P3509, DOI 10.1109/ICRA.2016.7487531; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Lizotte DJ, 2008, PRACTICAL BAYESIAN O; Lorenz R, 2016, NEUROIMAGE, V129, P320, DOI 10.1016/j.neuroimage.2016.01.032; Lourens MS, 2000, INTENS CARE MED, V26, P1612, DOI 10.1007/s001340000632; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Mockus J., 1978, GLOBAL OPTIMIZATION, V2, P2, DOI DOI 10.1007/978-94-009-0909-0_80394.90090; Mokus J., 1975, OPTIMIZATION TECHNIQ, P400, DOI [10.1007/3-540-07165-2_55, DOI 10.1007/3-540-07165-2_55]; Mooney LM, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0111-3; Ogawa Y, 2006, J CLIN ANESTH, V18, P87, DOI 10.1016/j.jclinane.2005.06.004; Panizzolo FA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0150-9; Perez-Cruz F, 2013, IEEE SIGNAL PROC MAG, V30, P40, DOI 10.1109/MSP.2013.2250352; Pfeiffer KA, 2002, MED SCI SPORT EXER, V34, P2057, DOI 10.1097/00005768-200212000-00029; Quesada RE, 2016, J BIOMECH, V49, P3452, DOI 10.1016/j.jbiomech.2016.09.015; Quinlivan BT, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aah4416; Ratkevicius A, 2006, J SPORT SCI MED, V5, P440; Roberts JW, 2009, ADV NEURAL INFORM PR, P1361; SCHAFFER C, 1993, MACH LEARN, V10, P153, DOI 10.1023/A:1022653209073; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; Selinger JC, 2014, J APPL PHYSIOL, V117, P1406, DOI 10.1152/japplphysiol.00445.2014; Seo K, 2016, IEEE INT CONF ROBOT, P4628, DOI 10.1109/ICRA.2016.7487663; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Swersky K., 2013, ADV NEURAL INFORM PR, V2, P2004, DOI DOI 10.1038/S41598-021-83582-6; Bui-Thanh T, 2012, SIAM J SCI COMPUT, V34, pA2837, DOI 10.1137/110851419; van Vaerenbergh S., 2012, IEEE INT WORKSH MACH, P1; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wehner M, 2013, IEEE INT CONF ROBOT, P3362, DOI 10.1109/ICRA.2013.6631046; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Zhang JJ, 2017, SCIENCE, V356, P1280, DOI 10.1126/science.aal5054	62	32	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184054	10.1371/journal.pone.0184054	http://dx.doi.org/10.1371/journal.pone.0184054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926613	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600008
J	Li, T; Gao, YQ; Dong, QK; Wang, H				Li, Tao; Gao, Yingqi; Dong, Qiankun; Wang, Hua			Degree sums and dense spanning trees	PLOS ONE			English	Article							WIENER POLARITY INDEX; SUBTREES	Finding dense spanning trees (DST) in unweighted graphs is a variation of the well studied minimum spanning tree problem (MST). We utilize established mathematical properties of extremal structures with the minimum sum of distances between vertices to formulate some general conditions on the sum of vertex degrees. We analyze the performance of various combinations of these degree sum conditions in finding dense spanning subtrees and apply our approach to practical examples. After briefly describing our algorithm we also show how it can be used on variations of DST, motivated by variations of MST. Our work provide some insights on the role of various degree sums in forming dense spanning trees and hopefully lay the foundation for finding fast algorithms or heuristics for related problems.	[Li, Tao; Gao, Yingqi; Dong, Qiankun] Nankai Univ, Coll Comp & Control Engn, Tianjin 300071, Peoples R China; [Wang, Hua] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China; [Wang, Hua] Georgia Southern Univ, Math Sci, Statesboro, GA 30460 USA	Nankai University; Nankai University; University System of Georgia; Georgia Southern University	Wang, H (corresponding author), Nankai Univ, Coll Software, Tianjin 300071, Peoples R China.; Wang, H (corresponding author), Georgia Southern Univ, Math Sci, Statesboro, GA 30460 USA.	hwang@georgiasouthern.edu			Natural Science Foundation of Tianjin [16JCYBJC15200, 17JCQNJC00300]; Simons Foundation [245307]	Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Simons Foundation	T. Li is partially supported by the Natural Science Foundation of Tianjin (No. 16JCYBJC15200). T. Li and Q. Dong are partially supported by the Natural Science Foundation of Tianjin (No. 17JCQNJC00300). H. Wang is partially supported by the Simons Foundation (No. 245307).; T. Li is partially supported by the Natural Science Foundation of Tianjin (No. 16JCYBJC15200), T. Li and Q. Dong are partially supported by the Natural Science Foundation of Tianjin (No. 17JCQNJC00300). H. Wang is partially supported by the Simons Foundation (No. 245307).	Amberg A, 1996, COMBINATORIAL OPTIMI, V1, P9; Bazlamacci CF, 2001, COMPUT OPER RES, V28, P767, DOI 10.1016/S0305-0548(00)00007-1; Chandler C., 2017, THESIS, P258; Darmann A., 2009, OPTIMIZATION ONLINE; Dobrynin AA, 2001, ACTA APPL MATH, V66, P211, DOI 10.1023/A:1010767517079; Frank P.W., 1992, ANN DISCRETE MATH, V53; JAMISON RE, 1984, J COMB THEORY B, V37, P70, DOI 10.1016/0095-8956(84)90046-7; JAMISON RE, 1983, J COMB THEORY B, V35, P207, DOI 10.1016/0095-8956(83)90049-7; Knudsen B, 2003, LECT N BIOINFORMAT, V2812, P433; Lei H, 2017, MATCH-COMMUN MATH CO, V78, P199; Ma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19066; NARULA SC, 1980, COMPUT OPER RES, V7, P239, DOI 10.1016/0305-0548(80)90022-2; Ozen M, 2016, THEORY APPL GRAPHS, V3; Ozen M, PREPRINT; Szekely LA, 2005, ADV APPL MATH, V34, P138, DOI 10.1016/j.aam.2004.07.002; Wagner S, 2016, MATH APPL, V159, P3; Wagner SG, 2007, SIAM J DISCRETE MATH, V21, P33, DOI 10.1137/050631446; WIENER H, 1947, J AM CHEM SOC, V69, P2636, DOI 10.1021/ja01203a022; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005	19	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184912	10.1371/journal.pone.0184912	http://dx.doi.org/10.1371/journal.pone.0184912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926585	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600052
J	Ambrisko, TD; Schramel, JP; Auer, U; Moens, YPS				Ambrisko, Tamas D.; Schramel, Johannes P.; Auer, Ulrike; Moens, Yves P. S.			Impact of four different recumbencies on the distribution of ventilation in conscious or anaesthetized spontaneously breathing beagle dogs: An electrical impedance tomography study	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; COMPUTED-TOMOGRAPHY; LUNG VENTILATION; PERFUSION; CONSOLIDATION; RECRUITMENT; NEED; EIT	The aim was to examine the effects of recumbency and anaesthesia on distribution of ventilation in beagle dogs using Electrical Impedance Tomography (EIT). Nine healthy beagle dogs, aging 3.7 +/- 1.7 (mean +/- SD) years and weighing 16.3 +/- 1.6 kg, received a series of treatments in a fixed order on a single occasion. Conscious dogs were positioned in right lateral recumbency (RLR) and equipped with 32 EIT electrodes around the thorax. Following five minutes of equilibration, two minutes of EIT recordings were made in each recumbency in the following order: RLR, dorsal (DR), left (LLR) and sternal (SR). The dogs were then positioned in RLR, premedicated (medetomidine 0.01, midazolam 0.1, butorphanol 0.1 mg kg(-1) iv) and pre-oxygenated. Fifteen minutes later anaesthesia was induced with 1 mg kg(-1) propofol iv and maintained with propofol infusion (0.1 +/- 0.2 mg kg(-1) minute(-1) iv). After induction, the animals were intubated and allowed to breathe spontaneously (FIO2 = 1). Recordings of EIT were performed again in four recumbencies similarly to conscious state. Centre of ventilation (COV) and global inhomogeneity (GI) index were calculated from the functional EIT images. Repeated-measures ANOVA and Bonferroni tests were used for statistical analysis (p < 0.05). None of the variables changed in the conscious state. During anaesthesia left-toright COV increased from 46.8 +/- 2.8% in DR to 49.8 +/- 2.9% in SR indicating a right shift, and ventral-to-dorsal COV increased from 49.8 +/- 1.7% in DR to 51.8 +/- 1.1% in LLR indicating a dorsal shift in distribution of ventilation. Recumbency affected distribution of ventilation in anaesthetized but not in conscious dogs. This can be related to loss of respiratory muscle tone (e.g. diaphragm) and changes in thoracic shape. Changing position of thoraco-abdominal organs under the EIT belt should be considered as alternative explanation of these findings.	[Ambrisko, Tamas D.; Schramel, Johannes P.; Auer, Ulrike; Moens, Yves P. S.] Univ Vet Med, Dept Compan Anim & Horses, Anaesthesiol & Perioperat Intens Care Med, Vienna, Austria	University of Veterinary Medicine Vienna	Ambrisko, TD (corresponding author), Univ Vet Med, Dept Compan Anim & Horses, Anaesthesiol & Perioperat Intens Care Med, Vienna, Austria.	tambrisko@hotmail.com		Ulrike, Auer/0000-0003-0390-2678	Gesellschaft zur Forderung Kynologischer Forschung e.V., Weilerswist, Germany	Gesellschaft zur Forderung Kynologischer Forschung e.V., Weilerswist, Germany	This work was supported by the Gesellschaft zur Forderung Kynologischer Forschung e.V., Weilerswist, Germany (http://gkf-boon.de/index.php/startserte.html). Funding was acquired by TDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Gesellschaft zur Forderung Kynologischer Forschung e.V., Weilerswist, Germany. The authors thank Dr. Martina Mosing for providing a CT image of a beagle dog that was used to create an EIT mesh for dogs. Preliminary results were presented as an Abstract at the 12th World Congress of Veterinary Anaesthesiology, Kyoto, Japan, 1st- 4th September 2015. None of the authors has any financial or personal relationships that could inappropriately influence or bias the content of the paper.	Adler A, 1998, J APPL PHYSIOL, V84, P726, DOI 10.1152/jappl.1998.84.2.726; Adler A, 1996, IEEE T BIO-MED ENG, V43, P414, DOI 10.1109/10.486261; Adler A, 1997, J APPL PHYSIOL, V83, P1762, DOI 10.1152/jappl.1997.83.5.1762; Adler A, 2012, PHYSIOL MEAS, V33, P679, DOI 10.1088/0967-3334/33/5/679; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; Ambrisko TD, 2016, PHYSIOL MEAS, V37, P175, DOI 10.1088/0967-3334/37/2/175; BEYDON L, 1992, CHEST, V102, P1697, DOI 10.1378/chest.102.6.1697; Bloomfield FH, 1999, PEDIATR RADIOL, V29, P459, DOI 10.1007/s002470050617; Chang H, 2002, J APPL PHYSIOL, V92, P745, DOI 10.1152/japplphysiol.00377.2001; Costa ELV, 2008, CRIT CARE MED, V36, P1230, DOI 10.1097/CCM.0b013e31816a0380; Costa ELV, 2009, CURR OPIN CRIT CARE, V15, P18, DOI 10.1097/MCC.0b013e3283220e8c; De Monte V, 2013, AM J VET RES, V74, P25, DOI 10.2460/ajvr.74.1.25; Frerichs I, 2006, AM J RESP CRIT CARE, V174, P772, DOI 10.1164/rccm.200512-1942OC; Gloning S, 2017, TIERAERZTL PRAX K H, V45, P15, DOI 10.15654/TPK-150569; Gomez-Laberge C, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/7/S13; Hoareau GL, 2011, J VET EMERG CRIT CAR, V21, P226, DOI 10.1111/j.1476-4431.2011.00635.x; Leonhardt S, 2012, INTENS CARE MED, V38, P1917, DOI 10.1007/s00134-012-2684-z; Luepschen H, 2007, PHYSIOL MEAS, V28, pS247, DOI 10.1088/0967-3334/28/7/S18; Marcucci C, 2001, J APPL PHYSIOL, V90, P421, DOI 10.1152/jappl.2001.90.2.421; Mosing M, 2016, VET ANAESTH ANALG; Newell JC, 1996, IEEE T BIO-MED ENG, V43, P133, DOI 10.1109/10.481982; Rocchi A., 2014, AVA C NOTT ASS VET A; Rooney D, 2009, PHYSIOL MEAS, V30, P1075, DOI 10.1088/0967-3334/30/10/008; Schibler A, 2009, PEDIATR PULM, V44, P851, DOI 10.1002/ppul.21000; Tusman G, 2010, BEST PRACT RES-CLIN, V24, P183, DOI 10.1016/j.bpa.2010.02.006; WEST JB, 1960, J APPL PHYSIOL, V15, P405, DOI 10.1152/jappl.1960.15.3.405; Zhao ZQ, 2009, INTENS CARE MED, V35, P1900, DOI 10.1007/s00134-009-1589-y	27	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183340	10.1371/journal.pone.0183340	http://dx.doi.org/10.1371/journal.pone.0183340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922361	gold, Green Published, Green Submitted			2022-12-27	WOS:000411059300004
J	Cieplak, AS				Cieplak, Andrzej Stanislaw			Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; INDUCED CONFORMATIONAL-CHANGES; PARTIALLY FOLDED STRUCTURE; PAIRED HELICAL FILAMENTS; ATOMIC-FORCE MICROSCOPY; SODIUM DODECYL-SULFATE; C-TERMINAL THREONINE; HUMAN PRION PROTEIN; O HYDROGEN-BONDS; A-BETA	Proteins associated with neurodegenerative diseases are highly pleiomorphic and may adopt an all-a-helical fold in one environment, assemble into all-beta-sheet or collapse into a coil in another, and rapidly polymerize in yet another one via divergent aggregation pathways that yield broad diversity of aggregates' morphology. A thorough understanding of this behaviour may be necessary to develop a treatment for Alzheimer's and related disorders. Unfortunately, our present comprehension of folding and misfolding is limited for want of a physicochemical theory of protein secondary and tertiary structure. Here we demonstrate that electronic configuration and hyperconjugation of the peptide amide bonds ought to be taken into account to advance such a theory. To capture the effect of polarization of peptide linkages on conformational and H-bonding propensity of the polypeptide backbone, we introduce a function of shielding tensors of the C-a atoms. Carrying no information about side chain-side chain interactions, this function nonetheless identifies basic features of the secondary and tertiary structure, establishes sequence correlates of the metamorphic and pHdriven equilibria, relates binding affinities and folding rate constants to secondary structure preferences, and manifests common patterns of backbone density distribution in amyloidogenic regions of Alzheimer's amyloid beta and tau, Parkinson's a-synuclein and prions. Based on those findings, a split-intein like mechanism of molecular recognition is proposed to underlie dimerization of A beta, tau, aS and PrPC, and divergent pathways for subsequent association of dimers are outlined; a related mechanism is proposed to underlie formation of PrP Sc fibrils. The model does account for: (i) structural features of paranuclei, off-pathway oligomers, non-fibrillar aggregates and fibrils; (ii) effects of incubation conditions, point mutations, isoform lengths, small-molecule assembly modulators and chirality of solid-liquid interface on the rate and morphology of aggregation; (iii) fibril-surface catalysis of secondary nucleation; and (iv) self-propagation of infectious strains of mammalian prions.	[Cieplak, Andrzej Stanislaw] Bilkent Univ, Dept Chem, Ankara, Turkey; [Cieplak, Andrzej Stanislaw] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Cieplak, Andrzej Stanislaw] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA	Ihsan Dogramaci Bilkent University; Yale University; Brandeis University	Cieplak, AS (corresponding author), Bilkent Univ, Dept Chem, Ankara, Turkey.; Cieplak, AS (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.; Cieplak, AS (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02254 USA.	cieplak@gmail.com	Ertan, Asli/AAE-6201-2021					Adhikary R, 2014, J AM CHEM SOC, V136, P13474, DOI 10.1021/ja503107h; Adler J, 2014, PHYS CHEM CHEM PHYS, V16, P7461, DOI 10.1039/c3cp54501f; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Albright TA, 2013, ORBITAL INTERACTIONS IN CHEMISTRY, 2ND EDITION, P1, DOI 10.1002/9781118558409; Alexander PA, 2009, P NATL ACAD SCI USA, V106, P21149, DOI 10.1073/pnas.0906408106; Anderson WJ, 2011, PROTEIN ENG DES SEL, V24, P765, DOI 10.1093/protein/gzr027; Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; [Anonymous], 2001, PROTEIN SCI S1, V10, P111; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Armstrong AH, 2011, BIOCHEMISTRY-US, V50, P4058, DOI 10.1021/bi200268w; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Ball KA, 2013, BIOPHYS J, V104, P2714, DOI 10.1016/j.bpj.2013.04.056; Banavar JR, 2007, ANNU REV BIOPH BIOM, V36, P261, DOI 10.1146/annurev.biophys.36.040306.132808; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Baranczak A, 2016, CURR OPIN CHEM BIOL, V32, P10, DOI 10.1016/j.cbpa.2016.01.009; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barre P, 2006, J MOL BIOL, V362, P312, DOI 10.1016/j.jmb.2006.07.018; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; Bateman DA, 2011, BIOPHYS J, V101, P2485, DOI 10.1016/j.bpj.2011.10.009; Beerten J, 2015, BIOINFORMATICS, V31, P1698, DOI 10.1093/bioinformatics/btv027; Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; BenTal N, 1997, J PHYS CHEM B, V101, P450, DOI 10.1021/jp961825r; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Berthelot K, 2013, BIOCHIMIE, V95, P12, DOI 10.1016/j.biochi.2012.07.011; Berthelot K, 2011, J MOL BIOL, V412, P137, DOI 10.1016/j.jmb.2011.07.009; Berthelot K, 2009, FASEB J, V23, P2254, DOI 10.1096/fj.08-125724; Bhowmik D, 2014, PHYS CHEM CHEM PHYS, V16, P885, DOI 10.1039/c3cp54151g; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Bockris J.OM., 1998, MODERN ELECTROCHEMIS, V1; Brogan APS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6058; Brogan APS, 2012, CHEM SCI, V3, P1839, DOI 10.1039/c2sc20143g; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Burnouf S, 2015, ACTA NEUROPATHOL, V130, P35, DOI 10.1007/s00401-015-1419-y; Burton RE, 1996, J MOL BIOL, V263, P311, DOI 10.1006/jmbi.1996.0577; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chakrabarti P, 1997, PROTEIN SCI, V6, P851; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chemuru S, 2016, J MOL BIOL, V428, P274, DOI 10.1016/j.jmb.2015.06.008; Chemuru S, 2014, BIOPOLYMERS, V102, P206, DOI 10.1002/bip.22470; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Chen YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061874; Cheng RP, 2012, AMINO ACIDS, V43, P195, DOI 10.1007/s00726-011-1064-2; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiu HP, 2006, J AM CHEM SOC, V128, P15556, DOI 10.1021/ja0640445; Chiu HP, 2009, J AM CHEM SOC, V131, P13192, DOI 10.1021/ja903631h; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Christopeit T, 2005, PROTEIN SCI, V14, P2125, DOI 10.1110/ps.051470405; CIEPLAK AS, 1985, J AM CHEM SOC, V107, P271, DOI 10.1021/ja00287a060; Cieplak AS, 2004, J ORG CHEM, V69, P3250, DOI 10.1021/jo0358372; CIEPLAK AS, 1994, STRUCT CHEM, V5, P85, DOI 10.1007/BF02265350; Cieplak AS, 1999, CHEM REV, V99, P1265, DOI 10.1021/cr980381n; CIEPLAK AS, 1981, J AM CHEM SOC, V103, P4540, DOI 10.1021/ja00405a041; Cieplak AS, 1994, STRUCTURE CORRELATIO, V1; Cieplak AS, 1999, AMIDE LINKAGE STRUCT; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Coleman BM, 2014, J VIROL, V88, P2690, DOI 10.1128/JVI.02720-13; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Conicella AE, 2014, BIOCHEMISTRY-US, V53, P3095, DOI 10.1021/bi500131a; Cota E, 2000, J MOL BIOL, V302, P713, DOI 10.1006/jmbi.2000.4053; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Cuervo A, 2014, P NATL ACAD SCI USA, V111, pE3624, DOI 10.1073/pnas.1405702111; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Daskalov A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004158; De Alba E, 1999, PROTEIN SCI, V8, P854; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; de la Paz ML, 2001, J MOL BIOL, V312, P229, DOI 10.1006/jmbi.2001.4918; Dean DN, 2016, BIOCHEMISTRY-US, V55, P2238, DOI 10.1021/acs.biochem.6b00161; Dearborn AD, 2016, J BIOL CHEM, V291, P2310, DOI 10.1074/jbc.M115.698787; Debye P, 1923, PHYS Z, V24, P185; Deechongkit S, 2004, J AM CHEM SOC, V126, P16762, DOI 10.1021/ja045934s; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904; Dewar M.J.S., 1975, PMO THEORY ORGANIC C; Dimitriadis G, 2004, P NATL ACAD SCI USA, V101, P3809, DOI 10.1073/pnas.0306433101; Dodson CA, 2015, FEBS LETT, V589, P1740, DOI 10.1016/j.febslet.2015.06.002; Doi T, 2012, BIOCHEM BIOPH RES CO, V428, P458, DOI 10.1016/j.bbrc.2012.10.096; Dubnovitsky A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066101; Economou NJ, 2016, J AM CHEM SOC, V138, P1772, DOI 10.1021/jacs.5b11913; Eildal JNN, 2013, J AM CHEM SOC, V135, P12998, DOI 10.1021/ja402875h; Elgabarty H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9318; Epiotis ND, 1977, TOP CURR CHEM, P70; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Eryilmaz E, 2014, J BIOL CHEM, V289, P14506, DOI 10.1074/jbc.R113.540302; Exner V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005335; Fabiola GF, 1997, ACTA CRYSTALLOGR D, V53, P316, DOI 10.1107/S0907444997000383; Faria TQ, 2015, PHYS CHEM CHEM PHYS, V17, P7255, DOI 10.1039/c4cp04549a; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; Ferguson N, 2001, J MOL BIOL, V307, P393, DOI 10.1006/jmbi.2000.4492; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Fischer FR, 2008, P NATL ACAD SCI USA, V105, P17290, DOI 10.1073/pnas.0806129105; Fisk JD, 2006, J AM CHEM SOC, V128, P7148, DOI 10.1021/ja060942p; Fleming I., 2011, MOL ORBITALS ORGANIC; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frisch M. J., 2016, GAUSSIAN 16 REVISION, V16; Fu Z, 2015, BIOCHEMISTRY-US, V54, P4197, DOI 10.1021/acs.biochem.5b00467; Fufezan C, 2010, PROTEINS, V78, P2831, DOI 10.1002/prot.22800; Fukunaga S, 2012, BIOCHEMISTRY-US, V51, P8125, DOI 10.1021/bi300839u; Gao GB, 2015, ANGEW CHEM INT EDIT, V54, P2245, DOI 10.1002/anie.201410768; Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Gendoo DMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027342; Georgieva ER, 2014, BIOPHYS J, V107, P1441, DOI 10.1016/j.bpj.2014.07.046; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Ghosh JC, 1918, J CHEM SOC, V113, P449, DOI 10.1039/ct9181300449; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Giri R, 2012, P NATL ACAD SCI USA, V109, P17772, DOI 10.1073/pnas.1201794109; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gleiter R., 2012, AROMATICITY OTHER CO, P72; Glendening ED, 1997, J AM CHEM SOC, V119, P12940, DOI 10.1021/ja970074j; Goldsteins G, 1999, P NATL ACAD SCI USA, V96, P3108, DOI 10.1073/pnas.96.6.3108; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Griffiths-Jones SR, 2000, J AM CHEM SOC, V122, P8350, DOI 10.1021/ja000787t; Groenning M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11443; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Gruning CSR, 2014, J BIOL CHEM, V289, P23209, DOI 10.1074/jbc.M114.560920; Gu L, 2014, J BIOL CHEM, V289, P27300, DOI 10.1074/jbc.M114.569004; Gu L, 2013, J BIOL CHEM, V288, P18673, DOI 10.1074/jbc.M113.457739; Gueroult M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041704; Habchi J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501244; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; HADDON RC, 1975, J AM CHEM SOC, V97, P3608, DOI 10.1021/ja00846a009; Hamill SJ, 1998, BIOCHEMISTRY-US, V37, P8071, DOI 10.1021/bi9801659; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; Harder E, 2008, J PHYS CHEM B, V112, P3509, DOI 10.1021/jp709729d; Hayden EY, 2015, BIOCHEMISTRY-US, V54, P4599, DOI 10.1021/acs.biochem.5b00280; He YA, 2012, STRUCTURE, V20, P283, DOI 10.1016/j.str.2011.11.018; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Hinderaker MP, 2003, PROTEIN SCI, V12, P1188, DOI 10.1110/ps.0241903; Ho BK, 2003, PROTEIN SCI, V12, P2508, DOI 10.1110/ps.03235203; Hoffmann R, 1998, THEOCHEM-J MOL STRUC, V424, P1, DOI 10.1016/S0166-1280(97)00219-4; HOFFMANN R, 1971, ACCOUNTS CHEM RES, V4, P1, DOI 10.1021/ar50037a001; Honda RP, 2014, J BIOL CHEM, V289, P30355, DOI 10.1074/jbc.M114.559450; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; Hubin E, 2015, CELL MOL LIFE SCI, V72, P4899, DOI 10.1007/s00018-015-1983-2; Gallea JI, 2014, J BIOL CHEM, V289, P26733, DOI 10.1074/jbc.M114.566695; Jarrold MF, 2007, PHYS CHEM CHEM PHYS, V9, P1659, DOI 10.1039/b612615d; Jarrold MF, 1999, ACCOUNTS CHEM RES, V32, P360, DOI 10.1021/ar960081x; Jemth P, 2005, J MOL BIOL, V350, P363, DOI 10.1016/j.jmb.2005.04.067; Jeong JS, 2013, J MOL BIOL, V425, P1765, DOI 10.1016/j.jmb.2013.02.005; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; Kadavath H, 2015, ANGEW CHEM INT EDIT, V54, P10347, DOI 10.1002/anie.201501714; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Kamer KJ, 2013, J ORG CHEM, V78, P2099, DOI 10.1021/jo302265k; Kendall J, 1922, J AM CHEM SOC, V44, P717, DOI 10.1021/ja01425a006; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; KLOTZ IM, 1962, J AM CHEM SOC, V84, P3461, DOI 10.1021/ja00877a009; Korshavn KJ, 2016, CHEM COMMUN, V52, P882, DOI 10.1039/c5cc08634e; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Kretner B, 2016, EMBO MOL MED, V8, P458, DOI 10.15252/emmm.201505952; Krishna N, 2011, INT J BIOL MACROMOL, V49, P218, DOI 10.1016/j.ijbiomac.2011.04.017; Kubelka J, 2003, J MOL BIOL, V329, P625, DOI 10.1016/S0022-2836(03)00519-9; Kukic P, 2013, J AM CHEM SOC, V135, P16968, DOI 10.1021/ja406995j; Kuloglu ES, 2001, BIOCHEMISTRY-US, V40, P12486, DOI 10.1021/bi011106p; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111492; Kumar A, 2012, J BIOL CHEM, V287, P21253, DOI 10.1074/jbc.M112.355156; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kung VM, 2015, ANGEW CHEM INT EDIT, V54, P14336, DOI 10.1002/anie.201506448; Kusumoto Y, 1998, P NATL ACAD SCI USA, V95, P12277, DOI 10.1073/pnas.95.21.12277; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Lambermon MHL, 2005, J NEUROCHEM, V95, P1667, DOI 10.1111/j.1471-4159.2005.03497.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lan MY, 2014, J CLIN NEUROSCI, V21, P513, DOI 10.1016/j.jocn.2013.03.038; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Larda ST, 2013, J AM CHEM SOC, V135, P10533, DOI 10.1021/ja404584s; Lario PI, 2003, J AM CHEM SOC, V125, P12787, DOI 10.1021/ja0289954; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lawrence JR, 2002, BIOPHYS CHEM, V101, P375, DOI 10.1016/S0301-4622(02)00173-4; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Leka O, 2014, FEBS J, V281, P2115, DOI 10.1111/febs.12783; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; LI SC, 1994, NAT STRUCT BIOL, V1, P368, DOI 10.1038/nsb0694-368; Li XH, 2015, J AM CHEM SOC, V137, P9218, DOI 10.1021/jacs.5b04561; Lim KH, 2016, BIOCHEMISTRY-US, V55, P5272, DOI 10.1021/acs.biochem.6b00649; Lim KH, 2016, BIOCHEMISTRY-US, V55, P1941, DOI 10.1021/acs.biochem.6b00164; Lipfert J, 2014, ANNU REV BIOCHEM, V83, P813, DOI 10.1146/annurev-biochem-060409-092720; Liu P, 2015, CELL REP, V11, P1760, DOI 10.1016/j.celrep.2015.05.021; Luo JH, 2014, BIOCHEMISTRY-US, V53, P6302, DOI 10.1021/bi5003579; Luo JH, 2014, J BIOL CHEM, V289, P27766, DOI 10.1074/jbc.M114.574947; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Lv ZJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02880; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; Ma K, 1999, J AM CHEM SOC, V121, P8698, DOI 10.1021/ja990864o; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Matsuzaki K, 2014, ACCOUNTS CHEM RES, V47, P2397, DOI 10.1021/ar500127z; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; Mc Donald JM, 2015, ALZHEIMERS DEMENT, V11, P1286, DOI 10.1016/j.jalz.2015.01.005; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Messa M, 2014, J BIOL CHEM, V289, P24143, DOI 10.1074/jbc.M114.576256; Meyer V, 2016, J BIOL CHEM, V291, P12271, DOI 10.1074/jbc.M116.715557; Mikhalyov I, 2010, BIOPHYS J, V99, P1510, DOI 10.1016/j.bpj.2010.06.043; Miles LA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01302; MilnerWhite EJ, 1997, PROTEIN SCI, V6, P2477; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Mizuno N, 2011, P NATL ACAD SCI USA, V108, P3252, DOI 10.1073/pnas.1011342108; Mo YR, 2007, ACCOUNTS CHEM RES, V40, P113, DOI 10.1021/ar068073w; Moriarty GM, 2013, FEBS LETT, V587, P1128, DOI 10.1016/j.febslet.2013.02.049; Muller-Schiffmann A, 2016, BRAIN, V139, P509, DOI 10.1093/brain/awv355; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Myers JK, 2001, NAT STRUCT BIOL, V8, P552, DOI 10.1038/88626; Nag S, 2011, J BIOL CHEM, V286, P13827, DOI 10.1074/jbc.M110.199885; Natesh R, 2003, ACTA CRYSTALLOGR D, V59, P105, DOI 10.1107/S0907444902020164; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nystrom S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10101; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; Pace CN, 2014, FEBS LETT, V588, P2177, DOI 10.1016/j.febslet.2014.05.006; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PADMANABHAN S, 1991, J MOL BIOL, V219, P135, DOI 10.1016/0022-2836(91)90553-I; Padmanabhan S, 1996, J MOL BIOL, V257, P726, DOI 10.1006/jmbi.1996.0197; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Parthasarathy S, 2015, J AM CHEM SOC, V137, P6480, DOI 10.1021/jacs.5b03373; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Pasquato N, 2007, J MOL BIOL, V366, P711, DOI 10.1016/j.jmb.2006.11.076; PAULING L, 1953, PROC R SOC SER B-BIO, V141, P21, DOI 10.1098/rspb.1953.0012; Penel S, 2003, PROTEIN ENG, V16, P957, DOI 10.1093/protein/gzg147; Pires RH, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2587; Pires RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044992; Pross A, 1981, PROGR PHYS ORGANIC C, V13; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qing GY, 2014, J AM CHEM SOC, V136, P10736, DOI 10.1021/ja5049626; Rajan R, 1997, BIOPOLYMERS, V42, P125, DOI 10.1002/(SICI)1097-0282(199708)42:2<125::AID-BIP1>3.0.CO;2-P; Ramachandran G, 2014, BIOCHEMISTRY-US, V53, P6550, DOI 10.1021/bi500528x; Ramachandran G, 2013, BIOCHEMISTRY-US, V52, P4107, DOI 10.1021/bi400209z; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Roche J, 2016, BIOCHEMISTRY-US, V55, P762, DOI 10.1021/acs.biochem.5b01259; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Ryan TM, 2015, J NEUROSCI, V35, P2871, DOI 10.1523/JNEUROSCI.2912-14.2015; Ryan TM, 2012, J BIOL CHEM, V287, P16947, DOI 10.1074/jbc.M111.321778; Sabareesan AT, 2016, J MOL BIOL, V428, P3935, DOI 10.1016/j.jmb.2016.08.015; Sabareesan AT, 2016, BIOPHYS J, V110, P1766, DOI 10.1016/j.bpj.2016.03.017; Sabate R, 2009, FEBS J, V276, P5053, DOI 10.1111/j.1742-4658.2009.07202.x; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; SALEMME FR, 1983, PROG BIOPHYS MOL BIO, V42, P95, DOI 10.1016/0079-6107(83)90005-6; Sandebring A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055847; Saro D, 2007, BIOCHEMISTRY-US, V46, P6340, DOI 10.1021/bi062088k; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Sebollela A, 2014, ACS CHEM NEUROSCI, V5, P1238, DOI 10.1021/cn500156r; Serag AA, 2001, BIOCHEMISTRY-US, V40, P9089, DOI 10.1021/bi010655s; Shabestari MH, 2016, J BIOL PHYS, V42, P299, DOI 10.1007/s10867-016-9408-5; Shah NH, 2013, J AM CHEM SOC, V135, P18673, DOI 10.1021/ja4104364; Shamovsky IL, 2000, J PHYS CHEM B, V104, P11296, DOI 10.1021/jp002590t; Shao HY, 1999, J MOL BIOL, V285, P755, DOI 10.1006/jmbi.1998.2348; Shelimov KB, 1997, J AM CHEM SOC, V119, P2987, DOI 10.1021/ja962914k; Shepherd TR, 2011, BIOCHEMISTRY-US, V50, P1296, DOI 10.1021/bi1013613; SHERIDAN RP, 1979, BIOPOLYMERS, V18, P2451, DOI 10.1002/bip.1979.360181006; Shivu B, 2013, BIOCHEMISTRY-US, V52, P5176, DOI 10.1021/bi400625v; SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007; Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50; Singh J, 2016, BIOCHEMISTRY-US, V55, P459, DOI 10.1021/acs.biochem.5b01266; Singh J, 2015, ANGEW CHEM INT EDIT, V54, P7529, DOI 10.1002/anie.201501011; Singh J, 2013, J MOL BIOL, V425, P3510, DOI 10.1016/j.jmb.2013.06.009; Sippl MJ, 2009, CURR OPIN STRUC BIOL, V19, P312, DOI 10.1016/j.sbi.2009.03.010; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Spitzer J, 2009, MICROBIOL MOL BIOL R, V73, P371, DOI 10.1128/MMBR.00010-09; Spivey AC, INTRO STEREOELECTRON; Sridhar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107647; Stanger HE, 2001, P NATL ACAD SCI USA, V98, P12015, DOI 10.1073/pnas.211536998; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Susa AC, 2014, J AM CHEM SOC, V136, P12912, DOI 10.1021/ja504031d; Tay WM, 2013, J MOL BIOL, V425, P2494, DOI 10.1016/j.jmb.2013.04.003; Terry C, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160035; Tew DJ, 2008, BIOPHYS J, V94, P2752, DOI 10.1529/biophysj.107.119909; Tiiman A, AIP ADV; Tosatto L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16696; Trevitt CR, 2014, J BIOL CHEM, V289, P25497, DOI 10.1074/jbc.M114.566588; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Tycko R, 2015, NEURON, V86, P632, DOI 10.1016/j.neuron.2015.03.017; Ueno H, 2014, BIOCHEMISTRY-US, V53, P7523, DOI 10.1021/bi501239q; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Vandersteen A, 2012, FEBS LETT, V586, P4088, DOI 10.1016/j.febslet.2012.10.022; Vazquez-Fernandez E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005835; Vignaud H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080262; Villemagne VL, 2010, J NEUROSCI, V30, P6315, DOI 10.1523/JNEUROSCI.5180-09.2010; Vitalis A, 2010, J MOL BIOL, V403, P148, DOI 10.1016/j.jmb.2010.08.003; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walti MA, 2015, CHEMBIOCHEM, V16, P659, DOI 10.1002/cbic.201402595; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wan W, 2014, P NATL ACAD SCI USA, V111, P5201, DOI 10.1073/pnas.1322933111; Wan W, 2013, J BIOL CHEM, V288, P29604, DOI 10.1074/jbc.M113.505511; Wan W, 2012, BIOPHYS J, V102, P2339, DOI [10.1016/j.bpj.2012.04.011, 10.1016/j.bpj.2012.04.01]; Wang CC, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00048; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wang Y, 2013, P NATL ACAD SCI USA, V110, pE3743, DOI 10.1073/pnas.1308381110; Wasmer C, 2008, ANGEW CHEM INT EDIT, V47, P5839, DOI 10.1002/anie.200704896; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053; Wathen B, 2011, CHEMBIOCHEM, V12, P1674, DOI 10.1002/cbic.201100156; Weinhold F, 2006, VALENCY BONDING NATU; WIBERG KB, 1995, J AM CHEM SOC, V117, P4261, DOI 10.1021/ja00120a006; Wiberg KB, 2003, AMIDE LINKAGE STRUCT; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Williams AD, 2005, P NATL ACAD SCI USA, V102, P7115, DOI 10.1073/pnas.0408582102; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; Wolff M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127865; Wu JIC, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2228-2; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Yagi-Utsumi M, 2011, INT J ALZHEIMERS DIS, V11; Yagi-Utsumi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146405; Yagi-Utsumi M, 2015, BIOL PHARM BULL, V38, P1668, DOI 10.1248/bpb.b15-00466; Yi XY, 2015, BIOCHEMISTRY-US, V54, P6323, DOI 10.1021/acs.biochem.5b00719; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang HM, 2010, LANGMUIR, V26, P7343, DOI 10.1021/la904237d; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288; Zhang YJ, 2012, J BIOL CHEM, V287, P748, DOI 10.1074/jbc.M111.281295; Zhang-Haagen B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150267; Zheng XY, 2015, ACS CHEM NEUROSCI, V6, P1732, DOI 10.1021/acschemneuro.5b00171; Zheng XY, 2012, J BIOL CHEM, V287, P6084, DOI 10.1074/jbc.C111.328575; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P15486, DOI 10.1073/pnas.2136623100; Zhu YJ, 2004, CHEM PHYS, V307, P99, DOI 10.1016/j.chemphys.2004.05.008; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200; Zou K, 2013, AM J PATHOL, V182, P2322, DOI 10.1016/j.ajpath.2013.01.053	363	11	11	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0180905	10.1371/journal.pone.0180905	http://dx.doi.org/10.1371/journal.pone.0180905			71	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922400	Green Submitted, Green Published, gold			2022-12-27	WOS:000411059300001
J	Roach, M; Sauermann, H				Roach, Michael; Sauermann, Henry			The declining interest in an academic career	PLOS ONE			English	Article							NEXT-GENERATION; SCIENTISTS; SOCIALIZATION; PREFERENCES; EDUCATION; STUDENTS; SCIENCE	There is increasing evidence that science & engineering PhD students lose interest in an academic career over the course of graduate training. It is not clear, however, whether this decline reflects students being discouraged from pursuing an academic career by the challenges of obtaining a faculty job or whether it reflects more fundamental changes in students' career goals for reasons other than the academic labor market. We examine this question using a longitudinal survey that follows a cohort of PhD students from 39 U.S. research universities over the course of graduate training to document changes in career preferences and to explore potential drivers of such changes. We report two main results. First, although the vast majority of students start the PhD interested in an academic research career, over time 55% of all students remain interested while 25% lose interest entirely. In addition, 15% of all students were never interested in an academic career during their PhD program, while 5% become more interested. Thus, the declining interest in an academic career is not a general phenomenon across all PhD students, but rather reflects a divergence between those students who remain highly interested in an academic career and other students who are no longer interested in one. Second, we show that the decline we observe is not driven by expectations of academic job availability, nor by related factors such as postdoctoral requirements or the availability of research funding. Instead, the decline appears partly due to the misalignment between students' changing preferences for specific job attributes on the one hand, and the nature of the academic research career itself on the other. Changes in students' perceptions of their own research ability also play a role, while publications do not. We discuss implications for scientific labor markets, PhD career development programs, and science policy.	[Roach, Michael] Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA; [Sauermann, Henry] ESMT European Sch Management & Technol, Berlin, Germany; [Sauermann, Henry] Natl Bur Econ Res, Cambridge, MA 02138 USA	Cornell University; European School of Management & Technology; National Bureau of Economic Research	Roach, M (corresponding author), Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA.	michael.roach@cornell.edu		Roach, Michael/0000-0002-9781-8567	NSF SciSIP [1262270]; NSF [1262270]; Ewing Marion Kauffman Foundation	NSF SciSIP(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NSF(National Science Foundation (NSF)); Ewing Marion Kauffman Foundation	This work was supported by the NSF SciSIP Award 1262270 and the Ewing Marion Kauffman Foundation Junior Faculty Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by NSF Scissor Award 1262270 and the Ewing Marion Kauffman Foundation. Results and opinions are our own and not necessarily those of the funders. We thank R. Alex Coots, Susan Fitzpatrick, Chris Golde, Rick Kahn, Paula Stephan, Susi Varvayanis, Ken Yancey and especially Shulamit Kahn for helpful comments and suggestions. We also thank the editor, Joshua Rosenbloom, and two reviewers for their valuable feedback on the manuscript.	Agarwal R, 2013, MANAGE SCI, V59, P950, DOI 10.1287/mnsc.1120.1582; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Austin AE, 2002, J HIGH EDUC, V73, P94, DOI 10.1353/jhe.2002.0001; Barham BL, 2014, RES POLICY, V43, P21, DOI 10.1016/j.respol.2013.08.007; Campbell RA, 2003, SOC STUD SCI, V33, P897, DOI 10.1177/0306312703336004; Cyranoski D, 2011, NATURE, V472, P276, DOI 10.1038/472276a; Davis, 2005, AM SCI S, V93, P1; Fox MF, 2001, SOC STUD SCI, V31, P109, DOI 10.1177/030631201031001006; Freeman R, 2001, SCIENCE, V294, P2293, DOI 10.1126/science.1067477; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Gibbs KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114736; Golde C., 2001, CROSS PURPOSES WHAT; Hackett EJ, 2005, SOC STUD SCI, V35, P787, DOI 10.1177/0306312705056045; Hermanowicz JC, 2006, SCI TECHNOL HUM VAL, V31, P135, DOI 10.1177/0162243905283637; Kahn S, 2017, NAT BIOTECHNOL, V35, P90, DOI 10.1038/nbt.3766; LAYTON ET, 1976, TECHNOL CULT, V17, P688, DOI 10.2307/3103675; McDowell GS, 2014, F1000RESEARCH, V3; National Academies, 2014, POSTD EXP REV; National Institutes of Health, 2014, NIH DIR BIOM WORKF I; National Research Council, 2010, DAT BAS ASS RES DOCT, DOI [10.17226/12994, DOI 10.17226/12994]; National Science Foundation, 2009, SURV EARN DOCT; OAXACA RL, 1994, J ECONOMETRICS, V61, P5, DOI 10.1016/0304-4076(94)90074-4; Roach M, 2010, RES POLICY, V39, P422, DOI 10.1016/j.respol.2010.01.004; Rosen S., 1986, HDB LABOR EC, V1, P641, DOI DOI 10.1016/S1573-4463(86)01015-5; Sauermann H, 2005, J VOCAT BEHAV, V66, P273, DOI 10.1016/j.jvb.2004.10.001; Sauermann H, 2016, SCIENCE, V352, P663, DOI 10.1126/science.aaf2061; Sauermann H, 2014, RES POLICY, V43, P32, DOI 10.1016/j.respol.2013.07.006; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Schillebeeckx M, 2013, NAT BIOTECHNOL, V31, P938, DOI 10.1038/nbt.2706; Stephan P., 2012, EC SHAPES SCI; Stephan P, 2013, BIOSCIENCE, V63, P245, DOI 10.1525/bio.2013.63.4.2; Tierney WG, 1997, J HIGH EDUC, V68, P1, DOI 10.2307/2959934	32	59	59	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184130	10.1371/journal.pone.0184130	http://dx.doi.org/10.1371/journal.pone.0184130			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922403	gold, Green Published			2022-12-27	WOS:000411059300011
J	Sasaki, F; Koga, T; Saeki, K; Okuno, T; Kazuno, S; Fujimura, T; Ohkawa, Y; Yokomizo, T				Sasaki, Fumiyuki; Koga, Tomoaki; Saeki, Kazuko; Okuno, Toshiaki; Kazuno, Saiko; Fujimura, Tsutomu; Ohkawa, Yasuyuki; Yokomizo, Takehiko			Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B-4 receptor 1	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; T-CELL RECRUITMENT; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; AIRWAY HYPERRESPONSIVENESS; MAINTENANCE THERAPY; LIPID MEDIATORS; IN-VIVO; BLT1; MICE	Leukotriene B-4 (LTB4) receptor 1 (BLT1) is a G protein-coupled receptor expressed in various leukocyte subsets; however, the precise expression of mouse BLT1 (mBLT1) has not been reported because a mBLT1 monoclonal antibody (mAb) has not been available. In this study, we present the successful establishment of a hybridoma cell line (clone 7A8) that produces a high-affinity mAb for mBLT1 by direct immunization of BLT1-deficient mice with mBLT1-overexpressing cells. The specificity of clone 7A8 was confirmed using mBLT1-overexpressing cells and mouse peripheral blood leukocytes that endogenously express BLT1. Clone 7A8 did not cross-react with human BLT1 or other G protein-coupled receptors, including human chemokine (C-X-C motif) receptor 4. The 7A8 mAb binds to the second extracellular loop of mBLT1 and did not affect LTB4 binding or intracellular calcium mobilization by LTB4. The 7A8 mAb positively stained Gr-1-positive granulocytes, CD11b-positive granulocytes/monocytes, F4/80-positive monocytes, CCR2-high and CCR2-low monocyte subsets in the peripheral blood and a CD4-positive T cell subset, Th1 cells differentiated in vitro from naive CD4-positive T cells. This mAb was able to detect Gr-1-positive granulocytes and monocytes in the spleens of naive mice by immunohistochemistry. Finally, intraperitoneal administration of 7A8 mAb depleted granulocytes and monocytes in the peripheral blood. We have therefore succeeded in generating a high-affinity anti-mBLT1 mAb that is useful for analyzing mBLT1 expression in vitro and in vivo.	[Sasaki, Fumiyuki; Koga, Tomoaki; Saeki, Kazuko; Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Kazuno, Saiko] Juntendo Univ, Grad Sch Med, Lab Prote, Tokyo, Japan; [Kazuno, Saiko] Juntendo Univ, Grad Sch Med, Biomol Sci Res Support Ctr, Tokyo, Japan; [Fujimura, Tsutomu] Tohoku Med & Pharmaceut Univ, Lab Bioanalyt Chem, Sendai, Miyagi, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan; [Koga, Tomoaki] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan	Juntendo University; Juntendo University; Juntendo University; Tohoku Medical & Pharmaceutical University; Kyushu University; Kumamoto University	Yokomizo, T (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Tokyo, Japan.	yokomizo-tky@umin.ac.jp	Ohkawa, Yasuyuki/ABG-1839-2021; Yokomizo, Takehiko/P-5673-2016	Ohkawa, Yasuyuki/0000-0001-6440-9954; Yokomizo, Takehiko/0000-0002-5219-1553; Fujimura, Tsutomu/0000-0003-1744-7725	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japan Society for the Promotion of Science (JSPS) [22116001, 22116002, 15H05901, 15H05904, 15H04708, 15H06604, 25860223, 15K19032, 24590386, 15K08316, 25460374]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Nakatomi Foundation; Takeda Science Foundation; Foundation for Strategic Research Projects in Private Universities of the MEXT [S1311011]; Institute for Environmental and Gender-Specific Medicine; CREST; JST [JPMJCR16G1]; JSPS [25116010, 17H03608]; Grants-in-Aid for Scientific Research [15H05897, 25116010, 17K19356] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japan Society for the Promotion of Science (JSPS); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Strategic Research Projects in Private Universities of the MEXT; Institute for Environmental and Gender-Specific Medicine; CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of the Japan Society for the Promotion of Science (JSPS: grant numbers 22116001, 22116002, 15H05901, 15H05904, 15H04708, and 15H06604 to TY, 25860223 and 15K19032 to TK, 24590386 and 15K08316 to KS, 25460374 to TO; http://www.jsps.go.jp/english/e-grants/index.html) and by grants from the Naito Foundation (http://www.naito-f.or.jp/en/), the Ono Medical Research Foundation (https://www.ono.co. jp/jp/zaidan/), the Uehara Memorial Foundation (http://www.ueharazaidan.or.jp/), the Mitsubishi Foundation (www.mitsubishi-zaidan.jp/en/index.html), the Nakatomi Foundation (http://www.nakatomi.or.jp/eni/), and the Takeda Science Foundation (http://www.takeda-sci.or.jp/). This study was supported in part by a Grant-in-Aid (S1311011 to TY) from the Foundation for Strategic Research Projects in Private Universities of the MEXT (http://www.mext.go.jp/en/index.htm) and by a grant from the Institute for Environmental and Gender-Specific Medicine (http://www. juntendo.ac.jp/english/department/gra/gender specific medicine/). This work was also supported by CREST (https://www.jst.go.jp/kisoken/crest/en/ index.html), JST (http://www.jst.go.jp/EN/index. html), Grant JPMJCR16G1 (to YO) (JSPS: grant numbers 25116010 and 17H03608 to YO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Basu S, 2007, J BIOL CHEM, V282, P10005, DOI 10.1074/jbc.M609552200; CASTROP J, 1995, IMMUNOBIOLOGY, V193, P281, DOI 10.1016/S0171-2985(11)80556-5; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; FRASER CM, 1980, P NATL ACAD SCI-BIOL, V77, P7034, DOI 10.1073/pnas.77.12.7034; Friedrich EB, 2003, ARTERIOSCL THROM VAS, V23, P1761, DOI 10.1161/01.ATV.0000092941.77774.3C; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hagemann UB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103776; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Harris GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035129; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Hikiji H, 2009, P NATL ACAD SCI USA, V106, P21294, DOI 10.1073/pnas.0905209106; Hrabovska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012892; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Ichiki T, 2016, FASEB J, V30, P1811, DOI 10.1096/fj.201500117; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lundeen KA, 2006, J IMMUNOL, V177, P3439, DOI 10.4049/jimmunol.177.5.3439; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Majumdar R, 2012, FEBS LETT, V586, P810, DOI 10.1016/j.febslet.2012.01.052; Martin A, 2009, PROTEIN SCI, V18, P727, DOI 10.1002/pro.55; Matsumoto Y, 2007, THROMB RES, V119, P319, DOI 10.1016/j.thromres.2006.01.023; Miyahara N, 2008, J IMMUNOL, V181, P1170, DOI 10.4049/jimmunol.181.2.1170; Nagata K, 1999, FEBS LETT, V459, P195, DOI 10.1016/S0014-5793(99)01251-X; Nagata N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175452; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohkubo H, 2013, FASEB J, V27, P3132, DOI 10.1096/fj.13-227421; Okamoto F, 2010, J BIOL CHEM, V285, P41113, DOI 10.1074/jbc.M110.175497; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Pass J, 2003, SCAND J IMMUNOL, V58, P298, DOI 10.1046/j.1365-3083.2003.01299.x; Pass J, 2007, THROMB HAEMOSTASIS, V97, P1013, DOI 10.1160/TH06-11-0644; Pettersson A, 2000, BIOCHEM BIOPH RES CO, V279, P520, DOI 10.1006/bbrc.2000.3989; Peyrassol X, 2016, J IMMUNOL, V196, P2893, DOI 10.4049/jimmunol.1500888; Riesselman M, 2007, J IMMUNOL, V179, P2520, DOI 10.4049/jimmunol.179.4.2520; Sabirsh A, 2006, BIOCHEMISTRY-US, V45, P5733, DOI 10.1021/bi060076t; Sanchez-Galan E, 2009, CARDIOVASC RES, V81, P216, DOI 10.1093/cvr/cvn277; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sasaki F, 2012, ANAL BIOCHEM, V425, P157, DOI 10.1016/j.ab.2012.03.014; Scott MJ, 2004, CLIN DIAGN LAB IMMUN, V11, P936, DOI 10.1128/CDLI.11.5.936-941.2004; Serezani CH, 2012, J IMMUNOL, V189, P906, DOI 10.4049/jimmunol.1200257; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Shimada M, 2002, J BIOL CHEM, V277, P31774, DOI 10.1074/jbc.M204166200; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Soares EM, 2013, J IMMUNOL, V190, P1614, DOI 10.4049/jimmunol.1202932; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Toda A, 2010, BIOCHIMIE, V92, P682, DOI 10.1016/j.biochi.2009.12.002; Tussiwand R, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00533; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2015, J BIOCHEM, V157, P65, DOI 10.1093/jb/mvu078	72	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185133	10.1371/journal.pone.0185133	http://dx.doi.org/10.1371/journal.pone.0185133			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922396	gold, Green Published, Green Submitted			2022-12-27	WOS:000411059300058
J	Dhillon, JKS; Riffe, C; Moore, BD; Ran, Y; Chakrabarty, P; Golde, TE; Giasson, BI				Dhillon, Jess-Karan S.; Riffe, Cara; Moore, Brenda D.; Ran, Yong; Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.			A novel panel of alpha-synuclein antibodies reveal distinctive staining profiles in synucleinopathies	PLOS ONE			English	Article							PARKINSONS-DISEASE; TRANSGENIC MODEL; LEWY BODIES; MOUSE MODEL; IMMUNOTHERAPY; PATHOLOGY; PROPAGATION; IMMUNIZATION; AGGREGATION; FIBRILS	Synucleinopathies are a spectrum of neurodegenerative diseases characterized by the intracellular deposition of the protein alpha-synuclein leading to multiple outcomes, including dementia and Parkinsonism. Recent findings support the notion that across the spectrum of synucleinopathies there exist diverse but specific biochemical modifications and/or structural conformations of alpha-synuclein, which would give rise to protein strain specific prion-like intercellular transmission, a proposed model that could explain synucleinopathies disease progression. Herein, we characterized a panel of antibodies with epitopes within both the C- and N- termini of alpha-synuclein. A comprehensive analysis of human pathological tissue and mouse models of synucleinopathy with these antibodies support the notion that alpha-synuclein exists in distinct modified forms and/or structural variants. Furthermore, these well-characterized and specific tools allow the investigation of biochemical changes associated with alpha-synuclein inclusion formation. We have identified several antibodies of interest with diverse staining and epitope properties that will prove useful in future investigations of strain specific disease progression and the development of targeted immunotherapeutic approaches to synucleinopathies.	[Giasson, Benoit I.] Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Giasson, BI (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	bgiasson@ufl.edu		Moore, Brenda/0000-0002-9685-6561	National Institute of Neurological Disorders and Stroke [NS089622, T32 NS082168]; National Institute on Aging [AG047266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS082168, R01NS089622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740, P50AG047266] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS089622) (BIG) and (T32 NS082168) (JSD) and the National Institute on Aging (AG047266) (TEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Ayers JI, 2017, J VIROL, V91, DOI 10.1128/JVI.02095-16; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Cookson MR, ANN REV BIOCH, V74, P29; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; El-Agnaf O, 2017, NEUROBIOL DIS, V104, P85, DOI 10.1016/j.nbd.2017.05.002; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; George JM, 2002, GENOME BIOL, V3; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Gustafsson G, 2017, CELL MOL NEUROBIOL, V37, P121, DOI 10.1007/s10571-016-0352-5; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; Lee JS, 2016, J MOV DISORD, V9, P14, DOI 10.14802/jmd.15059; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Lindstrom V, 2014, NEUROBIOL DIS, V69, P134, DOI 10.1016/j.nbd.2014.05.009; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mamais A, 2013, NEUROBIOL DIS, V58, P183, DOI 10.1016/j.nbd.2013.05.017; Mandler M, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0008-9; Mandler M, 2014, ACTA NEUROPATHOL, V127, P861, DOI 10.1007/s00401-014-1256-4; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; PAPP MI, 1992, J NEUROL SCI, V107, P172, DOI 10.1016/0022-510X(92)90286-T; Pieri L, 2016, BBA-GEN SUBJECTS, V1860, P8, DOI 10.1016/j.bbagen.2015.10.007; Rutherford NJ, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0029-4; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sanchez-Guajardo V, 2013, J NEUROPATH EXP NEUR, V72, P624, DOI 10.1097/NEN.0b013e31829768d2; Schenk DB, 2017, MOVEMENT DISORD, V32, P211, DOI 10.1002/mds.26878; Schneeberger A, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS11, DOI 10.1016/S1353-8020(11)70006-2; Schneeberger A, 2016, MOVEMENT DISORD, V31, P214, DOI 10.1002/mds.26377; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shahaduzzaman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116841; Spencer B, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0410-8; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Su JMF, 2004, BRAIN PATHOL, V14, P175, DOI 10.1111/j.1750-3639.2004.tb00050.x; Sulzer D, 2017, NATURE, V546, P656, DOI 10.1038/nature22815; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Uchihara T, 2016, ACTA NEUROPATHOL, V131, P49, DOI 10.1007/s00401-015-1485-1; Valera E, 2013, PHARMACOL THERAPEUT, V138, P311, DOI 10.1016/j.pharmthera.2013.01.013; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Waxman EA, 2008, ACTA NEUROPATHOL, V116, P37, DOI 10.1007/s00401-008-0375-1; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013	58	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184731	10.1371/journal.pone.0184731	http://dx.doi.org/10.1371/journal.pone.0184731			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910367	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200087
J	Mongeon, P; Smith, E; Joyal, B; Lariviere, V				Mongeon, Philippe; Smith, Elise; Joyal, Bruno; Lariviere, Vincent			The rise of the middle author: Investigating collaboration and division of labor in biomedical research using partial alphabetical authorship	PLOS ONE			English	Article							TEAMS; IMPACT	Contemporary biomedical research is performed by increasingly large teams. Consequently, an increasingly large number of individuals are being listed as authors in the bylines, which complicates the proper attribution of credit and responsibility to individual authors. Typically, more importance is given to the first and last authors, while it is assumed that the others (the middle authors) have made smaller contributions. However, this may not properly reflect the actual division of labor because some authors other than the first and last may have made major contributions. In practice, research teams may differentiate the main contributors from the rest by using partial alphabetical authorship (i.e., by listing middle authors alphabetically, while maintaining a contribution-based order for more substantial contributions). In this paper, we use partial alphabetical authorship to divide the authors of all biomedical articles in the Web of Science published over the 1980-2015 period in three groups: primary authors, middle authors, and supervisory authors. We operationalize the concept of middle author as those who are listed in alphabetical order in the middle of an authors' list. Primary and supervisory authors are those listed before and after the alphabetical sequence, respectively. We show that alphabetical ordering of middle authors is frequent in biomedical research, and that the prevalence of this practice is positively correlated with the number of authors in the bylines. We also find that, for articles with 7 or more authors, the average proportion of primary, middle and supervisory authors is independent of the team size, more than half of the authors being middle authors. This suggests that growth in authors lists are not due to an increase in secondary contributions (or middle authors) but, rather, in equivalent increases of all types of roles and contributions (including many primary authors and many supervisory authors). Nevertheless, we show that the relative contribution of alphabetically ordered middle authors to the overall production of knowledge in the biomedical field has greatly increased over the last 35 years.	[Mongeon, Philippe; Smith, Elise; Lariviere, Vincent] Univ Montreal, Ecole Bbibliothecon & Sci Informat, Montreal, PQ, Canada; [Joyal, Bruno] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Lariviere, Vincent] Univ Quebec, CIRST, OST, Succ Ctr Ville, Montreal, PQ, Canada	Universite de Montreal; McGill University; University of Quebec; University of Quebec Montreal	Mongeon, P (corresponding author), Univ Montreal, Ecole Bbibliothecon & Sci Informat, Montreal, PQ, Canada.	philippe.mongeon@umontreal.ca	Smith, Elise/AAI-3687-2020; Lariviere, Vincent/AAF-3179-2019; Mongeon, Philippe/H-1446-2012	Mongeon, Philippe/0000-0003-1021-059X	Social Sciences and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Funded by Social Sciences and Humanities Research Council of Canada.	Adams JD, 2005, RES POLICY, V34, P259, DOI 10.1016/j.respol.2005.01.014; Baerlocher MO, 2007, J INVEST MED, V55, P174, DOI 10.2310/6650.2007.06044; Birnholtz JP, 2006, J AM SOC INF SCI TEC, V57, P1758, DOI 10.1002/asi.20380; Boyack KW, 2013, EUR J CLIN INVEST, V43, P1339, DOI 10.1111/eci.12171; Bozeman B, 2004, RES POLICY, V33, P599, DOI 10.1016/j.respol.2004.01.008; CETINA KK, 1991, HIST POLIT ECON, V23, P105, DOI 10.1215/00182702-23-1-105; Cronin B, 2001, J AM SOC INF SCI TEC, V52, P558, DOI 10.1002/asi.1097; Cronin B, 1996, J DOC, V52, P188, DOI 10.1108/eb026967; de Beaver D., 1979, SCIENTOMETRICS, V1, P133; Defazio D, 2009, RES POLICY, V38, P293, DOI 10.1016/j.respol.2008.11.008; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; International Committee of Medical Journal Editors, 2015, REC COND; Ivanis A, 2008, J GEN INTERN MED, V23, P1303, DOI 10.1007/s11606-008-0599-8; Ivanis A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020206; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Lariviere V, 2015, J ASSOC INF SCI TECH, V66, P1323, DOI 10.1002/asi.23266; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; MAIENSCHEIN J, 1993, J HIST BIOL, V26, P167, DOI 10.1007/BF01061964; MERTON RK, 1957, AM SOCIOL REV, V22, P635, DOI 10.2307/2089193; Pontille D., 2006, SCI SOC, V67, P77; Pontille D., 2004, SIGNATURE SCI SOCIOL; Rennie D, 1998, AM J PUBLIC HEALTH, V88, P828, DOI 10.2105/AJPH.88.5.828; SMITH CG, 1971, ADMIN SCI QUART, V16, P486, DOI 10.2307/2391768; Smith D, 2000, REPORT HIGHER ED FUN; Waltman L, 2012, J INFORMETR, V6, P700, DOI 10.1016/j.joi.2012.07.008; Warner ET, 2016, J GEN INTERN MED, V31, P60, DOI 10.1007/s11606-015-3463-7; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; ZUCKERMAN HA, 1968, AM J SOCIOL, V74, P276, DOI 10.1086/224641	30	27	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184601	10.1371/journal.pone.0184601	http://dx.doi.org/10.1371/journal.pone.0184601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910344	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200066
J	Taib, T; Leconte, C; Van Steenwinckel, J; Cho, AH; Palmier, B; Torsello, E; Kuen, RL; Onyeomah, S; Ecomard, K; Benedetto, C; Coqueran, B; Novak, AC; Deou, E; Plotkine, M; Gressens, P; Marchand-Leroux, C; Besson, VC				Taib, Toufik; Leconte, Claire; Van Steenwinckel, Juliette; Cho, Angelo H.; Palmier, Bruno; Torsello, Egle; Kuen, Rene Lai; Onyeomah, Somfieme; Ecomard, Karine; Benedetto, Chiara; Coqueran, Berard; Novak, Anne-Catherine; Deou, Edwige; Plotkine, Michel; Gressens, Pierre; Marchand-Leroux, Catherine; Besson, Valerie C.			Neuroinflammation, myelin and behavior: Temporal patterns following mild traumatic brain injury in mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; WHITE-MATTER; AXONAL INJURY; IMPAIRMENT; DEFICITS; NEURODEGENERATION; INCREASES; PATHOLOGY; DAMAGE	Traumatic brain injury (TBI) results in white matter injury (WMI) that is associated with neurological deficits. Neuroinflammation originating from microglial activation may participate in WMI and associated disorders. To date, there is little information on the time courses of these events after mild TBI. Therefore we investigated (i) neuroinflammation, (ii) WMI and (iii) behavioral disorders between 6 hours and 3 months after mild TBI. For that purpose, we used experimental mild TBI in mice induced by a controlled cortical impact. (i) For neuroinflammation, IL-1b protein as well as microglial phenotypes, by gene expression for 12 microglial activation markers on isolated CD11b(+) cells from brains, were studied after TBI. IL-1b protein was increased at 6 hours and 1 day. TBI induced a mixed population of microglial phenotypes with both pro-inflammatory, anti-inflammatory and immunomodulatory markers from 6 hours to 3 days post-injury. At 7 days, microglial activation was completely resolved. (ii) Three myelin proteins were assessed after TBI on ipsi-and contralateral corpus callosum, as this structure is enriched in white matter. TBI led to an increase in 2', 3'-cyclic-nucleotide 3'-phosphodiesterase, a marker of immature and mature oligodendrocyte, at 2 days post-injury; a bilateral demyelination, evaluated by myelin basic protein, from 7 days to 3 months post-injury; and an increase in myelin oligodendrocyte glycoprotein at 6 hours and 3 days post-injury. Transmission electron microscopy study revealed various myelin sheath abnormalities within the corpus callosum at 3 months post-TBI. (iii) TBI led to sensorimotor deficits at 3 days post-TBI, and late cognitive flexibility disorder evidenced by the reversal learning task of the Barnes maze 3 months after injury. These data give an overall invaluable overview of time course of neuroinflammation that could be involved in demyelination and late cognitive disorder over a time-scale of 3 months in a model of mild TBI. This model could help to validate a pharmacological strategy to prevent post-traumatic WMI and behavioral disorders following mild TBI.	[Taib, Toufik; Leconte, Claire; Cho, Angelo H.; Palmier, Bruno; Torsello, Egle; Onyeomah, Somfieme; Ecomard, Karine; Benedetto, Chiara; Coqueran, Berard; Novak, Anne-Catherine; Deou, Edwige; Plotkine, Michel; Marchand-Leroux, Catherine; Besson, Valerie C.] Univ Paris 05, Fac Pharm Paris, Pharmacol Circulat Cerebrale EA4475, Sorbonne Paris Cite, Paris, France; [Van Steenwinckel, Juliette; Gressens, Pierre] Univ Paris Diderot, PROTECT U1141, INSERM, Sorbonne Paris Cite, Paris, France; [Kuen, Rene Lai] Univ Paris 05, Sorbonne Paris Cite, Cellular & Mol Imaging Platform, Fac Pharm Paris,INSERM US25,UMS CNRS 3612,CRP2, F-CRP2 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Besson, VC (corresponding author), Univ Paris 05, Fac Pharm Paris, Pharmacol Circulat Cerebrale EA4475, Sorbonne Paris Cite, Paris, France.	valerie.besson@parisdescartes.fr	gressens, pierre/M-7557-2017; BESSON, VALERIE/AAZ-9989-2020; MARCHAND-LEROUX, Catherine/L-7453-2017; besson, valerie C/L-7388-2017	gressens, pierre/0000-0002-0909-4221; BESSON, VALERIE/0000-0002-1491-2380; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; besson, valerie C/0000-0002-1491-2380; leconte, claire/0000-0002-8206-9938; Van Steenwinckel, Juliette/0000-0003-3463-4856	Fondation des Gueules Cassees	Fondation des Gueules Cassees	This work was supported by Fondation des Gueules Cassees (VCB; CML); 2013; 2014; 40-2015 (www.gueules-cassees.asso.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; BOISSIER JR, 1967, ARCH INT PHARMACOD T, V169, P312; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chou A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151418; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Girgis H, 2013, BRAIN RES, V1491, P78, DOI 10.1016/j.brainres.2012.10.049; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Ihara M, 2010, ACTA NEUROPATHOL, V119, P579, DOI 10.1007/s00401-009-0635-8; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JIN X, 2012, PLOS ONE, V7; Johns TG, 1999, J NEUROCHEM, V72, P1, DOI 10.1046/j.1471-4159.1999.0720001.x; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Leconte C, 2009, STROKE, V40, P3349, DOI 10.1161/STROKEAHA.109.557314; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Radtke C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/608496; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; SCOLDING NJ, 1989, IMMUNOLOGY, V67, P441; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Siopi E, 2013, NEUROPHARMACOLOGY, V67, P183, DOI 10.1016/j.neuropharm.2012.11.009; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	76	54	55	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184811	10.1371/journal.pone.0184811	http://dx.doi.org/10.1371/journal.pone.0184811			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910378	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200098
J	Kiang, JG; Smith, JT; Anderson, MN; Elliott, TB; Gupta, P; Balakathiresan, NS; Maheshwari, RK; Knollmann-Ritschel, B				Kiang, Juliann G.; Smith, Joan T.; Anderson, Marsha N.; Elliott, Thomas B.; Gupta, Paridhi; Balakathiresan, Nagaraja S.; Maheshwari, Radha K.; Knollmann-Ritschel, Barbara			Hemorrhage enhances cytokine, complement component 3, and caspase-3, and regulates microRNAs associated with intestinal damage after whole-body gamma-irradiation in combined injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; WOUND TRAUMA; IONIZING IRRADIATION; INCREASES SURVIVAL; MESSENGER-RNA; MICE; BLOOD; ACTIVATION	Hemorrhage following whole-body gamma-irradiation in a combined injury (CI) model increases mortality compared to whole-body gamma-irradiation alone (RI). The decreased survival in CI is accompanied by increased bone marrow injury, decreased hematocrit, and alterations of miRNA in the kidney. In this study, our aim was to examine cytokine homeostasis, susceptibility to systemic bacterial infection, and intestinal injury. More specifically, we evaluated the interleukin-6 (IL-6)-induced stress proteins including C-reactive protein (CRP), complement 3 (C3), Flt-3 ligand, and corticosterone. CD2F1 male mice received 8.75 Gy Co-60 gamma photons (0.6 Gy/min, bilateral) which was followed by a hemorrhage of 20% of the blood volume. In serum, RI caused an increase of IL-1, IL-2, IL-3, IL-5, IL-6, IL-12, IL-13, IL-15, IL17A, IL-18, G-CSF, CM-CSF, eotaxin, IFN-gamma, MCP-1, MIP, RANTES, and TNF-alpha, which were all increased by hemorrhage alone, except IL-9, IL-17A, and MCP-1. Nevertheless, CI further elevated RI-induced increases of these cytokines except for G-CSF, IFN-gamma and RANTES in serum. In the ileum, hemorrhage in the CI model significantly enhanced RI-induced IL-1 beta, IL-3, IL-6, IL-10, IL-12p70, IL-13, IL-18, and TNF-alpha concentrations. In addition, Proteus mirabilis Gram(-) was found in only 1 of 6 surviving RI mice on Day 15, whereas Streptococcus sanguinis Gram(+) and Sphingomonas paucimobilis Gram(-) were detected in 2 of 3 surviving CI mice (with 3 CI mice diseased due to inflammation and infection before day 15) at the same time point. Hemorrhage in the CI model enhanced the RIinduced increases in C3 and decreases in CRP concentrations. However, hemorrhage alone did not alter the basal levels, but hemorrhage in the CI model displayed similar increases in Flt-3 ligand levels as RI did. Hemorrhage alone altered the basal levels of corticosterone early after injury, which then returned to the baseline, but in RI mice and CI mice the increased corticosterone concentration remained elevated throughout the 15 day study. CI increased 8 miRNAs and decreased 10 miRNAs in serum, and increased 16 miRNA and decreased 6 miRNAs in ileum tissue. Among the altered miRNAs, CI increased miR-34 in the serum and ileum which targeted an increased phosphorylation of ERK, p38, and increased NF-gamma B, thereby leading to increased iNOS expression and activation of caspase-3 in the ileum. Further, let-7g/miR-98 targeted the increased phosphorylation of STAT3 in the ileum, which is known to bind to the iNOS gene. These changes may correlate with cell death in the ileum of CI mice. The histopathology displayed blunted villi and villus edema in RI and CI mice. Based on the in silico analysis, miR-15, miR-99, and miR-100 were predicted to regulate IL-6 and TNF. These results suggest that CI-induced alterations of cytokines/chemokines, CRP, and C3 cause a homeostatic imbalance and may contribute to the pathophysiology of the gastrointestinal injury. Inhibitory intervention in these responses may prove therapeutic for CI and improve recovery of the ileal morphologic damage.	[Kiang, Juliann G.; Smith, Joan T.; Anderson, Marsha N.; Elliott, Thomas B.] Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20889 USA; [Kiang, Juliann G.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA; [Kiang, Juliann G.] Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA; [Gupta, Paridhi; Balakathiresan, Nagaraja S.; Maheshwari, Radha K.; Knollmann-Ritschel, Barbara] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	United States Department of Defense; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Kiang, JG (corresponding author), Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20889 USA.; Kiang, JG (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA.; Kiang, JG (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA.	juliann.kiang@usuhs.edu	Balakathiresan, Nagaraja Sethuraman/O-3213-2019	Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070	Armed Forces Radiobiology Research Institute Intramural Funding [RAB3AL, RAB33326]	Armed Forces Radiobiology Research Institute Intramural Funding	JGK received the Armed Forces Radiobiology Research Institute Intramural Funding RAB3AL and RAB33326 to conduct experiments presented in this manuscript (URL: www.USUHS.edu/AFRRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Aziz KK, 2012, DIABETES METAB SYND, V6, P77, DOI 10.1016/j.dsx.2012.08.004; Abouheif MM, 2010, RHEUMATOLOGY, V49, P2054, DOI 10.1093/rheumatology/keq247; Barabanova Anzhelika V, 2006, Vojnosanit Pregl, V63, P477, DOI 10.2298/VSP0605477B; Bastard JP, 1999, CIRCULATION, V99, P2221; BAXTER H, 1953, PLAST RECONSTR SURG, V12, P439, DOI 10.1097/00006534-195312000-00007; BERG M, 1994, CYTOKINE, V6, P425, DOI 10.1016/1043-4666(94)90067-1; Biffl WL, 1996, J LEUKOCYTE BIOL, V59, P569, DOI 10.1002/jlb.59.4.569; BROOKS JW, 1952, ANN SURG, V136, P533, DOI 10.1097/00000658-195210000-00018; Chen J, 2016, CELL PHYSIOL BIOCHEM, V39, P2262, DOI 10.1159/000447919; Chen X, 2015, J FORMOS MED ASSOC, V114, P430, DOI 10.1016/j.jfma.2015.01.007; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; DAVIS AK, 1954, ANN SURG, V140, P726, DOI 10.1097/00000658-195411000-00012; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; ELLIOT TB, 1995, INT J RADIAT BIOL, V68, P311, DOI 10.1080/09553009514551241; Fukumoto R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090448; Fukumoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058389; GERY I, 1972, J EXP MED, V136, P128, DOI 10.1084/jem.136.1.128; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Ha CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109249; Iijima S, 1982, Acta Pathol Jpn, V32 Suppl 2, P237; Islam A, 2015, RADIAT RES, V184, P273, DOI 10.1667/RR14113.1; KERN S, 1995, BIOL REPROD, V53, P1407, DOI 10.1095/biolreprod53.6.1407; Kiang JG, 2004, CELL RES, V14, P450, DOI 10.1038/sj.cr.7290247; Kiang JG, 2012, NATOHFM223P5118, P1; Kiang JG, 2008, MOL PHARMACOL, V73, P738, DOI 10.1124/mol.107.041079; Kiang JG, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7582079; Kiang Juliann G, 2014, J Cell Sci Ther, V5, DOI 10.4172/2157-7013.1000190; Kiang JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139271; Kiang JG, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/215858; Kiang JG, 2014, HEALTH PHYS, V106, P720, DOI 10.1097/HP.0000000000000108; Kiang JG, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/481392; Kiang JG, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/821541; Kiang Juliann G, 2010, Adapt Med, V2, P1, DOI 10.4247/AM.2010.ABA004; Kiang JG, 2010, RADIAT RES, V173, P319, DOI 10.1667/RR1892.1; Kishi H, 2000, NEUROSURGERY, V47, P441, DOI 10.1097/00006123-200008000-00034; KORLOF B, 1956, Acta Chir Scand Suppl, V209, P1; Kuby J, 2007, KUBY IMMUNOLOGY, P396; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; LEDNEY GD, 1985, EXPERIENTIA, V41, P614, DOI 10.1007/BF02007684; LEDNEY GD, 1982, EXPERIENTIA, V38, P1228, DOI 10.1007/BF01959756; LEDNEY GD, 1981, EXPERIENTIA, V37, P193, DOI 10.1007/BF01963228; LEDNEY GD, 1982, EXP HEMATOL, V10, P263; Li XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122258; Lu XY, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-36; Matsuyama W, 2001, INTERNAL MED, V40, P1254, DOI 10.2169/internalmedicine.40.1254; McDonnel G. M, 1961, WT1428 DEF AT SUPP A; Mettler FA, 2007, HEALTH PHYS, V93, P462, DOI 10.1097/01.HP.0000278843.27969.74; Molyneux G, 2008, INT J EXP PATHOL, V89, P159, DOI 10.1111/j.1365-2613.2008.00580.x; Ni Wen-Juan, 2016, Microrna, V5, P83; NUNOMURA W, 1994, BBA-MOL BASIS DIS, V1227, P74, DOI 10.1016/0925-4439(94)90109-0; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; REED WR, 1994, AM J MED SCI, V308, P9, DOI 10.1097/00000441-199407000-00004; Rusk N, 2008, NAT METHODS, V5, P122, DOI 10.1038/nmeth0208-122a; Sakata H, 2012, BRAIN, V135, P3298, DOI 10.1093/brain/aws259; Sambur M. B., 1994, Radiatsionnaya Biologiya Radioekologiya, V34, P55; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; VALERIOTE FA, 1964, RADIAT RES, V22, P693, DOI 10.2307/3571550; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WodnarFilipowicz A, 1996, BLOOD, V88, P4493, DOI 10.1182/blood.V88.12.4493.bloodjournal88124493	63	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184393	10.1371/journal.pone.0184393	http://dx.doi.org/10.1371/journal.pone.0184393			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934227	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900027
J	Moussa, TAA; Al-Zahrani, HS; Almaghrabi, OA; Abdelmoneim, TS; Fuller, MP				Moussa, Tarek A. A.; Al-Zahrani, Hassan S.; Almaghrabi, Omar A.; Abdelmoneim, Tamer S.; Fuller, Michael P.			Comparative metagenomics approaches to characterize the soil fungal communities of western coastal region, Saudi Arabia	PLOS ONE			English	Article							MYCORRHIZAL FUNGI; DIVERSITY; REVEAL; RHIZOSPHERE; MICROBIOME	A total of 145007 reads were obtained from pyrosequencing for all the 4 samples. The total count ranged from 11,301,014 (Mecca old road) to 23,503,512 bp (Thuwal). A total of 460 fungal species belonging to 133 genera, 58 families, 33 orders, 13 classes and 4 phyla was identified across the four sites. The most abundant phylum at all four sites was Ascomycota followed by Basidiomycota. Four phyla (Ascomycota-99.31%, Basidiomycota-0.59%, Chytridiomycota-0.04%, Glomeromycota-0.03%) were detected in Khulais. Except for Glomeromycota, all phyla were detected at Mecca old road (Ascomycota-74.26%, Basidiomycota-25.71%, Chytridiomycota-0.01%) and Thuwal (Ascomycota-99.59%, Basidiomycota-0.40%, Chytridiomycota-0.002%); while only Ascomycota-90.98% and Basidiomycota-9.01% were detected in Asfan road. At the class level, Sordariomycetes was predominantly observed at Asfan road-59.88%, Khulais-68.26% and Thuwal-94.84%; while Pezizomycetes was dominant at Mecca old road-56.01%, was absent at Asfan road. Agaricomycetes was present only at Mecca old road-25.73%; while Tremello-mycetes-5.77%, Malasseizomycetes-2.13% and Microbotryomycetes-1.10% were found only at Asfan road. The phylogenetic trees revealed that clear genus level differences are visible across all the four sites, with an overall predominance of Thielavia followed by Madurella, Aspergillus, and Gelasinospora. Chaetomium sp., Aspergillus caespitosus and Aspergillus sp. were found in moderate (Mecca old road and Thuwal) to abundant (Asfan road and Khulais) quantities. Thielavia sp., Thielavia hyalocarpa and Madurella sp. are found in moderate quantities at Khulais and Mecca old road, while in abundant levels at Asfan road and Thuwal. Fusarium equisati and F. oxysporum were detected at Thuwal and Khulais. Sordaria araneosa was present at Khulais, while Malasseiza globosa species was detected in moderate quantities across all sites except Khulais.	[Moussa, Tarek A. A.; Al-Zahrani, Hassan S.; Almaghrabi, Omar A.; Abdelmoneim, Tamer S.] King Abdulaziz Univ, Biol Sci Dept, Fac Sci, Jeddah, Saudi Arabia; [Moussa, Tarek A. A.; Almaghrabi, Omar A.; Abdelmoneim, Tamer S.] Univ Jeddah, Biol Sci Dept, Fac Sci, Jeddah, Saudi Arabia; [Moussa, Tarek A. A.] Cairo Univ, Bot & Microbiol Dept, Fac Sci, Giza, Egypt; [Abdelmoneim, Tamer S.] Suez Canal Univ, Dept Agr Bot, Fac Agr, Ismailia, Egypt; [Fuller, Michael P.] Plymouth Univ, Sch Biol Sci, Fac Sci & Engn, Plymouth, Devon, England	King Abdulaziz University; University of Jeddah; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Suez Canal University; University of Plymouth	Moussa, TAA (corresponding author), King Abdulaziz Univ, Biol Sci Dept, Fac Sci, Jeddah, Saudi Arabia.; Moussa, TAA (corresponding author), Univ Jeddah, Biol Sci Dept, Fac Sci, Jeddah, Saudi Arabia.; Moussa, TAA (corresponding author), Cairo Univ, Bot & Microbiol Dept, Fac Sci, Giza, Egypt.	tarekmoussa@cu.edu.eg	Abdelmoneim, Tamer/AAC-2720-2019; Moussa, Tarek/F-4349-2010	Moussa, Tarek/0000-0002-5612-4366; Abdelmoneim, Tamer/0000-0002-2992-419X; Fuller, Michael/0000-0003-3461-9728	King Abdulaziz University, Jeddah [3-130-36-RG]; DSR	King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, under grant no. (3-130-36-RG). The authors, therefore, acknowledge with thanks DSR technical and financial support.; This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, under grant no. (3-130-36-RG). The authors, therefore, acknowledge with thanks DSR for technical and financial support.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Alef K, 1995, METHODS APPL SOIL MI; Almazroui M, 2012, INT J CLIMATOL, V32, P953, DOI 10.1002/joc.3446; BAESHEN NA, 2014, BOTHALIA J, V44, P301; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Darfaoui EM, 2010, RESPONSE CLIAMTE CHA, P1; El-Juhany L. I., 2013, World Applied Sciences Journal, V21, P710; El-Komy MH, 2013, PHYTOPATHOLOGY, V103, P39; Elsayed EA, 2013, EVIDENCE BASED COMPL; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Geml J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099852; Geml J, 2010, NEW PHYTOL, V187, P494, DOI 10.1111/j.1469-8137.2010.03283.x; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hedeler C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-426; Hegazy AK, 1998, J ARID ENVIRON, V38, P3, DOI 10.1006/jare.1997.0311; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; Huang CL, 2014, FUNGAL DIVERS, V66, P77, DOI 10.1007/s13225-014-0281-x; Jones EBG, 2009, FUNGAL DIVERS, V35, P1; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kim M, 2013, J MICROBIOL BIOTECHN, V23, P1347, DOI 10.4014/jmb.1306.06068; Kirk PM, 2001, AINSWORTH BISBYS DIC, P9; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Nam YJ, 2015, J GEN APPL MICROBIOL, V61, P67, DOI 10.2323/jgam.61.67; Nguyen HDT, 2008, PERSOONIA, V21, P57, DOI 10.3767/003158508X361334; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Orgiazzi A., 2013, Diversity, V5, P73; Peterson R. L., 2004, Mycorrhizas: anatomy and cell biology; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmit JP, 2007, BIODIVERS CONSERV, V16, P99, DOI 10.1007/s10531-006-9129-3; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Senthilkumaran R, 2012, INT J CURR MICROBIOL, V1, P29; Simoes MF, 2015, GENOM PROTEOM BIOINF, V13, P310, DOI 10.1016/j.gpb.2015.07.002; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; van der Maarel E, 2003, PHYTOCOENOLOGIA, V33, P187, DOI 10.1127/0340-269X/2003/0033-0187; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066829; Wu ZH, 2002, J ENVIRON MONITOR, V4, P377, DOI 10.1039/b200490a; Xu XM, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.22; Yasir M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0398-4	49	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185096	10.1371/journal.pone.0185096	http://dx.doi.org/10.1371/journal.pone.0185096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934322	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900086
J	Nasir, M; Baucom, BR; Georgiou, P; Narayanan, S				Nasir, Md; Baucom, Brian Robert; Georgiou, Panayiotis; Narayanan, Shrikanth			Predicting couple therapy outcomes based on speech acoustic features	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; MARITAL INTERACTION; OBSERVED COMMUNICATION; EMOTION RECOGNITION; THIN SLICES; FOLLOW-UP; PSYCHOTHERAPY; STABILITY; DIVORCE; SATISFACTION	Automated assessment and prediction of marital outcome in couples therapy is a challenging task but promises to be a potentially useful tool for clinical psychologists. Computational approaches for inferring therapy outcomes using observable behavioral information obtained from conversations between spouses offer objective means for understanding relationship dynamics. In this work, we explore whether the acoustics of the spoken interactions of clinically distressed spouses provide information towards assessment of therapy outcomes. The therapy outcome prediction task in this work includes detecting whether there was a relationship improvement or not (posed as a binary classification) as well as discerning varying levels of improvement or decline in the relationship status (posed as a multiclass recognition task). We use each interlocutor's acoustic speech signal characteristics such as vocal intonation and intensity, both independently and in relation to one another, as cues for predicting the therapy outcome. We also compare prediction performance with one obtained via standardized behavioral codes characterizing the relationship dynamics provided by human experts as features for automated classification. Our experiments, using data from a longitudinal clinical study of couples in distressed relations, showed that predictions of relationship outcomes obtained directly from vocal acoustics are comparable or superior to those obtained using human-rated behavioral codes as prediction features. In addition, combining direct signal-derived features with manually coded behavioral features improved the prediction performance in most cases, indicating the complementarity of relevant information captured by humans and machine algorithms. Additionally, considering the vocal properties of the interlocutors in relation to one another, rather than in isolation, showed to be important for improving the automatic prediction. This finding supports the notion that behavioral outcome, like many other behavioral aspects, is closely related to the dynamics and mutual influence of the interlocutors during their interaction and their resulting behavioral patterns.	[Nasir, Md; Georgiou, Panayiotis; Narayanan, Shrikanth] Univ Southern Calif, Dept Elect Engn, Los Angeles, CA 90089 USA; [Baucom, Brian Robert] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	University of Southern California; Utah System of Higher Education; University of Utah	Georgiou, P (corresponding author), Univ Southern Calif, Dept Elect Engn, Los Angeles, CA 90089 USA.	georgiou@sipi.usc.edu	Narayanan, Shrikanth S/D-5676-2012; Georgiou, Panayiotis Panos/E-8387-2018	Georgiou, Panayiotis Panos/0000-0002-0790-7161	NSF [1059095]; Direct For Computer & Info Scie & Enginr [1029373] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Funding was provided by NSF award 1059095.	Akbani R, 2004, LECT NOTES COMPUT SC, V3201, P39, DOI 10.1007/978-3-540-30115-8_7; Albrechtsen JS, 2009, J EXP SOC PSYCHOL, V45, P1052, DOI 10.1016/j.jesp.2009.05.017; AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Atkins DC, 2005, J CONSULT CLIN PSYCH, V73, P893, DOI 10.1037/0022-006X.73.5.893; BACHOROWSKI JA, 1995, PSYCHOL SCI, V6, P219, DOI 10.1111/j.1467-9280.1995.tb00596.x; Baucom BR, 2015, J CONSULT CLIN PSYCH, V83, P103, DOI 10.1037/a0038005; Baucom BR, 2009, J CONSULT CLIN PSYCH, V77, P160, DOI 10.1037/a0014405; Baucom DH, 2002, HDB COGNITIVE BEHAV, P411; Baucom KJW, 2015, BEHAV RES THER, V65, P18, DOI 10.1016/j.brat.2014.12.004; Baucom KJW, 2011, J CONSULT CLIN PSYCH, V79, P565, DOI 10.1037/a0025121; BENTLER PM, 1978, J CONSULT CLIN PSYCH, V46, P1053, DOI 10.1037/0022-006X.46.5.1053; Bitouk D, 2010, SPEECH COMMUN, V52, P613, DOI 10.1016/j.specom.2010.02.010; Black M., 2011, INTERSPEECH, P89; Black M, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2030; Black MP, 2013, SPEECH COMMUN, V55, P1, DOI 10.1016/j.specom.2011.12.003; Boersma Paul, 2002, GLOT INT, V5, P341; Bone D, 2014, J SPEECH LANG HEAR R, V57, P1162, DOI 10.1044/2014_JSLHR-S-13-0062; Broman C., 2002, J DIVORCE REMARRIAGE, V37, P151; Brown GL, 2012, J TURBUL, V13, P1, DOI 10.1080/14685248.2012.723805; Buehlman K.T., 1992, J FAMILY PSYCHOL, V5, P295, DOI DOI 10.1037/0893-3200.5.3-4.295; Can D, 2016, J COUNS PSYCHOL, V63, P343, DOI 10.1037/cou0000111; Carrere S, 2000, J FAM PSYCHOL, V14, P42, DOI 10.1037/0893-3200.14.1.42; Chakravarthula SN, 2015, INT CONF ACOUST SPEE, P2090, DOI 10.1109/ICASSP.2015.7178339; Christensen A, 2004, J CONSULT CLIN PSYCH, V72, P176, DOI 10.1037/0022-006X.72.2.176; Christensen A, 1995, INTEGRATIVE BEHAV CO; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Curhan JR, 2007, J APPL PSYCHOL, V92, P802, DOI 10.1037/0021-9010.92.3.802; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Epstein N., 1983, COGNITIVE THERAPY CO; Eyben F., 2010, ACM MULTIMEDIA MM, P1459, DOI DOI 10.1145/1873951.1874246; Farrus M., 2007, P 8 ANN C INT SPEECH, P778; France DJ, 2000, IEEE T BIO-MED ENG, V47, P829, DOI 10.1109/10.846676; FRICK RW, 1985, PSYCHOL BULL, V97, P412, DOI 10.1037/0033-2909.97.3.412; Georgiou P. G., 2011, P 2011 JOINT ACM WOR, P7, DOI [DOI 10.1145/2072572.2072576, 10.1145/2072572.2072576]; Georgiou PG, 2011, THATS AGGRAVATING VE, P87; Gibson J., 2011, INTERSPEECH, P1561; Giles H., 1997, ACCOMMODATION THEORY; Giles Howard, 1991, CONTEXTS ACCOMMODATI; Gottman J. M., 2008, CLIN HDB COUPLE THER, P138, DOI DOI 10.1037/0022-006X.61.1.78; Gottman J. M., 2013, MARITAL INTERACTION; GOTTMAN JM, 1993, J CONSULT CLIN PSYCH, V61, P6, DOI 10.1037/0022-006X.61.1.6; GOTTMAN JM, 1992, J PERS SOC PSYCHOL, V63, P221, DOI 10.1037/0022-3514.63.2.221; Gottman JM, 1998, J MARRIAGE FAM, V60, P5, DOI 10.2307/353438; Gottman JM, 2000, J MARRIAGE FAM, V62, P737, DOI 10.1111/j.1741-3737.2000.00737.x; GOTTMAN JM, 1989, J CONSULT CLIN PSYCH, V57, P47, DOI 10.1037/0022-006X.57.1.47; Gottman John Mordechai, 2014, WHAT PREDICTS DIVORC; Grimm M, 2007, SPEECH COMMUN, V49, P787, DOI 10.1016/j.specom.2007.01.010; HALFORD WK, 1993, J CONSULT CLIN PSYCH, V61, P51, DOI 10.1037/0022-006X.61.1.51; Han KJ, 2008, IEEE T AUDIO SPEECH, V16, P1590, DOI 10.1109/TASL.2008.2002085; Harvey, 2006, HDB DIVORCE RELATION, P85; Heavey C., 2002, COUPLES INTERACTION; Heyman RE, 2001, J MARRIAGE FAM, V63, P473, DOI 10.1111/j.1741-3737.2001.00473.x; Heyman RE, 2001, BEHAV THER, V32, P107, DOI 10.1016/S0005-7894(01)80047-2; Heyman RE, 2001, PSYCHOL ASSESSMENT, V13, P5, DOI 10.1037//1040-3590.13.1.5; Heyman RE, 2001, J FAM PSYCHOL, V15, P334, DOI 10.1037/0893-3200.15.2.334; Hillard D., 2003, P 2003 C N AM ASS CO, V2, P34, DOI [DOI 10.3115/1073483.1073495, 10.3115/1073483.1073495]; Howard KI, 1996, AM PSYCHOL, V51, P1059, DOI 10.1037/0003-066X.51.10.1059; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jacobson N.S., 1979, MARITAL THERAPY STRA; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnson SM, 1999, CLIN PSYCHOL-SCI PR, V6, P67, DOI 10.1093/clipsy/6.1.67; Jones J, 1998, COUPLES INTERACTION; Juslin PN., 2005, VOCAL EXPRESSION AFF; KARNEY BR, 1995, PSYCHOL BULL, V118, P3, DOI 10.1037/0033-2909.118.1.3; KELLER MB, 1987, ARCH GEN PSYCHIAT, V44, P540; Kim HK, 2007, J MARRIAGE FAM, V69, P55, DOI 10.1111/j.1741-3737.2006.00343.x; KRIPPEND.K, 1970, EDUC PSYCHOL MEAS, V30, P61, DOI 10.1177/001316447003000105; Kwon OW, 2003, P INT C EUROSPEECH; Lambert MJ, 1994, HDB PSYCHOTHERAPY BE; Lee CC, 2014, COMPUT SPEECH LANG, V28, P518, DOI 10.1016/j.csl.2012.06.006; Lee CC, 2011, SPEECH COMMUN, V53, P1162, DOI 10.1016/j.specom.2011.06.004; Lee CM, 2005, IEEE T SPEECH AUDI P, V13, P293, DOI 10.1109/TSA.2004.838534; LEWIS DD, 1992, SPEECH AND NATURAL LANGUAGE, P212; Li Y, 1998, ICSLP; Lord SP, 2015, J SUBST ABUSE TREAT, V49, P50, DOI 10.1016/j.jsat.2014.08.005; Menezes NM, 2006, PSYCHOL MED, V36, P1349, DOI 10.1017/S0033291706007951; Narayanan S, 2013, P IEEE, V101, P1203, DOI 10.1109/JPROC.2012.2236291; Nasir M, 2015, P INT DRESD GERM; Nasir M, 2015, INT CONF ACOUST SPEE, P1886, DOI 10.1109/ICASSP.2015.7178298; Ntalampiras S, 2012, IEEE T AFFECT COMPUT, V3, P116, DOI 10.1109/T-AFFC.2011.31; Ogles B. M., 1996, ASSESSING OUTCOME CL; Orlinsky DE, 1994, HDB PSYCHOTHERAPY BE; Ozgur A, 2005, LECT NOTES COMPUT SC, V3733, P606; Parris ES, 1996, INT CONF ACOUST SPEE, P685, DOI 10.1109/ICASSP.1996.543213; Pentland A, 2005, COMPUTER, V38, P33, DOI 10.1109/MC.2005.104; Pentland A, 2007, IEEE SIGNAL PROC MAG, V24, P108, DOI 10.1109/MSP.2007.4286569; Pianesi F., 2008, P 10 INT C MULT INT, P53, DOI [10.1145/1452392.1452404, DOI 10.1145/1452392.1452404]; Pittam Jeff, 1994, VOICE SOCIAL INTERAC, V5; Pitts MJ, 2008, HANDB APPL LINGUIST, V2, P15; Salzberg SL, 1997, DATA MIN KNOWL DISC, V1, P317, DOI 10.1023/A:1009752403260; Schuller B., 2007, INTERSPEECH, P2253; Schuller B, 2007, 2007 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING, VOLS 1 AND 2, P596, DOI 10.1109/ASRU.2007.4430180; Schuller B, 2011, COMPUTER ANALYSIS OF HUMAN BEHAVIOR, P227, DOI 10.1007/978-0-85729-994-9_9; Sevier M, 2008, BEHAV THER, V39, P137, DOI 10.1016/j.beth.2007.06.001; SMITH ML, 1977, AM PSYCHOL, V32, P752, DOI 10.1037/0003-066X.32.9.752; SNYDER DK, 1979, J MARRIAGE FAM, V41, P813, DOI 10.2307/351481; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Stanley SM, 2000, J MARRIAGE FAM, V62, P256, DOI 10.1111/j.1741-3737.2000.00256.x; Tseng SY, 2016, P INT SAN FRANC CA; Van Segbroeck M, 2013, INTERSPEECH; Vinciarelli A., 2008, P 10 INT C MULTIMODA, P61, DOI DOI 10.1145/1452392.1452405; Vinciarelli A, 2009, IMAGE VISION COMPUT, V27, P1743, DOI 10.1016/j.imavis.2008.11.007; Vlasenko B, 2007, LECT NOTES COMPUT SC, V4738, P139; Xia W, 2015, P INT DRESD GERM; Xia Wei, 2015, 16 ANN C INT SPEECH; Xiao B, 2013, INT CONF ACOUST SPEE, P3766, DOI 10.1109/ICASSP.2013.6638362	106	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185123	10.1371/journal.pone.0185123	http://dx.doi.org/10.1371/journal.pone.0185123			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934302	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900097
J	Wang, XF; Zhu, YT; Wang, JJ; Zeng, DX; Mu, CY; Chen, YB; Lei, W; Zhu, YH; Huang, JA				Wang, Xiao-fei; Zhu, Yi-tong; Wang, Jia-jia; Zeng, Da-xiong; Mu, Chuan-yong; Chen, Yan-bin; Lei, Wei; Zhu, Ye-han; Huang, Jian-an			The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients	PLOS ONE			English	Review							TUMOR-GROWTH; T-CELL; ADVANCED NSCLC; TH17 CELLS; IL-17; STATISTICS; ANGIOGENESIS; CHEMOTHERAPY; EXPRESSION; GENERATION	Background Interleukin-17 (IL-17) plays an important role in cancer progression. Previous studies remained controversial regarding the correlation between IL-17 expression and lung cancer (LC) prognosis. To comprehensively and quantitatively summarize the prognostic value of IL-17 expression in LC patients, a systematic review and meta-analysis were performed. Methods We identified the relevant literatures by searching the PubMed, EMBASE, Cochrane Library, SinoMed, China National Knowledge Infrastructure (CNKI) and Wanfang Data data-bases, up until April 1, 2017. Overall survival (OS), disease free survival (DFS) and clinicopathological characteristics were collected from relevant studies. Pooled hazard ratios (HR) and corresponding 95% confidence intervals (CI) were calculated to estimate the effective value of IL-17 expression on clinical outcomes. Results Six studies containing 479 Chinese LC patients were involved in this meta-analysis. The results indicated high IL-17 expression was independently correlated with poorer OS (HR = 1.82, 95% CI 1.44-2.29, P < 0.00001) and shorter DFS (HR = 2.41, 95% CI 1.42-4.08, P = 0.001) in LC patients. Further, when stratified by LC histological type (non-small cell lung cancer and small cell lung cancer), tumor stage (I-III,I-IV and IV), detection specimen (serum, intratumoral tissue and pleural effusion), test method (immunological histological chemistry and enzyme linked immunosorbent assay), and HR estimated method (reported and estimated), all of the results were statistically significant. These data indicated that elevated IL-17 expression is correlated with poor clinical outcomes in LC. The meta-analysis did not show heterogeneity or publication bias. Conclusions The present meta-analysis revealed that high IL-17 expression was an indicator of poor prognosis for Chinese patients with LC. It could potentially help to assess patients' prognosis and estimate treatment efficacy in therapeutic interventions.	[Wang, Xiao-fei; Wang, Jia-jia; Zeng, Da-xiong; Mu, Chuan-yong; Chen, Yan-bin; Lei, Wei; Zhu, Ye-han; Huang, Jian-an] Soochow Univ, Affiliated Hosp 1, Dept Resp Med, Suzhou, Jiangsu, Peoples R China; [Zhu, Yi-tong] Soochow Univ, Affiliated Hosp 1, Dept Boxi Med Ctr, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Lei, W; Zhu, YH (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Resp Med, Suzhou, Jiangsu, Peoples R China.	leiwei1978@163.com; zhuyehansz@sina.com		Lei, Wei/0000-0001-8498-7161	Youth Medical Talent of Jiangsu Province Science and Education to Enhance Sanitary Project [QNRC2016747]; China and National Natural Science Foundation of China [81300026]; Clinical Medical Center of Suzhou [Szzx201502]; Suzhou Key Laboratory for Respiratory Medicine [SZS201617]; Societal and Departmental Project of Suzhou in China [SS201630]	Youth Medical Talent of Jiangsu Province Science and Education to Enhance Sanitary Project; China and National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Medical Center of Suzhou; Suzhou Key Laboratory for Respiratory Medicine; Societal and Departmental Project of Suzhou in China	This work was supported by the Youth Medical Talent of Jiangsu Province Science and Education to Enhance Sanitary Project (No. QNRC2016747), the China and National Natural Science Foundation of China (No. 81300026) (http://www.nsfc.gov.cn/), the Clinical Medical Center of Suzhou (No. Szzx201502), Suzhou Key Laboratory for Respiratory Medicine (No. SZS201617) and the Societal and Departmental Project of Suzhou (No. SS201630) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Chen WQ, 2015, THORAC CANCER, V6, P209, DOI 10.1111/1759-7714.12169; Chen X, 2010, LUNG CANCER, V69, P348, DOI 10.1016/j.lungcan.2009.11.013; Eiro N, 2012, WORLD J GASTRO SURG, V4, P62, DOI 10.4240/wjgs.v4.i3.62; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong QY, 2015, CANCER-AM CANCER SOC, V121, P3080, DOI 10.1002/cncr.29584; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Lin QY, 2015, INT J BIOL MARKER, V30, pE359, DOI 10.5301/jbm.5000148; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Neurath MF, 2012, CYTOKINE GROWTH F R, V23, P315, DOI 10.1016/j.cytogfr.2012.08.009; Numasaki M, 2004, IMMUNOL LETT, V93, P39, DOI 10.1016/j.imlet.2004.01.014; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pennathur A, 2009, LANCET ONCOL, V10, P742, DOI 10.1016/S1470-2045(09)70205-0; Powell JW, 2009, LANCET ONCOL, V10, P885, DOI 10.1016/S1470-2045(09)70103-2; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Shi CL, 2014, CELL PHYSIOL BIOCHEM, V34, P743, DOI 10.1159/000363039; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Steiner GE, 2003, PROSTATE, V56, P171, DOI 10.1002/pros.10238; Tartour E, 1999, CANCER RES, V59, P3698; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wao H, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-10; Wu DY, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/463059; Wu FL, 2013, CELL PHYSIOL BIOCHEM, V32, P1566, DOI 10.1159/000356593; Xu CH, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-23; Xu CH, 2014, BIOMARKERS, V19, P287, DOI 10.3109/1354750X.2014.908954; Zeng YH, 2015, INT J CLIN EXP MED, V8, P10515; Zhang GQ, 2012, ASIAN PAC J CANCER P, V13, P3955, DOI 10.7314/APJCP.2012.13.8.3955; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang X, 2014, INT J CLIN EXP MED, V7, P3258; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	43	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185168	10.1371/journal.pone.0185168	http://dx.doi.org/10.1371/journal.pone.0185168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934305	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900109
J	Favaro, FM; Nader, N; Eurich, SO; Tripp, M; Varadaraju, N				Favaro, Francesca M.; Nader, Nazanin; Eurich, Sky O.; Tripp, Michelle; Varadaraju, Naresh			Examining accident reports involving autonomous vehicles in California	PLOS ONE			English	Article								Autonomous Vehicle technology is quickly expanding its market and has found in Silicon Valley, California, a strong foothold for preliminary testing on public roads. In an effort to promote safety and transparency to consumers, the California Department of Motor Vehicles has mandated that reports of accidents involving autonomous vehicles be drafted and made available to the public. The present work shows an in-depth analysis of the accident reports filed by different manufacturers that are testing autonomous vehicles in California (testing data from September 2014 to March 2017). The data provides important information on autonomous vehicles accidents' dynamics, related to the most frequent types of collisions and impacts, accident frequencies, and other contributing factors. The study also explores important implications related to future testing and validation of semi-autonomous vehicles, tracing the investigation back to current literature as well as to the current regulatory panorama.	[Favaro, Francesca M.] San Jose State Univ, Dept Aviat & Technol, San Jose, CA 95192 USA; [Favaro, Francesca M.; Nader, Nazanin; Eurich, Sky O.; Tripp, Michelle; Varadaraju, Naresh] San Jose State Univ, Res Ctr RiSA2S, San Jose, CA 95192 USA	California State University System; San Jose State University; California State University System; San Jose State University	Favaro, FM (corresponding author), San Jose State Univ, Dept Aviat & Technol, San Jose, CA 95192 USA.; Favaro, FM (corresponding author), San Jose State Univ, Res Ctr RiSA2S, San Jose, CA 95192 USA.	francesca.favaro@sjsu.edu	Nader, Nader/E-6358-2014	Nader, Nader/0000-0002-5744-7319	San Jose State University College of Engineering Grant; Mineta Transportation Institute (MTI) of San Jose, CA	San Jose State University College of Engineering Grant; Mineta Transportation Institute (MTI) of San Jose, CA	The present work was funded by the San Jose State University College of Engineering 2017 Grant for Research Professors to FMF. The work of the RiSA2S research center is also supported by the Mineta Transportation Institute (MTI) of San Jose, CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present work was funded by the San Jose State University College of Engineering 2017 Grant for Research Professors. The work of the RiSA<SUP>2</SUP>S research center is also supported by the Mineta Transportation Institute (MTI) of San Jose, CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J. M., 2014, AUTONOMOUS VEHICLE T; California Department of Motor Vehicles (CA DMV), 2015, AUT VEH DEP IN PRESS; California Department of Motor Vehicles (CA DMV), 2016, ART 3 7 AUT VEH; Davies A., 2017, VERY HUMAN PROBLEM B; Dixit VV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168054; DOT-National Highway Traffic Safety Administration (NHTSA), 2016, PREL REP SUMM 2015 T; Favaro FM, 2017, PSAM TOP 2017 HUM RE; Federal Highway Administration (FHWA), TRAFF VOL TRENDS; Kalra N, 2016, TRANSPORT RES A-POL, V94, P182, DOI 10.1016/j.tra.2016.09.010; NHTSA, 2016, 812318 DOT HS NHTSA, P1; Nilsson J, DEP SYST NETW WORKSH, P1; SAE, 2014, TAX DEF TERMS REL RO; Singh S., 2015, 812115 DOT HS NHTSA; Singh S, 2003, HS809540 DOT NHTSA; U.S. Department of Transportation, 2016, FED AUT VEH POL ACC; Waytz A, 2014, J EXP SOC PSYCHOL, V52, P113, DOI 10.1016/j.jesp.2014.01.005; Young K., 2007, DISTRACTED DRIVING, P379	17	139	139	11	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184952	10.1371/journal.pone.0184952	http://dx.doi.org/10.1371/journal.pone.0184952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931022	Green Published, gold			2022-12-27	WOS:000411314700044
J	Trimpert, C; Wesche, D; de Groot, T; Rodriguez, MMP; Wong, V; van den Berg, DTM; Cheval, L; Ariza, CA; Doucet, A; Stagljar, I; Deen, PMT				Trimpert, Christiane; Wesche, Daniel; de Groot, Theun; Rodriguez, Martha M. Pimentel; Wong, Victoria; van den Berg, Dennis T. M.; Cheval, Lydie; Ariza, Carolina A.; Doucet, Alain; Stagljar, Igor; Deen, Peter M. T.			NDFIP allows NEDD4/NEDD4L-induced AQP2 ubiquitination and degradation	PLOS ONE			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; EPITHELIAL NA+ CHANNEL; AQUAPORIN-2 WATER CHANNEL; LONG-TERM REGULATION; NEDD4 FAMILY; PROTEIN; EXPRESSION; PATHWAY; LIGASES; ENAC	Regulation of our water homeostasis is fine-tuned by dynamic translocation of Aquaporin-2 (AQP2)-bearing vesicles to and from the plasma membrane of renal principal cells. Whereas binding of vasopressin to its type-2 receptor initiates a cAMP-protein kinase A cascade and AQP2 translocation to the apical membrane, this is counteracted by protein kinase C-activating hormones, resulting in ubiquitination-dependent internalization of AQP2. The proteins targeting AQP2 for ubiquitin-mediated degradation are unknown. In collecting duct mpkCCD cells, siRNA knockdown of NEDD4 and NEDD4L E3 ligases yielded increased AQP2 abundance, but they did not bind AQP2. Membrane Yeast Two-Hybrid assays using full-length AQP2 as bait, identified NEDD4 family interacting protein 2 (NDFIP2) to bind AQP2. NDFIP2 and its homologue NDFIP1 have PY motifs by which they bind NEDD4 family members and bring them close to target proteins. In HEK293 cells, NDFIP1 and NDFIP2 bound AQP2 and were essential for NEDD4/NEDD4L-mediated ubiquitination and degradation of AQP2, an effect not observed with PY-lacking NDFIP1/2 proteins. In mpkCCD cells, downregulation of NDFIP1, NEDD4 and NEDD4L, but not NDFIP2, increased AQP2 abundance. In mouse kidney, Ndfip1 and Ndfip2 mRNA distribution was similar and high in proximal tubules and collecting ducts, which was also found for NDFIP1 proteins. Our results reveal that NEDD4/NEDD4L mediate ubiquitination and degradation of AQP2, but that NDFIP proteins are needed to connect NEDD4/NEDD4L to AQP2. As NDFIP1/2 bind many NEDD4 family E3 ligases, which are implicated in several cellular processes, NDFIP1/2 may be the missing link for AQP2 ubiquitination and degradation from different subcellular locations.	[Trimpert, Christiane; Wesche, Daniel; de Groot, Theun; Rodriguez, Martha M. Pimentel; van den Berg, Dennis T. M.; Ariza, Carolina A.; Deen, Peter M. T.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen, Netherlands; [Rodriguez, Martha M. Pimentel; Wong, Victoria; Stagljar, Igor] Univ Toronto, Dept Biochem & Mol Genet, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Cheval, Lydie; Doucet, Alain] Univ Paris 05, Univ Paris 06, Ctr Rech Cordeliers, Sorbonne Univ,Sorbonne Paris Cite,CNRS,UPMC,INSER, Paris, France	Radboud University Nijmegen; University of Toronto; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Deen, PMT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen, Netherlands.	Peter.Deen@radboudumc.nl	Deen, Peter MT/B-9854-2013; Ariza, Ana Carolina/AAR-2607-2021; Deen, P.M.T./H-8023-2014	Deen, Peter MT/0000-0002-7868-4655; Ariza, Ana Carolina/0000-0002-0302-4062; Deen, P.M.T./0000-0002-7868-4655; CHEVAL, LYDIE/0000-0003-2957-6487; Hubner, Christiane/0000-0003-3637-6395	Marie Curie Intra European Fellowship grant [272375]; Marie Curie Outgoing Fellowship grant [272375]; Kolff internship grant from the Dutch Kidney Foundation [KBS 11.048]	Marie Curie Intra European Fellowship grant; Marie Curie Outgoing Fellowship grant; Kolff internship grant from the Dutch Kidney Foundation	This study was supported by a Marie Curie Intra European Fellowship grant (272375) for CT (ec.europa.eu), a Marie Curie Outgoing Fellowship grant (272375) for TG (ec.europa.eu), and a Kolff internship grant from the Dutch Kidney Foundation (KBS 11.048) for MP (nierstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. H.R.B. Pelham (MRC Laboratory of Molecular Biology, Cambridge, UK) for kindly sharing the NDFIP constructs with us and Prof. O. Staub for providing us with the constructs for NEDD4 and NEDD4L constructs. This study was supported by a Marie Curie Intra European Fellowship grant (272375) for CT, a Marie Curie Outgoing Fellowship grant (272375) for TG, and a Kolff internship grant from the Dutch Kidney Foundation (KBS 11.048) for MP.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Boone M, 2011, AM J PHYSIOL-RENAL, V300, pF761, DOI 10.1152/ajprenal.00247.2010; Boone M, 2010, NEPHROL DIAL TRANSPL, V25, P48, DOI 10.1093/ndt/gfp409; Cheval L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046876; Cheval L, 2011, PHYSIOL GENOMICS, V43, P161, DOI 10.1152/physiolgenomics.00093.2010; de Mattia F, 2004, HUM MOL GENET, V13, P3045, DOI 10.1093/hmg/ddh339; DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Foot NJ, 2011, BLOOD, V117, P638, DOI 10.1182/blood-2010-07-295287; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jin HS, 2010, KIDNEY BLOOD PRESS R, V33, P15, DOI 10.1159/000275706; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kang YD, 2015, BIOCHEM J, V472, P71, DOI 10.1042/BJ20141282; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Lee YJ, 2011, AM J PHYSIOL-RENAL, V301, pF883, DOI 10.1152/ajprenal.00117.2011; Loffing-Cueni D, 2006, J AM SOC NEPHROL, V17, P1264, DOI 10.1681/ASN.2005060659; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Rotin D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00212; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; ten Broeke T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016873; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Trimpert C, 2012, NEPHROL DIAL TRANSPL, V27, P4389, DOI 10.1093/ndt/gfs292; Yu Ming-Jiun, MPKCCD TRANSCRIPTOME	43	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0183774	10.1371/journal.pone.0183774	http://dx.doi.org/10.1371/journal.pone.0183774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931009	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700012
J	Birech, Z; Mwangi, PW; Bukachi, F; Mandela, KM				Birech, Zephania; Mwangi, Peter Waweru; Bukachi, Fredrick; Mandela, Keith Makori			Application of Raman spectroscopy in type 2 diabetes screening in blood using leucine and isoleucine amino-acids as biomarkers and in comparative anti-diabetic drugs efficacy studies	PLOS ONE			English	Article							CONTROLLED-TRIAL; PIOGLITAZONE; ALLOXAN; PLASMA	Diabetes is an irreversible condition characterized by elevated blood glucose levels. Currently, there are no predictive biomarkers for this disease and the existing ones such as hemoglobin A1c and fasting blood glucose are used only when diabetes symptoms are noticed. The objective of this work was first to explore the potential of leucine and isoleucine amino acids as diabetes type 2 biomarkers using their Raman spectroscopic signatures. Secondly, we wanted to explore whether Raman spectroscopy can be applied in comparative efficacy studies between commercially available anti-diabetic drug pioglitazone and the locally used anti-diabetic herbal extract Momordica spinosa (Gilg.) Chiov. Sprague Dawley (SD) rat's blood was used and were pipetted onto Raman substrates prepared from conductive silver paste smeared glass slides. Prominent Raman bands associated with glucose (926, 1302, 1125 cm(-1)), leucine (1106, 1248, 1302, 1395 cm(-1)) and isolecucine (1108, 1248, 1437 and 1585 cm(-1)) were observed. The Raman bands centered at 1125 cm(-1), 1395 cm(-1) and 1437 cm(-1) associated respectively to glucose, leucine and isoleucine were chosen as biomarker Raman peaks for diabetes type 2. These Raman bands displayed decreased intensities in blood from diabetic SD rats administered antidiabetic drugs pioglitazone and herbal extract Momordica spinosa (Gilg.) Chiov. The intensity decrease indicated reduced concentration levels of the respective biomarker molecules: glucose (1125 cm(-1)), leucine (1395 cm(-1)) and isoleucine (1437 cm(-1)) in blood. The results displayed the power and potential of Raman spectroscopy in rapid (10 seconds) diabetes and pre-diabetes screening in blood (human or rat's) with not only glucose acting as a biomarker but also leucine and isoleucine amino-acids where intensities of respectively assigned bands act as references. It also showed that using Raman spectroscopic signatures of the chosen biomarkers, the method can be an alternative for performing comparative efficacy studies between known and new anti-diabetic drugs. Reports on use of Raman spectroscopy in type 2 diabetes mellitus screening with Raman bands associated with leucine and isoleucine molecules acting as reference is rare in literature. The use of Raman spectroscopy in prediabetes screening of blood for changes in levels of leucine and isoleucine amino acids is particularly interesting as once elevated levels are noticed, necessary interventions to prevent diabetes development can be initiated.	[Birech, Zephania] Univ Nairobi, Dept Phys, POB 30197-00100, Nairobi, Kenya; [Mwangi, Peter Waweru; Bukachi, Fredrick; Mandela, Keith Makori] Univ Nairobi, Dept Med Physiol, POB 30197-00100, Nairobi, Kenya	University of Nairobi; University of Nairobi	Birech, Z (corresponding author), Univ Nairobi, Dept Phys, POB 30197-00100, Nairobi, Kenya.; Mandela, KM (corresponding author), Univ Nairobi, Dept Med Physiol, POB 30197-00100, Nairobi, Kenya.	birech@uonbi.ac.ke; keithmandela@gmail.com	Mwangi, Peter Waweru/W-2562-2019; Mandela, Keith/K-4170-2019	Mwangi, Peter Waweru/0000-0002-9019-5969; Birech, Dr. Zephania/0000-0001-7445-1603	International Science Program (ISP), Uppsala University [KE04]	International Science Program (ISP), Uppsala University	This work was supported by International Science Program (ISP), Uppsala University for Grant KE04.	Almeida FM, 2006, J RAMAN SPECTROSC, V37, P1296, DOI 10.1002/jrs.1553; Barman I, 2012, ANAL CHEM, V84, P2474, DOI 10.1021/ac203266a; Behera TK, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - VEGETABLES, P217, DOI 10.1007/978-3-642-20450-0_10; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Ben O O, 2017, ANAL BIOANAL CHEM; Botta Raju, 2016, Sensing and Bio-Sensing Research, V9, P13, DOI 10.1016/j.sbsr.2016.05.001; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chen XP, 2015, J DIABETES INVEST, V6, P369, DOI 10.1111/jdi.12345; Delbanco AS, 2017, ECON BOT, P1; Dieing T, 2010, SPRINGER SER OPT SCI, V158, P61; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Firdous S, 2012, LASER PHYS, V22, P1090, DOI 10.1134/S1054660X12060023; Giesbertz P, 2016, CURR OPIN CLIN NUTR, V19, P48, DOI 10.1097/MCO.0000000000000235; Hernandez B, 2009, J PHYS CHEM B, V113, P3169, DOI 10.1021/jp809204d; Jenkins AL, 2005, SPECTROCHIM ACTA A, V61, P1585, DOI 10.1016/j.saa.2004.11.055; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Lin JY, 2014, J RAMAN SPECTROSC, V45, P884, DOI 10.1002/jrs.4574; Lin JQ, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S179354581350051X; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Maynard JD, 2007, DIABETES CARE, V30, P1120, DOI 10.2337/dc06-2377; ROBITAILLE L, 1988, CAN J PHYSIOL PHARM, V66, P613, DOI 10.1139/y88-095; Shah SH, 2011, CELL METAB, V13, P491, DOI 10.1016/j.cmet.2011.04.003; Shao JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048127; Silveira L, 2017, LASER MED SCI, P1; Szkudelski T, 2001, PHYSIOL RES, V50, P537; WHO, 2015, ANALYST, V140, P2266; Wrobel M., 2016, MATER SCI ENG, V104; Yamakado M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11918; Yoon MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070405; Zhao J, 2007, APPL SPECTROSC, V61, P1225, DOI 10.1366/000370207782597003; Zhou GM, 2007, ACTA CHIM SINICA, V65, P640; Zhu GY, 2011, SPECTROCHIM ACTA A, V78, P1187, DOI [10.1016/j.saa.2010.12.079, 10.1016/j.saa.2010.12.07]	32	19	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185130	10.1371/journal.pone.0185130	http://dx.doi.org/10.1371/journal.pone.0185130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926628	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600071
J	Burggren, WW; Elmonoufy, NA				Burggren, Warren W.; Elmonoufy, Nourhan A.			Critical developmental windows for morphology and hematology revealed by intermittent and continuous hypoxic incubation in embryos of quail (Coturnix coturnix)	PLOS ONE			English	Article							CHICKEN GALLUS-GALLUS; ACID-BASE-BALANCE; HIGH-ALTITUDE; HEART-RATE; OXYGEN-AFFINITY; JAPANESE-QUAIL; ORGAN GROWTH; CARDIOVASCULAR REGULATION; BLOOD-FLOW; IN-VIVO	Hypoxia during embryonic growth in embryos is frequently a powerful determinant of development, but at least in avian embryos the effects appear to show considerable intra- and inter-specific variation. We hypothesized that some of this variation may arise from different protocols that may or may not result in exposure during the embryo's critical window for hypoxic effects. To test this hypothesis, quail embryos (Coturnix coturnix) in the intact egg were exposed to hypoxia (similar to 15% O-2) during "early" (Day 0 through Day 5, abbreviated as D0-D5), "middle" (D6-D10) or "late" (D11-D15) incubation or for their entire 16-18 day incubation ("continuous hypoxia") to determine critical windows for viability and growth. Viability, body mass, beak and toe length, heart mass, and hematology (hematocrit and hemoglobin concentration) were measured on D5, D10, D15 and at hatching typically between D16 and D18 Viability rate was similar to 50-70% immediately following the exposure period in the early, middle and late hypoxic groups, but viability improved in the early and late groups once normoxia was restored. Middle hypoxia groups showed continuing low viability, suggesting a critical period from D6-D10 for embryo viability. The continuous hypoxia group experienced viability reaching <10% after D15. Hypoxia, especially during late and continuous hypoxia, also inhibited growth of body, beak and toe when measured at D15. Full recovery to normal body mass upon hatching occurred in all other groups except for continuous hypoxia. Contrary to previous avian studies, heart mass, hematocrit and hemoglobin concentration were not altered by any hypoxic incubation pattern. Although hypoxia can inhibit embryo viability and organ growth during most incubation periods, the greatest effects result from continuous or middle incubation hypoxic exposure. Hypoxic inhibition of growth can subsequently be "repaired" by catch-up growth if a final period of normoxic development is available. Collectively, these data indicate a critical developmental window for hypoxia susceptibility during the mid-embryonic period of development.	[Burggren, Warren W.; Elmonoufy, Nourhan A.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Burggren, WW (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA.	burggren@unt.edu	Burggren, Warren W/A-1561-2016	Burggren, Warren W/0000-0001-8023-420X	National Science Foundation [IOS1543301]	National Science Foundation(National Science Foundation (NSF))	This study was supported by operating grant IOS1543301 from the National Science Foundation (nsf.gov) to WB.; This study was supported by operating grant IOS1543301 from the National Science Foundation (nsf.gov) to WB. We are grateful to Dr. Amelie Crespel for providing a thoughtful critique of the manuscript.	Altimiras J, 2000, J EXP ZOOL, V286, P450, DOI 10.1002/(SICI)1097-010X(20000401)286:5<450::AID-JEZ2>3.0.CO;2-Y; Andrewartha SJ, 2014, RESP PHYSIOL NEUROBI, V195, P1, DOI 10.1016/j.resp.2014.01.019; Andrewartha SJ, 2011, RESP PHYSIOL NEUROBI, V179, P142, DOI 10.1016/j.resp.2011.07.010; Andrewartha SJ, 2011, RESP PHYSIOL NEUROBI, V178, P84, DOI 10.1016/j.resp.2011.04.014; Azzam MA, 2007, RESP PHYSIOL NEUROBI, V159, P155, DOI 10.1016/j.resp.2007.06.003; BARTELS H, 1985, AVIAT SPACE ENVIR MD, V56, P976; BAUMANN R, 1983, AM J PHYSIOL, V244, pR733, DOI 10.1152/ajpregu.1983.244.5.R733; BAUMANN R, 1992, PHYSIOL REV, V72, P941, DOI 10.1152/physrev.1992.72.4.941; Baumann R., 1984, RESPIRATION METABOLI, P221; Branum SR, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12712; Brunstrom B, 2009, GEN COMP ENDOCR, V163, P97, DOI 10.1016/j.ygcen.2009.01.006; Burggren W, 2004, AM J PHYSIOL-REG I, V287, pR1399, DOI 10.1152/ajpregu.00086.2004; Burggren W, 2002, COMP BIOCHEM PHYS A, V132, P661, DOI 10.1016/S1095-6433(02)00127-7; Burggren Warren W., 1998, Biological Bulletin National Taiwan Normal University, V33, P71; Burggren WW, 2016, REV BRAS ZOOTECN, V45, P709, DOI [10.1590/S1806-92902016001100010, 10.1590/s1806-92902016001100010]; Burggren WW, 2015, PHYSIOL BIOCHEM ZOOL, V88, P91, DOI 10.1086/679906; Burggren WW, 2011, RESP PHYSIOL NEUROBI, V178, P13, DOI 10.1016/j.resp.2011.05.001; Burggren WW, 2005, J EXP BIOL, V208, P105, DOI 10.1242/jeb.01349; Burggren WW, 2000, ZOOL-ANAL COMPLEX SY, V102, P148; BURTON RR, 1969, FED PROC, V28, P1170; Buzala M, 2015, POULTRY SCI, V94, P728, DOI 10.3382/ps/pev015; CAREY C, 1982, AUK, V99, P710; Chan T, 2005, RESP PHYSIOL NEUROBI, V145, P251, DOI 10.1016/j.resp.2004.09.005; Choi YM, 2013, POULTRY SCI, V92, P1870, DOI 10.3382/ps.2012-02892; Crossley DA, 2012, POULTRY SCI, V91, P2628, DOI 10.3382/ps.2012-02344; Crossley DA, 2003, J EXP BIOL, V206, P2703, DOI 10.1242/jeb.00476; Crossley DA, 2003, AM J PHYSIOL-REG I, V284, pR219, DOI 10.1152/ajpregu.00654.2001; Crossley DAI, 2016, COMPREHENSI IN PRESS; Crossley DA, 2010, J COMP PHYSIOL B, V180, P1057, DOI 10.1007/s00360-010-0473-y; Crossley DA, 2009, J MORPHOL, V270, P1400, DOI 10.1002/jmor.10764; Dragon S, 1999, J EXP BIOL, V202, P2787; Dzialowski EM, 2002, COMP BIOCHEM PHYS A, V131, P713, DOI 10.1016/S1095-6433(02)00009-0; El-Tarabany MS, 2016, J THERM BIOL, V61, P38, DOI 10.1016/j.jtherbio.2016.08.004; Everaert N, 2008, BRIT POULTRY SCI, V49, P574, DOI 10.1080/00071660802357025; Everaert N, 2011, COMP BIOCHEM PHYS A, V158, P215, DOI 10.1016/j.cbpa.2010.10.031; Fawcett TW, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S3; Ferner K, 2009, RESP PHYSIOL NEUROBI, V165, P49, DOI 10.1016/j.resp.2008.10.004; Gu S, 2012, DEV DYNAM, V241, P534, DOI 10.1002/dvdy.23727; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hammond CL, 2007, J EXP BIOL, V210, P2667, DOI 10.1242/jeb.005751; Hirst Claire E, 2015, Results Probl Cell Differ, V56, P99, DOI 10.1007/978-3-662-44608-9_5; Ho DH, 2011, J EXP BIOL, V214, P619, DOI 10.1242/jeb.046714; Hoper J, 1995, INT J MICROCIRC, V15, P186, DOI 10.1159/000178974; HOWE RS, 1995, AM J PHYSIOL-HEART C, V268, pH56, DOI 10.1152/ajpheart.1995.268.1.H56; Huang SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173698; Hyankova L, 2012, BRIT POULTRY SCI, V53, P592, DOI 10.1080/00071668.2012.736610; Ide R, 2016, RESP PHYSIOL NEUROBI, V230, P29, DOI 10.1016/j.resp.2016.05.005; ISAACKS RE, 1976, POULTRY SCI, V55, P1788, DOI 10.3382/ps.0551788; JESSEN TH, 1991, P NATL ACAD SCI USA, V88, P6519, DOI 10.1073/pnas.88.15.6519; Jonker SS, 2015, AM J PHYSIOL-REG I, V308, pR680, DOI 10.1152/ajpregu.00484.2014; Khandoker AH, 2003, COMP BIOCHEM PHYS A, V136, P289, DOI 10.1016/S1095-6433(03)00171-5; Kohl ZF, 2015, COMP BIOCHEM PHYS A, V190, P1, DOI 10.1016/j.cbpa.2015.07.023; Lewallen MA, 2015, RESP PHYSIOL NEUROBI, V219, P85, DOI 10.1016/j.resp.2015.08.004; Liu C, 2009, POULTRY SCI, V88, P2689, DOI 10.3382/ps.2009-00311; Liu HB, 2009, DEV DYNAM, V238, P2760, DOI 10.1002/dvdy.22103; McCracken KG, 2009, AM NAT, V174, P631, DOI 10.1086/606020; MCCUTCHEON IE, 1982, RESP PHYSIOL, V50, P153, DOI 10.1016/0034-5687(82)90014-7; METCALFE J, 1981, RESP PHYSIOL, V46, P81, DOI 10.1016/0034-5687(81)90091-8; MEUER HJ, 1992, RESP PHYSIOL, V90, P227, DOI 10.1016/0034-5687(92)90083-9; Miller SL, 2002, AM J OBSTET GYNECOL, V186, P261, DOI 10.1067/mob.2002.119629; Mortola JP, 2008, RESP PHYSIOL NEUROBI, V162, P223, DOI 10.1016/j.resp.2008.07.015; Mortola JP, 2013, RESP PHYSIOL NEUROBI, V188, P172, DOI 10.1016/j.resp.2013.05.030; Mortola JP, 2010, COMP BIOCHEM PHYS A, V155, P301, DOI 10.1016/j.cbpa.2009.11.003; Mortola JP, 2005, RESP PHYSIOL NEUROBI, V146, P97, DOI 10.1016/j.resp.2004.10.011; Mueller CA, 2016, J EXP BIOL, V219, P571, DOI 10.1242/jeb.125823; Mueller CA, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P739; Mueller CA, 2015, J COMP PHYSIOL B, V185, P315, DOI 10.1007/s00360-015-0886-8; Mueller CA, 2013, AM J PHYSIOL-REG I, V305, pR855, DOI 10.1152/ajpregu.00298.2013; Mulder ALM, 1998, J PHYSIOL-LONDON, V508, P281, DOI 10.1111/j.1469-7793.1998.281br.x; Mulder ALM, 2000, J PHYSIOL-LONDON, V527, P593, DOI 10.1111/j.1469-7793.2000.00593.x; OLANDER HJ, 1967, AVIAN DIS, V11, P609, DOI 10.2307/1588303; Osterman H, 2015, AM J PHYSIOL-REG I, V309, pR1204, DOI 10.1152/ajpregu.00499.2014; Reyna K, 2017, PLOS ONE IN PRESS; Ricklefs RE, 2006, P ROY SOC B-BIOL SCI, V273, P2077, DOI 10.1098/rspb.2006.3544; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; Rouwet EV, 2002, CIRCULATION, V105, P2791, DOI 10.1161/01.CIR.0000017497.47084.06; Sato M, 2006, COMP BIOCHEM PHYS A, V143, P382, DOI 10.1016/j.cbpa.2005.12.019; Sato Y, 2013, DEV GROWTH DIFFER, V55, P113, DOI 10.1111/dgd.12010; Sirsat SKG, 2016, J EXP BIOL, V219, P1214, DOI 10.1242/jeb.132282; SMITH AH, 1969, FED PROC, V28, P1092; Smith F, 2013, DIS MODEL MECH, V6, P915, DOI 10.1242/dmm.011064; STOCK MK, 1983, RESP PHYSIOL, V52, P1, DOI 10.1016/0034-5687(83)90132-9; Tazawa H, 2012, RESP PHYSIOL NEUROBI, V184, P86, DOI 10.1016/j.resp.2012.08.002; Tazawa H, 2011, COMP BIOCHEM PHYS A, V159, P225, DOI 10.1016/j.cbpa.2011.02.024; van Golde JMCG, 1999, J PHYSIOL-LONDON, V515, P243, DOI 10.1111/j.1469-7793.1999.243ad.x; VELARDE FL, 1991, CR ACAD SCI III-VIE, V313, P401; WEBER RE, 1993, J APPL PHYSIOL, V75, P2646, DOI 10.1152/jappl.1993.75.6.2646; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; Wilson RE, 2013, EVOLUTION, V67, P170, DOI 10.1111/j.1558-5646.2012.01740.x; WITZEL DA, 1990, POULTRY SCI, V69, P741, DOI 10.3382/ps.0690741; WOODARD AE, 1975, POULTRY SCI, V54, P1708, DOI 10.3382/ps.0541708; YERSIN AG, 1992, AVIAN DIS, V36, P189, DOI 10.2307/1591489; Yoneta H, 2007, COMP BIOCHEM PHYS A, V147, P529, DOI 10.1016/j.cbpa.2007.02.001; Yoshizaki N, 2002, POULTRY SCI, V81, P246, DOI 10.1093/ps/81.2.246; Yue XP, 1999, DEV DYNAM, V216, P28, DOI 10.1002/(SICI)1097-0177(199909)216:1<28::AID-DVDY5>3.3.CO;2-L; Yue XP, 2001, AM J PHYSIOL-HEART C, V280, pH2240, DOI 10.1152/ajpheart.2001.280.5.H2240; Zhang H, 2012, POULTRY SCI, V91, P3191, DOI 10.3382/ps.2012-02449	97	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0183649	10.1371/journal.pone.0183649	http://dx.doi.org/10.1371/journal.pone.0183649			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926567	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600004
J	Perez-Lachaud, G; Lachaud, JP				Perez-Lachaud, Gabriela; Lachaud, Jean-Paul			Hidden biodiversity in entomological collections: The overlooked co-occurrence of dipteran and hymenopteran ant parasitoids in stored biological material	PLOS ONE			English	Article							MUSEUM COLLECTIONS; 1ST RECORD; FORMICIDAE; DIVERSITY; PONERINAE; SPECIMENS; UNLOCKING; ATTACKING; BEHAVIOR; WHEELER	Biological collections around the world are the repository of biodiversity on Earth; they also hold a large quantity of unsorted, unidentified, or misidentified material and can house behavioral information on species that are difficult to access or no longer available to science. Among the unsorted, alcohol-preserved material stored in the Formicidae Collection of the ` El Colegio de la Frontera Sur' Research Center (Chetumal, Mexico), we found nine colonies of the ponerine ant Neoponera villosa, that had been collected in bromeliads at Calakmul (Campeche, Mexico) in 1999. Ants and their brood were revised for the presence of any sign of parasitism. Cocoons were dissected and their content examined under a stereomicroscope. Six N. villosa prepupae had been attacked by the ectoparasitoid syrphid fly Hypselosyrphus trigonus Hull (Syrphidae: Microdontinae), to date the only known dipteran species of the Microdontinae with a parasitoid lifestyle. In addition, six male pupae from three colonies contained gregarious endoparasitoid wasps. These were specialized in parasitizing this specific host caste as no gyne or worker pupae displayed signs of having been attacked. Only immature stages (larvae and pupae) of the wasp could be obtained. Due to the long storage period, DNA amplification failed; however, based on biological and morphological data, pupae were placed in the Encyrtidae family. This is the first record of an encyrtid wasp parasitizing N. villosa, and the second example of an encyrtid as a primary parasitoid of ants. Furthermore, it is also the first record of co-occurrence of a dipteran ectoparasitoid and a hymenopteran endoparasitoid living in sympatry within the same population of host ants. Our findings highlight the importance of biological collections as reservoirs of hidden biodiversity, not only at the taxonomic level, but also at the behavioral level, revealing complex living networks. They also highlight the need for funding in order to carry out biodiversity inventories and manage existing collections.	[Perez-Lachaud, Gabriela; Lachaud, Jean-Paul] Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Lachaud, Jean-Paul] Univ Toulouse UPS, Ctr Biol Integrat, Ctr Rech Cognit Anim, Toulouse, France	El Colegio de la Frontera Sur (ECOSUR); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE)	Lachaud, JP (corresponding author), Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico.; Lachaud, JP (corresponding author), Univ Toulouse UPS, Ctr Biol Integrat, Ctr Rech Cognit Anim, Toulouse, France.	jlachaud@ecosur.mx	Lachaud, Jean-Paul/H-4266-2019; LACHAUD, Jean-Paul/ABG-3831-2021	LACHAUD, Jean-Paul/0000-0002-5082-8987; Perez-Lachaud, Gabriela/0000-0002-8924-1606	Mexican 'Comision Nacional para el Conocimiento y Uso de la Biodiversidad' [CONABIO ME006]; French program 'Evaluation orientation de la Cooperation Scientifique' [ECOS-Nord/CONACyT M12A01]	Mexican 'Comision Nacional para el Conocimiento y Uso de la Biodiversidad'; French program 'Evaluation orientation de la Cooperation Scientifique'	Funds to JPL were partly provided by the Mexican 'Comision Nacional para el Conocimiento y Uso de la Biodiversidad' (Project CONABIO ME006 "Fortalecimiento de las colecciones de ECOSUR") and by the French program 'Evaluation orientation de la Cooperation Scientifique' (project ECOS-Nord/CONACyT M12A01 "Systematique, biogeographie et organisation sociale chez les especes du complexe Pachycondyla villosa et du genre Ectatomma"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aririo AH, 2010, BIODIV INFORM, V7, P81; Aronsen GP, 2017, B PEABODY MUS NAT HI, V58, P209, DOI 10.3374/014.058.0107; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; Brooks SJ, 2014, INT J BIOMETEOROL, V58, P1749, DOI 10.1007/s00484-013-0780-6; D'Elia J, 2016, CONDOR, V118, P703, DOI 10.1650/CONDOR-16-35.1; DEJEAN A, 1995, BIOTROPICA, V27, P57, DOI 10.2307/2388903; Dejean A, 1997, J NAT HIST, V31, P1313, DOI 10.1080/00222939700770741; DEJEAN A, 1990, SOCIOBIOLOGY, V17, P271; DiEuliis D, 2016, P NATL ACAD SCI USA, V113, P4, DOI 10.1073/pnas.1522680112; Donisthorpe HSJK., 1927, GUESTS BRIT ANTS THE; Feener DH, 1997, ANNU REV ENTOMOL, V42, P73, DOI 10.1146/annurev.ento.42.1.73; Fernandes Itanna Oliveira, 2014, Myrmecological News, V19, P133; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine B, 2012, CURR BIOL, V22, pR943, DOI 10.1016/j.cub.2012.10.029; Galindo-Leal C., 2003, CONT HERPETOLOGY, V1, P1, DOI DOI 10.17161/ch.vi1.11966; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Gonzalez CT, 2016, ANN ENTOMOL SOC AM, V109, P639, DOI 10.1093/aesa/saw023; GOSSWALD K., 1950, VERH DTSCH ZOOL MAIN, V1949, P256; Green SV, 1998, J INSECT CONSERV, V2, P151, DOI 10.1023/A:1009633811789; Grissell E. E., 1997, ANNOTATED KEYS GENER, V40392, P45; Guenard B, 2012, P NATL ACAD SCI USA, V109, P7368, DOI 10.1073/pnas.1113867109; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Harper GL, 2006, BIOL J LINN SOC, V88, P447, DOI 10.1111/j.1095-8312.2006.00632.x; Hill A, 2012, ZOOKEYS, P219, DOI 10.3897/zookeys.209.3472; Holldobler B., 1990, pi; Hull F. N., 1937, Psyche Cambridge Mass, V44, P12, DOI 10.1155/1937/46960; Johnson KG, 2011, BIOSCIENCE, V61, P147, DOI 10.1525/bio.2011.61.2.10; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Kempf WW, 1972, STUD ENTOMOL, V15, P1; Kistner D. H., 1982, Social insects. Vol. III, P1; Lachaud JP, 2015, INSECT SOC, V62, P121, DOI 10.1007/s00040-015-0390-x; Lachaud J. P., 1984, FOLIA ENTOMOL MEX, V61, P159; Lachaud J. P, 2013, FORMICIDAE DE MEXICO, P23; Lachaud Jean-Paul, 2012, Psyche (Cambridge), V2012; Lucas C, 2002, BIOL J LINN SOC, V75, P249, DOI 10.1111/j.1095-8312.2002.tb01425.x; Mackay W. P., 2010, SYSTEMATICS BIOL NEW; May RM, 2010, SCIENCE, V329, P41, DOI 10.1126/science.1191058; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Noyes JS., 2015, UNIVERSAL CHALCIDOID; PEREZ-BAUTISTA M, 1985, Folia Entomologica Mexicana, P119; Perez-Lachaud G, 2006, ANN ENTOMOL SOC AM, V99, P567, DOI 10.1603/0013-8746(2006)99[567:BABOKH]2.0.CO;2; Perez-Lachaud G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45530; Perez-Lachaud G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100155; Perez-Lachaud G, 2014, BIOL J LINN SOC, V111, P462, DOI 10.1111/bij.12220; Perez-Lachaud G, 2012, FLA ENTOMOL, V95, P1066, DOI 10.1653/024.095.0436; Polus E, 2007, BIODIVERS CONSERV, V16, P3423, DOI 10.1007/s10531-006-9008-y; Pozo C., 2003, COLECCIONES BIOL COL, P47; Pyke GH, 2010, BIOL REV, V85, P247, DOI 10.1111/j.1469-185X.2009.00098.x; Rettenmeyer CW, 2011, INSECT SOC, V58, P281, DOI 10.1007/s00040-010-0128-8; RICKLEFS RE, 1980, AUK, V97, P206; Sarukhan Jose, 2001, P419; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Scheper J, 2010, P NATL ACAD SCI USA, V107, P22169; Schmidt CA, 2014, ZOOTAXA, V3817, P1, DOI 10.11646/zootaxa.3817.1.1; Smith VS, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.209.3699; Stephens CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005725; Stork NE, 2015, P NATL ACAD SCI USA, V112, P7519, DOI 10.1073/pnas.1502408112; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Valenzuela-Gonzalez Jorge, 1995, Folia Entomologica Mexicana, V91, P9; Wheeler QD, 2012, SYST BIODIVERS, V10, P1, DOI 10.1080/14772000.2012.665095; Wild Alexander L., 2003, Boletin del Museo Nacional de Historia Natural del Paraguay, V14, P1; Witek M, 2014, INSECT SOC, V61, P307, DOI 10.1007/s00040-014-0362-6; WOJCIK DP, 1987, FLA ENTOMOL, V70, P181, DOI 10.2307/3495108	67	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184614	10.1371/journal.pone.0184614	http://dx.doi.org/10.1371/journal.pone.0184614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926617	Green Published, gold			2022-12-27	WOS:000411166600025
J	Song, Y; Soh, S; Shim, JK; Park, KU; Kwak, YL				Song, Young; Soh, Sarah; Shim, Jae-Kwang; Park, Kyoung-Un; Kwak, Young-Lan			Skin perfusion pressure as an indicator of tissue perfusion in valvular heart surgery: Preliminary results from a prospective, observational study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; MICROVASCULAR REACTIVITY; OXYGEN-SATURATION; LIMB ISCHEMIA; LACTATE; MICROCIRCULATION; HYPERTENSION; PREDICTION	Hemodynamic management aims to provide adequate tissue perfusion, which is often altered during cardiac surgery with cardiopulmonary bypass (CPB). We evaluated whether skin perfusion pressure (SPP) can be used for monitoring of adequacy of tissue perfusion in patients undergoing valvular heart surgery. Seventy-two patients undergoing valve replacement were enrolled. SPP and serum lactate level were assessed after anaesthesia induction (baseline), during CPB, after CPB-off, end of surgery, arrival at intensive care unit, and postoperative 6 h. Lactate was further measured until postoperative 48 h. Association of SPP with lactate and 30-day morbidity comprising myocardial infarction, acute kidney injury, stroke, prolonged intubation, sternal infection, reoperation, and mortality was assessed. Among the lactate levels, postoperative 6 h peak value was most closely linked to composite of 30-day morbidity. The SPP value during CPB and its% change from the baseline value were significantly associated with the postoperative 6 h peak lactate (r = -0.26, P = 0.030 and r = 0.47, P = 0.001, respectively). Optimal cut-off of% decrease in SPP during CPB from baseline value for the postoperative 6 h hyperlactatemia was 48% (area under curve, 0.808; 95% confidence interval (CI), 0.652-0.963; P = 0.001). Decrease in SPP >48% during CPB from baseline value was associated with a 12.8-fold increased risk of composite endpoint of 30-day morbidity (95% CI, 1.48-111.42; P = 0.021) on multivariate logistic regression. Large decrease in SPP during CPB predicts postoperative 6 h hyperlactatemia and 30-day morbidity, which implicates a promising role of SPP monitoring in the achievement of optimal perfusion during CPB.	[Song, Young; Soh, Sarah; Shim, Jae-Kwang; Park, Kyoung-Un; Kwak, Young-Lan] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Song, Young; Soh, Sarah; Shim, Jae-Kwang; Kwak, Young-Lan] Yonsei Univ, Coll Med, Anesthesia & Pain Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kwak, YL (corresponding author), Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea.; Kwak, YL (corresponding author), Yonsei Univ, Coll Med, Anesthesia & Pain Res Inst, Seoul, South Korea.	ylkwak@yuhs.ac	Kwak, Young-Lan/AAF-5093-2021	Kwak, Young-Lan/0000-0002-2984-9927; Song, Young/0000-0003-4597-387X; Shim, Jae-Kwang/0000-0001-9093-9692; Soh, Sarah/0000-0001-5022-4617	new faculty research seed money grant of our institution, Yonsei University College of Medicine in Republic of Korea [2015-32-0015]	new faculty research seed money grant of our institution, Yonsei University College of Medicine in Republic of Korea	This study was financially supported by a new faculty research seed money grant of our institution, Yonsei University College of Medicine in Republic of Korea (2015-32-0015). This does not alter adherence to PLOS ONE policies on sharing data and materials. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERA HM, 1995, J VASC SURG, V21, P823, DOI 10.1016/S0741-5214(05)80014-X; Ambrus R, 2017, J AM COLL SURG; Castronuovo JJ, 1997, J VASC SURG, V26, P629, DOI 10.1016/S0741-5214(97)70062-4; Cheng M, 2015, CELL BIOCHEM BIOPHYS, V73, P441, DOI 10.1007/s12013-015-0661-1; Cirillo F, 2001, ACTA CARDIOL, V56, P91, DOI 10.2143/AC.56.2.2005623; D'Aragon F, 2015, SHOCK, V43, P530, DOI 10.1097/SHK.0000000000000348; de Vroege R, 2004, PERFUSION-UK, V19, P267, DOI 10.1191/0267659104pf757oa; Demir IE, 2012, DIGEST SURG, V29, P226, DOI 10.1159/000338086; den Uil CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103978; Doerschug KC, 2007, AM J PHYSIOL-HEART C, V293, pH1065, DOI 10.1152/ajpheart.01237.2006; Ekbal NJ, 2013, CHEST, V143, P1799, DOI 10.1378/chest.12-1849; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Ince C, 2015, CRIT CARE, V19, DOI 10.1186/cc14726; Kara A, 2016, CURR OPIN ANESTHESIO, V29, P85, DOI 10.1097/ACO.0000000000000280; Kim TK, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1025-3; Kopp R, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0140-7; Laine GA, 2013, J CARDIOTHOR VASC AN, V27, P1271, DOI 10.1053/j.jvca.2013.02.031; Lo T, 2009, WOUNDS, V21, P310; Minton Jonathon, 2017, J Extra Corpor Technol, V49, P7; Monthe-Sagan K, 2016, J CRIT CARE, V31, P264, DOI 10.1016/j.jcrc.2015.09.026; Morel J, 2014, ACTA ANAESTH SCAND, V58, P835, DOI 10.1111/aas.12329; Murphy GS, 2009, ANESTH ANALG, V108, P1394, DOI 10.1213/ane.0b013e3181875e2e; Okamoto K, 2006, AM J KIDNEY DIS, V48, P269, DOI 10.1053/j.ajkd.2006.04.075; Park JH, 2016, INTENS CARE MED, V42, P1398, DOI 10.1007/s00134-016-4358-8; Park JT, 2017, KOREAN J ANESTHESIOL, V70, P258, DOI 10.4097/kjae.2017.70.3.258; Patila T, 2006, ANN THORAC SURG, V82, P2072, DOI 10.1016/j.athoracsur.2006.06.025; Ruel M, 2004, EUR J CARDIO-THORAC, V26, P1002, DOI 10.1016/j.ejcts.2004.07.040; Sallisalmi M, 2012, ACTA ANAESTH SCAND, V56, P298, DOI 10.1111/j.1399-6576.2011.02569.x; Schachtrupp A, 2005, SHOCK, V24, P153, DOI 10.1097/01.shk.0000172094.73918.c2; Schey BM, 2010, HEART LUNG, V39, P27, DOI 10.1016/j.hrtlng.2009.04.002; Smith RS, 2014, J CARDIOTHOR VASC AN, V28, P1217, DOI 10.1053/j.jvca.2014.03.016; Stafford-Smith M, 2005, PERFUSION-UK, V20, P53, DOI 10.1191/0267659105pf780oa; Suetrong B, 2016, CHEST, V149, P252, DOI 10.1378/chest.15-1703; Tsai FW, 2000, J VASC SURG, V32, P32, DOI 10.1067/mva.2000.107310; Xu JY, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0866-0; Yamada T, 2008, J VASC SURG, V47, P318, DOI 10.1016/j.jvs.2007.10.045	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184555	10.1371/journal.pone.0184555	http://dx.doi.org/10.1371/journal.pone.0184555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926643	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600023
J	Ferraz, MSA; Melo-Silva, HLC; Kihara, AH				Ayres Ferraz, Mariana Sacrini; Cardeal Melo-Silva, Hiago Lucas; Kihara, Alexandre Hiroaki			Optimizing information processing in neuronal networks beyond critical states	PLOS ONE			English	Article							CORTICAL NETWORKS; OLFACTORY-BULB; AVALANCHES; CONNEXIN36; RETINA; MEMORY; REPLAY; TRANSMISSION; HIPPOCAMPUS; PATTERNS	Critical dynamics have been postulated as an ideal regime for neuronal networks in the brain, considering optimal dynamic range and information processing. Herein, we focused on how information entropy encoded in spatiotemporal activity patterns may vary in critical networks. We employed branching process based models to investigate how entropy can be embedded in spatiotemporal patterns. We determined that the information capacity of critical networks may vary depending on the manipulation of microscopic parameters. Specifically, the mean number of connections governed the number of spatiotemporal patterns in the networks. These findings are compatible with those of the real neuronal networks observed in specific brain circuitries, where critical behavior is necessary for the optimal dynamic range response but the uncertainty provided by high entropy as coded by spatiotemporal patterns is not required. With this, we were able to reveal that information processing can be optimized in neuronal networks beyond critical states.	[Ayres Ferraz, Mariana Sacrini; Cardeal Melo-Silva, Hiago Lucas; Kihara, Alexandre Hiroaki] Univ Fed ABC, Nucleo Cognicao & Sistemas Complexos, Ctr Matemat Computacao & Cognicao, Sao Bernardo Do Campo, SP, Brazil	Universidade Federal do ABC (UFABC)	Kihara, AH (corresponding author), Univ Fed ABC, Nucleo Cognicao & Sistemas Complexos, Ctr Matemat Computacao & Cognicao, Sao Bernardo Do Campo, SP, Brazil.	alexandrekihara@gmail.com	KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Kihara, Alexandre H/C-2458-2012	KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; Kihara, Alexandre H/0000-0002-4027-7261	Sao Paulo Research Foundation (FAPESP) [2015/50122-0]; FAPESP [2014/16711-6]; CNPq [308608/2014-3]; UFABC; CNPq;  [DFG-IRTG 1740/2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UFABC; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This research is supported by grant 2015/50122-0 from Sao Paulo Research Foundation (FAPESP) and DFG-IRTG 1740/2. HCM is grateful for UFABC scholarship. MAF is grateful for CNPq scholarship. AHK is grateful for grants from FAPESP (2014/16711-6) and CNPq (308608/2014-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Campos JGF, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.042303; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Haldeman C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058101; Hennig MH, 2009, J NEUROSCI, V29, P1077, DOI 10.1523/JNEUROSCI.4880-08.2009; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kihara AH, 2009, J COMP NEUROL, V512, P651, DOI 10.1002/cne.21920; Kihara AH, 2006, NEUROSCI LETT, V393, P36, DOI 10.1016/j.neulet.2005.09.033; Kihara AH, 2006, J NEUROSCI RES, V83, P1331, DOI 10.1002/jnr.20815; Kinjo ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109149; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Kosaka T, 2005, NEUROSCIENCE, V134, P757, DOI 10.1016/j.neuroscience.2005.04.057; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Li XM, 2012, ACTA PHYS SIN-CH ED, V61, DOI 10.7498/aps.61.023104; Luczak A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00030; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Rasmussen RG, 2017, ELIFE, V6, DOI 10.7554/eLife.21409; Scarpetta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064162; Scarpetta S, 2013, J COMPUT NEUROSCI, V34, P319, DOI 10.1007/s10827-012-0423-7; Schmeltzer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121794; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Stein PSG, 2013, ANN NY ACAD SCI, V1279, P1, DOI 10.1111/nyas.12083; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013	34	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184367	10.1371/journal.pone.0184367	http://dx.doi.org/10.1371/journal.pone.0184367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922366	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300016
J	Epstein, T; Gatenby, RA; Brown, JS				Epstein, Tamir; Gatenby, Robert A.; Brown, Joel S.			The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand	PLOS ONE			English	Article							GRADIENTS; ATP; GLYCOLYSIS	To maintain optimal fitness, a cell must balance the risk of inadequate energy reserve for response to a potentially fatal perturbation against the long-term cost of maintaining high concentrations of ATP to meet occasional spikes in demand. Here we apply a game theoretic approach to address the dynamics of energy production and expenditure in eukaryotic cells. Conventionally, glucose metabolism is viewed as a function of oxygen concentrations in which the more efficient oxidation of glucose to CO2 and H2O produces all or nearly all ATP except under hypoxic conditions when less efficient (2 ATP/glucose vs. about 36ATP/glucose) anaerobic metabolism of glucose to lactic acid provides an emergency backup. We propose an alternative in which energy production is governed by the complex temporal and spatial dynamics of intracellular ATP demand. In the short term, a cell must provide energy for constant baseline needs but also maintain capacity to rapidly respond to fluxes in demand particularly due to external perturbations on the cell membrane. Similarly, longer-term dynamics require a trade-off between the cost of maintaining high metabolic capacity to meet uncommon spikes in demand versus the risk of unsuccessfully responding to threats or opportunities. Here we develop a model and computationally explore the cell's optimal mix of glycolytic and oxidative capacity. We find the Warburg effect, high glycolytic metabolism even under normoxic conditions, is represents a metabolic strategy that allow cancer cells to optimally meet energy demands posed by stochastic or fluctuating tumor environments.	[Epstein, Tamir; Gatenby, Robert A.; Brown, Joel S.] H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL 33607 USA; [Brown, Joel S.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Brown, Joel S.] Univ Illinois, Ctr Canc, Chicago, IL 60680 USA	H Lee Moffitt Cancer Center & Research Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Epstein, T (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL 33607 USA.	tamir.epstein@gmail.com			National Institute of Health / National Cancer Institut [U54CA143970-05]	National Institute of Health / National Cancer Institut	RAG received the financial support from the National Institute of Health / National Cancer Institute U54CA143970-05 (Physical Science Oncology Network EPSON]).	Aw TY, 2000, INT REV CYTOL, V192, P223; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Browne SE, 2013, J NEUROCHEM, V126, P301, DOI 10.1111/jnc.12321; Chronopoulos M, 2011, EUR J OPER RES, V213, P221, DOI 10.1016/j.ejor.2011.03.007; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Cochran J, 2014, NRELTP 6A20 61721, DOI 10.2172/1130630; Cohen Y, 2003, EVOL ECOL RES, V5, P819; Cohen Y., 2005, J APPL MATH, V2005, P403, DOI DOI 10.1155/JAM.2005.403; Cohen Y, 2009, EVOL ECOL RES, V11, P611; Epstein T, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-7; Gandelman M, 2013, J NEUROCHEM, V126, P382, DOI 10.1111/jnc.12286; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hippocrates Pare A, 1910, SCI PAPERS PHYSL MED; Hofmeyr JHS, 1995, J BIOENERG BIOMEMBR, V27, P479, DOI 10.1007/BF02110188; Hoppe A, 2011, BIOSYSTEMS, V105, P122, DOI 10.1016/j.biosystems.2011.05.006; Huberts NFD, 2015, DYN GAMES APPL, V5, P424, DOI 10.1007/s13235-015-0162-2; Huisman KJM, 2015, RAND J ECON, V46, P376, DOI 10.1111/1756-2171.12089; JONES DP, 1986, AM J PHYSIOL, V250, pC663, DOI 10.1152/ajpcell.1986.250.5.C663; Kirschen D., 2018, FUNDAMENTALS POWER S, V2nd ed.; Liebermeister W., 2014, ARXIV14045252; Mao LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058168; Moreno-Sanchez R, 2014, INT J BIOCHEM CELL B, V50, P10, DOI 10.1016/j.biocel.2014.01.025; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Silva AS, 2012, CANCER RES, V72, P6362, DOI 10.1158/0008-5472.CAN-12-2235; Stephens D., 2007, FORAGING BEHAV ECOLO; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Tilman D., 1980, AM NAT; Warburg O., 1924, BIOCH Z; Watkins S, 2011, J NEUROSCI, V31, P17250, DOI 10.1523/JNEUROSCI.3938-11.2011	36	89	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185085	10.1371/journal.pone.0185085	http://dx.doi.org/10.1371/journal.pone.0185085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922380	Green Submitted, Green Published, gold			2022-12-27	WOS:000411059300057
J	Jando, J; Camargo, SMR; Herzog, B; Verrey, F				Jando, Julia; Camargo, Simone M. R.; Herzog, Brigitte; Verrey, Francois			Expression and regulation of the neutral amino acid transporter B(0)AT1 in rat small intestine	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; BORDER MEMBRANE-VESICLES; DIETARY-REGULATION; HARTNUP DISORDER; SARS CORONAVIRUS; MOUSE; PEPTIDE; SLC6A19; PEPT-1; ACE2	Absorption of neutral amino acids across the luminal membrane of intestinal enterocytes is mediated by the broad neutral amino acid transporter B(0)AT1 (SLC6A19). Its intestinal expression depends on co-expression of the membrane-anchored peptidase angiotensin converting enzyme 2 (ACE2) and is additionally enhanced by aminopeptidase N (CD13). We investigated in this study the expression of B(0)AT1 and its auxiliary peptidases as well as its transport function along the rat small intestine. Additionally, we tested its possible short-and long-term regulation by dietary proteins and amino acids. We showed by immunofluorescence that B(0)AT1, ACE2 and CD13 co-localize on the luminal membrane of small intestinal villi and by Western blotting that their protein expression increases in distal direction. Furthermore, we observed an elevated transport activity of the neutral amino acid L-isoleucine during the nocturnal active phase compared to the inactive one. Gastric emptying was delayed by intragastric application of an amino acid cocktail but we observed no acute dietary regulation of B(0)AT1 protein expression and L-isoleucine transport. Investigation of the chronic dietary regulation of B(0)AT1, ACE2 and CD13 by different diets revealed an increased B(0)AT1 protein expression under amino acid-supplemented diet in the proximal section but not in the distal one and for ACE2 protein expression a reverse localization of the effect. Dietary regulation for CD13 protein expression was not as distinct as for the two other proteins. Ring uptake experiments showed a tendency for increased L-isoleucine uptake under amino acid-supplemented diet and in vivo L-isoleucine absorption was more efficient under high protein and amino acid-supplemented diet. Additionally, plasma levels of branched-chain amino acids were elevated under high protein and amino acid diet. Taken together, our experiments did not reveal an acute amino acid-induced regulation of B(0)AT1 but revealed a chronic dietary adaptation mainly restricted to the proximal segment of the small intestine.	[Verrey, Francois] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; Univ Zurich, NCCR Kidney CH, Zurich, Switzerland	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Verrey, F (corresponding author), Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.	francois.verrey@uzh.ch		Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824	Swiss National Science Foundation [310030_166430]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (http://www.snf.ch) grant 310030_166430 to FV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi SA, 2003, AM J PHYSIOL-GASTR L, V285, pG779, DOI 10.1152/ajpgi.00056.2003; Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Bohmer C, 2005, BIOCHEM J, V389, P745; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Cynober LA, 2002, NUTRITION, V18, P761, DOI 10.1016/S0899-9007(02)00780-3; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; DEBNAM ES, 1985, DIGESTION, V31, P25, DOI 10.1159/000199173; DIAMOND JM, 1984, J PHYSIOL-LONDON, V349, P419, DOI 10.1113/jphysiol.1984.sp015165; ERICKSON RH, 1995, BIOCHEM BIOPH RES CO, V216, P249, DOI 10.1006/bbrc.1995.2617; Fairweather SJ, 2012, BIOCHEM J, V446, P135, DOI 10.1042/BJ20120307; Fatima J, 2009, J GASTROINTEST SURG, V13, P634, DOI 10.1007/s11605-008-0776-4; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1069, DOI 10.1152/ajpgi.1992.262.6.G1069; FERRARIS RP, 1988, AM J PHYSIOL, V255, pG143, DOI 10.1152/ajpgi.1988.255.2.G143; FERRARIS RP, 1989, ANNU REV PHYSIOL, V51, P125, DOI 10.1146/annurev.ph.51.030189.001013; Ferraris RP, 2001, BIOCHEM J, V360, P265, DOI 10.1042/0264-6021:3600265; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Jean C, 2001, J NUTR, V131, P91, DOI 10.1093/jn/131.1.91; Jordi J, 2014, AM J PHYSL GASTROINT, V306; Jordi J, 2013, J PHYSIOL-LONDON, V591, P5611, DOI 10.1113/jphysiol.2013.258947; KARASOV WH, 1987, AM J PHYSIOL, V252, pG614, DOI 10.1152/ajpgi.1987.252.5.G614; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Ma K, 2012, PHARM RES-DORDR, V29, P535, DOI 10.1007/s11095-011-0580-9; Mentlein R, 2004, INT REV CYTOL, V235, P165, DOI 10.1016/S0074-7696(04)35004-7; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Mourad FH, 2009, AM J PHYSIOL-GASTR L, V297, pG292, DOI 10.1152/ajpgi.00100.2009; Muratsubaki H, 2011, INDIAN J CLIN BIOCHE, V26, P416, DOI 10.1007/s12291-011-0125-3; PLAKIDOUDYMOCK S, 1993, BIOCHEM J, V290, P59, DOI 10.1042/bj2900059; Qandeel HG, 2009, J SURG RES, V156, P123, DOI 10.1016/j.jss.2009.03.052; Riemann D, 1999, IMMUNOL TODAY, V20, P83, DOI 10.1016/S0167-5699(98)01398-X; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; SALLOUM RM, 1990, J SURG RES, V48, P635, DOI 10.1016/0022-4804(90)90244-V; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Sharp PA, 1996, GUT, V39, P545, DOI 10.1136/gut.39.4.545; Shiraga T, 1999, GASTROENTEROLOGY, V116, P354, DOI 10.1016/S0016-5085(99)70132-0; SHIRAZIBEECHEY SP, 1990, GASTROENTEROLOGY, V98, P676, DOI 10.1016/0016-5085(90)90288-C; Singer D, 2012, AM J PHYSIOL-GASTR L, V303, pG686, DOI 10.1152/ajpgi.00140.2012; Terada T, 2005, BIOCHEM PHARMACOL, V70, P1756, DOI 10.1016/j.bcp.2005.09.027; Terada T, 2004, CURR DRUG METAB, V5, P85, DOI 10.2174/1389200043489153; Thamotharan M, 1999, METABOLISM, V48, P681, DOI 10.1016/S0026-0495(99)90164-6; Verrey F, 2005, ANNU REV PHYSIOL, V67, P557, DOI 10.1146/annurev.physiol.67.031103.153949; Vuille-Dit-Bille RN, 2015, AMINO ACIDS, V47, P693, DOI 10.1007/s00726-014-1889-6	48	41	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184845	10.1371/journal.pone.0184845	http://dx.doi.org/10.1371/journal.pone.0184845			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915252	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000410861600017
J	Fehrholz, M; Seidenspinner, S; Kunzmann, S				Fehrholz, Markus; Seidenspinner, Silvia; Kunzmann, Steffen			Expression of surfactant protein B is dependent on cell density in H441 lung epithelial cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; GLUCOCORTICOID REGULATION; PRETERM INFANTS; GROWTH; RECEPTOR; TRANSCRIPTION; MODULATION; CULTURE	Background Expression of surfactant protein (SP)-B, which assures the structural stability of the pulmonary surfactant film, is influenced by various stimuli, including glucocorticoids; however, the role that cell-cell contact plays in SP-B transcription remains unknown. The aim of the current study was to investigate the impact of cell-cell contact on SP-B mRNA and mature SPB expression in the lung epithelial cell line H441. Methods Different quantities of H441 cells per growth area were either left untreated or incubated with dexamethasone. The expression of SP-B, SP-B transcription factors, and tight junction proteins were determined by qPCR and immunoblotting. The influence of cell density on SP-B mRNA stability was investigated using the transcription inhibitor actinomycin D. Results SP-B mRNA and mature SP-B expression levels were significantly elevated in untreated and dexamethasone-treated H441 cells with increasing cell density. High cell density as a sole stimulus was found to barely have an impact on SP-B transcription factor and tight junction mRNA levels, while its stimulatory ability on SP-B mRNA expression could be mimicked using SP-B-negative cells. SP-B mRNA stability was significantly increased in high-density cells, but not by dexamethasone alone. Conclusion SP-B expression in H441 cells is dependent on cell-cell contact, which increases mRNA stability and thereby potentiates the glucocorticoid-mediated induction of transcription. Loss of cell integrity might contribute to reduced SP-B secretion in damaged lung cells via downregulation of SP-B transcription. Cell density-mediated effects should thus receive greater attention in future cell culture-based research.	[Fehrholz, Markus; Seidenspinner, Silvia] Univ Wurzburg, Univ Childrens Hosp, Wurzburg, Germany; [Kunzmann, Steffen] Buergerhosp Frankfurt Main, Clin Neonatol, Frankfurt, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Fehrholz, M (corresponding author), Univ Wurzburg, Univ Childrens Hosp, Wurzburg, Germany.	markus.fehrholz@uni-wuerzburg.de			Deutsche Forschungsgemeinschaft (DE); University of Wuerzburg	Deutsche Forschungsgemeinschaft (DE)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by Deutsche Forschungsgemeinschaft (DE) and University of Wuerzburg, Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva E, 2015, CELL BIOCHEM FUNCT, V33, P386, DOI 10.1002/cbf.3125; Bachmeier BE, 2005, EXP CELL RES, V305, P83, DOI 10.1016/j.yexcr.2004.12.019; Berhane K, 2001, GENE, V268, P141, DOI 10.1016/S0378-1119(01)00417-6; Bersani I, 2012, EXPERT REV ANTI-INFE, V10, P573, DOI [10.1586/eri.12.34, 10.1586/ERI.12.34]; Boggaram V, 2003, FRONT BIOSCI-LANDMRK, V8, pD751, DOI 10.2741/1062; BROWER M, 1986, CANCER RES, V46, P798; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Daugherty BL, 2004, AM J PHYSIOL-LUNG C, V287, pL1266, DOI 10.1152/ajplung.00423.2003; Fehrholz M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153578; Fehrholz M, 2014, AM J PHYSIOL-LUNG C, V306, pL101, DOI 10.1152/ajplung.00257.2013; Fehrholz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051575; Foster CD, 2010, PEDIATR RES, V67, P585, DOI 10.1203/PDR.0b013e3181dbc708; Fukushima S, 2007, INT J ONCOL, V31, P1485; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; GOODMAN LV, 1989, J BIOL CHEM, V264, P5241; HAMBURGER AW, 1991, PATHOBIOLOGY, V59, P329, DOI 10.1159/000163672; Hattar K, 2001, J IMMUNOL, V166, P6287, DOI 10.4049/jimmunol.166.10.6287; Huang HW, 2008, AM J RESP CELL MOL, V38, P473, DOI 10.1165/rcmb.2007-0303OC; Jacobs AT, 2003, NITRIC OXIDE-BIOL CH, V8, P222, DOI 10.1016/S1089-8603(03)00027-2; Jobin C, 1997, INFLAMMATION, V21, P235, DOI 10.1023/A:1027326405788; Kavaliauskiene S, 2014, CELL MOL LIFE SCI, V71, P1097, DOI 10.1007/s00018-013-1441-y; Kim D. Y., 2014, SCI WORLD J, V2014, P1, DOI [DOI 10.4174/ASTR.2014.86.4.199.], 10.1155/2014/305452, DOI 10.1155/2014/305452]; Kim SW, 2015, INT J ONCOL, V46, P2067, DOI 10.3892/ijo.2015.2930; Koura AN, 1996, CANCER RES, V56, P3891; KUTOH E, 1995, EUR J BIOCHEM, V234, P557, DOI 10.1111/j.1432-1033.1995.557_b.x; Lee MW, 2013, BLOOD RES, V48, P107, DOI 10.5045/br.2013.48.2.107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; OREILLY MA, 1991, AM J PHYSIOL, V260, pL37, DOI 10.1152/ajplung.1991.260.2.L37; OSHIMA H, 1992, ENDOCRINOLOGY, V130, P2106, DOI 10.1210/en.130.4.2106; POCSIK E, 1994, J CELL BIOCHEM, V54, P453, DOI 10.1002/jcb.240540412; Ranayhossaini DJ, 2014, INT J MOL SCI, V15, P17686, DOI 10.3390/ijms151017686; Rozycki HJ, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00045; Schlingmann B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12276; Schlingmann B, 2015, SEMIN CELL DEV BIOL, V42, P47, DOI 10.1016/j.semcdb.2015.04.009; Schmitt-Ney M, 2004, EXP CELL RES, V295, P236, DOI 10.1016/j.yexcr.2003.12.022; Sporty JL, 2008, EXPERT OPIN DRUG MET, V4, P333, DOI [10.1517/17425255.4.4.333, 10.1517/17425255.4.4.333 ]; Tillis CC, 2011, AM J PHYSIOL-LUNG C, V300, pL940, DOI 10.1152/ajplung.00420.2010; VENKATESH VC, 1993, AM J RESP CELL MOL, V8, P222, DOI 10.1165/ajrcmb/8.2.222; Wang L, 2000, ENDOCRINOLOGY, V141, P2481, DOI 10.1210/en.141.7.2481; Whitsett JA, 1998, BBA-MOL BASIS DIS, V1408, P303, DOI 10.1016/S0925-4439(98)00076-3; Whitsett JA, 2015, AM J RESP CELL MOL, V53, P1, DOI 10.1165/rcmb.2015-0128PS; Wirbelauer J, 2009, J PERINATOL, V29, pS18, DOI 10.1038/jp.2009.30; ZEN K, 1994, EXP CELL RES, V215, P172, DOI 10.1006/excr.1994.1329; Zscheppang K, 2011, AM J RESP CELL MOL, V45, P761, DOI 10.1165/rcmb.2010-0179OC	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184556	10.1371/journal.pone.0184556	http://dx.doi.org/10.1371/journal.pone.0184556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910374	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200062
J	Hellum, M; Franco-Lie, I; Ovstebo, R; Hauge, T; Henriksson, CE				Hellum, Marit; Franco-Lie, Isabel; Ovstebo, Reidun; Hauge, Truls; Henriksson, Carola E.			The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls	PLOS ONE			English	Article							TISSUE FACTOR ACTIVITY; VENOUS THROMBOEMBOLISM; FACTOR EXPRESSION; MICROPARTICLES; BLOOD; PLASMA; INITIATION; PLATELET; COAGULATION; PREDICTION	Circulating microvesicles (MVs) are suggested to be important contributors to cancer-associated thrombosis due to the presence of surface-bound procoagulant molecules like tissue factor (TF) and phosphatidylserine (PS). Pancreatic cancer is considered to be one of the most prothrombotic malignancies. The aim of this study was to describe the impact of analytical variables on MV-associated thrombin generation in patients with pancreatic cancer and in healthy controls. MVs were isolated from citrated plasma and added to pooled normal plasma (PNP). Thrombin generation was measured by the calibrated automated thrombogram. The impact of corn trypsin inhibitor (CTI), anti-tissue factor pathway inhibitor (TFPI) antibodies and phospholipids was described. Antibodies against TF were used to assess TF-dependency, and MV-bound PS activity was measured with the Zymuphen MP-activity kit. MVs from the pancreatic cancer patients displayed higher thrombin generation and higher PS-activity than MVs from the healthy control group, while TF-dependency was observed in only 1 out of 13 patient samples. Adequate thrombin generation-curves were only achieved when CTI was omitted and anti-TFPI antibodies were added to PNP prepared in low contact-activating tubes. Addition of phospholipids reduced the significant differences between the two groups, and should be omitted. This modified thrombin generation assay could be useful for measurement of procoagulant circulating MVs, allowing the contribution from MVs affecting both the intrinsic and the extrinsic pathway to be measured.	[Hellum, Marit; Hauge, Truls; Henriksson, Carola E.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Hellum, Marit; Ovstebo, Reidun; Henriksson, Carola E.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Franco-Lie, Isabel; Hauge, Truls] Oslo Univ Hosp, Dept Gastroenterol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Henriksson, CE (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.; Henriksson, CE (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway.	carola.henriksson@medisin.uio.no			South-Eastern Norway Regional Health Authority through the Regional Research Network on Extracellular Vesicles (RRNEV)	South-Eastern Norway Regional Health Authority through the Regional Research Network on Extracellular Vesicles (RRNEV)	This project received funding from the South-Eastern Norway Regional Health Authority through the Regional Research Network on Extracellular Vesicles (RRNEV, http://www.extracellularvesicles.no/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MM, 2011, J THROMB HAEMOST, V9, P2251, DOI 10.1111/j.1538-7836.2011.04488.x; Ay C, 2011, J CLIN ONCOL, V29, P2099, DOI 10.1200/JCO.2010.32.8294; Bharthuar A, 2013, THROMB RES, V132, P180, DOI 10.1016/j.thromres.2013.06.026; Bidot L, 2008, J THROMB HAEMOST, V6, P913, DOI 10.1111/j.1538-7836.2008.02963.x; Boknas N, 2014, J THROMB HAEMOST, V12, P515, DOI 10.1111/jth.12503; Brodin E, 2009, TRANSL RES, V153, P124, DOI 10.1016/j.trsl.2008.12.004; Brummel-Ziedins KE, 2005, J THROMB HAEMOST, V3, P2497, DOI 10.1111/j.1538-7836.2005.01584.x; Campello E, 2016, BIOMARK MED, V10, P743, DOI 10.2217/bmm-2015-0063; Freyssinet JM, 2010, THROMB RES, V125, pS46, DOI 10.1016/j.thromres.2010.01.036; Gheldof D, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19728; Gheldof D, 2013, BLOOD COAGUL FIBRIN, V24, P567, DOI 10.1097/MBC.0b013e328360a56e; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Han X, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0054-8; Hellum M, 2014, THROMB RES, V133, P507, DOI 10.1016/j.thromres.2013.12.031; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Keuren JF, 2006, BRIT J HAEMATOL, V134, P307, DOI 10.1111/j.1365-2141.2006.06167.x; Key NS, 2010, SEMIN THROMB HEMOST, V36, P865, DOI 10.1055/s-0030-1267040; Khorana AA, 2008, J THROMB HAEMOST, V6, P1983, DOI 10.1111/j.1538-7836.2008.03156.x; Khorana AA, 2004, LANCET ONCOL, V5, P655, DOI 10.1016/S1470-2045(04)01606-7; Khorana AA, 2007, CLIN CANCER RES, V13, P2870, DOI 10.1158/1078-0432.CCR-06-2351; Kluft C, 2010, SEMIN THROMB HEMOST, V36, P791, DOI 10.1055/s-0030-1265296; Luddington R, 2004, J THROMB HAEMOST, V2, P1954, DOI 10.1111/j.1538-7836.2004.00964.x; Mooberry MJ, 2015, CYTOMETRY J INT SO A; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Nickel KF, 2015, BLOOD, V126, P1379, DOI 10.1182/blood-2015-01-622811; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Pabinger I, 2014, HEMATOL-AM SOC HEMAT, P410, DOI 10.1182/asheducation-2014.1.410; Pabinger I, 2013, BLOOD, V122, P2011, DOI 10.1182/blood-2013-04-460147; Ramstrom S, 2005, BLOOD COAGUL FIBRIN, V16, P447, DOI 10.1097/01.mbc.0000178827.52242.89; RAPAPORT SI, 1992, ARTERIOSCLER THROMB, V12, P1111, DOI 10.1161/01.ATV.12.10.1111; Rautou PE, 2013, EXPERT REV HEMATOL, V6, P91, DOI [10.1586/ehm.12.74, 10.1586/EHM.12.74]; Seto S, 2000, CANCER, V88, P295, DOI 10.1002/(SICI)1097-0142(20000115)88:2<295::AID-CNCR8>3.0.CO;2-U; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Tesselaar MET, 2009, J THROMB HAEMOST, V7, P1421, DOI 10.1111/j.1538-7836.2009.03504.x; Thaler J, 2012, J THROMB HAEMOST, V10, P1363, DOI 10.1111/j.1538-7836.2012.04754.x; Thaler J, 2014, TRANSL RES, V163, P145, DOI 10.1016/j.trsl.2013.06.009; Thaler J, 2013, EUR J CLIN INVEST, V43, P277, DOI 10.1111/eci.12042; Thaler J, 2011, ANN HEMATOL, V90, P447, DOI 10.1007/s00277-010-1111-1; Thomassen MCLGD, 2015, J THROMB HAEMOST, V13, P92, DOI 10.1111/jth.12766; Ueno T, 2000, BRIT J CANCER, V83, P164; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; van Doormaal FF, 2012, THROMB HAEMOSTASIS, V108, P160, DOI 10.1160/TH12-02-0099; Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110; Yuana Y, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29260	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184579	10.1371/journal.pone.0184579	http://dx.doi.org/10.1371/journal.pone.0184579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910348	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200063
J	Gera, T; Pena-Rosas, JP; Boy-Mena, E; Sachdev, HS				Gera, Tarun; Pena-Rosas, Juan Pablo; Boy-Mena, Evelyn; Sachdev, Harshpal S.			Lipid based nutrient supplements (LNS) for treatment of children (6 months to 59 months) with moderate acute malnutrition (MAM): A systematic review	PLOS ONE			English	Review							USE THERAPEUTIC FOOD; CORN-SOYA BLEND; MILDLY WASTED CHILDREN; TO-USE FOOD; MALAWIAN CHILDREN; RECOVERY RATES; WEIGHT-GAIN; MALNOURISHED CHILDREN; UNDERWEIGHT CHILDREN; FORTIFIED SPREADS	Background Moderate acute malnutrition is a major public health problem affecting children from low-and middle-income countries. Lipid nutrient supplements have been proposed as a nutritional intervention for its treatment. Objectives To evaluate the effectiveness and safety of LNS for the treatment of MAM in infants and children 6 to 59 months of age. Study design Systematic review of randomized-controlled trials and controlled before-after studies. Results Data from nine trials showed that use of LNS, in comparison to specially formulated foods, improved the recovery rate (RR 1.08; 95% CI 1.02-1.14, 8 RCTs, 8934 participants, low quality evidence); decreased the chances of no recovery (RR 0.70; 95% CI 0.58-0.85, 7 RCTs, 8364 participants, low quality evidence) and the risk of deterioration into severe acute malnutrition (RR 0.87; 95% CI 0.73-1.03, 6 RCTs, 6788 participants, low quality evidence). There was little impact on mortality (RR 0.94, 95% CI 0.54-1.52, 8 RCTs, 8364 participants, very-low-quality evidence) or default rate (RR 1.32; 95% CI 0.73-2.4, 7 studies, 7570 participants, low quality evidence). There was improvement in weight gain, weight-for-height z-scores, height-for-age z-scores and mid-upper arm circumference. Subset analyses suggested higher recovery rates with greater amount of calories provided and with ready-to-use therapeutic foods, in comparison to ready-to-use supplementary foods. One study comparing LNS with nutritional counselling (very low quality evidence) showed higher chance of recovery, lower risk of deteriorating into severe acute malnutrition and lower default rate, with no impact on mortality, and no recovery. Conclusions Evidence restricted to the African regions suggests that LNS may be slightly more effective than specially formulated fortified foods or nutritional counselling in recovery from MAM, lowering the risk of deterioration into SAM, and improving weight gain with little impact on mortality or default rate.	[Gera, Tarun] SL Jain Hosp, Dept Pediat, Delhi, India; [Pena-Rosas, Juan Pablo; Boy-Mena, Evelyn] WHO, Evidence & Programme Guidance, Dept Nutr Hlth & Dev, Geneva, Switzerland; [Sachdev, Harshpal S.] Sitaram Bhartia Inst Sci & Res, Dept Pediat & Clin Epidemiol, New Delhi, India	World Health Organization; Sitaram Bhartia Institute of Science & Research	Gera, T (corresponding author), SL Jain Hosp, Dept Pediat, Delhi, India.	tarun256@yahoo.com	Peña-Rosas, Juan Pablo/I-3248-2019	Peña-Rosas, Juan Pablo/0000-0002-6737-9831; Sachdev, Harshpal Singh/0000-0002-4956-9391	WHOI	WHOI	Tarun Gera received partial financial support from WHOI for this work. There was no additional external funding received for this study.	Ackatia-Armah RS, 2015, AM J CLIN NUTR, V101, P632, DOI 10.3945/ajcn.113.069807; Ackatia-Armah RS, 2012, FASEB, V26; Ackatia-Armah RS, 2015, ANN NUTR METAB, V63, P842; Ashworth A, 2009, FOOD NUTR BULL, V30, pS405, DOI 10.1177/15648265090303S304; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Briend A, 2015, FOOD NUTR BULL, V36, pS15, DOI 10.1177/15648265150361S103; Chang CY, 2013, J NUTR, V143, P215, DOI 10.3945/jn.112.168047; Child Trends, 2018, IMMIGRANT CHILDREN; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Collins S, 2004, EMERGENCY NUTR NET S, V2, P35; Community Based Managment of Severe Acute Malnutrition, 2007, COMM BAS MAN SEV AC; de Pee S, 2009, FOOD NUTR BULL, V30, pS434, DOI 10.1177/15648265090303S305; Defourny I, 2007, FIELD EXCHANGE, V31, P2; Delchevalerie P, READY TO USE SUPPLEM; Dewey KG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001314; Dibari F, 2012, J NUTR, V142, P955, DOI 10.3945/jn.111.156943; Diop EHI, 2003, AM J CLIN NUTR, V78, P302, DOI 10.1093/ajcn/78.2.302; Dube B, 2009, INDIAN PEDIATR, V46, P383; Fabiansen C, 2016, AM J CLIN NUTR, V103, P415, DOI 10.3945/ajcn.115.124644; Flax VL, 2010, APPETITE, V54, P504, DOI 10.1016/j.appet.2010.02.003; Friis H., EFFECTIVENESS IMPROV; Greiner T, 2014, BREASTFEEDING BRIEFS, V56, P1; Grellety E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044549; Gross R, 2006, LANCET, V367, P1209, DOI 10.1016/S0140-6736(06)68509-7; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Isanaka S, 2010, PEDIATRICS, V126, pE442, DOI 10.1542/peds.2009-2814; Iuel-Brockdorf AS, 2016, APPETITE, V99, P34, DOI 10.1016/j.appet.2015.12.030; Jones KD, 2014, FOOD NUTR BULL, V35, pS64, DOI 10.1177/15648265140352S110; Karakochuk C, 2012, AM J CLIN NUTR, V96, P911, DOI 10.3945/ajcn.111.029744; Kuusipalo H, 2006, J PEDIATR GASTR NUTR, V43, P525, DOI 10.1097/01.mpg.0000235981.26700.d3; Lagrone L, 2010, ANN TROP PAEDIATR, V30, P103, DOI 10.1179/146532810X12703901870651; LaGrone LN, 2012, AM J CLIN NUTR, V95, P212, DOI 10.3945/ajcn.111.022525; Lazzerini M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009584.pub2; Lenters LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S23; Lin CA, 2008, J NUTR, V138, P593, DOI 10.1093/jn/138.3.593; Maleta T, 2004, J PEDIATR GASTR NUTR, V38, P152; Marron B, 2015, FASEB J, P29; Matilsky DK, 2009, J NUTR, V139, P773, DOI 10.3945/jn.108.104018; McDonald C, 2014, FASEB J, P28; Medoua GN, 2016, PUBLIC HEALTH NUTR, V19, P363, DOI 10.1017/S1368980015001238; Nackers F, 2010, J TROP PEDIATRICS, V56, P407, DOI 10.1093/tropej/fmq019; NAVARROCOLORADO C, 2007, RETROSPECTIVE STUDY; Nikiema L, 2014, AM J CLIN NUTR, V100, P241, DOI 10.3945/ajcn.113.072538; Park SE, 2012, PEDIATR GASTROENTERO, V15, P210, DOI 10.5223/pghn.2012.15.4.210; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; PELLETIER DL, 1994, J NUTR, V124, pS2047; Phuka J, 2009, MATERN CHILD NUTR, V5, P159, DOI 10.1111/j.1740-8709.2008.00162.x; Phuka JC, 2008, ARCH PEDIAT ADOL MED, V162, P619, DOI 10.1001/archpedi.162.7.619; Purwestri RC, 2012, ASIA PAC J CLIN NUTR, V21, P374; Ramalingaswami V., 1996, PROGR NATIONS; Roy SK, 2005, J HEALTH POPUL NUTR, V23, P320; Scherbaum V, 2015, ASIA PAC J CLIN NUTR, V24, P152, DOI 10.6133/apjcn.2015.24.1.15; Singh AS, 2010, INDIAN PEDIATR, V47, P679, DOI 10.1007/s13312-010-0100-8; Steichen TJ, 1998, STATA TECHNICAL B, V44, P3; Sterne J. A. C., 2008, SYSTEMATIC REV HLTH, V323, P189, DOI [10.1002/9780470693926.ch11, DOI 10.1002/9780470693926.CH11]; Suri D, 2013, FASEB J, V27; Thakwalakwa C, 2010, J NUTR, V140, P2008, DOI 10.3945/jn.110.122499; Thakwalakwa CM, 2012, PUBLIC HEALTH NUTR, V15, P1755, DOI 10.1017/S1368980012003023; Thakwalakwa CM, 2014, MATERNAL CHILD NUTR; Tomedi A, 2012, PUBLIC HEALTH NUTR, V15, P749, DOI 10.1017/S1368980011002217; Traore T, 2013, ANN NUTR METAB, V63, P1024; van der Kam S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001952; Vanelli Maurizio, 2014, Acta Biomed, V85, P236; WHO, 2013, GUID UPD MAN SEV AC; World Health Organization, 2012, TECHN NOT SUPPL FOOD; World Health Organization, 2013, ESS NUTR ACT IMPR MA; YIP R, 1994, J NUTR, V124, pS2043	68	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0182096	10.1371/journal.pone.0182096	http://dx.doi.org/10.1371/journal.pone.0182096			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934235	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900002
J	Hall, J; Brault, A; Vincent, F; Weng, S; Wang, H; Dumlao, D; Aulabaugh, A; Aivazian, D; Castro, D; Chen, M; Culp, J; Dower, K; Gardner, J; Hawrylik, S; Golenbock, D; Hepworth, D; Horn, M; Jones, L; Jones, P; Latz, E; Li, J; Lin, LL; Lin, W; Lin, D; Lovering, F; Niljanskul, N; Nistler, R; Pierce, B; Plotnikova, O; Schmitt, D; Shanker, S; Smith, J; Snyder, W; Subashi, T; Trujillo, J; Tyminski, E; Wang, GX; Wong, J; Lefker, B; Dakin, L; Leach, K				Hall, Justin; Brault, Amy; Vincent, Fabien; Weng, Shawn; Wang, Hong; Dumlao, Darren; Aulabaugh, Ann; Aivazian, Dikran; Castro, Dana; Chen, Ming; Culp, Jeffrey; Dower, Ken; Gardner, Joseph; Hawrylik, Steven; Golenbock, Douglas; Hepworth, David; Horn, Mark; Jones, Lyn; Jones, Peter; Latz, Eicke; Li, Jing; Lin, Lih-Ling; Lin, Wen; Lin, David; Lovering, Frank; Niljanskul, Nootaree; Nistler, Ryan; Pierce, Betsy; Plotnikova, Olga; Schmitt, Daniel; Shanker, Suman; Smith, James; Snyder, William; Subashi, Timothy; Trujillo, John; Tyminski, Edyta; Wang, Guoxing; Wong, Jimson; Lefker, Bruce; Dakin, Leslie; Leach, Karen			Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay	PLOS ONE			English	Article							CYCLIC GMP-AMP; AICARDI-GOUTIERES-SYNDROME; CYTOSOLIC DNA SENSOR; EXONUCLEASE TREX1; STING PATHWAY; GENE; 2ND-MESSENGER; MUTATIONS; MECHANISM; SYNTHASE	Cyclic GMP-AMP synthase (cGAS) initiates the innate immune system in response to cytosolic dsDNA. After binding and activation from dsDNA, cGAS uses ATP and GTP to synthesize 2'0, 30' -cGAMP (cGAMP), a cyclic dinucleotide second messenger with mixed 20-50 and 30-50 phosphodiester bonds. Inappropriate stimulation of cGAS has been implicated in autoimmune disease such as systemic lupus erythematosus, thus inhibition of cGAS may be of therapeutic benefit in some diseases; however, the size and polarity of the cGAS active site makes it a challenging target for the development of conventional substrate-competitive inhibitors. We report here the development of a high affinity (K-D = 200 nM) inhibitor from a low affinity fragment hit with supporting biochemical and structural data showing these molecules bind to the cGAS active site. We also report a new high throughput cGAS fluorescence polarization (FP)-based assay to enable the rapid identification and optimization of cGAS inhibitors. This FP assay uses Cy5-labelled cGAMP in combination with a novel high affinity monoclonal antibody that specifically recognizes cGAMP with no cross reactivity to cAMP, cGMP, ATP, or GTP. Given its role in the innate immune response, cGAS is a promising therapeutic target for autoinflammatory disease. Our results demonstrate its druggability, provide a high affinity tool compound, and establish a high throughput assay for the identification of next generation cGAS inhibitors.	[Hall, Justin; Brault, Amy; Vincent, Fabien; Wang, Hong; Dumlao, Darren; Aulabaugh, Ann; Chen, Ming; Culp, Jeffrey; Hawrylik, Steven; Lin, Wen; Lin, David; Niljanskul, Nootaree; Pierce, Betsy; Plotnikova, Olga; Schmitt, Daniel; Shanker, Suman; Smith, James; Subashi, Timothy; Trujillo, John; Wong, Jimson] Pfizer, Med Design, Groton, CT 06340 USA; [Weng, Shawn; Nistler, Ryan; Tyminski, Edyta; Wang, Guoxing; Leach, Karen] Pfizer Ctr Therapeut Innovat CTI, Boston, MA USA; [Aivazian, Dikran; Castro, Dana; Horn, Mark; Snyder, William] Pfizer Ctr Therapeut Innovat CTI, San Diego, CA USA; [Dower, Ken; Lin, Lih-Ling] Pfizer, Inflammat & Immunol, Cambridge, MA USA; [Gardner, Joseph] Pfizer, External Res Solut, Groton, CT USA; [Golenbock, Douglas; Latz, Eicke] Univ Massachusetts, Sch Med, Worcester, MA USA; [Hepworth, David; Jones, Lyn; Jones, Peter; Li, Jing; Lovering, Frank; Lefker, Bruce; Dakin, Leslie] Pfizer, Med Design, Cambridge, MA USA; [Latz, Eicke] Univ Hosp Bonn, Inst Innate Immun, Bonn, Germany	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; University of Massachusetts System; University of Massachusetts Worcester; Pfizer; University of Bonn	Hall, J (corresponding author), Pfizer, Med Design, Groton, CT 06340 USA.	justin.hall@pfizer.com	Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666; Jones, Lyn/0000-0002-8388-5865; Lin, David/0000-0002-5471-9841	Pfizer	Pfizer(Pfizer)	Pfizer provided support in the form of salaries for the following authors: JH, AB, FV, SW, HW, DD, AA, DA, DC, MC, JC, KD, JG, SH, DH, MH, LJ, PJ, JL, LL, WL, DL, FL, NN, RN, BP, OP, DS, SS, JS, WS, TS, JT, ET, GW, JW, BL, LD, KL. Pfizer did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Bose D, 2016, CELL CHEM BIOL, V23, P1539, DOI 10.1016/j.chembiol.2016.10.014; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Chow J, 2015, VIROLOGY, V479, P104, DOI 10.1016/j.virol.2015.02.051; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hall JD, 2016, PROTEIN SCI, V25, P360, DOI 10.1002/pro.2821; Junt T, 2015, NAT REV IMMUNOL, V15, P529, DOI 10.1038/nri3875; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Kranzusch PJ, 2014, CELL, V158, P1011, DOI 10.1016/j.cell.2014.07.028; Lee-Kirsch MA, 2016, ANN REV MED; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Nyarko E, 2016, ARTHRITIS RHEUMATOL, V68; Perola E, 2012, J CHEM INF MODEL, V52, P1027, DOI 10.1021/ci200613b; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Shestakova TS, 2013, J ORG CHEM, V78, P6975, DOI 10.1021/jo4008207; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tao JL, 2016, IUBMB LIFE, V68, P858, DOI 10.1002/iub.1566; Unterholzner L, 2013, IMMUNOBIOLOGY, V218, P1312, DOI 10.1016/j.imbio.2013.07.007; Vance RE, 2016, IMMUNITY, V45, P227, DOI 10.1016/j.immuni.2016.08.006; Wang Q, 2015, EXPERT OPIN THER TAR, V19, P1397, DOI 10.1517/14728222.2015.1067303; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu XM, 2014, NUCLEIC ACIDS RES, V42, P8243, DOI 10.1093/nar/gku569; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003	37	64	71	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184843	10.1371/journal.pone.0184843	http://dx.doi.org/10.1371/journal.pone.0184843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934246	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900050
J	Piao, L; Fang, YH; Kubler, MM; Donnino, MW; Sharp, WW				Piao, Lin; Fang, Yong-Hu; Kubler, Manfred M.; Donnino, Michael W.; Sharp, Willard W.			Enhanced pyruvate dehydrogenase activity improves cardiac outcomes in a murine model of cardiac arrest	PLOS ONE			English	Article							GLUCOSE-OXIDATION; INDUCED HYPOTHERMIA; MILD HYPOTHERMIA; DICHLOROACETATE; RESUSCITATION; REPERFUSION; INHIBITION; METABOLISM; ISCHEMIA; SURVIVAL	Rationale Post-ischemic changes in cellular metabolism alter myocardial and neurological function. Pyruvate dehydrogenase (PDH), the limiting step in mitochondrial glucose oxidation, is inhibited by increased expression of PDH kinase (PDK) during ischemia/reperfusion injury. This results in decreased utilization of glucose to generate cellular ATP. Post-cardiac arrest (CA) hypothermia improves outcomes and alters metabolism, but its influence on PDH and PDK activity following CA are unknown. We hypothesized that therapeutic hypothermia (TH) following CA is associated with the inhibition of PDK activity and increased PDH activity. We further hypothesized that an inhibitor of PDK activity, dichloroacetate (DCA), would improve PDH activity and post-CA outcomes. Methods and results Anesthetized and ventilated adult female C57BL/6 wild-type mice underwent a 12-minute KCl-induced CA followed by cardiopulmonary resuscitation. Compared to normothermic (37 E C) CA controls, administering TH (30 degrees C) improved overall survival (72-hour survival rate: 62.5% vs. 28.6%, P<0.001), post-resuscitation myocardial function (ejection fraction: 50.9 +/- 3.1% vs. 27.2 +/- 2.0%, P<0.001; aorta systolic pressure: 132.7 +/- 7.3 vs. 72.3 +/- 3.0 mmHg, P<0.001), and neurological scores at 72-hour post CA (9.5 +/- 1.3 vs. 5.4 +/- 1.3, P<0.05). In both heart and brain, CA increased lactate concentrations (1.9-fold and 3.1-fold increase, respectively, P<0.01), decreased PDH enzyme activity (24% and 50% reduction, respectively, P<0.01), and increased PDK protein expressions (1.2-fold and 1.9-fold, respectively, P<0.01). In contrast, post-CA treatment with TH normalized lactate concentrations (P<0.01 and P<0.05) and PDK expressions (P<0.001 and P<0.05), while increasing PDH activity (P<0.01 and P<0.01) in both the heart and brain. Additionally, treatment with DCA (0.2 mg/g body weight) 30 min prior to CA improved both myocardial hemodynamics 2 hours post-CA (aortic systolic pressure: 123 +/- 3 vs. 96 +/- 4 mmHg, P<0.001) and 72-hour survival rates (50% vs. 19%, P<0.05) in normothermic animals. Conclusions Enhanced PDH activity in the setting of TH or DCA administration is associated with improved post-CA resuscitation outcomes. PDH is a promising therapeutic target for improving post-CA outcomes.	[Piao, Lin; Fang, Yong-Hu; Kubler, Manfred M.; Sharp, Willard W.] Univ Chicago, Sect Emergency Med, Chicago, IL 60637 USA; [Piao, Lin; Fang, Yong-Hu; Kubler, Manfred M.; Sharp, Willard W.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Internal Med, Boston, MA 02215 USA	University of Chicago; University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Sharp, WW (corresponding author), Univ Chicago, Sect Emergency Med, Chicago, IL 60637 USA.; Sharp, WW (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	wsharp@medicine.bsd.uchicago.edu	Sharp, Willard/AAB-9972-2020	Sharp, Willard/0000-0002-7175-3523	NIH [R01HL133675]; University of Chicago Women's Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133675] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Women's Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from NIH grant R01HL133675 and from the University of Chicago Women's Board.; This work was supported by funding from NIH grant R01HL133675 and from the University of Chicago Women's Board.	Azam MA, 2015, AM J PHYSIOL-HEART C, V309, pH1543, DOI 10.1152/ajpheart.00404.2015; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9; Fiskum G, 2008, ANN NY ACAD SCI, V1147, P129, DOI 10.1196/annals.1427.026; Gilbert NF, 2002, ANN THORAC SURG, V74, P1208, DOI 10.1016/S0003-4975(02)03873-0; GINSHAW SL, 1988, ANN EMERG MED, V17, P473, DOI 10.1016/S0196-0644(88)80239-7; Gorecka M, 2016, IRISH IR J MED SCI; Holzer M, 2002, NEW ENGL J MED, V346, P549; Huang CH, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0516-3; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Korvald C, 2000, AM J PHYSIOL-HEART C, V278, pH1345, DOI 10.1152/ajpheart.2000.278.4.H1345; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; LEWANDOWSKI ED, 1995, CIRCULATION, V91, P2071, DOI 10.1161/01.CIR.91.7.2071; Li J, 2015, AM J PHYSIOL-HEART C, V308, pH1414, DOI 10.1152/ajpheart.00748.2014; Makino J, 2005, CRIT CARE, V9, pR357, DOI 10.1186/cc3714; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; Masoud WGT, 2014, CARDIOVASC RES, V101, P30, DOI 10.1093/cvr/cvt216; Ning XH, 2007, AM J PHYSIOL-HEART C, V293, pH2119, DOI 10.1152/ajpheart.00123.2007; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Piao L, 2010, J MOL MED, V88, P1011, DOI 10.1007/s00109-010-0679-1; PULSINELLI WA, 1982, ANN NEUROL, V11, P499, DOI 10.1002/ana.410110510; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Shao ZH, 2010, AM J PHYSIOL-HEART C, V298, pH2164, DOI 10.1152/ajpheart.00994.2009; Sharp Willard W, 2015, Crit Care Med, V43, pe38, DOI 10.1097/CCM.0000000000000817; SHEU KFR, 1985, ANN NEUROL, V17, P444; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Stanley WC, 1997, CARDIOVASC RES, V33, P243, DOI 10.1016/S0008-6363(96)00245-3; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; Sun WQ, 2015, LIFE SCI, V121, P97, DOI 10.1016/j.lfs.2014.11.030; Sun YY, 2016, ONCOTARGET, V7, P31708, DOI 10.18632/oncotarget.9150; Taniguchi M, 2001, AM J PHYSIOL-HEART C, V280, pH1762, DOI 10.1152/ajpheart.2001.280.4.H1762; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Weinberg Guy L, 2007, Expert Rev Cardiovasc Ther, V5, P135, DOI 10.1586/14779072.5.2.135; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; Zhang XW, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1133-0; Zhao DH, 2008, RESUSCITATION, V77, P242, DOI 10.1016/j.resuscitation.2007.10.015; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185046	10.1371/journal.pone.0185046	http://dx.doi.org/10.1371/journal.pone.0185046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934276	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900080
J	Spilsbury, K; Rosenwax, L; Arendts, G; Semmens, JB				Spilsbury, Katrina; Rosenwax, Lorna; Arendts, Glenn; Semmens, James B.			The impact of community-based palliative care on acute hospital use in the last year of life is modified by time to death, age and underlying cause of death. A population-based retrospective cohort study	PLOS ONE			English	Article							CELL LUNG-CANCER; ADMINISTRATIVE DATA; END; ADMISSIONS; ACCESS; EMERGENCY; DISEASE; INTERVENTION; ASSOCIATION; MANAGEMENT	Objective Community-based palliative care is known to be associated with reduced acute care health service use. Our objective was to investigate how reduced acute care hospital use in the last year of life varied temporally and by patient factors. Methods A retrospective cohort study of the last year of life of 12,763 Western Australians who died from cancer or one of seven non-cancer conditions. Outcome measures were rates of hospital admissions and mean length of hospital stays. Multivariate analyses involved time-to-event and population averaged log-link gamma models. Results There were 28,939 acute care overnight hospital admissions recorded in the last year of life, an average of 2.3 (SD 2.2) per decedent and a mean length of stay of 9.2 (SD 10.3) days. Overall, the rate of hospital admissions was reduced 34% (95% CI 1-66) and the mean length of stay reduced 6% (95% CI 2-10) during periods of time decedents received community-based palliative care compared to periods of time not receiving this care. Decedents aged <70 years receiving community-based palliative care showed a reduced rate of hospital admission around five months before death, whereas for older decedents the reduction in hospital admissions was apparent a year before death. All decedents who were receiving community-based palliative care tended towards shorter hospital stays in the last month of life. Decedents with neoplasms had a mean length of stay three weeks prior to death while not receiving community-based palliative care of 9.6 (95% CI 9.3-9.9) days compared to 8.2 (95% CI 7.9-8.7) days when receiving community-based palliative care. Conclusion Rates of hospital admission during periods of receiving community-based palliative care were reduced with benefits evident five months before death and even earlier for older decedents. The mean length of hospital stay was also reduced while receiving community-based palliative care, mostly in the last month of life.	[Spilsbury, Katrina; Semmens, James B.] Curtin Univ, Fac Hlth Sci, Ctr Populat Hlth Res, Perth, WA, Australia; [Rosenwax, Lorna] Curtin Univ, Fac Hlth Sci, Sch Occupat Therapy & Social Work, Perth, WA, Australia; [Arendts, Glenn] Univ Western Australia, Harry Perkins Inst Med Res, Ctr Clin Res Emergency Med, Perth, WA, Australia; [Arendts, Glenn] Fiona Stanley Hosp, Dept Emergency Med, Perth, WA, Australia; [Semmens, James B.] Univ Notre Dame, Inst Hlth Res, Fremantle, WA, Australia	Curtin University; Curtin University; Harry Perkins Institute of Medical Research; University of Western Australia; University of Notre Dame Australia	Rosenwax, L (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Occupat Therapy & Social Work, Perth, WA, Australia.	L.Rosenwax@curtin.edu.au	Spilsbury, Katrina/B-5646-2016	Spilsbury, Katrina/0000-0002-7434-2957; Arendts, Glenn/0000-0001-7830-7756	Australian National Health and Medical Research Council [1029663]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by an Australian National Health and Medical Research Council project grant (#1029663) to Lorna Rosenwax. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandieri E, 2012, ANN ONCOL, V23, P2016, DOI 10.1093/annonc/mds103; Baumann AJ, 2015, J PAIN SYMPTOM MANAG, V50, P882, DOI 10.1016/j.jpainsymman.2015.07.014; Brumley Richard D, 2003, J Palliat Med, V6, P715, DOI 10.1089/109662103322515220; Burge FI, 2008, MED CARE, V46, P1203, DOI 10.1097/MLR.0b013e31817d931d; Cassel JB, 2016, J AM GERIATR SOC, V64, P2288, DOI 10.1111/jgs.14354; Chan KY, 2015, J PAIN SYMPTOM MANAG, V49, P145, DOI 10.1016/j.jpainsymman.2014.04.010; Costantini M, 2003, PALLIATIVE MED, V17, P315, DOI 10.1191/0269216303pm744oa; Couchoud C, 2016, NEPHROLOGY; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ferrell BR, 2017, J CLIN ONCOL, V35, P96, DOI 10.1200/JCO.2016.70.1474; Ferroni E, 2016, J PALLIAT MED, V19, P1260, DOI 10.1089/jpm.2016.0158; Glover J, REMOTE AREAS STAT GE; Irwin KE, 2013, CHRON RESP DIS, V10, P35, DOI 10.1177/1479972312471549; Iupati SPM, 2016, INTERN MED J, V46, P295, DOI 10.1111/imj.12947; Jablonski A, 2008, SEMIN DIALYSIS, V21, P206, DOI 10.1111/j.1525-139X.2007.00394.x; Lindskog M, 2015, EUR J CANCER, V51, P1331, DOI 10.1016/j.ejca.2015.04.001; Maltoni M, 2016, EUR J CANCER, V69, P110, DOI 10.1016/j.ejca.2016.10.004; Mandawat A, 2016, JAMA CARDIOL; McNamara BA, 2013, J PALLIAT MED, V16, P774, DOI 10.1089/jpm.2012.0403; Miccinesi G, 2003, CANCER CAUSE CONTROL, V14, P971, DOI 10.1023/B:CACO.0000007964.16319.98; Poonja Z, 2014, CLIN GASTROENTEROL H, V12, P692, DOI 10.1016/j.cgh.2013.08.027; Pouliot K, 2015, AM J HOSP PALLIAT CA; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Riolfi M, 2014, PALLIATIVE MED, V28, P403, DOI 10.1177/0269216313517283; Rosenwax L, 2016, BMC PALLIAT CARE, P15; Rosenwax LK, 2006, PALLIATIVE MED, V20, P439, DOI 10.1191/0269216306pm1146oa; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Seow H, 2016, J PALLIAT MED, V19, P263, DOI 10.1089/jpm.2015.0229; Spilsbury K, 2017, ANN EMERG MED, V69, P416, DOI 10.1016/j.annemergmed.2016.11.036; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Weber C, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-47; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	32	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185275	10.1371/journal.pone.0185275	http://dx.doi.org/10.1371/journal.pone.0185275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934324	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900138
J	Amanzougaghene, N; Fenollar, F; Sangare, AK; Sissoko, MS; Doumbo, OK; Raoult, D; Mediannikov, O				Amanzougaghene, Nadia; Fenollar, Florence; Sangare, Abdoul Karim; Sissoko, Mahamadou S.; Doumbo, Ogobara K.; Raoult, Didier; Mediannikov, Oleg			Detection of bacterial pathogens including potential new species in human head lice from Mali	PLOS ONE			English	Article							HUMAN-BODY LOUSE; BARTONELLA-QUINTANA; COXIELLA-BURNETII; EXPERIMENTAL-MODEL; HUMAN EHRLICHIOSIS; AFRICAN BODY; Q-FEVER; INFECTION; PREVALENCE; CAPITIS	In poor African countries, where no medical and biological facilities are available, the identification of potential emerging pathogens of concern at an early stage is challenging. Head lice, Pediculus humanus capitis, have a short life, feed only on human blood and do not transmit pathogens to their progeny. They are, therefore, a perfect tool for the xenodiagnosis of current or recent human infection. This study assessed the occurrence of bacterial pathogens from head lice collected in two rural villages from Mali, where a high frequency of head lice infestation had previously been reported, using molecular methods. Results show that all 600 head lice, collected from 117 individuals, belonged to clade E, specific to West Africa. Bartonella quintana, the causative agent of trench fever, was identified in three of the 600 (0.5%) head lice studied. Our study also shows, for the first time, the presence of the DNA of two pathogenic bacteria, namely Coxiella burnetii (5.1%) and Rickettsia aeschlimannii (0.6%), detected in human head lice, as well as the DNA of potential new species from the Anaplasma and Ehrlichia genera of unknown pathogenicity. The finding of several Malian head lice infected with B. quintana, C. burnetii, R. aeschlimannii, Anaplasma and Ehrlichia is alarming and highlights the need for active survey programs to define the public health consequences of the detection of these emerging bacterial pathogens in human head lice.	[Amanzougaghene, Nadia; Fenollar, Florence; Raoult, Didier; Mediannikov, Oleg] Aix Marseille Univ, AP HM, CNRS, INSERM,IRD,IHU Mediterranee Infect,URMITE, Marseille, France; [Sangare, Abdoul Karim; Sissoko, Mahamadou S.; Doumbo, Ogobara K.] Univ Bamako, Fac Med & Odontostomatol, Fac Pharm MRTC DEAP FMOS FAPH, Epidemiol Dept Parasit Dis, Bamako, Mali; [Raoult, Didier; Mediannikov, Oleg] Campus Int UCAD IRD, Dakar, Senegal	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University of Bamako	Raoult, D; Mediannikov, O (corresponding author), Aix Marseille Univ, AP HM, CNRS, INSERM,IRD,IHU Mediterranee Infect,URMITE, Marseille, France.; Raoult, D; Mediannikov, O (corresponding author), Campus Int UCAD IRD, Dakar, Senegal.	didier.raoult@gmail.com; olegusss1@gmail.com	RAOULT, Didier/A-8434-2008; Mediannikov, Oleg/H-4018-2015	RAOULT, Didier/0000-0002-0633-5974; Mediannikov, Oleg/0000-0001-6039-2008	IHU Mediterranee Infection	IHU Mediterranee Infection	This study was funded by the IHU Mediterranee Infection (http://en.mediterranee-infectioncom/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzougaghene N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005142; Amanzougaghene N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164659; Angelakis E, 2014, INT J INFECT DIS, V28, P107, DOI 10.1016/j.ijid.2014.05.029; Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Angelakis E, 2011, FEMS IMMUNOL MED MIC, V62, P244, DOI 10.1111/j.1574-695X.2011.00804.x; Ashfaq M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14188; Ayyadurai S, 2010, EMERG INFECT DIS, V16, P892, DOI 10.3201/eid1605.091280; BABUDIERI B., 1959, ADVANCES VET SCI, V5, P81; Benslimani A, 2005, EMERG INFECT DIS, V11, P216, DOI 10.3201/eid1102.040668; Bonilla DL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003724; Bonilla DL, 2009, EMERG INFECT DIS, V15, P912, DOI 10.3201/eid1506.090054; Boutellis A, 2013, EMERG INFECT DIS, V19, P796, DOI 10.3201/eid1905.121480; Boutellis A, 2012, VECTOR-BORNE ZOONOT, V12, P564, DOI 10.1089/vbz.2011.0845; BROUQUI P, 1994, EUR J EPIDEMIOL, V10, P695, DOI 10.1007/BF01719283; Brouqui P, 2011, ANNU REV ENTOMOL, V56, P357, DOI 10.1146/annurev-ento-120709-144739; Cutler S, 2012, COMP IMMUNOL MICROB, V35, P17, DOI 10.1016/j.cimid.2011.09.007; Dahmani M, 2017, TICKS TICK-BORNE DIS, V8, P18, DOI 10.1016/j.ttbdis.2016.09.009; Diatta G, 2014, AM J TROP MED HYG, V91, P291, DOI 10.4269/ajtmh.13-0685; Djiba ML, 2013, TROP ANIM HEALTH PRO, V45, P1557, DOI 10.1007/s11250-013-0399-y; Drali Rezak, 2013, PLoS One, V8, pe58088, DOI 10.1371/journal.pone.0058088; Drali R, 2015, AM J TROP MED HYG, V93, P990, DOI 10.4269/ajtmh.14-0686; Drancourt M, 1996, J CLIN MICROBIOL, V34, P1158, DOI 10.1128/JCM.34.5.1158-1160.1996; Drancourt M, 2005, J INFECT DIS, V191, P607, DOI 10.1086/427041; DUPONT HT, 1995, CLIN INFECT DIS, V21, P1126, DOI 10.1093/clinids/21.5.1126; Ehounoud CB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004367; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Fournier PE, 2002, EMERG INFECT DIS, V8, P1515, DOI 10.3201/eid0812.020111; Gatesy J, 1997, MOL PHYLOGENET EVOL, V7, P303, DOI 10.1006/mpev.1997.0402; GIROUD PAUL, 1954, BULL SOC PATHOL EXOT, V47, P764; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Houhamdi L, 2006, AM J TROP MED HYG, V74, P526, DOI 10.4269/ajtmh.2006.74.526; Houhamdi L, 2003, ANN NY ACAD SCI, V990, P617, DOI 10.1111/j.1749-6632.2003.tb07436.x; Houhamdi L, 2006, AM J TROP MED HYG, V74, P525; Houhamdi L, 2006, J INFECT DIS, V194, P1589, DOI 10.1086/508995; Kim JH, 2011, INSECT BIOCHEM MOLEC, V41, P332, DOI 10.1016/j.ibmb.2011.01.011; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Koehler JE, 1997, NEW ENGL J MED, V337, P1876, DOI 10.1056/NEJM199712253372603; La Scola B, 2001, J CLIN MICROBIOL, V39, P1707, DOI 10.1128/JCM.39.5.1707-1709.2001; Li W, PLOS NEGL TROP DIS, V4, pe641; Light JE, 2008, MOL PHYLOGENET EVOL, V47, P1203, DOI 10.1016/j.ympev.2008.03.014; Louw M, 2005, SAMJ S AFR MED J, V95, P948; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Ndip LM, 2009, ANN TROP MED PARASIT, V103, P719, DOI 10.1179/000349809X12554106963753; Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405; Parola P, 2001, EMERG INFECT DIS, V7, P1014, DOI 10.3201/eid0706.010616; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Parola P, 2011, EMERG INFECT DIS, V17, P883, DOI 10.3201/eid1705.100573; Piarroux R, 2013, EMERG INFECT DIS, V19, P505, DOI 10.3201/eid1903.121542; Raoult D, 2006, J INFECT DIS, V193, P112, DOI 10.1086/498534; RAOULT D, 1994, LANCET, V343, P977, DOI 10.1016/S0140-6736(94)90102-3; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; Raoult D., 2016, MICROBIOL SPECTR, V4; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Robinson D, 2003, PARASITOL RES, V90, P209, DOI 10.1007/s00436-003-0842-5; Rolain JM, 2002, ANTIMICROB AGENTS CH, V46, P2747, DOI 10.1128/AAC.46.9.2747-2751.2002; Roux V, 1999, J CLIN MICROBIOL, V37, P596, DOI 10.1128/JCM.37.3.596-599.1999; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Sangare AK, 2015, MED SANTE TROP, V25, P189, DOI 10.1684/mst.2015.0442; Sangare AK, 2014, AM J TROP MED HYG, V91, P294, DOI 10.4269/ajtmh.13-0707; Sasaki T, 2006, J MED ENTOMOL, V43, P110, DOI 10.1603/0022-2585(2006)043[0110:FMEOBQ]2.0.CO;2; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; Steinmann P, 2005, TROP MED INT HEALTH, V10, P612, DOI 10.1111/j.1365-3156.2005.01420.x; Sunantaraporn S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0742-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; UHAA IJ, 1992, AM J TROP MED HYG, V46, P161, DOI 10.4269/ajtmh.1992.46.161; Znazen A, 2005, AM J TROP MED HYG, V72, P503, DOI 10.4269/ajtmh.2005.72.503	67	32	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184621	10.1371/journal.pone.0184621	http://dx.doi.org/10.1371/journal.pone.0184621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931077	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700025
J	Fekry, M; Alshokry, W; Grela, P; Tchorzewski, M; Ahlgren, EC; Soderberg, CA; Gakh, O; Isaya, G; Al-Karadaghi, S				Fekry, Mostafa; Alshokry, Wessen; Grela, Przemyslaw; Tchorzewski, Marek; Ahlgren, Eva-Christina; Soderberg, Christopher A.; Gakh, Oleksandr; Isaya, Grazia; Al-Karadaghi, Salam			SAXS and stability studies of iron-induced oligomers of bacterial frataxin CyaY	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; ESCHERICHIA-COLI CYAY; X-RAY-SCATTERING; SULFUR CLUSTER BIOSYNTHESIS; YEAST FRATAXIN; FRIEDREICH ATAXIA; BINDING-PROPERTIES; 2FE-2S CLUSTERS; PROTEIN; MATURATION	Frataxin is a highly conserved protein found in both prokaryotes and eukaryotes. It is involved in several central functions in cells, which include iron delivery to biochemical processes, such as heme synthesis, assembly of iron-sulfur clusters (ISC), storage of surplus iron in conditions of iron overload, and repair of ISC in aconitase. Frataxin from different organisms has been shown to undergo iron-dependent oligomerization. At least two different classes of oligomers, with different modes of oligomer packing and stabilization, have been identified. Here, we continue our efforts to explore the factors that control the oligomerization of frataxin from different organisms, and focus on E. coli frataxin CyaY. Using small-angle X-ray scattering (SAXS), we show that higher iron-to-protein ratios lead to larger oligomeric species, and that oligomerization proceeds in a linear fashion as a results of iron oxidation. Native mass spectrometry and online size-exclusion chromatography combined with SAXS show that a dimer is the most common form of CyaY in the presence of iron at atmospheric conditions. Modeling of the dimer using the SAXS data confirms the earlier proposed head-to-tail packing arrangement of monomers. This packing mode brings several conserved acidic residues into close proximity to each other, creating an environment for metal ion binding and possibly even mineralization. Together with negative-stain electron microscopy, the experiments also show that trimers, tetramers, pentamers, and presumably higher-order oligomers may exist in solution. Nano-differential scanning fluorimetry shows that the oligomers have limited stability and may easily dissociate at elevated temperatures. The factors affecting the possible oligomerization mode are discussed	[Fekry, Mostafa; Alshokry, Wessen; Ahlgren, Eva-Christina; Al-Karadaghi, Salam] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden; [Fekry, Mostafa] Cairo Univ, Biophys Dept, Fac Sci, Giza, Egypt; [Grela, Przemyslaw; Tchorzewski, Marek] Marie Curie Sklodowska Univ, Dept Mol Biol, Lublin, Poland; [Soderberg, Christopher A.] Lund Univ, MAX Lab 4, Lund, Sweden; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA; [Gakh, Oleksandr; Isaya, Grazia] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA	Lund University; Egyptian Knowledge Bank (EKB); Cairo University; Maria Curie-Sklodowska University; Lund University; Mayo Clinic; Mayo Clinic	Al-Karadaghi, S (corresponding author), Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden.	Salam.Al-Karadaghi@biochemistry.lu.se	; Al-Karadaghi, Salam/F-1492-2011	Fekry, Mostafa/0000-0003-1818-5683; Grela, Przemyslaw/0000-0002-5930-416X; Tchorzewski, Marek/0000-0002-0718-4223; Al-Karadaghi, Salam/0000-0001-8608-0635	National Institute of Health [AG15709-19]; Vetenskapsradet; European Union Mobility Program Erasmus; The research School in Pharmaceutical Sciences at Lund University	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vetenskapsradet(Swedish Research Council); European Union Mobility Program Erasmus; The research School in Pharmaceutical Sciences at Lund University	Funded by National Institute of Health (https://www.nih.gov), grant AG15709-19 to IG Vetenskapsradet (http://www.vr.se) to SAK; European Union Mobility Program Erasmus (https://ec.europa.eu/programmes/erasmus-plus/) to Mostafa Fekry; The research School in Pharmaceutical Sciences at Lund University (FLAK, http://www.flak.lu.se<http://www.flak.lu.se/>)to Eva-Christina Ahlgren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao A, 2015, NEUROGENETICS; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2004, BIOCHEMISTRY-US, V43, P6511, DOI 10.1021/bi036049+; Ahlgren EC, 2017, PLOS ONE IN PRESS; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Faraj SE, 2013, FEBS OPEN BIO, V3, P310, DOI 10.1016/j.fob.2013.07.004; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gakh O, 2016, J BIOL CHEM, V291, P21296, DOI 10.1074/jbc.M116.738542; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gentry LE, 2013, BIOCHEMISTRY-US, V52, P6085, DOI 10.1021/bi400443n; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Grela P, 2010, BIOCHEMISTRY-US, V49, P924, DOI 10.1021/bi901811s; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Incardona MF, 2009, J SYNCHROTRON RADIAT, V16, P872, DOI 10.1107/S0909049509036681; Isaya G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00029; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Lee MG, 2000, ACTA CRYSTALLOGR D, V56, P920, DOI 10.1107/S0907444900005916; Mielcarek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122538; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Soderberg C, STRUCTURE COMPLEX YE; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Uchida T, 2017, BIOCHEMISTRY-US, V56, P2425, DOI 10.1021/acs.biochem.6b01304; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	61	1	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184961	10.1371/journal.pone.0184961	http://dx.doi.org/10.1371/journal.pone.0184961			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931050	gold, Green Published			2022-12-27	WOS:000411314700048
J	Spencer, M; Lenhart, A; Baker, J; Dickens, J; Weissman, A; Read, AJ; Saini, S; Saini, SD				Spencer, Marisa; Lenhart, Adrienne; Baker, Jason; Dickens, Joseph; Weissman, Arlene; Read, Andrew J.; Saini, Seema; Saini, Sameer D.			Primary care physicians are under-testing for celiac disease in patients with iron deficiency anemia: Results of a national survey	PLOS ONE			English	Article							UNITED-STATES; PREVALENCE; MANAGEMENT; CHILDREN; UPDATE; HEALTH	Background Iron deficiency anemia (IDA) is a common extra-intestinal manifestation of celiac disease (CD). Little is known about the frequency with which primary care physicians (PCPs) test for CD in patients with IDA. We aimed to describe how PCPs approach testing for CD in asymptomatic patients with IDA. Methods We electronically distributed a survey to PCPs who are members of the American College of Physicians. Respondents were asked whether they would test for CD (serologic testing, refer for esophagogastroduodenoscopy [EGD], or refer to GI) in hypothetical patients with new IDA, including: (1) a young Caucasian man, (2) a premenopausal Caucasian woman, (3) an elderly Caucasian man, and (4) a young African American man. These scenarios were chosen to assess for differences in testing for CD based on age, gender, and race. Multivariable logistic regression was used to identify independent predictors of testing. Results Testing for CD varied significantly according to patient characteristics, with young Caucasian men being the most frequently tested (61% of respondents reporting they would perform serologic testing in this subgroup (p<0.001)). Contrary to guideline recommendations, 80% of respondents reported they would definitely or probably start a patient with positive serologies for CD on a gluten free diet prior to confirmatory upper endoscopy. Conclusions PCPs are under-testing for CD in patients with IDA, regardless of age, gender, race, or postmenopausal status. The majority of PCPs surveyed reported they do not strictly adhere to established guidelines regarding a confirmatory duodenal biopsy in a patient with positive serology for CD.	[Spencer, Marisa; Baker, Jason; Read, Andrew J.; Saini, Seema; Saini, Sameer D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lenhart, Adrienne] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Dickens, Joseph] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Weissman, Arlene] Amer Coll Physicians, Res Ctr, Philadelphia, PA USA; [Saini, Sameer D.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Saini, Seema] Vet Affairs Med Ctr, Ambulatory Care, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; American College of Physicians; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Spencer, M (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	marisaspencer10@gmail.com	Read, Andrew/AAE-8386-2019	Read, Andrew/0000-0001-7336-8496	University of Michigan Department of Gastroenterology	University of Michigan Department of Gastroenterology	Funding was provided by the University of Michigan Department of Gastroenterology.	Bao F, 2012, ARCH PATHOL LAB MED, V136, P735, DOI 10.5858/arpa.2011-0572-RA; Bottaro G, 1999, AM J GASTROENTEROL, V94, P691, DOI 10.1111/j.1572-0241.1999.00938.x; Cannizzaro R, 2014, EUR J GASTROEN HEPAT, V26, P721, DOI 10.1097/MEG.0000000000000100; Cataldo F, 2007, WORLD J GASTROENTERO, V13, P2153, DOI 10.3748/wjg.v13.i15.2153; Cekin AH, 2012, TURK J GASTROENTEROL, V23, P490, DOI 10.4318/tjg.2012.0467; Choung RS, 2015, AM J GASTROENTEROL, V110, P455, DOI 10.1038/ajg.2015.8; CORAZZA GR, 1995, SCAND J GASTROENTERO, V30, P153, DOI 10.3109/00365529509093254; Ertekin V, 2013, TURK J GASTROENTEROL, V24, P334, DOI 10.4318/tjg.2013.0529; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Freeman HJ, 2015, WORLD J GASTROENTERO, V21, P9233, DOI 10.3748/wjg.v21.i31.9233; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Gokce S, 2015, PEDIATR INT, V57, P107, DOI 10.1111/ped.12448; Halfdanarson TR, 2007, BLOOD, V109, P412, DOI 10.1182/blood-2006-07-031104; Hershko C, 2009, SEMIN HEMATOL, V46, P339, DOI 10.1053/j.seminhematol.2009.06.002; Howard MR, 2002, J CLIN PATHOL, V55, P754, DOI 10.1136/jcp.55.10.754; Karnam US, 2004, SOUTH MED J, V97, P30, DOI 10.1097/01.SMJ.0000051059.23259.56; Leffler DA, 2010, AM J GASTROENTEROL, V105, P2520, DOI 10.1038/ajg.2010.276; Li M, 2009, AM J GASTROENTEROL, V104, P154, DOI 10.1038/ajg.2008.8; Nasr Ikram, 2012, Gastrointest Endosc Clin N Am, V22, P695, DOI 10.1016/j.giec.2012.07.012; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; Smukalla Scott, 2014, Clin Adv Hematol Oncol, V12, P100	24	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184754	10.1371/journal.pone.0184754	http://dx.doi.org/10.1371/journal.pone.0184754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931034	gold, Green Published, Green Submitted			2022-12-27	WOS:000411314700033
J	Bollegala, D; Hayashi, K; Kawarabayashi, K				Bollegala, Danushka; Hayashi, Kohei; Kawarabayashi, Ken-ichi			Learning linear transformations between counting-based and prediction-based word embeddings	PLOS ONE			English	Article							MODELS	Despite the growing interest in prediction-based word embedding learning methods, it remains unclear as to how the vector spaces learnt by the prediction-based methods differ from that of the counting-based methods, or whether one can be transformed into the other. To study the relationship between counting-based and prediction-based embeddings, we propose a method for learning a linear transformation between two given sets of word embeddings. Our proposal contributes to the word embedding learning research in three ways: (a) we propose an efficient method to learn a linear transformation between two sets of word embeddings, (b) using the transformation learnt in (a), we empirically show that it is possible to predict distributed word embeddings for novel unseen words, and (c) empirically it is possible to linearly transform counting-based embeddings to prediction-based embeddings, for frequent words, different POS categories, and varying degrees of ambiguities.	[Bollegala, Danushka] Univ Liverpool, Dept Comp Sci, Liverpool, Merseyside, England; [Hayashi, Kohei] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Kawarabayashi, Ken-ichi] Natl Inst Informat, Tokyo, Japan; [Bollegala, Danushka; Hayashi, Kohei; Kawarabayashi, Ken-ichi] Kawarabayashi ERATO Large Graph Project, Tokyo, Japan	University of Liverpool; National Institute of Advanced Industrial Science & Technology (AIST); Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Bollegala, D (corresponding author), Univ Liverpool, Dept Comp Sci, Liverpool, Merseyside, England.; Bollegala, D (corresponding author), Kawarabayashi ERATO Large Graph Project, Tokyo, Japan.	danushka@liverpool.ac.uk			ERATO Kawarabayashi Large Graph Project, JST	ERATO Kawarabayashi Large Graph Project, JST	This work was supported by ERATO Kawarabayashi Large Graph Project, JST.	Al-Rfou R, 2015, P 2015 SIAM INT C DA; [Anonymous], 2014, P NIPS; Arora S, 2016, T ASS COMPU IN PRESS; Baroni M, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P238; Bollegala D, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P730; Bollegala D, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P1222; Bruni E., 2012, P 50 ANN M ASS COMP, V1, P136, DOI [DOI 10.1109/ICRA.2016.7487801, 10.1109/ICRA.2016.7487801]; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Dean J, 2013, OC INT C LEARN REPR; Duchi J, 2011, J MACH LEARN RES, V12, P2121; Faruqui M, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL) AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (IJCNLP), VOL 2, P464; Faruqui M, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P1491; Finkelstein L, 2002, ACM T INFORM SYST, V20, P116, DOI 10.1145/503104.503110; Gutmann MU, 2012, J MACH LEARN RES, V13, P307; Hill F, 2015, COMPUT LINGUIST, V41, P665, DOI 10.1162/COLI_a_00237; Huang E. H., 2008, P 50 ANN M ASS COMP, P873; Iacobacci I, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P95; Jurgens D. A., 2012, P SEMEVAL; Kedem D., 2012, ADV NEURAL INFORM PR, P2582; Keerthi SS, BETTER UNDERSTANDING; Labutov I., 2013, ACL, P489; Levy O., 2015, T ASS COMPUT LINGUIS, V3, P211, DOI [10.1162/tacl_a_00134, DOI 10.1162/TACL_A_00134]; Levy Omer, 2014, CONLL; Ling Wang, 2015, P 2015 C N AM CHAPT, P1299, DOI [DOI 10.3115/V1/N15-1142, 10.3115/v1/N15-1142]; Luong Minh-Thang, 2013, CONLL; Maas A. L., 2011, P 49 ANN M ASS COMP, P142; Miller G., 1998, LANG COGNITIVE PROC, V6, P1; Mitchell J, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING, VOL 1, P1301; Neelakantan Arvind, 2014, P 2014 C EMPIRICAL M, DOI DOI 10.3115/V1/D14-1113; Passos Alexandre, 2014, CONLL, P78; Pennington J, 2014, EMNLP, V14, P1532, DOI DOI 10.3115/V1/D14-1162; Reisinger J., 2010, PROC HUMAN LANG TECH, P109; RUBENSTEIN H, 1965, COMMUN ACM, V8, P627, DOI 10.1145/365628.365657; Saul LK, 2004, J MACH LEARN RES, V4, P119, DOI 10.1162/153244304322972667; Schnabel Tobias, 2015, P 2015 C EMP METH NA, P298, DOI DOI 10.18653/V1/D15-1036; Socher R, 2013, P 2013 C EMP METH NA, P1631; Tsvetkov Y., 2015, P 2015 C EMPIRICAL M, P2049, DOI DOI 10.18653/V1/D15-1243; Turian J, 2009, P NIPS GRLL WORKSH; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; Woodsend Kristian, 2015, P EMNLP, P2482; Yogatama D, 2014, ARXIV; Zou W. Y., 2013, EMNLP, P1393	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184544	10.1371/journal.pone.0184544	http://dx.doi.org/10.1371/journal.pone.0184544			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926629	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600022
J	Hobson, EA; Smith-Vidaurre, G; Salinas-Melgoza, A				Hobson, Elizabeth A.; Smith-Vidaurre, Grace; Salinas-Melgoza, Alejandro			History of nonnative Monk Parakeets in Mexico	PLOS ONE			English	Article							MYIOPSITTA-MONACHUS; PROPAGULE PRESSURE; EXOTIC BIRDS; 1ST RECORD; SELECTION; DISPERSAL; EXPANSION; HABITAT; RANGE; SPAIN	Nonnative Monk Parakeets have been reported in increasing numbers across many cities in Mexico, and were formally classified as an invasive species in Mexico in late 2016. However, there has not been a large-scale attempt to determine how international pet trade and national and international governmental regulations have played a part in colonization, and when the species appeared in different areas. We describe the changes in regulations that led the international pet trade market to shift to Mexico, then used international trade data to determine how many parakeets were commercially imported each year and where those individuals originated. We also quantified the recent increases in Monk Parakeet (Myiopsitta monachus) sightings in Mexico in both the scientific literature and in citizen science reports. We describe the timeline of increased reports to understand the history of nonnative Monk Parakeets in Mexico. As in other areas where the species has colonized, the main mode of transport is through the international pet trade. Over half a million Monk Parakeets were commercially imported to Mexico during 2000-2015, with the majority of importation (90%) occurring in 2008-2014, and almost all (98%) were imported from Uruguay. The earliest record of a free-flying Monk Parakeet was observed during 1994-1995 in Mexico City, but sightings of the parakeets did not become geographically widespread in either the scientific literature or citizen science databases until 2012-2015. By 2015, parakeets had been reported in 97 cities in Mexico. Mexico City has consistently seen steep increases in reporting since this species was first reported in Mexico. Here we find that both national and international legal regulations and health concerns drove a rise and fall in Monk Parakeet pet trade importations, shortly followed by widespread sightings of feral parakeets across Mexico. Further monitoring of introduced Monk Parakeet populations in Mexico is needed to understand the establishment, growth and spread of introduced populations.	[Hobson, Elizabeth A.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Smith-Vidaurre, Grace] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Salinas-Melgoza, Alejandro] Univ Michoacana, Fac Biol, Morelia, Michoacan, Mexico	The Santa Fe Institute; New Mexico State University; Universidad Michoacana de San Nicolas de Hidalgo	Hobson, EA (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	ehobson@santafe.edu			ASU-SFI Center for Biosocial Complex Systems; Santa Fe Institute; Fulbright Study/Research grant; Laboratorio Nacional de Analisis y Sintesis Ecologica para la Conservacion de los Recursos Geneticos (CONACYT) [280505]; Santa Fe Institute Collaboration Fund	ASU-SFI Center for Biosocial Complex Systems; Santa Fe Institute; Fulbright Study/Research grant; Laboratorio Nacional de Analisis y Sintesis Ecologica para la Conservacion de los Recursos Geneticos (CONACYT); Santa Fe Institute Collaboration Fund	EAH was supported by a postdoctoral fellowship from the ASU-SFI Center for Biosocial Complex Systems, with additional funding from the Santa Fe Institute. GS-V was supported by a Fulbright Study/Research grant. AS-M was supported by the Laboratorio Nacional de Analisis y Sintesis Ecologica para la Conservacion de los Recursos Geneticos (CONACYT: Project No. 280505). The collaboration was further supported by the Santa Fe Institute Collaboration Fund for visiting researchers (AS-M and GS-V research visit, November 2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Juan Carlos Cantu for providing insight into the effect of changes in governmental regulations on parrot trade patterns (personal communication with AS-M). We also thank several reviewers for their comments which improved the manuscript. EAH was supported by a postdoctoral fellowship from the ASU-SFI Center for Biosocial Complex Systems, with additional funding from the Santa Fe Institute. GS-V was supported by a Fulbright Study/Research grant. AS-M was supported by the Laboratorio Nacional de Analisis y Sintesis EcolOgica para la ConservaciOn de los Recursos Geneticos (CONACYT: Project No. 280505). The collaboration was further supported by the Santa Fe Institute Collaboration Fund for visiting researchers (AS-M and GS-V research visit, November 2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Soto-Cruz Ricardo Abel, 2014, Huitzil, V15, P1; Alvarez JA, 2015, REGIONAL REPORTS; Alvarez Romero Jorge, 2008, ANIMALES EXOTICOS ME; Amano Tatsuya, 2016, PLoS Biol, V14, pe2000933, DOI 10.1371/journal.pbio.2000933; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2016, DIARIO OFICIAL FEDER, P46; Appelt CW, 2016, WILSON J ORNITHOL, V128, P556, DOI 10.1676/1559-4491-128.3.556; Avery M, 2012, WILSON J; Avery ML, 2002, PROC VERTEBR PEST C, P140; Avery ML, 2016, WILDLIFE DAMAGE MANA; Battisti C, 2016, ETHOL ECOL EVOL; Becker RA, 2016, MAPS DRAW GEOGRAPHIC; Bennett EL, 2008, STATE WILD 2008 2009, P62; Bucher EH, 2014, J BIOGEOGR, V41, P1160, DOI 10.1111/jbi.12282; Buhrman-Deever S, 2007, CONDOR; Burgio K.R., 2016, BIRDS N AM; Burgio KR, 2014, PEERJ, V2, DOI 10.7717/peerj.601; Butler C, 2005, J AVIAN MED SURG; CACCAMISE DF, 1977, WILSON BULL, V89, P346; Almazán-Núñez R. Carlos, 2015, Huitzil, V16, P48; Cassey P, 2004, GLOBAL CHANGE BIOL, V10, P417, DOI 10.1111/j.1529-8817.2003.00748.x; Chavez-Murillo C., 1999, CONTRIBUCION ESTUDIO; CITES, 2013, GUID US CITES TRAD D; Cooley ME, 1974, MONK PARAKEET MICHIG; Cumpian-Medellin JI, 2015, 14 C EST CONS AV MEX, P96; da Silva AG, 2010, MOL ECOL, V19, P3336, DOI 10.1111/j.1365-294X.2010.04749.x; Eberhard JR, WILSON B, V110, P463; *EBIRD, 2012, EBIRD ONL DAT BIRD D; Edelaar P, 2015, MOL ECOL, V24, P2164, DOI 10.1111/mec.13157; European Commission, 2007, NEW RUL CAP BIRD IMP; European Commission, 2005, AV INFL EU BANS IMP; European Commission, 2004, EU SUSP IMP PET BIRD; Forshaw J.M., 2006, PARROTS WORLD IDENTI; Goodenough AE, 2010, COMMUNITY ECOL, V11, P13, DOI 10.1556/ComEc.11.2010.1.3; Guerrero-Cárdenas Israel, 2012, Huitzil, V13, P156; Hobson EA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004411; Hobson EA, 2015, CURR ZOOL, V61, P55, DOI 10.1093/czoolo/61.1.55; Hobson EA, 2014, AUK, V131, P756, DOI 10.1642/AUK-14-14.1; Iriarte JA, 2005, REV CHIL HIST NAT, V78, P143, DOI 10.4067/S0716-078X2005000100010; Kibbe DP, 1973, BIRD CONTR SEM P INT, P74; Kyprianou M, 2005, OFFICIAL J EUROPEAN, P1; Kyprianou M, 2004, OFFICIAL J EUROPEAN, P1; Kyprianou M, 2006, OFFICIAL J EUROPE L, P1; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lopez-Castillo L, 2013, 12 C EST CONS AV MEX, P100; MacGregor-Fors I, 2011, REV MEX BIODIVERS, V82, P1053; MARTIN LF, 1993, AUK, V110, P930; Minor ES, 2012, URBAN ECOSYST, V15, P979, DOI 10.1007/s11252-012-0249-0; Mori E, 2015, PARASITOL RES, V114, P3277, DOI 10.1007/s00436-015-4548-2; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; Munoz-Jimenez JL, 2015, 1 C NAC FAUN NAT AMB, P6; Murrilo Chaavez C., 1999, CONTRIBUCION ESTUDIO; Neidermyer WJ, 1977, AM BIRDS, V31; Pablo López Rosa Elba, 2009, Huitzil, V10, P48; Pineda-López Rubén, 2013, Huitzil, V14, P56; Pineda-López Rubén, 2011, Huitzil, V12, P22; Postigo J, 2017, PEST MANAG; Procuraduria Federal de Proteccion al Ambiente, 2017, DISM 24 TRAT IL PSIT; Pruett-Jones S, 1998, MONK PARAKEETS US PO; Ramírez-Albores Jorge E., 2012, Huitzil, V13, P110; Ramírez-Bastida Patricia, 2015, Acta Zool. Mex, V31, P480; Reed JE, 2014, LANDSCAPE URBAN PLAN, V129, P65, DOI 10.1016/j.landurbplan.2014.04.016; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rodriguez-Pastor R, 2012, ANIM BIODIV CONSERV, V35, P107; Russello MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-217; Salgado-Miranda Celene, 2016, Huitzil, V17, P155; Sanchez Sanchez CA, 2010, USO HABITAT COMPORTA; Senar JC, 2006, ANIM BIODIV CONSERV, V39, P141; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Sol D, 1997, CONDOR, V99, P39, DOI 10.2307/1370222; Strubbe D, 2009, J BIOGEOGR; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Tayleur J., 2010, BOU P IMP NONN SPEC; Tinajero Romeo, 2015, Acta Zool. Mex, V31, P190; Torres-Aguilar V, 2015, 14 C EST CONS AV MEX, P48; Vall-Ilosera M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172851; VanBael S, 1996, WILSON BULL, V108, P584; Vargas-Gomez M, 2015, 1 C NAT FAUN NAT AMB, P8; Vazquez L, 2011, 11 C EST CONS AV MEX, P57; Viana IR, 2016, BIOL INVASIONS, V18, P1305, DOI 10.1007/s10530-016-1068-7; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Zuria I, 2014, 13 C EST CONS AV MEX, P140	82	8	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184771	10.1371/journal.pone.0184771	http://dx.doi.org/10.1371/journal.pone.0184771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926594	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600039
J	Petrara, MR; Cattelan, AM; Sasset, L; Freguja, R; Carmona, F; Sanavia, S; Zanchetta, M; Del Bianco, P; De Rossi, A				Petrara, Maria Raffaella; Cattelan, Anna Maria; Sasset, Lolita; Freguja, Riccardo; Carmona, Francesco; Sanavia, Silvia; Zanchetta, Marisa; Del Bianco, Paola; De Rossi, Anita			Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus	PLOS ONE			English	Article							PROTEASE INHIBITOR MONOTHERAPY; HIV-1-INFECTED CHILDREN; MICROBIAL TRANSLOCATION; ANTIRETROVIRAL THERAPY; PLASMA-LEVELS; B-CELLS; INFECTION; LOAD; DNA; DARUNAVIR/RITONAVIR	Objectives Although monotherapy (mART) effectiveness in maintaining viral suppression and CD4 cell count has been extensively examined in HIV-1-infected patients, its impact on HIV-1 reservoir, immune activation, microbial translocation and co-infection with Epstein-Barr Virus (EBV) is unclear. Methods This retrospective study involved 32 patients who switched to mART; patients were studied at baseline, 48 and 96 weeks after mART initiation. Thirty-two patients who continued combined antiretroviral therapy (cART) over the same period of time were included in the study. Markers of HIV-1 reservoir (HIV-1 DNA and intracellular HIV-1 RNA) were quantified by real-time PCR. Markers of T-(CD3(+)CD8(+)CD38(+)) and B-(CD19(+)CD80/86(+) and CD19(+)CD10-CD21(low)CD27(+)) cell activation were evaluated by flow cytometry. Plasma levels of microbial translocation markers were quantified by real-time PCR (16S ribosomal DNA and mitochondrial [mt] DNA) or by ELISA (LPS and sCD14). EBV was typed and quantified by multiplex real-time PCR. Results At baseline, no differences were found between mART and cART groups. Three (10%) mART-treated patients had a virological failure vs none in the cART group. Levels of HIV-1 DNA, intracellular HIV-1 RNA and EBV-DNA remained stable in the mART group, while decreased significantly in the cART group. Percentages of T-and B-activated cells significantly increased in the mART-treated patients, while remained at low levels in the cART-treated ones (p = 0.014 and p<0.001, respectively). Notably, levels of mtDNA remained stable in the cART group, but significantly rose in the mART one (p<0.001). Conclusions Long-term mART is associated with higher levels of T-and B-cell activation and, conversely to cART, does not reduce the size of HIV-1 reservoir and EBV co-infection.	[Petrara, Maria Raffaella; Freguja, Riccardo; De Rossi, Anita] Univ Padua, Sect Oncol & Immunol, Dept Surg Oncol & Gastroenterol, AIDS Reference Ctr, Padua, Italy; [Cattelan, Anna Maria] Azienda Osped, Div Infect & Trop Dis, Padua, Italy; [Cattelan, Anna Maria] Univ Padua, Padua, Italy; [Sasset, Lolita] Azienda Osped Rovigo, Div Infect Dis, Rovigo, Italy; [Carmona, Francesco; Sanavia, Silvia; Zanchetta, Marisa; Del Bianco, Paola; De Rossi, Anita] IRCCS, IOV, Padua, Italy	University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; ULSS 5 Polesana; Ospedale di Rovigo; IRCCS Istituto Oncologico Veneto (IOV)	De Rossi, A (corresponding author), Univ Padua, Sect Oncol & Immunol, Dept Surg Oncol & Gastroenterol, AIDS Reference Ctr, Padua, Italy.; De Rossi, A (corresponding author), IRCCS, IOV, Padua, Italy.	anita.derossi@unipd.it	De Rossi, Anita/Q-4845-2019; CATTELAN, ANNA MARIA/AAL-3654-2020; Petrara, Maria Raffaella/AAB-4806-2019; De Rossi, A./L-3128-2015; Del Bianco, Paola/F-4655-2014	De Rossi, Anita/0000-0001-6435-7509; CATTELAN, ANNA MARIA/0000-0003-2869-2945; Petrara, Maria Raffaella/0000-0003-3609-6107; De Rossi, A./0000-0001-6435-7509; Del Bianco, Paola/0000-0002-6597-0265	Associazione Italiana per la Ricerca sul Cancro [IG-14258, IG-19112]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was supported by Associazione Italiana per la Ricerca sul Cancro, grant no. IG-14258 and grant no. IG-19112.	Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x; Arenas-Pinto A, 2016, CLIN INFECT DIS, V63, P257, DOI 10.1093/cid/ciw279; Arribas JR, 2016, HIV MED, V17, P358, DOI 10.1111/hiv.12348; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Avettand-Fenoel V, 2010, J ANTIMICROB CHEMOTH, V65, P2212, DOI 10.1093/jac/dkq282; BENMARZOUKHIDALGO, 2015, MEDICINE, V94, DOI DOI 10.1097/MD.0000000000000781; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burighel N, 2006, HAEMATOL-HEMATOL J, V91, P244; Castagna A, 2014, AIDS, V28, P2269, DOI [10.1097/QAD.000000, 10.1097/QAD.0000000000000407]; Cossarizza A, 2004, AIDS, V18, P137, DOI 10.1097/00002030-200401230-00002; Cossarizza A, 2011, MITOCHONDRION, V11, P750, DOI 10.1016/j.mito.2011.06.005; Costenaro P, 2014, J CLIN MICROBIOL, V52, P2665, DOI 10.1128/JCM.00961-14; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Engels EA, 2010, JAIDS-J ACQ IMM DEF, V54, P78, DOI 10.1097/01.qai.0000371677.48743.8d; Freguja R, 2011, CLIN EXP IMMUNOL, V164, P373, DOI 10.1111/j.1365-2249.2011.04383.x; Gaidano G, 1995, ADV CANCER RES, V67, P113, DOI 10.1016/S0065-230X(08)60712-5; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Lambert-Niclot S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041390; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Marks MA, 2013, AIDS, V27, P469, DOI 10.1097/QAD.0b013e32835c1333; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Murray AJ, 2016, J IMMUNOL, V197, P407, DOI 10.4049/jimmunol.1600343; Ometto L, 2002, AIDS, V16, P839, DOI 10.1097/00002030-200204120-00003; Paton NI, 2015, LANCET HIV, V2, pE417, DOI 10.1016/S2352-3018(15)00176-9; Petrara MR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00311; Petrara MR, 2014, J INFECT DIS, V210, P392, DOI 10.1093/infdis/jiu099; Petrara MR, 2012, J CLIN VIROL, V53, P195, DOI 10.1016/j.jcv.2011.12.013; Righetti E, 2002, AIDS, V16, P63, DOI 10.1097/00002030-200201040-00009; Torres-Cornejo A, 2014, AIDS, V28, P201, DOI 10.1097/QAD.0000000000000060; Tran TA, 2015, J ANTIMICROB CHEMOTH, V70, P2627, DOI 10.1093/jac/dkv138; Zanchetta M, 2006, J INFECT DIS, V193, P1718, DOI 10.1086/504264	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185128	10.1371/journal.pone.0185128	http://dx.doi.org/10.1371/journal.pone.0185128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926641	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600070
J	Kim, Y; Wu, AG; Jaja-Chimedza, A; Graf, BL; Waterman, C; Verzi, MP; Raskin, I				Kim, Youjin; Wu, Alex G.; Jaja-Chimedza, Asha; Graf, Brittany L.; Waterman, Carrie; Verzi, Michael P.; Raskin, Ilya			Isothiocyanate-enriched moringa seed extract alleviates ulcerative colitis symptoms in mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; MOUSE MODEL; PHENETHYL ISOTHIOCYANATE; OXIDATIVE STRESS; CLINICAL-ASPECTS; GENE-EXPRESSION; OLEIFERA LEAVES; SULFORAPHANE	Moringa (Moringa oleifera Lam.) seed extract (MSE) has anti-inflammatory and antioxidant activities. We investigated the effects of MSE enriched in moringa isothiocyanate-1 (MIC-1), its putative bioactive, on ulcerative colitis (UC) and its anti-inflammatory/antioxidant mechanism likely mediated through Nrf2-signaling pathway. Dextran sulfate sodium (DSS)-induced acute (n = 8/group; 3% DSS for 5 d) and chronic (n = 6/group; cyclic rotations of 2.5% DSS/water for 30 d) UC was induced in mice that were assigned to 4 experimental groups: healthy control (water/vehicle), disease control (DSS/vehicle), MSE treatment (DSS/MSE), or 5-aminosalicyic acid (5-ASA) treatment (positive control; DSS/5-ASA). Following UC induction, water (vehicle), 150 mg/kg MSE, or 50 mg/kg 5-ASA were orally administered for 1 or 2 wks. Disease activity index (DAI), spleen/colon sizes, and colonic histopathology were measured. From colon and/or fecal samples, pro-inflammatory biomarkers, tight-junction proteins, and Nrf2-mediated enzymes were analyzed at protein and/or gene expression levels. Compared to disease control, MSE decreased DAI scores, and showed an increase in colon lengths and decrease in colon weight/length ratios in both UC models. MSE also reduced colonic inflammation/damage and histopathological scores (modestly) in acute UC. MSE decreased colonic secretions of pro-inflammatory keratinocyte-derived cytokine (KC), tumor necrosis factor (TNF)-alpha, nitric oxide (NO), and myeloperoxidase (MPO) in acute and chronic UC; reduced fecal lipocalin-2 in acute UC; downregulated gene expression of pro-inflammatory interleukin (IL)-1, IL-6, TNF-alpha, and inducible nitric oxide synthase (iNOS) in acute UC; upregulated expression of claudin-1 and ZO-1 in acute and chronic UC; and upregulated GSTP1,an Nrf2-mediated phase II detoxifying enzyme, in chronic UC. MSE was effective in mitigating UC symptoms and reducing UC-induced colonic pathologies, likely by suppressing proinflammatory biomarkers and increasing tight-junction proteins. This effect is consistent with Nrf2-mediated anti-inflammatory/antioxidant signaling pathway documented for other isothiocyanates similar to MIC-1. Therefore, MSE, enriched with MIC-1, may be useful in prevention and treatment of UC.	[Kim, Youjin] Nutrasorb LLC, Freehold, NJ 07728 USA; [Kim, Youjin; Jaja-Chimedza, Asha; Graf, Brittany L.; Raskin, Ilya] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA; [Wu, Alex G.; Verzi, Michael P.] Rutgers State Univ, Dept Genet, Piscataway Township, NJ USA; [Wu, Alex G.; Verzi, Michael P.] Rutgers State Univ, Human Genet Inst New Jersey, Piscataway Township, NJ USA; [Waterman, Carrie] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of California System; University of California Davis	Kim, Y (corresponding author), Nutrasorb LLC, Freehold, NJ 07728 USA.; Kim, Y (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.	youjin@nutrasorb.com			National Institute of Health National Center for Complementary and Integrative Health (NIH-NCCIH) [5R43AT008628-02]; NIH-NCCIH [P50 AT002776-06]; NIH Office of Dietary Supplements (NIH-ODS); Botanical Dietary Supplements Research Center (BDSRC) of Pennington Biomedical Research Center; NIH training grant [T32: 5T32AT004094]; FOGARTY INTERNATIONAL CENTER [K01TW009987] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [T32AT004094, P50AT002776, R43AT008628] Funding Source: NIH RePORTER	National Institute of Health National Center for Complementary and Integrative Health (NIH-NCCIH); NIH-NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Dietary Supplements (NIH-ODS); Botanical Dietary Supplements Research Center (BDSRC) of Pennington Biomedical Research Center; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	YK salary was paid by a SBIR grant # 5R43AT008628-02 from the National Institute of Health National Center for Complementary and Integrative Health (NIH-NCCIH), funding Nutrasorb, LLC. IR receives consulting income from Nutrasorb, LLC. IR was partially funded by a grant # 2-P50 AT002776-06 from the NIH-NCCIH and NIH Office of Dietary Supplements (NIH-ODS), funding the Botanical Dietary Supplements Research Center (BDSRC) of Pennington Biomedical Research Center, and AJ by an NIH training grant (# T32: 5T32AT004094). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bennett RN, 2003, J AGR FOOD CHEM, V51, P3546, DOI 10.1021/jf0211480; Boddupalli Sekhar, 2012, Frontiers in Genetics, V3, P7, DOI 10.3389/fgene.2012.00007; Boyanapalli SSS, 2014, CHEM RES TOXICOL, V27, P2036, DOI 10.1021/tx500234h; Brunelli D, 2010, BIOCHEM PHARMACOL, V79, P1141, DOI 10.1016/j.bcp.2009.12.008; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Cheenpracha S, 2010, BIOORGAN MED CHEM, V18, P6598, DOI 10.1016/j.bmc.2010.03.057; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Choi K, 2011, GASTROENTEROLOGY, V141, P1293, DOI 10.1053/j.gastro.2011.06.074; Edalat M, 2004, HISTOCHEM CELL BIOL, V122, P151, DOI 10.1007/s00418-004-0688-7; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Fahey J. W., 2005, TREES LIFE J, V1, P1, DOI DOI 10.1201/9781420039078.CH12; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Frink M, 2007, SHOCK, V28, P576, DOI 10.1097/shk.0b013e31814b8e0d; Fuentes Francisco, 2015, Curr Pharmacol Rep, V1, P179; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050; Islam MS, 2008, BRIT J PHARMACOL, V154, P812, DOI 10.1038/bjp.2008.137; Jaja-Chimedza A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182658; Jones DT, 2008, AM J GASTROENTEROL, V103, P2382, DOI 10.1111/j.1572-0241.2008.01999.x; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Lean QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128453; Leone A, 2015, INT J MOL SCI, V16, P12791, DOI 10.3390/ijms160612791; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Lirk Philipp, 2002, Current Drug Targets - Inflammation and Allergy, V1, P89, DOI 10.2174/1568010023344913; Lu M, 2016, MED RES REV, P1; Maillard M. H., 2010, INFLAMM BOWEL DIS, P119; Mbikay M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00024; Mikhailov TA, 2009, WORLD J GASTROENTERO, V15, P270, DOI 10.3748/wjg.15.270; Murphy CT, 2010, CLIN EXP IMMUNOL, V162, P188, DOI 10.1111/j.1365-2249.2010.04234.x; Murthy S, 2002, INFLAMM RES, V51, P522, DOI 10.1007/PL00012423; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Saxena Arpit, 2014, J Tradit Complement Med, V4, P203, DOI 10.4103/2225-4110.139111; Schulze HA, 2008, GENES IMMUN, V9, P240, DOI 10.1038/gene.2008.11; Stallhofer J, 2015, INFLAMM BOWEL DIS, V21, P2327, DOI 10.1097/MIB.0000000000000515; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Tumer TB, 2015, J AGR FOOD CHEM, V63, P1505, DOI 10.1021/jf505014n; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Wagner AE, 2013, J NUTR BIOCHEM, V24, P2085, DOI 10.1016/j.jnutbio.2013.07.009; Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679; Waterman C, 2014, PHYTOCHEMISTRY, V103, P114, DOI 10.1016/j.phytochem.2014.03.028; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	55	38	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184709	10.1371/journal.pone.0184709	http://dx.doi.org/10.1371/journal.pone.0184709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922365	Green Submitted, gold, Green Published			2022-12-27	WOS:000411059300023
J	Corte, GM; Plendl, J; Huenigen, H; Richardson, KC; Gemeinhardt, O; Niehues, SM				Corte, Giuliano M.; Plendl, Johanna; Huenigen, Hana; Richardson, Kenneth C.; Gemeinhardt, Ole; Niehues, Stefan M.			Refining experimental dental implant testing in the Gottingen Minipig using 3D computed tomography-A morphometric study of the mandibular canal	PLOS ONE			English	Article							ALVEOLAR NEUROVASCULAR BUNDLE; ERUPTION PATTERN; MINIATURE SWINE; COMPLICATIONS; BONE; MODEL; PLACEMENT; DENTISTRY; GROWTH; REGION	This study reports morphometric and age-related data of the mandibular canal and the alveolar ridge of the Gottingen Minipig to avoid complications during in vivo testing of endosseus dental implants and to compare these data with the human anatomy. Using 3D computed tomography, six parameters of the mandibular canal as well as the alveolar bone height and the alveolar ridge width were measured in Gottingen Minipigs aged 12, 17 and 21 months. Our null hypothesis assumes that the age and the body mass have an influence on the parameters measured. The study found that the volume, length and depth of the mandibular canal all increase with age. The width of the canal does not change significantly with age. The body mass does not have an influence on any of the measured parameters. The increase in canal volume appears to be due to loss of deep spongy bone in the posterior premolar and molar regions. This reduces the available space for dental implantations, negatively affecting implant stability and potentially the integrity of the inferior alveolar neurovascular bundle. Dynamic anatomical changes occur until 21 months. On ethical grounds, using minipigs younger than 21 months in experimental implant dentistry is inadvisable. Paradoxically the measurements of the 12 months old pigs indicate a closer alignment of their mandibular anatomy to that of humans suggesting that they may be better models for implant studies. Given the variability in mandibular canal dimensions in similar age cohorts, the use of imaging techniques is essential for the selection of individual minipigs for dental prosthetic interventions and thus higher success rates.	[Corte, Giuliano M.; Plendl, Johanna; Huenigen, Hana] Free Univ Berlin, Inst Vet Anat, Dept Vet Med, Berlin, Germany; [Richardson, Kenneth C.] Murdoch Univ, Sch Vet & Life Sci, Coll Vet Med, Murdoch, WA, Australia; [Gemeinhardt, Ole; Niehues, Stefan M.] Charite, Dept Radiol, Berlin, Germany	Free University of Berlin; Murdoch University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Corte, GM (corresponding author), Free Univ Berlin, Inst Vet Anat, Dept Vet Med, Berlin, Germany.	Giuliano.Corte@fu-berlin.de	Corte, Giuliano/ABE-6027-2021; Niehues, Stefan/AAM-2328-2021	Corte, Giuliano/0000-0002-1783-0444; Niehues, Stefan/0000-0001-6140-9385; Gemeinhardt, Ole/0000-0001-6090-865X	German FederalMinistry of Education and Research [031A262A]	German FederalMinistry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study is part of the Berlin Brandenburg research platform BB3R (www.bb3r.de) and was funded by the German FederalMinistry of Education and Research (grant number: 031A262A) (www.bmbf.de/en/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGLINGER R, 1975, RES EXP MED, V165, P251, DOI 10.1007/BF01971385; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x; Bollen PJA, 2005, LAB ANIM-UK, V39, P80, DOI 10.1258/0023677052886565; Buchanan-Smith HM, 2005, ANIM WELFARE, V14, P379; Cavalcanti M, 2014, DENTOMAXILLOFAC RAD; Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x; Christoffersen B, 2013, OBESITY, V21, P149, DOI 10.1002/oby.20249; Goodacre CJ, 1999, J PROSTHET DENT, V81, P537, DOI 10.1016/S0022-3913(99)70208-8; Greenstein G, 2008, J PERIODONTOL, V79, P1317, DOI 10.1902/jop.2008.070067 ; Hiebl B., 2010, ACP-APPL CARDIOPUL P, V14, P236; Ikeda K, 1996, AM J NEURORADIOL, V17, P579; Juodzbalys Gintaras, 2010, J Oral Maxillofac Res, V1, pe3, DOI 10.5037/jomr.2010.1103; Kamburoglu K, 2009, ORAL SURG ORAL MED O, V107, pE34, DOI 10.1016/j.tripleo.2008.10.012; Koppe T, 1994, Kaibogaku Zasshi, V69, P244; Koppe Thomas, 1997, Okajimas Folia Anatomica Japonica, V74, P39; Kraut RA, 2002, J AM DENT ASSOC, V133, P1351, DOI 10.14219/jada.archive.2002.0050; Kuribayashi A, 2014, DENTOMAXILLOFAC RAD; Leung CC, 2010, AM J ORTHOD DENTOFAC, V137, pS109, DOI 10.1016/j.ajodo.2009.07.013; Levine MH, 2007, J ORAL MAXIL SURG, V65, P470, DOI 10.1016/j.joms.2006.05.056; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; LINDH C, 1995, CLIN ORAL IMPLAN RES, V6, P96, DOI 10.1034/j.1600-0501.1995.060205.x; Liu T, 2009, CLIN ORAL IMPLAN RES, V20, P1212, DOI 10.1111/j.1600-0501.2009.01736.x; Michael Swindle M., 2008, SOURCEBOOK MODELS BI, P233, DOI DOI 10.1007/978-1-59745-285-4_26; MILLER CS, 1990, ORAL SURG ORAL MED O, V70, P791, DOI 10.1016/0030-4220(90)90023-L; Nkenke E, 2003, CLIN ORAL IMPLAN RES, V14, P312, DOI 10.1034/j.1600-0501.2003.120906.x; Olsen ML, 2004, CLIN ORAL IMPLAN RES, V15, P333, DOI 10.1111/j.1600-0501.2004.01016.x; Otto G., 1999, UNTERSUCHUNGEN POSTN; Pedersen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056612; Perdijk FBT, 2007, INT J ORAL MAX SURG, V36, P916, DOI 10.1016/j.ijom.2007.01.018; Pogrel MA, 2009, J ORAL MAXIL SURG, V67, P2452, DOI 10.1016/j.joms.2009.06.013; Rajchel J, 1985, INT J ADULT ORTHODON, V1, P37; Ruehe B, 2009, ORAL SURG ORAL MED O, V108, P699, DOI 10.1016/j.tripleo.2009.06.037; Russell WMS., 1959, MED J AUSTRALIA; Santos M, 2016, ANAT HISTOL EMBRYOL; Sato Iwao, 2005, Okajimas Folia Anatomica Japonica, V82, P95, DOI 10.2535/ofaj.82.95; Strauss A, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-7; Stricker A, 2014, CLIN ORAL IMPLAN RES, V25, P1265, DOI 10.1111/clr.12265; Svendsen O, 2006, EXP TOXICOL PATHOL, V57, P335, DOI 10.1016/j.etp.2006.03.003; Tolstunov L, 2014, J ORAL IMPLANTOL, V40, P365, DOI [10.1563/AAID-JOI-D-14-00023, 10.1563/aaid-joi-D-14-00023]; Verdonck HWD, 2008, CLIN ORAL IMPLAN RES, V19, P201, DOI 10.1111/j.1600-0501.2007.01457.x; Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x; Watanabe H, 2010, SURG RADIOL ANAT, V32, P343, DOI 10.1007/s00276-009-0570-3; WEAVER ME, 1966, ANAT REC, V154, P81, DOI 10.1002/ar.1091540107; WEAVER ME, 1969, ARCH ORAL BIOL, V14, P323, DOI 10.1016/0003-9969(69)90235-0; WEAVER ME, 1962, ARCH ORAL BIOL, V7, P17, DOI 10.1016/0003-9969(62)90044-4; Worthington P., 2004, INT J ORAL MAXILLOFA, V19	46	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184889	10.1371/journal.pone.0184889	http://dx.doi.org/10.1371/journal.pone.0184889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910382	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200112
J	Asahi, H; Inoue, SI; Niikura, M; Kunigo, K; Suzuki, Y; Kobayashi, F; Sendo, F				Asahi, Hiroko; Inoue, Shin-Ichi; Niikura, Mamoru; Kunigo, Keisuke; Suzuki, Yutaka; Kobayashi, Fumie; Sendo, Fujiro			Profiling molecular factors associated with pyknosis and developmental arrest induced by an opioid receptor antagonist and dihydroartemisinin in Plasmodium falciparum	PLOS ONE			English	Article							GLUTATHIONE-REDUCTASE INHIBITION; RESISTANCE REVERSER; ANTIMALARIAL ACTION; ARTEMISININ; CHLOROQUINE; MALARIA; SENSITIVITY; GROWTH; DELTA; 7-BENZYLIDENENALTREXONE	Malaria continues to be a devastating disease, largely caused by Plasmodium falciparum infection. We investigated the effects of opioid and cannabinoid receptor antagonists on the growth of intraerythrocytic P. falciparum. The delta opioid receptor antagonist 7-benzylide-nenaltrexone (BNTX) and the cannabinoid receptor antagonists rimonaband and SR144528 caused growth arrest of the parasite. Notably BNTX and the established antimalarial drug dihydroartemisinin induced prominent pyknosis in parasite cells after a short period of incubation. We compared genome-wide transcriptome profiles in P. falciparum with different degrees of pyknosis in response to drug treatment, and identified 11 transcripts potentially associated with the evoking of pyknosis, of which three, including glutathione reductase (PfGR), triose phosphate transporter (PfoTPT), and a conserved Plasmodium membrane protein, showed markedly different gene expression levels in accordance with the degree of pyknosis. Furthermore, the use of specific inhibitors confirmed PfGR but not PfoTPT as a possible factor contributing to the development of pyknosis. A reduction in total glutathione levels was also detected in association with increased pyknosis. These results further our understanding of the mechanisms responsible for P. falciparum development and the antimalarial activity of dihydroartemisinin, and provide useful information for the development of novel antimalarial agents.	[Asahi, Hiroko; Inoue, Shin-Ichi; Niikura, Mamoru; Kobayashi, Fumie] Kyorin Univ, Sch Med, Dept Infect Dis, Div Trop Dis & Parasitol, Tokyo, Japan; [Kunigo, Keisuke; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba, Japan; [Sendo, Fujiro] Geriatr Hlth Serv Facil, Miyuki Oka, Yamagata, Japan	Kyorin University; University of Tokyo	Asahi, H (corresponding author), Kyorin Univ, Sch Med, Dept Infect Dis, Div Trop Dis & Parasitol, Tokyo, Japan.	isseix20@ks.kyorin-u.ac.jp	niikura, mamoru/ABG-5467-2021; Inoue, Shin-Ichi/P-2911-2018	Inoue, Shin-Ichi/0000-0003-1244-826X; Niikura, Mamoru/0000-0002-1647-2745	Japan Society for the Promotion of Science [15K08451]; Strategic International Research Cooperative Program (SICP) from the Japan Agency for Medical Research and Development; Asia-Africa S & T Strategic Cooperation Promotion Program; Special Coordination Funds for Promoting Science & Technology, Core-to-Core Program; Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic International Research Cooperative Program (SICP) from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Asia-Africa S & T Strategic Cooperation Promotion Program; Special Coordination Funds for Promoting Science & Technology, Core-to-Core Program; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant in Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinaid/) to FK (No. 15K08451) and by a Strategic International Research Cooperative Program (SICP) from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/en/) to FK. The authors also gratefully acknowledge the support from the Asia-Africa S & T Strategic Cooperation Promotion Program by the Special Coordination Funds for Promoting Science & Technology, Core-to-Core Program, B. Asia-Africa Science Platforms by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinald/) to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA K, 1985, P NATL ACAD SCI USA, V82, P2543, DOI 10.1073/pnas.82.8.2543; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Asahi H, 2005, EXP PARASITOL, V109, P7, DOI 10.1016/j.exppara.2004.10.002; ASAHI H, 1994, PARASITOLOGY, V109, P397, DOI 10.1017/S0031182000080641; Asahi H, 2012, MALARIA PARASITES, P73; Asahi H, 2016, CURR TOP MED CHEM, V16, P3048, DOI 10.2174/1568026616999160215151704; Asahi H, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-167; Asahi H, 2013, CAN J MICROBIOL, V59, P485, DOI 10.1139/cjm-2013-0166; Asahi H, 2011, EXP PARASITOL, V127, P708, DOI 10.1016/j.exppara.2010.11.001; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Banerjee T, 2012, MOL BIOCHEM PARASIT, V186, P44, DOI 10.1016/j.molbiopara.2012.09.008; Bannister L, 2003, TRENDS PARASITOL, V19, P209, DOI 10.1016/S1471-4922(03)00086-2; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Becker K, 2003, BIOL CHEM, V384, P551, DOI 10.1515/BC.2003.063; Ben Mamoun C, 2010, DRUG DEVELOP RES, V71, P44, DOI 10.1002/ddr.20347; Benitez-Rangel E, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.37; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; Deharo E, 2003, BIOCHEM PHARMACOL, V66, P809, DOI 10.1016/S0006-2952(03)00396-4; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Desgrouas C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-327; Feng Y, 2012, CURR DRUG TARGETS, V13, P230, DOI 10.2174/138945012799201612; Gendron L, 2016, PHARMACOL REV, V68, P631, DOI 10.1124/pr.114.008979; Ginsburg H, 2003, REDOX REP, V8, P276, DOI 10.1179/135100003225002907; Himi T, 2002, LIFE SCI, V70, P1235, DOI 10.1016/S0024-3205(01)01503-X; JESSEN F, 1986, J MEMBRANE BIOL, V92, P195, DOI 10.1007/BF01869388; Kehr S, 2011, ANTIOXID REDOX SIGN, V15, P2855, DOI 10.1089/ars.2011.4029; Lehane AM, 2012, INT J PARASITOL-DRUG, V2, P47, DOI 10.1016/j.ijpddr.2011.11.001; Lim L, 2010, FEBS LETT, V584, P549, DOI 10.1016/j.febslet.2009.11.097; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Miyata Y, 2012, BIOORG MED CHEM LETT, V22, P5174, DOI 10.1016/j.bmcl.2012.06.085; Miyata Y, 2011, BIOORG MED CHEM LETT, V21, P4710, DOI 10.1016/j.bmcl.2011.06.085; Muller S, 2015, MOLECULES, V20, P10511, DOI 10.3390/molecules200610511; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; Thanh NV, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1680-8; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; PEGORARO S, 2017, NAT COMMUN, V8; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; RUMPHO ME, 1988, PLANT PHYSIOL, V86, P1193, DOI 10.1104/pp.86.4.1193; Seefeldt T, 2009, J BIOL CHEM, V284, P2729, DOI 10.1074/jbc.M802683200; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Teuscher F, 2012, ANTIMICROB AGENTS CH, V56, P428, DOI 10.1128/AAC.05456-11; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Vega-Rodriguez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128212; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10111; WHO, 2016, WORLD MAL REP 2016; WHO, 2020, REP ANT DRUG EFF RES; Witt KA, 2001, J PHARMACOL EXP THER, V298, P848; Zaveri NT, 2015, ACS CHEM NEUROSCI, V6, P646, DOI 10.1021/cn500367b; Zhao Y, 2009, FREE RADICAL BIO MED, V47, P176, DOI 10.1016/j.freeradbiomed.2009.04.022; Zhao Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P56, DOI 10.1016/j.abb.2009.03.001	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184874	10.1371/journal.pone.0184874	http://dx.doi.org/10.1371/journal.pone.0184874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934264	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900054
J	Tomasevic, L; Takemi, M; Siebner, HR				Tomasevic, Leo; Takemi, Mitsuaki; Siebner, Hartwig Roman			Synchronizing the transcranial magnetic pulse with electroencephalographic recordings effectively reduces inter-trial variability of the pulse artefact	PLOS ONE			English	Article							TMS; EEG	Background Electroencephalography (EEG) can capture the cortical response evoked by transcranial magnetic stimulation (TMS). The TMS pulse provokes a large artefact, which obscures the cortical response in the first milliseconds after TMS. Removing this artefact remains a challenge. Methods We delivered monophasic and biphasic TMS to a melon as head phantom and to four healthy participants and recorded the pulse artefact at 5 kHz with a TMS-compatible EEG system. Pulse delivery was either synchronized or non-synchronized to the clock of the EEG recording system. The effects of synchronization were tested at 10 and 20 kHz using the head phantom. We also tested the effect of a soft sheet placed between the stimulation coil and recording electrodes in both human and melon. Results & conclusion Synchronizing TMS and data acquisition markedly reduced trial-to-trial variability of the pulse artefact in recordings from the phantom or from the scalp. Reduced trial-to-trial variability was also observed at high sampling frequencies. The use of a soft sheet reduced the variability in recordings on the head phantom, but not in human participants. Effective reduction of the trial-to-trial variability renders it possible to create an artefact template for off-line filtering. Template-based subtraction of the artefact from the EEG signals is a prerequisite to effectively recover the immediate physiological response in the stimulated cortex and inter-connected areas.	[Tomasevic, Leo; Takemi, Mitsuaki; Siebner, Hartwig Roman] Univ Copenhagen, Hosp Hvidovre, Ctr Funct & Diagnost Imaging & Res, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Takemi, Mitsuaki] Univ Tokyo, Grad Sch Educ, Div Phys & Hlth Educ, Tokyo, Japan; [Siebner, Hartwig Roman] Univ Copenhagen, Hosp Bispebjerg, Dept Neurol, Copenhagen, Denmark	University of Copenhagen; University of Tokyo; University of Copenhagen	Tomasevic, L (corresponding author), Univ Copenhagen, Hosp Hvidovre, Ctr Funct & Diagnost Imaging & Res, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark.	leot@drcmr.dk	Takemi, Mitsuaki/J-2999-2019; Tomasevic, Leo/S-8910-2019	Takemi, Mitsuaki/0000-0001-5625-9167; Tomasevic, Leo/0000-0002-7738-5557	Novo Nordisk Foundation Interdisciplinary Synergy Program [NNF14OC0011413];  [16J02485]; Lundbeck Foundation [R186-2015-2138] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011413] Funding Source: researchfish	Novo Nordisk Foundation Interdisciplinary Synergy Program; ; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Novo Nordisk Foundation Interdisciplinary Synergy Program 2014 [Biophysically adjusted state-informed cortex stimulation (BASICS); NNF14OC0011413]. M.T. was supported by Grants-in-Aid for JSPS research fellows (#16J02485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Novo Nordisk Foundation Interdisciplinary Synergy Program 2014 ["Biophysically adjusted state-informed cortex stimulation (BASICS); NNF14OC0011413]. M.T. was supported by Grants-in-Aid for JSPS research fellows (#16J02485).	Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Kahkonen S, 2005, NEUROIMAGE, V24, P955, DOI 10.1016/j.neuroimage.2004.09.048; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Miniussi C, 2010, BRAIN TOPOGR, V22, P249, DOI 10.1007/s10548-009-0083-8; Neuling T, 2016, NEUROIMAGE IN PRESS; Rogasch NC, 2013, BRAIN STIMUL, V6, P868, DOI 10.1016/j.brs.2013.04.004; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Siebner HR, 2009, BRAIN STIMUL, V2, P58, DOI 10.1016/j.brs.2008.11.002; Thut G, 2005, J NEUROSCI METH, V141, P207, DOI 10.1016/j.jneumeth.2004.06.016; Veniero D, 2014, BRAIN STIMUL, V7, P759, DOI 10.1016/j.brs.2014.05.009; Veniero D, 2009, CLIN NEUROPHYSIOL, V120, P1392, DOI 10.1016/j.clinph.2009.04.023; Vernet M, 2014, NEUROMETHODS, V89, P197, DOI 10.1007/978-1-4939-0879-0_11; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963	13	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185154	10.1371/journal.pone.0185154	http://dx.doi.org/10.1371/journal.pone.0185154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934300	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900107
J	Kristensen, JB; Albrechtsen, T; Dahl-Nielsen, E; Jensen, M; Skovrind, M; Bornakke, T				Kristensen, Jakob Baek; Albrechtsen, Thomas; Dahl-Nielsen, Emil; Jensen, Michael; Skovrind, Magnus; Bornakke, Tobias			Parsimonious data: How a single Facebook like predicts voting behavior in multiparty systems	PLOS ONE			English	Article							SOCIAL MEDIA; LASSO	This study shows how liking politicians' public Facebook posts can be used as an accurate measure for predicting present-day voter intention in a multiparty system. We highlight that a few, but selective digital traces produce prediction accuracies that are on par or even greater than most current approaches based upon bigger and broader datasets. Combining the online and offline, we connect a subsample of surveyed respondents to their public Facebook activity and apply machine learning classifiers to explore the link between their political liking behaviour and actual voting intention. Through this work, we show that even a single selective Facebook like can reveal as much about political voter intention as hundreds of heterogeneous likes. Further, by including the entire political like history of the respondents, our model reaches prediction accuracies above previous multiparty studies (60-70%). The main contribution of this paper is to show how public like-activity on Facebook allows political profiling of individual users in a multiparty system with accuracies above previous studies. Beside increased accuracies, the paper shows how such parsimonious measures allows us to generalize our findings to the entire population of a country and even across national borders, to other political multiparty systems. The approach in this study relies on data that are publicly available, and the simple setup we propose can with some limitations, be generalized to millions of users in other multiparty systems.	[Kristensen, Jakob Baek] Univ Canterbury, Sch Social & Polit Sci, Christchurch, New Zealand; [Albrechtsen, Thomas; Dahl-Nielsen, Emil; Jensen, Michael] Nextwork AS, Dept Res, Copenhagen, Denmark; [Skovrind, Magnus] Dept Res Analyse & Tal FMBA, Copenhagen, Denmark; [Bornakke, Tobias] Univ Copenhagen, Dept Sociol, Copenhagen, Denmark	University of Canterbury; University of Copenhagen	Kristensen, JB (corresponding author), Univ Canterbury, Sch Social & Polit Sci, Christchurch, New Zealand.	jakob.kristensen@pg.canterbury.ac.nz		Kristensen, Jakob Baek/0000-0002-6737-4766; Kristensen, Jakob Baek/0000-0002-9821-5004; Bornakke, Tobias/0000-0002-8278-7630	Copenhagen University [KU16]; University of Canterbury, UC Doctoral Scholarship	Copenhagen University; University of Canterbury, UC Doctoral Scholarship	T.B was supported by a grant from the KU16 funding of Copenhagen University, J.B.K from University of Canterbury, UC Doctoral Scholarship. T.A., E.D, M.J. and M.S did not receive specific funding for this work but were allowed to participate in the process during work hour.	Adali S, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0159-7; Barclay FP, 2015, ASIAN J POLIT SCI, V23, P134, DOI 10.1080/02185377.2015.1020319; Campbell Angus., 1960, AM VOTER; Ceron A, 2015, ITAL J APPL STAT, V25, P237; Ceron A, 2016, INFORM SCIENCES, V367, P105, DOI 10.1016/j.ins.2016.05.052; Clarke H., 2009, PERFORMANCE POLITICS; Dalton RJ, 2016, INT J SOCIOL, V46, P8, DOI 10.1080/00207659.2016.1130410; David E, 2016, ONLINE INFORM REV, V40, P610, DOI 10.1108/OIR-09-2015-0308; Franch F, 2013, J INF TECHNOL POLITI, V10, P57, DOI 10.1080/19331681.2012.705080; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Giglietto F, 2012, LIKES WERE VOTES EMP; Jungherr Andreas, 2015, ANAL POLITICAL COMMU; Kalsnes B., 2017, 1 MONDAY; KINDER DR, 1980, POLITICAL BEHAV, V0002; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; Makazhanov A., 2014, SOCIAL NETWORK ANAL, V4, P1; Mavragani A, 2016, TECHNOL FORECAST SOC, V109, P1, DOI 10.1016/j.techfore.2016.04.028; Merrill S., 1999, UNIFIED THEORY VOTIN; Nie Norman H., 1999, CHANGING AM VOTER; Ohr D., 2013, POLITICAL LEADERS DE, P187; Petrocik JR, 1996, AM J POLIT SCI, V40, P825, DOI 10.2307/2111797; Quercia D., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P180, DOI 10.1109/PASSAT/SocialCom.2011.26; Schmidt AL, 2017, P NATL ACAD SCI USA, V114, P3035, DOI 10.1073/pnas.1617052114; Stubager Rune, 2013, KRISEVALG OKONOMIEN, P17; Sudhahar S, 2015, BIG DATA SOC, V21; Tett Gillian, 2017, FINANC TIMES; Theodoridis Thomas, 2015, P 24 INT C WORLD WID; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Verba S., 1987, PARTICIPATION AM POL; Volkova S, 2015, AAAI CONF ARTIF INTE, P4296; Watts D.J., 2013, BRIDGE FRONTIERS ENG, V43, P5; Wu YY, 2015, P NATL ACAD SCI USA, V112, P1036, DOI 10.1073/pnas.1418680112; Yasseri T, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0083-3; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	34	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184562	10.1371/journal.pone.0184562	http://dx.doi.org/10.1371/journal.pone.0184562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931023	gold, Green Submitted, Green Published			2022-12-27	WOS:000411314700022
J	Her, OS; Chen, YC; Yen, NS				Her, One-Soon; Chen, Ying-Chun; Yen, Nai-Shing			Mathematical values in the processing of Chinese numeral classifiers and measure words	PLOS ONE			English	Article							NUMBER	A numeral classifier is required between a numeral and a noun in Chinese, which comes in two varieties, sortal classifer (C) and measural classifier (M), also known as 'classifier' and 'measure word', respectively. Cs categorize objects based on semantic attributes and Cs and Ms both denote quantity in terms of mathematical values. The aim of this study was to conduct a psycholinguistic experiment to examine whether participants process C/Ms based on their mathematical values with a semantic distance comparison task, where participants judged which of the two C/M phrases was semantically closer to the target C/M. Results showed that participants performed more accurately and faster for C/Ms with fixed values than the ones with variable values. These results demonstrated that mathematical values do play an important role in the processing of C/Ms. This study may thus shed light on the influence of the linguistic system of C/Ms on magnitude cognition.	[Her, One-Soon; Chen, Ying-Chun] Natl Chengchi Univ, Grad Inst Linguist, Taipei, Taiwan; [Her, One-Soon; Yen, Nai-Shing] Natl Chengchi Univ, Res Ctr Mind Brain & Learning, Taipei, Taiwan; [Yen, Nai-Shing] Natl Chengchi Univ, Dept Psychol, Taipei, Taiwan	National Chengchi University; National Chengchi University; National Chengchi University	Yen, NS (corresponding author), Natl Chengchi Univ, Res Ctr Mind Brain & Learning, Taipei, Taiwan.; Yen, NS (corresponding author), Natl Chengchi Univ, Dept Psychol, Taipei, Taiwan.	nsy@nccu.edu.tw	chen, ying/HHS-8254-2022		Ministry of Science and Technology of Taiwan [MOST 103-2410-H-004-136-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan under the research grant MOST 103-2410-H-004-136-MY3. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Karen Lee, 1973, PAPERS 9 REGIONAL M, P1; Cheng CC, 2005, DIGITAL RESOURCES CT; Cui JX, 2013, NEUROPSYCHOLOGY, V27, P583, DOI 10.1037/a0033630; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; He J., 2008, STUDY MEASURES MODER; Her OS, 2012, LINGUA, V122, P1668, DOI 10.1016/j.lingua.2012.08.012; Her OS, 2012, LANG LINGUIST-TAIWAN, V13, P1211; Her OS, 2010, LANG LINGUIST-TAIWAN, V11, P527; Her OS, 2017, LINGUISTICS IN PRESS; Hsieh ML, 2008, INTERNAL STRUCTURE N; Li XP, 2012, LANG LINGUIST-TAIWAN, V13, P693; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Tai James, 1990, J CHINESE LANGUAGE T, V25, P35	13	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185047	10.1371/journal.pone.0185047	http://dx.doi.org/10.1371/journal.pone.0185047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926621	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600063
J	Medrzycki, P; Jarzyna, I; Obidzinski, A; Tokarska-Guzik, B; Sotek, Z; Pabjanek, P; Pytlarczyk, A; Sachajdakiewicz, I				Medrzycki, Piotr; Jarzyna, Ingeborga; Obidzinski, Artur; Tokarska-Guzik, Barbara; Sotek, Zofia; Pabjanek, Piotr; Pytlarczyk, Adam; Sachajdakiewicz, Izabela			Simple yet effective: Historical proximity variables improve the species distribution models for invasive giant hogweed (Heracleum mantegazzianum s. l.) in Poland	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION; PROPAGULE PRESSURE; PHRAGMITES-AUSTRALIS; PLANT; CONSTRAINTS; SCALES; CONSERVATION; BIODIVERSITY; PREDICTIONS; DISPERSAL	Species distribution models are scarcely applicable to invasive species because of their breaking of the models' assumptions. So far, few mechanistic, semi-mechanistic or statistical solutions like dispersal constraints or propagule limitation have been applied. We evaluated a novel quasi-semi-mechanistic approach for regional scale models, using historical proximity variables (HPV) representing a state of the population in a given moment in the past. Our aim was to test the effects of addition of HPV sets of different minimal recentness, information capacity and the total number of variables on the quality of the species distribution model for Heracleum mantegazzianum on 116000 km(2) in Poland. As environmental predictors, we used fragments of 103 1x1 km, world-wide, free-access rasters from WorldGrids. org. Single and ensemble models were computed using BIO-MOD2 package 3.1.47 working in R environment 3.1.0. The addition of HPV improved the quality of single and ensemble models from poor to good and excellent. The quality was the highest for the variants with HPVs based on the distance from the most recent past occurrences. It was mostly affected by the algorithm type, but all HPV traits (minimal recentness, information capacity, model type or the number of the time periods) were significantly important determinants. The addition of HPVs improved the quality of current projections, raising the occurrence probability in regions where the species had occurred before. We conclude that HPV addition enables semi-realistic estimation of the rate of spread and can be applied to the short-term forecasting of invasive or declining species, which also break equal-dispersal probability assumptions.	[Medrzycki, Piotr; Pytlarczyk, Adam; Sachajdakiewicz, Izabela] Univ Ecol & Management Warsaw, Fac Ecol, Lab Appl Plant Ecol, Warsaw, Poland; [Jarzyna, Ingeborga] Univ Warsaw, Fac Biol, Biol & Chem Res Ctr, Dept Plant Ecol & Environm Protect, Warsaw, Poland; [Obidzinski, Artur] Warsaw Univ Life Sci, Fac Forestry, Dept Forest Bot, Warsaw, Poland; [Tokarska-Guzik, Barbara] Univ Silesia Katowice, Fac Biol & Environm Protect, Deptartment Bot & Nat Protect, Katowice, Poland; [Sotek, Zofia] Univ Szczecin, Dept Bot & Nat Conservat, Fac Biol, Szczecin, Poland; [Pabjanek, Piotr] Univ Warsaw, Fac Geog & Reg Studies, Dept Geoinformat Cartog & Remote Sensing, Warsaw, Poland	University of Warsaw; Warsaw University of Life Sciences; University of Silesia in Katowice; University of Szczecin; University of Warsaw	Medrzycki, P (corresponding author), Univ Ecol & Management Warsaw, Fac Ecol, Lab Appl Plant Ecol, Warsaw, Poland.	piotr.medrzycki@pser.pl	Tokarska-Guzik, Barbara/L-8891-2019	Tokarska-Guzik, Barbara/0000-0002-4058-1220; Jarzyna, Ingeborga/0000-0002-6676-8210; Medrzycki, Piotr/0000-0002-3203-1034; Sotek, Zofia/0000-0002-8303-9044	Wyzsza Szkola Ekologii i Zarzadzania [21/2013]; European Union from the European Regional Development Fund under the Operational Programme Innovative Economy; University of Ecology and Management in Warsaw [21/2013]	Wyzsza Szkola Ekologii i Zarzadzania; European Union from the European Regional Development Fund under the Operational Programme Innovative Economy; University of Ecology and Management in Warsaw	The first author was awarded a research grant from his university - i.e. Wyzsza Szkola Ekologii i Zarzadzania (Award Number: 21/2013; Recipient: Piotr Medrzycki, Ph.D.) - covering costs of gathering data on giant hogweed distribution in Poland in 2013. The study was partly carried out at the Biological and Chemical Research Centre, University of Warsaw, established within the project co-financed by European Union from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Damien Georges from the BIOMOD team for his valuable help in getting our BIO-MOD2 scripts running and Matthew E. Gladden for proofreading the text. The study was partly founded by a research grant No.: 21/2013 awarded by University of Ecology and Management in Warsaw, covering costs of gathering data on giant hogweed distribution in Poland, and was partly carried out at the Biological and Chemical Research Centre, University of Warsaw, established within the project co-financed by European Union from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007-2013. We are also grateful to the anonymous reviewers for their very constructive comments that allowed us to improve a first ms version.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], BIOMOD2 ENSEMBLE PLA; Beauregard F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092642; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bosso L, 2017, ENVIRON MANAGE, V60, P304, DOI 10.1007/s00267-017-0882-8; Caffrey JM, 1999, HYDROBIOLOGIA, V415, P223, DOI 10.1023/A:1003854221931; Clegg L, 1974, T BOT SOC EDINBURGH, V42, P223, DOI [10.1080/03746607408685282, DOI 10.1080/03746607408685282]; Collingham YC, 2000, J APPL ECOL, V37, P13, DOI 10.1046/j.1365-2664.2000.00556.x; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; Dawson FH, 1999, HYDROBIOLOGIA, V415, P193, DOI 10.1023/A:1003872325274; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Dostal P, 2013, ECOL LETT, V16, P1277, DOI 10.1111/ele.12166; Elith J., 2013, PREDICTING DISTRIBUT, V69, P77; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Fischer M.M., 2014, HDB REGIONAL SCI, P1477, DOI [10.1007/978-3-642-23430-9_72, DOI 10.1007/978-3-642-23430-9, DOI 10.1007/978-3-642-23430-9_72]; Fortin MJ, 2009, GEOGR ANAL, V41, P392, DOI 10.1111/j.1538-4632.2009.00766.x; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Kabuce N., ONLINE DATABASE EURO; Klingenstein F., 2007, NOBANIS INVASIVE ALI; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054861; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Laman N A, 2009, GIGANTSKIE BORSHHEVI; Leroy B, 2016, ECOGRAPHY, V39, P599, DOI 10.1111/ecog.01388; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Long AL, 2017, WETLANDS, V37, P45, DOI 10.1007/s13157-016-0838-4; Maheu-Giroux M, 2007, LANDSCAPE ECOL, V22, P285, DOI 10.1007/s10980-006-9024-z; Moenickes S, 2013, BIOL INVASIONS, V15, P61, DOI 10.1007/s10530-012-0268-z; Mokany K, 2011, DIVERS DISTRIB, V17, P374, DOI 10.1111/j.1472-4642.2010.00735.x; Mujuni N, 2014, USE SPECIES DISTRIBU; Nehrbass N, 2006, PERSPECT PLANT ECOL, V7, P253, DOI 10.1016/j.ppees.2005.11.001; Nehrbass N., 2006, USING ECOLOGICAL MOD; Nehrbass N, 2007, ECOL MODEL, V201, P377, DOI 10.1016/j.ecolmodel.2006.10.004; Nielsen C, 2008, DIVERS DISTRIB, V14, P307, DOI 10.1111/j.1472-4642.2007.00456.x; Parry Hazel R., 2013, NeoBiota, V18, P41; Pellissier L, 2013, J BIOGEOGR, V40, P1939, DOI 10.1111/jbi.12140; Phillips ND, 2017, J BIOGEOGR, P1; Pysek P, 2008, DIVERS DISTRIB, V14, P355, DOI 10.1111/j.1472-4642.2007.00431.x; Reuter HI, 2012, DIGITAL SOIL ASSESSMENTS AND BEYOND, P287; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Sachajdakiewicz I, 2014, WYTYCZNE DOTYCZQCE Z; Sachajdakiewicz I, 2014, RAPORT KORICOWY SPI; Sachajdakiewicz I., 2008, THESIS; Schmitt T, 2014, GLOBAL CHANGE BIOL, V20, P2045, DOI 10.1111/gcb.12462; Sheppard AW, 2006, WEED RES, V46, P93, DOI 10.1111/j.1365-3180.2006.00497.x; Simpson M., 2011, GEOMORPHOLOGY, V3, P5; Simpson M, 2013, ENVIRON CONSERV, V40, P167, DOI 10.1017/S037689291200032X; Sosnowskyi H., 2013, DAT HER MANT; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thiele J., 2012, CAB Reviews, V7, P1, DOI [10.1079/PAVSNNR20127017, 10.1079/PAVSNNR20127020, 10.1079/PAVSNNR20127016, 10.1079/PAVSNNR20127018, 10.1079/PAVSNNR20127019]; Thiele J, 2008, J NAT CONSERV, V16, P61, DOI 10.1016/j.jnc.2007.08.002; Thomas SM, 2013, LANDSCAPE ECOL, V28, P81, DOI 10.1007/s10980-012-9816-2; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tokarska-Guzik B., 2005, ESTABLISHMENT SPREAD; Tokarska-Guzik B., 2001, BUTION ATLAS VASCULA, P274; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wallentin G., 2013, INT J GEOINFORMATICS, V9; Warren RJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00393.1; Welk E, 2004, ECOL MODEL, V179, P551, DOI 10.1016/j.ecolmodel.2004.04.020; Zhang H, 2000, WEATHER FORECAST, V15, P80, DOI 10.1175/1520-0434(2000)015<0080:VOCPF>2.0.CO;2; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4	67	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184677	10.1371/journal.pone.0184677	http://dx.doi.org/10.1371/journal.pone.0184677			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926580	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600033
J	Andrade, GM; da Silveira, JC; Perrini, C; Del Collado, M; Gebremedhn, S; Tesfaye, D; Meirelles, FV; Perecin, F				Andrade, Gabriella Mamede; da Silveira, Juliano Coelho; Perrini, Claudia; Del Collado, Maite; Gebremedhn, Samuel; Tesfaye, Dawit; Meirelles, Flavio Vieira; Perecin, Felipe			The role of the PI3K-Akt signaling pathway in the developmental competence of bovine oocytes	PLOS ONE			English	Article							IN-VITRO; PRIMORDIAL FOLLICLES; OXIDATIVE STRESS; GENE-EXPRESSION; OVARIAN-CANCER; CELLS; QUALITY; PTEN; ACTIVATION; APOPTOSIS	The ovarian follicle encloses oocytes in a microenvironment throughout their growth and acquisition of competence. Evidence suggests a dynamic interplay among follicular cells and oocytes, since they are constantly exchanging "messages". We dissected bovine ovarian follicles and recovered follicular cells (FCs-granulosa and cumulus cells) and cumulus-oocyte complexes (COCs) to investigate whether the PI3K-Akt signaling pathway impacted oocyte quality. Following follicle rupture, COCs were individually selected for in vitro cultures to track the follicular cells based on oocyte competence to reach the blastocyst stage after parthenogenetic activation. Levels of PI3K-Akt signaling pathway components in FCs correlated with oocyte competence. This pathway is upregulated in FCs from follicles with high-quality oocytes that are able to reach the blastocyst stage, as indicated by decreased levels of PTEN and increased levels of the PTEN regulators bta-miR-494 and bta-miR-20a. Using PI3K-Akt responsive genes, we showed decreased FOXO3a levels and BAX levels in lower quality groups, indicating changes in cell cycle progression, oxidative response and apoptosis. Based on these results, the measurement of levels of PI3K-Akt pathway components in FCs from ovarian follicles carrying oocytes with distinct developmental competences is a useful tool to identify putative molecular pathways involved in the acquisition of oocyte competence.	[Andrade, Gabriella Mamede; da Silveira, Juliano Coelho; Del Collado, Maite; Meirelles, Flavio Vieira; Perecin, Felipe] Univ Sao Paulo, Fac Anim Sci & Food Engn, Vet Med Dept, Pirassununga, SP, Brazil; [Perrini, Claudia] Univ Milan, Reprod Unit, Large Anim Hosp, Lodi, Italy; [Gebremedhn, Samuel; Tesfaye, Dawit] Univ Bonn, Inst Anim Sci ITW, Bonn, Germany	Universidade de Sao Paulo; University of Milan; University of Bonn	Perecin, F (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Vet Med Dept, Pirassununga, SP, Brazil.	fperecin@usp.br	Gebremedhn, Samuel/AAQ-3139-2020; Andrade, Gabriella M/F-9881-2012; Silveira, Juliano C/B-3086-2013; Meirelles, Flavio V/B-5048-2010; del Collado, Maite/M-4870-2015; Da Silveira, Juliano/AAH-9784-2020; Perecin, Felipe/C-7268-2012; CTC USP, CEPID 13 18/J-8951-2014	Andrade, Gabriella M/0000-0002-8095-3738; Silveira, Juliano C/0000-0002-4796-6393; Meirelles, Flavio V/0000-0003-0372-4920; del Collado, Maite/0000-0002-4098-4855; Da Silveira, Juliano/0000-0002-4796-6393; Perecin, Felipe/0000-0003-2009-5863; CTC USP, CEPID 13 18/0000-0002-7123-9524; Gebremedhn, Samuel/0000-0002-9977-2347	Sao Paulo Research Foundation (FAPESP) [2014/21034-3, 2014/22887-0, 2013/08135-2, 2012/50533-2]; National Counsel of Technological and Scientific Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo Research Foundation (FAPESP grants 2014/21034-3; 2014/22887-0; 2013/08135-2 and 2012/50533-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors like to thank the staff and students at the Laboratory of Molecular Morphophysiology and Development (LMMD) for all their help with the sample collections and laboratory procedures. This work was supported by the Sao Paulo Research Foundation (FAPESP grants 2014/21034-3; 2014/22887-0; 2013/08135-2 and 2012/50533-2) and the National Counsel of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Andreas E, 2016, CELL TISSUE RES, P1; Brenkman AB, 2003, TRENDS MOL MED, V9, P464, DOI 10.1016/j.molmed.2003.09.003; Combelles CMH, 2010, REPRODUCTION, V139, P871, DOI 10.1530/REP-09-0390; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Driancourt MA, 1998, REPROD NUTR DEV, V38, P345, DOI 10.1051/rnd:19980401; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Feng WG, 2007, THERIOGENOLOGY, V67, P1339, DOI 10.1016/j.theriogenology.2007.01.017; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gebremedhn S, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137539; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Krisher RL, 2013, ANNU REV ANIM BIOSCI, V1, P393, DOI 10.1146/annurev-animal-031412-103647; Lai K, 2015, J CLIN PATHOL, V68, P253, DOI 10.1136/jclinpath-2015-202885; Li HJ, 2009, ANIM REPROD SCI, V114, P89, DOI 10.1016/j.anireprosci.2008.09.018; Liu LH, 2010, LIFE SCI, V86, P192, DOI 10.1016/j.lfs.2009.12.002; Lonergan P, 2003, REPROD DOMEST ANIM, V38, P259, DOI 10.1046/j.1439-0531.2003.00437.x; Luo X, 2013, CELL PROLIFERAT, V46, P436, DOI 10.1111/cpr.12038; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Makker A, 2014, J MOL ENDOCRINOL, V53, pR103, DOI 10.1530/JME-14-0220; Marx D, 1997, ANTICANCER RES, V17, P2233; McLaughlin M, 2014, MOL HUM REPROD, V20, P736, DOI 10.1093/molehr/gau037; Mermillod P, 2008, REPROD DOMEST ANIM, V43, P393, DOI 10.1111/j.1439-0531.2008.01190.x; Neri C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00015; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Sangalli JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101022; Sharma I, 2012, REPRODUCTION, V144, P373, DOI 10.1530/REP-12-0079; Sirard M. A., 2013, Oocyte physiology and development in domestic animals, P191; Sirard MA, 2003, REPRODUCTION, P117; Wang L-Q, 2014, REPROD FERTILITY DEV; Xu M, 2012, CELL MOL LIFE SCI, V69, P3601, DOI 10.1007/s00018-012-1129-8; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5	34	41	47	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185045	10.1371/journal.pone.0185045	http://dx.doi.org/10.1371/journal.pone.0185045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922408	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300054
J	De Zanet, D; Battiston, M; Lombardi, E; Specogna, R; Trevisan, F; De Marco, L; Affanni, A; Mazzucato, M				De Zanet, Denise; Battiston, Monica; Lombardi, Elisabetta; Specogna, Ruben; Trevisan, Francesco; De Marco, Luigi; Affanni, Antonio; Mazzucato, Mario			Impedance biosensor for real-time monitoring and prediction of thrombotic individual profile in flowing blood	PLOS ONE			English	Article							WHOLE-BLOOD; GROWTH	A new biosensor for the real-time analysis of thrombus formation is reported. The fast and accurate monitoring of the individual thrombotic risk represents a challenge in cardiovascular diagnostics and in treatment of hemostatic diseases. Thrombus volume, as representative index of the related thrombotic status, is usually estimated with confocal microscope at the end of each in vitro experiment, without providing a useful behavioral information of the biological sample such as platelets adhesion and aggregation in flowing blood. Our device has been developed to work either independently or integrated with the microscopy system; thus, images of the fluorescently labeled platelets are acquired in real-time during the whole blood perfusion, while the global electrical impedance of the blood sample is simultaneously monitored between a pair of specifically designed gold microelectrodes. Fusing optical and electrical data with a novel technique, the dynamic of thrombus formation events in flowing blood can be reconstructed in real-time, allowing an accurate extrapolation of the three-dimensional shape and the spatial distribution of platelet thrombi forming and growing within artificial capillaries. This biosensor is accurate and it has been used to discriminate different hemostatic conditions and to identify weakening and detaching platelet aggregates. The results obtained appear compatible with those quantified with the traditional optical method. With advantages in terms of small size, user-friendliness and promptness of response, it is a promising device for the fast and automatic individual health monitoring at the Point of Care (POC).	[De Zanet, Denise; Specogna, Ruben; Trevisan, Francesco; Affanni, Antonio] Univ Udine, Polytech Dept Engn & Architecture, Udine, Italy; [De Zanet, Denise; Battiston, Monica; Lombardi, Elisabetta; De Marco, Luigi; Mazzucato, Mario] Natl Canc Inst CRO IRCCS, Dept Translat Res, Stem Cells Unit, Aviano, Pordenone, Italy	University of Udine; IRCCS Aviano (CRO)	Mazzucato, M (corresponding author), Natl Canc Inst CRO IRCCS, Dept Translat Res, Stem Cells Unit, Aviano, Pordenone, Italy.	mmazzucato@cro.it	Specogna, Ruben/E-6574-2018; Mazzucato, Mario/ABF-5472-2020; Lombardi, Elisabetta/AAC-2396-2020; Battiston, Monica/S-8997-2019	Mazzucato, Mario/0000-0001-8319-053X; Lombardi, Elisabetta/0000-0002-3688-9281; Battiston, Monica/0000-0001-6657-4195	Italian Ministry of Health [RF-2010-2316198, RF-2010-2317993]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grant from the Italian Ministry of Health RF-2010-2316198 and RF-2010-2317993 (Dr. Luigi De Marco, Dr. Mario Mazzucato).	Affanni A, 2016, MEASUREMENT, V79, P260, DOI 10.1016/j.measurement.2015.05.045; Affanni A, 2013, IEEE T INSTRUM MEAS, V62, P2954, DOI 10.1109/TIM.2013.2266012; Affanni A, 2012, IEEE IMTC P, P1477; Affanni A, 2013, J PHYS C SERIES, V459; Affanni A., 2011, IEEE INT S MED MEAS, P80; Affanni A, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2281987; Affanni A, 2012, IEEE T BIO-MED ENG, V59, P2619, DOI 10.1109/TBME.2012.2207897; Agilent Technology, 2008, AG E4980A PREC LCR M; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Bonanno LM, 2007, BIOSENS BIOELECTRON, V23, P444, DOI 10.1016/j.bios.2007.05.008; Branchford BR, 2015, THROMB RES, V136, P13, DOI 10.1016/j.thromres.2015.05.012; Chen D, 2017, BIOSENS BIOELECTRON, V91, P465, DOI 10.1016/j.bios.2016.12.063; Claesson K, 2016, THROMB HAEMOSTASIS, V115, P1178, DOI 10.1160/TH15-10-0799; Eils R, 2003, J CELL BIOL, V161, P477, DOI 10.1083/jcb.200302097; HIRSCH FG, 1950, BLOOD, V5, P1017, DOI 10.1182/blood.V5.11.1017.1017; HUBBELL JA, 1986, REV SCI INSTRUM, V57, P892, DOI 10.1063/1.1138830; JCGM, 2008, JCGM 100 2008 EVALUA; Lei KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076243; Li M, 2012, LAB CHIP, V12, P1355, DOI 10.1039/c2lc21145a; Mazzucato M, 2004, BLOOD, V104, P3221, DOI 10.1182/blood-2004-03-1145; Mazzucato Mario, 2007, Ann Ist Super Sanita, V43, P130; Mazzucato M, 2009, BLOOD, V114, P2793, DOI 10.1182/blood-2008-12-193490; Pearson Karl, 1895, P ROY SOC LONDON, V58, P240, DOI [DOI 10.1098/RSPL.1895.0041, 10.1098/rspl.1895.0041]; Puckett LG, 2003, BIOSENS BIOELECTRON, V18, P675, DOI 10.1016/S0956-5663(03)00033-2; Roest M, 2011, J THROMB HAEMOST, V9, P2322, DOI 10.1111/j.1538-7836.2011.04492.x; Ruggeri M., 2013, PLATELETS, P399, DOI [DOI 10.1016/B978-0-12-387837-3.00020-1, 10.1016/B978-0-12-387837-3.00020-1]; Van Kruchten R, 2012, PLATELETS, V23, P229, DOI 10.3109/09537104.2011.630848; Westein E, 2012, PLATELETS, V23, P501, DOI 10.3109/09537104.2012.709653; Zhang YS, 2016, LAB CHIP, V16, P4097, DOI 10.1039/c6lc00380j; Zhbanov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129337	31	5	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184941	10.1371/journal.pone.0184941	http://dx.doi.org/10.1371/journal.pone.0184941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922391	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300049
J	Tibuakuu, M; Kamimura, D; Kianoush, S; DeFilippis, AP; Al Rifai, M; Reynolds, LM; White, WB; Butler, KR; Mosley, TH; Turner, ST; Kullo, IJ; Hall, ME; Blaha, MJ				Tibuakuu, Martin; Kamimura, Daisuke; Kianoush, Sina; DeFilippis, Andrew P.; Al Rifai, Mahmoud; Reynolds, Lindsay M.; White, Wendy B.; Butler, Kenneth R.; Mosley, Thomas H.; Turner, Stephen T.; Kullo, Iftikhar J.; Hall, Michael E.; Blaha, Michael J.			The association between cigarette smoking and inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; QUALITY-CONTROL; LONG-TERM; ATHEROSCLEROSIS; MARKERS; MEN; INTERLEUKIN-6	To inform the study and regulation of emerging tobacco products, we sought to identify sensitive biomarkers of tobacco-induced subclinical cardiovascular damage by testing the cross-sectional associations of smoking with 17 biomarkers of inflammation in 2,702 GENOA study participants belonging to sibships ascertained on the basis of hypertension. Cigarette smoking was assessed by status, intensity (number of cigarettes per day), burden (pack-years of smoking), and time since quitting. We modeled biomarkers as geometric mean (GM) ratios using generalized estimating equations (GEE). The mean age of participants was 61 +/- 10 years; 64.5% were women and 54.4% African American. The prevalence of smoking was 12.2%. After adjusting for potential confounders, 6 of 17 biomarkers were significantly higher among current smokers at a Bonferroni adjusted p-value threshold (p < 0.003). High sensitivity C-reactive protein was the most elevated biomarker among current smokers when compared to never smokers [GM ratio = 1.39 (95% CI: 1.23, 1.57); p < 0.001]. Among former smokers, each pack-year of cigarettes smoked was associated with a 0.4% higher serum level of hsCRP [GM ratio = 1.004 (95% CI: 1.001, 1.006); p = 0.002] and each 5-year lapsed since quitting was associated with a 4% lower serum level of hsCRP [GM ratio = 0.96 (95% CI: 0.93, 0.99); p = 0.006]. However, we found no significant association of smoking intensity or burden with biomarkers of inflammation among current smokers. HsCRP appears to be the most sensitive biomarker of inflammation associated with cigarette smoking of those investigated, and could be a useful biomarker of smoking-related injury for the study and regulation of emerging tobacco products.	[Tibuakuu, Martin; Kianoush, Sina; Al Rifai, Mahmoud; Blaha, Michael J.] Johns Hopkins Sch Med, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21205 USA; [Tibuakuu, Martin] St Lukes Hosp, Dept Med, Chesterfield, MO USA; [Kamimura, Daisuke; Hall, Michael E.] Univ Mississippi, Med Ctr, Div Cardiol, Jackson, MS 39216 USA; [DeFilippis, Andrew P.] Univ Louisville, Sch Med, Div Cardiol, Louisville, KY 40292 USA; [Al Rifai, Mahmoud] Univ Kansas, Sch Med, Dept Med, Wichita, KS 67214 USA; [Reynolds, Lindsay M.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [White, Wendy B.] Tougaloo Coll, Jackson Heart Study, Jackson, MS USA; [Butler, Kenneth R.; Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Kullo, Iftikhar J.] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA	Johns Hopkins University; Johns Hopkins Medicine; Saint Luke's Hospital - Missouri; University of Mississippi; University of Mississippi Medical Center; University of Louisville; University of Kansas; University of Kansas Medical Center; Wake Forest University; Tougaloo College; University of Mississippi; University of Mississippi Medical Center; Mayo Clinic; Mayo Clinic	Blaha, MJ (corresponding author), Johns Hopkins Sch Med, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21205 USA.	mblaha1@jhmi.edu	Butler, Kenneth Ray/S-3328-2019; White, Wendy/AAG-9791-2020; Turner, Stephen/GXM-4654-2022	White, Wendy/0000-0003-0923-8165; Reynolds, Lindsay/0000-0001-6157-0144	American Heart Association Tobacco Regulation and Addiction Center (A-TRAC) [NIH 1 P50 HL120163-01]; National Institutes of Health [U01-HL054463, U01-HL054464, U01-HL081331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL120163, U54HL120163] Funding Source: NIH RePORTER	American Heart Association Tobacco Regulation and Addiction Center (A-TRAC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This analysis was supported by funding from the American Heart Association Tobacco Regulation and Addiction Center (A-TRAC, NIH 1 P50 HL120163-01), a member of the Food and Drug Administration (FDA) Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P50). The data used in this investigation were collected during a study supported by grants U01-HL054463, U01-HL054464, and U01-HL081331 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rifai M, 2017, ATHEROSCLEROSIS; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; [Anonymous], 2014, HLTH CONSMOK 50 YE; [Anonymous], 2012, PREV TOB UYOUTH YO; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Boerwinkle E, 2002, HYPERTENSION, V39, P3; Center for Disease Control and Prevention,, 2010, TOB SMOK CAUS DIS BI; Connolly GN, 2008, JAMA-J AM MED ASSOC, V299, P2629, DOI 10.1001/jama.299.22.2629; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Ellington AA, 2009, CLIN CHEM, V55, P1092, DOI 10.1373/clinchem.2008.120717; Food and Drugs Administration, FDA PROP EXT ITS TOB; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; Granger CB, 2004, CIRCULATION, V109, P1697, DOI 10.1161/01.CIR.0000121563.47232.2A; Helmersson J, 2005, ATHEROSCLEROSIS, V181, P201, DOI 10.1016/j.atherosclerosis.2004.11.026; Hwang SJ, 1997, CIRCULATION, V96, P4219; Inoue-Choi M, 2017, JAMA INTERN MED, V177, P87, DOI 10.1001/jamainternmed.2016.7511; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Karakas M, 2012, J INTERN MED, V271, P43, DOI 10.1111/j.1365-2796.2011.02397.x; Kim CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009065; King CC, 2017, ARTERIOSCL THROM VAS, V37, P374, DOI [10.1161/ATVBAHA.116.308728, 10.1161/atvbaha.116.308728]; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Levitzky YS, 2008, ATHEROSCLEROSIS, V201, P217, DOI 10.1016/j.atherosclerosis.2007.12.058; Lindsey JB, 2009, DIABETES VASC DIS RE, V6, P7, DOI 10.3132/dvdr.2009.002; Liu JM, 2011, CANCER EPIDEM BIOMAR, V20, P1760, DOI 10.1158/1055-9965.EPI-10-0987; McDermott DH, 2005, CIRCULATION, V112, P1113, DOI 10.1161/CIRCULATIONAHA.105.543579; McEvoy JW, 2015, ARTERIOSCL THROM VAS, V35, P1002, DOI 10.1161/ATVBAHA.114.304960; McEvoy JW, 2015, ARTERIOSCL THROM VAS, V35, P700, DOI 10.1161/ATVBAHA.114.304562; Newson R, 2003, STATA J, V3, P445; Ohsawa M, 2005, PREV MED, V41, P651, DOI 10.1016/j.ypmed.2005.02.002; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rom O, 2013, RESP PHYSIOL NEUROBI, V187, P5, DOI 10.1016/j.resp.2013.01.013; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Royston P, 2011, MULTIPLE IMPUTATION, V45, P20; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Schulz R, 2009, CIRCULATION, V119, P1355, DOI 10.1161/CIRCULATIONAHA.108.846105; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Southwell BG, 2012, AM J HEALTH PROMOT, V26, P331, DOI 10.4278/ajhp.111004-CIT-357; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; Troseid M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-11; WESTGARD JO, 1981, CLIN CHEM, V27, P493; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang Y, 2016, ENVIRON RES, V146, P395, DOI 10.1016/j.envres.2016.01.026	47	45	44	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184914	10.1371/journal.pone.0184914	http://dx.doi.org/10.1371/journal.pone.0184914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922371	Green Submitted, gold, Green Published			2022-12-27	WOS:000411059300042
J	Grubel, J; Thrash, T; Holscher, C; Schinazi, VR				Grubel, Jascha; Thrash, Tyler; Holscher, Christoph; Schinazi, Victor R.			Evaluation of a conceptual framework for predicting navigation performance in virtual reality	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; SPATIAL REPRESENTATIONS; CEREBRAL HEMISPHERES; PERCEPTION; LOCOMOTION; KNOWLEDGE; SYSTEMS; ENVIRONMENTS; INFORMATION; CATEGORIES	Previous research in spatial cognition has often relied on simple spatial tasks in static environments in order to draw inferences regarding navigation performance. These tasks are typically divided into categories (e.g., egocentric or allocentric) that reflect different two-systems theories. Unfortunately, this two-systems approach has been insufficient for reliably predicting navigation performance in virtual reality (VR). In the present experiment, participants were asked to learn and navigate towards goal locations in a virtual city and then perform eight simple spatial tasks in a separate environment. These eight tasks were organised along four orthogonal dimensions (static/dynamic, perceived/remembered, egocentric/allocentric, and distance/direction). We employed confirmatory and exploratory analyses in order to assess the relationship between navigation performance and performances on these simple tasks. We provide evidence that a dynamic task (i.e., intercepting a moving object) is capable of predicting navigation performance in a familiar virtual environment better than several categories of static tasks. These results have important implications for studies on navigation in VR that tend to over-emphasise the role of spatial memory. Given that our dynamic tasks required efficient interaction with the human interface device (HID), they were more closely aligned with the perceptuomotor processes associated with locomotion than wayfinding. In the future, researchers should consider training participants on HIDs using a dynamic task prior to conducting a navigation experiment. Performances on dynamic tasks should also be assessed in order to avoid confounding skill with an HID and spatial knowledge acquisition.	[Grubel, Jascha; Thrash, Tyler; Holscher, Christoph; Schinazi, Victor R.] Swiss Fed Inst Technol, Dept Humanities Social & Polit Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Grubel, J (corresponding author), Swiss Fed Inst Technol, Dept Humanities Social & Polit Sci, Zurich, Switzerland.	jgruebel@student.ethz.ch	Grübel, Jascha/AAX-4975-2020; Schinazi, Victor/AAI-5672-2020	Grübel, Jascha/0000-0002-6428-4685; Schinazi, Victor/0000-0002-2345-2806	ETH Startup Grant for the Chair of Cognitive Science	ETH Startup Grant for the Chair of Cognitive Science	The study was funded by the ETH Startup Grant for the Chair of Cognitive Science.	Allen GL, 2004, HUMAN SPATIAL MEMORY: REMEMBERING WHERE, P41; Avraamides MN, 2008, COGN PROCESS, V9, P93, DOI 10.1007/s10339-007-0188-5; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Byrne RW, 1982, NORMALITY PATHOLOGY, P239; Chabris CF, 1998, CURR DIR PSYCHOL SCI, V7, P8, DOI 10.1111/1467-8721.ep11521809; Chen JL, 1999, PRESENCE-TELEOP VIRT, V8, P671, DOI 10.1162/105474699566558; Clark A., 1998, BEING THERE PUTTING; Creem SH, 2001, ACTA PSYCHOL, V107, P43, DOI 10.1016/S0001-6918(01)00021-X; Creem SH, 2001, J EXP PSYCHOL HUMAN, V27, P218, DOI 10.1037/0096-1523.27.1.218; Creem SH, 1998, PSYCHON B REV, V5, P22, DOI 10.3758/BF03209455; Denis M, 1999, APPL COGNITIVE PSYCH, V13, P145, DOI 10.1002/(SICI)1099-0720(199904)13:2<145::AID-ACP550>3.0.CO;2-4; Diwadkar VA, 1997, PSYCHOL SCI, V8, P302, DOI 10.1111/j.1467-9280.1997.tb00442.x; EASTON RD, 1995, J EXP PSYCHOL LEARN, V21, P483, DOI 10.1037/0278-7393.21.2.483; Fajen BR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00085; Farrell MJ, 1999, J MOTOR BEHAV, V31, P39, DOI 10.1080/00222899909601890; Filimon F., 2015, FRONT HUM NEUROSCI, P9; Friedman A, 2008, MEM COGNITION, V36, P467, DOI 10.3758/MC.36.3.467; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson JJ, 1947, AVIATION PSYCHOL RES; Gillner S, 1998, J COGNITIVE NEUROSCI, V10, P445, DOI 10.1162/089892998562861; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grubel J, 2014, THESIS; Grubel J, 2017, EVALUATION CONCEPTUA; Guttman L, 1944, PSYCHOMETRIKA, V9, P1, DOI 10.1007/BF02288709; HEFT H, 1983, POPUL ENVIRON, V6, P133, DOI 10.1007/BF01258956; Heft H., 1996, CONSTRUCTION COGNITI, P105; Hegarty M, 2002, INTELLIGENCE, V30, P425, DOI 10.1016/S0160-2896(02)00116-2; Hegarty M., 2005, CAM BRIDGE HDB VISUO, P121, DOI DOI 10.1017/CBO9780511610448.005; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Hollerbach JM, 2002, HUM FAC ER, P239; HUTTENLOCHER J, 1991, PSYCHOL REV, V98, P352, DOI 10.1037/0033-295X.98.3.352; Huttenlocher J, 2000, J EXP PSYCHOL GEN, V129, P220, DOI 10.1037//0096-3445.129.2.220; Jung S., 2008, NEW TRENDS PSYCHOMET, P141; Jung S, 2013, BEHAV PROCESS, V97, P90, DOI 10.1016/j.beproc.2012.11.016; Jung S, 2011, BEHAV RES METHODS, V43, P701, DOI 10.3758/s13428-011-0077-9; Kearns MJ, 2002, PERCEPTION, V31, P349, DOI 10.1068/p3311; Kitchin R., 2002, COGNITION GEOGRAPHIC; KOSSLYN SM, 1992, J EXP PSYCHOL HUMAN, V18, P562, DOI 10.1037/0096-1523.18.2.562; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; Kosslyn SM, 1994, NATURE, V372, P289, DOI DOI 10.1038/372289a0; Kraemer DJM, 2017, J EXP PSYCHOL LEARN, V43, P611, DOI 10.1037/xlm0000314; Lapointe JF, 2011, COMPUT HUM BEHAV, V27, P2186, DOI 10.1016/j.chb.2011.06.014; Loomis JM, 1999, BEHAV RES METH INS C, V31, P557, DOI 10.3758/BF03200735; Loomis JM, 2003, VIRTUAL AND ADAPTIVE ENVIRONMENTS: APPLICATIONS, IMPLICATIONS, AND HUMAN PERFORMANCE ISSUES, P21; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; May M, 2004, COGNITIVE PSYCHOL, V48, P163, DOI 10.1016/S0010-0285(03)00127-0; McKinley RA, 2011, AVIAT SPACE ENVIR MD, V82, P635, DOI 10.3357/ASEM.2958.2011; Mirman D, 2015, NEUROPSYCHOLOGIA, V76, P208, DOI 10.1016/j.neuropsychologia.2015.02.014; Montello D. R., 2005, NAVIGATION; Montello DR, 2004, HUMAN SPATIAL MEMORY: REMEMBERING WHERE, P251; Mou WM, 2006, J EXP PSYCHOL LEARN, V32, P1274, DOI 10.1037/0278-7393.32.6.1274; Mou WM, 2002, J EXP PSYCHOL LEARN, V28, P162, DOI 10.1037//0278-7393.28.1.162; Mou WM, 2004, J EXP PSYCHOL LEARN, V30, P142, DOI 10.1037/0278-7393.30.1.142; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Newcombe N.S., 2000, MAKING SPACE DEV SPA; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Piaget J., 1967, CHILDS CONCEPT SPACE; Razzaque S., 2001, REDIRECTED WALKING, P105, DOI [10.2312/egs.20011036, DOI 10.2312/EGS.20011036]; Riecke BE, 2010, LECT NOTES ARTIF INT, V6222, P234, DOI 10.1007/978-3-642-14749-4_21; RIESER JJ, 1989, J EXP PSYCHOL LEARN, V15, P1157, DOI 10.1037/0278-7393.15.6.1157; Ruddle RA, 2006, PRESENCE-TELEOP VIRT, V15, P637, DOI 10.1162/pres.15.6.637; Ruddle RA, 2006, PSYCHOL SCI, V17, P460, DOI 10.1111/j.1467-9280.2006.01728.x; Ruddle RA, 2013, ACM T APPL PERCEPT, V10, DOI 10.1145/2465780.2465785; Schinazi VR, 2013, HIPPOCAMPUS, V23, P515, DOI 10.1002/hipo.22111; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Shemyakin F. N, 1962, PSYCHOL SCI USSR, P186; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; Slater M., 1995, ACM T COMPUT INTERAC, V2, P201, DOI [10.1145/210079.210084, DOI 10.1145/210079.210084]; THORNDYKE PW, 1982, COGNITIVE PSYCHOL, V14, P560, DOI 10.1016/0010-0285(82)90019-6; Thrash T, 2015, PRESENCE-TELEOP VIRT, V24, P322, DOI 10.1162/PRES_a_00237; Thurstone LL, 1947, MULTIPLE FACTOR ANAL; Waller D, 2007, BEHAV RES METHODS, V39, P835, DOI 10.3758/BF03192976; Waller D, 2006, J EXP PSYCHOL LEARN, V32, P867, DOI 10.1037/0278-7393.32.4.867; Wang RF, 2012, PSYCHON B REV, V19, P575, DOI 10.3758/s13423-012-0258-2; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Weisberg SM, 2014, J EXP PSYCHOL LEARN, V40, P669, DOI 10.1037/a0035261; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Wraga M, 2000, PSYCHOL SCI, V11, P239, DOI 10.1111/1467-9280.00248; Yates A., 1988, MULTIVARIATE EXPLORA	84	9	9	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184682	10.1371/journal.pone.0184682	http://dx.doi.org/10.1371/journal.pone.0184682			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0WP	28915266	gold, Green Submitted, Green Published			2022-12-27	WOS:000410861600014
J	Kong, KA; Park, J; Hong, SH; Hong, YS; Sung, YA; Lee, H				Kong, Kyoung Ae; Park, Junbeom; Hong, So-hyeon; Hong, Young Sun; Sung, Yeon-Ah; Lee, Hyejin			Associations between body mass index and mortality or cardiovascular events in a general Korean population	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; FAT-FREE MASS; RISK-FACTORS; FOLLOW-UP; WAIST CIRCUMFERENCE; HEMORRHAGIC STROKE; MEN; OBESITY; WOMEN; METAANALYSIS	Background/Objectives The relationship between body mass index (BMI) and mortality remains controversial. Furthermore, the association between BMI and cardiovascular events (CVE) is not conclusive and may differ by ethnicity. We aimed to estimate the associations between the BMI and mortality or cardiovascular disease in a general Korean population. Subjects/Methods This study was based on a sample cohort database released by the Korean National Health Insurance Service. We analyzed a total of 415,796 adults older than 30 years of age who had undergone a national health examination at least once from 2002 to 2012. Hazard ratios for death and cardiovascular events were calculated using Cox proportional hazards models. Results For both men and women, BMI and overall mortality showed a U-shaped association, with the lowest mortality rate among those with a BMI of 25-27.4 kg/m(2). Compared with them, subjects with a BMI >= 30kg/m(2), men with a BMI < 25 kg/m(2), and women with a BMI < 22.5 kg/m(2) showed significantly higher overall mortality. Additionally, men with a BMI < 22.5 kg/m(2) and women with a BMI < 20 kg/m(2) displayed an increased risk of cardiovascular mortality. Unlike the mortality trend, the CVD events trend showed a linearly positive association. The risk of a CVE was the lowest in men with a BMI ranging from 20 to 22.4 kg/m(2) and in women with a BMI < 20 kg/m(2). Conclusions The BMI showed a U-shaped association with overall mortality, where slightly obese subjects showed the lowest rate of mortality. The CVE exhibited a linear association with the BMI, where the lowest risk was observed for normal weight subjects in a general Korean population.	[Kong, Kyoung Ae] Ewha Womans Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Junbeom] Ewha Womans Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea; [Hong, So-hyeon; Hong, Young Sun; Sung, Yeon-Ah; Lee, Hyejin] Ewha Womans Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Lee, H (corresponding author), Ewha Womans Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	hyejinlee@ewha.ac.kr	Park, Junbeom/AAH-6065-2021		Ewha Womans University	Ewha Womans University	The work was supported by the Ewha Womans University Research Grant of 2017.; The work was supported by the Ewha Womans University Research Grant of 2017.	Antonopoulos AS, 2016, OBES REV, V17, P989, DOI 10.1111/obr.12440; Bonaventure A, 2010, ATHEROSCLEROSIS, V210, P243, DOI 10.1016/j.atherosclerosis.2009.10.043; Braun N, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14265; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Cui RZ, 2005, STROKE, V36, P1377, DOI 10.1161/01.STR.0000169925.57251.4e; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Heitmann BL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3292; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Jackson CL, 2014, J GEN INTERN MED, V29, P25, DOI 10.1007/s11606-013-2553-7; Jahangir E, 2014, PROG CARDIOVASC DIS, V57, P127, DOI 10.1016/j.pcad.2014.01.001; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kim NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139924; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Kurth T, 2002, ARCH INTERN MED, V162, P2557, DOI 10.1001/archinte.162.22.2557; Lavie CJ, 2016, PROG CARDIOVASC DIS, V58, P537, DOI 10.1016/j.pcad.2016.01.008; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Njolstad I, 1996, CIRCULATION, V94, P2877; Patel AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109153; Ponce-Garcia Isabel, 2015, PLoS One, V10, pe0127369, DOI 10.1371/journal.pone.0127369; Prado CM, 2015, CURR OPIN CLIN NUTR, V18, P535, DOI 10.1097/MCO.0000000000000216; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; Rodriguez BL, 2002, STROKE, V33, P230, DOI 10.1161/hs0102.101081; Saito I, 2011, INT J OBESITY, V35, P283, DOI 10.1038/ijo.2010.131; Sharma A, 2015, AM J CARDIOL, V115, P1428, DOI 10.1016/j.amjcard.2015.02.024; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Sturgeon JD, 2007, STROKE, V38, P2718, DOI 10.1161/STROKEAHA.107.487090; van Dis I, 2009, EUR J CARDIOV PREV R, V16, P729, DOI 10.1097/HJR.0b013e328331dfc0; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; World Health Organization (WHO), 2000, WHO TECHN REP SER, P256, DOI DOI 10.1007/978-0-387-71799-9_454; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Zhu SK, 2003, ANN EPIDEMIOL, V13, P286, DOI 10.1016/S1047-2797(02)00417-9	41	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0185024	10.1371/journal.pone.0185024	http://dx.doi.org/10.1371/journal.pone.0185024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915262	gold, Green Published, Green Submitted			2022-12-27	WOS:000410861600028
J	Pusterla, JM; Schneck, E; Funari, SS; Deme, B; Tanaka, M; Oliveira, RG				Pusterla, Julio M.; Schneck, Emanuel; Funari, Sergio S.; Deme, Bruno; Tanaka, Motomu; Oliveira, Rafael G.			Cooling induces phase separation in membranes derived from isolated CNS myelin	PLOS ONE			English	Article							X-RAY-DIFFRACTION; NERVOUS-SYSTEM MYELIN; AIR-WATER-INTERFACE; ELECTRON-MICROSCOPY; NEUTRON-SCATTERING; MONOLAYERS; VESICLES; TRANSITIONS; BEHAVIOR; NERVES	Purified myelin membranes (PMMs) are the starting material for biochemical analyses such as the isolation of detergent-insoluble glycosphingolipid-rich domains (DIGs), which are believed to be representatives of functional lipid rafts. The normal DIGs isolation protocol involves the extraction of lipids under moderate cooling. Here, we thus address the influence of cooling on the structure of PMMs and its sub-fractions. Thermodynamic and structural aspects of periodic, multilamellar PMMs are examined between 4 degrees C and 45 degrees C and in various biologically relevant aqueous solutions. The phase behavior is investigated by small-angle X-ray scattering (SAXS) and differential scanning calorimetry (DSC). Complementary neutron diffraction (ND) experiments with solid-supported myelin multilayers confirm that the phase behavior is unaffected by planar confinement. SAXS and ND consistently show that multilamellar PMMs in pure water become heterogeneous when cooled by more than 10-15 degrees C below physiological temperature, as during the DIGs isolation procedure. The heterogeneous state of PMMs is stabilized in physiological solution, where phase coexistence persists up to near the physiological temperature. This result supports the general view that membranes under physiological conditions are close to critical points for phase separation. In presence of elevated Ca2+ concentrations (> 10 mM), phase coexistence is found even far above physiological temperatures. The relative fractions of the two phases, and thus presumably also their compositions, are found to vary with temperature. Depending on the conditions, an "expanded" phase with larger lamellar period or a "compacted" phase with smaller lamellar period coexists with the native phase. Both expanded and compacted periods are also observed in DIGs under the respective conditions. The observed subtle temperature-dependence of the phase behavior of PMMs suggests that the composition of DIGs is sensitive to the details of the isolation protocol.	[Pusterla, Julio M.; Oliveira, Rafael G.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBC, Dept Quim Biol, Cordoba, Argentina; [Schneck, Emanuel] Max Planck Inst Colloids & Interfaces, Biomat Dept, Potsdam, Germany; [Funari, Sergio S.] DESY, HASYLAB, Hamburg, Germany; [Deme, Bruno] ILL Grenoble, Grenoble, France; [Tanaka, Motomu] Heidelberg Univ, Biophys Chem 2, Inst Phys Chem, Heidelberg, Germany; [Tanaka, Motomu] Heidelberg Univ, BIOQUANT, Heidelberg, Germany; [Tanaka, Motomu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan	National University of Cordoba; Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Institut Laue-Langevin (ILL); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Kyoto University	Oliveira, RG (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBC, Dept Quim Biol, Cordoba, Argentina.	rafaeltum@gmail.com	Tanaka, Motomu/S-5949-2016; Demé, Bruno/AAG-1620-2021	Tanaka, Motomu/0000-0003-3663-9554; Demé, Bruno/0000-0002-9523-7662; Pusterla, Julio Martin/0000-0002-2996-5290; Schneck, Emanuel/0000-0001-9769-2194; Oliveira, Rafael Gustavo/0000-0001-5948-5338	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [11220150100621CO]; Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) [2012-2583]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina); Secretaria de Ciencia y Tecnologia, University of Cordoba (SECyT-UNC); Alexander von Humboldt Foundation	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT)(FONCyT); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina); Secretaria de Ciencia y Tecnologia, University of Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) grant no. 11220150100621CO, Fondo para la Investigacion Cientifica y Tecnologica (FONCyT) grant no. 2012-2583, Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina) and Secretaria de Ciencia y Tecnologia, University of Cordoba (SECyT-UNC) to RGO. RGO is career investigators of CONICET (Argentina). JMP is doctoral fellow from CONICET. RGO thanks the Alexander von Humboldt Foundation for a postdoctoral research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitis DN, 2002, J NEUROSCI RES, V70, P8, DOI 10.1002/jnr.10383; CHIA LS, 1984, P NATL ACAD SCI-BIOL, V81, P1871, DOI 10.1073/pnas.81.6.1871; Denninger AR, 2015, BIOPHYS J, V109, P1387, DOI 10.1016/j.bpj.2015.08.012; Denninger AR, 2014, ACTA CRYSTALLOGR D, V70, P3198, DOI 10.1107/S1399004714023815; ELKES J, 1953, EXP CELL RES, V4, P82, DOI 10.1016/0014-4827(53)90190-6; FINEAN JB, 1988, CHEM PHYS LIPIDS, V46, P63, DOI 10.1016/0009-3084(88)90115-6; HALEY JE, 1981, CELL MOL NEUROBIOL, V1, P175, DOI 10.1007/BF00710718; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; INOUYE H, 1989, BIOPHYS J, V56, P129, DOI 10.1016/S0006-3495(89)82658-X; INOUYE H, 1988, BIOPHYS J, V53, P235, DOI 10.1016/S0006-3495(88)83085-6; Inouye H., 2009, MOL NUCL AGGREGATION, P73; Jin AJ, 1999, BIOCHEMISTRY-US, V38, P13275, DOI 10.1021/bi9912084; JOHNSTON DS, 1988, BIOCHIM BIOPHYS ACTA, V939, P603, DOI 10.1016/0005-2736(88)90108-3; KARTHIGASAN J, 1988, J NEUROCHEM, V51, P228, DOI 10.1111/j.1471-4159.1988.tb04860.x; Keller SL, 1998, PHYS REV LETT, V81, P5019, DOI 10.1103/PhysRevLett.81.5019; KERN W, 1970, RCA REV, V31, P187; Kim T, 1999, J NEUROCYTOL, V28, P281, DOI 10.1023/A:1007001427597; Kirschner D., 1984, DIFFRACTION STUDIES, P51; KIRSCHNER DA, 1975, P NATL ACAD SCI USA, V72, P3513, DOI 10.1073/pnas.72.9.3513; KIRSCHNER DA, 1979, J CELL BIOL, V82, P140, DOI 10.1083/jcb.82.1.140; KIRSCHNER DA, 1980, J ULTRA MOL STRUCT R, V73, P211, DOI 10.1016/S0022-5320(80)90125-2; Larocca JN, 2006, CURRENT PROTOCOLS CE, P33; Luzzati V, 1999, J MOL BIOL, V286, P1389, DOI 10.1006/jmbi.1998.2587; MATEU L, 1995, J MOL BIOL, V245, P110, DOI 10.1006/jmbi.1994.0011; MELCHIOR V, 1979, BIOCHIM BIOPHYS ACTA, V554, P204, DOI 10.1016/0005-2736(79)90019-1; Min Y, 2011, BIOPHYS J, V100, P1490, DOI 10.1016/j.bpj.2011.02.009; MOSCARELLO MA, 1983, BIOCHIM BIOPHYS ACTA, V728, P201, DOI 10.1016/0005-2736(83)90472-8; Nagle JF, 2016, SOFT MATTER, V12, P1884, DOI 10.1039/c5sm02336j; Oliveira RG, 2010, BIOPHYS J, V99, P1500, DOI 10.1016/j.bpj.2010.06.053; Oliveira RG, 2002, BBA-BIOMEMBRANES, V1561, P238, DOI 10.1016/S0005-2736(02)00350-4; Oliveira RG, 1998, BBA-BIOMEMBRANES, V1370, P127, DOI 10.1016/S0005-2736(97)00254-X; Oliveira RG, 2000, NEUROCHEM RES, V25, P77, DOI 10.1023/A:1007591516539; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; Petrascu AM, 1998, J MACROMOL SCI PHYS, VB37, P463, DOI 10.1080/00222349808220487; Rosetti CM, 2005, BBA-BIOMEMBRANES, V1668, P75, DOI 10.1016/j.bbamem.2004.11.009; RUIZSANZ J, 1992, EUR BIOPHYS J BIOPHY, V21, P169, DOI 10.1007/BF00196760; Sackmann E., 1995, HDB BIOL PHYS A&B, V1A, P213, DOI [10.1016/S1383-8121(06)80022-9, DOI 10.1016/S1383-8121(06)80022-9]; Schlaich A, 2015, PHYSICA A, V418, P105, DOI 10.1016/j.physa.2014.06.088; Schmitt FO, 1935, RADIOLOGY, V25, P131; Schneck E, 2011, BIOPHYS J, V100, P2151, DOI 10.1016/j.bpj.2011.03.011; Schneck E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061924; SEDZIK J, 1984, J NEUROCHEM, V43, P1415, DOI 10.1111/j.1471-4159.1984.tb05402.x; SEDZIK J, 1995, J NEUROSCI RES, V41, P145, DOI 10.1002/jnr.490410202; Taylor C.M., 2004, MYELIN BIOL DISORDER, V1; Taylor CM, 2002, J NEUROCHEM, V81, P993, DOI 10.1046/j.1471-4159.2002.00884.x; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; WORTHINGTON CR, 1976, BIOCHIM BIOPHYS ACTA, V436, P707, DOI 10.1016/0005-2736(76)90452-1; WORTHINGTON CR, 1980, ARCH BIOCHEM BIOPHYS, V201, P429, DOI 10.1016/0003-9861(80)90531-7; WORTHINGTON CR, 1981, INT J BIOL MACROMOL, V3, P159, DOI 10.1016/0141-8130(81)90057-X	51	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184881	10.1371/journal.pone.0184881	http://dx.doi.org/10.1371/journal.pone.0184881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915267	Green Published, Green Submitted, gold			2022-12-27	WOS:000410861600020
J	Byun, SJ; Bae, WH; Jung, SM; Lee, SW; Park, YB; Song, JJ				Byun, Se Jin; Bae, William Han; Jung, Seung Min; Lee, Sang-Won; Park, Yong-Beom; Song, Jason Jungsik			Fever as an initial manifestation of spondyloarthritis: A retrospective study	PLOS ONE			English	Article							SOCIETY CLASSIFICATION CRITERIA; ANKYLOSING-SPONDYLITIS; CLINICAL-ASPECTS; DOUBLE-BLIND; ARTHRITIS; EFFICACY	Objectives: We aimed to evaluate a wide spectrum of clinical features of adult patients with spondyloarthritis (SpA) whose initial manifestation was fever, using the Assessment of SpondyloArthritis international Society (ASAS) classification criteria. Methods: We retrospectively collected the electronic medical records of hospitalized SpA patients who initially presented to the Severance Hospital (Seoul, Korea) with fever from January 2010 to May 2016. As a control group, we also recruited one-hundred consecutive patients who were diagnosed with SpA in our outpatient clinic. Clinical features and laboratory findings were compared in two patient groups. Results: There were 26 patients who had fever as initial presentation of SpA (reactive arthritis 50%, undifferentiated SpA 26.9%, ankylosing spondylitis 15.4%, enteropathic arthritis 3.8%, psoriatic arthritis 3.8%). Peripheral SpA was more common in febrile SpA patients than in control SpA patients (65.4% vs 24.0%, p<0.001). Febrile SpA patients were less frequently HLA-B27 positive than control SpA patients (52.2% vs 77.0%, p<0.05). At baseline, systemic inflammatory markers were significantly higher in the febrile SpA patients (white blood cell count, 11.57 vs 7.81 cells/mu L, p<0.001; erythrocyte sedimentation rate, 69.2 vs 41.0 mm/h, p<0.001; C-reactive protein, 109.6 vs 15.3 mg/L, p<0.001). The proportion of patients treated with systemic steroids was significantly higher in febrile SpA patients (57.7% vs. 11.0%, p<0.001). The proportion of patients who visited rheumatology specialty was significantly lower in febrile SpA patients than in control SpA patients (7.7% vs 59.0%, p<0.001). Conclusion: Various subgroups of SpA can be presented with fever as an initial manifestation. Febrile SpA patients demonstrated higher systemic inflammation and a lower chance to visit rheumatology in early stage. When evaluating febrile patients with any clinical features of SpA, clinicians are advised to consider performing SpA-focused evaluation including HLA-B27 or a simple sacroiliac joint radiograph.	[Byun, Se Jin; Bae, William Han; Jung, Seung Min; Lee, Sang-Won; Park, Yong-Beom; Song, Jason Jungsik] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Song, Jason Jungsik] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Song, JJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea.; Song, JJ (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea.	JSKSONG@yuhs.ac		Lee, Sang-Won/0000-0002-8038-3341; Jung, Seung Min/0000-0003-3465-2181; Song, Jason/0000-0003-0662-7704	Basic Science Research Program through National Research Foundation of Korea [2015R1C1A1A01053140]; Ministry of Education, Science, and Technology	Basic Science Research Program through National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program (2015R1C1A1A01053140) through the National Research Foundation of Korea, and funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten D, 2013, ARTHRITIS RHEUM-US, V65, P12, DOI 10.1002/art.37829; Behar VM, 2016, JOINT BONE SPINE; Carter JD, 2009, RHEUM DIS CLIN N AM, V35, P21, DOI 10.1016/j.rdc.2009.03.010; Courcoul A, 2017, JOINT BONE SPINE; Danve A, 2015, CLIN RHEUMATOL, V34, P987, DOI 10.1007/s10067-015-2958-2; del Rio-Martinez P, 2016, SEMINARS ARTHRITIS R; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Fauci AS, 2015, HARRISONS PRINCIPLES, V1; Guo RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128979; Haibel H, 2014, ANN RHEUM DIS, V73, P243, DOI 10.1136/annrheumdis-2012-203055; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Inman RD, 1999, J RHEUMATOL, V26, P1219; Maugars Y, 1996, BRIT J RHEUMATOL, V35, P767; Pato E, 2000, J RHEUMATOL, V27, P2198; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Seo MR, 2015, CLIN RHEUMATOL, V34, P1397, DOI 10.1007/s10067-014-2768-y; Stolwijk C, 2013, ANN RHEUMATIC DIS; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van der Heijde D, 2011, ANN RHEUM DIS, V70, P905, DOI 10.1136/ard.2011.151563; van Tubergen A, 2015, NAT REV RHEUMATOL, V11, P110, DOI 10.1038/nrrheum.2014.181; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Ward MM, 2016, ARTHRITIS RHEUMATOL, V68, P282, DOI 10.1002/art.39298; ZELICKSON BD, 1991, ARCH DERMATOL, V127, P1339, DOI 10.1001/archderm.127.9.1339; Zochling J, 2010, BEST PRACT RES CL RH, V24, P747, DOI 10.1016/j.berh.2011.02.002	25	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184323	10.1371/journal.pone.0184323	http://dx.doi.org/10.1371/journal.pone.0184323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910361	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200041
J	Qin, J; Song, QJ; Shi, AN; Li, S; Zhang, MC; Zhang, B				Qin, Jun; Song, Qijian; Shi, Ainong; Li, Song; Zhang, Mengchen; Zhang, Bo			Genome-wide association mapping of resistance to Phytophthora sojae in a soybean [Glycine max (L.) Merr.] germplasm panel from maturity groups IV and V	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ROOT-ROT; IDENTIFICATION; TOLERANCE; SOFTWARE; QTL; YIELD	Phytophthora sojae, an oomycete pathogen of soybean, causes stem and root rot, resulting in annual economic loss up to $2 billion worldwide. Varieties with P. sojae resistance are environmental friendly to effectively reduce disease damages. In order to improve the resistance of P. sojae and broaden the genetic diversity in Southern soybean cultivars and germplasm in the U.S., we established a P. sojae resistance gene pool that has high genetic diversity, and explored genomic regions underlying the host resistance to P. sojae races 1, 3, 7, 17 and 25. A soybean germplasm panel from maturity groups (MGs) IV and V including 189 accessions originated from 10 countries were used in this study. The panel had a high genetic diversity compared to the 6,749 accessions from MGs IV and V in USDA Soybean Germplasm Collection. Based on disease evaluation dataset of these accessions inoculated with P. sojae races 1, 3, 7, 17 and 25, which are publically available, five accessions in this panel were resistant to all races. Genome-wide association analysis identified a total of 32 significant SNPs, which were clustered in resistance-associated genomic regions, among those, ss715619920 was only 3kb away from the gene Glyma. 14g087500, a subtilisin protease. Gene expression analysis showed that the gene was down-regulated more than 4 fold (log2 fold > 2.2) in response to P. sojae infection. The identified molecular markers and genomic regions that are associated with the disease resistance in this gene pool will greatly assist the U.S. Southern soybean breeders in developing elite varieties with broad genetic background and P. sojae resistance.	[Qin, Jun; Li, Song; Zhang, Bo] Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA; [Qin, Jun; Zhang, Mengchen] Hebei Acad Agr & Forestry Sci, Cereal & Oil Crop Inst, Minist Agr,Natl Soybean Improvement Ctr Shijiazhu, North China Key Lab Biol & Genet Improvement Soyb, Shijiazhuang, Hebei, Peoples R China; [Song, Qijian] ARS, USDA, Soybean Genom & Improvement Lab, Beltsville, MD USA; [Shi, Ainong] Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA	Virginia Polytechnic Institute & State University; Hebei Academy of Agricultural & Forestry Sciences; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville	Zhang, B (corresponding author), Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA.	bozhang@vt.edu	Shi, Ainong/L-6384-2017	Shi, Ainong/0000-0002-1066-7920				Akond M, 2013, SNP BASED GENETIC LI; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; CHURCHILL GA, 1994, GENETICS, V138, P963; Dorrance AE, 2000, PLANT DIS, V84, P1303, DOI 10.1094/PDIS.2000.84.12.1303; Dorrance AE, 2003, PLANT DIS, V87, P308, DOI 10.1094/PDIS.2003.87.3.308; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Figueiredo A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00739; Han YP, 2008, EUPHYTICA, V162, P231, DOI 10.1007/s10681-007-9558-4; Huang JQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2434-7; Kaeuffer R, 2007, HEREDITY, V99, P374, DOI 10.1038/sj.hdy.6801010; Kandel H., 2010, SOYBEAN PRODUCTION F; LANDER ES, 1989, GENETICS, V121, P185; Lee S, 2014, THEOR APPL GENET, V127, P429, DOI 10.1007/s00122-013-2229-z; Lee S, 2013, CROP SCI, V53, P1022, DOI 10.2135/cropsci2012.10.0578; Lee S, 2013, THEOR APPL GENET, V126, P1121, DOI 10.1007/s00122-013-2040-x; Li LH, 2016, MOL GENET GENOMICS, V291, P1095, DOI 10.1007/s00438-015-1164-x; Lin F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-18; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Ping JQ, 2016, THEOR APPL GENET, V129, P445, DOI 10.1007/s00122-015-2638-2; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Ryley MJ, 1998, PLANT DIS, V82, P1048, DOI 10.1094/PDIS.1998.82.9.1048; Schmitthenner A.F., 1999, COMPENDIUM SOYBEAN D, V4th edn, P39; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schneider R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2918-5; Shi AN, 2016, EUPHYTICA, V208, P143, DOI 10.1007/s10681-015-1610-1; Song QJ, 2015, G3-GENES GENOM GENET, V5, P1999, DOI 10.1534/g3.115.019000; Stasko AK, 2016, CROP SCI, V56, P2476, DOI 10.2135/cropsci2015.12.0749; Sun JT, 2014, J GENET, V93, P355, DOI 10.1007/s12041-014-0383-y; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tucker DM, 2010, CROP SCI, V50, P628, DOI 10.2135/cropsci2009.03.0161; Wang H., 2012, BMC GENOMICS, V13, P1; Wang HH, 2012, CROP SCI, V52, P609, DOI 10.2135/cropsci2011.06.0336; Wang HH, 2010, PLANT GENOME-US, V3, P23, DOI 10.3835/plantgenome2009.12.0029; Weng CR, 2007, EUPHYTICA, V158, P81, DOI 10.1007/s10681-007-9428-0; Wu X, 2011, PLANT BREEDING, V130, P144, DOI 10.1111/j.1439-0523.2010.01799.x; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhou LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-49	39	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184613	10.1371/journal.pone.0184613	http://dx.doi.org/10.1371/journal.pone.0184613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910339	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200068
J	Al-Ahmad, MM; Amir, N; Dhanasekaran, S; John, A; Abdulrazzaq, YM; Ali, BR; Bastaki, SMA				Al-Ahmad, Mohammad M.; Amir, Naheed; Dhanasekaran, Subramanian; John, Anne; Abdulrazzaq, Yousef M.; Ali, Bassam R.; Bastaki, Salim M. A.			Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis	PLOS ONE			English	Article							CAFFEINE URINARY METABOLITES; NAT2 PHENOTYPES; JAPANESE POPULATION; TURKISH POPULATION; 5'-FLANKING REGION; DRUG-INTERACTIONS; ENZYMES; RISK; PHARMACOGENETICS; SCHIZOPHRENIA	Cytochrome P450 1A2 (CYP1A2) is one of the CYP450 mixed-function oxidase system that is of clinical importance due to the large number of drug interactions associated with its induction and inhibition. In addition, significant inter-individual differences in the elimination of drugs metabolized by CYP1A2 enzyme have been observed which are largely due to the highly polymorphic nature of CYP1A2 gene. However, there are limited studies on CYP1A2 phenotypes and CYP1A2 genotypes among Emiratis and thus this study was carried out to fill this gap. Five hundred and seventy six non-smoker Emirati subjects were asked to consume a soft drink containing caffeine (a non-toxic and reliable probe for predicting CYP1A2 phenotype) and then provide a buccal swab along with a spot urine sample. Taq-Man Real Time PCR was used to determine the CYP1A2 genotype of each individual. Phenotyping was carried out by analyzing the caffeine metabolites using High Performance Liquid Chromatography (HPLC) analysis. We found that 1.4%, 16.3% and 82.3% of the Emirati subjects were slow, intermediate and rapid CYP1A2 metabolizers, respectively. In addition, we found that 1.4% of the subjects were homozygote for derived alleles while 16.1% were heterozygote and 82.5% were homozygote for the ancestral allele. The genotype frequency of the ancestral allele, CYP1A2* 1A/* 1A, is the highest in this population, followed by CYP1A2 * 1A/* 1C and CYP1A2 * 1A/* 1K genotypes, with frequencies of 0.825, 0.102 and 0.058, respectively. The degree of phenotype/genotype concordance was equal to 81.6%. The CYP1A2* 1C/* 1C and CYP1A2* 3/* 3 genotypes showed significantly the lowest enzyme phenotypic activity. The frequency of slow activity CYP1A2 enzyme alleles is very low among Emiratis which correlates with the presence of low frequencies of derived alleles in CYP1A2 gene.	[Al-Ahmad, Mohammad M.; Amir, Naheed; Dhanasekaran, Subramanian; Bastaki, Salim M. A.] UAE Univ, Coll Med & Hlth Sci, Dept Pharmacol, Abu Dhabi, U Arab Emirates; [John, Anne; Ali, Bassam R.] UAE Univ, Coll Med & Hlth Sci, Dept Pathol, Abu Dhabi, U Arab Emirates; [Abdulrazzaq, Yousef M.] UAE Univ, Coll Med & Hlth Sci, Dept Pediat, Abu Dhabi, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University	Bastaki, SMA (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Pharmacol, Abu Dhabi, U Arab Emirates.	sbastaki@uaeu.ac.ae	Abdulrazzaq, Yousef M./G-5069-2017; amir, naheed/AAP-5152-2020	Abdulrazzaq, Yousef M./0000-0001-5853-6578; Ali, Bassam R/0000-0003-1306-6618; Alahmad, Mohammad M./0000-0003-0344-4056	Emirates Foundation for Philanthropy [21M059]; Emirates Foundation; UAEU [21M059]	Emirates Foundation for Philanthropy; Emirates Foundation; UAEU	This study was funded (AAMD/HREC No: 21M059) by the Emirates Foundation for Philanthropy.; We thank the departments of Pharmacology and Pathology lab staff at the United Arab Emirates University for their assistance in this study. We also thank the Emirates Foundation, and UAEU for funding this research (AAMD/HREC No: 21M059).	Abdulrazzaq YM, 1997, CLIN GENET, V51, P167; Afonina I, 1997, NUCLEIC ACIDS RES, V25, P2657, DOI 10.1093/nar/25.13.2657; Aklillu E, 2003, MOL PHARMACOL, V64, P659, DOI 10.1124/mol.64.3.659; Al-Gazali L, 2010, HUM MUTAT, V31, P505, DOI 10.1002/humu.21232; Altayli E, 2009, INT UROL NEPHROL, V41, P259, DOI 10.1007/s11255-008-9444-6; Bilgen T, 2008, RUSS J GENET+, V44, P989, DOI 10.1134/S1022795408080140; Blaszkewicz M, 2004, ANAL HAZARDOUS SUBST, V9; Bolt HM, 2005, ARCH TOXICOL, V79, P196, DOI 10.1007/s00204-004-0622-8; Browning SL, 2010, PHARMACOGENET GENOM, V20, P647, DOI 10.1097/FPC.0b013e32833e90eb; BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003; Chevalier D, 2001, Hum Mutat, V17, P355, DOI 10.1002/humu.49; Chida M, 1999, JPN J CANCER RES, V90, P899, DOI 10.1111/j.1349-7006.1999.tb00832.x; Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135; Ghotbi R, 2007, EUR J CLIN PHARMACOL, V63, P537, DOI 10.1007/s00228-007-0288-2; Grabar PB, 2008, EUR J CLIN PHARMACOL, V64, P871, DOI 10.1007/s00228-008-0498-2; Guengerich FP, 1999, MUTAT RES-FUND MOL M, V428, P115, DOI 10.1016/S1383-5742(99)00039-3; Guessous I, 2012, HUM MOL GENET, V21, P1; Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625; Hamdy SI, 2003, BRIT J CLIN PHARMACO, V55, P321, DOI 10.1046/j.1365-2125.2003.01787.x; Heard-Bay F, 1999, PERSPECTIVES UAE, P254; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Laika B, 2010, PHARMACOGENOMICS J, V10, P20, DOI 10.1038/tpj.2009.32; Lin KM, 2010, PHARMACOGENOMICS, V11, P1535, DOI [10.2217/pgs.10.128, 10.2217/PGS.10.128]; Muscat JE, 2008, BIOCHEM PHARMACOL, V76, P929, DOI 10.1016/j.bcp.2008.07.024; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; NAKAJIMA M, 1994, CANCER EPIDEM BIOMAR, V3, P413; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Obase Y, 2003, CLIN PHARMACOL THER, V73, P468, DOI 10.1016/S0009-9236(03)00013-4; Olkkola KT, 2005, ANESTH ANALG, V100, P1352, DOI 10.1213/01.ANE.0000148123.79437.F9; Popat RA, 2011, EUR J NEUROL, V18, P756, DOI 10.1111/j.1468-1331.2011.03353.x; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qumsieh RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028943; Saruwatari J, 2002, CLIN PHARMACOL THER, V72, P200, DOI 10.1067/mcp.2002.126173; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Spina E, 2007, BASIC CLIN PHARMACOL, V100, P4, DOI 10.1111/j.1742-7843.2007.00017.x; Suzuki H, 2008, CARCINOGENESIS, V29, P1184, DOI 10.1093/carcin/bgn085; TANG BK, 1994, PHARMACOGENETICS, V4, P117, DOI 10.1097/00008571-199406000-00002; Tay JKX, 2007, PROG NEURO-PSYCHOPH, V31, P1297, DOI 10.1016/j.pnpbp.2007.05.013; Tiwari AK, 2005, PHARMACOGENOMICS J, V5, P60, DOI 10.1038/sj.tpj.6500282; Wang B, 2009, CURR MED CHEM, V16, P4066, DOI 10.2174/092986709789378198; Wang ZY, 2015, THER CLIN RISK MANAG, V11, P449, DOI 10.2147/TCRM.S80437; Woolhouse NM, 1997, PHARMACOGENETICS, V7, P73, DOI 10.1097/00008571-199702000-00010; Yilmaz SG, 2017, OMICS, V21, P177, DOI 10.1089/omi.2016.0188; Zhou HJ, 2004, ARCH BIOCHEM BIOPHYS, V422, P23, DOI 10.1016/j.abb.2003.11.019; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302; Zhou SF, 2009, AAPS J, V11, P481, DOI 10.1208/s12248-009-9127-y; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	47	12	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183424	10.1371/journal.pone.0183424	http://dx.doi.org/10.1371/journal.pone.0183424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934216	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900011
J	Anderson, WH; Ha, JW; Couper, DJ; O'Neal, WK; Barr, RG; Bleecker, ER; Carretta, EE; Cooper, CB; Doerschuk, CM; Drummond, MB; Han, MK; Hansel, NN; Kim, V; Kleerup, EC; Martinez, FJ; Rennard, SI; Tashkin, D; Woodruff, PG; Paine, R; Curtis, JL; Kanner, RE				Anderson, Wayne H.; Ha, Jae Wook; Couper, David J.; O'Neal, Wanda K.; Barr, R. Graham; Bleecker, Eugene R.; Carretta, Elizabeth E.; Cooper, Christopher B.; Doerschuk, Claire M.; Drummond, M. Bradley; Han, MeiLan K.; Hansel, Nadia N.; Kim, Victor; Kleerup, Eric C.; Martinez, Fernando J.; Rennard, Stephen I.; Tashkin, Donald; Woodruff, Prescott G.; Paine, Robert, III; Curtis, Jeffrey L.; Kanner, Richard E.		SPIROMICS Res Grp	Variability in objective and subjective measures affects baseline values in studies of patients with COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GEORGES-RESPIRATORY-QUESTIONNAIRE; QUALITY-OF-LIFE; INSPIRATORY CAPACITY; EXERCISE CAPACITY; LUNG-DISEASE; TESTS; SUBPOPULATIONS; ADJUDICATION; EXACERBATION	Rationale Understanding the reliability and repeatability of clinical measurements used in the diagnosis, treatment and monitoring of disease progression is of critical importance across all disciplines of clinical practice and in clinical trials to assess therapeutic efficacy and safety. Objectives Our goal is to understand normal variability for assessing true changes in health status and to more accurately utilize this data to differentiate disease characteristics and outcomes. Methods Our study is the first study designed entirely to establish the repeatability of a large number of instruments utilized for the clinical assessment of COPD in the same subjects over the same period. We utilized SPIROMICS participants (n = 98) that returned to their clinical center within 6 weeks of their baseline visit to repeat complete baseline assessments. Demographics, spirometry, questionnaires, complete blood cell counts (CBC), medical history, and emphysema status by computerized tomography (CT) imaging were obtained. Results Pulmonary function tests (PFTs) were highly repeatable (ICC's >0.9) but the 6 minute walk (6MW) was less so (ICC = 0.79). Among questionnaires, the Saint George's Respiratory Questionnaire (SGRQ) was most repeatable. Self-reported clinical features, such as exacerbation history, and features of chronic bronchitis, often produced kappa values <0.6. Reported age at starting smoking and average number of cigarettes smoked were modestly repeatable (kappa = 0.76 and 0.79). Complete blood counts (CBC) variables produced intraclass correlation coefficients (ICC) values between 0.6 and 0.8. Conclusions PFTs were highly repeatable, while subjective measures and subject recall were more variable. Analyses using features with poor repeatability could lead to misclassification and outcome errors. Hence, care should be taken when interpreting change in clinical features based on measures with low repeatability. Efforts to improve repeatability of key clinical features such as exacerbation history and chronic bronchitis are warranted.	[Anderson, Wayne H.; Doerschuk, Claire M.; Drummond, M. Bradley] Univ North Carolina Chapel Hill, Marsico Lung Inst, Dept Med, Pulm & Crit Care Med, Chapel Hill, NC USA; [Ha, Jae Wook; Couper, David J.] Univ North Carolina Chapel Hill, Dept Biostat, Chapel Hill, NC USA; [O'Neal, Wanda K.; Doerschuk, Claire M.] Univ North Carolina Chapel Hill, Dept Med, Cyst Fibrosis Res Ctr, Marsico Lung Inst, Chapel Hill, NC USA; [Barr, R. Graham] Columbia Univ, Med Ctr, New York, NY USA; [Bleecker, Eugene R.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Carretta, Elizabeth E.] Univ North Carolina Chapel Hill, Dept Biostat, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; [Cooper, Christopher B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Han, MeiLan K.] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Hansel, Nadia N.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Kim, Victor] Temple Univ, Dept Thorac Med & Surg, Sch Med, Philadelphia, PA USA; [Kleerup, Eric C.; Tashkin, Donald] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Martinez, Fernando J.] New York Presbyterian Hosp, Weill Cornell Med Ctr, Weill Cornell Med Coll, Dept Med, New York, NY USA; [Rennard, Stephen I.] Univ Nebraska, Div Pulm & Crit Care Med, Omaha, NE 68182 USA; [Woodruff, Prescott G.] Univ Calif San Francisco, Sch Med, Dept Med, Div Pulm Crit Care Sleep & Allergy, San Francisco, CA USA; [Woodruff, Prescott G.] Univ Calif San Francisco, Sch Med, Cardiovasc Res Inst, San Francisco, CA USA; [Paine, Robert, III; Kanner, Richard E.] Univ Utah, Dept Internal Med, Div Pulm & Crit Care Med, Salt Lake City, UT 84112 USA; [Paine, Robert, III; Kanner, Richard E.] Univ Utah, Dept Vet Affairs Med Ctr, Salt Lake City, UT 84112 USA; [Curtis, Jeffrey L.] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Curtis, Jeffrey L.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA; [Rennard, Stephen I.] AstraZeneca, Early Clin Dev, Innovat Med, Melbourn, Herts, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Columbia University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; NewYork-Presbyterian Hospital; University of Nebraska System; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; AstraZeneca	Anderson, WH (corresponding author), Univ North Carolina Chapel Hill, Marsico Lung Inst, Dept Med, Pulm & Crit Care Med, Chapel Hill, NC USA.	wayne_anderson@med.unc.edu		Drummond, Michael/0000-0002-6968-4610; Couper, David/0000-0002-4313-9235	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C]; Foundation for the NIH from AstraZeneca; Bellerophon Pharmaceuticals; Boehringer-Ingelheim Pharmaceuticals, Inc; Chiesi Farmaceutici SpA; Forest Research Institute, Inc; GSK; Grifols Therapeutics, Inc; Ikaria, Inc; Nycomed GmbH; Takeda Pharmaceutical Company; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals, Inc.; Sanofi; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL137880] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000911] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for the NIH from AstraZeneca; Bellerophon Pharmaceuticals; Boehringer-Ingelheim Pharmaceuticals, Inc(Boehringer Ingelheim); Chiesi Farmaceutici SpA(Chiesi Pharmaceuticals Inc); Forest Research Institute, Inc; GSK(GlaxoSmithKline); Grifols Therapeutics, Inc; Ikaria, Inc; Nycomed GmbH; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Novartis Pharmaceuticals Corporation(Novartis); Regeneron Pharmaceuticals, Inc.(Regeneron); Sanofi; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C), the Foundation for the NIH from AstraZeneca; Bellerophon Pharmaceuticals; Boehringer-Ingelheim Pharmaceuticals, Inc; Chiesi Farmaceutici SpA; Forest Research Institute, Inc; GSK; Grifols Therapeutics, Inc; Ikaria, Inc; Nycomed GmbH; Takeda Pharmaceutical Company; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals, Inc.; and Sanofi. Nonfinancial support for bronchodilators used for testing in the study from Foundation for the NIH, Boehringer Ingelheim and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shair K, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-100; Anderson WH, 2016, AM J RESP CRIT CARE, V193; Brigham J, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1248; Bui MKL, 2017, ANN AM THORAC SOC; Buysse D J, 1989, Psychiatry Res, V28, P193; Calverley PMA, 2013, LANCET RESP MED, V1, P564, DOI 10.1016/S2213-2600(13)70086-9; Celli BR, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-66; Couper D, 2014, THORAX, V69, P491, DOI 10.1136/thoraxjnl-2013-203897; CURTIS JR, 1994, THORAX, V49, P162, DOI 10.1136/thx.49.2.162; Enright PL, 2004, AM J RESP CRIT CARE, V169, P235, DOI 10.1164/rccm.200204-347OC; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Frei A, 2016, CHEST, V150, P860, DOI 10.1016/j.chest.2016.06.031; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Herpel LB, 2006, AM J RESP CRIT CARE, V173, P1106, DOI 10.1164/rccm.200506-975OC; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Jones Paul W, 2005, COPD, V2, P75; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kim V, 2015, ANN AM THORAC SOC, V12, P332, DOI 10.1513/AnnalsATS.201411-518OC; Klooster K, 2015, RESPIRATION, V90, P306, DOI 10.1159/000439056; KNOX AJ, 1988, THORAX, V43, P388, DOI 10.1136/thx.43.5.388; Lange Peter, 2016, Int J Chron Obstruct Pulmon Dis, V11 Spec Iss, P3, DOI 10.2147/COPD.S85976; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Puhan MA, 2011, EUR RESPIR J, V37, P784, DOI 10.1183/09031936.00063810; Puhan MA, 2007, RESP MED, V101, P308, DOI 10.1016/j.rmed.2006.04.023; Ramon MA, 2016, RESPIROLOGY, V21, P476, DOI 10.1111/resp.12723; Rennard Stephen I, 2008, Proc Am Thorac Soc, V5, P878, DOI 10.1513/pats.200804-035QC; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Salzman SH, 2012, RESP CARE, V57, P50, DOI 10.4187/respcare.01585; Tantucci C, 2012, INT J CHRONIC OBSTR, V7, P95, DOI 10.2147/COPD.S27480; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vogelmeier C., 2015, GLOBAL STRATEGY DIAG, V2015; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yan S, 1997, AM J RESP CRIT CARE, V156, P55, DOI 10.1164/ajrccm.156.1.9608113; Zhang Y, 2013, RESP CARE, V58, P1923, DOI 10.4187/respcare.01927	37	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184606	10.1371/journal.pone.0184606	http://dx.doi.org/10.1371/journal.pone.0184606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934249	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900035
J	Mahasa, KJ; Eladdadi, A; de Pillis, L; Ouifki, R				Mahasa, Khaphetsi Joseph; Eladdadi, Amina; de Pillis, Lisette; Ouifki, Rachid			Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; NEWCASTLE-DISEASE-VIRUS; SELECTIVE REPLICATION; ANTITUMOR IMMUNITY; CANCER-TREATMENT; CELLS; IMMUNOTHERAPY; INNATE; SUPPRESSION; ADENOVIRUS	In the present paper, we address by means of mathematical modeling the following main question: How can oncolytic virus infection of some normal cells in the vicinity of tumor cells enhance oncolytic virotherapy? We formulate a mathematical model describing the interactions between the oncolytic virus, the tumor cells, the normal cells, and the antitumoral and antiviral immune responses. The model consists of a system of delay differential equations with one (discrete) delay. We derive the model's basic reproductive number within tumor and normal cell populations and use their ratio as a metric for virus tumor-specificity. Numerical simulations are performed for different values of the basic reproduction numbers and their ratios to investigate potential trade-offs between tumor reduction and normal cells losses. A fundamental feature unravelled by the model simulations is its great sensitivity to parameters that account for most variation in the early or late stages of oncolytic virotherapy. From a clinical point of view, our findings indicate that designing an oncolytic virus that is not 100% tumor-specific can increase virus particles, which in turn, can further infect tumor cells. Moreover, our findings indicate that when infected tissues can be regenerated, oncolytic viral infection of normal cells could improve cancer treatment.	[Mahasa, Khaphetsi Joseph] Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, Stellenbosch, South Africa; [Eladdadi, Amina] Coll St Rose, Albany, NY USA; [de Pillis, Lisette] Harvey Mudd Coll, Claremont, CA 91711 USA; [Ouifki, Rachid] Univ Pretoria, Dept Math & Appl Math, Pretoria, South Africa	National Research Foundation - South Africa; Stellenbosch University; Claremont Colleges; Harvey Mudd College; University of Pretoria	Mahasa, KJ (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, Stellenbosch, South Africa.	mahasa@aims.ac.za	Ouifki, Rachid/A-4064-2017	Ouifki, Rachid/0000-0001-7697-1792; dePillis, Lisette/0000-0002-9839-3636; Mahasa, Khaphetsi Joseph/0000-0003-0017-3780	Society for Mathematical Biology (SMB)	Society for Mathematical Biology (SMB)	We thank Prof. Peter Hinow and the anonymous referee for their helpful comments and suggestions that helped in the revision of this paper. KJ Mahasa would like to acknowledge and thank the Society for Mathematical Biology (SMB) for granting him the SMB Landahl-Busenberg Award to present this research at the SMB2017 annual meeting in Salt Lake City in Utah, USA.	Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; Alkayyal AA, 2016, J TAIBAH UNIV MED SC, V11, P187, DOI 10.1016/j.jtumed.2016.04.002; Alvarez-Breckenridge CA, 2015, CURR OPIN VIROL, V13, P25, DOI 10.1016/j.coviro.2015.03.015; Baba A. I., 2007, COMP ONCOLOGY, P119; Bajzer Z, 2008, J THEOR BIOL, V252, P109, DOI 10.1016/j.jtbi.2008.01.016; Bridle BW, 2010, MOL THER, V18, P1430, DOI 10.1038/mt.2010.98; Bridle BW, 2009, MOL THER, V17, P1814, DOI 10.1038/mt.2009.154; Carolan LA, 2016, J VIROL, V90, P2838, DOI 10.1128/JVI.02797-15; Cassady KA, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020043; Chang W, 2003, ANAL IMMUNOTHERAPY C; Chiocca EA, 2014, CANCER IMMUNOL RES, V2, P295, DOI 10.1158/2326-6066.CIR-14-0015; Crittenden MR, 2005, IMMUNOLOGY, V114, P11, DOI 10.1111/j.1365-2567.2004.02001.x; Crivelli JJ, 2012, J BIOL DYNAM, V6, P104, DOI 10.1080/17513758.2011.613486; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; de Pillis LG, 2003, COMPUTATIONAL FLUID AND SOLID MECHANICS 2003, VOLS 1 AND 2, PROCEEDINGS, P1661; de Pillis L, 2013, DISCRETE CONT DYN-B, V18, P915, DOI 10.3934/dcdsb.2013.18.915; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233; Downs-Canner S, 2016, MOL THER, V24, P1492, DOI 10.1038/mt.2016.101; Eftimie R, 2016, B MATH BIOL, V78, P2091, DOI 10.1007/s11538-016-0214-9; Eftimie R, 2011, B MATH BIOL, V73, P2932, DOI 10.1007/s11538-011-9653-5; Eftimie R, 2011, B MATH BIOL, V73, P2, DOI 10.1007/s11538-010-9526-3; El-Shemi AG, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0353-8; Enderling H, 2014, CURR PHARM DESIGN, V20, P4934; Fiola C, 2006, INT J CANCER, V119, P328, DOI 10.1002/ijc.21821; Friedman A, 2006, CANCER RES, V66, P2314, DOI 10.1158/0008-5472.CAN-05-2661; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Greiner J, 2006, BLOOD, V108, P4109, DOI 10.1182/blood-2006-01-023127; Guo ZS, 2008, BBA-REV CANCER, V1785, P217, DOI 10.1016/j.bbcan.2008.02.001; Hastie E, 2012, J GEN VIROL, V93, P2529, DOI 10.1099/vir.0.046672-0; Hoeller C, 2016, CANCER IMMUNOL IMMUN, V65, P1015, DOI 10.1007/s00262-016-1860-3; Jha BK, 2013, MOL THER, V21, P1749, DOI 10.1038/mt.2013.112; Kaufman HL, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-11; Kim PS, 2015, MATH BIOSCI ENG, V12, P841, DOI 10.3934/mbe.2015.12.841; Kirschner D, 1998, J MATH BIOL, V37, P235, DOI 10.1007/s002850050127; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Ku-Carrillo RA, 2016, APPL MATH MODEL, V40, P4908, DOI 10.1016/j.apm.2015.12.018; Kwon OJ, 2011, J CONTROL RELEASE, V155, P317, DOI 10.1016/j.jconrel.2011.06.014; Lemay CG, 2012, MOL THER, V20, P1791, DOI 10.1038/mt.2012.128; Leveille S, 2011, J VIROL, V85, P12160, DOI 10.1128/JVI.05703-11; Lichty BD, 2004, HUM GENE THER, V15, P821, DOI 10.1089/1043034041839208; Macnamara C, 2015, J THEOR BIOL, V377, P1, DOI 10.1016/j.jtbi.2015.04.004; Marchini A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010009; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Matveeva OV, 2015, MOL THER-ONCOLYTICS, V2, DOI 10.1038/mto.2015.17; Melen GJ, 2016, CANCER LETT, V371, P161, DOI 10.1016/j.canlet.2015.11.036; Miller AC, 2014, VIRUS ADAPT TREAT, V6, P11; Msaouel P, 2012, CURR PHARM BIOTECHNO, V13, P1732, DOI 10.2174/138920112800958896; Msaouel P, 2009, CURR OPIN MOL THER, V11, P43; Okamoto KW, 2014, J THEOR BIOL, V358, P166, DOI 10.1016/j.jtbi.2014.04.030; Paiva LR, 2009, CANCER RES, V69, P1205, DOI 10.1158/0008-5472.CAN-08-2173; Parato KA, 2012, MOL THER, V20, P749, DOI 10.1038/mt.2011.276; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Ribacka C, 2008, CURR GENE THER, V8, P88, DOI 10.2174/156652308784049372; Rommelfanger DM, 2012, GENE THER, V19, P543, DOI 10.1038/gt.2011.132; Ruf B, 2015, MOL THER-ONCOLYTICS, V2, DOI 10.1038/mto.2015.18; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Smith TT, 2014, ONCOLYTIC VIROTHER, V3, P21, DOI 10.2147/OV.S52749; Tollefson AE, 1996, J VIROL, V70, P2296, DOI 10.1128/JVI.70.4.2296-2306.1996; Tong AW, 2012, CURR PHARM BIOTECHNO, V13, P1750; Turnbull S, 2015, VIRUSES-BASEL, V7, P6291, DOI 10.3390/v7122938; Vaha-Koskela M, 2014, BIOMEDICINES, V2, P163, DOI 10.3390/biomedicines2020163; Wein LM, 2003, CANCER RES, V63, P1317; Wiesel M, 2009, APMIS, V117, P356, DOI 10.1111/j.1600-0463.2009.02459.x; Willmon C, 2009, MOL THER, V17, P1667, DOI 10.1038/mt.2009.194; Wodarz D, 2001, CANCER RES, V61, P3501; Wodarz D, 2014, J VIROL, V88, P13240, DOI 10.1128/JVI.02096-14; Wodarz D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004271; Woller N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00188; Wollmann G, 2010, J VIROL, V84, P1563, DOI 10.1128/JVI.02040-09; Workenhe ST, 2015, FUTURE ONCOL, V11, P675, DOI 10.2217/fon.14.254; Workenhe ST, 2014, MOL THER, V22, P251, DOI 10.1038/mt.2013.220; Wu JT, 2001, B MATH BIOL, V63, P731, DOI 10.1006/bulm.2001.0245; Yarbro CH, 2011, CANC NURSING	74	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184347	10.1371/journal.pone.0184347	http://dx.doi.org/10.1371/journal.pone.0184347			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934210	gold, Green Published			2022-12-27	WOS:000411339900026
J	Qian, C; Wong, CWY; Wu, ZL; He, QM; Xia, HM; Tam, PKH; Wong, KKY; Lui, VCH				Qian, Chen; Wong, Carol Wing Yan; Wu, Zhongluan; He, Qiuming; Xia, Huimin; Tam, Paul Kwong Hang; Wong, Kenneth Kak Yuen; Lui, Vincent Chi Hang			Stage specific requirement of platelet-derived growth factor receptor-alpha in embryonic development	PLOS ONE			English	Article							PROTEASE-ACTIVATED LIGAND; CARDIAC NEURAL CREST; PDGF BETA-RECEPTOR; CRANIOFACIAL MUSCLES; CELL-DEVELOPMENT; DEFICIENT MICE; MOUSE EMBRYO; TUBE DEFECTS; EVOLUTION; MORPHOGENESIS	Background Platelet-derived growth factor receptor alpha (PDGFR alpha) is a cell-surface receptor tyrosine kinase for platelet-derived growth factors. Correct timing and level of Pdgfra expression is crucial for embryo development, and deletion of Pdgfra caused developmental defects of multiple endoderm and mesoderm derived structures, resulting in a complex phenotypes including orofacial cleft, spina bifida, rib deformities, and omphalocele in mice. However, it is not clear if deletion of Pdgfra at different embryonic stages differentially affects these structures. Purpose To address the temporal requirement of Pdgfra in embryonic development. Methods We have deleted the Pdgfra in Pdgfra-expressing tissues at different embryonic stages in mice, examined and quantified the developmental anomalies. Results Current study showed that (i) conditional deletion of Pdgfra at different embryonic days (between E7.5 and E10.5) resulted in orofacial cleft, spina bifida, rib cage deformities, and omphalocele, and (ii) the day of Pdgfra deletion influenced the combinations, incidence and severities of these anomalies. Deletion of Pdgfra caused apoptosis of Pdgfra-expressing tissues, and developmental defects of their derivatives. Conclusion Orofacial cleft, spina bifida and omphalocele are among the commonest skeletal and abdominal wall defects of newborns, but their genetic etiologies are largely unknown. The remarkable resemblance of our conditional Pdgfra knockout embryos to theses human congenital anomalies, suggesting that dysregulated PDGFRA expression could cause these anomalies in human. Future work should aim at defining (a) the regulatory elements for the expression of the human PDGFRA during embryonic development, and (b) if mutations / sequence variations of these regulatory elements cause these anomalies.	[Qian, Chen; Wong, Carol Wing Yan; Wu, Zhongluan; Tam, Paul Kwong Hang; Wong, Kenneth Kak Yuen; Lui, Vincent Chi Hang] Univ Hong Kong, Dept Surg, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [He, Qiuming; Xia, Huimin] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Pediat Surg, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; Guangzhou Medical University	Lui, VCH (corresponding author), Univ Hong Kong, Dept Surg, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	vchlui@hku.hk	Wong, Kenneth K. Y./B-9920-2008; /C-4359-2009	/0000-0002-1758-8854	Health and Medical Research Fund, HKSAR [02132306]; Seed Fund for Basic Research, HKU [201411159117]	Health and Medical Research Fund, HKSAR; Seed Fund for Basic Research, HKU	This work is partly supported by the Health and Medical Research Fund, HKSAR (Project No.: 02132306) and Seed Fund for Basic Research, HKU (Project No.: 201411159117) to VCHL.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Au KS, 2005, AM J MED GENET A, V139A, P194, DOI 10.1002/ajmg.a.31002; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bleyl SB, 2007, EUR J HUM GENET, V15, P950, DOI 10.1038/sj.ejhg.5201872; Bleyl SB, 2010, HUM MOL GENET, V19, P1286, DOI 10.1093/hmg/ddq005; Bostrom H, 2002, DEV DYNAM, V223, P155, DOI 10.1002/dvdy.1225.abs; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Bronner ME, 2012, DEV BIOL, V366, P1, DOI 10.1016/j.ydbio.2012.03.011; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Carter TC, 2011, AM J MED GENET A, V155A, P14, DOI 10.1002/ajmg.a.33755; Chan WY, 2004, DEVELOPMENT, V131, P3367, DOI 10.1242/dev.01197; COULY GF, 1992, DEVELOPMENT, V114, P1; Fan Q, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002402; HEIDARAN MA, 1991, J BIOL CHEM, V266, P20232; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Joosten PHLJ, 2002, BBA-MOL BASIS DIS, V1588, P254, DOI 10.1016/S0925-4439(02)00175-8; Joosten PHLJ, 2001, NAT GENET, V27, P215, DOI 10.1038/84867; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karlsson L, 2000, DEVELOPMENT, V127, P3457; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; KOHLER N, 1974, EXP CELL RES, V87, P297, DOI 10.1016/0014-4827(74)90484-4; Kontges G, 1996, DEVELOPMENT, V122, P3229; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Le Douarin NM, 2012, CURR OPIN GENET DEV, V22, P381, DOI 10.1016/j.gde.2012.06.001; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; Rattanasopha S, 2012, EUR J HUM GENET, V20, P1058, DOI 10.1038/ejhg.2012.55; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; Saga Y, 1999, DEVELOPMENT, V126, P3437; Sambasivan R, 2011, DEVELOPMENT, V138, P2401, DOI 10.1242/dev.040972; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Sauka-Spengler T, 2006, CURR OPIN GENET DEV, V16, P360, DOI 10.1016/j.gde.2006.06.006; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; Soriano P, 1997, DEVELOPMENT, V124, P2691; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; WESTERMARK B, 1976, EXP CELL RES, V98, P170, DOI 10.1016/0014-4827(76)90476-6; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Zhu FP, 2004, MOL GENET METAB, V81, P127, DOI 10.1016/j.ymgme.2003.11.003	47	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184473	10.1371/journal.pone.0184473	http://dx.doi.org/10.1371/journal.pone.0184473			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934221	Green Submitted, gold, Green Published			2022-12-27	WOS:000411339900030
J	Schlichting, D; Sommerfeld, C; Muller-Graf, C; Selhorst, T; Greiner, M; Gerofke, A; Ulbig, E; Gremse, C; Spolders, M; Schafft, H; Lahrssen-Wiederholt, M				Schlichting, Daniela; Sommerfeld, Christine; Mueller-Graf, Christine; Selhorst, Thomas; Greiner, Matthias; Gerofke, Antje; Ulbig, Ellen; Gremse, Carl; Spolders, Markus; Schafft, Helmut; Lahrssen-Wiederholt, Monika			Copper and zinc content in wild game shot with lead or non-lead ammunition - implications for consumer health protection	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; RED DEER; RIFLE BULLETS; HEAVY-METALS; ROE DEER; MEAT; TISSUES; MUSCLE; BOAR; SPECTROMETRY	The aim of this study was to examine the contamination of game meat with copper and zinc and establish whether the use of alternative (non-lead) ammunition can lead to higher or unsafe levels of copper and zinc in the meat of roe deer, wild boar and red deer. The research project "Safety of game meat obtained through hunting" (LEMISI) was conducted in Germany with the purpose of examining the entry of lead as well as copper and zinc into the meat of hunted game when using either lead or non-lead ammunition. The outcome of this study shows that the usage of both lead-based ammunition and alternative non-lead ammunition results in the entry of copper and zinc into the edible parts of the game. Using non-lead ammunition does not entail dangerously elevated levels of copper and zinc, so replacing lead ammunition with alternative ammunition does not introduce a further health problem with regard to these metals. The levels of copper and zinc in game meat found in this study are in the range found in previous studies of game. The content of copper and zinc in game meat is also comparable to those regularly detected in meat and its products from livestock (pig, cattle, sheep) for which the mean human consumption rate is much higher. From the viewpoint of consumer health protection, the use of non-lead ammunition does not pose an additional hazard through copper and zinc contamination. A health risk due to the presence of copper and zinc in game meat at typical levels of consumer exposure is unlikely for both types of ammunition.	[Schlichting, Daniela; Sommerfeld, Christine; Mueller-Graf, Christine; Selhorst, Thomas; Greiner, Matthias; Gerofke, Antje; Ulbig, Ellen; Gremse, Carl; Spolders, Markus; Schafft, Helmut; Lahrssen-Wiederholt, Monika] German Fed Inst Risk Assessment, Berlin, Germany	Federal Institute for Risk Assessment	Schlichting, D (corresponding author), German Fed Inst Risk Assessment, Berlin, Germany.	Daniela.Schlichting@bfr.bund.de	; Greiner, Matthias/D-2812-2013	Gremse, Carl/0000-0002-9936-4255; Greiner, Matthias/0000-0003-4974-5970; Gerofke, Antje/0000-0001-6270-3869; Muller-Graf, Christine/0000-0002-0122-7528	Federal Ministry of Food and Agriculture (BMEL) in Germany; European Poultry, Egg and Game Association (EPEGA); Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)	Federal Ministry of Food and Agriculture (BMEL) in Germany; European Poultry, Egg and Game Association (EPEGA); Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)	The study was supported mainly by the Federal Ministry of Food and Agriculture (BMEL) in Germany (http://www.bmel.de) but also by the listed Lander (Mecklenburg-Western Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hesse, North Rhine-Westphalia, Hamburg and Bremen) and organisms (European Poultry, Egg and Game Association (EPEGA), Deutscher Jagdverband e.V. (DJV, German Hunting Association), Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association), Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters), Verband der Hersteller von Jagd-, Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition), Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)). A lot of people helped obtaining the data: the hunters, game traders and others, but were not employed or contracted to do so. The funders had no active role in study design, analysis, decision to publish or preparation of the manuscript.; We would like to express our thanks for the support and funding provided by the Federal Ministry of Food and Agriculture (BMEL) in Germany (http://www.bmel.de) but also by the listed Lander (Mecklenburg-Western Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hesse, North Rhine-Westphalia, Hamburg and Bremen) and organisms (European Poultry, Egg and Game Association (EPEGA), Deutscher Jagdverband e.V. (DJV, German Hunting Association), Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association), Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters), Verband der Hersteller von Jagd-, Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition), Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)). A lot of people helped obtaining the data: the hunters, game traders and others, but were not employed or contracted to do so. The funders had no active role in study design, analysis, decision to publish or preparation of the manuscript. A lot of people were involved in this project and we would like to thank them for their valuable contributions, especially Dr. Niels Bandick.	Amici A, 2012, ITAL J ANIM SCI, V11, DOI 10.4081/ijas.2012.e65; Bilandzic N, 2012, FOOD CONTROL, V27, P284, DOI 10.1016/j.foodcont.2012.03.020; Borges DLG, 2006, GRAPHITE FURNACE ATO; Chen JR, 2001, ANAL CHIM ACTA, V450, P215, DOI 10.1016/S0003-2670(01)01367-8; Dannenberger D, 2013, MEAT SCI, V94, P39, DOI 10.1016/j.meatsci.2012.12.010; Garcia MHD, 2011, J ENVIRON SCI HEAL A, V46, P109, DOI 10.1080/10934529.2011.532422; EFSA (European Food Safety Authority), 2014, EFSA J, V12, P3870; Ertl K, 2016, FOOD ADDIT CONTAM B, V9, P120, DOI 10.1080/19393210.2016.1151464; FALANDYSZ J, 1994, SCI TOTAL ENVIRON, V141, P59, DOI 10.1016/0048-9697(94)90018-3; Falandysz J, 2005, FOOD ADDIT CONTAM A, V22, P141, DOI 10.1080/02652030500047273; Federal Office of Consumer Protection and Food Safety (BVL), 2015, FED OFF CONS PROT FO; Federal Office of Consumer Protection and Food Safety (BVL), 2011, FED OFF CONS PROT FO; Federal Office of Consumer Protection and Food Safety (BVL), 2008, FED OFF CONS PROT FO; Federal Office of Consumer Protection and Food Safety (BVL), 2013, FED OFF CONS PROT FO; Federal Office of Consumer Protection and Food Safety (BVL), 2001, LEB MON 2001; Gasparik J, 2004, J ENVIRON SCI HEAL A, V39, P2105, DOI 10.1081/ESE-120039378; Gasparik J, 2012, J ENVIRON SCI HEAL A, V47, P1212, DOI 10.1080/10934529.2012.672065; German Federal Institute for Risk Assessment (BfR), 2014, RES PROJ SAF GAM MEA; Haldimann M, 2002, EUR FOOD RES TECHNOL, V215, P375, DOI 10.1007/s00217-002-0581-3; Hofbauer P, 2011, GAME MEAT HYGIENE IN FOCUS: MICROBIOLOGY, EPIDEMIOLOGY, RISK ANALYSIS AND QUALITY ASSURANCE, P273; Hou X., 2006, INDUCTIVELY COUPLED; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Irschik I, 2014, COMPOSITION BULLETS, P363; Irschik I, 2013, EUR J WILDLIFE RES, V59, P129, DOI 10.1007/s10344-012-0656-9; Jarzynska G, 2011, ENVIRON INT, V37, P882, DOI 10.1016/j.envint.2011.02.017; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Lahrssen-Wiederhott M, 2015, FLEISCHWIRTSCHAFT, V95, P99; Lazarus M, 2008, FOOD ADDIT CONTAM A, V25, P270, DOI 10.1080/02652030701364923; Muller-Graf C, 2017, GAME MEAT HYGIENE: FOOD SAFETY AND SECURITY, P201, DOI 10.3920/978-90-8686-840-7_12; Muthers S, 2010, METEOROL Z, V19, P641, DOI 10.1127/0941-2948/2010/0485; Nardi EP, 2009, FOOD CHEM, V112, P727, DOI 10.1016/j.foodchem.2008.06.010; Paulsen P, 2015, J FOOD SAF FOOD QUAL, V66, P128, DOI 10.2376/0003-925X-66-128; R-Core-Team, 2015, LANG ENV STAT COMP; Roslewska A, 2012, J ELEMENTOL, DOI DOI 10.5601/JELEM.2015.20.943; Sachs L, 2009, ENCY MEASUREMENT STA, V3, P103; Sager M., 2005, Ernahrung, V29, P199; Scientific Committee on Food, 2006, TOL UPP INT LEV VIT; STRMISKOVA G, 1992, NAHRUNG, V36, P307, DOI 10.1002/food.19920360316; Morales JSV, 2011, FOOD ADDIT CONTAM A, V28, P1021, DOI 10.1080/19440049.2011.583282; Volk F, 2012, LEBENSMITTELHYGIENIS	41	15	15	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184946	10.1371/journal.pone.0184946	http://dx.doi.org/10.1371/journal.pone.0184946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934259	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900061
J	Tumiotto, C; Riviere, L; Bellecave, P; Recordon-Pinson, P; Vilain-Parce, A; Guidicelli, GL; Fleury, H				Tumiotto, Camille; Riviere, Lionel; Bellecave, Pantxika; Recordon-Pinson, Patricia; Vilain-Parce, Alice; Guidicelli, Gwenda-Line; Fleury, Herve		Provir Latitude 45 Collaborating	Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA	PLOS ONE			English	Article							CLASS-I; RESISTANCE MUTATIONS; NEURAL-NETWORKS; RESERVOIR; THERAPY; SIZE; CURE	One of the strategies for curing viral HIV-1 is a therapeutic vaccine involving the stimulation of cytotoxic CD8-positive T cells (CTL) that are Human Leucocyte Antigen (HLA)-restricted. The lack of efficiency of previous vaccination strategies may have been due to the immunogenic peptides used, which could be different from a patient's virus epitopes and lead to a poor CTL response. To counteract this lack of specificity, conserved epitopes must be targeted. One alternative is to gather as many data as possible from a large number of patients on their HIV-1 proviral archived epitope variants, taking into account their genetic background to select the best presented CTL epitopes. In order to process big data generated by Next-Generation Sequencing (NGS) of the DNA of HIV-infected patients, we have developed a software package called TutuGenetics. This tool combines an alignment derived either from Sanger or NGS files, HLA typing, target gene and a CTL epitope list as input files. It allows automatic translation after correction of the alignment obtained between the HxB2 reference and the reads, followed by automatic calculation of the MHC IC50 value for each epitope variant and the HLA allele of the patient by using NetMHCpan 3.0, resulting in a csv file as output result. We validated this new tool by comparing Sanger and NGS (454, Roche) sequences obtained from the proviral DNA of patients at success of ART included in the Provir Latitude 45 study and showed a 90% correlation between the quantitative results of NGS and Sanger. This automated analysis combined with complementary samples should yield more data regarding the archived CTL epitopes according to the patients' HLA alleles and will be useful for screening epitopes that in theory are presented efficiently to the HLA groove, thus constituting promising immunogenic peptides for a therapeutic vaccine.	[Tumiotto, Camille; Riviere, Lionel; Bellecave, Pantxika; Recordon-Pinson, Patricia; Vilain-Parce, Alice; Fleury, Herve] CHU Bordeaux, Lab Virol, Bordeaux, France; [Tumiotto, Camille; Riviere, Lionel; Bellecave, Pantxika; Recordon-Pinson, Patricia; Vilain-Parce, Alice; Fleury, Herve] CNRS, UMR 5234, Bordeaux, France; [Guidicelli, Gwenda-Line] CHU Bordeaux, Lab Immunol, Bordeaux, France	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Fleury, H (corresponding author), CHU Bordeaux, Lab Virol, Bordeaux, France.; Fleury, H (corresponding author), CNRS, UMR 5234, Bordeaux, France.	herve.fleury@u-bordeaux.fr	Recordon-Pinson, Patricia/AAV-1295-2021; Tumiotto, Camille/AAD-5003-2022; Tumiotto, Camille/V-5960-2019	Recordon-Pinson, Patricia/0000-0001-6002-0941; 	Merck Avenir [DS-2016-0005]	Merck Avenir	This study has been funded by Merck company, GERMATAN, and is now funded by Merck Avenir (ref DS-2016-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Barton K, 2016, TRENDS MICROBIOL, V24, P345, DOI 10.1016/j.tim.2016.01.006; Bellecave P, 2016, AIDS RES HUM RETROV, V32, P85, DOI [10.1089/aid.2015.0201, 10.1089/AID.2015.0201]; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deng K, 2015, NATURE; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Llano A, 2013, HIV MOL IMMUNOLOGY, V2013; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Papuchon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100452; Papuchon J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069029; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Rask TS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1032-7; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Vandrovcova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100475	24	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185211	10.1371/journal.pone.0185211	http://dx.doi.org/10.1371/journal.pone.0185211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934310	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900126
J	Boot, A; Oosting, J; van Eendenburg, JDH; Kuppen, PJK; Morreau, H; van Wezel, T				Boot, Arnoud; Oosting, Jan; van Eendenburg, Jaap D. H.; Kuppen, Peter J. K.; Morreau, Hans; van Wezel, Tom			Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines	PLOS ONE			English	Article							DNA METHYLATION; COLON-CANCER; EXPRESSION; PHENOTYPE; GENOME	Genetic and epigenetic alterations mark colorectal cancer (CRC). Global hypomethylation is observed in nearly all CRC, but a distinct subset of CRC show the CpG Island Methylator Phenotype (CIMP). These tumors show DNA hypermethylation of a specific subset of CpG islands, resulting in transcriptional downregulation of nearby genes. Recently we reported the establishment of novel CRC cell lines derived from primary and metastatic CRC tissues. In this study we describe the DNA methylation profiling of these low passage CRC cell lines. We generated global DNA methylation profiles with Infinium HumanMethylation450 Bead-Chips and analysed them in conjunction with matching gene expression profiles. Multidimensional scaling of the DNA methylation and gene expression datasets showed that BRAF mutated cell lines form a distinct group. In this group we investigated the 706 loci which we have previously identified to be hypermethylated in BRAF mutant CRC. We validated the significant findings in the The Cancer Genome Atlas colon adenocarcinoma data-set. Our analysis identified ELOVL5, FAM127B, MTERF1, ZNF606 to be subject to transcriptional downregulation through DNA hypermethylation in CRC. We further investigated ELOVL5 with qPCR and immunohistochemical staining, validating our results, but did not find a clear relation between ELOVL5 expression and tumor stage or relapse free survival. ELOVL5, FAM127B, MTERF1, ZNF606 are involved in important cellular processes such as apoptosis, lipogenesis and the downstream transcriptional effect of the MAPK-pathway. We have identified a DNA methylation profile regulating key cellular processes in CRC, resulting in a growth advantage to the tumor cells.	[Boot, Arnoud; Oosting, Jan; van Eendenburg, Jaap D. H.; Morreau, Hans; van Wezel, Tom] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Kuppen, Peter J. K.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Wezel, T (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	t.van_wezel@lumc.nl	Kuppen, Peter/J-2342-2016; van Wezel, Tom/Z-3092-2019; van Wezel, Tom/AAL-5626-2021	Kuppen, Peter/0000-0002-0294-3251; van Wezel, Tom/0000-0001-5773-7730; Boot, Arnoud/0000-0002-7717-7416	EUROTRANS-BIO project FAST-SEQ	EUROTRANS-BIO project FAST-SEQ	This work was supported by the EUROTRANS-BIO project FAST-SEQ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng YW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0254-7; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dihal AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079898; Fang MG, 2014, MOL CELL, V55, P904, DOI 10.1016/j.molcel.2014.08.010; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Kaneda A, 2011, CANCER SCI, V102, P18, DOI 10.1111/j.1349-7006.2010.01712.x; Law AYS, 2008, EXP CELL RES, V314, P1823, DOI 10.1016/j.yexcr.2008.03.001; Lee DW, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0106-0; Maximov V, 2002, MED HYPOTHESES, V59, P670, DOI 10.1016/S0306-9877(02)00223-2; Mitchell SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-54; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ni C, 2015, CANCER LETT, V356, P579, DOI 10.1016/j.canlet.2014.10.002; Ou Y, 2005, BIOCHEM BIOPH RES CO, V333, P1034, DOI 10.1016/j.bbrc.2005.05.192; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Schalkwyk LC, 2013, BMC GENOMICS, V14, P293; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Serra RW, 2014, ELIFE, V3, DOI 10.7554/eLife.02313; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shikama A, 2015, BIOCH BIOPHYS RES CO; Shin G, 2011, CANCER INFORM, V10, P149, DOI 10.4137/CIN.S7226; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Terzioglu M, 2013, CELL METAB, V17, P618, DOI 10.1016/j.cmet.2013.03.006; van Roon EH, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-2; Voorneveld PW, 2017, GASTROENTEROLOGY; Zaytseva YY, 2014, CARCINOGENESIS, V35, P1341, DOI 10.1093/carcin/bgu042; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	32	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184900	10.1371/journal.pone.0184900	http://dx.doi.org/10.1371/journal.pone.0184900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931069	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700041
J	Conte-Grand, C; Britz, R; Dahanukar, N; Raghavan, R; Pethiyagoda, R; Tan, HH; Hadiaty, RK; Yaakob, NS; Ruber, L				Conte-Grand, Cecilia; Britz, Ralf; Dahanukar, Neelesh; Raghavan, Rajeev; Pethiyagoda, Rohan; Tan, Heok Hui; Hadiaty, Renny K.; Yaakob, Norsham S.; Ruber, Lukas			Barcoding snakeheads (Teleostei, Channidae) revisited: Discovering greater species diversity and resolving perpetuated taxonomic confusions	PLOS ONE			English	Article							FRESH-WATER FISHES; SINGLE-LOCUS DATA; PHYLOGENETIC ANALYSES; SEQUENCE DATA; DATA SETS; DELIMITATION; MODELS; RARITY; GMYC	Snakehead fishes of the family Channidae are predatory freshwater teleosts from Africa and Asia comprising 38 valid species. Snakeheads are important food fishes (aquaculture, live food trade) and have been introduced widely with several species becoming highly invasive. A channid barcode library was recently assembled by Serrao and co-workers to better detect and identify potential and established invasive snakehead species outside their native range. Comparing our own recent phylogenetic results of this taxonomically confusing group with those previously reported revealed several inconsistencies that prompted us to expand and improve on previous studies. By generating 343 novel snakehead coxI sequences and combining them with an additional 434 coxI sequences from GenBank we highlight several problems with previous efforts towards the assembly of a snakehead reference barcode library. We found that 16.3% of the channid coxI sequences deposited in GenBank are based on misidentifications. With the inclusion of our own data we were, however, able to solve these cases of perpetuated taxonomic confusion. Different species delimitation approaches we employed (BIN, GMYC, and PTP) were congruent in suggesting a potentially much higher species diversity within snakeheads than currently recognized. In total, 90 BINs were recovered and within a total of 15 currently recognized species multiple BINs were identified. This higher species diversity is mostly due to either the incorporation of undescribed, narrow range, endemics from the Eastern Himalaya biodiversity hotspot or the incorporation of several widespread species characterized by deep genetic splits between geographically well-defined lineages. In the latter case, over-lumping in the past has deflated the actual species numbers. Further integrative approaches are clearly needed for providing a better taxonomic understanding of snakehead diversity, new species descriptions and taxonomic revisions of the group.	[Conte-Grand, Cecilia; Ruber, Lukas] Naturhistor Museum Burgergemeinde Bern, Bern, Switzerland; [Britz, Ralf] Nat Hist Museum, Dept Nat Hist Museum, London, England; [Dahanukar, Neelesh] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Dahanukar, Neelesh] Zoo Outreach Org, Syst Ecol & Conservat Lab, Coimbatore, Tamil Nadu, India; [Raghavan, Rajeev] Kerala Univ Fisheries & Ocean Studies, Dept Fisheries Resource Management, Kochi, Kerala, India; [Pethiyagoda, Rohan] Australian Museum, Ichthyol Sect, Sydney, NSW, Australia; [Tan, Heok Hui] Natl Univ Singapore, Lee Kong Chian Nat Hist Museum, Singapore, Singapore; [Hadiaty, Renny K.] Indonesian Inst Sci, Res Ctr Biol, Museum Zool Bogoriense, Cibinong, Indonesia; [Yaakob, Norsham S.] Forest Res Inst Malaysia, Kuala Lumpur, Malaysia; [Ruber, Lukas] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	Natural History Museum London; Indian Institute of Science Education & Research (IISER) Pune; Kerala University of Fisheries & Ocean Studies; Australian Museum; National University of Singapore; Bogor Zoology Museum; Indonesian Institute of Sciences; Institute Penyelidikan Perhutanan Malaysia; University of Bern	Ruber, L (corresponding author), Naturhistor Museum Burgergemeinde Bern, Bern, Switzerland.	lukas.ruber@nmbe.ch	Raghavan, Rajeev/ABD-8719-2021; Dahanukar, Neelesh/B-2816-2012; Rüber, Lukas/D-5436-2013	Dahanukar, Neelesh/0000-0001-7162-9023; Rüber, Lukas/0000-0003-0125-008X; Pethiyagoda, Rohan/0000-0001-7215-9617	Mohammed Bin Zayed Species Conservation Fund [1225670]; North of England Zoological Society-Chester Zoo; Department of Science and Technology (DST), Government of India [IFA12-LSBM-21]; National University of Singapore (NUS) [R-264-001-004-272, R-154-000-318-112, R-154-000-270-112, R-347-000-198-490]; Natural Environmental Research Council (NERC) [NE/F003749/1]; National Geographic [8509-08]; NERC [NE/F003749/1] Funding Source: UKRI; Natural Environment Research Council [NE/F003749/1] Funding Source: researchfish	Mohammed Bin Zayed Species Conservation Fund; North of England Zoological Society-Chester Zoo; Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); National University of Singapore (NUS)(National University of Singapore); Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Geographic(National Geographic Society); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Mohammed Bin Zayed Species Conservation Fund, http://www.speciesconservation.org, (Project 1225670) and North of England Zoological Society-Chester Zoo, http://www.chesterzoo.org (RR); Department of Science and Technology (DST), Government of India for an Inspire Research Grant, http://www. inspire-dst.gov.in [IFA12-LSBM-21] (ND); National University of Singapore, http://www.nus.edu.sg, (NUS, R-264-001-004-272, R-154-000-318-112, R-154-000-270-112, R-347-000-198-490) (HH); Natural Environmental Research Council (NERC, NE/F003749/1) (LR, RB); National Geographic, http://www.nationalgeographic.com/explorers/grants-programs/cre-application/, (8509-08) (LR) and North of England Zoological Society-Chester Zoo, http://www.chesterzoo.org (LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2010, MOL PHYLOGENET EVOL, V56, P707, DOI 10.1016/j.ympev.2010.03.027; Ahrens D, 2016, SYST BIOL, V65, P478, DOI 10.1093/sysbio/syw002; [Anonymous], 2021, SPLITS SPECIES LIMIT; Benziger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021272; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; BONOU C A, 1985, Revue d'Hydrobiologie Tropicale, V18, P267; Britz R, 2017, ZOOTAXA IN PRESS; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2015, J ZOOL SYST EVOL RES, V53, P259, DOI 10.1111/jzs.12103; Collins RA, 2014, SYST BIOL, V63, P1005, DOI 10.1093/sysbio/syu060; Courtenay RW, 2004, US GEOLOGICAL SURVEY, V1251; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dellicour S, 2015, SYST BIOL, V64, P900, DOI 10.1093/sysbio/syu130; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Flot JF, 2015, SYST BIOL, V64, P897, DOI 10.1093/sysbio/syv071; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Jayarama KC, 2010, FRESHWATER FISHES IN; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; Khedkar GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101460; Lakra WS, 2010, BIOCHEM SYST ECOL, V38, P1212, DOI 10.1016/j.bse.2010.12.012; Lakra WS, 2016, MITOCHONDRIAL DNA A, V27, P4510, DOI 10.3109/19401736.2015.1101540; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li X, 2006, ICHTHYOL RES, V53, P148, DOI 10.1007/s10228-005-0321-3; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murray AM, 2006, J PALEONTOL, V80, P1172, DOI 10.1666/0022-3360(2006)80[1172:ANCTCF]2.0.CO;2; Nwani CD, 2011, MITOCHONDR DNA, V22, P43, DOI 10.3109/19401736.2010.536537; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pethiyagoda R., 1991, FRESHWATER FISHES SR, DOI DOI 10.1093/sysbio/syw095; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Raghavan R, 2013, BIOL CONSERV, V164, P158, DOI 10.1016/j.biocon.2013.04.019; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; ROBERTS TR, 1975, ZOOL J LINN SOC-LOND, V57, P249, DOI 10.1111/j.1096-3642.1975.tb01893.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Scott David, 2013, Management of Biological Invasions, V4, P265; Serrao NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099546; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tan HH, 2013, RAFFLES B ZOOL, V61, P893; Tan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052089; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; TEUGELS G G, 1984, Cybium, V8, P1; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2014, SYST BIOL, V63, P993, DOI 10.1093/sysbio/syu052; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhu SR, 2013, BIOCHEM SYST ECOL, V51, P117, DOI 10.1016/j.bse.2013.08.011	58	45	50	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184017	10.1371/journal.pone.0184017	http://dx.doi.org/10.1371/journal.pone.0184017			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931084	gold, Green Submitted, Green Published			2022-12-27	WOS:000411314700013
J	Eby, DW; Molnar, LJ; Kostyniuk, LP; St Louis, RM; Zanier, N				Eby, David W.; Molnar, Lisa J.; Kostyniuk, Lidia P.; St Louis, Renee M.; Zanier, Nicole			Characteristics of informal caregivers who provide transportation assistance to older adults	PLOS ONE			English	Article							NATIONAL PROFILE; OUTCOMES SCALE; HEALTH	The study aim was to gain a better understanding of the characteristics of informal caregivers who provide transportation assistance and to explore the types and frequency of this assistance. A telephone survey was administered to a representative sample of 268 informal caregivers (age 45-80) who provide transportation assistance to older adults (age 70 and older) in Michigan. Responses were analyzed overall and by the caregiver sex and care recipient age. Informal transportation caregivers were: most often women; on average 61 years old; generally college educated; employed full- or part-time jobs; relatively healthy; providing care to a parent/family member 1-4 times per week, living close to the care recipient; and providing assistance by giving rides. Less than one-half of caregivers sought information to help them provide assistance. No significant burden was reported and there were few differences by sex of the caregiver of the age group of the care recipient.	[Eby, David W.; Molnar, Lisa J.; Kostyniuk, Lidia P.; St Louis, Renee M.; Zanier, Nicole] Univ Michigan, Transportat Res Inst, Ann Arbor, MI 48109 USA; [Eby, David W.; Molnar, Lisa J.; Kostyniuk, Lidia P.; St Louis, Renee M.; Zanier, Nicole] ATLAS Ctr, Michigan Ctr Adv Safe Transportat Lifespan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eby, DW (corresponding author), Univ Michigan, Transportat Res Inst, Ann Arbor, MI 48109 USA.; Eby, DW (corresponding author), ATLAS Ctr, Michigan Ctr Adv Safe Transportat Lifespan, Ann Arbor, MI 48109 USA.	eby@umich.edu		St. Louis, Renee M./0000-0002-4751-2420; Eby, David W./0000-0001-8650-0628	Michigan Department of Transportation (MDOT) [2010-0296 for OR09102]	Michigan Department of Transportation (MDOT)	This work was supported by a contract with the Michigan Department of Transportation (MDOT; 2010-0296 for OR09102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakas T, 1999, NURS RES, V48, P250, DOI 10.1097/00006199-199909000-00005; Bakas T, 2006, NURS RES, V55, P346, DOI 10.1097/00006199-200609000-00007; Beverly Foundation, 2004, TRANSP PROGR SEN R S; Chang C. F., 1991, J APPLIED GERONTOLOG, V10, P343, DOI DOI 10.1177/073346489101000308; Dickerson AE, 2007, GERONTOLOGIST, V47, P578, DOI 10.1093/geront/47.5.578; Eby D., 2009, MAINTAINING SAFE MOB; Eby D.W., 2015, KEEPING OLDER ADULTS; Eby D. W., 2016, UMTRI201618; Eby D. W., 2011, RC1562 MICH DEP TRAN; Family Caregiver Alliance, 2005, FSSCS200506 FAM CAR; Foley DJ, 2002, AM J PUBLIC HEALTH, V92, P1284, DOI 10.2105/AJPH.92.8.1284; Kostyniuk LP, 2003, J SAFETY RES, V34, P407, DOI 10.1016/j.jsr.2003.09.001; Molnar L. J., 2008, CONSENSUS BASED RECO; Molnar LJ, 2014, TRAFFIC INJ PREV, V15, P262, DOI 10.1080/15389588.2013.808742; National Alliance for Caregiving (NAC) and the AARP Public Policy Institute, 2015, CAR US 2015 REP; Navaie-Waliser M, 2001, GERONTOLOGIST, V41, P733, DOI 10.1093/geront/41.6.733; Ortman J. M., 2014, P251140 US CENS BUR; Roth DL, 2015, GERONTOLOGIST, V55, P309, DOI 10.1093/geront/gnu177; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; STONE R, 1987, GERONTOLOGIST, V27, P616, DOI 10.1093/geront/27.5.616; Turner A, 2012, HEALTH REP, V23, P33; US Census Bureau, 2010, CENS VIEW MICH 2010; Wolff JL, 2006, GERONTOLOGIST, V46, P344, DOI 10.1093/geront/46.3.344; YOUNG RF, 1989, GERONTOLOGIST, V29, P660, DOI 10.1093/geront/29.5.660	24	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184085	10.1371/journal.pone.0184085	http://dx.doi.org/10.1371/journal.pone.0184085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931027	Green Submitted, gold, Green Published			2022-12-27	WOS:000411314700014
J	Randles, D; Harlow, I; Inzlicht, M				Randles, Daniel; Harlow, Iain; Inzlicht, Michael			A pre-registered naturalistic observation of within domain mental fatigue and domain-general depletion of self-control	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; EGO-DEPLETION; LIMITED RESOURCE; SLEEP-WAKE; TESTS	Self-control is often believed to operate as if it were a finite, domain-general resource. However, recent attempts to demonstrate this under transparent conditions have failed to yield positive results. In the current study, we monitor two groups of students (N1 = 8,867, N2 = 8,754) over separate 17-week intervals with 24-hour coverage, as they engage in voluntary learning and self-testing using an online program. We use daily behavior to assess whether time-of-day effects support domain-general theories of self-control. Additionally, we assess whether mental fatigue emerges within task during prolonged persistent effort. Results reveal within-task fatigue emerges within an hour on-task. However, there is a negligible effect on ability throughout the day. Additionally, time-of-day has no detrimental effect on motivation; rather there is a strong tendency to increase learning time at night. Results are consistent with theories indicating people lose motivation within a specific task, but at odds with theories that argue for a domain-general self-control resource.	[Randles, Daniel; Inzlicht, Michael] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Harlow, Iain] Cerego, Learning & Data Sci Grp, San Francisco, CA USA; [Inzlicht, Michael] Univ Toronto, Rotman Sch Management, Toronto, ON, Canada	University of Toronto; University of Toronto	Randles, D (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.	michael.inzlicht@utoronto.ca			Social Sciences and Humanities Research Council of Canada [RN242784-BFP-SSHRC-01045]; Cerego, a private corporation; Cerego; Social Sciences and Humanities Research Council; Natural Sciences and Engineering Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Cerego, a private corporation; Cerego; Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The 1st author (Daniel Randles) received financial support provided by the Social Sciences and Humanities Research Council of Canada, Banting Postdoctoral Fellowship (RN242784-BFP-SSHRC-01045). The 2nd author (lain Harlow) received financial support provided by Cerego, a private corporation. Cerego provided support in the form of salary and supplied data (gathered during their normal business operation). The 3rd author acknowledges support from the Social Sciences and Humanities Research Council and Natural Sciences and Engineering Research Council of Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, beyond what was previously described. The specific roles of all authors are articulated in the "author contributions" section.	[Anonymous], 2021, ELEMENTS EVOLUTIONAR; Baumeister RF, 1996, PSYCHOL INQ, V7, P1, DOI 10.1207/s15327965pli0701_1; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Carter EC, 2015, J EXP PSYCHOL GEN, V144, P796, DOI 10.1037/xge0000083; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Danziger S, 2011, P NATL ACAD SCI USA, V108, P6889, DOI 10.1073/pnas.1018033108; Hagger MS, 2016, PERSPECT PSYCHOL SCI, V11, P546, DOI 10.1177/1745691616652873; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hopstaken JF, 2015, PSYCHOPHYSIOLOGY, V52, P305, DOI 10.1111/psyp.12339; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Intons-Peterson MJ, 1998, J EXP PSYCHOL LEARN, V24, P362, DOI 10.1037/0278-7393.24.2.362; Lurquin JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147770; Monk TH, 2005, J BIOL RHYTHM, V20, P366, DOI 10.1177/0748730405277378; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Sievertsen HH, 2016, P NATL ACAD SCI USA, V113, P2621, DOI 10.1073/pnas.1516947113; Yoon IY, 2003, J AM GERIATR SOC, V51, P1085, DOI 10.1046/j.1532-5415.2003.51356.x	17	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0182980	10.1371/journal.pone.0182980	http://dx.doi.org/10.1371/journal.pone.0182980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931013	Green Submitted, gold, Green Published			2022-12-27	WOS:000411314700007
J	Meng, XN; Chen, QM; Fan, HY; Song, TF; Cui, N; Zhao, JY; Jia, SM; Meng, KX				Meng, Xiang Nan; Chen, Qiu Min; Fan, Hai Yan; Song, Tie Feng; Cui, Na; Zhao, Ju Yong; Jia, Shu Min; Meng, Ke Xin			Molecular characterization, expression analysis and heterologous expression of two translationally controlled tumor protein genes from Cucumis sativus	PLOS ONE			English	Article							TCTP; CLONING; GROWTH; ARABIDOPSIS; DROSOPHILA; STRESS; GTPASE; RICE; SALT	The translationally controlled tumor protein (TCTP) is a family of abundant and ubiquitous proteins involved in several important primary functions. Cucumbers harbor two TCTP genes, CsTCTP1 and CsTCTP2; however, their functional roles remain unclear. In this study, we isolated CsTCTP1 and CsTCTP2 (XP-004134215 and XP-004135602, respectively) promoters, full-length cDNA and genomic sequences from Cucumis sativus. Bioinformatics analysis, containing cis-acting elements, structural domains, phylogenetic tree and conserved motifs, suggested the conservation and divergence of CsTCTP1 and CsTCTP2, thus providing knowledge regarding their functions. Expression analysis indicated that CsTCTP1 and CsTCTP2 exhibited tissue-specific expression and were regulated by biotic or abiotic stresses in C. sativus. Furthermore, CsTCTP1 and CsTCTP2 were regulated by ABA and may be associated with the TOR (target of rapamycin) signaling pathway. In a prokaryotic expression analysis, CsTCTP1 and CsTCTP2 showed positive responses to salt and heat stresses and a negative response to drought and HgCl2 stresses. TCTP may exert multiple functions in various cellular processes.	[Meng, Xiang Nan] Shenyang Agr Univ, Coll Hort, Shenyang, Liaoning, Peoples R China; [Chen, Qiu Min; Fan, Hai Yan; Cui, Na; Jia, Shu Min] Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang, Liaoning, Peoples R China; [Fan, Hai Yan] Shenyang Agr Univ, Minist Educ, Key Lab Protected Hort, Shenyang, Liaoning, Peoples R China; [Song, Tie Feng; Zhao, Ju Yong] Liaoning Acad Agr Sci, Shenyang, Liaoning, Peoples R China; [Meng, Ke Xin] Shenyang Agr Univ, Foreign Languages Dept, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University; Shenyang Agricultural University; Shenyang Agricultural University	Fan, HY (corresponding author), Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang, Liaoning, Peoples R China.; Fan, HY (corresponding author), Shenyang Agr Univ, Minist Educ, Key Lab Protected Hort, Shenyang, Liaoning, Peoples R China.	Hyfan74@163.com			National Natural Science Foundation of China [31772314]; Natural Science Foundation of Liaoning Province of China [20170540802]; Program for Science and Technology Plan of Shenyang [171246]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province of China(Natural Science Foundation of Liaoning Province); Program for Science and Technology Plan of Shenyang	This study was funded by National Natural Science Foundation of China (31772314), Natural Science Foundation of Liaoning Province of China (20170540802) and Program for Science and Technology Plan of Shenyang (171246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Cao BH, 2010, PLANT CELL TISS ORG, V103, P217, DOI 10.1007/s11240-010-9769-6; Chou MX, 2016, PLANT MOL BIOL, V90, P389, DOI 10.1007/s11103-015-0424-9; Deng Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00789; Fan HY, 2014, ACTA PHYSIOL PLANT, V36, P1781, DOI 10.1007/s11738-014-1552-6; Gutierrez-Galeano DF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00361; Hoepflinger MC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-135; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jones AME, 2006, PLANT PHYSIOL, V142, P1603, DOI 10.1104/pp.106.086231; Kim YM, 2012, MOL CELLS, V33, P617, DOI 10.1007/s10059-012-0080-8; Le TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11501; Li Gang, 2010, Bulletin of Botanical Research, V30, P441; Liu WY, 2009, J INTEGR PLANT BIOL, V51, P825, DOI 10.1111/j.1744-7909.2009.00853.x; MAKRIDES S, 1988, NUCLEIC ACIDS RES, V16, P2349, DOI 10.1093/nar/16.5.2349; PAY A, 1992, PLANT MOL BIOL, V19, P501, DOI 10.1007/BF00023399; Reddy PS, 2012, MOL BIOL REP, V39, P7163, DOI 10.1007/s11033-012-1548-5; Santa Brigida AB, 2014, MOL BIOL REP, V41, P1787, DOI 10.1007/s11033-014-3028-6; Schmidt I, 2007, FEBS J, V274, P5416, DOI 10.1111/j.1742-4658.2007.06069.x; Su YC, 2013, PLANT CELL REP, V32, P1503, DOI 10.1007/s00299-013-1463-9; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Toscano-Morales R, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1071003; Toscano-Morales R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00468; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Vincent D, 2007, J EXP BOT, V58, P1873, DOI 10.1093/jxb/erm012; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Wang FJ, 2012, J ENVIRON SCI, V24, P2149, DOI 10.1016/S1001-0742(11)61062-0; Wang Z, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/165631; Xiong Y, 2014, PLANT PHYSIOL, V164, P499, DOI 10.1104/pp.113.229948; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; [郑舒扬 Zheng Shuyang], 2014, [生物技术通报, Biotechnology Bulletin], P72	33	4	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184872	10.1371/journal.pone.0184872	http://dx.doi.org/10.1371/journal.pone.0184872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926624	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600047
J	Jayaswal, PK; Dogra, V; Shanker, A; Sharma, TR; Singh, NK				Jayaswal, Pawan Kumar; Dogra, Vivek; Shanker, Asheesh; Sharma, Tilak Raj; Singh, Nagendra Kumar			A tree of life based on ninety-eight expressed genes conserved across diverse eukaryotic species	PLOS ONE			English	Article							SINGLE-COPY GENES; DIVERGENCE TIMES; MAXIMUM-LIKELIHOOD; BOX PROTEINS; EVOLUTIONARY; SEQUENCE; ORIGIN; PLANT; RICE; FUNGI	Rapid advances in DNA sequencing technologies have resulted in the accumulation of large data sets in the public domain, facilitating comparative studies to provide novel insights into the evolution of life. Phylogenetic studies across the eukaryotic taxa have been reported but on the basis of a limited number of genes. Here we present a genome-wide analysis across different plant, fungal, protist, and animal species, with reference to the 36,002 expressed genes of the rice genome. Our analysis revealed 9831 genes unique to rice and 98 genes conserved across all 49 eukaryotic species analysed. The 98 genes conserved across diverse eukaryotes mostly exhibited binding and catalytic activities and shared common sequence motifs; and hence appeared to have a common origin. The 98 conserved genes belonged to 22 functional gene families including 26S protease, actin, ADP-ribosylation factor, ATP synthase, casein kinase, DEAD-box protein, DnaK, elongation factor 2, glyceraldehyde 3-phosphate, phosphatase 2A, ras-related protein, Ser/Thr protein phosphatase family protein, tubulin, ubiquitin and others. The consensus Bayesian eukaryotic tree of life developed in this study demonstrated widely separated clades of plants, fungi, and animals. Musa acuminata provided an evolutionary link between monocotyledons and dicotyledons, and Salpingoeca rosetta provided an evolutionary link between fungi and animals, which indicating that protozoan species are close relatives of fungi and animals. The divergence times for 1176 species pairs were estimated accurately by integrating fossil information with synonymous substitution rates in the comprehensive set of 98 genes. The present study provides valuable insight into the evolution of eukaryotes.	[Jayaswal, Pawan Kumar; Dogra, Vivek; Sharma, Tilak Raj; Singh, Nagendra Kumar] IARI, Natl Res Ctr Plant Biotechnol, New Delhi, India; [Jayaswal, Pawan Kumar] Banasthali Univ, Banasthali, Rajasthan, India; [Shanker, Asheesh] Cent Univ South Bihar, Ctr Biol Sci, Bioinformat Programme, Patna, Bihar, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Banasthali Vidyapith; Central University of South Bihar	Singh, NK (corresponding author), IARI, Natl Res Ctr Plant Biotechnol, New Delhi, India.	nksingh4@gmail.com	Singh, Nouratan/N-9377-2017; Jayaswal, Pawan/ACY-7264-2022	Singh, Nouratan/0000-0002-8063-8375; Jayaswal, Pawan/0000-0003-3335-8044	Department of Biotechnology [BT/PR/11184/BID/07/263/2008]; Network Project on Transgenic in Crops (NPTC); Ministry of Science and Technology; Indian Council of Agricultural Research, Ministry of Agriculture, Government of India	Department of Biotechnology; Network Project on Transgenic in Crops (NPTC); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Indian Council of Agricultural Research, Ministry of Agriculture, Government of India	This work is supported by the Department of Biotechnology (BT/PR/11184/BID/07/263/2008) and Network Project on Transgenic in Crops (NPTC) with funding support from Ministry of Science and Technology and Indian Council of Agricultural Research, Ministry of Agriculture, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2013, MOL BIOL EVOL, V30, P1853, DOI 10.1093/molbev/mst086; Alfoldi J, 2013, GENOME RES, V23, P1063, DOI 10.1101/gr.157503.113; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2005, FOSSIL INSECT; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Assis R, 2013, P NATL ACAD SCI USA, V110, P17409, DOI 10.1073/pnas.1313759110; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; Bininda-Emonds ORP, 2001, SYST BIOL, V50, P565, DOI 10.1080/106351501750435112; Buchmann Stephen, 2015, REASON FLOWERS THEIR; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; Carmel L, 2007, GENOME RES, V17, P1045, DOI 10.1101/gr.5978207; Cavalier-Smith T, 2014, MOL PHYLOGENET EVOL, V81, P71, DOI 10.1016/j.ympev.2014.08.012; Cheng XF, 2012, NEW PHYTOL, V195, P71, DOI 10.1111/j.1469-8137.2012.04147.x; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Crane PR, 2004, AM J BOT, V91, P1683, DOI 10.3732/ajb.91.10.1683; Davis CC, 2011, CURR BIOL, V21, pR995, DOI 10.1016/j.cub.2011.11.020; Deshmukh RK, 2016, J PLANT BIOCHEM BIOT, V25, P142, DOI 10.1007/s13562-015-0319-5; Dodds P, 2009, FUNCT PLANT BIOL, V36, P395, DOI 10.1071/FP08320; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durian G, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00812; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Eichinger L, 2003, EMBO J, V22, P1941, DOI 10.1093/emboj/cdg214; FitzGerald PC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r53; Foster CB, 2005, J GEOL SOC LONDON, V162, P653, DOI 10.1144/0016-764904-047; Friis EM, 2004, P NATL ACAD SCI USA, V101, P16565, DOI 10.1073/pnas.0407174101; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Herendeen P.S., 1992, ADV LEGUME SYSTEMATI, P57; HUELSENBECK JP, 1991, SYST ZOOL, V40, P458, DOI 10.2307/2992240; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Iost I, 2006, NUCLEIC ACIDS RES, V34, P4189, DOI 10.1093/nar/gkl500; Jackson S, 2006, PLANT CELL, V18, P1100, DOI 10.1105/tpc.106.042192; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiao YN, 2014, PLANT CELL, V26, P2792, DOI 10.1105/tpc.114.127597; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krull M, 2007, GENOME RES, V17, P1139, DOI 10.1101/gr.6320607; KUMA K, 1995, J MOL EVOL, V41, P238; Lai JS, 2004, GENOME RES, V14, P1924, DOI 10.1101/gr.2701104; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Li WH, 2007, MOL EVOLUTION; Li Z, 2017, GENOME BIOL EVOL, V9, P1130, DOI 10.1093/gbe/evx070; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Linzey DW, 2012, VERTEBRATE BIOL; LOOMIS WF, 1990, P NATL ACAD SCI USA, V87, P9093, DOI 10.1073/pnas.87.23.9093; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Mar JC, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-8; Marco C., 2006, SOC BIOINFORMATICA I, V5, P28; Martin WF, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0330; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matsuo T, 2011, FEBS LETT, V585, P1495, DOI 10.1016/j.febslet.2011.02.025; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Murat F, 2012, GENOME BIOL EVOL, V4, P917, DOI 10.1093/gbe/evs066; MUSE SV, 1992, GENETICS, V132, P269; NEI M, 1986, MOL BIOL EVOL, V3, P418; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Ohno S., 1970, P1; PARAG HA, 1987, EMBO J, V6, P55, DOI 10.1002/j.1460-2075.1987.tb04718.x; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paterson AH, 2004, CURR OPIN BIOTECH, V15, P120, DOI 10.1016/j.copbio.2004.03.001; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Phillips MJ, 2016, SYST BIOL, V65, P546, DOI 10.1093/sysbio/syv115; Rambaut A., FIGTREE V1 3 1; Rambaut A., 2014, TRACER V1 6; Rochette NC, 2014, MOL BIOL EVOL, V31, P832, DOI 10.1093/molbev/mst272; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruta M, 2004, BONES MOL CROWN TETR; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schittek B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-231; Shemi A, 2015, AUTOPHAGY, V11, P701, DOI 10.1080/15548627.2015.1034407; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Singh NK, 2007, FUNCT INTEGR GENOMIC, V7, P17, DOI 10.1007/s10142-006-0033-4; Singh NK, 2004, FUNCT INTEGR GENOMIC, V4, P102, DOI 10.1007/s10142-004-0109-y; Singh VP, 2006, GYMNOSPERM NAKED SE; Smiley CJ, 1985, LATE CENOZOIC HIST P; Smith JM, 1993, THEORY EVOLUTION; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Takahashi K, 2000, J HERED, V91, P198, DOI 10.1093/jhered/91.3.198; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Theissen G, 2004, CRIT REV PLANT SCI, V23, P129, DOI 10.1080/07352680490433240; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Visscher H, 2004, P NATL ACAD SCI USA, V101, P12952, DOI 10.1073/pnas.0404472101; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Zeng LP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5956; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zheng FY, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2736-9	116	4	4	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184276	10.1371/journal.pone.0184276	http://dx.doi.org/10.1371/journal.pone.0184276			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922368	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300014
J	Pattison, S; Mitchell, C; Lade, S; Leong, T; Busuttil, RA; Boussioutas, A				Pattison, Sharon; Mitchell, Catherine; Lade, Stephen; Leong, Trevor; Busuttil, Rita A.; Boussioutas, Alex			Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer	PLOS ONE			English	Article							GENE-EXPRESSION; CARCINOMA; SURGERY; ADENOCARCINOMA; MUTATIONS; SUBTYPES; TRENDS; RHOA	Background Survival from gastric cancer remains poor, particularly in Western populations. Previous pre-clinical and subgroup analyses of clinical trials have suggested differing benefits from fluoropyrimidine-based chemotherapeutics for diffuse and intestinal gastric cancer. This analysis examines patterns of relapse with and without adjuvant chemotherapy after curative resection for gastric cancer in these subtypes to explore the Lauren classification as a predictive marker of benefit for fluoropyrimidine-based adjuvant chemotherapy. Patients and methods Gastric cancer patients enrolled in an ongoing tissue banking study were analysed, 164 patients who would currently be considered for adjuvant therapy after curative resection were included in the analysis. Patients who did and did not receive adjuvant chemotherapy were compared. The primary end point was relapse free survival. Results Approximately 50% of patients received adjuvant chemotherapy, the majority receiving a fluoropyrimidine-based regimen. The comparison of Kaplan-Meier curves for patients who did and did not receive adjuvant chemotherapy are different between patients with intestinal and diffuse gastric cancer, and suggest that there may be a benefit in intestinal gastric cancer. The hazard ratio for adjuvant chemotherapy for intestinal gastric cancer was 0.56, (95% CI 0.27-1.17), suggesting a trend towards benefit that was lacking in diffuse gastric cancer patients (1.26, 95% CI 0.70-2.38). The patterns of relapse after adjuvant chemotherapy also differed between diffuse and intestinal gastric cancer. More than 50% of diffuse gastric cancer patients who received adjuvant chemotherapy relapsed within 12 months of surgery despite similar surgical parameters. Conclusions Lauren classification is prognostic in gastric cancer. This analysis adds further evidence that it may also be predictive of benefit for fluoropyrimidine-based chemotherapeutics, with lower chemosensitivity seen in diffuse gastric cancer. Treating diffuse and intestinal gastric cancer as separate entities, with identification of efficacious treatments for diffuse gastric cancer will help in improving outcomes from gastric cancer.	[Pattison, Sharon] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand; [Mitchell, Catherine; Lade, Stephen] Peter MacCallum Canc Ctr, Dept Pathol, Parkville, Vic, Australia; [Lade, Stephen; Busuttil, Rita A.; Boussioutas, Alex] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia; [Leong, Trevor] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Parkville, Vic, Australia; [Leong, Trevor] Univ Melbourne, Dept Pathol, Parkville, Vic, Australia; [Busuttil, Rita A.; Boussioutas, Alex] Peter MacCallum Canc Ctr, Upper Gastrointestinal Translat Res Lab, Parkville, Vic, Australia; [Busuttil, Rita A.; Boussioutas, Alex] Univ Melbourne, Dept Med, Parkville, Vic, Australia	University of Otago; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne	Boussioutas, A (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia.; Boussioutas, A (corresponding author), Peter MacCallum Canc Ctr, Upper Gastrointestinal Translat Res Lab, Parkville, Vic, Australia.; Boussioutas, A (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic, Australia.	alex.boussioutas@petermac.org		Boussioutas, Alex/0000-0002-8109-6897; Pattison, Sharon/0000-0003-2188-3423	National Health and Medical Research Council (NHMRC) [ID288714, ID454584]; Cancer Australia [ID570996]; Peter Mac Foundation grant [APP1030980]; NHMRC post-graduate scholarship [APP1039393]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; Peter Mac Foundation grant; NHMRC post-graduate scholarship(National Health and Medical Research Council (NHMRC) of Australia)	Collection and curation of the study cohort has been funded through a number of grants National Health and Medical Research Council (NHMRC) project grants (2004-2006 ID288714; 2007-2009 ID454584); 2009-2011 Cancer Australia ID570996; 2012-2014 Peter Mac Foundation grant ID APP1030980. S Pattison was supported a NHMRC post-graduate scholarship APP1039393. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bittoni A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078544; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Boussioutas A, 2003, CANCER RES, V63, P2569; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Faria GR, 2013, INT J SURG, V11, P472, DOI 10.1016/j.ijsu.2013.04.004; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; LAUREN PA, 1993, CANCER-AM CANCER SOC, V71, P2926, DOI 10.1002/1097-0142(19930515)71:10<2926::AID-CNCR2820711007>3.0.CO;2-X; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Marrelli D, 2011, BRIT J SURG, V98, P1273, DOI 10.1002/bjs.7528; Park SH, 2015, J CLIN ONCOL, V33, P3130, DOI 10.1200/JCO.2014.58.3930; Pattison S, 2016, ANZ J SURG, V86, P469, DOI 10.1111/ans.12915; Qiu MZ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-58; Smalley SR, 2012, J CLIN ONCOL, V30, P2327, DOI 10.1200/JCO.2011.36.7136; Smyth E, 2016, J CLIN ONCOL; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Yoon C, 2016, CLIN CANCER RES, V22, P971, DOI 10.1158/1078-0432.CCR-15-1356	25	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183891	10.1371/journal.pone.0183891	http://dx.doi.org/10.1371/journal.pone.0183891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922362	Green Published, gold			2022-12-27	WOS:000411059300008
J	Renna, LV; Bose, F; Iachettini, S; Fossati, B; Saraceno, L; Milani, V; Colombo, R; Meola, G; Cardani, R				Renna, Laura Valentina; Bose, Francesca; Iachettini, Sara; Fossati, Barbara; Saraceno, Lorenzo; Milani, Valentina; Colombo, Roberto; Meola, Giovanni; Cardani, Rosanna			Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GLUCOSE-TRANSPORT; MICROTUBULE NETWORK; CENTRAL NUCLEATION; DIABETIC SUBJECTS; CHLORIDE CHANNEL; CTG REPEAT; PROTEIN; GLUT4; RNA	Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are autosomal dominant multisystemic disorders caused by expansion of microsatellite repeats. In both forms, the mutant transcripts accumulate in nuclear foci altering the function of alternative splicing regulators which are necessary for the physiological mRNA processing. Missplicing of insulin receptor (IR) gene (INSR) has been associated with insulin resistance, however, it cannot be excluded that post-receptor signalling abnormalities could also contribute to this feature in DM. We have analysed the insulin pathway in skeletal muscle biopsies and in myotube cultures from DM patients to assess whether downstream metabolism might be dysregulated and to better characterize the mechanism inducing insulin resistance. DM skeletal muscle exhibits alterations of basal phosphorylation levels of Akt/PKB, p70S6K, GSK3 beta and ERK1/2, suggesting that these changes might be accompanied by a lack of further insulin stimulation. Alterations of insulin pathway have been confirmed on control and DM myotubes expressing fetal INSR isoform (INSR-A). The results indicate that insulin action appears to be lower in DM than in control myotubes in terms of protein activation and glucose uptake. Our data indicate that post-receptor signalling abnormalities might contribute to DM insulin resistance regardless the alteration of INSR splicing.	[Renna, Laura Valentina; Bose, Francesca; Iachettini, Sara; Meola, Giovanni; Cardani, Rosanna] Policlin San Donato, IRCCS, Lab Muscle Histopathol & Mol Biol, San Donato Milanese, Italy; [Fossati, Barbara; Meola, Giovanni] Policlin San Donato, IRCCS, Dept Neurol, San Donato Milanese, Italy; [Saraceno, Lorenzo; Meola, Giovanni] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Milani, Valentina] Policlin San Donato, IRCCS, Sci Directorate, Milan, Italy; [Colombo, Roberto] Univ Milan, Dept Biosci, Milan, Italy	IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; University of Milan; IRCCS Policlinico San Donato; University of Milan	Cardani, R (corresponding author), Policlin San Donato, IRCCS, Lab Muscle Histopathol & Mol Biol, San Donato Milanese, Italy.	rosanna.cardani@grupposandonato.it	Renna, Laura Valentina/ABH-7699-2020; IACHETTINI, SARA/AAY-6180-2021; Meola, Giovanni/K-4775-2016; cardani, rosanna/ABH-6525-2020; Milani, Valentina/AAB-5367-2019	Renna, Laura Valentina/0000-0003-1316-7478; IACHETTINI, SARA/0000-0002-9442-0326; Meola, Giovanni/0000-0001-6396-717X; cardani, rosanna/0000-0001-8858-4327; Milani, Valentina/0000-0002-2989-981X; Bose', Francesca/0000-0003-3898-1572	MDF-Myotonic Dystrophy Foundation; Wyck Foundation; FMM-Fondazione Malattie Miotoniche; Italian Ministry of Health [RF-2010-2314711]	MDF-Myotonic Dystrophy Foundation; Wyck Foundation; FMM-Fondazione Malattie Miotoniche; Italian Ministry of Health(Ministry of Health, Italy)	This work is supported by MDF-Myotonic Dystrophy Foundation and Wyck Foundation Postdoctoral Research Award to LVR, and by FMM-Fondazione Malattie Miotoniche to RC. The Italian Registry for Myotonic Dystrophy Type 1 and Type 2 is funded by the Italian Ministry of Health (RF-2010-2314711) to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2012, ARTERIOSCL THROM VAS, V32, P2068, DOI 10.1161/ATVBAHA.111.241984; ANNANE D, 1994, CIRCULATION, V90, P2629, DOI 10.1161/01.CIR.90.6.2629; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Bassez G, 2008, J NEUROPATH EXP NEUR, V67, P319, DOI 10.1097/NEN.0b013e31816b4acc; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533; Botta A, 2013, GENES-BASEL, V4, P275, DOI 10.3390/genes4020275; Brockhoff M, 2017, J CLIN INVEST, V127, P549, DOI 10.1172/JCI89616; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Cardani R, 2004, EUR J HISTOCHEM, V48, P437; Cardani R, 2014, NEUROMUSCULAR DISORD, V24, P1042, DOI 10.1016/j.nmd.2014.06.435; Cardani R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083777; Cardani R, 2009, NEUROMUSCULAR DISORD, V19, P335, DOI 10.1016/j.nmd.2009.03.002; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; FIORELLI M, 1992, NEUROLOGY, V42, P91, DOI 10.1212/WNL.42.1.91; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Furling D, 1999, ENDOCRINOLOGY, V140, P4244, DOI 10.1210/en.140.9.4244; Gao ZH, 2013, P NATL ACAD SCI USA, V110, P13570, DOI 10.1073/pnas.1308806110; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; GORDEN P, 1969, J CLIN ENDOCR METAB, V29, P684, DOI 10.1210/jcem-29-5-684; Groh WJ, 2008, NEW ENGL J MED, V358, P2688, DOI 10.1056/NEJMoa062800; Harper PS, 2001, MYOTONIC DYSTROPHY; Iachettini S, 2015, EUR J HISTOCHEM, V59, P251, DOI 10.4081/ejh.2015.2562; Jones K, 2015, P NATL ACAD SCI USA, V112, P8041, DOI 10.1073/pnas.1422273112; Jones K, 2012, J CLIN INVEST, V122, P4461, DOI 10.1172/JCI64081; KAKEHI T, 1990, J LAB CLIN MED, V115, P688; Kelley DE, 1996, J CLIN INVEST, V97, P2705, DOI 10.1172/JCI118724; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Liu LZ, 2013, MOL CELL ENDOCRINOL, V365, P64, DOI 10.1016/j.mce.2012.09.005; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meola G, 2000, MUSCLE NERVE, V23, P1789, DOI 10.1002/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO;2-4; Meola G, 2014, BIOCH BIOPHYS ACTA; Morrone A, 1997, J CLIN INVEST, V99, P1691, DOI 10.1172/JCI119332; Moxley Richard T 3rd, 2002, Neuromuscul Disord, V12, P306, DOI 10.1016/S0960-8966(01)00284-X; MOXLEY RT, 1978, J CLIN INVEST, V62, P857, DOI 10.1172/JCI109198; MOXLEY RT, 1980, NEUROLOGY, V30, P1077, DOI 10.1212/WNL.30.10.1077; MOXLEY RT, 1984, ANN NEUROL, V15, P157, DOI 10.1002/ana.410150208; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Olson AL, 2001, J BIOL CHEM, V276, P10706, DOI 10.1074/jbc.M007610200; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Pisani V, 2008, MUSCLE NERVE, V38, P1405, DOI 10.1002/mus.21122; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Santoro M, 2013, MOL CELL BIOCHEM, V380, P259, DOI 10.1007/s11010-013-1681-z; Savkur RS, 2004, AM J HUM GENET, V74, P1309, DOI 10.1086/421528; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; TEVAARWERK GJM, 1979, J CLIN ENDOCR METAB, V49, P216, DOI 10.1210/jcem-49-2-216; Valaperta R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/958510; Vihola A, 2003, NEUROLOGY, V60, P1854, DOI 10.1212/01.WNL.0000065898.61358.09; WALSH J C, 1970, Brain Behavior and Evolution, V93, P731, DOI 10.1093/brain/93.4.731	66	23	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184987	10.1371/journal.pone.0184987	http://dx.doi.org/10.1371/journal.pone.0184987			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915272	Green Submitted, Green Published, gold			2022-12-27	WOS:000410861600024
J	Kappel, S; Mendl, MT; Barrett, DC; Murrell, JC; Whay, HR				Kappel, Sarah; Mendl, Michael T.; Barrett, David C.; Murrell, Joanna C.; Whay, Helen R.			Lateralized behaviour as indicator of affective state in dairy cows	PLOS ONE			English	Article							FALSE DISCOVERY RATE; COGNITIVE BIAS; CATTLE; RESPONSES; LAMENESS; STIMULI; EMOTION; HORSES; BRAIN; SHEEP	In humans, there is evidence that sensory processing of novel or threatening stimuli is right hemisphere dominated, especially in people experiencing negative affective states. There is also evidence for similar lateralization in a number of non-human animal species. Here we investigate whether this is also the case in domestic cattle that may experience long-term negative states due to commonly occurring conditions such as lameness. Health and welfare implications associated with pain in lame cows are a major concern in dairy farming. Behavioural tests combining animal behaviour and cognition could make a meaningful contribution to our understanding of disease-related changes in sensory processing in animals, and consequently enhance their welfare. We presented 216 lactating Holstein-Friesian cows with three different unfamiliar objects which were placed either bilaterally (e.g. two yellow party balloons, two black/white checkerboards) or hung centrally (a Kong (TM)) within a familiar area. Cows were individually exposed to the objects on three consecutive days, and their viewing preference/eye use, exploration behaviour/nostril use, and stop position during approach was assessed. Mobility (lameness) was repeatedly scored during the testing period. Overall, a bias to view the right rather than the left object was found at initial presentation of the bilateral objects. More cows also explored the right object rather than the left object with their nose. There was a trend for cows appearing hesitant in approaching the objects by stopping at a distance to them, to then explore the left object rather than the right. In contrast, cows that approached the objects directly had a greater tendency to contact the right object. No significant preference in right or left eye/nostril use was found when cows explored the centrally-located object. We found no relationship between lameness and lateralized behaviour. Nevertheless, observed trends suggesting that lateralized behaviour in response to bilaterally located unfamiliar objects may reflect an immediate affective response are discussed. Further study is needed to understand the impact of long-term affective states on hemispheric dominance and lateralized behaviour.	[Kappel, Sarah; Mendl, Michael T.; Barrett, David C.; Murrell, Joanna C.; Whay, Helen R.] Univ Bristol, Bristol Vet Sch, Langford, North Somerset, England	University of Bristol	Kappel, S (corresponding author), Univ Bristol, Bristol Vet Sch, Langford, North Somerset, England.	sk14101@bristol.ac.uk	Mendl, Michael/D-7220-2016	Mendl, Michael/0000-0002-5302-1871; Kappel, Sarah/0000-0002-8877-5462	University of Bristol [DFASGC1227]; BBSRC [BB/J004197/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J004197/1] Funding Source: researchfish	University of Bristol; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the University of Bristol (grant number DFASGC1227). The recipient for this grant was HRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew RJ, ADV VERTEBRATE NEURO; Archer S, 2010, IN PRACTICE, V32, P492, DOI 10.1136/inp.c6672; Austin NP, 2007, LATERALITY, V12, P464, DOI 10.1080/13576500701495307; Barnard S, 2016, ANIM COGN, V19, P207, DOI 10.1007/s10071-015-0928-3; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benjamini Y, 1999, J STAT PLAN INFER, V82, P163, DOI 10.1016/S0378-3758(99)00040-3; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Davidson R.J., 1995, CEREBRAL ASYMMETRY E, P361; Des Roches ADB, 2008, PHYSIOL BEHAV, V94, P487, DOI 10.1016/j.physbeh.2008.03.002; Farmer K, 2010, ANIM COGN, V13, P229, DOI 10.1007/s10071-009-0260-x; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hemsworth PH, 1996, APPL ANIM BEHAV SCI, V50, P43, DOI 10.1016/0168-1591(96)01067-2; Larose C, 2007, LATERALITY ASYMMETRI, V11, P355; Leliveld LMC, 2013, APPL ANIM BEHAV SCI, V145, P1, DOI 10.1016/j.applanim.2013.02.002; MATHEWS A, 1994, ANNU REV PSYCHOL, V45, P25, DOI 10.1146/annurev.psych.45.1.25; McGreevy PD, 2005, APPL ANIM BEHAV SCI, V92, P337, DOI 10.1016/j.applanim.2004.11.012; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; O'Callaghan K, 2002, IN PRACTICE, V24, P212, DOI 10.1136/inpract.24.4.212; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; Phillips C, 2002, CATTLE BEHAV WELFARE; Phillips CJC, 2015, J DAIRY SCI, V98, P2389, DOI 10.3168/jds.2014-8648; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Robins A, 2010, LATERALITY, V15, P514, DOI 10.1080/13576500903049324; Rogers LJ, 2010, APPL ANIM BEHAV SCI, V127, P1, DOI 10.1016/j.applanim.2010.06.008; ROGERS LJ, 1979, PHARMACOL BIOCHEM BE, V10, P679, DOI 10.1016/0091-3057(79)90320-4; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Rogers LJ, 2002, CAMBRIDGE; Rogers LJ, 2013, CAMBRIDGE; Schwarz N, 2000, COGNITION EMOTION, V14, P433, DOI 10.1080/026999300402745; Siniscalchi M, 2013, CURR BIOL, V23, P2279, DOI 10.1016/j.cub.2013.09.027; Siniscalchi M, 2011, ANIM BEHAV, V82, P399, DOI 10.1016/j.anbehav.2011.05.020; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; Vallortigara G, 2017, APA HDB COMP PSYCHOL, V1, P557, DOI [10.1037/0000011-027, DOI 10.1037/0000011-027]; Versace E, 2007, BEHAV BRAIN RES, V184, P72, DOI 10.1016/j.bbr.2007.06.016; Versace E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00233; von Keyserlingk MAG, 2009, J DAIRY SCI, V92, P4101, DOI 10.3168/jds.2009-2326; Whay H, 2002, PRACT, P444; Whay HR, 1998, VET J, V156, P23, DOI 10.1016/S1090-0233(98)80058-0; Whay HR, 1997, VET J, V154, P155, DOI 10.1016/S1090-0233(97)80053-6	42	13	14	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184933	10.1371/journal.pone.0184933	http://dx.doi.org/10.1371/journal.pone.0184933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910416	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200122
J	Zielinski, B; Plichta, A; Misztal, K; Spurek, P; Brzychczy-Wloch, M; Ochonska, D				Zielinski, Bartosz; Plichta, Anna; Misztal, Krzysztof; Spurek, Przemyslaw; Brzychczy-Wloch, Monika; Ochonska, Dorota			Deep learning approach to bacterial colony classification	PLOS ONE			English	Article							AUTOMATIC IDENTIFICATION	In microbiology it is diagnostically useful to recognize various genera and species of bacteria. It can be achieved using computer-aided methods, which make the recognition processes more automatic and thus significantly reduce the time necessary for the classification. Moreover, in case of diagnostic uncertainty (the misleading similarity in shape or structure of bacterial cells), such methods can minimize the risk of incorrect recognition. In this article, we apply the state of the art method for texture analysis to classify genera and species of bacteria. This method uses deep Convolutional Neural Networks to obtain image descriptors, which are then encoded and classified with Support Vector Machine or Random Forest. To evaluate this approach and to make it comparable with other approaches, we provide a new dataset of images. DIBaS dataset (Digital Image of Bacterial Species) contains 660 images with 33 different genera and species of bacteria.	[Zielinski, Bartosz; Misztal, Krzysztof; Spurek, Przemyslaw] Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland; [Plichta, Anna] Cracow Univ Technol, Dept Comp Sci, 24 Warszawska St, PL-31422 Krakow, Poland; [Brzychczy-Wloch, Monika] Jagiellonian Univ, Med Coll, Chair Microbiol, Dept Bacteriol Microbial Ecol & Parasitol, 18 Czysta St, PL-31121 Krakow, Poland; [Ochonska, Dorota] Jagiellonian Univ, Med Coll, Fac Med, Chair Microbiol,Dept Infect Epidemiol, 18 Czysta St, PL-31121 Krakow, Poland	Jagiellonian University; Cracow University of Technology; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Misztal, K (corresponding author), Jagiellonian Univ, Fac Math & Comp Sci, 6 Lojasiewicza St, PL-30348 Krakow, Poland.	krzysztof.misztal@uj.edu.pl		Misztal, Krzysztof/0000-0003-2480-3505	National Science Centre (Poland) [2015/19/D/ST6/01215, 2015/19/D/ST6/01472, 2012/07/N/ST6/02192]; PL-Grid infrastructure	National Science Centre (Poland); PL-Grid infrastructure	The work of B. Zielinski was supported by the National Science Centre (Poland) under grant agreement no 2015/19/D/ST6/01215; 2016-2019. The work of P. Spurek was supported by the National Science Centre (Poland) under grant agreement no. 2015/19/D/ST6/01472; 2016-2019. The work of K. Misztal was supported by the National Science Centre (Poland) under grant agreement no. 2012/07/N/ST6/02192; 2012-2017. This research was supported in part by PL-Grid infrastructure.; The work of B. Zielinski was supported by the National Science Centre (Poland) under grant agreement no 2015/19/D/ST6/01215; 2016-2019.; The work of P. Spurek was supported by the National Science Centre (Poland) under grant agreement no. 2015/19/D/ST6/01472; 2016-2019.; The work of K. Misztal was supported by the National Science Centre (Poland) under grant agreement no. 2012/07/N/ST6/02192; 2012-2017.; This research was supported in part by PL-Grid infrastructure.	Ahmed WM, 2013, IEEE J BIOMED HEALTH, V17, P232, DOI 10.1109/TITB.2012.2222654; Ates H, 2009, 2009 24TH INTERNATIONAL SYMPOSIUM ON COMPUTER AND INFORMATION SCIENCES, P18, DOI 10.1109/ISCIS.2009.5291926; Blackburn N, 1998, APPL ENVIRON MICROB, V64, P3246; Bosch A, 2006, LECT NOTES COMPUT SC, V3954, P517; Chatfield K, 2014, ARXIV140535312014; Cimpoi M, 2016, INT J COMPUT VISION, V118, P65, DOI 10.1007/s11263-015-0872-3; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; De Bruyne K, 2011, SYST APPL MICROBIOL, V34, P20, DOI 10.1016/j.syapm.2010.11.003; Forero MG, 2006, J MICROSC-OXFORD, V223, P120, DOI 10.1111/j.1365-2818.2006.01610.x; Hiremath P., 2009, P IEEE INT C SIGN IM, P209; Holmberg M, 1998, BIOTECHNOL TECH, V12, P319, DOI 10.1023/A:1008862617082; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu J, 2001, MICROB ECOL, V41, P173, DOI 10.1007/s002480000004; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Perner P., 2001, MED DATA ANAL, V2199, P219; Perronnin F., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383266; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Simonyan K, 2014, ARXIV140915562014; Snoek J., 2012, ADV NEURAL INFORM PR, V2, P2951, DOI DOI 10.48550/ARXIV.1206.2944; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Trattner S, 2004, IEEE T MED IMAGING, V23, P807, DOI 10.1109/TMI.2004.827481	24	52	55	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184554	10.1371/journal.pone.0184554	http://dx.doi.org/10.1371/journal.pone.0184554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910352	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200061
J	Alahnomi, RA; Zakaria, Z; Ruslan, E; Ab Rashid, SR; Bahar, AAM; Shaaban, A				Alahnomi, Rammah A.; Zakaria, Z.; Ruslan, E.; Ab Rashid, S. R.; Bahar, Amyrul Azuan Mohd; Shaaban, Azizah			Microwave bio-sensor based on symmetrical split ring resonator with spurline filters for therapeutic goods detection	PLOS ONE			English	Article							DEFECTED GROUND STRUCTURE; HARMONIC SUPPRESSION; PERMITTIVITY	A novel symmetrical split ring resonator (SSRR) based microwave sensor with spurline filters for detecting and characterizing the properties of solid materials has been developed. Due to the weak perturbation in the interaction of material under test (MUT) and planar microwave sensor, spurline filters were embedded to the SSRR microwave sensor which effectively enhanced Q-factor with suppressing the undesired harmonic frequency. The spurline filter structures force the presented sensor to resonate at a fundamental frequency of 2.2 GHz with the capabilities of suppressing rejected harmonic frequency and miniaturization in circuit size. A wide bandwidth rejection is achieved by using double spurlines filters with high Q-factor achievement (up to 652.94) compared to single spurline filter. The new SSRR sensor with spurline filters displayed desired properties such as high sensitivity, accuracy, and performance with a 1.3% typical percentage error in the measurement results. Furthermore, the sensor has been successfully applied for detecting and characterizing solid materials (such as Roger 5880, Roger 4350, and FR4) and evidently demonstrated that it can suppress the harmonic frequency effectively. This novel design with harmonic suppression is useful for various applications such as food industry (meat, fruit, vegetables), biological medicine (derived from proteins and other substances produced by the body), and Therapeutic goods (antiseptics, vitamins, anti-psychotics, and other medicines).	[Alahnomi, Rammah A.; Zakaria, Z.; Ab Rashid, S. R.; Bahar, Amyrul Azuan Mohd] Univ Tek Malaysia Melaka UTeM, Ctr Telecommun Res & Innovat CeTRI, Durian Tunggal, Melaka, Malaysia; [Ruslan, E.] Univ Tek Malaysia Melaka UTeM, Fac Technol Engn, Durian Tunggal, Melaka, Malaysia; [Shaaban, Azizah] Univ Tek Malaysia Melaka UTeM, Fac Mfg Engn, Dept Mat Engn, Durian Tunggal, Melaka, Malaysia	University Teknikal Malaysia Melaka; University Teknikal Malaysia Melaka; University Teknikal Malaysia Melaka	Alahnomi, RA; Zakaria, Z (corresponding author), Univ Tek Malaysia Melaka UTeM, Ctr Telecommun Res & Innovat CeTRI, Durian Tunggal, Melaka, Malaysia.	alrammah89@gmail.com; zahriladha@utem.edu.my	Ruslan, Eliyana/ABG-4527-2021; Zakaria, Zahriladha/AAR-8298-2020; Bahar, Amyrul Azuan Mohd/S-3620-2016; Alahnomi, Rammah/AAF-2206-2020	Ruslan, Eliyana/0000-0003-1323-9101; Zakaria, Zahriladha/0000-0003-1467-405X; Alahnomi, Rammah/0000-0001-9224-4130	UTeM Zamalah Scheme; Centre for Research and Innovation Management (CRIM); Universiti Teknikal Malaysia Melaka (UTeM); Ministry of Higher Education Malaysia (MOHE) [FRGS/1/2015/SG02/FKEKK/03/F00265]	UTeM Zamalah Scheme; Centre for Research and Innovation Management (CRIM); Universiti Teknikal Malaysia Melaka (UTeM); Ministry of Higher Education Malaysia (MOHE)(Ministry of Education, Malaysia)	This work was supported by UTeM Zamalah Scheme and funded by Centre for Research and Innovation Management (CRIM), Universiti Teknikal Malaysia Melaka (UTeM), and the Ministry of Higher Education Malaysia (MOHE) under research grant number FRGS/1/2015/SG02/FKEKK/03/F00265. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AS, 2015, MOB INF SYST, V2015, P1, DOI 10.1155/2015/641027; Alahnomi R.A., 2015, INT J APPL ENG RES, V10, P18395; Alahnomi RA, 2015, 2015 IEEE JORD C APP, P3; Alahnomi RA, 2016, MICROW OPT TECHN LET, V58, P2106, DOI 10.1002/mop.29979; Angkawisittpan N., 2012, ELECT REV, P178; Angkawisittpan N., 2012, INT J PHYS SCI, V7, P31; Ansari MAH, 2015, IEEE SENS J, V15, P7181, DOI 10.1109/JSEN.2015.2469683; Boybay MS, 2012, IEEE T INSTRUM MEAS, V61, P3039, DOI 10.1109/TIM.2012.2203450; Chen L. F., 2004, MICROWAVE ELECT MEAS; Il Kwon Kim, 2006, 2006 IEEE Antennas and Propagation Society International Symposium (IEEE Cat. No. 06CH37758C), P1483; Jilani MT, 2016, MICROW OPT TECHN LET, V58, P4, DOI 10.1002/mop.29487; Kulkarni S, 2015, IEEE T MICROW THEORY, V63, P2411, DOI 10.1109/TMTT.2015.2451110; Lee CS, 2014, IEEE MICROW WIREL CO, V24, P563, DOI 10.1109/LMWC.2014.2318900; Li Ke, 2011, Proceedings of the 2011 IEEE International Conference on Microwave Technology & Computational Electromagnetics (ICMTCE 2011), P233, DOI 10.1109/ICMTCE.2011.5915498; Lim JS, 2001, IEEE MICROW WIREL CO, V11, P170, DOI 10.1109/7260.916333; Liu HW, 2005, IEEE MICROW WIREL CO, V15, P55, DOI 10.1109/LMWC.2004.842809; Pozar DM, 2012, MICROWAVE ENG; RoyChoudhury S, 2016, BIOSENS BIOELECTRON; Rusni IM, 2014, SENSORS-BASEL, V14, P13134, DOI 10.3390/s140713134; Sun X, 2003, IEEE; Sung YJ, 2004, IEEE MICROW WIREL CO, V14, P7, DOI 10.1109/LMWC.2003.821499; Woo DJ, 2005, IEEE T MICROW THEORY, V53, P2139, DOI 10.1109/TMTT.2005.848772; Yatao Peng, 2013, Progress In Electromagnetics Research C, V36, P159; Zhou JH, 2013, INT CONF MEASURE, P234, DOI 10.1109/MIC.2013.6757955	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185122	10.1371/journal.pone.0185122	http://dx.doi.org/10.1371/journal.pone.0185122			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934301	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900096
J	Zhou, Z; Cong, PH; Tian, Y; Zhu, YM				Zhou, Zhe; Cong, Peihua; Tian, Yi; Zhu, Yanmin			Using RNA-seq data to select reference genes for normalizing gene expression in apple roots	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; QUANTITATIVE-PCR; RT-PCR; IDENTIFICATION; VALIDATION; ALIGNMENT; GENOME; TOOL	Gene expression in apple roots in response to various stress conditions is a less-explored research subject. Reliable reference genes for normalizing quantitative gene expression data have not been carefully investigated. In this study, the suitability of a set of 15 apple genes were evaluated for their potential use as reliable reference genes. These genes were selected based on their low variance of gene expression in apple root tissues from a recent RNA-seq data set, and a few previously reported apple reference genes for other tissue types. Four methods, Delta Ct, geNorm, NormFinder and BestKeeper, were used to evaluate their stability in apple root tissues of various genotypes and under different experimental conditions. A small panel of stably expressed genes, MDP0000095375, MDP0000147424, MDP0000233640, MDP0000326399 and MDP0000173025 were recommended for normalizing quantitative gene expression data in apple roots under various abiotic or biotic stresses. When the most stable and least stable reference genes were used for data normalization, significant differences were observed on the expression patterns of two target genes, MdLecRLK5 (MDP0000228426, a gene encoding a lectin receptor like kinase) and MdMAPK3 (MDP0000187103, a gene encoding a mitogen-activated protein kinase). Our data also indicated that for those carefully validated reference genes, a single reference gene is sufficient for reliable normalization of the quantitative gene expression. Depending on the experimental conditions, the most suitable reference genes can be specific to the sample of interest for more reliable RT-qPCR data normalization.	[Zhou, Zhe; Cong, Peihua; Tian, Yi] Chinese Acad Agr Sci, Inst Pomol, Xingcheng, Liaoning, Peoples R China; [Zhu, Yanmin] ARS, USDA, Tree Fruit Res Lab, Wenatchee, WA 98801 USA	Chinese Academy of Agricultural Sciences; Institute of Pomology, CAAS; United States Department of Agriculture (USDA)	Cong, PH (corresponding author), Chinese Acad Agr Sci, Inst Pomol, Xingcheng, Liaoning, Peoples R China.; Zhu, YM (corresponding author), ARS, USDA, Tree Fruit Res Lab, Wenatchee, WA 98801 USA.	congph@163.com; yanmin.zhu@ars.usda.gov			USDA; Washington Tree Fruit Research Commission	USDA(United States Department of Agriculture (USDA)); Washington Tree Fruit Research Commission	This work was supported by USDA base fund and the research fund from Washington Tree Fruit Research Commission.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borges AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111399; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bowen JH, 29 INT HORT C HORT S, P179; Bowen J, 2014, TREE GENET GENOMES, V10, P751, DOI 10.1007/s11295-014-0720-6; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hoang VL, 2016, PEERJ, V4; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanubile A, 2015, MOL PLANT MICROBE IN, V28, P546, DOI 10.1094/MPMI-09-14-0269-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; Mazzola M, 1997, PHYTOPATHOLOGY, V87, P582, DOI 10.1094/PHYTO.1997.87.6.582; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shin SB, 2016, PHYSIOL MOL PLANT P, V94, P16, DOI 10.1016/j.pmpp.2016.03.003; Shin SB, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.53; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stanton KA, 2017, G3-GENES GENOM GENET, V7, P1085, DOI 10.1534/g3.116.038075; Sun HP, 2016, PLANT PHYSIOL BIOCH, V108, P286, DOI 10.1016/j.plaphy.2016.07.022; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Zhu Y, 2017, INT J PLANT GENOM	44	29	31	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185288	10.1371/journal.pone.0185288	http://dx.doi.org/10.1371/journal.pone.0185288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934340	Green Submitted, gold, Green Published			2022-12-27	WOS:000411339900141
J	Dowell, AC; Cobby, E; Wen, KS; Devall, AJ; During, V; Anderson, J; James, ND; Cheng, KK; Zeegers, MP; Bryan, RT; Taylor, GS				Dowell, Alexander C.; Cobby, Ellen; Wen, Kaisheng; Devall, Adam J.; During, Vinnie; Anderson, Jane; James, Nicholas D.; Cheng, Kar K.; Zeegers, Maurice P.; Bryan, Richard T.; Taylor, Graham S.			Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; IL-17; RECURRENCE; EXPRESSION; CYTOKINES; PROGRESSION; PROGNOSIS; SURVIVAL; THERAPY	The tumour immune microenvironment is considered to influence cancer behaviour and outcome. Using a panel of markers for innate and adaptive immune cells we set out to characterise and understand the bladder tumour microenvironment of 114 patients from a prospective multicentre cohort of newly-diagnosed bladder cancer patients, followed-up for 4.33 +/- 1.71 years. We found IL-17-positive cells were significantly increased in primary and concomitant carcinoma in situ (CIS), p<0.0001, a highly malignant lesion which is the most significant single risk factor for disease progression. Further characterisation of the tumour immunophenotype identified IL-17+ cells as predominantly mast cells rather than T-cells, in contrast to most other tumour types. Expression of the IL-17-receptor in bladder tumours, and functional effects and gene expression changes induced by IL-17 in bladder tumour cells in vitro suggest a role in tumour behaviour. Finally, we assessed the effects of IL-17 in the context of patient outcome, following intravesical BCG immunotherapy which is the standard of care; higher numbers of IL-17+ cells were associated with improved event-free survival (p = 0.0449, HR 0.2918, 95% CI 0.08762-0.9721) in patients with primary and concomitant CIS (n = 41), we propose a model of IL-17+ Mast cells mechanism of action. Thus, in the context of bladder CIS, IL-17+ mast cells predict favourable outcome following BCG immunotherapy indicative of a novel mechanism of BCG immunotherapy in UBC and could form the basis of a stratified approach to treatment.	[Dowell, Alexander C.; Taylor, Graham S.] Univ Birmingham, Inst Immunol & Immunotherapy, Vincent Dr, Birmingham, W Midlands, England; [Cobby, Ellen] Royal Shrewsbury Hosp, Shrewsbury, Salop, England; [Wen, Kaisheng; During, Vinnie; Anderson, Jane; James, Nicholas D.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Devall, Adam J.] Univ Birmingham, Inst Appl Hlth Res, Birmingham Clin Trials Unit, Public Hlth Bldg, Edgbaston, England; [Cheng, Kar K.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Zeegers, Maurice P.] Maastricht Univ, Nutr & Translat Res Metab Sch NUTRIM, Maastricht, Netherlands; [Zeegers, Maurice P.] Maastricht Univ, Care & Publ Hlth Res Inst, Sch CAPHRI, Maastricht, Netherlands; [Zeegers, Maurice P.; Bryan, Richard T.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); University of Birmingham	Bryan, RT (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England.	r.t.bryan@bham.ac.uk	Bryan, Richard T/AAJ-9325-2021; Cheng, Kar/AAL-8899-2021; Devall, Adam/AAC-9646-2022	Bryan, Richard T/0000-0003-2853-4293; Cheng, Kar/0000-0002-1516-1857; Zeegers, Maurice/0000-0002-2387-083X; Dowell, Alexander/0000-0002-1909-7047; Taylor, Graham/0000-0002-4807-2797	Birmingham Cancer Research UK Centre Development Fund [DF-21/TC/0710]	Birmingham Cancer Research UK Centre Development Fund	This work was supported by the Birmingham Cancer Research UK Centre Development Fund DF-21/TC/0710. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abol-Enein H, 2005, EUR UROL, V48, P202, DOI 10.1016/j.eururo.2005.04.006; Amicarella F, 2015, GUT; Antoni S., 2016, EUR UROL; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Bryan RT, 2013, BJU INT, V112, P169, DOI 10.1111/bju.12032; Chavan S, 2014, EUR UROL, V66, P59, DOI 10.1016/j.eururo.2013.10.001; Chen X, 2010, LUNG CANCER, V69, P348, DOI 10.1016/j.lungcan.2009.11.013; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Di Pierro GB, 2012, CURR GENOMICS, V13, P395, DOI 10.2174/138920212801619232; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Kamat AM, 2016, EUR UROL, V69, P197, DOI 10.1016/j.eururo.2015.06.023; Keijsers RRMC, 2014, EXP DERMATOL, V23, P799, DOI 10.1111/exd.12487; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lin LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028984; Lin Y, 2015, CLIN TRANSL ONCOL, V17, P50, DOI 10.1007/s12094-014-1197-3; Liu XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106834; Liu XX, 2014, FUTURE ONCOL, V10, P1443, DOI [10.2217/fon.14.79, 10.2217/FON.14.79]; Liu YB, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0174-8; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Melillo RM, 2010, ONCOGENE, V29, P6203, DOI 10.1038/onc.2010.348; Mrabet-Dahbi S, 2009, EXP DERMATOL, V18, P437, DOI 10.1111/j.1600-0625.2009.00878.x; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Nakae S, 2005, P NATL ACAD SCI USA, V102, P6467, DOI 10.1073/pnas.0501912102; Noordenbos T, 2016, J LEUKOCYTE BIOL, V100, P453, DOI 10.1189/jlb.3HI1215-542R; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Otto W, 2012, WORLD J UROL, V30, P875, DOI 10.1007/s00345-012-0974-2; RILEY GF, 1995, MED CARE, V33, P828, DOI 10.1097/00005650-199508000-00007; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Sibilano R, 2012, J IMMUNOL, V189, P120, DOI 10.4049/jimmunol.1200009; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Suurmond J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3466; Sylvester RJ, 2005, UROLOGY, V66, P90, DOI 10.1016/j.urology.2005.06.135; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Sylvester RJ, 2005, J UROLOGY, V174, P86, DOI 10.1097/01.ju.0000162059.64886.1c; Takeuchi A, 2011, EUR J IMMUNOL, V41, P246, DOI 10.1002/eji.201040773; Thalmann GN, 2000, J UROLOGY, V164, P2129, DOI 10.1016/S0022-5347(05)66983-2; Thalmann GN, 1997, J UROLOGY, V158, P1340, DOI 10.1016/S0022-5347(01)64210-1; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Wallace DMA, 2002, BJU INT, V89, P868, DOI 10.1046/j.1464-410X.2002.02776.x; Wang B, 2013, CANCER IMMUNOL IMMUN, V62, P1575, DOI 10.1007/s00262-013-1460-4; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x; Zeegers MP, 2010, BJU INT, V105, P784, DOI 10.1111/j.1464-410X.2009.08849.x; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195; Zuiverloon TCM, 2016, EUR UROL, V69, P201, DOI 10.1016/j.eururo.2015.07.010; Zuiverloon TCM, 2012, EUR UROL, V61, P128, DOI 10.1016/j.eururo.2011.09.026; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	57	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184841	10.1371/journal.pone.0184841	http://dx.doi.org/10.1371/journal.pone.0184841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931051	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700038
J	Li, O; Xiao, R; Sun, LH; Guan, CL; Kong, DD; Hu, XF				Li, Ou; Xiao, Rong; Sun, Lihua; Guan, Chenglin; Kong, Dedong; Hu, Xiufang			Bacterial and diazotrophic diversities of endophytes in Dendrobium catenatum determined through barcoded pyrosequencing	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; PLANT-GROWTH; SPHINGOMONAS-PAUCIMOBILIS; ASSOCIATIVE CYANOBACTERIA; NITROGEN-FIXATION; GENETIC DIVERSITY; NIFH GENES; SP NOV.; ROOTS; ORCHID	As an epiphyte orchid, Dendrobium catenatum relies on microorganisms for requisite nutrients. Metagenome pyrosequencing based on 16S rRNA and nifH genes was used to characterize the bacterial and diazotrophic communities associated with D. catenatum collected from 5 districts in China. Based on Meta-16S rRNA sequencing, 22 bacterial phyla and 699 genera were identified, distributed as 125 genera from 8 phyla and 319 genera from 10 phyla shared by all the planting bases and all the tissues, respectively. The predominant Proteobacteria varied from 71.81% (GZ) to 96.08% (YN), and Delftia (10.39-38.42%), Burkholderia (2.71-15.98%), Escherichia/Shigella (4.90-25.12%), Pseudomonas (2.68-30.72%) and Sphingomonas (1.83-2.05%) dominated in four planting bases. Pseudomonas (17.94-22.06%), Escherichia/Shigella (6.59-11.59%), Delftia (9.65-22.14%) and Burkholderia (3.12-11.05%) dominated in all the tissues. According to Meta-nifH sequencing, 4 phyla and 45 genera were identified, while 17 genera and 24 genera from 4 phyla were shared by all the planting bases and all the tissues, respectively. Burkholderia and Bradyrhizobium were the most popular in the planting bases, followed by Methylovirgula and Mesorhizobium. Mesorhizobium was the most popular in different tissues, followed by Bei-jerinckia, Xanthobacter, and Burkholderia. Among the genera, 39 were completely overlapped with the results based on the 16S rRNA gene. In conclusion, abundant bacteria and diazotrophs were identified in common in different tissues of D. catenatum from five planting bases, which might play a great role in the supply of nutrients such as nitrogen. The exact abundance of phylum and genus on the different tissues from different planting bases need deeper sequencing with more samples.	[Li, Ou; Xiao, Rong; Guan, Chenglin; Hu, Xiufang] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Sun, Lihua] Zhejiang Acad Med Sci, Hangzhou, Zhejiang, Peoples R China; [Kong, Dedong] Zhejiang Univ, Agr Expt Stn, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Zhejiang Academy of Medical Sciences; Zhejiang University	Hu, XF (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.; Kong, DD (corresponding author), Zhejiang Univ, Agr Expt Stn, Hangzhou, Zhejiang, Peoples R China.	ntzx@zju.edu.cn; huxiuf@zstu.edu.cn			National Natural Science Foundation of China [81673537]; Zhejiang Natural Science Foundation of China [LY16C030002, LY15C010005]; Key research and development projects of Zhejiang Province [2015C02030]; Zhejiang Province Public Agricultural Project [2014C32117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation of China; Key research and development projects of Zhejiang Province; Zhejiang Province Public Agricultural Project	The research is supported by National Natural Science Foundation of China (81673537), Zhejiang Natural Science Foundation of China (LY16C030002 & LY15C010005), Key research and development projects of Zhejiang Province (2015C02030), and Zhejiang Province Public Agricultural Project (2014C32117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research is supported by National Natural Science Foundation of China (81673537), Zhejiang Natural Science Foundation of China (LY16C030002 & LY15C010005), Key research and development projects of Zhejiang Province (2015C02030), and Zhejiang Province Public Agricultural Project (2014C32117). We are grateful to Dr. Greg Duns for his valuable comments on the manuscript.	Ahmad F, 2008, MICROBIOL RES, V163, P173, DOI 10.1016/j.micres.2006.04.001; Araujo WL, 2001, CAN J MICROBIOL, V47, P229, DOI 10.1139/cjm-47-3-229; Asis CA, 2004, LETT APPL MICROBIOL, V38, P19, DOI 10.1046/j.1472-765X.2003.01434.x; Balachandar D, 2008, BRAZ J MICROBIOL, V39, P68, DOI [10.1590/S1517-83822008000100017, 10.1590/S1517-838220080001000017]; Baldani JI, 2005, AN ACAD BRAS CIENC, V77, P549, DOI 10.1590/S0001-37652005000300014; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Banerjee MR, 2009, Unite states patent US, Patent No. 7491535; Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Berg G., 2015, PRINCIPLES PLANT MIC, P419, DOI [DOI 10.1007/978-3-319-08575-3_44, 10.1007/978-3-319-08575-3_44]; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bolhuis H, 2010, ISME J, V4, P121, DOI 10.1038/ismej.2009.99; BOTTOMLEY PJ, 1990, APPL ENVIRON MICROB, V56, P533, DOI 10.1128/AEM.56.2.533-540.1990; BOWEN GD, 1979, SOIL BIOL BIOCHEM, V11, P119, DOI 10.1016/0038-0717(79)90087-7; Brundrett M.C., 2006, MICROBIAL ROOT ENDOP, P281; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chinese Pharmacopoeia Commission, 2005, PHARMACOPOEIA PEOPLE; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; CORPE WA, 1982, DEV IND MICROBIOL, V23, P483; da Silva JAT, 2015, PLANTA, V242, P1, DOI 10.1007/s00425-015-2301-9; Dalton DA, 2004, FEMS MICROBIOL ECOL, V49, P469, DOI 10.1016/j.femsec.2004.04.010; De Meyer SE, 2015, SOIL BIOL BIOCHEM, V83, P1, DOI 10.1016/j.soilbio.2015.01.002; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelhard M, 2000, ENVIRON MICROBIOL, V2, P131, DOI 10.1046/j.1462-2920.2000.00078.x; Frey-Klett P, 2005, NEW PHYTOL, V168, P4, DOI 10.1111/j.1469-8137.2005.01553.x; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Graff A, 2003, SYST APPL MICROBIOL, V26, P445, DOI 10.1078/072320203322497482; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Hoppe B, 2016, SCI REP-UK, V6, DOI 10.1038/srep10498; Hou XQ, 2009, J INTEGR PLANT BIOL, V51, P374, DOI 10.1111/j.1744-7909.2008.00777.x; Hsueh PR, 1998, CLIN INFECT DIS, V26, P676, DOI 10.1086/514595; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Iguchi Hiroyuki, 2015, Microorganisms, V3, P137, DOI 10.3390/microorganisms3020137; Jacquemyn H, 2013, MICROBIOLOGYOPEN, V2, P644, DOI 10.1002/mbo3.103; Jarabo-Lorenzo A, 2003, SYST APPL MICROBIOL, V26, P611, DOI 10.1078/072320203770865927; Jones WE, 1998, ANN BOT-LONDON, V82, P189, DOI 10.1006/anbo.1998.0664; Kang YS, 2007, INT J SYST EVOL MICR, V57, P2849, DOI 10.1099/ijs.0.65262-0; Kenzaka T, 2001, J HEALTH SCI, V47, P353, DOI 10.1248/jhs.47.353; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; LEIFERT C, 1989, J APPL BACTERIOL, V67, P353, DOI 10.1111/j.1365-2672.1989.tb02505.x; Li M, 2012, SYST APPL MICROBIOL, V35, P239, DOI 10.1016/j.syapm.2012.02.004; LIDSTROMOCONNOR ME, 1983, J GEN MICROBIOL, V129, P3139; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu DeGuo, 2011, Guizhou Agricultural Sciences, P169; Ma YN, 2017, CURR PHARM ANAL, V13; Madhaiyan M, 2007, INT J SYST EVOL MICR, V57, P326, DOI 10.1099/ijs.0.64603-0; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; MCINROY JA, 1995, PLANT SOIL, V173, P337, DOI 10.1007/BF00011472; Mehnaz S, 2006, MICROB ECOL, V51, P326, DOI 10.1007/s00248-006-9039-7; MEYER JR, 1986, SOIL BIOL BIOCHEM, V18, P185, DOI 10.1016/0038-0717(86)90025-8; Morel MA, 2011, ARCH MICROBIOL, V193, P63, DOI 10.1007/s00203-010-0632-2; Mosin O, 2014, EUR J MOL BIOTECHNOL, V5, P131, DOI DOI 10.13187/ejmb.2014.5.131; Mulet M, 2009, MOL CELL PROBE, V23, P140, DOI 10.1016/j.mcp.2009.02.001; Nouioui I, 2011, ANTON LEEUW INT J G, V100, P579, DOI 10.1007/s10482-011-9613-y; Omer ZS, 2004, FEMS MICROBIOL ECOL, V47, P319, DOI 10.1016/S0168-6496(04)00003-0; Peix A, 2001, SOIL BIOL BIOCHEM, V33, P103, DOI 10.1016/S0038-0717(00)00120-6; Poly F, 2001, RES MICROBIOL, V152, P95, DOI 10.1016/S0923-2508(00)01172-4; Prasannakumar SP, 2015, LETT APPL MICROBIOL, V61, P460, DOI 10.1111/lam.12479; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Rai AN, 2000, NEW PHYTOL, V147, P449, DOI 10.1046/j.1469-8137.2000.00720.x; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Sahoo K, 2009, INDIAN J MAR SCI, V38, P249; Sandrasagaran UM, 2014, PAK J BOT, V46, P719; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shekhovtsova N. V., 2013, Advances in Bioscience and Biotechnology, V4, P35; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SMALL FJ, 1995, J BACTERIOL, V177, P6170, DOI 10.1128/jb.177.21.6170-6175.1995; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stovold GE, 2001, AUSTRALAS PLANT PATH, V30, P73, DOI 10.1071/AP00066; Tsavkelova EA, 2005, MICROBIOLOGY+, V74, P46, DOI 10.1007/s11021-005-0027-6; Tsavkelova EA, 2003, MICROBIOLOGY+, V72, P86, DOI 10.1023/A:1022286225013; Tsavkelova EA, 2003, MICROBIOLOGY+, V72, P92, DOI 10.1023/A:1022238309083; Tsavkelova E, 2011, BACTERIA IN AGROBIOLOGY: PLANT GROWTH RESPONSES, P221, DOI 10.1007/978-3-642-20332-9_11; Tsavkelova EA, 2007, MICROBIOL RES, V162, P69, DOI 10.1016/j.micres.2006.07.014; vandenBergh ERE, 1996, J BACTERIOL, V178, P888, DOI 10.1128/jb.178.3.888-893.1996; Videira SS, 2009, FEMS MICROBIOL LETT, V293, P11, DOI 10.1111/j.1574-6968.2008.01475.x; Vijayabaskar P., 2011, ADV BIOL RES, V5, P99; Vyas P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-174; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weber OB, 1999, PLANT SOIL, V210, P103, DOI 10.1023/A:1004623523179; Wiegel J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P290, DOI 10.1007/0-387-30745-1_16; Xavier LJC, 2003, SOIL BIOL BIOCHEM, V35, P471, DOI 10.1016/S0038-0717(03)00003-8; Xiao CH, 2010, J BASIC MICROB, V50, P373, DOI 10.1002/jobm.200900317; Xie CH, 2006, INT J SYST EVOL MICR, V56, P889, DOI 10.1099/ijs.0.64056-0; Yang SJ, 2014, MICROB BIOTECHNOL, V7, P611, DOI 10.1111/1751-7915.12148; Yu J, 2013, APPL MICROBIOL BIOT, V97, P9825, DOI 10.1007/s00253-013-5294-y; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105	96	13	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184717	10.1371/journal.pone.0184717	http://dx.doi.org/10.1371/journal.pone.0184717			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931073	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700030
J	Caraher, EJ; Kwon, S; Haider, SH; Crowley, G; Lee, A; Ebrahim, M; Zhang, LQ; Chen, LC; Gordon, T; Liu, ML; Prezant, DJ; Schmidt, AM; Nolan, A				Caraher, Erin J.; Kwon, Sophia; Haider, Syed H.; Crowley, George; Lee, Audrey; Ebrahim, Minah; Zhang, Liqun; Chen, Lung-Chi; Gordon, Terry; Liu, Mengling; Prezant, David J.; Schmidt, Ann Marie; Nolan, Anna			Receptor for advanced glycation end-products and World Trade Center particulate induced lung function loss: A case-cohort study and murine model of acute particulate exposure	PLOS ONE			English	Article							YORK-CITY FIREFIGHTERS; AIR-FLOW OBSTRUCTION; SMOOTH-MUSCLE-CELLS; SOLUBLE RECEPTOR; CENTER DISASTER; INFLAMMATORY RESPONSE; LYSOPHOSPHATIDIC ACID; ANTIINFLAMMATORY ROLE; METABOLIC SYNDROME; EPITHELIAL-CELLS	World Trade Center-particulate matter(WTC-PM) exposure and metabolic-risk are associated with WTC-Lung Injury(WTC-LI). The receptor for advanced glycation end-products (RAGE) is most highly expressed in the lung, mediates metabolic risk, and single-nucleotide polymorphisms at the AGER-locus predict forced expiratory volume(FEV). Our objectives were to test the hypotheses that RAGE is a biomarker of WTC-LI in the FDNY-cohort and that loss of RAGE in a murine model would protect against acute PM-induced lung disease. We know from previous work that early intense exposure at the time of the WTC collapse was most predictive of WTC-LI therefore we utilized a murine model of intense acute PM-exposure to determine if loss of RAGE is protective and to identify signaling/cytokine intermediates. This study builds on a continuing effort to identify serum biomarkers that predict the development of WTC-LI. A case-cohort design was used to analyze a focused cohort of male never-smokers with normal pre-9/11 lung function. Odds of developing WTC-LI increased by 1.2, 1.8 and 1.0 in firefighters with soluble RAGE (sRAGE) >= 97pg/mL, CRP >= 2.4mg/L, and MMP-9 <= 397ng/mL, respectively, assessed in a multivariate logistic regression model (ROCAUC of 0.72). Wild type(WT) and RAGE-deficient(Ager(-/-)) mice were exposed to PM or PBS-control by oropharyngeal aspiration. Lung function, airway hyperreactivity, bronchoalveolar lavage, histology, transcription factors and plasma/BAL cytokines were quantified. WT-PM mice had decreased FEV and compliance, and increased airway resistance and methacholine reactivity after 24-hours. Decreased IFN-Y and increased LPA were observed in WT-PM mice; similar findings have been reported for firefighters who eventually develop WTC-LI. In the murine model, lack of RAGE was protective from loss of lung function and airway hyperreactivity and was associated with modulation of MAP kinases. We conclude that in a multivariate adjusted model increased sRAGE is associated with WTC-LI. In our murine model, absence of RAGE mitigated acute deleterious effects of PM and may be a biologically plausible mediator of PM-related lung disease.	[Caraher, Erin J.; Kwon, Sophia; Haider, Syed H.; Crowley, George; Lee, Audrey; Ebrahim, Minah; Zhang, Liqun; Nolan, Anna] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10003 USA; [Zhang, Liqun] Army Gen Hosp, PLA, Dept Resp Med, Beijing, Peoples R China; [Chen, Lung-Chi; Gordon, Terry; Liu, Mengling; Nolan, Anna] NYU, Sch Med, Dept Environm Med, New York, NY 10003 USA; [Liu, Mengling] NYU, Sch Med, Dept Populat Hlth, Div Biostat, New York, NY USA; [Prezant, David J.; Nolan, Anna] Fire Dept New York, Bur Hlth Serv, Brooklyn, NY 11201 USA; [Prezant, David J.; Nolan, Anna] Fire Dept New York, Off Med Affairs, Brooklyn, NY 11201 USA; [Prezant, David J.] Montefiore Med Ctr, Dept Med, Pulm Med Div, Bronx, NY 10467 USA; [Prezant, David J.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Schmidt, Ann Marie] NYU, Sch Med, Dept Biochem, Div Endocrinol, New York, NY 10016 USA; [Schmidt, Ann Marie] NYU, Sch Med, Dept Mol Pharmacol & Pathol, Div Endocrinol, New York, NY USA	New York University; New York University; New York University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University; New York University	Nolan, A (corresponding author), NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10003 USA.; Nolan, A (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10003 USA.; Nolan, A (corresponding author), Fire Dept New York, Bur Hlth Serv, Brooklyn, NY 11201 USA.; Nolan, A (corresponding author), Fire Dept New York, Off Med Affairs, Brooklyn, NY 11201 USA.	anna.nolan@med.nyu.edu	Nolan, Anna/C-2796-2012	Nolan, Anna/0000-0002-0631-1171; Liu, Mengling/0000-0001-9758-8522; Chen, Lung Chi/0000-0003-1154-2107; Kwon, Sophia/0000-0003-3639-5107	National Heart Lung and Blood Institute [R01HL119326, K23HL08419]; National Institute of Occupational Safety and Health [U10-OH008243, U10-OH008242]; National Institute of Environmental Health Sciences [P30-00260, UL1RR029893]; National Institutes of Health [UL1TR001445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U01OH011300] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by National Heart Lung and Blood Institute (R01HL119326, K23HL08419), National Institute of Occupational Safety and Health (U10-OH008243, U10-OH008242), National Institute of Environmental Health Sciences (P30-00260, UL1RR029893), National Institutes of Health (UL1TR001445), and the Saperstein Scholars Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2016, CHEST, V149, P1419, DOI 10.1016/j.chest.2015.10.067; Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Allen IC, SPRINGER SCI BUSINES; Antao VC, 2013, EUR RESPIR J, V41, P999, DOI 10.1183/09031936.00181112; Balmes JR, 2012, CHEST, V142, P278, DOI 10.1378/chest.12-0126; Berger KI, 2013, CHEST, V144, P249, DOI 10.1378/chest.12-1411; Berkman N, 1996, IMMUNOLOGY, V87, P599, DOI 10.1046/j.1365-2567.1996.477579.x; Beucher J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041913; Boulet Louis-Philippe, 2005, Can Respir J, V12, P371; BRUNEKREEF B, 1993, J EXPO ANAL ENV EPID, V3, P117; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Caffrey AK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004625; Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889; Carbognin E, 2016, EMBO J, V35, P618, DOI 10.15252/embj.201592629; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Cheng DT, 2013, AM J RESP CRIT CARE, V188, P948, DOI 10.1164/rccm.201302-0247OC; CHO S, 2013, AM J RESP CRIT CARE, V187; Cho S, 2013, CTS-CLIN TRANSL SCI, V6, P136; Collins RA, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-142; Corvol H, 2012, J CYST FIBROS, V11, P63, DOI 10.1016/j.jcf.2011.09.006; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; de Castro HA, 2009, REV SAUDE PUBL, V43, P26, DOI 10.1590/S0034-89102009000100004; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Ferrier NV, 2011, AM J RESP CRIT CARE, V183; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P981, DOI 10.1289/ehp.5931; Ge X, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-110; Geyh AS, 2005, J OCCUP ENVIRON HYG, V2, P179, DOI 10.1080/15459620590923154; Gold JA, 2003, INFECT IMMUN, V71, P3521, DOI 10.1128/IAI.71.6.3521-3528.2003; HABER PS, 1983, J APPL PHYSIOL, V54, P837, DOI 10.1152/jappl.1983.54.3.837; Hamakawa H, 2011, AM J RESP CELL MOL, V45, P517, DOI 10.1165/rcmb.2010-0473OC; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; Hartney JM, 2013, METHODS MOL BIOL, V1032, P205, DOI 10.1007/978-1-62703-496-8_16; He M, 2007, AM J PHYSIOL-LUNG C, V293, pL1427, DOI 10.1152/ajplung.00075.2007; Holguin F, 2012, AM J RESP CRIT CARE, V185, P352, DOI 10.1164/rccm.201112-2172ED; Hoonhorst SJM, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0363-2; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hunt LC, 2013, HISTOCHEM CELL BIOL, V139, P13, DOI 10.1007/s00418-012-1018-0; Jabaudon M, 2015, RESPIROLOGY, V20, P1131, DOI 10.1111/resp.12583; Jabaudon M, 2015, AM J RESP CRIT CARE, V192, P191, DOI 10.1164/rccm.201501-0020OC; John M, 1997, J IMMUNOL, V158, P1841; Katsuoka F, 1997, BIOCHEM BIOPH RES CO, V238, P512, DOI 10.1006/bbrc.1997.7263; Kazeros A, 2015, J OCCUP ENVIRON MED, V57, P610, DOI 10.1097/JOM.0000000000000458; Kazeros A, 2013, J ASTHMA, V50, P25, DOI 10.3109/02770903.2012.743149; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kurimoto E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-5; Kwon S, 2013, CTS-CLIN TRANSL SCI, V6, P151; Kwon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076099; Laki J, 2006, INT IMMUNOL, V18, P1585, DOI 10.1093/intimm/dxl091; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; LUM H, 1990, J APPL PHYSIOL, V68, P2280, DOI 10.1152/jappl.1990.68.6.2280; Manichaikul A, 2017, ANN AM THORACIC SOC; Manigrasso MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep22450; Matsumoto H, 2015, J TRAUMA ACUTE CARE, V78, P1086, DOI [10.1097/TA.0000000000000653, 10.1097/TA.0000000000000651]; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; McGovern TK, 2013, JOVE-J VIS EXP, DOI 10.3791/50172; Metz VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041823; MIETTINEN O, 1982, SCAND J WORK ENV HEA, V8, P7; Miller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164041; Milutinovic PS, 2012, AM J PATHOL, V181, P1215, DOI 10.1016/j.ajpath.2012.06.031; Mitzner W, 2008, J APPL PHYSIOL, V105, P1980, DOI 10.1152/japplphysiol.90968.2008; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052587; Munoz-Barrutia A, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/734734; Naveed B, 2012, AM J RESP CRIT CARE, V185; Naveed B, 2012, AM J RESP CRIT CARE, V185, P392, DOI 10.1164/rccm.201109-1672OC; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Nolan A, 2004, INFLAMMATION, V28, P271, DOI 10.1007/s10753-004-6050-3; Nolan A, 2004, SHOCK, V22, P538, DOI 10.1097/01.shk.0000143416.20649.30; Nolan A, 2008, AM J RESP CRIT CARE, V177, P301, DOI 10.1164/rccm.200703-515OC; Nolan A, 2012, CHEST, V142, P412, DOI 10.1378/chest.11-1202; Novali M, 2015, RESP PHYSIOL NEUROBI, V218, P11, DOI 10.1016/j.resp.2015.07.007; OLDMIXON EH, 1994, J MICROSC-OXFORD, V175, P60, DOI 10.1111/j.1365-2818.1994.tb04788.x; Patel HJ, 2003, J IMMUNOL, V170, P2663, DOI 10.4049/jimmunol.170.5.2663; Penyige A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-152; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; PRENTICE RL, 1986, BIOMETRICS, V42, P301, DOI 10.2307/2531051; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Quinton LJ, 2012, J IMMUNOL, V188, P6300, DOI 10.4049/jimmunol.1200256; Rai V, 2012, J EXP MED, V209, P2339, DOI 10.1084/jem.20120873; Ramsgaard L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009604; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P411, DOI 10.1165/rcmb.2010-0231OC; Rice MB, 2015, AM J RESP CRIT CARE, V191, P656, DOI 10.1164/rccm.201410-1875OC; Rivera-Sanchez YM, 2004, J APPL PHYSIOL, V96, P2200, DOI 10.1152/japplphysiol.00960.2003; Robichaud A, 2015, AM J PHYSIOL-LUNG C, V308, pL837, DOI 10.1152/ajplung.00343.2014; Rom William N, 2010, Proc Am Thorac Soc, V7, P142, DOI 10.1513/pats.200908-092RM; Rom WN, 2002, AM J RESP CRIT CARE, V166, P797, DOI 10.1164/rccm.200206-576OC; Rundle AG, 2005, CANCER EPIDEM BIOMAR, V14, P1899, DOI 10.1158/1055-9965.EPI-04-0860; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Ryu MH, 2014, AM J PHYSIOL-LUNG C, V307, pL765, DOI 10.1152/ajplung.00100.2014; Sabbagh MN, 2011, ALZ DIS ASSOC DIS, V25, P206, DOI 10.1097/WAD.0b013e318204b550; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Sambamurthy N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118979; SCHENCK E, 2013, AM J RESP CRIT CARE, V187; Schenck Edward J, 2014, BMJ Open, V4, pe005575, DOI 10.1136/bmjopen-2014-005575; Schmidt AM, 2015, VASC PHARMACOL, V72, P1, DOI 10.1016/j.vph.2015.06.011; SCHWARTZ J, 1995, THORAX, V50, P531, DOI 10.1136/thx.50.5.531; Shalaby KH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-82; Shvedova AA, 2014, AM J PHYSIOL-LUNG C, V306, pL170, DOI 10.1152/ajplung.00167.2013; Song F, 2014, DIABETES, V63, P1948, DOI 10.2337/db13-1636; Soutiere SE, 2004, RESP PHYSIOL NEUROBI, V140, P283, DOI 10.1016/j.resp.2004.02.003; Standiford Theodore J, 2005, Proc Am Thorac Soc, V2, P226, DOI 10.1513/pats.200501-010AC; Su X, 2009, AM J PHYSIOL-LUNG C, V297, pL1, DOI 10.1152/ajplung.90546.2008; Sukkar MB, 2012, EUR RESPIR J, V39, P721, DOI 10.1183/09031936.00022011; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Szatmari I, 2008, EMBO J, V27, P2353, DOI 10.1038/emboj.2008.160; Timonen KL, 2002, OCCUP ENVIRON MED, V59, P129, DOI 10.1136/oem.59.2.129; Toure F, 2008, BIOCHEM J, V416, P255, DOI 10.1042/BJ20080054; Tsukiji J, 2014, BIOMARKERS, V19, P159, DOI 10.3109/1354750X.2014.891047; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Vela L, 2016, J BIOMOLECULAR SCREE; Wang G, 2005, METABOLISM, V54, P590, DOI 10.1016/j.metabol.2004.11.017; Wang K, 2006, J PHARMACOL EXP THER, V317, P37, DOI 10.1124/jpet.105.095125; Waseda K, 2015, AM J RESP CELL MOL, V52, P482, DOI 10.1165/rcmb.2014-0027OC; Weiden M. D., 2012, EUROPEAN RESP J, P1023; Weiden MD, 2015, SEMIN RESP CRIT CARE, V36, P323, DOI 10.1055/s-0035-1547349; Weiden MD, 2013, EUR RESPIR J, V41, P1023, DOI 10.1183/09031936.00077012; Weiden MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040016; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580; Winden DR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-108; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yan SF, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S146239940900101X; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; YANG QH, 1991, J APPL PHYSIOL, V71, P76, DOI 10.1152/jappl.1991.71.1.76; Yonchuk JG, 2015, AM J RESP CRIT CARE, V192, P785, DOI 10.1164/rccm.201501-0137PP; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Zhou B, 2013, FASEB J, V27; Zhu M, 2001, J IMMUNOL, V166, P2049, DOI 10.4049/jimmunol.166.3.2049	141	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184331	10.1371/journal.pone.0184331	http://dx.doi.org/10.1371/journal.pone.0184331			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926576	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600014
J	Liu, ML; Clarke, CJ; Salama, MF; Choim, YJ; Obeid, LM; Hannun, YA				Liu, Mengling; Clarke, Christopher J.; Salama, Mohamed F.; Choim, Yeon Ja; Obeid, Lina M.; Hannun, Yusuf A.			Co-ordinated activation of classical and novel PKC isoforms is required for PMA-induced mTORC1 activation	PLOS ONE			English	Article							PROTEIN-KINASE-C; TUMOR-SUPPRESSOR COMPLEX; PROMOTING PHORBOL ESTERS; PHOSPHOLIPASE-D; RAG GTPASES; RECYCLING ENDOSOMES; SIGNALING PATHWAYS; PHOSPHATIDIC-ACID; DEPENDENT MANNER; AMINO-ACIDS	Protein kinase C (PKC) has been shown to activate the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway, a central hub in the regulation of cell metabolism, growth and proliferation. However, the mechanisms by which PKCs activate mTORC1 are still ambiguous. Our previous study revealed that activation of classical PKCs (cPKC) results in the perinuclear accumulation of cPKC and phospholipase D2 (PLD2) in recycling endosomes in a PLD2-dependent manner. Here, we report that mTORC1 activation by phorbol 12,13-myristate acetate (PMA) requires both classic, cPKC, and novel PKC (nPKC) isoforms, specifically PKC., acting through distinct pathways. The translocation of mTOR to perinuclear lysosomes was detected after treatment of PKC activators, which was not colocalized with PKCa-or RAB11-positive endosomes and was not inhibited by PLD inhibitors. We found that PKC. inhibition by siRNA or bisindolylmaleimide I effectively decreased mTOR accumulation in lysosomes and its activity. Also, we identified that PKC. plays a role upstream of the v-ATPase/Ragulator/Rag pathway in response to PMA. These data provides a spatial aspect to the regulation of mTORC1 by sustained activation of PKC, requiring co-ordinated activation of two distinct elements, the perinuclear accumulation of cPKC-and PLD-containing endosomes and the nPKC-dependent translation of of mTOR in the perinuclear lysosomes. The close proximity of these two distinct compartments shown in this study suggests the possibility that transcompartment signaling may be a factor in the regulation of mTORC1 activity and also underscores the importance of PKC. as a potential therapeutic target of mTORC-related disorders.	[Liu, Mengling; Clarke, Christopher J.; Salama, Mohamed F.; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Liu, Mengling; Clarke, Christopher J.; Choim, Yeon Ja; Obeid, Lina M.; Hannun, Yusuf A.] Stony Brook Univ Hosp, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Salama, Mohamed F.] Mansoura Univ, Fac Vet Med, Dept Biochem, Mansoura, Egypt; [Choim, Yeon Ja; Hannun, Yusuf A.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Egyptian Knowledge Bank (EKB); Mansoura University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), Stony Brook Univ Hosp, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Salama, Mohamed/S-3493-2019; Salama, Mohamed F/C-9010-2017	Salama, Mohamed/0000-0002-0002-9108; Salama, Mohamed F/0000-0002-0002-9108; Liu, Mengling/0000-0003-1309-0087	NIH [HL 43707, CA97132]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants HL 43707 and CA97132 award to Y.A.H., https://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeder SE, 2004, ONCOGENE, V23, P9062, DOI 10.1038/sj.onc.1208093; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; El Osta M, 2014, FASEB J, V28, P495, DOI 10.1096/fj.13-230557; El-Osta MA, 2011, J BIOL CHEM, V286, P19340, DOI 10.1074/jbc.M110.152330; Fan Q. W., 2009, SCI SIGNAL, V2, pra4, DOI DOI 10.1126/SCISIGNAL.2000014; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Feng X, 2000, J BIOL CHEM, V275, P17024, DOI 10.1074/jbc.275.22.17024; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Fonseca BD, 2011, J BIOL CHEM, V286, P27111, DOI 10.1074/jbc.M111.260794; HEMING TA, 1995, J LEUKOCYTE BIOL, V57, P600, DOI 10.1002/jlb.57.4.600; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Kikumori M, 2012, J MED CHEM, V55, P5614, DOI 10.1021/jm300566h; Kim YM, 2012, MOL CELL, V46, P833, DOI 10.1016/j.molcel.2012.04.007; Kitatani K, 2007, J BIOL CHEM, V282, P20647, DOI 10.1074/jbc.M609162200; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Leseux L, 2008, BLOOD, V111, P285, DOI 10.1182/blood-2007-04-085092; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080721; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin TD, 2014, MOL CELL, V53, P209, DOI 10.1016/j.molcel.2013.12.004; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; NANDA A, 1992, J BIOL CHEM, V267, P22740; Padron D, 2006, MOL BIOL CELL, V17, P598, DOI 10.1091/mbc.E05-05-0389; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoon MS, 2015, MOL CELL, V58, P549, DOI 10.1016/j.molcel.2015.03.028; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Yoshida S, 2015, J CELL BIOL, V211, P159, DOI 10.1083/jcb.201504097; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	49	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184818	10.1371/journal.pone.0184818	http://dx.doi.org/10.1371/journal.pone.0184818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926616	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600043
J	Aloy, MA; Adsuara, JE; Cerda-Duran, P; Obergaulinger, M; Esteve-Taboada, JJ; Ferrer-Blasco, T; Montes-Mico, R				Aloy, M. A.; Adsuara, J. E.; Cerda-Duran, P.; Obergaulinger, M.; Esteve-Taboada, J. J.; Ferrer-Blasco, T.; Montes-Mico, R.			Estimation of the mechanical properties of the eye through the study of its vibrational modes	PLOS ONE			English	Article							X-RAY OSCILLATIONS; BIOMECHANICAL PROPERTIES; MATHEMATICAL-MODEL; BIOMETER; VISCOELASTICITY; ACCOMMODATION; REPEATABILITY; FLUCTUATIONS; DISCOVERY; CORNEA	Measuring the eye's mechanical properties in vivo and with minimally invasive techniques can be the key for individualized solutions to a number of eye pathologies. The development of such techniques largely relies on a computational modelling of the eyeball and, it optimally requires the synergic interplay between experimentation and numerical simulation. In Astrophysics and Geophysics the remote measurement of structural properties of the systems of their realm is performed on the basis of (helio-) seismic techniques. As a biomechanical system, the eyeball possesses normal vibrational modes encompassing rich information about its structure and mechanical properties. However, the integral analysis of the eyeball vibrational modes has not been performed yet. Here we develop a new finite difference method to compute both the spheroidal and, specially, the toroidal eigenfrequencies of the human eye. Using this numerical model, we show that the vibrational eigenfrequencies of the human eye fall in the interval 100 Hz-10 MHz. We find that compressible vibrational modes may release a trace on high frequency changes of the intraocular pressure, while incompressible normal modes could be registered analyzing the scattering pattern that the motions of the vitreous humour leave on the retina. Existing contact lenses with embebed devices operating at high sampling frequency could be used to register the microfluctuations of the eyeball shape we obtain. We advance that an inverse problem to obtain the mechanical properties of a given eye (e.g., Young's modulus, Poisson ratio) measuring its normal frequencies is doable. These measurements can be done using non-invasive techniques, opening very interesting perspectives to estimate the mechanical properties of eyes in vivo. Future research might relate various ocular pathologies with anomalies in measured vibrational frequencies of the eye.	[Aloy, M. A.; Adsuara, J. E.; Cerda-Duran, P.; Obergaulinger, M.] Univ Valencia, Dept Astron & Astrophys, E-46100 Burjassot, Spain; [Esteve-Taboada, J. J.; Ferrer-Blasco, T.; Montes-Mico, R.] Univ Valencia, Dept Opt & Optometry & Vis Sci, E-46100 Burjassot, Spain	University of Valencia; University of Valencia	Aloy, MA (corresponding author), Univ Valencia, Dept Astron & Astrophys, E-46100 Burjassot, Spain.	miguel.a.aloy@uv.es	Aloy, Miguel A/K-9941-2014; Esteve, Jose/ABB-6548-2021; Aloy, Miguel-Ángel/ABC-1245-2021; Cerda-Duran, Pablo/D-7857-2015; Adsuara, Jose E./AAB-5516-2019	Aloy, Miguel A/0000-0002-5552-7681; Aloy, Miguel-Ángel/0000-0002-5552-7681; Cerda-Duran, Pablo/0000-0003-4293-340X; Adsuara, Jose E./0000-0002-3842-965X; Montes-Mico, Robert/0000-0001-6179-8261; Esteve-Taboada, Jose Juan/0000-0001-8663-6373	Spanish Government Grant Explora [SAF2013-49284-EXP]; Spanish Ministerio de Economia y Competitividad, Subsecretaria de Estado de Investigacion Desarrollo e Innovacion [SAF2013-49284-EXP]	Spanish Government Grant Explora; Spanish Ministerio de Economia y Competitividad, Subsecretaria de Estado de Investigacion Desarrollo e Innovacion	This work was supported by Spanish Ministerio de Economia y Competitividad, Subsecretaria de Estado de Investigacion Desarrollo e Innovacion (URL: http://www.idi.mineco.gob.es/portal/site/MICINN), Grant Explora Ciencia SAF2013-49284-EXP.; Authors acknowledge financial support from the Spanish Government Grant Explora (SAF2013-49284-EXP).	Adsuara JE, 2017, J COMPUT PHYS, V332, P446, DOI 10.1016/j.jcp.2016.12.020; Adsuara JE, 2016, J COMPUT PHYS, V321, P369, DOI 10.1016/j.jcp.2016.05.053; Adsuara JE, 2017, SPEEDING FEW ORDERS; AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Akca BI, 2015, BIOMED OPT EXPRESS, V6, P3313, DOI 10.1364/BOE.6.003313; Akman A, 2015, BRIT J OPHTHALMOLOGY; Bonfiglio A, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0020-8; CAMPBELL FW, 1959, J PHYSIOL-LONDON, V145, P579, DOI 10.1113/jphysiol.1959.sp006164; CHARMAN WN, 1988, OPHTHAL PHYSL OPT, V8, P153, DOI 10.1111/j.1475-1313.1988.tb01031.x; Chung CW, 2016, INVEST OPHTH VIS SCI, V57, P236, DOI 10.1167/iovs.15-18053; COQUART L, 1992, J BIOMECH, V25, P1105, DOI 10.1016/0021-9290(92)90067-B; de Guillebon Z H, 1972, RETINAL TRACTION VIT, V11, P46; DEGUILLEBON H, 1972, ARCH OPHTHALMOL-CHIC, V87, P545, DOI 10.1001/archopht.1972.01000020547012; Downs JC, 2011, INVEST OPHTH VIS SCI, V52, P7365, DOI 10.1167/iovs.11-7955; Dubra A, 2004, THESIS; Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015; Ethier CR, 2004, ANNU REV BIOMED ENG, V6, P249, DOI 10.1146/annurev.bioeng.6.040803.140055; Ferrer-Blasco T, 2017, GRAEF ARCH CLIN EXP, V255, P343, DOI 10.1007/s00417-016-3555-z; Gough D.O., 1991, SOLAR INTERIOR ATMOS, P519; Hirneiss C, 2011, ACTA OPHTHALMOL, V89, pE189, DOI 10.1111/j.1755-3768.2010.02093.x; Hugar DL, 2013, MAT SCI ENG C-MATER, V33, P1867, DOI 10.1016/j.msec.2013.02.009; Israel GL, 2005, ASTROPHYS J, V628, pL53, DOI 10.1086/432615; JONES IL, 1992, EYE, V6, P556, DOI 10.1038/eye.1992.121; Kling S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0920; Kling S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104904; Koprowski R, 2015, J BIOPHOTONICS, V8, P968, DOI 10.1002/jbio.201400137; Kunert KS, 2016, J CATARACT REFR SURG, V42, P76, DOI 10.1016/j.jcrs.2015.07.039; Lam A, 2005, AM J OPHTHALMOL, V140, P329, DOI 10.1016/j.ajo.2005.02.014; Leonardi M, 2009, ACTA OPHTHALMOL, V87, P433, DOI 10.1111/j.1755-3768.2008.01404.x; Lombardo M, 2009, J CATARACT REFR SURG, V35, P1266, DOI 10.1016/j.jcrs.2009.02.029; Love AEH, 1944, TREATISE MATH THEORY, V4; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; Lyubimov GA, 2007, FLUID DYNAM+, V42, P684, DOI 10.1134/S001546280705002X; Mansouri Kaweh, 2014, J Ophthalmic Vis Res, V9, P260; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; MAURICE D M, 1958, Br J Ophthalmol, V42, P321; Meskauskas J, 2011, J FLUID MECH, V685, P1, DOI 10.1017/jfm.2011.263; Morita T, 2012, ACTA OPHTHALMOL, V90, pE48, DOI 10.1111/j.1755-3768.2011.02242.x; Nenadic IZ, 2011, PHYS MED BIOL, V56, P2245, DOI 10.1088/0031-9155/56/7/021; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Oliveira C, 2006, J GLAUCOMA, V15, P190, DOI 10.1097/01.ijg.0000212220.42675.c5; Rue J, 1996, THESIS; Salimi S, 2011, J BIOMECHANICAL ENG, V133, P433; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sigal IA, 2009, BIOMECH MODEL MECHAN, V8, P99, DOI 10.1007/s10237-008-0119-0; Srivannaboon S, 2015, J CATARACT REFR SURG, V41, P2224, DOI 10.1016/j.jcrs.2015.03.019; Strohmayer TE, 2005, ASTROPHYS J, V632, pL111, DOI 10.1086/497911; Tejwani S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097591; Terai N, 2012, CURR EYE RES, V37, P553, DOI 10.3109/02713683.2012.669007; Tian X, 2016, FRONTIERS SYSTEMS NE, V10; Uchio E, 1999, BRIT J OPHTHALMOL, V83, P1106, DOI 10.1136/bjo.83.10.1106; VISSCHER WM, 1991, J ACOUST SOC AM, V90, P2154, DOI 10.1121/1.401643; Vorontsov SV, 2002, SCIENCE, V296, P101, DOI 10.1126/science.1069190; Walton KA, 2002, EXP EYE RES, V74, P173, DOI 10.1006/exer.2001.1136; WEINBAUM S, 1965, B MATH BIOPHYS, V27, P325, DOI 10.1007/BF02478410; Zhang XY, 2015, ULTRASOUND MED BIOL, V41, P1461, DOI 10.1016/j.ultrasmedbio.2014.12.017; ZIMMERMAN RL, 1980, BIOPHYS J, V29, P539, DOI 10.1016/S0006-3495(80)85152-6	58	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183892	10.1371/journal.pone.0183892	http://dx.doi.org/10.1371/journal.pone.0183892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922351	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300009
J	Dholakia, U; Clark-Price, SC; Keating, SCJ; Stern, AW				Dholakia, Urshulaa; Clark-Price, Stuart C.; Keating, Stephanie C. J.; Stern, Adam W.			Anesthetic effects and body weight changes associated with ketamine-xylazine-lidocaine administered to CD-1 mice	PLOS ONE			English	Article							MINIMUM ALVEOLAR CONCENTRATION; CONTINUOUS-RATE INFUSION; INTRAVENOUS LIDOCAINE; INTRAPERITONEAL INJECTION; POSTOPERATIVE ANALGESIA; ENDOTRACHEAL INTUBATION; SYSTEMIC LIDOCAINE; LABORATORY MICE; COUGH RESPONSE; RATS	Anesthesia for mice is commonly performed through the injection of parenteral agents via the intraperitoneal (IP) route. Variability in anesthetic sensitivities has been noted in mice resulting in inconsistencies in anesthetic depth and/or mortality. Anesthetic protocols that improve consistency and safety are needed. The objectives of this study were to assess the effects of intraperitoneal (IP) ketamine (95 mg/kg) and xylazine (7 mg/kg) alone or combined with lidocaine at 4, 8, or 16 mg/kg on time to loss (LRR) and return (RRR) of righting reflex, duration of immobilization and loss of pedal withdrawal response (PWR), body weight and histopathology in CD-1 mice. In a prospective, randomized trial, 36 male CD-1 mice, 4-6 weeks of age were randomly assigned to 5 groups: saline (SA, n = 4); ketamine-xylazine (KX, n = 8); ketamine-xylazine-lidocaine 4 mg/kg (KXL4, n = 8); ketamine-xylazine-lidocaine 8 mg/kg (KXL8, n = 8); ketamine-xylazine-lidocaine 16 mg/kg (KXL16, n = 8). Two mice in each group were euthanized at day 2 post-injection and the remaining mice were euthanized at day 11 post-injection. After IP injection, LRR and RRR, duration of immobilization and loss of PWR, body weight and histopathology were evaluated. LRR occurred sooner in mice receiving KXL16 compared with KX, with median (range) times of 78 (62-104) and 107 (91-298) seconds, respectively. Loss of PWR occurred in 1, 5, 4, 6 mice for groups KX, KXL4, KXL8, and KXL16 respectively. Median (range) duration of absent PWR was longer in mice receiving KXL16 at 13 (0-30) minutes, compared to KX at 0 (0-9) minutes. Duration of immobilization and RRR were not different between groups. Weight loss occurred 2 days following anesthesia but was not different between groups. Weight gain was significantly greater in all lidocaine groups 11 days post-injection compared to KX. No mortality or histopathologic abnormalities were observed in any group. Lidocaine administered with ketamine and xylazine shortens the onset of anesthesia in mice and improves anesthetic depth without prolonging recovery time.	[Dholakia, Urshulaa; Clark-Price, Stuart C.; Keating, Stephanie C. J.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Stern, Adam W.] Univ Illinois, Dept Pathobiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Clark-Price, SC (corresponding author), Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA.	sccp@illinois.edu	, Adam/AAY-4010-2021	, Adam/0000-0002-6794-6592				Adler DMT, 2017, VET J, V223, P31, DOI 10.1016/j.tvjl.2017.05.001; Alves HC, 2009, LAB ANIM-UK, V43, P27, DOI 10.1258/la.2008.007036; Antognini JF, 2005, COMPARATIVE MED, V55, P413; Arras M, 2001, COMPARATIVE MED, V51, P443; Baker NJ, 2011, J AM ASSOC LAB ANIM, V50, P916; Bellini L, 2016, JAVMA-J AM VET MED A, V248, P422, DOI 10.2460/javma.248.4.422; Bittencourt AL, 1997, EUR J PHARMACOL, V330, P109, DOI 10.1016/S0014-2999(97)00182-9; BLAHA MD, 2008, J AM ASSOC LAB ANIM, V47, P8; Brennan MP, 2009, LAB ANIMAL, V38, P87, DOI 10.1038/laban0309-87; Buitrago S, 2008, J AM ASSOC LAB ANIM, V47, P11; Burnside WM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-48; Cheung HMC, 2011, CAN J ANESTH, V58, P443, DOI 10.1007/s12630-011-9479-5; Cook VL, 2008, EQUINE VET J, V40, P353, DOI 10.2746/042516408X293574; Cook VL, 2009, AM J VET RES, V70, P1259, DOI 10.2460/ajvr.70.10.1259; De Oliveira GS, 2012, ANESTH ANALG, V115, P262, DOI 10.1213/ANE.0b013e318257a380; DEJONG RH, 1980, ANESTH ANALG, V59, P401; Enderle AK, 2008, VET ANAESTH ANALG, V35, P297, DOI 10.1111/j.1467-2995.2007.00391.x; Erickson RL, 2016, J AM ASSOC LAB ANIM, V55, P548; Euasobhon P, 2016, COCHRANE DB SYST REV, V18; Flecknell PA, 2013, VET ANAESTH ANALG, P754; Fleischmann T, 2016, LAB ANIM-UK, V50, P264, DOI 10.1177/0023677216631458; Gaertner DJ, 2008, AM COLL LAB, P239, DOI 10.1016/B978-012373898-1.50014-0; Harvey KP, 2009, AM J SURG, V198, P231, DOI 10.1016/j.amjsurg.2008.10.015; Hayes JH, 1999, LAB ANIM-UK, V33, P16, DOI 10.1258/002367799780578534; He SQ, 2010, J AM ASSOC LAB ANIM, V49, P45; Jaber SM, 2014, J AM ASSOC LAB ANIM, V53, P684; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Khan ZH, 2016, ANESTH PAIN MED, V6; KIRSCHENBAUM HL, 1982, AM J HOSP PHARM, V39, P1013, DOI 10.1093/ajhp/39.6.1013; Lauretti Gabriela Rocha, 2008, Rev. Bras. Anestesiol., V58, P280, DOI 10.1590/S0034-70942008000300011; Lev Roneet, 1994, Journal of Emergency Medicine, V12, P499, DOI 10.1016/0736-4679(94)90347-6; LILES JH, 1992, LAB ANIM, V26, P180, DOI 10.1258/002367792780740558; McCarthy GC, 2010, DRUGS, V70, P1149, DOI 10.2165/10898560-000000000-00000; Panti A, 2016, VET ANAESTH ANALG, V43, P405, DOI 10.1111/vaa.12332; Re M, 2016, J AM ASSOC LAB ANIM, V55, P317; Rioja GE., 2015, VET ANAESTH ANALG, P332; Sakuragi T, 1996, REGION ANESTH, V21, P239; Schnellbacher RW, 2013, AM J VET RES, V74, P1377, DOI 10.2460/ajvr.74.11.1377; Serrano-Caballero JM, 2013, VET MED-CZECH, V58, P364, DOI 10.17221/6917-VETMED; Silva A, 2012, LAB ANIM-UK, V46, P85, DOI 10.1258/la.2012.011135; Struck MB, 2011, J AM ASSOC LAB ANIM, V50, P344; Svendsen O, 2007, LAB ANIM-UK, V41, P197, DOI 10.1258/002367707780378140; Thompson KR, 2016, VET ANAESTH ANALG, V43, P371, DOI 10.1111/vaa.12303; Torfs S, 2009, J VET INTERN MED, V23, P606, DOI 10.1111/j.1939-1676.2009.0311.x; Valverde A, 2004, VET ANAESTH ANALG, V31, P264, DOI 10.1111/j.1467-2995.2004.00165.x; van der Wal S, 2015, ACTA ANAESTH SCAND, V59, P47, DOI 10.1111/aas.12417; Weibel S, 2016, BRIT J ANAESTH, V116, P770, DOI 10.1093/bja/aew101; Welberg LAM, 2006, J AM ASSOC LAB ANIM, V45, P13; WHELAN G, 1992, LAB ANIM-UK, V26, P153, DOI 10.1258/002367792780740602; Wilson J, 2008, VET ANAESTH ANALG, V35, P289, DOI 10.1111/j.1467-2995.2007.00389.x	50	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184911	10.1371/journal.pone.0184911	http://dx.doi.org/10.1371/journal.pone.0184911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910423	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200118
J	Lorbeer, R; Hetterich, H; Strobl, R; Schafnitzel, A; Patscheider, H; Schindler, A; Muller-Peltzer, K; Sommer, W; Peters, A; Meisinger, C; Heier, M; Rathmann, W; Bamberg, F; Grill, E				Lorbeer, Roberto; Hetterich, Holger; Strobl, Ralf; Schafnitzel, Anina; Patscheider, Hannah; Schindler, Andreas; Mueller-Peltzer, Katharina; Sommer, Wieland; Peters, Annette; Meisinger, Christa; Heier, Margit; Rathmann, Wolfgang; Bamberg, Fabian; Grill, Eva			Lack of association of MRI determined subclinical cardiovascular disease with dizziness and vertigo in a cross-sectional population-based study	PLOS ONE			English	Article							CAROTID-ARTERY; EPIDEMIOLOGY; OCCLUSION; LESIONS; STROKE; COMMON	Objective We investigated the association between subclinical cardiovascular diseases assessed by MRI examination and symptoms of dizziness and vertigo in participants of a population-based sample. Methods Data from 400 participants (169 women) aged from 39 to 73 of a cross-sectional MRI sub-study of the "Kooperative Gesundheitsforschung in der Region Augsburg" (KORA) FF4 study from the south of Germany was used. MRI determined subclinical cardiovascular diseases include left and right ventricular structure and function as well as the presence of carotid plaque and carotid wall thickness. Cerebrum diseases include white matter lesions (WML) and cerebral microbleeds (CMB). The main outcomes of dizziness and vertigo were assessed by standardized interview. Logistic regression models were applied and adjusted odds ratios (OR) with 95% confidence intervals (CI) were provided. Results Lifetime and 12-month prevalence of dizziness and vertigo were 30% (95% CI 26% to 35%) and 21% (95% CI 17% to 26%) respectively in this sample. On multivariable analysis, cardiac and carotid measurements were not associated with dizziness and vertigo excluding orthostatic vertigo (20%, 95CI 16% to 24%). Only in male participants, there was a significant association between WML and the presence of dizziness and vertigo (OR = 2.95, 95% CI 1.08 to 8.07). There was no significant association of CMB with dizziness and vertigo. However, CMB and WML were tending to associate with a higher risk of dizziness and vertigo in the whole sample (CMB: OR = 1.48, 95% CI 0.70; 3.15; WML: OR = 1.71, 95% CI 0.80 to 3.67;), in persons with prediabetes and diabetes (WML: OR = 2.71, 95% CI 0.89 to 8.23) and in men with normal glucose metabolism (CMB: OR = 2.60, 95% CI 0.56 to 12.0; WML: OR = 3.08, 95% CI 0.58 to 16.5). Conclusions In this sample of participants without manifest cardiovascular diseases, subclinical left and right ventricular function and carotid structure were consistently not associated with dizziness and vertigo. Subclinical cerebrum measurements, however, tend to increase the risk for dizziness and vertigo, especially in men and in persons with prediabetes or diabetes.	[Lorbeer, Roberto; Hetterich, Holger; Schafnitzel, Anina; Patscheider, Hannah; Schindler, Andreas; Mueller-Peltzer, Katharina; Sommer, Wieland; Bamberg, Fabian] Univ Hosp, LMU Munich, Dept Radiol, Munich, Germany; [Strobl, Ralf; Grill, Eva] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometr & Epidemiol, Munich, Germany; [Peters, Annette; Meisinger, Christa; Heier, Margit] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Peters, Annette] German Ctr Diabet Res DZD EV, Neuherberg, Germany; [Peters, Annette] German Ctr Cardiovasc Dis Res DZHK EV, Munich, Germany; [Meisinger, Christa] UNIKA T Augsburg, LMU Munich, Chair Epidemiol, Augsburg, Germany; [Heier, Margit] Cent Hosp Augsburg, KORA Myocardial Infarct Registry, Augsburg, Germany; [Rathmann, Wolfgang] German Diabet Ctr, Dept Biometr & Epidemiol, Dusseldorf, Germany; [Bamberg, Fabian] Eberhard Karls Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Grill, Eva] Ludwig Maximilians Univ Munchen, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Grill, Eva] Ludwig Maximilians Univ Munchen, Munich Ctr Hlth Sci MC Hlth, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; University of Munich; Deutsches Diabetes-Zentrum (DDZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of Munich	Lorbeer, R (corresponding author), Univ Hosp, LMU Munich, Dept Radiol, Munich, Germany.	roberto.lorbeer@med.uni-muenchen.de	Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Peters, Annette/A-6117-2011; Grill, Eva/AAF-8104-2020	Peters, Annette/0000-0001-6645-0985; Grill, Eva/0000-0002-0273-7984	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilians-Universitat as part of LM Uinnovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft); Siemens Healthcare; German Federal Ministry of Education and Research [01E01401]	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health); Ludwig-Maximilians-Universitat as part of LM Uinnovativ; German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Siemens Healthcare(Siemens AG); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ. The KORAMRI sub-study received funding by the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft). The KORA-MRI sub study was supported by an unrestricted research grant from Siemens Healthcare. Research on vertigo was supported by funds from the German Federal Ministry of Education and Research under the Grant Code 01E01401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad H, 2015, J NEUROL SCI, V358, P428, DOI 10.1016/j.jns.2015.09.006; Bamberg F, 2017, DIABETES, V66, P158, DOI 10.2337/db16-0630; Barin K, 2011, OTOLARYNG CLIN N AM, V44, P437, DOI 10.1016/j.otc.2011.01.013; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; Du Bois D, 1989, Nutrition, V5, P303; Fernandez L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00144; Fujishima M, 2000, INTERNAL MED, V39, P727, DOI 10.2169/internalmedicine.39.727; Gillett RC, 2011, AM FAM PHYSICIAN, V83, P879; Grover S, 2011, J NUCL CARDIOL, V18, P351, DOI 10.1007/s12350-010-9334-z; Jonsson R, 2004, J VESTIBUL RES-EQUIL, V14, P47; Kerber KA, 2006, STROKE, V37, P2484, DOI 10.1161/01.STR.0000240329.48263.0d; Kerwin William, 2007, Top Magn Reson Imaging, V18, P371; Komiyama M, 2006, SURG NEUROL, V66, P513, DOI 10.1016/j.surneu.2006.02.037; Kroenke K, 2000, SOUTH MED J, V93, P160; Lai SL, 2005, J NEUROL SCI, V238, P101, DOI 10.1016/j.jns.2005.06.012; Mueller M, 2014, QUAL LIFE RES, V23, P2301, DOI 10.1007/s11136-014-0684-x; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Pollak L, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.402; Post RE, 2010, AM FAM PHYSICIAN, V82, P361; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Seissler J, 2012, EUR J ENDOCRINOL, V167, P847, DOI 10.1530/EJE-12-0472; Stevens KN, 2008, AGE AGEING, V37, P300, DOI 10.1093/ageing/afn019; Tabara Y, 2015, STROKE, V46, P16, DOI 10.1161/STROKEAHA.114.006704; Tarnutzer AA, 2011, CAN MED ASSOC J, V183, P1025, DOI 10.1503/cmaj.100174; Tehrani ASS, 2014, NEUROLOGY, V83, P169, DOI 10.1212/WNL.0000000000000573; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184858	10.1371/journal.pone.0184858	http://dx.doi.org/10.1371/journal.pone.0184858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910373	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200109
J	Ni, X; Wang, A; Zhang, L; Shan, LY; Zhang, HC; Li, L; Si, JQ; Luo, J; Li, XZ; Ma, KT				Ni, Xin; Wang, Ai; Zhang, Liang; Shan, Li-ya; Zhang, Hai-chao; Li, Li; Si, Jun-qiang; Luo, Jian; Li, Xin-zhi; Ma, Ke-tao			Up-regulation of gap junction in peripheral blood T lymphocytes contributes to the inflammatory response in essential hypertension	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; IMMUNE-SYSTEM; CELL-ACTIVATION; SEX-DIFFERENCES; RAT MODEL; CONNEXINS; EXPRESSION; PRESSURE; CHANNELS; HEMICHANNELS	Inflammation has been shown to play an important role in the mechanisms involved in the pathogenesis of hypertension. Connexins (Cxs)-based gap junction channels (GJCs) or hemichannels (HCs) are involved in the maintenance of homeostasis in the immune system. However, the role of Cx43-based channels in T lymphocytes in mediating the immune response in essential hypertension is not fully understand. The present study was designed to investigate the role of Cxs-based channels in T-lymphocytes in the regulation of hypertension-mediated inflammation. The surface expressions of T lymphocyte subtypes, Cx40/Cx43, and inflammatory cytokines (IFN-gamma (interferon-gamma) and TNF-alpha (tumor necrosis factor alpha)) in T cells, as well as gap junction communication of peripheral blood lymphocytes from essential hypertensive patients (EHs) and normotensive healthy subjects (NTs) were detected by flow cytometry. Expression levels and phosphorylation of Cx43 protein in peripheral blood lymphocytes of EHs and NTs were analyzed by Western blot. The proliferation rate of peripheral blood mononuclear cells (PBMCs) after treatment with a Cxs inhibitor was examined by a CCK-8 assay. The levels of inflammatory cytokines were detected using ELISA. Within the CD3(+) T cell subsets, we found a significant trend toward an increase in the percentage of CD4(+) T cells and CD4(+)/CD8(+) ratio as well as in serum levels of IFN-gamma and TNF-alpha in the peripheral blood of EHs compared with those in NTs. Moreover, the peripheral blood lymphocytes of EH patients exhibited enhanced GJCs formation, increased Cx43 protein level and Cx43 phosphorylation at Ser368, and a significant increase in Cx40/Cx43 surface expressions levels in CD4(+)or CD8(+) T lymphocytes. Cx43-based channel inhibition by a mimetic peptide greatly reduced the exchange of dye between lymphocytes, proliferation of stimulated lymphocytes and the pro-inflammatory cytokine levels of EHs and NTs. Our data suggest that Cx40/Cx43-based channels in lymphocytes may be involved in the regulation of T lymphocyte proliferation and the production of proinflammatory cytokines, which contribute to the hypertensive inflammatory response.	[Ni, Xin; Wang, Ai; Zhang, Liang; Shan, Li-ya; Zhang, Hai-chao; Li, Li; Si, Jun-qiang; Li, Xin-zhi; Ma, Ke-tao] Shihezi Univ, Med Coll, Dept Physiol, Shihezi, Xinjiang, Peoples R China; [Ni, Xin; Wang, Ai; Zhang, Liang; Shan, Li-ya; Zhang, Hai-chao; Li, Li; Si, Jun-qiang; Ma, Ke-tao] Shihezi Univ, Med Coll, Key Lab Xingjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Luo, Jian] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Li, Xin-zhi] Shihezi Univ, Med Coll, Dept Pathophysiol, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University; Xinjiang Medical University; Shihezi University	Li, XZ; Ma, KT (corresponding author), Shihezi Univ, Med Coll, Dept Physiol, Shihezi, Xinjiang, Peoples R China.; Ma, KT (corresponding author), Shihezi Univ, Med Coll, Key Lab Xingjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.; Luo, J (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China.; Li, XZ (corresponding author), Shihezi Univ, Med Coll, Dept Pathophysiol, Shihezi, Xinjiang, Peoples R China.	docsummer@163.com; lixinzhi@shzu.edu.cn; maketao@hotmail.com			National Natural Science Foundation of China [81660271, 81460098, 81560081, 81600325]; International Cooperation Project of Shihezi University [GJHZ201603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of Shihezi University	This work was supported by the grants from the National Natural Science Foundation of China (nos. 81660271 to Ke-Tao Ma, 81460098 to Xin-Zhi Li, 81560081 to Jun-Qiang Si and 81600325 to Liang Zhang); and International Cooperation Project of Shihezi University (nos. GJHZ201603 to Ke-tao Ma).	Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Bermudez-Fajardo A, 2007, J LEUKOCYTE BIOL, V82, P608, DOI 10.1189/jlb.0307134; Corvalan LA, 2007, J CELL PHYSIOL, V211, P649, DOI 10.1002/jcp.20971; Cruciani V, 2002, BIOL CELL, V94, P433, DOI 10.1016/S0248-4900(02)00014-X; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Elgueta R, 2009, J IMMUNOL, V183, P277, DOI 10.4049/jimmunol.0801854; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Gooch JL, 2014, CURR OPIN NEPHROL HY, V23, P473, DOI 10.1097/MNH.0000000000000052; Harrison DG, 2010, CURR OPIN PHARMACOL, V10, P203, DOI 10.1016/j.coph.2010.01.006; Leibowitz A, 2011, CURR HYPERTENS REP, V13, P465, DOI 10.1007/s11906-011-0224-9; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mattson DL, 2006, HYPERTENSION, V48, P149, DOI 10.1161/01.HYP.0000228320.23697.29; Mendoza-Naranjo A, 2011, J IMMUNOL, V187, P3121, DOI 10.4049/jimmunol.1100378; Muller DN, 2011, CURR OPIN NEPHROL HY, V20, P113, DOI 10.1097/MNH.0b013e3283436f88; Mylvaganam S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00172; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Oviedo-Orta E, 2000, IMMUNOLOGY, V99, P578, DOI 10.1046/j.1365-2567.2000.00991.x; Oviedo-Orta E, 2002, CELL BIOL INT, V26, P253, DOI 10.1006/cbir.2001.0840; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Oviedo-Orta E, 2010, J LEUKOCYTE BIOL, V88, P79, DOI 10.1189/jlb.0909613; Pruijm M, 2013, J HUM HYPERTENS, V27, P169, DOI 10.1038/jhh.2012.12; Rajnai H, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/528098; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Rodriguez-Iturbe B, 2002, AM J PHYSIOL-RENAL, V282, pF191, DOI 10.1152/ajprenal.0197.2001; Saez JC, 2014, FEBS LETT, V588, P1205, DOI 10.1016/j.febslet.2014.03.004; Saez PJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/742734; Singh MV, 2014, IMMUNOL RES, V59, P243, DOI 10.1007/s12026-014-8548-6; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Stout RF, 2015, J BIOL CHEM, V290, P23497, DOI 10.1074/jbc.M115.659979; Su V, 2014, FEBS LETT, V588, P1212, DOI 10.1016/j.febslet.2014.01.013; Tian N, 2007, AM J PHYSIOL-HEART C, V292, pH1018, DOI 10.1152/ajpheart.00487.2006; Tinsley JH, 2009, AM J HYPERTENS, V22, P1107, DOI 10.1038/ajh.2009.125; Tipton AJ, 2014, CLIN THER, V36, P1882, DOI 10.1016/j.clinthera.2014.07.011; Tittarelli A, 2014, J IMMUNOL, V192, P1313, DOI 10.4049/jimmunol.1301297; Trott DW, 2014, ADV PHYSIOL EDUC, V38, P20, DOI 10.1152/advan.00063.2013; Trott DW, 2014, HYPERTENSION, V64, P1108, DOI 10.1161/HYPERTENSIONAHA.114.04147; Wallace K, 2014, HYPERTENS PREGNANCY, V33, P41, DOI 10.3109/10641955.2013.835820; Wallace K, 2011, HYPERTENSION, V57, P949, DOI 10.1161/HYPERTENSIONAHA.110.168344; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Willebrords J, 2016, CRIT REV BIOCHEM MOL, V51, P413, DOI 10.1080/10409238.2016.1204980; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441	43	18	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184773	10.1371/journal.pone.0184773	http://dx.doi.org/10.1371/journal.pone.0184773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910394	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200093
J	Shrestha, SK; Lamour, K; Young-Kelly, H				Shrestha, Sandesh K.; Lamour, Kurt; Young-Kelly, Heather			Genome sequences and SNP analyses of Corynespora cassiicola from cotton and soybean in the southeastern United States reveal limited diversity	PLOS ONE			English	Article							POTENTIAL BIOCONTROL AGENT; LEAF-SPOT; TARGET SPOT; 1ST REPORT; PATHOGENICITY; GENE; DNA	Corynespora cassiicola attackes diverse agriculturally important plants, including soybean and cotton, in the US. It is a reemerge pathogen on cotton in southeastern US. Whole genome sequences of four cotton and one soybean isolate from Tennessee were used to develop single nucleotide polymorphism markers for cotton isolates. Cotton isolates had little diversity at the genome level and very little differentiation from the soybean isolate. Analysis of 75 isolates from cotton and soybean, using targeted-sequencing of 22 polymorphic SNP sites, revealed eight multi-locus genotypes and it appears a single clonal lineage predominates across the southeastern region. The cotton and soybean genome sequences were significantly different from the public reference genome derived from a rubber isolate and the utility of these novel resources will be discussed.	[Shrestha, Sandesh K.; Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Young-Kelly, Heather] Univ Tennessee, Dept Entomol & Plant Pathol, Jackson, TN 38301 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Young-Kelly, H (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Jackson, TN 38301 USA.	youngkelly@utk.edu		Lamour, Kurt/0000-0001-6407-8825				Andrews S., 2010, FASTQC QUALITY CONTR; BLAZQUEZ C H, 1967, Proceedings of the Florida State Horticultural Society, V80, P177; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Butler S, 2016, PLANT DIS, V100, P535, DOI 10.1094/PDIS-07-15-0785-PDN; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Conner KN, 2013, PLANT DIS, V97, P1379, DOI 10.1094/PDIS-02-13-0133-PDN; de Liyanage AS, 1986, J RUBB RES I SRI LAN, V65, P47; de Macedo DM, 2013, PLANT DIS, V97, P496, DOI 10.1094/PDIS-06-12-0598-RE; Deon M, 2014, FUNGAL BIOL-UK, V118, P32, DOI 10.1016/j.funbio.2013.10.011; Deon M, 2012, PLANT SCI, V185, P227, DOI 10.1016/j.plantsci.2011.10.017; Dixon LJ, 2009, PHYTOPATHOLOGY, V99, P1015, DOI 10.1094/PHYTO-99-9-1015; Faske T, COTTON DIS ALERT COR; Faske T, TARGET SPOT SOYBEAN; Fulmer A, 2014, CANADIAN J PLANT PAT, V36, P407; Furukawa T, 2008, J GEN PLANT PATHOL, V74, P117, DOI 10.1007/s10327-008-0073-9; Garibaldi A, 2007, PLANT DIS, V91, P1361, DOI 10.1094/PDIS-91-10-1361B; Jayasuriya K.E., 2007, J SCI BIO SCI, V36, P138; KINGSLAND GC, 1986, TROP PEST MANAGE, V32, P283; Koenning S, 2015, COTTON DIS UPDATE LE; Koenning SR, 2006, PLANT DIS, V90, P974, DOI 10.1094/PD-90-0974C; Kurt S., 2005, Pakistan Journal of Biological Sciences, V8, P618, DOI 10.3923/pjbs.2005.618.621; LAKSHMANAN P, 1990, PHYTOPARASITICA, V18, P171, DOI 10.1007/BF02981234; Lamour K, 2006, MYCOLOGIA, V98, P514, DOI 10.3852/mycologia.98.3.514; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Hieu ND, 2014, J RUBBER RES, V17, P187; Pereira JM, 2003, BIOL CONTROL, V26, P21, DOI 10.1016/S1049-9644(02)00112-3; Qi YX, 2011, EUR J PLANT PATHOL, V130, P83, DOI 10.1007/s10658-010-9734-6; Romruensukharom P., 2005, Journal of Rubber Research, V8, P38; Schlub R, 2007, 2 INT S TOM DIS, V808, P25; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; SEAMAN WL, 1965, CAN J BOTANY, V43, P1461, DOI 10.1139/b65-154; Shimomoto Y, 2008, J GEN PLANT PATHOL, V74, P335, DOI 10.1007/s10327-008-0100-x; Shimomoto Y, 2015, J GEN PLANT PATHOL, V81, P226, DOI 10.1007/s10327-015-0584-0; Silva W. P. K., 2000, Plant Disease, V84, P202, DOI 10.1094/PDIS.2000.84.2.202D; Silva WPK, 2003, MYCOL RES, V107, P567, DOI 10.1017/S0953756203007755; Silva WPK, 1998, PLANT PATHOL, V47, P267, DOI 10.1046/j.1365-3059.1998.00245.x; Silva WPK, 1995, AUST J BOT, V43, P609, DOI 10.1071/BT9950609; Smith Linda R., 2008, THESIS; Sumabat LG, 2017, PHYTOPATHOLOGY, V107, pS31; Tu ND, 2013, BIOTECHNIQUES, V55, P69, DOI 10.2144/000114052; Wei CT., 1950, MYCOL PAP, V34, P1; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wrather A, 2010, PLANT HLTH PROGR, DOI [10.1094/PHP-2010-0125-01-RS, DOI 10.1094/PHP-2010-0125-01-RS]; Wrather JA, 2003, PLANT HLTH PROGR, DOI [10.1094/PHP-2003-0325-01-RV, DOI 10.1094/PHP-2003-0325-01-RV]; Yamada H, 2013, J INFECT CHEMOTHER, V19, P1167, DOI 10.1007/s10156-013-0579-8; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	47	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184908	10.1371/journal.pone.0184908	http://dx.doi.org/10.1371/journal.pone.0184908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910414	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200115
J	Kemp, JA				Kemp, Jonathan A.			The physics of unwound and wound strings on the electric guitar applied to the pitch intervals produced by tremolo/vibrato arm systems	PLOS ONE			English	Article								The physics of wound and unwound strings on the electric guitar are presented here, and the pitch intervals produced by the movements of a Fender Stratocaster tremolo unit are explained. Predicted changes in pitch sensitivity of different strings are given, and experimentally verified, for changes in saddle height, the distance of string free to move behind the nut and ratio of diameters/masses of the core and windings of wound strings. Also, it is shown that changes to the gauge of strings (assuming the string tension is sufficient for linear behaviour and in absence of changes to other construction details) don't alter the pitch intervals produced by a given angle of tremolo arm use assuming the instrument is set up with the same sounding pitches and starting bridge angle. It is demonstrated that it not possible to equalise the relative sensitivity of unwound steel stings on a Fender Stratocaster type tremolo unit through string construction techniques. The ratio of core to winding mass in the string, on the other hand, was found to be a very powerful design parameter for choosing the sensitivity of the string to tremolo arm use and standard pitch bends. For instance, the pitch intervals produced by operation of tremolo arm for wound strings may be made to approximately match that for one of the unwound strings if they share very similar core gauges (assuming the winding masses are chosen to give approximately the same tension at their sounding pitches). Such a design, only available currently by custom order, also delivers the optimum equalisation in sensitivity of strings for standard string bends (due to these also being produced by altering the length of the string to generate changes in tension and therefore pitch).	[Kemp, Jonathan A.] Univ St Andrews, Mus Ctr, St Andrews, Fife, Scotland; [Kemp, Jonathan A.] Univ St Andrews, SUPA, Sch Phys & Astron, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews	Kemp, JA (corresponding author), Univ St Andrews, Mus Ctr, St Andrews, Fife, Scotland.; Kemp, JA (corresponding author), Univ St Andrews, SUPA, Sch Phys & Astron, St Andrews, Fife, Scotland.	jk50@st-andrews.ac.uk		Kemp, Jonathan/0000-0002-3861-4863				Bigsby PA, 1953, TAILPIECE VIBRATO ST; Childs PRN, 2014, MECHANICAL DESIGN ENGINEERING HANDBOOK, P625, DOI 10.1016/B978-0-08-097759-1.00015-0; Donahue T, 2015, HARPSICHORD STRINGIN, P134; Fender CL, 1956, TREMOLO DEVICE STRIN; Gough C., 2007, SPRINGER HDB ACOUSTI, P543; Grimes DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102088; Jahnel F, 1981, MANUAL GUITAR TECHNO, p[116, 200]; Jones RS, 1968, FRETTED INSTRUMENTS; Oberg E, 2012, MACHINERYS HDB, p[377, 513]; Osuga T, 1987, TREMOLO MECH GUITAR; Ozer J, 2008, QUANTITATIVE ANAL MU; Rose FD, 1979, GUITAR TREMOLO METHO; Schryer TG, 2005, TREMOLO DEVICE STRIN; Steinberger N, 1987, TREMOLO LEVER ANGLE; Verheyen C, 2016, C VERHEYEN BALANCED	15	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184803	10.1371/journal.pone.0184803	http://dx.doi.org/10.1371/journal.pone.0184803			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934268	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900045
J	Liu, MJ; Shi, DB; Li, J				Liu, Meijun; Shi, Dongbo; Li, Jiang			Double-edged sword of interdisciplinary knowledge flow from hard sciences to humanities and social sciences: Evidence from China	PLOS ONE			English	Article							ACADEMIC DISCIPLINES; CROSS-DISCIPLINARY; IMPACT FACTOR; CITATION; COLLABORATION; INFORMATION; MANAGEMENT; EVOLUTION; BIONANOTECHNOLOGY; INTEGRATION	Humanities and Social Sciences (HSS) increasingly absorb knowledge from Hard Sciences, i.e., Science, Technology, Agriculture and Medicine (STAM), as testified by a growing number of citations. However, whether citing more Hard Sciences brings more citations to HSS remains to be investigated. Based on China's HSS articles indexed by the Web of Science during 1998-2014, this paper estimated two-way fixed effects negative binomial models, with journal effects and year effects. Findings include: (1) An inverse U-shaped curve was observed between the percentage of STAM references to the HSS articles and the number of citations they received; (2) STAM contributed increasing knowledge to China's HSS, while Science and Technology knowledge contributed more citations to HSS articles. It is recommended that research policy should be adjusted to encourage HSS researchers to adequately integrate STAM knowledge when conducting interdisciplinary research, as overcited STAM knowledge may jeopardize the readability of HSS articles.	[Liu, Meijun] Univ Hong Kong, Div Informat & Technol Studies, Hong Kong, Peoples R China; [Shi, Dongbo] Shanghai Jiao Tong Univ, Sch Int & Publ Affairs, Shanghai, Peoples R China; [Shi, Dongbo] Hunan Univ, Sch Econ & Trade, Changsha, Hunan, Peoples R China; [Li, Jiang] Zhejiang Univ, Dept Informat Resource Management, Hangzhou, Zhejiang, Peoples R China	University of Hong Kong; Shanghai Jiao Tong University; Hunan University; Zhejiang University	Li, J (corresponding author), Zhejiang Univ, Dept Informat Resource Management, Hangzhou, Zhejiang, Peoples R China.	li-jiang@zju.edu.cn	Li, Jiang/Z-1709-2019; Liu, Meijun/GOK-0637-2022	Li, Jiang/0000-0001-5769-8647; Liu, Meijun/0000-0002-2800-5511	National Natural Science Foundation of China (NSFC) [71673242]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study is financially supported by the National Natural Science Foundation of China (No. 71673242).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.r We acknowledge the National Natural Science Foundation of China (NSFC Grant No. 71673242) for financial support. We thank anonymous reviewers for helpful comments.	Ahuja G, 2001, STRATEGIC MANAGE J, V22, P521, DOI 10.1002/smj.176; Allison PD, 2002, SOCIOL METHODOL, V32, P247, DOI 10.1111/1467-9531.00117; [Anonymous], 2015, CHINESE S T J CITATI; Arunachalam S, 2000, CURR SCI INDIA, V79, P621; BELSLEY DA, 1980, J ECONOMETRICS, V14, P203, DOI 10.1016/0304-4076(80)90091-3; Bordons M, 1996, SCIENTOMETRICS, V37, P279, DOI 10.1007/BF02093625; Bornmann L, 2014, J INFORMETR, V8, P175, DOI 10.1016/j.joi.2013.11.005; Bruce A, 2004, FUTURES, V36, P457, DOI 10.1016/j.futures.2003.10.003; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Cummings JN, 2005, SOC STUD SCI, V35, P703, DOI 10.1177/0306312705055535; Deng Z. L., 2009, INT COMMUNICATIONS, V0, P59; Fischer J, 2007, TRENDS ECOL EVOL, V22, P621, DOI 10.1016/j.tree.2007.08.016; Fisher E, 2014, HIGHER LEVEL RESPONS; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; HEBERLEIN TA, 1988, SOC NATUR RESOUR, V1, P5, DOI 10.1080/08941928809380634; Heck N, 2015, FISH RES, V167, P30, DOI 10.1016/j.fishres.2015.01.008; Huang C, 2014, SCIENTOMETRICS, V99, P689, DOI 10.1007/s11192-013-1199-x; Huang PCC, 2015, MOD CHINA, V41, P131, DOI 10.1177/0097700415570420; Huutoniemi K, 2010, RES POLICY, V39, P79, DOI 10.1016/j.respol.2009.09.011; Judge TA, 2007, ACAD MANAGE J, V50, P491; Karlovcec M, 2015, SCIENTOMETRICS, V102, P433, DOI 10.1007/s11192-014-1355-y; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P126, DOI 10.1002/asi.21226; LEPAIR C, 1980, SCIENTOMETRICS, V2, P177, DOI 10.1007/BF02016696; Levitt JM, 2008, J AM SOC INF SCI TEC, V59, P1973, DOI 10.1002/asi.20914; Li J, 2016, J ASSOC INF SCI TECH, V67, P432, DOI 10.1002/asi.23380; Li J, 2015, SCIENTOMETRICS, V102, P1997, DOI 10.1007/s11192-014-1471-8; Liu WS, 2015, J INFORMETR, V9, P555, DOI 10.1016/j.joi.2015.05.007; Liu YX, 2013, J INFORMETR, V7, P651, DOI 10.1016/j.joi.2013.04.002; Lockett A, 2005, J MANAGE INQUIRY, V14, P139, DOI 10.1177/1056492605276645; Mills P, 2011, PHILOS T R SOC B, V366, P2035, DOI 10.1098/rstb.2010.0411; Mimouni M, 2016, SCIENTOMETRICS, V108, P1455, DOI 10.1007/s11192-016-2025-z; Mooney HA, 2013, P NATL ACAD SCI USA, V110, P3665, DOI 10.1073/pnas.1107484110; Morillo F, 2003, J AM SOC INF SCI TEC, V54, P1237, DOI 10.1002/asi.10326; Nyhus PJ, 2002, SOC NATUR RESOUR, V15, P923, DOI 10.1080/08941920290107657; Peri G, 2005, REV ECON STAT, V87, P308, DOI 10.1162/0034653053970258; PORTER AL, 1985, SCIENTOMETRICS, V8, P161, DOI 10.1007/BF02016934; PRATT AD, 1977, J AM SOC INFORM SCI, V28, P285, DOI 10.1002/asi.4630280508; Rafols I, 2007, INNOVATION-ABINGDON, V20, P395, DOI 10.1080/13511610701760770; Rafols I, 2007, SCIENTOMETRICS, V70, P633, DOI 10.1007/s11192-007-0305-3; Rafols I, 2010, SCIENTOMETRICS, V82, P263, DOI 10.1007/s11192-009-0041-y; Shi DB, 2017, J ASSOC INF SCI TECH, V68, P780, DOI 10.1002/asi.23706; Somaya D, 2007, ORGAN SCI, V18, P922, DOI 10.1287/orsc.1070.0292; Steele TW, 2000, J AM SOC INFORM SCI, V51, P476, DOI 10.1002/(SICI)1097-4571(2000)51:5<476::AID-ASI8>3.3.CO;2-7; Stirling A., 1998, SPRU ELECT WORKING P, V28, P1; Sun JJ, 2016, SCIENTOMETRICS, V107, P745, DOI 10.1007/s11192-016-1884-7; Tang L, 2013, J INFORMETR, V7, P330, DOI 10.1016/j.joi.2012.11.010; URATA H, 1990, SCIENTOMETRICS, V18, P309, DOI 10.1007/BF02017767; Van Noorden R, 2015, NATURE, V525, P306, DOI 10.1038/525306a; Vanclay JK, 2013, J INFORMETR, V7, P265, DOI 10.1016/j.joi.2012.11.009; Veldkamp A, 2009, SUSTAINABLE AGRICULTURE, P673, DOI 10.1007/978-90-481-2666-8_41; Vieira ES, 2010, J INFORMETR, V4, P1, DOI 10.1016/j.joi.2009.06.002; Wang J, 2015, PLOS ONE, V10, DOI DOI https://doi.org/10.1371/journal.pone.0140581; Wang J, 2015, J INFORMETR, V9, P197, DOI 10.1016/j.joi.2014.12.006; Wang J, 2013, SCIENTOMETRICS, V94, P851, DOI 10.1007/s11192-012-0775-9; Wang XW, 2015, SCIENTOMETRICS, V103, P555, DOI 10.1007/s11192-015-1547-0; Yegros-Yegros A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135095; Zhang L, 2016, J ASSOC INF SCI TECH, V67, P1257, DOI 10.1002/asi.23487	58	4	4	7	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184977	10.1371/journal.pone.0184977	http://dx.doi.org/10.1371/journal.pone.0184977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934277	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900069
J	Tudorancea, I; Porumb, V; Trandabat, A; Neaga, D; Tamba, B; Iliescu, R; Dimofte, GM				Tudorancea, Ionut; Porumb, Vlad; Trandabat, Alexandru; Neaga, Decebal; Tamba, Bogdan; Iliescu, Radu; Dimofte, Gabriel M.			New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves	PLOS ONE			English	Article							FIBRILLATION CATHETER ABLATION; WHOLE-BODY HYPERTHERMIA; INTRAPERITONEAL CHEMOTHERAPY; TEMPERATURE DISTRIBUTION; CANCER-THERAPY; RATIONALE; ANTENNA; RADIOTHERAPY; THRESHOLDS; DOSIMETRY	Purpose Our aim was to develop a new experimental model for in vivo hyperthermia using non-directional microwaves, applicable to small experimental animals. We present an affordable approach for targeted microwave heat delivery to an isolated liver lobe in rat, which allows rapid, precise and stable tissue temperature control. Materials and methods A new experimental model is proposed. We used a commercial available magnetron generating 2450 MHz, with 4.4V and 14A in the filament and 4500V anodic voltage. Modifications were required in order to adjust tissue heating such as to prevent overheating and to allow for fine adjustments according to real-time target temperature. The heating is controlled using a virtual instrument application implemented in LabView (R) and responds to 0.1 degrees C variations in the target. Ten healthy adult male Wistar rats, weighing 250-270 g were used in this study. The middle liver lobe was the target for controlled heating, while the rest of the living animal was protected. Results In vivo microwave delivery using our experimental setting is safe for the animals. Target tissue temperature rises from 30 degrees C to 40 degrees C with 3.375 degrees C/second (R-2 = 0.9551), while the increment is lower it the next two intervals (40-42 degrees C and 42-44 degrees C) with 0.291 degrees C/s (R-2 = 0.9337) and 0.136 degrees C/s (R-2 = 0.7894) respectively, when testing in sequences. After reaching the desired temperature, controlled microwave delivery insures a very stable temperature during the experiments. Conclusions We have developed an inexpensive and easy to manufacture system for targeted hyperthermia using non-directional microwave radiation. This system allows for fine and stable temperature adjustments within the target tissue and is ideal for experimental models testing below or above threshold hyperthermia	[Tudorancea, Ionut] Grigore T Popa Univ Med & Pharm, Dept Physiol, Iasi, Romania; [Porumb, Vlad; Dimofte, Gabriel M.] Grigore T Popa Univ Med & Pharm, Dept Surg, Iasi, Romania; [Porumb, Vlad; Dimofte, Gabriel M.] Reg Inst Oncol, Dept Surg, Iasi, Romania; [Trandabat, Alexandru] Gheorghe Asachi Tech Univ, Fac Elect Engn, Iasi, Romania; [Neaga, Decebal] Reg Inst Oncol, Dept Engn, Iasi, Romania; [Tamba, Bogdan; Iliescu, Radu] Grigore T Popa Univ Med & Pharm, Dept Pharmacol, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Regional Institute of Oncology IASI; Regional Institute of Oncology IASI; Grigore T Popa University of Medicine & Pharmacy	Porumb, V (corresponding author), Grigore T Popa Univ Med & Pharm, Dept Surg, Iasi, Romania.; Porumb, V (corresponding author), Reg Inst Oncol, Dept Surg, Iasi, Romania.	porumbvlad@ymail.com	Dimofte, Mihail Gabriel/GXG-4768-2022; Trandabat, Alexandru Florentin/C-7999-2011; Tamba, Bogdan Ionel/J-6231-2014; Iliescu, Radu/C-5116-2011	Trandabat, Alexandru Florentin/0000-0001-7280-7653; Tamba, Bogdan Ionel/0000-0001-9868-1999; Iliescu, Radu/0000-0002-9124-577X	ERA-Net EuroNanoMed JTC program	ERA-Net EuroNanoMed JTC program	This work was developed within the research grant CheTherDel (Chemo-hyperthermal Delivery-Combined chemo-hyperthermal control of hepatic tumors, based on microwave-activated subendothelial-targeted nano-assemblies), funded by ERA-Net EuroNanoMed JTC 2011 program.	Baronzio GF, 2006, CANC TREATMENT PRIME; Bollemeijer JG, 1998, LAB INVESTIGATIONS, V227, P271; Brace CL, 2009, CURR PROBL DIAGN RAD, V38, P61, DOI 10.1067/j.cpradiol.2007.08.011; Carrafiello Gianpaolo, 2008, Int J Surg, V6 Suppl 1, pS65, DOI 10.1016/j.ijsu.2008.12.028; Chakaravarthi G, 2015, INT J HYPERTHER, V31, P737, DOI 10.3109/02656736.2015.1068957; Chatterjee DK, 2011, THER DELIV, V2, P1001, DOI 10.4155/TDE.11.72; CHEUNG AY, 1984, CANCER RES, V44, P4736; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Dewhirst MW, 2005, INT J HYPERTHER, V21, P779, DOI 10.1080/02656730500271668; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Diakite M, 2013, MAGN RESON MED, V69, P1122, DOI 10.1002/mrm.24322; Duck F.A., 1990, MED PHYS, V18; Gao SY, 2016, ONCOTARGET, V7, P57367, DOI 10.18632/oncotarget.10350; Goldberg SN, 1996, ACAD RADIOL, V3, P212, DOI 10.1016/S1076-6332(96)80443-0; HERMAN TS, 1982, J NATL CANCER I, V68, P487; Horsman MR, 2007, CLIN ONCOL-UK, V19, P418, DOI 10.1016/j.clon.2007.03.015; HUME SP, 1985, RADIOTHER ONCOL, V3, P165, DOI 10.1016/S0167-8140(85)80021-9; Ibitoye ZA, 2015, MED ENG PHYS, V37, P384, DOI 10.1016/j.medengphy.2015.01.015; Ichinoseki-Sekine N, 2007, BRIT J SPORT MED, V41, P425, DOI 10.1136/bjsm.2006.032540; Issels R, 1999, ONKOLOGIE, V22, P374, DOI 10.1159/000026986; Jauchem James R., 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P79, DOI 10.1515/jbcpp-2015-0011; Kano E, 1987, Gan No Rinsho, V33, P1657; Kok HP, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0503-8; Lieberman Shari, 2009, REV WHOLE BODY HYPER; MAETA M, 1987, CANCER-AM CANCER SOC, V59, P1101, DOI 10.1002/1097-0142(19870315)59:6<1101::AID-CNCR2820590610>3.0.CO;2-G; Mallory M, 2016, CRIT REV ONCOL HEMAT, V97, P56, DOI 10.1016/j.critrevonc.2015.08.003; Mathe G., 2001, 24 INT C CLIN HYP RO; Morimura Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P1510, DOI 10.1001/archopht.122.10.1510; Okmen Z, 2000, J MICROWAVE POWER EE, V35, P225; Planinsic G, 2008, EUR J PHYS, V29, P369, DOI 10.1088/0143-0807/29/2/017; RAMASWAMY H, 1991, J FOOD SCI, V56, P550, DOI 10.1111/j.1365-2621.1991.tb05321.x; Rettenmaier MA, 2015, INT J HYPERTHER, V31, P396, DOI 10.3109/02656736.2015.1007399; Rijnen Z, 2015, INT J HYPERTHER, P1; Singh LP, 2015, INT J CURR PHARM CLI, V5, P184; Suvernev AV, 1995, VISCERAL TUMORS TOMS, P97; SUZUKI T, 1995, TOHOKU J EXP MED, V177, P39, DOI 10.1620/tjem.177.39; Vargas Hernan I, 2014, ANN SURG ONCOL, V11, P139; Verhaart RF, 2015, INT J HYPERTHER, V31, P686, DOI 10.3109/02656736.2015.1052855; Vernon CC, 1996, INT J RADIAT ONCOL, V35, P731; Vertrees RA, 2002, PERFUSION-UK, V17, P279, DOI 10.1191/0267659102pf588oa; Wappling-Raaholt B, 2002, J MICROWAVE POWER EE, V37, P97; Wehner H, 2001, INT J HYPERTHER, V17, P19, DOI 10.1080/02656730150201561; Winkler R, TWISTED SHIELDED TAL; Witkamp AJ, 2001, CANCER TREAT REV, V27, P365, DOI 10.1053/ctrv.2001.0232; Yarmolenko PS, 2011, INT J HYPERTHER, V27, P320, DOI 10.3109/02656736.2010.534527; Zhai F, 2016, ELECTROMAGN BIOL MED, V35, P8, DOI 10.3109/15368378.2014.954289; Zhang HJ, 2013, INT J HYPERTHER, V29, P582, DOI 10.3109/02656736.2013.803606	47	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184810	10.1371/journal.pone.0184810	http://dx.doi.org/10.1371/journal.pone.0184810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934251	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900046
J	Bollas, A; Shahriyari, L				Bollas, Audrey; Shahriyari, Leili			The role of backward cell migration in two-hit mutants' production in the stem cell niche	PLOS ONE			English	Article							IMMORTAL STRAND HYPOTHESIS; MONOCLONAL CONVERSION; MUTATION-SELECTION; CANCER INITIATION; DYNAMICS; CRYPT; PROLIFERATION; SEGREGATION; MODEL	It has been discovered that there are two stem cell groups in the intestinal crypts: central stem cells (CeSCs), which are at the very bottom of the crypt, and border stem cells (BSCs), which are located between CeSCs and transit amplifying cells (TAs). Moreover, backward cell migration from BSCs to CeSCs has been observed. Recently, a bi-compartmental stochastic model, which includes CeSCs and BSCs, has been developed to investigate the probability of two-hit mutant production in the stem cell niche. In this project, we improve this stochastic model by adding the probability of backward cell migration to the model. The model suggests that the probability of two-hit mutant production increases when the frequency of backward cell migration increases. Furthermore, a small non-zero probability of backward cell migration leads to the largest range of optimal values for the frequency of symmetric divisions and the portion of divisions at each stem cell compartment in terms of delaying 2-hit mutant production. Moreover, the probability of two-hit mutant production is more sensitive to the probability of symmetric divisions than to the rate of backward cell migrations. The highest probability of two-hit mutant production corresponds to the case when all stem cell's divisions are asymmetric.	[Bollas, Audrey] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA; [Shahriyari, Leili] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Shahriyari, L (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	shahriyari.1@mbi.osu.edu			Mathematical Biosciences Institute; National Science Foundation [DMS 1440386]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	This research has been supported in part by the Mathematical Biosciences Institute and the National Science Foundation under grant DMS 1440386 (https://www.nsf.gov, LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PLOS COMPUTATIONAL B, V10; Bravo R, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-66; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; d'Onofrio A, 2007, J THEOR BIOL, V244, P367, DOI 10.1016/j.jtbi.2006.08.022; Ding DC, 2015, CELL TRANSPLANT, V24, P339, DOI 10.3727/096368915X686841; Durrett R, 2016, J MATH BIOL, V72, P1369, DOI 10.1007/s00285-015-0912-1; Fletcher AG, 2012, J THEOR BIOL, V300, P118, DOI 10.1016/j.jtbi.2012.01.021; Ganta C, 2009, CANCER RES, V69, P1815, DOI 10.1158/0008-5472.CAN-08-2750; Greco V, 2010, DEVELOPMENT, V137, P1585, DOI 10.1242/dev.041103; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Kagawa Y, 2014, J GASTROENTEROL, V49, P263, DOI 10.1007/s00535-013-0887-x; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komarova NL, 2007, MATH MOD METH APPL S, V17, P1647, DOI 10.1142/S021820250700242X; Komarova NL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0014; Komarova NL, 2003, J THEOR BIOL, V223, P433, DOI 10.1016/S0022-5193(03)00120-6; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Liu XF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03173; Maurya DK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-590; Mirams GR, 2012, J THEOR BIOL, V312, P143, DOI 10.1016/j.jtbi.2012.08.002; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Nowak MA, 2002, P NATL ACAD SCI USA, P99; Pin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037115; POTTEN CS, 1992, GUT, V33, P71, DOI 10.1136/gut.33.1.71; Potten CS, 2002, J CELL SCI, V115, P2381; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rodriguez-Brenes IA, 2011, P NATL ACAD SCI USA, V108, P18983, DOI 10.1073/pnas.1107621108; Shahriyari L, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa5a61; Shahriyari L., 2016, BIORXIV; Shahriyari L, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0977; Shahriyari L, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0141-6; Shahriyari L, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/5/055001; Shahriyari L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076195; Shirayeh AM, 2016, ARXIV161004089; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Traulsen A, 2010, BIOESSAYS, V32, P1003, DOI 10.1002/bies.201000025; Werner B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0349; Wodarz D, 2014, DYNAMICS CANC MATH F	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184651	10.1371/journal.pone.0184651	http://dx.doi.org/10.1371/journal.pone.0184651			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931019	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700027
J	Huang, JC; Zhang, L; Kang, BY; Zhu, TT; Li, YF; Zhao, FY; Qu, Y; Mu, DZ				Huang, Jichong; Zhang, Li; Kang, Bingyao; Zhu, Tingting; Li, Yafei; Zhao, Fengyan; Qu, Yi; Mu, Dezhi			Association between perinatal hypoxic-ischemia and periventricular leukomalacia in preterm infants: A systematic review and meta-analysis	PLOS ONE			English	Review							OBSTETRIC RISK-FACTORS; RENIN-ANGIOTENSIN SYSTEM; PATENT DUCTUS-ARTERIOSUS; BIRTH-WEIGHT INFANTS; WHITE-MATTER INJURY; CEREBRAL-PALSY; METABOLIC-ACIDOSIS; PREMATURE RUPTURE; GESTATIONAL-AGE; DAMAGE	Background Although investigators have implicated hypoxic-ischemia (HI) as a potential cause of periventricular leukomalacia (PVL), the role of clinical risk factors or markers for HI in the development of PVL remains controversial. The aim of this study was to identify perinatal HI-related factors associated with PVL. Method The PubMed, EMBASE, and Cochrane Library databases were searched. The last search was performed on January 2017. Summary effect estimates (pooled odds ratios [ORs]) were calculated for each risk factor using fixed or random effects models with tests for heterogeneity and publication bias. Results Fifteen studies with a total of 12,851 participants were included in this meta-analysis, and 14 potential risk factors were analyzed. The pooled results showed that mothers with oligohydramnios (OR, 1.55; 95% confidence interval [CI], 1.05 to 2.30), preterm infants with acidemia (OR, 1.87; 95% CI, 1.18 to 2.97), 1-minute Apgar score <7 (OR 2.69; 95% CI, 1.13 to 6.41), 5-minute Apgar score <7 (OR, 1.89; 95% CI, 1.39 to 2.56), apnea (OR, 1.76; 95% CI, 1.07 to 2.90), respiratory distress syndrome (OR, 1.46; 95% CI, 1.04 to 2.03), and seizures (OR, 4.60; 95% CI, 2.84 to 7.46) were associated with increased risk of PVL. Conclusion This study identified perinatal HI-related risk factors for the development of PVL in preterm infants. Future large-scale prospective clinical studies are required to validate and extend these findings.	[Huang, Jichong; Zhang, Li; Kang, Bingyao; Zhu, Tingting; Li, Yafei; Zhao, Fengyan; Qu, Yi; Mu, Dezhi] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Sichuan, Peoples R China; [Huang, Jichong; Zhang, Li; Kang, Bingyao; Zhu, Tingting; Li, Yafei; Zhao, Fengyan; Qu, Yi; Mu, Dezhi] Sichuan Univ, Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth De, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Mu, DZ (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Sichuan, Peoples R China.; Mu, DZ (corresponding author), Sichuan Univ, Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth De, Chengdu, Sichuan, Peoples R China.	mudz@scu.edu.cn		Qu, Yi/0000-0002-9993-8810; Mu, Dezhi/0000-0002-2599-7041	National Science Foundation of China [81330016, 81630038]; Major State Basic Research Development Program [2013CB967404, 2012BAI04604]; Science and Technology Bureau of Sichuan province [2014SZ0149, 2016TD0002]; Ministry of Health of China [1311200003303]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Science and Technology Bureau of Sichuan province; Ministry of Health of China	This work was supported by the National Science Foundation of China (no. 81330016, 81630038), the Major State Basic Research Development Program (2013CB967404, 2012BAI04604), the Grants from Science and Technology Bureau of Sichuan province (2014SZ0149, 2016TD0002), and the Grant of clinical discipline program (neonatology) from the Ministry of Health of China (1311200003303).; This work was supported by the National Science Foundation of China (No.81330016, 81630038), the Major State Basic Research Development Program (2013CB967404, 2012BAI04B04), the Grants from Science and Technology Bureau of Sichuan province (2014SZ0149, 2016TD0002), and the Grant of clinical discipline program (Neonatology) from the Ministry of Health of China (1311200003303).	Adams-Chapman I, 2013, J PEDIATR-US, V163, P961, DOI 10.1016/j.jpeds.2013.04.034; Al Tawil KI, 2012, PEDIATR NEUROL, V46, P149, DOI 10.1016/j.pediatrneurol.2011.12.008; Ancel PY, 2005, AM J OBSTET GYNECOL, V193, P178, DOI 10.1016/j.ajog.2004.11.057; Bauer M, 2009, EARLY HUM DEV, V85, P163, DOI 10.1016/j.earlhumdev.2008.07.007; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Carlo WA, 2012, J PEDIATR-US, V160, P781, DOI 10.1016/j.jpeds.2011.10.007; Cooper AC, 1999, PLACENTA, V20, P467, DOI 10.1053/plac.1999.0404; Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ekin A, 2015, J MATERN-FETAL NEO M, V28, P1918, DOI 10.3109/14767058.2014.972927; Folkerth RD, 2006, PEDIATR DEVEL PATHOL, V9, P3, DOI 10.2350/06-01-0024.1; GOLDABER KG, 1991, OBSTET GYNECOL, V78, P1103; Graham EM, 2004, AM J OBSTET GYNECOL, V191, P1305, DOI 10.1016/j.ajog.2004.06.058; Hatzidaki E, 2009, ACTA OBSTET GYN SCAN, V88, P110, DOI 10.1080/00016340802503039; Iliodromiti S, 2014, LANCET, V384, P1749, DOI 10.1016/S0140-6736(14)61135-1; Ito M, 2002, J CLIN ENDOCR METAB, V87, P1871, DOI 10.1210/jc.87.4.1871; Kakita H, 2009, BRAIN DEV-JPN, V31, P641, DOI 10.1016/j.braindev.2008.10.008; Kubota H, 2001, ACTA PAEDIATR, V90, P302, DOI 10.1080/080352501300067659; Lemmers PMA, 2008, PEDIATRICS, V121, P142, DOI 10.1542/peds.2007-0925; Leuthner SR, 2004, PEDIATR CLIN N AM, V51, P737, DOI 10.1016/j.pcl.2004.01.016; LEVITON A, 1990, EARLY HUM DEV, V24, P1, DOI 10.1016/0378-3782(90)90002-Z; Locatelli A, 2005, AM J OBSTET GYNECOL, V193, P947, DOI 10.1016/j.ajog.2005.06.039; Low JA, 1997, AM J OBSTET GYNECOL, V177, P1391, DOI 10.1016/S0002-9378(97)70080-2; Mukhopadhyay K, 2013, INDIAN PEDIATR, V50, P1119, DOI 10.1007/s13312-013-0305-8; Murata Y, 2005, BRAIN DEV-JPN, V27, P17, DOI 10.1016/j.braindev.2004.02.011; Nemerofsky SL, 2008, AM J PERINAT, V25, P661, DOI 10.1055/s-0028-1090594; Oda N, 2008, FETAL DIAGN THER, V24, P345, DOI 10.1159/000161573; Osmond E, 2014, ACTA PAEDIATR, V103, P820, DOI 10.1111/apa.12583; Perlman JM, 1996, PEDIATRICS, V97, P822; Pladys P, 2001, ACTA PAEDIATR, V90, P309, DOI 10.1080/080352501300067677; Resch B, 2012, EARLY HUM DEV, V88, P27, DOI 10.1016/j.earlhumdev.2011.06.011; Resch B, 2000, EUR J PEDIATR, V159, P663, DOI 10.1007/PL00008403; Robertson HT, 2009, J APPL PHYSIOL, V106, P1034, DOI 10.1152/japplphysiol.00015.2009; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Silva AM, 2006, OBSTET GYNECOL, V107, P550, DOI 10.1097/01.AOG.0000195066.43243.56; Spinillo A, 1998, BRIT J OBSTET GYNAEC, V105, P865, DOI 10.1111/j.1471-0528.1998.tb10231.x; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; Tsimis ME, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.108; Vincer MJ, 2006, PEDIATRICS, V118, pE1621, DOI 10.1542/peds.2006-1522; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Wells GA, 2015, NEWCASTLE OTTAWA SCO; Wharton KN, 2004, EARLY HUM DEV, V77, P77, DOI 10.1016/j.earlhumdev.2004.02.001; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Zupan V, 1996, DEV MED CHILD NEUROL, V38, P1061	46	23	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184993	10.1371/journal.pone.0184993	http://dx.doi.org/10.1371/journal.pone.0184993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931047	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700053
J	Kenchington, EL; Baillie, SM; Kenchington, TJ; Bentzen, P				Kenchington, Ellen L.; Baillie, Shauna M.; Kenchington, Trevor J.; Bentzen, Paul			Barcoding Atlantic Canada's mesopelagic and upper bathypelagic marine fishes	PLOS ONE			English	Article							BENTHOSEMA-GLACIALE; NORTH-ATLANTIC; SEXUAL-DIMORPHISM; DNA; RIDGE; LANTERNFISH; SPECIATION; UTILITY; MYCTOPHIFORMES; HIGHLIGHTS	DNA barcode sequences were developed from 557 mesopelagic and upper bathypelagic teleost specimens collected in waters off Atlantic Canada. Confident morphological identifications were available for 366 specimens, of 118 species and 93 genera, which yielded 328 haplotypes. Five of the species were novel to the Barcode of Life Database ( BOLD). Most of the 118 species conformed to expectations of monophyly and the presence of a "barcode gap", though some known weaknesses in existing taxonomy were confirmed and a deficiency in published keys was revealed. Of the specimens for which no firm morphological identification was available, 156 were successfully identified to species, and a further 11 to genus, using their barcode sequences and a combination of distance-and character-based methods. The remaining 24 specimens were from species for which no reference barcode is yet available or else ones confused by apparent misidentification of publicly available sequences in BOLD. Addition of the new sequences to those previously in BOLD contributed support to recent taxonomic revisions of Chiasmodon and Poromitra, while it also revealed 18 cases of potential cryptic speciation. Most of the latter appear to result from genetic divergence among populations in different ocean basins, while the general lack of strong horizontal environmental gradients within the deep sea has allowed morphology to be conserved. Other examples of divergence appear to distinguish individuals living under the sub-tropical gyre of the North Atlantic from those under that ocean's sub-polar gyre. In contrast, the available sequences for two myctophid species, Benthosema glaciale and Notoscopelus elongatus, showed genetic structuring on finer geographic scales. The observed structure was not consistent with recent suggestions that "resident" populations of myctophids can maintain allopatry despite the mixing of ocean waters. Rather, it indicates that the very rapid speciation characteristic of the Myctophidae is both on-going and detectable using barcodes.	[Kenchington, Ellen L.; Kenchington, Trevor J.] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada; [Baillie, Shauna M.; Bentzen, Paul] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University	Kenchington, EL (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada.	Ellen.Kenchington@dfo-mpo.gc.ca		Bentzen, Paul/0000-0003-4288-7730				Aliabadian M, 2014, CONTRIB ZOOL, V83, P79, DOI 10.1163/18759866-08301004; BADCOCK J, 1988, B MAR SCI, V42, P16; BADCOCK J, 1981, DEEP-SEA RES, V28, P1477, DOI 10.1016/0198-0149(81)90093-5; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bower AS, 2008, J PHYS OCEANOGR, V38, P104, DOI 10.1175/2007JPO3686.1; Catul V, 2011, REV FISH BIOL FISHER, V21, P339, DOI 10.1007/s11160-010-9176-4; Creer S, 2016, METHODS ECOL EVOL, V7, P1008, DOI 10.1111/2041-210X.12574; Davis MP, 2014, MAR BIOL, V161, P1139, DOI 10.1007/s00227-014-2406-x; Denton JSS, 2015, EVOLUTION, V69, P2425, DOI 10.1111/evo.12743; Denton JSS, 2014, MOL PHYLOGENET EVOL, V76, P270, DOI 10.1016/j.ympev.2014.02.009; DeVaney SC, 2009, NORTHEAST NAT, V16, P409, DOI 10.1656/045.016.n308; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Fock HO, 2004, DEEP-SEA RES PT I, V51, P953, DOI 10.1016/j.dsr.2004.03.004; FRANCIS MP, 1981, NEW ZEAL J ZOOL, V8, P403, DOI 10.1080/03014223.1981.10430620; Gaither MR, 2016, FISH FISH, V17, P664, DOI 10.1111/faf.12136; Gordeeva N, 2014, J ICHTHYOL+, V54, P642, DOI DOI 10.1134/S003294521406006X; Gordeeva N. V., 2011, J ICHTHYOL+, V51, P152, DOI DOI 10.1134/S0032945211020032; Gordeeva NV, 2014, J ICHTHYOL, V54, P882; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; Herring PJ, 2000, PHILOS T ROY SOC B, V355, P1273, DOI 10.1098/rstb.2000.0682; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Johnson GD, 2009, BIOL LETTERS, V5, P235, DOI 10.1098/rsbl.2008.0722; Kenchington T. J., 2009, Canadian Technical Report of Fisheries and Aquatic Sciences, V2853, P1; Kenchington TJ, 2014, CAN TECH REP FISH AQ, V3114; Kotlyar A. N., 2009, J ICHTHYOL+, V49, P421; Kotlyar A. N., 2008, J ICHTHYOL+, V48, P553, DOI DOI 10.1134/S0032945208080018; Kotlyar A. N., 2009, J ICHTHYOL+, V49, P563; Kotlyar A. N., 2008, J ICHTHYOL+, V48, P479, DOI DOI 10.1134/S0032945208070011; Kotlyar A. N., 2009, J ICHTHYOL+, V49, P710, DOI DOI 10.1134/S0032945209090021; Kotlyar A. N., 2010, J ICHTHYOL+, V50, P231, DOI DOI 10.1134/S0032945210030033; Krishnamurthy PK, 2012, BIODIVERS CONSERV, V21, P1901, DOI 10.1007/s10531-012-0306-2; Kristoffersen JB, 2009, MAR BIOL RES, V5, P596, DOI 10.1080/17451000903042479; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavoue A S, 2009, BIOL J LINN SOC, V98, P923; Lavoue S, 2008, MOL PHYLOGENET EVOL, V47, P1111, DOI 10.1016/j.ympev.2007.12.002; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Marshall N. B., 1954, P380; McCusker MR, 2013, MOL ECOL RESOUR, V13, P177, DOI 10.1111/1755-0998.12043; Melo MRS, 2009, COPEIA, P583, DOI 10.1643/CI-08-048; Miya M, 1997, NATURE, V389, P803, DOI 10.1038/39774; Moore JA, 2003, NORTHEAST NAT, V10, P159, DOI 10.1656/1092-6194(2003)010[0159:AALODF]2.0.CO;2; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Oliveira LM, 2016, J FISH BIOL, V89, P2741, DOI 10.1111/jfb.13169; Olteanu M, 2013, MOL ECOL RESOUR, V13, P976, DOI 10.1111/1755-0998.12047; Priede IG, 2013, DEEP-SEA RES PT II, V98, P220, DOI 10.1016/j.dsr2.2013.06.012; Prokofiev A. M., 2009, J ICHTHYOL, V49, P899, DOI DOI 10.1134/S0032945209100063; Prokofiev AM, 2010, J ICHTHYOL, V50, P503; Prokofiev AM, 2014, J ICHTHYOL, V54, P631, DOI DOI 10.1134/S0032945214060137; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Robinson C, 2010, DEEP-SEA RES PT II, V57, P1504, DOI 10.1016/j.dsr2.2010.02.018; Sarkar IN, 2002, J BIOMED INFORM, V35, P111, DOI 10.1016/S1532-0464(02)00504-X; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Smith PJ, 2011, J FISH BIOL, V78, P355, DOI 10.1111/j.1095-8649.2010.02846.x; Brandao JHSG, 2016, BIOCHEM SYST ECOL, V65, P214, DOI 10.1016/j.bse.2016.02.012; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Suneetha KB, 2001, SARSIA, V86, P203, DOI 10.1080/00364827.2001.10420476; Sutton TT, 2008, DEEP-SEA RES PT II, V55, P161, DOI 10.1016/j.dsr2.2007.09.013; Sutton TT, 2013, J FISH BIOL, V83, P1508, DOI 10.1111/jfb.12263; Svendsen FM, 2013, MAR BIODIVERS, V43, P407, DOI 10.1007/s12526-013-0168-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tunnicliffe V., 2010, MARINE ECOLOGY, V31, P1; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Winterbottom R, 2014, ZOOKEYS, P79, DOI 10.3897/zookeys.381.6445; Zahuranec B. J., 2000, SMITHS CONTR ZOOL, V607, P69; Zahuranec B, 2012, MAR GENOM, V7, P7, DOI 10.1016/j.margen.2012.05.001; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x	73	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185173	10.1371/journal.pone.0185173	http://dx.doi.org/10.1371/journal.pone.0185173			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931082	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700075
J	Brito, NC; Rabello, A; Cota, GF				Brito, Nayara Castelano; Rabello, Ana; Cota, Glaucia Fernandes			Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review	PLOS ONE			English	Review							RIO-DE-JANEIRO; MEGLUMINE ANTIMONIATE; SODIUM STIBOGLUCONATE; TOPICAL PAROMOMYCIN; COMBINED CRYOTHERAPY; SINGLE LESIONS; DOUBLE-BLIND; GLUCANTIME; METAANALYSES; EPIDEMIOLOGY	Background The mainstays of cutaneous leishmaniasis (CL) treatment, in several world regions, are pentavalent antimony (Sb-v) compounds administered parenterally, despite their recognized toxicity, which requires frequent laboratory monitoring and complicates their use in areas with scarce infrastructure. As result of these drawbacks, the WHO Expert Committee on leishmaniasis has expanded the recommendations for the use of local therapies, including Sbv intralesional infiltration (IL-Sb-v), as CL therapy alternatives even in the New World. However, the efficacy of these approaches has never been compiled. The aim of this study was to critically and systematically assess the efficacy of IL-Sb-v for CL treatment. Methodology The PRISMA guidelines for systematic reviews and the Cochrane manual were followed. The sources used were the MEDLINE and LILACS databases and the International Clinical Trials Registry Platform of the World Health Organization. The outcome of interest was a clinical cure, defined as complete re-epithelialization of all lesions. The IL-Sb-v pooled cure rate was estimated for several subgroups and direct comparisons were performed when possible. Results Thirty nine articles (40 studies) involving 5679 patients treated with IL-Sb-v infiltration were included. In direct comparison, only three studies involving 229 patients compared IL-Sb-v infiltration versus placebo and no difference was observed (OR: 1,9; 95% IC 0,93 to 3,82) based on cure rate 69.6% (95% CI 17.6-96.1%) and 83,2% (95% CI 66-92.7%) for placebo and IL-Sb-v, respectively. In an alternative and non-comparative analysis, gathering all study arms using the intervention, the pooled IL-Sb-v efficacy rate was 75% (95% CI 68-81%). In the Old World, the observed overall IL-Sb-v efficacy rate was 75% (95% CI 66-82%), and the cure rates were significantly higher with sodium stibogluconate (SSG) than with meglumine antimoniate (MA): 83% (95% CI 75-90%) versus 68% (95% CI 54-79%), p = 0.03. Studies directly comparing IL-Sb-v with topical 15% paromomycin ointment, IL hypertonic saline, radiofrequency-induced heat therapy, topical trichloroacetic acid and cryotherapy showed no significant difference in efficacy between the interventions. The analyses suggested a higher efficacy of IL-Sb-v combined with cryotherapy (81.8%, 95% IC 62.4-92.4%) when compared with IL-Sb-v alone (53.3%, 95% IC 46.1-66%), OR: 3.14 (95% CI 1.1-8.9), p = 0.03. In the New World, the global IL-Sb v efficacy was 77%(95% CI 66-85%). In contrast with the Old World, a significant difference favoring MA in relation to SSG was observed: 61% (95% CI 49-73%) versus 82% (95% CI 70-89%). By comparing IL infiltration schedules, it was determined that patients submitted to IL-Sb-v treatments longer than 14 days had higher cure rates. Conclusions Despite the high heterogeneity and low methodological quality of studies, an indirect comparison shows that the antimony infiltration efficacy rate is similar to that reported for antimony systemic use. The evidence gathered thus far is insufficient to identify the ideal IL therapeutic regime or estimate the rates of adverse events and mucosal late complications.	[Brito, Nayara Castelano; Rabello, Ana; Cota, Glaucia Fernandes] Fiocruz MS, Fundacao Oswaldo Cruz, Pesquisas Clin & Polit Publ Doencas Infectoparasi, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Cota, GF (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Pesquisas Clin & Polit Publ Doencas Infectoparasi, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	cola@cpqrr.fiocruz.br	Cota, Glaucia/ABC-5378-2020; Castelano, Nayara C/S-4519-2018	Cota, Glaucia/0000-0003-0538-7403; Castelano, Nayara C/0000-0002-2711-6519; Castelano, Nayara/0000-0002-8366-9126	National Counsel Technological and Scientific Developments - CNPq [304881/2009-0]	National Counsel Technological and Scientific Developments - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	AR is funded by National Counsel Technological and Scientific Developments - CNPq (grant number: 304881/2009-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2014, AM J TROP MED HYG, V91, P901, DOI 10.4269/ajtmh.13-0737; Cardona-Arias JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122569; Asilian A, 2004, INT J DERMATOL, V43, P281, DOI 10.1111/j.1365-4632.2004.02002.x; Asilian A, 2003, ANN TROP MED PARASIT, V97, P493, DOI 10.1179/000349803225001373; Bailey MS, 2007, CLIN DERMATOL, V25, P203, DOI 10.1016/j.clindermatol.2006.05.008; Banihashemi M, 2015, J CUTAN MED SURG, V19, P35, DOI 10.2310/7750.2014.13193; Ben Salah A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002749; Ben Salah A, 2013, NEW ENGL J MED, V368, P524, DOI 10.1056/NEJMoa1202657; Ben Salah A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000432; Blum J, 2012, INT HEALTH, V4, P153, DOI 10.1016/j.inhe.2012.06.004; Bumb RA, 2013, BRIT J DERMATOL, V168, P1114, DOI 10.1111/bjd.12205; Bumb RA, 2010, BRIT J DERMATOL, V163, P854, DOI 10.1111/j.1365-2133.2010.09865.x; Chahed M. K., 1999, Archives de l'Institut Pasteur de Tunis, V76, P13; Cota GF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149697; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; da Silva RE, 2016, MEM I OSWALDO CRUZ, V111, P512, DOI 10.1590/0074-02760160183; Vasconcellos ECFE, 2012, AM J TROP MED HYG, V87, P257, DOI 10.4269/ajtmh.2012.11-0612; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; ELDAROUTI MA, 1990, INT J DERMATOL, V29, P56, DOI 10.1111/j.1365-4362.1990.tb03759.x; Faghihi G, 2003, CLIN EXP DERMATOL, V28, P13, DOI 10.1046/j.1365-2230.2003.01169.x; Fathy Fouad M., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P881; FRANKE ED, 1990, ANN INTERN MED, V113, P934, DOI 10.7326/0003-4819-113-12-934; GASSER RA, 1994, CLIN INFECT DIS, V18, P83, DOI 10.1093/clinids/18.1.83; GHOSN S, 1979, CURR MED RES OPIN, V6, P280, DOI 10.1185/03007997909109438; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Jaffary F, 2016, DERMAT RES PRACT, V2016, DOI 10.1155/2016/6462804; Kim DH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000381; Layegh Pouran, 2011, J Parasitol Res, V2011, P656523, DOI 10.1155/2011/656523; Layegh P, 2009, AM J TROP MED HYG, V80, P172, DOI 10.4269/ajtmh.2009.80.172; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lopez-Carvajal L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1663-3; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maleki Masoud, 2012, Indian J Dermatol, V57, P118, DOI 10.4103/0019-5154.94279; Mohammadzadeh M, 2013, J INFECT PUBLIC HEAL, V6, P120, DOI 10.1016/j.jiph.2012.11.003; Nilforoushzadeh MA, 2014, J SKIN STEM CELL, V1; NILFOROUSHZADEH MA, 2003, IRANIAN J DERMATOLOG, V2, P34; Nilforoushzadeh MA, 2012, J RES MED SCI, V17; Nilforoushzadeh Mohammad Ali, 2007, BMC Complement Altern Med, V7, P13, DOI 10.1186/1472-6882-7-13; Oliveira WCd, 1990, AN BRAS DERMATOL, V65, P201; OliveiraNeto MP, 1997, INT J DERMATOL, V36, P463, DOI 10.1046/j.1365-4362.1997.00188.x; Olliaro P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002130; PAHO, 2013, LEISHM AM REC TRAT C; PAHO/ OMS, 2016, INF EP AM LEISHM; Qasmi S, 2008, Dermatol Online J, V14, P18; Rajabi O, 2016, DERMATOL THER; Ranawaka RR, 2015, INT J DERMATOL, V54, P555, DOI 10.1111/ijd.12685; Ranawaka RR, 2010, J DERMATOL TREAT, V21, P286, DOI 10.3109/09546630903287445; Refai FW, 2014, EFFICACY SAFETY THER; Sadeghian G, 2006, INT J DERMATOL, V45, P819, DOI 10.1111/j.1365-4632.2006.02867.x; Safi N, 2012, MIL MED, V177, P345, DOI 10.7205/MILMED-D-11-00161; Salmanpour R, 2006, INT J DERMATOL, V45, P1115, DOI 10.1111/j.1365-4632.2006.02822.x; Shazad B, 2005, EUR J DERMATOL, V15, P85; Solomon M, 2009, J EUR ACAD DERMATOL, V23, P1189, DOI 10.1111/j.1468-3083.2009.03157.x; Solomon M, 2014, J AM ACAD DERMATOL, V71, P271, DOI 10.1016/j.jaad.2013.12.047; Soto J, 2016, AM J TROP MED HYG, V94, P852, DOI 10.4269/ajtmh.15-0640; Soto J, 2013, CLIN INFECT DIS, V56, P1255, DOI 10.1093/cid/cit049; Stahl HC, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0619-8; Tuon FF, 2008, INT J DERMATOL, V47, P109, DOI 10.1111/j.1365-4632.2008.03417.x; van Thiel PP, 2010, AM J TROP MED HYG, V83, P1295, DOI 10.4269/ajtmh.2010.10-0143; Wells GA, 2011, NEWCASTLE OTTAWA SCA; WHO, 2010, WHO TECH REP SER, V949, P1; Yepez Y., 1995, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V35, P71; Yesilova Y, 2016, J DERMATOL TREAT, V27, P83, DOI 10.3109/09546634.2015.1054778	63	47	49	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184777	10.1371/journal.pone.0184777	http://dx.doi.org/10.1371/journal.pone.0184777			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926630	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600040
J	Lin, YS; Bai, Y; Liu, P; Yang, XJ; Qin, W; Gu, JQ; Ding, DG; Tian, J; Wang, MY				Lin, Yusong; Bai, Yan; Liu, Peng; Yang, Xuejuan; Qin, Wei; Gu, Jianqin; Ding, Degang; Tian, Jie; Wang, Meiyun			Alterations in regional homogeneity of resting-state cerebral activity in patients with chronic prostatitis/chronic pelvic pain syndrome	PLOS ONE			English	Article							OPIOID RECEPTOR AVAILABILITY; ANTERIOR CINGULATE CORTEX; NATIONAL-INSTITUTES; SYMPTOM INDEX; BRAIN; HEALTH; ACTIVATION; MECHANISMS; PLACEBO; BINDING	The purpose of this study was to explore the neural mechanism in Chronic prostatitis/Chronic pelvic pain syndrome (CP/CPPS) using resting-state functional magnetic resonance imaging. The functional magnetic resonance imaging was performed on 31 male CP/CPPS-patients and 31 age and education matched male healthy controls on a 3-T magnetic resonance imaging unit. A two-sample t-test was adopted to reveal the regional homogeneity between the patients and healthy controls. The mean regional homogeneity values in the alerted brain regions of patients were correlated with the clinical measurements by using Pearson's correlation analyses. The CP/CPPS-patients had significantly decreased regional homogeneity in the bilateral anterior cingulate cortices, insular cortices and right medial prefrontal cortex, while significantly increased regional homogeneity in the brainstem and right thalamus compared with the healthy controls. In the CP/CPPSpatients, the mean regional homogeneity value in the left anterior cingulate cortex, bilateral insular cortices and brainstem were respectively correlated with the National Institutes of Health Chronic Prostatitis Symptom Index total score and pain subscale. These brain regions are important in the pain modulation process. Therefore, an impaired pain modulatory system, either by decreased descending pain inhibition or enhanced pain facilitation, may explain the pain symptoms in CP/CPPS.	[Lin, Yusong] Zhengzhou Univ, Cooperat Innovat Ctr Internet Healthcare, Zhengzhou, Henan, Peoples R China; [Lin, Yusong] Zhengzhou Univ, Sch Software & Appl Technol, Zhengzhou, Henan, Peoples R China; [Bai, Yan; Wang, Meiyun] Zhengzhou Univ, Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China; [Bai, Yan; Gu, Jianqin; Ding, Degang; Wang, Meiyun] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Bai, Yan; Wang, Meiyun] Henan Key Lab Med Imaging Neurol Dis, Xinjiang, Peoples R China; [Bai, Yan; Wang, Meiyun] Henan Univ, Med Sch, Zhengzhou, Henan, Peoples R China; [Liu, Peng; Yang, Xuejuan; Qin, Wei] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Gu, Jianqin; Wang, Meiyun] Zhengzhou Univ, Peoples Hosp, Henan Prov Clin Big Data Anal & Serv Engn Res Ctr, Zhengzhou, Henan, Peoples R China; [Ding, Degang] Zhengzhou Univ, Peoples Hosp, Dept Urol, Zhengzhou, Henan, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Henan University; Xidian University; Zhengzhou University; Zhengzhou University; Chinese Academy of Sciences; Institute of Automation, CAS	Wang, MY (corresponding author), Zhengzhou Univ, Peoples Hosp, Dept Radiol, Zhengzhou, Henan, Peoples R China.; Ding, DG; Wang, MY (corresponding author), Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China.; Wang, MY (corresponding author), Henan Key Lab Med Imaging Neurol Dis, Xinjiang, Peoples R China.; Wang, MY (corresponding author), Henan Univ, Med Sch, Zhengzhou, Henan, Peoples R China.; Wang, MY (corresponding author), Zhengzhou Univ, Peoples Hosp, Henan Prov Clin Big Data Anal & Serv Engn Res Ctr, Zhengzhou, Henan, Peoples R China.; Ding, DG (corresponding author), Zhengzhou Univ, Peoples Hosp, Dept Urol, Zhengzhou, Henan, Peoples R China.; Tian, J (corresponding author), Chinese Acad Sci, Inst Automat, Beijing, Peoples R China.	bghlh2007@126.com; jie.tian@ia.ac.cn; mywang@ha.edu.cn	Tian, Jie/H-1190-2011	Tian, Jie/0000-0003-0498-0432	National Natural Science Foundation of China [31470047, 81641168, 81271565, 81601466, 81271644, 81471811]; Henan Province Scientific and Technological Innovation Talents Project [164200510014]; Henan Province Scientific and Technological Cooperation Project [152106000014]; Key Project of Henan Medical Science and Technology Project [201501011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Province Scientific and Technological Innovation Talents Project; Henan Province Scientific and Technological Cooperation Project; Key Project of Henan Medical Science and Technology Project	Research by MW was funded by the National Natural Science Foundation of China (No. 31470047, 81641168 and 81271565), Henan Province Scientific and Technological Innovation Talents Project (No. 164200510014), Henan Province Scientific and Technological Cooperation Project (No. 152106000014) and Key Project of Henan Medical Science and Technology Project (No. 201501011). Research by YB was funded by the National Natural Science Foundation of China (No. 81601466). Research by PL was funded by the National Natural Science Foundation of China (No. 81271644). Research by WQ was funded by the National Natural Science Foundation of China (No. 81471811).	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Bao CH, 2016, PAIN, V157, P1037, DOI 10.1097/j.pain.0000000000000479; Baumgartner U, 2006, NEUROIMAGE, V30, P692, DOI 10.1016/j.neuroimage.2005.10.033; Collins MM, 1998, J UROLOGY, V159, P1224, DOI 10.1016/S0022-5347(01)63564-X; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dunckley P, 2005, J NEUROSCI, V25, P7333, DOI 10.1523/JNEUROSCI.1100-05.2005; Dunckley P, 2005, NEUROSCIENCE, V133, P533, DOI 10.1016/j.neuroscience.2005.02.041; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Foerster BR, 2012, ARTHRITIS RHEUM-US, V64, P579, DOI 10.1002/art.33339; Gao JJ, 2014, J SEX MED, V11, P3093, DOI 10.1111/jsm.12696; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Harris RE, 2007, J NEUROSCI, V27, P10000, DOI 10.1523/JNEUROSCI.2849-07.2007; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; Jiang LL, 2016, NEUROSCIENTIST, V22, P486, DOI 10.1177/1073858415595004; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; JONES AKP, 1994, BRIT J RHEUMATOL, V33, P909; Kessler TM, 2016, EUR UROL, V69, P298, DOI 10.1016/j.eururo.2015.09.028; Kwon JK, 2013, INT NEUROUROL J, V17, P48, DOI 10.5213/inj.2013.17.2.48; Labus JS, 2014, PAIN, V155, P137, DOI 10.1016/j.pain.2013.09.020; Li HJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/374828; Liu J, 2013, PAIN, V154, P110, DOI 10.1016/j.pain.2012.09.016; Lui F, 2010, PAIN, V151, P816, DOI 10.1016/j.pain.2010.09.021; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; Magistro G, 2016, EUR UROL, V69, P286, DOI 10.1016/j.eururo.2015.08.061; Matthey A, 2013, PAIN PHYSICIAN, V16, pE553; Mochizuki H, 2007, NEUROIMAGE, V36, P706, DOI 10.1016/j.neuroimage.2007.04.003; Mordasini L, 2012, J UROLOGY, V188, P2233, DOI 10.1016/j.juro.2012.08.043; Nickel JC, 2008, NEW ENGL J MED, V359, P2663, DOI 10.1056/NEJMoa0803240; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Schulz E, 2015, CEREB CORTEX, V25, P4407, DOI 10.1093/cercor/bhv043; Stoeter P, 2007, NEUROIMAGE, V36, P418, DOI 10.1016/j.neuroimage.2007.01.052; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Wagenlehner FME, 2013, EUR UROL, V63, P953, DOI 10.1016/j.eururo.2012.10.042; Xia Y, 2016, EUR J NUTR; Yelle MD, 2009, J NEUROSCI, V29, P10264, DOI 10.1523/JNEUROSCI.4648-08.2009; Yen Chen-Tung, 2013, Acta Anaesthesiol Taiwan, V51, P73, DOI 10.1016/j.aat.2013.06.011; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	45	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e184896	10.1371/journal.pone.0184896	http://dx.doi.org/10.1371/journal.pone.0184896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926645	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600050
J	Qiu, CF; Lawrence, W; Gelaye, B; Stoner, L; Frederick, IO; Enquobahrie, DA; Sorensen, TK; Williams, MA				Qiu, Chunfang; Lawrence, Wayne; Gelaye, Bizu; Stoner, Lee; Frederick, Ihunnaya O.; Enquobahrie, Daniel A.; Sorensen, Tanya K.; Williams, Michelle A.			Risk of glucose intolerance and gestational diabetes mellitus in relation to maternal habitual snoring during early pregnancy	PLOS ONE			English	Article							SLEEP DISTURBANCES; WOMEN; POPULATION; HYPERTENSION; DISORDERS; DURATION; OUTCOMES; DISEASE; APNEA; MEN	Background Obstructive sleep apnea (OSA) or habitual snoring is known to be associated with impaired glucose tolerance and type 2 diabetes among both men and non-pregnant women. We examined the association of habitual snoring during early pregnancy with risk of impaired glucose tolerance (IGT) and gestational diabetes mellitus (GDM). Methods A cohort of 1,579 women was interviewed during early pregnancy. We collected information about snoring frequency during early pregnancy. Results from screening and diagnostic tests for IGT and GDM were abstracted from medical records. Multivariate logistic regression models were fitted to estimate odds ratios (OR) and 95% confidence intervals (95% CI) of IGT and GDM associated with snoring in early pregnancy. Results Overall, women who snored "most or all of the time" had a 2.1-fold increased odds of IGT (OR 2.10; 95% CI 1.31-3.35) and a 2.5-fold increased odds of GDM (OR 2.50; 95% CI 1.34-4.67) as compared with women who never snored. Compared with lean women (pre-pregnancy body mass index (BMI) < 25 kg/m(2)) who did not snore, lean snorers had a 2-fold increased odds of GDM (OR = 1.99, 95% CI: 1.07-3.68). The odds of GDM risk was particularly elevated among overweight women (BMI-25 kg/m(2)) who snored (OR = 5.01; 95% CI 2.71-9.26). However, there was no evidence of an interaction between overweight and snoring with GDM risk (p-value = 0.144). Conclusions These findings, if confirmed, may have important implications for tailoring prenatal care for overweight pregnant women, and/or those with a history of habitual snoring in early pregnancy.	[Qiu, Chunfang; Frederick, Ihunnaya O.; Sorensen, Tanya K.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA 98104 USA; [Lawrence, Wayne; Gelaye, Bizu; Williams, Michelle A.] Harvard T Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Stoner, Lee] Univ N Carolina, Dept Sport & Exercise Sci, Chapel Hill, NC USA; [Enquobahrie, Daniel A.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA	Swedish Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Qiu, CF (corresponding author), Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA 98104 USA.	Qiu4free@gmail.com	Lawrence, Wayne/N-3626-2016; Stoner, Lee/C-8504-2011	Lawrence, Wayne/0000-0002-2992-5897; Stoner, Lee/0000-0002-0682-2270	National Institutes of Health [T37-MD-001449, R01HD-055566, R01HD-32562]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055566] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032562] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [T37MD001449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Our research was supported by awards from the National Institutes of Health (T37-MD-001449, R01HD-055566 and R01HD-32562). There was no additional external funding received for this study.	Al-Delaimy WK, 2002, AM J EPIDEMIOL, V155, P387, DOI 10.1093/aje/155.5.387; American Diabetes Association, 2011, DIABETES CARE S1, V34, ps15; Balserak BI, 2013, SLEEP BREATH, V17, P1093, DOI 10.1007/s11325-013-0809-4; BLIWISE DL, 1991, CHEST, V99, P600, DOI 10.1378/chest.99.3.600; Carroll JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118467; Elmasry A, 2000, J INTERN MED, V248, P13, DOI 10.1046/j.1365-2796.2000.00683.x; Facco FL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.041; Ge X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148732; GISLASON T, 1993, CHEST, V103, P1147, DOI 10.1378/chest.103.4.1147; Izci-Balserak B, 2010, CURR OPIN PULM MED, V16, P574, DOI 10.1097/MCP.0b013e32833f0d55; JENNUM P, 1995, CHEST, V108, P138, DOI 10.1378/chest.108.1.138; Lindberg E, 2007, RESP MED, V101, P1283, DOI 10.1016/j.rmed.2006.10.015; Louis J, 2012, OBSTET GYNECOL, V120, P1085, DOI 10.1097/AOG.0b013e31826eb9d8; Luque-Fernandez MA, 2013, DIABETES CARE, V36, P3353, DOI 10.2337/dc13-0778; O'Brien LM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.034; O'Keeffe M, 2013, INT J OBESITY, V37, P765, DOI 10.1038/ijo.2012.142; Orta OR, 2015, J AFFECT DISORDERS, V172, P390, DOI 10.1016/j.jad.2014.10.032; Polotsky VY, 2003, J PHYSIOL-LONDON, V552, P253, DOI 10.1113/jphysiol.2003.048173; Qiu CF, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-17; Reutrakul S, 2011, DIABETES CARE, V34, P2454, DOI 10.2337/dc11-0780; Sabanayagam C, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/879134; Sharma SK, 2016, SLEEP BREATH, V20, P87, DOI 10.1007/s11325-015-1188-9; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Tuomilehto H, 2008, DIABETES OBES METAB, V10, P468, DOI 10.1111/j.1463-1326.2007.00729.x; Ugur MG, 2012, CLIN EXP OBSTET GYN, V39, P214; Williams CJ, 2007, DIABETES CARE, V30, P1233, DOI 10.2337/dc06-2107	26	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184966	10.1371/journal.pone.0184966	http://dx.doi.org/10.1371/journal.pone.0184966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926639	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600056
J	Wei, SQ; Perera, MLW; Sakhtemanil, R; Bhagwat, AS				Wei, Shanqiao; Perera, Madusha L. W.; Sakhtemanil, Ramin; Bhagwat, Ashok S.			A novel class of chemicals that react with abasic sites in DNA and specifically kill B cell cancers	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; BASE EXCISION-REPAIR; APURINIC/APYRIMIDINIC ENDONUCLEASE-1 INHIBITORS; ALKYLATING AGENT TEMOZOLOMIDE; SINGLE-STRANDED-DNA; GENOMIC URACIL; SOMATIC HYPERMUTATION; PROPARGYL ALCOHOL; AID EXPRESSION; BREAST-CANCER	Most B cell cancers overexpress the enzyme activation-induced deaminase at high levels and this enzyme converts cytosines in DNA to uracil. The constitutive expression of this enzyme in these cells greatly increases the uracil content of their genomes. We show here that these genomes also contain high levels of abasic sites presumably created during the repair of uracils through base-excision repair. We further show that three alkoxyamines with an alkyne functional group covalently link to abasic sites in DNA and kill immortalized cell lines created from B cell lymphomas, but not other cancers. They also do not kill normal B cells. Treatment of cancer cells with one of these chemicals causes strand breaks, and the sensitivity of the cells to this chemical depends on the ability of the cells to go through the S phase. However, other alkoxyamines that also link to abasic sites-but lack the alkyne functionality- do not kill cells from B cell lymphomas. This shows that the ability of alkoxyamines to covalently link to abasic sites is insufficient for their cytotoxicity and that the alkyne functionality may play a role in it. These chemicals violate the commonly accepted bioorthogonality of alkynes and are attractive prototypes for anti-B cell cancer agents.	[Wei, Shanqiao; Perera, Madusha L. W.; Sakhtemanil, Ramin; Bhagwat, Ashok S.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Bhagwat, Ashok S.] Wayne State Univ, Immunol & Microbiol, Detroit, MI 48202 USA	Wayne State University; Wayne State University	Bhagwat, AS (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.; Bhagwat, AS (corresponding author), Wayne State Univ, Immunol & Microbiol, Detroit, MI 48202 USA.	axb@chem.wayne.edu	Bhagwat, Ashok/ABA-3861-2020; Bhagwat, Ashok/AAU-4186-2021	Bhagwat, Ashok/0000-0003-1188-0579; Sakhtemani, Ramin/0000-0001-5342-9415	NIH grant [R01 GM 057200]; Grants Plus award from the Wayne State University; Thomas C. Rumble University Graduate Fellowship from Wayne State University; Summer dissertation fellowship from Wayne State University	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants Plus award from the Wayne State University; Thomas C. Rumble University Graduate Fellowship from Wayne State University; Summer dissertation fellowship from Wayne State University	The work reported here was supported by NIH grant R01 GM 057200 and a Grants Plus award from the Wayne State University to A.S.B., and a Thomas C. Rumble University Graduate Fellowship and Summer dissertation fellowship from Wayne State University to S. W.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; ARCHER TE, 1985, J ENVIRON SCI HEAL B, V20, P593, DOI 10.1080/03601238509372497; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dingler FA, 2014, EUR J IMMUNOL, V44, P1925, DOI 10.1002/eji.201444482; Feng Zhiwei, 2015, Journal of Chemical Biology, V8, P79, DOI 10.1007/s12154-015-0131-7; Fishel ML, 2008, DNA REPAIR, V7, P177, DOI 10.1016/j.dnarep.2007.09.008; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Futagami S, 2008, DIGESTION, V78, P93, DOI 10.1159/000167978; Goellner EM, 2011, CANCER RES, V71, P2308, DOI 10.1158/0008-5472.CAN-10-3213; Greeve J, 2003, BLOOD, V101, P3574, DOI 10.1182/blood-2002-08-2424; Hardianti MS, 2004, LEUKEMIA, V18, P826, DOI 10.1038/sj.leu.2403323; HUANG CH, 1981, BIOCHEMISTRY-US, V20, P233, DOI 10.1021/bi00505a001; IDE H, 1993, BIOCHEMISTRY-US, V32, P8276, DOI 10.1021/bi00083a031; Krokan HE, 2014, DNA REPAIR, V19, P38, DOI 10.1016/j.dnarep.2014.03.028; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Liu L, 1999, CLIN CANCER RES, V5, P2908; Lossos IS, 2004, LEUKEMIA, V18, P1775, DOI 10.1038/sj.leu.2403488; Luo MH, 2004, ANTICANCER RES, V24, P2127; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Montaldi AP, 2013, CLIN EXP MED, V13, P279, DOI 10.1007/s10238-012-0201-x; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nyland RL, 2010, J MED CHEM, V53, P1200, DOI 10.1021/jm9014857; OBRIEN R, 1970, J HISTOCHEM CYTOCHEM, V18, P581, DOI 10.1177/18.8.581; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Peters Carrie E, 2005, Methods Mol Biol, V302, P95; Pettersen HS, 2015, DNA REPAIR, V25, P60, DOI 10.1016/j.dnarep.2014.11.006; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Rai G, 2012, J MED CHEM, V55, P3101, DOI 10.1021/jm201537d; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Shalhout S, 2014, MOL CELL BIOL, V34, P4019, DOI 10.1128/MCB.00589-14; Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296; Smit LA, 2003, CANCER RES, V63, P3894; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Srinivasan A, 2012, BIOCHEMISTRY-US, V51, P6246, DOI 10.1021/bi300490r; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Taverna P, 2001, MUTAT RES-DNA REPAIR, V485, P269, DOI 10.1016/S0921-8777(01)00076-3; Thakur SA, 2013, TOXICOLOGY, V314, P100, DOI 10.1016/j.tox.2013.09.002; TICHY M, 1985, ENVIRON HEALTH PERSP, V61, P321, DOI 10.2307/3430082; van Swieten PF, 2005, ORG BIOMOL CHEM, V3, P20, DOI 10.1039/b412558d; Visnes T, 2009, PHILOS T R SOC B, V364, P563, DOI 10.1098/rstb.2008.0186; Wei SQ, 2015, DNA REPAIR, V27, P9, DOI 10.1016/j.dnarep.2014.12.006; Wille U, 2013, CHEM REV, V113, P813, DOI 10.1021/cr100359d; Yan L, 2007, CLIN CANCER RES, V13, P1532, DOI 10.1158/1078-0432.CCR-06-1595; Zou GM, 2009, J CELL PHYSIOL, V219, P209, DOI 10.1002/jcp.21666	52	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185010	10.1371/journal.pone.0185010	http://dx.doi.org/10.1371/journal.pone.0185010			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926604	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600061
J	Laskar, RA; Khan, S				Laskar, Rafiul Amin; Khan, Samiullah			Assessment on induced genetic variability and divergence in the mutagenized lentil populations of microsperma and macrosperma cultivars developed using physical and chemical mutagenesis	PLOS ONE			English	Article							MUTATION	Induced mutagenesis was employed to create genetic variation in the lentil cultivars for yield improvement. The assessments were made on genetic variability, character association, and genetic divergence among the twelve mutagenized populations and one parent population of each of the two lentil cultivars, developed by single and combination treatments with gamma rays and hydrazine hydrates. Analysis of variance revealed significant inter-population differences for the observed quantitative phenotypic traits. The sample mean of six treatment populations in each of the cultivar exhibited highly superior quantitative phenotypic traits compared to their parent cultivars. The higher values of heritability and genetic advance with a high genotypic coefficient of variation for most of the yield attributing traits confirmed the possibilities of lentil yield improvement through phenotypic selection. The number of pods and seeds per plant appeared to be priority traits in selection for higher yield due to their strong direct association with yield. The cluster analysis divided the total populations into three divergent groups in each lentil cultivar with parent genotypes in an independent group showing the high efficacy of the mutagens. Considering the highest contribution of yield trait to the genetic divergence among the clustered population, it was confirmed that the mutagenic treatments created a wide heritable variation for the trait in the mutant populations. The selection of high yielding mutants from the mutant populations of DPL 62 (100 Gy) and Pant L 406 (100Gy + 0.1% HZ) in the subsequent generation is expected to give elite lentil cultivars. Also, hybridization between members of the divergent group would produce diverse segregants for crop improvement. Apart from this, the induced mutations at loci controlling economically important traits in the selected high yielding mutants have successfully contributed in diversifying the accessible lentil genetic base and will definitely be of immense value to the future lentil breeding programmes in India.	[Laskar, Rafiul Amin; Khan, Samiullah] Aligarh Muslim Univ, Dept Bot, Mutat Breeding Lab, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Laskar, RA (corresponding author), Aligarh Muslim Univ, Dept Bot, Mutat Breeding Lab, Aligarh, Uttar Pradesh, India.	rafihkd@gmail.com	LASKAR, RAFIUL AMIN/K-5865-2014	LASKAR, RAFIUL AMIN/0000-0002-4279-3972				Afuape S. O., 2011, African Journal of Plant Science, V5, P123; Ahmad F, 2015, PLOS ONE, V10, P9; Al-Ghzawi A. L. A., 2011, Advances in Environmental Biology, V5, P3676; Ali A, 2012, ASIAN J PLANT SCI, V1, P420; Allard R.W., 1960, PRINCIPLES PLANT BRE, P92; Amin R., 2015, COGENT FOOD AGR, V1; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Barulina E.I., 1930, B APPL BOT GENET PL, V40, P265, DOI DOI 10.1023/A:1018306723777; Beaumont Mark A., 1998, P315; BOROJEVIO K., 1972, Proceedings of a Latin American study group on induced mutations and plant improvement, Buenos Aires, 16-20 November 1970., P237; Cubero J. I., 1981, Lentils, P15; Dhumal KN, 2012, ADROVIC FERIZ PROF, P208; Erskine W., 2009, The lentil: botany, production and uses, P4, DOI 10.1079/9781845934873.0004; ERSKINE W, 1990, ANIM FEED SCI TECH, V28, P61, DOI 10.1016/0377-8401(90)90068-J; Erskine W, 1998, EUPHYTICA, V101, P207, DOI 10.1023/A:1018306723777; GREGORY WC, 1965, RAD BOT S, V5, P429; Ignacimuthu S., 1993, Journal of Nuclear Agriculture and Biology, V22, P133; ISTA (International Seed Testing Association), 1985, SEED SCI TECHNOL, V3, P299; Joshi Prashant, 2004, Indian Journal of Genetics & Plant Breeding, V64, P155; KAUL MLH, 1983, BIOL ZBL, V102, P559; Khan S., 1998, J IND BOT SOC, V77, P95; Laskar R. A., 2015, Journal of Agronomy, V14, P102, DOI 10.3923/ja.2015.102.111; LOESCH P. J., 1964, CROP SCI, V4, P73; Malek MA, 2014, SCI WORLD J, DOI 10.1155/2014/968796; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Muduli K. C., 2008, Journal of Crop Science and Biotechnology, V11, P63; Najeeb S., 2009, Maize Genetics Cooperation Newsletter, P46; Ogunniyan DJ, 2014, NIGERIAN J GENETICS, V28, P24; Rizwan M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171846; Rohman M. M., 2004, Asian Journal of Plant Sciences, V3, P211; SAKAI KAN-ICHI, 1964, RADIAT BOT, V4, P141, DOI 10.1016/S0033-7560(64)80065-X; Sharma B., 1995, P S GEN RES ED CURR, VIII, P1210; Shin JM, 2011, AFR J AGR RES, V6, P1447; Siddiqui MA, 2009, PAK J BOT, V41, P1189; Singh R.K., 1985, BIOMETRICAL METHODS; Solanki IS, 2016, LEGUME RES, V39, P170, DOI 10.18805/lr.v39i2.9529; Swaminathan M. S., 1969, 12 P INT C GEN TOK, V3, P327; Wani M.R., 2006, THAI J AGR SCI, V39, P83; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waxman D, 2003, GENETICS, V164, P1615	40	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184598	10.1371/journal.pone.0184598	http://dx.doi.org/10.1371/journal.pone.0184598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922405	gold, Green Published, Green Submitted			2022-12-27	WOS:000411059300019
J	Baltes, A; Akpinar, F; Inankur, B; Yin, J				Baltes, Ashley; Akpinar, Fulya; Inankur, Bahar; Yin, John			Inhibition of infection spread by co-transmitted defective interfering particles	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; RIBONUCLEIC-ACID SYNTHESIS; INFLUENZA RNA; REPLICATION; GENOME; CELLS; IDENTIFICATION; SENSITIVITY; COMPETITION; GENERATION	Although virus release from host cells and tissues propels the spread of many infectious diseases, most virus particles are not infectious; many are defective, lacking essential genetic information needed for replication. When defective and viable particles enter the same cell, the defective particles can multiply while interfering with viable particle production. Defective interfering particles (DIPs) occur in nature, but their role in disease pathogenesis and spread is not known. Here, we engineered an RNA virus and its DIPs to express different fluorescent reporters, and we observed how DIPs impact viral gene expression and infection spread. Across thousands of host cells, co-infected with infectious virus and DIPs, gene expression was highly variable, but average levels of viral reporter expression fell at higher DIP doses. In cell populations spatial patterns of infection spread provided the first direct evidence for the co-transmission of DIPs with infectious virus. Patterns of spread were highly sensitive to the behavior of initial or early co-infected cells, with slower overall spread stemming from higher early DIP doses. Under such conditions striking patterns of patchy gene expression reflected localized regions of DIP or virus enrichment. From a broader perspective, these results suggest DIPs contribute to the ecological and evolutionary persistence of viruses in nature.	[Baltes, Ashley; Akpinar, Fulya; Inankur, Bahar; Yin, John] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Baltes, Ashley; Akpinar, Fulya; Inankur, Bahar; Yin, John] Univ Wisconsin, Wisconsin Inst Discovery, Syst Biol Theme, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yin, J (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.; Yin, J (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Syst Biol Theme, Madison, WI 53706 USA.	john.yin@wisc.edu		Yin, John/0000-0001-6146-0594	National Institute of Allergy and Infectious Disease; National Institutes of Health (USA) [Al091646, Al104317, T32-HG002760]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI104317] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health (USA): Al091646 (J.Y.), Al104317 (J.Y.), T32-HG002760 (A.M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Akpinar F, 2016, J VIROL, V90, P7552, DOI 10.1128/JVI.00807-16; Akpinar F, 2016, J VIROL, V90, P1599, DOI 10.1128/JVI.02190-15; Akpinar F, 2015, J VIROL METHODS, V218, P71, DOI 10.1016/j.jviromet.2015.02.006; BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; BELLETT AJD, 1959, J GEN MICROBIOL, V21, P498, DOI 10.1099/00221287-21-3-498; Clark NR, 2011, STOCHASTIC MODEL VIR; Dimmock NJ, 2015, VIRUSES-BASEL, V7, P3768, DOI 10.3390/v7072796; DOYLE M, 1973, P NATL ACAD SCI USA, V70, P2105, DOI 10.1073/pnas.70.7.2105; Duhaut SD, 1996, VIROLOGY, V216, P326, DOI 10.1006/viro.1996.0068; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Frank SA, 2000, J THEOR BIOL, V206, P279, DOI 10.1006/jtbi.2000.2120; Frensing T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072288; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GIACHETTI C, 1989, VIROLOGY, V170, P264, DOI 10.1016/0042-6822(89)90375-9; Grdzelishvili VZ, 2006, VIROLOGY, V350, P394, DOI 10.1016/j.virol.2006.02.021; Haseltine EL, 2008, B MATH BIOL, V70, P1730, DOI 10.1007/s11538-008-9316-3; Henson R., 2013, DSCATTER FLOW CYTOME; Hofacre A, 2012, VIROLOGY, V423, P89, DOI 10.1016/j.virol.2011.11.014; HOLLAND J J, 1990, P151; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; HUANG AS, 1972, J VIROL, V9, P909, DOI 10.1128/JVI.9.6.909-916.1972; Huang AS, 1977, DEFECTIVE INTERFERIN, p73 ; Iwai A, 2006, J VIRAL HEPATITIS, V13, P523, DOI 10.1111/j.1365-2893.2006.00760.x; Kim H, 2004, ANTIMICROB AGENTS CH, V48, P1017, DOI 10.1128/AAC.48.3.1017-1020.2004; Klasse PJ, 2015, PROG MOL BIOL TRANSL, V129, P285, DOI 10.1016/bs.pmbts.2014.10.012; KRAMER MJ, 1983, J INTERFERON RES, V3, P425, DOI 10.1089/jir.1983.3.425; Laske T, 2016, VIRUS RES, V213, P90, DOI 10.1016/j.virusres.2015.11.016; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; LAZZARINI RA, 1981, CELL, V26, P145, DOI 10.1016/0092-8674(81)90298-1; Li D, 2011, PLOS ONE, V6; Li T, 1997, VIROLOGY, V232, P248, DOI 10.1006/viro.1997.8571; MEIER E, 1984, J VIROL, V51, P515, DOI 10.1128/JVI.51.2.515-521.1984; Metzger VT, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002015; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; Noble S, 2004, VACCINE, V22, P3018, DOI 10.1016/j.vaccine.2004.02.013; Odagiri T, 1997, J VIROL, V71, P2138, DOI 10.1128/JVI.71.3.2138-2145.1997; OTSUKI K, 1979, ARCH VIROL, V60, P249, DOI 10.1007/BF01317496; PALMA EL, 1974, J INFECT DIS, V129, P402, DOI 10.1093/infdis/129.4.402; PATTNAIK AK, 1995, VIROLOGY, V206, P760, DOI 10.1016/S0042-6822(95)80005-0; Perrault J, 1981, ORIGIN REPLICATION D, P151; Pesko KN, 2012, VIROLOGY, V427, P10, DOI 10.1016/j.virol.2012.01.028; Ram PJ, IMAGE PROCESSING IMA; RAO DD, 1982, J VIROL, V41, P210, DOI 10.1128/JVI.41.1.210-221.1982; Rast LI, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004799; Saira K, 2013, J VIROL, V87, P8064, DOI 10.1128/JVI.00240-13; SEKELLICK MJ, 1980, VIROLOGY, V104, P247, DOI 10.1016/0042-6822(80)90385-2; Smith CM, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080237; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; STAMPFER M, 1969, J VIROL, V4, P154, DOI 10.1128/JVI.4.2.154-161.1969; Stauffer KA, 2009, J GEN VIROL, V90, P888, DOI 10.1099/vir.0.005249-0; Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08; Swick A, 2014, BIOTECHNOL BIOENG, V111, P1200, DOI 10.1002/bit.25170; Thompson KAS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-257; Timm A, 2012, VIROLOGY, V424, P11, DOI 10.1016/j.virol.2011.12.005; Timm C, 2014, J VIROL, V88, P2623, DOI 10.1128/JVI.02675-13; Vogel R, 2011, ANAL CHEM, V83, P3499, DOI 10.1021/ac200195n; von Magnus P., 1947, MINERAL GEOL, V24; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; Warrick JW, 2016, PLOS ONE, V11; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Yuan TTT, 1998, J VIROL, V72, P2168, DOI 10.1128/JVI.72.3.2168-2176.1998	65	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184029	10.1371/journal.pone.0184029	http://dx.doi.org/10.1371/journal.pone.0184029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915264	Green Published, gold, Green Submitted			2022-12-27	WOS:000410861600008
J	Brotons, P; Bassat, Q; Lanaspa, M; Henares, D; Perez-Arguello, A; Madrid, L; Balcells, R; Acacio, S; Andres-Franch, M; Marcos, MA; Valero-Rello, A; Munoz-Almagro, C				Brotons, Pedro; Bassat, Quique; Lanaspa, Miguel; Henares, Desiree; Perez-Arguello, Amaresh; Madrid, Lola; Balcells, Reyes; Acacio, Sozinho; Andres-Franch, Maria; Angeles Marcos, Maria; Valero-Rello, Ana; Munoz-Almagro, Carmen			Nasopharyngeal bacterial load as a marker for rapid and easy diagnosis of invasive pneumococcal disease in children from Mozambique	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; YOUNG-CHILDREN; SPUTUM SAMPLES; COLONIZATION; DENSITY; SEROTYPES; VIRUSES; RATES; ASSAY	Background Current diagnostic methods for detection of Streptococcus pneumoniae in children with suspected invasive pneumococcal disease have limitations of accuracy, timeliness, and patient convenience. This study aimed to determine the performance of pneumococcal load quantified with a real-time polymerase-chain reaction in nasopharyngeal samples to diagnose invasive pneumococcal disease in children. Methods Matched case-control study of patients < 5 years of age with invasive pneumococcal disease admitted to the Manhica District Hospital (Mozambique) and asymptomatic controls recruited in different periods between 2006 and 2014. Cases were confirmed by a positive bacterial culture for S. pneumoniae in blood or cerebrospinal fluid. Nasopharyngeal aspirates were collected from cases and controls and pneumococcal density was quantified by lytA real-time polymerase-chain reaction. Results Thirty cases (median age 12.8 months) and sixty controls (median age 11.7 months) were enrolled and 70% of them were male. Nasopharyngeal pneumococcal carriage was high in both groups: 28/30 (93.3%) for cases vs. 53/60 (88.3%) for controls (p = 0.71). Mean nasopharyngeal pneumococcal load was identified as a marker for invasive pneumococcal disease (7.0 log(10) copies/mL in cases vs. 5.8 log10 copies/mL in controls, p<0.001) and showed good discriminatory power ( AUC-ROC: 82.1%, 95% CI 72.5%-91.8%). A colonization density of 6.5 log(10) copies/mL was determined as the optimal cut-off value to distinguish cases from controls (sensitivity 75.0%, specificity 73.6%). Conclusion Use of non-invasive nasopharyngeal aspirates coupled with rapid and accurate quantification of pneumococcal load by real-time polymerase chain reaction has the potential to become a useful surrogate marker for early diagnosis of invasive pneumococcal disease in children.	[Brotons, Pedro; Henares, Desiree; Perez-Arguello, Amaresh; Andres-Franch, Maria; Valero-Rello, Ana; Munoz-Almagro, Carmen] Univ Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Mol Microbiol Dept, Barcelona, Spain; [Brotons, Pedro; Andres-Franch, Maria; Valero-Rello, Ana; Munoz-Almagro, Carmen] Inst Salud Carlos III, CIBERESP, Madrid, Spain; [Bassat, Quique; Lanaspa, Miguel; Madrid, Lola; Angeles Marcos, Maria] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Bassat, Quique] CISM, Maputo, Mozambique; [Bassat, Quique; Lanaspa, Miguel; Madrid, Lola; Balcells, Reyes; Acacio, Sozinho] ICREA, Pg Lluis Co 23, Barcelona, Spain; [Bassat, Quique] Univ Barcelona, Pediat Dept, Pediat Infect Dis Unit, Hosp Sant Joan de Deu, Barcelona, Spain; [Bassat, Quique] Univ Europea Madrid, Madrid, Spain; [Munoz-Almagro, Carmen] Univ Int Catalunya, Sch Med, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; ICREA; University of Barcelona; European University of Madrid; Universitat Internacional de Catalunya (UIC)	Munoz-Almagro, C (corresponding author), Univ Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Mol Microbiol Dept, Barcelona, Spain.; Munoz-Almagro, C (corresponding author), Inst Salud Carlos III, CIBERESP, Madrid, Spain.; Munoz-Almagro, C (corresponding author), Univ Int Catalunya, Sch Med, Barcelona, Spain.	cma@sjdhospitalbarcelona.org	Lanaspa, Miguel/AAO-4971-2020; Muñoz-Almagro, Carmen/N-7248-2015; Rello, Ana Valero/J-9479-2015; Bassat, Quique/P-2341-2016; Henares Bonilla, Desiree/K-2543-2017	Muñoz-Almagro, Carmen/0000-0001-5586-404X; Rello, Ana Valero/0000-0002-0126-1128; Bassat, Quique/0000-0003-0875-7596; Madrid, Lola/0000-0003-4034-6033; Henares Bonilla, Desiree/0000-0003-2631-2718; Lanaspa, Miguel/0000-0002-9310-177X	Fondo Europeo de Desarrollo Regional (FEDER); Ministry of Science and Innovation, Institute de Salud Carlos III (ISCIII), Projects of Research on Health [PI13/01729]; program Miguel Servet of the Institute de Salud Carlos III [Plan Nacional de I+D+I] [CP11/00269]; World Health Organization [WHO-C6-181-489]; Bill & Melinda Gates Foundation [OPP50092]; Spanish Agency for International Cooperation and Developement (AECID)	Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Ministry of Science and Innovation, Institute de Salud Carlos III (ISCIII), Projects of Research on Health; program Miguel Servet of the Institute de Salud Carlos III [Plan Nacional de I+D+I]; World Health Organization(World Health Organization); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Spanish Agency for International Cooperation and Developement (AECID)	This work was supported by Fondo Europeo de Desarrollo Regional (FEDER) and the Ministry of Science and Innovation, Institute de Salud Carlos III (ISCIII), Projects of Research on Health [FIS project number PI13/01729, Principal Investigator: Carmen Munoz-Almagro]. Quique Bassat had during the time of the study a fellowship from the program Miguel Servet of the Institute de Salud Carlos III [Plan Nacional de I+D+I 2008-2011, grant number: CP11/00269] (http://www.isciii.es/). The OVERLAP Project was supported by a grant from the World Health Organization [grant number: WHO-C6-181-489] (http://www.who.int/es/). The RAPID Project was supported by the Bill & Melinda Gates Foundation [grant number: OPP50092] (http://www.gatesfeundatien.org/es/). The Centro de Investigacao em Saude de Manhica - Fundacao Manhica (CISM - FM) receives financial support from the Spanish Agency for International Cooperation and Developement (AECID). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Albrich WC, 2014, J CLIN MICROBIOL, V52, P4224, DOI 10.1128/JCM.01553-14; Almagro C, 2014, CLIN MICROBIOL INFEC, V20, pO745; Anh DD, 2007, TOHOKU J EXP MED, V213, P167, DOI 10.1620/tjem.213.167; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2009, INFECT IMMUN, V77, P1613, DOI 10.1128/IAI.00871-08; Brook I, 2010, INT J PEDIATR OTORHI, V74, P447, DOI 10.1016/j.ijporl.2010.01.006; Ciruela P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3061-6; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; del Amo E, 2014, CLIN MICROBIOL INFEC, V20, P684, DOI 10.1111/1469-0691.12422; Dowell SF, 2001, CLIN INFECT DIS, V32, P824, DOI 10.1086/319205; Fan RR, 2016, EMERG INFECT DIS, V22, P1996, DOI 10.3201/eid2211.160902; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kuczmarski RJ., 2000, ADV DATA, P1; Lanaspa M, 2014, BIOMARK MED, V8, P1057, DOI [10.2217/BMM.14.65, 10.2217/bmm.14.65]; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Morpeth Susan C, 2014, Biomol Detect Quantif, V2, P1; Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030; Stralin K, 2014, J CLIN MICROBIOL, V52, P83, DOI 10.1128/JCM.01742-13; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Yang S, 2005, J CLIN MICROBIOL, V43, P3221, DOI 10.1128/JCM.43.7.3221-3226.2005	34	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184762	10.1371/journal.pone.0184762	http://dx.doi.org/10.1371/journal.pone.0184762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910402	Green Published, gold			2022-12-27	WOS:000410859200092
J	Liang, X; Liao, CY; Soupir, ML; Jarboe, LR; Thompson, ML; Dixon, PM				Liang, Xiao; Liao, Chunyu; Soupir, Michelle L.; Jarboe, Laura R.; Thompson, Michael L.; Dixon, Philip M.			Escherichia coli attachment to model particulates: The effects of bacterial cell characteristics and particulate properties	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; E. COLI; SUSPENDED PARTICLES; SURFACE-PROPERTIES; BACILLUS-SUBTILIS; SOIL PARTICLES; INTACT CORES; TRANSPORT; ADHESION; SURVIVAL	E. coli bacteria move in streams freely in a planktonic state or attached to suspended particulates. Attachment is a dynamic process, and the fraction of attached microorganisms is thought to be affected by both bacterial characteristics and particulate properties. In this study, we investigated how the properties of cell surfaces and stream particulates influence attachment. Attachment assays were conducted for 77 E. coli strains and three model particulates (ferrihydrite, Ca-montmorillonite, or corn stover) under environmentally relevant conditions. Surface area, particle size distribution, and total carbon content were determined for each type of particulate. Among the three particulates, attachment fractions to corn stover were significantly larger than the attachments to 2-line ferrihydrite (p-value = 0.0036) and Ca-montmorillonite (p-value = 0.022). Furthermore, attachment to Ca-montmorillonite and corn stover was successfully modeled by a Generalized Additive Model (GAM) using cell characteristics as predictor variables. The natural logarithm of the net charge on the bacterial surface had a significant, positive, and linear impact on the attachment of E. coli bacteria to Ca-montmorillonite (p-value = 0.013), but it did not significantly impact the attachment to corn stover (p-value = 0.36). The large diversities in cell characteristics among 77 E. coli strains, particulate properties, and attachment fractions clearly demonstrated the inadequacy of using a static parameter or linear coefficient to predict the attachment behavior of E. coli in stream water quality models.	[Liang, Xiao; Soupir, Michelle L.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA; [Liao, Chunyu; Jarboe, Laura R.] Iowa State Univ, Dept Microbiol, Ames, IA USA; [Jarboe, Laura R.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA; [Thompson, Michael L.] Iowa State Univ, Dept Agron, Ames, IA USA; [Dixon, Philip M.] Iowa State Univ, Dept Stat, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; Iowa State University	Soupir, ML (corresponding author), Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA.	msoupir@iastate.edu	Dixon, Philip Michael/I-4843-2019	Dixon, Philip Michael/0000-0002-1778-0686; Liao, Chunyu/0000-0002-5563-3513; Soupir, Michelle/0000-0003-3449-1146	National Science Foundation [CBET-1236510]	National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by the National Science Foundation (CBET-1236510); opinions, findings, and conclusions are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparatin of the manuscript.	Baffaut C, 2010, T ASABE, V53, P1585; Bai S, 2005, WATER RES, V39, P5232, DOI 10.1016/j.watres.2005.10.013; BITTON G, 1972, APPL MICROBIOL, V23, P870, DOI 10.1128/AEM.23.5.870-874.1972; Bolster CH, 2009, J ENVIRON QUAL, V38, P465, DOI 10.2134/jeq2008.0137; Bolster CH, 2001, J CONTAM HYDROL, V50, P287, DOI 10.1016/S0169-7722(01)00106-1; BURTON GA, 1987, APPL ENVIRON MICROB, V53, P633, DOI 10.1128/AEM.53.4.633-638.1987; Chapra S.C., 2008, SURFACE WATER QUALIT; Corry JEL, 2007, FOOD MICROBIOL, V24, P230, DOI 10.1016/j.fm.2006.05.003; DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832, DOI 10.1128/AEM.55.4.832-836.1989; Dimkpa CO, 2011, J HAZARD MATER, V188, P428, DOI 10.1016/j.jhazmat.2011.01.118; Dogsa I, 2005, BIOPHYS J, V89, P2711, DOI 10.1529/biophysj.105.061648; Dong HL, 2002, ENVIRON SCI TECHNOL, V36, P891, DOI 10.1021/es010144t; Dorner SM, 2006, ENVIRON SCI TECHNOL, V40, P4746, DOI 10.1021/es060426z; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Entry JA, 2000, J ENVIRON QUAL, V29, P1206, DOI 10.2134/jeq2000.00472425002900040026x; Fein JB, 2005, GEOCHIM COSMOCHIM AC, V69, P1123, DOI 10.1016/j.gca.2004.07.033; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; FONTES DE, 1991, APPL ENVIRON MICROB, V57, P2473, DOI 10.1128/AEM.57.9.2473-2481.1991; Foppen JW, 2010, WATER RES, V44, P1202, DOI 10.1016/j.watres.2009.08.034; Fuller ME, 2000, WATER RESOUR RES, V36, P2417, DOI 10.1029/2000WR900075; Gagliardi JV, 2000, APPL ENVIRON MICROB, V66, P877, DOI 10.1128/AEM.66.3.877-883.2000; GANNON JT, 1991, APPL ENVIRON MICROB, V57, P190, DOI 10.1128/AEM.57.1.190-193.1991; Goulter RM, 2009, LETT APPL MICROBIOL, V49, P1, DOI 10.1111/j.1472-765X.2009.02591.x; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; HACH, TOT FEC E COL US MEM; HARTLEY MG, 1993, GUT, V34, P63, DOI 10.1136/gut.34.1.63; Hipsey MR, 2006, WATER AIR SOIL POLL, V170, P191, DOI 10.1007/s11270-006-3010-6; Im Sun-A, 2010, Immune Netw, V10, P230, DOI 10.4110/in.2010.10.6.230; Jamieson R, 2005, WATER RES, V39, P2665, DOI 10.1016/j.watres.2005.04.040; Jamieson R. C., 2002, CAN BIOSYST ENG, V44, P1; Jeng HWC, 2005, J ENVIRON SCI HEAL A, V40, P779, DOI 10.1081/ESE-200048264; Kim JW, 2010, ECOL MODEL, V221, P1592, DOI 10.1016/j.ecolmodel.2010.03.005; Kosmulski M, 2009, J COLLOID INTERF SCI, V337, P439, DOI 10.1016/j.jcis.2009.04.072; Krometis LAH, 2007, WATER RES, V41, P506, DOI 10.1016/j.watres.2006.09.029; Lenntech, IR WAT REACT MECH EN; Levy J, 2007, J CONTAM HYDROL, V89, P71, DOI 10.1016/j.jconhyd.2006.08.006; Liang X, 2014, J APPL MICROBIOL, V117, P1730, DOI 10.1111/jam.12660; Liang X, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01732; Liao C, 2015, J APPL MICROBIOL, V119, P315, DOI 10.1111/jam.12860; Liao CY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00708; LINDAHL M, 1981, BIOCHIM BIOPHYS ACTA, V677, P471, DOI 10.1016/0304-4165(81)90261-0; Liu Y, 2004, J BIOTECHNOL, V110, P251, DOI 10.1016/j.jbiotec.2004.02.012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matthysse AG, 2008, APPL ENVIRON MICROB, V74, P2384, DOI 10.1128/AEM.01854-07; Miller CM, 2010, ADHESION SURFACE ENE; Mohapatra BR, 2008, WATER SCI TECHNOL, V58, P537, DOI 10.2166/wst.2008.424; Muirhead RW, 2006, APPL ENVIRON MICROB, V72, P3406, DOI 10.1128/AEM.72.5.3406-3411.2006; Niemela S. I., 2002, UNCERTAINTY QUANTITA; Oliver DM, 2007, WATER AIR SOIL POLL, V185, P369, DOI 10.1007/s11270-007-9451-8; Omoike A, 2004, BIOMACROMOLECULES, V5, P1219, DOI 10.1021/bm034461z; Pachepsky YA, 2008, INT AGROPHYS, V22, P61; Pachepsky YA, 2006, AGR WATER MANAGE, V86, P81, DOI 10.1016/j.agwat.2006.06.010; Pandey PK, 2012, WATER RES, V46, P115, DOI 10.1016/j.watres.2011.10.019; Parikh SJ, 2006, LANGMUIR, V22, P8492, DOI 10.1021/la061359p; Pembrey RS, 1999, APPL ENVIRON MICROB, V65, P2877; Piorkowski G, 2013, WATER RES, V47, P6701, DOI 10.1016/j.watres.2013.09.003; Rad AY, 1998, J BIOMED MATER RES, V41, P349, DOI 10.1002/(SICI)1097-4636(19980905)41:3<349::AID-JBM2>3.0.CO;2-C; Rhoton FE, 2009, J ENVIRON QUAL, V38, P1887, DOI 10.2134/jeq2008.0454; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Russo SA, 2011, J ENVIRON ENG-ASCE, V137, P697, DOI 10.1061/(ASCE)EE.1943-7870.0000363; Mendonca RCS, 2012, FOOD CONTROL, V23, P389, DOI 10.1016/j.foodcont.2011.08.004; SCHALLENBERG M, 1993, ECOLOGY, V74, P919, DOI 10.2307/1940816; SCHILLINGER JE, 1985, J WATER POLLUT CON F, V57, P384; SCHOLL M A, 1990, Journal of Contaminant Hydrology, V6, P321, DOI 10.1016/0169-7722(90)90032-C; Schwertmann U., 2000, IRON OXIDES LAB PREP, DOI DOI 10.1002/9783527613229; SHERER BM, 1992, J ENVIRON QUAL, V21, P591, DOI 10.2134/jeq1992.00472425002100040011x; Shin HS, 2001, WATER SCI TECHNOL, V43, P193, DOI 10.2166/wst.2001.0373; Soupir ML, 2008, J AM WATER RESOUR AS, V44, P1591, DOI 10.1111/j.1752-1688.2008.00262.x; Terrio PJ, 1996, ANAL SUSPENDED SEDIM, P61801; Tessier D., 1990, Soil colloids and their associations in aggregates., P387; USEPA, 1986, AMB WAT QUAL CRIT BA; USEPA, 2014, WAT ASS TRACK ENV RE; Van der Bruggen B, 2003, ENVIRON POLLUT, V122, P435, DOI 10.1016/S0269-7491(02)00308-1; VANDERMEI HC, 1991, CARIES RES, V25, P415, DOI 10.1159/000261404; WAN JM, 1995, WATER RESOUR RES, V31, P1627, DOI 10.1029/95WR01255; Wenck, 2013, STRESS ID REP VERM R; Zhao WQ, 2014, WATER RES, V53, P35, DOI 10.1016/j.watres.2014.01.009; Zita A, 1997, APPL ENVIRON MICROB, V63, P1168, DOI 10.1128/AEM.63.3.1168-1170.1997	78	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184664	10.1371/journal.pone.0184664	http://dx.doi.org/10.1371/journal.pone.0184664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910343	Green Published, gold			2022-12-27	WOS:000410859200074
J	Mo, FH; Jiang, XQ; Duan, SY; Xiao, Z; Xiao, S; Shi, W				Mo, Fuhao; Jiang, Xiaoqing; Duan, Shuyong; Xiao, Zhi; Xiao, Sen; Shi, Wei			Parametric analysis of occupant ankle and tibia injuries in frontal impact	PLOS ONE			English	Article							CRASHES	Objective Non-fatal tibia and ankle injuries without proper protection from the restraint system has gotten wide attention from researchers. This study aimed to investigate occupant tibia and ankle injuries under realistic frontal impact environment that is rarely considered in previous experimental and simulant studies. Methods An integrated occupant-vehicle model was established by coupling an isolated car cab model and a hybrid occupant model with a biofidelic pelvis-lower limb model, while its loading conditions were extracted from the realistic full-frontal impact test. A parametric study was implemented concerning instrument panel (IP) design and pedal intrusion/rotation parameters. Results The significant influences of the IP angle, pedal intrusion and pedal rotation on tibia axial force, tibia bending moment and ankle dorsiflexion angle are noted. By coupling their effects, a new evaluation index named CAIEI (Combined Ankle Injury Evaluation Index) is established to evaluate ankle injury (including tibia fractures in ankle region) risk and severity in robustness. Conclusions Overall results and analysis indicate that ankle dorsiflexion angle should be considered when judging the injury in lower limb under frontal impact. Meanwhile, the current index with coupling effects of tibia axial force, bending moment and ankle dorsiflexion angle is in a good correlation with the simulation injury outcomes.	[Mo, Fuhao; Xiao, Zhi; Shi, Wei] Hunan Univ, State Key Lab Adv Design & Mfg Vehicle Body, Changsha, Hunan, Peoples R China; [Jiang, Xiaoqing] CRRC Zhuzhou Inst CO LTD, Zhuzhou, Peoples R China; [Duan, Shuyong; Xiao, Sen] Hebei Univ Technol, Sch Mech Engn, Tianjin, Peoples R China	Hunan University; CRRC Corporation; Hebei University of Technology	Xiao, S (corresponding author), Hebei Univ Technol, Sch Mech Engn, Tianjin, Peoples R China.	xiaosen@hnu.edu.cn	MO, Fuhao/HCI-3604-2022		National Natural Science Foundation of China [51405150, 51475154]; Hunan Province Science and Technology Plan [2015JJ3052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Province Science and Technology Plan	This study was sponsored by the National Natural Science Foundation of China (Grant No. 51405150 and 51475154) and Hunan Province Science and Technology Plan (Grant No. 2015JJ3052).	Begeman P, 1997, 7 INJ PREV BIOM S DE; China Automotive Technology & Research Center, 2013, CNCAP STANDARD VERSI; Chong M, 2007, J TRAUMA, V62, P720, DOI 10.1097/01.ta.0000222577.43192.a6; Hoglund N, 2003, INT J CRASHWORTHINES, V8, P285, DOI 10.1533/ijcr.2003.0237; Jiang XQ, 2014, THESIS; Kuppa S, 2001, 17 INT TECHN C ENH S; Kuppa S., 2003, 18 INT TECHN C ENH S; Laituri Tony R, 2006, Stapp Car Crash J, V50, P97; [刘志新 Liu Zhixin], 2008, [汽车工程, Automotive Engineering], V30, P969; Morgan RM, 1991, SAE C P; Otte D., 1996, SAE C P; Otte D, 1992, SAE C P; Portier L, 1997, SAE C P; Rudd Rodney, 2004, Stapp Car Crash J, V48, P1; Rudd RW, 2009, 21 INT TECHN C ENH S; Shin J, 2012, ANN BIOMED ENG, V40, P2519, DOI 10.1007/s10439-012-0607-3; Sochor MR, 2003, SAE C P; Thomas P, 1995, SAE C P; Yoganandan N, 2014, TRAFFIC INJ PREV, V15, pS151, DOI 10.1080/15389588.2014.935357; Zhu HT, 2009, AUTOMOT ENG, V31, P1143	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184521	10.1371/journal.pone.0184521	http://dx.doi.org/10.1371/journal.pone.0184521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910377	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200054
J	Choi, J; Kwon, J; Shin, JW; Lee, J; Lee, S; Kook, MS				Choi, Jaewan; Kwon, Junki; Shin, Joong Won; Lee, Jiyun; Lee, Saem; Kook, Michael S.			Quantitative optical coherence tomography angiography of macular vascular structure and foveal avascular zone in glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OCULAR PERFUSION-PRESSURE; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD PROGRESSION; HEAD BLOOD-FLOW; RISK-FACTOR; NONINVASIVE VISUALIZATION; CIRCADIAN FLUCTUATION; INTRAOCULAR-PRESSURE; DIABETIC-RETINOPATHY	Objective The study aimed to evaluate the quantitative characteristics of the macular vessel density (VD) and foveal avascular zone (FAZ) in glaucoma using optical coherence tomography angiography (OCT-A). Design Cross-sectional, age-and sex-matched case-control study. Methods Fifty-two eyes of 52 patients with primary open angle glaucoma and 52 eyes from 52 healthy participants were recruited retrospectively. OCT-A was performed on a 3 x 3-mm macular region centered on the fovea. OCT-A scans were manually graded to define the FAZ. Paraf-oveal VD in superficial and deep retina were analyzed in the circular-and quadrant-segmented zone. The FAZ parameters included size, perimeter, and circularity index. The regression analysis among VD and FAZ-related parameters and ocular parameters was performed, and the diagnostic ability was calculated with refractive error adjusted. Results For both groups, the mean age and the sex ratio was not different between groups. With refractive error adjusted, the average macular VD was lower in glaucoma than in the control group for superficial (P = 0.013), deep (P < 0.001), and the whole retina (P = 0.002). There were increased FAZ perimeter and decreased FAZ circularity index in glaucoma when compared with controls (P < 0.001). In the multivariate regression models, FAZ circularity index were significantly associated with decreased peripapillary RNFL thickness (P = 0.007) and macular GCIPL thickness (P = 0.009) measured by OCT. The refractive-error adjusted area under receiver operating characteristics was highest for FAZ circularity index (0.905; 95% CI, 0.844-0.966), followed by temporal deep retinal VD (0.870; 95% CI, 0.803-0.937) and FAZ perimeter (0.858; 95% CI, 0.784-0.932). Conclusions Decreased macular VD, increased FAZ perimeter, and decreased FAZ circularity index were observed in eyes with glaucoma using OCT-A. With refractive error adjusted, these parameters showed considerable diagnostic value for glaucoma. FAZ circularity index may be a novel biomarker representing disruption of the parafoveal capillary network in glaucoma, as supported by its association with structural parameters.	[Choi, Jaewan; Lee, Saem] Cent Seoul Eye Ctr, Seoul, South Korea; [Kwon, Junki; Shin, Joong Won; Lee, Jiyun; Kook, Michael S.] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kook, MS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea.	mskook@amc.seoul.kr						Abe RY, 2016, OPHTHALMOLOGY, V123, P552, DOI 10.1016/j.ophtha.2015.10.046; Adhi M, 2016, INVEST OPHTH VIS SCI, V57, pOCT486, DOI 10.1167/iovs.15-18907; Al-Sheikh M, 2017, INVEST OPHTH VIS SCI, V58, P2063, DOI 10.1167/iovs.16-21289; AREND O, 1991, BRIT J OPHTHALMOL, V75, P514, DOI 10.1136/bjo.75.9.514; Balaratnasingam C, 2016, OPHTHALMOLOGY, V123, P2352, DOI 10.1016/j.ophtha.2016.07.008; Banitt M, 2013, CURR OPIN OPHTHALMOL, V24, P125, DOI 10.1097/ICU.0b013e32835d9245; Bojikian KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154691; Browning DJ, 2012, ANATOMY PATHOLOGIC A, P12; CARTER CJ, 1990, OPHTHALMOLOGY, V97, P49; CARTWRIGHT MJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P898; Choi J, 2006, INVEST OPHTH VIS SCI, V47, P831, DOI 10.1167/iovs.05-1053; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P104, DOI 10.1167/iovs.06-0615; Choi J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141905; Choi J, 2013, INVEST OPHTH VIS SCI, V54, P6150, DOI 10.1167/iovs.13-12093; Conrath J, 2005, EYE, V19, P322, DOI 10.1038/sj.eye.6701456; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di G, 2016, GRAEF ARCH CLIN EXP, V254, P873, DOI 10.1007/s00417-015-3143-7; Domalpally A, 2013, OPHTHALMOLOGY, V120, P2666, DOI 10.1016/j.ophtha.2013.07.047; Flammer J, 1998, PROG RETIN EYE RES, V17, P267, DOI 10.1016/S1350-9462(97)00006-2; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Freiberg FJ, 2016, GRAEF ARCH CLIN EXP, V254, P1051, DOI 10.1007/s00417-015-3148-2; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; HAMARD P, 1994, BRIT J OPHTHALMOL, V78, P449, DOI 10.1136/bjo.78.6.449; Harris A, 1998, SURV OPHTHALMOL, V42, P509, DOI 10.1016/S0039-6257(98)00011-3; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kaiser HJ, 1997, AM J OPHTHALMOL, V123, P320, DOI 10.1016/S0002-9394(14)70127-8; Kang JW, 2016, RETINA PHILADELPHIA; Kim DY, 2012, INVEST OPHTH VIS SCI, V53, P85, DOI 10.1167/iovs.11-8249; Kim HJ, 2016, INVEST OPHTH VIS SCI, V57, P4799, DOI 10.1167/iovs.16-19214; Kim TW, 2013, CURR EYE RES, V38, P903, DOI 10.3109/02713683.2013.800888; Kuehlewein L, 2015, INVEST OPHTH VIS SCI, V56, P3984, DOI 10.1167/iovs.15-16510; Kwon J, 2017, INVEST OPHTH VIS SCI, V58, P1637, DOI 10.1167/iovs.16-21079; Lee EJ, 2015, OPHTHALMOLOGY, V122, P721, DOI 10.1016/j.ophtha.2014.10.007; Leveque PM, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6956717; Mammo Z, 2016, AM J OPHTHALMOL, V170, P41, DOI 10.1016/j.ajo.2016.07.015; Mendis KR, 2010, INVEST OPHTH VIS SCI, V51, P5864, DOI 10.1167/iovs.10-5333; Nicolela MT, 1996, AM J OPHTHALMOL, V122, P775, DOI 10.1016/S0002-9394(14)70373-3; Okada M, 2014, OPHTHALMOLOGY, V121, P763, DOI 10.1016/j.ophtha.2013.09.049; Muniz JAPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115291; Polska E, 2004, BRIT J OPHTHALMOL, V88, P533, DOI 10.1136/bjo.2003.028480; Rao HL, 2016, AM J OPHTHALMOL, V171, P75, DOI 10.1016/j.ajo.2016.08.030; ROJANAPONGPUN P, 1993, GRAEF ARCH CLIN EXP, V231, P375, DOI 10.1007/BF00919643; SCHULZER M, 1992, OPHTHALMOLOGY, V99, P1468; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; Shiga Y, 2016, CURR EYE RES, V41, P1447, DOI 10.3109/02713683.2015.1127974; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sommer A, 2011, ARCH OPHTHALMOL-CHIC, V129, P785, DOI 10.1001/archophthalmol.2011.117; Spraul CW, 2002, VISION RES, V42, P923, DOI 10.1016/S0042-6989(02)00022-6; Sung KR, 2011, INVEST OPHTH VIS SCI, V52, P737, DOI 10.1167/iovs.10-5351; Tam J, 2010, INVEST OPHTH VIS SCI, V51, P1691, DOI 10.1167/iovs.09-4483; Tan CS, 2016, INVEST OPHTH VIS SCI, V57, pOCT224, DOI 10.1167/iovs.15-18869; Tan CS, 2016, AM J OPHTHALMOL, V165, P201, DOI 10.1016/j.ajo.2016.02.035; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Weinreb R N, 1994, J Glaucoma, V3 Suppl 1, pS55; WOLF S, 1993, OPHTHALMOLOGY, V100, P1561; XU H, 2016, MEDICINE, V95; Yarmohammadi A., 2016, OPHTHALMOLOGY; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944; Yousefi S, 2014, PHYS MED BIOL, V59, P6693, DOI 10.1088/0031-9155/59/22/6693; Yousefi S, 2013, BIOMED OPT EXPRESS, V4, P1214, DOI 10.1364/BOE.4.001214	60	70	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184948	10.1371/journal.pone.0184948	http://dx.doi.org/10.1371/journal.pone.0184948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934255	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900062
J	Teruya, K; Oguma, A; Nishizawa, K; Kamitakahara, H; Dohura, K				Teruya, Kenta; Oguma, Ayumi; Nishizawa, Keiko; Kamitakahara, Hiroshi; Dohura, Katsumi			DPyrene conjugation and spectroscopic analysis of hydroxypropyl methylcellulose compounds successfully demonstrated a local dielectric difference associated with in vivo anti-prion activity	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; DIBLOCK METHYLCELLULOSE; FLUORESCENCE PROBE; PHAGOCYTIC UPTAKE; AQUEOUS-SOLUTION; PARTICLE-SIZE; DERIVATIVES; CELLULOSE; MICE	Our previous study on prion-infected rodents revealed that hydroxypropyl methylcellulose compounds (HPMCs) with different molecular weights but similar composition and degree of substitution have different levels of long-lasting anti-prion activity. In this study, we searched these HPMCs for a parameter specifically associated with in vivo anti-prion activity by analyzing in vitro chemical properties and in vivo tissue distributions. Infrared spectroscopic and thermal analyses revealed no differences among HPMCs, whereas pyrene conjugation and spectroscopic analysis revealed that the fluorescence intensity ratio of peak III/peak I correlated with anti-prion activity. This correlation was more clearly demonstrated in the anti-prion activity of the 1-year pre-infection treatment than that of the immediate postinfection treatment. In addition, the intensity ratio of peak III/peak I negatively correlated with the macrophage uptake level of HPMCs in our previous study. However, the in vivo distribution pattern was apparently not associated with anti-prion activity and was different in the representative tissues. These findings suggest that pyrene conjugation and spectroscopic analysis are powerful methods to successfully demonstrate local dielectric differences in HPMCs and provide a feasible parameter denoting the long-lasting anti-prion activity of HPMCs in vivo.	[Teruya, Kenta; Oguma, Ayumi; Nishizawa, Keiko; Dohura, Katsumi] Tohoku Univ, Dept Neurochem, Grad Sch Med, Sendai, Miyagi, Japan; [Kamitakahara, Hiroshi] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Kyoto, Kyoto, Japan	Tohoku University; Kyoto University	Dohura, K (corresponding author), Tohoku Univ, Dept Neurochem, Grad Sch Med, Sendai, Miyagi, Japan.	doh-ura@med.tohoku.ac.jp	Kamitakahara, Hiroshi/L-6710-2018; Teruya, Kenta/L-1530-2019	Kamitakahara, Hiroshi/0000-0002-0130-1919; 	Japan Agency for Medical Research and Development [15ek0109012h0002, 16ek0109012h0003]; Ministry of Health, Labor and Welfare [nanchi-ippan-H26-017]; Japan Society for the Promotion of Science [22390172]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from Japan Agency for Medical Research and Development (15ek0109012h0002, 16ek0109012h0003) (http://www.amed.go.jp/en/), Ministry of Health, Labor and Welfare (nanchi-ippan-H26-017) (http://www.mhlw.go.jp/english/index.html) and Japan Society for the Promotion of Science (22390172) (https://www.jsps.go.jp/english/index.html) to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama E, 2007, J COLLOID INTERF SCI, V311, P438, DOI 10.1016/j.jcis.2007.03.009; ASANO H, 1989, COLLOID POLYM SCI, V267, P935, DOI 10.1007/BF01410343; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; Bruce ME, 2000, IMMUNOL TODAY, V21, P442, DOI 10.1016/S0167-5699(00)01696-0; Burdock GA, 2007, FOOD CHEM TOXICOL, V45, P2341, DOI 10.1016/j.fct.2007.07.011; DONG DC, 1984, CAN J CHEM, V62, P2560, DOI 10.1139/v84-437; Evertsson H, 1997, MACROMOLECULES, V30, P2377, DOI 10.1021/ma961552y; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Ford JL, 1999, INT J PHARM, V179, P209, DOI 10.1016/S0378-5173(98)00339-1; FORSTER T, 1969, ANGEW CHEM INT EDIT, V8, P333, DOI 10.1002/anie.196903331; Giles K, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a023747; GORZINSKI SJ, 1986, DRUG CHEM TOXICOL, V9, P83, DOI 10.3109/01480548608998268; Hifumi H, 2016, INT J PHARMACEUT, V515, P57, DOI 10.1016/j.ijpharm.2016.09.085; ILLUM L, 1986, INT J PHARM, V29, P53; Iwasaki Y, 2017, NEUROPATHOLOGY, V37, P174, DOI 10.1111/neup.12355; Joshi SC, 2011, MATERIALS, V4, P1861, DOI 10.3390/ma4101861; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Kenward AG, 2007, BIOCHEMISTRY-US, V46, P4261, DOI 10.1021/bi602473r; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; KNIGHT HF, 1952, J AM PHARM ASSOC SCI, V41, P427, DOI 10.1002/jps.3030410807; Kulicke WM, 2005, MACROMOL SYMP, V223, P151, DOI 10.1002/masy.200550511; Makino K, 2003, COLLOID SURFACE B, V27, P33, DOI 10.1016/S0927-7765(02)00042-5; Muller RH, 1997, PHARMACEUT RES, V14, P18, DOI 10.1023/A:1012043131081; Nakagawa A, 2012, LANGMUIR, V28, P12609, DOI 10.1021/la3026528; Nakagawa A, 2011, J POLYM SCI POL CHEM, V49, P4964, DOI 10.1002/pola.24952; Nakagawa A, 2011, J POLYM SCI POL PHYS, V49, P1539, DOI 10.1002/polb.22343; NAKAJIMA A, 1971, B CHEM SOC JPN, V44, P3272, DOI 10.1246/bcsj.44.3272; [Nutrient Sources added to Food (ANS) EFSA Panel on Food Additives], 2015, EFSA J, V13, P4088, DOI DOI 10.2903/j.efsa.2015.4088; OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Raeber A J, 2001, Dev Immunol, V8, P291, DOI 10.1155/2001/95404; Salman H, 2006, EXP BIOL MED, V231, P112; SARKAR N, 1995, CARBOHYD POLYM, V27, P177, DOI 10.1016/0144-8617(95)00061-B; Sim Valerie L., 2009, Infectious Disorders - Drug Targets, V9, P81; Stewart LA, 2008, NEUROLOGY, V70, P1272, DOI 10.1212/01.wnl.0000308955.25760.c2; Teruya K, 2016, COLD SPRING HARBOR P, V7; Teruya K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006045; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; WINNIK FM, 1987, J PHYS CHEM-US, V91, P594, DOI 10.1021/j100287a021	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185357	10.1371/journal.pone.0185357	http://dx.doi.org/10.1371/journal.pone.0185357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934337	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900149
J	Wagener, N; Edelmann, D; Benner, A; Zigeuner, R; Borgmann, H; Wolff, I; Krabbe, LM; Musquera, M; Dell'Oglio, P; Capitanio, U; Klatte, T; Cindolo, L; May, M; Brookman-May, SD				Wagener, Nina; Edelmann, Dominic; Benner, Axel; Zigeuner, Richard; Borgmann, Hendrik; Wolff, Ingmar; Krabbe, Laura M.; Musquera, Mireia; Dell'Oglio, Paolo; Capitanio, Umberto; Klatte, Tobias; Cindolo, Luca; May, Matthias; Brookman-May, Sabine D.		EAU YAU Kidney Canc Grp	Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease	PLOS ONE			English	Article							PROGNOSTIC VALUE; SURVIVAL; CLASSIFICATION; MULTICENTER; EVEROLIMUS; SUBTYPES; TYPE-1; IMPACT	Renal cell carcinoma (RCC) comprises a heterogenous group of tumors. Traditionally, papillary RCC (pRCC) is associated with a favorable outcome compared to clear cell RCC (ccRCC), while other series report equivalent or worse prognosis. In this paper we comparatively evaluate outcome of pRCC versus ccRCC in two large multi-institutional databases (cohort study), including distribution of pRCC subtypes 1 and 2. Retrospective data of 1,943 surgically treated pRCC patients from 17 European/North American centers between 1984-2015 were compared to 5,600 ccRCC patients from a database comprising 11 European/North American centers (1984-2011). Median follow-up was 64.6 months. Differences between pRCC, subtypes, and ccRCC were compared with t-tests, Chi<^>2-tests, and exact Fisher tests. Cancer-specific mortality was analyzed with cumulative incidence curves and Cox cause-specific hazard models. The robustness of our results was examined with sensitivity analyses. We present that cancer-specific mortality rates and variables as stage, lymph node, and distant metastasis differ significantly between groups. Furthermore, we demonstrate that patients with non-metastatic pRCC had a significantly better cancer-specific mortality (HR 0.76, p = 0.007), when compared to ccRCC. Additionally, pRCC type 2 versus ccRCC exhibited no difference in cancer-specific mortality (HR 0.9, p = 0.722), whereas pRCC type 1 versus ccRCC displayed a risk of death reduced by 69% (p = 0.044). Taken together, outcome of pRCC versus ccRCC varies significantly in non-metastatic disease. Furthermore, pRCC type 2 exhibited no difference in cancer-specific mortality, whereas pRCC type 1 displayed a significantly reduced risk of death. Consequently, there is urgent need to respect histopathological entities and their subtypes, when assigning follow-up or targeted therapy to RCC patients.	[Wagener, Nina] Heidelberg Univ, Mannheim Med Ctr, Dept Urol, Mannheim, Germany; [Edelmann, Dominic; Benner, Axel] German Canc Res Ctr, Div Biostat, Heidelberg, Germany; [Zigeuner, Richard] Med Univ Graz, Dept Urol, Graz, Austria; [Borgmann, Hendrik] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Urol, Mainz, Germany; [Wolff, Ingmar] Carl Thiem Klinikum Cottbus, Dept Urol, Cottbus, Germany; [Krabbe, Laura M.] Univ Munster, Dept Urol, Med Ctr, Munster, Germany; [Musquera, Mireia] Univ Barcelona, Hosp Clin, Dept Urol, Barcelona, Spain; [Dell'Oglio, Paolo; Capitanio, Umberto] Univ Vita Salute, Unit Urol, San Raffaele Sci Inst, URI, Milan, Italy; [Dell'Oglio, Paolo; Capitanio, Umberto] Univ Vita Salute, Div Expt Oncol, San Raffaele Sci Inst, URI, Milan, Italy; [Klatte, Tobias] Med Univ Vienna, Dept Urol, Vienna, Austria; [Cindolo, Luca] San Pio de Pietrelcina Hosp, Dept Urol, Vasto, Italy; [May, Matthias] St Elisabeth Hosp Straubing, Dept Urol, Straubing, Germany; [Brookman-May, Sabine D.] LMU, Dept Urol, Munich, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Graz; Johannes Gutenberg University of Mainz; University of Munster; University of Barcelona; Hospital Clinic de Barcelona; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Medical University of Vienna; University of Munich	Wagener, N (corresponding author), Heidelberg Univ, Mannheim Med Ctr, Dept Urol, Mannheim, Germany.; Brookman-May, SD (corresponding author), LMU, Dept Urol, Munich, Germany.	Nina.Wagener@medma.uni-heidelberg.de; sabine.brookman-may@email.de	capitanio, umberto/AAC-5344-2022; Wolff, Ingmar/Y-4974-2019; Cindolo, Luca/Q-8342-2016; Borgmann, Hendrik/F-4658-2015; Wolff, Ingmar/ABG-7840-2021	Wolff, Ingmar/0000-0003-4197-6643; Borgmann, Hendrik/0000-0002-3955-564X; Gilfrich, Christian/0000-0003-0211-0636; Musquera Felip, Mireia/0000-0002-5915-9935	Medical Faculty Mannheim, University of Heidelberg, Germany; Deutsche Forschungsgemeinschaft, Germany	Medical Faculty Mannheim, University of Heidelberg, Germany; Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG))	This work was funded by Medical Faculty Mannheim, University of Heidelberg, Germany (Grant "SablNe") and Deutsche Forschungsgemeinschaft and Medical Faculty Mannheim, University of Heidelberg, Germany (Funding program Open Access Publishing") to N. Wagener. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alomari AK, 2015, HUM PATHOL, V46, P1418, DOI 10.1016/j.humpath.2015.06.006; Amin MB, 2002, AM J SURG PATHOL, V26, P281, DOI 10.1097/00000478-200203000-00001; Armstrong AJ, 2016, LANCET ONCOL, V17, P378, DOI 10.1016/S1470-2045(15)00515-X; Beck SDW, 2004, ANN SURG ONCOL, V11, P71, DOI 10.1007/BF02524349; Bigot P, 2016, WORLD J UROL, V34, P347, DOI 10.1007/s00345-015-1634-0; Capitanio U, 2009, BJU INT, V103, P1496, DOI 10.1111/j.1464-410X.2008.08259.x; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; Cornejo KM, 2015, HUM PATHOL, V46, P1411, DOI 10.1016/j.humpath.2015.07.001; Delahunt B, 1997, MODERN PATHOL, V10, P537; Delahunt B, 2001, HUM PATHOL, V32, P590, DOI 10.1053/hupa.2001.24984; Canfield S., 2016, EAU GUIDELINES 2016; Eble J, 2004, WHO TUMORS PATHOLOGY; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Keegan KA, 2012, J UROLOGY, V188, P391, DOI 10.1016/j.juro.2012.04.006; Klatte T, 2009, CLIN CANCER RES, V15, P1162, DOI 10.1158/1078-0432.CCR-08-1229; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Leibovich BC, 2010, J UROLOGY, V183, P1309, DOI 10.1016/j.juro.2009.12.035; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Novara G., 2009, EUROPEAN UROLOGY, V58, P588, DOI DOI 10.1016/J.EURUR0.2010.07.006; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; Pignot G, 2007, UROLOGY, V69, P230, DOI 10.1016/j.urology.2006.09.052; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1; Steffens S, 2012, EUR J CANCER, V48, P2347, DOI 10.1016/j.ejca.2012.05.002; Sukov WR, 2012, J UROLOGY, V187, P54, DOI 10.1016/j.juro.2011.09.053; Teloken PE, 2009, J UROLOGY, V182, P2132, DOI 10.1016/j.juro.2009.07.019; Therneau T, 2016, R PROGRAMMING LANGUA; Tilki D, 2014, EUR UROL, V66, P577, DOI 10.1016/j.eururo.2013.06.048; Turajlic S, 2016, EUR J CANCER, V69, P223, DOI 10.1016/j.ejca.2016.10.002; Vera-Badillo FE, 2015, EUR UROL, V67, P740, DOI 10.1016/j.eururo.2014.05.010; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Waldert M, 2008, BJU INT, V102, P1381, DOI 10.1111/j.1464-410X.2008.07999.x	31	20	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184173	10.1371/journal.pone.0184173	http://dx.doi.org/10.1371/journal.pone.0184173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934212	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900021
J	Weyrauch, AK; Jakob, M; Schierhorn, A; Klosgen, RB; Hinderberger, D				Weyrauch, Anna Katharina; Jakob, Mario; Schierhorn, Angelika; Kloesgen, Ralf Bernd; Hinderberger, Dariush			Purification of rabbit serum histidine-proline-rich glycoprotein via preparative gel electrophoresis and characterization of its glycosylation patterns	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; HIGH-AFFINITY; BLOOD-PLASMA; BINDS; CARBOXYMETHYLCELLULOSE; SEQUENCE; CADMIUM; HEME; ZINC	Histidine-Proline-rich Glycoprotein (HPRG) is a plasma protein of vertebrates and several marine bivalves. Due to its multidomain structure consisting of several regions HPRG can interact with a variety of ligands, however the exact physiological role has not been discovered yet. Past purification approaches out of plasma or serum often led to co-purification of other proteins so that for a profound understanding of the function it is important to obtain a protein of high purity. Recent purification strategies were based upon metale chelate affinity chromatography followed by anion exchange chromatography or size exclusion chromatography, respectively. A large amount of serum albumin, the major plasma protein, also elutes from metale chelate affinity chromatography columns. Separation of rabbit HPRG from rabbit serum albumin could not be achieved via the above named methods by us. We present a method of purification of rabbit serum HPRG by means of metal affinity chromatography and preparative gel electrophoresis, which makes it possible to obtain HPRG practically devoid of impurities as assessed by mass spectrometry analysis. Moreover, we characterize the amount of glycosylation of HPRG and-to the best of our knowledge for the first time-the glycosylation pattern of rabbit HPRG.	[Weyrauch, Anna Katharina; Hinderberger, Dariush] Martin Luther Univ Halle Wittenberg, Div Phys Chem, Inst Chem, Halle An Der Saale, Saxony Anhalt, Germany; [Jakob, Mario; Kloesgen, Ralf Bernd] Martin Luther Univ Halle Wittenberg, Div Plant Physiol, Inst Biol, Halle An Der Saale, Saxony Anhalt, Germany; [Schierhorn, Angelika] Martin Luther Univ Halle Wittenberg, Serv Unit Mass Spectrometry, Inst Biochem & Biotechnol, Halle An Der Saale, Saxony Anhalt, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Hinderberger, D (corresponding author), Martin Luther Univ Halle Wittenberg, Div Phys Chem, Inst Chem, Halle An Der Saale, Saxony Anhalt, Germany.	dariush.hinderberger@chemie.uni-halle.de	Hinderberger, Dariush/B-7865-2008					Abebe AT, 2007, COMP BIOCHEM PHYS B, V147, P74, DOI 10.1016/j.cbpb.2006.12.010; Borza DB, 1996, BIOCHEMISTRY-US, V35, P1925, DOI 10.1021/bi952061t; Castellanos-Serra L, 1999, ELECTROPHORESIS, V20, P732, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<732::AID-ELPS732>3.3.CO;2-H; GUTHANS SL, 1982, ARCH BIOCHEM BIOPHYS, V218, P320, DOI 10.1016/0003-9861(82)90350-2; Hauer RS, 2013, BBA-MOL CELL RES, V1833, P957, DOI 10.1016/j.bbamcr.2013.01.030; HAUPT H, 1972, H-S Z PHYSIOL CHEM, V353, P1125, DOI 10.1515/bchm2.1972.353.2.1125; HEIMBURGER N, 1972, H-S Z PHYSIOL CHEM, V353, P1133, DOI 10.1515/bchm2.1972.353.2.1133; Hennis B, 1991, EVALUATION SITES SYN; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Jones AL, 2004, J BIOL CHEM, V279, P30114, DOI 10.1074/jbc.M401996200; Kassaar O, 2014, BLOOD, V123, P1948, DOI 10.1182/blood-2013-11-535963; KOIDE T, 1987, FEBS LETT, V216, P17, DOI 10.1016/0014-5793(87)80748-2; KOIDE T, 1982, FEBS LETT, V141, P222, DOI 10.1016/0014-5793(82)80052-5; KOIDE T, 1986, BIOCHEMISTRY-US, V25, P2220, DOI 10.1021/bi00356a055; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; LEUNG LLK, 1986, J CLIN INVEST, V77, P1305, DOI 10.1172/JCI112435; LIJNEN HR, 1980, J BIOL CHEM, V255, P214; LODISH HF, 1993, J BIOL CHEM, V268, P20598; Miller I, 2004, PROTEOMICS, V4, P257, DOI 10.1002/pmic.200300546; MORGAN WT, 1978, BIOCHIM BIOPHYS ACTA, V535, P319, DOI 10.1016/0005-2795(78)90098-3; MORGAN WT, 1981, BIOCHEMISTRY-US, V20, P1054, DOI 10.1021/bi00508a002; Nair PS, 1999, ARCH BIOCHEM BIOPHYS, V366, P8, DOI 10.1006/abbi.1999.1196; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patel KK, 2013, IUBMB LIFE, V65, P550, DOI 10.1002/iub.1168; Poon IKH, 2011, BLOOD, V117, P2093, DOI 10.1182/blood-2010-09-303842; Poon IKH, 2010, INT J BIOCHEM CELL B, V42, P1507, DOI 10.1016/j.biocel.2010.05.008; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ronca F, 2015, BIOCHIMIE, V118, P207, DOI 10.1016/j.biochi.2015.09.024; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Simantov R, 2001, J CLIN INVEST, V107, P45, DOI 10.1172/JCI9061; SMITH A, 1985, THROMB RES, V40, P653, DOI 10.1016/0049-3848(85)90303-2; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TSUTSUI K, 1982, J BIOL CHEM, V257, P3925; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wakabayashi S, 2013, INT REV CEL MOL BIO, V304, P467, DOI 10.1016/B978-0-12-407696-9.00009-9; Wang BL, 2014, J AM SOC MASS SPECTR, V25, P729, DOI 10.1007/s13361-013-0823-6; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	39	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184968	10.1371/journal.pone.0184968	http://dx.doi.org/10.1371/journal.pone.0184968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934288	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900067
J	Zarychta-Wisniewska, W; Burdzinska, A; Zagozdzon, R; Dybowski, B; Butrym, M; Gajewski, Z; Paczek, L				Zarychta-Wisniewska, Weronika; Burdzinska, Anna; Zagozdzon, Radoslaw; Dybowski, Bartosz; Butrym, Marta; Gajewski, Zdzislaw; Paczek, Leszek			In vivo imaging system for explants analysis-A new approach for assessment of cell transplantation effects in large animal models	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PRECURSOR CELLS; VITRO; DIFFERENTIATION; THERAPY; AUTOFLUORESCENCE	Introduction Despite spectacular progress in cellular transplantology, there are still many concerns about the fate of transplanted cells. More preclinical studies are needed, especially on large animal models, to bridge the translational gap between basic research and the clinic. Herein, we propose a novel approach in analysis of cell transplantation effects in large animals explants using in vivo imaging system (IVIS (R)) or similar equipment. Material and methods In the in vitro experiment cells labeled with fluorescent membrane dyes: DID (far red) or PKH26 (orange) were visualized with IVIS (R). The correlation between the fluorescence signal and cell number with or without addition of minced muscle tissue was calculated. In the ex vivo study urethras obtained from goats after intraurethral cells (n = 9) or PBS (n = 4) injections were divided into 0.5 cm cross-slices and analyzed by using IVIS (R). Automatic algorithm followed or not by manual setup was used to separate specific dye signal from tissue autofluorescence. The results were verified by systematic microscopic analysis of standard 10 mu m specimens prepared from slices before and after immunohistochemical staining. Comparison of obtained data was performed using diagnostic test function. Results Fluorescence signal strength in IVIS (R) was directly proportional to the number of cells regardless of the dye used and detectable for minimum 0.25x10(6) of cells. DID-derived signal was much less affected by the background signal in comparison to PKH26 in in vitro test. Using the IVIS (R) to scan explants in defined arrangement resulted in precise localization of DID but not PKH26 positive spots. Microscopic analysis of histological specimens confirmed the specificity (89%) and sensitivity (80%) of IVIS (R) assessment relative to DID dye. The procedure enabled successful immunohistochemical staining of specimens derived from analyzed slices. Conclusions The IVIS (R) system under appropriate conditions of visualization and analysis can be used as a method for ex vivo evaluation of cell transplantation effects. Presented protocol allows for evaluation of cell delivery precision rate, enables semi-quantitative assessment of signal, preselects material for further analysis without interfering with the tissue properties. Far red dyes are appropriate fluorophores to cell labeling for this application.	[Zarychta-Wisniewska, Weronika; Burdzinska, Anna; Butrym, Marta; Paczek, Leszek] Med Univ Warsaw, Transplantat Inst, Dept Immunol Transplant Med & Internal Dis, Warsaw, Poland; [Zagozdzon, Radoslaw] Med Univ Warsaw, Transplantat Inst, Dept Clin Immunol, Warsaw, Poland; [Zagozdzon, Radoslaw; Paczek, Leszek] Polish Acad Sci, Inst Biochem & Biophys, Dept Bioinformat, Warsaw, Poland; [Dybowski, Bartosz] Med Univ Warsaw, Dept Urol, Warsaw, Poland; [Butrym, Marta] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden; [Gajewski, Zdzislaw] Warsaw Univ Life Sci, WULS SGGW, Fac Vet Med, Vet Res Ctr,Dept Large Anim Dis Clin, Warsaw, Poland; [Gajewski, Zdzislaw] Warsaw Univ Life Sci, WULS SGGW, Fac Vet Med, Ctr Biomed Res, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Medical University of Warsaw; Lund University; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Burdzinska, A (corresponding author), Med Univ Warsaw, Transplantat Inst, Dept Immunol Transplant Med & Internal Dis, Warsaw, Poland.	anna.burdzinska@wum.edu.pl	Gajewski, Zdzislaw/N-1481-2016; Zagozdzon, Radoslaw/AAC-4298-2019; Zarychta-Wiśniewska, Weronika/A-7389-2019; Burdzinska, Anna/Q-2402-2016	Gajewski, Zdzislaw/0000-0001-8779-5050; Zagozdzon, Radoslaw/0000-0002-7957-2372; Zarychta-Wiśniewska, Weronika/0000-0002-1383-2151; Burdzinska, Anna/0000-0001-7148-5971; Paczek, Leszek/0000-0003-0160-3009	Foundation for Polish Science; European Union	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union(European Commission)	This study was supported within Parent Bridge program of the Foundation for Polish Science, co-financed by the European Union under the European Regional Development Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badra S, 2013, J UROLOGY, V190, P1938, DOI 10.1016/j.juro.2013.04.052; Bouchlaka MN, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1143996; Burdzinska A, 2016, ANAT REC; Burdzinska A, 2013, UROLOGY, V82, DOI 10.1016/j.urology.2013.03.030; Carr LK, 2013, J UROLOGY, V189, P595, DOI 10.1016/j.juro.2012.09.028; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Corcos J, 2011, NEUROUROL URODYNAM, V30, P447, DOI 10.1002/nau.20998; Davis AS, 2014, J HISTOCHEM CYTOCHEM, V62, P405, DOI 10.1369/0022155414531549; Drost AC, 2009, ANN NY ACAD SCI, V1176, P135, DOI 10.1111/j.1749-6632.2009.04610.x; Eberli D, 2012, CELL TRANSPLANT, V21, P2089, DOI 10.3727/096368911X623835; ELBERGER AJ, 1990, J HISTOCHEM CYTOCHEM, V38, P735, DOI 10.1177/38.5.2110209; Gabr H, 2015, CELL TRANSPLANT, V24, P1813, DOI 10.3727/096368914X683025; Gandolfi F, 2011, THERIOGENOLOGY, V75, P1416, DOI 10.1016/j.theriogenology.2011.01.026; Guenoun J, 2013, CONTRAST MEDIA MOL I, V8, P165, DOI 10.1002/cmmi.1513; Gunetti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045538; Haas SJP, 2000, ACTA HISTOCHEM, V102, P273, DOI 10.1078/S0065-1281(04)70035-5; Harding J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt171; Holzer N, 2005, NEUROMUSCULAR DISORD, V15, P237, DOI 10.1016/j.nmd.2004.11.001; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Kulesza A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161693; Lassailly F, 2010, BLOOD, V115, P5347, DOI 10.1182/blood-2009-05-224030; Li P, 2013, STEM CELLS DEV, V22, P340, DOI 10.1089/scd.2012.0357; Mitterberger M, 2008, EUR UROL, V53, P169, DOI 10.1016/j.eururo.2007.07.026; Mohtasebi MS, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/457614; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Palero JA, 2007, BIOPHYS J, V93, P992, DOI 10.1529/biophysj.106.099457; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Pietzner J, 2013, HUM MOL GENET, V22, P493, DOI 10.1093/hmg/dds448; Spikins D, 2005, NAT BIOTECHNOL, V435, P969; Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350; Xu H, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3258838; Xue Gai, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P910, DOI 10.3760/cma.j.issn.1007-3418.2014.12.007; Yiou R, 2002, BJU INT, V89, P298, DOI 10.1046/j.1464-4096.2001.01618.x; Yukawa H, 2015, CELL MED, V7, P75, DOI 10.3727/215517914X685169	35	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184588	10.1371/journal.pone.0184588	http://dx.doi.org/10.1371/journal.pone.0184588			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931067	gold, Green Published, Green Submitted			2022-12-27	WOS:000411314700023
J	Banks, LM; Kelly, SA; Kyegombe, N; Kuper, H; Devries, K				Banks, Lena Morgon; Kelly, Susan A.; Kyegombe, Nambusi; Kuper, Hannah; Devries, Karen			"If he could speak, he would be able to point out who does those things to him" : Experiences of violence and access to child protection among children with disabilities in Uganda and Malawi	PLOS ONE			English	Article							DOMESTIC VIOLENCE; EXPOSURE; METAANALYSIS; INTERVENTIONS; PREVALENCE; POVERTY; RISK	Introduction There is growing evidence that children with disabilities face an increased risk of violence globally. While child protection mechanisms to prevent and respond to violence-including formal government systems and more informal programmes and activities run by local communities or NGOs-are slowly becoming operationalised in low-and-middle-income countries, little is known about whether existing mechanisms are disability-inclusive. The aim of this study is to provide a better understanding of children with disabilities' experiences of violence and their access to available child protection mechanisms in low resource settings. Methods This study was conducted in Kasungu and Mulanje districts in Malawi and Kamuli district in Uganda between October-December 2015. In-depth, semi-structured interviews were conducted with approximately 20 purposively selected child/caregiver pairs in each country (43 pairs total). Interviews with key informants involved in the provision of child protection and disability support were also conducted. All interviews were recorded, transcribed and coded in NVivo. Thematic Analysis, complemented by constant comparison as described in Grounded Theory, was used to analyse the data. Results Almost all children with disabilities reported experiencing violence, with verbal abuse and bullying the most common forms. Very few of these children sought recourse through available child protection mechanisms. Some of the key factors impeding access to child protection for children with disabilities included: lack of local government disability-inclusive planning and budgeting; centralization of limited disability and social protection services; financial barriers to seeking and receiving care; and stigma and negative attitudes toward disabilities. Conclusion Children with disabilities face both high levels of violence and high barriers to accessing available child protection mechanisms. There is an urgent need to ensure that all efforts to prevent and respond to violence against children are more disability-inclusive. In addition, it may be appropriate to target child protection mechanisms specifically toward children with disabilities because of the different and intersecting vulnerabilities that they face.	[Banks, Lena Morgon; Kuper, Hannah] London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Evidence Disabil, London, England; [Kelly, Susan A.; Kyegombe, Nambusi; Devries, Karen] London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, Dept Global Hlth & Dev, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Banks, LM (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Evidence Disabil, London, England.	morgon.banks@lshtm.ac.uk	Kyegombe, Nambusi/ABC-9970-2020; Devries, Karen/K-1083-2016	Kyegombe, Nambusi/0000-0002-3986-0361; Banks, Lena Morgon/0000-0002-4585-1103; Devries, Karen/0000-0001-8935-2181	Plan International [PHGHZG89]	Plan International	This study was funded by Plan International (project number: PHGHZG89). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACPF, 2011, REAL CHILDR DIS S AF; ACPF, 2010, BREAK SIL VIOL CHILD; ACPF (African Child Policy Forum), 2014, AFR REP CHILDR DIS P; [Anonymous], 2005, STAT WORLDS CHILDR 2; [Anonymous], 2011, WORLD REP DIS; Baker-Henningham H, 2009, CHILD ABUSE NEGLECT, V33, P296, DOI 10.1016/j.chiabu.2008.05.011; Banks LM, 2014, EC COSTS EXCLUSION G; Boersma M., 2013, PROTECTING CHILDREN, V24, P11; Braithwaite J, 2009, ALTER, V3, P219, DOI 10.1016/j.alter.2008.10.002; Breen A, 2015, CHILD ABUSE NEGLECT, V48, P131, DOI 10.1016/j.chiabu.2015.04.022; De Koker P, 2014, J ADOLESCENT HEALTH, V54, P3, DOI 10.1016/j.jadohealth.2013.08.008; Devries KM, 2015, LANCET GLOB HEALTH, V3, pE378, DOI 10.1016/S2214-109X(15)00060-1; Devries KM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1017; Evans SE, 2008, AGGRESS VIOLENT BEH, V13, P131, DOI 10.1016/j.avb.2008.02.005; Gershoff ET, 2013, CHILD DEV PERSPECT, V7, P133, DOI 10.1111/cdep.12038; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Glaser B.G., 1968, DISCOV GROUNDED THEO; [Government of the Republic of Malawi Office NS], 2012, INT HOUS SURV 2010 2; Government of the Republic of Uganda, 2014, POV STAT REP 2014 ST; Groce N., 2005, VIOLENCE DISABLED CH; Hillis S, 2016, GLOBAL PREVALENCE YE; Holt S, 2008, CHILD ABUSE NEGLECT, V32, P797, DOI 10.1016/j.chiabu.2008.02.004; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Jones L, 2012, LANCET; Jones L, 2012, LANCET, V380, P899, DOI 10.1016/S0140-6736(12)60692-8; Kuper H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107300; McCabe KM, 2005, AM J ORTHOPSYCHIAT, V75, P575, DOI 10.1037/0002-9432.75.4.575; Mikton C, 2014, J INTERPERS VIOLENCE, V29, P3207, DOI 10.1177/0886260514534530; Ministry of Gender C Disability and Social Welfare of the Republic of Malawi UNICEF Centre for Social Research at the Univeristy of Malawi Centers for Disease Control and Prevention., 2014, VIOL CHILDR YOUNG WO; Mont D, 2011, WORLD BANK ECON REV, V25, P323, DOI 10.1093/wber/lhr019; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Saile R, 2014, CHILD ABUSE NEGLECT, V38, P135, DOI 10.1016/j.chiabu.2013.10.007; Save the Children, 2011, OUT SHAD SEX VIOL CH; Stark L, 2016, SOC SCI MED, V152, P125, DOI 10.1016/j.socscimed.2016.01.052; Terre des hommes, 2007, HIDD SHAM VIOL CHILD; Tharp AT, 2012, J SAFETY RES, V43, P291, DOI 10.1016/j.jsr.2012.08.014; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; United Nations Economic and Social Council, 2008, UNICEF CHILD PROT ST; Weaver CM, 2008, J COMMUNITY PSYCHOL, V36, P96, DOI 10.1002/jcop.20219; World Health Organization, CHILD MALTR 2017; Wright EM, 2013, CHILD ABUSE NEGLECT, V37, P899, DOI 10.1016/j.chiabu.2013.04.010; Zaidi A, 2005, REV INCOME WEALTH, P89	42	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0183736	10.1371/journal.pone.0183736	http://dx.doi.org/10.1371/journal.pone.0183736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH4XT	28926598	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000411166600006
J	Dutzmann, J; Musmann, RJ; Haertle, M; Daniel, JM; Sonnenschein, K; Schafer, A; Kolkhof, P; Bauersachs, J; Sedding, DG				Dutzmann, Jochen; Musmann, Robert-Jonathan; Haertle, Marco; Daniel, Jan-Marcus; Sonnenschein, Kristina; Schaefer, Andreas; Kolkhof, Peter; Bauersachs, Johann; Sedding, Daniel G.			The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; BAY 94-8862; EPLERENONE; ALDOSTERONE; MICE; HYPERPLASIA	Background The novel nonsteroidal mineralocorticoid receptor (MR) antagonist finerenone holds promise to be safe and efficient in the treatment of patients with heart failure and/or chronic kidney disease. However, its effects on vascular function remain elusive. Purpose The aim of this study was to determine the functional effect of selective MR antagonism by finerenone in vascular cells in vitro and the effect on vascular remodeling following acute vascular injury in vivo. Methods and results In vitro, finerenone dose-dependently reduced aldosterone-induced smooth muscle cell (SMC) proliferation, as quantified by BrdU incorporation, and prevented aldosteroneinduced endothelial cell (EC) apoptosis, as measured with a flow cytometry based caspase 3/7 activity assay. In vivo, oral application of finerenone resulted in an accelerated re-endothelialization 3 days following electric injury of the murine carotid artery. Furthermore, finerenone treatment inhibited intimal and medial cell proliferation following wire-induced injury of the murine femoral artery 10 days following injury and attenuated neointimal lesion formation 21 days following injury. Conclusion Finerenone significantly reduces apoptosis of ECs and simultaneously attenuates SMC proliferation, resulting in accelerated endothelial healing and reduced neointima formation of the injured vessels. Thus, finerenone appears to provide favorable vascular effects through restoring vascular integrity and preventing adverse vascular remodeling.	[Dutzmann, Jochen; Musmann, Robert-Jonathan; Haertle, Marco; Daniel, Jan-Marcus; Sonnenschein, Kristina; Schaefer, Andreas; Bauersachs, Johann; Sedding, Daniel G.] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Kolkhof, Peter] Bayer AG, Global Drug Discovery, Cardiol Res, Wuppertal, Germany	Hannover Medical School; Bayer AG	Sedding, DG (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany.		Schäfer, Andreas/AAQ-9512-2021; Haertlé, Marco/GON-4471-2022		Bayer Pharma AG (Wuppertal, Germany); Hannover Medical School (Hochschulinterne Leistungsforderung, HiLF); German Heart Foundation (Deutsche Herzstiftung); German Research Foundation (Cluster of excellence REBIRTH)	Bayer Pharma AG (Wuppertal, Germany); Hannover Medical School (Hochschulinterne Leistungsforderung, HiLF); German Heart Foundation (Deutsche Herzstiftung); German Research Foundation (Cluster of excellence REBIRTH)	This study was supported by a fund from Bayer Pharma AG (Wuppertal, Germany) to DGS and JB. The funder provided support in the form of salaries for author PK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. JD has received research support from the Hannover Medical School (Hochschulinterne Leistungsforderung, HiLF). KS has received a grant of the German Heart Foundation (Deutsche Herzstiftung). DGS and JB received research support from the German Research Foundation (Cluster of excellence REBIRTH).	Amano T, 2006, AM J CARDIOL, V97, P785, DOI 10.1016/j.amjcard.2005.10.017; Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Barfacker L, 2014, J CARDIOVASC PHARM; Bauersachs J, 2015, HYPERTENSION, V65, P257, DOI 10.1161/HYPERTENSIONAHA.114.04488; Bauersachs J, 2013, EUR HEART J, V34, P2426, DOI 10.1093/eurheartj/eht235; Boehm O, 2007, BIOL CHEM, V388, P547, DOI 10.1515/BC.2007.061; Carmeliet P, 1997, AM J PATHOL, V150, P761; Daniel JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0261-9; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Favre J, 2011, AM J PHYSIOL-HEART C, V300, pH2035, DOI 10.1152/ajpheart.00552.2010; Filippatos G, 2016, EUR HEART J, V37, P2105, DOI 10.1093/eurheartj/ehw132; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Galigniana MD, 1996, LIFE SCI, V59, P511, DOI 10.1016/0024-3205(96)00331-1; Gueret A, 2016, HYPERTENSION, V67, P717, DOI 10.1161/HYPERTENSIONAHA.115.06709; Ivanes F, 2012, EUR HEART J, V33, P191, DOI 10.1093/eurheartj/ehr176; Jia GH, 2016, CIRC RES, V118, P935, DOI 10.1161/CIRCRESAHA.115.308269; Kolkhof P, 2015, CURR OPIN NEPHROL HY, V24, P417, DOI 10.1097/MNH.0000000000000147; Kursaklioglu H, 2004, ANN ACAD MED SINGAP, V33, P769; Le HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145958; Montalescot G, 2014, EUR HEART J, V35, P2295, DOI 10.1093/eurheartj/ehu164; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 2013, EUR HEART J, V34, P2453, DOI 10.1093/eurheartj/eht187; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; Pruthi D, 2014, ARTERIOSCL THROM VAS, V34, P355, DOI 10.1161/ATVBAHA.113.302854; Raz-Pasteur A, 2012, J CARDIOVASC PHARM, V60, P508, DOI 10.1097/FJC.0b013e31826f5535; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Sun JY, 2016, ARTERIOSCL THROM VAS, V36, P874, DOI 10.1161/ATVBAHA.115.307031; Wakabayashi K, 2006, INT J CARDIOL, V107, P260, DOI 10.1016/j.ijcard.2005.03.078; Zwadlo C, 2013, CURR OPIN PHARMACOL, V13, P280, DOI 10.1016/j.coph.2012.12.007	30	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184888	10.1371/journal.pone.0184888	http://dx.doi.org/10.1371/journal.pone.0184888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926607	Green Submitted, gold, Green Published			2022-12-27	WOS:000411166600048
J	Makowska, M				Makowska, Marta			Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health	PLOS ONE			English	Article							PRESCRIBING PATTERNS; REPRESENTATIVES; GIFTS	Objective This article aims to describe how Polish physicians cooperate with the pharmaceutical industry and show how this relationship may pose a threat to public health. Methods It considers the results of an online survey of 379 physicians. The survey was hosted by surveymonkey. com with links from a Polish physicians' website 9Medycyna Praktyczna) between 29 October 2013 and 31 December 2013. The sample was purposive, respondents having to be physicians working in Poland. Results The majority of respondents 996.8%) said that they had talked with pharmaceutical sales representatives 9PSRs) in their practice, with 85% saying that they had had regular contact with them. Despite the existing legal ban in Poland, 35% of respondents admitted that they had usually met with PSRs in their office during working hours. As many as 81.8% of surveyed doctors said that they had taken part in an educational meeting organized by the pharmaceutical industry at least once during the 12 months preceding the study. A majority of the respondents 972.3%) said they trusted the information provided by PSRs. Over one third of respondents 936.4%) claimed that Polish doctors accepted gifts of a type that they should not accept according to Polish law. Conclusions The study showed that Polish physicians cooperate in different ways with pharmaceutical companies and have frequent contact with them. This can influence their knowledge and doctors whose knowledge of drugs is based mainly on information from pharmaceutical industry materials may prescribe medicines in a biased way, possibly exposing their patients to sub-optimal treatments and burdening both their patients and the state budget with unnecessary costs. Lack of trust in doctors and pharmaceutical companies have other implications too: there may be a decline of faith in the efficacy of therapy and patients may be encouraged to engage in self-diagnosis and self-treatment. For these reasons it is necessary to increase transparency and strengthen the ethical guidelines surrounding the physician -pharmaceutical industry relationship in Poland. The present findings also have implications for public health policy.	[Makowska, Marta] Warsaw Univ Life Sci, Fac Social Sci, Warsaw, Poland	Warsaw University of Life Sciences	Makowska, M (corresponding author), Warsaw Univ Life Sci, Fac Social Sci, Warsaw, Poland.	marta_makowska@sggm.pl	Makowska, Marta/S-2762-2018; Dangal, Ganesh/O-1989-2017	Makowska, Marta/0000-0002-0785-6237; Dangal, Ganesh/0000-0002-5834-5525				Agrawal S, 2016, NEW ENGL J MED, V374, P906, DOI 10.1056/NEJMp1509103; Caudill TS, 1996, ARCH FAM MED, V5, P201, DOI 10.1001/archfami.5.4.201; Chimonas S, 2007, J GEN INTERN MED, V22, P184, DOI 10.1007/s11606-006-0041-z; Cialdini R., 2003, INFLUENCE SCI PRACTI; Creyer EH, 1998, MARK HEALTH SERV, V18, P34; Czaplinski J, DIAGNOZA SPO O ECZNA; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Golinowska S., 2011, HLTH SYSTEMS TRANSIT, V13; Grande D, 2012, J GEN INTERN MED, V27, P274, DOI 10.1007/s11606-011-1760-3; Halperin EC, 2004, INT J RADIAT ONCOL, V59, P1477, DOI 10.1016/j.ijrobp.2004.01.052; Katz D, 2010, AM J BIOETHICS, V10, P11, DOI 10.1080/15265161.2010.519226; Kitsis EA, 2011, AM J BIOETHICS, V11, P51, DOI 10.1080/15265161.2010.535600; Makowska, 2016, ETYCZNE WYZWANIA REL; Makowska M., 2010, ETYCZNE STANDARDY MA; Nissen SE, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010035; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Ornstein Charles, 2016, NOW THERES PROOF DOC; Othman N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006350; Ozieranski P, 2012, HEALTH ECON POLICY L, V7, P175, DOI 10.1017/S1744133111000168; PAlil Z, 2013, SEKTOR FARAMACEUTYCZ; Polak P, 2011, NOWE FORMY KORUPCJI; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Zipkin DA, 2005, J GEN INTERN MED, V20, P777, DOI 10.1111/j.1525-1497.2005.0134.x	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184862	10.1371/journal.pone.0184862	http://dx.doi.org/10.1371/journal.pone.0184862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926592	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600045
J	Salabert, AS; Vaysse, L; Beaurain, M; Alonso, M; Arribarat, G; Lotterie, JA; Loubinoux, I; Tafani, M; Payoux, P				Salabert, Anne-Sophie; Vaysse, Laurence; Beaurain, Marie; Alonso, Mathieu; Arribarat, Germain; Lotterie, Jean-Albert; Loubinoux, Isabelle; Tafani, Mathieu; Payoux, Pierre			Imaging grafted cells with [F-18] FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model	PLOS ONE			English	Article							REPORTER GENE-EXPRESSION; PRECLINICAL EVALUATION; EXTENSIVE METHYLATION; TRANSGENE EXPRESSION; FOCUSED ULTRASOUND; IN-VIVO; PET; PROMOTER; THERAPY; STROKE	Introduction Cell transplantation is an innovative therapeutic approach after brain injury to compensate for tissue damage. To have real-time longitudinal monitoring of intracerebrally grafted cells, we explored the feasibility of a molecular imaging approach using thymidine kinase HSV1-TK gene encoding and [F-18]FHBG as a reporter probe to image enzyme expression. Methods A stable neuronal cell line expressing HSV1-TK was developed with an optimised mammalian expression vector to ensure long-term transgene expression. After [F-18]FHBG incubation under defined parameters, calibration ranges from 1 X 10(4) to 3 X 10(6) Neuro2A-TK cells were analysed by gamma counter or by PET-camera. In parallel, grafting with different quantities of [F-18]FHBG prelabelled Neuro2A-TK cells was carried out in a rat brain injury model induced by stereotaxic injection of malonate toxin. Image acquisition of the rats was then performed with PET/CT camera to study the [F-18]FHBG signal of transplanted cells in vivo. Results Under the optimised incubation conditions, [F-18]FHBG cell uptake rate was around 2.52%. In-vitro calibration range analysis shows a clear linear correlation between the number of cells and the signal intensity. The PET signal emitted into rat brain correlated well with the number of cells injected and the number of surviving grafted cells was recorded via the in-vitro calibration range. PET/CT acquisitions also allowed validation of the stereotaxic injection procedure. Technique sensitivity was evaluated under 5 X 104 grafted cells in vivo. No [F-18]FHBG or [F-18]metabolite release was observed showing a stable cell uptake even 2 h post -graft. Conclusion The development of this kind of approach will allow grafting to be controlled and ensure longitudinal follow-up of cell viability and biodistribution after intracerebral injection.	[Salabert, Anne-Sophie; Vaysse, Laurence; Beaurain, Marie; Arribarat, Germain; Lotterie, Jean-Albert; Loubinoux, Isabelle; Tafani, Mathieu; Payoux, Pierre] Univ Toulouse, INSERM, UPS, ToNIC,Toulouse NeuroImaging Ctr,UMR1214, Toulouse, France; [Salabert, Anne-Sophie; Alonso, Mathieu; Tafani, Mathieu] Univ Hosp, Radiopharm Unit, Toulouse, France; [Lotterie, Jean-Albert; Payoux, Pierre] Univ Hosp, Nucl Med Unit, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse	Salabert, AS (corresponding author), Univ Toulouse, INSERM, UPS, ToNIC,Toulouse NeuroImaging Ctr,UMR1214, Toulouse, France.; Salabert, AS (corresponding author), Univ Hosp, Radiopharm Unit, Toulouse, France.	anne-sophie.salabert@inserm.fr	Payoux, Pierre/AGU-9727-2022; Loubinoux, Isabelle/E-5537-2016	Payoux, Pierre/0000-0002-1374-1620; Loubinoux, Isabelle/0000-0003-4461-0890; Vaysse, Laurence/0000-0001-6371-9360; ARRIBARAT, Germain/0000-0002-8754-8110; Beaurain, Marie/0000-0002-5301-871X	French National Agency for Research [ANR-11-LABX-0018-01]	French National Agency for Research(French National Research Agency (ANR))	This work has been supported in part by a grant from the French National Agency for Research called "Investissements d'Avenir" no ANR-11-LABX-0018-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alauddin MM, 2010, CURR TOP MED CHEM, V10, P1617; Alauddin MM, 2001, J NUCL MED, V42, P1682; Bazzani RP, 2016, BIOMATERIALS, V93, P20, DOI 10.1016/j.biomaterials.2016.03.029; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Buursma AR, 2006, NUCL MED COMMUN, V27, P25, DOI 10.1097/01.mnm.0000186609.12895.20; Chen LB, 2006, NUCL MED BIOL, V33, P575, DOI 10.1016/j.nucmedbio.2006.01.011; Daadi MM, 2013, CELL TRANSPLANT, V22, P881, DOI 10.3727/096368912X656144; Eissenberg LG, 2014, FRONT PHARMACOL, P5; Eissenberg LG, 2015, MOL THER, V23, P1110, DOI 10.1038/mt.2015.48; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399; Hynynen K, 2008, ADV DRUG DELIVER REV, V60, P1209, DOI 10.1016/j.addr.2008.03.010; Johnson M, 2009, J NUCL MED, V50, P757, DOI 10.2967/jnumed.108.058438; Kanda GN, 2014, INT J PHARMACEUT, V464, P27, DOI 10.1016/j.ijpharm.2014.01.025; Likar Y, 2008, J NUCL MED, V49, P713, DOI 10.2967/jnumed.107.046425; Liu XF, 2014, PROG NEUROBIOL, V115, P92, DOI 10.1016/j.pneurobio.2013.11.007; Loser P, 1998, J VIROL, V72, P180; Micci MA, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0129-7; Mitsui M, 2009, J GENE MED, V11, P435, DOI 10.1002/jgm.1317; Moisan A, 2014, CEREBROVASC DIS, V38, P344, DOI 10.1159/000368597; Muller U, 2013, AM J NUCL MED MOLEC, V3, P71; Ponde DE, 2004, NUCL MED BIOL, V31, P133, DOI 10.1016/S0969-8051(03)00096-9; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Ray P, 2011, J BIOSCIENCES, V36, P499, DOI 10.1007/s12038-011-9079-0; Raymond SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002175; Schaller BJ, 2008, CURR MOL MED, V8, P711, DOI 10.2174/156652408786733766; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Su H, 2004, MOL IMAGING BIOL, V6, P139, DOI 10.1016/j.mibio.2004.02.001; Sullivan EV, 2006, ALCOHOL CLIN EXP RES, V30, P1234, DOI 10.1111/j.1530-0277.2006.00145.x; Tensaouti F, 2008, EUR SOC MAGN RES MED, P2; Tjuvajev JG, 2002, J NUCL MED, V43, P1072; Tsuchiya R, 2002, BRAIN RES, V956, P221, DOI 10.1016/S0006-8993(02)03518-7; Varma NRS, 2011, J STEM CELLS REGEN, V7, P41; Vaysse L, 2015, BEHAV NEUROSCI; Waerzeggers Y, 2008, MOL IMAGING, V7, P77, DOI 10.2310/7290.2008.0010; Yaghoubi S, 2001, J NUCL MED, V42, P1225; Yaghoubi SS, 2006, NAT PROTOC, V1, P3069, DOI 10.1038/nprot.2006.459; Yaghoubi SS, 2012, THERANOSTICS, V2, P374, DOI 10.7150/thno.3677; Yang FY, 2007, ULTRASOUND MED BIOL, V33, P1421, DOI 10.1016/j.ultrasmedbio.2007.04.006; Yang FY, 2015, ONCOTARGET, V6, P36260, DOI 10.18632/oncotarget.5389; Zhao C, 2010, OPEN NUCL MED J, V2, P171, DOI DOI 10.2174/1876388X01002010171	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184630	10.1371/journal.pone.0184630	http://dx.doi.org/10.1371/journal.pone.0184630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926581	Green Submitted, gold, Green Published			2022-12-27	WOS:000411166600027
J	Treibich, C; Lescher, S; Sagaon-Teyssier, L; Ventelou, B				Treibich, Carole; Lescher, Sabine; Sagaon-Teyssier, Luis; Ventelou, Bruno			The expected and unexpected benefits of dispensing the exact number of pills	PLOS ONE			English	Article							ANTIBIOTIC USE; RESISTANCE; EUROPE; ADHERENCE	Background From November 2014 to November 2015, an experiment in French community pharmacies replaced traditional pre-packed boxes by per-unit dispensing of pills in the exact numbers prescribed, for 14 antibiotics. Methods A cluster randomised control trial was carried out in 100 pharmacies. 75 pharmacies counted out the medication by units (experimental group), the other 25 providing the treatment in the existing pharmaceutical company boxes (control group). Data on patients under the two arms were compared to assess the environmental, economic and health effects of this change in drug dispensing. In particular, adherence was measured indirectly by comparing the number of pills left at the end of the prescribed treatment. Results Out of the 1185 patients included during 3 sessions of 4 consecutive weeks each, 907 patients experimented the personalized delivery and 278 were assigned to the control group, consistent with a 1/3 randomization-rate at the pharmacy level. 80% of eligible patients approved of the per-unit dispensing of their treatment. The initial packaging of the drugs did not match with the prescription in 60% of cases and per-unit dispensing reduced by 10% the number of pills supplied. 13.1% of patients declared that they threw away pills residuals instead of recycling-no differences between groups. Finally, per-unit dispensing appeared to improve adherence to antibiotic treatment (marginal effect 0.21, IC 95, 0.14-0.28). Conclusions Supplying antibiotics per unit is not only beneficial in terms of a reduced number of pills to reimburse or for the environment (less pills wasted and non-recycled), but also has a positive and unexpected impact on adherence to treatment, and thus on both individual and public health.	[Treibich, Carole; Ventelou, Bruno] Aix Marseille Univ, Dept AMSE, CNRS, EHESS & Cent, Marseille, France; [Lescher, Sabine; Sagaon-Teyssier, Luis; Ventelou, Bruno] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France; [Sagaon-Teyssier, Luis; Ventelou, Bruno] Observ Reg Sante Provence Alpes Cote Azur, ORS PACA, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Treibich, C (corresponding author), Aix Marseille Univ, Dept AMSE, CNRS, EHESS & Cent, Marseille, France.	carole.treibich@univ.amu.fr		Sagaon-Teyssier, Luis/0000-0001-7318-6596; Treibich, Carole/0000-0001-5582-868X	Agence Nationale de Securite du Medicaments et des produits de sante (FRANCE), programme Drug Safe, Convention entre I'ANSM et I'Universite de Bordeaux [2014S029]; Direction Generale de la Sante (FRANCE), Convention du entre la DGS et I'INSERM; DGS (Direction Generale de la Sante, French Ministry of Health); French National Agency for the Safety of Medicines and Health Products (Agence Nationale de Securite du Medicament)	Agence Nationale de Securite du Medicaments et des produits de sante (FRANCE), programme Drug Safe, Convention entre I'ANSM et I'Universite de Bordeaux; Direction Generale de la Sante (FRANCE), Convention du entre la DGS et I'INSERM; DGS (Direction Generale de la Sante, French Ministry of Health); French National Agency for the Safety of Medicines and Health Products (Agence Nationale de Securite du Medicament)	The research project is funded by 1. Agence Nationale de Securite du Medicaments et des produits de sante (FRANCE), programme Drug Safe, Convention 2014S029 entre I'ANSM et I'Universite de Bordeaux, author: BV; 2. Direction Generale de la Sante (FRANCE), Convention du 09/10/2014 entre la DGS et I'INSERM, author: not applicable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research project is funded by the DGS (Direction Generale de la Sante, French Ministry of Health), covering data collection; Bruno Ventelou also benefited from the support of the "Drug-Safe" program from the French National Agency for the Safety of Medicines and Health Products (Agence Nationale de Securite du Medicament), for statistical analysis. We also thank Cyril Berenger and Armand Elegbe, for data management.	ANSM, 2014, EV CONS ANT FRANC EN; Fernandes M, 2014, INT J CLIN PHARM-NET, V36, P86, DOI 10.1007/s11096-013-9850-4; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Mayor S, 2005, BRIT MED J, V330, P383, DOI 10.1136/bmj.330.7488.383; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Prevention ECfD Control, 2017, ANTIMICROBIAL RESIST; Suffoletto B, 2012, ACAD EMERG MED, V19, P949, DOI 10.1111/j.1553-2712.2012.01411.x; Wahl LM, 2000, P ROY SOC B-BIOL SCI, V267, P835, DOI 10.1098/rspb.2000.1079	9	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184420	10.1371/journal.pone.0184420	http://dx.doi.org/10.1371/journal.pone.0184420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926636	gold, Green Submitted, Green Published			2022-12-27	WOS:000411166600018
J	Uriguen, JA; Garcia-Zapirain, B; Artieda, J; Iriarte, J; Valencia, M				Antonio Uriguen, Jose; Garcia-Zapirain, Begona; Artieda, Julio; Iriarte, Jorge; Valencia, Miguel			Comparison of background EEG activity of different groups of patients with idiopathic epilepsy using Shannon spectral entropy and cluster-based permutation statistical testing	PLOS ONE			English	Article							ELECTROENCEPHALOGRAMS	Idiopathic epilepsy is characterized by generalized seizures with no apparent cause. One of its main problems is the lack of biomarkers to monitor the evolution of patients. The only tools they can use are limited to inspecting the amount of seizures during previous periods of time and assessing the existence of interictal discharges. As a result, there is a need for improving the tools to assist the diagnosis and follow up of these patients. The goal of the present study is to compare and find a way to differentiate between two groups of patients suffering from idiopathic epilepsy, one group that could be followed-up by means of specific electroencephalographic (EEG) signatures (intercritical activity present), and another one that could not due to the absence of these markers. To do that, we analyzed the background EEG activity of each in the absence of seizures and epileptic intercritical activity. We used the Shannon spectral entropy (SSE) as a metric to discriminate between the two groups and performed permutation-based statistical tests to detect the set of frequencies that show significant differences. By constraining the spectral entropy estimation to the [6.25-12.89) Hz range, we detect statistical differences (at below 0.05 alpha-level) between both types of epileptic patients at all available recording channels. Interestingly, entropy values follow a trend that is inversely related to the elapsed time from the last seizure. Indeed, this trend shows asymptotical convergence to the SSE values measured in a group of healthy subjects, which present SSE values lower than any of the two groups of patients. All these results suggest that the SSE, measured in a specific range of frequencies, could serve to follow up the evolution of patients suffering from idiopathic epilepsy. Future studies remain to be conducted in order to assess the predictive value of this approach for the anticipation of seizures.	[Antonio Uriguen, Jose; Garcia-Zapirain, Begona] Univ Deusto, Deustotech Life eVida, Bilbao, Spain; [Artieda, Julio; Iriarte, Jorge] Univ Navarra, CUN, Pamplona, Spain; [Valencia, Miguel] Univ Navarra, CIMA, Pamplona, Spain; [Artieda, Julio; Iriarte, Jorge; Valencia, Miguel] Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain	University of Deusto; University of Navarra; University of Navarra	Valencia, M (corresponding author), Univ Navarra, CIMA, Pamplona, Spain.; Valencia, M (corresponding author), Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain.	mvustarroz@unav.es	Valencia, Miguel/C-3055-2009; Zapirain, Begoña Garcia/L-5619-2014; Artieda, Julio/L-4704-2014	Valencia, Miguel/0000-0001-5617-5270; Zapirain, Begoña Garcia/0000-0002-9356-1186; Artieda, Julio/0000-0003-0987-0873; Uriguen, Jose Antonio/0000-0003-0172-4281	Bizkaia:Talent; European Union's Seventh Framework Programme; Marie Curie Actions - People; Regional, National and International Programmes [267230]; Departamento de Salud, Gobierno de Navarra [114/2014]	Bizkaia:Talent; European Union's Seventh Framework Programme; Marie Curie Actions - People; Regional, National and International Programmes; Departamento de Salud, Gobierno de Navarra	Jose Antonio Uriguen is in part funded by Bizkaia:Talent and the European Union's Seventh Framework Programme. Marie Curie Actions - People. Co-funding of Regional, National and International Programmes. Grant agreement n. 267230. Julio Artieda and Miguel Valencia acknowledge support from the Departamento de Salud, Gobierno de Navarra (114/2014).	Abasolo D, 2008, MED BIOL ENG COMPUT, V46, P1019, DOI 10.1007/s11517-008-0392-1; Abasolo D, 2006, PHYSIOL MEAS, V27, P241, DOI 10.1088/0967-3334/27/3/003; Abasolo D, 2007, P 29 ANN INT C IEEE, P321; Alotaiby TN, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-183; Uriguen JA, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/031001; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Engel J, 2007, EPILEPSY COMPREHENSI; Escudero J, 2006, PHYSIOL MEAS, V27, P1091, DOI 10.1088/0967-3334/27/11/004; Esteller R, 1999, INT CONF ACOUST SPEE, P2343, DOI 10.1109/ICASSP.1999.758408; Giannakakis G., 2015, MODERN ELECTROENCEPH, V91, P131; Giannakakis G, 2013, IEEE ENG MED BIO, P413, DOI 10.1109/EMBC.2013.6609524; Gomez Carlos, 2010, Open Biomed Eng J, V4, P223, DOI 10.2174/1874120701004010223; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1726, DOI 10.1111/j.1469-8986.2011.01272.x; Guerrero-Mosquera C, 2010, MED BIOL ENG COMPUT, V48, P321, DOI 10.1007/s11517-010-0590-5; Hornero R, 2003, SEVENTH INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND ITS APPLICATIONS, VOL 2, PROCEEDINGS, P5, DOI 10.1109/ISSPA.2003.1224801; Hornero R, 1999, IEEE ENG MED BIOL, V18, P73, DOI 10.1109/51.805149; Hornero R, 2008, IEEE T BIO-MED ENG, V55, P1658, DOI 10.1109/TBME.2008.919872; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; Kannathal N, 2005, COMPUT METH PROG BIO, V80, P187, DOI 10.1016/j.cmpb.2005.06.012; Liang ZH, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00016; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mirzaei A, 2010, INT CONF BIOMED, P878, DOI 10.1109/BMEI.2010.5639894; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Paivinen N, 2005, COMPUT METH PROG BIO, V79, P151, DOI 10.1016/j.cmpb.2005.04.006; POWELL GE, 1979, J PHYS A-MATH GEN, V12, P2053, DOI 10.1088/0305-4470/12/11/017; Poza J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026010; Quiroga RQ, 2000, PHYS REV E, V62, P8380, DOI 10.1103/PhysRevE.62.8380; Subha DP, 2010, J MED SYST, V34, P195, DOI 10.1007/s10916-008-9231-z	29	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184044	10.1371/journal.pone.0184044	http://dx.doi.org/10.1371/journal.pone.0184044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922360	gold, Green Submitted, Green Published			2022-12-27	WOS:000411059300010
J	Cummings, LC; Thota, PN; Willis, JE; Chen, YW; Cooper, GS; Furey, N; Bednarchik, B; Alashkar, BM; Dumot, J; Faulx, AL; Fink, SP; Kresak, AM; Abusneineh, B; Barnholtz-Sloan, J; Leahy, P; Veigl, ML; Chak, A; Markowitz, SD				Cummings, Linda C.; Thota, Prashanthi N.; Willis, Joseph E.; Chen, Yanwen; Cooper, Gregory S.; Furey, Nancy; Bednarchik, Beth; Alashkar, Bronia M.; Dumot, John; Faulx, Ashley L.; Fink, Stephen P.; Kresak, Adam M.; Abusneineh, Basel; Barnholtz-Sloan, Jill; Leahy, Patrick; Veigl, Martina L.; Chak, Amitabh; Markowitz, Sanford D.			A nonrandomized trial of vitamin D supplementation for Barrett's esophagus	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; D-RECEPTOR EXPRESSION; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; 25-HYDROXYVITAMIN D; GASTROESOPHAGEAL-REFLUX; COLORECTAL-CANCER; GENE-EXPRESSION; LASER CAPTURE; RISK-FACTOR; ADENOCARCINOMA	Background Vitamin D deficiency may increase esophageal cancer risk. Vitamin D affects genes regulating proliferation, apoptosis, and differentiation and induces the tumor suppressor 15-hydroxyprostaglandin dehydrogenase (PGDH) in other cancers. This nonrandomized interventional study assessed effects of vitamin D supplementation in Barrett's esophagus (BE). We hypothesized that vitamin D supplementation may have beneficial effects on gene expression including 15-PGDH in BE. Methods BE subjects with low grade or no dysplasia received vitamin D-3 (cholecalciferol) 50,000 international units weekly plus a proton pump inhibitor for 12 weeks. Esophageal biopsies from normal plus metaplastic BE epithelium and blood samples were obtained before and after vitamin D supplementation. Serum 25-hydroxyvitamin D was measured to characterize vitamin D status. Esophageal gene expression was assessed using microarrays. Results 18 study subjects were evaluated. The baseline mean serum 25-hydroxyvitamin D level was 27 ng/mL (normal >= 30 ng/mL). After vitamin D supplementation, 25-hydroxyvitamin D levels rose significantly (median increase of 31.6 ng/mL, p<0.001). There were no significant changes in gene expression from esophageal squamous or Barrett's epithelium including 15-PGDH after supplementation. Conclusion BE subjects were vitamin D insufficient. Despite improved vitamin D status with supplementation, no significant alterations in gene expression profiles were noted. If vitamin D supplementation benefits BE, a longer duration or higher dose of supplementation may be needed.	[Cummings, Linda C.; Cooper, Gregory S.; Furey, Nancy; Dumot, John; Faulx, Ashley L.; Chak, Amitabh; Markowitz, Sanford D.] Univ Hosp Cleveland, Dept Med, Med Ctr, 2074 Abington Rd, Cleveland, OH 44106 USA; [Cummings, Linda C.; Cooper, Gregory S.; Alashkar, Bronia M.; Dumot, John; Faulx, Ashley L.; Fink, Stephen P.; Chak, Amitabh; Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Cummings, Linda C.; Willis, Joseph E.; Chen, Yanwen; Cooper, Gregory S.; Fink, Stephen P.; Kresak, Adam M.; Barnholtz-Sloan, Jill; Leahy, Patrick; Veigl, Martina L.; Chak, Amitabh; Markowitz, Sanford D.] Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Cummings, Linda C.; Abusneineh, Basel] Louis Stokes Cleveland Vet Affairs Med Ctr, Med Serv, Cleveland, OH 44106 USA; [Thota, Prashanthi N.] Cleveland Clin, Inst Digest Dis, Cleveland, OH 44106 USA; [Willis, Joseph E.] Univ Hosp Cleveland, Dept Pathol, Med Ctr, Cleveland, OH 44106 USA; [Willis, Joseph E.; Kresak, Adam M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Bednarchik, Beth] Univ Hosp Cleveland, Med Ctr, William T Dahms Clin Res Unit, Cleveland, OH 44106 USA; [Leahy, Patrick; Veigl, Martina L.] Case Western Reserve Univ, Div Gen Med Sci, Cleveland, OH 44106 USA; [Abusneineh, Basel] Baptist Hosp, Dept Internal Med, Pensacola, FL USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University	Cummings, LC (corresponding author), Univ Hosp Cleveland, Dept Med, Med Ctr, 2074 Abington Rd, Cleveland, OH 44106 USA.; Cummings, LC (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.; Cummings, LC (corresponding author), Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.; Cummings, LC (corresponding author), Louis Stokes Cleveland Vet Affairs Med Ctr, Med Serv, Cleveland, OH 44106 USA.	linda.cummings@case.edu	Barnholtz-Sloan, Jill/A-4817-2011	Barnholtz-Sloan, Jill/0000-0001-6190-9304; Fink, Stephen/0000-0003-4107-7912; Cummings, Linda/0000-0002-8767-2795	American College of Gastroenterology Clinical Research Award; Case GI SPORE (National Institutes of Health) [P50 CA150964]; Cleveland Digestive Health Research Center Pilot/Feasibility Award; Case Comprehensive Cancer Center (National Institutes of Health) [P30 CA043703]; Case Barrett's Esophagus Translational Research Network (National Institutes of Health) [U54 CA163060]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000439]; Gene Expression & Genotyping Facility; Tissue Procurement & Histology Core Facility; Biostatistics & Bioinformatics Core, all Shared Resources of the Case Comprehensive Cancer Center (National Institutes of Health) [P30 CA43703]; National Institutes of Health [P50 CA150964, P30 CA043703, UL1 TR000439, K12 CA076917, U54 CM63060]; American College of Gastroenterology Junior Faculty Development Award; NATIONAL CANCER INSTITUTE [P30CA043703, U54CA163060, P50CA150964] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	American College of Gastroenterology Clinical Research Award; Case GI SPORE (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Digestive Health Research Center Pilot/Feasibility Award; Case Comprehensive Cancer Center (National Institutes of Health); Case Barrett's Esophagus Translational Research Network (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Gene Expression & Genotyping Facility; Tissue Procurement & Histology Core Facility; Biostatistics & Bioinformatics Core, all Shared Resources of the Case Comprehensive Cancer Center (National Institutes of Health); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Gastroenterology Junior Faculty Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study received support from multiple sources including an American College of Gastroenterology Clinical Research Award (gi.org, awarded to LCC), Case GI SPORE (National Institutes of Health (www.nih.gov) grant P50 CA150964, awarded to SDM), Cleveland Digestive Health Research Center Pilot/Feasibility Award (awarded to LCC), Case Comprehensive Cancer Center (National Institutes of Health grant P30 CA043703) Protocol Specific Research Support (awarded to LCC), and Case Barrett's Esophagus Translational Research Network (National Institutes of Health grant U54 CA163060, awarded to AC). In addition, this research was supported in part by National Center for Advancing Translational Sciences, National Institutes of Health grant UL1 TR000439. This work was supported by the Gene Expression & Genotyping Facility, Tissue Procurement & Histology Core Facility and the Biostatistics & Bioinformatics Core, all Shared Resources of the Case Comprehensive Cancer Center (National Institutes of Health grant P30 CA43703). This material is the result of work supported with resources and the use of facilities at the Louis Stokes Cleveland Veterans Affairs Medical Center. LCC was also supported by National Institutes of Health grant K12 CA076917 (Clinical Oncology Career Development Program) and an American College of Gastroenterology Junior Faculty Development Award. AC, SDM, JBS, YC, and JEW were supported by National Institutes of Health grants U54 CM63060 (Case Barrett's Esophagus Translational Research Network) and P50 CA150964 (Case GI SPORE). GSC was supported by National Institutes of Health grants P50 CA150964 (Case GI SPORE), UL1 TR000439 (Case Clinical & Translational Science Collaborative), and P30 CA043703 (Case Comprehensive Cancer Center). SPF was supported by National Institutes of Health grant P50 CA150964 (Case GI SPORE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, AM J EPIDEMIOL, V172, P94, DOI 10.1093/aje/kwq121; Baurska H, 2011, J STEROID BIOCHEM, V126, P46, DOI 10.1016/j.jsbmb.2011.04.006; Buttar NS, 2002, JNCI-J NATL CANCER I, V94, P422; Chak A, 2015, CLIN GASTROENTEROL H, V13, P665, DOI 10.1016/j.cgh.2014.08.040; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; De Gottardi A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-48; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; El-Serag HB, 2009, SCAND J GASTROENTERO, V44, P787, DOI 10.1080/00365520902898127; Falk GW, 2012, GASTROENTEROLOGY, V143, P917, DOI 10.1053/j.gastro.2012.06.044; Fichera A, 2007, J SURG RES, V142, P239, DOI 10.1016/j.jss.2007.02.038; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Gray NA, 2011, AM J GASTROENTEROL, V106, P1899, DOI 10.1038/ajg.2011.255; Greer KB, 2012, GUT, V61, P665, DOI 10.1136/gutjnl-2011-300641; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Hines SL, 2010, NUTRITION, V26, P255, DOI 10.1016/j.nut.2009.08.020; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Houghton LA, 2006, AM J CLIN NUTR, V84, P694, DOI 10.1093/ajcn/84.4.694; Hyland PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093219; Ish-Shalom S, 2008, J CLIN ENDOCR METAB, V93, P3430, DOI 10.1210/jc.2008-0241; Janmaat VT, 2015, MOL MED, V21, P346, DOI 10.2119/molmed.2012.00336; Jenab M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5500; Kastelein F, 2011, GASTROENTEROLOGY, V141, P2000, DOI 10.1053/j.gastro.2011.08.036; Krishnan AV, 2010, ENDOCRINOLOGY, V151, P32, DOI 10.1210/en.2009-0855; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lofdahl HE, 2008, BRIT J CANCER, V99, P1506, DOI 10.1038/sj.bjc.6604701; Markowitz SD, 2007, NEW ENGL J MED, V356, P2195, DOI 10.1056/NEJMe078044; Moreno J, 2005, CANCER RES, V65, P7917, DOI 10.1158/0008-5472.CAN-05-1435; Mulholland HG, 2011, BRIT J NUTR, V106, P732, DOI 10.1017/S0007114511000742; Nguyen DM, 2010, GASTROENTEROLOGY, V138, P2260, DOI 10.1053/j.gastro.2010.02.045; Park WG, 2015, AM J GASTROENTEROL, V110, P60, DOI 10.1038/ajg.2014.384; Pepper KJ, 2009, ENDOCR PRACT, V15, P95, DOI 10.4158/EP.15.2.95; Piazuelo E, 2006, PROSTAG OTH LIPID M, V81, P150, DOI 10.1016/j.prostaglandins.2006.09.002; Pohl H, 2010, CANCER EPIDEM BIOMAR, V19, P1468, DOI 10.1158/1055-9965.EPI-10-0012; Ryan AM, 2008, ANN SURG, V247, P909, DOI 10.1097/SLA.0b013e3181612cac; Sabo E, 2008, CLIN CANCER RES, V14, P6440, DOI 10.1158/1078-0432.CCR-08-0302; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Song MY, 2016, CANCER PREV RES, V9, P664, DOI 10.1158/1940-6207.CAPR-16-0053; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Thiel A, 2009, CLIN CANCER RES, V15, P4572, DOI 10.1158/1078-0432.CCR-08-2518; Thota PN, 2016, DIGEST DIS SCI, V61, P247, DOI 10.1007/s10620-015-3823-5; Trowbridge R, 2012, EXP MOL PATHOL, V93, P246, DOI 10.1016/j.yexmp.2012.05.007; Trowbridge R, 2012, EXP MOL PATHOL, V93, P147, DOI 10.1016/j.yexmp.2012.04.018; Tseng-Rogenski S, 2010, AM J PATHOL, V176, P1462, DOI 10.2353/ajpath.2010.090875; Vaughan TL, 2005, LANCET ONCOL, V6, P945, DOI 10.1016/S1470-2045(05)70431-9; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Wesa KM, 2015, NUTR CANCER, V67, P424, DOI 10.1080/01635581.2015.998838; Wilson KT, 1998, CANCER RES, V58, P2929; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yan M, 2009, P NATL ACAD SCI USA, V106, P9409, DOI 10.1073/pnas.0902367106; Yang G, 2015, REV ADHES ADHES, V3, P216, DOI 10.7569/RAA.2015.097305; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zgaga L, 2016, CANCER EPIDEM BIOMAR, V25, P877, DOI 10.1158/1055-9965.EPI-15-1162; Zhao C, 2011, GASTROENTEROLOGY, V140	55	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184928	10.1371/journal.pone.0184928	http://dx.doi.org/10.1371/journal.pone.0184928			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922414	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300045
J	Nault, R; Fader, KA; Harkema, JR; Zacharewski, T				Nault, Rance; Fader, Kelly A.; Harkema, Jack R.; Zacharewski, Tim			Loss of liver-specific and sexually dimorphic gene expression by aryl hydrocarbon receptor activation in C57BL/6 mice	PLOS ONE			English	Article							FEMALE MOUSE-LIVER; GROWTH-HORMONE; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN TCDD; HEPATIC-FIBROSIS; LIPID-METABOLISM; ZINC FINGERS; BINDING; ZHX2; 3-METHYLCHOLANTHRENE; HEPATOTOXICITY	The aryl hydrocarbon receptor (AhR) is a highly conserved transcription factor that mediates a broad spectrum of species-, strain-, sex-, age-, tissue-, and cell-specific responses elicited by structurally diverse ligands including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Dose-dependent effects on liver-specific and sexually dimorphic gene expression were examined in male and female mice gavaged with TCDD every 4 days for 28 or 92 days. RNA-seq data revealed the coordinated repression of 181 genes predominately expressed in the liver including albumin (3.7-fold), alpha-fibrinogen (14.5-fold), and beta-fibrinogen (17.4-fold) in males with corresponding AhR enrichment at 2 hr. Liver-specific genes exhibiting sexually dimorphic expression also demonstrated diminished divergence between sexes. For example, male-biased Gstp1 was repressed 3.0-fold in males and induced 4.5-fold in females, which were confirmed at the protein level. Disrupted regulation is consistent with impaired GHR-JAK2-STAT5 signaling and inhibition of female specific CUX2-mediated transcription as well as the repression of other key transcriptional regulators including Ghr, Stat5b, Bcl6, Hnf4a, Hnf6, Foxa1/2/3, and Zhx2. Attenuated liver-specific and sexually dimorphic gene expression was concurrent with the induction of fetal genes such as alpha-fetoprotein. The results suggest AhR activation causes the loss of liver-specific and sexually dimorphic gene expression producing a functionally "de-differentiated" hepatic phenotype.	[Nault, Rance; Fader, Kelly A.; Zacharewski, Tim] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Nault, Rance; Fader, Kelly A.; Zacharewski, Tim] Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA; [Harkema, Jack R.] Michigan State Univ, Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Zacharewski, T (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.; Zacharewski, T (corresponding author), Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA.	tzachare@msu.edu		Fader, Kelly/0000-0002-8797-5577; Nault, Rance/0000-0002-6822-4962	National Institute of Environmental Health Sciences Superfund Research Program [NIEHS SRP P42ES04911]; AgBioResearch at MSU; MSU Barnett Rosenberg Endowed Assistantship and Integrative Training in the Pharmacological Sciences grant [NIH 5T32GM092715]; Canadian Institutes of Health Research (CIHR) Doctoral Foreign Study Award [DFS-140386]	National Institute of Environmental Health Sciences Superfund Research Program; AgBioResearch at MSU; MSU Barnett Rosenberg Endowed Assistantship and Integrative Training in the Pharmacological Sciences grant; Canadian Institutes of Health Research (CIHR) Doctoral Foreign Study Award(Canadian Institutes of Health Research (CIHR))	This work was supported by the National Institute of Environmental Health Sciences Superfund Research Program (NIEHS SRP P42ES04911). TRZ is supported by AgBioResearch at MSU. RN was supported by the MSU Barnett Rosenberg Endowed Assistantship and Integrative Training in the Pharmacological Sciences grant (NIH 5T32GM092715). KAF is supported by the Canadian Institutes of Health Research (CIHR) Doctoral Foreign Study Award (DFS-140386).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; Bunger MK, 2008, TOXICOL SCI, V106, P83, DOI 10.1093/toxsci/kfn149; Cheng XG, 2014, TOXICOL APPL PHARM, V278, P65, DOI 10.1016/j.taap.2014.04.013; Conforto TL, 2012, MOL CELL BIOL, V32, P4611, DOI 10.1128/MCB.00886-12; Creasy Kate Townsend, 2016, Gene Expression, V17, P7, DOI 10.3727/105221616X691712; Della Torre S, 2017, CELL METAB, V25, P499, DOI 10.1016/j.cmet.2017.01.006; Dere E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-365; EMMETT EA, 1985, ENVIRON HEALTH PERSP, V60, P185, DOI 10.2307/3429960; Fader KA, 2017, TOXICOL APPL PHARM, V321, P1, DOI 10.1016/j.taap.2017.02.006; Fasano M, 2007, IUBMB LIFE, V59, P436, DOI 10.1080/15216540701474523; Fernandez-Perez Leandro, 2013, Front Endocrinol (Lausanne), V4, P66, DOI 10.3389/fendo.2013.00066; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gargalovic PS, 2010, CIRC-CARDIOVASC GENE, V3, P60, DOI 10.1161/CIRCGENETICS.109.902320; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Huang GM, 2012, MOL PHARMACOL, V81, P338, DOI 10.1124/mol.111.075952; Hurst JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep44992; Jiang JY, 2017, J BIOL CHEM, V292, P6765, DOI 10.1074/jbc.M116.768275; Jin L, 2009, DEV BIOL, V336, P294, DOI 10.1016/j.ydbio.2009.09.026; Kang MJ, 2005, J PROTEOME RES, V4, P1248, DOI 10.1021/pr049756d; Kociba R J, 1979, Ann N Y Acad Sci, V320, P397, DOI 10.1111/j.1749-6632.1979.tb56620.x; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lebensztejn DM, 2016, ACTA BIOCHIM POL, V63, P459, DOI 10.18388/abp.2015_1252; Lee C, 2012, CAN J PHYSIOL PHARM, V90, P1354, DOI [10.1139/Y2012-099, 10.1139/y2012-099]; Lee J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1840-6; Morford LA, 2007, HEPATOLOGY, V46, P1541, DOI 10.1002/hep.21825; Mu X, 2015, J CLIN INVEST, V125, P3891, DOI 10.1172/JCI77995; Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026; Nault R, 2016, TOXICOL SCI; Nault R, 2017, CHEM RES TOXICOL, V30, P1060, DOI 10.1021/acs.chemrestox.6b00430; Nault R, 2016, TOXICOL SCI, V154, P381, DOI 10.1093/toxsci/kfw175; Nault R, 2016, TOXICOL SCI, V154, P253, DOI 10.1093/toxsci/kfw163; Nault R, 2016, TOXICOL SCI, V149, P358, DOI 10.1093/toxsci/kfv245; Nault R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1527-z; NORSTEDT G, 1984, CELL, V36, P805, DOI 10.1016/0092-8674(84)90030-8; Nukaya M, 2004, FEBS LETT, V558, P96, DOI 10.1016/S0014-5793(03)01528-X; Oshida K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148308; Oshida K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150284; Peterson ML, 2011, SEMIN CANCER BIOL, V21, P21, DOI 10.1016/j.semcancer.2011.01.001; Prokopec SD, 2015, TOXICOL APPL PHARM, V284, P188, DOI 10.1016/j.taap.2015.02.012; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Safe S, 2001, TOXICOL LETT, V120, P1, DOI 10.1016/S0378-4274(01)00301-0; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Timsit YE, 2000, TOXICOL APPL PHARM, V163, P105, DOI 10.1006/taap.1999.8862; Timsit YE, 2002, ENDOCRINOLOGY, V143, P3284, DOI 10.1210/en.2002-220212; VOS JG, 1974, TOXICOL APPL PHARM, V29, P229, DOI 10.1016/0041-008X(74)90060-X; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhang YX, 2016, GENE DEV, V30, P1636, DOI 10.1101/gad.281972.116; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7	55	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184842	10.1371/journal.pone.0184842	http://dx.doi.org/10.1371/journal.pone.0184842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922406	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300033
J	Schneider, T; Frieling, D; Schroeder, J; Regelsberger, J; Schoen, G; Fiehler, J; Gellissen, S				Schneider, Tanja; Frieling, David; Schroeder, Julian; Regelsberger, Jan; Schoen, Gerhard; Fiehler, Jens; Gellissen, Susanne			Perihematomal diffusion restriction as a common finding in large intracerebral hemorrhages in the hyperacute phase	PLOS ONE			English	Article							HEMATOMA VOLUME; BLOOD-PRESSURE; MRI; ISCHEMIA; INJURY; STROKE; EDEMA; REGION	Purpose There is growing evidence that a perihematomal area of restricted diffusion (PDR) exists in intraparenchymal hemorrhages (IPH) within 1 week of symptom onset (SO). Here, we study characteristics and the clinical impact of the PDR in patients with hyperacute (<= 6 hours from SO) IPH by means of apparent diffusion coefficient (ADC). Methods This monocentric, retrospective study includes 83 patients with first-ever primary IPH from 09/2002-10/2015. 3D volumetric segmentation was performed for the IPH, PDR, and perihematomal edema (PHE) on fluid-attenuated inversion recovery, T2*/susceptibility weighted images, and ADC images. Results A PDR was seen in 56/83 patients (67.5%) presenting with hyperacute IPH. Multivariate logistic regression analysis revealed every 10-year increase of age (HR 1.929, 95% CI 1.047-3.552, P = .035) and male gender (HR 5.672, 95% CI 1.038-30.992, P = .045) as significant predictors of the presence of a PDR, but not IPH size, IPH location, nor National Institutes of Health Stroke Scale Score (NIHSS) at admission. We found no difference in NIHSS at discharge, hematoma removal, or mortality rate in PDR-positive patients. ADC values of the PDR show a step-wise normalization with increasing time from SO. Conclusions Occurrence of a PDR is a common finding in supratentorial hyperacute IPH, but shows no adverse short-term clinical impact. It may represent transient oligemic and metabolic changes.	[Schneider, Tanja; Frieling, David; Fiehler, Jens; Gellissen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Schroeder, Julian] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Schoen, Gerhard] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Schneider, Tanja] Schon Klin Hamburg Eilbek, Dept Diagnost & Intervent Radiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schneider, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.; Schneider, T (corresponding author), Schon Klin Hamburg Eilbek, Dept Diagnost & Intervent Radiol, Hamburg, Germany.	tan.schneider@uke.de						Belli G, 2016, J MAGN RESON IMAGING, V43, P213, DOI 10.1002/jmri.24956; Burgess RE, 2008, STROKE, V39, P2017, DOI 10.1161/STROKEAHA.107.505719; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Carhuapoma JR, 2000, STROKE, V31, P726, DOI 10.1161/01.STR.31.3.726; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Fainardi E, 2013, NEURORADIOLOGY, V55, P145, DOI 10.1007/s00234-012-1093-x; Gioia LC, 2015, STROKE, V46, P1541, DOI 10.1161/STROKEAHA.114.008304; Kidwell CS, 2001, NEUROLOGY, V57, P1611, DOI 10.1212/WNL.57.9.1611; Lemke AJ, 2003, ROFO-FORTSCHR RONTG, V175, P958; Li N, 2013, STROKE, V44, P1144, DOI 10.1161/STROKEAHA.111.000056; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; MTESW PL, 2009, DIFFUSION WEIGHTED M; Olivot JM, 2010, STROKE, V41, P2681, DOI 10.1161/STROKEAHA.110.590638; Orakcioglu B, 2005, EXP NEUROL, V193, P369, DOI 10.1016/j.expneurol.2005.01.017; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; Schellinger PD, 2003, STROKE, V34, P1674, DOI 10.1161/01.STR.0000076010.10696.55; Silvera S, 2005, AM J NEURORADIOL, V26, P236; Stosser S, 2016, CEREBROVASC DIS, V42, P280, DOI 10.1159/000446549; Whang JS, 2015, CLIN RADIOL, V70, P909, DOI 10.1016/j.crad.2015.04.006; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; Yousem DM, 2010, NEURORADIOLOGY; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184518	10.1371/journal.pone.0184518	http://dx.doi.org/10.1371/journal.pone.0184518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922367	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300018
J	Lodin, K; Lekander, M; Syk, J; Alving, K; Petrovic, P; Andreasson, A				Lodin, Karin; Lekander, Mats; Syk, Jorgen; Alving, Kjell; Petrovic, Predrag; Andreasson, Anna			Longitudinal co-variations between inflammatory cytokines, lung function and patient reported outcomes in patients with asthma	PLOS ONE			English	Article							SELF-RATED HEALTH; QUALITY-OF-LIFE; INDUCED SICKNESS BEHAVIOR; HUMAN AWARENESS; DEPRESSION; ASSOCIATION; SYMPTOMS; WOMEN; BODY; QUESTIONNAIRE	Background Asthma is a chronic inflammatory respiratory disorder associated with reduced lung function and poor quality of life. The condition is also associated with poor self-rated health, a major predictor of objective health trajectories. Of biological correlates to self-rated health, evidence suggests a role for inflammatory cytokines and related sickness behaviours. However, this is mainly based on cross-sectional data, and the relation has not been investigated in patients with chronic inflammatory conditions. Objective To investigate inflammatory cytokines, lung function, sickness behaviour and asthma-related quality of life as determinants of self-rated health in patients with asthma, and to investigate if these variables co-vary over time. Methods Plasma cytokines (IL-5, IL-6), lung function (FEV1), sickness behaviour, asthma-related quality of life and self-rated health were assessed in 181 patients with allergic asthma aged 18-64 years in a one-year longitudinal study. Mixed effect regression models and Spearman's correlation were performed to analyse the associations between repeated measurements. Results More sickness behaviour and poorer asthma-related quality of life were associated with poorer self-rated health (p's<0.001). In men, both low and high levels of interleukin (IL)-6 and poorer lung function were related with poorer self-rated health (p's<0.05). Over the year, improved asthma-related quality of life was associated with better self-rated health (Spearman's rho = -0.34 women,-0.36 men, p's<0.01). Further, if sickness behaviour decreased, self-rated health improved, but only in women (Rho = -0.21, p<0.05). Increased FEV1 in men was associated with an increase in IL-6 (Rho = 0.24, p<0.05) as well as improved self-rated health (Rho = -0.21, p<0.05) and asthma-related quality of life (Rho = 0.29, p<0.01) over the year. Conclusion The study highlights the importance of subjectively perceived sickness behaviour and asthma-related quality of life together with lung function as determinants of self-rated health in asthmatic patients. The importance of inflammatory activation for patient reported outcomes in chronic inflammatory conditions need further investigation.	[Lodin, Karin; Syk, Jorgen; Andreasson, Anna] Karolinska Inst, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Lodin, Karin; Lekander, Mats; Petrovic, Predrag] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lekander, Mats; Andreasson, Anna] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Syk, Jorgen] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Syk, Jorgen; Alving, Kjell] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Syk, Jorgen] Stockholm Cty Council, Acad Primary Hlth Care Ctr, Stockholm, Sweden; [Andreasson, Anna] Macquarie Univ, Dept Psychol, N Ryde, NSW, Australia	Karolinska Institutet; Karolinska Institutet; Stockholm University; Karolinska Institutet; Uppsala University; Stockholm County Council; Macquarie University	Lodin, K (corresponding author), Karolinska Inst, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden.; Lodin, K (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	karin.lodin@ki.se	Petrovic, Predrag/AAS-6736-2020; Lodin, Karin/AAG-3077-2020	Petrovic, Predrag/0000-0002-5536-945X; 	Stockholm County Council (PickUp); Centre for Allergy Research; Swedish Asthma and Allergy Association's Research Foundation; Aerocrine AB (NIOX MINO instruments); Centre for Family Medicine, Karolinska Institutet	Stockholm County Council (PickUp); Centre for Allergy Research; Swedish Asthma and Allergy Association's Research Foundation; Aerocrine AB (NIOX MINO instruments); Centre for Family Medicine, Karolinska Institutet	The study was funded by the Stockholm County Council (PickUp), Centre for Allergy Research, and Centre for Family Medicine, Karolinska Institutet, and the Swedish Asthma and Allergy Association's Research Foundation. Support was also received from Aerocrine AB (NIOX MINO instruments). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2012, SLEEP MED, V13, P674, DOI 10.1016/j.sleep.2011.12.013; Andreasson A., 2016, J HLTH PSYCHOL; Andreasson AN, 2012, J HLTH PSYCHOL; Andreasson A, 2007, BRAIN BEHAV IMMUN, V21, P147, DOI 10.1016/j.bbi.2006.08.002; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Buchel C, 2014, NEURON, V81, P1223, DOI 10.1016/j.neuron.2014.02.042; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dixon ML, 2014, BRAIN RES, V1572, P26, DOI 10.1016/j.brainres.2014.05.012; Ehrs PO, 2006, CHEST, V129, P624, DOI 10.1378/chest.129.3.624; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1; Geuter S, 2017, ANN REV NEUROSCI; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Illi J, 2012, CYTOKINE, V58, P437, DOI 10.1016/j.cyto.2012.02.015; Janszky I, 2005, BRAIN BEHAV IMMUN, V19, P555, DOI 10.1016/j.bbi.2005.01.001; Johnson RW, 2002, VET IMMUNOL IMMUNOP, V87, P443, DOI 10.1016/S0165-2427(02)00069-7; Joseph Jose, 2004, BMC Pulm Med, V4, P2, DOI 10.1186/1471-2466-4-2; Juniper EF, 2004, EUR RESPIR J, V23, P287, DOI 10.1183/09031936.04.00064204; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Leidy NK, 1998, QUAL LIFE RES, V7, P127, DOI 10.1023/A:1008853325724; Lekander M, 2004, PSYCHOSOM MED, V66, P559, DOI 10.1097/01.psy.0000130491.95823.94; Lekander M, 2016, BRAIN BEHAV IMMUN, V56, P34, DOI 10.1016/j.bbi.2015.12.018; Lin YL, 2016, J MOL MED, V94, P51, DOI 10.1007/s00109-015-1325-8; Mak A, 2013, LUPUS, V22, P254, DOI 10.1177/0961203312471872; McGuinness D, 1997, J IMMUNOL METHODS, V201, P99, DOI 10.1016/S0022-1759(96)00216-5; Muehlenbein M. P., 2015, AM J PHYS ANTHR; Patil SP, 2011, ANN ALLERG ASTHMA IM, V106, P205, DOI 10.1016/j.anai.2010.11.019; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rietveld S, 2007, BEHAV RES THER, V45, P977, DOI 10.1016/j.brat.2006.07.009; Rosenkranz MA, 2016, BRAIN BEHAV IMMUN, V58, P18, DOI 10.1016/j.bbi.2016.03.024; Rosenkranz MA, 2009, NEUROIMAGE, V47, P972, DOI 10.1016/j.neuroimage.2009.05.042; Rosenzweig JRC, 2004, RESP MED, V98, P1157, DOI 10.1016/j.rmed.2004.04.001; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Syk J, 2013, J ALLER CL IMM-PRACT, V1, P639, DOI 10.1016/j.jaip.2013.07.013; Syk J, 2012, CLIN RESPIR J, V6, P150, DOI 10.1111/j.1752-699X.2011.00259.x; Tanno K, 2012, J PSYCHOSOM RES, V73, P225, DOI 10.1016/j.jpsychores.2012.05.013; Tizard Ian, 2008, Animal Health Research Reviews, V9, P87, DOI 10.1017/S1466252308001448; Unden AL, 2007, CLIN SCI, V112, P363, DOI 10.1042/CS20060128; Warnoff C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009440; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wilson SR, 2012, J ALLERGY CLIN IMMUN, V129, pS88, DOI 10.1016/j.jaci.2011.12.988; Woodfolk JA, 2015, ALLERGOL INT, V64, P295, DOI 10.1016/j.alit.2015.06.001	53	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0185019	10.1371/journal.pone.0185019	http://dx.doi.org/10.1371/journal.pone.0185019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0WP	28915273	Green Submitted, Green Published, gold			2022-12-27	WOS:000410861600027
J	Griffen, TC; Haley, MS; Fontanini, A; Maffei, A				Griffen, Trevor C.; Haley, Melissa S.; Fontanini, Alfredo; Maffei, Arianna			Rapid plasticity of visually evoked responses in rat monocular visual cortex	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; CORTICAL INHIBITION; SYNAPTIC RESPONSES; EXPERIENCE; NEURONS; PERIODS; ABSENCE	Sensory cortical circuits are shaped by experience during sensitive periods in development. In the primary visual cortex (V1) altered visual experience results in changes in visual responsiveness of cortical neurons. The experience-dependent refinement of the circuit in V1 is thought to rely on competitive interactions between feedforward circuits driven by the two eyes. However, recent data have provided evidence for an additional role of cortico-cortical circuits in this process. Indeed, experience-dependent changes in intracortical circuits can be induced rapidly and may result in rapid-onset functional changes. Unilateral occlusion of vision rapidly alters visual responsiveness, synaptic strength and connectivity of local circuits in the binocular region of V1 (V1b), where the inputs from the two eyes converge. In the monocular region of rodent V1 (V1m), where feedforward inputs from the ipsilateral eye are virtually absent, visual deprivation induces rapid plasticity in local circuits; however, functional changes seem to occur only after long periods of deprivation. In V1m there is currently no evidence for functional changes occurring within a time window compatible with that of local circuit plasticity. Here, we probed the visual responsiveness of neurons in rat V1m and assessed the effect of one day unilateral eye lid suture on single neuron visual responses. We report a novel form of plasticity within V1m that occurs on a timescale consistent with the earliest known changes in synaptic strength. Our data provide new insights into how sensory experience can rapidly modulate neuronal responses, even in the absence of direct competition between feedforward thalamocortical inputs.	[Griffen, Trevor C.; Haley, Melissa S.; Fontanini, Alfredo; Maffei, Arianna] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA; [Griffen, Trevor C.; Maffei, Arianna] SUNY Eye Inst, Syracuse, NY 13202 USA; [Griffen, Trevor C.] SUNY Stony Brook, Med Scientist Training Program, Stony Brook, NY 11794 USA; [Fontanini, Alfredo; Maffei, Arianna] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Maffei, A (corresponding author), SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA.; Maffei, A (corresponding author), SUNY Eye Inst, Syracuse, NY 13202 USA.; Maffei, A (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	Arianna.Maffei@StonyBrook.edu		Maffei, Arianna/0000-0001-6755-8904	NIH/R01 [EY019885]; Whitehall Foundation; NIHGM MSTP Training award [T32-GM008444]	NIH/R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; NIHGM MSTP Training award	This study was supported by NIH/R01 EY019885 and the Whitehall Foundation Award to A.M and by NIHGM MSTP Training award T32-GM008444 to T.C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini A, 1999, J NEUROSCI, V19, P4388; Caleo M, 1999, EUR J NEUROSCI, V11, P2979, DOI 10.1046/j.1460-9568.1999.00737.x; Coleman JE, 2009, NEUROSCIENCE, V161, P561, DOI 10.1016/j.neuroscience.2009.03.045; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Iurilli G, 2012, CEREB CORTEX, V22, P2171, DOI 10.1093/cercor/bhr304; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Krahe TE, 2011, J NEUROSCI, V31, P6842, DOI 10.1523/JNEUROSCI.1173-11.2011; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Ma WP, 2013, J NEUROSCI, V33, P11276, DOI 10.1523/JNEUROSCI.5598-12.2013; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Manning KA, 2009, NEUROSCIENCE, V163, P695, DOI 10.1016/j.neuroscience.2009.06.060; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Priebe NJ, 2008, J NEUROSCI, V28, P8553, DOI 10.1523/JNEUROSCI.2182-08.2008; Restani L, 2009, NEURON, V64, P707, DOI 10.1016/j.neuron.2009.10.019; Stone ME, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00003; Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Trachtenberg JT, 2015, CURR OPIN NEUROBIOL, V35, P44, DOI 10.1016/j.conb.2015.06.006; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; TYLER CW, 1977, INVEST OPHTH VIS SCI, V16, P1070; Wang L, 2013, J NEUROSCI, V33, P4181, DOI 10.1523/JNEUROSCI.4423-12.2013; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184618	10.1371/journal.pone.0184618	http://dx.doi.org/10.1371/journal.pone.0184618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910338	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200069
J	Lee, WJ; Jung, KH; Ryu, YJ; Kim, JM; Lee, ST; Chu, K; Kim, M; Lee, SK; Roh, JK				Lee, Woo-Jin; Jung, Keun-Hwa; Ryu, Young Jin; Kim, Jeong-Min; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu			Cystatin C, a potential marker for cerebral microvascular compliance, is associated with white-matter hyperintensities progression	PLOS ONE			English	Article							SMALL VESSEL DISEASE; AUSTRIAN STROKE PREVENTION; CHRONIC KIDNEY-DISEASE; INTERSTITIAL FLUID; ARTERIAL STIFFNESS; AMYLOID ANGIOPATHY; BRAIN; DRAINAGE; LEUKOARAIOSIS; PULSATILITY	Cerebral white matter hyperintensities (WMHs) are central MRI markers of the brain aging process, but the mechanisms for its progression remain unclear. In this study, we aimed to determine whether the baseline serum cystatin C level represented one mechanism underlying WMH progression, and whether it was associated with the long-term progression of cerebral WMH volume in MRI. 166 consecutive individuals who were >= 50 years of age and who underwent initial/follow-up MRI evaluations within an interval of 34-45 months were included. Serum cystatin C level, glomerular-filtration rate (GFR), and other laboratory parameters were measured at their initial evaluation and at the end of follow-up. Cerebrovascular risk factors, medications, and blood-pressure parameters were also reviewed. WMH progression rate was measured by subtracting WMH volume at baseline from that at the follow-up using volumetric analysis, divided by the MRI intervals. At baseline, WMH volume was 9.61 +/- 13.17 mL, mean GFR was 77.3 +/- 22.8 mL/min, and mean cystatin C level was 0.92 +/- 0.52 mg/L. After 37.9 +/- 3.4 months, the change in WMH volume was 3.64 +/- 6.85 mL, the progression rate of WMH volume was 1.18 +/- 2.28 mL/year, the mean Delta GFR was 2.4 +/- 7.9 mL/min, and the mean Delta cystatin C was 0.03 +/- 0.34 mg/L. The progression rate of WMH volume was linearly associated with cystatin C level (B coefficient = 0.856; 95% confidence interval [CI] 0.174-1.538; P = 0.014), along with the baseline WMH volume (B = 0.039; 95% CI 0.019-0.059; P<0.001), after adjusting for the conventional vascular risk factors, laboratory parameters, medication profiles, and GFR. Especially, patients with a baseline level of cystatin C >= 1.00 mg/L exhibited a much higher progression rate of WMH as compared with those with a baseline level of cystatin C <1.00 mg/L (1.60 +/- 1.91 mL/year vs. 0.82 +/- 1.63 mL/year, P = 0.010). We concluded that serum cystatin C level is independently associated with the long-term progression rate of the cerebral WMH volume. Therefore, serum cystatin C level might predict the progression of cerebral WMH.	[Lee, Woo-Jin; Jung, Keun-Hwa; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Jung, Keun-Hwa; Lee, Soon-Tae; Chu, Kon; Kim, Manho; Lee, Sang Kun] Seoul Natl Univ, Neurosci Res Inst SNUMRC, Coll Med, Program Neurosci, Seoul, South Korea; [Ryu, Young Jin] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jeong-Min] Chung Ang Univ Hosp, Dept Neurol, Seoul, South Korea; [Roh, Jae-Kyu] Armed Forces Capital Hosp, Dept Neurol, Sungnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital	Jung, KH (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.; Jung, KH (corresponding author), Seoul Natl Univ, Neurosci Res Inst SNUMRC, Coll Med, Program Neurosci, Seoul, South Korea.	jungkh@gmail.com		Kim, Jeong-Min/0000-0001-7213-5527; Jung, Keun-Hwa/0000-0003-1433-8005; Lee, Soon-Tae/0000-0003-4767-7564; Chu, Kon/0000-0001-5863-0302	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2016M3C7A1914002]; JW Pharmaceutical (Republic of Korea) [0620160950]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; JW Pharmaceutical (Republic of Korea)	This research was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002) (http://english.msip.go.kr/english.main/main.do). Jung KH was supported by research grant from JW Pharmaceutical (Republic of Korea, 0620160950).	Godin O, 2011, CIRCULATION, V123, P266, DOI 10.1161/CIRCULATIONAHA.110.961052; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Hsieh TJ, 2009, RADIOLOGY, V252, P518, DOI 10.1148/radiol.2523080484; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Khatri M, 2007, STROKE, V38, P3121, DOI 10.1161/STROKEAHA.107.493593; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lee W-J, 2017, RADIOLOGY; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Markus HS, 2005, STROKE, V36, P1410, DOI 10.1161/01.STR.0000169924.60783.d4; Meng D, 2016, RADIOLOGY; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Nederkoorn PJ, 2003, RADIOLOGY, V228, P677, DOI 10.1148/radiol.2283020824; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Peralta CA, 2009, AM J EPIDEMIOL; Peralta CA, 2012, AM J KIDNEY DIS, V59, P41, DOI 10.1053/j.ajkd.2011.08.015; Sachdev P, 2007, NEUROLOGY, V68, P214, DOI 10.1212/01.wnl.0000251302.55202.73; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Schmidt R, 2005, ANN NEUROL, V58, P610, DOI 10.1002/ana.20630; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Scuteri A, 2014, J ALZHEIMERS DIS, V42, pS401, DOI 10.3233/JAD-141416; Seliger SL, 2005, J AM SOC NEPHROL, V16, P3721, DOI 10.1681/ASN.2005010006; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Takahashi W, 2012, J STROKE CEREBROVASC, V21, P18, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.015; van den Heuvel DMJ, 2004, NEUROLOGY, V63, P1699, DOI 10.1212/01.WNL.0000143058.40388.44; Wada M, 2010, EUR J NEUROL, V17, P383, DOI 10.1111/j.1468-1331.2009.02809.x; Wang ZZ, 1997, APMIS, V105, P41, DOI 10.1111/j.1699-0463.1997.tb00538.x; Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Weller RO, 2015, BRAIN PATHOL, V25, P63, DOI 10.1111/bpa.12218; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Yang S, 2017, J STROKE CEREBROVASC, V26, P186, DOI 10.1016/j.jstrokecerebrovasdis.2016.09.007	37	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184999	10.1371/journal.pone.0184999	http://dx.doi.org/10.1371/journal.pone.0184999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910415	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200124
J	Chen, CT; Liu, CY; Yu, YB; Liu, CJ; Hsiao, LT; Gau, JP; Chiou, TJ; Liu, JH; Liu, YC				Chen, Chien-Ting; Liu, Chun-Yu; Yu, Yuan-Bin; Liu, Chia-Jen; Hsiao, Liang-Tsai; Gau, Jyh-Pyng; Chiou, Tzeon-Jye; Liu, Jing-Hwang; Liu, Yao-Chung			Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT PROJECT; HEPATITIS-C; CHRONIC GVHD; CLINICAL-TRIALS; ADULT PATIENTS; SEVERITY; CRITERIA; IMPACT; CHILDREN; SURVIVAL	Chronic graft-versus-host-disease (cGvHD) is a serious complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Among various organ-specific cGvHD, the cGvHD of liver is less well-characterized. In this study, we applied the National Institutes of Health 2014 scoring criteria of cGvHD to analyze a retrospective cohort of 362 allo-HSCT recipients focusing on cGvHD of liver. The overall incidence of liver cGvHD with a score of 3 by 1.5 years post-transplant was 5.8% (21/362). Poor outcome, in terms of overall survival (OS), were observed in patients with scores of 3 liver cGvHD, comparing to those with scores less than 3 (hazard ratio [HR] 2.037, 95% confidence interval [CI] 1.123-3.696, P = 0.019). In multivariate analysis, male gender (HR 4.004, P = 0.042) and chronic hepatitis C virus (HCV) infection status (HR 19.087, P < 0.001) were statistically significant risk factors for scores of 3 liver cGvHD. Our results indicate that liver cGvHD with scores of 3 has a grave prognosis following allo-HSCT, and that HCV carrier status and male are risk factors. Early recognition of this devastating complication might help in prompt immunosuppressive therapy and reducing late poor outcome.	[Chen, Chien-Ting; Yu, Yuan-Bin; Liu, Chia-Jen; Hsiao, Liang-Tsai; Gau, Jyh-Pyng; Liu, Jing-Hwang; Liu, Yao-Chung] Taipei Vet Gen Hosp, Div Hematol, Dept Med, Taipei, Taiwan; [Chen, Chien-Ting; Liu, Chun-Yu; Yu, Yuan-Bin; Liu, Chia-Jen; Hsiao, Liang-Tsai; Gau, Jyh-Pyng; Chiou, Tzeon-Jye; Liu, Jing-Hwang; Liu, Yao-Chung] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Liu, Chun-Yu] Taipei Vet Gen Hosp, Div Med Oncol, Dept Oncol, Taipei, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Div Transfus Med, Dept Med, Taipei, Taiwan; [Yu, Yuan-Bin] Far Eastern Mem Hosp, Div Hematol & Oncol, New Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Far Eastern Memorial Hospital	Liu, YC (corresponding author), Taipei Vet Gen Hosp, Div Hematol, Dept Med, Taipei, Taiwan.; Liu, YC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	ycliu17@vghtpe.gov.tw						Arai S, 2011, BLOOD, V118, P4242, DOI 10.1182/blood-2011-03-344390; Arai Y, 2016, BONE MARROW TRANSPL, V51, P96, DOI 10.1038/bmt.2015.205; Baird K, 2013, BIOL BLOOD MARROW TR, V19, P632, DOI 10.1016/j.bbmt.2013.01.013; Bresters D, 2008, BONE MARROW TRANSPL, V41, P27, DOI 10.1038/sj.bmt.1705887; Brook G, 2010, INT J STD AIDS, V21, P669, DOI 10.1258/ijsa.2010.010234; Carlens S, 1998, BONE MARROW TRANSPL, V22, P755, DOI 10.1038/sj.bmt.1701423; Cho BS, 2009, LEUKEMIA, V23, P78, DOI 10.1038/leu.2008.276; Couriel D, 2006, BIOL BLOOD MARROW TR, V12, P375, DOI 10.1016/j.bbmt.2006.02.003; Dhingra S, 2016, WORLD J GASTROENTERO, V22, P1357, DOI 10.3748/wjg.v22.i4.1357; Dudek AZ, 2003, BIOL BLOOD MARROW TR, V9, P657, DOI 10.1016/S1083-8791(03)00242-8; Elderman M, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0075-9; Evans AT, 2015, AM J SURG PATHOL, V39, P212, DOI 10.1097/PAS.0000000000000345; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Gallardo D, 2006, LEUKEMIA, V20, P1461, DOI 10.1038/sj.leu.2404263; Gratwohl A, 2009, CANCER-AM CANCER SOC, V115, P4715, DOI 10.1002/cncr.24531; GUMBER SC, 1995, ANN INTERN MED, V123, P615, DOI 10.7326/0003-4819-123-8-199510150-00008; Inamoto Y, 2013, BLOOD, V121, P5098, DOI 10.1182/blood-2012-10-464198; Jacobsohn DA, 2012, BLOOD, V120, P2545, DOI 10.1182/blood-2012-04-424135; Jagasia MH, 2014, BIOL BLOOD MARROW TR; Konuma T, 2014, BONE MARROW TRANSPL, V49, P634, DOI 10.1038/bmt.2014.10; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lim ABM, 2015, BONE MARROW TRANSPL, V50, P566, DOI 10.1038/bmt.2014.313; Liu YC, 2015, BRIT J HAEMATOL, V169, P737, DOI 10.1111/bjh.13357; Martires KJ, 2011, BLOOD, V118, P4250, DOI 10.1182/blood-2011-04-350249; Nakasone H, 2013, AM J HEMATOL, V88, P477, DOI 10.1002/ajh.23436; Nishio N, 2009, BONE MARROW TRANSPL, V44, P303, DOI 10.1038/bmt.2009.33; Perez-Simon JA, 2008, BIOL BLOOD MARROW TR, V14, P1163, DOI 10.1016/j.bbmt.2008.07.015; Pidala J, 2013, BIOL BLOOD MARROW TR, V19, P784, DOI 10.1016/j.bbmt.2013.02.001; Pidala J, 2009, BLOOD, V114, P7, DOI 10.1182/blood-2008-10-182592; Ramos CA, 2009, HAEMATOL-HEMATOL J, V94, P249, DOI 10.3324/haematol.13756; Randolph SSB, 2004, BLOOD, V103, P347, DOI 10.1182/blood-2003-07-2603; Ruutu T, 2014, BONE MARROW TRANSPL, V49, P168, DOI 10.1038/bmt.2013.107; Skert C, 2006, HAEMATOL-HEMATOL J, V91, P258; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; Strasser SI, 2000, HEPATOLOGY, V32, P1265, DOI 10.1053/jhep.2000.20067; Subbarao G, 2006, PEDIATR TRANSPLANT, V10, P682, DOI 10.1111/j.1399-3046.2006.00532.x	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185210	10.1371/journal.pone.0185210	http://dx.doi.org/10.1371/journal.pone.0185210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934311	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900125
J	Gomez-Mora, E; Massanella, M; Garcia, E; Giles, D; Bernado, M; Urrea, V; Carrillo, J; Ouchi, D; Puig, J; Negredo, E; Clotet, B; Blanco, J; Cabrera, C				Gomez-Mora, Elisabet; Massanella, Marta; Garcia, Elisabet; Giles, David; Bernado, Marta; Urrea, Victor; Carrillo, Jorge; Ouchi, Dan; Puig, Jordi; Negredo, Eugenia; Clotet, Bonaventura; Blanco, Julia; Cabrera, Cecilia			Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4(+) T-cell immune recovery	PLOS ONE			English	Article							IMMUNOGLOBULIN-G ANTIBODY; LINKED IMMUNOSORBENT-ASSAY; PRIMARY CMV INFECTION; PREGNANT-WOMEN; ANTIRETROVIRAL THERAPY; IGG AVIDITY; PREDICT MORTALITY; HOMOSEXUAL MEN; NORFOLK COHORT; HEART-DISEASE	Some HIV-infected c-ART-suppressed individuals show incomplete CD4(+) T-cell recovery, abnormal T-cell activation and higher mortality. One potential source of immune activation could be coinfection with cytomegalovirus (CMV). IgG and IgM levels, immune activation, inflammation and T-cell death in c-ART-suppressed individuals with CD4(+) T-cell counts >350 cells/mu L (immunoconcordant, n = 133) or <350 cells/mu L (immunodiscordant, n = 95) were analyzed to evaluate the effect of CMV humoral response on immune recovery. In total, 27 HIV-uninfected individuals were included as controls. In addition, the presence of CMV IgM antibodies was retrospectively analyzed in 58 immunoconcordant individuals and 66 immunodiscordant individuals. Increased CMV IgG levels were observed in individuals with poor immune reconstitution (p = 0.0002). Increased CMV IgG responses were significantly correlated with lower nadir and absolute CD4(+) T-cell counts. In contrast, CMV IgG responses were positively correlated with activation (HLA-DR+) and death markers in CD4(+) T-cells and activated memory CD8(+) T-cells (CD45RA(-)CD38(+)). Longitudinal subanalysis revealed an increased frequency of IgM(+) samples in individuals with poor CD4(+) T-cell recovery, and an association was observed between retrospective IgM positivity and the current level of IgG. The magnitude of the humoral immune response to CMV is associated with nadir CD4(+) T-cell counts, inflammation, immune activation and CD4(+) T-cell death, thus suggesting that CMV infection may be a relevant driving force in the increased morbidity/mortality observed in HIV+ individuals with poor CD4(+) T-cell recovery.	[Gomez-Mora, Elisabet; Massanella, Marta; Garcia, Elisabet; Urrea, Victor; Carrillo, Jorge; Ouchi, Dan; Clotet, Bonaventura; Blanco, Julia; Cabrera, Cecilia] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa AIDS Res Inst, Inst Recerca Germans Trias & Pujol IGTP, Barcelona, Spain; [Massanella, Marta] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Ctr Rech CHUM, Montreal, PQ, Canada; [Giles, David; Bernado, Marta] Biokit, Barcelona, Spain; [Puig, Jordi; Negredo, Eugenia; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita SIDA, Barcelona, Spain; [Negredo, Eugenia; Clotet, Bonaventura; Blanco, Julia] Univ Vic, Cent Catalunya, UVIC UCC, Vic, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Universite de Montreal; Hospital Germans Trias i Pujol; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Cabrera, C (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa AIDS Res Inst, Inst Recerca Germans Trias & Pujol IGTP, Barcelona, Spain.	ccabrera@irsicaixa.es	Ouchi, Dan/R-5319-2019; Blanco, Julià/A-5347-2008; Carrillo, Jorge/AAL-9481-2021; Cabrera, Cecilia/S-1113-2019; Urrea, Victor/ABF-9634-2021; Massanella, Marta/P-8619-2016	Ouchi, Dan/0000-0002-8630-152X; Blanco, Julià/0000-0002-2225-0217; Carrillo, Jorge/0000-0003-0221-5948; Cabrera, Cecilia/0000-0002-9941-6828; Massanella, Marta/0000-0002-3326-151X; Urrea, Victor/0000-0002-2577-856X; Negredo, Eugenia/0000-0001-5298-1734	Ministerio de Sanidad y Politica Social [EC11-045]; Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA' [RD12/0017/0002]; Spanish Institute de Salud Carlos III (ISCIII) [RD12/0017/0002]; European Fund for Regional Development (FEDER); ISCIII; Health Department of the Catalan Government (Generalitat de Catalunya); Biokit	Ministerio de Sanidad y Politica Social(Spanish Government); Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA'; Spanish Institute de Salud Carlos III (ISCIII); European Fund for Regional Development (FEDER)(European Commission); ISCIII(Instituto de Salud Carlos III); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Biokit	This work was supported by the EC11-045 project (Ministerio de Sanidad y Politica Social) and the Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA' (RD12/0017/0002). Grant RD12/0017/0002 is co-funded by the Spanish Institute de Salud Carlos III (ISCIII) and the European Fund for Regional Development (FEDER). C.C. and J.B. are supported by the ISCIII and the Health Department of the Catalan Government (Generalitat de Catalunya). DG and MB are employees of Biokit. Biokit provided support in the form of salaries for the authors [DG and MB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arias RA, 2013, J VIROL, V87, P4486, DOI 10.1128/JVI.02425-12; Brunt SJ, 2016, AIDS RES HUM RETROV, V32, P567, DOI [10.1089/aid.2015.0328, 10.1089/AID.2015.0328]; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Daiminger A, 1999, J CLIN VIROL, V13, P161, DOI 10.1016/S1386-6532(99)00028-1; DETELS R, 1987, INT J EPIDEMIOL, V16, P271, DOI 10.1093/ije/16.2.271; Dollard SC, 2011, CLIN VACCINE IMMUNOL, V18, P1895, DOI 10.1128/CVI.05228-11; Erlandson KM, 2015, AIDS RES HUM RETROV, V31, P905, DOI [10.1089/aid.2015.0085, 10.1089/AID.2015.0085]; Freeman M.L., 2015, CLIN INFECT DIS; Gianella S, 2014, J INFECT DIS, V209, P452, DOI 10.1093/infdis/jit434; Gianella S, 2013, J INFECT DIS, V207, P898, DOI 10.1093/infdis/jis777; Gianella S, 2012, J VIROL, V86, P1307, DOI 10.1128/JVI.06077-11; Gkrania-Klotsas E, 2013, CLIN INFECT DIS, V56, P1421, DOI 10.1093/cid/cit083; Gkrania-Klotsas E, 2012, J INFECT DIS, V206, P1897, DOI 10.1093/infdis/jis620; GrangeotKeros L, 1997, J INFECT DIS, V175, P944, DOI 10.1086/513996; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hummel M, 2002, J CLIN VIROL, V25, pS123; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Kaye S, 2008, J INFECT DIS, V197, P1307, DOI 10.1086/586715; Lazzarotto T, 1997, CLIN DIAGN LAB IMMUN, V4, P469, DOI 10.1128/CDLI.4.4.469-473.1997; Lazzarotto T, 1999, CLIN DIAGN LAB IMMUN, V6, P127, DOI 10.1128/CDLI.6.1.127-129.1999; Lazzarotto T, 2008, J CLIN VIROL, V41, P192, DOI 10.1016/j.jcv.2007.10.015; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Longenecker CT, 2014, AIDS, V28, P969, DOI 10.1097/QAD.0000000000000158; Lurain NS, 2016, AIDS RES HUM RETROV, V32, P134, DOI [10.1089/aid.2015.0169, 10.1089/AID.2015.0169]; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Massanella M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0601-2; Massanella M, 2013, EXPERT REV CLIN IMMU, V9, P1135, DOI 10.1586/1744666X.2013.842897; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; MCVOY MA, 1989, J INFECT DIS, V160, P1, DOI 10.1093/infdis/160.1.1; Munro SC, 2005, J CLIN MICROBIOL, V43, P4713, DOI 10.1128/JCM.43.9.4713-4718.2005; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; NIELSEN SL, 1988, J CLIN MICROBIOL, V26, P654, DOI 10.1128/JCM.26.4.654-661.1988; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Patel EU, 2017, AIDS, V31, P807, DOI [10.1097/qad.0000000000001412, 10.1097/QAD.0000000000001412]; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Prince HE, 2014, CLIN VACCINE IMMUNOL, V21, P1377, DOI 10.1128/CVI.00487-14; RCT, 2016, LANG ENV STAT COMP; REVELLO MG, 1991, J VIROL METHODS, V35, P315, DOI 10.1016/0166-0934(91)90073-9; REYNOLDS DW, 1973, NEW ENGL J MED, V289, P1, DOI 10.1056/NEJM197307052890101; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schaftenaar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099243; Sheth PM, 2006, J INFECT DIS, V193, P45, DOI 10.1086/498576; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Slyker J, 2014, CLIN INFECT DIS, V58, P564, DOI 10.1093/cid/cit727; Slyker JA, 2012, J VIROL, V86, P11373, DOI 10.1128/JVI.00790-12; Smith DM, 2016, CLIN INFECT DIS; Sorlie PD, 2000, ARCH INTERN MED, V160, P2027, DOI 10.1001/archinte.160.13.2027; Springer KL, 2004, J ANTIMICROB CHEMOTH, V54, P582, DOI 10.1093/jac/dkh396; STAGNO S, 1985, J CLIN MICROBIOL, V21, P930, DOI 10.1128/JCM.21.6.930-935.1985; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; van der Heiden M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26892; Varani Stefania, 2011, Herpesviridae, V2, P6, DOI 10.1186/2042-4280-2-6	56	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184433	10.1371/journal.pone.0184433	http://dx.doi.org/10.1371/journal.pone.0184433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934217	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900028
J	Lovric, G; Oikonomidis, IV; Mokso, R; Stampanoni, M; Roth-Kleiner, M; Schittny, JC				Lovric, Goran; Oikonomidis, Ioannis Vogiatzis; Mokso, Rajmund; Stampanoni, Marco; Roth-Kleiner, Matthias; Schittny, Johannes C.			Automated computer-assisted quantitative analysis of intact murine lungs at the alveolar scale	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; FUNCTIONAL RESIDUAL CAPACITY; DENDRITIC MICROSTRUCTURES; MORPHOLOGICAL EVOLUTION; REGIONAL VENTILATION; PHASE; RESOLUTION; IMAGE; CT; TOMOGRAPHY	Using state-of-the-art X-ray tomographic microscopy we can image lung tissue in three dimensions in intact animals down to a micrometer precision. The structural complexity and hierarchical branching scheme of the lung at this level of details, however, renders the extraction of biologically relevant quantities particularly challenging. We have developed a methodology for a detailed description of lung inflation patterns by measuring the size and the local curvature of the parenchymal airspaces. These quantitative tools for morphological and topological analyses were applied to high-resolution murine 3D lung image data, inflated at different pressure levels under immediate post mortem conditions. We show for the first time direct indications of heterogeneous intra-lobar and inter-lobar distension patterns at the alveolar level. Furthermore, we did not find any indication that a cyclic opening-and-collapse (recruitment) of a large number of alveoli takes place.	[Lovric, Goran] Ecole Polytech Fed Lausanne, Ctr Imagerie BioMed, CH-1015 Lausanne, Switzerland; [Lovric, Goran; Oikonomidis, Ioannis Vogiatzis; Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5234 Villigen, Switzerland; [Lovric, Goran; Stampanoni, Marco] Swiss Fed Inst Technol, Inst Biomed Engn, CH-8092 Zurich, Switzerland; [Oikonomidis, Ioannis Vogiatzis; Schittny, Johannes C.] Univ Bern, Inst Anat, CH-3012 Bern, Switzerland; [Mokso, Rajmund] Lund Univ, Max Lab 4, SE-22100 Lund, Sweden; [Roth-Kleiner, Matthias] Univ Hosp Lausanne CHUV, Clin Neonatol, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Lund University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lovric, G (corresponding author), Ecole Polytech Fed Lausanne, Ctr Imagerie BioMed, CH-1015 Lausanne, Switzerland.; Lovric, G (corresponding author), Paul Scherrer Inst, Swiss Light Source, CH-5234 Villigen, Switzerland.; Lovric, G (corresponding author), Swiss Fed Inst Technol, Inst Biomed Engn, CH-8092 Zurich, Switzerland.	goran.lovric@psi.ch	Schittny, Johannes C/U-2956-2017; Lovric, Goran/J-9358-2013; Lovric, Goran/AID-6860-2022; Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/GRR-9695-2022; Stampanoni, Marco/J-4099-2013; Mokso, Rajmund/J-5557-2013	Schittny, Johannes C/0000-0003-4025-3961; Lovric, Goran/0000-0002-0833-4043; Lovric, Goran/0000-0002-0833-4043; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Mokso, Rajmund/0000-0002-2245-2775	National Competence Center in Biomedical Imaging (NCCBI) [1126.0076]; Swiss National Science Foundation (SNF) [CR2312-135550];  [310030-153468]	National Competence Center in Biomedical Imaging (NCCBI); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); 	The study was supported by the National Competence Center in Biomedical Imaging (NCCBI, http://www.nccbi.ch/), grant No. 1126.0076 (M.S), and the Swiss National Science Foundation (SNF, http://www.snf.ch/), grant No. CR2312-135550 (M.S.) with partial contribution from grant No. 310030-153468 (J.C.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge F. Arcadu, D. Pelt, S.F. Barre and G. Mikuljan for their help at the experiment, J. Fife, M. Kagias and K. Mader for fruitful discussions. This study was supported by the National Competence Center in Biomedical Imaging (NCCBI), grant No.1126.0076, and the Swiss National Science Foundation (SNF), grant No. CR23I2-135550 with partial contribution from grant No. 310030-153468.	Abbena E, 2006, TXB MATH; Adam JF, 2009, CLIN EXP PHARMACOL P, V36, P95, DOI 10.1111/j.1440-1681.2008.05043.x; Albert SP, 2009, J APPL PHYSIOL, V106, P757, DOI 10.1152/japplphysiol.90735.2008; Babin D, 2013, PHYS MED BIOL, V58, P8041, DOI 10.1088/0031-9155/58/22/8041; Barre SF, 2016, AM J PHYSIOL-LUNG C, V311, pL1082, DOI 10.1152/ajplung.00325.2016; Barre SF, 2014, PHYSL REPORTS, V2, P1; Bayat S, 2008, EUR J RADIOL, V68, pS78, DOI 10.1016/j.ejrad.2008.04.043; Chang S, 2016, SCI REPORTS, V1, P8760; Chang S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01304; David Cohen-Steiner, 2003, P 19 ANN S COMP GEOM, P312, DOI DOI 10.1145/777792.777839; Dubsky S, 2012, J R SOC INTERFACE, V9, P2213, DOI 10.1098/rsif.2012.0116; Duong T, 2007, J STAT SOFTW, V21, P1, DOI 10.18637/jss.v021.i07; Escolar JD, 2004, HISTOL HISTOPATHOL, V19, P159, DOI 10.14670/HH-19.159; Fife JL, 2009, ACTA MATER, V57, P2418, DOI 10.1016/j.actamat.2009.01.036; Haberthur D, 2010, J SYNCHROTRON RADIAT, V17, P590, DOI 10.1107/S0909049510019618; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hooper SB, 2009, CLIN EXP PHARMACOL P, V36, P117, DOI 10.1111/j.1440-1681.2008.05109.x; Howells MR, 2009, J ELECTRON SPECTROSC, V170, P1, DOI 10.1016/j.elspec.2009.01.004; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Irvine S, 2014, OPT EXPRESS, V22, P27257, DOI 10.1364/OE.22.027257; Kang N, 2012, IEEE COMPUT GRAPH, V32, P29, DOI 10.1109/MCG.2012.65; Kitchen MJ, 2004, PHYS MED BIOL, V49, P4335, DOI 10.1088/0031-9155/49/18/010; Kuijpers NCW, 2002, MATER CHARACT, V48, P379, DOI 10.1016/S1044-5803(02)00289-9; Lavoue Guillaume, 2012, Proceedings of the International Conference on Computer Graphics Theory and Applications (GRAPP 2012) and International Conference on Information Visualization Theory and Applications (IVAPP 2012), P206; Leong AFT, 2014, BIOMED OPT EXPRESS, V5, P4024, DOI 10.1364/BOE.5.004024; Leong AFT, 2013, OPT EXPRESS, V21, P27905, DOI 10.1364/OE.21.027905; Levine JA, 2012, IEEE COMPUT GRAPH, V32, P22, DOI 10.1109/MCG.2012.91; Lewis RA, 2005, PHYS MED BIOL, V50, P5031, DOI 10.1088/0031-9155/50/21/006; Liu YX, 2014, IEEE T BIO-MED ENG, V61, P2057, DOI 10.1109/TBME.2014.2313564; Lovric G, 2016, PHYS MEDICA, V32, P1771, DOI 10.1016/j.ejmp.2016.08.012; Lovric G, 2013, J APPL CRYSTALLOGR, V46, P856, DOI 10.1107/S0021889813005591; Marone F, 2012, J SYNCHROTRON RADIAT, V19, P1029, DOI 10.1107/S0909049512032864; Mendoza R, 2003, METALL MATER TRANS A, V34, P481, DOI 10.1007/s11661-003-0084-2; Mertens M, 2009, CRIT CARE MED, V37, P2604, DOI 10.1097/CCM.0b013e3181a5544d; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; MIYAMOTO K, 1994, RES PATTERN FORMATIO, P507; Mokso R, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/49/494004; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Porra L, 2004, J APPL PHYSIOL, V96, P1899, DOI 10.1152/japplphysiol.00866.2003; Porra L, 2011, CRIT CARE MED, V39, P1731, DOI 10.1097/CCM.0b013e318218a375; R Core Team, 2018, R LANG ENV STAT COMP; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Schittny JC, 2017, CELL TISSUE RES, V367, P427, DOI 10.1007/s00441-016-2545-0; Schroeder W., 2006, VISUALIZATION TOOLKI, V4th; Sera T, 2008, PHYS MED BIOL, V53, P4285, DOI 10.1088/0031-9155/53/16/005; Siew ML, 2009, J APPL PHYSIOL, V106, P1487, DOI 10.1152/japplphysiol.91591.2008; Smaldone GC, 2012, J APPL PHYSIOL, V113, P1945, DOI 10.1152/japplphysiol.00545.2012; Stahr CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29438; Suhonen H, 2008, PHYS MED BIOL, V53, P775, DOI 10.1088/0031-9155/53/3/016; Szilvasi-Nagy M, 2008, J GEOM GRAPH, V12, P63; Taubin G, 2000, STAR P EUROGRAPHICS; te Pas AB, 2009, PEDIATR RES, V65, P537, DOI 10.1203/PDR.0b013e31819da21b; Tran H, 2013, J MATER SCI, V48, P3198, DOI 10.1007/s10853-012-7100-0; Tschanz SA, 2009, J APPL PHYSIOL, V117, P89; Unglert CI, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126015; Vasilescu DM, 2012, P NATL ACAD SCI USA, P1; Vasilescu DM, 2013, J APPL PHYSIOL, V114, P716, DOI 10.1152/japplphysiol.00855.2012; Wang GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089252; Weibel ER, 2009, SWISS MED WKLY, V139, P375, DOI smw-12270; Xiao XH, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2744224	64	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183979	10.1371/journal.pone.0183979	http://dx.doi.org/10.1371/journal.pone.0183979			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934236	Green Published, Green Accepted, gold			2022-12-27	WOS:000411339900015
J	Shaqura, M; Mohamed, DM; Aboryag, NB; Bedewi, L; Dehe, L; Treskatsch, S; Shakibaei, M; Schafer, M; Mousa, SA				Shaqura, Mohammed; Mohamed, Doaa M.; Aboryag, Noureddin B.; Bedewi, Lama; Dehe, Lukas; Treskatsch, Sascha; Shakibaei, Mehdi; Schaefer, Michael; Mousa, Shaaban A.			Pathological alterations in liver injury following congestive heart failure induced by volume overload in rats	PLOS ONE			English	Article							CELL-DEATH; OXIDATIVE STRESS; CYTOCHROME-C; APOPTOSIS; DYSFUNCTION; PRESSURE; METAANALYSIS; MECHANISMS; PROGNOSIS; MORTALITY	Heart failure has emerged as a disease with significant public health implications. Following progression of heart failure, heart and liver dysfunction are frequently combined in hospitalized patients leading to increased morbidity and mortality. Here, we investigated the underlying pathological alterations in liver injury following heart failure. Heart failure was induced using a modified infrarenal aortocaval fistula (ACF) in male Wistar rats. Sham operated and ACF rats were compared for their morphometric and hemodynamic data, for histopathological and ultrastructural changes in the liver as well as differences in the expression of apoptotic factors. ACF-induced heart failure is associated with light microscopic signs of apparent congestion of blood vessels, increased apoptosis and breakdown of hepatocytes and inflammatory cell inifltration were observed. The glycogen content depletion associated with the increased hepatic fibrosis, lipid globule formation was observed in ACF rats. Moreover, cytoplasmic organelles are no longer distinguishable in many ACF hepatocytes with degenerated fragmented rough endoplasmic reticulum, shrunken mitochondria and heavy cytoplasm vacuolization. ACF is associated with the upregulation of the hepatic TUNEL-positive cells and proapoptotic factor Bax protein concomitant with the mitochondrial leakage of cytochrome C into the cell cytoplasm and the transfer of activated caspase 3 from the cytoplasm into the nucleus indicating intrinsic apoptotic events. Taken together, the results demonstrate that ACF-induced congestive heart failure causes liver injury which results in hepatocellular apoptotic cell death mediated by the intrinsic pathway of mitochondrial cytochrome C leakage and subsequent transfer of activated caspase 3 into to the nucleus to initiate overt DNA fragmentation and cell death.	[Shaqura, Mohammed; Mohamed, Doaa M.; Aboryag, Noureddin B.; Bedewi, Lama; Dehe, Lukas; Treskatsch, Sascha; Schaefer, Michael; Mousa, Shaaban A.] Campus Virchow Klinikum, Charite Univ Berlin, Dept Anaesthesiol & Intens Care Med, Berlin, Germany; [Shakibaei, Mehdi] Ludwig Maximilians Univ Munchen, Dept Anat, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich	Mousa, SA (corresponding author), Campus Virchow Klinikum, Charite Univ Berlin, Dept Anaesthesiol & Intens Care Med, Berlin, Germany.	shaaban.mousa@charite.de	Treskatsch, Sascha/ABB-2449-2021; Mohamed, Doaa/AAI-4658-2021; Schäfer, Michael/AAB-1395-2020; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Mohamed, Doaa/0000-0003-1144-3184; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Schaefer, Michael/0000-0002-1581-706X; Treskatsch, Sascha/0000-0002-0549-7680; Shaqura, Mohammed/0000-0002-4289-2188; Dehe, Lukas/0000-0002-8690-4005				Allen LA, 2016, JAMA CARDIOLOGY; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Bechmann LP, 2008, LIVER INT, V28, P713, DOI 10.1111/j.1478-3231.2007.01566.x; Behroozaghdam M, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.24609; BENEDETTI A, 1988, LIVER, V8, P172; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Canbay A, 2009, Z GASTROENTEROL, V47, P807, DOI 10.1055/s-0028-1109058; Damman K, 2007, J CARD FAIL, V13, P599, DOI 10.1016/j.cardfail.2007.04.008; de Silva R, 2006, EUR HEART J, V27, P569, DOI 10.1093/eurheartj/ehi696; Deng JX, 2008, FREE RADICAL BIO MED, V44, P375, DOI 10.1016/j.freeradbiomed.2007.09.023; Donati A, 2016, CURR OPIN ANESTHESIO, V29, P172, DOI 10.1097/ACO.0000000000000296; Fadda E, 2008, BBA-BIOENERGETICS, V1777, P277, DOI 10.1016/j.bbabio.2007.11.010; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; GARCIA R, 1990, CARDIOVASC RES, V24, P430, DOI 10.1093/cvr/24.5.430; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Guo Y, 2013, J BUON, V18, P477; Gurwitz JH, 2013, AM J MED, V126, P393, DOI 10.1016/j.amjmed.2012.10.022; Herzer K, 2011, ANN HEPATOL, V10, P174, DOI 10.1016/S1665-2681(19)31566-2; Horvath B, 2017, GASTROENTEROL RES, V10, P182, DOI 10.14740/gr875e; LEIST M, 1995, AM J PATHOL, V146, P1220; Li CP, 2014, GENET MOL RES, V13, P3991, DOI 10.4238/2014.May.23.10; Liu Y, 2012, EUR J CANCER, V48, P2125, DOI 10.1016/j.ejca.2012.02.009; Losser MR, 1996, SEMIN LIVER DIS, V16, P357, DOI 10.1055/s-2007-1007249; Louie CY, 2015, MODERN PATHOL, V28, P932, DOI 10.1038/modpathol.2015.40; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mayer P., 1981, MITTHEILUNGEN ZOOLOG, V10, P170; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Mousa SA, 2004, ENDOCRINOLOGY, V145, P1331, DOI 10.1210/en.2003-1287; Mousa SA, 2016, PAIN, V157, P910, DOI 10.1097/j.pain.0000000000000459; Mueller S, 2016, WORLD J GASTROENTERO, V22, P10482, DOI 10.3748/wjg.v22.i48.10482; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Saha DC, 2007, J AM ASSOC LAB ANIM, V46, P74; Seervi M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.90; Shaqura M, 2014, NEUROPHARMACOLOGY, V85, P142, DOI 10.1016/j.neuropharm.2014.05.026; SHERLOCK S, 1950, Postgrad Med J, V26, P472; Toledo FD, 2014, ARCH TOXICOL, V88, P1695, DOI 10.1007/s00204-014-1219-5; Treskatsch S, 2015, INT J CARDIOL, V197, P327, DOI 10.1016/j.ijcard.2015.06.067; Treskatsch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087531; Tsamandas AC, 2003, MODERN PATHOL, V16, P1273, DOI 10.1097/01.MP.0000097367.56816.5E; TSUNODA K, 1986, CIRC RES, V59, P256, DOI 10.1161/01.RES.59.3.256; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Yang M, 2014, LIVER TRANSPLANT, V20, P1372, DOI 10.1002/lt.23958; Yip WW, 2006, SEMIN DIAGN PATHOL, V23, P149, DOI 10.1053/j.semdp.2006.11.002; Zhao X, 1997, Zhonghua Nei Ke Za Zhi, V36, P658	46	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184161	10.1371/journal.pone.0184161	http://dx.doi.org/10.1371/journal.pone.0184161			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934226	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900020
J	Stacy, NI; Isaza, R; Wiedner, E				Stacy, Nicole I.; Isaza, Ramiro; Wiedner, Ellen			First report of changes in leukocyte morphology in response to inflammatory conditions in Asian and African elephants (Elephas maximus and Loxodonta africana)	PLOS ONE			English	Article							ACUTE-PHASE PROTEIN; CLINICAL INFECTION; DISEASE; VALUES	Although the hematology of healthy elephants has been well-described, published information on hematological changes during disease is limited. The objective of this study was to describe qualitative morphological changes in the leukocytes of Asian and African elephants (Elephas maximus and Loxodonta africana) diagnosed with a variety of inflammatory conditions. Twenty-five of 27 elephants had morphological changes in their leukocytes, although only 16 of these had a concurrent inflammatory leukogram. Morphological changes included heterophil left-shifting with or without concurrent dysgranulopoiesis, toxicity, or hypersegmentation, reactive lymphocytes, plasma cells, and/or vacuolated monocytes. Although the observed leukocyte morphological changes are non-specific, their early recognition upon blood film evaluation may provide important, clinically-relevant information, particularly if the leukogram is normal. This case series is the first description of qualitative morphological changes in the leukocytes of elephants in association with inflammation.	[Stacy, Nicole I.; Isaza, Ramiro] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA; [Wiedner, Ellen] The Wilds, Cumberland, OH USA	State University System of Florida; University of Florida	Stacy, NI (corresponding author), Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA.	stacyn@ufl.edu		Stacy, Nicole/0000-0003-4258-4414				ALLEN JL, 1985, J ZOO ANIM MED, V16, P98, DOI 10.2307/20094754; Fuery A, 2016, J ZOO WILDLIFE MED, V47, P319, DOI 10.1638/2015-0074.1; Fuery A, 2016, J ZOO WILDLIFE MED, V47, P311, DOI 10.1638/2015-0072.1; Guyton AC, 2015, GUYTON HALL TXB MED, P455; Harr KE, 2010, SCHALMS VET HEMATOLO, Vsixth, P942; Harr K, 2006, J ZOO WILDLIFE MED, V37, P151, DOI 10.1638/05-023.1; Harr Kendal, 2001, P209; Harvey J.W., 2011, VET HEMATOLOGY DIAGN; Isaza R, 2014, J VET DIAGN INVEST, V26, P616, DOI 10.1177/1040638714543923; Landolfi JA, 2010, J ZOO WILDLIFE MED, V41, P445, DOI 10.1638/2009-0163.1; Richman Laura K., 2012, P496; Richman LK, 2000, J WILDLIFE DIS, V36, P1, DOI 10.7589/0090-3558-36.1.1; Schalm OW, 1975, VET HEMATOLOGY, P271; Schmitt DL, 2000, J ZOO WILDLIFE MED, V31, P518, DOI 10.1638/1042-7260(2000)031[0518:UOFFTT]2.0.CO;2; Stanton JJ, 2013, J ZOO WILDLIFE MED, V44, P605, DOI 10.1638/2012-0174R1.1; Swami SK, 2016, ANIM BIOTECHNOL, V27, P66, DOI 10.1080/10495398.2015.1088449	16	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185277	10.1371/journal.pone.0185277	http://dx.doi.org/10.1371/journal.pone.0185277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934325	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900139
J	Tudesq, JJ; Dunyach-Remy, C; Combescure, C; Doncesco, R; Laureillard, D; Lavigne, JP; Sotto, A				Tudesq, Jean-Jacques; Dunyach-Remy, Catherine; Combescure, Christophe; Doncesco, Regine; Laureillard, Didier; Lavigne, Jean-Philippe; Sotto, Albert			Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients	PLOS ONE			English	Article							IMMUNE ACTIVATION; SYSTEMIC INFLAMMATION; BACTERIAL-DNA; PLASMA-LEVELS; HEPATITIS-C; VIRUS; INDIVIDUALS; PROGRESSION; COINFECTION; FIBROSIS	Microbial translocation (MT) is characterized by bacterial products passing into the blood through the gut barrier and is a key phenomenon in the pathophysiology of Human Immunodeficiency Virus (HIV) infection. MT is also associated with liver damage in Hepatitis C Virus (HCV) patients. The aim of the study was to assess MT in plasma of HIV-HCV co-infected patients. 16S rDNA (16 S Ribosomal DNA subunit) marker and other markers of MT such as Lipopolysaccharide (LPS)-binding protein (LBP), soluble CD14 (sCD14), intestinal fatty acid binding protein (I-FABP) were used. Clinical, biological and immunological characteristics of the population were studied in order to correlate them with the intensity of the MT. We demonstrate that indirect markers of MT, LBP and CD14s, and a marker of intestinal permeability (I-FABP) are significantly higher in HIV-HCV co-infected patients than in healthy controls (17.0 vs 2.6 mu g/mL, p < 0.001; 1901.7 vs 1255.0 ng/mL, p = 0.018); 478.3 vs 248.1 pg/mL, p < 0.001, respectively), while a direct marker of MT (16S rDNA copies) is not different between these two populations. However, plasma 16S rDNA was significantly higher in co-infected patients with long-standing HIV infections (RGM = 1.47 per 10 years, CI95% = [1.04: 2.06], p = 0.03). Our findings show that in HIV-HCV co-infected patients, plasma 16S rDNA levels, directly reflecting MT, seem to be linked to the duration of HIV infection, while elevated levels of LBP and sCD14 reflect only a persistence of immune activation. The levels of these markers were not correlated with HCV evolution.	[Tudesq, Jean-Jacques; Dunyach-Remy, Catherine; Laureillard, Didier; Lavigne, Jean-Philippe; Sotto, Albert] Montpellier Univ, INSERM, Nimes, France; [Dunyach-Remy, Catherine; Lavigne, Jean-Philippe] Nimes Univ Hosp, Dept Microbiol, Nimes, France; [Combescure, Christophe] Univ Geneva, Div Clin Epidemiol, Dept Hlth & Community Med, Geneva, Switzerland; [Combescure, Christophe] Univ Hosp Geneva, Geneva, Switzerland; [Doncesco, Regine; Laureillard, Didier; Sotto, Albert] Nimes Univ Hosp, Dept Infect Dis, Nimes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Nimes; University of Geneva; University of Geneva; Universite de Montpellier; CHU de Nimes	Dunyach-Remy, C (corresponding author), Montpellier Univ, INSERM, Nimes, France.; Dunyach-Remy, C (corresponding author), Nimes Univ Hosp, Dept Microbiol, Nimes, France.	catherine.remy@chu-nimes.fr	Sotto, Albert/AFJ-9023-2022; Tudesq, Jean-Jacques/ABG-1918-2020; Lavigne, Jean-Philippe/E-1756-2014	Tudesq, Jean-Jacques/0000-0003-4879-8106; Lavigne, Jean-Philippe/0000-0002-9484-0304; Laureillard, Didier/0000-0002-0104-9047; Sotto, Albert/0000-0002-6463-9386; Dunyach-Remy, Catherine/0000-0001-6884-470X				Abad-Fernandez M, 2013, JAIDS-J ACQ IMM DEF, V64, P149, DOI 10.1097/QAI.0b013e31829a2f12; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Baroncelli S, 2009, J CLIN VIROL, V46, P367, DOI 10.1016/j.jcv.2009.09.011; Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Bonacini M, 2004, AIDS, V18, P2039, DOI 10.1097/00002030-200410210-00008; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Ferri E, 2010, J INFECT DIS, V202, P176, DOI 10.1086/653215; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Kramski M, 2011, J CLIN MICROBIOL, V49, P3691, DOI 10.1128/JCM.01018-11; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Nystrom J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118643; Psomas C, 2013, BLOOD, V122, P2282, DOI 10.1182/blood-2013-06-507012; Sacchi P, 2015, DIGEST LIVER DIS, V47, P218, DOI 10.1016/j.dld.2014.11.012; Shmagel KV, 2016, HIV MED, V17, P581, DOI 10.1111/hiv.12357; Steele AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097171; Zhu Y, 2013, WORLD J GASTROENTERO, V19, P8963, DOI 10.3748/wjg.v19.i47.8963	21	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183372	10.1371/journal.pone.0183372	http://dx.doi.org/10.1371/journal.pone.0183372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934209	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900010
J	Wijnrocx, K; Van Bruggen, LWL; Eggelmeijer, W; Noorman, E; Jacques, A; Buys, N; Janssens, S; Mandigers, PJJ				Wijnrocx, Katrien; Van Bruggen, Leonie W. L.; Eggelmeijer, Wieteke; Noorman, Erik; Jacques, Arnold; Buys, Nadine; Janssens, Steven; Mandigers, Paul J. J.			Twelve years of chiari-like malformation and syringomyelia scanning in Cavalier King Charles Spaniels in the Netherlands: Towards a more precise phenotype	PLOS ONE			English	Article							LABRADOR RETRIEVERS; MOUNTAIN DOG; OTITIS-MEDIA; HIP; PREVALENCE; DYSPLASIA	Chiari-like malformation (CM), syringomyelia (SM) and middle ear effusion (also called PSOM) are three conditions that frequently occur in Cavalier King Charles Spaniels (CKCS). Both CM and SM are currently screened in the Netherlands prior to breeding and are graded according to the British Veterinary Association's Kennel Club (BVA/KC) scheme. This study evaluated the prevalence and estimated genetic parameter of CM, SM and middle ear effusion from 12 years of screening results. For SM, the classical method using the BVA/KC scheme, was compared with exact measuring of the central canal dilation. For CM, the BVA/KC scheme was compared with a more detailed scheme. Next to this the presence of microchip artifacts was assessed. 1249 screening of 1020 dogs were re-evaluated. Results indicated the presence of CM in all dogs, suggesting it has become a breed-specific characteristic. And although different grades of CM were observed, the condition did not deteriorate over time. SM was present in 39% of the dogs and a clear age effect was demonstrated, with SM increasing with age. This emphasizes the importance of screening at appropriate age, since SM can worsen with increasing age. One alternative is to promote repeated measures. The presence of middle ear effusion in this study was 19%-21% for dogs younger than 3 years, and 32%-38% for dogs older than 3 years. In as much as 60%, microchip artifacts were noticed, leading to the recommendation to place microchips in another location in breeds that are susceptible to developing SM. Finally, this study estimated the heritability of CM in this population, due to the lack of phenotypic variance, to be very low at 0.02-0.03. The heritability for SM central canal dilatation to be 0.30, compared to 0.13 for the classical BVA/KC method, using a model including the age effect and the combined effect of veterinary clinic and year of the evaluation. Genetic correlations were rather small, ranging from 0.16-0.33. As a conclusion, screening for SM and CM in the entire population should be maintained, and a selection scheme against SM should be based on estimated breeding values for the exact measurement of the central canal dilatation.	[Wijnrocx, Katrien; Buys, Nadine; Janssens, Steven] Katholieke Univ Leuven, Livestock Genet, Dept Biosyst, Leuven, Belgium; [Van Bruggen, Leonie W. L.; Eggelmeijer, Wieteke; Mandigers, Paul J. J.] Univ Utrecht, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Noorman, Erik] Dierenklin Heuvel, Best, Netherlands; [Jacques, Arnold] Cavaliers Life Fdn, Oudenaarde, Belgium	KU Leuven; Utrecht University	Mandigers, PJJ (corresponding author), Univ Utrecht, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	p.j.j.mandigers@uu.nl	Janssens, Steven/ABE-6370-2020	Janssens, Steven/0000-0002-5588-3889; Mandigers, Paul/0000-0003-2547-6673; Buys, Nadine/0000-0002-7313-3088	Flemish government	Flemish government(European Commission)	Katrien Wijnrocx, the first author, has been granted a grant of the Flemish government that allowed her to do a PhD on sustainable breeding of Pedigree dogs. This study is a part of her PhD study. But the study itself is not funded nor did we receive any payment to perform this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Cross HR, 2009, J SMALL ANIM PRACT, V50, P399, DOI 10.1111/j.1748-5827.2009.00799.x; Driver CJ, 2013, VET J, V198, P551, DOI 10.1016/j.tvjl.2013.07.014; Driver CJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-215; Falconer D. S., 1996, INTRO QUANTITATIVE G; Freeman AC, 2014, J VET INTERN MED, V28, P1551, DOI 10.1111/jvim.12421; Hayes GM, 2010, VET REC, V167, P55, DOI 10.1136/vr.b4886; Hou YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009410; Knowler SP, 2011, VET REC, V169, P681, DOI 10.1136/vr.100062; Knowler SP, 2014, PLOS ONE, V9; Knowler SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151280; Lewis TW, 2011, VET J, V189, P227, DOI 10.1016/j.tvjl.2011.06.024; Lewis TW, 2010, ANIM WELFARE, V19, P93; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012797; Lewis T, 2010, VET J, V183, P345, DOI 10.1016/j.tvjl.2009.10.022; Malm S, 2008, J ANIM BREED GENET, V125, P403, DOI 10.1111/j.1439-0388.2008.00725.x; Marino DJ, 2012, AM J VET RES, V73, P105, DOI 10.2460/ajvr.73.1.105; Miglior F, 2005, J DAIRY SCI, V88, P1255, DOI 10.3168/jds.S0022-0302(05)72792-2; Misztal I., 2002, P 7 WORLD C GEN APPL, p28.07; Parker JE, 2011, VET REC, V168, DOI 10.1136/vr.d1726; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Rusbridge C, 2007, J SMALL ANIM PRACT, V48, P432, DOI 10.1111/j.1748-5827.2007.00344.x; Rusbridge C, 2009, J SMALL ANIM PRACT, V50, P386, DOI 10.1111/j.1748-5827.2009.00744.x; Rusbridge C., 2007, THESIS; Shaw TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033660; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Stern-Bertholtz W, 2003, J SMALL ANIM PRACT, V44, P253, DOI 10.1111/j.1748-5827.2003.tb00151.x; Thofner MS, 2015, J VET INTERN MED, V29, P243, DOI 10.1111/jvim.12475	29	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184893	10.1371/journal.pone.0184893	http://dx.doi.org/10.1371/journal.pone.0184893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934242	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900058
J	Yang, SX; Petraglia, MD; Hou, YM; Yue, JP; Deng, CL; Zhu, RX				Yang, Shi-Xia; Petraglia, Michael D.; Hou, Ya-Mei; Yue, Jian-Ping; Deng, Cheng-Long; Zhu, Ri-Xiang			The lithic assemblages of Donggutuo, Nihewan basin: Knapping skills of early pleistocene hominins in North China	PLOS ONE			English	Article							MIDPLEISTOCENE CLIMATE TRANSITION; PALEOLITHIC SITE; OLDUVAI GORGE; BIPOLAR; ENVIRONMENT; TECHNOLOGY; CENJIAWAN; RECORD; QUARTZ; FLINT	Donggutuo (DGT) is one of the richest archaeological localities in the Nihewan Basin of North China, thereby providing key information about the technological behaviours of early hominins in eastern Asia. Although DGT has been subject of multiple excavations and technological studies over the past several decades, few detailed studies on the lithic assemblages have been published. Here we summarize and describe the DGT lithic assemblages, examining stone tool reduction methods and technological skills. DGT dates to ca. 1.1 Ma, close to the onset of the mid-Pleistocene climate transition (MPT), indicating that occupations at DGT coincided with increased environmental instability. During this time interval, the DGT knappers began to apply innovative flaking methods, using free hand hard hammer percussion (FHHP) to manufacture pre-determined core shapes, small flakes and finely retouched tools, while occasionally using the bipolar technique, in contrast to the earlier and nearby Nihewan site of Xiaochangliang (XCL). Evidence for some degree of planning and predetermination in lithic reduction at DGT parallels technological developments in African Oldowan sites, suggesting that innovations in early industries may be situational, sometimes corresponding with adaptations to changes in environments and local conditions.	[Yang, Shi-Xia; Deng, Cheng-Long; Zhu, Ri-Xiang] Chinese Acad Sci, State Key Lab Lithospher Evolut, Inst Geol & Geophys, Beijing, Peoples R China; [Yang, Shi-Xia; Hou, Ya-Mei; Yue, Jian-Ping] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Petraglia, Michael D.] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Yue, Jian-Ping; Deng, Cheng-Long; Zhu, Ri-Xiang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, SX (corresponding author), Chinese Acad Sci, State Key Lab Lithospher Evolut, Inst Geol & Geophys, Beijing, Peoples R China.; Yang, SX (corresponding author), Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China.	sxyang@ivpp.ac.cn	Petraglia, Michael/ABA-9748-2021; Zhu, Rixiang/F-2126-2018; Deng, Chenglong/B-8871-2009	Zhu, Rixiang/0000-0002-4985-925X; Deng, Chenglong/0000-0003-1848-3170; Petraglia, Michael/0000-0003-2522-5727	National Natural Science Foundation of China [41602021, 41690112, 41621004, L1524016]; Ministry of Science and Technology of China [2014FY110300]; Max Planck Society	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This research is supported by grants from the National Natural Science Foundation of China (Nos. 41602021, 41690112, 41621004 and L1524016; http://www.nsfc.gov.cn/), under the "ideas" to work on early human behaviors in North China. Additional funding for analyses was contributed by Ministry of Science and Technology of China (No. 2014FY110300; http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Xiao-Cong GUO of the Institute of Vertebrate Paleontology and Paleoanthropology, Chinese Academy of Sciences, for helping prepare Fig 5. MDP wishes to acknowledge the support of the Max Planck Society. We thank the Editor, Robin Dennell and an anonymous reviewer for their assistance and insightful comments, which helped us to improve this article.	An ZH, 2005, GEOLOGY, V33, P705, DOI 10.1130/G21423.1; [Anonymous], 1999, QUATERNARY SCI; Barbour G.B., 1925, B GEOLOGICAL SOC CHI, V4, P53; Burdukiewicz JM, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P195, DOI 10.1007/978-0-387-76487-0_11; Byrne F, 2015, QUATERN INT; Chen C, 2003, EARLY PLEISTOCENE LI, P422; [陈淳 Chen Chun], 2002, [人类学学报, Acta Anthropologica Sinica], V21, P23; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; De La Pena P, 2015, LITHIC TECHNOL, V40, P316, DOI 10.1080/01977261.2015.1123947; de la Torre I, 2004, CURR ANTHROPOL, V45, P439, DOI 10.1086/422079; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Deng CL, 2008, QUATERNARY RES, V69, P77, DOI 10.1016/j.yqres.2007.10.006; Deng CL, 2006, EARTH PLANET SC LETT, V241, P248, DOI 10.1016/j.epsl.2005.10.020; Dennell RW, 2013, QUATERN INT, V295, P223, DOI 10.1016/j.quaint.2012.02.012; Diez-Martin F, 2011, AM ANTIQUITY, V76, P690, DOI 10.7183/0002-7316.76.4.690; Ding ZL, 2005, EARTH PLANET SC LETT, V237, P45, DOI 10.1016/j.epsl.2005.06.036; Ding ZL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000725; Du SS, 2008, COLLECTION STUDIES A, V7, P232; Gao X, 2002, ANTIQUITY, V76, P397, DOI 10.1017/S0003598X00090517; Guan Y, 2016, QUATERN INT, V400, P86, DOI 10.1016/j.quaint.2015.07.008; Gurtov AN, 2014, QUATERN INT, V322, P285, DOI 10.1016/j.quaint.2013.08.010; Hilgen FJ, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P923, DOI 10.1016/B978-0-444-59425-9.00029-9; [侯亚梅 Hou Yamei], 2003, [人类学学报, Acta Anthropologica Sinica], V22, P279; Hou YM, 2008, ANTHROPOLOGIE, V112, P457, DOI 10.1016/j.anthro.2008..04.004; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Hou YM, 2000, THESIS CHINESE ACAD, P1; Ikawa-Smith F., 1978, EARLY PALEOLITHIC S, P1, DOI DOI 10.1515/9783110810035.1; Inizan ML, 1999, TECHNOLOGY TERMINOLO, P96; Jia LP, 1972, ACTA ARCHAEOLOGICAL, V1, P39; Keates SG, 2010, QUATERN INT, V223, P408, DOI 10.1016/j.quaint.2010.01.017; Kuman K, 2016, QUATERN INT, V400, P58, DOI 10.1016/j.quaint.2015.07.052; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Li H, 1948, C R PALEVOL; Li H.M., 1982, QUATERNARY GEOLOGY E, P33; Li HM, 2008, QUATERNARY RES, V69, P250, DOI 10.1016/j.yqres.2007.11.002; Li J., 1995, APPL LITHIC REFITTIN, V7, P25; Li YC, 1996, GEOGR TERRIT RES, V12, P55; Liu Y, 2013, QUATERN INT, V295, P215, DOI 10.1016/j.quaint.2012.09.024; Medina-Elizalde M, 2005, SCIENCE, V310, P1009, DOI 10.1126/science.1115933; Movius H.L., 1948, T AM PHILOS SOC, V38, P329; Mudelsee M, 1997, EARTH PLANET SC LETT, V151, P117, DOI 10.1016/S0012-821X(97)00114-3; Pei SW, 2009, CHINESE SCI BULL, V54, P3896, DOI 10.1007/s11434-009-0646-9; Pei SW, 2001, ACTA ANTHR SIN, V21, P271; Pelegrin J, 2005, STONE KNAPPING NECES, P23; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P546, DOI 10.1029/97PA01019; SCHICK K, 1991, J HUM EVOL, V21, P13, DOI 10.1016/0047-2484(91)90033-R; Schick K.D., 1993, EVOL ANTHR ISSUES NE, V2, P22, DOI DOI 10.1002/EVAN.1360020105; Schick KD, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P449; Semaw S, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P173, DOI 10.1007/978-0-387-76487-0_10; Shen C., 2004, ASIAN PERSPECT, V43, P281; Shen C, 2010, VERTEBR PALEOBIOL PA, P169, DOI 10.1007/978-90-481-9094-2_13; Singer BS, 1999, J GEOPHYS RES-SOL EA, V104, P679, DOI 10.1029/1998JB900016; TEXIER PJ, 1995, CR ACAD SCI II, V320, P647; Toth N., 1982, THESIS; [王红强 Wang Hongqiang], 2007, [第四纪研究, Quaternary Sciences], V27, P1081; Wang HQ, 2006, SCI CHINA SER D, V49, P295, DOI 10.1007/s11430-006-0295-7; Wang HQ, 2005, QUATERNARY RES, V64, P1, DOI 10.1016/j.yqres.2005.04.001; Wei Q, 2011, NIHEWAN RIFT EARLY M, P132; [卫奇 Wei Qi], 2014, [人类学学报, Acta Anthropologica Sinica], V33, P254; Wei Qi, 1985, Acta Anthropologica Sinica, V4, P223; Wu FL, 2007, EARTH PLANET SC LETT, V257, P160, DOI 10.1016/j.epsl.2007.02.029; Xie F., 1990, J ANTHR, V9, P265; Xie F., 2006, PALEOLITHIC ARCHEOLO, P278; Xu QH, 1998, ARCHAEOLOGICAL CORPU, P505; Yang SX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155793; Yuan B., 2011, NIHEWAN RIFT PALEO H; Yuan B., 1996, SCI CHINA SER D, V26, P67; [朱日祥 Zhu Rixiang], 2007, [第四纪研究, Quaternary Sciences], V27, P922; Zhu RX, 2004, NATURE, V431, P559, DOI 10.1038/nature02829; Zhu RX, 2001, NATURE, V413, P413, DOI 10.1038/35096551	70	12	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185101	10.1371/journal.pone.0185101	http://dx.doi.org/10.1371/journal.pone.0185101			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FH7CN	28934295	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900089
J	Bright, FM; Vink, R; Byard, RW; Duncan, JR; Krous, HF; Paterson, DS				Bright, Fiona M.; Vink, Robert; Byard, Roger W.; Duncan, Jhodie R.; Krous, Henry F.; Paterson, David S.			Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex	PLOS ONE			English	Article							RAT IN-VITRO; TRACTUS-SOLITARIUS; INFERIOR OLIVE; DEVELOPMENTAL ABNORMALITIES; PREBOTZINGER COMPLEX; RESPIRATORY NETWORK; BARORECEPTOR REFLEX; EXPRESSING NEURONS; MEDULLA-OBLONGATA; CEREBELLAR	Sudden infant death syndrome (SIDS) involves failure of arousal to potentially life threatening events, including hypoxia, during sleep. While neuronal dysfunction and abnormalities in neurotransmitter systems within the medulla oblongata have been implicated, the specific pathways associated with autonomic and cardiorespiratory failure are unknown. The neuropeptide substance P (SP) and its tachykinin neurokinin-1 receptor (NK1R) have been shown to play an integral role in the modulation of homeostatic function in the medulla, including regulation of respiratory rhythm generation, integration of cardiovascular control, and modulation of the baroreceptor reflex and mediation of the chemoreceptor reflex in response to hypoxia. Abnormalities in SP neurotransmission may therefore result in autonomic dysfunction during sleep and contribute to SIDS deaths. [125 I] Bolton Hunter SP autoradiography was used to map the distribution and density of the SP, NK1R to 13 specific nuclei intimately related to cardiorespiratory function and autonomic control in the human infant medulla of 55 SIDS and 21 control (non-SIDS) infants. Compared to controls, SIDS cases exhibited a differential, abnormal developmental profile of the SP/NK1R system in the medulla. Furthermore the study revealed significantly decreased NK1R binding within key medullary nuclei in SIDS cases, principally in the nucleus tractus solitarii (NTS) and all three subdivisions of the inferior portion of the olivo-cerebellar complex; the principal inferior olivary complex (PIO), medial accessory olive (MAO) and dorsal accessory olive (DAO). Altered NK1R binding was significantly influenced by prematurity and male sex, which may explain the increased risk of SIDS in premature and male infants. Abnormal NK1R binding in these medullary nuclei may contribute to the defective interaction of critical medullary mechanisms with cerebellar sites, resulting in an inability of a SIDS infant to illicit appropriate respiratory and motor responses to life threatening challenges during sleep. These observations support the concept that abnormalities in a multi-neurotransmitter network within key nuclei of the medullary homeostatic system may underlie the pathogenesis of a subset of SIDS cases.	[Bright, Fiona M.; Byard, Roger W.] Univ Adelaide, Discipline Anat & Pathol, Adelaide Med Sch, Adelaide, SA, Australia; [Bright, Fiona M.; Paterson, David S.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bright, Fiona M.; Paterson, David S.] Harvard Med Sch, Boston, MA 02115 USA; [Vink, Robert] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia; [Duncan, Jhodie R.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Krous, Henry F.] Childrens Hospital San Diego, Dept Pathol, San Diego, CA USA	University of Adelaide; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of South Australia; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Bright, FM (corresponding author), Univ Adelaide, Discipline Anat & Pathol, Adelaide Med Sch, Adelaide, SA, Australia.; Bright, FM (corresponding author), Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA.; Bright, FM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	fiona.bright@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012; Bright, Fiona/ABE-8441-2020	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Bright, Fiona/0000-0002-1255-2350	River's Gift SIDS charity Australia, as part of an International SIDS research fellowship; River's Gift	River's Gift SIDS charity Australia, as part of an International SIDS research fellowship; River's Gift	Study was funded and supported in full by River's Gift SIDS charity Australia, as part of an International SIDS research fellowship awarded to Dr Fiona M Bright, http://www.riversgift.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by River's Gift SIDS charity Australia as part of an International SIDS fellowship awarded to FMB. The authors sincerely thank River's Gift for their support. The authors acknowledge Dr. Felicia Tratchenberg, and Ryan Harrison from New England Research Institutes (NERI), Watertown, MA, USA, for assistance with statistical analysis of data and thank the San Diego Medical Examiner system for assistance in the accrual of tissue specimens.	Abdala APL, 2006, BRAIN RES, V1119, P165, DOI 10.1016/j.brainres.2006.08.059; Azizi SA, 2007, NEUROSCIENTIST, V13, P616, DOI 10.1177/1073858407299286; Broadbelt KG, 2011, J NEUROPATH EXP NEUR, V70, P799, DOI 10.1097/NEN.0b013e31822c09bc; Coffman KA, 2011, P NATL ACAD SCI USA, V108, P16068, DOI 10.1073/pnas.1107904108; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; Doi A, 2010, J NEUROSCI, V30, P8251, DOI 10.1523/JNEUROSCI.5361-09.2010; Doi A, 2008, RESP PHYSIOL NEUROBI, V164, P96, DOI 10.1016/j.resp.2008.06.007; Duncan JR, 2010, JAMA-J AM MED ASSOC, V303, P430, DOI 10.1001/jama.2010.45; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Garcia AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060695; GILLIS RA, 1980, BRAIN RES, V181, P476, DOI 10.1016/0006-8993(80)90633-2; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Gregg KV, 1997, J CHEM NEUROANAT, V12, P211, DOI 10.1016/S0891-0618(96)00207-4; Harper RM, 2000, PEDIATR RES, V48, P140, DOI 10.1203/00006450-200008000-00004; Harper RM, 2000, BRAIN RES BULL, V53, P125, DOI 10.1016/S0361-9230(00)00317-8; Holley HS, 2012, RESP PHYSIOL NEUROBI, V180, P79, DOI 10.1016/j.resp.2011.10.012; Kinney Hannah C, 2009, Dev Psychobiol, V51, P223, DOI 10.1002/dev.20367; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Kinney H, 2009, ACTA NEUROPATHOL, V117, P247, DOI 10.1007/s00401-009-0490-7; KINNEY HC, 1992, J NEUROPATH EXP NEUR, V51, P115, DOI 10.1097/00005072-199203000-00001; KINNEY HC, 1983, PEDIATRICS, V72, P181; Kinney HC, 2002, J NEUROPATH EXP NEUR, V61, P427, DOI 10.1093/jnen/61.5.427; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Lavezzi AM, 2011, NEUROPATHOLOGY, V31, P405, DOI 10.1111/j.1440-1789.2010.01190.x; Lessard A, 2010, EXP NEUROL, V223, P634, DOI 10.1016/j.expneurol.2010.02.013; Massari VJ, 1998, BRAIN RES, V785, P329, DOI 10.1016/S0006-8993(97)01335-8; Mazzone SB, 1999, BRAIN RES, V826, P139, DOI 10.1016/S0006-8993(99)01247-0; Mehboob R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00320; Mehboob R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00082; Morgado-Valle C, 2004, J PHYSIOL-LONDON, V555, P783, DOI 10.1113/jphysiol.2003.060350; MORILAK DA, 1988, NEUROSCI LETT, V94, P131, DOI 10.1016/0304-3940(88)90283-2; Nattie EE, 2004, J PHYSIOL-LONDON, V556, P235, DOI 10.1113/jphysiol.2003.059766; Nichols NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088161; Olszewski J., 1954, CYTOARCHITECHTURE HU; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; QUIRION R, 1986, J NEUROSCI, V6, P2187; Seagard JL, 2000, J AUTONOM NERV SYST, V78, P77, DOI 10.1016/S0165-1838(99)00060-0; Shvarev YN, 2006, EUR J NEUROSCI, V24, P2253, DOI 10.1111/j.1460-9568.2006.05087.x; Sridhar R, 2003, PEDIATR PULM, V36, P113, DOI 10.1002/ppul.10287; TAKASHIMA S, 1985, EXP NEUROL, V90, P580, DOI 10.1016/0014-4886(85)90155-4; Telgkamp P, 2002, J NEUROPHYSIOL, V88, P206, DOI 10.1152/jn.2002.88.1.206; Wenninger JM, 2004, J APPL PHYSIOL, V97, P1620, DOI 10.1152/japplphysiol.00952.2003; YAMAMOTO Y, 1985, ACTA PHYSIOL SCAND, V124, P449, DOI 10.1111/j.1748-1716.1985.tb07681.x	46	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184958	10.1371/journal.pone.0184958	http://dx.doi.org/10.1371/journal.pone.0184958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931039	Green Published, gold, Green Accepted			2022-12-27	WOS:000411314700047
J	Pan, W; Guo, Y; Jin, L; Liao, SJ				Pan, Wei; Guo, Ying; Jin, Lei; Liao, ShuJie			Medical resource inventory model for emergency preparation with uncertain demand and stochastic occurrence time under considering different risk preferences at the airport	PLOS ONE			English	Article							VALUE-AT-RISK; MANAGEMENT; OPTIMIZATION; LOGISTICS; DECISION; ISSUES	With the high accident rate of civil aviation, medical resource inventory becomes more important for emergency management at the airport. Meanwhile, medical products usually are time-sensitive and short lifetime. Moreover, we find that the optimal medical resource inventory depends on multiple factors such as different risk preferences, the material shelf life and so on. Thus, it becomes very complex in a real-life environment. According to this situation, we construct medical resource inventory decision model for emergency preparation at the airport. Our model is formulated in such a way as to simultaneously consider uncertain demand, stochastic occurrence time and different risk preferences. For solving this problem, a new programming is developed. Finally, a numerical example is presented to illustrate the proposed method. The results show that it is effective for determining the optimal medical resource inventory for emergency preparation with uncertain demand and stochastic occurrence time under considering different risk preferences at the airport.	[Pan, Wei] Wuhan Univ, Sch Econ & Management, Wuhan, Hubei, Peoples R China; [Guo, Ying] Shandong Univ, Sch Management, Jinan, Shandong, Peoples R China; [Jin, Lei; Liao, ShuJie] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China	Wuhan University; Shandong University; Huazhong University of Science & Technology	Jin, L; Liao, SJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China.	ljin@tjh.tjmu.edu.cn; sjliao@tjh.tjmu.edu.cn			National Nature Science Foundation of China (NSFC) [U1333115, 71373188, 81672085, 81372804, 30901586, 71572096]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study is supported by the National Nature Science Foundation of China (NSFC) (Grant no. U1333115, 71373188, 81672085, 81372804, 30901586, 71572096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by the National Nature Science Foundation of China (NSFC) (Grant no. U1333115, 71373188, 81672085,81372804, 30901586,71572096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamon B.M., 2006, INT J LOGIST-RES APP, V9, P1, DOI DOI 10.1080/13675560500453667; Cha EJ, 2012, RELIAB ENG SYST SAFE, V104, P27, DOI 10.1016/j.ress.2012.04.002; Chan TCY, 2014, EUR J OPER RES, V238, P876, DOI 10.1016/j.ejor.2014.04.038; Cheaitou A, 2009, INT J PROD ECON, V118, P118, DOI 10.1016/j.ijpe.2008.08.031; Chew EP, 2006, EUR J OPER RES, V174, P1979, DOI 10.1016/j.ejor.2005.05.011; Das R, 2014, EUR J OPER RES, V235, P616, DOI 10.1016/j.ejor.2013.12.042; Delia A. R., 2016, J BUSINESS LOGISTICS, V37, P59, DOI [10.1111/jbl.12112, DOI 10.1111/JBL.12112]; Demirag OC, 2013, OMEGA-INT J MANAGE S, V41, P1053, DOI 10.1016/j.omega.2013.02.001; HarbaughWT Krause K, 2002, EXPT EC, V5, P53; Holguin-Veras J, 2007, TRANSP RES RECORD, P76, DOI 10.3141/2022-09; Jammernegg W, 2013, INT J PROD ECON, V143, P410, DOI 10.1016/j.ijpe.2011.10.017; Jammernegg W, 2009, INT J PROD ECON, V118, P269, DOI 10.1016/j.ijpe.2008.08.023; Jian Hui-yun, 2013, Control and Decision, V28, P1446; Kischka P., 2007, REV MANAG SCI, V1, P93; Matsuyama K, 2006, EUR J OPER RES, V171, P170, DOI 10.1016/j.ejor.2004.08.030; Mete HO, 2010, INT J PROD ECON, V126, P76, DOI 10.1016/j.ijpe.2009.10.004; Noyan N., 2013, RISK AVERSE 2 STAGE; Ozguven Eren Erman, 2014, J Emerg Manag, V12, P269, DOI 10.5055/jem.2014.0179; Pan W., 2015, MANAGE REV, V27, P195, DOI DOI 10.14120/J.CNKI.CN11-5057/F.2015.10.020; Piantadosi J, 2008, J HYDROL, V348, P320, DOI 10.1016/j.jhydrol.2007.10.007; Qin JC, 2012, COMPUT OPER RES, V39, P1909, DOI 10.1016/j.cor.2011.07.008; Qiu RZ, 2014, INT J PROD RES, V52, P7472, DOI 10.1080/00207543.2014.937509; Rawls C.G., 2012, SOCIO-ECON PLAN SCI, V46, P46, DOI DOI 10.1016/J.SEPS.2011.10.002; Rawls CG, 2010, TRANSPORT RES B-METH, V44, P521, DOI 10.1016/j.trb.2009.08.003; Rockafellar R. T., 2000, J RISK, V2, P21, DOI 10.21314/JOR.2000.038; Rockafellar RT, 2002, J BANK FINANC, V26, P1443, DOI 10.1016/S0378-4266(02)00271-6; Saracoglu I, 2014, EXPERT SYST APPL, V41, P8189, DOI 10.1016/j.eswa.2014.07.003; Schmitt AJ, 2012, COMPUT OPER RES, V39, P850, DOI 10.1016/j.cor.2010.08.004; Van Wassenhove LN, 2006, J OPER RES SOC, V57, P475, DOI 10.1057/palgrave.jors.2602125; Whybark DC, 2007, INT J PROD ECON, V108, P228, DOI 10.1016/j.ijpe.2006.12.012; Wu L. S. Y., 2001, WORKING PAPER; Wu M, 2013, EUR J OPER RES, V231, P328, DOI 10.1016/j.ejor.2013.05.044	32	1	1	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0183472	10.1371/journal.pone.0183472	http://dx.doi.org/10.1371/journal.pone.0183472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931007	Green Submitted, gold, Green Published			2022-12-27	WOS:000411314700010
J	Martin, A; Gremse, C; Selhorst, T; Bandick, N; Muller-Graf, C; Greiner, M; Lahrssen-Wiederholt, M				Martin, Annett; Gremse, Carl; Selhorst, Thomas; Bandick, Niels; Mueller-Graf, Christine; Greiner, Matthias; Lahrssen-Wiederholt, Monika			Hunting of roe deer and wild boar in Germany: Is non-lead ammunition suitable for hunting?	PLOS ONE			English	Article							LEAD-FREE; RIFLE AMMUNITION; EXPOSURE; BULLETS	Background Non-lead hunting ammunition is an alternative to bullets that contain lead. The use of lead ammunition can result in severe contamination of game meat, thus posing a health risk to consumers. With any kind of ammunition for hunting, the terminal effectiveness of bullets is an animal welfare issue. Doubts about the effectiveness of non-lead bullets for a humane kill of game animals in hunting have been discussed. The length of the escape distance after the shot has been used previously as an indicator for bullet performance. Objective The object of this study was to determine how the bullet material (lead or non-lead) influences the observed escape distances. Methods 1,234 records of the shooting of roe deer (Capreolus capreolus) and 825 records of the shooting of wild boar (Sus scrofa) were evaluated. As the bullet material cannot be regarded as the sole cause of variability of escape distances, interactions of other potential influencing variables like shot placement, shooting distance, were analyzed using conditional regression trees and two-part hurdle models. Results The length of the escape distance is not influenced by the use of lead or non-lead ammunition with either roe deer or wild boar. With roe deer, the length of the escape distance is influenced significantly by the shot placement and the type of hunting. Increasing shooting distances increased the length of the escape distance. With wild boar, shot placement and the age of the animals were found to be a significant influencing factor on the length of the escape distance. Conclusions The length of the escape distance can be used as an indicator for adequate bullet effectiveness for humane killings of game animals in hunting. Non-lead bullets already exist which have an equally reliable killing effect as lead bullets.	[Martin, Annett; Selhorst, Thomas; Mueller-Graf, Christine; Greiner, Matthias] BfR Fed Inst Risk Assessment, Dept Exposure, Berlin, Germany; [Gremse, Carl; Lahrssen-Wiederholt, Monika] BfR Fed Inst Risk Assessment, Dept Safety Food Chain, Berlin, Germany; [Bandick, Niels] BfR Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany	Federal Institute for Risk Assessment; Federal Institute for Risk Assessment; Federal Institute for Risk Assessment	Martin, A (corresponding author), BfR Fed Inst Risk Assessment, Dept Exposure, Berlin, Germany.	annett.martin@bfr.bund.de	Greiner, Matthias/D-2812-2013	Greiner, Matthias/0000-0003-4974-5970; Muller-Graf, Christine/0000-0002-0122-7528; Gremse, Carl/0000-0002-9936-4255	Federal Ministry of Food and Agriculture (BMEL) in Germany; Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development); European Poultry, Egg and Game Association (EPEGA); Federal Ministry of Food and Agriculture (BMEL); German Hunting Association (DJV); Bavarian Hunting Association (BJV); Association of German Professional Hunters (BDB); Federation of Hunting and Sport Weapon and Ammunition Manufacturers; German Lander of Mecklen-burg-West Pomerania; German Lander of Lower Saxony; German Lander of Saxony-Anhalt; German Lander of Bavaria; German Lander of Hessen; German Lander of North Rhine-Westphalia; German Lander of Hamburg; German Lander of Bremen	Federal Ministry of Food and Agriculture (BMEL) in Germany; Deutscher Jagdverband e.V. (DJV, German Hunting Association); Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association); Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters); Verband der Hersteller von Jagd-; Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition); Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development); European Poultry, Egg and Game Association (EPEGA); Federal Ministry of Food and Agriculture (BMEL); German Hunting Association (DJV); Bavarian Hunting Association (BJV); Association of German Professional Hunters (BDB); Federation of Hunting and Sport Weapon and Ammunition Manufacturers; German Lander of Mecklen-burg-West Pomerania; German Lander of Lower Saxony; German Lander of Saxony-Anhalt; German Lander of Bavaria; German Lander of Hessen; German Lander of North Rhine-Westphalia; German Lander of Hamburg; German Lander of Bremen	The study was supported mainly by the Federal Ministry of Food and Agriculture (BMEL) in Germany (http://www.bmel.de) but also by the listed Lander (Mecklenburg-Western Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hesse, North Rhine-Westphalia, Hamburg and Bremen) and organisms (European Poultry, Egg and Game Association (EPEGA), Deutscher Jagdverband e.V. (DJV, German Hunting Association), Bayerischer Jagdverband e.V. (BJV, Bavarian Hunting Association), Bundesverband Deutscher Berufsjager e.V. (German Association of Professional Hunters), Verband der Hersteller von Jagd-, Sportwaffen and Munition e.V. (JSM, Association of the Manufacturers of Hunting and Sports Weapons and Ammunition), Universitat fur Nachhaltige Entwicklung Eberswalde (HNEE, University for Sustainable Development)). A lot of people helped obtaining the data: the hunters, game traders and others, but were not employed or contracted to do so. The funders had no active role in study design, analysis, decision to publish or preparation of the manuscript.; We would like to thank the following project partners for their support and financial assistance:; The Federal Ministry of Food and Agriculture (BMEL), the German Lander of Mecklen-burg-West Pomerania, Lower Saxony, Saxony-Anhalt, Bavaria, Hessen, North Rhine-Westphalia, Hamburg and Bremen, the German Hunting Association (DJV), the Bavarian Hunting Association (BJV), the Association of German Professional Hunters (BDB), and the industry stakeholders, represented by the European Poultry, Egg and Game Wholesale and Import Society (EPEGA), as well as the Federation of Hunting and Sport Weapon and Ammunition Manufacturers. A lot of people were involved in this project and we would like to thank them for their valuable contributions especially Dr. Antje Gerofke, Daniela Schlichting, Christine Sommerfeld, Dr. Markus Spolders, Dr. Ellen Ulbig and Dr. Helmut Schaffi to name only a few.	Alexander J, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1570; Bahr B, 2013, BFR S FORSCH ZUM THE; Berrens K, 1996, U JAGD LEXIKON; BfR, 2014, RES PROJ SAF GAM MEA; Brodowski G, 1998, FLEISCHWIRTSCHAFT, V78, P1298; Caudell Joe N., 2012, Human-Wildlife Interactions, V6, P105; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Deutscher Jagdverband, 2016, JAHR BUND DEUTSCHL; DEVA Deutsche Versuchs-und Pruf-Anstalt fur Jagd-und Sportwaffen e. V, 2011, SCHL ZUM FORSCH 1 AB; Doring V, 2007, PRAKTISCHE WILDBRETH, P17; Drees E., 2008, WILDBRETHYGIENE BEGL, P29; Gawlick H, 1975, ZIELBALLISTISCHE UNT; Gottlein A, 2013, BFR S FORSCH ZUM THE; Gremse C, 2012, ABSCHLUSSBERICHT 1 E; Gremse C, 2015, ENTWICKLUNG BEGRU E; Gremse C, 2014, ENTSCHEIDUNGSHILFEVO; Gremse F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102015; Hacklander K., 2015, EIGNUNG BLEIFREIER B; Haseder IE, 2000, KNAURS GROSSES JAGDL; Hoffmann D, 2013, BFR S FORSCH ZUM THE; Hothorn T, 2015, PARTY LAB RECURSIVE; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Kanstrup N, 2016, EUR J WILDLIFE RES, V62, P333, DOI 10.1007/s10344-016-1006-0; Knott Jeff, 2009, Conservation Evidence, V6, P71; Krone O., 2009, INGESTION LEAD SPENT; Lahrssen-Wiederholt M, 2013, BFR S FORSCH ZUM THE; Lahrssen-Wiederhott M, 2015, FLEISCHWIRTSCHAFT, V95, P99; Langgemach T, 2006, NATUR LANDSCHAFT, V81, P320; Madry MM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034003; Muller-Graf C, 2017, GAME MEAT HYGIENE: FOOD SAFETY AND SECURITY, P201, DOI 10.3920/978-90-8686-840-7_12; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; Pfannenstiel HD, 2014, TOTUNGSWIRKUNG TIERS; Spicher V, 2008, BLEIVERGIFTUNGEN BEI, P81; Steinhauser N., 2014, GESCHOSSWIRKUNG KUGE; Tavecchia G, 2001, J APPL ECOL, V38, P1197, DOI 10.1046/j.0021-8901.2001.00684.x; Thomas VG, 2013, AMBIO, V42, P737, DOI 10.1007/s13280-012-0361-7; Trinogga A, 2013, SCI TOTAL ENVIRON, V443, P226, DOI 10.1016/j.scitotenv.2012.10.084; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V393, P291, DOI 10.1016/j.scitotenv.2008.01.022; [TVT Tierarztlichen Vereinigung fur Tierschutz e. V.], 2011, 123 TVT; Ulbig E, 2013, BFR S FORSCH ZUM THE; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	43	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185029	10.1371/journal.pone.0185029	http://dx.doi.org/10.1371/journal.pone.0185029			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926620	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600062
J	Alkozei, A; Smith, R; Dailey, NS; Bajaj, S; Killgore, WDS				Alkozei, Anna; Smith, Ryan; Dailey, Natalie S.; Bajaj, Sahil; Killgore, William D. S.			Acute exposure to blue wavelength light during memory consolidation improves verbal memory performance	PLOS ONE			English	Article							PREFRONTAL CORTEX; LOCUS-COERULEUS; ALERTNESS; SENSITIVITY; INVOLVEMENT	Acute exposure to light within the blue wavelengths has been shown to enhance alertness and vigilance, and lead to improved speed on reaction time tasks, possibly due to activation of the noradrenergic system. It remains unclear, however, whether the effects of blue light extend beyond simple alertness processes to also enhance other aspects of cognition, such as memory performance. The aim of this study was to investigate the effects of a thirty minute pulse of blue light versus placebo (amber light) exposure in healthy normally rested individuals in the morning during verbal memory consolidation (i.e., 1.5 hours after memory acquisition) using an abbreviated version of the California Verbal Learning Test (CVLT-II). At delayed recall, individuals who received blue light (n = 12) during the consolidation period showed significantly better long-delay verbal recall than individuals who received amber light exposure (n = 18), while controlling for the effects of general intelligence, depressive symptoms and habitual wake time. These findings extend previous work demonstrating the effect of blue light on brain activation and alertness to further demonstrate its effectiveness at facilitating better memory consolidation and subsequent retention of verbal material. Although preliminary, these findings point to a potential application of blue wavelength light to optimize memory performance in healthy populations. It remains to be determined whether blue light exposure may also enhance performance in clinical populations with memory deficits.	[Alkozei, Anna; Smith, Ryan; Dailey, Natalie S.; Bajaj, Sahil; Killgore, William D. S.] Univ Arizona, Coll Med, Dept Psychiat, Tucson, AZ 85721 USA	University of Arizona	Killgore, WDS (corresponding author), Univ Arizona, Coll Med, Dept Psychiat, Tucson, AZ 85721 USA.	killgore@psychiatry.arizona.edu	Bajaj, Sahil/C-6580-2016	Bajaj, Sahil/0000-0003-0629-6036; Smith, Ryan/0000-0002-4448-185X; Dailey, Natalie S./0000-0003-4800-4118	U.S. Army US Army MOMRP Grant [W81XWH-11-1-0056]; Arizona Health Education Centers (AHEC) Research Grant	U.S. Army US Army MOMRP Grant; Arizona Health Education Centers (AHEC) Research Grant	This study was supported by a U.S. Army US Army MOMRP Grant (W81XWH-11-1-0056) as well as by an Arizona Health Education Centers (AHEC) Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkozei A, 2016, SLEEP, V39, P1671, DOI 10.5665/sleep.6090; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Chellappa SL, 2014, P NATL ACAD SCI USA, V111, P6087, DOI 10.1073/pnas.1320005111; Delis D. C., 2000, CVLT 2 CALIFORNIA VE; Dijk DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000145; FlorinLechner SM, 1996, BRAIN RES, V742, P89, DOI 10.1016/S0006-8993(96)00967-5; FOOTE SL, 1991, PROG BRAIN RES, V88, P521; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; Lockley SW, 2006, SLEEP, V29, P161; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; Protopopescu X, 2008, HIPPOCAMPUS, V18, P985, DOI 10.1002/hipo.20468; Riemersma-van Der Lek RF, 2008, JAMA-J AM MED ASSOC, V299, P2642, DOI 10.1001/jama.299.22.2642; Ruger M, 2006, AM J PHYSL REGULATOR, V290, pR1413; Sara SJ, 1999, LEARN MEMORY, V6, P88; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; Tully K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-15; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; Vandewalle G, 2013, J COGNITIVE NEUROSCI, V25, P2072, DOI 10.1162/jocn_a_00450; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Wechsler D, 2011, WASI 2 WECHSLER ABBR	26	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184884	10.1371/journal.pone.0184884	http://dx.doi.org/10.1371/journal.pone.0184884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922397	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300039
J	Canestrari, D; Bolopo, D; Turlings, TCJ; Roder, G; Marcos, JM; Baglione, V				Canestrari, Daniela; Bolopo, Diana; Turlings, Ted C. J.; Roder, Gregory; Marcos, Jose M.; Baglione, Vittorio			Formal comment to Soler et al.: Great spotted cuckoo nestlings have no antipredatory effect on magpie or carrion crow host nests in southern Spain	PLOS ONE			English	Editorial Material							BROOD PARASITISM; MUTUALISM; EVOLUTION; ECOLOGY; CHICKS		[Canestrari, Daniela] Univ Oviedo, Dept Biol Organisms & Syst BOS, Oviedo, Spain; [Canestrari, Daniela] UO, CSIC, UMIB, Res Unit Biodivers, Mieres, Spain; [Bolopo, Diana] Univ Cape Town, FitzPatrick Inst African Ornithol, Cape Town, South Africa; [Turlings, Ted C. J.; Roder, Gregory] Univ Neuchatel, Inst Biol, Neuchatel, Switzerland; [Marcos, Jose M.; Baglione, Vittorio] Univ Valladolid, Dept Agroforestry, Palencia, Spain; [Baglione, Vittorio] Sustainable Forest Management Res Inst, Palencia, Spain; [Baglione, Vittorio] Univ Leon, Dept Biodiversidad & Gest Ambiental, Leon, Spain	University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); University of Cape Town; University of Neuchatel; Universidad de Valladolid; Universidad de Leon	Canestrari, D (corresponding author), Univ Oviedo, Dept Biol Organisms & Syst BOS, Oviedo, Spain.; Canestrari, D (corresponding author), UO, CSIC, UMIB, Res Unit Biodivers, Mieres, Spain.	canestraridaniela@uniovi.es	Turlings, Ted CJ/E-8671-2012; Bolopo, Diana/AAU-2798-2020; Bolopo, Diana/K-3413-2017	Turlings, Ted CJ/0000-0002-8315-785X; Bolopo, Diana/0000-0002-7989-534X; Bolopo, Diana/0000-0002-7989-534X; Roder, Gregory/0000-0002-7110-294X; Canestrari, Daniela/0000-0001-9112-0208	Spanish Ministry of Economy and Competitiveness [CGL2016-77636-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness, Projects CGL2016-77636-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-de-Reyna L, 1998, OX ORN SER, V9, P129; Baglione V, 2017, BEHAV ECOL, V28, P49, DOI 10.1093/beheco/arw131; Canestrari D, 2014, SCIENCE, V343, P1350, DOI 10.1126/science.1249008; Canestrari D, 2009, ANIM BEHAV, V77, P1337, DOI 10.1016/j.anbehav.2009.02.009; Cheney KL, 2005, BIOL LETTERS, V1, P162, DOI 10.1098/rsbl.2004.0288; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Hatchwell BJ, 2017, BEHAV ECOL, V28, P360, DOI 10.1093/beheco/arx009; Leimar O, 2010, COOPERATION DIRECT F, P2619; Nakagawa S, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0196-3; Payne RB, 2005, THE CUCKOOS; Roder G, 2014, J CHEM ECOL, V40, P320, DOI 10.1007/s10886-014-0426-0; Siepielski AM, 2007, P ROY SOC B-BIOL SCI, V274, P1799, DOI 10.1098/rspb.2007.0449; Soler M, 1998, OECOLOGIA, V117, P381, DOI 10.1007/s004420050671; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173080; Trnka A, 2016, J AVIAN BIOL, V47, P288, DOI 10.1111/jav.00785	16	1	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184446	10.1371/journal.pone.0184446	http://dx.doi.org/10.1371/journal.pone.0184446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922382	gold, Green Published, Green Submitted			2022-12-27	WOS:000411059300017
J	Fu, HJ; Zhang, B; Tong, JL; Bedell, H; Zhang, HC; Yang, YT; Nie, CC; Luo, YD; Liu, XL				Fu, Haojie; Zhang, Bin; Tong, Jianliang; Bedell, Harold; Zhang, Hecheng; Yang, Yating; Nie, Chaochao; Luo, Yingdong; Liu, Xiaoling			Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; TREATMENTS TRIALS; CHOROIDAL NEOVASCULARIZATION; VISION LOSS; FILLING-IN; METAMORPHOPSIA; RANIBIZUMAB; BEVACIZUMAB; MORPHOLOGY; MEMBRANE	Purpose To measure visual acuity and metamorphopsia in patients with age-related macular degeneration (AMD) and to explore their relationship with macular lesions. Methods In this cross-sectional study, a total of 32 normal subjects (32 eyes) and 35 AMD patients (35 eyes) were recruited. They were categorized into 4 groups: normal, dry AMD, non-active wet AMD, and active wet AMD. Best-corrected visual acuity (BCVA) was measured using the Early Treatment Diabetic Retinopathy Study protocol. Metamorphopsia was quantified with the orientation discrimination threshold (ODT). Macular lesions, including drusen, subretinal fluid (SRF), intra-retinal fluid (IRF), pigmented epithelium detachment (PED), and scarring, were identified with spectral-domain optical coherence tomography (SD-OCT). A linear regression model was established to identify the relationships between the functional and structural changes. Results BCVA progressively worsened across the normal, dry AMD, non-active wet AMD, and active wet AMD groups (P < 0.001), and ODT increased across the groups (P < 0.001). The correlation between BCVA and ODT varied among the groups. The partial correlation between BCVA and ODT was -0.61 (P < 0.001). Linear regression showed that ODT significantly depended on IRF (beta = 0.61, P < 0.001), SRF (beta = 0.34, P = 0.003), and scarring (beta = 0.26, P = 0.050), while BCVA significantly depended only on scarring (beta = -0.52, P < 0.001), and IRF (beta = -0.36, P = 0.016). Conclusions From dry AMD to active wet AMD, BCVA gradually worsened while ODT increased. The correlation between BCVA and ODT varied among these groups, indicating that AMD lesions affect them differently. ODT and BCVA should be used concurrently for better monitoring of the disease.	[Fu, Haojie; Zhang, Hecheng; Yang, Yating; Nie, Chaochao; Luo, Yingdong; Liu, Xiaoling] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Zhang, Bin] Nova Southeastern Univ, Coll Optometry, Davie, FL USA; [Tong, Jianliang] Brain Trauma Fdn, New York, NY USA; [Bedell, Harold] Univ Houston, Coll Optometry, Houston, TX USA; [Tong, Jianliang] New England Coll Optometry, Boston, MA USA	Wenzhou Medical University; Nova Southeastern University; University of Houston System; University of Houston	Liu, XL (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	drliuxiaolin@163.com	Zhang, Bin/GOH-1376-2022; Liu, Xiaoling/HGD-3566-2022	Yang, yating/0000-0001-7073-0162				Arimura E, 2011, INVEST OPHTH VIS SCI, V52, P128, DOI 10.1167/iovs.09-3535; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Bae SW, 2013, INDIAN J OPHTHALMOL, V61, P172, DOI 10.4103/0301-4738.112162; Bedell HE, 2009, OPTOMETRY VISION SCI, V86, P485, DOI 10.1097/OPX.0b013e31819fa6e2; Bloch SB, 2013, AM J OPHTHALMOL, V156, P116, DOI 10.1016/j.ajo.2013.02.012; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brar VS, 2010, MOL VIS, V16, P1848; Bringmann A, 2004, OPHTHALMIC RES, V36, P241, DOI 10.1159/000081203; Buschini E, 2011, PROG NEUROBIOL, V95, P14, DOI 10.1016/j.pneurobio.2011.05.011; Cherepanoff S, 2010, BRIT J OPHTHALMOL, V94, P918, DOI 10.1136/bjo.2009.165563; De Weerd P, 2006, PROG BRAIN RES, V154, P227, DOI 10.1016/S0079-6123(06)54012-9; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Jaffe GJ, 2013, OPHTHALMOLOGY, V120, P1860, DOI 10.1016/j.ophtha.2013.01.073; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KINGSMITH PE, 1994, VISION RES, V34, P885, DOI 10.1016/0042-6989(94)90039-6; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; Kleiner M, 2007, PERCEPTION, V36, P14; Liu L, 2010, OPTOMETRY VISION SCI, V87, P532, DOI 10.1097/OPX.0b013e3181e3dc10; Loewenstein A, 2003, OPHTHALMOLOGY, V110, P966, DOI 10.1016/S0161-6420(03)00074-5; Lovie-Kitchin Jan, 2005, Clin Exp Optom, V88, P292; Luckoff A, 2016, EMBO MOL MED, V8, P670, DOI 10.15252/emmm.201505994; Manabe K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153817; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Okamoto F, 2012, INVEST OPHTH VIS SCI, V53, P6770, DOI 10.1167/iovs.12-9683; Olsen TW, 2004, OPHTHALMOLOGY, V111, P250, DOI 10.1016/j.ophtha.2003.05.030; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Querques G, 2010, BRIT J OPHTHALMOL, V94, P292, DOI 10.1136/bjo.2009.170670; Ritter M, 2011, BRIT J OPHTHALMOL, V95, P381, DOI 10.1136/bjo.2009.175976; Schmidt-Erfurth U, 2015, OPHTHALMOLOGY, V122, P822, DOI 10.1016/j.ophtha.2014.11.017; SCHUCHARD RA, 1993, ARCH OPHTHALMOL-CHIC, V111, P776, DOI 10.1001/archopht.1993.01090060064024; Sharma S, 2016, OPHTHALMOLOGY, V123, P865, DOI 10.1016/j.ophtha.2015.12.002; Simader C, 2014, OPHTHALMOLOGY, V121, P1237, DOI 10.1016/j.ophtha.2013.12.029; Simunovic MP, 2015, RETINA-J RET VIT DIS, V35, P1285, DOI 10.1097/IAE.0000000000000581; Singer MA, 2012, OPHTHALMOLOGY, V119, P1175, DOI 10.1016/j.ophtha.2011.12.016; Suzuki M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-176; Wang YZ, 2002, INVEST OPHTH VIS SCI, V43, P2055; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Weinberger D, 1996, AM J OPHTHALMOL, V122, P864, DOI 10.1016/S0002-9394(14)70383-6; Williams MA, 2009, AGE AGEING, V38, P648, DOI 10.1093/ageing/afp136; Willoughby AS, 2015, OPHTHALMOLOGY, V122, P1846, DOI 10.1016/j.ophtha.2015.05.042; Zur D, 2003, VISION RES, V43, P971, DOI 10.1016/S0042-6989(03)00038-5	45	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185070	10.1371/journal.pone.0185070	http://dx.doi.org/10.1371/journal.pone.0185070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922378	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300055
J	Kumar, D; Al Hassan, M; Naranjo, MA; Agrawal, V; Boscaiu, M; Vicente, O				Kumar, Dinesh; Al Hassan, Mohamad; Naranjo, Miguel A.; Agrawal, Veena; Boscaiu, Monica; Vicente, Oscar			Effects of salinity and drought on growth, ionic relations, compatible solutes and activation of antioxidant systems in oleander (Nerium oleander L.)	PLOS ONE			English	Article							ABIOTIC STRESS TOLERANCE; SALT STRESS; LIPID-PEROXIDATION; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; NACL STRESS; PROLINE; HALOPHYTES; BIOSYNTHESIS	Nerium oleander is an ornamental species of high aesthetic value, grown in arid and semiarid regions because of its drought tolerance, which is also considered as relatively resistant to salt; yet the biochemical and molecular mechanisms underlying oleander's stress tolerance remain largely unknown. To investigate these mechanisms, one-year-old oleander seedlings were exposed to 15 and 30 days of treatment with increasing salt concentrations, up to 800 mM NaCl, and to complete withholding of irrigation; growth parameters and biochemical markers characteristic of conserved stress-response pathways were then determined in stressed and control plants. Strong water deficit and salt stress both caused inhibition of growth, degradation of photosynthetic pigments, a slight (but statistically significant) increase in the leaf levels of specific osmolytes, and induction of oxidative stress - as indicated by the accumulation of malondialdehyde (MDA), a reliable oxidative stress marker - accompanied by increases in the levels of total phenolic compounds and antioxidant flavonoids and in the specific activities of ascorbate peroxidase (APX) and glutathione reductase (GR). High salinity, in addition, induced accumulation of Na + and Cl -in roots and leaves and the activation of superoxide dismutase (SOD) and catalase (CAT) activities. Apart from anatomical adaptations that protect oleander from leaf dehydration at moderate levels of stress, our results indicate that tolerance of this species to salinity and water deficit is based on the constitutive accumulation in leaves of high concentrations of soluble carbohydrates and, to a lesser extent, of glycine betaine, and in the activation of the aforementioned antioxidant systems. Moreover, regarding specifically salt stress, mechanisms efficiently blocking transport of toxic ions from the roots to the aerial parts of the plant appear to contribute to a large extent to tolerance in Nerium oleander.	[Kumar, Dinesh; Al Hassan, Mohamad; Naranjo, Miguel A.; Vicente, Oscar] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia, Spain; [Kumar, Dinesh; Agrawal, Veena] Univ Delhi, Dept Bot, Delhi, India; [Boscaiu, Monica] Univ Politecn Valencia, Inst Agroforestal Mediterraneo, Valencia, Spain; [Al Hassan, Mohamad] New Zealand Inst Plant & Food Res Ltd PFR, Auckland, New Zealand	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Delhi; Universitat Politecnica de Valencia; New Zealand Institute for Plant & Food Research Ltd	Boscaiu, M (corresponding author), Univ Politecn Valencia, Inst Agroforestal Mediterraneo, Valencia, Spain.	mobosnea@eaf.upv.es	Vicente, Oscar/A-3858-2009; Boscaiu, Monica/H-7878-2015; Al Hassan, Mohamad/E-3097-2017	Vicente, Oscar/0000-0001-5076-3784; Boscaiu, Monica/0000-0002-9691-4223; Al Hassan, Mohamad/0000-0002-2297-3394	Polytechnic University of Valencia; NAMASTE fellowship from the European Union; Erasmus Mundus pre-doctoral scholarship; European Commission (Welcome Consortium)	Polytechnic University of Valencia; NAMASTE fellowship from the European Union; Erasmus Mundus pre-doctoral scholarship; European Commission (Welcome Consortium)	This work was financed by internal funds of the Polytechnic University of Valencia to Monica Boscaiu and Oscar Vicente. Dinesh Kumar's stay in Valencia was financed by a NAMASTE fellowship from the European Union, and Mohamad Al Hassan was a recipient of an Erasmus Mundus pre-doctoral scholarship financed by the European Commission (Welcome Consortium).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al Hassan M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00473; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Ashraf M, 2010, BIOTECHNOL ADV, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bautista I, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-015-2025-2; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Blainski A, 2013, MOLECULES, V18, P6852, DOI 10.3390/molecules18066852; Bose J, 2014, J EXP BOT, V65, P1241, DOI 10.1093/jxb/ert430; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caverzan A, 2016, GENET MOL BIOL, V39, P1, DOI 10.1590/1678-4685-GMB-2015-0109; Cazzonelli CI, 2011, FUNCT PLANT BIOL, V38, P833, DOI 10.1071/FP11192; Cicevan R, 2016, PEERJ, V4, DOI 10.7717/peerj.2133; Cicevan R, 2015, PROPAG ORNAM PLANTS, V15, P63; CONNELL JP, 1986, PLANT PHYSIOL, V82, P351, DOI 10.1104/pp.82.2.351; Croser C, 2001, ENVIRON POLLUT, V115, P9, DOI 10.1016/S0269-7491(01)00097-5; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; delRio LA, 1996, BIOCHEM SOC T, V24, P434, DOI 10.1042/bst0240434; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Field C. B, 2014, IPCC CLIMATE CHANGE; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Fita A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00978; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; FLOWERS TJ, 1986, Q REV BIOL, V61, P313, DOI 10.1086/415032; Gil R, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu049; Gil R, 2013, FUNCT PLANT BIOL, V40, P805, DOI 10.1071/FP12359; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gomez JM, 2004, J EXP BOT, V55, P119, DOI 10.1093/jxb/erh013; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; GRIEVE CM, 1983, PLANT SOIL, V70, P303, DOI 10.1007/BF02374789; Gunes A, 2007, J PLANT INTERACT, V2, P105, DOI 10.1080/17429140701529399; HAJJI M, 1979, PHYSIOL VEG, V17, P517; Hamamoto S, 2015, CURR OPIN BIOTECH, V32, P113, DOI 10.1016/j.copbio.2014.11.025; HERRERA J, 1991, BOT J LINN SOC, V106, P147, DOI 10.1111/j.1095-8339.1991.tb02289.x; Hoagland D.R., 1950, CALIF AES C, V347, P1, DOI DOI 10.1016/S0140-6736(00)73482-9; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hussain I, 2014, PLANT BIOSYST, V148, P1016, DOI 10.1080/11263504.2013.798369; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jisha KC, 2016, RICE SCI, V23, P242, DOI 10.1016/j.rsci.2016.08.002; Lenzi A, 2009, SCI HORTIC-AMSTERDAM, V122, P426, DOI 10.1016/j.scienta.2009.05.022; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lokhande V.H., 2012, ENV ADAPTATIONS STRE, P29, DOI DOI 10.1007/978-1-4614-0815-4_2; Lopez Gonzalez G, 1993, REGENERACION CUBIERT, P95; Manousaki E, 2011, IND ENG CHEM RES, V50, P656, DOI 10.1021/ie100270x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ozgur R, 2013, FUNCT PLANT BIOL, V40, P832, DOI 10.1071/FP12389; Pagen FJJ, 1988, OLEANDERS NERIUM L O; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Quartacci MF, 2001, J EXP BOT, V52, P77, DOI 10.1093/jexbot/52.354.77; Saed-Moucheshi A, 2014, J PLANT NUTR, V37, P1573, DOI 10.1080/01904167.2013.868483; Santos CV, 2004, SCI HORTIC-AMSTERDAM, V103, P93, DOI 10.1016/j.scienta.2004.04.009; Schiop ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135419; Shabala L, 2005, PLANTA, V222, P1041, DOI 10.1007/s00425-005-0074-2; Shabala S, 2003, FUNCT PLANT BIOL, V30, P507, DOI 10.1071/FP03016; Shankar V, 2016, APPL BIOCHEM BIOTECH, V178, P267, DOI 10.1007/s12010-015-1870-1; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Slama I, 2015, ANN BOT-LONDON, V115, P433, DOI 10.1093/aob/mcu239; Soussi M, 1998, J EXP BOT, V49, P1329, DOI 10.1093/jexbot/49.325.1329; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Taffouo V. D., 2010, International Journal of Botany, V6, P53; Taibi K, 2016, S AFR J BOT, V105, P306, DOI 10.1016/j.sajb.2016.03.011; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Volkov V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00873; WEIMBERG R, 1987, PHYSIOL PLANTARUM, V70, P381, DOI 10.1111/j.1399-3054.1987.tb02832.x; Wu L, 2001, STUDIES SALT TOLERAN; Yan K, 2017, PLANT PHYSIOL BIOCH, V112, P326, DOI 10.1016/j.plaphy.2017.01.020; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	79	77	79	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185017	10.1371/journal.pone.0185017	http://dx.doi.org/10.1371/journal.pone.0185017			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922384	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300053
J	Arcarons, N; Morato, R; Vendrell, M; Yeste, M; Lopez-Bejar, M; Rajapaksha, K; Anzar, M; Mogas, T				Arcarons, Nuria; Morato, Roser; Vendrell, Meritxell; Yeste, Marc; Lopez-Bejar, Manel; Rajapaksha, Kosala; Anzar, Muhammad; Mogas, Teresa			Cholesterol added prior to vitrification on the cryotolerance of immature and in vitro matured bovine oocytes	PLOS ONE			English	Article							METHYL-BETA-CYCLODEXTRIN; PLASMA-MEMBRANE CHOLESTEROL; EARLY EMBRYO DEVELOPMENT; DEVELOPMENTAL COMPETENCE; BLASTOCYST DEVELOPMENT; BODIPY-CHOLESTEROL; GERMINAL VESICLE; CRYOPRESERVATION; EXPRESSION; IMPROVE	This study examines whether incorporating cholesterol-loaded methyl-beta-cyclodextrin (CLC) in the bovine oocyte plasma membrane improves oocyte tolerance to vitrification. In vitro matured oocytes were incubated with 2 mg/ml BODIPY-labeled CLC for different time intervals in FCS or PVA supplemented medium or exposed to different CLC concentrations to examine the subcellular localization of cholesterol by confocal microscopy live-cell imaging. Subsequently, the effects of optimized CLC concentrations and incubation times prior to vitrification on early embryo development were assessed. Then, we evaluated the effects of pretreatment with 2 mg/ml CLC for 30 min before the vitrification of immature (GV) and in vitro matured (MII) oocytes on developmental competence and gene expression. Our results indicate a high plasma membrane labeling intensity after 30 min of incubation with 2 mg/ml CLC for 30 min, regardless of the holding medium used. When oocytes were incubated with 1 mg/ml, 2 mg/ml and 3 mg/ml of CLC, intense labeling was observed at the plasma membrane after 40, 30 and 20 min, respectively. CLC pre-treatment before the vitrification of bovine oocytes did not affect subsequent cleavage and embryo development rates irrespective of CLC concentrations, incubation times or meiotic stage. However, pretreatment seems to improve the quality of embryos derived from vitrified oocytes, mainly when oocytes were vitrified at the GV stage.	[Arcarons, Nuria; Morato, Roser; Vendrell, Meritxell; Mogas, Teresa] Univ Autonomous Barcelona, Dept Anim Med & Surg, Cerdanyola Del Valles, Spain; [Vendrell, Meritxell; Lopez-Bejar, Manel] Univ Autonomous Barcelona, Dept Anim Hlth & Anat, Cerdanyola Del Valles, Spain; [Yeste, Marc] Univ Girona, Inst Food & Agr Technol, Girona, Spain; [Rajapaksha, Kosala; Anzar, Muhammad] Univ Saskatchewan, Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Saskatoon, SK, Canada; [Rajapaksha, Kosala; Anzar, Muhammad] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK, Canada	Universitat de Girona; Agriculture & Agri Food Canada; University of Saskatchewan; University of Saskatchewan	Mogas, T (corresponding author), Univ Autonomous Barcelona, Dept Anim Med & Surg, Cerdanyola Del Valles, Spain.	teresa.mogas@uab.cat	Lopez-Bejar, Manel/S-2429-2019; Yeste, Marc/G-5945-2012; Mogas, Teresa/M-3746-2015	Lopez-Bejar, Manel/0000-0001-9490-6126; Yeste, Marc/0000-0002-2209-340X; Mogas, Teresa/0000-0002-6733-1328	Spanish Ministry of Science and Innovation [AGL2013-46769]; Generalitat de Catalunya [2014 SGR 547]; FPU scholarship [FPU12-01419]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); FPU scholarship(Spanish Government)	This study was supported by: the Spanish Ministry of Science and Innovation (Project AGL2013-46769), http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem. 7eeac5cd345b4f34f09dfd1001432ea0/?vgnextoid=83b192b9036c2210VgM/CM1000001d04140 aRCRD, to TM and MLB; The Generalitat de Catalunya (Project No. 2014 SGR 547), http://agaur.gencat.catteniinici/index.html, to TM and MLB; and NA was supported by FPU scholarship (FPU12-01419), http://www.mecd.gob.es/servicios-alciudadano-mecd/en/catalogo/general/education/998758/ficha.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jonathan Lamarre, from the University of Guelph, for his valuable comments on this manuscript. This study was supported by the Spanish Ministry of Science and Innovation (Project AGL2013-46769) and Generalitat de Catalunya (Project No. 2014 SGR 547). NA was supported by FPU scholarship (FPU12-01419).	Agca Y, 2000, MOL REPROD DEV, V55, P212, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;212::AID-MRD11&gt;3.0.CO;2-M; Agca Y, 1998, MOL REPROD DEV, V49, P408, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt;408::AID-MRD8&gt;3.0.CO;2-R; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arcarons N, 2015, REPROD FERT DEVELOP, V28, P1560; Ariola FS, 2009, BIOPHYS J, V96, P2696, DOI 10.1016/j.bpj.2008.12.3922; Balasubramanian S, 2007, THERIOGENOLOGY, V68, P265, DOI 10.1016/j.theriogenology.2007.05.044; Buschiazzo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062919; Christian AE, 1997, J LIPID RES, V38, P2264; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Horvath G, 2006, THERIOGENOLOGY, V66, P1026, DOI 10.1016/j.theriogenology.2006.03.004; Jimenez-Trigos E, 2013, CRYOBIOLOGY, V67, P106, DOI 10.1016/j.cryobiol.2013.05.006; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lange Y, 1999, J LIPID RES, V40, P2264; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Lopera-Vasquez R, 2015, REPROD FERTILITY DEV; Morato R, 2008, CRYOBIOLOGY, V57, P137, DOI 10.1016/j.cryobiol.2008.07.003; Morato R, 2011, CRYOBIOLOGY, V63, P240, DOI 10.1016/j.cryobiol.2011.09.002; MULDREW K, 1994, BIOPHYS J, V66, P532, DOI 10.1016/S0006-3495(94)80806-9; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Opiela J, 2009, ANN ANIM SCI, V9, P3; Prentice-Biensch JR, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-73; Purdy PH, 2004, BIOL REPROD, V71, P522, DOI 10.1095/biolreprod.103.025577; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Rizos D, 2001, THERIOGENOLOGY, V56, P1, DOI 10.1016/S0093-691X(01)00538-6; ROTTEM S, 1973, BIOCHIM BIOPHYS ACTA, V323, P495, DOI 10.1016/0005-2736(73)90158-2; RUFFING NA, 1993, CRYOBIOLOGY, V30, P562, DOI 10.1006/cryo.1993.1059; Sagirkaya H, 2006, REPRODUCTION, V131, P895, DOI 10.1530/rep.1.01021; Salinas-Flores L, 2008, CRYOLETTERS, V29, P391; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Seidel GE, 2006, THERIOGENOLOGY, V65, P228, DOI 10.1016/j.theriogenology.2005.09.025; Shirazi A, 2016, THERIOGENOLOGY, V86, P2136, DOI 10.1016/j.theriogenology.2016.07.005; Shirazi A, 2014, ZYGOTE, V22, P165, DOI 10.1017/S096719941200038X; Spricigo JFW, 2012, CRYOBIOLOGY, V65, P319, DOI 10.1016/j.cryobiol.2012.09.001; Sripunya N, 2010, J REPROD DEVELOP, V56, P176, DOI 10.1262/jrd.09-108H; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093641; Wang F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001819; Wustner D, 2011, CHEM PHYS LIPIDS, V164, P221, DOI 10.1016/j.chemphyslip.2011.01.004; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5; Zeron Y, 1999, CRYOBIOLOGY, V38, P35, DOI 10.1006/cryo.1998.2139; Zhang H, 2014, MOL REPROD DEV, V81, P87, DOI 10.1002/mrd.22287; Zhao MT, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104471; Zhou GB, 2013, ANIM BIOTECHNOL, V24, P94, DOI 10.1080/10495398.2012.755466; Zhou XL, 2010, CRYOBIOLOGY, V61, P66, DOI 10.1016/j.cryobiol.2010.05.002; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	51	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184714	10.1371/journal.pone.0184714	http://dx.doi.org/10.1371/journal.pone.0184714			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910399	Green Published, gold			2022-12-27	WOS:000410859200083
J	Horswill, C; Trathan, PN; Ratcliffe, N				Horswill, Cat; Trathan, Philip N.; Ratcliffe, Norman			Linking extreme interannual changes in prey availability to foraging behaviour and breeding investment in a marine predator, the macaroni penguin	PLOS ONE			English	Article							BREATH-HOLD DIVERS; ROCKHOPPER PENGUINS; EUDYPTES-CHRYSOLOPHUS; PROVISIONING BEHAVIOR; SOUTH GEORGIA; VARIABILITY; PERFORMANCE; CHRYSOCOME; SURVIVAL; CLIMATE	Understanding the mechanisms that link prey availability to predator behaviour and population change is central to projecting how a species may respond to future environmental pressures. We documented the behavioural responses and breeding investment of macaroni penguins Eudyptes chrysolophus across five breeding seasons where local prey density changed by five-fold; from very low to highly abundant. When prey availability was low, foraging trips were significantly longer and extended overnight. Birds also foraged farther from the colony, potentially in order to reach more distant foraging grounds and allow for increased search times. These extended foraging trips were also linked to a marked decrease in fledgling weights, most likely associated with reduced rates of provisioning. Furthermore, by comparing our results with previous work on this population, it appears that lowered first-year survival rates associated, at least partially, with fledging masses were also evident for this cohort. This study integrates a unique set of prey density, predator behaviour and predator breeding investment data to highlight a possible behavioural mechanism linking perturbations in prey availability to population demography.	[Horswill, Cat; Trathan, Philip N.; Ratcliffe, Norman] NERC, British Antarctic Survey, Cambridge, England; [Horswill, Cat] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Glasgow	Horswill, C (corresponding author), NERC, British Antarctic Survey, Cambridge, England.; Horswill, C (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	catrsw@gmail.com		Horswill, Cat/0000-0002-1795-0753	National Environmental Research Council [NE/152797/X]; NERC PhD studentship grant [NE/I52797/X]; NERC [bas0100035] Funding Source: UKRI; Natural Environment Research Council [bas0100035] Funding Source: researchfish	National Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC PhD studentship grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by National Environmental Research Council, http://www.nerc.ac.uk/, Grant No. NE/152797/X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the research assistants at Bird Island, South Georgia (2001-2005). We also thank Sophie Fielding for many discussions regarding krill density and distribution around South Georgia, Brendan F. Godley, Tom Hart and Jon A. Green for reading various earlier versions of this manuscript, Jason Matthiopoulos, Esther L. Jones and Debbie J. F. Russell for technical advice on early model development and coding, as well as Helen Peat and Jenny Thomas for data management. This paper is a contribution to the Ecosystems programme of the British Antarctic Survey. This analysis was funded by a NERC PhD studentship grant number NE/I52797/X.	Barlow KE, 2002, MAR ECOL PROG SER, V232, P291, DOI 10.3354/meps232291; Barlow KE, 2002, IBIS, V144, P248, DOI 10.1046/j.1474-919X.2002.00046.x; Baylis AMM, 2013, POLAR BIOL, V36, P1007, DOI 10.1007/s00300-013-1324-6; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Bost CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9220; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cherel Y, 1999, MAR BIOL, V134, P375, DOI 10.1007/s002270050554; Cimino MA, 2014, MAR ECOL PROG SER, V513, P253, DOI 10.3354/meps10928; Crossin GT, 2015, MAR ECOL PROG SER, V530, P163, DOI 10.3354/meps11320; CROXALL JP, 1993, J ZOOL, V230, P31, DOI 10.1111/j.1469-7998.1993.tb02670.x; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; Dehnhard N, 2014, IBIS, V156, P548, DOI 10.1111/ibi.12167; Fielding S, 2014, ICES J MAR SCI, V71, P2578, DOI 10.1093/icesjms/fsu104; Fox J, 2015, PACKAGE CAR V 2 0 25; Green JA, 2009, POLAR BIOL, V32, P645, DOI 10.1007/s00300-008-0568-z; Hart T, 2010, ANIM BEHAV, V79, P845, DOI 10.1016/j.anbehav.2009.12.033; Hart T, 2010, MAR BIOL, V157, P1543, DOI 10.1007/s00227-010-1428-2; Hennicke JC, 2005, MAR ECOL PROG SER, V296, P173, DOI 10.3354/meps296173; Horswill C, 2016, ECOLOGY, V97, P1919, DOI 10.1002/ecy.1452; Horswill C, 2016, MAR ECOL PROG SER, V548, P233, DOI 10.3354/meps11626; Horswill C, 2014, J ANIM ECOL, V83, P1057, DOI 10.1111/1365-2656.12229; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kock K-H., 1992, ANTARCTIC FISH FISHE; Morrison KW, 2016, BEHAV ECOL SOCIOBIOL, V70, P467, DOI 10.1007/s00265-016-2060-z; Murphy EJ, 2007, P ROY SOC B-BIOL SCI, V274, P3057, DOI 10.1098/rspb.2007.1180; Olsson O, 1997, POLAR BIOL, V18, P161, DOI 10.1007/s003000050172; Pinheiro J, 2016, NLME LINEAR MIXED EF; Putz K, 2002, AQUAT CONSERV, V12, P75, DOI 10.1002/aqc.478; Ratcliffe N, 2014, J BIOGEOGR, V41, P1183, DOI 10.1111/jbi.12279; Reid K, 1996, POLAR BIOL, V16, P105, DOI 10.1007/BF02390431; Rey AR, 2007, IBIS, V149, P826; Senner NR, 2015, J ANIM ECOL, V84, P1164, DOI 10.1111/1365-2656.12381; Sherley RB, 2017, CURR BIOL, V27, P563, DOI 10.1016/j.cub.2016.12.054; Sherley RB, 2013, MAR ECOL PROG SER, V473, P291, DOI 10.3354/meps10070; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Sparling CE, 2007, ANIM BEHAV, V74, P207, DOI 10.1016/j.anbehav.2006.06.022; Sumner M, 2013, TRIP SPATIAL ANAL AN; Sumner MD, 2013, TRIPESTIMATION METRO; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; Trathan PN, 2006, MAR ECOL PROG SER, V323, P239, DOI 10.3354/meps323239; Trathan PN, 2008, MAR ECOL PROG SER, V370, P285, DOI 10.3354/meps07638; Trathan PN, 2003, FISH OCEANOGR, V12, P569, DOI 10.1046/j.1365-2419.2003.00268.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Waluda CM, 2012, MAR ECOL PROG SER, V466, P261, DOI 10.3354/meps09930; Whitehead TO, 2017, MAR ECOL PROG SER, V565, P227, DOI 10.3354/meps12017; Williams T.D., 1995, PENGUINS; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Zimmer I, 2011, DOES FORAGING PERFOR, V6; Zuur Alain F., 2009, P1	52	13	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184114	10.1371/journal.pone.0184114	http://dx.doi.org/10.1371/journal.pone.0184114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910405	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000410859200032
J	Huizer, K; Mustafa, DAM; Spelt, JC; Kros, JM; Sacchetti, A				Huizer, Karin; Mustafa, Dana A. M.; Spelt, J. Clarissa; Kros, Johan M.; Sacchetti, Andrea			Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; CORD BLOOD; ANGIOGENIC CYTOKINES; MICROPARTICLES; DISTINCT; BIOLOGY; NEOVASCULARIZATION; IDENTIFICATION; INFLAMMATION; ENUMERATION	The characterization of circulating endothelial progenitor cells (EPCs) is fundamental to any study related to angiogenesis. Unfortunately, current literature lacks consistency in the definition of EPC subsets due to variations in isolation strategies and inconsistencies in the use of lineage markers. Here we address critical points in the identification of hematopoietic progenitor cells (HPCs), circulating endothelial cells (CECs), and culture-generated outgrowth endothelial cells (OECs) from blood samples of healthy adults (AB) and umbilical cord (UCB). Peripheral blood mononuclear cells (PBMCs) were enriched using a Ficoll-based gradient followed by an optimized staining and gating strategy to enrich for the target cells. Sorted EPC populations were subjected to RT-PCR for tracing the expression of markers beyond the limits of cell surface-based immunophenotyping. Using CD34, CD133 and c-kit staining, combined with FSC and SSC, we succeeded in the accurate and reproducible identification of four HPC subgroups and found significant differences in the respective populations in AB vs. UCB. Co-expression analysis of endothelial markers on HPCs revealed a complex pattern characterized by various subpopulations. CECs were identified by using CD34, KDR, CD45, and additional endothelial markers, and were subdivided according to their apoptotic state and expression of c-kit. Comparison of UCB-CECs vs. AB-CECs revealed significant differences in CD34 and KDR levels. OECs were grown from PBMC-fractions We found that viable c-kit(+) CECs are a candidate circulating precursor for CECs. RT-PCR to angiogenic factors and receptors revealed that all EPC subsets expressed angiogenesis-related molecules. Taken together, the improvements in immunophenotyping and gating strategies resulted in accurate identification and comparison of better defined cell populations in a single procedure.	[Huizer, Karin; Mustafa, Dana A. M.; Spelt, J. Clarissa; Kros, Johan M.; Sacchetti, Andrea] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Kros, JM (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	j.m.kros@erasmusmc.nl	Mustafa, Dana/AAQ-6530-2021	Mustafa, Dana/0000-0003-0644-078X				Ackermann Bradley L., 2002, Current Topics in Medicinal Chemistry, V2, P53, DOI 10.2174/1568026023394605; Alvarez P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/312656; Becher MU, 2010, HERZ, V35, P342, DOI 10.1007/s00059-010-3360-0; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Blann AD, 2006, ATHEROSCLEROSIS, V188, P12, DOI 10.1016/j.atherosclerosis.2005.12.024; Burger D, 2012, J AM SOC HYPERTENS, V6, P85, DOI 10.1016/j.jash.2011.11.003; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Dome B, 2009, CRIT REV ONCOL HEMAT, V69, P108, DOI 10.1016/j.critrevonc.2008.06.009; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fang S, 2012, PLOS BIOL, V10; Fang ST, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001407; George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24; Hristov M, 2012, J IMMUNOL METHODS, V381, P9, DOI 10.1016/j.jim.2012.04.003; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Kraan J, 2012, J THROMB HAEMOST, V10, P931, DOI 10.1111/j.1538-7836.2012.04681.x; Kraan J, 2012, DRUG DISCOV TODAY, V17, P710, DOI 10.1016/j.drudis.2012.01.011; Lanuti P, 2012, J IMMUNOL METHODS, V380, P16, DOI 10.1016/j.jim.2012.03.007; Lopez-Holgado N, 2007, CYTOTHERAPY, V9, P14, DOI 10.1080/14653240601047726; Matsuoka Y, 2011, STEM CELLS, V29, P1783, DOI 10.1002/stem.721; Mayani H, 2003, ARCH MED RES, V34, P476, DOI 10.1016/j.arcmed.2003.08.004; MAYANI H, 1992, EUR J HAEMATOL, V49, P225; Mayani H, 2010, EXPERT REV HEMATOL, V3, P401, DOI 10.1586/EHM.10.37; Mayr M, 2011, AM J MED, V124, P489, DOI 10.1016/j.amjmed.2011.01.015; Mund JA, 2013, ANGIOGENESIS, V16, P953, DOI 10.1007/s10456-013-9368-3; Mund JA, 2012, ARTERIOSCL THROM VAS, V32, P1045, DOI 10.1161/ATVBAHA.111.244210; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Popa ER, 2006, J MOL CELL CARDIOL, V41, P86, DOI 10.1016/j.yjmcc.2006.04.021; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Schewe M, 2016, CELL STEM CELL, V19, P38, DOI 10.1016/j.stem.2016.05.023; Schmidt-Lucke C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013790; Schmidt-Lucke C, 2010, ATHEROSCLEROSIS, V211, P249, DOI 10.1016/j.atherosclerosis.2010.02.007; Shaked Y, 2006, J CLIN ONCOL, V24, P4040, DOI 10.1200/JCO.2006.07.1175; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Singh N, 2012, J AM COLL CARDIOL, V60, P324, DOI 10.1016/j.jacc.2012.02.065; Smythe J, 2008, TISSUE ENG PT C-METH, V14, P59, DOI 10.1089/tec.2007.0251; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Tung JW, 2007, CLIN LAB MED, V27, P453, DOI 10.1016/j.cll.2007.05.001; Tura O, 2013, STEM CELLS, V31, P338, DOI 10.1002/stem.1280; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Vaughan Erin E, 2012, Methods Mol Biol, V916, P351, DOI 10.1007/978-1-61779-980-8_25; Vroling L, 2010, BRIT J CANCER, V102, P268, DOI 10.1038/sj.bjc.6605477; Wagner W, 2004, BLOOD, V104, P675, DOI 10.1182/blood-2003-10-3423; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433	52	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184895	10.1371/journal.pone.0184895	http://dx.doi.org/10.1371/journal.pone.0184895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910385	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200113
J	Tanaka, C; Tagami, T; Matsumoto, H; Matsuda, K; Kim, S; Moroe, Y; Fukuda, R; Unemoto, K; Yokota, H				Tanaka, Chie; Tagami, Takashi; Matsumoto, Hisashi; Matsuda, Kiyoshi; Kim, Shiei; Moroe, Yuta; Fukuda, Reo; Unemoto, Kyoko; Yokota, Hiroyuki			Recent trends in 30-day mortality in patients with blunt splenic injury: A nationwide trauma database study in Japan	PLOS ONE			English	Article							ENDOVASCULAR BALLOON OCCLUSION; PRACTICE MANAGEMENT GUIDELINE; HOSPITAL CARDIAC-ARREST; NONOPERATIVE MANAGEMENT; EASTERN ASSOCIATION; COMPUTED-TOMOGRAPHY; SURGERY; ADULTS; EMBOLIZATION; EXPERIENCE	Background Splenic injury frequently occurs after blunt abdominal trauma; however, limited epidemiological data regarding mortality are available. We aimed to investigate mortality rate trends after blunt splenic injury in Japan. Methods We retrospectively identified 1,721 adults with blunt splenic injury (American Association for the Surgery of Trauma splenic injury scale grades III-V) from the 2004-2014 Japan Trauma Data Bank. We grouped the records of these patients into 3 time phases: phase I (2004-2008), phase II (2009-2012), and phase III (2013-2014). Over the 3 phases, we analysed 30-day mortality rates and investigated their association with the prevalence of certain initial interventions (Mantel-Haenszel trend test). We further performed multiple imputation and multivariable analyses for comparing the characteristics and outcomes of patients who underwent TAE or splenectomy/splenorrhaphy, adjusting for known potential confounders and for within-hospital clustering using generalised estimating equation. Results Over time, there was a significant decrease in 30-day mortality after splenic injury (p < 0.01). Logistic regression analysis revealed that mortality significantly decreased over time (from phase I to phase II, odds ratio: 0.39, 95% confidence interval: 0.22-0.67; from phase I to phase III, odds ratio: 0.34, 95% confidence interval: 0.19-0.62) for the overall cohort. While the 30-day mortality for splenectomy/splenorrhaphy diminished significantly over time (p = 0.01), there were no significant differences regarding mortality for non-operative management, with or without transcatheter arterial embolisation (p = 0.43, p = 0.29, respectively). Conclusions In Japan, in-hospital 30-day mortality rates decreased significantly after splenic injury between 2004 and 2014, even after adjustment for within-hospital clustering and other factors independently associated with mortality. Over time, mortality rates decreased significantly after splenectomy/splenorrhaphy, but not after non-operative management. This information is useful for clinicians when making decisions about treatments for patients with blunt splenic injury.	[Tanaka, Chie; Tagami, Takashi; Moroe, Yuta; Fukuda, Reo; Unemoto, Kyoko] Nippon Med Sch, Tama Nagayama Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Tagami, Takashi] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Matsumoto, Hisashi] Nippon Med Sch, Chiba Hokusoh Hosp, Dept Emergency & Crit Care Med, Chiba, Japan; [Matsuda, Kiyoshi; Yokota, Hiroyuki] Musashikosugi Hosp, Nippon Med Sch, Dept Emergency & Crit Care Med, Kawasaki, Kanagawa, Japan; [Kim, Shiei] Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan	Nippon Medical School; University of Tokyo; Nippon Medical School; Nippon Medical School; Nippon Medical School	Tagami, T (corresponding author), Nippon Med Sch, Tama Nagayama Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan.; Tagami, T (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan.	t-tagami@nms.ac.jp	Tagami, Takashi/HGA-3038-2022	Tagami, Takashi/0000-0001-6953-1932	Suzuki Foundation Science Research Fund;  [KAKENHI-15H05685]	Suzuki Foundation Science Research Fund; 	This work was supported by funds from the Grants-in-Aid for Scientific Research, Japan (grant number: KAKENHI-15H05685) and the Suzuki Foundation Science Research Fund to Takashi Tagami. The funders had no role in the execution of this study or interpretation of the results.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bhullar IS, 2012, J TRAUMA ACUTE CARE, V72, P1127, DOI 10.1097/TA.0b013e3182569849; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; Chikuda H, 2014, EMERG MED J, V31, P201, DOI 10.1136/emermed-2012-202058; Cirocchi R, 2013, CRIT CARE, V17, DOI 10.1186/cc12868; Cirocchi R, 2014, ULUS TRAVMA ACIL CER, V20, P91, DOI 10.5505/tjtes.2014.99442; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Eastern Association for the Surgery of Trauma (EAST), 2003, AD HOC COMM PRACT MA; El-Matbouly M, 2016, SURG-J R COLL SURG E, V14, P52, DOI 10.1016/j.surge.2015.08.001; Haan JM, 2005, J TRAUMA, V58, P492, DOI 10.1097/01.TA.0000154575.49388.74; Hamlat CA, 2012, ANN SURG, V255, P165, DOI 10.1097/SLA.0b013e31823840ca; Hoff WS, 2002, J TRAUMA, V53, P602, DOI 10.1097/00005373-200209000-00038; Hondo K, 2013, J AM COLL SURGEONS, V217, P850, DOI 10.1016/j.jamcollsurg.2013.05.026; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Inoue J, 2016, J TRAUMA ACUTE CARE, V80, P559, DOI 10.1097/TA.0000000000000968; Jacoby RC, 2008, TRAUMA, P661; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Kimura A, 2013, J TRAUMA ACUTE CARE, V75, P202, DOI 10.1097/TA.0b013e3182905ef7; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mashiko Kunihiro, 2005, Journal of Nippon Medical School, V72, P194, DOI 10.1272/jnms.72.194; Medicine AftAoA, 2008, ABBREVIATED INJURY S; Moore EE, 2010, J TRAUMA, V69, P1600, DOI 10.1097/TA.0b013e318201124e; Moore FA, 2008, J TRAUMA, V65, P1007, DOI 10.1097/TA.0b013e31818a93bf; Norii T, 2015, J TRAUMA ACUTE CARE, V78, P721, DOI 10.1097/TA.0000000000000578; Olthof DC, 2013, J TRAUMA ACUTE CARE, V74, P546, DOI 10.1097/TA.0b013e31827d5e3a; Peitzman AB, 2005, J AM COLL SURGEONS, V201, P179, DOI 10.1016/j.jamcollsurg.2005.03.037; Peitzman AB, 2000, J TRAUMA, V49, P177, DOI 10.1097/00005373-200008000-00002; Raza M, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-14; Richardson JD, 2005, J AM COLL SURGEONS, V200, P648, DOI 10.1016/j.jamcollsurg.2004.11.005; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Sabe AA, 2009, J TRAUMA, V67, P565, DOI 10.1097/TA.0b013e3181b17010; Scarborough JE, 2016, J AM COLL SURGEONS, V223, P249, DOI 10.1016/j.jamcollsurg.2016.03.043; SOS- KANTO_ 2012_ study_ group, 2015, RESUSCITATION, V97, P76; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Surgeons ACo, 2008, ADV TRAUM LIF SUPP P; Suzuki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145963; Tagami T, 2015, ACUTE MED SURG, V2, P225, DOI 10.1002/ams2.102; Tagami T, 2013, CIRCULATION, V127, pE567, DOI 10.1161/CIRCULATIONAHA.112.154773; TEASDALE G, 1974, LANCET, V2, P81; van der Vlies CH, 2010, CARDIOVASC INTER RAD, V33, P1079, DOI 10.1007/s00270-010-9943-6; Velmahos GC, 2010, MANAGEMENT MOST SEVE	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184690	10.1371/journal.pone.0184690	http://dx.doi.org/10.1371/journal.pone.0184690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910356	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200078
J	Beuscher, S; Kruger, S; Ehrmann, W; Schmiedl, G; Milker, Y; Arz, H; Schulz, H				Beuscher, Sarah; Krueger, Stefan; Ehrmann, Werner; Schmiedl, Gerhard; Milker, Yvonne; Arz, Helge; Schulz, Hartmut			End-member modelling as a tool for climate reconstruction-An Eastern Mediterranean case study	PLOS ONE			English	Article							CLAY MINERAL DISTRIBUTION; DEEP-SEA FAN; AEGEAN SEA; SAHARAN DUST; CHEMICAL-COMPOSITION; LATE QUATERNARY; PLIOCENE SEDIMENTS; SURFACE SEDIMENTS; SUSPENDED MATTER; MARINE-SEDIMENTS	The Eastern Mediterranean Sea is a sink for terrigenous sediments from North Africa, Europe and Asia Minor. Its sediments therefore provide valuable information on the climate dynamics in the source areas and the associated transport processes. We present a high-resolution dataset of sediment core M40/4_SL71, which was collected SW of Crete and spans the last ca. 180 kyr. We analysed the clay mineral composition, the grain size distribution within the silt fraction, and the abundance of major and trace elements. We tested the potential of end-member modelling on these sedimentological datasets as a tool for reconstructing the climate variability in the source regions and the associated detrital input. For each dataset, we modelled three end members. All end members were assigned to a specific provenance and sedimentary process. In total, three end members were related to the Saharan dust input, and five were related to the fluvial sediment input. One end member was strongly associated with the sapropel layers. The Saharan dust end members of the grain size and clay mineral datasets generally suggest enhanced dust export into the Eastern Mediterranean Sea during the dry phases with short-term increases during Heinrich events. During the African Humid Periods, dust export was reduced but may not have completely ceased. The loading patterns of two fluvial end members show a strong relationship with the Northern Hemisphere insolation, and all fluvial end members document enhanced input during the African Humid Periods. The sapropel end member most likely reflects the fixation of redox-sensitive elements within the anoxic sapropel layers. Our results exemplify that end-member modelling is a valuable tool for interpreting extensive and multidisciplinary datasets.	[Beuscher, Sarah; Krueger, Stefan; Ehrmann, Werner; Milker, Yvonne] Univ Leipzig, Inst Geophys & Geol, Leipzig, Germany; [Schmiedl, Gerhard; Milker, Yvonne] Univ Hamburg, Centrum Erdsyst Forsch & Nachhaltigkeit, Hamburg, Germany; [Arz, Helge] Leibniz Inst Ostseeforsch, Rostock, Germany; [Schulz, Hartmut] Univ Tubingen, Fachbereich Geowissensch, Tubingen, Germany	Leipzig University; University of Hamburg; Leibniz Institut fur Ostseeforschung Warnemunde; Eberhard Karls University of Tubingen	Beuscher, S (corresponding author), Univ Leipzig, Inst Geophys & Geol, Leipzig, Germany.	sarah.beuscher@uni-leipzig.de	Arz, Helge/A-6659-2013; Schmiedl, Gerhard/E-6644-2017	Schmiedl, Gerhard/0000-0002-2177-6858; Arz, Helge Wolfgang/0000-0002-1997-1718	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG); DFG; University of Leipzig within the programme of Open Access Publishing	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Leipzig within the programme of Open Access Publishing	We thank the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) for providing financial support to carry out the project, and also acknowledge the support of the DFG and the University of Leipzig within the programme of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSU AE, 1995, PALAEOGEOGR PALAEOCL, V116, P71, DOI 10.1016/0031-0182(94)00092-M; BISCAYE PE, 1965, GEOL SOC AM BULL, V76, P803, DOI 10.1130/0016-7606(1965)76[803:MASORD]2.0.CO;2; Blanchet CL, 2013, EARTH PLANET SC LETT, V364, P98, DOI 10.1016/j.epsl.2013.01.009; Boere AC, 2011, GEOBIOLOGY, V9, P377, DOI 10.1111/j.1472-4669.2011.00290.x; Caley T, 2011, QUATERNARY SCI REV, V30, P3705, DOI 10.1016/j.quascirev.2011.09.015; Caquineau S, 1998, GEOPHYS RES LETT, V25, P983, DOI 10.1029/98GL00569; CHESTER R, 1977, MAR GEOL, V24, P201, DOI 10.1016/0025-3227(77)90028-7; Collins JA, 2013, CLIM PAST, V9, P1181, DOI 10.5194/cp-9-1181-2013; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; Dekov VM, 1997, SCI TOTAL ENVIRON, V201, P195, DOI 10.1016/S0048-9697(97)84057-0; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Ehrmann W, 2007, PALAEOGEOGR PALAEOCL, V249, P36, DOI 10.1016/j.palaeo.2007.01.004; Ehrmann W, 2007, INT J EARTH SCI, V96, P769, DOI 10.1007/s00531-006-0119-1; Ehrmann W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170989; Ehrmann W, 2016, CLIM PAST, V12, P713, DOI 10.5194/cp-12-713-2016; Ehrmann W, 2013, GLOBAL PLANET CHANGE, V107, P186, DOI 10.1016/j.gloplacha.2013.05.010; Emeis KC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2000PA000617; Engelstaedter S, 2006, EARTH-SCI REV, V79, P73, DOI 10.1016/j.earscirev.2006.06.004; Foucault A, 2000, PALAEOGEOGR PALAEOCL, V158, P311, DOI 10.1016/S0031-0182(00)00056-0; Frignani M, 2005, MAR GEOL, V222, P113, DOI 10.1016/j.margeo.2005.06.016; GANOR E, 1991, ATMOS ENVIRON A-GEN, V25, P2665, DOI 10.1016/0960-1686(91)90196-E; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Goudie AS, 2001, EARTH-SCI REV, V56, P179, DOI 10.1016/S0012-8252(01)00067-8; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Grobe H, 2003, GEOGRAPHIC INFORM SY; Guerzoni S, 1997, DEEP-SEA RES PT II, V44, P631, DOI 10.1016/S0967-0645(96)00096-3; Hamann Y, 2008, MAR GEOL, V248, P97, DOI 10.1016/j.margeo.2007.10.009; Hamann Y, 2009, QUATERNARY RES, V71, P453, DOI 10.1016/j.yqres.2009.01.001; Hammer O., 2001, PALAEONTOLOGICAL STA, V4; Hieke W, 1998, CRUISE NO 40, P99; Itambi AC, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2007PA001570; Jolly D, 1998, QUATERNARY SCI REV, V17, P629, DOI 10.1016/S0277-3791(98)00015-8; Just J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004146; Kotthoff U, 2008, QUATERNARY SCI REV, V27, P832, DOI 10.1016/j.quascirev.2007.12.001; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Krom MD, 1999, MAR GEOL, V160, P45, DOI 10.1016/S0025-3227(99)00015-8; Larrasoana JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076514; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lezine AM, 2011, QUATERNARY SCI REV, V30, P3001, DOI 10.1016/j.quascirev.2011.07.006; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Lykousis V, 2002, J MARINE SYST, V33, P313, DOI 10.1016/S0924-7963(02)00064-7; MALDONADO A, 1981, SEDIMENTOLOGY, V28, P21, DOI 10.1111/j.1365-3091.1981.tb01659.x; Marino G, 2015, NATURE, V522, P197, DOI 10.1038/nature14499; Mattsson JO, 1996, J ARID ENVIRON, V32, P111, DOI 10.1006/jare.1996.0011; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Moreno T, 2006, CHEMOSPHERE, V65, P261, DOI 10.1016/j.chemosphere.2006.02.052; Mulitza S, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001637; NIHLEN T, 1995, Z GEOMORPHOL, V39, P341; NIHLEN T, 1995, TELLUS B, V47, P365, DOI 10.1034/j.1600-0889.47.issue3.7.x; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Passier HF, 1997, GEOLOGY, V25, P519, DOI 10.1130/0091-7613(1997)025<0519:PCMASI>2.3.CO;2; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Poulos SE, 2009, CONT SHELF RES, V29, P2045, DOI 10.1016/j.csr.2008.11.010; PYE K, 1992, EARTH SURF PROCESSES, V17, P271, DOI 10.1002/esp.3290170306; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Renssen H, 2006, QUATERN INT, V150, P95, DOI 10.1016/j.quaint.2005.01.001; Revel M, 2010, QUATERNARY SCI REV, V29, P1342, DOI 10.1016/j.quascirev.2010.02.006; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; ROSSIGNOLSTRICK M, 1983, NATURE, V304, P46, DOI 10.1038/304046a0; Sartori R, 1975, SUSPENDED MINERAL MA, V23, P309; Scerri EML, 2014, QUATERNARY SCI REV, V101, P207, DOI 10.1016/j.quascirev.2014.07.019; Scheuvens D, 2013, EARTH-SCI REV, V116, P170, DOI 10.1016/j.earscirev.2012.08.005; SCHUTZ L, 1982, ATMOS ENVIRON, V16, P171, DOI 10.1016/0004-6981(82)90324-9; Seidel M, 2015, MATH GEOSCI, V47, P995, DOI 10.1007/s11004-015-9609-7; SUTHERLAND HE, 1984, MAR GEOL, V56, P79, DOI 10.1016/0025-3227(84)90007-0; TOMADIN L, 1991, MAR GEOL, V100, P35, DOI 10.1016/0025-3227(91)90222-P; Tomadin L., 1981, SEDIMENTARY BASINS M, P313; Tomadin L., 2000, ATTI ACCAD NAZ LIN, V11, P161, DOI [10.1007/BF02904649, DOI 10.1007/BF02904649]; VENKATARATHNAM K, 1971, MAR GEOL, V11, P261, DOI 10.1016/0025-3227(71)90028-4; WALLING DE, 1989, HYDROBIOLOGIA, V176, P125, DOI 10.1007/BF00026549; WEAVER CE, 1977, SEDIMENT GEOL, V17, pR9, DOI 10.1016/0037-0738(77)90062-8; Wehausen R, 1999, MAR GEOL, V153, P161, DOI 10.1016/S0025-3227(98)00083-8; Wehausen R, 2000, PALAEOGEOGR PALAEOCL, V158, P325, DOI 10.1016/S0031-0182(00)00057-2; Weldeab S, 2003, PALAEOGEOGR PALAEOCL, V191, P169, DOI 10.1016/S0031-0182(02)00711-3; Weldeab S, 2002, CHEM GEOL, V186, P139, DOI 10.1016/S0009-2541(01)00415-6; Weldeab S, 2002, GEOCHIM COSMOCHIM AC, V66, P3585, DOI 10.1016/S0016-7037(02)00954-7; Weldeab S, 2014, PALAEOGEOGR PALAEOCL, V410, P200, DOI 10.1016/j.palaeo.2014.06.001; Weltje GJ, 1997, MATH GEOL, V29, P503, DOI 10.1007/BF02775085; Yarincik KM, 2000, PALEOCEANOGRAPHY, V15, P593, DOI 10.1029/1999PA000401; Zhao YL, 2012, QUATERNARY SCI REV, V57, P58, DOI 10.1016/j.quascirev.2012.10.009	80	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185136	10.1371/journal.pone.0185136	http://dx.doi.org/10.1371/journal.pone.0185136			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934332	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900101
J	Demmler, KM; Klasen, S; Nzuma, JM; Qaim, M				Demmler, Kathrin M.; Klasen, Stephan; Nzuma, Jonathan M.; Qaim, Matin			Supermarket purchase contributes to nutrition-related non-communicable diseases in urban Kenya	PLOS ONE			English	Article							INSTRUMENTAL VARIABLES; TRANSITION; INCOME; DIET; CONSUMPTION; REVOLUTION; HOUSEHOLDS; INDONESIA; PATTERNS; OBESITY	Background While undernutrition and related infectious diseases are still pervasive in many developing countries, the prevalence of non-communicable diseases (NCD), typically associated with high body mass index (BMI), is rapidly rising. The fast spread of supermarkets and related shifts in diets were identified as possible factors contributing to overweight and obesity in developing countries. Potential effects of supermarkets on people's health have not been analyzed up till now. Objective This study investigates the effects of purchasing food in supermarkets on people's BMI, as well as on health indicators such as fasting blood glucose (FBG), blood pressure (BP), and the metabolic syndrome. Design This study uses cross-section observational data from urban Kenya. Demographic, anthropometric, and bio-medical data were collected from 550 randomly selected adults. Purchasing food in supermarkets is defined as a binary variable that takes a value of one if any food was purchased in supermarkets during the last 30 days. In a robustness check, the share of food purchased in supermarkets is defined as a continuous variable. Instrumental variable regressions are applied to control for confounding factors and establish causality. Results Purchasing food in supermarkets contributes to higher BMI (+1.8 kg/m(2)) (P< 0.01) and an increased probability (+20 percentage points) of being overweight or obese (P< 0.01). Purchasing food in supermarkets also contributes to higher levels of FBG (+ 0.3 mmol/L) (P< 0.01) and a higher likelihood (+ 16 percentage points) of suffering from pre-diabetes (P< 0.01) and the metabolic syndrome (+7 percentage points) (P< 0.01). Effects on BP could not be observed. Conclusions Supermarkets and their food sales strategies seem to have direct effects on people's health. In addition to increasing overweight and obesity, supermarkets contribute to nutrition-related NCDs. Effects of supermarkets on nutrition and health can mainly be ascribed to changes in the composition of people's food choices.	[Demmler, Kathrin M.; Qaim, Matin] Univ Goettingen, Dept Agr Econ & Rural Dev, Gottingen, Germany; [Klasen, Stephan] Univ Goettingen, Dept Econ, Gottingen, Germany; [Nzuma, Jonathan M.] Univ Nairobi, Dept Agr Econ, Nairobi, Kenya	University of Gottingen; University of Gottingen; University of Nairobi	Demmler, KM (corresponding author), Univ Goettingen, Dept Agr Econ & Rural Dev, Gottingen, Germany.	kathrin-maria.demmler@agr.uni-goettingen.de	Nzuma, Jonathan/AAV-8401-2020; Qaim, Matin/P-4489-2016	Qaim, Matin/0000-0003-4143-0763	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [RTG 1666]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This work was financially supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) under grant number RTG 1666, see http://www.dfg.de/en/index.jsp. DFG had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Andersson C. I. M., 2015, American Journal of Agricultural Economics, V97, P1247, DOI 10.1093/ajae/aav006; Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; [Anonymous], 2015, GLOB HLTH OBS IND ES; Asfaw A, 2008, DEV POLICY REV, V26, P227, DOI 10.1111/j.1467-7679.2008.00407.x; Asfaw A, 2011, HEALTH ECON, V20, P184, DOI 10.1002/hec.1579; Bommer C, 2017, LANCET DIABETES ENDO, V5, P423, DOI 10.1016/S2213-8587(17)30097-9; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; Chege CGK, 2015, WORLD DEV, V72, P394, DOI 10.1016/j.worlddev.2015.03.016; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Demmler KM, 2017, WORLD DEV; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Di Falco S, 2011, AM J AGR ECON, V93, P825, DOI 10.1093/ajae/aar006; Duflo E, 2001, AM ECON REV, V91, P795, DOI 10.1257/aer.91.4.795; Food and Agriculture Organisation of the United Nations, 2015, M 2015 INT HUNG TARG; Gruber J, 2000, J POLIT ECON, V108, P1162, DOI 10.1086/317682; Hawkes C, 2008, DEV POLICY REV, V26, P657, DOI 10.1111/j.1467-7679.2008.00428.x; Herman WH, 2013, DIABETES CARE, V36, P775, DOI 10.2337/dc13-0270; Hill R. C., 2008, PRINCIPLES ECONOMETR; Institute of Medicine (U.S.) and Institute of Medicine, 2005, DIET REF INT EN CARB; International Diabetes Federation, 2015, DIABETES ATLAS, V7th; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177; Kenya National Bureau of Statistics, 2010, POP DISTR ADM UN; Kimenju SC, 2016, FOOD SECUR, V8, P571, DOI 10.1007/s12571-016-0566-x; Kimenju SC, 2015, PUBLIC HEALTH NUTR, V18, P3224, DOI 10.1017/S1368980015000919; Leigh JP, 2004, J CLIN EPIDEMIOL, V57, P284, DOI 10.1016/j.jclinepi.2003.08.006; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Mergenthaler M, 2009, FOOD POLICY, V34, P426, DOI 10.1016/j.foodpol.2009.03.009; Minot N, 2015, B INDONES ECON STUD, V51, P375, DOI 10.1080/00074918.2015.1104410; Minten B, 2012, QUIET REVOLUTION STA; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Okafor Christian I, 2012, Indian J Endocrinol Metab, V16, P56, DOI 10.4103/2230-8210.91191; Planet Retail, 2016, COUNTR REP KEN; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Popkin B, 2007, AGR ECON-BLACKWELL, V37, P199, DOI 10.1111/j.1574-0862.2007.00245.x; Popkin BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0631-4; Popkin BM, 2014, FOOD POLICY, V47, P91, DOI 10.1016/j.foodpol.2014.05.001; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Qaim M, 2017, P NUTR SOC, V76, P12, DOI 10.1017/S0029665116000598; Reardon T, 2012, P NATL ACAD SCI USA, V109, P12332, DOI 10.1073/pnas.1003160108; Rischke R, 2015, FOOD POLICY, V52, P9, DOI 10.1016/j.foodpol.2015.02.001; Roemling C, 2013, ECON HUM BIOL, V11, P563, DOI 10.1016/j.ehb.2013.07.001; Tessier S, 2008, J NUTR, V138, P768, DOI 10.1093/jn/138.4.768; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Timmer CP, 2009, WORLD DEV, V37, P1812, DOI 10.1016/j.worlddev.2008.08.022; Toiba H, 2015, B INDONES ECON STUD, V51, P389, DOI 10.1080/00074918.2015.1111997; Umberger WJ, 2015, AM J AGR ECON, V97, P510, DOI 10.1093/ajae/aau111; Vellakkal S, 2015, J NUTR, V145, P1942, DOI 10.3945/jn.115.211250; WHO, 2013, WHODCOWHD20132; Wooldridge J.M., 2015, INTRO ECONOMETRICS M; World Economic Forum Harvard School of Public Health, 2011, GLOBAL EC BURDEN NON; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2022, GLOB HLTH OBS; World Health Organization (WHO), 2014, WHO EUR NUTR BOD MAS; Zhou YJ, 2015, FOOD POLICY, V55, P92, DOI 10.1016/j.foodpol.2015.07.001	61	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185148	10.1371/journal.pone.0185148	http://dx.doi.org/10.1371/journal.pone.0185148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934333	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900105
J	Janggen, C; Grani, C; Brunner, J; Trachsel, LD; Windecker, S; Eser, P; Raber, L; Wilhelm, M				Janggen, Christoph; Grani, Christoph; Brunner, Jonas; Trachsel, Lukas D.; Windecker, Stephan; Eser, Prisca; Raber, Lorenz; Wilhelm, Matthias			Sports engagement and age at first myocardial infarction in men under 55 years of age	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR RISK; INFLAMMATORY MARKERS; PHYSICAL-ACTIVITY; SUDDEN-DEATH; ATHEROSCLEROSIS; EXERCISE; SMOKING; MECHANISMS	Objective Low levels of physical activity in childhood are associated with clustering of cardiovascular risk factors (CVRF) as predisposition for atherosclerosis. We assessed the association between sports engagement and age at first myocardial infarction (MI) in a cohort of men under 55 years of age. Methods The Bern percutaneous coronary intervention Registry (NCT 02241291) was analyzed from March 2009 until January 2012. Male patients with first MI, age 18 to 54 years and body mass index <= 25kg/m(2) were included. Patients were stratified into two groups based on their starting age with organized sports >= 1 h/week outside school (EARLY: <18, CONTROL: >= 18 years or never). We assessed age at time of first MI, CVRF, and volume of sports training. Results Of 4,394 consecutive patients, 123 fulfilled the inclusion criteria (EARLY n = 81, CONTROL n = 42). Age at the time of first MI was 3 years younger in the EARLY compared to the CONTROL group (46.8 +/- 6.0 vs. 49.8 +/- 4.6 years, p = 0.006). Total lifetime training hours, and average yearly training hours, both, before and after age 18, were significantly greater in the EARLY group. Years of training <18 years were weakly inversely correlated with age at first MI (r(2) = 0.075, p = 0.002). The proportion of sports-related MI was not different between EARLY and CONTROL (13.6% vs. 11.9%). Patients in the EARLY group had fewer CVRF (2 vs. 3; p = 0.001). Prevalence of smoking was equally high in both groups (63.0% and 64.3%). Conclusions In our patients aged 54 and younger, the first MI occurred 3 years earlier in those who started regular sports activity before age 18, despite a more active lifestyle and favorable CVRF profile.	[Janggen, Christoph; Grani, Christoph; Brunner, Jonas; Trachsel, Lukas D.; Windecker, Stephan; Eser, Prisca; Raber, Lorenz; Wilhelm, Matthias] Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland	University of Bern; University Hospital of Bern	Wilhelm, M (corresponding author), Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland.	matthias.wilhelm@insel.ch	Eser, Prisca/AAE-3758-2021; Wilhelm, Matthias/AAS-9456-2020	Wilhelm, Matthias/0000-0003-4541-3995; Grani, Christoph/0000-0001-6029-0597				Ahmadi N, 2015, BRAIN INJURY, V29, P1635, DOI 10.3109/02699052.2015.1075149; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Anton MM, 2006, ATHEROSCLEROSIS, V185, P201, DOI 10.1016/j.atherosclerosis.2005.05.034; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BERLIN I, 1990, EUR J CLIN PHARMACOL, V38, P57, DOI 10.1007/BF00314804; Burke AP, 1999, JAMA-J AM MED ASSOC, V281, P921, DOI 10.1001/jama.281.10.921; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Ferrucci L, 1999, AM J EPIDEMIOL, V149, P645, DOI 10.1093/oxfordjournals.aje.a009865; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; Gilman SE, 2003, J EPIDEMIOL COMMUN H, V57, P802, DOI 10.1136/jech.57.10.802; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kvaavik E, 2009, PEDIATRICS, V123, pE80, DOI 10.1542/peds.2008-1118; Laitinen TT, 2012, CIRCULATION, V125, P1971, DOI 10.1161/CIRCULATIONAHA.111.073585; Lamprecht M, 2008, SPORT SCHWEIZ 2008 S; Merghani A, 2017, CIRCULATION; Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosis.2005.10.009; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; Mohlenkamp S, 2008, EUR HEART J, V29, P1903, DOI 10.1093/eurheartj/ehn163; Niessner A, 2006, ATHEROSCLEROSIS, V186, P160, DOI 10.1016/j.atherosclerosis.2005.06.047; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Ribeiro F, 2010, INT J CARDIOL, V141, P214, DOI 10.1016/j.ijcard.2009.09.548; Roberts R, 2007, CAN J CARDIOL, V23, p7A, DOI 10.1016/S0828-282X(07)71000-0; Roberts R, 2012, CLIN CARDIOL, V35, P536, DOI 10.1002/clc.22002; Rowe GC, 2014, CIRCULATION, V129, P798, DOI 10.1161/CIRCULATIONAHA.113.001590; Schuler G, 2013, EUR HEART J, V34, P1790, DOI 10.1093/eurheartj/eht111; Schwartz Robert S, 2014, Mo Med, V111, P89; Swardfager W, 2012, AM HEART J, V163, P666, DOI 10.1016/j.ahj.2011.12.017; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Taylor BA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004498; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Toss F, 2013, AM HEART J, V165, P164, DOI 10.1016/j.ahj.2012.10.030; Wang YY, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-179; Wilhelm M, 2014, SCAND J MED SCI SPOR, V24, P519, DOI 10.1111/sms.12030; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184035	10.1371/journal.pone.0184035	http://dx.doi.org/10.1371/journal.pone.0184035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934213	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900018
J	Kan, JL; Liu, TL; Ma, N; Li, H; Li, XG; Wang, JY; Zhang, BL; Chang, YH; Lin, J				Kan, Jialiang; Liu, Tingli; Ma, Na; Li, Hui; Li, Xiaogang; Wang, Jinyan; Zhang, Baolong; Chang, Youhong; Lin, Jing			Transcriptome analysis of Callery pear (Pyrus calleryana) reveals a comprehensive signalling network in response to Alternaria alternata	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE FAMILY; ARABIDOPSIS; TOLERANCE; BIOSYNTHESIS; LIPOXYGENASE; EXPRESSION; MECHANISM; PROTEINS; TCP15	The pear is an important temperate fruit worldwide that is produced by a group of species in the genus Pyrus. Callery pear (Pyrus calleryana Decne) is characterized by high resistance to multiple diseases, good adaptability, and high ornamental value, and is therefore widely planted in pear orchards for edible fruit production or as stock. Plant pathogens are a major threat to pear yield. Black spot disease, caused by the filamentous fungus Alternaria alternata, is one of the most serious diseases in pear. Elucidation of resistant genes to black spot disease is extremely important for understanding the underlying mechanisms as well as for the development of resistant cultivars. In this study, high-throughput single-strand RNA-sequencing was used to compare the transcriptome profiles of Callery pear leaves before and after A. alternata incubation for 7 days. The analysis yielded 73.3 Gb of clean data that were mapped onto the reference genome of the Chinese pear, and differentially expressed gene(DEG) s were identified with | log2FC| >= 1. Functional annotation demonstrated that black spot disease promoted great changes in the overall metabolism, and enrichment analysis of gene ontology terms showed that most of them are closely linked to signalling network and photosynthesis. Specifically, the genes included mainly transcription factors and genes involved in calcium signalling and ethylene and jasmonate pathways. Eight members of the ethylene response factor transcription factor gene family Group IX, including ERF1, ERF7, and ERF105, were up-regulated to 2.03-3.37-fold compared with CK, suggesting their role in the defence response to pathogen infection. Additionally, multiple transcription factors involved in biotic stresses, such as NAC78, NAC2, MYB44, and bHLH28, were up-regulated. Furthermore, we identified 144 long non-coding (lnc) RNAs, providing new insight into the involvement of lncRNAs in the response to black spot disease. Our study provides valuable data on the molecular genetics and functional genomic mechanisms of resistance to black spot disease in Callery pear. A good understanding of the molecular response to this disease will allow the development of durable and environmentally friendly control strategies.	[Kan, Jialiang; Ma, Na; Li, Hui; Li, Xiaogang; Chang, Youhong; Lin, Jing] Jiangsu Acad Agr Sci, Jiangsu Key Lab Hort Crop Genet Improvement, Inst Hort, Nanjing, Jiangsu, Peoples R China; [Liu, Tingli; Wang, Jinyan; Zhang, Baolong] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences	Chang, YH; Lin, J (corresponding author), Jiangsu Acad Agr Sci, Jiangsu Key Lab Hort Crop Genet Improvement, Inst Hort, Nanjing, Jiangsu, Peoples R China.	cyh@jass.ac.cn; lj84390224@126.com			Jiangsu Agricultural Science and Technology Independent Innovation Fund of China [CX(15)1023]; Outstanding Youth Fund of Jiangsu Province [BK20160016]	Jiangsu Agricultural Science and Technology Independent Innovation Fund of China; Outstanding Youth Fund of Jiangsu Province	This study was funded by the Jiangsu Agricultural Science and Technology Independent Innovation Fund of China (CX(15)1023) and the Outstanding Youth Fund of Jiangsu Province (BK20160016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Jiangsu Agricultural Science and Technology Independent Innovation Fund of China (CX(15)1023) and the Outstanding Youth Fund of Jiangsu Province (BK20160016). We thank the staff of Nanjing Huasequen Biotechnologies Co, Ltd., China for help with the bioinformatics analysis.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Baudry A, 1993, PLANT DIS, P77; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; BOHLMANN H, 1988, EMBO J, V7, P1559, DOI 10.1002/j.1460-2075.1988.tb02980.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolt S, 2017, PLANT CELL ENVIRON, V40, P108, DOI 10.1111/pce.12838; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Duyvesteijn RGE, 2005, MOL MICROBIOL, V57, P1051, DOI 10.1111/j.1365-2958.2005.04751.x; EPPLE P, 1995, PLANT PHYSIOL, V109, P813, DOI 10.1104/pp.109.3.813; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Gil-Amado JA, 2013, PLANT CELL PHYSIOL, V54, P244, DOI 10.1093/pcp/pcs179; Gladman NP, 2016, PLANT CELL, V28, P1279, DOI 10.1105/tpc.15.01022; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Han L, 2012, INT J ONCOL, V40, P2004, DOI 10.3892/ijo.2012.1413; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-311; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li Y, 2004, CRIT REV PLANT SCI, V23, P381, DOI 10.1080/07352680490505123; Li Y, 2016, CHINESE AGR SCI B, V32, P150; Lucero LE, 2015, PLANT J, V84, P267, DOI 10.1111/tpj.12992; Morishita T, 2009, PLANT CELL PHYSIOL, V50, P2210, DOI 10.1093/pcp/pcp159; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; SANADA T, 1988, J JPN SOC HORTIC SCI, V57, P159; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; SIMMONS EG, 1993, MYCOTAXON, V48, P109; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Tan HW, 2015, GENOME, V58, P463, DOI 10.1139/gen-2015-0074; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vannini C, 2006, PHYSIOL MOL PLANT P, V69, P26, DOI 10.1016/j.pmpp.2006.12.005; Viola IL, 2016, PLANT PHYSIOL, V170, P74, DOI 10.1104/pp.15.01016; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Xu YY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1887-4; Yabuta Y, 2011, PLANT SCI, V181, P421, DOI 10.1016/j.plantsci.2011.07.001; Yi X, 2015, NUCLEIC ACIDS RES, V43, pD982, DOI 10.1093/nar/gku1162	46	14	15	9	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184988	10.1371/journal.pone.0184988	http://dx.doi.org/10.1371/journal.pone.0184988			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934298	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900073
J	Ma, XL; Kuete, M; Gu, XL; Zhou, H; Xiong, CL; Li, HG				Ma, Xiulan; Kuete, Martin; Gu, Xiuli; Zhou, Hui; Xiong, Chengliang; Li, Honggang			Recurrent deletions of the X chromosome linked CNV64, CNV67, and CNV69 shows geographic differences across China and no association with idiopathic infertility in men	PLOS ONE			English	Article							GENETIC-FACTORS; HAN CHINESE; GENOME; MUTATIONS	A recent study found that three recurrent deletions of X chromosome linked copy number variations (CNVs), CNV64, CNV67 and CNV69 were associated with idiopathic male infertility in Spanish and Italian populations, especially CNV67 resembling the azoospermia factor deletions. That merits further investigations among different populations. This study was conducted to examine the prevalence of the three CNVs deletions and their associations with idiopathic male infertility in Chinese Han population. The present study included a large population of 1550 Chinese Han subjects recruited between 2014 and 2016. In total, 714 infertile participants were diagnosed as idiopathic infertility with different conditions (288 with non-obstructive azoospermia, 210 oligozoospermia and 216 asthenospermia) and 836 fertile participants (vasectomized men). The fertile participants were recruited from the representative areas: the north (Hebei and Shanxi), center (Hubei and Jiangsu), and south (Guangdong) of China. All patients were recruited from Hubei province. A multiplex PCR system was established to screen the deletion of the three CNVs, and deletion was confirmed by general PCR. Similar rates of these deletions were observed in infertile men and fertile participants (Hubei), and among the different conditions of infertility. Moreover, CNV64 and CNV67 map distribution geographically differed across China. The three CNVs in fertile groups of other regions were similar, except for Guangdong. No association between the three CNVs deletions and idiopathic male infertility was observed. CNV67 is rare in central China, albeit large sample size study for confirmation is warranted. It seems that the association between these CNVs deletions and idiopathic male infertility is ethnic dependent. There is still need to screen the CNVs deletions in other ethnicities. We suggested to consider the stratification patterns and geographic differences when prescribing CNVs deletions screening as a test in male infertility.	[Ma, Xiulan; Kuete, Martin; Zhou, Hui; Xiong, Chengliang; Li, Honggang] Huazhong Univ Sci & Technol, Family Planning Res Inst, Ctr Reprod Med, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Kuete, Martin] Univ Montagnes, Fac Hlth Sci, Bangante, Cameroon; [Gu, Xiuli; Zhou, Hui; Xiong, Chengliang; Li, Honggang] Tongji Reprod Med Hosp, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, HG (corresponding author), Huazhong Univ Sci & Technol, Family Planning Res Inst, Ctr Reprod Med, Tongji Med Coll, Wuhan, Hubei, Peoples R China.; Li, HG (corresponding author), Tongji Reprod Med Hosp, Wuhan, Hubei, Peoples R China.	lhgyx@hotmail.com			National Natural Science Foundation of China [81571493]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81571493).; This work was supported by the National Natural Science Foundation of China (Grant No. 81571493). The authors thank all the volunteers who participated in this study, as well as the clinical staff from the five centers who helped to collect the patient histories and the blood samples. We also thank all the research members of the Family Planning Research Institute of Tongji Medical College for their valuable guidance and contributions.	Aston KI, 2014, ANDROLOGY-US, V2, P315, DOI 10.1111/j.2047-2927.2014.00188.x; BANSAL SK, 2016, SCI REP UK, V6; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chianese C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097746; Chylikova B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156102; Giachini C, 2010, INT J ANDROL, V33, P90; Giachini C, 2009, J CLIN ENDOCR METAB, V94, P4016, DOI 10.1210/jc.2009-1029; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Hu ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4857; Hu ZB, 2012, NAT GENET, V44, P183, DOI 10.1038/ng.1040; Ji ZY, 2016, ASIAN J ANDROL; Jungwirth A, 2012, EUR UROL, V62, P324, DOI 10.1016/j.eururo.2012.04.048; Knauff EAH, 2011, FERTIL STERIL, V95, P1584, DOI 10.1016/j.fertnstert.2011.01.018; Krausz C., 2012, PLOS ONE, P7; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Lo Giacco D, 2014, J MED GENET, V51, P340, DOI 10.1136/jmedgenet-2013-101988; Lopes A, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/487695; Ma Q, 2016, REPROD SCI, V23, P1434, DOI 10.1177/1933719116641758; Massart A, 2012, ASIAN J ANDROL, V14, P40, DOI 10.1038/aja.2011.67; Mukherjee A, 2015, ANIM BIOTECHNOL, V26, P65, DOI 10.1080/10495398.2014.887020; Sato Y, 2015, HUM REPROD, V30, P1510, DOI 10.1093/humrep/dev088; Song SH, 2012, GENE, V506, P248, DOI 10.1016/j.gene.2012.06.030; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stouffs K, 2012, BBA-MOL BASIS DIS, V1822, P1864, DOI 10.1016/j.bbadis.2012.05.012; Suo C, 2012, EUR J HUM GENET, V20, P102, DOI 10.1038/ejhg.2011.139; Trarbach EB, 2011, ASIAN J ANDROL, V13, P203, DOI 10.1038/aja.2010.115; Tuttelmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019426; World Health Organization, 2010, WHO LAB MAN EX HUM S; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yan JH, 2011, EUR J OBSTET GYN R B, V159, P371, DOI 10.1016/j.ejogrb.2011.07.033; Yu JM, 2012, HUM REPROD, V27, P25, DOI 10.1093/humrep/der377; Zhou XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139485; Zhou XY, 2015, PLOS ONE, V10	35	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185084	10.1371/journal.pone.0185084	http://dx.doi.org/10.1371/journal.pone.0185084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934280	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900084
J	Turino, C; Bertran, S; Gavalda, R; Teixido, I; Woehrle, H; Rue, M; Solsona, F; Escarrabill, J; Colls, C; Garcia-Altes, A; de Batlle, J; de-la-Torre, MS; Barbe, F				Turino, Cecilia; Bertran, Sandra; Gavalda, Ricard; Teixido, Ivan; Woehrle, Holger; Rue, Montserrat; Solsona, Francesc; Escarrabill, Joan; Colls, Cristina; Garcia-Altes, Anna; de Batlle, Jordi; Sanchez de-la-Torre, Manuel; Barbe, Ferran			Characterization of the CPAP-treated patient population in Catalonia	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE; ASSOCIATION; HYPERTENSION; ACCIDENTS; DISEASE; HEALTH; ASTHMA	There are different phenotypes of obstructive sleep apnoea (OSA), many of which have not been characterised. Identification of these different phenotypes is important in defining prognosis and guiding the therapeutic strategy. The aim of this study was to characterise the entire population of continuous positive airway pressure (CPAP)-treated patients in Catalonia and identify specific patient profiles using cluster analysis. A total of 72,217 CPAP-treated patients who contacted the Catalan-Health System (Cat-Salut) during the years 2012 and 2013 were included. Six clusters were identified, classified as "Neoplastic patients" (Cluster 1, 10.4%), "Metabolic syndrome patients" (Cluster 2, 27.7%), "Asthmatic patients" (Cluster 3, 5.8%), "Musculoskeletal and joint disorder patients" (Cluster 4, 10.3%), "Patients with few comorbidities" (Cluster 5, 35.6%) and "Oldest and cardiac disease patients" (Cluster 6, 10.2%). Healthcare facility use and mortality were highest in patients from Cluster 1 and 6. Conversely, patients in Clusters 2 and 4 had low morbidity, mortality and healthcare resource use. Our findings highlight the heterogeneity of CPAP-treated patients, and suggest that OSA is associated with a different prognosis in the clusters identified. These results suggest the need for a comprehensive and individualised approach to CPAP treatment of OSA.	[Turino, Cecilia; Bertran, Sandra; de Batlle, Jordi; Sanchez de-la-Torre, Manuel; Barbe, Ferran] Hosp Univ Arnau Vilanova & Santa Maria, Grp Translat Res Resp Med, IRBLleida, Lleida, Spain; [Turino, Cecilia; Bertran, Sandra; de Batlle, Jordi; Sanchez de-la-Torre, Manuel; Barbe, Ferran] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Gavalda, Ricard] UPC BarcelonaTech, Dept Comp Sci, Barcelona, Spain; [Teixido, Ivan; Solsona, Francesc] Univ Lleida, Dept Comp Sci, Lleida, Spain; [Teixido, Ivan; Solsona, Francesc] Univ Lleida, INSPIRES, Lleida, Spain; [Woehrle, Holger] Resp Ctr Ulm, Sleep & Ventilat Ctr Blaubeuren, Ulm, Germany; [Rue, Montserrat] IRBLleida, Unit Bioestat & Epidemiol, Lleida, Spain; [Escarrabill, Joan] Hosp Clin Barcelona, Chron Care Program, Barcelona, Spain; [Escarrabill, Joan] Minist Hlth, Master Plan Resp Dis, Barcelona, Spain; [Escarrabill, Joan] REDISSEC, Barcelona, Spain; [Colls, Cristina; Garcia-Altes, Anna] Govt Catalonia, Publ Hlth Dept, Barcelona, Spain	University Hospital Arnau de Vilanova; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Politecnica de Catalunya; Universitat de Lleida; Universitat de Lleida; University of Barcelona; Hospital Clinic de Barcelona	Barbe, F (corresponding author), Hosp Univ Arnau Vilanova & Santa Maria, Grp Translat Res Resp Med, IRBLleida, Lleida, Spain.; Barbe, F (corresponding author), Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.	febarbe.lleida.ics@gencat.cat	Rue, Montserrat/B-5663-2009; de la Torre, Manuel Sanchez/B-5578-2009; Sánchez-de-la-Torre, Manuel/AAC-9514-2022; Sanchez-de-la-Torre, Manuel/AAP-2663-2020; Barbé, Ferran/A-5988-2010; de Batlle, Jordi/G-6724-2016; Solsona, Francesc/AAR-4195-2020	Rue, Montserrat/0000-0002-7862-9365; de la Torre, Manuel Sanchez/0000-0002-5695-348X; Sanchez-de-la-Torre, Manuel/0000-0002-5695-348X; Barbé, Ferran/0000-0002-2340-8928; de Batlle, Jordi/0000-0003-3500-6608; Gavalda, Ricard/0000-0003-4736-7179	Spanish Respiratory Society (SEPAR); Associacio Lleidatana de Respiratori (ALLER); ResMed	Spanish Respiratory Society (SEPAR); Associacio Lleidatana de Respiratori (ALLER); ResMed	This study was supported by the Spanish Respiratory Society (SEPAR), Associacio Lleidatana de Respiratori (ALLER) and ResMed, a company that provides diagnostic services and treatment for sleep apnoea. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ResMed paid the salaries of the author HW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157318; Barbe F, 1998, AM J RESP CRIT CARE, V158, P18, DOI 10.1164/ajrccm.158.1.9709135; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Catala R, 2016, ARCH BRONCONEUMOL, V52, P461, DOI 10.1016/j.arbres.2016.02.005; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Gozal D, 2016, SLEEP, V39, P1493, DOI 10.5665/sleep.6004; Greenberg-Dotan S, 2007, SLEEP, V30, P1173, DOI 10.1093/sleep/30.9.1173; Howell S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-96; Jennum P, 2017, SLEEP MED, V36, P62, DOI 10.1016/j.sleep.2017.04.018; Kent BD, 2015, J THORAC DIS, V7, P1343, DOI 10.3978/j.issn.2072-1439.2015.08.11; Lacedonia D, 2016, J SLEEP RES, V25, P724, DOI 10.1111/jsr.12429; Madama D, 2016, REV PORT PNEUMOL, V22, P6, DOI 10.1016/j.rppnen.2015.08.005; Martinez-Garcia MA, 2009, SLEEP MED, V10, P104, DOI 10.1016/j.sleep.2007.11.009; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Pamidi Sushmita, 2012, Front Neurol, V3, P126; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Sanchez-de-la-Torre M, 2013, LANCET RESP MED, V1, P61, DOI 10.1016/S2213-2600(12)70051-6; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Teodorescu M, 2015, JAMA-J AM MED ASSOC, V313, P156, DOI 10.1001/jama.2014.17822; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Trzepizur W, 2013, CHEST, V143, P1584, DOI 10.1378/chest.12-1652; Ye LC, 2014, EUR RESPIR J, V44, P1600, DOI 10.1183/09031936.00032314	24	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185191	10.1371/journal.pone.0185191	http://dx.doi.org/10.1371/journal.pone.0185191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934303	Green Submitted, gold, Green Published			2022-12-27	WOS:000411339900117
J	Mrowinski, MJ; Fronczak, P; Fronczak, A; Ausloos, M; Nedic, O				Mrowinski, Maciej J.; Fronczak, Piotr; Fronczak, Agata; Ausloos, Marcel; Nedic, Olgica			Artificial intelligence in peer review: How can evolutionary computation support journal editors?	PLOS ONE			English	Article								With the volume of manuscripts submitted for publication growing every year, the deficiencies of peer review (e.g. long review times) are becoming more apparent. Editorial strategies, sets of guidelines designed to speed up the process and reduce editors' workloads, are treated as trade secrets by publishing houses and are not shared publicly. To improve the effectiveness of their strategies, editors in small publishing groups are faced with undertaking an iterative trial-and-error approach. We show that Cartesian Genetic Programming, a nature-inspired evolutionary algorithm, can dramatically improve editorial strategies. The artificially evolved strategy reduced the duration of the peer review process by 30%, without increasing the pool of reviewers (in comparison to a typical human-developed strategy). Evolutionary computation has typically been used in technological processes or biological ecosystems. Our results demonstrate that genetic programs can improve real-world social systems that are usually much harder to understand and control than physical systems.	[Mrowinski, Maciej J.; Fronczak, Piotr; Fronczak, Agata] Warsaw Univ Technol, Fac Phys, Koszykowa 75, PL-00662 Warsaw, Poland; [Ausloos, Marcel] Univ Leicester, Sch Management, Univ Rd, Leicester LE1 7RH, Leics, England; [Nedic, Olgica] Univ Belgrade, Inst Applicat Nucl Energy INEP, Banatska 31b, Belgrade, Serbia; [Nedic, Olgica] Serbian Chem Soc, Karnegijeva 4-3, Belgrade 11120, Serbia	Warsaw University of Technology; University of Leicester; University of Belgrade	Mrowinski, MJ (corresponding author), Warsaw Univ Technol, Fac Phys, Koszykowa 75, PL-00662 Warsaw, Poland.	mrow@if.pw.edu.pl	Fronczak, Agata/AAT-6002-2021; Nedic, Olgica/H-3843-2019; Ausloos, Marcel/AAC-8812-2020; Fronczak, Piotr/GLS-8248-2022	Nedic, Olgica/0000-0003-2042-0056; Ausloos, Marcel/0000-0001-9973-0019; Fronczak, Piotr/0000-0003-4452-9718; Mrowinski, Maciej/0000-0002-3952-0260; Fronczak, Agata/0000-0002-4301-3288	COST Action [TD1306]	COST Action(European Cooperation in Science and Technology (COST))	This publication is supported by the COST Action TD1306 "New frontiers of peer review" (http:/www.cost.eu/COST Actions/tdp/TD1306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication is supported by the COST Action TD1306 "New frontiers of peer review".	Ausloos M, 2016, PHYSICA A, V456, P197, DOI 10.1016/j.physa.2016.03.032; Ausloos M, 2016, SCIENTOMETRICS, V106, P347, DOI 10.1007/s11192-015-1704-5; Baker D, 2002, RES SCI EDUC, V32, P171, DOI 10.1023/A:1016073927593; Bourke-Waite A, 2015, INSIGHTS, V28, P93, DOI 10.1629/uksg.243; Cawley V., 2011, INT J SOCIAL SCI HUM, V1, P205; Miller J. F., 2000, Genetic Programming and Evolvable Machines, V1, P7, DOI 10.1023/A:1010016313373; Miller J.F., 2011, CARTESIAN GENETIC PR; MILLER JF, 2000, GENETIC PROGRAMMING, V0001, P00259, DOI DOI 10.1023/A:1010066330916; Mrowinski MJ, 2016, SCIENTOMETRICS, V107, P271, DOI 10.1007/s11192-016-1871-z; Mulligan A, 2013, J AM SOC INF SCI TEC, V64, P132, DOI 10.1002/asi.22798; Nguyen VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132557; Nicholas D, 2015, LEARN PUBL, V28, P15, DOI 10.1087/20150104; Powell K, 2016, NATURE, V530, P148, DOI 10.1038/530148a; Resnik DB, 2008, SCI ENG ETHICS, V14, P305, DOI 10.1007/s11948-008-9059-4; Squazzoni F, 2011, JASSS-J ARTIF SOC S, V14, DOI 10.18564/jasss.1821; Wager E, 2006, ETHICS WHAT IS IT NA; Ware M., 2008, PEER REV SCHOLARLY J, V28, P2; Ware Mark, 2015, COPYRIGHT FAIR USE S	18	18	18	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184711	10.1371/journal.pone.0184711	http://dx.doi.org/10.1371/journal.pone.0184711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931033	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700029
J	Tian, L; Liu, LR; Yin, YH; Huang, MC; Chen, YB; Xu, XL; Wu, PZ; Li, MR; Wu, GJ; Jiang, HW; Chen, YP				Tian, Lu; Liu, Leru; Yin, Yehu; Huang, Mingchao; Chen, Yanbo; Xu, Xinlan; Wu, Pingzhi; Li, Meiru; Wu, Guojiang; Jiang, Huawu; Chen, Yaping			Heterogeneity in the expression and subcellular localization of POLYOL/MONOSACCHARIDE TRANSPORTER genes in Lotus japonicus	PLOS ONE			English	Article							MONOSACCHARIDE TRANSPORTER; TRANSMEMBRANE TOPOLOGY; MANNITOL DEHYDROGENASE; SORBITOL TRANSPORTERS; SUGAR-TRANSPORT; MEMBRANE; SUCROSE; PHLOEM; CELERY; IDENTIFICATION	Polyols can serve as a means for the translocation of carbon skeletons and energy between source and sink organs as well as being osmoprotective solutes and antioxidants which may be involved in the resistance of some plants to biotic and abiotic stresses. Polyol/Mono-saccharide transporter (PLT) proteins previously identified in plants are involved in the loading of polyols into the phloem and are reported to be located in the plasma membrane. The functions of PLT proteins in leguminous plants are not yet clear. In this study, a total of 14 putative PLT genes (LjPLT1-14) were identified in the genome of Lotus japonicus and divided into 4 clades based on phylogenetic analysis. Different patterns of expression of LjPLT genes in various tissues were validated by qRT-PCR analysis. Four genes (LjPLT3, 4, 11, and 14) from clade II were expressed at much higher levels in nodule than in other tissues. Moreover, three of these genes (LjPLT3, 4, and 14) showed significantly increased expression in roots after inoculation with Mesorhizobium loti. Three genes (LjPLT1, 3, and 9) responded when salinity and/or osmotic stresses were applied to L. japonicus. Transient expression of GFP-LjPLT fusion constructs in Arabidopsis and Nicotiana benthamiana protoplasts indicated that the LjPLT1, LjPLT6 and LjPLT7 proteins are localized to the plasma membrane, but LjPLT2 (clade IV), LjPLT3, 4, 5 (clade II) and LjPLT8 (clade III) proteins possibly reside in the Golgi apparatus. The results suggest that members of the LjPLT gene family may be involved in different biological processes, several of which may potentially play roles in nodulation in this nitrogen-fixing legume.	[Tian, Lu; Liu, Leru; Yin, Yehu; Huang, Mingchao; Chen, Yanbo; Xu, Xinlan; Wu, Pingzhi; Li, Meiru; Wu, Guojiang; Jiang, Huawu; Chen, Yaping] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Tian, Lu; Liu, Leru; Yin, Yehu; Huang, Mingchao; Chen, Yanbo; Xu, Xinlan; Wu, Pingzhi; Li, Meiru; Wu, Guojiang; Jiang, Huawu; Chen, Yaping] Chinese Acad Sci, South China Bot Garden, Guangdong Prov Key Lab Appl Bot, Guangzhou, PR, Peoples R China; [Tian, Lu; Liu, Leru; Yin, Yehu; Huang, Mingchao; Chen, Yanbo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, YP (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.; Chen, YP (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangdong Prov Key Lab Appl Bot, Guangzhou, PR, Peoples R China.	chenyp@scbg.ac.cn			National Natural Science Foundation of China [31572195, 31570242]; Natural Science Foundation of Guangdong [2014A030313713]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (Guojiang Wu, No. 31572195; Yaping Chen, No. 31570242) and the Natural Science Foundation of Guangdong (Yaping Chen, No. 2014A030313713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Natural Science Foundation of China (31572195; 31570242) and the Natural Science Foundation of Guangdong (2014A030313713). The authors are grateful to Mr. Ce Fang, Miss. Nannan Huang, Mr. Gong Wang, Miss. Yong Zhu and Mr. Xuegang Sun for help of the confocal microscope.	BIELESKI RL, 1985, AUST J PLANT PHYSIOL, V12, P657, DOI 10.1071/PP9850657; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Buckhout T.J., 1996, PHOTOASSIMILATE DIST, P229; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cao H, 2011, J EXP BOT, V62, P4595, DOI 10.1093/jxb/err178; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; Conde A, 2015, J EXP BOT, V66, P889, DOI 10.1093/jxb/eru446; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1766, DOI 10.1093/pcp/pcr121; DAIE J, 1986, J AM SOC HORTIC SCI, V111, P216; DAIE J, 1987, PLANTA, V171, P474, DOI 10.1007/BF00392294; DAVIS JM, 1988, PLANT PHYSIOL, V86, P129, DOI 10.1104/pp.86.1.129; Desbrosses GG, 2005, PLANT PHYSIOL, V137, P1302, DOI 10.1104/pp.104.054957; Doidy J, 2012, TRENDS PLANT SCI, V17, P413, DOI 10.1016/j.tplants.2012.03.009; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Dusotoit-Coucaud A, 2010, PLANT CELL PHYSIOL, V51, P1878, DOI 10.1093/pcp/pcq151; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan RC, 2009, PLANT PHYSIOL, V150, P1880, DOI 10.1104/pp.109.141374; Aguayo MF, 2013, PLANT SCI, V205, P63, DOI 10.1016/j.plantsci.2013.01.012; Gao ZF, 2003, PLANT PHYSIOL, V131, P1566, DOI 10.1104/pp.102.016725; Gendre D, 2015, PROTOPLASMA, V252, P385, DOI 10.1007/s00709-014-0693-1; Hamilton AJ, 1999, MED MYCOL, V37, P375, DOI 10.1046/j.1365-280X.1999.00208.x; Hedrich R, 2015, CURR OPIN PLANT BIOL, V25, P63, DOI 10.1016/j.pbi.2015.04.008; Jennings DB, 1998, P NATL ACAD SCI USA, V95, P15129, DOI 10.1073/pnas.95.25.15129; Johnson DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-64; Jordan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23502; Juchaux-Cachau M, 2007, PLANT PHYSIOL, V145, P62, DOI 10.1104/pp.107.103143; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kalliampakou KI, 2011, MOL MEMBR BIOL, V28, P1, DOI 10.3109/09687688.2010.500626; Klepek YS, 2005, PLANT CELL, V17, P204, DOI 10.1105/tpc.104.026641; Klepek YS, 2010, J EXP BOT, V61, P537, DOI 10.1093/jxb/erp322; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Noiraud N, 2001, PLANT PHYSIOL BIOCH, V39, P717, DOI 10.1016/S0981-9428(01)01292-X; Noiraud N, 2001, PLANT CELL, V13, P695, DOI 10.1105/tpc.13.3.695; Pereira I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088180; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Ramsperger-Gleixner M, 2004, PLANT PHYSIOL, V134, P147, DOI 10.1104/pp.103.027136; Reinders A, 2005, J BIOL CHEM, V280, P1594, DOI 10.1074/jbc.M410831200; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seidel T, 2004, J BIOTECHNOL, V112, P165, DOI 10.1016/j.jbiotec.2004.04.027; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Watari J, 2004, PLANT CELL PHYSIOL, V45, P1032, DOI 10.1093/pcp/pch121; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Wienkoop S, 2003, PLANT PHYSIOL, V131, P1080, DOI 10.1104/pp.102.015362; Wormit A, 2006, PLANT CELL, V18, P3476, DOI 10.1105/tpc.106.047290	48	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185269	10.1371/journal.pone.0185269	http://dx.doi.org/10.1371/journal.pone.0185269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931056	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700079
J	Kitahara, K; Hayashi, Y; Yano, S; Kondo, T				Kitahara, Kosuke; Hayashi, Yoshikatsu; Yano, Shiro; Kondo, Toshiyuki			Target-directed motor imagery of the lower limb enhances event-related desynchronization	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; EEG; CLASSIFICATION; STIMULATION; MOVEMENTS	Event-related desynchronization/synchronization (ERD/S) is an electroencephalogram (EEG) feature widely used as control signals for Brain-Computer Interfaces (BCIs). Nevertheless, the underlying neural mechanisms and functions of ERD/S are largely unknown, thus investigating them is crucial to improve the reliability of ERD/S-based BCIs. This study aimed to identify Motor Imagery (MI) conditions that enhance ERD/S. We investigated following three questions: 1) whether target-directed MI affects ERD/S, 2) whether MI with sound imagery affects ERD/S, and 3) whether ERD/S has a body part dependency of MI. Nine participants took part in the experiments of four MI conditions; they were asked to imagine right foot dorsiflexion (F), right foot dorsiflexion and the sound of a bass drum when the sole touched the floor (FS), right leg extension (L), and right leg extension directed toward a soccer ball (LT). Statistical comparison revealed that there were significant differences between conditions L and LT in beta-band ERD and conditions F and L in beta-band ERS. These results suggest that mental rehearsal of target-directed lower limb movement without real sensory stimuli can enhance beta-band ERD; furthermore, MI of foot dorsiflexion induces significantly larger beta-band ERS than that of leg extension. These findings could be exploited for the training of BCIs such as powered prosthetics for disabled person and neurorehabilitation system for stroke patients.	[Kitahara, Kosuke; Yano, Shiro; Kondo, Toshiyuki] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Koganei, Tokyo, Japan; [Hayashi, Yoshikatsu] Univ Reading, Sch Biol Sci, Biomed Engn, Reading, Berks, England	Tokyo University of Agriculture & Technology; University of Reading	Kitahara, K (corresponding author), Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Koganei, Tokyo, Japan.	kitahara@livingsys.lab.tuat.ac.jp	Kondo, Toshiyuki/B-9972-2013; Hayashi, Yoshikatsu/R-4543-2019; Yano, Shiro/F-2940-2015	Kondo, Toshiyuki/0000-0001-8200-9276; Hayashi, Yoshikatsu/0000-0002-9207-6322; Yano, Shiro/0000-0002-7094-5996; Hayashi, Yoshikastu/0000-0001-5876-1417	Japan Society for the Promotion of Science KAKENHI [JP26120005, JP16H03219]; Grants-in-Aid for Scientific Research [16H03219] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The research was partially supported by Japan Society for the Promotion of Science KAKENHI (https.//www.jsps.go.jp/english/index.html) (Grant number JP26120005 and JP16H03219), and TK received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimardani M, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00052; Avanzini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037534; Carlson T, 2013, IEEE ROBOT AUTOM MAG, V20, P65, DOI 10.1109/MRA.2012.2229936; Cassady K, 2014, TECHNOLOGY, V2, P254, DOI 10.1142/S233954781450023X; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Graimann B, 2002, CLIN NEUROPHYSIOL, V113, P43, DOI 10.1016/S1388-2457(01)00697-6; Hanakawa T, 2016, NEUROSCI RES, V104, P56, DOI 10.1016/j.neures.2015.11.003; Hashimoto Y, 2013, CLIN NEUROPHYSIOL, V124, P2153, DOI 10.1016/j.clinph.2013.05.006; Hashimoto Y, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-117; Hayashi Y, 2012, P IEEE RAS-EMBS INT, P1733, DOI 10.1109/BioRob.2012.6290919; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; KALCHER J, 1995, ELECTROEN CLIN NEURO, V94, P381, DOI 10.1016/0013-4694(95)00040-6; Kitahara K, 2015, IEEE ENG MED BIO, P6630, DOI 10.1109/EMBC.2015.7319913; Kondo T, 2015, HUM MOVEMENT SCI, V43, P239, DOI 10.1016/j.humov.2014.08.014; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kwak NS, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056009; Leeb Robert, 2007, Comput Intell Neurosci, P79642, DOI 10.1155/2007/79642; Li LQ, 2015, INT J FUZZY SYST, V2015, P12, DOI [DOI 10.1371/J0URNAL.P0NE.0144256, DOI 10.1016/J.ARCH0RALBI0.2015.12.002]; Lopez-Larraz E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-153; Malouin Francine, 2007, J Neurol Phys Ther, V31, P20; Nakayashiki K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-90; Neuper C, 1999, J CLIN NEUROPHYSIOL, V16, P373, DOI 10.1097/00004691-199907000-00010; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Ortner R, 2012, P IEEE RAS-EMBS INT, P219, DOI 10.1109/BioRob.2012.6290800; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Prasad G, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-60; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Royer AS, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016005; Vuckovic A, 2013, CLIN NEUROPHYSIOL, V124, P1586, DOI 10.1016/j.clinph.2013.02.016; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Yeo SS, 2013, NEUROREHABILITATION, V32, P861, DOI 10.3233/NRE-130910; Yuan H, 2014, IEEE T BIO-MED ENG, V61, P1425, DOI 10.1109/TBME.2014.2312397	36	8	8	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184245	10.1371/journal.pone.0184245	http://dx.doi.org/10.1371/journal.pone.0184245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926593	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000411166600012
J	Weh, E; Takeuchi, H; Muheisen, S; Haltiwanger, RS; Semina, EV				Weh, Eric; Takeuchi, Hideyuki; Muheisen, Sanaa; Haltiwanger, Robert S.; Semina, Elena V.			Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome	PLOS ONE			English	Article							ER QUALITY-CONTROL; O-FUCOSYLATION; B3GALTL MUTATION; C-MANNOSYLATION; PROTEIN; IDENTIFICATION; DEFICIENCY; MEMBRANE; PATIENT; FAMILY	Peters Plus Syndrome (PPS) is a rare autosomal recessive disease characterized by ocular defects, short stature, brachydactyly, characteristic facial features, developmental delay and other highly variable systemic defects. Classic PPS is caused by loss-of-function mutations in the B3GLCT gene encoding for a beta 3-glucosyltransferase that catalyzes the attachment of glucose via a beta 1-3 glycosidic linkage to O-linked fucose on thrombospondin type 1 repeats (TSRs). B3GLCT was shown to participate in a non-canonical ER quality control mechanism; however, the exact molecular processes affected in PPS are not well understood. Here we report the identification and characterization of two zebrafish orthologs of the human B3GLCT gene, b3glcta and b3glctb. The b3glcta and b3glctb genes encode for 496-aa and 493-aa proteins with 65% and 57% identity to human B3GLCT, respectively. Expression studies demonstrate that both orthologs are widely expressed with strong presence in embryonic tissues affected in PPS. In vitro glucosylation assays demonstrated that extracts from wildtype embryos contain active b3glct enzyme capable of transferring glucose from UDP-glucose to an O-fucosylated TSR, indicating functional conservation with human B3GLCT. To determine the developmental role of the zebrafish genes, single and double b3glct knockouts were generated using TALEN-induced genome editing. Extracts from double homozygous b3glct(-/-) embryos demonstrated complete loss of in vitro b3glct activity. Surprisingly, b3glct(-/-) homozygous fish developed normally. Transcriptome analyses of head and trunk tissues of b3glct(-/-) 24-hpf embryos identified 483 shared differentially regulated transcripts that may be involved in compensation for b3glct function in these embryos. The presented data show that both sequence and function of B3GLCT/b3glct genes is conserved in vertebrates. At the same time, complete b3glct deficiency in zebrafish appears to be inconsequential and possibly compensated for by a yet unknown mechanism.	[Weh, Eric; Muheisen, Sanaa; Semina, Elena V.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Weh, Eric; Muheisen, Sanaa; Semina, Elena V.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Weh, Eric; Semina, Elena V.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Semina, Elena V.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Weh, Eric] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; [Takeuchi, Hideyuki] Nagoya Univ, Sch Med, Dept Mol Biochem, Nagoya, Aichi, Japan	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University System of Georgia; University of Georgia; Medical College of Wisconsin; University of Michigan System; University of Michigan; Nagoya University	Semina, EV (corresponding author), Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA.; Semina, EV (corresponding author), Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA.; Semina, EV (corresponding author), Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA.	esemina@mcw.edu	Takeuchi, Hideyuki/AAZ-9210-2020	Semina, Elena/0000-0003-0531-3586	National Institutes of Health [R01EY015518, R01GM061126, P30EY001931]; Children's Hospital of Wisconsin; NATIONAL EYE INSTITUTE [R01EY015518, P30EY001931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Wisconsin; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health awards R01EY015518 (EVS), R01GM061126 (RSH), and P30EY001931 as well as funds provided by the Children's Hospital of Wisconsin (EVS).	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Al-Gazali L, 2009, AM J MED GENET A, V149A, P251, DOI 10.1002/ajmg.a.32626; Aldahmesh MA, 2013, HUM MUTAT, V34, P1195, DOI 10.1002/humu.22374; Aliferis K, 2010, OPHTHALMIC GENET, V31, P205, DOI 10.3109/13816810.2010.512355; Arakawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30795; Carvalho A, 2017, EUR J PHARM; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chou JY, 2014, CURR TOP MEMBR, V73, P357, DOI 10.1016/B978-0-12-800223-0.00010-4; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Corso-Diaz X, 2012, MOL VIS, V18, P2770; D'Osualdo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130635; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Dassie-Ajdid J, 2009, CLIN GENET, V76, P490, DOI 10.1111/j.1399-0004.2009.01253.x; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; DEALMEIDA JCC, 1991, J MED GENET, V28, P277, DOI 10.1136/jmg.28.4.277; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Faletra F, 2011, OPHTHALMIC GENET, V32, P256, DOI 10.3109/13816810.2011.587082; Gosselin P, 2013, NUCLEIC ACIDS RES, V41, P7783, DOI 10.1093/nar/gkt569; Gu Y, 2012, ACTA PHARMACOL SIN, V33, P941, DOI 10.1038/aps.2012.60; Guo CX, 2015, J CELL MOL MED, V19, P2273, DOI 10.1111/jcmm.12619; Haldeman-Englert CR, 2009, AM J MED GENET A, V149A, P1842, DOI 10.1002/ajmg.a.32980; Hanna NN, 2010, J AAPOS, V14, P181, DOI 10.1016/j.jaapos.2010.02.003; Harissi-Dagher Mona, 2008, Int Ophthalmol Clin, V48, P35, DOI 10.1097/IIO.0b013e318169526c; Hay DL, 2016, BIOCHEM SOC T, V44, P568, DOI 10.1042/BST20150237; Heinonen TYK, 2003, BIOCHEM BIOPH RES CO, V309, P166, DOI 10.1016/S0006-291X(03)01540-7; Hess D, 2008, J BIOL CHEM, V283, P7354, DOI 10.1074/jbc.M710251200; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; Ito S, 2017, SEMIN CELL DEV BIOL, V62, P142, DOI 10.1016/j.semcdb.2016.11.005; Kapoor S, 2008, INDIAN J PEDIATR, V75, P635, DOI 10.1007/s12098-008-0122-6; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Le Goff C, 2011, HUM MOL GENET, V20, pR163, DOI 10.1093/hmg/ddr361; Leonhard-Melief C, 2010, METHOD ENZYMOL, V480, P401, DOI 10.1016/S0076-6879(10)80018-7; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Motoyama O, 2010, CLIN EXP NEPHROL, V14, P381, DOI 10.1007/s10157-010-0283-2; Neve EPA, 2003, EXP CELL RES, V288, P70, DOI 10.1016/S0014-4827(03)00161-7; Nishizaka H, 1996, J IMMUNOL, V156, P2309; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Planells-Ferrer L, 2016, J NEUROCHEM, V139, P11, DOI 10.1111/jnc.13729; Preissler S, 2017, NAT STRUCT MOL BIOL, V24, P23, DOI 10.1038/nsmb.3337; Reis LM, 2008, AM J MED GENET A, V146A, P2603, DOI 10.1002/ajmg.a.32498; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Shimizu R, 2010, CONGENIT ANOM, V50, P197, DOI 10.1111/j.1741-4520.2010.00282.x; Siala O, 2012, GENE, V507, P68, DOI 10.1016/j.gene.2012.06.052; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; Tuli N, 2009, CASES J, V2; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weh E, 2014, CLIN GENET, V86, P142, DOI 10.1111/cge.12241; Wenniger-Prick LJJMMD, 2002, ANN GENET-PARIS, V45, P97; WESTBERG J, 1995, GENOMICS, V29, P1, DOI 10.1006/geno.1995.1208; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yang Y, 2005, MOL CELLS, V20, P173; Yiu WH, 2010, CELL BIOCHEM FUNCT, V28, P31, DOI 10.1002/cbf.1613	70	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184903	10.1371/journal.pone.0184903	http://dx.doi.org/10.1371/journal.pone.0184903			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926587	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600051
J	Ahn, D; Yeo, CK; Han, SY; Kim, JK				Ahn, Dongbin; Yeo, Chang Ki; Han, Soon Yong; Kim, Jeong Kyu			The accessory parotid gland and facial process of the parotid gland on computed tomography	PLOS ONE			English	Article							AGE; MANAGEMENT; TUMORS	The purpose of this study was to determine the incidence of an anterior extension of the parotid gland, such as an accessory parotid gland (APG) or facial process (FP) and to evaluate its characteristics on computed tomography (CT) scans. We reviewed CT scans of 1,600 parotid glands from 800 patients. An APG on CT was defined as a soft-tissue mass of the same density as the main parotid gland, located at the anterior part of the main parotid gland, and completely separate from the main parotid gland. An FP was defined as a lobe of the parotid gland protruding anteriorly over the anterior edge of the ramus of the mandible on CT and showing continuity with the main gland. The overall incidence rates and characteristics of APGs and FPs were evaluated according to age, sex, and side. The incidence rates of APGs and FPs were 10.2% (163/1,600) and 28.3% (452/1,600), respectively. The mean size of an APG was 15.8 mm x 5.0 mm and the mean distance from the main parotid gland was 10.5 mm. The FP reached anteriorly between the anterior edge of the mandibular ramus and the anterior border of the masseter muscle in 405 (89.6%) cases, while it extended over the anterior border of the masseter muscle in 47 (10.4%) cases. The incidence rates of APGs and FPs decreased and increased, respectively, with increasing age, showing significant linear correlations. However, the incidence of an anterior extension of the parotid gland (either an APG or an FP) was similar across all age groups. The present study showed that CT might be helpful in identifying anterior extensions of the parotid gland including APGs and FPs. The anatomical information gained from this study contributes to a better understanding of APGs and FPs and how their incidence changes with age.	[Ahn, Dongbin] Kyungpook Natl Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea; [Yeo, Chang Ki; Han, Soon Yong] Keimyung Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea; [Kim, Jeong Kyu] Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea	Kyungpook National University; Keimyung University; Catholic University of Daegu	Kim, JK (corresponding author), Catholic Univ Daegu, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea.	doctorjkkim@cu.ac.kr	Vlantis, Alexander/J-9785-2017	Vlantis, Alexander/0000-0003-3109-5236				BATSAKIS JG, 1988, ANN OTO RHINOL LARYN, V97, P434, DOI 10.1177/000348948809700420; Choi JS, 2013, ARCH ORAL BIOL, V58, P1635, DOI 10.1016/j.archoralbio.2013.07.008; FROMMER J, 1977, ORAL SURG ORAL MED O, V43, P671, DOI 10.1016/0030-4220(77)90049-4; Klotz DA, 2000, LARYNGOSCOPE, V110, P1627, DOI 10.1097/00005537-200010000-00010; Kurabayashi T, 1997, DENTOMAXILLOFAC RAD, V26, P347, DOI 10.1038/sj.dmfr.4600301; Lin DT, 2004, LARYNGOSCOPE, V114, P1652, DOI 10.1097/00005537-200409000-00028; Mahne A, 2007, SEMIN NUCL MED, V37, P88, DOI 10.1053/j.semnuclmed.2006.10.003; Newberry TR, 2014, AM J OTOLARYNG, V35, P48, DOI 10.1016/j.amjoto.2013.08.018; SCOTT J, 1987, J ORAL PATHOL MED, V16, P505, DOI 10.1111/j.1600-0714.1987.tb00681.x; TOH H, 1993, ANAT REC, V236, P586, DOI 10.1002/ar.1092360319; Toh H, 1988, Fukuoka Shika Daigaku Gakkai Zasshi, V14, P389; Yang X, 2011, ORAL SURG ORAL MED O, V112, P290, DOI 10.1016/j.tripleo.2010.10.023	12	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184633	10.1371/journal.pone.0184633	http://dx.doi.org/10.1371/journal.pone.0184633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915265	Green Published, Green Submitted, gold			2022-12-27	WOS:000410861600012
J	Choi, ES; Cho, SH; Kim, JH				Choi, Eun Sil; Cho, Soo Hyun; Kim, Jung-Ha			Relationship between rectus abdominis muscle thickness and metabolic syndrome in middle-aged men	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; TESTOSTERONE; STRENGTH; ASSOCIATION; ATTENUATION; ACTIVATION; DIAGNOSIS; ADULTS; WOMEN; OLDER	Background and objective Skeletal muscle has been suggested as an important factor in the pathophysiology of metabolic syndrome. During the aging process, muscle mass is lost in specific body parts. However, few studies have investigated the relationship between site-specific muscle loss assessed using computed tomography (CT) and metabolic syndrome. This study was conducted to investigate the association between metabolic syndrome and rectus abdominis muscle thickness at the umbilicus level (RAM), which reflects site-specific muscle loss of the abdomen using CT image. Methods This cross-sectional study was conducted on 725 middle-aged Korean men. Anthropometric evaluation and biochemical tests were performed. The RAMs of the subjects were measured from CT images taken at the umbilicus level. Results The mean RAM (mean +/- SD) of subjects with metabolic syndrome was 2.46 +/- 0.01, which was thinner than that of subjects without metabolic syndrome (2.52 +/- 0.01, p<0.01). Moreover, RAM decreased as the number of metabolic syndrome components increased (p-value for trend<0.01). RAM was positively correlated with body mass index (r = 0.21, p<0.01), skeletal muscle index (r = 0.26, p<0.01), and creatinine (r = 0.12, p<0.01), while RAM was negatively correlated with age(r = -0.11, p<0.01), abdominal circumference(r = -0.22, p<0.01), fasting glucose (r = -0.10, p<0.01), and triglycerides(r = -0.15, p<0.01). Using a stepwise multiple logistic regression analysis, we found that RAM was an independent factor associated with metabolic syndrome (OR: 0.861, 95% CI, 0.779-0.951, p<0.01). The result was not different in the statistical analysis including the components of MS (OR: 0.860, 95% CI, 0.767-0.965, p = 0.01). Conclusion RAM was associated with metabolic syndrome in middle-aged men. Moreover, site-specific muscle loss at the abdomen, as evaluated by RAM, also may be a predictor of metabolic syndrome like SMI.	[Choi, Eun Sil; Cho, Soo Hyun; Kim, Jung-Ha] Chung Ang Univ Hosp, Coll Med, Dept Family Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital	Kim, JH (corresponding author), Chung Ang Univ Hosp, Coll Med, Dept Family Med, Seoul, South Korea.	girlpower219@cau.ac.kr	Cho, Soo Hyun/AAZ-4770-2021	Cho, Soo Hyun/0000-0002-0054-2366; , Jung-Ha/0000-0002-7630-9501				Abe T, 2011, CLIN PHYSIOL FUNCT I, V31, P320, DOI 10.1111/j.1475-097X.2011.01021.x; Abe T, 2011, J SPORT SCI MED, V10, P145; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alexandersen P, 2004, ATHEROSCLEROSIS, V173, P157, DOI 10.1016/S0021-9150(03)00242-9; Anderson DE, 2013, J GERONTOL A-BIOL, V68, P317, DOI 10.1093/gerona/gls168; Atlantis E, 2009, METABOLISM, V58, P1013, DOI 10.1016/j.metabol.2009.02.027; Chen Xin, 2006, Zhonghua Yi Xue Za Zhi, V86, P1474; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; 이석민, 2006, 에너지공학, V15, P1; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Hasselager R, 2014, LANGENBECK ARCH SURG, V399, P287, DOI 10.1007/s00423-014-1174-x; Ido A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143858; Koo HS, 2015, CLIN ENDOCRINOL, V82, P509, DOI 10.1111/cen.12509; Kosola J, 2013, METABOLISM, V62, P992, DOI 10.1016/j.metabol.2013.01.013; Larsen BA, 2015, J CLIN ENDOCR METAB, V100, pE105, DOI 10.1210/jc.2014-2839; Lauritzen HPMM, 2010, DIABETES, V59, P2134, DOI 10.2337/db10-0233; LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809; Liu Y, 2008, J INT MED RES, V36, P496, DOI 10.1177/147323000803600314; Londono FJ, 2012, ANN NUTR METAB, V61, P41, DOI 10.1159/000339267; Marchetti PH, 2011, J SPORT SCI MED, V10, P322; Park BS, 2013, DIABETES METAB J, V37, P458, DOI 10.4093/dmj.2013.37.6.458; Ramamani A, 1999, CAN J PHYSIOL PHARM, V77, P300, DOI 10.1139/cjpp-77-4-300; Rolland Y, 2004, AM J CLIN NUTR, V79, P552; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Schafer AL, 2010, J CLIN ENDOCR METAB, V95, pE368, DOI 10.1210/jc.2010-0780; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Steensberg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1272, DOI 10.1152/ajpendo.00255.2002; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994	30	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0185040	10.1371/journal.pone.0185040	http://dx.doi.org/10.1371/journal.pone.0185040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915276	Green Submitted, Green Published, gold			2022-12-27	WOS:000410861600029
J	Hranilovic, A; Bely, M; Masneuf-Pomarede, I; Jiranek, V; Albertin, W				Hranilovic, Ana; Bely, Marina; Masneuf-Pomarede, Isabelle; Jiranek, Vladimir; Albertin, Warren			The evolution of Lachancea thermotolerans is driven by geographical determination, anthropisation and flux between different ecosystems	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-THERMOTOLERANS; MICROSATELLITE MARKERS; POPULATION GENOMICS; ACID PRODUCTION; R PACKAGE; YEAST; WINE; FERMENTATION; DIVERSITY	The yeast Lachancea thermotolerans (formerly Kluyveromyces thermotolerans) is a species with remarkable, yet underexplored, biotechnological potential. This ubiquist occupies a range of natural and anthropic habitats covering a wide geographic span. To gain an insight into L. thermotolerans population diversity and structure, 172 isolates sourced from diverse habitats worldwide were analysed using a set of 14 microsatellite markers. The resultant clustering revealed that the evolution of L. thermotolerans has been driven by the geography and ecological niche of the isolation sources. Isolates originating from anthropic environments, in particular grapes and wine, were genetically close, thus suggesting domestication events within the species. The observed clustering was further validated by several means including, population structure analysis, F-statistics, Mantel's test and the analysis of molecular variance (AMOVA). Phenotypic performance of isolates was tested using several growth substrates and physicochemical conditions, providing added support for the clustering. Altogether, this study sheds light on the genotypic and phenotypic diversity of L. thermotolerans, contributing to a better understanding of the population structure, ecology and evolution of this non-Saccharomyces yeast.	[Hranilovic, Ana; Jiranek, Vladimir] Australian Res Council Training Ctr Innovat Wine, Adelaide, SA, Australia; [Hranilovic, Ana; Jiranek, Vladimir] Univ Adelaide, Dept Wine & Food Sci, Urbrrae, SA, Australia; [Bely, Marina; Masneuf-Pomarede, Isabelle; Albertin, Warren] Univ Bordeaux, Inst Sci Vigne & Vin, Unite Rech Enol, Villenave Dornon, France; [Masneuf-Pomarede, Isabelle] Bordeaux Sci Agro, Gradignan, France; [Albertin, Warren] Bordeaux INP, ENSCBP, Pessac, France	University of Adelaide; UDICE-French Research Universities; Universite de Bordeaux	Albertin, W (corresponding author), Univ Bordeaux, Inst Sci Vigne & Vin, Unite Rech Enol, Villenave Dornon, France.; Albertin, W (corresponding author), Bordeaux INP, ENSCBP, Pessac, France.	warren.albertin@u-bordeaux.fr		Albertin, Warren/0000-0002-7385-9882; Masneuf-Pomarede, Isabelle/0000-0002-8806-8944	Wine Australia; ISW; Wine Australia [AGT1524]	Wine Australia(Australian Grape and Wine Authority); ISW; Wine Australia(Australian Grape and Wine Authority)	This research was conducted by the Australian Research Council Industrial Transformation Training Centre for Innovative Wine Production (Project IC130100005) to VJ with support from the Wine Australia and industry partners. AH received an ISW Travel Grant and Wine Australia Travel Grant (AGT1524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin W, 2016, FRONTIERS MICROBIOLO; Albertin W, 2014, FOOD MICROBIOL, V42, P188, DOI 10.1016/j.fm.2014.03.012; Albertin W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094246; Almeida P, 2015, MOL ECOL, V24, P5412, DOI 10.1111/mec.13341; Banilas G, 2016, MICROBIOL RES, V193, P1, DOI 10.1016/j.micres.2016.08.010; Benito A, 2016, FOOD TECHNOL BIOTECH, V54, P135, DOI 10.17113/ftb.54.02.16.4220; Boone C, 2014, GENETICS, V198, P435, DOI 10.1534/genetics.114.169128; Borneman AR, 2016, G3-GENES GENOM GENET, V6, P957, DOI 10.1534/g3.115.025692; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Chessel D., 2004, R NEWS, V4, P5; Clark L, 2017, MOL ECOLOGY RESOURCE; DEQUIN S, 1994, BIO-TECHNOL, V12, P173, DOI 10.1038/nbt0294-173; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fleet GH, 2008, FEMS YEAST RES, V8, P979, DOI 10.1111/j.1567-1364.2008.00427.x; Francesca N, 2012, ENV MICROBIOL REP, V4, P105, DOI 10.1111/j.1758-2229.2011.00310.x; Freely KC, 2014, GENOME BIOL EVOL, V6, P2586, DOI 10.1093/gbe/evu203; Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Gobbi M, 2013, FOOD MICROBIOL, V33, P271, DOI 10.1016/j.fm.2012.10.004; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hyma KE, 2013, MOL ECOL, V22, P2917, DOI 10.1111/mec.12155; Jolly NP, 2014, FEMS YEAST RES, V14, P215, DOI 10.1111/1567-1364.12111; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kapsopoulou K, 2007, WORLD J MICROB BIOT, V23, P735, DOI 10.1007/s11274-006-9283-5; Kelly DE, 2001, COMPAR FUNCT GENOM, V2, P236, DOI 10.1002/cfg.95; Knight S, 2015, ISME J, V9, P361, DOI 10.1038/ismej.2014.132; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P511, DOI 10.1016/B978-0-444-52149-1.00041-0; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Lemon J., 2006, R R NEWS; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Malpertuy A, 2000, FEBS LETT, V487, P113, DOI 10.1016/S0014-5793(00)02290-0; MANTEL N, 1967, CANCER RES, V27, P209; Masneuf-Pomarede I, 2015, FRONTIERS MICROBIOLO; Masneuf-Pomarede I, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow002; Masneuf-Pomarede I, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov045; MORA J, 1990, AM J ENOL VITICULT, V41, P156; Naumova ES, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1356, DOI 10.1134/S0006297907120097; Palanca L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075332; Paolocci F, 2006, APPL ENVIRON MICROB, V72, P2390, DOI 10.1128/AEM.72.4.2390-2393.2006; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pebesma E.J., 2005, R NEWS, V5; Prosperi MC, 2011, NATURE COMMUNICATION; RCore Team, 2020, R LANG ENV STAT COMP; Ristic R., 2016, Wine and Viticulture Journal, V31, P33; Robinson HA, 2016, ECOL EVOL, V6, P1236, DOI 10.1002/ece3.1919; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer M, 2010, BIOTECHNOL GENET ENG, V27, P229, DOI 10.1080/02648725.2010.10648152; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Sipiczki M., 2016, FRONTIERS MICROBIOLO; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Strope PK, 2015, GENOME RES, V25, P762, DOI 10.1101/gr.185538.114; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; WITTE V, 1989, J BASIC MICROB, V29, P707, DOI 10.1002/jobm.3620291014	59	35	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184652	10.1371/journal.pone.0184652	http://dx.doi.org/10.1371/journal.pone.0184652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910346	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200072
J	Moore, EA; Xu, YZ				Moore, Elaine Ann; Xu, Yao-Zhong			The effect of S-substitution at the O6-guanine site on the structure and dynamics of a DNA oligomer containing a G: T mismatch	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; FORCE-FIELD; DUPLEX DNA; REPAIR; 6-THIOGUANINE; THIOGUANINE; MECHANISMS; SYSTEM; DAMAGE; WATER	The effect of S-substitution on the O-6 guanine site of a 13-mer DNA duplex containing a G: T mismatch is studied using molecular dynamics. The structure, dynamic evolution and hydration of the S-substituted duplex are compared with those of a normal duplex, a duplex with S-substitution on guanine, but no mismatch and a duplex with just a G: T mismatch. The S-substituted mismatch leads to cell death rather than repair. One suggestion is that the G: T mismatch recognition protein recognises the S-substituted mismatch (G(S) : T) as G: T. This leads to a cycle of futile repair ending in DNA breakage and cell death. We find that some structural features of the helix are similar for the duplex with the G: T mismatch and that with the S-substituted mismatch, but differ from the normal duplex, notably the helical twist. These differences arise from the change in the hydrogen-bonding pattern of the base pair. However a marked feature of the S-substituted G: T mismatch duplex is a very large opening. This showed considerable variability. It is suggested that this enlarged opening would lend support to an alternative model of cell death in which the mismatch protein attaches to thioguanine and activates downstream damage-response pathways. Attack on the sulphur by reactive oxygen species, also leading to cell death, would also be aided by the large, variable opening.	[Moore, Elaine Ann; Xu, Yao-Zhong] Open Univ, Sch Life Hlth & Chem Sci, STEM Fac, Milton Keynes, Bucks, England	Open University - UK	Moore, EA (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, STEM Fac, Milton Keynes, Bucks, England.	e.a.moore@open.ac.uk		Xu, Yao/0000-0002-5713-8030; Moore, Elaine/0000-0003-4418-0536	 [CHEM449]		This work was supported by CHEM449, http://www.nscas.ac.uk, provision of computer time 20 000 hours. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Salgado F, 2006, MAGN RESON CHEM, V44, P1081, DOI 10.1002/mrc.1902; [Anonymous], 2008, AMBER 10; Bohon J, 2003, NUCLEIC ACIDS RES, V31, P1331, DOI 10.1093/nar/gkg203; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; El Hassan MA, 1998, J MOL BIOL, V282, P331, DOI 10.1006/jmbi.1998.1994; Gueranger Q, 2014, J INVEST DERMATOL, V134, P1408, DOI 10.1038/jid.2013.509; Houlleberghs H, 2016, P NATL ACAD SCI USA, V113, P4128, DOI 10.1073/pnas.1520813113; Isaacs RJ, 2004, J AM CHEM SOC, V126, P583, DOI 10.1021/ja037333r; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Kryachko E, 2001, J PHYS CHEM A, V105, P3379, DOI 10.1021/jp003703b; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lavery R, 2010, NUCLEIC ACIDS RES, V38, P299, DOI 10.1093/nar/gkp834; Li GM, 1999, ONCOL RES, V11, P393; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schneider B, 1995, BIOPHYS J, V69, P2661, DOI 10.1016/S0006-3495(95)80136-0; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Somerville L, 2003, J BIOL CHEM, V278, P1005, DOI 10.1074/jbc.M204243200; Spackova N, 2004, J AM CHEM SOC, V126, P14642, DOI 10.1021/ja0468628; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Tessmer I, 2008, J BIOL CHEM, V283, P36646, DOI 10.1074/jbc.M805712200; Villani G, 2009, J PHYS CHEM B, V113, P2128, DOI 10.1021/jp807670f; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b	31	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184801	10.1371/journal.pone.0184801	http://dx.doi.org/10.1371/journal.pone.0184801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910418	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000410859200096
J	Puffe, L; Dittrich, K; Klauer, KC				Puffe, Lydia; Dittrich, Kerstin; Klauer, Karl Christoph			The influence of the Japanese waving cat on the joint spatial compatibility effect: A replication and extension of Dolk, Hommel, Prinz, and Liepelt (2013)	PLOS ONE			English	Article							S-R COMPATIBILITY; DUAL-PROCESS MODEL; RESPONSE CORRESPONDENCE; SIMON; STIMULUS; TASK; PERCEPTION; FRAMEWORK; OWN; TEC	In a joint go/no-go Simon task, each of two participants is to respond to one of two non-spatial stimulus features by means of a spatially lateralized response. Stimulus position varies horizontally and responses are faster and more accurate when response side and stimulus position match (compatible trial) than when they mismatch (incompatible trial), defining the social Simon effect or joint spatial compatibility effect. This effect was originally explained in terms of action/task co-representation, assuming that the co-actor's action is automatically co-represented. Recent research by Dolk, Hommel, Prinz, and Liepelt (2013) challenged this account by demonstrating joint spatial compatibility effects in a task-setting in which non-social objects like a Japanese waving cat were present, but no real co-actor. They postulated that every sufficiently salient object induces joint spatial compatibility effects. However, what makes an object sufficiently salient is so far not well defined. To scrutinize this open question, the current study manipulated auditory and/or visual attention-attracting cues of a Japanese waving cat within an auditory (Experiment 1) and a visual joint go/no-go Simon task (Experiment 2). Results revealed that joint spatial compatibility effects only occurred in an auditory Simon task when the cat provided auditory cues while no joint spatial compatibility effects were found in a visual Simon task. This demonstrates that it is not the sufficiently salient object alone that leads to joint spatial compatibility effects but instead, a complex interaction between features of the object and the stimulus material of the joint go/no-go Simon task.	[Puffe, Lydia; Dittrich, Kerstin; Klauer, Karl Christoph] Albert Ludwigs Univ Freiburg, Dept Psychol, Freiburg, Germany	University of Freiburg	Puffe, L (corresponding author), Albert Ludwigs Univ Freiburg, Dept Psychol, Freiburg, Germany.	lydia.puffe@psychologie.uni-freiburg.de			Baden-Wurttemberg Stiftung; German Research Foundation (DFG); University of Freiburg	Baden-Wurttemberg Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	The research reported in this paper was supported by a grant of the Baden-Wurttemberg Stiftung to the second author (https://www.bwstiftung.de/bildung/programme/hochschule/eliteprogramm-fuer-postdocs/). The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing (https://www.ub.uni-freiburg.de/unterstuetzung/elektronisch-publizieren/open-access/publikationsfonds/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge U, 2004, J EXP PSYCHOL HUMAN, V30, P365, DOI 10.1037/0096-1523.30.2.365; Bundesen C, 1998, PHILOS T ROY SOC B, V353, P1271, DOI 10.1098/rstb.1998.0282; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; Dittrich K, 2014, PSYCHOL RES-PSYCH FO, V78, P387, DOI 10.1007/s00426-014-0551-y; Dittrich K, 2013, ATTEN PERCEPT PSYCHO, V75, P1725, DOI 10.3758/s13414-013-0524-z; Dittrich K, 2012, ATTEN PERCEPT PSYCHO, V74, P911, DOI 10.3758/s13414-012-0304-1; Dolk T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00974; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Dolk T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00084; Eder AB, 2008, J EXP PSYCHOL GEN, V137, P262, DOI 10.1037/0096-3445.137.2.262; Eid M, 2010, STAT FORSCHUNGSMETHO, P99; EIMER M, 1995, ACTA PSYCHOL, V90, P301, DOI 10.1016/0001-6918(95)00022-M; Guagnano D, 2010, COGNITION, V114, P348, DOI 10.1016/j.cognition.2009.10.008; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 1996, Q J EXP PSYCHOL-A, V49, P546, DOI 10.1080/027249896392496; Hommel B, 2009, PSYCHOL SCI, V20, P794, DOI 10.1111/j.1467-9280.2009.02367.x; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; Kiernan D, 2012, PSYCHON B REV, V19, P914, DOI 10.3758/s13423-012-0283-1; Klempova B, 2015, J PSYCHOL RES, V80, P449; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Lammertyn J, 2007, EXP PSYCHOL, V54, P202, DOI 10.1027/1618-3169.54.3.202; Lien MC, 2016, PSYCHOL RES-PSYCH FO, V80, P912, DOI 10.1007/s00426-015-0699-0; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; Memelink J, 2013, PSYCHOL RES-PSYCH FO, V77, P249, DOI 10.1007/s00426-012-0435-y; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prinz W, 2012, OPEN MINDS: THE SOCIAL MAKING OF AGENCY AND INTENTIONALITY, P1; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Schwarz W, 2012, PSYCHON B REV, V19, P555, DOI 10.3758/s13423-012-0254-6; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; SIMON JR, 1970, J EXP PSYCHOL, V86, P97, DOI 10.1037/h0029783; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Stenzel A, 2016, ATTEN PERCEPT PSYCHO, V78, P143, DOI 10.3758/s13414-015-0994-2; Stenzel A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00595; Tsai CC, 2006, EXP BRAIN RES, V175, P353, DOI 10.1007/s00221-006-0557-9; van Steenbergen H., 2007, THESIS; Vesper C, 2010, NEURAL NETWORKS, V23, P998, DOI 10.1016/j.neunet.2010.06.002; Voss A, 2007, BEHAV RES METHODS, V39, P797, DOI 10.3758/BF03192971; Wenke D, 2011, REV PHILOS PSYCHOL, V2, P147, DOI 10.1007/s13164-011-0057-0; Zhang J, 1997, J EXP PSYCHOL HUMAN, V23, P1543, DOI 10.1037/0096-1523.23.5.1543	41	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184844	10.1371/journal.pone.0184844	http://dx.doi.org/10.1371/journal.pone.0184844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910413	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200105
J	Gotz, TI; Lahmer, G; Strnad, V; Bert, C; Hensel, B; Tome, AM; Lang, EW				Goetz, Th. I.; Lahmer, G.; Strnad, V.; Bert, Ch.; Hensel, B.; Tome, A. M.; Lang, E. W.			A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patients	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; SINGULAR-SPECTRUM ANALYSIS; INTERSTITIAL BRACHYTHERAPY; SIMULTANEOUS LOCALIZATION; MUTUAL-INFORMATION; TIME-SERIES; DYNAMICS; IRRADIATION; PEARSONS; PROSTATE	During High Dose Rate Brachytherapy (HDR-BT) the spatial position of the radiation source inside catheters implanted into a female breast is determined via electromagnetic tracking (EMT). Dwell positions and dwell times of the radiation source are established, relative to the patient's anatomy, from an initial X-ray-CT-image. During the irradiation treatment, catheter displacements can occur due to patient movements. The current study develops an automatic analysis tool of EMT data sets recorded with a solenoid sensor to assure concordance of the source movement with the treatment plan. The tool combines machine learning techniques such as multi-dimensional scaling (MDS), ensemble empirical mode decomposition (EEMD), singular spectrum analysis (SSA) and particle filter (PF) to precisely detect and quantify any mismatch between the treatment plan and actual EMT measurements. We demonstrate that movement artifacts as well as technical signal distortions can be removed automatically and reliably, resulting in artifact-free reconstructed signals. This is a prerequisite for a highly accurate determination of any deviations of dwell positions from the treatment plan.	[Goetz, Th. I.; Lang, E. W.] Univ Regensburg, CIML, Biophys, D-93040 Regensburg, Germany; [Goetz, Th. I.; Lahmer, G.; Strnad, V.; Bert, Ch.] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Tome, A. M.] Univ Aveiro, DETI, IEETA, P-3810193 Aveiro, Portugal; [Goetz, Th. I.; Hensel, B.] Univ Erlangen Nurnberg, Ctr Med Phys & Engn, D-91052 Erlangen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Regensburg; University of Erlangen Nuremberg; Universidade de Aveiro; University of Erlangen Nuremberg	Gotz, TI (corresponding author), Univ Regensburg, CIML, Biophys, D-93040 Regensburg, Germany.; Gotz, TI (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany.; Gotz, TI (corresponding author), Univ Erlangen Nurnberg, Ctr Med Phys & Engn, D-91052 Erlangen, Germany.	theresa.goetz@biologie.uni-regensburg.de	Hensel, Bernhard/C-6995-2013; Bert, Christoph/C-2585-2013	Bert, Christoph/0000-0002-8539-6600; Tome, Ana Maria/0000-0002-1210-0266				Abdi H, 2007, METRIC MULTIDIMENSIO; Al-Subari K, 2015, J NEUROSCI METH, V253, P193, DOI 10.1016/j.jneumeth.2015.06.020; Al-Subari K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119489; Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x; [Anonymous], 2017, MULT SCAL APPL EL TR; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Ashby FG, 2007, SCHOLARPEDIA, V2; Bailey T, 2006, IEEE ROBOT AUTOM MAG, V13, P108, DOI 10.1109/MRA.2006.1678144; Balachandran R, 2009, P SPIE MED IM VIS IM; Bert C, 2016, J CONTEMP BRACHYTHER, V8, P448, DOI 10.5114/jcb.2016.63356; Bharat S, 2014, BRACHYTHERAPY, V13, P640, DOI 10.1016/j.brachy.2014.05.012; Borg I., 2005, SPRINGER SERIES STAT, V2; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Cha S, 2007, CITY, V1, DOI DOI 10.1007/S00167-009-0884-Z; Cox T. F, 1994, MULTIDIMENSIONAL SCA; Damato AL, 2014, MED PHYS, V41, DOI 10.1118/1.4894710; Danilchenko A, 2010, LECT NOTES COMPUT SC, V6363, P587; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; Egghe L, 2009, J AM SOC INF SCI TEC, V60, P1027, DOI 10.1002/asi.21009; Elekta, FLEX EM TRACK RES MA; Franz AM, 2014, IEEE T MED IMAGING, V33, P1702, DOI 10.1109/TMI.2014.2321777; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Golyandina N., 2001, ANAL TIME SERIES STR, DOI DOI 10.1201/9781420035841; Gotz TI, 2017, PHYS MED BI IN PRESS; Harris TJ, 2010, PHYSICA D, V239, P1958, DOI 10.1016/j.physd.2010.07.005; Hassani H., 2007, DATA SCI J, V5, P239, DOI DOI 10.6339/JDS.2007.05(2).396; Hauke J, 2011, QUAEST GEOGR, V30, P87, DOI 10.2478/v10117-011-0021-1; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kellermeier M, 2016, ESTRO 35, P58; Kellermeier M, 2016, BRACHYTHERAPY, V15, pS39; Kellermeier M, 2017, J APPL CLIN MED PHYS, V18, P211, DOI 10.1002/acm2.12021; Kindratenko V. V., 2000, Virtual Reality, V5, P169, DOI 10.1007/BF01409422; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Liu JS, 1999, SEQUENTIAL MONTE CAR; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Okamoto H, 2014, J RADIAT RES, V55, P780, DOI 10.1093/jrr/rru001; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Pearson Karl, 1895, P ROY SOC LONDON, V58, P240, DOI [DOI 10.1098/RSPL.1895.0041, 10.1098/rspl.1895.0041]; PIKE ER, 1984, IEE PROC-F, V131, P660, DOI 10.1049/ip-f-1.1984.0100; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Poulin E, 2016, BRACHYTHERAPY, V15, P102, DOI 10.1016/j.brachy.2015.09.010; Sadjadi H, 2016, IEEE T BIO-MED ENG, V63, P1771, DOI 10.1109/TBME.2015.2502138; Shannon Claude E., 1948, MATH THEORY COMMUNIC, V27, P379; Strnad V, 2016, LANCET, V387, P229, DOI 10.1016/S0140-6736(15)00471-7; Strnad V, 2015, RADIOTHER ONCOL, V115, P342, DOI 10.1016/j.radonc.2015.06.010; Taneja I. J., 1995, ADV IMAG ELECT PHYS, V91, P37, DOI DOI 10.1016/S1076-5670(08)70106-X; Teixeira AR, 2006, COMPUT METH PROG BIO, V83, P125, DOI 10.1016/j.cmpb.2006.06.003; Teixeira AR, 2009, IEEE T INSTRUM MEAS, V58, P2433, DOI 10.1109/TIM.2009.2016385; Tome AM, 2010, STAT INTERFACE, V3, P345; VAUTARD R, 1992, PHYSICA D, V58, P95, DOI 10.1016/0167-2789(92)90103-T; VAUTARD R, 1989, PHYSICA D, V35, P395, DOI 10.1016/0167-2789(89)90077-8; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Zeiler A, 2010, RECENT ADV BIOMEDICA, P27; Zhou J, 2015, CANCER MANAG RES, V7, P199, DOI 10.2147/CMAR.S46042	58	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183608	10.1371/journal.pone.0183608	http://dx.doi.org/10.1371/journal.pone.0183608			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934238	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900012
J	Hysong, SJ; SoRelle, R; Smitham, KB; Petersen, LA				Hysong, Sylvia J.; SoRelle, Richard; Smitham, Kristen Broussard; Petersen, Laura A.			Reports of unintended consequences of financial incentives to improve management of hypertension	PLOS ONE			English	Article							HEALTH-SERVICES RESEARCH; PRIMARY-CARE; PERFORMANCE; PAY; METAANALYSIS; QUALITY; ENGLAND	Background Given the increase in financial-incentive programs nationwide, many physicians and physician groups are concerned about potential unintended consequences of providing financial incentives to improve quality of care. However, few studies examine whether actual unintended consequences result from providing financial incentives to physicians. We sought to document the extent to which the unintended consequences discussed in the literature were observable in a randomized clinical trial (RCT) of financial incentives. Methods We conducted a qualitative observational study nested within a larger RCT of financial incentives to improve hypertension care. We conducted 30-minute telephone interviews with primary care personnel at facilities participating in the RCT housed at12 geographically dispersed Veterans Affairs Medical Centers nationwide. Participants answered questions about unintended effects, clinic team dynamics, organizational impact on care delivery, study participation. We employed a blend of inductive and deductive qualitative techniques for analysis. Participants Sixty-five participants were recruited from RCT enrollees and personnel not enrolled in the larger RCT, plus one primary care leader per site. Results Emergent themes included possible patient harm, emphasis on documentation over improving care, reduced professional morale, and positive spillover. All discussions of unintended consequences involving patient harm were only concerns, not actual events. Several unintended consequences concerned ancillary initiatives for quality improvement (e.g., practice guidelines and performance measurement systems) rather than financial incentives. Conclusions Many unintended consequences of financial incentives noted were either only concerns or attributable to ancillary quality-improvement initiatives. Actual unintended consequences included improved documentation of care without necessarily improving actual care, and positive unintended consequences.	[Hysong, Sylvia J.; Smitham, Kristen Broussard; Petersen, Laura A.] Michael E DeBakey VA Med Ctr, Houston VA HSR&D Ctr Innovat Qual Effectiveness &, Houston, TX 77030 USA; [Hysong, Sylvia J.; Smitham, Kristen Broussard; Petersen, Laura A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Corporal Michael J Crescenz VA Med Ctr, VISN Ctr Evaluat PACT CEPACT 4, Philadelphia, PA USA	Baylor College of Medicine; Baylor College of Medicine	Hysong, SJ (corresponding author), Michael E DeBakey VA Med Ctr, Houston VA HSR&D Ctr Innovat Qual Effectiveness &, Houston, TX 77030 USA.; Hysong, SJ (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	hysong@bcm.edu	Hysong, Sylvia J./B-8420-2008	Hysong, Sylvia J./0000-0002-9063-5207	US Department of Veterans Affairs Health Services Research and Development Program [IIR-04-349]; National Heart Lung and Blood Institute of the National Institutes of Health [R01 HL079173-01]; American Recovery and Reinvestment Act [NHLBI 1RQ1HL079173-52]; American Heart Association Established Investigator Award [0540043N]; Robert Wood Johnson Foundation Generalist Physician Faculty Scholar [045444]; NHLBI Investigator Research Supplement to Promote Diversity in Health-Related Research [1R01HL079173-S1, CDA 07-0181]	US Department of Veterans Affairs Health Services Research and Development Program(US Department of Veterans Affairs); National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Recovery and Reinvestment Act; American Heart Association Established Investigator Award(American Heart Association); Robert Wood Johnson Foundation Generalist Physician Faculty Scholar(Robert Wood Johnson Foundation (RWJF)); NHLBI Investigator Research Supplement to Promote Diversity in Health-Related Research	The work reported here was funded by the US Department of Veterans Affairs Health Services Research and Development Program (grant # IIR-04-349 [PI Laura A. Peterson, MD, MPH]) and the National Heart Lung and Blood Institute of the National Institutes of Health (Grant # R01 HL079173-01 [P1 Laura A. Petersen, MD, MPH]), the American Recovery and Reinvestment Act of 2010 (NHLBI 1RQ1HL079173-52). Dr. Petersen was a recipient of the American Heart Association Established Investigator Award (Grant number 0540043N) and was a Robert Wood Johnson Foundation Generalist Physician Faculty Scholar (Grant number 045444) at the time that this study was planned and funded. Dr. Hysong was a recipient of an NHLBI Investigator Research Supplement to Promote Diversity in Health-Related Research (1R01HL079173-S1) during the early stages of the study and is currently a VA HSR&D Career Development Awardee (CDA 07-0181). The work was also supported with the use of resources and facilities at the Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (CIN13-413). The funders played no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review, or approval of the manuscript and decision to submit the manuscript for publication. The views expressed reflect those of the authors and not necessarily those of the Department of Veterans Affairs, National Institutes of Health, US Government or Baylor College of Medicine.	Campbell SA, 2008, ANN FAM MED, V6, P228, DOI 10.1370/afm.844; Campbell SM, 2010, ANN FAM MED, V8, P499, DOI 10.1370/afm.1145; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Committee on Quality of Health Care in America Institute of Medicine, 2006, REW PROV PERF AL INC; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Glaser B.G., 1968, DISCOV GROUNDED THEO; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hysong SJ, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-9; Hysong SJ, 2009, MED CARE, V47, P356, DOI 10.1097/MLR.0b013e3181893f6b; Kizer KW, 2014, NEW ENGL J MED, V371, P295, DOI 10.1056/NEJMp1406852; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Lester H, 2013, BRIT J GEN PRACT, V63, pE408, DOI 10.3399/bjgp13X668203; McDonald R, 2009, ANN FAM MED, V7, P121, DOI 10.1370/afm.946; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Morgan RO, 2005, HEALTH SERV RES, V40, P1573, DOI 10.1111/j.1475-6773.2005.00448.x; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Petersen LA, 2013, JAMA-J AM MED ASSOC, V310, P1042, DOI 10.1001/jama.2013.276303; Petersen LA, 2012, ANN INTERN MED, V156, P728, DOI 10.7326/0003-4819-156-10-201205150-00011; Petersen LA, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-114; Powell AA, 2012, J GEN INTERN MED, V27, P405, DOI 10.1007/s11606-011-1906-3; [Primary Care Management Module (PCMM) Department of Veterans Affairs], 2009, VHA HDB; Strauss A., 1998, BASICS QUALITATIVE R; United States Department of Veterans Affairs, 2008, US DEP VET AFF VA HD; Weyer Sharon M, 2008, Qual Manag Health Care, V17, P47, DOI 10.1097/01.QMH.0000308637.04850.ac	25	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184856	10.1371/journal.pone.0184856	http://dx.doi.org/10.1371/journal.pone.0184856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934258	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900052
J	Ling, YH; Xu, LN; Zhu, L; Sui, MH; Zheng, Q; Li, WY; Liu, Y; Fang, FG; Zhang, XR				Ling, Yinghui; Xu, Lina; Zhu, Long; Sui, Menghua; Zheng, Qi; Li, Wenyong; Liu, Yong; Fang, Fugui; Zhang, Xiaorong			Identification and analysis of differentially expressed long non-coding RNAs between multiparous and uniparous goat (Capra hircus) ovaries	PLOS ONE			English	Article							MICRORNAS; GENES; TRANSCRIPTS; MULTIPLE; CELLS; SEQ; FSH	Long non-coding RNAs (lncRNAs) play important roles in almost all biological processes. However, there is little information on the effects of lncRNAs on ovulation and lambing rates. In the present study, we used high-throughput RNA sequencing to identify differentially expressed lncRNAs between the ovaries of multiparous (Mul) and uniparous (Uni) Anhui White goats. Among the 107,255,422 clean reads, 183,754 lncRNAs were significantly differentially expressed between the Uni and Mul. Among them, 455 lncRNAs were co-expressed between the two samples, whereas, 157,523 lncRNAs were uniquely expressed in the Uni, and 25,776 uniquely lncRNAs were expressed in the Mul. Through Cis role analysis, 24 lncRNAs were predicted to overlap with cis-regulatory elements, which involved in Progesterone-mediated oocyte maturation, Steroid biosynthesis, Oocyte meiosis, and gonadotropin-releasing hormone (GnRH) signaling pathway. These 4 pathways were related to ovulation, and the KEGG pathway analysis on target genes of the differentially expressed lncRNAs confirmed this results. In addition, 10 lncRNAs harbored precursors of 40 miRNAs, such as TCONS_00320849 related to a mature miRNA sequence, miR-365a, which was reported to be related to proliferation, were annotated in the precursor analysis of miRNAs. The present expand the understanding of lncRNA biology and contribute to the annotation of the goat genome. The study will provide a resource for lncRNA studies of ovulation and lambing.	[Ling, Yinghui; Zhu, Long; Sui, Menghua; Zheng, Qi; Fang, Fugui; Zhang, Xiaorong] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China; [Ling, Yinghui; Zhu, Long; Sui, Menghua; Zheng, Qi; Fang, Fugui; Zhang, Xiaorong] Local Anim Genet Resources Conservat & Biobreedin, Hefei, Anhui, Peoples R China; [Xu, Lina] Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Anhui, Peoples R China; [Li, Wenyong; Liu, Yong] Fuyang Normal Univ, Key Lab Embryo Dev & Reprod Regulat Anhui Prov, Fuyang, Anhui, Peoples R China	Anhui Agricultural University; Anhui Academy of Agricultural Sciences; Fuyang Normal University	Fang, FG; Zhang, XR (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China.; Fang, FG; Zhang, XR (corresponding author), Local Anim Genet Resources Conservat & Biobreedin, Hefei, Anhui, Peoples R China.	332792872@qq.com; zhangxiaorong01@163.com			National Natural Science Foundation of China [31772566, 31472096]; Natural Science Foundation of Anhui Province [1708085MC61]; Key Research Projects of Natural Science in Anhui Colleges and Universities [KJ2017A334]; Agricultural Science and Technology Innovation Program of China [ASTIP-1A513]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Key Research Projects of Natural Science in Anhui Colleges and Universities; Agricultural Science and Technology Innovation Program of China	This research was supported by the National Natural Science Foundation of China (31772566, 31472096), the Natural Science Foundation of Anhui Province (1708085MC61), the Key Research Projects of Natural Science in Anhui Colleges and Universities (KJ2017A334) and the Agricultural Science and Technology Innovation Program of China (ASTIP-1A513).	Abdelmohsen K, 2013, AGING CELL, V12, P890, DOI 10.1111/acel.12115; Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bernhardt ML, 2011, BIOL REPROD, V84, P526, DOI 10.1095/biolreprod.110.086488; Boulanger L, 2014, CURR BIOL, V24, P404, DOI 10.1016/j.cub.2013.12.039; Caballero J, 2015, REPROD FERT DEVELOP, V27, P40, DOI 10.1071/RD14338; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Corsini E, 2002, TOXICOL IN VITRO, V16, P427, DOI 10.1016/S0887-2333(02)00023-1; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Eswards CA, 2007, CURR OPIN CELL BOIL, V19, P281; Ganguly A, 2013, RES VET SCI, V95, P374, DOI 10.1016/j.rvsc.2013.03.013; Gayen S, 2016, P NATL ACAD SCI USA, V113, pE309, DOI 10.1073/pnas.1515971113; Gholkar AA, 2016, CELL REP, V14, P180, DOI 10.1016/j.celrep.2015.12.035; Gordon Carmichael, 2012, FASEB J, V26, P203; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hadjimichael C, 2016, STEM CELL REP, V6, P292, DOI 10.1016/j.stemcr.2016.01.004; Herndon MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126527; Jena SC, 2014, MOL REPROD DEV, V81, P350, DOI 10.1002/mrd.22303; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lakhotia SC, 2015, J GENET, V94, P575, DOI 10.1007/s12041-015-0566-1; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Ling YH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-339; Luan XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113211; Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598; MESSINIS IE, 1990, HUM REPROD, V5, P153, DOI 10.1093/oxfordjournals.humrep.a137060; Moqadam FA, 2014, LEUKEMIA, V28, P1008, DOI 10.1038/leu.2013.308; Moskowitz A, 2009, INVEST OPHTH VIS SCI, V50, P950, DOI 10.1167/iovs.08-2544; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strozzi F, 2009, ANIM GENET, V40, P125, DOI 10.1111/j.1365-2052.2008.01780.x; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VANDERMEER M, 1994, HUM REPROD, V9, P1612, DOI 10.1093/oxfordjournals.humrep.a138761; Wang F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07146; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xie PG, 2015, INT J CLIN EXP MED, V8, P14764; Yue MH, 2016, BBA-GENE REGUL MECH, V1859, P112, DOI 10.1016/j.bbagrm.2015.07.015; Zhou WH, 2015, IRAN J BASIC MED SCI, V18, P1027	49	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183163	10.1371/journal.pone.0183163	http://dx.doi.org/10.1371/journal.pone.0183163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934224	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900006
J	Mandle, L; Wolny, S; Bhagabati, N; Helsingen, H; Hamel, P; Bartlett, R; Dixon, A; Horton, R; Lesk, C; Manley, D; De Mel, M; Bader, D; Myint, SNW; Myint, W; Mon, MS				Mandle, Lisa; Wolny, Stacie; Bhagabati, Nirmal; Helsingen, Hanna; Hamel, Perrine; Bartlett, Ryan; Dixon, Adam; Horton, Radley; Lesk, Corey; Manley, Danielle; De Mel, Manishka; Bader, Daniel; Myint, Sai Nay Won; Myint, Win; Mon, Myat Su			Assessing ecosystem service provision under climate change to support conservation and development planning in Myanmar	PLOS ONE			English	Article							BIODIVERSITY; PEOPLE	Inclusion of ecosystem services (ES) information into national-scale development and climate adaptation planning has yet to become common practice, despite demand from decision makers. Identifying where ES originate and to whom the benefits flow-under current and future climate conditions-is especially critical in rapidly developing countries, where the risk of ES loss is high. Here, using Myanmar as a case study, we assess where and how ecosystems provide key benefits to the country's people and infrastructure. We model the supply of and demand for sediment retention, dry-season baseflows, flood risk reduction and coastal storm protection from multiple beneficiaries. We find that locations currently providing the greatest amount of services are likely to remain important under the range of climate conditions considered, demonstrating their importance in planning for climate resilience. Overlap between priority areas for ES provision and biodiversity conservation is higher than expected by chance overall, but the areas important for multiple ES are under-represented in currently designated protected areas and Key Biodiversity Areas. Our results are contributing to development planning in Myanmar, and our approach could be extended to other contexts where there is demand for national-scale natural capital information to shape development plans and policies.	[Mandle, Lisa; Wolny, Stacie; Hamel, Perrine] Stanford Univ, Dept Biol, Nat Capital Project, Stanford, CA 94305 USA; [Mandle, Lisa; Wolny, Stacie; Hamel, Perrine] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Bhagabati, Nirmal; Bartlett, Ryan; Dixon, Adam] World Wildlife Fund, 1250 24th St,NW, Washington, DC 20037 USA; [Helsingen, Hanna; Myint, Sai Nay Won; Myint, Win] World Wide Fund Nat, Yangon, Myanmar; [Dixon, Adam] Univ Maryland Baltimore Cty, Dept Geog & Environm Syst, Baltimore, MD 21228 USA; [Horton, Radley; Lesk, Corey; Manley, Danielle; De Mel, Manishka; Bader, Daniel] Columbia Univ, Earth Inst, Ctr Climate Syst Res, New York, NY USA; [Horton, Radley; Lesk, Corey; Manley, Danielle; De Mel, Manishka; Bader, Daniel] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Mon, Myat Su] Minist Nat Resources & Environm Conservat, Forest Dept, Nay Pyi Taw, Myanmar	Stanford University; Stanford University; World Wildlife Fund; World Wildlife Fund; University System of Maryland; University of Maryland Baltimore County; Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Mandle, L (corresponding author), Stanford Univ, Dept Biol, Nat Capital Project, Stanford, CA 94305 USA.; Mandle, L (corresponding author), Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA.	lmandle@stanford.edu		Mandle, Lisa/0000-0002-1420-8529; Horton, Radley/0000-0002-5574-9962	Leona M. and Harry B. Helmsley Charitable Trust	Leona M. and Harry B. Helmsley Charitable Trust	This work was supported with funding from the Leona M. and Harry B. Helmsley Charitable Trust (http://helmsleytrust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADB (Asian Development Bank), 2012, SUPP MYANM REF INCL, P5; ADB (Asian Development Bank), 2016, BAS 2016 STAT; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 1997, WORLD MANGROVE ATLAS; [Anonymous], 2013, MYANM BIOD CONS INV; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Bank World, 2015, MYANM EMP PEOPL INCL; Barbier EB, 2016, RESOUR ENERGY ECON, P1; BirdLife International Conservation International WCS Myanmar, 2013, KEY BIOD AR MYANM; Boerema A, 2017, J APPL ECOL, V54, P358, DOI 10.1111/1365-2664.12696; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Cubasch U, CLIMATE CHANGE 2013; Droogers P., 2002, Irrigation and Drainage Systems, V16, P33, DOI 10.1023/A:1015508322413; Egoh B, 2009, BIOL CONSERV, V142, P553, DOI 10.1016/j.biocon.2008.11.009; Emerton L., 2013, EC VALUE FOREST ECOS; Food and Agriculture Organization of the United Nations ( FAO ), 2012, COUNTR PROGR FRAM 20; Gaughan AE, 2013, PLOS ONE, P8; Goldstein JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179008; Gonzalez P, 2010, GLOBAL ECOL BIOGEOGR, V19, P755, DOI 10.1111/j.1466-8238.2010.00558.x; Guannel G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158094; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Hamel P, 2017, ECOSYST SERV, V24, P1, DOI 10.1016/j.ecoser.2016.12.008; Hamel P, 2015, SCI TOTAL ENVIRON, V524, P166, DOI 10.1016/j.scitotenv.2015.04.027; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Horton R, 2015, KNOWLEDGE BASE CLIMA, V1336, P36, DOI DOI 10.1111/NYAS.12593; Horton R., 2016, ASSESSING CLIMATE RI, P88; IPCC, 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; IUCN, 2016, GUID US GLOB STAND I, VFirst; Jones HP, 2012, NAT CLIM CHANGE, V2, P504, DOI 10.1038/NCLIMATE1463; Keeler BL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600219; Kreft S., GLOBAL CLIMATE RISK; Langhans SD, 2014, ECOL INDIC, V45, P494, DOI 10.1016/j.ecolind.2014.05.014; Latt KT, 2011, MYANMAR PROTECTED AR; Lehner B., 2011, GLOBAL RESERVOIR DAM, P1; Lentz EE, 2016, NATURE CLIMATE CHANG, P1; Mandle L, 2015, FRONT ECOL ENVIRON, V13, P309, DOI 10.1890/140337; McKenzie E, 2014, ENVIRON PLANN C, V32, P320, DOI 10.1068/c12292j; MIMU (Myanmar Information Management Unit), 2015, FLOOD AFF VILL LIST; Ministry of Immigration and Population (2015a), 2015, 2014 MYANM POP HOUS; MoNREC (Ministry of Natural Resources and Environmental Conservation), 2016, MYAN CLIM CHANG STRA; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Myanmar News Agency, 2016, WORLD ENV DAY CEL NA; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; NASA National Aeronautics and Space Administration, 2015, NEX GLOB DAIL DOWNSC; National Environmental Conservation Committee (NECC) Ministry of Environmental Conservation and Forestry Department of Meterology and Hydrology Ministry of Transport & United Nations Environment Programme, 2012, WEATHER SHOWS EVIDEN; Nay Pyi Taw Myanmar, 2016, NAT LAND US POL; Neugarten RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168575; NRCS, 2004, NAT ENG HDB 630, P79; Ouyang Z, 2016, SCIENCE, V352, P1455, DOI 10.1126/science.aaf2295; Park CE, 2015, J CLIMATE, V28, P2884, DOI 10.1175/JCLI-D-13-00753.1; Pollescha NL, 2016, ECOL ECON, V130, P195, DOI 10.1016/j.ecolecon.2016.06.018; Posner SM, 2016, P NATL ACAD SCI USA, V113, P1760, DOI 10.1073/pnas.1502452113; Rao M, 2013, AMBIO, V42, P789, DOI 10.1007/s13280-013-0423-5; Reddy SMW, 2015, ECOSYST SERV, V12, P94, DOI 10.1016/j.ecoser.2014.12.001; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Runting RK, 2016, GLOB CHANG BIOL; Sharp R, 2015, INVEST 3 2 0 USERS G; Srinivasan UT, 2010, CLIM POLICY, V10, P298, DOI 10.3763/cpol.2009.0652; Stocker T. F., 2013, CLIMATE CHANGE 2013; Tallis H., 2012, INCLUSIVE WEALTH REP; Tignor M., 2013, CLIMATE CHANGE 2013; UNDP, 2015, HUMAN DEV REPORT 201; [UNDP (United Nations Development Programme). MOAI (Ministry of Agriculture and Irrigation) FAO (Food and Agriculture Organization)], 2005, DIG AGR ATL UN MYANM; UNEP-WCMC, 2010, GLOB DISTR WARM WAT; UNEP-WCMC Short FT, 2005, GLOB DISTR SEAGR VER; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Webb EL, 2014, GLOBAL ENVIRON CHANG, V24, P321, DOI 10.1016/j.gloenvcha.2013.10.007	68	22	23	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184951	10.1371/journal.pone.018495	http://dx.doi.org/10.1371/journal.pone.018495			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934282				2022-12-27	WOS:000411339900064
J	Temu, TM; Lane, KA; Shen, CY; Ng'ang'a, L; Akwanalo, CO; Chen, PS; Emonyi, W; Heckbert, SR; Koech, MM; Manji, I; Vatta, M; Velazquez, EJ; Wessel, J; Kimaiyo, S; Inui, TS; Bloomfield, GS				Temu, Tecla M.; Lane, Kathleen A.; Shen, Changyu; Ng'ang'a, Loise; Akwanalo, Constantine O.; Chen, Peng-Sheng; Emonyi, Wilfred; Heckbert, Susan R.; Koech, Myra M.; Manji, Imran; Vatta, Matteo; Velazquez, Eric J.; Wessel, Jennifer; Kimaiyo, Sylvester; Inui, Thomas S.; Bloomfield, Gerald S.			Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya	PLOS ONE			English	Article							RHEUMATIC HEART-DISEASE; GLOBAL BURDEN; FOLLOW-UP; REGISTRY; COUNTRIES; EPIDEMIOLOGY; MANAGEMENT; DESIGN; REMEDY; RATIONALE	Background Atrial fibrillation (AF) is a major contributor to the global cardiovascular disease burden. The clinical profile and outcomes of AF patients with valvular heart diseases in sub-Saharan Africa (SSA) have not been adequately described. We assessed clinical features and 12-month outcomes of patients with valvular AF (vAF) in comparison to AF patients without valvular heart disease (nvAF) in western Kenya. Methods We performed a cohort study with retrospective data gathering to characterize risk factors and prospective data collection to characterize their hospitalization, stroke and mortality rates. Results The AF patients included 77 with vAF and 69 with nvAF. The mean (SD) age of vAF and nvAF patients were 37.9(14.5) and 69.4(12.3) years, respectively. There were significant differences (p< 0.001) between vAF and nvAF patients with respect to female sex (78% vs. 55%), rates of hypertension (29% vs. 73%) and heart failure (10% vs. 49%). vAF patients were more likely to be taking anticoagulation therapy compared to those with nvAF (97% vs. 76%; p< 0.01). After 12-months of follow-up, the overall mortality, hospitalization and stroke rates for vAF patients were high, at 10%, 34% and 5% respectively, and were similar to the rates in the nvAF patients (15%, 36%, and 5%, respectively). Conclusion Despite younger age and few comorbid conditions, patients with vAF in this developing country setting are at high risk for nonfatal and fatal outcomes, and are in need of interventions to improve short and long-term outcomes.	[Temu, Tecla M.] Univ Nairobi, Dept Med Microbiol, Coll Hlth Sci, Nairobi, Kenya; [Lane, Kathleen A.] Indiana Univ Sch Med, Dept Biostat, Indiana Univ, Indianapolis, IN 46202 USA; [Shen, Changyu] Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA; [Shen, Changyu] Harvard Med Sch, Boston, MA USA; [Ng'ang'a, Loise; Velazquez, Eric J.; Bloomfield, Gerald S.] Duke Univ, Dept Med, Duke Clin Res Inst, Durham, NC USA; [Ng'ang'a, Loise; Velazquez, Eric J.; Bloomfield, Gerald S.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Akwanalo, Constantine O.; Emonyi, Wilfred; Koech, Myra M.; Manji, Imran; Kimaiyo, Sylvester] Moi Teaching & Referral Hosp, Div Med, Eldoret, Kenya; [Akwanalo, Constantine O.; Emonyi, Wilfred; Manji, Imran; Kimaiyo, Sylvester; Inui, Thomas S.] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Chen, Peng-Sheng; Vatta, Matteo; Inui, Thomas S.] Indiana Univ, Baptist Healthcare Ctr, Indianapolis, IN 46204 USA; [Chen, Peng-Sheng; Vatta, Matteo; Wessel, Jennifer] Indiana Univ, Dept Med, Indianapolis, IN USA; [Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Kimaiyo, Sylvester] Moi Univ, Dept Med, Sch Med, Coll Hlth Sci, Eldoret, Kenya	University of Nairobi; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Duke University; Duke University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Washington; University of Washington Seattle; Moi University	Temu, TM (corresponding author), Univ Nairobi, Dept Med Microbiol, Coll Hlth Sci, Nairobi, Kenya.	Tecla_Temu@alumni.brown.edu	Manji, Imran/K-8514-2019	Manji, Imran/0000-0001-8715-9804; Temu, Tecla/0000-0002-0056-4143; Wessel, Jennifer/0000-0002-7031-0085	NIH [R42DA043391, P01HL78931, R01HL71140]; Medtronic-Zipes Endowment of Indiana University; Indiana University Health-Indiana University School of Medicine Strategic Research Initiative; Fogarty International Center of the National Institutes of Health (NIH) [R25TW009345]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medtronic-Zipes Endowment of Indiana University; Indiana University Health-Indiana University School of Medicine Strategic Research Initiative; Fogarty International Center of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported in part by NIH Grants R42DA043391, P01HL78931, R01HL71140, a Medtronic-Zipes Endowment of Indiana University and the Indiana University Health-Indiana University School of Medicine Strategic Research Initiative. TT has been supported by award from Fogarty International Center of the National Institutes of Health (NIH) R25TW009345. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Bloomfield GS, 2015, AM HEART J, V170, P455, DOI 10.1016/j.ahj.2015.06.008; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Engelgau MM, 2016, GLOB HEART, V11, P5, DOI 10.1016/j.gheart.2015.12.016; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Healey JS, 2016, LANCET, V388, P1161, DOI 10.1016/S0140-6736(16)30968-0; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Karthikeyan G, 2012, AM HEART J, V163, P535, DOI 10.1016/j.ahj.2012.01.003; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Moran A, 2013, PROG CARDIOVASC DIS, V56, P234, DOI 10.1016/j.pcad.2013.09.019; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Ntep-Gweth M, 2010, EUROPACE, V12, P482, DOI 10.1093/europace/euq006; Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; Rahman F, 2014, NAT REV CARDIOL, V11, P639, DOI 10.1038/nrcardio.2014.118; Shavadia J, 2013, CARDIOVASC J AFR, V24, P6, DOI 10.5830/CVJA-2012-064; Sliwa K, 2010, HEART, V96, P1878, DOI 10.1136/hrt.2010.206938; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Wen-Hang QI, 2005, INT J CARDIOL, V105, P283, DOI 10.1016/j.ijcard.2004.12.042; Zubaid M, 2011, CIRC-CARDIOVASC QUAL, V4, P477, DOI 10.1161/CIRCOUTCOMES.110.959700; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449; Zuhlke L, 2016, CIRCULATION, V134, P1456, DOI 10.1161/CIRCULATIONAHA.116.024769	23	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185204	10.1371/journal.pone.0185204	http://dx.doi.org/10.1371/journal.pone.0185204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934312	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900121
J	Elmariah, S				Elmariah, Sammy			Formal comment to Toyota et al.: Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration	PLOS ONE			English	Editorial Material							DRUG-ELUTING STENTS		[Elmariah, Sammy] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02115 USA; [Elmariah, Sammy] Baim Inst Clin Res, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Elmariah, S (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02115 USA.; Elmariah, S (corresponding author), Baim Inst Clin Res, Boston, MA 02215 USA.	selmariah@mgh.harvard.edu	Elmariah, Sammy/AAG-8752-2021					Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Elmariah S, 2014, LANCET; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; Stefanescu Schmidt AC, 2017, CIRCULATION; Toyota T, PLOS ONE; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775	8	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184513	10.1371/journal.pone.0184513	http://dx.doi.org/10.1371/journal.pone.0184513			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931024	gold, Green Published			2022-12-27	WOS:000411314700021
J	McBirney, M; King, SE; Pappalardo, M; Houser, E; Unkefer, M; Nilsson, E; Sadler-Riggleman, I; Beck, D; Winchester, P; Skinner, MK				McBirney, Margaux; King, Stephanie E.; Pappalardo, Michelle; Houser, Elizabeth; Unkefer, Margaret; Nilsson, Eric; Sadler-Riggleman, Ingrid; Beck, Daniel; Winchester, Paul; Skinner, Michael K.			Atrazine induced epigenetic transgenerational inheritance of disease, lean phenotype and sperm epimutation pathology biomarkers	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; ADULT-ONSET DISEASE; ENVIRONMENTAL-FACTORS; PRENATAL EXPOSURE; RISK-ASSESSMENT; ADIPOSE-TISSUE; HEALTH-RISK; RATS; OBESITY; MICE	Ancestral environmental exposures to a variety of environmental toxicants and other factors have been shown to promote the epigenetic transgenerational inheritance of adult onset disease. The current study examined the potential transgenerational actions of the herbicide atrazine. Atrazine is one of the most commonly used herbicides in the agricultural industry, in particular with corn and soy crops. Outbred gestating female rats were transiently exposed to a vehicle control or atrazine. The F1 generation offspring were bred to generate the F2 generation and then the F2 generation bred to generate the F3 generation. The F1, F2 and F3 generation control and atrazine lineage rats were aged and various pathologies investigated. The male sperm were collected to investigate DNA methylation differences between the control and atrazine lineage sperm. The F1 generation offspring (directly exposed as a fetus) did not develop disease, but weighed less compared to controls. The F2 generation (grand-offspring) was found to have increased frequency of testis disease and mammary tumors in males and females, early onset puberty in males, and decreased body weight in females compared to controls. The transgenerational F3 generation rats were found to have increased frequency of testis disease, early onset puberty in females, behavioral alterations (motor hyperactivity) and a lean phenotype in males and females. The frequency of multiple diseases was significantly higher in the transgenerational F3 generation atrazine lineage males and females. The transgenerational transmission of disease requires germline (egg or sperm) epigenetic alterations. The sperm differential DNA methylation regions (DMRs), termed epimutations, induced by atrazine were identified in the F1, F2 and F3 generations. Gene associations with the DMRs were identified. For the transgenerational F3 generation sperm, unique sets of DMRs (epimutations) were found to be associated with the lean phenotype or testis disease. These DMRs provide potential biomarkers for transgenerational disease. The etiology of disease appears to be in part due to environmentally induced epigenetic transgenerational inheritance, and epigenetic biomarkers may facilitate the diagnosis of the ancestral exposure and disease susceptibility. Observations indicate that although atrazine does not promote disease in the directly exposed F1 generation, it does have the capacity to promote the epigenetic transgenerational inheritance of disease.	[McBirney, Margaux; King, Stephanie E.; Pappalardo, Michelle; Houser, Elizabeth; Unkefer, Margaret; Nilsson, Eric; Sadler-Riggleman, Ingrid; Beck, Daniel; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Washington, DC 99164 USA; [Winchester, Paul] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Washington State University; Indiana University System; Indiana University-Purdue University Indianapolis	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Washington, DC 99164 USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020		Gerber Foundation [3631]; John Templeton Foundation [50183]; National Institutes of Health [ES012974]; Gerber Foundation grant; John Templeton Foundation grant; NIH grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	Gerber Foundation; John Templeton Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerber Foundation grant; John Templeton Foundation grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by: Gerber Foundation (3631) to PW MKS; John Templeton Foundation (50183) to MKS; and National Institutes of Health (ES012974) to MKS.; We acknowledge Dr. Millissia Ben Maamar, Ms. Hannah Kimbel, Ms. Deepika Kubsad, Ms. Marlee Lawley, Ms. Heidi Skinner, Mr. Ryan Thompson, Ms. Jayleana Barton, Mr. Ryan Feser, Ms. Mackenzie Hastings, and Ms. Jennifer Madrid Thorson for technical assistance and Ms. Heather Johnson for assistance in preparation of the manuscript. We thank Dr. Gerlinde Metz, University of Lethbridge, Canada, for behavioral data analysis advice. This study was supported by a Gerber Foundation grant to PW and MKS, John Templeton Foundation grant to MKS and NIH grant to MKS.	Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Chen JY, 2013, J ENVIRON SCI HEAL B, V48, P637, DOI 10.1080/03601234.2013.777308; Chusyd DE, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00010; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davis LK, 2011, REPROD TOXICOL, V32, P43, DOI 10.1016/j.reprotox.2011.04.004; Doyle TJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106104; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eldridge JC, 2008, REV ENVIRON CONTAM T, V196, P147, DOI 10.1007/978-0-387-78444-1_6; Eldridge JC, 1999, STEROIDS, V64, P672, DOI 10.1016/S0039-128X(99)00051-3; Fraites MJP, 2011, REPROD TOXICOL, V32, P52, DOI 10.1016/j.reprotox.2011.04.003; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hao CX, 2016, NUCLEIC ACIDS RES, V44, P9784, DOI 10.1093/nar/gkw840; Haque MM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2748-5; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jowa L, 2011, J ENVIRON SCI HEAL C, V29, P91, DOI 10.1080/10590501.2011.577681; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 2013, HORM BEHAV, V64, P250, DOI 10.1016/j.yhbeh.2013.03.014; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lin ZM, 2013, NEUROTOXICOL TERATOL, V39, P26, DOI 10.1016/j.ntt.2013.06.002; Magnusdottir E, 2012, CURR OPIN GENET DEV, V22, P466, DOI 10.1016/j.gde.2012.06.002; Manikkam M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102091; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Marques BG, 1998, AM J PHYSIOL-REG I, V275, pR1898, DOI 10.1152/ajpregu.1998.275.6.R1898; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McCarrey JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168038; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morris DL, 2016, TRANSL RES, V172, P1, DOI 10.1016/j.trsl.2016.02.010; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Narotsky MG, 2001, REPROD TOXICOL, V15, P61, DOI 10.1016/S0890-6238(00)00111-8; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Parent AS, 2016, ENDOCR DEV, V29, P174, DOI 10.1159/000438885; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salian S, 2009, LIFE SCI, V85, P11, DOI 10.1016/j.lfs.2009.04.005; Sass JB, 2006, INT J OCCUP ENV HEAL, V12, P260; Schneider P, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00043; Schuster A, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvw001; Scialli AR, 2014, BIRTH DEFECTS RES B, V101, P199, DOI 10.1002/bdrb.21099; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Shnorhavorian M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170085; Skinner MK, 2015, EPIGENETICS-US, V10, P762, DOI 10.1080/15592294.2015.1062207; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-692; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Song Y, 2014, BIOMED ENVIRON SCI, V27, P281, DOI 10.3967/bes2014.050; Taylor JA, 2011, J STEROID BIOCHEM, V127, P83, DOI 10.1016/j.jsbmb.2011.07.005; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; UGAZIO G, 1991, RES COMMUN CHEM PATH, V74, P349; United States GS, 2006, QUAL OUR NAT WAT PES; Victor-Costa AB, 2010, REPROD TOXICOL, V29, P323, DOI 10.1016/j.reprotox.2009.12.006; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Walters JL, 2015, TOXICOL APPL PHARM, V289, P185, DOI 10.1016/j.taap.2015.09.026; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Wolstenholme JT, 2013, HORM BEHAV, V64, P833, DOI 10.1016/j.yhbeh.2013.09.007; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Xie F, 2012, CELL PHYSIOL BIOCHEM, V29, P111, DOI 10.1159/000337592	86	85	87	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184306	10.1371/journal.pone.0184306	http://dx.doi.org/10.1371/journal.pone.0184306			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931070	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700018
J	Mei, SY; Karimnezhad, A; Forest, M; Bickel, DR; Greenwood, CMT				Mei, Shuyan; Karimnezhad, Ali; Forest, Marie; Bickel, David R.; Greenwood, Celia M. T.			The performance of a new local false discovery rate method on tests of association between coronary artery disease (CAD) and genome-wide genetic variants	PLOS ONE			English	Article							COMMON SNPS; REPLICATION; HYPOTHESIS; VALIDATION; INFERENCE; POWER	The maximum entropy (ME) method is a recently-developed approach for estimating local false discovery rates (LFDR) that incorporates external information allowing assignment of a subset of tests to a category with a different prior probability of following the null hypothesis. Using this ME method, we have reanalyzed the findings from a recent large genomewide association study of coronary artery disease (CAD), incorporating biologic annotations. Our revised LFDR estimates show many large reductions in LFDR, particularly among the genetic variants belonging to annotation categories that were known to be of particular interest for CAD. However, among SNPs with rare minor allele frequencies, the reductions in LFDR were modest in size.	[Mei, Shuyan; Greenwood, Celia M. T.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Karimnezhad, Ali] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Karimnezhad, Ali; Bickel, David R.] Univ Ottawa, Fac Med, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Karimnezhad, Ali; Bickel, David R.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Forest, Marie; Greenwood, Celia M. T.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Bickel, David R.] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Greenwood, Celia M. T.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Greenwood, Celia M. T.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada	McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Lady Davis Institute; McGill University; University of Ottawa; McGill University; McGill University	Greenwood, CMT (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Greenwood, CMT (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.; Greenwood, CMT (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.; Greenwood, CMT (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	celia.greenwood@mcgill.ca		Greenwood, Celia/0000-0002-2427-5696; Abbas-Aghababazadeh, Farnoosh/0000-0001-6427-9379	CIHR Operating grant [123508]; Canadian Institutes of Health Research; NSER Coperating grant	CIHR Operating grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSER Coperating grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded primarily by CIHR Operating grant #123508, awarded to DB and CG by the Canadian Institutes of Health Research, and also by an NSER Coperating grant to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AK made his contributions while a postdoctoral fellow at the University of Ottawa with DB. This work was funded primarily by CIHR Operating grant # 123508 to DB, and also by an NSERC operating grant to CG. We would like to acknowledge the substantial assistance of Majid Nikpay with providing the data and annotations, and assisting with understanding of these data.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aghababazadah FA, 2016, WORKING PAPER; [Anonymous], WORKING PAPER; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickel DR, 2015, INT J APPROX REASON, V66, P53, DOI 10.1016/j.ijar.2015.07.012; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B., 2010, LARGE SCALE INFERENC; Efron B, 2015, LOCFDR VIGNETTE; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Efron B, 2007, J AM STAT ASSOC, V102, P93, DOI 10.1198/016214506000001211; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Greenwood CMT, 2007, GENET EPIDEMIOL, V31, P396, DOI 10.1002/gepi.20220; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Karimnezhad A, INCORPORATING UNPUB; Karimnezhad A, 2016, WORKING PAPER; Konig IR, 2011, BRIEF BIOINFORM, V12, P253, DOI 10.1093/bib/bbq074; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Li C, 2008, HUM HERED, V65, P129, DOI 10.1159/000109730; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nikpay M, 2017, CARDIOVASC RES; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Padilla M, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1807; Scheid S, 2005, BIOINFORMATICS, V21, P2921, DOI 10.1093/bioinformatics/bti436; Sinha R, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S23; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang Y, 2013, IEEE ACM T COMPUT BI, V10, P98, DOI 10.1109/TCBB.2012.140; Yang ZY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-87	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185174	10.1371/journal.pone.0185174	http://dx.doi.org/10.1371/journal.pone.0185174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931044	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700076
J	Moura, ARSS; Kretz, CB; Ferreira, IE; Nunes, AMPB; de Moraes, JC; Reis, MG; McBride, AJA; Wang, X; Campos, LC				Silva Simoes Moura, Ana Rafaela; Kretz, Cecilia Batmalle; Ferreira, Italo Eustaquio; Pithon Borges Nunes, Amelia Maria; de Moraes, Jose Cassio; Reis, Mitermayer Galvao; Alexander McBride, Alan John; Wang, Xin; Campos, Leila Carvalho			Molecular characterization of Neisseria meningitidis isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil	PLOS ONE			English	Article							PREDICTED STRAIN COVERAGE; SEROGROUP-B; MULTICOMPONENT VACCINE; HIGH PREVALENCE; DISEASE; CARRIAGE; DIVERSITY; RECOMMENDATIONS; EPIDEMIOLOGY; 4CMENB	Characterization of meningococci isolated from the pharynx is essential towards understanding the dynamics of meningococcal carriage and disease. Meningococcal isolates, collected from adolescents resident in Salvador, Brazil during 2014, were characterized by multilocus sequence typing, genotyping or whole-genome sequencing. Most were nongroupable (61.0%), followed by genogroups B (11.9%) and Y (8.5%). We identified 34 different sequence types (STs), eight were new STs, distributed among 14 clonal complexes (cc), cc1136 represented 20.3% of the nongroupable isolates. The porA and fetA genotypes included P1.18,25 - 37 (11.9%), P1.18-1,3 (10.2%); F5-5 (23.7%), F4-66 (16.9%) and F1-7 (13.6%). The porB class 3 protein and the fHbp subfamily A (variants 2 and 3) genotypes were found in 93.0 and 71.0% of the isolates, respectively. NHBA was present in all isolates, and while most lacked NadA (94.9%), we detected the hyperinvasive lineages B: P1.19,15: F5-1: ST-639 (cc32); C: P1.22,14 - 6: F3-9: ST-3780 (cc103) and W: P1.5,2: F1-1: ST-11 (cc11). This is the first report on the genetic diversity and vaccine antigen prevalence among N. meningitidis carriage isolates in the Northeast of Brazil. This study highlights the need for ongoing characterization of meningococcal isolates following the introduction of vaccines and for determining public health intervention strategies.	[Silva Simoes Moura, Ana Rafaela; Ferreira, Italo Eustaquio; Pithon Borges Nunes, Amelia Maria; Reis, Mitermayer Galvao; Alexander McBride, Alan John; Campos, Leila Carvalho] FIOCRUZ BA, Inst Goncalo Moniz, Lab Patol & Biol Mol, Salvador, BA, Brazil; [Kretz, Cecilia Batmalle; Wang, Xin] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Atlanta, GA USA; [de Moraes, Jose Cassio] Fac Ciencias Med Santa Casa Sao Paulo, Sao Paulo, Brazil; [Alexander McBride, Alan John] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Nucleo Biotecnol, Pelotas, RS, Brazil	Fundacao Oswaldo Cruz; Centers for Disease Control & Prevention - USA; Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade Federal de Pelotas	Campos, LC (corresponding author), FIOCRUZ BA, Inst Goncalo Moniz, Lab Patol & Biol Mol, Salvador, BA, Brazil.	lccampos@bahia.fiocruz.br	McBride, Alan/D-4106-2012; Reis, Mitermayer/AAO-9742-2020; MORAES, JOSE C/H-6788-2012; Campos, Leila/AAO-3207-2021	McBride, Alan/0000-0001-9682-540X; Reis, Mitermayer/0000-0002-3051-9060; Campos, Leila/0000-0001-9150-464X; Kruemmel, Ana Rafaela/0000-0002-7406-1223	Ministerio da Saude, Brazil [TC335/2013]; Fundacao de Amparo a Pesquisa do Estado da Bahia FAPESB [SUS 007/2014]	Ministerio da Saude, Brazil; Fundacao de Amparo a Pesquisa do Estado da Bahia FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	This work was supported by Ministerio da Saude, Brazil (http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/secretarias/svs) (grant number TC335/2013) [LCC], and Fundacao de Amparo a Pesquisa do Estado da Bahia FAPESB (http://www.fapesb.ba.gov.br) (grant number SUS 007/2014) [LCC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2014, EPIDEMIOL INFECT, V142, P2461, DOI 10.1017/S0950268814001149; Cardoso CW, 2012, VACCINE, V30, P5541, DOI 10.1016/j.vaccine.2012.06.044; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Claus H, 2012, VACCINE, V30, P155, DOI 10.1016/j.vaccine.2011.11.050; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; de Filippis I, 2005, DIAGN MICR INFEC DIS, V53, P161, DOI 10.1016/j.diagmicrobio.2005.06.015; de Filippis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033016; de Moraes JC, 2015, PEDIATR INFECT DIS J, V34, P1197, DOI 10.1097/INF.0000000000000853; Diaz J, 2016, J INFECT PUBLIC HLTH; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Gasparini R, 2014, J CLIN MICROBIOL, V52, P1901, DOI 10.1128/JCM.03584-13; Gorla MCO, 2012, ENFERM INFEC MICR CL, V30, P56, DOI 10.1016/j.eimc.2011.07.022; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jounio U, 2012, J CLIN MICROBIOL, V50, P264, DOI 10.1128/JCM.05385-11; Kretz CB, 2016, EMERG INFECT DIS, V22, P1762, DOI 10.3201/eid2210.160468; Lemos APS, 2010, J INFECTION, V60, P209, DOI 10.1016/j.jinf.2009.11.014; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Moreno J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135497; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Safadi MAP, 2014, EMERG INFECT DIS, V20, P806, DOI 10.3201/eid2005.130948; Nunes AMPB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166475; Russell Joanne E, 2004, Emerg Infect Dis, V10, P674; Safadi MAP, 2013, EXPERT REV VACCINES, V12, P903, DOI 10.1586/14760584.2013.814879; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; de Lemos APS, 2007, J CLIN MICROBIOL, V45, P1266, DOI 10.1128/JCM.02510-06; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe M, 2010, P NATL ACAD SCI USA, V107, P6811, DOI 10.1073/pnas.0912115107; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Wasko I, 2016, VACCINE, V34, P510, DOI 10.1016/j.vaccine.2015.11.070; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	49	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185038	10.1371/journal.pone.0185038	http://dx.doi.org/10.1371/journal.pone.0185038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931058	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700063
J	Barker, TH; George, RP; Howarth, GS; Whittaker, AL				Barker, Timothy Hugh; George, Rebecca Peta; Howarth, Gordon Stanley; Whittaker, Alexandra Louise			Assessment of housing density, space allocation and social hierarchy of laboratory rats on behavioural measures of welfare	PLOS ONE			English	Article							MICE MUS-MUSCULUS; AGGRESSIVE-BEHAVIOR; COGNITIVE BIAS; GROUP-SIZE; OPEN-FIELD; STRESS; RESPONSES; BRAIN	Minimum space allowances for laboratory rats are legislated based on weight and stocking rates, with the understanding that increased housing density encourages crowding stress. However, there is little evidence for these recommendations, especially when considering positive welfare outcomes. This study consisted of two experiments which investigated the effects of housing density (rats per cage), space allocation (surface area per rat) and social rank (dominance hierarchy) on the ability to perform simple behavioural tests. Male Sprague Dawley (SD) rats (n = 64) were allocated to either high-density (n = 8) or low-density (n = 8) cages. The second experiment investigated the effects of surface area. SD rats (n = 40) were housed in dyads in either the large (n = 10) or small (n = 10) cage. In both experiments, animals were tested on a judgment bias paradigm, with their responses to an ambiguous stimulus being ascribed as optimistic or pessimistic. Animals were also tested on open-field, novelobject recognition and social-interaction tests. Recordings were taken from 1700-2100h daily for rat observation and social rank establishment. Dominant animals responded with significantly more optimistic decisions compared to subordinates for both the housing density (p<0.001) and space allocation (p = 0.0015) experiment. Dominant animals responded with increased social affiliative behaviours in the social-interaction test, and spent more time in the centre of the open-field test for both experiments. No significance was detected between housing density or space allocation treatments. These findings suggest that social rank is a significantly greater modifier of affective state than either housing density or space allocation. This finding has not yet been reported and suggests that future drafts of housing guidelines should consider animal social status in addition to floor space requirements.	[Barker, Timothy Hugh; George, Rebecca Peta; Howarth, Gordon Stanley; Whittaker, Alexandra Louise] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy Campus, Wasleys, SA, Australia; [Howarth, Gordon Stanley] Children Youth & Womens Hlth Serv, Gastroenterol Dept, Adelaide, SA, Australia	University of Adelaide	Barker, TH (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Roseworthy Campus, Wasleys, SA, Australia.	timothy.barker@adelaide.edu.au	Howarth, Gordon/AAM-8699-2020; Whittaker, Alexandra L/D-9642-2013; Barker, Timothy H/C-3300-2018; Barker, Timothy Hugh/P-2356-2019	Howarth, Gordon/0000-0001-6979-6084; Whittaker, Alexandra L/0000-0001-9011-8296; Barker, Timothy H/0000-0002-6897-814X; Barker, Timothy Hugh/0000-0002-6897-814X				Allen KP, 2016, J AM ASSOC LAB ANIM, V55, P21; [Anonymous], 2010, GUID CAR US AGR AN R; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Barker TH, 2017, PHYSIOL BEHAV, V173, P124, DOI 10.1016/j.physbeh.2017.02.006; BARNARD CJ, 1994, PARASITOLOGY, V108, P487, DOI 10.1017/S0031182000077349; BARNETT S. A., 1958, PROC ZOOL SOC LONDON, V130, P107; Bean K, 2008, LAB ANIMAL, V37, P421, DOI 10.1038/laban0908-421; BENUS RF, 1987, BEHAVIOUR, V100, P105, DOI 10.1163/156853987X00099; Bethell EJ, 2015, J APPL ANIM WELF SCI, V18, pS18, DOI 10.1080/10888705.2015.1075833; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; BLANCHARD DC, 1993, BEHAV BRAIN RES, V58, P113, DOI 10.1016/0166-4328(93)90096-9; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; BUTLER RG, 1980, ANIM BEHAV, V28, P78, DOI 10.1016/S0003-3472(80)80010-8; CALHOUN JB, 1962, SCI AM, V206, P139; Clegg ILK, 2017, BEHAV BRAIN RES, V322, P115, DOI 10.1016/j.bbr.2017.01.026; Council of Europe, 1997, RES ACC CAR LAB AN A; Creel RH, 1915, PUBLIC HEALTH REP, V30, P1679, DOI 10.2307/4572430; Davis JF, 2009, NEUROSCIENCE, V162, P23, DOI 10.1016/j.neuroscience.2009.04.039; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Gaskill BN, 2015, J AM ASSOC LAB ANIM, V54, P497; Hurst JL, 1996, ANIM BEHAV, V52, P335, DOI 10.1006/anbe.1996.0179; Hurst JL, 1999, ANIM BEHAV, V58, P563, DOI 10.1006/anbe.1999.1165; Inagaki H, 2005, PHYSIOL BEHAV, V84, P17, DOI 10.1016/j.physbeh.2004.10.006; Kloke V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105431; Lucas LR, 2004, NEUROSCIENCE, V124, P449, DOI 10.1016/j.neuroscience.2003.12.009; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; National Health and Medical Research Council, 2004, AUSTR COD PRACT CAR; National Research Council, 2011, GUIDE CARE USE LAB A; Patterson-Kane Emily G., 2002, Journal of Applied Animal Welfare Science, V5, P63, DOI 10.1207/S15327604JAWS0501_5; POOLE TB, 1976, ANIM BEHAV, V24, P476, DOI 10.1016/S0003-3472(76)80056-5; POOLE TB, 1973, ANIM BEHAV, V21, P788, DOI 10.1016/S0003-3472(73)80105-8; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Sams-Dodd F, 1998, PSYCHOPHARMACOLOGY, V135, P182, DOI 10.1007/s002130050500; SAMSDODD F, 1995, J NEUROSCI METH, V59, P157, DOI 10.1016/0165-0270(94)00173-E; Seehuus B, 2013, APPL ANIM BEHAV SCI, V148, P85, DOI 10.1016/j.applanim.2013.07.008; STOKOLS D, 1972, PSYCHOL REV, V79, P275, DOI 10.1037/h0032706; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; Temple D, 2011, APPL ANIM BEHAV SCI, V131, P29, DOI 10.1016/j.applanim.2011.01.013; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; Wallace M., 2015, NAT PROTOC, V10; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Whittaker AL, 2012, LAB ANIM-UK, V46, P3, DOI 10.1258/la.2011.011049	43	19	19	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185135	10.1371/journal.pone.0185135	http://dx.doi.org/10.1371/journal.pone.0185135			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926644	gold, Green Published			2022-12-27	WOS:000411166600072
J	Reyna, KS; Burggren, WW				Reyna, Kelly S.; Burggren, Warren W.			Altered embryonic development in northern bobwhite quail (Colinus virginianus) induced by pre-incubation oscillatory thermal stresses mimicking global warming predictions	PLOS ONE			English	Article							EGG STORAGE; INCUBATION-TEMPERATURE; CHICKEN EMBRYOS; SYNCHRONIZATION; RESPONSES; TIME; HATCHABILITY; PATTERN; GROWTH; TURKEY	Global warming is likely to alter reproductive success of ground-nesting birds that lay eggs normally left unattended for days or even weeks before actual parental incubation, especially in already warm climates. The native North American bobwhite quail (Colinus virginianus) is such a species, and pre-incubation quail eggs may experience temperatures >= 45 degrees C. Yet, almost nothing is known about embryonic survival after such high pre-incubation temperatures. Freshly laid bobwhite quail eggs were exposed during a 12 day pre-incubation period to one of five thermal regimes: low oscillating temperatures (25-40 degrees C, mean = 28.9 degrees C), high oscillating temperatures (30-45 degrees C, mean = 33.9 degrees C), low constant temperatures (28.85 degrees C), high constant temperatures (mean = 33.9 degrees C), or commercially employed pre-incubation temperatures (20 degrees C). After treatment, eggs were then incubated at a standard 37.5 degrees C to determine subsequent effects on embryonic development rate, survival, water loss, hatching, and embryonic oxygen consumption. Both quantity of heating degree hours during pre-incubation and specific thermal regime (oscillating vs. non-oscillating) profoundly affected important aspects of embryo survival and indices of development and growth Pre-incubation quail eggs showed a remarkable tolerance to constant high temperatures (up to 45 degrees C), surviving for 4.5 +/- 0.3 days of subsequent incubation, but high oscillating pre-incubation temperature increased embryo survival (mean survival 12.2 +/- 1.8 days) and led to more rapid development than high constant temperature (maximum 38.5 degrees C), even though both groups experienced the same total heating degree-hours. Oxygen consumption was similar to 200-300 mu l O-2.egg.min(-1) at hatching in all groups, and was not affected by pre-incubation conditions. Oscillating temperatures, which are the norm for pre-incubation quail eggs in their natural habitat, thus enhanced survival at higher temperatures. However, a 5 degrees C increase in pre-incubation temperature, which equates to the predicted long-term increases of 5 degrees C or more, nonetheless reduced hatching rate by approximately 50%. Thus, while pre-incubation bobwhite eggs may be resiliant to moderate oscillating temperature increases, global warming will likely severely impact wild bobwhite quail populations, especially in their strongholds in southern latitudes.	[Reyna, Kelly S.; Burggren, Warren W.] Univ North Texas, Dept Biol Sci, Dev Integrat Biol Res Grp, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Reyna, KS (corresponding author), Univ North Texas, Dept Biol Sci, Dev Integrat Biol Res Grp, Denton, TX 76203 USA.	Kelly.Reyna@unt.edu	Burggren, Warren W/A-1561-2016	Burggren, Warren W/0000-0001-8023-420X; Reyna, Kelly/0000-0003-3202-2135	National Science Foundation [IOS 1543301]	National Science Foundation(National Science Foundation (NSF))	This research was funded by National Science Foundation grant IOS 1543301 to W. Burggren. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan S, 2013, ARC TIERZ, V18, P789; Alsop FM, 1919, ANAT REC, V15, P307; Alvine T, 2014, J COMP PHYSIOL B, V184, P107, DOI 10.1007/s00360-013-0777-9; Apanius V., 1998, AVIAN GROWTH DEV EVO; ARORA KL, 1966, POULTRY SCI, V45, P958, DOI 10.3382/ps.0450958; Beitinger TL, 2006, BIOSTATISTICS HELPBO; Branum SR, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12712; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; DECUYPERE E, 1992, WORLD POULTRY SCI J, V48, P28, DOI 10.1079/WPS19920004; Diamond SE, 2016, ANN NEW YORK ACAD SC; Dillon ME, 2016, INTEGR COMP BIOL, V56, P14, DOI 10.1093/icb/icw024; Dozier W, 2010, BOBWHITE QUAIL PRODU; El-Tarabany MS, 2016, J THERM BIOL, V61, P38, DOI 10.1016/j.jtherbio.2016.08.004; Fasenko GM, 2007, POULTRY SCI, V86, P1020, DOI 10.1093/ps/86.5.1020; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; French NA, 1997, POULTRY SCI, V76, P124, DOI 10.1093/ps/76.1.124; Gill F. B., 1999, ORNITHOLOGY; Guthery F.S., 2000, ON BOBWHITES; Guthery FS, 2004, WILDLIFE MONOGR, V159, P1; Guthery FS, 2000, QUAIL 4 4 NAT QUAIL; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamidu JA, 2011, POULTRY SCI, V90, P1749, DOI 10.3382/ps.2011-01361; Haron A, 2017, COMP BIOCHEM PHYS A, V203, P32, DOI 10.1016/j.cbpa.2016.08.015; HENDRICKX AG, 1965, BIOL BULL-US, V129, P523, DOI 10.2307/1539730; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KOSIN IL, 1956, POULTRY SCI, V35, P1384, DOI 10.3382/ps.0351384; Lawson CR, 2015, ECOL LETT, V18, P724, DOI 10.1111/ele.12437; Loyau T, 2015, ANIMAL, V9, P76, DOI 10.1017/S1751731114001931; Maatjens CM, 2016, POULTRY SCI, V95, P956, DOI 10.3382/ps/pev447; MATHER CM, 1976, BRIT POULTRY SCI, V17, P471, DOI 10.1080/00071667608416302; MAYES FJ, 1984, WORLD POULTRY SCI J, V40, P131, DOI 10.1079/WPS19840011; MILLER ER, 1975, POULTRY SCI, V54, P901, DOI 10.3382/ps.0540901; Mortola JP, 2012, RESP PHYSIOL NEUROBI, V181, P109, DOI 10.1016/j.resp.2012.02.002; Mueller CA, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P739; Narinc D, 2016, ANIMAL, V10, P1328, DOI 10.1017/S1751731116000276; OPPENHEIM RW, 1975, DEV PSYCHOBIOL, V8, P103, DOI 10.1002/dev.420080203; PANI PK, 1969, POULTRY SCI, V48, P665, DOI 10.3382/ps.0480665; Pendlebury CJ, 2004, J EXP BIOL, V207, P2065, DOI 10.1242/jeb.00999; Proudfoot FG., 1969, FERTILITY HATCHABILI, P127; Reijrink IAM, 2010, POULTRY SCI, V89, P1225, DOI 10.3382/ps.2009-00182; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; Reyna KS., 2012, P NATL QUAIL S, V7, P138; Romanoff A., 1960, THE AVIAN EMBRYO, V1, P429; Stoddard H.L., 1931, BOBWHITE QUAIL ITS H; Stoleson SH, 1999, J ANIM ECOL, V68, P951, DOI 10.1046/j.1365-2656.1999.00342.x; Tazawa Hiroshi, 2000, P617, DOI 10.1016/B978-012747605-6/50025-0; VINCE MA, 1964, NATURE, V203, P1192, DOI 10.1038/2031192a0; VINCE MA, 1984, J EXP ZOOL, V229, P273, DOI 10.1002/jez.1402290213; VINCE MA, 1968, ANIM BEHAV, V16, P332, DOI 10.1016/0003-3472(68)90017-1; VISSCHEDIJK AH, 1968, BRIT POULTRY SCI, V9, P173, DOI 10.1080/00071666808415707; VLECK CM, 1980, AM ZOOL, V20, P405; Warkentin KM., 2007, COMP BIOCH PHYSL A; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; WILLIAMS JB, 1988, CONDOR, V90, P187, DOI 10.2307/1368447; WILSON HR, 1991, POULT SCI S, V22, P145; Zar JH, 1999, BIOSTATISTICAL ANAL	56	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184670	10.1371/journal.pone.0184670	http://dx.doi.org/10.1371/journal.pone.0184670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926597	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600030
J	Askovich, PS; Ramsey, SA; Diercks, AH; Kennedy, KA; Knijnenburg, TA; Aderem, A				Askovich, Peter S.; Ramsey, Stephen A.; Diercks, Alan H.; Kennedy, Kathleen A.; Knijnenburg, Theo A.; Aderem, Alan			Identifying novel transcription factors involved in the inflammatory response by using binding site motif scanning in genomic regions defined by histone acetylation	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; SYSTEMS BIOLOGY; GENE-EXPRESSION; REGULATORY CIRCUIT; INNATE IMMUNITY; IDENTITY; LPS; LIPOPOLYSACCHARIDE; IDENTIFICATION; REPRESENTATION	The innate immune response to pathogenic challenge is a complex, multi-staged process involving thousands of genes. While numerous transcription factors that act as master regulators of this response have been identified, the temporal complexity of gene expression changes in response to pathogen-associated molecular pattern receptor stimulation strongly suggest that additional layers of regulation remain to be uncovered. The evolved pathogen response program in mammalian innate immune cells is understood to reflect a compromise between the probability of clearing the infection and the extent of tissue damage and inflammatory sequelae it causes. Because of that, a key challenge to delineating the regulators that control the temporal inflammatory response is that an innate immune regulator that may confer a selective advantage in the wild may be dispensable in the lab setting. In order to better understand the complete transcriptional response of primary macrophages to the bacterial endotoxin lipopolysaccharide (LPS), we designed a method that integrates temporally resolved gene expression and chromatin-accessibility measurements from mouse macrophages. By correlating changes in transcription factor binding site motif enrichment scores, calculated within regions of accessible chromatin, with the average temporal expression profile of a gene cluster, we screened for transcriptional factors that regulate the cluster. We have validated our predictions of LPS-stimulated transcriptional regulators using ChIP-seq data for three transcription factors with experimentally confirmed functions in innate immunity. In addition, we predict a role in the macrophage LPS response for several novel transcription factors that have not previously been implicated in immune responses. This method is applicable to any experimental situation where temporal gene expression and chromatin-accessibility data are available.	[Askovich, Peter S.; Diercks, Alan H.; Kennedy, Kathleen A.; Aderem, Alan] Ctr Infect Dis Res, Seattle, WA 98109 USA; [Ramsey, Stephen A.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Knijnenburg, Theo A.] Inst Syst Biol, Seattle, WA USA; [Kennedy, Kathleen A.] Mol Med Res Inst, Flora Biosci, Sunnyvale, CA USA	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Oregon State University; Institute for Systems Biology (ISB)	Askovich, PS; Aderem, A (corresponding author), Ctr Infect Dis Res, Seattle, WA 98109 USA.	peter.askovich@cidresearch.org; alan.aderem@cidresearch.org			National Institutes of Health [U19 AI100627, R01 AI032972, R01 AI025032, HL098807]; National Science Foundation [1557605-DMS, 1553728-DBI]; Medical Research Foundation of Oregon; PhRMA Foundation; Oregon State University Division of Health Sciences; Div Of Biological Infrastructure [1553728] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Medical Research Foundation of Oregon; PhRMA Foundation; Oregon State University Division of Health Sciences; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Institutes of Health (nih.gov/) awards U19 AI100627, R01 AI032972, and R01 AI025032 to A. A. and HL098807 to S.A.R., the National Science Foundation (nsf.gov/) awards 1557605-DMS and 1553728-DBI to S.A.R., the Medical Research Foundation of Oregon (ohsu.edu/xd/about/foundation/about/medical-research-foundation/) New Investigator Grant award to S.A.R., the PhRMA Foundation (phrmafoundation.org/) Informatics Grant award to S.A.R., and Oregon State University Division of Health Sciences (health.oregonstate.edu/) Interdisciplinary Research Grant award to S.A.R.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Askovich PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074863; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Choudhury M, 2016, GENE REGUL SYST BIO, V10, P105, DOI 10.4137/GRSB.S40768; D'Alessio AC, 2015, STEM CELL REP, V5, P763, DOI 10.1016/j.stemcr.2015.09.016; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Garneau H, 2009, J CELL PHYSIOL, V221, P350, DOI 10.1002/jcp.21859; Gat-Viks I, 2013, NAT BIOTECHNOL, V31, P342, DOI 10.1038/nbt.2519; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Gottschalk RA, 2013, SEMIN IMMUNOL, V25, P201, DOI 10.1016/j.smim.2012.11.002; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Knijnenburg TA, 2014, NAT METHODS, V11, P689, DOI [10.1038/NMETH.2924, 10.1038/nmeth.2924]; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu YL, 2014, HUM MOL GENET, V23, P2145, DOI 10.1093/hmg/ddt610; Ly LL, 2013, AM J CANCER RES, V3, P339; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Mancino A, 2015, GENE DEV, V29, P394, DOI 10.1101/gad.257592.114; MCKUSICK VA, 1980, AM J MED, V69, P267, DOI 10.1016/0002-9343(80)90388-5; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Nurgazieva D, 2015, J IMMUNOL, V194, P709, DOI 10.4049/jimmunol.1300272; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Pertea M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-206; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Qureshi ST, 1999, INFLAMM RES, V48, P613, DOI 10.1007/s000110050511; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ramsey SA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004828; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; Raza S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-36; RIPLEY B., 2001, MSOR CONNECTIONS NEW, V1, P23, DOI [10.11120/msor.2001.01010023, DOI 10.11120/MSOR.2001.01010023, DOI 10.11120/MS0R.2001.01010023]; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Shang XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135971; Sun K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02404-w; Sun K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084500; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033474; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x; Zhang Z, 2010, GENES IMMUN, V11, P124, DOI 10.1038/gene.2009.66	57	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184850	10.1371/journal.pone.0184850	http://dx.doi.org/10.1371/journal.pone.0184850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922390	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300034
J	Chu, SY; Chen, Q; Chen, Y; Bao, YX; Wu, M; Zhang, J				Chu, Shuyuan; Chen, Qian; Chen, Yan; Bao, Yixiao; Wu, Min; Zhang, Jun			Cesarean section without medical indication and risk of childhood asthma, and attenuation by breastfeeding	PLOS ONE			English	Article							ALLERGIC DISEASES; DELIVERY; CHINA; MODE	Background Previous studies suggest that caesarean section (CS) may increase the risk of asthma in children, but none of them could preclude potential confounding effects of underlying medical indications for CS. We aim to assess the association between CS itself (without medical indications) and risk of childhood asthma. Methods We conducted a hospital-based case-control study on childhood asthma with 573 cases and 812 controls in Shanghai. Unconditional logistic regression models in SAS were employed to control for potential confounders. Results Our study found that CS without medical indication was significantly associated with elevated asthma risk (adjusted OR = 1.58 [95% CI 1.17-2.13]). However, this risk was attenuated in children fed by exclusive breastfeeding in the first six months after birth (adjusted OR = 1.39 [95% CI 0.92-2.10]). In contrast, the risk was more prominent in children with non-exclusive breastfeeding or bottle feeding (adjusted OR = 1.91 [95% CI 1.22-2.99]). Conclusions CS without medical indication was associated with an increased risk of childhood asthma. Exclusive breastfeeding in infancy may attenuate this risk.	[Chu, Shuyuan] Guilin Med Univ, Lab Resp Dis, Affiliated Hosp, Guilin, Peoples R China; [Chu, Shuyuan; Chen, Qian; Chen, Yan; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China; [Chen, Yan; Bao, Yixiao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat, Shanghai, Peoples R China; [Wu, Min] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Zhang, Jun] Guilin Med Univ, Sch Publ Hlth, Guilin, Peoples R China	Guilin Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guilin Medical University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China.; Zhang, J (corresponding author), Guilin Med Univ, Sch Publ Hlth, Guilin, Peoples R China.	zhangjun@xinhuamed.com.cn			National Natural Science Foundation of China [81273091, 81530086]; Shanghai Municipal Health and Family Planning Commission [GWIV-26, 15GWZK0401]; Shanghai Science and Technology Commission [14XD1403300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health and Family Planning Commission; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	The work was supported by the National Natural Science Foundation of China (81273091, 81530086); Shanghai Municipal Health and Family Planning Commission (GWIV-26; 15GWZK0401); Shanghai Science and Technology Commission (14XD1403300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Black M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001973; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Kaplan JL, 2011, PEDIATR RES, V69, P465, DOI 10.1203/PDR.0b013e318217638a; Leung JYY, 2015, CLIN EXP ALLERGY, V45, P1109, DOI 10.1111/cea.12548; Ma JQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-568; Munblit D, 2016, CURR OPIN ALLERGY CL, V16, P427, DOI 10.1097/ACI.0000000000000303; Politis I, 2008, ADV EXP MED BIOL, V606, P253, DOI 10.1007/978-0-387-74087-4_10; Soto-Ramirez N, 2012, ALLERGY ASTHMA CL IM, V8, DOI 10.1186/1710-1492-8-11; Sou SC, 2006, J CLIN EPIDEMIOL, V59, P429, DOI 10.1016/j.jclinepi.2005.08.010; Tedner SG, 2012, CLIN EXP ALLERGY, V42, P1430, DOI 10.1111/j.1365-2222.2012.03997.x; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Turner SW, 2010, THORAX, V65, P391, DOI 10.1136/thx.2008.111385; Wong GWK, 2013, ALLERGY ASTHMA IMMUN, V5, P251, DOI 10.4168/aair.2013.5.5.251; Zhang J, 2008, OBSTET GYNECOL, V111, P1077, DOI 10.1097/AOG.0b013e31816e349e	18	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184920	10.1371/journal.pone.0184920	http://dx.doi.org/10.1371/journal.pone.0184920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922410	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300043
J	Ebbo, M; Grados, A; Samson, M; Groh, M; Loundou, A; Rigolet, A; Terrier, B; Guillaud, C; Carra-Dalliere, C; Renou, F; Pozdzik, A; Labauge, P; Palat, S; Berthelot, JM; Pennaforte, JL; Wynckel, A; Lebas, C; Le Gouellec, N; Quemeneur, T; Dahan, K; Carbonnel, F; Leroux, G; Perlat, A; Mathian, A; Cacoub, P; Hachulla, E; Costedoat-Chalumeau, N; Harle, JR; Schleinitz, N				Ebbo, Mikael; Grados, Aurelie; Samson, Maxime; Groh, Matthieu; Loundou, Anderson; Rigolet, Aude; Terrier, Benjamin; Guillaud, Constance; Carra-Dalliere, Clarisse; Renou, Frederic; Pozdzik, Agnieszka; Labauge, Pierre; Palat, Sylvain; Berthelot, Jean-Marie; Pennaforte, Jean-Loup; Wynckel, Alain; Lebas, Celine; Le Gouellec, Noemie; Quemeneur, Thomas; Dahan, Karine; Carbonnel, Franck; Leroux, Gaelle; Perlat, Antoinette; Mathian, Alexis; Cacoub, Patrice; Hachulla, Eric; Costedoat-Chalumeau, Nathalie; Harle, Jean-Robert; Schleinitz, Nicolas			Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; AUTOIMMUNE PANCREATITIS; DIAGNOSTIC-CRITERIA; SYSTEMIC-DISEASE; IGG4; MULTICENTER; DACRYOADENITIS; MAINTENANCE; PREDICTORS; STATEMENT	Objectives To assess efficacy and safety of rituximab (RTX) as induction therapy, maintenance of remission and treatment of relapses in a cohort of IgG4-related disease (IgG4-RD) patients. Methods Nationwide retrospective multicenter study of IgG4-RD patients treated with at least one course of RTX. Clinical, biological and radiological response, relapse rate and drug tolerance were analyzed. Kaplan-Meier curves were plotted and risk factors for relapse studied with a Cox regression model. Results Among 156 IgG4-RD patients included in the French database, 33 received rituximab. Clinical response was noted in 29/31 (93.5%) symptomatic patients. Glucocorticoids withdrawal was achieved in 17 (51.5%) patients. During a mean follow-up of 24.8 +/- 21 months, 13/31 (41.9%) responder patients relapsed after a mean delay of 19 +/- 11 months after RTX. Active disease, as defined by an IgG4-RD Responder Index > 9 before RTX, was significantly associated with relapse (HR = 3.68, 95% CI: 1.1, 12.6) (P = 0.04), whereas maintenance therapy with systematic (i.e. before occurrence of a relapse) RTX retreatment was associated with longer relapse-free survival (41 versus 21 months; P = 0.02). Eight severe infections occurred in 4 patients during follow-up (severe infections rate of 12.1/100 patientyears) and hypogammaglobulinemia <= 5 g/l in 3 patients. Conclusion RTX is effective for both induction therapy and treatment of relapses in IgG4-RD, but relapses are frequent after B-cell reconstitution. Maintenance therapy with systematic RTX infusions is associated with longer relapse-free survival and might represent a novel treatment strategy. Yet, the high rate of infections and the temporary effect of RTX might be hindrances to such strategy.	[Ebbo, Mikael; Grados, Aurelie; Harle, Jean-Robert; Schleinitz, Nicolas] Aix Marseille Univ, Dept Internal Med, Hop Timone, AP HM, Marseille, France; [Samson, Maxime] Dijon Univ Hosp, Dept Internal Med & Clin Immunol, Dijon, France; [Groh, Matthieu; Terrier, Benjamin; Costedoat-Chalumeau, Nathalie] Univ Rene Descartes Paris, Dept Internal Med, Ctr Natl Reference Malad Syst & Autoimmunes Rares, Hop Cochin, Sorbonne Paris Cite, Paris, France; [Loundou, Anderson] Aix Marseille Univ, Unite Aide Methodol, AP HM, Marseille, France; [Rigolet, Aude; Leroux, Gaelle; Cacoub, Patrice] Univ Pierre & Marie Curie Paris VI, Dept Internal Med & Clin Immunol, AP HP, Hop Pitie Salpetriere DHUI2B, Paris, France; [Guillaud, Constance] Hop Henri Mondor, Dept Internal Med, AP HP, Creteil, France; [Carra-Dalliere, Clarisse; Labauge, Pierre] CHRU Montpellier, Dept Neurol, Montpellier, France; [Renou, Frederic] CHU Reunion Site Felix Guyon, Dept Internal Med, St Denis, Reunion, France; [Pozdzik, Agnieszka] Clin Univ Bruxelles, Erasme Hosp, Dept Nephrol, Brussels, Belgium; [Palat, Sylvain] CHU Limoges, Dept Internal Med, Limoges, France; [Berthelot, Jean-Marie] CHU Nantes, Dept Rheumatol, Nantes, France; [Pennaforte, Jean-Loup] CHU Reims, Dept Internal Med, Reims, France; [Wynckel, Alain] CHU Reims, Dept Nephrol, Reims, France; [Lebas, Celine] CHRU Lille, Dept Nephrol, Lille, France; [Le Gouellec, Noemie; Quemeneur, Thomas] CH Valenciennes, Dept Nephrol & Internal Med, Valenciennes, France; [Dahan, Karine] Hop Tenon, Dept Nephrol, AP HP, Paris, France; [Carbonnel, Franck] CHU Bicetre, Dept Gastroenterol, Le Kremlin Bicetre, France; [Perlat, Antoinette] CHU Rennes, Dept Internal Med, Hop Sud, Rennes, France; [Mathian, Alexis] Univ Pierre & Marie Curie Paris VI, Dept Internal Med, Ctr Natl Reference Malad Syst & Autoimmunes Rares, Hop Pitie Salpetriere, Paris, France; [Hachulla, Eric] Univ Lille, Huriez Hosp, Dept Internal Med, Natl Referral Ctr Autoimmune & Syst Dis, Lille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Montpellier; CHU de Montpellier; CHU Reunion; Universite Libre de Bruxelles; CHU Limoges; Nantes Universite; CHU de Nantes; CHU de Reims; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Lille - ISITE; CHU Lille; CH de Valenciennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Ebbo, M (corresponding author), Aix Marseille Univ, Dept Internal Med, Hop Timone, AP HM, Marseille, France.	mikael.ebbo@ap-hm.fr	HACHULLA, ERIC/R-8488-2018; Samson, Maxime/ABE-1461-2021; schleinitz, nicolas/AAL-6751-2020	HACHULLA, ERIC/0000-0001-7432-847X; Samson, Maxime/0000-0002-6547-232X; schleinitz, nicolas/0000-0001-9449-3392; Carra-Dalliere, Clarisse/0000-0002-0985-3662; Labauge, Pierre/0000-0001-7759-8555				Akiyama M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1064-4; Akiyama M, 2015, ARTHRITIS RHEUMATOL, V67, P2476, DOI 10.1002/art.39209; Brito-Zeron P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004002; Campochiaro C, 2016, SCAND J RHEUMATOL, V45, P135, DOI 10.3109/03009742.2015.1055796; Carruthers MN, 2015, ANN RHEUM DIS, V74, P1171, DOI 10.1136/annrheumdis-2014-206605; Carruthers MN, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/259408; Charles P, 2016, ARTHRITIS RHEUMA S10, P68; Della-Torre E, 2017, INT J RHEUM DIS, V20, P276, DOI 10.1111/1756-185X.13021; Della-Torre E, 2015, ANN RHEUM DIS, V74, P2236, DOI 10.1136/annrheumdis-2014-205799; Della-Torre E, 2015, RHEUMATOLOGY, V54, P1934, DOI 10.1093/rheumatology/kev244; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Ebbo M, 2012, MEDICINE, V91, P49, DOI 10.1097/MD.0b013e3182433d77; Fernandez-Codina A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001275; Gottenberg JE, 2010, ARTHRITIS RHEUM-US, V62, P2625, DOI 10.1002/art.27555; Grados A, 2015, REV MED INTERNE, V36, P395, DOI 10.1016/j.revmed.2014.11.007; Grados A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00235; Guillevin L, 2014, NEW ENGL J MED, V371, P1771, DOI 10.1056/NEJMoa1404231; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Hart PA, 2013, GUT, V62, P1607, DOI 10.1136/gutjnl-2012-302886; Inoue D, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000680; Kamisawa T, 2015, LANCET, V385, P1460, DOI 10.1016/S0140-6736(14)60720-0; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Khellaf M, 2014, BLOOD, V124, P3228, DOI 10.1182/blood-2014-06-582346; Khosroshahi A, 2015, ARTHRITIS RHEUMATOL, V67, P1688, DOI 10.1002/art.39132; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Khosroshahi A, 2010, ARTHRITIS RHEUM-US, V62, P1755, DOI 10.1002/art.27435; Lin W, 2015, RHEUMATOLOGY, V54, P1982, DOI 10.1093/rheumatology/kev203; Maehara T, 2017, ANN RHEUM DIS, V76, P377, DOI 10.1136/annrheumdis-2016-209139; Masaki Y, 2010, J RHEUMATOL, V37, P1380, DOI 10.3899/jrheum.091153; Masamune A, 2017, GUT, V66, P487, DOI 10.1136/gutjnl-2016-312049; Mattoo H, 2016, J ALLERGY CLIN IMMUN, V138, P825, DOI 10.1016/j.jaci.2015.12.1330; Mattoo H, 2014, J ALLERGY CLIN IMMUN, V134, P679, DOI 10.1016/j.jaci.2014.03.034; McMahon BA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001366; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Raissian Y, 2011, J AM SOC NEPHROL, V22, P1343, DOI 10.1681/ASN.2011010062; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Terrier B, 2010, ARTHRIT CARE RES, V62, P1787, DOI 10.1002/acr.20318; Terrier B, 2010, ARTHRITIS RHEUM-US, V62, P2458, DOI 10.1002/art.27541; Topazian M, 2008, CLIN GASTROENTEROL H, V6, P364, DOI 10.1016/j.cgh.2007.12.020; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Wallace ZS, 2016, RHEUMATOLOGY, V55, P1000, DOI 10.1093/rheumatology/kev438; Wallace ZS, 2015, ARTHRITIS RHEUMATOL, V67, P2466, DOI 10.1002/art.39205; Wallace ZS, 2015, ANN RHEUM DIS, V74, P190, DOI 10.1136/annrheumdis-2014-205233; Wu A, 2015, EYE, V29, P122, DOI 10.1038/eye.2014.251; Yamamoto M, 2016, ANN RHEUM DIS, V75, P1576, DOI 10.1136/annrheumdis-2016-209368; Yamamoto M, 2015, ANN RHEUM DIS, V74, DOI [10.1136/annrheumdis-2015-207640, 10.1136/annrheumdis-2015-207625]; Yamamoto M, 2015, MOD RHEUMATOL, V25, P199, DOI 10.3109/14397595.2014.950036; Yamamoto M, 2015, RHEUMATOLOGY, V54, P45, DOI 10.1093/rheumatology/keu228; Zaidan M, 2011, NEPHROL DIAL TRANSPL, V26, P2047, DOI 10.1093/ndt/gfr097	50	117	123	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0183844	10.1371/journal.pone.0183844	http://dx.doi.org/10.1371/journal.pone.0183844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915275	Green Published, gold, Green Submitted			2022-12-27	WOS:000410861600006
J	Radmark, L; Hanson, LLM; Horwitz, EB; Osika, W				Radmark, Lina; Hanson, Linda L. Magnusson; Horwitz, Eva Bojner; Osika, Walter			Prevalence of mind and body exercises (MBE) in relation to demographics, self-rated health, and purchases of prescribed psychotropic drugs and analgesics	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; ALTERNATIVE MEDICINE; COGNITIVE THERAPY; MAJOR DEPRESSION; BEHAVIORAL-MODEL; ANXIETY; YOGA; COMPLEMENTARY; WORK; CARE	This study aims to identify any differences regarding gender, age, socioeconomic status (SES), self-rated health, perceived stress and the purchase of prescribed drugs among people who practice mind and body exercises (MBE) extensively compared to people who do not. Methods: The study includes 3,913 men and 4,803 women aged 20-72 who participated in the Swedish Longitudinal Occupational Survey of Health (SLOSH). The respondents were divided into three groups depending on frequency of MBE practice (never/seldom/often). Measures regarding MBE practice, health behaviors, self-rated health, and illnesses were drawn from the SLOSH questionnaire, while more objective measures of socioeconomic status and education were derived from registry data. In addition, data on purchases of prescription drugs for all respondents were included in the study. These data were obtained from the Swedish Prescribed Drug Register, which contains information about prescription drugs dispensed at Swedish pharmacies. Separate analyses were performed for mental MBE (mindfulness, meditation, relaxation techniques) and physical MBE (yoga, Tai Chi, Qi Gong), respectively. Results: A high intensity MBE practice is cross-sectionally related to poor self-assessed health (sleeping problems, pain, depressive symptoms, mental disorders), high levels of stress, and high levels of purchases of psychotropic drugs and analgesics. These cross-sectional relationships are generally stronger for mental MBE than for bodily-directed MBE. More women than men are practicing MBE on a regular basis, and physically active people participate to a greater extent in MBE compared with the physically inactive. Conclusion: Overall, the study shows that frequent participation in mind and body exercises is associated with high levels of purchases of psychotropic drugs and analgesics as well as with poor self-assessed health and high levels of stress. However, since this is a cross-sectional study, it is impossible to establish cause and effect, and to further investigate the associations found; longitudinal studies that can account for temporality between covariates and MBE use are needed.	[Radmark, Lina; Osika, Walter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Radmark, Lina; Horwitz, Eva Bojner; Osika, Walter] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Social Sustainabil, Stockholm, Sweden; [Radmark, Lina; Hanson, Linda L. Magnusson] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Horwitz, Eva Bojner] Uppsala Univ, Dept Publ Hlth, Uppsala, Sweden; [Osika, Walter] Stress Clin, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University; Uppsala University	Radmark, L (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Radmark, L (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Social Sustainabil, Stockholm, Sweden.; Radmark, L (corresponding author), Stockholm Univ, Stress Res Inst, Stockholm, Sweden.	lina.radmark@ki.se	Hanson, Linda L Magnusson/D-2435-2017	Hanson, Linda L Magnusson/0000-0002-2908-1903	Ekhaga foundation [2013-58]; Kempe-Carlgrenska foundation	Ekhaga foundation; Kempe-Carlgrenska foundation	This study was funded by Ekhaga foundation (grant no. 2013-58) and Kempe-Carlgrenska foundation (http://www.kc-fonden.se/). The funding sources were neither involved in the conduct of the research nor the preparation of the article.	Akerstedt T, 2015, SLEEP, V38, P1129, DOI 10.5665/sleep.4828; Almqvist C, 2011, EUR J EPIDEMIOL, V26, P67, DOI 10.1007/s10654-010-9521-x; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andersen RM, 2008, MED CARE, V46, P647, DOI [10.1097/MLR.0b013e31817a835d, 10.1097/MLR.0b013e31817f4d48]; [Anonymous], [No title captured]; Asberg M., 2003, UTMATTNINGSSYNDROM S; Asberg Marie, 2013, Lakartidningen, V110, P484; Barnes P. M., 2008, COMPLEMENTARY ALTERN; Bengtsson K., MINDFULNESS; Bussing A, 2012, J PAIN, V13, P1, DOI 10.1016/j.jpain.2011.10.001; Bystritsky A, 2012, PSYCHOSOMATICS, V53, P266, DOI 10.1016/j.psym.2011.11.009; Chen KW, 2012, DEPRESS ANXIETY, V29, P545, DOI 10.1002/da.21964; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Clarke TC., 2015, TRENDS USE COMPLEMEN, P79; Cramer H, 2013, DEPRESS ANXIETY, V30, P1068, DOI 10.1002/da.22166; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Falkenberg T, 2005, SCANDINAVIAN J PRIMA, V23, P57; Field Tiffany, 2011, Complement Ther Clin Pract, V17, P1, DOI 10.1016/j.ctcp.2010.09.007; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Hanson LLM, 2014, SCAND J WORK ENV HEA, V40, P66, DOI 10.5271/sjweh.3378; Hanson LLM, 2014, SCAND J PUBLIC HEALT, V42, P82, DOI 10.1177/1403494813500591; Hanson LLM, 2011, SLEEP, V34, P1403, DOI 10.5665/SLEEP.1288; Hanson LLM, 2009, INT ARCH OCC ENV HEA, V82, P951, DOI 10.1007/s00420-009-0406-9; Hasson Dan, 2006, Popul Health Metr, V4, P8, DOI 10.1186/1478-7954-4-8; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Kinsten A, 2007, SWEDISH LONGITUDINAL; Kuyken W, 2015, HEALTH TECHNOL ASSES, V19, DOI 10.3310/hta19730; Leineweber C, 2013, EUR J PUBLIC HEALTH, V23, P710, DOI 10.1093/eurpub/cks064; Li AW, 2012, ALTERN MED REV, V17, P21; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Meyer HB, 2012, J NEUROPSYCH CLIN N, V24, P152, DOI 10.1176/appi.neuropsych.11040090; NOMESCO, 2004, MED CONS NORD COUNTR; NOMESCO, 2010, MED CONS NORD COUNTR; Nordin M, 2013, SLEEP BIOL RHYTHMS, V11, P216, DOI 10.1111/sbr.12024; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Pilkington K, 2005, J AFFECT DISORDERS, V89, P13, DOI 10.1016/j.jad.2005.08.013; Ravindran AV, 2013, J AFFECT DISORDERS, V150, P707, DOI 10.1016/j.jad.2013.05.042; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; SBU, 2014, 223 SBU; SBU, 2014, MED MOT STRESS VID O; Stenfors C., 2014, BMC PSYCHOL, V2, P741, DOI [10.1186/2050-7283-2-3, DOI 10.1186/2050-7283-2-3]; Stenfors CUD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060637; Sundquist J, 2015, BRIT J PSYCHIAT, V206, P128, DOI 10.1192/bjp.bp.114.150243; Sze JA, 2010, EMOTION, V10, P803, DOI 10.1037/a0020146; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; The National Board of Health and Welfare (Socialstyrelsen), SOC STAT; Thorne S, 2002, INT J NURS STUD, V39, P671, DOI 10.1016/S0020-7489(02)00005-6; Uebelacker LA, 2010, J PSYCHIATR PRACT, V16, P22, DOI 10.1097/01.pra.0000367775.88388.96; van Zoonen K, 2015, J AFFECT DISORDERS, V173, P105, DOI 10.1016/j.jad.2014.10.062; Wahlstrom M, 2008, ACTA PSYCHIAT SCAND, V118, P73, DOI 10.1111/j.1600-0447.2008.01192.x; Wang CC, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-23; Williams Nerys, 2014, Occup Med (Lond), V64, P473, DOI 10.1093/occmed/kqu058; Yonkers KA, 2003, DEPRESS ANXIETY, V17, P173, DOI 10.1002/da.10106	56	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184635	10.1371/journal.pone.0184635	http://dx.doi.org/10.1371/journal.pone.0184635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0WP	28915274	Green Published, gold, Green Submitted			2022-12-27	WOS:000410861600013
J	Puengel, T; Krenkel, O; Kohlhepp, M; Lefebvre, E; Luedde, T; Trautwein, C; Tacke, F				Puengel, Tobias; Krenkel, Oliver; Kohlhepp, Marlene; Lefebvre, Eric; Luedde, Tom; Trautwein, Christian; Tacke, Frank			Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; PHARMACOLOGICAL INHIBITION; MACROPHAGE INFILTRATION; HEPATIC RECRUITMENT; FIBROSIS; HOMEOSTASIS; RESIDENT; PHASE; CCR2	A hallmark of acute hepatic injury is the recruitment of neutrophils, monocytes and lymphocytes, including natural killer (NK) or T cells, towards areas of inflammation. The recruitment of leukocytes from their reservoirs bone marrow or spleen into the liver is directed by chemokines such as CCL2 (for monocytes) and CCL5 (for lymphocytes). We herein elucidated the impact of chemokine receptor inhibition by the dual CCR2 and CCR5 inhibitor cenicriviroc (CVC) on the composition of myeloid and lymphoid immune cell populations in acute liver injury. CVC treatment effectively inhibited the migration of bone marrow monocytes and splenic lymphocytes (NK, CD4 T-cells) towards CCL2 or CCL5 in vitro. When liver injury was induced by an intraperitoneal injection of carbon tetrachloride (CCl4) in mice, followed by repetitive oral application of CVC, flow cytometric and unbiased t-SNE analysis of intrahepatic leukocytes demonstrated that dual CCR2/CCR5 inhibition in vivo significantly decreased numbers of monocyte derived macrophages in acutely injured livers. CVC also reduced numbers of Kupffer cells (KC) or monocyte derived macrophages with a KC-like phenotype, respectively, after injury. In contrast to the inhibitory effects in vitro, CVC had no impact on the composition of hepatic lymphoid cell populations in vivo. Effective inhibition of monocyte recruitment was associated with reduced inflammatory macrophage markers and moderately ameliorated hepatic necroses at 36h after CCl4. In conclusion, dual CCR2/CCR5 inhibition primarily translates into reduced monocyte recruitment in acute liver injury in vivo, suggesting that this strategy will be effective in reducing inflammatory macrophages in conditions of liver disease.	[Puengel, Tobias; Krenkel, Oliver; Kohlhepp, Marlene; Luedde, Tom; Trautwein, Christian; Tacke, Frank] RWTH Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Lefebvre, Eric] Allergan Plc, San Francisco, CA USA	RWTH Aachen University; RWTH Aachen University Hospital; AbbVie; Allergan	Tacke, F (corresponding author), RWTH Univ Hosp Aachen, Dept Med 3, Aachen, Germany.	frank.tacke@gmx.net	Tacke, Frank/ABF-2212-2020; Luedde, Tom/AAE-9135-2022	Luedde, Tom/0000-0002-6288-8821; Puengel, Tobias/0000-0003-2662-6127; Tacke, Frank/0000-0001-6206-0226	German Research Foundation (DFG) [Ta434/5-1, SFB/TRR57]; Interdisciplinary Center for Clinical Research (IZKF) Aachen	German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Aachen	This work was supported by the German Research Foundation (DFG; Ta434/5-1 and SFB/TRR57) and the Interdisciplinary Center for Clinical Research (IZKF) Aachen. The funder provided support in the form of salaries for authors [EL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; This work was supported by the German Research Foundation (DFG; Ta434/5-1 and SFB/ TRR57) and the Interdisciplinary Center for Clinical Research (IZKF) Aachen.	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Ajuebor MN, 2005, J IMMUNOL, V174, P8027, DOI 10.4049/jimmunol.174.12.8027; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Chalmers SA, 2015, DISCOV MED, V20, P43; Choi DY, 2015, ARCH TOXICOL, V89, P211, DOI 10.1007/s00204-014-1253-3; Chu HX, 2014, J CEREBR BLOOD F MET, V34, P1425, DOI 10.1038/jcbfm.2014.120; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Friedman S, 2016, CONTEMP CLIN TRIALS, V47, P356, DOI 10.1016/j.cct.2016.02.012; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Jakubzick CV, 2017, MONOCYTE DIFFERENTIA; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Krenkel Oliver, 2014, Hepatobiliary Surg Nutr, V3, P331, DOI 10.3978/j.issn.2304-3881.2014.11.01; Lefebvre E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158156; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Mohs A, 2017, J HEPATOL, V66, P743, DOI 10.1016/j.jhep.2016.12.011; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682; Perez-Martinez L, 2014, J ANTIMICROB CHEMOTH, V69, P1903, DOI 10.1093/jac/dku071; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Tacke F., 2017, J HEPATOL; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; You Q, 2013, BIOCHEM PHARMACOL, V86, P836, DOI 10.1016/j.bcp.2013.07.006; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574	33	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184694	10.1371/journal.pone.0184694	http://dx.doi.org/10.1371/journal.pone.0184694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910354	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200080
J	Adeyemi, O; Alvarez-Laviada, A; Schultz, F; Ibrahim, E; Trauner, M; Williamson, C; Glukhov, AV; Gorelik, J				Adeyemi, Oladipupo; Alvarez-Laviada, Anita; Schultz, Francisca; Ibrahim, Effendi; Trauner, Michael; Williamson, Catherine; Glukhov, Alexey V.; Gorelik, Julia			Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis	PLOS ONE			English	Article							INTRAHEPATIC CHOLESTASIS; BILE-ACID; IN-VITRO; RAT CARDIOMYOCYTES; ELECTROPHYSIOLOGICAL PROPERTIES; CA2+ CHANNEL; FETAL HEART; PREGNANCY; SODIUM; HEMODYNAMICS	Background Increased maternal serum bile acid concentrations in intrahepatic cholestasis of pregnancy (ICP) are associated with fetal cardiac arrhythmias. Ursodeoxycholic acid (UDCA) has been shown to demonstrate anti-arrhythmic properties via preventing ICP-associated cardiac conduction slowing and development of reentrant arrhythmias, although the cellular mechanism is still being elucidated. Methods High-resolution fluorescent optical mapping of electrical activity and electrocardiogram measurements were used to characterize effects of UDCA on one-day-old neonatal and adult female Langendorff-perfused rat hearts. ICP was modelled by perfusion of taurocholic acid (TC, 400 mu M). Whole-cell calcium currents were recorded from neonatal rat and human fetal cardiomyocytes. Results TC significantly prolonged the PR interval by 11.0 +/- 3.5% (P<0.05) and slowed ventricular conduction velocity (CV) by 38.9 +/- 5.1% (P<0.05) exclusively in neonatal and not in maternal hearts. A similar CV decline was observed with the selective T-type calcium current (I-Ca, T) blocker mibefradil 1 mu M (23.0 +/- 6.2%, P<0.05), but not with the L-type calcium current (I-Ca, L) blocker nifedipine 1 mu M (6.9 +/- 6.6%, NS). The sodium channel blocker lidocaine (30 mu M) reduced CV by 60.4 +/- 4.5% (P<0.05). UDCA co-treatment was protective against CV slowing induced by TC and mibefradil, but not against lidocaine. UDCA prevented the TC-induced reduction in the ICa, T density in both isolated human fetal (-10.2 +/- 1.5 versus -5.5 +/- 0.9 pA/pF, P<0.05) and neonatal rat ventricular myocytes (-22.3 +/- 1.1 versus -9.6 +/- 0.8 pA/pF, P<0.0001), whereas UDCA had limited efficacy on the I-Ca, L. Conclusion Our findings demonstrate that I-Ca, T plays a significant role in ICP-associated fetal cardiac conduction slowing and arrhythmogenesis, and is an important component of the fetus-specific anti-arrhythmic activity of UDCA.	[Adeyemi, Oladipupo; Alvarez-Laviada, Anita; Schultz, Francisca; Ibrahim, Effendi; Glukhov, Alexey V.; Gorelik, Julia] Imperial Coll London, Natl Heart & Lung Inst, Dept Cardiovasc Sci, London, England; [Schultz, Francisca; Williamson, Catherine] Imperial Coll London, Inst Reprod & Dev Biol, London, England; [Ibrahim, Effendi] MARA Technol Univ, Fac Med, Sungai Buloh, Malaysia; [Trauner, Michael] Med Univ Vienna, Dept Med 3, Vienna, Austria; [Williamson, Catherine] Kings Coll London, Womens Hlth Acad Ctr, London, England; [Glukhov, Alexey V.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA	Imperial College London; Imperial College London; Medical University of Vienna; University of London; King's College London; University of Wisconsin System; University of Wisconsin Madison	Glukhov, AV; Gorelik, J (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Dept Cardiovasc Sci, London, England.; Glukhov, AV (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA.	aglukhov@medicine.wisc.edu; j.gorelik@ic.ac.uk		Gorelik, Julia/0000-0003-1148-9158; Trauner, Michael/0000-0002-1275-6425; Schultz, Francisca/0000-0002-8923-2128	National Institute for Health Research (NIHR) Biomedical Research Centres based at Imperial College Healthcare NHS Trust and Imperial College London and at Guy's and St Thomas' NHS Foundation Trust; HRUK; Universiti Teknologi MARA in Malaysia; NIH grant [R01-HL126802]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126802] Funding Source: NIH RePORTER	National Institute for Health Research (NIHR) Biomedical Research Centres based at Imperial College Healthcare NHS Trust and Imperial College London and at Guy's and St Thomas' NHS Foundation Trust; HRUK; Universiti Teknologi MARA in Malaysia; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Tissue samples were provided by the Imperial College Healthcare NHS Trust Tissue Bank. The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centres based at Imperial College Healthcare NHS Trust and Imperial College London and at Guy's and St Thomas' NHS Foundation Trust-CW, HRUK-JG, Universiti Teknologi MARA in Malaysia-El, NIH grant R01-HL126802-JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Al Inizi S, 2006, INT J GYNECOL OBSTET, V93, P53, DOI 10.1016/j.ijgo.2005.12.030; ANDERSON KP, 1990, CIRCULATION, V81, P1024, DOI 10.1161/01.CIR.81.3.1024; Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Bahrle S, 1998, J HEART LUNG TRANSPL, V17, P592; Baruch Y, 1999, AM J GASTROENTEROL, V94, P3000, DOI 10.1111/j.1572-0241.1999.01450.x; BINAH O, 1987, N-S ARCH PHARMACOL, V335, P160; Brites D, 1998, EUR J OBSTET GYN R B, V80, P31, DOI 10.1016/S0301-2115(98)00086-4; Ferron L, 2002, J MOL CELL CARDIOL, V34, P533, DOI 10.1006/jmcc.2002.1535; Fouad YM, 2014, WORLD J HEPATOL, V6, P41, DOI 10.4254/wjh.v6.i1.41; Geenes V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083828; Geenes V, 2014, HEPATOLOGY, V59, P1482, DOI 10.1002/hep.26617; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Glukhov AV, 2010, AM J PHYSIOL-HEART C, V299, pH482, DOI 10.1152/ajpheart.00756.2009; Gorelik J, 2004, BJOG-INT J OBSTET GY, V111, P867, DOI 10.1111/j.1471-0528.2004.00166.x; Gorelik J, 2003, BJOG-INT J OBSTET GY, V110, P467, DOI 10.1016/S1470-032(03)02973; Joutsiniemi T, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0324-0; Kadir SHSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009689; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; KOTAKE H, 1989, BRIT J PHARMACOL, V98, P357, DOI 10.1111/j.1476-5381.1989.tb12604.x; Lee WY, 1999, ARCH PHARM RES, V22, P479, DOI 10.1007/BF02979156; Leuranguer V, 2000, AM J PHYSIOL-HEART C, V279, pH2540, DOI 10.1152/ajpheart.2000.279.5.H2540; Miragoli M, 2011, HEPATOLOGY, V54, P1282, DOI 10.1002/hep.24492; Niwa N, 2004, AM J PHYSIOL-HEART C, V286, pH2257, DOI 10.1152/ajpheart.01043.2003; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; Rainer PP, 2013, HEART, V99, P1685, DOI 10.1136/heartjnl-2013-304163; Rajesh KG, 2005, J MOL CELL CARDIOL, V39, P766, DOI 10.1016/j.yjmcc.2005.07.014; Scalia S, 2000, J PHARM PHARMACOL, V52, P383, DOI 10.1211/0022357001774129; Schiedermaier P, 2000, DIGESTION, V61, P107, DOI 10.1159/000007742; Schultz F, 2016, PROG BIOPHYS MOL BIO, V120, P149, DOI 10.1016/j.pbiomolbio.2016.01.003; Shaw RM, 1997, CIRC RES, V81, P727; Strehlow SL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.035; von Haehling S, 2012, J AM COLL CARDIOL, V59, P585, DOI 10.1016/j.jacc.2011.10.880; Williamson C, 2001, CLIN SCI, V100, P363, DOI 10.1042/CS20000164; Williamson C, 2014, OBSTET GYNECOL, V124, P120, DOI 10.1097/AOG.0000000000000346; Wong F, 1999, CLIN SCI, V96, P467, DOI 10.1042/CS19980275	35	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183167	10.1371/journal.pone.0183167	http://dx.doi.org/10.1371/journal.pone.0183167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934223	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900007
J	Mackin, D; Fave, XN; Zhang, LF; Yang, JZ; Jones, AK; Ng, CS; Court, L				Mackin, Dennis; Fave, Xenia; Zhang, Lifei; Yang, Jinzhong; Jones, A. Kyle; Ng, Chaan S.; Court, Laurence			Harmonizing the pixel size in retrospective computed tomography radiomics studies	PLOS ONE			English	Article							TEXTURE ANALYSIS; FEATURES; VARIABILITY; REPRODUCIBILITY; STABILITY	Consistent pixel sizes are of fundamental importance for assessing texture features that relate intensity and spatial information in radiomics studies. To correct for the effects of variable pixel sizes, we combined image resampling with Butterworth filtering in the frequency domain and tested the correction on computed tomography (CT) scans of lung cancer patients reconstructed 5 times with pixel sizes varying from 0.59 to 0.98 mm. One hundred fifty radiomics features were calculated for each preprocessing and field-of-view combination. Intra-patient agreement and inter-patient agreement were compared using the overall concordance correlation coefficient (OCCC). To further evaluate the corrections, hierarchical clustering was used to identify patient scans before and after correction. To assess the general applicability of the corrections, they were applied to 17 CT scans of a radiomics phantom. The reduction in the inter-scanner variability relative to non-small cell lung cancer patient scans was quantified. The variation in pixel sizes caused the intra-patient variability to be large (OCCC < 95%) relative to the inter-patient variability in 79% of the features. However, with the resampling and filtering corrections, the intra-patient variability was relatively large in only 10% of the features. With the filtering correction, 8 of 8 patients were correctly clustered, in contrast to only 2 of 8 without the correction. In the phantom study, resampling and filtering the images of a rubber particle cartridge substantially reduced variability in 61% of the radiomics features and substantially increased variability in only 6% of the features. Surprisingly, resampling without filtering tended to increase the variability. In conclusion, applying a correction based on resampling and Butterworth low-pass filtering in the frequency domain effectively reduced variability in CT radiomics features caused by variations in pixel size. This correction may also reduce the variability introduced by other CT scan acquisition parameters.	[Mackin, Dennis; Fave, Xenia; Zhang, Lifei; Yang, Jinzhong; Court, Laurence] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Mackin, Dennis; Fave, Xenia; Court, Laurence] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Jones, A. Kyle] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Ng, Chaan S.] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Mackin, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA.; Mackin, D (corresponding author), Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA.	dsmackin@mdanderson.org	Mackin, Dennis/Y-1503-2019	Mackin, Dennis/0000-0002-2557-5340; Court, Laurence/0000-0002-3241-6145	National Cancer Institute of the National Institutes of Health [R03CA178495]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health under award number R03CA178495. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Barnhart HX, 2002, BIOMETRICS, V58, P1020, DOI 10.1111/j.0006-341X.2002.01020.x; Basu S, 2011, IEEE SYS MAN CYBERN, P1306, DOI 10.1109/ICSMC.2011.6083840; Bogowicz M, 2016, PHYS MED BIOL, V61, P8736, DOI 10.1088/1361-6560/61/24/8736; Butterworth S., 1930, EXP WIRELESS WIRELES, V7, P536; Clarke LP, 2014, TRANSL ONCOL, V7, P1, DOI 10.1593/tlo.13832; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; Depeursinge A, 2015, INVEST RADIOL, V50, P261, DOI 10.1097/RLI.0000000000000127; Duda D, 2013, LECT NOTES COMPUT SC, V8104, P96, DOI 10.1007/978-3-642-40925-7_10; Fave X, 2015, COMPUT MED IMAG GRAP, V44, P54, DOI 10.1016/j.compmedimag.2015.04.006; Fried DV, 2014, INT J RADIAT ONCOL, V90, P834, DOI 10.1016/j.ijrobp.2014.07.020; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Ganeshan B, 2011, INVEST RADIOL, V46, P160, DOI 10.1097/RLI.0b013e3181f8e8a2; Ganeshan B, 2009, EUR J RADIOL, V70, P101, DOI 10.1016/j.ejrad.2007.12.005; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; Gonzalez RC, 2009, DIGITAL IMATE PROCES; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He L, 2016, SCI REPORTS, V6; Hunter LA, 2013, MED PHYS, V40, DOI 10.1118/1.4829514; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Mattonen SA, 2014, MED PHYS, V41, DOI 10.1118/1.4866219; Miles KA, 2013, CANCER IMAGING, V13, P400, DOI 10.1102/1470-7330.2013.9045; Oxnard GR, 2011, J CLIN ONCOL, V29, P3114, DOI 10.1200/JCO.2010.33.7071; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; R Core Team, 2013, R LANG ENV STAT COMP; Shafiq-Ul-Hassan M., 2017, MED PHYS; Zhang Lifei, 2015, Med Phys, V42, P1341, DOI 10.1118/1.4908210; Zhao B., 2016, SCI REPORTS, V6	32	97	101	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0178524	10.1371/journal.pone.0178524	http://dx.doi.org/10.1371/journal.pone.0178524			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934225	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900001
J	Tsuchiya, S; Buhr, ED; Higashide, T; Sugiyama, K; Van Gelder, RN				Tsuchiya, Shunsuke; Buhr, Ethan D.; Higashide, Tomomi; Sugiyama, Kazuhisa; Van Gelder, Russell N.			Light entrainment of the murine intraocular pressure circadian rhythm utilizes non-local mechanisms	PLOS ONE			English	Article							DEEP BRAIN PHOTORECEPTOR; AQUEOUS-HUMOR DYNAMICS; PERIPHERAL-TISSUES; HEALTHY-ADULTS; MOUSE; MICE; MELANOPSIN; RABBITS; OSCILLATORS; RECEPTORS	Purpose Intraocular pressure (IOP) is known to have a strong circadian rhythm, yet how light/dark cycles entrain this rhythm is unknown. The purpose of this study was to assess whether, like the retina, the mammalian ciliary body and IOP clocks have an intrinsic ability to entrain to light/dark cycles. Methods Iris-ciliary body complexes were obtained from period2:luciferase (PER2::LUC) mice and cultured to measure bioluminescence rhythmicity. Pairs of the iris-ciliary body complex were exposed to antiphasic 9:15 h light/dark cycle in vitro. After 4 days of exposure to light/dark cycles, bioluminescence was recorded to establish their circadian phases. In addition, pairs of the iris-ciliary body complex co-cultured with the retinas or corneas of wild-type mice were also investigated. The IOP circadian changes of free-running Opn4(-/-); rd1/rd1 mice whose behavior was antiphasic to wild-type were measured by a rebound tonometry, and compared with wild-type mice. Opn3, Opn4, and Opn5 mRNA expression in the iris-ciliary body were analyzed using RT-PCR. Results The iris/ciliary body complex expressed Opn3, Opn4, and Opn5 mRNA; however, unlike in retina and cornea, neither the iris-CB complex nor the co-cultured complex was directly entrained by light-dark cycle in vitro. The diurnal IOP change of Opn4(-/-); rd1/rd1 mice showed an antiphasic pattern to wild-type mice and their rhythms followed the whole-animal behavioral rhythm. Conclusions Despite expressing mRNA for several non-visual opsins, circadian rhythms of the iris-ciliary body complex of mice do not entrain directly to light-dark cycles ex vivo. Unlike retina, the iris/ciliary body clocks of blind mice remain synchronized to the organismal behavioral rhythm rather than local light-dark cycles. These results suggest that IOP rhythm entrainment is mediated by a systemic rather than local signal in mice.	[Tsuchiya, Shunsuke; Buhr, Ethan D.; Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA; [Tsuchiya, Shunsuke; Higashide, Tomomi; Sugiyama, Kazuhisa] Kanazawa Univ, Dept Ophthalmol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Van Gelder, Russell N.] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Kanazawa University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA.; Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.; Van Gelder, RN (corresponding author), Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA.	russvg@uw.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659; Buhr, Ethan/0000-0002-9250-6644	National Institutes of Health [P30 EY001730]; Research to Prevent Blindness; Mark J. Daily, MD Research Fund; Japan Society for the Promotion of Science [17K11420]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Mark J. Daily, MD Research Fund; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by National Institutes of Health P30 EY001730, an unrestricted grant from Research to Prevent Blindness, the Mark J. Daily, MD Research Fund, and Japan Society for the Promotion of Science Grant-in-Aid for scientific research 17K11420.	Aihara M, 2003, EXP EYE RES, V77, P681, DOI 10.1016/j.exer.2003.08.011; Aihara M, 2008, INVEST OPHTH VIS SCI, V49, P929, DOI 10.1167/iovs.07-0386; Alcantara-Contreras S, 2011, NEUROSCI LETT, V494, P61, DOI 10.1016/j.neulet.2011.02.056; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P492, DOI 10.1001/archopht.1963.00960050494011; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Blackshaw S, 1999, J NEUROSCI, V19, P3681; BRASLOW RA, 1987, INVEST OPHTH VIS SCI, V28, P1730; Buhr ED, 2015, P NATL ACAD SCI USA, V112, P13093, DOI 10.1073/pnas.1516259112; Buhr ED, 2014, P NATL ACAD SCI USA, V111, P8625, DOI 10.1073/pnas.1323350111; Dalvin LA, 2015, INVEST OPHTH VIS SCI, V56, P2657, DOI 10.1167/iovs.15-16449; De Moraes CG, 2016, OPHTHALMOLOGY; Dibner C., 2010, ANN REV PHYSL; GREGORY DS, 1990, INVEST OPHTH VIS SCI, V31, P715; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; LIU JHK, 1995, J OCUL PHARMACOL TH, V11, P379, DOI 10.1089/jop.1995.11.379; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4050, DOI 10.1167/iovs.06-0183; Maslenikow Z, 1904, Z AUGENHEILKD, V11, P564; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moore CG, 1996, CURR EYE RES, V15, P185, DOI 10.3109/02713689608997412; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Nakane Y, 2014, CURR BIOL, V24, pR596, DOI 10.1016/j.cub.2014.05.038; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Nau CB, 2013, INVEST OPHTH VIS SCI, V54, P7623, DOI [10.1167/iovs.13-12690, 10.1167/iovs.12-12690]; Nissila J, 2012, J COMP PHYSIOL A, V198, P833, DOI 10.1007/s00359-012-0754-x; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; ROWLAND JM, 1981, CURR EYE RES, V1, P169, DOI 10.3109/02713688109001822; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; Sidler-Huguenin A, 1898, BEITR AUGENHEILKD, V32; Sit AJ, 2008, INVEST OPHTH VIS SCI, V49, P1473, DOI 10.1167/iovs.07-1139; Stokes J, 2000, INVEST OPHTH VIS SCI, V41, P1629; Tsuchiya S, 2017, CURR EYE RES, V42, P1013, DOI 10.1080/02713683.2016.1264605; Van Gelder RN, 2003, SCIENCE, V300, P1534, DOI 10.1126/science.1085446; Wang WH, 2005, INVEST OPHTH VIS SCI, V46, P4617, DOI 10.1167/iovs.05-0781; Wilensky J T, 1991, Trans Am Ophthalmol Soc, V89, P757; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhao M, 2010, INVEST OPHTH VIS SCI, V51, P3145, DOI 10.1167/iovs.09-4415	40	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184790	10.1371/journal.pone.0184790	http://dx.doi.org/10.1371/journal.pone.0184790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934261	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900044
J	William, D; Mokri, P; Lamp, N; Linnebacher, M; Classen, CF; Erbersdobler, A; Schneider, B				William, Doreen; Mokri, Poroshista; Lamp, Nora; Linnebacher, Michael; Classen, Carl Friedrich; Erbersdobler, Andreas; Schneider, Bjoern			Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ONCOGENE AMPLIFICATION; HUMAN GLIOMAS; PHASE-III; EXPRESSION; TRIAL; DNA; CYCLOOXYGENASE-2; TEMOZOLOMIDE; MAINTENANCE	Glioblastoma multiforme (GBM) is the most common and lethal brain tumor in adults. It is known that amplification of the epidermal growth factor receptor gene (EGFR) occurs in approximately 40% of GBM, leading to enhanced activation of the EGFR signaling pathway and promoting tumor growth. Although GBM mutations are stably maintained in GBM in vitro models, rapid loss of EGFR gene amplification is a common observation during cell culture. To maintain EGFR amplification in vitro, heterotopic GBM xenografts with elevated EGFR copy number were cultured under varying serum conditions and EGF concentrations. EGFR copy numbers were assessed over several passages by quantitative PCR and chromogenic in situ hybridization. As expected, in control assays with 10% FCS, cells lost EGFR amplification with increasing passage numbers. However, cells cultured under serum free conditions stably maintained elevated copy numbers. Furthermore, EGFR protein expression positively correlated with genomic amplification levels. Although elevated EGFR copy numbers could be maintained over several passages in vitro, levels of EGFR amplification were variable and dependent on the EGF concentration in the medium. In vitro cultures of GBM cells with elevated EGFR copy number and corresponding EGFR protein expression should prove valuable preclinical tools to gain a better understanding of EGFR driven glioblastoma and assist in the development of new improved therapies.	[William, Doreen; Mokri, Poroshista; Classen, Carl Friedrich] Univ Med Rostock, Children & Adolescents Hosp, Rostock, Germany; [Lamp, Nora; Erbersdobler, Andreas; Schneider, Bjoern] Univ Med Rostock, Inst Pathol, Rostock, Germany; [Linnebacher, Michael] Univ Med Rostock, Dept Gen Surg Mol Oncol & Immunotherapy, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	William, D (corresponding author), Univ Med Rostock, Children & Adolescents Hosp, Rostock, Germany.	doreen.william@med.uni-rostock.de	Linnebacher, Michael/AAT-3763-2021; William, Doreen/AHA-1288-2022	Linnebacher, Michael/0000-0001-8054-1402; 				Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; Chen C, 2015, J NEURO-ONCOL, V122, P595, DOI 10.1007/s11060-015-1752-y; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dijkstra JR, 2012, J MOL DIAGN, V14, P187, DOI 10.1016/j.jmoldx.2012.01.002; DOLECEK TA, 2005, NEUROONCOLOGY S5, V14, P1, DOI DOI 10.1093/NEUONC/N0S218; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; HUMPHREY PA, 1988, CANCER RES, V48, P2231; Kircher SM, 2016, CANCER J, V22, P182, DOI 10.1097/PPO.0000000000000192; Lee EQ, 2015, CLIN CANCER RES, V21, P3610, DOI 10.1158/1078-0432.CCR-14-3220; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lyustikman Y, 2008, NEOPLASIA, V10, P501, DOI 10.1593/neo.08206; Maletzki C, 2016, ONCOTARGET, V7, P53583, DOI 10.18632/oncotarget.10677; Matsuda H, 2005, FORENSIC SCI INT, V152, P109, DOI 10.1016/j.forsciint.2004.07.019; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; McCoach CE, 2016, DRUG TODAY, V52, P561, DOI 10.1358/dot.2016.52.10.2541343; MULERIS M, 1994, ONCOGENE, V9, P2717; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Nikolaev S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6690; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pollo B, 2011, NEUROL SCI, V32, pS209, DOI 10.1007/s10072-011-0802-2; Schulte A, 2012, CLIN CANCER RES, V18, P1901, DOI 10.1158/1078-0432.CCR-11-3084; Shinojima N, 2003, CANCER RES, V63, P6962; Shono T, 2001, CANCER RES, V61, P4375; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thorne AH, 2016, NEURO-ONCOLOGY, V18, P914, DOI 10.1093/neuonc/nov319; Turner KM, 2017, NATURE, V543, P122, DOI 10.1038/nature21356; Westphal M, 2015, EUR J CANCER, V51, P522, DOI 10.1016/j.ejca.2014.12.019; William D, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1128-5; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185208	10.1371/journal.pone.0185208	http://dx.doi.org/10.1371/journal.pone.0185208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934307	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900123
J	Yang, ZH; van Busschbach, J; Timman, R; Janssen, MF; Luo, N				Yang, Zhihao; van Busschbach, Jan; Timman, Reinier; Janssen, M. F.; Luo, Nan			Logical inconsistencies in time trade-off valuation of EQ-5D-5L health states: Whose fault is it?	PLOS ONE			English	Article							VALUES; PREFERENCE	Introduction Inconsistency in the time trade-off (TTO) task in EQ-5D-5L occurs when a respondent gives a higher value to a logically worse health state, the occurrence of inconsistency compromises the quality of the data. It is not yet clear which factors are associated with individual level inconsistency. Relating inconsistency to the characteristics of the respondent, interviewer, and the interview process could be helpful in understanding the causes of inconsistency. The objective of this paper is to discover the factors associated with individual level inconsistencies. Methods Twenty interviewers interviewed 1,296 respondents and each respondent valued 10 health states using the EQ-VT platform in 5 cities in China. At the respondent level, inconsistency was identified in terms of severity and quantity and related to the respondent's background characteristics, the time and iterations spent on the wheelchair example task, and the formal TTO tasks, using multilevel multinomial regression analyses. Interviewers' impact on inconsistencies was analyzed using single level multinomial regression analyses. Results In the full dataset, slight inconsistency was more related to the interview process (Time spent on TTO task: RRR = 1.246 with 95% CI: 1.076,1.441; time spent on Wheelchair example: RRR = 0.815 with 95% CI: 0.699,0.952) while severe inconsistency was more related to respondent's gender (Gender: RRR = 2.347 with 95% CI: 1.429,3.855). One Interviewer (Interviewer 7: RRR = 7.335 with 95% CI: 1.908,28.195) and interviewer's experience (Sequence: RRR = 0.511 with 95% CI: 0.385,0.678) in general showed strong influence over inconsistency in the TTO task. Conclusion In conclusion, logical inconsistency in the valuation of EQ-5D-5L health states is associated not only with respondents' characteristics but also with interviewers' performance and theinterview process. The role of interviewers and the importance of interviewer training may be more crucial than hitherto believed. This finding could be generalizable to other interviewer-administered health-state valuation study.	[Yang, Zhihao; van Busschbach, Jan; Timman, Reinier] Erasmus Univ, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Yang, Zhihao] Guizhou Med Univ, Hlth Serv Management Dept, Guiyang, Guizhou, Peoples R China; [Janssen, M. F.] EuroQol Grp, Rotterdam, Netherlands; [Luo, Nan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	Erasmus University Rotterdam; Guizhou Medical University; National University of Singapore	Yang, ZH (corresponding author), Erasmus Univ, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands.; Yang, ZH (corresponding author), Guizhou Med Univ, Hlth Serv Management Dept, Guiyang, Guizhou, Peoples R China.	z.yang@erasmusmc.nl	Busschbach, Jan/P-1584-2019	Busschbach, Jan/0000-0002-8602-0381; Yang, Zhihao/0000-0001-5468-0847				Augustovski F, 2016, QUAL LIFE RES, V25, P323, DOI 10.1007/s11136-015-1086-4; Badia X, 1999, SOC SCI MED, V49, P943, DOI 10.1016/S0277-9536(99)00182-3; Craig BM, 2006, HEALTH ECON, V15, P835, DOI 10.1002/hec.1108; Devlin NJ, 2003, HEALTH ECON, V12, P529, DOI 10.1002/hec.741; Dolan P, 1996, SOC SCI MED, V42, P609, DOI 10.1016/0277-9536(95)00161-1; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Janssen BMF, 2013, EUR J HEALTH ECON, V14, pS5, DOI 10.1007/s10198-013-0503-2; Jin XJ, 2016, QUAL LIFE RES, V25, P979, DOI 10.1007/s11136-015-1129-x; Kularatna S, 2015, QUAL LIFE RES, V24, P1785, DOI 10.1007/s11136-014-0906-2; Lamers LM, 2006, MED DECIS MAKING, V26, P173, DOI 10.1177/0272989X06286480; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Luo N, 2017, VALUE HEALTH, V20, P662, DOI 10.1016/j.jval.2016.11.016; Luo N, 2013, QUAL LIFE RES, V22, P885, DOI 10.1007/s11136-012-0200-0; Mulhern B., 2015, EUROQOL WORKING PAPE; Ohinmaa A, 1999, EUROQOL PLEN M 1 2 O, P57; Oppe M, 2017, POWER ELICITIN UNPUB; Oppe M, 2016, PHARMACOECONOMICS, V34, P993, DOI 10.1007/s40273-016-0404-1; Oppe M, 2014, VALUE HEALTH, V17, P445, DOI 10.1016/j.jval.2014.04.002; Ramos-Goni JM, 2017, VALUE HEALTH, V20, P466, DOI 10.1016/j.jval.2016.10.012; Shah KK, 2015, EUROQOL WORKING PAPE; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Tongsiri S, 2011, VALUE HEALTH, V14, P1142, DOI 10.1016/j.jval.2011.06.005; Xie F., 2015, MED CARE	23	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184883	10.1371/journal.pone.0184883	http://dx.doi.org/10.1371/journal.pone.0184883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934266	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900055
J	Zheng, YM; Jit, M; Wu, JT; Yang, J; Leung, K; Liao, QH; Yu, HJ				Zheng, Yaming; Jit, Mark; Wu, Joseph T.; Yang, Juan; Leung, Kathy; Liao, Qiaohong; Yu, Hongjie			Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China	PLOS ONE			English	Article							CHILDREN; BURDEN	Background Hand, foot and mouth disease (HFMD) is a common illness in China that mainly affects infants and children. The objective of this study is to assess the economic cost and health-related quality of life associated with HFMD in China. Method A telephone survey of caregivers were conducted in 31 provinces across China. Caregivers of laboratory-confirmed HFMD patients who were registered in the national HFMD enhanced surveillance database during 2012-2013 were invited to participate in the survey. Total costs included direct medical costs (outpatient care, inpatient care and self-medication), direct non-medical costs (transportation, nutrition, accommodation and nursery), and indirect costs for lost income associated with caregiving. Health utility weights elicited using EuroQol EQ-5D-3L and EQ-Visual Analogue Scale (VAS) were used to calculate associated loss in quality adjusted life years (QALYs). Results The subjects comprised 1136 mild outpatients, 1124 mild inpatients, 1170 severe cases and 61 fatal cases. The mean total costs for mild outpatients, mild inpatients, severe cases and fatal cases were $201 (95% CI $187, $215), $1072 (95% CI $999, $1144), $3051 (95% CI $2905, $3197) and $2819 (95% CI $2068, $3571) respectively. The mean QALY losses per HFMD episode for mild outpatients, mild inpatients and severe cases were 3.6 (95% CI 3.4, 3,9), 6.9 (95% CI 6.4, 7.4) and 13.7 (95% CI 12.9, 14.5) per 1000 persons. Cases who were diagnosed with EV-A71 infection and had longer duration of illness were associated with higher total cost and QALY loss. Conclusion HFMD poses a high economic and health burden in China. Our results provide economic and health utility data for cost-effectiveness analysis for HFMD vaccination in China.	[Zheng, Yaming; Yang, Juan; Liao, Qiaohong] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Jit, Mark] Publ Hlth England, Modelling & Econ Unit, London, England; [Jit, Mark] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Wu, Joseph T.; Leung, Kathy] Univ Hong Kong, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Yu, Hongjie] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China	Chinese Center for Disease Control & Prevention; Public Health England; University of London; London School of Hygiene & Tropical Medicine; University of Hong Kong; World Health Organization; Fudan University	Yu, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China.	cfetpyhj@vip.sina.com	Leung, Kathy/D-5605-2017; Wu, Joseph/ABD-5880-2021; Jit, Mark/HDM-7797-2022; Yu, Hongjie/GZK-5351-2022; Wu, Joseph Tsz Kei/C-4450-2009	Leung, Kathy/0000-0003-4777-388X; Wu, Joseph Tsz Kei/0000-0002-3155-5987; Jit, Mark/0000-0001-6658-8255	National Science Fund for Distinguished Young Scholars [81525023]; WHO Study on Seasonal Influenza Vaccine Use in China Program; Diagnosis Standard for National Notifiable Disease Program; Study on Suitable Technology for Early Detection and Automatic Early Warning of Outbreak of Infectious Diseases; National Institute of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); WHO Study on Seasonal Influenza Vaccine Use in China Program; Diagnosis Standard for National Notifiable Disease Program; Study on Suitable Technology for Early Detection and Automatic Early Warning of Outbreak of Infectious Diseases; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the National Science Fund for Distinguished Young Scholars (No. 81525023) (http://www.nsfc.gov.cn/publish/portal1/) (HY), WHO Study on Seasonal Influenza Vaccine Use in China Program (HY), Diagnosis Standard for National Notifiable Disease Program (HY), Study on Suitable Technology for Early Detection and Automatic Early Warning of Outbreak of Infectious Diseases (HY), National Institute of General Medical Sciences grant U54GM088558 (JTW). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	[Anonymous], 2016, HFMD SURV SUMM W PAC; [Anonymous], EXCH RAT 2013; China Food and Drug Administration, CHIN FOOD DRUG ADM A; [Chinese Center for Disease Control and Prevention Division of infectious disease], 2016, INF DIS REP; Gan ZK, 2015, HUM VACC IMMUNOTHER, V11, P2400, DOI 10.1080/21645515.2015.1059980; General office of Ministry of Health, 2010, HFMD CLIN DIAGN TREA; He T, 2012, SHANGHAI J PREVENTIV, V24, P476; Herdman M, 2016, VALUE HEALTH, V19, P255, DOI 10.1016/j.jval.2015.11.003; Karimi M, 2016, PHARMACOECONOMICS, V34, P645, DOI 10.1007/s40273-016-0389-9; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Ma T, 2014, PREV MED TRIB, V20, P484; Ma Ying, 2012, THESIS; Martin Alan, 2008, J Med Econ, V11, P471, DOI 10.3111/13696990802321047; National Bureau of Statistics of People Republic of China, GDP PER CAP 2013; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; [秦玉君 QIN Yu-jun], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P1319; Shi P, 2014, CHIN J DIS CONTROL P, V18, P577; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Takahashi S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001958; The central peoples government of Peoples Republic OF China, NOT STAFF WORK HOURS; Thorrington D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135672; Thorrington D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105153; Wang ZL, 2016, EPIDEMIOL INFECT, V144, P138, DOI 10.1017/S0950268815001569; Wu JT, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001975; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yang TianChi, 2012, Disease Surveillance, V27, P520; Yu Shicheng, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P271; Yuan GP, 2013, SHANGHAI J PREV MED, V25, P577	29	9	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184266	10.1371/journal.pone.0184266	http://dx.doi.org/10.1371/journal.pone.0184266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934232	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900025
J	Belkacem, N; Serafini, N; Wheeler, R; Derrien, M; Boucinha, L; Couesnon, A; Cerf-Bensussan, N; Boneca, IG; Di Santo, JP; Taha, MK; Bourdet-Sicard, REL				Belkacem, Nouria; Serafini, Nicolas; Wheeler, Richard; Derrien, Muriel; Boucinha, Lilia; Couesnon, Aurelie; Cerf-Bensussan, Nadine; Boneca, Ivo Gomperts; Di Santo, James P.; Taha, Muhamed-Kkeir; Bourdet-Sicard, Raphaelle			Lactobacillus paracasei feeding improves immune control of influenza infection in mice	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; FERMENTED DAIRY PRODUCT; CASEI DN-114 001; VIRUS INFECTION; MICROBIOTA; DURATION; CONSUMPTION; PROBIOTICS; EFFICACY; BACTERIA	Respiratory tract infections such as flu cause severe morbidity and mortality and are among the leading causes of death in children and adults worldwide. Commensal microbiota is critical for orchestrating tissue homeostasis and immunity in the intestine. Probiotics represent an interesting source of immune modulators and several clinical studies have addressed the potential beneficial effects of probiotics against respiratory infections. Therefore, we have investigated the mechanisms of protection conferred by L. paracasei CNCM I-1518 strain in a mouse model of influenza infection. Notably, local myeloid cells accumulation is generated in the lungs after seven days feeding with L. paracasei prior to viral infection. L. paracaseifed mice showed reduced susceptibility to the influenza infection, associated with less accumulation of inflammatory cells in the lungs, faster viral clearance and general health improvement. Interestingly, Allobaculum was significantly increased in L. paracaseifed mice 7 days after influenza infection, even if the gut microbiota composition was not altered overall. L. paracasei-purified peptidoglycan partially recapitulated the protective phenotype observed with the entire bacteria. Collectively, our results demonstrate that oral consumption of L. paracasei CNCM I-1518 modulates lung immunity was associated with an improved control of influenza infection. These results further extend the beneficial role for certain lactobacilli to alleviate the burden of respiratory tract infections.	[Belkacem, Nouria; Taha, Muhamed-Kkeir] Inst Pasteur, Invas Bacterial Infect Unit, Paris, France; [Belkacem, Nouria; Boucinha, Lilia; Couesnon, Aurelie; Bourdet-Sicard, Raphaelle] Bioaster, Paris, France; [Serafini, Nicolas; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, Paris, France; [Serafini, Nicolas; Di Santo, James P.] INSERM, U1223, Paris, France; [Wheeler, Richard; Boneca, Ivo Gomperts] Inst Pasteur, Unite Biol & Genet Paroi Bacterienne, Dept Microbiol, Paris, France; [Wheeler, Richard; Boneca, Ivo Gomperts] INSERM, Paris, France; [Derrien, Muriel] DanoneNutricia Res, Palaiseau, France; [Couesnon, Aurelie; Cerf-Bensussan, Nadine] Univ Paris 05, Sorbonne Paris Cite, INSERM, U1163,Lab Intestinal Immun, Paris, France; [Couesnon, Aurelie; Cerf-Bensussan, Nadine] Inst Imagine, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Taha, MK (corresponding author), Inst Pasteur, Invas Bacterial Infect Unit, Paris, France.; Bourdet-Sicard, REL (corresponding author), Bioaster, Paris, France.	mktaha@pasteur.fr; Raphaelle.BOURDET-SICARD@danone.com	Derrien, Muriel/AAS-6845-2021; Cerf-Bensussan, nadine/H-9505-2017; Di Santo, James P/M-4298-2014; SERAFINI, nicolas/S-5675-2019; Boneca, Ivo G/H-1677-2014; WHEELER, Richard/AAB-8262-2022	Derrien, Muriel/0000-0001-8841-9153; Cerf-Bensussan, nadine/0000-0003-0665-1245; Di Santo, James P/0000-0002-7146-1862; SERAFINI, nicolas/0000-0002-7440-4353; Boneca, Ivo G/0000-0001-8122-509X; WHEELER, Richard/0000-0002-9249-2377	CI IMMUNOBIOTIC [1307014/00 IRT BAP301]; Danone [30000221]; Institut Pasteur; Danone Nutricia Research; Bioaster	CI IMMUNOBIOTIC; Danone(Danone Nutricia); Institut Pasteur(European Commission); Danone Nutricia Research(Danone Nutricia); Bioaster	The study was supported by the following grants: CI IMMUNOBIOTIC 1307014/00 IRT BAP301, Danone 30000221 as well as by the Institut Pasteur. In addition to funding, Danone Nutricia Research and Bioaster provided coordination and management. In addition, Danone Nutricia Research made available Lactobacilli strains and performed Microbiota analysis. The funders had no role in study design, decision to publish, or preparation of the manuscript. MD and RBS are employed by Danone Nutricia Research. Danone Nutricia Research provided support in the form of salaries for authors MD and RBS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso JM, 2003, FEMS MICROBIOL LETT, V222, P99, DOI 10.1016/S0378-1097(03)00252-0; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins JW, 2014, J INFECT DIS, V210, P1029, DOI 10.1093/infdis/jiu205; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; de Araujo GV, 2015, J PEDIAT-BRAZIL, V91, P413, DOI 10.1016/j.jped.2015.03.002; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; GRAVENSTEIN S, 1994, J AM GERIATR SOC, V42, P245, DOI 10.1111/j.1532-5415.1994.tb01746.x; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Guillemard E, 2010, BRIT J NUTR, V103, P58, DOI 10.1017/S0007114509991395; Guillemard E, 2010, J AM COLL NUTR, V29, P455, DOI 10.1080/07315724.2010.10719882; Hao QK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006895.pub3; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; He Y, 2017, CRIT REV MICROBIOL, V43, P81, DOI [10.1080/1040841X.2016.1176988, 10.1080/1040841x.2016.1176988]; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kawase M, 2012, FEMS IMMUNOL MED MIC, V64, P280, DOI 10.1111/j.1574-695X.2011.00903.x; King S, 2014, BRIT J NUTR, V112, P41, DOI 10.1017/S0007114514000075; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leyer GJ, 2009, PEDIATRICS, V124, pE172, DOI 10.1542/peds.2008-2666; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Merenstein D, 2010, EUR J CLIN NUTR, V64, P669, DOI 10.1038/ejcn.2010.65; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Nagai T, 2011, INT IMMUNOPHARMACOL, V11, P2246, DOI 10.1016/j.intimp.2011.09.012; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Szatanik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022210; Wang J, 2014, J EXP MED, V211, P2397, DOI 10.1084/jem.20140625; Wheeler RM, 2014, J ADV NURS, V70, P350, DOI 10.1111/jan.12197; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961; Zarantonelli ML, 2013, CELL HOST MICROBE, V13, P735, DOI 10.1016/j.chom.2013.04.016	53	51	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e184976	10.1371/journal.pone.0184976	http://dx.doi.org/10.1371/journal.pone.0184976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931041	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700051
J	Sinche, M; Layton, RL; Brandt, PD; O'Connell, AB; Hall, JD; Freeman, AM; Harrell, JR; Cook, JG; Brennwald, PJ				Sinche, Melanie; Layton, Rebekah L.; Brandt, Patrick D.; O'Connell, Anna B.; Hall, Joshua D.; Freeman, Ashalla M.; Harrell, Jessica R.; Cook, Jeanette Gowen; Brennwald, Patrick J.			An evidence-based evaluation of transferrable skills and job satisfaction for science PhDs	PLOS ONE			English	Article							US	PhD recipients acquire discipline-specific knowledge and a range of relevant skills during their training in the life sciences, physical sciences, computational sciences, social sciences, and engineering. Empirically testing the applicability of these skills to various careers held by graduates will help assess the value of current training models. This report details results of an Internet survey of science PhDs (n = 8099) who provided ratings for fifteen transferrable skills. Indeed, analyses indicated that doctoral training develops these transferrable skills, crucial to success in a wide range of careers including research-intensive (RI) and non-research-intensive (NRI) careers. Notably, the vast majority of skills were transferrable across both RI and NRI careers, with the exception of three skills that favored RI careers (creativity/innovative thinking, career planning and awareness skills, and ability to work with people outside the organization) and three skills that favored NRI careers (time management, ability to learn quickly, ability to manage a project). High overall rankings suggested that graduate training imparted transferrable skills broadly. Nonetheless, we identified gaps between career skills needed and skills developed in PhD training that suggest potential areas for improvement in graduate training. Therefore, we suggest that a twopronged approach is crucial to maximizing existing career opportunities for PhDs and developing a career-conscious training model: 1) encouraging trainees to recognize their existing individual skill sets, and 2) increasing resources and programmatic interventions at the institutional level to address skill gaps. Lastly, comparison of job satisfaction ratings between PhD-trained employees in both career categories indicated that those in NRI career paths were just as satisfied in their work as their RI counterparts. We conclude that PhD training prepares graduates for a broad range of satisfying careers, potentially more than trainees and program leaders currently appreciate.	[Sinche, Melanie] Jackson Lab Genom Med, Farmington, CT USA; [Layton, Rebekah L.; Brandt, Patrick D.; O'Connell, Anna B.; Hall, Joshua D.; Freeman, Ashalla M.; Harrell, Jessica R.; Cook, Jeanette Gowen; Brennwald, Patrick J.] Univ North Carolina Chapel Hill, Off Grad Educ, Chapel Hill, NC 27599 USA; [Cook, Jeanette Gowen] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC USA; [Brennwald, Patrick J.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC USA	Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Layton, RL (corresponding author), Univ North Carolina Chapel Hill, Off Grad Educ, Chapel Hill, NC 27599 USA.	rlayton@unc.edu	Hall, Joshua/AAV-3953-2020; Layton, Rebekah L./K-9572-2019	Hall, Joshua/0000-0002-3941-8004; Layton, Rebekah L./0000-0001-7113-1348; Cook, Jeanette/0000-0003-0849-7405	National Institutes of Health (NIH) [DP7OD020317]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP7OD020317] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health (NIH) award number DP7OD020317 (https://commonfund.nih.gov/workforce/fundedresearch) supported work on this manuscript in the form of salary support for R.L.L. and P.D.B. while writing this manuscript. Co-Pricipal investigators on the grant included P.D.B., J.G.C., and P.J.B. The content contained herein does not reflect the views of the NIH and the authors are solely responsible for its content. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; American Institutes for Research, 2014, ISS BRIEF NON CAR ST; [Anonymous], 2014, NIH BROADENING EXPER; [Anonymous], 2014, NATURE; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Gibbs KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114736; Janssen K, 2014, CAREER OPTIONS BIOME; Keenan E., 2015, PHDS DO HAVE TRANS 1; Layton RL, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-01-0066; NACE, 2013, JOB OUTL CLASS 2014; National Center for Science and Engineering Statistics Directorate for Social, 2015, DIR SOC BEH EC SCI D; National Institutes of Health, 2012, NIH DOC REP; National Science Foundation, 2014, SCI ENG IND; National Science Foundation National Center for Science and Engineering Statistics, 2013, SESTAT MET EXPL; National Science Foundation National Center for Science and Engineering Statistics, 2015, DOCT REC MAJ FIELD S; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Shapiro DT, 2001, J HIGH EDUC, V72, P532, DOI 10.1080/00221546.2001.11777113; Sinche MV, 2016, NEXT GEN PHD GUIDE C; Singh S., 2015, TRAINIGN CAREER OUTC; Tabachnick BG, 2007, LOGISTIC REGRESSION	20	45	45	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185023	10.1371/journal.pone.0185023	http://dx.doi.org/10.1371/journal.pone.0185023			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931079	gold, Green Published, Green Submitted			2022-12-27	WOS:000411314700059
J	Danowitz, M; Barry, JC; Solounias, N				Danowitz, Melinda; Barry, John C.; Solounias, Nikos			The earliest ossicone and post-cranial record of Giraffa	PLOS ONE			English	Article							MAMMALIA; SIWALIKS; MORPHOLOGY; MIOCENE	The oldest Giraffa material presently known consists of dental specimens. The oldest post-cranial Giraffa material belongs to the Plio-Pleistocene taxon Giraffa sivalensis, where the holotype is a third cervical vertebra. We describe three non-dental specimens from the Early Late Miocene of the Potwar Plateau, including an 8.1 million year old ossicone, 9.4 million year old astragalus, and 8.9 million year old metatarsal and refer them to Giraffa. The described ossicone exhibits remarkable similarities with the ossicones of a juvenile modern giraffe, including the distribution of secondary bone growth, posterior curvature, and concave pitted undersurface where the ossicone would attach to the skull. The astragalus has a notably flat grove of the trochlea, medial twisting between the trochlea and the head, and a square-shaped sustentacular facet, all of which characterize the astragalus of Giraffa camelopardalis. The newly described astragalus is narrow and rectangular, unlike the boxy shaped bone of the modern giraffe. The metatarsal is large in size and has a shallow central trough created by thin medial and lateral ridges, a feature unique to Giraffa and Sivatherium. Our described material introduce the earliest non-dental material of Giraffa, a genus whose extinct representation is otherwise dominated by teeth, and demonstrate that the genus has been morphologically consistent over 9 million years.	[Danowitz, Melinda; Solounias, Nikos] New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Danowitz, Melinda] Alfred I DuPont Hosp Children, Dept Pediat, Wilmington, DE USA; [Barry, John C.] Peabody Museum, Dept Human Evolutionary Biol, Cambridge, MA USA; [Solounias, Nikos] Amer Museum Nat Hist, Dept Paleontol, New York, NY 10024 USA	New York Institute Technology; Nemours Alfred I. duPont Hospital for Children; American Museum of Natural History (AMNH)	Solounias, N (corresponding author), New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.; Solounias, N (corresponding author), Amer Museum Nat Hist, Dept Paleontol, New York, NY 10024 USA.	nsolouni@nyit.edu						Aftab K, 2016, J ANIM PLANT SCI, V26, P833; Aftab K., 2013, BIOLOGIA, V59, P233; Akbar Khan Muhammad, 2006, Journal of Applied Sciences, V6, P131; Akhtar M., 1991, ACTA SCI-ANIM SCI, V1, P145; Barr WA, 2014, J MORPHOL, V275, P1201, DOI 10.1002/jmor.20279; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Basu C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0940; BEHRENSMEYER AK, 1995, PALAEOGEOGR PALAEOCL, V115, P37, DOI 10.1016/0031-0182(94)00106-I; Bhatti ZH, 2012, PAK J ZOOL, V44, P1689; Bohlin B., 1926, Palaeontologia Sinica Series C, V4, P1; Cautley PT., 1843, P GEOLOGICAL SOC LON, V4, P235; Colbert E.H., 1935, T AM PHILOS SOC, V26, P1, DOI DOI 10.2307/1005467; Danowitz M, 2016, PALAEONTOL ELECTRON, V19, P1; Danowitz M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150393; Davis EB, 2012, PALAEONTOL ELECTRON, V15; DeGusta D, 2003, J ARCHAEOL SCI, V30, P1009, DOI 10.1016/S0305-4403(02)00286-8; Fennessy J, 2016, CURR BIOL, V26, P2543, DOI 10.1016/j.cub.2016.07.036; GANEY T, 1990, ANAT REC, V227, P497, DOI 10.1002/ar.1092270413; Geraads D., 1979, B MUS NATN HIST PA C, V4, P377; Geraads D, 2013, J VERTEBR PALEONTOL, V33, P470, DOI 10.1080/02724634.2013.723657; Gradstein FM, 2012, GEOGRAPHIC TIME SCAL; HAMILTON WR, 1978, PHILOS T R SOC B, V283, P165, DOI 10.1098/rstb.1978.0019; Hou Sukuan, 2014, Zitteliana Reihe B, V32, P91; Matthew WD, 1930, B AM MUS NAT HIST, V56, P437; Nanda A.C., 2005, Himalayan Geology, V26, P93; Pilgrim G.E., 1911, MEM GEOL SURV INDIA, V4, P1; Pilgrim GE., 1910, REC GEOL SURV INDIA, V40, P69; Prothero DR, 2014, INTEGR ZOOL, V9, P383, DOI 10.1111/1749-4877.12054; SOLOUNIAS N, 1988, J MAMMAL, V69, P845, DOI 10.2307/1381645; Solounias N, 1999, HOMINOID EVOLUTION C, P436, DOI DOI 10.1017/CBO9780511542329.022; Solounias N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151310; Solounias Nikos, 2007, P257; SPINAGE C A, 1968, East African Wildlife Journal, V6, P53; Thewissen JGM, 1999, SYST BIOL, V48, P21, DOI 10.1080/106351599260418; van Sittert SJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1135	35	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185139	10.1371/journal.pone.0185139	http://dx.doi.org/10.1371/journal.pone.0185139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926638	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600073
J	Kawade, K; Tsukaya, H				Kawade, Kensuke; Tsukaya, Hirokazu			Probing the stochastic property of endoreduplication in cell size determination of Arabidopsis thaliana leaf epidermal tissue	PLOS ONE			English	Article							PROTEIN EXPRESSION; DEVELOPING LEAVES; GENE-EXPRESSION; CYCLE ARREST; GROWTH; PROLIFERATION; PLANTS; NOISE; TRANSCRIPTOME; MECHANISMS	Cell size distribution is highly reproducible, whereas the size of individual cells often varies greatly within a tissue. This is obvious in a population of Arabidopsis thaliana leaf epidermal cells, which ranged from 1,000 to 10,000 mu m(2) in size. Endoreduplicationis a specialized cell cycle in which nuclear genome size (ploidy) is doubled in the absence of cell division. Although epidermal cells require endoreduplication to enhance cellular expansion, the issue of whether this mechanism is sufficient for explaining cell size distribution remains unclear due to a lack of quantitative understanding linking the occurrence of endoreduplication with cell size diversity. Here, we addressed this question by quantitatively summarizing ploidy profile and cell size distribution using a simple theoretical framework. We first found that endoreduplication dynamics is a Poisson process through cellular maturation. This finding allowed us to construct a mathematical model to predict the time evolution of a ploidy profile with a single rate constant for endoreduplication occurrence in a given time. We reproduced experimentally measured ploidy profile in both wild-type leaf tissue and endoreduplication-related mutants with this analytical solution, further demonstrating the probabilistic property of endoreduplication. We next extended the mathematical model by incorporating the element that cell size is determined according to ploidy level to examine cell size distribution. This analysis revealed that cell size is exponentially enlarged 1.5 times every endoreduplication round. Because this theoretical simulation successfully recapitulated experimentally observed cell size distributions, we concluded that Poissonian endoreduplication dynamics and exponential size-boosting are the sources of the broad cell size distribution in epidermal tissue. More generally, this study contributes to a quantitative understanding whereby stochastic dynamics generate steady-state biological heterogeneity.	[Kawade, Kensuke; Tsukaya, Hirokazu] Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan; [Kawade, Kensuke] Natl Inst Basic Biol, Okazaki, Aichi, Japan; [Kawade, Kensuke] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Tsukaya, Hirokazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); University of Tokyo	Kawade, K (corresponding author), Okazaki Inst Integrat Biosci, Okazaki, Aichi, Japan.; Kawade, K (corresponding author), Natl Inst Basic Biol, Okazaki, Aichi, Japan.; Kawade, K (corresponding author), Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan.	kawa-ken@ribb.ac.jp	Tsukaya, Hirokazu/A-2614-2013	Tsukaya, Hirokazu/0000-0002-4430-4538; Kawade, Kensuke/0000-0003-1701-4567	BIO-NEXT project from Okazaki Institute for Integrative Bioscience; Sumitomo Foundation [150238]; Japan Society for the Promotion of Science [17K15147, 25113002]; Grants-in-Aid for Scientific Research [17K15147, 25113002] Funding Source: KAKEN	BIO-NEXT project from Okazaki Institute for Integrative Bioscience; Sumitomo Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by BIO-NEXT project from Okazaki Institute for Integrative Bioscience (K.K. and H.T.), Grant for Basic Science Research Projects from The Sumitomo Foundation (150238) (K.K.), and Grants-in-aid for Young scientists (B) (17K15147) (K.K.) and Scientific research on innovation areas (25113002) (H.T.) from Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bertin N, 2007, J EXP BOT, V58, P1903, DOI 10.1093/jxb/erm052; Boettiger AN, 2013, BIOPHYS J, V105, P2629, DOI 10.1016/j.bpj.2013.10.033; Boudolf V, 2004, PLANT CELL, V16, P2683, DOI 10.1105/tpc.104.024398; Boudolf V, 2009, PLANT PHYSIOL, V150, P1482, DOI 10.1104/pp.109.140269; Breuer C, 2010, CURR OPIN PLANT BIOL, V13, P654, DOI 10.1016/j.pbi.2010.10.006; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elsner J, 2012, ANN BOT-LONDON, V109, P897, DOI 10.1093/aob/mcs005; Floyd DL, 2010, BIOPHYS J, V99, P360, DOI 10.1016/j.bpj.2010.04.049; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Ginzberg MB, 2015, SCIENCE, V348, DOI 10.1126/science.1245075; Hervieux N, 2016, CURR BIOL, V26, P1019, DOI 10.1016/j.cub.2016.03.004; Hong LL, 2016, DEV CELL, V38, P15, DOI 10.1016/j.devcel.2016.06.016; Imai KK, 2006, PLANT CELL, V18, P382, DOI 10.1105/tpc.105.037309; Javelle M, 2011, NEW PHYTOL, V189, P17, DOI 10.1111/j.1469-8137.2010.03514.x; Kalve S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00362; Katagiri Y, 2016, DEVELOPMENT, V143, P1120, DOI 10.1242/dev.130021; Kawade K, 2013, CURR BIOL, V23, P788, DOI 10.1016/j.cub.2013.03.044; Kazama T, 2010, PLANT CELL PHYSIOL, V51, P1046, DOI 10.1093/pcp/pcq051; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Meyer HM, 2017, ELIFE, V6, DOI [10.7554/elife.19131, 10.7554/eLife.19131]; Modi S, 2017, BIOPHYS J, V112, P2408, DOI 10.1016/j.bpj.2017.04.050; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Narukawa H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134547; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; POETHIG S, 1989, TRENDS GENET, V5, P273, DOI 10.1016/0168-9525(89)90101-7; Roeder AHK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000367; Sako K, 2010, PLANT SIGNAL BEHAV, V5, P1119, DOI 10.4161/psb.5.9.12479; Savaldi-Goldstein S, 2007, NATURE, V446, P199, DOI 10.1038/nature05618; Serrano-Mislata A, 2015, CURR BIOL, V25, P2991, DOI 10.1016/j.cub.2015.10.008; Skirycz A, 2011, PLANT CELL, V23, P1876, DOI 10.1105/tpc.111.084160; Sonoda Y, 2009, PLANT J, V60, P68, DOI 10.1111/j.1365-313X.2009.03932.x; Sugiyama M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003957; Szymkowiak EJ, 1996, ANNU REV PLANT PHYS, V47, P351, DOI 10.1146/annurev.arplant.47.1.351; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; White DE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002952; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107	44	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185050	10.1371/journal.pone.0185050	http://dx.doi.org/10.1371/journal.pone.0185050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926847	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600064
J	Buonomo, OC; Caredda, E; Portarena, I; Vanni, G; Orlandi, A; Bagni, C; Petrella, G; Palombi, L; Orsaria, P				Buonomo, Oreste Claudio; Caredda, Emanuele; Portarena, Ilaria; Vanni, Gianluca; Orlandi, Augusto; Bagni, Claudia; Petrella, Giuseppe; Palombi, Leonardo; Orsaria, Paolo			New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes	PLOS ONE			English	Article							DOXORUBICIN PLUS CYCLOPHOSPHAMIDE; HER-2 NEU ONCOGENE; TUMOR SIZE; PROGNOSTIC-FACTORS; ESTROGEN-RECEPTOR; SURVIVAL; CARCINOMA; TRASTUZUMAB; EXPRESSION; OUTCOMES	Despite advances in treatment, up to 30% of patients with early breast cancer (BC) experience distant disease relapse. However, a comprehensive understanding of tumor spread and site-specific recurrence patterns remains lacking. This retrospective case-control study included 103 consecutive patients with metastatic BC admitted to our institution (2000-2013). Cases were matched according to age, tumor biology, and clinicopathological features to 221 patients with non-metastatic BC (control group). The median follow-up period among the 324 eligible patients was 7.3 years. While relatively low values for sensitivity (71%) and specificity (56%) were found for axillary lymph node (ALN) involvement as an indicator of risk and pattern of distant relapse, nodal status remained the most powerful predictor of metastases (OR: 3.294; CL: 1.9-5.5). Rates of dissemination and metastatic efficiency differed according to molecular subtype. HER2-positive subtypes showed a stronger association with systemic spread (OR: 2.127; CL: 1.2-3.8) than other subgroups. Classification as Luminal or Non-Luminal showed an increased risk of lung and distant nodal recurrence, and a decreased risk in bone metastases in the Non-Luminal group (OR: 2.9, 3.345, and 0.2, respectively). Tumors with HER2 overexpression had a significantly high risk for distant relapse (OR: 2.127) compared with HER2-negative tumors and also showed higher central nervous system (CNS) and lung metastatic potential (OR: 5.6 and 2.65, respectively) and low risk of bone disease progression (OR: 0.294). Furthermore, we found significant associations between biological profiles and sites of recurrence. A new process of clinical/diagnostic staging, including molecular subtypes, could better predict the likelihood of distant relapses and their anatomical location. Recognition and appreciation of clinically distinct molecular subtypes may assist in evaluation of the probability of distant relapses and their sites. Our analysis provides new insights into management of metastatic disease behavior, to lead to an optimal disease-tailored approach and appropriate follow-up.	[Buonomo, Oreste Claudio; Vanni, Gianluca; Petrella, Giuseppe; Orsaria, Paolo] Tor Vergata Univ Hosp, Dept Surg, Rome, Italy; [Caredda, Emanuele; Bagni, Claudia; Palombi, Leonardo] Tor Vergata Univ Hosp, Dept Biomed & Prevent, Rome, Italy; [Portarena, Ilaria] Tor Vergata Univ Hosp, Dept Internal Med, Med Oncol Unit, Rome, Italy; [Orlandi, Augusto] Tor Vergata Univ Hosp, Dept Biomed & Prevent, Anat Pathol, Rome, Italy	University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata	Palombi, L (corresponding author), Tor Vergata Univ Hosp, Dept Biomed & Prevent, Rome, Italy.	leonardo.palombi@gmail.com	Vanni, Gianluca/AAJ-9743-2020; Palombi, Leonardo/I-4043-2019; Orlandi, Augusto/AHE-8753-2022; Caredda, Emanuele/AAB-5230-2020; Orsaria, Paolo/AAX-7057-2021	Palombi, Leonardo/0000-0003-1806-5278; Caredda, Emanuele/0000-0002-2828-6202; Orsaria, Paolo/0000-0002-6224-7784; Bagni, Claudia/0000-0002-4419-210X; vanni, gianluca/0000-0002-3006-5855				ANBAZHAGAN R, 1991, ANN ONCOL, V2, P47, DOI 10.1093/oxfordjournals.annonc.a057824; Arriagada R, 2006, CANCER-AM CANCER SOC, V106, P743, DOI 10.1002/cncr.21659; ARRIAGADA R, 1992, BREAST CANCER RES TR, V21, P101, DOI 10.1007/BF01836956; Atahan IL, 2008, ACTA ONCOL, V47, P232, DOI 10.1080/02841860701678761; Azzato EM, 2009, BRIT J CANCER, V100, P1806, DOI 10.1038/sj.bjc.6605062; BARNES DM, 1988, BRIT J CANCER, V58, P448, DOI 10.1038/bjc.1988.238; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bonadonna G, 2003, MED ONCOLOGICA; BORG A, 1990, CANCER RES, V50, P4332; BUZZONI R, 1991, J CLIN ONCOL, V9, P2134, DOI 10.1200/JCO.1991.9.12.2134; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Chia SK, 2004, J CLIN ONCOL, V22, P1630, DOI 10.1200/JCO.2004.09.070; Chung YL, 2002, INT J CANCER, V97, P306, DOI 10.1002/ijc.1614; Clayton AJ, 2004, BRIT J CANCER, V91, P639, DOI 10.1038/sj.bjc.6601970; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; Duan XF, 2013, INT J CLIN ONCOL, V18, P26, DOI 10.1007/s10147-011-0336-x; Engel J, 2003, EUR J CANCER, V39, P1794, DOI 10.1016/S0959-8049(03)00422-2; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Gajdos C, 1999, ANN SURG, V230, P692, DOI 10.1097/00000658-199911000-00012; Fernandez AG, 2012, BREAST, V21, P366, DOI 10.1016/j.breast.2012.03.004; Ge QD, 2012, ASIAN PAC J CANC PRE, V13; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Lin NU, 2012, CANCER-AM CANCER SOC, V118, P5463, DOI 10.1002/cncr.27581; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Montemurro F, 2013, ANN ONCOL, V24, P2715, DOI 10.1093/annonc/mdt287; Nabholtz JM PT, 2002, P AN M AM SOC CLIN, V21, p36a; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Olson EM, 2013, BREAST, V22, P525, DOI 10.1016/j.breast.2012.12.006; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Rosenberg J, 2005, BREAST CANCER RES TR, V89, P47, DOI 10.1007/s10549-004-1470-1; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Saip P, 2008, BREAST, V17, P451, DOI 10.1016/j.breast.2008.03.004; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smalley RV, 1997, CANCER, V40, P625; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; SPYRATOS F, 1992, J NATL CANCER I, V84, P1266, DOI 10.1093/jnci/84.16.1266; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; Wo JY, 2011, J CLIN ONCOL, V29, P2619, DOI 10.1200/JCO.2010.29.5907; Wulfkuhle JD, 2008, J PROTEOME RES, V7, P1508, DOI 10.1021/pr7008127	49	61	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184680	10.1371/journal.pone.0184680	http://dx.doi.org/10.1371/journal.pone.0184680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922402	Green Submitted, Green Published, gold			2022-12-27	WOS:000411059300022
J	Clerc, A; Reynaud, Q; Durupt, S; Chapuis-Cellier, C; Nove-Josserand, R; Durieu, I; Lega, JC				Clerc, Axelle; Reynaud, Quitterie; Durupt, Steaphane; Chapuis-Cellier, Colette; Nove-Josserand, Raphaeele; Durieu, Isabelle; Lega, Jean Christophe			Elevated IgG4 serum levels in patients with cystic fibrosis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SUBCLASS LEVELS; BETA-LACTAMASE; LUNG-DISEASE; IMMUNOGLOBULIN; ASSOCIATION; INHIBITION; ANTIBODIES; INFECTION; ADULTS	Objective Serum immunoglobulin (Ig) G4 elevation has been associated with several pathological conditions other than IgG4-related disease (IgG4-RD). In cystic fibrosis (CF), an elevation of specific IgG4 has been associated with colonization and infection by Pseudomonas aeruginosa. IgG4 elevation may be a marker of chronic infection or inflammatory stimulation. The aim of this study was to explore the prevalence of elevated IgG4 levels in CF and its correlation with the major clinical and microbiological features found in CF patients. Methods In a cross-sectional study, we analyzed data from a large cohort of adult CF patients attending the CF center of Lyon University Hospital. An elevated IgG4 level was defined as being above the cut-off value of 135 mg/dL. Results One hundred and sixty-five CF patients were analyzed. An IgG4 elevation was detected in 43 patients (26%). Compared with the control group (<= 135 mg/dL), high IgG4 patients exhibited a greater prevalence of Staphylococcus aureus colonization and higher IgG, IgG1, IgG2 and IgE levels. No significant differences were observed in terms of pulmonary function, colonization with Pseudomonas aeruginosa, or the annual rate of bronchial exacerbations. Conclusion An elevated IgG4 serum level was frequently detected in adult CF patients and did not appear to be associated with poor lung function. We suggest that IgG4 elevation is a marker of the activation of tolerance. Its clinical significance remains to be demonstrated.	[Clerc, Axelle; Reynaud, Quitterie; Durupt, Steaphane; Nove-Josserand, Raphaeele; Durieu, Isabelle; Lega, Jean Christophe] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Med Interne, Pierre Benite, France; [Clerc, Axelle; Reynaud, Quitterie; Durupt, Steaphane; Nove-Josserand, Raphaeele; Durieu, Isabelle; Lega, Jean Christophe] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Reference Mucoviscidose, Pierre Benite, France; [Reynaud, Quitterie; Durieu, Isabelle] EA Hlth Serv & Performance Res HESPER, F-7425 Lyon, France; [Reynaud, Quitterie; Durieu, Isabelle; Lega, Jean Christophe] Univ Claude Bernard Lyon 1, Lyon, France; [Chapuis-Cellier, Colette] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Immunol, Pierre Benite, France; [Durieu, Isabelle; Lega, Jean Christophe] Claude Bernard Univ Lyon 1, Lab Biometrie & Biol Evolut, Equipe Evaluat & Modelisat Essais Therapeut, UMR 5558, Lyon, France	CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Reynaud, Q (corresponding author), Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Med Interne, Pierre Benite, France.; Reynaud, Q (corresponding author), Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Reference Mucoviscidose, Pierre Benite, France.; Reynaud, Q (corresponding author), EA Hlth Serv & Performance Res HESPER, F-7425 Lyon, France.	quitterie.reynaud@chu-lyon.fr						Bernardi DM, 2013, J PEDIAT-BRAZIL, V89, P40, DOI 10.1016/j.jped.2013.02.007; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; BRETT MM, 1986, ARCH DIS CHILD, V61, P1114, DOI 10.1136/adc.61.11.1114; Ciofu O, 1997, CLIN EXP IMMUNOL, V108, P88, DOI 10.1046/j.1365-2249.1997.d01-994.x; Ebbo M, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/602809; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Garside JP, 2005, PEDIATR PULM, V39, P135, DOI 10.1002/ppul.20050; James LK, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0600-2; Lachenal F, 2009, EUR RESPIR J, V34, P1079, DOI 10.1183/09031936.00006009; Levy H, 2007, PEDIATR PULM, V42, P256, DOI 10.1002/ppul.20563; MATTHEWS WJ, 1980, NEW ENGL J MED, V302, P245, DOI 10.1056/NEJM198001313020501; Moffitt KL, 2014, J CYST FIBROS, V13, P63, DOI 10.1016/j.jcf.2013.06.002; MOSS RB, 1988, NEW ENGL REG ALLERGY, V9, P57; Nixon LS, 1998, AM J RESP CRIT CARE, V157, P1764, DOI 10.1164/ajrccm.157.6.9704086; Petersen TD, 1996, THORAX, V51, P733, DOI 10.1136/thx.51.7.733; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Proesmans M, 2011, J CYST FIBROS, V10, P128, DOI 10.1016/j.jcf.2010.12.004; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; SHAKIB F, 1976, CLIN ALLERGY, V6, P237, DOI 10.1111/j.1365-2222.1976.tb01902.x; SHRYOCK TR, 1986, J CLIN MICROBIOL, V23, P513, DOI 10.1128/JCM.23.3.513-516.1986; WHEELER WB, 1984, J PEDIATR-US, V104, P695, DOI 10.1016/S0022-3476(84)80946-4; Yun J, 2014, ASIA PAC ALLERGY, V4, P172, DOI 10.5415/apallergy.2014.4.3.172	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0181888	10.1371/journal.pone.0181888	http://dx.doi.org/10.1371/journal.pone.0181888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922375	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300002
J	Eerkens, JW; Hull, B; Goodman, J; Evoy, A; Kapp, JD; Hussain, S; Green, RE				Eerkens, Jelmer W.; Hull, Bryna; Goodman, Jena; Evoy, Angela; Kapp, Joshua D.; Hussain, Sidra; Green, Richard E.			Stable C and N isotope analysis of hair suggest undernourishment as a factor in the death of a mummified girl from late 19th century San Francisco, CA	PLOS ONE			English	Article							NUTRITIONAL STRESS; NITROGEN; STARVATION; DIET; PHYSIOLOGY; CEMETERY; PROTEIN; GROWTH; CARBON; EAT	The chance discovery of a 1.5-3.5 years old mummified girl presents a unique opportunity to further our understanding of health and disease among children in 19 th Century San Francisco. This study focuses on carbon and nitrogen stable isotope signatures in serial samples of hair that cover the last 14 months of her life. Results suggest an initial omnivorous diet with little input from marine resources or C4 plants. Around six months before death delta(15) N starts a steady increase, with a noticeable acceleration just two months before she died. The magnitude of delta(15) N change, +1.5 parts per thousand in total, is consistent with severe undernourishment or starvation. Cemetery records from this time period in San Francisco indicate high rates of infant and child mortality, mainly due to bacterial-borne infectious diseases, about two orders of magnitude higher than today. Taken together, we hypothesize that the girl died after a prolonged battle with such an illness. Results highlight the tremendous impacts that modern sanitation and medicine have had since the 1800s on human health and lifespan in the United States.	[Eerkens, Jelmer W.; Hull, Bryna; Goodman, Jena; Evoy, Angela] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Kapp, Joshua D.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Hussain, Sidra; Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Davis; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Eerkens, JW (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	jweerkens@ucdavis.edu		Green, Richard/0000-0003-0516-5827; Eerkens, Jelmer/0000-0002-2150-8917	UCD Faculty Research Grant from the University of California Davis	UCD Faculty Research Grant from the University of California Davis	Funding was provided through a UCD Faculty Research Grant to JWE from the University of California Davis.	AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; Baque CSO, 2012, INT J COSMETIC SCI, V34, P111, DOI 10.1111/j.1468-2494.2011.00687.x; Barth J H, 1987, Pediatr Dermatol, V4, P173, DOI 10.1111/j.1525-1470.1987.tb00775.x; Beaumont J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160065; Brignoli H. P., 1997, INFANT CHILD MORTALI, P91; Buzon MR, 2005, HIST ARCHAEOL, V39, P1; Centers for Disease Control and Prevention, UND CAUS DEATH; Chatten C., 1997, EXCAVATIONS CALIFORN; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dulloo AG, 1999, BRIT J NUTR, V82, P339, DOI 10.1017/S0007114599001580; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Hansen Gladys, 1980, SAN FRANCISCO ALMANA; Herring DA, 1991, NE HIST ARCHAEOL, V20, P54; Hillson S., 1992, AM J PHYS ANTHROPOL; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; KLIGMAN AM, 1961, ARCH DERMATOL, V83, P175, DOI 10.1001/archderm.1961.01580080005001; Lockwood C., 1978, SUDDENLY SAN FRANCIS; Macko SA, 1999, PHILOS T ROY SOC B, V354, P65, DOI 10.1098/rstb.1999.0360; McCue MD, 2008, RAPID COMMUN MASS SP, V22, P2307, DOI 10.1002/rcm.3615; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; MYERS RJ, 1951, ANN NY ACAD SCI, V53, P562, DOI 10.1111/j.1749-6632.1951.tb31957.x; Neuberger FM, 2013, FORENSIC SCI INT, V226, P22, DOI 10.1016/j.forsciint.2012.10.037; PECORARO V, 1964, J INVEST DERMATOL, V42, P427, DOI 10.1038/jid.1964.92; Petzke KJ, 2005, RAPID COMMUN MASS SP, V19, P1392, DOI 10.1002/rcm.1925; Preston S. H., 1991, FATAL YEARS CHILD MO; Proctor WA., 1950, LOCATION REGULATION; Rushton DH, 2002, CLIN EXP DERMATOL, V27, P400; Schoeller DA, 1999, J ARCHAEOL SCI, V26, P667, DOI 10.1006/jasc.1998.0391; SFgenealogy, GEN HIST SAN FRANC B; Shelton TV, 2008, CALIF HIST, V85, P26, DOI 10.2307/40495163; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Smith B. R., 2007, BERK PLANN J, V20, P61; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; Trotter M, 1948, AM J PHYS ANTHROP-NE, V6, P489, DOI 10.1002/ajpa.1330060417; Valkovic V, 1988, HUMAN HAIR TRACE ELE; WADA E, 1991, CRIT REV FOOD SCI, V30, P361, DOI 10.1080/10408399109527547; Williams LJ, 2011, AM J PHYS ANTHROPOL, V145, P125, DOI 10.1002/ajpa.21479	39	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184921	10.1371/journal.pone.0184921	http://dx.doi.org/10.1371/journal.pone.0184921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922420	Green Published, gold			2022-12-27	WOS:000411059300044
J	Murdock, J; Allen, C; Borner, K; Light, R; McAlister, S; Ravenscroft, A; Rose, R; Rose, D; Otsuka, J; Bourget, D; Lawrence, J; Reed, C				Murdock, Jaimie; Allen, Colin; Borner, Katy; Light, Robert; McAlister, Simon; Ravenscroft, Andrew; Rose, Robert; Rose, Doori; Otsuka, Jun; Bourget, David; Lawrence, John; Reed, Chris			Multi-level computational methods for interdisciplinary research in the HathiTrust Digital Library	PLOS ONE			English	Article							SCIENCE; LOGIC	We show how faceted search using a combination of traditional classification systems and mixed-membership topic models can go beyond keyword search to inform resource discovery, hypothesis formulation, and argument extraction for interdisciplinary research. Our test domain is the history and philosophy of scientific work on animal mind and cognition. The methods can be generalized to other research areas and ultimately support a system for semi-automatic identification of argument structures. We provide a case study for the application of the methods to the problem of identifying and extracting arguments about anthropomorphism during a critical period in the development of comparative psychology. We show how a combination of classification systems and mixed-membership models trained over large digital libraries can inform resource discovery in this domain. Through a novel approach of "drill-down" topic modeling-simultaneously reducing both the size of the corpus and the unit of analysis-we are able to reduce a large collection of fulltext volumes to a much smaller set of pages within six focal volumes containing arguments of interest to historians and philosophers of comparative psychology. The volumes identified in this way did not appear among the first ten results of the keyword search in the HathiTrust digital library and the pages bear the kind of close reading needed to generate original interpretations that is the heart of scholarly work in the humanities. Zooming back out, we provide a way to place the books onto a map of science originally constructed from very different data and for different purposes. The multilevel approach advances understanding of the intellectual and societal contexts in which writings are interpreted.	[Murdock, Jaimie; Allen, Colin; Borner, Katy; Rose, Robert; Rose, Doori] Indiana Univ, Program Cognit Sci, Bloomington, IN 47405 USA; [Murdock, Jaimie; Borner, Katy; Light, Robert] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Allen, Colin] Indiana Univ, Dept Hist & Philosophy Sci & Med, Bloomington, IN 47405 USA; [Allen, Colin] Univ Pittsburgh, Dept Hist & Philosophy Sci, Pittsburgh, PA 15260 USA; [Borner, Katy] Indiana Univ, Network Sci Inst IUNI, Bloomington, IN USA; [Borner, Katy] Univ Duisburg Essen, Dept Comp Sci & Appl Cognit Sci, User Ctr Social Media, Duisburg, Germany; [McAlister, Simon; Ravenscroft, Andrew] Univ East London, Cass Sch Educ & Communities, Int Ctr Publ Pedag ICPuP, London, England; [Rose, Robert] Indiana Univ, Dept Math, Bloomington, IN 47405 USA; [Otsuka, Jun] Kyoto Univ, Dept Philosophy, Kyoto, Japan; [Bourget, David] Univ Western Ontario, Dept Philosophy, London, ON, Canada; [Lawrence, John; Reed, Chris] Univ Dundee, Ctr Argument Technol, Dundee, Scotland	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington; University of Duisburg Essen; University of East London; Indiana University System; Indiana University Bloomington; Kyoto University; Western University (University of Western Ontario); University of Dundee	Allen, C (corresponding author), Indiana Univ, Program Cognit Sci, Bloomington, IN 47405 USA.; Allen, C (corresponding author), Indiana Univ, Dept Hist & Philosophy Sci & Med, Bloomington, IN 47405 USA.; Allen, C (corresponding author), Univ Pittsburgh, Dept Hist & Philosophy Sci, Pittsburgh, PA 15260 USA.	prof.colin.allen@gmail.com	Otsuka, Jun/L-1919-2019	Otsuka, Jun/0000-0003-4774-9740; Reed, Chris/0000-0002-6849-1374; Lawrence, John/0000-0003-1162-097X	National Endowment for Humanities (NEH) Office of Digital Humanities (ODH) Digging Into Data Challenge [HJ-50092-12]; Indiana University; HathiTrust Research Center (HTRC)	National Endowment for Humanities (NEH) Office of Digital Humanities (ODH) Digging Into Data Challenge; Indiana University; HathiTrust Research Center (HTRC)	This work was funded by the National Endowment for Humanities (NEH) Office of Digital Humanities (ODH) Digging Into Data Challenge ("Digging by Debating"; PIs Allen, Borner, Ravenscroft, McAlister, Reed, and Bourget; award no. HJ-50092-12). The authors thank the Indiana University Cognitive Science Program for continued supplemental research funding, and especially for research fellowships for Jaimie Murdock and Robert Rose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the National Endowment for Humanities (NEH) Office of Digital Humanities (ODH) Digging Into Data Challenge ("Digging by Debating"; PIs Allen, Borner, Ravenscroft, Reed, and Bourget; award no. HJ-50092-12). The authors thank the Indiana University Cognitive Science Program for continued supplemental research funding, and especially for research fellowships for Jaimie Murdock and Robert Rose. We also thank the HathiTrust Research Center (HTRC) for their support of research activities and generous access to materials.	Agirre E, 2006, TEXT SPEECH LANGUAGE, V33, P384; Allen C, 2015, STANFORD ENCY PHILOS; Allen C., 1999, SPECIES MIND PHILOS; Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Andrews K., 2016, STANFORD ENCY PHILOS; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boakes R., 1984, DARWIN BEHAV PSYCHOL; Borner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039464; Borgman C.L., 2002, ANNU REV INFORM SCI, V36, P2, DOI [10.1002/aris.1440360102, DOI 10.1002/ARIS.1440360102, 10.1002/aris.1440360102.arXiv:https://asistdl.onlinelibrary.wiley, DOI 10.1002/ARIS.1440360102.ARXIV:HTTPS://ASISTDL.ONLINELIBRARY.WILEY]; Bu┬rner K., 2010, ATLAS SCI VISUALIZIN; Capitanu B, 2015, EXTRACTED FEATURE DA, V0.2; Chaney AJ- B, 2012, ICWSM; Chang J., 2009, ADV NEURAL INFORM PR, P288, DOI DOI 10.5555/2984093.2984126; Chesnevar C, 2006, KNOWL ENG REV, V21, P293, DOI 10.1017/S0269888906001044; Christenson H, 2011, LIBR RESOUR TECH SER, V55, P93, DOI 10.5860/lrts.55n2.93; Chuang J., 2015, P 2015 C N AM CHAPT, P175, DOI DOI 10.3115/V1/N15-1018; Cocho G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121898; Conway P., 2010, P 7 INT C PRES DIG O, P95; Coyle K, 2006, J ACAD LIBR, V32, P641, DOI 10.1016/j.acalib.2006.08.002; Cronin B., 2003, New Review of Academic Librarianship, V9, P1, DOI 10.1080/13614530410001692004; de Rijcke S, 2016, RES EVALUAT, V25, P161, DOI 10.1093/reseval/rvv038; Demarest B, 2015, J ASSOC INF SCI TECH, V66, P1374, DOI 10.1002/asi.23271; DOYLE LB, 1961, J ACM, V8, P553, DOI 10.1145/321088.321095; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Feynman R., 1964, FEYNMANN LECT PHYS; Fox C., 1990, SIGIR Forum, V24, P19, DOI 10.1145/378881.378888; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; HACKING I, 1990, NEW LITERARY HIST, V21, P343, DOI 10.2307/469257; Hamilton W.L., 2016, DIACHRONIC WORD EMBE; Hamilton WL, 2016, CULTURAL SHIFT LINGU; Holmberg KV, 2014, MONOGR ORAL SCI, V24, P1, DOI [10.1159/000358776, 10.1007/s11192-014-1229-3]; Hu YN, 2014, MACH LEARN, V95, P423, DOI 10.1007/s10994-013-5413-0; KAPLAN N, 1965, AM DOC, V16, P179, DOI 10.1002/asi.5090160305; Karki R, 1996, J INFORM SCI, V22, P323, DOI 10.1177/016555159602200501; Keller E. F., 1983, FEELING ORGANISM; Kichuk D, 2015, PORTAL-LIBR ACAD, V15, P59, DOI 10.1353/pla.2015.0005; Kuhn T., 1979, ESSENTIAL TENSION SE, P3; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; LAUDAN L, 1986, SYNTHESE, V69, P141, DOI 10.1007/BF00413981; Lawrence J., 2014, P 1 WORKSH ARG MIN B, P79; Lawrence J, 2012, FRONT ARTIF INTEL AP, V245, P515, DOI 10.3233/978-1-61499-111-3-515; LIU MX, 1993, J DOC, V49, P370, DOI 10.1108/eb026920; Loper, 2009, NATURAL LANGUAGE PRO; LUHN HP, 1957, IBM J RES DEV, V1, P309, DOI 10.1147/rd.14.0309; Manning, 2008, P C EMP METH NAT LAN, P363, DOI [DOI 10.3115/1613715.1613763, DOI 10.3115/1613715]; McAlister S, 2014, BIG DATA ARGUMENT AN; Medlar A, 2017, CHIIR'17: PROCEEDINGS OF THE 2017 CONFERENCE HUMAN INFORMATION INTERACTION AND RETRIEVAL, P313, DOI 10.1145/3020165.3022141; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mihalcea R, 2010, WORD SENSE DISAMBIGU, P1027; Moretti, 2013, DISTANT READING; Murdock J, 2015, P 29 AAAI C AAAI 15; Murdock J, 2017, COGNITION, V159, P117, DOI 10.1016/j.cognition.2016.11.012; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Odlyzko A, 2002, LEARN PUBL, V15, P7, DOI 10.1087/095315102753303634; Pilkington R., 2016, DISCOURSE DIALOGUE T; Pilkington R.M., 2000, INT J ARTIFICIAL INT, V11, P273; Reed C, 2007, KNOWL ENG REV, V22, P87, DOI 10.1017/S0269888907001051; Reid CR, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0030; Rockwell G, 2016, HERMENEUTICA; Steinle F, 1997, PHILOS SCI, V64, pS65, DOI 10.1086/392587; Tangherlini TR, 2013, POETICS, V41, P725, DOI 10.1016/j.poetic.2013.08.002; Underwood T, 2014, REPRESENTATIONS, P64, DOI 10.1525/rep.2014.127.5.64; Vincent L, 2007, PROC INT CONF DOC, P819; Washburn DA, 2010, PSYCHOL REC, P60; Washburn M.F., 1908, ANIMAL MIND TXB COMP; Waters CK, 2007, HIST PHIL LIFE SCI, V29, P275; Weingart SB, 2015, ERKENNTNIS, V80, P201, DOI 10.1007/s10670-014-9621-1; Xing Wei, 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P178; York J., 2009, ARCHIVING C, P5; Yuan TM, 2011, KNOWL ENG REV, V26, P159, DOI 10.1017/S026988891100004X; Zeng J., 2014, P 5 ACM WORKSH SCI C, P9, DOI [DOI 10.1145/2608029.2608031, 10.1145/2608029.2608031]	73	3	3	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184188	10.1371/journal.pone.0184188	http://dx.doi.org/10.1371/journal.pone.0184188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922416	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300012
J	Perry, T; Laffin, M; Fedorak, RN; Thiesen, A; Dicken, B; Madsen, KL				Perry, Troy; Laffin, Michael; Fedorak, Richard N.; Thiesen, Aducio; Dicken, Bryan; Madsen, Karen L.			Ileocolic resection is associated with increased susceptibility to injury in a murine model of colitis	PLOS ONE			English	Article							DENDRITIC CELLS; NATURAL-HISTORY; CROHNS-DISEASE; MACROPHAGES; MICROBIOTA; SUBSETS	Ileocolic resection (ICR) is the most common intestinal resection performed for Crohn's disease, with recurrences commonly occurring at the site of the anastomosis. This study used an animal model of ICR in wild-type mice to examine immunologic changes that developed around the surgical anastomosis and how these changes impacted gut responses to minor acute injury. ICR was performed in adult 129S1/SvlmJ mice and results compared with mice receiving sham or no surgery. Dextran sodium sulfate was given either on post-operative day 9 or day 24 to evaluate immune responses in the intestine both immediately following surgery and after a period of healing. Fecal occult blood measurements and animal weights were taken daily. Cytokine levels were measured in ileal and colonic tissue. Bacterial load in the neo-terminal ileum was measured using qPCR. Immune cell populations in the intestinal tissue, mesenteric lymph nodes, and spleen were assessed using flow cytometry. Cytokine secretion in response to microbial products was measured in isolated mesenteric lymph nodes and spleen cells. ICR resulted in an initial elevation of inflammatory markers in the terminal ileum and colon followed by enhanced levels of bacterial growth in the neo-terminal ileum. Intestinal surgical resection resulted in the recruitment of innate immune cells into the colon that exhibited a non-responsiveness to microbial stimuli. DSS colitis phenotype was more severe in the ileocolic resection groups and this was associated with local and systemic immunosuppression as evidenced by a reduced cytokine responses to microbial stimuli. This study reveals the development of an immune non-responsiveness to microbial products following ileocolic resection that is associated with enhanced levels of bacterial growth in the neo-terminal ileum. These surgical-induced altered immune-microbial interactions in the intestine may contribute to disease recurrence at the surgical anastomosis site following ileocolic resections in patients with Crohn's disease.	[Perry, Troy; Laffin, Michael; Dicken, Bryan] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Fedorak, Richard N.; Madsen, Karen L.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Fedorak, Richard N.; Madsen, Karen L.] Univ Alberta, CEGIIR, Edmonton, AB, Canada; [Thiesen, Aducio] Univ Alberta, Dept Lab Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Madsen, KL (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.; Madsen, KL (corresponding author), Univ Alberta, CEGIIR, Edmonton, AB, Canada.	karen.madsen@ualberta.ca	Madsen, Karen L/H-5898-2011	Laffin, Michael/0000-0003-4933-2789	Canadian Institutes for Health Research; Alberta Innovates; Alberta IBD Consortium; Canadian Surgical Research Fund; Edmonton Civic Employees Research Assistance Fund; Alberta Innovates Technology; Innovates Centre of Research Excellence (iCORE)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates; Alberta IBD Consortium; Canadian Surgical Research Fund; Edmonton Civic Employees Research Assistance Fund; Alberta Innovates Technology; Innovates Centre of Research Excellence (iCORE)	This study was financially supported by the Canadian Institutes for Health Research; Alberta Innovates; Alberta IBD Consortium; Canadian Surgical Research Fund; the Edmonton Civic Employees Research Assistance Fund; Alberta Innovates Technology; and the Innovates Centre of Research Excellence (iCORE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buisson A, 2012, ALIMENT PHARM THER, V35, P625, DOI 10.1111/j.1365-2036.2012.05002.x; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; De Cruz P, 2015, J GASTROEN HEPATOL, V30, P268, DOI 10.1111/jgh.12694; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Goldfarb Y, 2011, ANN SURG, V253, P798, DOI 10.1097/SLA.0b013e318211d7b5; Horowitz M, 2015, NAT REV CLIN ONCOL, V12, P213, DOI 10.1038/nrclinonc.2014.224; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kish L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062220; Koleva PT, 2012, BRIT J NUTR, V108, P1633, DOI 10.1017/S0007114511007203; Kuhn KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114195; Marik PE, 2012, J TRAUMA ACUTE CARE, V73, P801, DOI 10.1097/TA.0b013e318265cf87; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; Perry T, 2014, JOVE-J VIS EXP, DOI 10.3791/52106; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Sakuraba A, 2009, GASTROENTEROLOGY, V137, P1736, DOI 10.1053/j.gastro.2009.07.049; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; van der Bij GJ, 2009, ANN SURG, V249, P727, DOI 10.1097/SLA.0b013e3181a3ddbd; Weisser SB, 2011, J LEUKOCYTE BIOL, V90, P483, DOI 10.1189/jlb.0311124	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184660	10.1371/journal.pone.0184660	http://dx.doi.org/10.1371/journal.pone.0184660			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922370	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300021
J	Bockerman, P; Bryson, A; Viinikainen, J; Hakulinen, C; Hintsanen, M; Pehkonen, J; Viikari, J; Raitakari, O				Bockerman, Petri; Bryson, Alex; Viinikainen, Jutta; Hakulinen, Christian; Hintsanen, Mirka; Pehkonen, Jaakko; Viikari, Jorma; Raitakari, Olli			The biometric antecedents to happiness	PLOS ONE			English	Article							CARDIOVASCULAR RISK; YOUNG FINNS; PHYSICAL-ACTIVITY; HEALTH; LIFE; YOUTH; HYPERTENSION; PERSONALITY; ADULTHOOD; CHILDREN	It has been suggested that biological markers are associated with human happiness. We contribute to the empirical literature by examining the independent association between various aspects of biometric wellbeing measured in childhood and happiness in adulthood. Using Young Finns Study data (n = 1905) and nationally representative linked data we examine whether eight biomarkers measured in childhood (1980) are associated with happiness in adulthood (2001). Using linked data we account for a very rich set of confounders including age, sex, body size, family background, nutritional intake, physical activity, income, education and labour market experiences. We find that there is a negative relationship between triglycerides and subjective well-being but it is both gender-and age-specific and the relationship does not prevail using the later measurements (1983/1986) on triglycerides. In summary, we conclude that none of the eight biomarkers measured in childhood predict happiness robustly in adulthood.	[Bockerman, Petri] Turku Sch Econ & Business Adm, Turku, Finland; [Bockerman, Petri] Labour Inst Econ Res, Helsinki, Finland; [Bockerman, Petri; Bryson, Alex] IZA, Bonn, Germany; [Bryson, Alex] UCL, Dept Social Sci, London, England; [Bryson, Alex] NIESR, London, England; [Viinikainen, Jutta; Pehkonen, Jaakko] Jyvaskyla Univ, Sch Business & Econ, Jyvaskyla, Finland; [Hakulinen, Christian] Univ Helsinki, Dept Psychol & Logoped, Fac Med, Helsinki, Finland; [Hintsanen, Mirka] Univ Oulu, Unit Psychol, Oulu, Finland; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Viikari, Jorma] Turku Univ Hosp, Div Med, Turku, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Pehkonen, Jaakko] Univ Jyvaskyla, Jyvaskyla, Finland	University of Turku; IZA Institute Labor Economics; University of London; University College London; University of Jyvaskyla; University of Helsinki; University of Oulu; University of Turku; University of Turku; University of Turku; University of Turku; University of Jyvaskyla	Bockerman, P (corresponding author), Turku Sch Econ & Business Adm, Turku, Finland.; Bockerman, P (corresponding author), Labour Inst Econ Res, Helsinki, Finland.; Bockerman, P (corresponding author), IZA, Bonn, Germany.	petri.bockerman@labour.fi; jakko.k.pehkonen@jyu.fi	Raitakari, Olli/AAQ-7389-2021; Hintsanen, Mirka/B-6012-2008; Böckerman, Petri/M-4969-2013	Hintsanen, Mirka/0000-0003-2673-0901; Böckerman, Petri/0000-0002-5372-2985; Pehkonen, Jaakko/0000-0002-9684-7139; Viinikainen, Jutta/0000-0002-4252-3147; Hakulinen, Christian/0000-0001-8629-9960	Academy of Finland [286284, 134309, 126925, 121584, 124282, 129378, 117787, 41071]; Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals [X51001]; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; Strategic Research Council [293120]; Yrjb Jahnsson Foundation [6664, 6646]; OP Group Research Foundation	Academy of Finland(Academy of Finland); Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; Strategic Research Council; Yrjb Jahnsson Foundation; OP Group Research Foundation	The Young Finns Study has been financially supported by the Academy of Finland: grants 286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skid); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (grant X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; and Diabetes Research Foundation of Finnish Diabetes Association. The Palkansaaja Foundation supported the use of linked data. Bockerman thanks the Strategic Research Council funding for the project Work, Inequality and Public Policy (293120). Jutta Viinikainen appreciates financial support from the Yrjb Jahnsson Foundation (grant 6664) and OP Group Research Foundation. Jaakko Pehkonen acknowledges financial support from the Yrjb Jahnsson Foundation (grant 6646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M. D., 2015, 1366 CEP; Barak Y, 2006, AUTOIMMUN REV, V5, P523, DOI 10.1016/j.autrev.2006.02.010; Blanchflower D. G., 2011, INTRO STRUCTUR UNPUB; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; Blanchflower DG, 2008, J HEALTH ECON, V27, P218, DOI 10.1016/j.jhealeco.2007.06.002; Blanchflower DG, 2013, SOC INDIC RES, V114, P785, DOI 10.1007/s11205-012-0173-y; Bockerman P, 2017, J ECON BEHAV ORGAN, V142, P259, DOI 10.1016/j.jebo.2017.08.003; Bockerman P, 2014, J HAPPINESS STUD, V15, P857, DOI 10.1007/s10902-013-9453-8; Bockerman P, 2012, ILR REV, V65, P244, DOI 10.1177/001979391206500203; Bryson A, 2011, HLTH SURVEY ENGLAND, pThe Health and Social Care Information Centre; Bryson A, 2017, HUM RELAT, V70, P1017, DOI 10.1177/0018726717693073; Bryson A, 2017, ECON J, V127, P106, DOI 10.1111/ecoj.12269; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Clark AE, 2017, PSE WORKING PAPERS; De Neve JE, 2012, J NEUROSCI PSYCHOL E, V5, P193, DOI 10.1037/a0030292; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; Delanghe JR, 2011, CLIN KIDNEY J, V4, P83, DOI 10.1093/ndtplus/sfq211; Doraiswamy PM, 2015, SPIRITUAL CLIN PRACT, V2, P18, DOI 10.1037/scp0000061; Eriksen TLM, 2014, J HUM RESOUR, V49, P839; Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1; Hills P, 1998, PERS INDIV DIFFER, V25, P523, DOI 10.1016/S0191-8869(98)00082-8; Hintsanen M, 2009, J RES PERS, V43, P618, DOI 10.1016/j.jrp.2009.03.013; Juonala M, 2005, CIRCULATION, V112, P1486, DOI 10.1161/CIRCULATIONAHA.104.502161; Kapteyn A, 2015, SOC INDIC RES, V123, P625, DOI 10.1007/s11205-014-0753-0; Katsaiti MS, 2012, APPL ECON, V44, P4101, DOI 10.1080/00036846.2011.587779; Mojon-Azzi S, 2011, APPL ECON LETT, V18, P183, DOI 10.1080/13504850903508291; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Nouri R, 2015, DO HAPPINESS OPTIMIS; Oswald AJ, 2007, ECON J, V117, pF441, DOI 10.1111/j.1468-0297.2007.02077_1.x; Oswald AJ, 2015, J LABOR ECON, V33, P789, DOI 10.1086/681096; Oswald AJ, 2011, REV ECON STAT, V93, P1118, DOI 10.1162/REST_a_00133; Persico N, 2004, J POLIT ECON, V112, P1019, DOI 10.1086/422566; Porkka KVK, 1997, AM J EPIDEMIOL, V146, P64, DOI 10.1093/oxfordjournals.aje.a009192; Pulkki-Raback L, 2015, CIRCULATION, V131, P245, DOI 10.1161/CIRCULATIONAHA.113.007104; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Raitakari OT, 1997, MED SCI SPORT EXER, V29, P1055, DOI 10.1097/00005768-199708000-00011; Rouch I, 2014, J NUTR HEALTH AGING, V18, P840, DOI [10.1007/s12603-014-0488-2, 10.1007/s12603-014-0557-6]; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Steel P, 2008, PSYCHOL BULL, V134, P138, DOI 10.1037/0033-2909.134.1.138; Steptoe A, 2012, PSYCHOSOM MED, V74, P501, DOI 10.1097/PSY.0b013e31824f82c8; Steptoe A, 2011, SOC COGN AFFECT NEUR, V6, P226, DOI 10.1093/scan/nsq032; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Takahara M, 2014, REV ENDOCR METAB DIS, V15, P317, DOI 10.1007/s11154-014-9294-8	43	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184887	10.1371/journal.pone.0184887	http://dx.doi.org/10.1371/journal.pone.0184887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0WP	28915269	Green Published, gold			2022-12-27	WOS:000410861600021
J	Quan, C; Li, CY; Xue, JG; Yue, JW; Zhang, CG				Quan, Cheng; Li, Chunyong; Xue, Jiguo; Yue, Jingwei; Zhang, Chenggang			Mirror-normal difference in the late phase of mental rotation: An ERP study	PLOS ONE			English	Article							MIRROR/NORMAL LETTER DISCRIMINATIONS; EVENT-RELATED POTENTIALS; BRAIN-POTENTIALS; TIME; NEGATIVITY; ACTIVATION; TASK	Mirror-normal letter discriminations are thought to require mental rotation in order to transform the rotated alphanumeric character into its canonical orientation. Moreover, out-of-plane rotation is likely to occur after in-plane rotation to fully normalize the mirror version before the final mirror-normal judgment. The so-called rotation-related negativity, which varies with orientation, is found in both ERPonset (averaged with respect to stimulus onset) and ERPRT (averaged with respect to response time), representing the involvement of mental rotation in both time windows. Additionally, the mean amplitude of ERPRT correlates with individual performance. We performed a comprehensive analysis of the mirror-normal differences in the early and late phases of mental rotation and deduced that out-of-plane rotation is more likely to occur in the late phase and interacts with both in-plane rotation and the decision- making process, as indicated by both behavioral and electrophysiological findings.	[Quan, Cheng; Li, Chunyong; Xue, Jiguo; Yue, Jingwei; Zhang, Chenggang] Beijing Inst Radiat Med, State Key Lab Prote, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Yue, JW; Zhang, CG (corresponding author), Beijing Inst Radiat Med, State Key Lab Prote, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China.	jwyuecn@gmail.com; zhangcg@bmi.ac.cn	Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304; Quan, Cheng/0000-0003-1859-9683				Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Chen J, 2014, J NERV MENT DIS, V202, P594, DOI 10.1097/NMD.0000000000000167; Cooper L.A., 1973, VISUAL INFORM PROCES, P75, DOI [10.1016/B978-0-12-170150-5.50009-3, DOI 10.1016/B978-0-12-170150-5.50009-3]; COOPER LA, 1976, PERCEPT PSYCHOPHYS, V19, P296, DOI 10.3758/BF03204234; CORBALLIS MC, 1978, CAN J PSYCHOL, V32, P186, DOI 10.1037/h0081685; Dalecki M, 2012, HUM MOVEMENT SCI, V31, P1151, DOI 10.1016/j.humov.2011.12.001; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DITUNNO PL, 1990, CORTEX, V26, P177, DOI 10.1016/S0010-9452(13)80349-8; Hamm JP, 2004, NEUROPSYCHOLOGIA, V42, P810, DOI 10.1016/j.neuropsychologia.2003.11.009; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; Heil M, 1997, J EXP PSYCHOL HUMAN, V23, P681, DOI 10.1037/0096-1523.23.3.681; Heil M, 1996, J PSYCHOPHYSIOL, V10, P326; Heil M, 1998, ACTA PSYCHOL, V99, P217, DOI 10.1016/S0001-6918(98)00012-2; Hoffler TN, 2010, EDUC PSYCHOL REV, V22, P245, DOI 10.1007/s10648-010-9126-7; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KORIAT A, 1985, PERCEPT PSYCHOPHYS, V37, P429, DOI 10.3758/BF03202874; Kung E, 2010, MEM COGNITION, V38, P206, DOI 10.3758/MC.38.2.206; Ma QG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154479; Masaki H, 2004, PSYCHOPHYSIOLOGY, V41, P220, DOI 10.1111/j.1469-8986.2004.00150.x; MCCLELLAND JL, 1979, PSYCHOL REV, V86, P287, DOI 10.1037/0033-295X.86.4.287; Milivojevic B, 2011, NEUROPSYCHOLOGIA, V49, P3758, DOI 10.1016/j.neuropsychologia.2011.09.034; Milivojevic B, 2009, NEUROREPORT, V20, P1507, DOI 10.1097/WNR.0b013e32832ea6fd; Milivojevic B, 2009, J COGNITIVE NEUROSCI, V21, P945, DOI 10.1162/jocn.2009.21085; Mullen T, 2013, 35 ANN INT C IEEE EN; Nunez-Pena MI, 2009, BRAIN COGNITION, V69, P180, DOI 10.1016/j.bandc.2008.07.003; Paschke K, 2012, NEUROPSYCHOLOGIA, V50, P1844, DOI 10.1016/j.neuropsychologia.2012.04.010; PERONNET F, 1989, BRAIN COGNITION, V9, P279, DOI 10.1016/0278-2626(89)90037-7; Picton T., 1990, J CLIN NEUROPHYSIOL, V7, P450; Provost A, 2015, PSYCHOL REV, V122, P735, DOI 10.1037/a0039706; Riecansky I, 2008, NEUROPSYCHOLOGIA, V46, P3069, DOI 10.1016/j.neuropsychologia.2008.06.016; Riecansky I, 2013, BRAIN COGNITION, V83, P163, DOI 10.1016/j.bandc.2013.07.011; Riecansky I, 2010, NEUROSCI LETT, V482, P133, DOI 10.1016/j.neulet.2010.07.017; Roberts JE, 2003, INT J PSYCHOPHYSIOL, V50, P235, DOI 10.1016/S0167-8760(03)00195-8; Searle JA, 2016, MEM COGNITION, V44, P124, DOI 10.3758/s13421-015-0540-4; Searle JA, 2012, MEM COGNITION, V40, P594, DOI 10.3758/s13421-011-0172-2; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; STUSS DT, 1983, ELECTROEN CLIN NEURO, V56, P133, DOI 10.1016/0013-4694(83)90068-8; ter Horst AC, 2012, PSYCHOPHYSIOLOGY, V49, P566, DOI 10.1111/j.1469-8986.2011.01322.x; Tomasino B, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00693; Viarouge A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095756; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P452, DOI 10.1111/j.1469-8986.1989.tb01951.x; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	44	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184963	10.1371/journal.pone.0184963	http://dx.doi.org/10.1371/journal.pone.0184963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0WP	28915254	Green Submitted, Green Published, gold			2022-12-27	WOS:000410861600023
J	Buffet, C; Hecale-Perlemoine, K; Bricaire, L; Dumont, F; Baudry, C; Tissier, F; Bertherat, J; Cochand-Priollet, B; Raffin-Sanson, ML; Cormier, F; Groussin, L				Buffet, Camille; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Dumont, Florent; Baudry, Camille; Tissier, Frederique; Bertherat, Jerome; Cochand-Priollet, Beatrix; Raffin-Sanson, Marie-Laure; Cormier, Francoise; Groussin, Lionel			DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers	PLOS ONE			English	Article							FEEDBACK INHIBITION; CARCINOMA CELLS; BIOLOGICAL CHARACTERIZATION; THERAPEUTIC IMPLICATIONS; KINASE PHOSPHATASES; PCCL3 CELLS; PAPILLARY; EXPRESSION; THYROTROPIN; APOPTOSIS	Background Molecular alterations of the MAPK pathway are frequently observed in papillary thyroid carcinomas (PTCs). It leads to a constitutive activation of the signalling pathway through an increase in MEK and ERK phosphorylation. ERK is negatively feedback-regulated by Dual Specificity Phosphatases (DUSPs), especially two ERK-specific DUSPs, DUSP5 (nuclear) and DUSP6 (cytosolic). These negative MAPK regulators may play a role in thyroid carcinogenesis. Methods MAPK pathway activation was analyzed in 11 human thyroid cancer cell lines. Both phosphatases were studied in three PCCL3 rat thyroid cell lines that express doxycycline inducible PTC oncogenes (RET/PTC3, H-RAS (V12) or BRAF (V600E)). Expression levels of DUSP5 and DUSP6 were quantified in 39 human PTCs. The functional role of DUSP5 and DUSP6 was investigated through their silencing in two human BRAF (V600E) carcinoma cell lines. Results BRAF (V600E) human thyroid cancer cell lines expressed higher phospho-MEK levels but not higher phospho-ERK levels. DUSP5 and DUSP6 are specifically induced by the MEK-ERK pathway in the three PTC oncogenes inducible thyroid cell lines. This negative feedback loop explains the tight regulation of p-ERK levels. DUSP5 and DUSP6 mRNA are overexpressed in human PTCs, especially in BRAF (V600E) mutated PTCs. DUSP5 and/or DUSP6 siRNA inactivation did not affect proliferation in two BRAF (V600E) mutated cell lines, which may be explained by a compensatory increase in other phosphatases. In the light of this, we observed a marked DUSP6 upregulation upon DUSP5 inactivation. Despite this, DUSP5 and DUSP6 positively control cell migration and invasion. Conclusions Our results are in favor of a stronger activation of the MAPK pathway in BRAF(V600E) PTCs. DUSP5 and DUSP6 have pro-tumorigenic properties in two BRAF (V600E) PTC cell line models.	[Buffet, Camille; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Dumont, Florent; Baudry, Camille; Tissier, Frederique; Bertherat, Jerome; Cormier, Francoise; Groussin, Lionel] INSERM, Inst Cochin, U1016, Paris, France; [Buffet, Camille; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Dumont, Florent; Baudry, Camille; Tissier, Frederique; Bertherat, Jerome; Cormier, Francoise; Groussin, Lionel] CNRS, UMR8104, Paris, France; [Buffet, Camille; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Dumont, Florent; Baudry, Camille; Tissier, Frederique; Bertherat, Jerome; Cormier, Francoise; Groussin, Lionel] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Tissier, Frederique] Hop La Pitie Salpetriere, Dept Pathol, Paris, France; [Bertherat, Jerome; Groussin, Lionel] Cochin Hosp, Dept Endocrinol, Paris, France; [Cochand-Priollet, Beatrix] Cochin Hosp, Dept Pathol, Paris, France; [Raffin-Sanson, Marie-Laure] Ambroise Pare Hop, Dept Endocrinol, Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Buffet, C (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.; Buffet, C (corresponding author), CNRS, UMR8104, Paris, France.; Buffet, C (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	camille.buffet@aphp.fr		BERTHERAT, Jerome/0000-0003-2551-3008; Groussin, Lionel/0000-0003-1476-475X; Cormier, Francoise/0000-0002-6904-5122	American Thyroid Association [ATA R06059KK]; French Fondation ARC pour la Recherche contre le Cancer; French National Academy of Medicine; Ile de France Regional Health Agency	American Thyroid Association; French Fondation ARC pour la Recherche contre le Cancer; French National Academy of Medicine; Ile de France Regional Health Agency	This work was supported by the American Thyroid Association [ATA R06059KK], a predoctoral fellowship from the French Fondation ARC pour la Recherche contre le Cancer, the French National Academy of Medicine and a predoctoral and doctoral fellowship from the Ile de France Regional Health Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Bellou S, 2009, AM J PHYSIOL-CELL PH, V297, pC1477, DOI 10.1152/ajpcell.00058.2009; Bluthgen N, 2009, FEBS J, V276, P1024, DOI 10.1111/j.1742-4658.2008.06846.x; Buffet C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145484; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chung SH, 2002, JPN J CANCER RES, V93, P1358, DOI 10.1111/j.1349-7006.2002.tb01245.x; Degl'Innocenti D, 2013, ENDOCR-RELAT CANCER, V20, P23, DOI 10.1530/ERC-12-0078; Dultz LA, 2013, SURGERY, V154, P1239, DOI 10.1016/j.surg.2013.06.024; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; GIOANNI J, 1991, B CANCER, V78, P1053; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Gustavsson B, 1996, MOL CELL ENDOCRINOL, V121, P143, DOI 10.1016/0303-7207(96)03859-2; HELDIN NE, 1991, ENDOCRINOLOGY, V129, P2187, DOI 10.1210/endo-129-4-2187; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Karlsson M, 2004, J BIOL CHEM, V279, P41882, DOI 10.1074/jbc.M406720200; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Kurebayashi J, 2000, J CLIN ENDOCR METAB, V85, P2889, DOI 10.1210/jc.85.8.2889; Lee JJ, 2007, THYROID, V17, P289, DOI 10.1089/thy.2006.0246; Lee JU, 2012, EUR J ENDOCRINOL, V167, P93, DOI 10.1530/EJE-12-0010; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Mitsiades CS, 2007, MOL CANCER THER, V6, P1070, DOI 10.1158/1535-7163.MCT-06-0449; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Nunes-Xavier C, 2011, ANTI-CANCER AGENT ME, V11, P109, DOI 10.2174/187152011794941190; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Ricarte JC, 2013, J CLIN INVEST, V123, P4935, DOI 10.1172/JCI69766; Rushworth LK, 2014, P NATL ACAD SCI USA, V111, P18267, DOI 10.1073/pnas.1420159112; Salerno P, 2010, J CLIN ENDOCR METAB, V95, P450, DOI 10.1210/jc.2009-0373; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shin SH, 2013, AM J PATHOL, V182, P1275, DOI 10.1016/j.ajpath.2013.01.004; Shirokawa JM, 2000, MOL ENDOCRINOL, V14, P1725, DOI 10.1210/me.14.11.1725; TANAKA J, 1987, VIROLOGY, V161, P62, DOI 10.1016/0042-6822(87)90171-1; Wang JW, 2003, MOL ENDOCRINOL, V17, P1425, DOI 10.1210/me.2003-0041; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xu XL, 2003, CANCER RES, V63, P4561; Yano Y, 2007, ONCOL REP, V18, P441; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Zeliadt NA, 2008, TOXICOL APPL PHARM, V232, P408, DOI 10.1016/j.taap.2008.08.007; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zuo H, 2007, PATHOL INT, V57, P12, DOI 10.1111/j.1440-1827.2007.02050.x	44	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184861	10.1371/journal.pone.0184861	http://dx.doi.org/10.1371/journal.pone.0184861			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910386	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200110
J	Li, ZH; Kuhn, G; Schirmer, M; Muller, R; Ruffoni, D				Li, Zihui; Kuhn, Gisela; Schirmer, Michael; Mueller, Ralph; Ruffoni, Davide			Impaired bone formation in ovariectomized mice reduces implant integration as indicated by longitudinal in vivo micro-computed tomography	PLOS ONE			English	Article							TRABECULAR BONE; CAUDAL VERTEBRAE; CORTICAL BONE; MECHANICAL STIMULATION; POSTMENOPAUSAL WOMEN; ESTROGEN DEFICIENCY; OSTEOPOROTIC BONE; CANCELLOUS BONE; TAIL VERTEBRAE; TITANIUM-ALLOY	Although osteoporotic bone, with low bone mass and deteriorated bone architecture, provides a less favorable mechanical environment than healthy bone for implant fixation, there is no general agreement on the impact of osteoporosis on peri-implant bone (re) modeling, which is ultimately responsible for the long term stability of the bone-implant system. Here, we inserted an implant in a mouse model mimicking estrogen deficiency-induced bone loss and we monitored with longitudinal in vivo micro-computed tomography the spatio-temporal changes in bone (re) modeling and architecture, considering the separate contributions of trabecular, endocortical and periosteal surfaces. Specifically, 12 week-old C57BL/6J mice underwent OVX/SHM surgery; 9 weeks after we inserted special metal-ceramics implants into the 6th caudal vertebra and we measured bone response with in vivo micro-CT weekly for the following 6 weeks. Our results indicated that ovariectomized mice showed a reduced ability to increase the thickness of the cortical shell close to the implant because of impaired peri-implant bone formation, especially at the periosteal surface. Moreover, we observed that healthy mice had a significantly higher loss of trabecular bone far from the implant than estrogen depleted animals. Such behavior suggests that, in healthy mice, the substantial increase in peri-implant bone formation which rapidly thickened the cortex to secure the implant may raise bone resorption elsewhere and, specifically, in the trabecular network of the same bone but far from the implant. Considering the already deteriorated bone structure of estrogen depleted mice, further bone loss seemed to be hindered. The obtained knowledge on the dynamic response of diseased bone following implant insertion should provide useful guidelines to develop advanced treatments for osteoporotic fracture fixation based on local and selective manipulation of bone turnover in the peri-implant region.	[Li, Zihui; Kuhn, Gisela; Mueller, Ralph; Ruffoni, Davide] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Schirmer, Michael] Pfm Med Titanium Gmbh, Nurnberg, Germany; [Ruffoni, Davide] Univ Liege, Dept Aerosp & Mech Engn, Mech Biol & Bioinspired Mat Res Unit, Liege, Belgium	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Liege	Ruffoni, D (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.; Ruffoni, D (corresponding author), Univ Liege, Dept Aerosp & Mech Engn, Mech Biol & Bioinspired Mat Res Unit, Liege, Belgium.	druffoni@ulg.ac.be	Ruffoni, Davide/GQP-0042-2022; Müller, Ralph/A-1198-2008	Müller, Ralph/0000-0002-5811-7725; Ruffoni, Davide/0000-0003-3714-7594; LI, ZIHUI/0000-0002-8506-7356	Chinese Scholarship Council; DR of the European Calcified Tissue Society	Chinese Scholarship Council(China Scholarship Council); DR of the European Calcified Tissue Society	ZL acknowledges support of the Chinese Scholarship Council and DR of the European Calcified Tissue Society Postdoctoral Fellowship 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman AR, 2015, BONE, V81, P370, DOI 10.1016/j.bone.2015.07.037; Basler SE, 2013, MED ENG PHYS, V35, P1442, DOI 10.1016/j.medengphy.2013.03.016; Birkhold AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep23480; Birkhold AI, 2014, BONE, V66, P15, DOI 10.1016/j.bone.2014.05.013; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brouwers JEM, 2007, J ORTHOP RES, V25, P1325, DOI 10.1002/jor.20439; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6; Chatterjee M, 2015, OSTEOPOROSIS INT, V26, P281, DOI 10.1007/s00198-014-2824-0; Cheung WH, 2016, INJURY, V47, pS21, DOI 10.1016/S0020-1383(16)47004-X; CHOW JWM, 1993, AM J PHYSIOL, V265, pE340, DOI 10.1152/ajpendo.1993.265.2.E340; Farr JN, 2015, NAT REV ENDOCRINOL, V11, P513, DOI 10.1038/nrendo.2015.89; Fini M, 1997, INT J ARTIF ORGANS, V20, P291, DOI 10.1177/039139889702000510; Fini M, 2002, INT J ORAL MAX IMPL, V17, P28; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Funk JF, 2009, CLIN ORTHOP RELAT R, V467, P3199, DOI 10.1007/s11999-009-0902-y; Gabet Y, 2010, J BONE MINER RES, V25, P575, DOI 10.1359/jbmr.090808; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Goldhahn J, 2008, OSTEOPOROSIS INT, V19, P761, DOI 10.1007/s00198-007-0515-9; Heaney RP, 2003, OSTEOPOROSIS INT, V14, pS12, DOI 10.1007/s00198-003-1466-4; Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001; Irish J, 2013, J ORTHOP RES, V31, P800, DOI 10.1002/jor.22294; Jariwala SH, 2016, J ORTHOP RES; Jenny G, 2016, J BIOMED MATER RES A, V104, P2898, DOI 10.1002/jbm.a.35805; Kettenberger U, 2014, BIOMATERIALS, V35, P9995, DOI 10.1016/j.biomaterials.2014.09.005; Kohler T, 2007, BONE, V41, P659, DOI 10.1016/j.bone.2007.05.018; Kurth AHA, 2005, BONE, V37, P204, DOI 10.1016/j.bone.2004.12.017; Lambers F, 2011, FUNCTIONAL BONE IMAG; Lambers FM, 2015, J BIOMECH, V48, P1179, DOI 10.1016/j.jbiomech.2014.11.020; Lambers FM, 2013, BONE, V55, P325, DOI 10.1016/j.bone.2013.04.016; Lambers FM, 2012, CALCIFIED TISSUE INT, V90, P108, DOI 10.1007/s00223-011-9553-6; Lambers FM, 2011, BONE, V49, P1340, DOI 10.1016/j.bone.2011.08.035; Li ZH, 2015, BONE, V81, P468, DOI 10.1016/j.bone.2015.08.017; Lu YT, 2016, J BIOMECH, V49, P2095, DOI 10.1016/j.jbiomech.2016.05.022; Lukas C, 2013, BONE, V56, P55, DOI 10.1016/j.bone.2013.05.005; Marco F, 2005, MICRON, V36, P630, DOI 10.1016/j.micron.2005.07.008; Marquezan M, 2012, CLIN ORAL IMPLAN RES, V23, P767, DOI 10.1111/j.1600-0501.2011.02228.x; MUELLER M, 1991, J BONE MINER RES, V6, P401; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; Ozawa S, 2002, BONE, V30, P137, DOI 10.1016/S8756-3282(01)00646-9; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Recker R, 2004, J BONE MINER RES, V19, P1628, DOI 10.1359/JBMR.040710; Rocca M, 2002, BIOMATERIALS, V23, P1017, DOI 10.1016/S0142-9612(01)00213-7; Ruffoni D, 2012, BIOMECH MODEL MECHAN, V11, P313, DOI 10.1007/s10237-011-0312-4; Ruffoni D, 2012, BONE, V50, P733, DOI 10.1016/j.bone.2011.11.027; Ruffoni D, 2008, J BONE MINER RES, V23, P1905, DOI 10.1359/JBMR.080711; Schulte FA, 2014, COMPUT METHOD BIOMEC, V17, P539, DOI 10.1080/10255842.2012.699526; Schulte FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062172; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Szulc P, 2006, J BONE MINER RES, V21, P1856, DOI 10.1359/JBMR.060904; Tarantino U, 2011, AGING CLIN EXP RES, V23, P62; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Verdelis K, 2011, BONE, V49, P580, DOI 10.1016/j.bone.2011.05.013; Vidigal GM, 2009, CLIN ORAL IMPLAN RES, V20, P1272, DOI 10.1111/j.1600-0501.2009.01739.x; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089343; Webster D, 2010, BIOMECH MODEL MECHAN, V9, P737, DOI 10.1007/s10237-010-0210-1; Webster DJ, 2008, COMPUT METHOD BIOMEC, V11, P435, DOI 10.1080/10255840802078014; Weigt C., 2013, INTERACTION MECH LOA; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Yamazaki M, 1999, ORAL SURG ORAL MED O, V87, P411, DOI 10.1016/S1079-2104(99)70239-8	61	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184835	10.1371/journal.pone.0184835	http://dx.doi.org/10.1371/journal.pone.0184835			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910363	Green Published, gold			2022-12-27	WOS:000410859200103
J	Mezmur, M; Navaneetham, K; Letamo, G; Bariagaber, H				Mezmur, Markos; Navaneetham, Kannan; Letamo, Gobopamang; Bariagaber, Hadgu			Individual, household and contextual factors associated with skilled delivery care in Ethiopia: Evidence from Ethiopian demographic and health surveys	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; SERVICES	Despite evidence that social contexts are key determinants of health, research into factors associated with maternal health service utilization in Ethiopia has often focused on individual and household factors. The downside is that this underestimates the importance of taking contextual factors into account when planning appropriate interventions in promoting safe motherhood in the country. The purpose of this study is to fill this knowledge gap drawing attention to the largely unexplored contextual factors affecting the uptake of skilled attendance at delivery in a nationally representative sample. Data for the study comes from two rounds of the Ethiopian Demographic and Health Surveys (EDHS) conducted in the year 2005 and 2011. Analysis was done using a two-level multivariable multilevel logistic regression model with data from 14, 242 women who had a live birth in the five years preceding the surveys clustered within 540 (in the year 2005) and 624 (in the year 2011) communities. The results of the study point to multiple levels of measured and unmeasured factors affecting the uptake of skilled delivery care in the country. At community level, place of residence, community level of female education and fertility significantly predict the uptake of skilled delivery care. At individual and household level, maternal age, birth order, maternal education, household wealth and access to media predict the uptake of such service. Thus, there is a need to consider community contexts in the design of maternal health programs and employ multi-sectorial approach to addressing barriers at different levels. For example, improving access and availability of skilled delivery care should eventually enhance the uptake of such services at community level in Ethiopia. At individual level, efforts to promote the uptake of such services should constitute targeted interventions paying special attention to the needs of the youth, the multiparous, the less educated and women in the poorest households.	[Mezmur, Markos; Navaneetham, Kannan; Letamo, Gobopamang; Bariagaber, Hadgu] Univ Botswana, Dept Populat Studies, Gaborone, Botswana	University of Botswana	Navaneetham, K (corresponding author), Univ Botswana, Dept Populat Studies, Gaborone, Botswana.	Kannan.Navaneetham@mopipi.ub.bw	Letamo, Gobopamang/AAC-9390-2021; Navaneetham, Kannan/K-6390-2014	Letamo, Gobopamang/0000-0001-7256-4700; Navaneetham, Kannan/0000-0002-5847-4669; Satihal, Dayanand/0000-0002-9575-8265				Abeje G, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-22; Achia TNO, 2015, WOMEN HEALTH, V55, P203, DOI 10.1080/03630242.2014.979971; Adjiwanou V, 2014, HEALTH PLACE, V29, P67, DOI 10.1016/j.healthplace.2014.06.001; Ali J., 2012, J HEALTH DEV, V26, P265; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Andersen RM, 2008, MED CARE, V46, P647, DOI [10.1097/MLR.0b013e31817a835d, 10.1097/MLR.0b013e31817f4d48]; [Anonymous], 2011, ETHIOPIA DEMOGRAPHIC, P452; Aremu O, 2012, INT J PREVENTIVE MED, V3, P278; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Babalola SO, 2014, REV PANAM SALUD PUBL, V36, P1; Birmeta K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-256; Fekadu M, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.29; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gage A, 2007, SOC SCI MED, V06; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Kruk ME, 2010, HEALTH POLICY, V97, P209, DOI 10.1016/j.healthpol.2010.05.002; Osorio AM, 2014, CAD SAUDE PUBLICA, V30, P1079, DOI 10.1590/0102-311X00073513; McTavish S, 2010, SOC SCI MED, V71, P1958, DOI 10.1016/j.socscimed.2010.09.007; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Ombaka JH., 2015, AM J PUBLIC HLTH RES, V3, P21, DOI DOI 10.12691/AJPHR-3-1-4; Ononokpono D, 2014, PAN AFR MED, P17; Pearson L, 2011, INT J GYNAECOL OBSTE, V115; Prusty R, 2015, INT J POPULATION RES, V2015, P531; Sepehri A, 2008, SOC SCI MED, V67, P1009, DOI 10.1016/j.socscimed.2008.06.005; Singh P, 2013, HLTH POLICY PLAN, V1, P18; Snijers T, 1999, MULTILEVEL ANAL INTR; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P1, DOI DOI 10.1016/J.HEALTHPLACE.2011.12.006; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	32	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184688	10.1371/journal.pone.0184688	http://dx.doi.org/10.1371/journal.pone.0184688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910341	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200077
J	Zou, H; Zhu, XR; Zhang, J; Wang, Y; Wu, XZ; Liu, F; Xie, XF; Chen, XS				Zou, He; Zhu, Xiuruo; Zhang, Jia; Wang, Yi; Wu, Xiaozhen; Liu, Fang; Xie, Xiaofeng; Chen, Xiaoshu			Reference equations for the six-minute walk distance in the healthy Chinese population aged 18-59 years	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; REFERENCE VALUES; ELDERLY ADULTS; BLOOD-PRESSURE; EXERCISE; CAPACITY; GENDER; WOMEN; YOUNG; MEN	Background The six-minute walk test (6MWT) is a safe, simple, inexpensive tool for evaluating the functional exercise capacity of patients with chronic respiratory disease. However, there is a lack of standard reference equations for the six-minute walk distance (6MWD) in the healthy Chinese population aged 18-59 years. Aims The purposes of the present study were as follows: 1) to measure the anthropometric data and walking distance of a sample of healthy Chinese Han people aged 18-59 years; 2) to construct reference equations for the 6MWD; 3) to compare the measured 6MWD with previously published equations. Method The anthropometric data, demographic information, lung function, and walking distance of Chinese adults aged 18-59 years were prospectively measured using a standardized protocol. We obtained verbal consent from all the subjects before the test, and the study design was approved by the ethics committee of Wenzhou People's Hospital. The 6MWT was performed twice, and the longer distance was used for further analysis. Results A total of 643 subjects (319 females and 324 males) completed the 6MWT, and average walking distance was 601.6 +/- 55.51 m. The walking distance was compared between females and males (578 +/- 49.85 m vs. 623 +/- 52.53 m; p < 0.0001) and between physically active subjects and sedentary subjects (609.3 +/- 56.17 m vs. 592 +/- 53.23 m; p < 0.0001). Pearson's correlation indicated that the 6MWD was significantly correlated with various demographic and the 6MWT variables, such as age, height, weight, body mass index (BMI), heart rate after the test and the difference in the heart rate before and after the test. Stepwise multiple regression analysis showed that age and height were independent predictors associated with the 6MWD. The reference equations from white, Canadian and Chilean populations tended to overestimate the walking distance in our subjects, while Brazilian and Arabian equations tended to underestimate the walking distance. There was no significant difference in the walking distance between Korean reference equations and the results of the current study. Conclusion In summary, age and height were the most significant predictors of the 6MWD, and regression equations could explain approximately 34% and 28% of the distance variance in the female and male groups, respectively.	[Zou, He; Zhu, Xiuruo; Wang, Yi; Wu, Xiaozhen; Liu, Fang; Xie, Xiaofeng; Chen, Xiaoshu] Wenzhou Med Univ, Wenzhou Peoples Hosp, Wenzhou Clin Inst 3, Dept Cardiovasc Med, Wenzhou, Zhejiang, Peoples R China; [Zhang, Jia] Wenzhou Med Univ, Wenzhou Peoples Hosp, Wenzhou Clin Inst 3, Dept Inspect Med, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Chen, XS (corresponding author), Wenzhou Med Univ, Wenzhou Peoples Hosp, Wenzhou Clin Inst 3, Dept Cardiovasc Med, Wenzhou, Zhejiang, Peoples R China.	476159415@163.com	Zou, He/GXH-0280-2022					Alameri H, 2009, RESP MED, V103, P1041, DOI 10.1016/j.rmed.2009.01.012; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 1990, MED SCI SPORT EXER, V22, P265; Barnett SR, 1999, HYPERTENSION, V33, P1195, DOI 10.1161/01.HYP.33.5.1195; Beske SD, 2001, J APPL PHYSIOL, V91, P2088, DOI 10.1152/jappl.2001.91.5.2088; Camarri B, 2006, RESP MED, V100, P658, DOI 10.1016/j.rmed.2005.08.003; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; COGGAN AR, 1993, J APPL PHYSIOL, V75, P2125, DOI 10.1152/jappl.1993.75.5.2125; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Fernandes L, 2016, J CLIN DIAGNOSTIC RE, V10; Gibbons W J, 2001, J Cardiopulm Rehabil, V21, P87, DOI 10.1097/00008483-200103000-00005; GILLUM RF, 1988, AM HEART J, V116, P163, DOI 10.1016/0002-8703(88)90262-1; Iwama AM, 2009, BRAZ J MED BIOL RES, V42, P1080, DOI 10.1590/S0100-879X2009005000032; Jenkins Sue, 2009, Physiotherapy Theory and Practice, V25, P516, DOI [10.1080/09593980802664711, 10.3109/09593980802664711]; Kim AL, 2014, TUBERC RESPIR DIS, V76, P269, DOI 10.4046/trd.2014.76.6.269; KING B, 1989, THORAX, V44, P402, DOI 10.1136/thx.44.5.402; Lord SR, 2002, ARCH PHYS MED REHAB, V83, P907, DOI 10.1053/apmr.2002.33227; Minson CT, 2000, CIRCULATION, V101, P862, DOI 10.1161/01.CIR.101.8.862; Nishijima Y, 2015, INT J CHRONIC OBSTR, V10, P439, DOI 10.2147/COPD.S76836; Osses R, 2010, REV MED CHILE, V138, P1124, DOI /S0034-98872010000900006; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Poh H, 2006, RESPIROLOGY, V11, P211, DOI 10.1111/j.1440-1843.2006.00820.x; Saad HB, 2009, RESP MED, V103, P74, DOI 10.1016/j.rmed.2008.07.023; Salzman SH, 2009, CHEST, V135, P1345, DOI 10.1378/chest.07-1682; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; WILSON RC, 1989, CLIN SCI, V76, P277, DOI 10.1042/cs0760277	30	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184669	10.1371/journal.pone.0184669	http://dx.doi.org/10.1371/journal.pone.0184669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910353	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200076
J	Ahmad, AA; Stulberg, MJ; Mershon, JP; Mollov, DS; Huang, Q				Ahmad, Abdelmonim Ali; Stulberg, Michael J.; Mershon, John Patrick; Mollov, Dimitre S.; Huang, Qi			Molecular and biological characterization of phi Rs551, a filamentous bacteriophage isolated from a race 3 biovar 2 strain of Ralstonia solanacearum	PLOS ONE			English	Article							PSEUDOMONAS-SOLANACEARUM; GENOMIC CHARACTERIZATION; PHI-RSM; PHYTOPATHOGEN; VIRULENCE; SEQUENCE; TOMATO; GENES; PHAGE; BIOCONTROL	A filamentous bacteriophage, designated phi Rs551, was isolated and purified from the quarantine and select agent phytopathogen Ralstonia solanacearum race 3 biovar 2 strain UW551 (phylotype IIB sequevar 1) grown under normal culture conditions. Electron microscopy suggested that phi Rs551 is a member of the family Inoviridae, and is about 1200 nm long and 7 nm wide phi Rs551 has a genome of 7929 nucleotides containing 14 open reading frames, and is the first isolated virion that contains a resolvase (ORF13) and putative type-2 phage repressor (ORF14). Unlike other R. solanacearum phages isolated from soil, the genome sequence of phi Rs551 is not only 100% identical to its prophage sequence in the deposited genome of R. solanacearum strain UW551 from which the phage was isolated, but is also surprisingly found with 100% identity in the deposited genomes of 10 other phylotype II sequevar 1 strains of R. solanacearum. Furthermore, it is homologous to genome RS-09-161, resulting in the identification of a new prophage, designated RSM10, in a R. solanacearum strain from India. When ORF13 and a core attP site of phi Rs551 were either deleted individually or in combination, phage integration was not observed, suggesting that similar to other filamentous R. solanacearum phi RSM phages, phi Rs551 relies on its resolvase and the core att sequence for site-directed integration into its susceptible R. solanacearum strain. The integration occurred four hours after phage infection. Infection of a susceptible R. solanacearum strain RUN302 by phi Rs551 resulted in less fluidal colonies and EPS production, and reduced motilities of the bacterium. Interestingly, infection of RUN302 by phi Rs551 also resulted in reduced virulence, rather than enhanced or loss of virulence caused by other phi RSM phages. Study of bacteriophages of R. solanacearum would contribute to a better understanding of the phage-bacterium-environment interactions in order to develop integrated management strategies to combat R. solanacearum.	[Ahmad, Abdelmonim Ali; Stulberg, Michael J.; Mershon, John Patrick; Huang, Qi] USDA ARS, Floral & Nursery Plants Res Unit, US Natl Arboretum, Beltsville, MD 20705 USA; [Ahmad, Abdelmonim Ali] Menia Univ, Fac Agr, Dept Plant Pathol, El Minia, Egypt; [Mollov, Dimitre S.] USDA ARS, Natl Germplasm Resources Lab, Beltsville, MD USA; [Stulberg, Michael J.] USDA, CPHST Beltsville Lab, APHIS, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA); Egyptian Knowledge Bank (EKB); Minia University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Huang, Q (corresponding author), USDA ARS, Floral & Nursery Plants Res Unit, US Natl Arboretum, Beltsville, MD 20705 USA.	qi.huang@ars.usda.gov	Ahmad, Abdelmonim Ali/AAY-5762-2020	Ahmad, Abdelmonim/0000-0001-9857-8385; Mollov, Dimitre/0000-0002-4750-6194; Stulberg, Michael/0000-0001-8640-1291	U. S. Department of Agriculture, Agricultural Research Service	U. S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was financially supported by the U. S. Department of Agriculture, Agricultural Research Service.; This research was financially supported by the U. S. Department of Agriculture, Agricultural Research Service. We thank Joseph Mowery and the Beltsville Electron and Confocal Microscope Unit for technical assistance. We also thank John Hartung in the U. S. and Ahmed Askora in Egypt for critical review of our manuscript.	Addy HS, 2012, PHYTOPATHOLOGY, V102, P469, DOI 10.1094/PHYTO-11-11-0319-R; Addy HS, 2012, PHYTOPATHOLOGY, V102, P244, DOI 10.1094/PHYTO-10-11-0277; Ahmad AA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00321; ALLEN C, 1991, MOL PLANT MICROBE IN, V4, P147, DOI 10.1094/MPMI-4-147; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Askora A, 2009, VIROLOGY, V384, P69, DOI 10.1016/j.virol.2008.11.007; Askora A, 2014, MOL GENET GENOMICS, V289, P589, DOI 10.1007/s00438-014-0835-3; Askora A, 2011, J BIOSCI BIOENG, V111, P109, DOI 10.1016/j.jbiosc.2010.10.001; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bhunchoth A, 2015, J APPL MICROBIOL, V118, P1023, DOI 10.1111/jam.12763; Cellier G, 2012, APPL ENVIRON MICROB, V78, P2367, DOI 10.1128/AEM.06123-11; Clarke CR, 2015, PHYTOPATHOLOGY, V105, P597, DOI 10.1094/PHYTO-12-14-0373-R; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; Fujiwara A, 2011, APPL ENVIRON MICROB, V77, P4155, DOI 10.1128/AEM.02847-10; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Jeong KS, 2008, PLANT PATHOLOGY J, V24, P143, DOI 10.5423/PPJ.2008.24.2.143; Kawasaki T, 2007, J BIOSCI BIOENG, V104, P451, DOI 10.1263/jbb.104.451; Kawasaki T, 2007, J BACTERIOL, V189, P5792, DOI 10.1128/JB.00540-07; Kawasaki T, 2016, VIROLOGY, V492, P73, DOI 10.1016/j.virol.2016.02.011; Kawasaki T, 2009, J BACTERIOL, V191, P422, DOI 10.1128/JB.01263-08; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; KELMAN A, 1994, BACTERIAL WILT, P1; Liu HL, 2001, MICROBIOL-SGM, V147, P3215, DOI 10.1099/00221287-147-12-3215; Murugaiyan S, 2011, J APPL MICROBIOL, V110, P296, DOI 10.1111/j.1365-2672.2010.04882.x; Ramesh R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00323-14; ROBERTS DP, 1988, J BACTERIOL, V170, P1445, DOI 10.1128/jb.170.4.1445-1451.1988; Sambrook J., 2001, MOL CLONING LAB MANU; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; Stulberg MJ, 2016, J MICROBIOL METH, V123, P101, DOI 10.1016/j.mimet.2016.02.010; Stulberg MJ, 2015, PLANT DIS, V99, P333, DOI 10.1094/PDIS-05-14-0483-RE; Tans-Kersten J, 2001, J BACTERIOL, V183, P3597, DOI 10.1128/JB.183.12.3597-3605.2001; Thi BVT, 2015, ARCH VIROL; Van TTB, 2014, MICROBIOL IMMUNOL, V58, P697, DOI 10.1111/1348-0421.12203; Wilson SR, 1994, ORIGINS LIFE CENTRAL, P11; Xu J, 2011, J BACTERIOL, V193, P4261, DOI 10.1128/JB.05384-11; Yamada T., 2012, BACTERIOPHAGES; Yamada T, 2007, MICROBIOL-SGM, V153, P2630, DOI 10.1099/mic.0.2006/001453-0; Yamada T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00325	40	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185034	10.1371/journal.pone.0185034	http://dx.doi.org/10.1371/journal.pone.0185034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934297	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900077
J	Akhter, S; Chakraborty, S; Moutinho, D; Alvarez-Coiradas, E; Rosa, I; Vinuela, J; Dominguez, E; Garcia, A; Requena, JR				Akhter, Shamim; Chakraborty, Sandipan; Moutinho, Daniela; Alvarez-Coiradas, Elia; Rosa, Isaac; Vinuela, Juan; Dominguez, Eduardo; Garcia, Angel; Requena, Jesus R.			The human VGF-derived bioactive peptide TLQP-21 binds heat shock 71 kDa protein 8 (HSPA8) on the surface of SH-SY5Y cells	PLOS ONE			English	Article							INDUCE PENILE ERECTION; SECONDARY STRUCTURE; NEUROPEPTIDE VGF; RECEPTOR C3AR1; EARLY PHASE; MALE RATS; PREDICTION; PREVENTS; IDENTIFICATION; CONTRIBUTES	VGF (non-acronymic) is a secreted chromogranin/secretogranin that gives rise to a number of bioactive peptides by a complex proteolysis mechanism. VGF-derived peptides exert an extensive array of biological effects in energy metabolism, mood regulation, pain, gastric secretion function, reproduction and, perhaps, cancer. It is therefore surprising that very little is known about receptors and binding partners of VGF-derived peptides and their downstream molecular mechanisms of action. Here, using affinity chromatography and mass spectrometry-based protein identification, we have identified the heat shock cognate 71 kDa protein A8 (HSPA8) as a binding partner of human TLQP-21 on the surface of human neuro-blastomaSH-SY5Y cells. Binding of TLQP-21 to membrane associated HSPA8 in live SHSY5Y cells was further supported by cross-linking to live cells. Interaction between HSPA8 and TLQP-21 was confirmed in vitro by label-free Dynamic Mass Redistribution (DMR) studies. Furthermore, molecular modeling studies show that TLQP-21 can be docked into the HSPA8 peptide binding pocket. Identification of HSPA8 as a cell surface binding partner of TLQP-21 opens new avenues to explore the molecular mechanisms of its physiological actions, and of pharmacological modulation thereof.	[Akhter, Shamim; Moutinho, Daniela; Rosa, Isaac; Garcia, Angel; Requena, Jesus R.] Univ Santiago de Compostela, IDIS, CIMUS Biomed Res Inst, Santiago De Compostela, Spain; [Akhter, Shamim] Khulna Univ, Biotechnol & Genet Engn Discipline, Khulna, Bangladesh; [Chakraborty, Sandipan] Univ Calcutta, Dept Microbiol, Kolkata, India; [Alvarez-Coiradas, Elia; Dominguez, Eduardo] Univ Santiago de Compostela, IDIS, BioFarma Res Grp, CIMUS, Santiago De Compostela, Spain; [Vinuela, Juan] Santiago Univ Hosp, Immunol Lab, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Khulna University; University of Calcutta; Universidade de Santiago de Compostela	Requena, JR (corresponding author), Univ Santiago de Compostela, IDIS, CIMUS Biomed Res Inst, Santiago De Compostela, Spain.	jesus.requena@usc.es	Dominguez, Eduardo/AAD-6578-2020; Chakraborty, Sandipan/T-8968-2017; Garcia, Angel/F-6736-2016; Requena, Jesús/ABH-2344-2020; Moutinho, Daniela/Y-7010-2019	Dominguez, Eduardo/0000-0003-3359-5867; Chakraborty, Sandipan/0000-0001-8759-1074; Garcia, Angel/0000-0003-1176-5917; Vinuela, Juan Evaristo/0000-0001-7778-901X; Moutinho, Daniela/0000-0002-8554-4765; Requena, Jesus/0000-0003-1954-4975	ERANET-NEURON grant DISCover through the Spanish funding partner Instituto de Salud Carlos III [PI09/2688]; European Community Erasmus Mundus EXPERTS II Predoctoral Fellowship; ERANET-NEURON grant DISCover [ISCIII PI09/2688]; Erasmus Mundus EXPERTS II Predoctoral Fellowship	ERANET-NEURON grant DISCover through the Spanish funding partner Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Community Erasmus Mundus EXPERTS II Predoctoral Fellowship; ERANET-NEURON grant DISCover; Erasmus Mundus EXPERTS II Predoctoral Fellowship	This work was supported by ERANET-NEURON grant DISCover through the Spanish funding partner Instituto de Salud Carlos III (www.isciii.es), grant: PI09/2688 to JRR. SA is the recipient of a European Community Erasmus Mundus EXPERTS II Predoctoral Fellowship (http://www.expertsasia.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by ERANET-NEURON grant DISCover (ISCIII PI09/2688). SA is the recipient of an Erasmus Mundus EXPERTS II Predoctoral Fellowship. Authors gratefully acknowledge Dr. Soumalee Basu (Department of Microbiology, University of Calcutta, India) for providing us the computational facility at Centre for High Performance Computing for Modern Biology, Ballygunge Science College, University of Calcutta, India.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bartolomucci A, 2008, Eat Weight Disord, V13, pe49; Bartolomucci A, 2009, GENES NUTR, V4, P49, DOI 10.1007/s12263-009-0110-0; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Cero C, 2014, STRUCTURE, V22, P1744, DOI 10.1016/j.str.2014.10.001; Chakraborty S, 2015, CHEM BIOL DRUG DES, V86, P938, DOI 10.1111/cbdd.12541; Chen S, 2005, J NEUROSCI RES, V81, P522, DOI 10.1002/jnr.20575; Chen YC, 2013, J BIOL CHEM, V288, P34638, DOI 10.1074/jbc.M113.510917; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Fairbanks CA, 2014, PAIN, V155, P1229, DOI 10.1016/j.pain.2014.03.012; Fishelson Z, 2001, INT IMMUNOL, V13, P983, DOI 10.1093/intimm/13.8.983; Fitter S, 2017, STEM CELLS, V35, P940, DOI 10.1002/stem.2560; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Muller S, 2008, ARTHRITIS RHEUM-US, V58, P3873, DOI 10.1002/art.24027; Nesvizhskii A.I., 2007, METHODS MOL BIOL, V367, P87, DOI DOI 10.1385/1-59745-275-0:87; Page N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005273; Pinilla L, 2011, AM J PHYSIOL-ENDOC M, V300, pE837, DOI 10.1152/ajpendo.00598.2010; Portela-Gomes GM, 2010, REGUL PEPTIDES, V165, P12, DOI 10.1016/j.regpep.2010.02.011; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Ramos A, 2014, HUM MOL GENET, V23, P5859, DOI 10.1093/hmg/ddu303; Razzoli M, 2012, BEHAV BRAIN RES, V229, P333, DOI 10.1016/j.bbr.2012.01.038; Riedl MS, 2009, J NEUROSCI, V29, P13377, DOI 10.1523/JNEUROSCI.1127-09.2009; Rindi G, 2007, J CLIN ENDOCR METAB, V92, P2811, DOI 10.1210/jc.2007-0035; Rizzi R, 2008, NEUROSCI LETT, V441, P129, DOI 10.1016/j.neulet.2008.06.018; ROSSI A, 1992, INT J DEV NEUROSCI, V10, P527, DOI 10.1016/0736-5748(92)90053-3; Rozek W, 2013, TUMOR BIOL, V34, P1773, DOI 10.1007/s13277-013-0716-0; Sarrio S, 2000, MOL CELL BIOL, V20, P5164, DOI 10.1128/MCB.20.14.5164-5174.2000; Severini C, 2009, BRIT J PHARMACOL, V157, P984, DOI 10.1111/j.1476-5381.2009.00192.x; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sibilia V, 2012, AMINO ACIDS, V42, P1261, DOI 10.1007/s00726-010-0818-6; Stephens SB, 2012, CELL METAB, V16, P33, DOI 10.1016/j.cmet.2012.05.011; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Succu S, 2005, NEUROPHARMACOLOGY, V49, P1017, DOI 10.1016/j.neuropharm.2005.05.015; Succu S, 2004, EUR J NEUROSCI, V20, P3035, DOI 10.1111/j.1460-9568.2004.03781.x; TAKENAKA IM, 1995, J BIOL CHEM, V270, P19839, DOI 10.1074/jbc.270.34.19839; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Thakker-Varia S, 2010, J NEUROSCI, V30, P9368, DOI 10.1523/JNEUROSCI.5987-09.2010; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; TRANI E, 1995, J NEUROCHEM, V65, P2441; Watson Elizabeth, 2009, BMC Physiology, V9, P19, DOI 10.1186/1472-6793-9-19; Wiersma VR, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00007; Zimmer R, 2013, ANN RHEUM DIS, V72, P1830, DOI 10.1136/annrheumdis-2012-202460	54	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185176	10.1371/journal.pone.0185176	http://dx.doi.org/10.1371/journal.pone.0185176			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934328	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900112
J	Chen, H; Xiao, GQ; Chai, XL; Lin, XG; Fang, J; Teng, SS				Chen, Heng; Xiao, Guoqiang; Chai, Xueliang; Lin, Xingguan; Fang, Jun; Teng, Shuangshuang			Transcriptome analysis of sex-related genes in the blood clam Tegillarca granosa	PLOS ONE			English	Article							MOLECULAR-CLONING; BETA-CATENIN; EXPRESSION; SRY; PROTEIN; DIFFERENTIATION; GAMETOGENESIS; ANTAGONIZES; EVOLUTION; BIVALVIA	Background Blood clams (Tegillarca granosa) are one of the most commercial shellfish in China and South Asia with wide distribution in Indo-Pacific tropical to temperate estuaries. However, recent data indicate a decline in the germplasm of this species. Furthermore, the molecular mechanisms underpinning reproductive regulation remain unclear and information regarding genetic diversity is limited. Understanding the reproductive biology of shellfish is important in interpreting their embryology development, reproduction and population structure. Transcriptome sequencing (RNA-seq) rapidly obtains genetic sequence information from almost all transcripts of a particular tissue and currently represents the most prevalent and effective method for constructing genetic expression profiles. Results Non-reference RNA-seq, an Illumina HiSeq2500 Solexa system, and de novo assembly were used to construct a gonadal expression profile of the blood clam. A total of 63.75 Gb of clean data, with at least 89.46% of Quality30 (Q30), were generated which was then combined into 214,440 transcripts and 125,673 unigenes with a mean length of 1,122.63 and 781.30 base pairs (bp). In total, 27,325 genes were annotated by comparison with public databases. Of these, 2,140 and 2,070 differentially expressed genes (DEGs) were obtained (T05 T08 vs T01 T02 T04, T06 T07 vs T01 T02 T04; in which T01-T04 and T05-T08 represent biological replicates of individual female and male clams, respectively) and classified into two groups according to the evaluation of biological replicates. Then 35 DEGs and 5 sex-related unigenes, in other similar species, were investigated using qRT-PCR, the results of which were confirmed to data arising from RNA-seq. Among the DEGs, sex-related genes were identified, including forkhead box L2 (Foxl2), sex determining region Y-box (Sox), beta-catenin (beta-catenin), chromobox homolog (CBX) and Sex-lethal (Sxl). In addition, 6,283 simple sequence repeats (SSRs) and 614,710 single nucleotide polymorphisms (SNPs) were identified from the RNA-seq results. Conclusions This study provided the first complete gonadal transcriptome data for the blood clam and allowed us to search many aspects of gene sequence information, not limited to gender. This data will improve our understanding of the transcriptomics and reproductive biology of the blood clam. Furthermore, molecular markers such as SSRs and SNPs will be useful in the analysis of genetic evolution, bulked segregant analysis (BSA) and genome-wide association studies (GWAS). Our transcriptome data will therefore provide important genetic information for the breeding and conservation of germplasm.	[Chen, Heng; Xiao, Guoqiang; Chai, Xueliang; Lin, Xingguan; Fang, Jun; Teng, Shuangshuang] Zhejiang Mariculture Res Inst, Wenzhou, Zhejiang, Peoples R China; [Chen, Heng; Xiao, Guoqiang; Chai, Xueliang; Lin, Xingguan; Fang, Jun; Teng, Shuangshuang] Zhejiang Key Lab Exploitat & Preservat Coastal Bi, Wenzhou, Zhejiang, Peoples R China; [Chen, Heng; Xiao, Guoqiang; Chai, Xueliang; Lin, Xingguan; Fang, Jun; Teng, Shuangshuang] Chinese Acad Fishery Sci, Engn Res Ctr Marine Bivalves, Wenzhou, Zhejiang, Peoples R China	Chinese Academy of Fishery Sciences	Teng, SS (corresponding author), Zhejiang Mariculture Res Inst, Wenzhou, Zhejiang, Peoples R China.; Teng, SS (corresponding author), Zhejiang Key Lab Exploitat & Preservat Coastal Bi, Wenzhou, Zhejiang, Peoples R China.; Teng, SS (corresponding author), Chinese Acad Fishery Sci, Engn Res Ctr Marine Bivalves, Wenzhou, Zhejiang, Peoples R China.	188175998@qq.com			earmarked fund for Modern Agro-industry Technology Research System [CARS-47]; Wenzhou public welfare science and technology project [N20160006]; Zhejiang public welfare science and technology projuct [2015C33090]; Seed Science and Technology Innovation Project of Wenzhou City [N20120017]	earmarked fund for Modern Agro-industry Technology Research System; Wenzhou public welfare science and technology project; Zhejiang public welfare science and technology projuct; Seed Science and Technology Innovation Project of Wenzhou City	This work was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-47) received by XL Chai; Wenzhou public welfare science and technology project (N20160006) received by SS Teng; Zhejiang public welfare science and technology projuct (2015C33090) received by GQ Xiao; The Seed Science and Technology Innovation Project of Wenzhou City (N20120017) received by GQ Xiao. The funders had a role in study design and decision to publish.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, INT J CHEM ENG; Balazs H, 2009, DEVELOPMENT, V136, P3881, DOI 10.1242/dev.034637; Bao YB, 2013, GENET MOL RES, V12, P1143, DOI 10.4238/2013.April.10.9; Bao YB, 2011, FISH SHELLFISH IMMUN, V31, P517, DOI 10.1016/j.fsi.2011.05.029; Bao YB, 2011, FISH SHELLFISH IMMUN, V30, P729, DOI 10.1016/j.fsi.2010.12.002; Barbara PD, 2001, BIOL REPROD, V64, P775, DOI 10.1095/biolreprod64.3.775; Baumann C, 2011, GENES-BASEL, V2, P59, DOI 10.3390/genes2010059; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bettinazzi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153631; Birk OS, 2000, NATURE, V403, P909, DOI 10.1038/35002622; Cai YY, 1995, OVERVIEW BIVALVES; Chen XH, 2015, CELL BIOCHEM BIOPHYS, V71, P837, DOI 10.1007/s12013-014-0271-3; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis TL, 1997, DEVELOPMENT, V124, P1019; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Gailey DA, 2006, MOL BIOL EVOL, V23, P633, DOI 10.1093/molbev/msj070; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Hamaoka BY, 2004, P NATL ACAD SCI USA, V101, P11673, DOI 10.1073/pnas.0402559101; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Hossain A, 2001, J BIOL CHEM, V276, P16817, DOI 10.1074/jbc.M009056200; Hu YC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003629; Huang XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084352; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang T, 2013, MOL BIOL REP, V40, P2187, DOI 10.1007/s11033-012-2279-3; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Katoh-Fukui Y, 2012, ENDOCRINOLOGY, V153, P913, DOI 10.1210/en.2011-1055; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; Kobayashi T, 2004, DEV DYNAM, V231, P518, DOI 10.1002/dvdy.20158; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Larney C, 2014, DEVELOPMENT, V141, P2195, DOI 10.1242/dev.107052; Lavery R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003170; Lee SH, 2016, BIOCHEM BIOPH RES CO, V469, P884, DOI 10.1016/j.bbrc.2015.12.070; Li CH, 2011, COMP BIOCHEM PHYS B, V159, P64, DOI 10.1016/j.cbpb.2011.02.003; Li JM, 2014, OR SURG OR MED OR PA, V118, P330, DOI 10.1016/j.oooo.2014.05.007; Li Y., 2016, COMP MATH MATH PHYS, V2016, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.1109/TSG.2015.2508923; Liu XL, 2012, DEV GENES EVOL, V222, P279, DOI 10.1007/s00427-012-0410-z; [陆荣茂 LU Rongmao], 2008, [上海水产大学学报, Journal of Shanghai Fisheries University], V17, P625; Lv SS, 2015, MAR DRUGS, V13, P1466, DOI 10.3390/md13031466; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Milani L, 2014, CURR GENET, V60, P163, DOI 10.1007/s00294-014-0420-7; Ministry of Agriculture Bureau of Fisheries, 2015, CHINA FISHERY STAT Y; Miyamoto Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-44; Naillat F, 2015, EXP CELL RES, V332, P163, DOI 10.1016/j.yexcr.2015.01.010; Naimi A, 2009, COMP BIOCHEM PHYS B, V154, P134, DOI 10.1016/j.cbpb.2009.05.011; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Santerre C, 2012, SEX DEV, V6, P210, DOI 10.1159/000338085; Santerre C, 2014, COMP BIOCHEM PHYS A, V167, P68, DOI 10.1016/j.cbpa.2013.09.018; Schepers G, 2003, J BIOL CHEM, V278, P28101, DOI 10.1074/jbc.M304067200; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; SHEN MM, 1988, CELL, V54, P1019, DOI 10.1016/0092-8674(88)90117-1; Shetty S, 2002, CYTOGENET GENOME RES, V99, P245, DOI 10.1159/000071600; Smietanka B, 2016, MITOCHONDRIAL DNA A, V27, P1634, DOI 10.3109/19401736.2014.958704; Streit A, 1999, GENETICS, V152, P1573; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Sun X, 2015, G3-GENES GENOM GENET, V5, P2865, DOI 10.1534/g3.115.023721; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tang JJ, 2014, ONCOTARGET, V5, P10778, DOI 10.18632/oncotarget.2502; Teaniniuraitemoana V, 2016, J EXP ZOOL PART A, V325, P13, DOI 10.1002/jez.1992; Teaniniuraitemoana V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122819; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Tong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134280; Wang Qing, 2012, Oceanologia et Limnologia Sinica / Hai Yang Yu Hu Chao, V43, P88; Xu WH, 2015, ARCH MED SCI, V11, P849, DOI 10.5114/aoms.2015.53305; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Yu FF, 2011, J SHELLFISH RES, V30, P247, DOI 10.2983/035.030.0208; Zhao L, 2015, DEVELOPMENT, V142, P1083, DOI 10.1242/dev.122184	75	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184584	10.1371/journal.pone.0184584	http://dx.doi.org/10.1371/journal.pone.0184584			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934256	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900033
J	Chinkhumba, J; De Allegri, M; Mazalale, J; Brenner, S; Mathanga, D; Muula, AS; Robberstad, B				Chinkhumba, Jobiba; De Allegri, Manuela; Mazalale, Jacob; Brenner, Stephan; Mathanga, Don; Muula, Adamson S.; Robberstad, Bjarne			Household costs and time to seek care for pregnancy related complications: The role of results-based financing	PLOS ONE			English	Article							HEALTH-CARE; MATERNAL MORTALITY; PERFORMANCE; SATISFACTION; PERCEPTIONS; INCENTIVES; HOSPITALS; QUALITY; ILLNESS; INCOME	Results-based financing (RBF) schemes-including performance based financing (PBF) and conditional cash transfers (CCT)-are increasingly being used to encourage use and improve quality of institutional health care for pregnant women in order to reduce maternal and neonatal mortality in low-income countries. While there is emerging evidence that RBF can increase service use and quality, little is known on the impact of RBF on costs and time to seek care for obstetric complications, although the two represent important dimensions of access. We conducted this study to fill the existing gap in knowledge by investigating the impact of RBF (PBF+CCT) on household costs and time to seek care for obstetric complications in four districts in Malawi. The analysis included data on 2,219 women with obstetric complications from three waves of a population-based survey conducted at baseline in 2013 and repeated in 2014(midline) and 2015(endline). Using a before and after approach with controls, we applied generalized linear models to study the association between RBF and household costs and time to seek care. Results indicated that receipt of RBF was associated with a significant reduction in the expected mean time to seek care for women experiencing an obstetric complication. Relative to non-RBF, time to seek care in RBF areas decreased by 27.3% (95% CI: 28.4-25.9) at midline and 34.2% (95% CI: 37.8-30.4) at endline. No substantial change in household costs was observed. We conclude that the reduced time to seek care is a manifestation of RBF induced quality improvements, prompting faster decisions on care seeking at household level. Our results suggest RBF may contribute to timely emergency care seeking and thus ultimately reduce maternal and neonatal mortality in beneficiary populations.	[Chinkhumba, Jobiba; Mazalale, Jacob; Mathanga, Don; Muula, Adamson S.] Univ Malawi, Sch Publ Hlth & Family Med, Dept Publ Hlth, Coll Med, Blantyre, Malawi; [Chinkhumba, Jobiba; Robberstad, Bjarne] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [De Allegri, Manuela; Mazalale, Jacob; Brenner, Stephan] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	University of Malawi; University of Bergen; Ruprecht Karls University Heidelberg	Chinkhumba, J (corresponding author), Univ Malawi, Sch Publ Hlth & Family Med, Dept Publ Hlth, Coll Med, Blantyre, Malawi.; Chinkhumba, J (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	jchinkhumba@mac.medcol.mw	Mazalale, Jacob/AAE-3204-2022; Robberstad, Bjarne/AAG-9322-2020; Muula, Adamson/AAF-1153-2020; Mazalale, Jacob/D-8972-2018	Mazalale, Jacob/0000-0001-9856-1268; Robberstad, Bjarne/0000-0002-0708-2016; Mazalale, Jacob/0000-0001-9856-1268	Norwegian Ministry of Foreign Affairs [MWI 12/0010]; United States Agency for International Development under Translating Research into Action [GHS-A-00-09-00015-00]	Norwegian Ministry of Foreign Affairs; United States Agency for International Development under Translating Research into Action(United States Agency for International Development (USAID))	This research project is funded through a grant by the Norwegian Ministry of Foreign Affairs to the Government of Malawi under Programme Title MWI 12/0010 Effect Evaluation of Performance Based Financing in Health Sector. The Malawi College of Medicine as implementing institution is recipient of this grant. This study was co-funded by the United States Agency for International Development under Translating Research into Action, Cooperative Agreement No. GHS-A-00-09-00015-00. This study is made possible by the support of the American People through the United States Agency for International Development (USAID). The findings of this study are the sole responsibility of study team and do not necessarily reflect the views of USAID or the United States Government.; This research project is funded through a grant by the Norwegian Ministry of Foreign Affairs to the Government of Malawi under Programme Title MWI 12/0010 Effect Evaluation of Performance Based Financing in Health Sector. The Malawi College of Medicine as implementing institution is recipient of this grant.; This study was co-funded by the United States Agency for International Development under Translating Research into Action, Cooperative Agreement No. GHS-A-00-09-00015-00. This study is made possible by the support of the American People through the United States Agency for International Development (USAID). The findings of this study are the sole responsibility of study team and do not necessarily reflect the views of USAID or the United States Government.	Andaleeb SS, 2001, SOC SCI MED, V52, P1359, DOI 10.1016/S0277-9536(00)00235-5; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bayarsaikhan D, 2016, INT H HEALTHCARE, V2; Binyaruka P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135013; Blough DK., 2000, HLTH SERV OUTCOMES R, V1, P185, DOI [DOI 10.1023/A:1012597123667, 10.1023/A%3A1012597123667, DOI 10.1023/A%3A1012597123667]; Bonfrer I, 2014, SOC SCI MED, V123, P96, DOI 10.1016/j.socscimed.2014.11.004; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Brenner S, 2015, FINAL RESULTS RBF4MN; Brenner S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-180; Brighton A, 2013, INT J GYNECOL OBSTET, V120, P224, DOI 10.1016/j.ijgo.2012.09.017; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Dangal G., 2014, NEPAL J OBSTET GYNEC, V17, P8; De Walque D, 2012, 5973 WORLD BANK DEV; Echoka Elizabeth, 2014, Pan Afr Med J, V17 Suppl 1, P4, DOI 10.11694/pamj.supp.2014.17.1.3042; Eichler R, 2014, J HEALTH POPUL NUTR, P36; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Honda A, 2011, REPROD HEALTH MATTER, V19, P10, DOI 10.1016/S0968-8080(11)37559-3; Hussein J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001264; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Kambala C, 2011, MALAWI MED J, V23, P1; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P308, DOI 10.1016/j.ijgo.2005.12.003; Maine D, 1991, SAFE MOTHERHOOD PROG; Manning W, 2013, IHEA WORLD C SYDN AU; Mazalale J, 2015, TROP MED INT HEALTH; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Meessen B, 2011, B WORLD HEALTH ORGAN, V89, P153, DOI 10.2471/BLT.10.077339; Mihaylova B, 2011, HEALTH ECON, V20, P897, DOI 10.1002/hec.1653; Ministry of Health, 2014, MAL NAT HLTH ACC SUB; Nahar S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-11; National Statistical Office, 2014, MAL MDG ENDL SURV 20; Orenstein LAV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046638; Srivastava A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0525-0; Stanton ME, 2013, J HEALTH POPUL NUTR, V31, P1; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thorsen VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052090; Turcotte-Tremblay AM, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0103-9; Ugwu NU, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0050-7; Varian H, 2005, INTERMEDIATE MICROEC, P141; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wilhelm DJ, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1652-7; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038467	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0182326	10.1371/journal.pone.0182326	http://dx.doi.org/10.1371/journal.pone.0182326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934320	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900004
J	de Castro-Catala, M; Mora-Solano, A; Kwapil, TR; Cristobal-Narvaez, P; Sheinbaum, T; Racioppi, A; Barrantes-Vidal, N; Rosa, A				de Castro-Catala, Marta; Mora-Solano, Aurea; Kwapil, Thomas R.; Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Racioppi, Anna; Barrantes-Vidal, Neus; Rosa, Araceli			The genome-wide associated candidate gene ZNF804A and psychosis-proneness: Evidence of sex-modulated association	PLOS ONE			English	Article							WISCONSIN SCHIZOTYPY SCALES; O-METHYLTRANSFERASE COMT; SCHIZOPHRENIA SUSCEPTIBILITY; BIPOLAR DISORDER; NEUROCOGNITIVE PERFORMANCE; DIMENSIONAL STRUCTURE; RISK VARIANT; SHORT FORMS; BRAIN; RS1344706	Background The Zinc finger protein 804A (ZNF804A) is a promising candidate gene for schizophrenia and the broader psychosis phenotype that emerged from genome-wide association studies. It is related to neurodevelopment and associated to severe symptoms of schizophrenia and alterations in brain structure, as well as positive schizotypal personality traits in non-clinical samples. Moreover, a female-specific association has been observed between ZNF804A and schizophrenia. Aim The present study examined the association of two ZNF804A polymorphisms (rs1344706 and rs7597593) with the positive dimension of schizotypy and psychotic-like experiences in a sample of 808 non-clinical subjects. Additionally, we wanted to explore whether the sexual differences reported in schizophrenia are also present in psychosis-proneness. Results Our results showed an association between rs7597593 and both schizotypy and psychoticlike experiences. These associations were driven by females, such those carrying the C allele had higher scores in the positive dimension of both variables compared to TT allele homozygotes. Conclusion The findings of the present study support the inclusion of ZNF804 variability in studies of the vulnerability for the development of psychopathology in non-clinical samples and consideration of sex as a moderator of this association.	[de Castro-Catala, Marta; Mora-Solano, Aurea; Rosa, Araceli] Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Seccio Zool & Antropol Biol, Barcelona, Spain; [de Castro-Catala, Marta; Rosa, Araceli] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Kwapil, Thomas R.; Barrantes-Vidal, Neus] Univ North Carolina Greensboro, Dept Psychol, Greensboro, NC USA; [Kwapil, Thomas R.] Univ Illinois Champaign Urbana, Dept Psychol, Champaign, IL USA; [Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Racioppi, Anna; Barrantes-Vidal, Neus] Univ Autonoma Barcelona, Fac Psicol, Dept Psicol Clin & Salut, Barcelona, Spain; [Barrantes-Vidal, Neus] St Pere Claver Fundacio Sanitaria, Barcelona, Spain; [Barrantes-Vidal, Neus; Rosa, Araceli] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain	University of Barcelona; University of Barcelona; University of North Carolina; University of North Carolina Greensboro; University of Illinois System; University of Illinois Urbana-Champaign; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Rosa, A (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Seccio Zool & Antropol Biol, Barcelona, Spain.; Rosa, A (corresponding author), Univ Barcelona, Inst Biomed, Barcelona, Spain.; Rosa, A (corresponding author), Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain.	araceli.rosa@ub.edu	Cristóbal-Narváez, Paula/AFU-7048-2022; Sheinbaum, Tamara/A-8008-2016; Rosa, Araceli/Q-2099-2016; Barrantes-Vidal, Neus/A-9578-2013; Racioppi, Anna/ABC-8658-2020; de Castro-Catala, Marta/E-2246-2019; Kwapil, Thomas/I-3163-2019; Cristóbal-Narváez, Paula/K-3265-2017; Kwapil, Thomas R./L-1127-2014	Cristóbal-Narváez, Paula/0000-0001-8184-6347; Sheinbaum, Tamara/0000-0002-2268-7697; Rosa, Araceli/0000-0001-6935-3785; Barrantes-Vidal, Neus/0000-0002-8671-1238; Racioppi, Anna/0000-0002-5575-2811; de Castro-Catala, Marta/0000-0002-5550-4885; Cristóbal-Narváez, Paula/0000-0001-8184-6347; Kwapil, Thomas R./0000-0003-1116-5954	Spanish Ministry of Economy and Competitiveness [PSI2011-30321-C02-01, PSI2011-30321-C02-02, PSI2014-54009-R, PSI2014-56303-REDT-PROMOSAM]; Fundacio la Marato de TV3 [091110]; Comissionat per a Universitats i Recerca of the Generalitat de Catalunya [2014SGR1070, 2014SGR1636]; Academia Research Award (ICREA) from the Catalan Government	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacio la Marato de TV3; Comissionat per a Universitats i Recerca of the Generalitat de Catalunya(Generalitat de Catalunya); Academia Research Award (ICREA) from the Catalan Government	This work was supported by research projects funded by the Spanish Ministry of Economy and Competitiveness (PSI2011-30321-C02-01 and C02-02, PSI2014-54009-R, Red de Excelencia PSI2014-56303-REDT-PROMOSAM: Investigacion en Procesos, Mecanismos y Tratamientos Psicologicos para la Promocion de la Salud Mental), Fundacio la Marato de TV3 (091110), Comissionat per a Universitats i Recerca of the Generalitat de Catalunya (2014SGR1070 and 2014SGR1636). N. Barrantes-Vidal is funded by the Academia Research Award (ICREA) from the Catalan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrantes-Vidal N, 2015, SCHIZOPHRENIA BULL, V41, pS408, DOI 10.1093/schbul/sbu191; Chang H, 2017, ZNF804A CLIN ASS BIO, P14; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124597; Cummings E, 2010, SCHIZOPHR RES, V122, P273, DOI 10.1016/j.schres.2010.05.022; de Castro-Catala M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/829237; Deans PJM, 2016, BIOL PSYCHIAT, P1053; del Re EC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.117; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; Eckblad M.L., 1982, REVISED SOCIAL ANHED; Fanous AH, 2007, MOL PSYCHIATR, V12, P958, DOI 10.1038/sj.mp.4001996; Girgenti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032404; Godar SC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00071; Gross GM, 2015, SCHIZOPHR RES, V166, P80, DOI 10.1016/j.schres.2015.05.016; Gross GM, 2012, SCHIZOPHR RES, V134, P267, DOI 10.1016/j.schres.2011.11.032; Gurung R, 2015, PSYCHOL MED, V45, P2461, DOI 10.1017/S0033291715000537; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; Hatzimanolis A, 2015, AM J MED GENET B, V168, P392, DOI 10.1002/ajmg.b.32323; Hess JL, 2014, AM J MED GENET B, V165, P28, DOI 10.1002/ajmg.b.32207; Hill MJ, 2011, MOL PSYCHIATR, V16, P787, DOI 10.1038/mp.2011.21; Hill MJ, 2012, AM J PSYCHIAT, V169, P1301, DOI 10.1176/appi.ajp.2012.11121845; Hill MJ, 2012, HUM MOL GENET, V21, P1018, DOI 10.1093/hmg/ddr532; Hinna KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132456; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Kwapil TR, 2008, SCHIZOPHRENIA BULL, V34, P444, DOI 10.1093/schbul/sbm098; Kwapil TR, 2013, J ABNORM PSYCHOL, V122, P807, DOI 10.1037/a0033759; Laruelle M, 2014, CURR OPIN PHARMACOL, V14, P97, DOI 10.1016/j.coph.2014.01.001; Li M, 2012, AM J MED GENET B, V159B, P794, DOI 10.1002/ajmg.b.32084; Mallas EJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1570; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Paulus FM, 2013, HUM BRAIN MAPP, V34, P304, DOI 10.1002/hbm.21434; R Development Core Team, 2008, LANG ENV STAT COMP; Rao SQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41140; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ros-Morente A, 2010, ACTAS ESP PSIQUIATRI, V38, P33; Ros-Morente A, 2011, ACTAS ESP PSIQUIATRI, V39, P95; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015; Stefanis NC, 2013, SCHIZOPHRENIA BULL, V39, P1252, DOI 10.1093/schbul/sbs110; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Sun Y, 2015, SCHIZOPHR RES, V162, P124, DOI 10.1016/j.schres.2015.01.036; Tao R, 2014, JAMA PSYCHIAT, V71, P1112, DOI 10.1001/jamapsychiatry.2014.1079; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Walters JTR, 2010, ARCH GEN PSYCHIAT, V67, P692, DOI 10.1001/archgenpsychiatry.2010.81; Wang J, 2016, NEUROSCI LETT, V618, P14, DOI 10.1016/j.neulet.2016.02.048; Wang TY, 2014, INT J NEUROPSYCHOPH, V17, P211, DOI 10.1017/S1461145713001296; Wang Y, 2010, PSYCHIAT RES, V179, P147, DOI 10.1016/j.psychres.2009.03.029; Wassink TH, 2012, ARCH GEN PSYCHIAT, V69, P885, DOI 10.1001/archgenpsychiatry.2011.2116; Wei QL, 2015, AM J MED GENET B, V168, P265, DOI 10.1002/ajmg.b.32308; Wheeler B, 2010, LMPERM PERMUTATION T; Wickramasinghe A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.198; Yasuda Y, 2011, NEUROSCI LETT, V495, P216, DOI 10.1016/j.neulet.2011.03.069; Zhang FY, 2011, BIOL PSYCHIAT, V69, P914, DOI 10.1016/j.biopsych.2011.01.003	55	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185072	10.1371/journal.pone.0185072	http://dx.doi.org/10.1371/journal.pone.0185072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931092	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700068
J	Deng, J; Gao, H; Gao, Z; Zhao, HX; Yang, Y; Wu, QF; Wu, B; Jiang, CJ				Deng, Jie; Gao, Hua; Gao, Zhen; Zhao, Huaxian; Yang, Ying; Wu, Qiaofen; Wu, Bo; Jiang, Chengjian			Identification and molecular characterization of a metagenome-derived L-lysine decarboxylase gene from subtropical soil microorganisms	PLOS ONE			English	Article							ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; CADAVERINE PRODUCTION; STRUCTURE PREDICTION; GENOME SEQUENCE; HAFNIA-ALVEI; BIOSYNTHESIS; PEPTIDOGLYCAN; FERMENTATION; EXPRESSION	L-lysine decarboxylase (LDC, EC 4.1.1.18) is a key enzyme in the decarboxylation of Llysine to 1,5-pentanediamine and efficiently contributes significance to biosynthetic capability. Metagenomic technology is a shortcut approach used to obtain new genes from uncultured microorganisms. In this study, a subtropical soil metagenomic library was constructed, and a putative LDC gene named ldc1E was isolated by function-based screening strategy through the indication of pH change by L-lysine decarboxylation. Amino acid sequence comparison and homology modeling indicated the close relation between Ldc1E and other putative LDCs. Multiple sequence alignment analysis revealed that Ldc1E contained a highly conserved motif Ser-X-His-Lys (Pxl), and molecular docking results showed that this motif was located in the active site and could combine with the cofactor pyridoxal 5'-phosphate. The ldc1E gene was subcloned into the pET-30a(+) vector and highly expressed in Escherichia coli BL21 (DE3) pLysS. The recombinant protein was purified to homogeneity. The maximum activity of Ldc1E occurred at pH 6.5 and 40 degrees C using L-lysine monohydrochloride as the substrate. Recombinant Ldc1E had apparent K-m, k(cat), and k(cat)/K-m values of 1.08 +/- 0.16 mM, 5.09 +/- 0.63 s(-1), and 4.73x10 3 s(-1) M-1, respectively. The specific activity of Ldc1E was 1.53 +/- 0.06 U mg(-1) protein. Identifying a metagenome-derived LDC gene provided a rational reference for further gene modifications in industrial applications.	[Deng, Jie; Gao, Hua; Gao, Zhen; Zhao, Huaxian; Wu, Qiaofen; Jiang, Chengjian] Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Yang, Ying; Wu, Bo] Guangxi Univ Nationalities, Coll Ocean & Biotechnol, Nanning, Guangxi, Peoples R China	Guangxi University; Guangxi Minzu University	Jiang, CJ (corresponding author), Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China.	jiangcj0520@gmail.com		Jiang, Chengjian/0000-0001-6887-7560	National Natural Science Foundation of China [31760437, 21262003]; Excellent Teaching Program of Guangxi High Education-Program of Advantageous and Characteristic Specialty (Excellent Undergraduate Major)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Teaching Program of Guangxi High Education-Program of Advantageous and Characteristic Specialty (Excellent Undergraduate Major)	This research was supported by the National Natural Science Foundation of China (Grant No. 31760437, 21262003) (CJJ), and the 2016 Excellent Teaching Program of Guangxi High Education-Program of Advantageous and Characteristic Specialty (Excellent Undergraduate Major) (CJJ).	Abbott SL, 2003, J CLIN MICROBIOL, V41, P2348, DOI 10.1128/JCM.41.6.2348-2357.2003; Alexopoulos E, 2008, ACTA CRYSTALLOGR F, V64, P700, DOI 10.1107/S1744309108018757; Andreeva A, 2016, BIOCHEM SOC T, V44, P937, DOI 10.1042/BST20160053; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bhatia SK, 2016, REV ENVIRON SCI BIO, V15, P639, DOI 10.1007/s11157-016-9415-9; Brady SF, 2000, J AM CHEM SOC, V122, P12903, DOI 10.1021/ja002990u; Bunsupa S, 2012, PLANT CELL, V24, P1202, DOI 10.1105/tpc.112.095885; Burgmann H, 2001, J MICROBIOL METH, V45, P7, DOI 10.1016/S0167-7012(01)00213-5; Daniel R, 2004, CURR OPIN BIOTECH, V15, P199, DOI 10.1016/j.copbio.2004.04.005; FECKER LF, 1986, MOL GEN GENET, V203, P177, DOI 10.1007/BF00330400; Flores FJ, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-5; GANI D, 1991, PHILOS T ROY SOC B, V332, P131, DOI 10.1098/rstb.1991.0041; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hintze BJ, 2016, PROTEINS, V84, P1177, DOI 10.1002/prot.25039; Hirao T, 2000, J BACTERIOL, V182, P1154, DOI 10.1128/JB.182.4.1154-1157.2000; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kandiah E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24601; Kanjee U, 2010, JOVE-J VIS EXP, V46, P2094; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Kim JY, 2016, J MICROBIOL BIOTECHN, V26, P909, DOI 10.4014/jmb.1602.02012; Kim YH, 2015, J MICROBIOL BIOTECHN, V25, P2110, DOI 10.4014/jmb.1505.05063; Kind S, 2014, METAB ENG, V25, P113, DOI 10.1016/j.ymben.2014.05.007; Kind S, 2011, METAB ENG, V13, P617, DOI 10.1016/j.ymben.2011.07.006; Kind S, 2010, METAB ENG, V12, P341, DOI 10.1016/j.ymben.2010.03.005; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Lemonnier M, 1998, MICROBIOL-SGM, V144, P751, DOI 10.1099/00221287-144-3-751; Li M, 2014, J IND MICROBIOL BIOT, V41, P701, DOI 10.1007/s10295-014-1409-4; Li NQ, 2016, ENG LIFE SCI, V16, P299, DOI 10.1002/elsc.201500037; Li NQ, 2014, BIOTECHNOL BIOPROC E, V19, P965, DOI 10.1007/s12257-014-0352-6; Li YD, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-85; Ma WC, 2015, BIOTECHNOL LETT, V37, P799, DOI 10.1007/s10529-014-1753-5; Malet H, 2014, ELIFE, V3, DOI 10.7554/eLife.03653; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Meneses C, 2016, MOLECULES, V21, DOI 10.3390/molecules21070831; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Mimitsuka T, 2007, BIOSCI BIOTECH BIOCH, V71, P2130, DOI 10.1271/bbb.60699; MOMANY C, 1995, J MOL BIOL, V252, P643, DOI 10.1006/jmbi.1995.0526; MOMANY C, 1995, PROTEIN SCI, V4, P849; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Qian ZG, 2011, BIOTECHNOL BIOENG, V108, P93, DOI 10.1002/bit.22918; Sagong HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166667; Schneider J, 2011, APPL MICROBIOL BIOT, V91, P17, DOI 10.1007/s00253-011-3252-0; Sugawara A, 2014, J BIOSCI BIOENG, V118, P496, DOI 10.1016/j.jbiosc.2014.04.013; Takatsuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1, DOI 10.1271/bbb.68.1; Takatsuka Y, 1999, BIOSCI BIOTECH BIOCH, V63, P1063, DOI 10.1271/bbb.63.1063; Tsuge Y, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0411-0; Uria AR, 2016, ADV FOOD NUTR RES, V78, P1, DOI 10.1016/bs.afnr.2016.05.001; Voget S, 2003, APPL ENVIRON MICROB, V69, P6235, DOI 10.1128/AEM.69.10.6235-6242.2003; Wang C, 2015, BIOTECHNOL BIOPROC E, V20, P439, DOI 10.1007/s12257-014-0690-4; Yoon H, 2015, TOX RESEARCH, V31, P299, DOI 10.5487/TR.2015.31.3.299	50	8	10	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185060	10.1371/journal.pone.0185060	http://dx.doi.org/10.1371/journal.pone.0185060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931053	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700066
J	Talakoub, O; Marquez-Chin, C; Popovic, MR; Navarro, J; Fonoff, ET; Hamani, C; Wong, W				Talakoub, Omid; Marquez-Chin, Cesar; Popovic, Milos R.; Navarro, Jessie; Fonoff, Erich T.; Hamani, Clement; Wong, Willy			Reconstruction of reaching movement trajectories using electrocorticographic signals in humans	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; LOCAL-FIELD POTENTIALS; ARM MOVEMENTS; MAGNETOENCEPHALOGRAPHIC SIGNALS; MOTOR CORTEX; HAND; MONKEY; REPRESENTATION; RECORDINGS; KINEMATICS	In this study, we used electrocorticographic (ECoG) signals to extract the onset of arm movement as well as the velocity of the hand as a function of time. ECoG recordings were obtained from three individuals while they performed reaching tasks in the left, right and forward directions. The ECoG electrodes were placed over the motor cortex contralateral to the moving arm. Movement onset was detected from gamma activity with near perfect accuracy (> 98%), and a multiple linear regression model was used to predict the trajectory of the reaching task in three-dimensional space with an accuracy exceeding 85%. An adaptive selection of frequency bands was used for movement classification and prediction. This demonstrates the efficacy of developing a real-time brain-machine interface for arm movements with as few as eight ECoG electrodes.	[Talakoub, Omid; Wong, Willy] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Talakoub, Omid; Popovic, Milos R.; Wong, Willy] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Marquez-Chin, Cesar; Popovic, Milos R.] Univ Hlth Network, Toronto Rehabil Inst, Rehabil Engn Lab, Toronto, ON, Canada; [Marquez-Chin, Cesar] Univ Hlth Network, Toronto Rehabil Inst, Neural Engn Lab, Toronto, ON, Canada; [Navarro, Jessie; Fonoff, Erich T.] Univ Sao Paulo, Med Sch, Dept Neurol, Div Funct Neurosurg,Inst Psychiat,Hosp Clin, Sao Paulo, Brazil; [Hamani, Clement] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; Universidade de Sao Paulo; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wong, W (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada.; Wong, W (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	willy.wong@utoronto.ca	Fonoff, Erich Talamoni/E-4327-2012	Fonoff, Erich Talamoni/0000-0001-7831-9941; Popovic, Milos R/0000-0002-2837-2346; Wong, Willy/0000-0002-3900-3140; Marquez-Chin, Cesar/0000-0002-9916-4122	Natural Sciences and Engineering Research Council [249669, 458039]; CRANIA; Toronto Rehabilitation Institute's Foundation; PVE/CNPq - PVECNPq/CNDCT [400201/2012]; PVE/CNPq-PVE CNPq/CNDCT [400201/2012]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); CRANIA; Toronto Rehabilitation Institute's Foundation; PVE/CNPq - PVECNPq/CNDCT; PVE/CNPq-PVE CNPq/CNDCT	This project was funded by the Natural Sciences and Engineering Research Council (Grants #249669 and #458039), CRANIA Project, Toronto Rehabilitation Institute's Foundation, and PVE/CNPq - PVECNPq/CNDCT (Grant#400201/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the Natural Sciences and Engineering Research Council (Grants #249669 and #458039), CRANIA Project, Toronto Rehabilitation Institute's Foundation, and PVE/CNPq-PVE CNPq/CNDCT (Grant#400201/2012).	Anderson NR, 2012, EXP BRAIN RES, V223, P1, DOI 10.1007/s00221-012-3226-1; Averbeck BB, 2005, J NEUROPHYSIOL, V93, P508, DOI 10.1152/jn.00357.2004; Bai O, 2008, J NEURAL ENG, V5, P24, DOI 10.1088/1741-2560/5/1/003; Bai O, 2011, CLIN NEUROPHYSIOL, V122, P364, DOI 10.1016/j.clinph.2010.07.010; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Bougrain L, 2009, J NEURAL ENG; Bradberry TJ, 2008, IEEE ENG MED BIO, P5306, DOI 10.1109/IEMBS.2008.4650412; Chen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083534; Chin CM, 2007, J NEURAL ENG, V4, P146, DOI 10.1088/1741-2560/4/2/014; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; Georgopoulos AP, 2005, EXP BRAIN RES, V167, P132, DOI 10.1007/s00221-005-0028-8; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Graimann B, 2004, IEEE T BIO-MED ENG, V51, P954, DOI 10.1109/TBME.2004.826671; Graimann B, 2003, IEEE T NEUR SYS REH, V11, P276, DOI 10.1109/TNSRE.2003.816863; Heldman DA, 2006, IEEE T NEUR SYS REH, V14, P180, DOI 10.1109/TNSRE.2006.875549; HOGAN N, 1984, J NEUROSCI, V4, P2745; Jiang N, 2015, CLIN NEUROPHYSIOL, V126, P154, DOI 10.1016/j.clinph.2014.05.003; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Levine SP, 2000, IEEE T REHABIL ENG, V8, P180, DOI 10.1109/86.847809; Liang NY, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00091; Mehring C, 2004, J PHYSIOL-PARIS, V98, P498, DOI 10.1016/j.jphysparis.2005.09.016; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Milekovic T, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046003; Nakanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072085; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Talakoub O, 2016, SCI REP-UK, V6, DOI 10.1038/srep34930; Talakoub O, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00431; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Teixeira Manoel Jacobsen, 2013, Acta Neurochir Suppl, V117, P73, DOI 10.1007/978-3-7091-1482-7_12; Townsend BR, 2006, J NEUROPHYSIOL, V96, P2578, DOI 10.1152/jn.01086.2005; Waldert S, 2009, J PHYSIOL-PARIS, V103, P244, DOI 10.1016/j.jphysparis.2009.08.007; Wang Zuoguan, 2012, Front Neuroeng, V5, P15, DOI 10.3389/fneng.2012.00015; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Yeom HG, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026006; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001; Zhuang J, 2010, IEEE T BIO-MED ENG, V57, P1774, DOI 10.1109/TBME.2010.2047015	49	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0182542	10.1371/journal.pone.0182542	http://dx.doi.org/10.1371/journal.pone.0182542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931054	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700004
J	Maltz, MR; Treseder, KK; McGuire, KL				Maltz, Mia R.; Treseder, Kathleen K.; McGuire, Krista L.			Links between plant and fungal diversity in habitat fragments of coastal shrubland	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; LANDSCAPE FRAGMENTATION; FUNCTIONAL DIVERSITY; MICROBIAL DIVERSITY; CHITINASE ACTIVITY; SOIL MICROBES; BIODIVERSITY; FOREST; CELLULOSE; RESPONSES	Habitat fragmentation is widespread across ecosystems, detrimentally affecting biodiversity. Although most habitat fragmentation studies have been conducted on macroscopic organisms, microbial communities and fungal processes may also be threatened by fragmentation. This study investigated whether fragmentation, and the effects of fragmentation on plants, altered fungal diversity and function within a fragmented shrubland in southern California. Using fluorimetric techniques, we assayed enzymes from plant litter collected from fragments of varying sizes to investigate enzymatic responses to fragmentation. To isolate the effects of plant richness from those of fragment size on fungi, we deployed litter bags containing different levels of plant litter diversity into the largest fragment and incubated in the field for one year. Following field incubation, we determined litter mass loss and conducted molecular analyses of fungal communities. We found that leaf-litter enzyme activity declined in smaller habitat fragments with less diverse vegetation. Moreover, we detected greater litter mass loss in litter bags containing more diverse plant litter. Additionally, bags with greater plant litter diversity harbored greater numbers of fungal taxa. These findings suggest that both plant litter resources and fungal function may be affected by habitat fragmentation's constraints on plants, possibly because plant species differ chemically, and may thus decompose at different rates. Diverse plant assemblages may produce a greater variety of litter resources and provide more ecological niche space, which may support greater numbers of fungal taxa. Thus, reduced plant diversity may constrain both fungal taxa richness and decomposition in fragmented coastal shrublands. Altogether, our findings provide evidence that even fungi may be affected by human-driven habitat fragmentation via direct effects of fragmentation on plants. Our findings underscore the importance of restoring diverse vegetation communities within larger coastal sage scrub fragments and suggest that this may be an effective way to improve the functional capacity of degraded sites.	[Maltz, Mia R.] Univ Calif Riverside, Ctr Conservat Biol, Riverside, CA 92521 USA; [Treseder, Kathleen K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [McGuire, Krista L.] Univ Oregon, Dept Biol, Eugene, OR 97403 USA	University of California System; University of California Riverside; University of California System; University of California Irvine; University of Oregon	Maltz, MR (corresponding author), Univ Calif Riverside, Ctr Conservat Biol, Riverside, CA 92521 USA.	mmaltz@uci.edu	Treseder, Kathleen K/E-5148-2011	Treseder, Kathleen K/0000-0003-2847-6935; McGuire Meliora, Krista/0000-0002-8970-8827	Kearney Foundation of Soil Science; U.S. National Science Foundation [DEB-1256896, DEB-1457160, EAR-1411942]; Office of Biological and Environmental Research of the Office of Science, U.S. Department of Energy [DE-SC0016410]; Mycological Society of America (Forest Fungal Ecology Research Award); Mycological Society of America (Translational Mycology Postdoctoral Award)	Kearney Foundation of Soil Science; U.S. National Science Foundation(National Science Foundation (NSF)); Office of Biological and Environmental Research of the Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); Mycological Society of America (Forest Fungal Ecology Research Award); Mycological Society of America (Translational Mycology Postdoctoral Award)	This project was funded by research grants from the Kearney Foundation of Soil Science, the U.S. National Science Foundation (DEB-1256896, DEB-1457160, and EAR-1411942), grant DE-SC0016410 from the Office of Biological and Environmental Research of the Office of Science, U.S. Department of Energy, and the Mycological Society of America (Forest Fungal Ecology Research Award and the Translational Mycology Postdoctoral Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego N, 2014, FUNGAL ECOL, V8, P18, DOI 10.1016/j.funeco.2013.12.007; Alexopoulos CJ, 1979, INTRO MYCOLOGY; Allison SD, 2005, ECOL LETT, V8, P626, DOI 10.1111/j.1461-0248.2005.00756.x; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison SD, 2007, SOIL ENZYMES LINKING; Alster CJ, 2013, SOIL BIOL BIOCHEM, V64, P68, DOI 10.1016/j.soilbio.2013.03.034; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amend AS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00109; Ashford OS, 2013, SOIL BIOL BIOCHEM, V62, P5, DOI 10.1016/j.soilbio.2013.03.001; Aziz NH, 2002, FOOD CONTROL, V13, P281, DOI 10.1016/S0956-7135(02)00028-2; Baldrian P, 2008, BR MYCOL SY, V28, P19; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; BENGTSSON G, 1993, OECOLOGIA, V93, P296, DOI 10.1007/BF00317684; Berlemont R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00639; Billings SA, 2008, LANDSCAPE ECOL, V23, P581, DOI 10.1007/s10980-008-9218-7; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Bolger DT, 1997, ECOL APPL, V7, P552, DOI 10.1890/1051-0761(1997)007[0552:RORTHF]2.0.CO;2; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Burkey TV, 1997, AM NAT, V150, P568, DOI 10.1086/286082; Caesar-TonThat TC, 2000, BIOL FERT SOILS, V32, P374, DOI 10.1007/s003740000263; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CHRISTENSEN M, 1989, MYCOLOGIA, V81, P1, DOI 10.2307/3759446; Dighton J., 2016, FUNGI ECOSYSTEM PROC, V2nd; Edman M, 2004, OIKOS, V104, P35, DOI 10.1111/j.0030-1299.2004.12454.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Flores-Renteria D, 2016, SOIL BIOL BIOCHEM, V92, P79, DOI 10.1016/j.soilbio.2015.09.015; Flores-Renteria D, 2015, MICROB ECOL, V69, P798, DOI 10.1007/s00248-015-0584-9; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Gao Hui, 2007, Journal of Ecology and Rural Environment, V23, P24; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; Glassman SI, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1677; Grilli G, 2012, PLANT ECOL, V213, P155, DOI 10.1007/s11258-011-9966-3; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grinnell J., 1917, Auk Cambridge Mass, V34; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hansen RA, 1998, APPL SOIL ECOL, V9, P17, DOI 10.1016/S0929-1393(98)00048-1; HARDER W, 1983, ANNU REV MICROBIOL, V37, P1, DOI 10.1146/annurev.mi.37.100183.000245; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hely C, 2000, CAN J FOREST RES, V30, P674, DOI 10.1139/cjfr-30-5-674; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; Hynson NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138158; Ibanez I, 2014, J ECOL, V102, P882, DOI 10.1111/1365-2745.12223; Irwin EG, 2007, P NATL ACAD SCI USA, V104, P20672, DOI 10.1073/pnas.0705527105; Ives AR, 1995, AM NAT, V146, P911, DOI 10.1086/285831; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; KroonBatenburg LMJ, 1997, GLYCOCONJUGATE J, V14, P677, DOI 10.1023/A:1018509231331; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leeflang BR, 2006, ACS SYM SER, V930, P133; Leyva C, 2006, NAT AREA J, V26, P117, DOI 10.3375/0885-8608(2006)26[117:CLFBTD]2.0.CO;2; Loreau M, 1998, P ROY SOC B-BIOL SCI, V265, P33, DOI 10.1098/rspb.1998.0260; Loreau M, 2001, P ROY SOC B-BIOL SCI, V268, P303, DOI 10.1098/rspb.2000.1366; Malmivaara-Lamsa M, 2008, SOIL BIOL BIOCHEM, V40, P1612, DOI 10.1016/j.soilbio.2008.01.013; Mangan SA, 2004, OECOLOGIA, V141, P687, DOI 10.1007/s00442-004-1684-2; McCaull J, 1994, NATURAL COMMUNITY CO; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068278; McGuire KL, 2010, ECOLOGY, V91, P2324, DOI 10.1890/09-0654.1; McTiernan KB, 1997, OIKOS, V78, P527, DOI 10.2307/3545614; Morin PJ, 2000, NATURE, V403, P718, DOI 10.1038/35001706; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; Nol E, 2005, CONSERV BIOL, V19, P836, DOI 10.1111/j.1523-1739.2005.00367.x; Norden J, 2013, J ECOL, V101, P701, DOI 10.1111/1365-2745.12085; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Raghubanshi AS, 2009, TROP ECOL, V50, P57; Riquelme M, 2007, EUKARYOT CELL, V6, P1853, DOI 10.1128/EC.00088-07; Riutta T, 2012, SOIL BIOL BIOCHEM, V49, P124, DOI 10.1016/j.soilbio.2012.02.028; RODRIGUEZKABANA R, 1983, PLANT SOIL, V75, P95, DOI 10.1007/BF02178617; Rubinoff D, 2001, CONSERV BIOL, V15, P1374, DOI 10.1046/j.1523-1739.2001.00176.x; Sanchez-Leon E, 2011, EUKARYOT CELL, V10, P683, DOI 10.1128/EC.00280-10; Schimel J, 2013, FRONT ECOL ENVIRON, V11, P405, DOI 10.1890/13.WB.016; Searle KR, 2010, OECOLOGIA, V163, P815, DOI 10.1007/s00442-010-1610-8; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Shay PE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01097; SINSABAUGH RL, 1991, AGR ECOSYST ENVIRON, V34, P43, DOI 10.1016/0167-8809(91)90092-C; SINSABAUGH RL, 1994, BIOL FERT SOILS, V17, P69, DOI 10.1007/BF00418675; Sinsabaugh RL, 2002, BOOK SOIL P, P249; SINSABAUGH RL, 2005, FUNGAL COMMUNITY ITS, P349, DOI DOI 10.1201/9781420027891.CH17; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sirulnik AG, 2007, APPL SOIL ECOL, V36, P1, DOI 10.1016/j.apsoil.2006.11.004; SOULE ME, 1992, OIKOS, V63, P39, DOI 10.2307/3545514; Soulee ME, 1987, VIABLE POPULATIONS C; Staddon P, 2010, ECOL LETT, V13, P543, DOI 10.1111/j.1461-0248.2010.01450.x; Staff SS, 1999, AGR USDO; Syphard AD, 2007, LANDSCAPE ECOL, V22, P431, DOI 10.1007/s10980-006-9025-y; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391	98	7	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184991	10.1371/journal.pone.0184991	http://dx.doi.org/10.1371/journal.pone.0184991			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926606	gold, Green Published			2022-12-27	WOS:000411166600060
J	Morrison, D; Wang, HY; Hahne, AC; Jones, BC; DeBruine, LM				Morrison, Danielle; Wang, Hongyi; Hahne, Amanda C.; Jones, Benedict C.; DeBruine, Lisa M.			Predicting the reward value of faces and bodies from social perception	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; BODY; VIEW	Social judgments of faces are thought to be underpinned by two perceptual components: valence and dominance. Recent work using a standard key-press task to assess reward value found that these valence and dominance components were both positively related to the reward value of faces. Although bodies play an important role in human social interaction, the perceptual dimensions that underpin social judgments of bodies and their relationship to the reward value of bodies are not yet known. The current study investigated these issues. We replicated previous studies showing that valence and dominance underpin social judgments of faces and that both components are positively related to the reward value of faces. By contrast, social judgments of bodies were underpinned by a single component that reflected aspects of both perceived valence and perceived dominance and was positively correlated with the reward value of bodies. These results highlight differences in how observers process faces and bodies.	[Morrison, Danielle; Wang, Hongyi; Jones, Benedict C.; DeBruine, Lisa M.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Hahne, Amanda C.] Humboldt State Univ, Psychol Dept, Arcata, CA 95521 USA	University of Glasgow; California State University System; California State Polytechnic University, Humboldt	Morrison, D (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	d.morrison.4@research.gla.ac.uk	DeBruine, Lisa M/A-6990-2008; Jones, Benedict/A-7850-2008	DeBruine, Lisa M/0000-0002-7523-5539; Jones, Benedict/0000-0001-7777-0220				Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2001, J STAT SOFTW, V67, P1; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Emerson J.D., 1983, TRANSFORMING DATA UN, P97; Emerson JD., 1983, MATH ASPECTS TRANSFO, P247; Hahn AC, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0978; Hahn AC, 2014, NEUROSCI BIOBEHAV R, V46, P591, DOI 10.1016/j.neubiorev.2014.08.015; Honekopp J, 2007, EVOL HUM BEHAV, V28, P106, DOI 10.1016/j.evolhumbehav.2006.09.001; Kret ME, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00028; KUZNETSOVA A, 2016, IMERTEST TESTS LINEA; McAleer P., 2014, PLOONE PUBLIC LIB, V9, P1, DOI [10.1371/journal.pone.0090779, DOI 10.1371/J0URNAL.P0NE.0090779]; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Sell A, 2012, HUM NATURE-INT BIOS, V23, P30, DOI 10.1007/s12110-012-9131-2; Thornhill R, 1999, EVOL HUM BEHAV, V20, P105, DOI 10.1016/S1090-5138(98)00044-0; Tovee MJ, 2001, BRIT J PSYCHOL, V92, P391, DOI 10.1348/000712601162257; Wang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161114	20	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185093	10.1371/journal.pone.0185093	http://dx.doi.org/10.1371/journal.pone.0185093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH4XT	28926615	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000411166600069
J	Yuan, MM; Feng, C; Wang, SY; Zhang, WW; Chen, M; Jiang, H; Feng, XS				Yuan, Mingmei; Feng, Cong; Wang, Shouyun; Zhang, Weiwei; Chen, Mo; Jiang, Hong; Feng, Xuesong			Selection of possible signature peptides for the detection of bovine lactoferrin in infant formulas by LC-MS/MS	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; MILK; PROTEINS; QUANTIFICATION; TRANSFERRIN; PRODUCTS	An LC-MS/MS assay based on a signature peptide was developed and fully validated for the quantitation of bovine lactoferrin in infant formulas. Three unreported signature peptides were derived and identified from the tryptic peptides of bovine lactoferrin. The peptide ETTVFENLPEK was used for quantification based on assay performance. The blank matrix camel milk powder and bovine lactoferrin protein standards were mixed and spiked with stable isotope-labeled internal standard to establish a calibration curve. The established method was extensively validated by determining the linearity (R-2 > 0.999), sensitivity (limit of quantitation, 0.16 mg/100 g), recovery (83.1-91.6%), precision (RSD < 5.4%) and repeatability (RSD < 7.7%). To validate the applicability of the method, four different brands of infant formulas in China were analysed. The acquired contents of bovine lactoferrin were 52.60-150.56 mg/100 g.	[Yuan, Mingmei; Wang, Shouyun; Feng, Xuesong] China Med Univ, Sch Pharm, Dept Pharmaceut Anal, Shenyang, Liaoning, Peoples R China; [Feng, Cong; Zhang, Weiwei; Chen, Mo; Jiang, Hong] China Med Univ, Sch Publ Hlth, Dept Hlth Lab Technol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Jiang, H (corresponding author), China Med Univ, Sch Publ Hlth, Dept Hlth Lab Technol, Shenyang, Liaoning, Peoples R China.	hjiang@cmu.edu.cn			Medical Education and Research Projects; Society of Medical Education; China Medical Association; China Association of Higher Education [2016A-YF002]; 13th Five-year Plan Project of Liaoning Higher Education Institute [GHZD160007]	Medical Education and Research Projects; Society of Medical Education; China Medical Association; China Association of Higher Education; 13th Five-year Plan Project of Liaoning Higher Education Institute	This work was financially supported by Medical Education and Research Projects in 2016, Society of Medical Education, China Medical Association and China Association of Higher Education (2016A-YF002). Also, it was part of a project funded by the 13th Five-year Plan Project of Liaoning Higher Education Institute (GHZD160007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; AISEN P, 1972, BIOCHIM BIOPHYS ACTA, V257, P314, DOI 10.1016/0005-2795(72)90283-8; Ansari P, 2011, ANAL BIOANAL CHEM, V399, P1105, DOI 10.1007/s00216-010-4422-0; Christoph Czerwenka, 2007, ANAL CHEM, V79, P5165; E.M. Agency, 2012, DRUG EVALUATION RES, V35, P396; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Hanson Lars A, 2002, Semin Neonatol, V7, P275, DOI 10.1016/S1084-2756(02)90124-7; IYER S, 1993, EUR J CLIN NUTR, V47, P232; Kanyshkova TG, 2003, EUR J BIOCHEM, V270, P3353, DOI 10.1046/j.1432-1033.2003.03715.x; Kappeler SR, 1999, INT DAIRY J, V9, P481, DOI 10.1016/S0958-6946(99)00117-X; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Lonnerdal B, 2016, J PEDIATR-US, V173, pS4, DOI 10.1016/j.jpeds.2016.02.070; Lutter P, 2011, J AOAC INT, V94, P1043; Maneva A, 2016, Z NATURFORSCH C, V58, P256; Manzoni P, 2016, J PEDIATR-US, V173, pS43, DOI 10.1016/j.jpeds.2016.02.075; Nowak P, 2013, J CHROMATOGR A, V1321, P127, DOI 10.1016/j.chroma.2013.10.073; Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n; Pattamatta U, 2013, CURR EYE RES, V38, P1110, DOI 10.3109/02713683.2013.811259; Qu J, 2006, ANAL CHEM, V78, P4543, DOI 10.1021/ac0521697; Tsakali E, 2014, J DAIRY SCI, V97, P4832, DOI 10.3168/jds.2013-7526; van Altena SEC, 2016, VET IMMUNOL IMMUNOP, V174, P11, DOI 10.1016/j.vetimm.2016.04.005; van den Broek I, 2013, J CHROMATOGR B, V929, P161, DOI 10.1016/j.jchromb.2013.04.030; Velona T, 1999, PEDIATR RES, V45, P658, DOI 10.1203/00006450-199905010-00008; Wakabayashi H, 2006, INT DAIRY J, V16, P1241, DOI 10.1016/j.idairyj.2006.06.013; Yiping Ren, 2010, Analytica Chimica Acta, V667, P96; Zhang JS, 2014, ANAL CHIM ACTA, V829, P33, DOI 10.1016/j.aca.2014.04.025	26	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184152	10.1371/journal.pone.0184152	http://dx.doi.org/10.1371/journal.pone.0184152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926582	gold, Green Submitted, Green Published			2022-12-27	WOS:000411166600010
J	Yaya, S; Bishwajit, G; Ekholuenetale, M; Shah, V; Kadio, B; Udenigwe, O				Yaya, Sanni; Bishwajit, Ghose; Ekholuenetale, Michael; Shah, Vaibhav; Kadio, Bernard; Udenigwe, Ogochukwu			Timing and adequate attendance of antenatal care visits among women in Ethiopia	PLOS ONE			English	Article							SKILLED BIRTH ATTENDANCE; DELIVERY; SERVICE; ZONE	Introduction Although ANC services are increasingly available to women in low and middle-income countries, their inadequate use persists. This suggests a misalignment between aims of the services and maternal beliefs and circumstances. Owing to the dearth of studies examining the timing and adequacy of content of care, this current study aims to investigate the timing and frequency of ANC visits in Ethiopia. Methods Data was obtained from the nationally representative 2011 Ethiopian Demographic and Health Survey (EDHS) which used a two-stage cluster sampling design to provide estimates for the health and demographic variables of interest for the country. Our study focused on a sample of 10,896 women with history of at least one childbirth event. Percentages of timing and adequacy of ANC visits were conducted across the levels of selected factors. Variables which were associated at 5% significance level were examined in the multivariable logistic regression model for association between timing and frequency of ANC visits and the explanatory variables while controlling for covariates. Furthermore, we presented the approach to estimate marginal effects involving covariate-adjusted logistic regression with corresponding 95% CI of delayed initiation of ANC visits and inadequate ANC attendance. The method used involved predicted probabilities added up to a weighted average showing the covariate distribution in the population. Results Results indicate that 66.3% of women did not use ANC at first trimester and 22.3% had ANC less than 4 visits. The results of this study were unique in that the association between delayed ANC visits and adequacy of ANC visits were examined using multivariable logistic model and the marginal effects using predicted probabilities. Results revealed that older age interval has higher odds of inadequate ANC visits. More so, type of place of residence was associated with delayed initiation of ANC visits, with rural women having the higher odds of delayed initiation of ANC visits (OR = 1.65; 95% CI: 1.26-2.18). However, rural women had 44% reduction in the odds of having inadequate ANC visits. In addition, multiparity showed higher odds of delayed initiation of ANC visit when compared to the primigravida (OR = 2.20; 95% CI: 1.07-2.69). On the contrary, there was 36% reduction in the odds of multigravida having inadequate ANC visits when compared to the women who were primigravida. There were higher odds of inadequacy in ANC visits among women who engaged in sales/business, agriculture, skilled manual and other jobs when compared to women who currently do not work, after adjusting for covariates. From the predictive margins, assuming the distribution of all covariates remained the same among respondents, but everyone was aged 15-19 years, we would expect 71.8% delayed initiation of ANC visit. If everyone was aged 20-24years, 73.4%; 25-29years, 66.5%; 30-34years, 64.8%; 35-39years, 65.6%; 40-44 years, 59.6% and 45-49 years, we would expect 70.1% delayed initiation of ANC visit. If instead the distribution of age was as observed and for other covariates remained the same among respondents, but no respondent lived in the rural, we would expect about 61.4% delayed initiation of ANC visit; if however, everyone lived in the rural, and we would expect 71.6% delayed initiation in ANC visit. Model III revealed the predictive margins of all factors examined for delayed initiation for ANC visits, while Model IV presented the predictive marginal effects of the determinants of adequacy of ANC visits. Conclusion The precise mechanism by which these factors affect ANC visits remain blurred at best. There may be factors on the demand side like the women's empowerment, financial support of the husband, knowledge of ANC visits in the context of timing, frequency and the expectations of ANC visits might be mediating the effects through the factors found associated in this study. Supply side factors like the quality of ANC services, skilled staff, and geographic location of the health centers also mediate their effects through the highlighted factors. Irrespective of the knowledge about the precise mechanism of action, policy makers could focus on improving women's empowerment, improving women's education, reducing wealth inequity and facilitating improved utilization of ANC through modifications on the supply side factors such as geographic location and focus on hard to reach women.	[Yaya, Sanni; Udenigwe, Ogochukwu] Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada; [Bishwajit, Ghose] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan, Hubei, Peoples R China; [Ekholuenetale, Michael] Womens Hlth & Act Res Ctr, Benin, Nigeria; [Shah, Vaibhav; Kadio, Bernard] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada	University of Ottawa; Huazhong University of Science & Technology; University of Ottawa	Yaya, S (corresponding author), Univ Ottawa, Sch Int Dev & Global Studies, Fac Social Sci, Ottawa, ON, Canada.	sanni.yaya@uOttawa.ca	Yaya, Sanni/C-1079-2019; Ekholuenetale, Michael/AAL-3655-2021	Yaya, Sanni/0000-0002-4876-6043; Ekholuenetale, Michael/0000-0002-2372-3020; Udenigwe, Ogochukwu/0000-0001-6844-8854				Adjiwanou V, 2013, SOC SCI MED, V86, P26, DOI 10.1016/j.socscimed.2013.02.047; Agha S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0979-8; Alkema L, 2015, SYSTEMATIC ANAL UN M, V6736, P1; Anastasi E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0695-9; Andrew EVW, 2014, PLOS ONE, V9; Antenatal Nigatu R., 2011, AFR HEALTH SCI, V11, P390; Bbaale E, 2011, AUSTRALAS MED J, V4, P431, DOI 10.4066/AMJ.2011.729; Beeckman K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-527; Belayneh T, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/132494; Bishwajit G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3915-y; Central Statistical Agency/Ethiopia and ICF International, 2012, ETH DEM HLTH SURV 20; Downe S, 2016, BJOG-INT J OBSTET GY, V123, P529, DOI 10.1111/1471-0528.13819; Dutamo Z, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1047-1; FDRE. (Federal Democratic Republic of Ethiopia), 2016, ETH WAT SECT DEV PRO; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Gebremeskel F, 2015, J ENV PUBLIC HLTH, V2015, P1; Gudayu TW, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-287; Gupta S., 2014, PLOS ONE, V9; Jennings L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-297; Kawungezi Peter Chris, 2015, Open J Prev Med, V5, P132; Mbuagbaw L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010994.pub2; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Pena-Rosas JP, 2017, BJOG INT J OBSTET GY; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Tadele N, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2057-y; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; Tariku A, 2010, ETHIOP J HEALTH DEV, V24, P226; Till SR, 2015, INCENTIVES INCREASIN, DOI [10.1002/14651858, DOI 10.1002/14651858]; Vogel JP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-19; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2015, WHO 2015 TRENDS MAT; Wilmoth J, 2009, B WORLD HEALTH ORGAN, V87, P256, DOI 10.2471/BLT.07.048280; Wilunda C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0067-y; Yaya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171573; Yeoh PL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152167	36	66	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184934	10.1371/journal.pone.0184934	http://dx.doi.org/10.1371/journal.pone.0184934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922383	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300046
J	Edwardson, DW; Boudreau, J; Mapletoft, J; Lanner, C; Kovala, AT; Parissenti, AM				Edwardson, Derek W.; Boudreau, Justin; Mapletoft, Jonathan; Lanner, Carita; Kovala, A. Thomas; Parissenti, Amadeo M.			Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; P-GLYCOPROTEIN EXPRESSION; EPITHELIAL OVARIAN-CANCER; EARLY BREAST-CANCER; NF-KAPPA-B; MULTIDRUG-RESISTANCE; IN-VITRO; LIPID-A; SIGNAL-TRANSDUCTION; ADJUVANT DOCETAXEL	Tumor Necrosis Factor alpha (TNF-alpha) has been shown to be released by tumor cells in response to docetaxel, and lipopolysaccharides (LPS), the latter through activation of toll-like receptor 4 (TLR4). However, it is unclear whether the former involves TLR4 receptor activation through direct binding of the drug to TLR4 at the cell surface. The current study was intended to better understand drug-induced TNF-a production in tumor cells, whether from short-term drug exposure or in cells selected for drug resistance. ELISAs were employed to measure cytokine release from breast and ovarian tumor cells in response to several structurally distinct chemotherapy agents and/or TLR4 agonists or antagonists. Drug uptake and drug sensitivity studies were also performed. We observed that several drugs induced TNF-arelease from multiple tumor cell lines. Docetaxel-induced cytokine production was distinct from that of LPS in both MyD88-positive (MCF-7) and MyD88-deficient (A2780) cells. The acquisition of docetaxel resistance was accompanied by increased constitutive production of TNF-alpha and CXCL1, which waned at higher levels of resistance. In docetaxel-resistant MCF-7 and A2780 cell lines, the production of TNF-a could not be significantly augmented by docetaxel without the inhibition of P-gp, a transporter protein that promotes drug efflux from tumor cells. Pretreatment of tumor cells with LPS sensitized MyD88positive cells (but not MyD88-deficient) to docetaxel cytotoxicity in both drug-naive and drug-resistant cells. Our findings suggest that taxane-induced inflammatory cytokine production from tumor cells depends on the duration of exposure, requires cellular drug-accumulation, and is distinct from the LPS response seen in breast tumor cells. Also, stimulation of the LPS-induced pathway may be an attractive target for treatment of drug-resistant disease.	[Edwardson, Derek W.; Kovala, A. Thomas; Parissenti, Amadeo M.] Laurentian Univ, PhD Program Biomol Sci, Sudbury, ON, Canada; [Boudreau, Justin; Lanner, Carita; Kovala, A. Thomas; Parissenti, Amadeo M.] Laurentian Univ, Dept Biol, Sudbury, ON, Canada; [Mapletoft, Jonathan; Lanner, Carita; Kovala, A. Thomas; Parissenti, Amadeo M.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada; [Lanner, Carita; Kovala, A. Thomas; Parissenti, Amadeo M.] Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada; [Parissenti, Amadeo M.] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Parissenti, Amadeo M.] Univ Ottawa, Div Oncol, Fac Med, Ottawa, ON, Canada	Laurentian University; Laurentian University; Laurentian University; Northern Ontario School of Medicine; Health Sciences North; Northern Ontario School of Medicine; University of Ottawa	Parissenti, AM (corresponding author), Laurentian Univ, PhD Program Biomol Sci, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Hlth Sci North Res Inst, Sudbury, ON, Canada.; Parissenti, AM (corresponding author), Univ Ottawa, Div Oncol, Fac Med, Ottawa, ON, Canada.	aparissenti@laurentian.ca		Kovala, A. Thomas/0000-0002-2908-5613	Northern Cancer Foundation of Sudbury from Northern Ontario School of Medicine	Northern Cancer Foundation of Sudbury from Northern Ontario School of Medicine	The study was supported by a grant from the Northern Cancer Foundation of Sudbury, along with additional support for the purchase of reagents through a grant to Tom Kovala from the Northern Ontario School of Medicine, https://www.ncfsudbury.com/; http://www.nosm.ca/research/default.aspx.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Al-Bataineh MM, 2010, BIOPHARM DRUG DISPOS, V31, P506, DOI 10.1002/bdd.731; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Ardestani S, 2013, CANCER RES, V73, P3938, DOI 10.1158/0008-5472.CAN-13-0002; Armstrong L, 2006, AM J RESP CELL MOL, V34, P219, DOI 10.1165/rcmb.2005-0087OC; Armstrong SR, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-40; Baker SD, 2004, CLIN CANCER RES, V10, P1976, DOI 10.1158/1078-0432.CCR-0842-03; Baldridge JR, 2002, J ENDOTOXIN RES, V8, P453, DOI 10.1179/096805102125001064; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; BERKOVA N, 1995, ANTICANCER RES, V15, P863; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BIEDLER JL, 1970, CANCER RES, V30, P1174; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BOGDAN C, 1992, J LEUKOCYTE BIOL, V52, P119, DOI 10.1002/jlb.52.1.119; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Buoncervello M, 2012, NEOPLASIA, V14, P855, DOI 10.1593/neo.121020; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Crown J, 2004, ONCOLOGIST, V9, P24, DOI 10.1634/theoncologist.9-suppl_2-24; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Dowling JK, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.22; Eltahir A, 1998, AM J SURG, V175, P127, DOI 10.1016/S0002-9610(97)00279-1; Erba E, 2000, BRIT J CANCER, V82, P1732; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Globocan, 2012, EST CANC INC MORT PR; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Good DW, 2012, J BIOL CHEM, V287, P20208, DOI 10.1074/jbc.M111.336255; Guo BQ, 2004, BREAST CANCER RES TR, V85, P31, DOI 10.1023/B:BREA.0000021046.29834.12; Jeyaseelan S, 2010, J IMMUNOL J IMMUNOL, V185, P6214; JOHNSON AG, 1956, J EXP MED, V103, P225, DOI 10.1084/jem.103.2.225; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawasaki K, 2003, J ENDOTOXIN RES, V9, P301, DOI 10.1179/096805103225002548; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; Lu L, 2015, J CONTROL RELEASE, V210, P134, DOI 10.1016/j.jconrel.2015.05.282; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Markauskas A, 2014, INT J GYNECOL CANCER, V24, P1420, DOI 10.1097/IGC.0000000000000241; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Martin M, 2010, NEW ENGL J MED, V363, P2200, DOI 10.1056/NEJMoa0910320; Masereeuw R, 2010, J BIOMED BIOTECHNOL, V2010; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; MILLER TP, 1991, J CLIN ONCOL, V9, P17, DOI 10.1200/JCO.1991.9.1.17; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Moore A, 1999, VACCINE, V17, P2517, DOI 10.1016/S0264-410X(99)00062-6; NIEHORSTER M, 1990, BIOCHEM PHARMACOL, V40, P1601, DOI 10.1016/0006-2952(90)90461-S; Nobili S, 2006, CURR DRUG TARGETS, V7, P861, DOI 10.2174/138945006777709593; Nobili S, 2014, LEUKEMIA LYMPHOMA, V55, P2071, DOI 10.3109/10428194.2013.866665; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; PARKER MM, 1983, JAMA-J AM MED ASSOC, V250, P3324, DOI 10.1001/jama.250.24.3324; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; Ran S, 2015, CANCER RES, V75, P2405, DOI 10.1158/0008-5472.CAN-14-3525; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; Reed K, 2008, EPIGENETICS-US, V3, P270, DOI 10.4161/epi.3.5.6868; Reife RA, 2005, J IMMUNOL REF, V175, P4490; Resman N, 2008, FEBS LETT, V582, P3929, DOI 10.1016/j.febslet.2008.10.037; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Sedgwick JD, 2000, IMMUNOL TODAY, V21, P110, DOI 10.1016/S0167-5699(99)01573-X; Sharma B, 2013, MOL CANCER THER, V12, P799, DOI 10.1158/1535-7163.MCT-12-0529; Shi Z, 2012, BREAST CANCER RES TR, V135, P737, DOI 10.1007/s10549-012-2196-0; Shirakawa K, 1999, JPN J CANCER RES, V90, P1380, DOI 10.1111/j.1349-7006.1999.tb00723.x; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Smith IE, 2006, BRIT MED J, V332, P223, DOI 10.1136/bmj.332.7535.223; Smith IE, 2006, BMJ-BRIT MED J, V332, P34, DOI 10.1136/bmj.332.7532.34; Sprowl JA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3083; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Taylor CW, 1997, BREAST CANCER RES TR, V42, P7, DOI 10.1023/A:1005716214718; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Trevejo JM, 2001, P NATL ACAD SCI USA, V98, P12162, DOI 10.1073/pnas.211423598; Trock BJ, 1997, J NATL CANCER I, V89, P917, DOI 10.1093/jnci/89.13.917; Tunggal JK, 2000, INT J CANCER, V86, P101, DOI 10.1002/(SICI)1097-0215(20000401)86:1<101::AID-IJC16>3.0.CO;2-I; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Visintin A, 2005, PHARM INHIBITION END; Vitiello M, 2004, CYTOKINE, V27, P15, DOI 10.1016/j.cyto.2004.03.010; Wang AC, 2014, ONCOL LETT, V7, P871, DOI 10.3892/ol.2013.1759; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wang Y, 2011, CYTOKINE, V56, P365, DOI 10.1016/j.cyto.2011.06.005; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wu Z, 2015, EUR J PAIN, V19, P889, DOI 10.1002/ejp.613; Yan B, 2006, CANCER RES, V66, P11565, DOI 10.1158/0008-5472.CAN-06-2540; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yu CH, 2007, CELL PHYSIOL BIOCHEM, V20, P853, DOI 10.1159/000110445; Zhang YT, 2012, CELL BIOL TOXICOL, V28, P269, DOI 10.1007/s10565-012-9221-2; Zimmer SM, 2008, J BIOL CHEM, V283, P27916, DOI 10.1074/jbc.M802826200	96	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0183662	10.1371/journal.pone.0183662	http://dx.doi.org/10.1371/journal.pone.0183662			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915246	Green Published, Green Submitted, gold			2022-12-27	WOS:000410861600004
J	Monostori, P; Klinke, G; Richter, S; Barath, A; Fingerhut, R; Baumgartner, MR; Kolker, S; Hoffmann, GF; Gramer, G; Okun, JG				Monostori, Peter; Klinke, Glynis; Richter, Sylvia; Barath, Akos; Fingerhut, Ralph; Baumgartner, Matthias R.; Koelker, Stefan; Hoffmann, Georg F.; Gramer, Gwendolyn; Okun, Juergen G.			Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; FALSE-POSITIVE RATE; VITAMIN-B-12 DEFICIENCY; ELECTROSPRAY-IONIZATION; 2-METHYLCITRIC ACID; TOTAL HOMOCYSTEINE; LIQUID-CHROMATOGRAPHY; PHENOTYPIC SPECTRUM; ORGANIC ACIDURIAS; INBORN-ERRORS	Background and aims Increased propionylcarnitine levels in newborn screening are indicative for a group of potentially severe disorders including propionic acidemia (PA), methylmalonic acidemias and combined remethylation disorders (MMACBL). This alteration is relatively non-specific, resulting in the necessity of confirmation and differential diagnosis in subsequent tests. Thus, we aimed to develop a multiplex approach for concurrent determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid from the same dried blood spot (DBS) as in primary screening (second-tier test). We also set out to validate the method using newborn and follow-up samples of patients with confirmed PA or MMACBL. Methods The assay was developed using liquid chromatography-tandem mass spectrometry and clinically validated with retrospective analysis of DBS samples from PA or MMACBL patients. Results Reliable determination of all three analytes in DBSs was achieved following simple and fast (< 20 min) sample preparation without laborious derivatization or any additional pipetting steps. The method clearly distinguished the pathological and normal samples and differentiated between PA and MMACBL in all stored newborn specimens. Methylcitric acid was elevated in all PA samples; 3-hydroxypropionic acid was also high in most cases. Methylmalonic acid was increased in all MMACBL specimens; mostly together with methylcitric acid. Conclusions A liquid chromatography-tandem mass spectrometry assay allowing simultaneous determination of the biomarkers 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in DBSs has been developed. The assay can use the same specimen as in primary screening (second-tier test) which may reduce the need for repeated blood sampling. The presented preliminary findings suggest that this method can reliably differentiate patients with PA and MMACBL in newborn screening. The validated assay is being evaluated prospectively in a pilot project for extension of the German newborn screening panel ("Newborn screening 2020"; Newborn Screening Center, University Hospital Heidelberg).	[Monostori, Peter; Klinke, Glynis; Richter, Sylvia; Koelker, Stefan; Hoffmann, Georg F.; Gramer, Gwendolyn; Okun, Juergen G.] Univ Hosp Heidelberg, Div Neuropediat & Metab Med, Dept Gen Pediat, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Barath, Akos] Univ Szeged, Dept Pediat, Szeged, Hungary; [Fingerhut, Ralph; Baumgartner, Matthias R.] Univ Childrens Hosp Zurich, Childrens Res Ctr, Div Metab, Zurich, Switzerland	Ruprecht Karls University Heidelberg; Szeged University; University Children's Hospital Zurich	Monostori, P (corresponding author), Univ Hosp Heidelberg, Div Neuropediat & Metab Med, Dept Gen Pediat, Ctr Pediat & Adolescent Med, Heidelberg, Germany.	monostoripeter@gmail.com	Baumgartner, Matthias/Q-2855-2017; Fingerhut, Ralph/AAY-5061-2021	Baumgartner, Matthias/0000-0002-9270-0826; Fingerhut, Ralph/0000-0002-9674-8931; Gramer, Gwendolyn/0000-0001-7596-6529	Dietmar Hopp Foundation, St. Leon Rot; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Dietmar Hopp Foundation, St. Leon Rot; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This work and the pilot study "Newborn screening 2020" at the Newborn Screening Center of the University Hospital Heidelberg are generously supported by the Dietmar Hopp Foundation, St. Leon Rot (http://dietmar-hopp-stiftung.de). We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dirbashi OY, 2017, J MED SCREEN, V24, P58, DOI 10.1177/0969141316645824; Al-Dirbashi OY, 2014, JIMD REP, V16, P65, DOI 10.1007/8904_2014_321; Baumgartner MR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0130-8; de Sain-van der Velden MGM, 2015, ANAL CHIM ACTA, V853, P435, DOI 10.1016/j.aca.2014.10.043; Dhondt JL, 2010, J INHERIT METAB DIS, V33, pS211, DOI 10.1007/s10545-010-9138-y; Dietzen DJ, 2009, CLIN CHEM, V55, P1615, DOI 10.1373/clinchem.2009.131300; Estrella J, 2014, J INHERIT METAB DIS, V37, P881, DOI 10.1007/s10545-014-9727-2; Fingerhut R, 2009, ANAL CHEM, V81, P3571, DOI 10.1021/ac8022235; Fu XW, 2013, JIMD REP, V10, P69, DOI 10.1007/8904_2012_205; Goldenberg AJ, 2016, MATERN CHILD HLTH J, V20, P693, DOI 10.1007/s10995-015-1869-9; Heringer J, 2016, J INHERIT METAB DIS, V39, P341, DOI 10.1007/s10545-015-9907-8; Hinton CF, 2010, J PEDIATR-US, V157, P162, DOI 10.1016/j.jpeds.2010.03.006; Horster F, 2017, JIMD REP, V32, P105, DOI 10.1007/8904_2016_537; Jain R, 2015, J CHILD NEUROL, V30, P641, DOI 10.1177/0883073813516194; Kolker S, 2015, J INHERIT METAB DIS, V38, P1059, DOI 10.1007/s10545-015-9840-x; Kolker S, 2015, J INHERIT METAB DIS, V38, P1041, DOI 10.1007/s10545-015-9839-3; Krawczyk H, 2007, J INHERIT METAB DIS, V30, P263, DOI 10.1007/s10545-007-0420-6; La Marca G, 2007, CLIN CHEM, V53, P1364, DOI 10.1373/clinchem.2007.087775; Lim JS, 2014, MOL GENET METAB, V113, P53, DOI 10.1016/j.ymgme.2014.07.018; Lindner M, 2008, J INHERIT METAB DIS, V31, P379, DOI 10.1007/s10545-008-0892-z; Lo SY, 2016, CLIN BIOCHEM, V49, P967, DOI 10.1016/j.clinbiochem.2016.05.010; Loeber JG, 2012, J INHERIT METAB DIS, V35, P603, DOI 10.1007/s10545-012-9483-0; Matern D, 2007, J INHERIT METAB DIS, V30, P585, DOI 10.1007/s10545-007-0691-y; Papp F, 2011, EGESZSEGTUDOMANY, V55, P19; Podebrad F, 1999, HRC-J HIGH RES CHROM, V22, P604; Remane D, 2010, RAPID COMMUN MASS SP, V24, P859, DOI 10.1002/rcm.4459; Roschinger W, 2015, MONATSSCHR KINDERH, V163, P142, DOI 10.1007/s00112-014-3297-0; Schroder TH, 2014, J NUTR, V144, P1658, DOI 10.3945/jn.114.194829; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Scolamiero E, 2014, CLIN BIOCHEM, V47, P312, DOI 10.1016/j.clinbiochem.2014.08.020; Shigematsu Y, 2010, J INHERIT METAB DIS, V33, pS283, DOI 10.1007/s10545-010-9111-9; Singh G, 2016, PEDIATR BLOOD CANCER, V63, P740, DOI 10.1002/pbc.25828; Slaughter JL, 2010, PEDIATRICS, V126, P910, DOI 10.1542/peds.2010-0943; Strnadova KA, 2007, CLIN CHEM, V53, P717, DOI 10.1373/clinchem.2006.076679; Therrell BL, 2015, SEMIN PERINATOL, V39, P171, DOI 10.1053/j.semperi.2015.03.002; Torresani T, 2007, PAEDIATRICA, V18, P56; Turgeon CT, 2010, CLIN CHEM, V56, P1686, DOI 10.1373/clinchem.2010.148957; Wagner M, 2016, MASS SPECTROM REV, V35, P361, DOI 10.1002/mas.21441; Whitehead VM, 2006, BRIT J HAEMATOL, V134, P125, DOI 10.1111/j.1365-2141.2006.06133.x	39	35	36	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184897	10.1371/journal.pone.0184897	http://dx.doi.org/10.1371/journal.pone.0184897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915261	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000410861600022
J	Seak, CJ; Yen, DHT; Ng, CJ; Wong, YC; Hsu, KH; Seak, JCY; Chen, HY; Seak, CK				Seak, Chen-June; Yen, David Hung-Tsang; Ng, Chip-Jin; Wong, Yon-Cheong; Hsu, Kuang-Hung; Seak, Joanna Chen-Yeen; Chen, Hsien-Yi; Seak, Chen-Ken			Rapid Emergency Medicine Score: A novel prognostic tool for predicting the outcomes of adult patients with hepatic portal venous gas in the emergency department	PLOS ONE			English	Article							EARLY WARNING SCORE; ACUTE PHYSIOLOGY; MORTALITY	Objective This study aims to evaluate the performance of Rapid Emergency Medicine Score (REMS), Rapid Acute Physiology Score (RAPS), and Modified Early Warning Score (MEWS) in ascertaining the severity of illness and predicting the mortality of adult hepatic portal venous gas (HPVG) patients presenting to the emergency department (ED). This will assist emergency physicians (EPs) in risk stratification. Methods Data for 66 adult HPVG patients who visited the EDs of 2 research hospitals between October 1999 and April 2016 were analyzed. REMS, RAPS, and MEWS were calculated based on data in the ED, and probability of death was calculated for each patient based on these scores. The ability of REMS, RAPS, and MEWS to predict group mortality was assessed by using receiver operating characteristic (ROC) curve analysis and calibration analysis. Results The sensitivity, specificity, and accuracy for each scoring system were 92.1%, 89.3%, and 90.9% for REMS, 86.8%, 82.1%, and 84.8% for RAPS, and 78.9%, 89.3%, and 83.3% for MEWS respectively. In the ROC curve analysis, the areas under the curve for REMS, RAPS, and MEWS were 0.929, 0.877, and 0.856 respectively. Conclusion Our study is the largest series performed in a population of adult HPVG patients in the ED. The results from this study demonstrate that REMS is superior in predicting the mortality of these patients compared to RAPS and MEWS. We therefore recommend that REMS be used for outcome prediction and risk stratification of adult HPVG in the ED.	[Seak, Chen-June; Ng, Chip-Jin; Chen, Hsien-Yi] Chang Gung Mem Hosp, Dept Emergency Med, Lin Kou Med Ctr, Taoyuan, Taiwan; [Seak, Chen-June; Ng, Chip-Jin; Wong, Yon-Cheong; Chen, Hsien-Yi] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Seak, Chen-June; Yen, David Hung-Tsang] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Sch Med, Taipei, Taiwan; [Seak, Chen-June] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Yen, David Hung-Tsang] Taipei Vet Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Wong, Yon-Cheong] Chang Gung Mem Hosp, Div Emergency & Crit Care Radiol, Dept Med Imaging & Intervent, Lin Kou Med Ctr, Taoyuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Taoyuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Hsu, Kuang-Hung] Chang Gung Mem Hosp, Dept Urol, Lin Kou Med Ctr, Taoyuan, Taiwan; [Seak, Joanna Chen-Yeen; Seak, Chen-Ken] Sarawak Gen Hosp, Kuching, Sarawak, Malaysia	Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; National Taiwan University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Ng, CJ (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, Lin Kou Med Ctr, Taoyuan, Taiwan.; Ng, CJ (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Hsu, KH (corresponding author), Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Taoyuan, Taiwan.; Hsu, KH (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan.; Hsu, KH (corresponding author), Chang Gung Mem Hosp, Dept Urol, Lin Kou Med Ctr, Taoyuan, Taiwan.	ngowl@ms3.hinet.net; khsu@mail.cgu.edu.tw	bulut, mehtap/AAX-5571-2021; Smith, Gary B/A-8235-2013; Wong, Yon Cheong/F-8411-2010	Wong, Yon Cheong/0000-0001-8831-3295; Goh, Zhong Ning Leonard/0000-0002-9252-0323; SEAK, CHEN-JUNE/0000-0003-0984-8385; Hsu, Kuang-Hung/0000-0003-2642-7689	Ministry of Science and Technology of Taiwan [NSC-104- 2410-H-182-028-MY2]; Chang Gung Memorial Hospital in Taiwan [CORPG3F0931]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital)	This work was supported by the Ministry of Science and Technology of Taiwan [NSC-104- 2410-H-182-028-MY2] and Chang Gung Memorial Hospital in Taiwan (CORPG3F0931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; This work was supported by the Ministry of Science and Technology of Taiwan [NSC-104-2410-H-182-028-MY2] and Chang Gung Memorial Hospital in Taiwan (CORPG3F0931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Er-Chien, Cho B.S for her assistance in analyzing part of the data and the editing process. We are also grateful to Goh Zhong Ning Leonard for his critical review of the manuscript, as well as language editing, formatting, and proofreading of this publication in its final version.	Abboud B, 2009, WORLD J GASTROENTERO, V15, P3585, DOI 10.3748/wjg.15.3585; Armagan E, 2008, EUR J EMERG MED, V15, P338, DOI 10.1097/MEJ.0b013e3283034222; Bulut M, 2014, EMERG MED J, V31, P476, DOI 10.1136/emermed-2013-202444; Dundar ZD, 2016, EUR J EMERG MED, V23, P406, DOI 10.1097/MEJ.0000000000000274; Faberman RS, 1997, AM J ROENTGENOL, V169, P1535, DOI 10.2214/ajr.169.6.9393159; Ghanem-Zoubi NO, 2011, CRIT CARE, V15, DOI 10.1186/cc10102; Goodacre S, 2006, EMERG MED J, V23, P372, DOI 10.1136/emj.2005.028522; Hargrove J, 2005, CRIT CARE, V9, P376, DOI 10.1186/cc3518; Imhoff BF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004738; Kinoshita H, 2001, ARCH SURG-CHICAGO, V136, P1410, DOI 10.1001/archsurg.136.12.1410; LIEBMAN PR, 1978, ANN SURG, V187, P281, DOI 10.1097/00000658-197803000-00012; Monneuse O, 2007, WORLD J SURG, V31, P1065, DOI 10.1007/s00268-006-0589-0; Muscari F, 1999, Chirurgie, V124, P69, DOI 10.1016/S0001-4001(99)80045-2; Olsson T, 2004, J INTERN MED, V255, P579, DOI 10.1111/j.1365-2796.2004.01321.x; Olsson T, 2003, ACAD EMERG MED, V10, P1040, DOI 10.1197/S1069-6563(03)00342-7; RHEE KJ, 1990, ANN EMERG MED, V19, P552, DOI 10.1016/S0196-0644(05)82188-2; RHEE KJ, 1987, AM J EMERG MED, V5, P278, DOI 10.1016/0735-6757(87)90350-0; Seak CJ, 2014, AM J EMERG MED, V32, P1481, DOI 10.1016/j.ajem.2014.09.011; Seak CJ, 2014, AM J EMERG MED, V32, P972, DOI 10.1016/j.ajem.2014.05.016; Shah PA, 2011, RADIOGRAPHICS, V31, P1403, DOI 10.1148/rg.315095108; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Subbe CP, 2003, ANAESTHESIA, V58, P797, DOI 10.1046/j.1365-2044.2003.03258.x; WOLFE JN, 1955, AMER J ROENTGENOL RA, V74, P486	23	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184813	10.1371/journal.pone.0184813	http://dx.doi.org/10.1371/journal.pone.0184813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915258	Green Submitted, gold, Green Published			2022-12-27	WOS:000410861600016
J	Shaikeea, AJD; Basu, S; Tyagi, A; Sharma, S; Hans, R; Bansal, L				Shaikeea, Angkur Jyoti Dipanka; Basu, Saptarshi; Tyagi, Abhishek; Sharma, Saksham; Hans, Rishabh; Bansal, Lalit			Universal representations of evaporation modes in sessile droplets	PLOS ONE			English	Article							HEAT-TRANSFER; DYNAMICS; SURFACES; ARRAYS; PATTERNS	In this work, we provide a simple method to represent the contact line dynamics of an evaporating sessile droplet. As a droplet evaporates, two distinct contact line dynamics are observed. They are collectively known as modes of evaporation, namely Constant Contact Radius (CCR) and Constant Contact Angle (CCA). Another intermediate mode-Stick-Slide (SS) or mixed mode is also commonly observed. In this article, we are able to provide a graphical representation to these modes (named as MOE plot), which is visually more comprehensive especially for comparative studies. In addition, the method facilitates quantitative estimation for mode of evaporation (named as MOE fraction or MOEf), which doesn't exist in literature. Thus, various substrates can now be compared based on mode of evaporation (or contact line dynamics), which are governed by fluid property and surface characteristics.	[Shaikeea, Angkur Jyoti Dipanka] Univ Oxford, Dept Engn Sci, Oxford, England; [Basu, Saptarshi; Tyagi, Abhishek; Sharma, Saksham; Hans, Rishabh; Bansal, Lalit] Indian Inst Sci, Dept Mech Engn, Bangalore, Karnataka, India	University of Oxford; Indian Institute of Science (IISC) - Bangalore	Basu, S (corresponding author), Indian Inst Sci, Dept Mech Engn, Bangalore, Karnataka, India.	sbasu@mecheng.iisc.ernet.in	Bansal, Lalit/AAB-5554-2019; Basu, Saptarshi/GLT-7514-2022	Bansal, Lalit/0000-0003-0085-0227; Sharma, Saksham/0000-0003-1669-1179				Basu S, 2016, SOFT MATTER, V12, P4896, DOI 10.1039/c6sm00837b; Chakraborty M, 2017, SENSOR ACTUAT B-CHEM, V239, P562, DOI 10.1016/j.snb.2016.06.145; Chang C, 2013, LAB CHIP, V13, P1817, DOI [10.1039/c3lc41418c, 10.1039/c3lc41418]; Datta SS, 2010, LANGMUIR, V26, P18612, DOI 10.1021/la103874z; Dugas V, 2005, LANGMUIR, V21, P9130, DOI 10.1021/la050764y; Farshchian B, 2017, APPL SURF SCI, V396, P359, DOI 10.1016/j.apsusc.2016.10.153; Filatov NA, 2016, J PHYS CONF SER, V741, DOI 10.1088/1742-6596/741/1/012052; Francois M, 2002, PROG AEROSP SCI, V38, P275, DOI 10.1016/S0376-0421(02)00006-4; Gao A, 2011, NAN ENG MOL SYST NEM, P241; Hu DH, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.042805; Laghezza G, 2016, SOFT MATTER, V12, P5787, DOI 10.1039/c6sm00767h; Miljkovic N, 2012, ACS NANO, V6, P1776, DOI 10.1021/nn205052a; Nguyen TAH, 2017, CHEM ENG SCI, V167, P78, DOI 10.1016/j.ces.2017.04.001; PICKNETT RG, 1977, J COLLOID INTERF SCI, V61, P336, DOI 10.1016/0021-9797(77)90396-4; Seo C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00497-x; Sharma Sanjiv, 2013, Methods Mol Biol, V949, P207, DOI 10.1007/978-1-62703-134-9_15; Shembekar N, 2016, LAB CHIP, V16, P1314, DOI 10.1039/c6lc00249h; Shin DH, 2009, MICROELECTRON ENG, V86, P1350, DOI 10.1016/j.mee.2009.01.026; Stauber J. M., 2014, J FLUID MECH, P744; Susarrey-Arce A, 2016, LANGMUIR, V32, P7159, DOI 10.1021/acs.langmuir.6b01658; Wagner O, 2016, LAB CHIP, V16, P65, DOI 10.1039/c5lc00823a; Wang JZ, 2004, NAT MATER, V3, P171, DOI 10.1038/nmat1073; Xiao J, 2012, LANGMUIR, V28, P4434, DOI 10.1021/la2034565; Xu KR, 2016, ANAL CHEM, V88, P2652, DOI 10.1021/acs.analchem.5b03764; Zhang Q., 2017, SCI REPORTS, P7	25	12	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184997	10.1371/journal.pone.0184997	http://dx.doi.org/10.1371/journal.pone.0184997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915263	Green Published, Green Submitted, gold			2022-12-27	WOS:000410861600026
J	Ripka, WL; Ulbricht, L; Gewehr, PM				Ripka, Wagner Luis; Ulbricht, Leandra; Gewehr, Pedro Miguel			Body composition and prediction equations using skinfold thickness for body fat percentage in Southern Brazilian adolescents	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; WAIST CIRCUMFERENCE; CHILDREN; OBESITY; PREVALENCE; OVERWEIGHT; CHILDHOOD; FATNESS; MODEL; RISK	Objectives The purpose of this study was to: a) determine the nutritional status of Brazilian adolescents, and; b) present a skinfold thickness model (ST) to estimate body fat developed with Brazilian samples, using dual energy x-ray absorptiometry (DXA) as reference method. Methods The main study group was composed of 374 adolescents, and further 42 adolescents for the validation group. Weight, height, waist circumference measurements, and body mass index (BMI) were collected, as well as nine ST-biceps (BI), triceps (TR), chest (CH), axillary (AX) subscapularis (SB), abdominal (AB), suprailiac (SI), medial thigh (TH), calf (CF), and fat percentage (%BF) obtained by DXA. Results The prevalence of overweight in adolescents was 20.9%, and obesity 5.8%. Regression analysis through ordinary least square method (OLS) allowed obtainment of three equations with values of R-2 = 0.935, 0.912 and 0.850, standard error estimated = 1.79, 1.78 and 1.87, and bias = 0.06, 0.20 and 0.05, respectively. Conclusion the innovation of this study lies in presenting new regression equations for predicting body fat in Southern Brazilian adolescents based on a representative and heterogeneous sample from DXA.	[Ripka, Wagner Luis; Gewehr, Pedro Miguel] Univ Tecnol Fed Parana, Grad Program Elect & Comp Engn, Curitiba, Parana, Brazil; [Ulbricht, Leandra] Univ Tecnol Fed Parana, Grad Program Biomed Engn, Curitiba, Parana, Brazil	Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidade Tecnologica Federal do Parana; Pontificia Universidade Catolica do Parana; Universidade Federal do Parana; Universidade Tecnologica Federal do Parana	Ripka, WL (corresponding author), Univ Tecnol Fed Parana, Grad Program Elect & Comp Engn, Curitiba, Parana, Brazil.	ripka.w@gmail.com	Ripka, Wagner/J-7503-2015; Ulbricht, Leandra/H-8535-2012	Ripka, Wagner/0000-0002-6191-1188; Ulbricht, Leandra/0000-0002-9514-2938; gewehr, pedro miguel/0000-0002-9694-7906	Programa de Pesquisa para o Sistema Unico de Salide: Gestao Compartilhada em SaUde PPSUS [41614 - FA]; Federal University of Technology-Parana [982/2013]	Programa de Pesquisa para o Sistema Unico de Salide: Gestao Compartilhada em SaUde PPSUS; Federal University of Technology-Parana	This project received funding from Programa de Pesquisa para o Sistema Unico de Salide: Gestao Compartilhada em SaUde PPSUS edition 04/2012, project number: 41614 - FA, agreement 982/2013 with Federal University of Technology-Parana. The funders had no role in the study design, data collection and analysis, decision to publish, preparation of the manuscript, and none of the authors received a salary. The resources were used to cover the expenses of the adolescents' DXA assessment.	Bacopoulou F, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0366-z; Cicek B, 2014, J PAK MED ASSOC, V64, P1154; De Miguel-Etayo P, 2013, WORLD REV NUTR DIET, V108, P98, DOI 10.1159/000351493; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dismuke C., 2006, METHODS OUTCOMES RES, V93, P93; Feldmann L.R.A., 2012, RBONE REV BRASILEIRA, V3, P225; Flavel NA, 2012, ACTA PAEDIATR, V101, P1253, DOI 10.1111/apa.12024; Freedman DS, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0493-6; Goyal Ramesh K, 2010, J Assoc Physicians India, V58, P151; Hussain Z, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004194; ICB Almeida AMd Santos AS Barbosa DBVbody mass index and of waist circumference on adolescents, 2008, ARQUIVOS BRASILEIROS, V90, P426; Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20; Klimek-Piotrowska W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122274; Lohman TG, 1992, CAD SAUDE PUBLICA, pS116; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Lyra CO, 2012, ANN HUM BIOL, V39, P275, DOI 10.3109/03014460.2012.685106; Machado-Rodrigues AM, 2016, J SCHOOL HEALTH, V86, P54, DOI 10.1111/josh.12350; Marfell-Jones M., 2006, INT SOC ADVANCEMENT; Maroco J., 2007, STAT ANAL SPSS APPL; Nooyens ACJ, 2007, AM J CLIN NUTR, V85, P1533, DOI 10.1093/ajcn/85.6.1533; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Perini Talita Adão, 2005, Rev Bras Med Esporte, V11, P81, DOI 10.1590/S1517-86922005000100009; Rank M, 2013, J PEDIATR-US, V163, P137, DOI 10.1016/j.jpeds.2013.01.020; Rodriguez G, 2005, EUR J CLIN NUTR, V59, P1158, DOI 10.1038/sj.ejcn.1602226; Schommer VA, 2014, ARQ BRAS CARDIOL, V102, P312, DOI 10.5935/abc.20140038; Sigulem D M, 2000, J Pediatr (Rio J), V76 Suppl 3, pS275; Silva DRP, 2013, REV ASSOC MED BRAS, V59, P475, DOI [10.1016/j.ramb.2013.03.006, 10.1016/S2255-4823(13)70507-1]; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Sopher AB, 2004, PEDIATRICS, V113, P1285, DOI 10.1542/peds.113.5.1285; WHO, 2006, WHO CHILD GROWTH STA; Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282; World Health Organization, 2015, ADOLESCENT HEALTH	33	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184854	10.1371/journal.pone.0184854	http://dx.doi.org/10.1371/journal.pone.0184854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910398	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200108
J	Zhang, XW; Han, XZ; Yu, WT; Wang, P; Cheng, WX				Zhang, Xiuwei; Han, Xiaozeng; Yu, Wantai; Wang, Peng; Cheng, Weixin			Priming effects on labile and stable soil organic carbon decomposition: Pulse dynamics over two years	PLOS ONE			English	Article							MICROBIAL BIOMASS; TEMPERATURE SENSITIVITY; MATTER; MECHANISMS; STABILIZATION; NITROGEN; INPUTS; BIODEGRADATION; RESPIRATION; FRACTIONS	Soil organic carbon (SOC) is a major component in the global carbon cycle. Yet how input of plant litter may influence the loss of SOC through a phenomenon called priming effect remains highly uncertain. Most published results about the priming effect came from short-term investigations for a few weeks or at the most for a few months in duration. The priming effect has not been studied at the annual time scale. In this study for 815 days, we investigated the priming effect of added maize leaves on SOC decomposition of two soil types and two treatments (bare fallow for 23 years, and adjacent old-field, represent stable and relatively labile SOC, respectively) of SOC stabilities within each soil type, using a natural C-13-isotope method. Results showed that the variation of the priming effect through time had three distinctive phases for all soils: (1) a strong negative priming phase during the first period (approximate to 0-90 days); (2) a pulse of positive priming phase in the middle (approximate to 70-160 and 140-350 days for soils from Hailun and Shenyang stations, respectively); and (3) a relatively stabilized phase of priming during the last stage of the incubation (>160 days and >350 days for soils from Hailun and Shenyang stations, respectively). Because of major differences in soil properties, the two soil types produced different cumulative priming effects at the end of the experiment, a positive priming effect of 3-7% for the Mollisol and a negative priming effect of 4-8% for the Alfisol. Although soil types and measurement times modulated most of the variability of the priming effect, relative SOC stabilities also influenced the priming effect for a particular soil type and at a particular dynamic phase. The stable SOC from the bare fallow treatment tended to produce a narrower variability during the first phase of negative priming and also during the second phase of positive priming. Averaged over the entire experiment, the stable SOC (i.e., the bare fallow) was at least as responsive to priming as the relatively labile SOC (i.e., the old-field) if not more responsive. The annual time scale of our experiment allowed us to demonstrate the three distinctive phases of the priming effect. Our results highlight the importance of studying the priming effect by investigating the temporal dynamics over longer time scales.	[Zhang, Xiuwei; Yu, Wantai; Wang, Peng; Cheng, Weixin] Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Liaoning, Peoples R China; [Zhang, Xiuwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Han, Xiaozeng] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Harbin, Heilongjiang, Peoples R China; [Cheng, Weixin] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; University of California System; University of California Santa Cruz	Cheng, WX (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Forest Ecol & Management, Shenyang, Liaoning, Peoples R China.; Han, XZ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Harbin, Heilongjiang, Peoples R China.; Cheng, WX (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	xzhan@iga.ac.cn; wxcheng@ucsc.edu	Cheng, Weixin/F-4968-2011	Cheng, Weixin/0000-0003-2964-2376	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB15030302]; National Basic Research Program of China (973Program) [2015CB150802]; National Natural Science Foundation of China [31200479, 31570620]; US National Science Foundation [DEB-1354098]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation(National Science Foundation (NSF))	This work was supported by Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB15030302), National Basic Research Program of China (973Program) (2015CB150802), National Natural Science Foundation of China (31200479, 31570620), US National Science Foundation (Grant No. DEB-1354098).; This work was supported by the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB15030302), National Basic Research Program of China (973 Program) (2015CB150802), and National Natural Science Foundation of China (31200479, 31570620). A grant from US National Science Foundation (Grant No. DEB-1354098) supported Cheng's work.	Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Blagodatskaya E, 2011, SOIL BIOL BIOCHEM, V43, P159, DOI 10.1016/j.soilbio.2010.09.028; Cardinael R, 2015, BIOGEOCHEMISTRY; Castellano MJ, 2015, GLOBAL CHANGE BIOL, V21, P3200, DOI 10.1111/gcb.12982; Cheng WX, 2014, NEW PHYTOL, V201, P31, DOI 10.1111/nph.12440; Cheng WX, 2003, SOIL SCI SOC AM J, V67, P1418, DOI 10.2136/sssaj2003.1418; Cheng WX, 1996, PLANT SOIL, V183, P263, DOI 10.1007/BF00011441; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Derrien D, 2014, SOIL BIOL BIOCHEM, V76, P149, DOI 10.1016/j.soilbio.2014.04.030; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Fontaine S, 2011, SOIL BIOL BIOCHEM, V43, P86, DOI 10.1016/j.soilbio.2010.09.017; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Guenet B, 2012, SOIL BIOL BIOCHEM, V52, P43, DOI 10.1016/j.soilbio.2012.04.001; Guenet B, 2010, APPL SOIL ECOL, V46, P436, DOI 10.1016/j.apsoil.2010.09.006; Hamer U, 2005, SOIL BIOL BIOCHEM, V37, P445, DOI 10.1016/j.soilbio.2004.07.037; Hopkins FM, 2014, SOIL BIOL BIOCHEM, V76, P57, DOI 10.1016/j.soilbio.2014.04.028; HORVATH RS, 1972, BACTERIOL REV, V36, P146, DOI 10.1128/MMBR.36.2.146-155.1972; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Li HB, 2015, COMMUN SOIL SCI PLAN, V46, P405, DOI 10.1080/00103624.2014.956887; Lohnis F, 1926, SOIL SCI, V22, P253, DOI 10.1097/00010694-192610000-00001; Luo ZK, 2016, SOIL BIOL BIOCHEM, V101, P96, DOI 10.1016/j.soilbio.2016.07.011; MARTIN JP, 1980, SOIL SCI SOC AM J, V44, P1250, DOI 10.2136/sssaj1980.03615995004400060024x; Ohm H, 2007, J PLANT NUTR SOIL SC, V170, P551, DOI 10.1002/jpln.200625087; Perelo LW, 2006, SOIL BIOL BIOCHEM, V38, P912, DOI 10.1016/j.soilbio.2005.07.013; Salome C, 2010, GLOBAL CHANGE BIOL, V16, P416, DOI 10.1111/j.1365-2486.2009.01884.x; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Shahbaz M, 2017, BIOL FERT SOILS, V53, P287, DOI 10.1007/s00374-016-1174-9; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; STOTT DE, 1983, PLANT SOIL, V70, P15, DOI 10.1007/BF02374746; Sullivan BW, 2013, SOIL BIOL BIOCHEM, V58, P293, DOI 10.1016/j.soilbio.2012.12.007; Thiessen S, 2013, SOIL BIOL BIOCHEM, V57, P739, DOI 10.1016/j.soilbio.2012.10.029; Tian QX, 2014, SOIL BIOL BIOCHEM, V68, P329, DOI 10.1016/j.soilbio.2013.10.015; Trumbore SE, 2008, SCIENCE, V321, P1455, DOI 10.1126/science.1160232; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; WU J, 1993, SOIL BIOL BIOCHEM, V25, P1435, DOI 10.1016/0038-0717(93)90058-J; Xiao C, 2015, PRIMING SOIL ORGANIC, P649; Zhang WW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052849, 10.1371/journal.pone.0054779]	42	37	38	13	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184978	10.1371/journal.pone.0184978	http://dx.doi.org/10.1371/journal.pone.0184978			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934287	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900070
J	Deckert, A; Neuhann, F; Klose, C; Bruckner, T; Beiersmann, C; Haloka, J; Nsofwa, M; Banda, G; Brune, M; Reutter, H; Rothenbacher, D; Zeier, M				Deckert, Andreas; Neuhann, Florian; Klose, Christina; Bruckner, Thomas; Beiersmann, Claudia; Haloka, John; Nsofwa, Mannie; Banda, Greg; Brune, Maik; Reutter, Helmut; Rothenbacher, Dietrich; Zeier, Martin			Assessment of renal function in routine care of people living with HIV on ART in a resource-limited setting in urban Zambia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; INFECTED ADULTS; SOUTH-AFRICA; FOLLOW-UP; TENOFOVIR; IMPAIRMENT; ASSOCIATION; DYSFUNCTION	Introduction Data on renal impairment in sub-Saharan Africa (SSA) remains scarce, determination of renal function is not part of routine assessments. We evaluated renal function and blood pressure in a cohort of people living with HIV (PLWH) on antiretroviral treatment (ART) in the Renal Care Zambia project (ReCaZa). Methods Using routine data from an HIV outpatient clinic from 2011-2013, we retrospectively estimated the glomerular filtration rate (eGFR, CKD-Epi formula) of PLWH on ART in Lusaka, Zambia. Data were included if adults had had at least one serum creatinine recorded and had been on ART for a minimum of three months. We investigated the differences in eGFR between ART subgroups with and without tenofovir disproxil fumarate (TDF), and applied multivariable linear models to associate ART and eGFR, adjusted for eGFR before ART initiation. Results and discussion Among 1118 PLWH (63,3% female, mean age 41.8 years, 83% ever on TDF; median duration 1461 [range 98 to 4342] days) on ART, 28.3% had an eGFR <90 ml/min, and 5.5% <60 ml/min at their last measurement. Information on other conditions associated with renal impairment was not systematically documented. Fourteen per cent of the PLWH who later switched to TDF-free ART had an initial eGFR lower 60ml/min. Nineteen percent had first-time hypertensive readings at their last visit. The multivariable models suggest that physicians acted according to guidelines and replaced TDF-containing ART if patients developed moderate/severe renal impairment. Conclusions Assessment of renal function in SSA remains a challenge. The vast majority of PLWH benefit from long-term ART, including improved renal function. However, approximately 5% of PLWH on ART may have clinically relevant decreased eGFR, and 27% hypertension. While a routine renal assessment might not be feasible, strategies to identify patients at risk are warranted. Targeted monitoring prior and during ART is recommended, however, should not delay ART access.	[Deckert, Andreas; Neuhann, Florian; Beiersmann, Claudia] Heidelberg Univ Hosp, Inst Publ Hlth, Heidelberg, Germany; [Klose, Christina; Bruckner, Thomas] Heidelberg Univ Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Haloka, John; Nsofwa, Mannie; Banda, Greg; Reutter, Helmut] CHRESO Univ, Lusaka, Zambia; [Brune, Maik] Heidelberg Univ Hosp, Internal Med & Clin Chem 1, Heidelberg, Germany; [Rothenbacher, Dietrich] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Zeier, Martin] Heidelberg Univ Hosp, Div Nephrol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ulm University; Ruprecht Karls University Heidelberg	Deckert, A (corresponding author), Heidelberg Univ Hosp, Inst Publ Hlth, Heidelberg, Germany.	a.deckert@uni-heidelberg.de		Rothenbacher, Dietrich/0000-0002-3563-2791	Else Kroner-Fresenius Stiftung (EKFS) [2013_A84]	Else Kroner-Fresenius Stiftung (EKFS)	The ReCaZa study was enabled by a grant of the Else Kroner-Fresenius Stiftung (EKFS), EKFS project 2013_A84, http://www.ekfs.de/. The funding source was neither involved in design or conduct of the study, nor in the collection, management, analysis, interpretation of the data, or the preparation, review, approval of the manuscript, or the decision to submit the manuscript for publication. The authors declare that they have no other relevant financial interests.	Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Cailhol J, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-40; Chadwick DR, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0192-4; Neto LFDP, 2016, BRAZ J INFECT DIS, V20, P14, DOI 10.1016/j.bjid.2015.09.004; Elias A., 2013, PHARM PHARMACOL-RUSS, V4, P651, DOI [10.4236/pp.2013.49092, DOI 10.4236/PP.2013.49092]; Fabian J, 2009, NAT REV NEPHROL, V5, P591, DOI 10.1038/nrneph.2009.141; Glaser N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130453; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kalayjian RC, 2008, AIDS, V22, P481, DOI 10.1097/QAD.0b013e3282f4706d; Kamkuemah M, 2015, TROP MED INT HEALTH, V20, P518, DOI 10.1111/tmi.12446; Laprise C, 2013, CLIN INFECT DIS, V56, P567, DOI 10.1093/cid/cis937; Lucas GM, 2016, AIDS, V30, P619, DOI [10.1097/QAD.0000000000000949, 10.1097/QAD.0000000000000592]; Milburn J, 2016, NEPHROL DIAL TRANSPL; Ministry of Health, GOV REP ZAMB NAT HLT; Ministry of Health, GOV REP ZAMB NAT HUM; Ministry of Health Government of the Republic of Zambia, 2015, NAT TRAIN OP PLAN 20; Mocroft A, 2016, LANCET HIV, V3, pE23, DOI 10.1016/S2352-3018(15)00211-8; Mocroft A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001809; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mulenga L, 2014, CLIN INFECT DIS, V58, P1473, DOI 10.1093/cid/ciu117; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sauerbrei W, 2008, MULTIVARIABLE MODEL; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2014, WORLD FACTBOOK; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223; World Bank, 2014, WORLD DEV IND ZAMB	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184766	10.1371/journal.pone.0184766	http://dx.doi.org/10.1371/journal.pone.0184766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931037	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700034
J	Muniz, CP; Cavalcante, LTF; Jia, HW; Zheng, HQ; Tang, SH; Augusto, AM; Pissinatti, A; Fedullo, LP; Santos, AF; Soares, MA; Switzer, WM				Muniz, Claudia P.; Cavalcante, Liliane T. F.; Jia, Hongwei; Zheng, HaoQiang; Tang, Shaohua; Augusto, Anderson M.; Pissinatti, Alcides; Fedullo, Luiz P.; Santos, Andre F.; Soares, Marcelo A.; Switzer, William M.			Zoonotic infection of Brazilian primate workers with New World simian foamy virus	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; NONHUMAN-PRIMATES; WIDE DISTRIBUTION; RHESUS MACAQUES; MACACA-MULATTA; CENTRAL-AFRICA; HUMANS; REPLICATION; IDENTIFICATION; RETROVIRUSES	Simian foamy viruses (SFVs) are retroviruses present in nearly all nonhuman primates (NHPs), including Old World primates (OWP) and New World primates (NWP). While all confirmed human infections with SFV are from zoonotic transmissions originating from OWP, little is known about the zoonotic transmission potential of NWP SFV. We conducted a longitudinal, prospective study of 56 workers occupationally exposed to NWP in Brazil. Plasma from these workers was tested using Western blot (WB) assays containing NWP SFV antigens. Genomic DNA from blood and buccal swabs was analyzed for the presence of proviral SFV sequences by three nested PCR tests and a new quantitative PCR assay. Exposure histories were obtained and analyzed for associations with possible SFV infection. Ten persons (18%) tested seropositive and two persons were seroindeterminate (3.6%) for NWP SFV. Six persons had seroreactivity over 2-3 years suggestive of persistent infection. All SFV NWP WB-positive workers reported at least one incident involving NWP, including six reporting NWP bites. NWP SFV viral DNA was not detected in the blood or buccal swabs from all 12 NWP SFV seroreactive workers. We also found evidence of SFV seroreversion in three workers suggestive of possible clearance of infection. Our findings suggest that NWP SFV can be transmitted to occupationally-exposed humans and can elicit specific humoral immune responses but infection remains well-controlled resulting in latent infection and may occasionally clear.	[Muniz, Claudia P.; Cavalcante, Liliane T. F.; Santos, Andre F.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Muniz, Claudia P.; Jia, Hongwei; Zheng, HaoQiang; Tang, Shaohua; Switzer, William M.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Lab Branch, Atlanta, GA USA; [Augusto, Anderson M.; Fedullo, Luiz P.] Fundacao Jardim Zool Cidade Rio De Janeiro, Rio De Janeiro, Brazil; [Pissinatti, Alcides] Ctr Primatol Rio De Janeiro, Rio De Janeiro, Brazil; [Soares, Marcelo A.] Inst Nacl Canc, Programa Oncovirol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Centers for Disease Control & Prevention - USA; National Cancer Institute (Inca)	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Lab Branch, Atlanta, GA USA.	bis3@cdc.gov	Soares, Marcelo A/G-5662-2010; Santos, Andre FA/I-5734-2016		Brazilian Science Council (CNPq) grant [480529/2013-2]; Rio de Janeiro State Science Foundation (FAPERJ) grant [E-26/103.059/2011]; CDC intramural funding	Brazilian Science Council (CNPq) grant; Rio de Janeiro State Science Foundation (FAPERJ) grant; CDC intramural funding	This work was funded by the Brazilian Science Council (CNPq) grant 480529/2013-2 awarded to AFS, by the Rio de Janeiro State Science Foundation (FAPERJ) grant # E-26/103.059/2011 awarded to MAS, and by CDC intramural funding.	Betsem E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002306; Boneva RS, 2007, AIDS RES HUM RETROV, V23, P1330, DOI 10.1089/aid.2007.0104; Brooks JI, 2007, TRANSFUSION, V47, P162, DOI 10.1111/j.1537-2995.2007.01079.x; Brooks JI, 2002, LANCET, V360, P387, DOI 10.1016/S0140-6736(02)09597-1; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; CARE FOR THE WILD INTERNATIONAL, 2007, GOING POT NEOTR BUSH; Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054; Choudhary A, 2013, VIRUSES-BASEL, V5, P1414, DOI 10.3390/v5061414; Cummins JE, 2005, J VIROL, V79, P13186, DOI 10.1128/JVI.79.20.13186-13189.2005; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Falcone V, 1999, VIROLOGY, V257, P7, DOI 10.1006/viro.1999.9634; Gessain A, 2013, VIROLOGY, V435, P187, DOI 10.1016/j.virol.2012.09.035; Ghersi BM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0214-0; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; Huang F, 2012, AIDS RES HUM RETROV, V28, P591, DOI [10.1089/AID.2011.0305, 10.1089/aid.2011.0305]; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Katzourakis A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-61; Khan AS, 2006, TRANSFUSION, V46, P1352, DOI 10.1111/j.1537-2995.2006.00862.x; Mouinga-Ondeme A, 2013, VIRUSES-BASEL, V5, P1536, DOI 10.3390/v5061536; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Muniz CP, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0217-x; Muniz CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067568; Murray SM, 2008, J VIROL, V82, P5981, DOI 10.1128/JVI.00367-08; Murray SM, 2006, J VIROL, V80, P663, DOI 10.1128/JVI.80.2.663-670.2006; Pacheco B, 2010, J VIROL, V84, P4095, DOI 10.1128/JVI.02631-09; Peeters M, 2014, AIDS REV, V16, P23; Rua R, 2015, CURR OPIN VIROL, V10, P47, DOI 10.1016/j.coviro.2014.12.003; Rua R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077072; Rua R, 2012, J VIROL, V86, P909, DOI 10.1128/JVI.06235-11; Sandstrom PA, 2000, LANCET, V355, P551, DOI 10.1016/S0140-6736(99)05292-7; Soliven K, 2013, J VIROL, V87, P13628, DOI 10.1128/JVI.01989-13; Stenbak CR, 2014, J VIROL, V88, P982, DOI 10.1128/JVI.03154-13; Switzer WM, 2008, J INFECT DIS, V197, P1389, DOI 10.1086/587493; Switzer WM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157709; Switzer WM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-100; Switzer WM, 2004, J VIROL, V78, P2780, DOI 10.1128/JVI.78.6.2780-2789.2004; Switzer WM, 2001, TRANSPLANTATION, V71, P959, DOI 10.1097/00007890-200104150-00022; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Xu FW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-198; Yee JL, 2016, J MED PRIMATOL, V45, P55, DOI 10.1111/jmp.12209	41	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184502	10.1371/journal.pone.0184502	http://dx.doi.org/10.1371/journal.pone.0184502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931021	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700020
J	Munera-Bedoya, OD; Cassoli, LD; Machado, PF; Ceron-Munoz, MF				David Munera-Bedoya, Oscar; Cassoli, Laerte D.; Machado, Paulo F.; Fernando Ceron-Munoz, Mario			Influence of attitudes and behavior of milkers on the hygienic and sanitary quality of milk	PLOS ONE			English	Article							MANAGEMENT-PRACTICES; MASTITIS; PREVALENCE; FARMERS	Recognizing how human behaviors affect the milk process can be useful to understand variations in hygienic and sanitary parameters in bulk tank milk. Furthermore, this knowledge could be used to design management programs that guarantee milk quality, favoring the optimization of such processes. Forty-six milkers from the same number of dairy farms in Antioquia province (Colombia) were interviewed to establish the main factors associated to milk quality. Technical knowledge, motivations, and behavior of the personnel and its effect on hygienic and sanitary quality of milk were evaluated. Quality was assessed in terms of colony-forming units (CFU) and somatic cell count (SCC) in bulk tank milk. Two factors from a multivariate mixed data analysis were evaluated. One of those factors explained 9.51% of the total variability, related with in-farm availability and use of tools and the relationships between milker and manager. The other factor, associated with work environment and recognition, explained 6.97% of the total variability. The variables that best explained CFU levels were Knowledge of the udder condition at milking, and Milking type (parlor or pasture). The SCC was associated to knowledge of animal handling, schooling of milkers, milking site, and the groups derived from the cluster analysis by farm. In conclusion, milker attitudes and behaviors can affect CFU and SCC in bulk tank milk.	[David Munera-Bedoya, Oscar; Fernando Ceron-Munoz, Mario] Univ Antioquia, Fac Ciencias Agr, Medellin, Antioquia, Colombia; [David Munera-Bedoya, Oscar; Fernando Ceron-Munoz, Mario] Univ Antioquia, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Antioquia, Colombia; [Cassoli, Laerte D.; Machado, Paulo F.] Univ Sao Paulo, Clin Leite, ESALQ, Piracicaba, SP, Brazil	Universidad de Antioquia; Universidad de Antioquia; Universidade de Sao Paulo	Munera-Bedoya, OD (corresponding author), Univ Antioquia, Fac Ciencias Agr, Medellin, Antioquia, Colombia.; Munera-Bedoya, OD (corresponding author), Univ Antioquia, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Antioquia, Colombia.	grupogamma@udea.edu.co	Cerón-Muñoz, Mario Fernando/AAD-9778-2020; Cassoli, Laerte/H-2038-2012	Cerón-Muñoz, Mario Fernando/0000-0002-7233-6625; 	Secretaria de Agricultura y Desarrollo Rural de Antioquia; Universidad Nacional de Colombia; Universidad de Antioquia; Sistema General de Regalias-SGR [2012AS180031]; Comite para el Desarrollo de la Investigacion - CODI [ES84160119]; COLCIENCIAS Doctoral Study Program in Colombia [567]; General Royalties System-GRS (Colombia) [2012AS180031]; Committee for research development-CODI [2016 ES84160119]	Secretaria de Agricultura y Desarrollo Rural de Antioquia; Universidad Nacional de Colombia; Universidad de Antioquia; Sistema General de Regalias-SGR; Comite para el Desarrollo de la Investigacion - CODI; COLCIENCIAS Doctoral Study Program in Colombia; General Royalties System-GRS (Colombia); Committee for research development-CODI	This work was supported by Secretaria de Agricultura y Desarrollo Rural de Antioquia, Universidad Nacional de Colombia (Sede Medellin), Universidad de Antioquia, Sistema General de Regalias-SGR, agreement No 2012AS180031; and Comite para el Desarrollo de la Investigacion - CODI, agreement Estrategia de Sustentabilidad ES84160119 GaMMA group. COLCIENCIAS Doctoral Study Program in Colombia (agreement 567 of 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article is part of the project "Strengthening dairy chain productivity in the Northern Antioquia district", agreement No 2012AS180031, signed by the Secretary of Agriculture and Rural Development of Antioquia, Universidad Nacional de Colombia (Medellin), and Universidad de Antioquia, with funding from the General Royalties System-GRS (Colombia). This study received financial support from the Committee for research development-CODI (a Strategy for Sustainability 2016 ES84160119 GaMMA research group) and COLCIENCIAS Doctoral Study Program in Colombia (call 567 of 2012).	Ajzen I, 2005, HANDBOOK OF ATTITUDES, P173; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; BIGRASPOULIN M, 1985, PREV VET MED, V3, P241, DOI 10.1016/0167-5877(85)90019-4; Blowey R, 2010, MASTITIS CONTROL IN DAIRY HERDS, 2ND EDITION, P1, DOI 10.1079/9781845935504.0000; Calderon A, 2008, REV COLOMB CIENC PEC, V21, P582; Ceron-Munoz M. F., 2007, Revista Colombiana de Ciencias Pecuarias, V20, P472; Dufour S, 2011, J DAIRY SCI, V94, P563, DOI 10.3168/jds.2010-3715; Elmoslemany AM, 2009, J DAIRY SCI, V92, P2634, DOI 10.3168/jds.2008-1812; Husson F., 2010, PRINCIPAL COMPONENT, P1; Jansen J, 2009, PREV VET MED, V92, P210, DOI 10.1016/j.prevetmed.2009.08.015; Jansen J, 2012, 8 SEM INT LECH CARN, P63; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leach KA, 2010, RES VET SCI, V89, P318, DOI 10.1016/j.rvsc.2010.02.017; Lind A.-K., 2012, ACTA VET SCAND, V54, P1; PP J, 2004, REV STAT APPL, V52, P93; R Core Team, 2013, R LANG ENV STAT COMP; Ramírez Vásquez Nicolás, 2011, Rev. Med. Vet., P31; Reyes J, 2010, REV ELEC VET, V11, p[1, 10]; Santana R, 2009, B INIA, V148, P1; TARABLA HD, 1990, BRIT VET J, V146, P157, DOI 10.1016/0007-1935(90)90008-Q; Trujillo CM, 2011, REV COLOMB CIENC PEC, V24, P11; Valeeva NI, 2007, J DAIRY SCI, V90, P4466, DOI 10.3168/jds.2007-0095	22	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184640	10.1371/journal.pone.0184640	http://dx.doi.org/10.1371/journal.pone.0184640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926583	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600028
J	Zens, TJ; Danobeitia, JS; Chlebeck, PJ; Zitur, LJ; Odorico, S; Brunner, K; Coonen, J; Capuano, S; D'Alessandrol, AM; Matkowskyj, K; Zhong, WX; Torrealba, J; Fernandez, L				Zens, Tiffany J.; Danobeitia, Juan S.; Chlebeck, Peter J.; Zitur, Laura J.; Odorico, Scott; Brunner, Kevin; Coonen, Jennifer; Capuano, Saverio; D'Alessandrol, Anthony M.; Matkowskyj, Kristina; Zhong, Weixiong; Torrealba, Jose; Fernandez, Luis			Guidelines for the management of a brain death donor in the rhesus macaque: A translational transplant model	PLOS ONE			English	Article							DECEASED ORGAN DONORS; CARE MEDICINE/AMERICAN COLLEGE; CHEST PHYSICIANS/ASSOCIATION; ICU SOCIETY; PRETREATMENT; PROCUREMENT; KIDNEY; INFLAMMATION; DOPAMINE	Introduction The development of a translatable brain death animal model has significant potential to advance not only transplant research, but also the understanding of the pathophysiologic changes that occur in brain death and severe traumatic brain injury. The aim of this paper is to describe a rhesus macaque model of brain death designed to simulate the average time and medical management described in the human literature. Methods Following approval by the Institutional Animal Care and Use Committee, a brain death model was developed. Non-human primates were monitored and maintained for 20 hours after brain death induction. Vasoactive agents and fluid boluses were administered to maintain hemodynamic stability. Endocrine derangements, particularly diabetes insipidus, were aggressively managed. Results A total of 9 rhesus macaque animals were included in the study. The expected hemodynamic instability of brain death in a rostral to caudal fashion was documented in terms of blood pressure and heart rate changes. During the maintenance phase of brain death, the animal's temperature and hemodynamics were maintained with goals of mean arterial pressure greater than 60mmHg and heart rate within 20 beats per minute of baseline. Resuscitation protocols are described so that future investigators may reproduce this model. Conclusion We have developed a reproducible large animal primate model of brain death which simulates clinical scenarios and treatment. Our model offers the opportunity for researchers to have translational model to test the efficacy of therapeutic strategies prior to human clinical trials.	[Zens, Tiffany J.; Danobeitia, Juan S.; Chlebeck, Peter J.; Zitur, Laura J.; Odorico, Scott; D'Alessandrol, Anthony M.; Fernandez, Luis] Univ Wisconsin, Dept Surg, Div Transplantat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brunner, Kevin; Coonen, Jennifer; Capuano, Saverio] Univ Wisconsin, Wisconsin Primate Res Ctr, Madison, WI USA; [Matkowskyj, Kristina; Zhong, Weixiong] Univ Wisconsin, Dept Pathol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Torrealba, Jose] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fernandez, L (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	luisf@surgery.wisc.edu	Danobeitia, Juan/AAC-5327-2020	Danobeitia, Juan/0000-0003-1641-3822; ZITUR, LAURA/0000-0002-1238-2726	National Institutes of Health NIH [1-R01-A1110617-01A1]; NIH [T32 AI125231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110617, T32AI125231] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health NIH #1-R01-A1110617-01A1 (PI: Luis Fernandez) and an NIH training grant NIH #T32 AI125231 is funding Dr. Danobeitia's postdoctoral research fellowship in the lab.; This work was supported by National Institutes of Health NIH #1-R01-AI110617-01A1 (PI: LAF) and NIH # T32 AI125231 training grant. We would also like to acknowledge the National Primate Center at the University of Wisconsin for the excellent technical support on the care of our animals and Alpha Genesis for the kind support on providing animals and resources for our research.	Amatschek S, 2012, J HEPATOL, V56, P1305, DOI 10.1016/j.jhep.2012.01.020; Blasco V, 2007, CRIT CARE, V11, DOI 10.1186/cc6120; Blasi-Ibanez A, 2009, ANESTHESIOLOGY, V110, P333, DOI 10.1097/ALN.0b013e318194ca8a; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Chen L, 2016, TRANSPL P, V48, P205, DOI 10.1016/j.transproceed.2016.01.007; Danobeitia JS, 2015, CELL TRANSPLANT, V24, P1863, DOI 10.3727/096368914X681045; Floerchinger B, 2012, TRANSPLANT REV-ORLAN, V26, P54, DOI 10.1016/j.trre.2011.10.001; Frontera JA, 2010, NEUROCRIT CARE, V12, P103, DOI 10.1007/s12028-009-9292-y; Goarin JP, 1996, ANESTH ANALG, V83, P41, DOI 10.1097/00000539-199607000-00008; Herodin F, 2005, EUR CYTOKINE NETW, V16, P104; Hoeger S, 2007, TRANSPL INT, V20, P790, DOI 10.1111/j.1432-2277.2007.00510.x; Kolkert JLP, 2007, LAB ANIM-UK, V41, P363, DOI 10.1258/002367707781282848; Kotloff RM, 2015, CRIT CARE MED, V43, P1291, DOI 10.1097/CCM.0000000000000958; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; Marasco S, 2013, TRANSPL P, V45, P33, DOI 10.1016/j.transproceed.2012.08.008; Marques RG, 2004, TRANSPL P, V36, P1048, DOI 10.1016/j.transproceed.2004.04.043; Minambres E, 2010, NEPHROL DIAL TRANSPL, V25, P2352, DOI 10.1093/ndt/gfq054; Muller E, 2015, TRANSPLANTATION, V99, P1743, DOI 10.1097/TP.0000000000000896; Niemann CU, 2015, NEW ENGL J MED, V373, P2687, DOI 10.1056/NEJMc1511744; Nijboer WN, 2010, CRIT CARE MED, V38, P1155, DOI 10.1097/CCM.0b013e3181cf6e78; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Plurad DS, 2012, AM J SURG, V204, P856, DOI 10.1016/j.amjsurg.2012.05.011; Remuzzi G, 1999, J AM SOC NEPHROL, V10, P2591; Spindler RS, 2015, TRANSPLANTATION, V99, P935, DOI 10.1097/TP.0000000000000577; Uno Y, 2015, DRUG METAB PHARMACOK, V30, P130, DOI 10.1016/j.dmpk.2014.10.002; Uno Y, 2011, DRUG METAB REV, V43, P346, DOI 10.3109/03602532.2010.549492; Valenza F, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-12; Westphal GA, 2016, CLIN TRANSPLANT, V30, P138, DOI 10.1111/ctr.12667; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103; Wood KE, 2007, CURR OPIN ANESTHESIO, V20, P97, DOI 10.1097/ACO.0b013e3280895ac8; Youn TS, 2014, CRIT CARE CLIN, V30, P813, DOI 10.1016/j.ccc.2014.06.010; Yuan QP, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-52; Zhang SJ, 2014, EXP CLIN TRANSPLANT, V12, P469, DOI 10.6002/ect.2013.0229	33	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0182552	10.1371/journal.pone.0182552	http://dx.doi.org/10.1371/journal.pone.0182552			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926566	Green Submitted, gold, Green Published			2022-12-27	WOS:000411166600002
J	Yen, CH; Hung, CL; Lee, PY; Tsai, JP; Lai, YH; Su, CH; Yeh, HI; Hou, CJY; Chien, KL				Yen, Chih-Hsuan; Hung, Chung-Lieh; Lee, Ping-Ying; Tsai, Jui-Peng; Lai, Yau-Huei; Su, Cheng-Huang; Yeh, Hung-I; Hou, Charles Jia-Yin; Chien, Kuo-Liong			Segmental arterial stiffness in relation to B-type natriuretic peptide with preserved systolic heart function	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; CARDIOVASCULAR RISK; DIASTOLIC FUNCTION; EJECTION FRACTION; AORTIC STIFFNESS; BLOOD-PRESSURE; FAILURE; DISEASE; INDEX; HYPERTENSION	Background Central arterial stiffness has been shown to play a key role in cardiovascular disease. However, evidence regarding such arterial stiffness from various arterial segments in relation to B-type natriuretic peptide (BNP) remains elusive. Methods A total of 1255 participants (47.8% men; mean age: 62.6 +/- 12.3 [SD] years) with preserved left ventricular function (ejection fraction >= 50%) and >= 1 risk factors were consecutively studied. Arterial pulse wave velocity (PWV) by automatic device (VP-2000; Omron Healthcare) for heart-femoral (hf-PWV), brachial-ankle (ba-PWV), and heart-carotid (hc-PWV) segments were obtained and related to BNP concentrations (Abbott Diagnostics, Abbott Park, IL, USA). Results Subjects in the highest hf-PWV quartile were older and had worse renal function and higher blood pressure (all P < 0.05). Elevated PWV (m/s) was correlated with elevated BNP (pg/ml) (beta coefficient = 19.3, 12.4, 5.9 for hf-PWV, ba-PWV, hc-PWV respectively, all p < 0.05). After accounting for clinical co-variates and left ventricle mass index (LVMI), both hf-PWV and ba-PWV were correlated with higher BNP (beta coefficient = 8.3, 6.4 respectively, P < 0.01 for each). Adding both hf-PWV and ba-PWV to LVMI significantly expanded ROC in predicting abnormal BNP>100 pg/ml (both P < 0.01), but only hf-PWV presented significant integrated discrimination improvement to predict risk for BNP concentrations (0.7%, P = 0.029). Conclusion A significant segmental PWV associated with biomarker BNP concentrations suggests that arterial stiffness is associated with myocardial damage.	[Yen, Chih-Hsuan; Hung, Chung-Lieh; Lee, Ping-Ying; Tsai, Jui-Peng; Lai, Yau-Huei; Su, Cheng-Huang; Yeh, Hung-I; Hou, Charles Jia-Yin] Mackay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Yen, Chih-Hsuan; Hung, Chung-Lieh; Lee, Ping-Ying; Tsai, Jui-Peng; Lai, Yau-Huei; Su, Cheng-Huang; Hou, Charles Jia-Yin] Nursing & Management Coll, Mackay Med, Taipei, Taiwan; [Yen, Chih-Hsuan; Tsai, Jui-Peng; Chien, Kuo-Liong] Natl Taiwan Univ, Sch Publ Hlth, Inst Prevent Med, Taipei, Taiwan; [Yeh, Hung-I] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ, Med Coll, Dept Internal Med Cardiol, Taipei, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; National Taiwan University; Mackay Medical College; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chien, KL (corresponding author), Natl Taiwan Univ, Sch Publ Hlth, Inst Prevent Med, Taipei, Taiwan.; Chien, KL (corresponding author), Natl Taiwan Univ, Med Coll, Dept Internal Med Cardiol, Taipei, Taiwan.; Chien, KL (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.	klchien@ntu.edu.tw	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; CHIEN, KUO-LIONG/0000-0003-4979-8351	Ministry of Science and Technology (Taiwan) [NSC-101-2314-B-195-020, NSC103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3, NSC102-2314-B-002-046-MY3]; Mackay Memorial Hospital [10271, 10248, 10220, 10253, 10375, 10358, E-102003]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This research supported by Ministry of Science and Technology (Taiwan) (NSC-101-2314-B-195-020, NSC103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3, NSC102-2314-B-002-046-MY3), and funds from Mackay Memorial Hospital (10271, 10248, 10220, 10253, 10375, 10358,E-102003).	Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Borlaug BA, 2011, CIRCULATION, V123, P2006, DOI 10.1161/CIRCULATIONAHA.110.954388; Bueno H, 2010, JAMA; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Chen CH, 1998, J AM COLL CARDIOL, V32, P1221, DOI 10.1016/S0735-1097(98)00374-X; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; de Simone G, 1999, HYPERTENSION, V33, P800, DOI 10.1161/01.HYP.33.3.800; Greenland P, 2010, CIRCULATION, V122, pe584; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Guyton AC, 1986, PA WB SAUNDERS, P206; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Kang S, 2010, EUR HEART J, V31, P2799, DOI 10.1093/eurheartj/ehq296; Kass DA, 2005, HYPERTENSION, V46, P185, DOI 10.1161/01.HYP.0000168053.34306.d4; Koji Y, 2004, AM J CARDIOL, V94, P868, DOI 10.1016/j.amjcard.2004.06.020; Kullo IJ, 2007, J AM COLL CARDIOL, V49, P1413, DOI 10.1016/j.jacc.2006.11.039; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; Liao ZY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003053; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mahmud A, 2005, HYPERTENSION, V46, P1118, DOI 10.1161/01.HYP.0000185463.27209.b0; Mahmud A, 2002, AM J HYPERTENS, V15, P1092, DOI 10.1016/S0895-7061(02)02982-5; Maisel AS, 2012, J AM COLL CARDIOL, V60, P277, DOI 10.1016/j.jacc.2012.03.057; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; OROURKE M, 1990, HYPERTENSION, V15, P339, DOI 10.1161/01.HYP.15.4.339; Qiu H, 2007, CIRCULATION, V116, P669, DOI 10.1161/CIRCULATIONAHA.107.689208; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Ryabov V., 2012, POLSKI PRZEGLAD KARD, V14, P165; Shroff GR, 2009, J HUM HYPERTENS, V23, P783, DOI 10.1038/jhh.2009.17; Sung SH, 2009, AM J CARDIOL, V103, P1411, DOI 10.1016/j.amjcard.2009.01.355; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Takami T, 2003, HYPERTENS RES, V26, P609, DOI 10.1291/hypres.26.609; Tang WHW, 2008, J AM COLL CARDIOL, V52, P1671, DOI 10.1016/j.jacc.2008.08.026; Tartiere JM, 2006, J HUM HYPERTENS, V20, P213, DOI 10.1038/sj.jhh.1001965; van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044; Vlachopoulos C., 2010, JACC, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Yambe M, 2004, HYPERTENS RES, V27, P625, DOI 10.1291/hypres.27.625; Yu WC, 2008, J HUM HYPERTENS, V22, P24, DOI 10.1038/sj.jhh.1002259; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29; Zile MR, 2010, CIRCULATION, V121, P1393, DOI 10.1161/CIRCULATIONAHA.109.909614; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183747	10.1371/journal.pone.0183747	http://dx.doi.org/10.1371/journal.pone.0183747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922407	Green Submitted, Green Published, gold			2022-12-27	WOS:000411059300006
J	De, R; Liu, LY; Qian, Y; Zhu, RA; Deng, J; Wang, F; Sun, Y; Dong, HJ; Jia, LP; Zhao, LQ				De, Ri; Liu, Liying; Qian, Yuan; Zhu, Runan; Deng, Jie; Wang, Fang; Sun, Yu; Dong, Huijin; Jia, Liping; Zhao, Linqing			Risk of acute gastroenteritis associated with human bocavirus infection in children: A systematic review and meta-analysis	PLOS ONE			English	Review							INTESTINAL DISEASE; FECAL SAMPLES; PREVALENCE; PATHOGENS; STOOL	Human bocaviruses (HBoVs), which were first identified in 2005 and are composed of genotypes 1-4, have been increasingly detected worldwide in pediatric patients with acute gastroenteritis. To investigate if HBoV infection is a risk factor of acute gastroenteritis in children younger than 5 years old, we searched PubMed, Embase (via Ovid), the Chinese Biomedical Literature Database (CBM), and the Cochrane Library for studies assessing the prevalence of HBoVs in individuals from Oct 25, 2005 to Oct 31, 2016. We included studies using PCR-based diagnostics for HBoVs from stool specimens of patients with or without acute gastroenteritis that carried out research for over 1 year on pediatric patients aged younger than 5 years old. The primary outcome was the HBoV prevalence among all cases with acute gastroenteritis. Pooled estimates of the HBoV prevalence were then generated by fitting linear mixed effect meta-regression models. Of the 36 studies included, the pooled HBoV prevalence in 20,591 patients with acute gastroenteritis was 6.90% (95% confidence interval (95% CI): 5.80-8.10%). In the ten studies with a control group, HBoVs were detected in 12.40% of the 3,620 cases with acute gastroenteritis and in 12.22% of the 2,030 control children (odds ratio (OR): 1.44; 95% CI: 0.95-2.19, p = 0.09 between case and control groups). HBoV1 and HBoV2 were detected in 3.49% and 8.59% of acute gastroenteritis cases, respectively, and in 2.22% and 5.09% of control children, respectively (OR: 1.40; 95% CI: 0.61-3.25; p = 0.43 and OR: 1.68; 95% CI: 1.21-2.32; p = 0.002, respectively). Current evidence suggests that the overall HBoV prevalence in children younger than 5 years old is not significantly different between groups with or without acute gastroenteritis. However, when HBoV1 was excluded, the HBoV2 prevalence was significantly different between these two groups, which may imply that HBoV2 is a risk factor of acute gastroenteritis in children younger than 5 years old.	[De, Ri; Liu, Liying; Qian, Yuan; Zhu, Runan; Deng, Jie; Wang, Fang; Sun, Yu; Dong, Huijin; Jia, Liping; Zhao, Linqing] Capital Inst Pediat, Beijing Key Lab Etiol Viral Dis Children, Lab Virol, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Zhao, LQ (corresponding author), Capital Inst Pediat, Beijing Key Lab Etiol Viral Dis Children, Lab Virol, Beijing, Peoples R China.	linqingz525@163.com	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022; wang, fang/GYD-4295-2022		Beijing Municipal Commission of Health and Family [2014-2-1132]; Beijing Natural Science Foundation of China [7152026]	Beijing Municipal Commission of Health and Family; Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was supported by grants from the Beijing Municipal Commission of Health and Family "The Special Fund for Capital Health Research and Development" (No. 2014-2-1132) and the Beijing Natural Science Foundation of China (No. 7152026).	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Alam MM, 2015, J MED VIROL, V87, P656, DOI 10.1002/jmv.24090; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Amar CFL, 2005, DIAGN MOL PATHOL, V14, P90, DOI 10.1097/01.pas.0000162752.61155.d1; Broccolo F, 2015, J CLIN VIROL, V72, P75, DOI 10.1016/j.jcv.2015.09.008; Campe H, 2008, J CLIN VIROL, V43, P340, DOI 10.1016/j.jcv.2008.07.014; Campos GS, 2016, J MED VIROL, V88, P166, DOI 10.1002/jmv.24293; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Jin Y, 2011, J CLIN VIROL, V52, P251, DOI 10.1016/j.jcv.2011.07.012; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001; Lu XY, 2008, EMERG INFECT DIS, V14, P1332, DOI 10.3201/eid1408.080300; Ong DSY, 2016, J CLIN VIROL, V74, P45, DOI 10.1016/j.jcv.2015.11.027; Shang XP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171307; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Zhao M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160603	23	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184833	10.1371/journal.pone.0184833	http://dx.doi.org/10.1371/journal.pone.0184833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910409	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200102
J	Karlsson, J; Gouveia-Figueira, S; Alhouayek, M; Fowler, CJ				Karlsson, Jessica; Gouveia-Figueira, Sandra; Alhouayek, Mireille; Fowler, Christopher J.			Effects of tumour necrosis factor alpha upon the metabolism of the endocannabinoid anandamide in prostate cancer cells	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOID ANANDAMIDE; N-ACYLETHANOLAMINES; CELLULAR UPTAKE; TNF-ALPHA; CARCINOMA-CELLS; PHOSPHOLIPASE-D; EXPRESSION; 2-ARACHIDONOYLGLYCEROL; INHIBITION	Tumour necrosis factor a (TNF alpha) is involved in the pathogenesis of prostate cancer, a disease where disturbances in the endocannabinoid system are seen. In the present study we have investigated whether treatment of DU145 human prostate cancer cells affects anandamide (AEA) catabolic pathways. Additionally, we have investigated whether cyclooxygenase- 2 (COX-2) can regulate the uptake of AEA into cells. Levels of AEA synthetic and catabolic enzymes were determined by qPCR. AEA uptake and hydrolysis in DU145 and RAW264.7 macrophage cells were assayed using AEA labeled in the arachidonic and ethanolamine portions of the molecule, respectively. Levels of AEA, related N-acylethanolamines (NAEs), prostaglandins (PG) and PG-ethanolamines (PG-EA) in DU145 cells and medium were quantitated by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) analysis. TNF alpha treatment of DU145 cells increased mRNA levels of PTSG2 (gene of COX-2) and decreased the mRNA of the AEA synthetic enzyme N-acylphosphatidylethanolamine selective phospholipase D. mRNA levels of the AEA hydrolytic enzymes fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase were not changed. AEA uptake in both DU145 and RAW264.7 cells was inhibited by FAAH inhibition, but not by COX-2 inhibition, even in RAW264.7 cells where the expression of this enzyme had greatly been induced by lipopolysaccharide + interferon. treatment. AEA and related NAEs were detected in DU145 cells, but PGs and PGE(2)-EA were only detected when the cells had been preincubated with 100 nM AEA. The data demonstrate that in DU145 cells, TNFa treatment changes the relative expression of the enzymes involved in the hydrolytic and oxygenation catabolic pathways for AEA. In RAW264.7 cells, COX-2, in contrast to FAAH, does not regulate the cellular accumulation of AEA. Further studies are necessary to determine the extent to which inflammatory mediators are involved in the abnormal endocannabinoid signalling system in prostate cancer.	[Karlsson, Jessica; Alhouayek, Mireille; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Pharmacol Unit, Umea, Sweden; [Gouveia-Figueira, Sandra] Umea Univ, Dept Chem, Umea, Sweden; [Gouveia-Figueira, Sandra] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea, Sweden	Umea University; Umea University; Swedish University of Agricultural Sciences	Karlsson, J (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Pharmacol Unit, Umea, Sweden.	jessica.karlsson@umu.se	Fowler, Christopher J./M-6313-2019; Alhouayek, Mireille/R-5058-2018	Fowler, Christopher J./0000-0002-6658-7874; Alhouayek, Mireille/0000-0002-9193-0718; Karlsson, Jessica/0000-0001-8572-5841	Swedish Medical Research Council [12158]; Cancer Research Fund Norrland / Lion's Cancer Research Fund [LP 16-2129]; Umea University Medical Faculty	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Cancer Research Fund Norrland / Lion's Cancer Research Fund; Umea University Medical Faculty	This work was supported by grants from the Swedish Medical Research Council (Grant no. 12158, medicine, to CJF) (https://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html), the Cancer Research Fund Norrland / Lion's Cancer Research Fund (Grant no. LP 16-2129, to CJF) (http://www.cancerforskningsfonden.se) and the Research Funds of Umea University Medical Faculty (to CJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berdyshev EV, 1997, EUR J PHARMACOL, V330, P231, DOI 10.1016/S0014-2999(97)01007-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; Brown KL, 2013, BBA-MOL CELL BIOL L, V1831, P1098, DOI 10.1016/j.bbalip.2013.03.006; Cipriano M, 2013, EUR J PHARMACOL, V720, P383, DOI 10.1016/j.ejphar.2013.09.065; Curran-Everett D, 2012, ADV PHYSIOL EDUC, V36, P181, DOI 10.1152/advan.00072.2012; De Petrocellis L, 1998, P NATL ACAD SCI USA, V95, P8375, DOI 10.1073/pnas.95.14.8375; Denkert C, 2007, PROSTATE, V67, P361, DOI 10.1002/pros.20467; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Endsley MP, 2007, INT J CANCER, V121, P984, DOI 10.1002/ijc.22761; Fernandes JV, 2015, PATHOL ONCOL RES, V21, P527, DOI 10.1007/s12253-015-9913-z; Fernandez-Solari J, 2006, ANN NY ACAD SCI, V1008, P238; Field A, 2012, DISCOVERING STAT USI, P617; Fowler CJ, 2008, PHARMACOL RES, V58, P72, DOI 10.1016/j.phrs.2008.07.002; Fowler CJ, 2013, FEBS J, V280, P1895, DOI 10.1111/febs.12212; Fowler CJ, 2017, ENDOCANNABI IN PRESS, V80; Gabrielsson L, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.300; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Glass M, 2005, J LIPID RES, V46, P1364, DOI 10.1194/jlr.C500006-JLR200; Gouveia-Figueira S, 2015, PROSTAG OTH LIPID M, V121, P110, DOI 10.1016/j.prostaglandins.2015.06.003; Gouveia-Figueira S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139212; Jacobsson SOP, 2001, J PHARMACOL EXP THER, V299, P951; Jayasooriya RGPT, 2013, ONCOL LETT, V5, P341, DOI 10.3892/ol.2012.968; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Ligresti A, 2016, PHYSIOL REV, V96, P1593, DOI 10.1152/physrev.00002.2016; Liu YS, 2014, MOL CELL PROTEOMICS, V13, P1753, DOI 10.1074/mcp.M114.038273; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Madaan S, 2000, BJU INT, V86, P736, DOI 10.1046/j.1464-410x.2000.00867.x; McKinney MK, 2006, BIOCHEMISTRY-US, V45, P9016, DOI 10.1021/bi0608010; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; MolinaHolgado F, 1997, NEUROREPORT, V8, P1929, DOI 10.1097/00001756-199705260-00027; Morelli MB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-921; Nicolussi S, 2015, VITAM HORM, V98, P441, DOI 10.1016/bs.vh.2014.12.011; Nithipatikom K, 2004, CANCER RES, V64, P8826, DOI 10.1158/0008-5472.CAN-04-3136; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Petersen G, 2005, J NEUROCHEM, V93, P299, DOI 10.1111/j.1471-4159.2005.03013.x; Rakhshan F, 2000, J PHARMACOL EXP THER, V292, P960; Rodriguez-Berriguete G, 2013, CYTOKINE, V64, P555, DOI 10.1016/j.cyto.2013.09.003; Ruiz-Llorente L, 2004, BRIT J PHARMACOL, V141, P457, DOI 10.1038/sj.bjp.0705628; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; Schmid PC, 2002, LIPIDS, V37, P907, DOI 10.1007/s11745-002-0978-z; SCHMID PC, 1995, FEBS LETT, V375, P117, DOI 10.1016/0014-5793(95)01194-J; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; So OY, 1998, J BIOL CHEM, V273, P5801, DOI 10.1074/jbc.273.10.5801; Subbarayan V, 2001, CANCER RES, V61, P2720; Tanasescu R, 2010, IMMUNOBIOLOGY, V215, P588, DOI 10.1016/j.imbio.2009.12.005; Team RC, 2016, R LANG ENV STAT COMP, V3.3.2; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401; Thors L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012275; Galheigo MRU, 2016, PROSTATE, V76, P917, DOI 10.1002/pros.23181; Wang J, 2006, J BIOL CHEM, V281, P12325, DOI 10.1074/jbc.M512359200; Wang J, 2008, J BIOCHEM, V144, P685, DOI 10.1093/jb/mvn122; Yang YY, 2010, J HEPATOL, V53, P298, DOI 10.1016/j.jhep.2010.03.011	59	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0185011	10.1371/journal.pone.0185011	http://dx.doi.org/10.1371/journal.pone.0185011			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910408	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200126
J	Stathopoulou, C; Kapsetaki, M; Stratigi, K; Spilianakis, C				Stathopoulou, Chrysoula; Kapsetaki, Manouela; Stratigi, Kalliopi; Spilianakis, Charalampos			Long non-coding RNA SeT and miR-155 regulate the Tnf alpha gene allelic expression profile	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; INFLAMMATORY RESPONSE; X-INACTIVATION; MICRORNA; IMMUNE; MECHANISMS; MACROPHAGES; DEFICIENT; MICE; STIMULATION	It is becoming increasingly appreciated that the non-coding genome may have a great impact on the regulation of chromatin structure and gene expression. The innate immune response can be mediated upon lipopolysaccharide stimulation of macrophages which leads to immediate transcriptional activation of early responsive genes including tumor necrosis factor alpha (Tnf alpha). The functional role of non-coding RNAs, such as lncRNAs and microRNAs, on the transcriptional activation of proinflammatory genes and the subsequent regulation of the innate immune response is still lacking mechanistic insights. In this study we wanted to unravel the functional role of the lncRNA SeT, which is encoded from the murine Tnfa gene locus, and miR-155 on the transcriptional regulation of the Tnfa gene. We utilized genetically modified mice harboring either a deletion of the SeT promoter elements or the mature miR-155 and studied the response of macrophages to lipopolysaccharide (LPS) stimulation. We found that decreased expression of the lncRNA SeT in murine primary macrophages resulted in increased mortality of mice challenged with LPS, which was corroborated by increased Tnfa steady state mRNA levels and a higher frequency of biallelically expressing macrophages. On the contrary, miR-155 deletion resulted in reduced Tnfa mRNA levels supported by a lower frequency of biallelically expressing macrophages upon stimulation with LPS. In both cases, in the absence of either lncRNA SeT or miR-155 we observed a deregulation of the Tnfa allele homologous pairing, previously shown to regulate the switch from mono-to bi-allelic gene expression. Although lncRNA SeT was not found to be a direct target of miR-155 its stability was increased upon miR-155 deletion. This study suggests a role of the non-coding genome in mediating Tnfa mRNA dosage control based on the regulation of homologous pairing of gene alleles and their subsequent biallelic expression.	[Stathopoulou, Chrysoula] Dept Mol Biol & Genet, Bldg 10 Univ Campus, Dragana Alexandroupolis, Greece; [Stathopoulou, Chrysoula; Kapsetaki, Manouela; Stratigi, Kalliopi; Spilianakis, Charalampos] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Nikolaou Plastira 100, Iraklion, Greece; [Stratigi, Kalliopi; Spilianakis, Charalampos] Univ Crete, Dept Biol, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete	Spilianakis, C (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Nikolaou Plastira 100, Iraklion, Greece.; Spilianakis, C (corresponding author), Univ Crete, Dept Biol, Iraklion, Greece.	spiliana@imbb.forth.gr	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923	FONDATION SANTE; European Union (European Social Fund ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES	FONDATION SANTE; European Union (European Social Fund ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES	This work was supported by a FONDATION SANTE research grant and has been cofinanced by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a FONDATION SANTE research grant and has been co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES. We thank Despoina Tsoukatou for help with the in vivo experiments and Anastassios Oulas for performing the in silico analysis for potential miR-155 seed sequences identified on SeT 1ncRNA sequence.	Ahadi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24922; Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; ARNOLDUS EPJ, 1989, HUM GENET, V83, P231, DOI 10.1007/BF00285162; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Burgess DJ, 2011, NAT REV GENET, V12; Cai B, 2014, NEOPLASMA, V61, P379, DOI 10.4149/neo_2014_075; Chisholm KM, 2012, PLOS ONE, V7; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Deligianni C, 2012, EMBO REP, V13, P819, DOI 10.1038/embor.2012.112; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Doxaki C, 2015, J IMMUNOL, V195, P5750, DOI 10.4049/jimmunol.1500615; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hrdlickova B, 2014, BBA-MOL BASIS DIS, V1842, P1910, DOI 10.1016/j.bbadis.2014.03.011; Hu YL, 2010, NUCLEIC ACIDS RES, V38, P5472, DOI 10.1093/nar/gkq337; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marahrens Y, 1999, GENE DEV, V13, P2624, DOI 10.1101/gad.13.20.2624; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Matsui M, 2013, NUCLEIC ACIDS RES, V41, P10086, DOI 10.1093/nar/gkt777; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Migeon BR, 1996, AM J HUM GENET, V58, P161; Monajembashi S, 2005, BIOPHYS J, V88, P2309, DOI 10.1529/biophysj.104.048728; Moran N.C., 2012, GENE DEV, V25, P1915; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Oulas A, 2012, RNA BIOL, V9, P1196, DOI 10.4161/rna.21725; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Qian M, 2016, TUMOR BIOL, V37, P3879, DOI 10.1007/s13277-015-3838-8; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Roberts TC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.40; Scadden D, 2009, MOL CELL, V35, P395, DOI 10.1016/j.molcel.2009.08.005; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Stratigi K, 2015, P NATL ACAD SCI USA, V112, pE1577, DOI 10.1073/pnas.1502182112; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thatcher KN, 2005, HUM MOL GENET, V14, P785, DOI 10.1093/hmg/ddi073; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yang L, 2016, GENE DEV, V30, P1747, DOI 10.1101/gad.281162.116; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoon JH, 2014, SEMIN CELL DEV BIOL, V34, P9, DOI 10.1016/j.semcdb.2014.05.015; Zhang L, 2014, HEPATOB PANCREAT DIS, V13, P138, DOI 10.1016/S1499-3872(14)60024-2; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zhang Y, 2016, CELL MOL IMMUNOL, V13, P138, DOI 10.1038/cmi.2015.68; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19	89	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184788	10.1371/journal.pone.0184788	http://dx.doi.org/10.1371/journal.pone.0184788			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910376	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200095
J	Sugawara, Y; Akeda, Y; Sakamoto, N; Takeuchi, D; Motooka, D; Nakamura, S; Hagiya, H; Yamamoto, N; Nishi, I; Yoshida, H; Okada, K; Zin, KN; Aye, MM; Tonomo, K; Hamada, S				Sugawara, Yo; Akeda, Yukihiro; Sakamoto, Noriko; Takeuchi, Dan; Motooka, Daisuke; Nakamura, Shota; Hagiya, Hideharu; Yamamoto, Norihisa; Nishi, Isao; Yoshida, Hisao; Okada, Kazuhisa; Zin, Khwar Nyo; Aye, Mya Mya; Tonomo, Kazunori; Hamada, Shigeyuki			Genetic characterization of bla(NDM)-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; INCFII-TYPE PLASMIDS; ACINETOBACTER-BAUMANNII; MOLECULAR EPIDEMIOLOGY; ENTEROBACTERIACEAE; SEQUENCE; NDM-1; IDENTIFICATION; DISSEMINATION; ACQUISITION	The bacterial enzyme New Delhi metallo-beta-lactamase hydrolyzes almost all beta-lactam antibiotics, including carbapenems, which are drugs of last resort for severe bacterial infections. The spread of carbapenem-resistant Enterobacteriaceae that carry the New Delhi metallo-beta-lactamase gene, bla(NDM), poses a serious threat to public health. In this study, we genetically characterized eight carbapenem-resistant Escherichia coli isolates from a tertiary care hospital in Yangon, Myanmar. The eight isolates belonged to five multilocus-sequence types and harbored multiple antimicrobial-resistance genes, resulting in resistance against nearly all of the antimicrobial agents tested, except colistin and fosfomycin. Nine plasmids harboring bla(NDM) genes were identified from these isolates. Multiple bla(NDM) genes were found in the distinct Inc-replicon types of the following plasmids: an IncA/C-2 plasmid harboring bla(NDM-1) (n = 1), IncX3 plasmids harboring bla(NDM-4) (n = 2) or bla(NDM-7) (n = 1), IncFII plasmids harboring bla(NDM-4) (n = 1) or bla(NDM-5) (n = 3), and a multireplicon F plasmid harboring bla(NDM-5) (n = 1). Comparative analysis highlighted the diversity of the bla(NDM)-harboring plasmids and their distinct characteristics, which depended on plasmid replicon types. The results indicate circulation of phylogenetically distinct strains of carbapenem-resistant E. coli with various plasmids harboring bla(NDM) genes in the hospital.	[Sugawara, Yo; Akeda, Yukihiro; Sakamoto, Noriko; Takeuchi, Dan; Okada, Kazuhisa; Hamada, Shigeyuki] Osaka Univ, Thailand Japan Res Collaborat Ctr Emerging & Reem, Res Inst Microbial Dis, Suita, Osaka, Japan; [Akeda, Yukihiro; Hagiya, Hideharu; Yamamoto, Norihisa; Yoshida, Hisao; Tonomo, Kazunori] Osaka Univ Hosp, Div Infect Control & Prevent, Suita, Osaka, Japan; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Res Inst Microbial Dis, Dept Infect Metagen, Suita, Osaka, Japan; [Nishi, Isao] Osaka Univ Hosp, Lab Clin Invest, Suita, Osaka, Japan; [Zin, Khwar Nyo] Yangon Gen Hosp, Clin Lab Dept, Yangon, Myanmar; [Aye, Mya Mya] Dept Med Res, Bacteriol Res Div, Yangon, Myanmar	Osaka University; Osaka University; Osaka University; Osaka University	Sugawara, Y; Akeda, Y (corresponding author), Osaka Univ, Thailand Japan Res Collaborat Ctr Emerging & Reem, Res Inst Microbial Dis, Suita, Osaka, Japan.; Akeda, Y (corresponding author), Osaka Univ Hosp, Div Infect Control & Prevent, Suita, Osaka, Japan.	y1yo2yo3@biken.osaka-u.ac.jp; akeda@biken.osaka-u.ac.jp	Nakamura, Shota/E-3033-2010	Nakamura, Shota/0000-0003-2058-5942; Okada, Kazuhisa/0000-0002-1225-7933	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministry of Education, Culture, Sport, Science and Technology in Japan (MEXT); Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [16H06946] Funding Source: KAKEN	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministry of Education, Culture, Sport, Science and Technology in Japan (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministry of Education, Culture, Sport, Science and Technology in Japan (MEXT), and Japan Agency for Medical Research and Development (AMED, URL: http://www.amed.gojp/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba M, 2016, ANTIMICROB AGENTS CH, V60, P2972, DOI 10.1128/AAC.01950-15; Bonnin RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034752; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chen L, 2016, ANTIMICROB AGENTS CH, V60, P1258, DOI 10.1128/AAC.02661-15; Chen ZH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00294; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Cuzon G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061322; del Castillo CS, 2013, ANTIMICROB AGENTS CH, V57, P120, DOI 10.1128/AAC.01239-12; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Espedido BA, 2015, J CLIN PATHOL, V68, P835, DOI 10.1136/jclinpath-2015-203044; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Fiett J, 2014, ANTIMICROB AGENTS CH, V58, P1203, DOI 10.1128/AAC.01197-13; Gottig S, 2013, J ANTIMICROB CHEMOTH, V68, P1737, DOI 10.1093/jac/dkt088; Gofebiewski M, 2007, ANTIMICROB AGENTS CH, V51, P3789; Harmer CJ, 2014, MICROB DRUG RESIST, V20, P416, DOI 10.1089/mdr.2014.0012; He SS, 2015, MBIO, V6, DOI 10.1128/mBio.00762-15; Hsu LY, 2017, CLIN MICROBIOL REV, V30, P1, DOI [10.1128/CMR.00042-16, 10.1128/cmr.00042-16]; Hu HY, 2012, ANTIMICROB AGENTS CH, V56, P1698, DOI 10.1128/AAC.06199-11; INOUE M, 1983, PLASMID, V9, P86, DOI 10.1016/0147-619X(83)90033-1; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Krishnaraju M, 2015, INDIAN J MED MICROBI, V33, P30, DOI 10.4103/0255-0857.148373; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282; Ma L, 1998, ANTIMICROB AGENTS CH, V42, P1181, DOI 10.1128/AAC.42.5.1181; Myat TO, 2017, EMERG INFECT DIS, V23, P857, DOI 10.3201/eid2305.161100; Nordmann P, 2012, ANTIMICROB AGENTS CH, V56, P2184, DOI 10.1128/AAC.05961-11; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6065, DOI 10.1128/AAC.00117-12; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1087, DOI 10.1128/AAC.05620-11; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rahman M, 2014, INT J ANTIMICROB AG, V44, P30, DOI 10.1016/j.ijantimicag.2014.03.003; Sartor AL, 2014, ANTIMICROB AGENTS CH, V58, P5589, DOI 10.1128/AAC.02425-14; Sekizuka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025334; Shin J, 2016, ANTIMICROB AGENTS CH, V60, P1932, DOI 10.1128/AAC.02722-15; Sugawara H, 2009, 20 INT C GEN INF GIW; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Wailan AM, 2014, EXPERT REV ANTI-INFE, V12, P91, DOI 10.1586/14787210.2014.856756; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Yamamoto N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2312-1; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	49	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184720	10.1371/journal.pone.0184720	http://dx.doi.org/10.1371/journal.pone.0184720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910381	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200084
J	Cui, JA; Liu, X; Wang, YL; Liu, HF				Cui, Jianan; Liu, Xin; Wang, Yile; Liu, Huafeng			Deep reconstruction model for dynamic PET images	PLOS ONE			English	Article							EMISSION-TOMOGRAPHY; REGULARIZATION; ALGORITHMS; MAXIMUM	Accurate and robust tomographic reconstruction from dynamic positron emission tomography (PET) acquired data is a difficult problem. Conventional methods, such as the maximum likelihood expectation maximization (MLEM) algorithm for reconstructing the activity distribution-based on individual frames, may lead to inaccurate results due to the checkerboard effect and limitation of photon counts. In this paper, we propose a stacked sparse auto-encoder based reconstruction framework for dynamic PET imaging. The dynamic reconstruction problem is formulated in a deep learning representation, where the encoding layers extract the prototype features, such as edges, so that, in the decoding layers, the reconstructed results are obtained through a combination of those features. The qualitative and quantitative results of the procedure, including the data based on a Monte Carlo simulation and real patient data demonstrates the effectiveness of our method.	[Cui, Jianan; Wang, Yile; Liu, Huafeng] Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Zhejiang, Peoples R China; [Liu, Xin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Liu, HF (corresponding author), Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Zhejiang, Peoples R China.	liuhf@zju.edu.cn	Cui, Jianan/Y-9764-2019		National Natural Science Foundation of China [61525106, 61427807]; National Key Technology Research and Development Program of China [2016YFC1300302]; Zhejiang Medical Science and Technology Projects [201128375, 20143675]; Hangzhou Huazheng Medical Equipment Co. Ltd. [491030-121602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Zhejiang Medical Science and Technology Projects; Hangzhou Huazheng Medical Equipment Co. Ltd.	This work is supported in part by the National Natural Science Foundation of China (No: 61525106, 61427807), by National Key Technology Research and Development Program of China (No: 2016YFC1300302), by Zhejiang Medical Science and Technology Projects (201128375, 20143675), and by Hangzhou Huazheng Medical Equipment Co. Ltd. (491030-121602).; This work is supported in part by the National Natural Science Foundation of China (No: 61525106, 61427807), by National Key Technology Research and Development Program of China (No: 2016YFC1300302), by Zhejiang Medical Science and Technology Projects (201128375, 20143675), and by Hangzhou Huazheng Medical Equipment Co. Ltd. (491030-121602).	Cabello J, 2013, IEEE T NUCL SCI, V60, P3364, DOI 10.1109/TNS.2013.2278121; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; FESSLER JA, 1995, IEEE T IMAGE PROCESS, V4, P1417, DOI 10.1109/83.465106; Hecht-Nielsen R., 1989, NEURAL NETWORKS, V1, P445; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; ISHII T, 2013, REVERBERANT SPEECH R; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Kreutz-Delgado K, 2003, NEURAL COMPUT, V15, P349, DOI 10.1162/089976603762552951; LEVITAN E, 1987, IEEE T MED IMAGING, V6, P185, DOI 10.1109/TMI.1987.4307826; Lu X, 2013, SPEECH ENHANCEMENT B; Ollinger JM, 1997, IEEE SIGNAL PROC MAG, V14, P43, DOI 10.1109/79.560323; Rahmim A, 2005, PHYS MED BIOL, V50, P4887, DOI 10.1088/0031-9155/50/20/010; Rahmim A, 2009, MED PHYS, V36, P3654, DOI 10.1118/1.3160108; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558; Verhaeghe J, 2008, IEEE T MED IMAGING, V27, P943, DOI 10.1109/TMI.2008.923698; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xu J, 2016, IEEE T MED IMAGING, V35, P119, DOI 10.1109/TMI.2015.2458702; Zubal I, 2003, ZUBAL PHANTOM DATA V	19	25	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184667	10.1371/journal.pone.0184667	http://dx.doi.org/10.1371/journal.pone.0184667			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934254	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900038
J	Gibson, AM; Muggeridge, DJ; Hughes, AR; Kelly, L; Kirk, A				Gibson, Ann-Marie; Muggeridge, David J.; Hughes, Adrienne R.; Kelly, Louise; Kirk, Alison			An examination of objectively-measured sedentary behavior and mental well-being in adults across week days and weekends	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; DEPRESSIVE SYMPTOMS; TIME; OBESITY; ASSOCIATIONS; TELEVISION; ANXIETY	Background Limited research has explored the links between sedentary behaviour, mental health and quality of life. This study examines objectively measured sedentary behaviour and perceived mental health and quality of life across week days and weekends. Methods 42 adults (19M, 23F; mean age 38yrs (range 18-67) & BMI 24.8kg/m(2) (range 18.7-33.8) wore an activPAL monitor 24h/day for one week and completed the Hospital Anxiety and Depression Scale (HADS) and SF12 Health Survey. Average weekday and weekend day sitting time was computed. Differences between sitting (Group 1 = < 8hrs/day, Group 2 = 8-10 hrs/day, Group 3 = > 10hrs/day) and components of the HADS and SF12 health survey were examined using an ANCOVA with a measure of physical activity (step count) included as a covariate. Results Average sitting time on a weekday was 9hrs 29mins (range 5hrs 52mins to 12hrs 55mins) and 8hrs 59mins (range 4hrs, 07mins to 14hrs, 40mins) on a weekend day. There was a main effect (p< 0.05) for weekday sitting time on total anxiety and depression (HADS) and mental health and vitality (SF12). Planned contrasts identified individuals in group 1 had lower anxiety and depression and higher mental health and vitality scores than individuals in groups 2 or 3 (p< 0.05). No difference was found between individuals in group 2 and group 3 (p> 0.05). No main effects were found for weekend sitting (p> 0.05). Conclusions Weekday sitting time below 8 hours/day is associated with better perceived mental health and quality of life.	[Gibson, Ann-Marie; Muggeridge, David J.; Hughes, Adrienne R.; Kirk, Alison] Univ Strathclyde, Sch Psychol Sci & Hlth, Phys Act Hlth, Glasgow, Lanark, Scotland; [Kelly, Louise] Calif Lutheran Univ, Dept Exercise Sci, Thousand Oaks, CA USA	University of Strathclyde; California Lutheran University	Gibson, AM (corresponding author), Univ Strathclyde, Sch Psychol Sci & Hlth, Phys Act Hlth, Glasgow, Lanark, Scotland.	annmarie.gibson@strath.ac.uk		Kirk, Alison/0000-0002-6534-3763; Muggeridge, David/0000-0003-2630-2384; Gibson, Ann-Marie/0000-0003-2516-7985				Atkin AJ, 2012, ANN BEHAV MED, V43, P181, DOI 10.1007/s12160-011-9320-y; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Brown WJ, 2003, INT J OBESITY, V27, P1340, DOI 10.1038/sj.ijo.0802426; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Cohen J.E., 1988, STAT POWER ANAL BEHA; Hagstromer E, 2010, AM J EPIDEMIOL; Hamer M, 2013, BRAIN BEHAV IMMUN, V33, P29, DOI 10.1016/j.bbi.2013.05.001; Health & Social Care Information Centre, 2013, HLTH SURV ENGL 2012, V1; Health & Social Care Information Centre, MENT HLTH B ANN REP; Kang M, 2015, MEAS PHYS EDUC EXERC, V19, P105, DOI 10.1080/1091367X.2015.1055566; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Lucas M, 2011, AM J EPIDEMIOL, V174, P1017, DOI 10.1093/aje/kwr218; Maher CA, 2013, OBESITY, V21, pE730, DOI 10.1002/oby.20430; Mikkelsen SS, 2010, PREV MED, V51, P471, DOI 10.1016/j.ypmed.2010.09.008; Sanchez-Villegas A, 2008, MED SCI SPORT EXER, V40, P827, DOI 10.1249/MSS.0b013e31816348b9; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; Teychenne M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1843-x; Teychenne M, 2014, MENT HEALTH PHYS ACT, V7, P30, DOI 10.1016/j.mhpa.2013.09.005; Teychenne M, 2011, INT J BEHAV MED, V17, P246, DOI 10.1007/s12529-010-9075-z; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Uijtdewilligen L, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-107; US Department of Health and Human Services, 2009, MENT ILLN SURV AD US; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Zhai L, 2015, BRIT J SPORT MED, V49, P705, DOI 10.1136/bjsports-2014-093613; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185143	10.1371/journal.pone.0185143	http://dx.doi.org/10.1371/journal.pone.0185143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934319	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000411339900103
J	Hu, WS; Rajendran, P; Tzang, BS; Yeh, YL; Shen, CY; Chen, RJ; Ho, TJ; Padma, VV; Chen, YH; Huang, CY				Hu, Wei-Syun; Rajendran, Peramaiyan; Tzang, Bor-Show; Yeh, Yu-Lan; Shen, Chia-Yao; Chen, Ray-Jade; Ho, Tsung-Jung; Padma, Viswanadha Vijaya; Chen, Yi-Hsing; Huang, Chih-Yang			Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARDIOVASCULAR-DISEASE; FAT ACCUMULATION; IMMUNE-RESPONSE; GUT FLORA; REUTERI; METABOLISM; MICROBIOTA; INFLAMMATION; AUTOIMMUNITY	Systemic lupus erythematosus (SLE) is a disease that mostly affects women. Accelerated atherosclerosis is a high-risk factor associated with SLE patients. SLE associated with cardiovascular disease is one of the most important causes of death. In this study, we demonstrated that Lactobacillus paracasei GMNL-32(GMNL-32), a probiotic species, exhibits anti-fibrosis and anti-apoptotic effects on the cardiac tissue of NZB/WF1 mice. Female NZB/W F1 mice, a well-known and commonly used lupus-prone mouse strain, were treated with or without GMNL-32 administration for 12 weeks. Oral administration of GMNL-32 to NZB/WF1 mice significantly increased the ventricular thickness when compared to that of NZB/WF1 mice. Administration of GMNL-32 significantly attenuated the cardiac cell apoptosis that was observed in exacerbate levels in the control NZB/WF1 mice. Further, the cellular morphology that was slightly distorted in the NZB/WF1 was effectively alleviated in the treatment group mice. In addition, GMNL-32 reduced the level of Fas death receptor-related pathway of apoptosis signaling and enhanced anti-apoptotic proteins. These results indicate that GMNL-32 exhibit an effective protective effect on cardiac cells of SLE mice. Thus, GMNL-32 may be a potential therapeutic strategy against SLE associated arthrosclerosis.	[Hu, Wei-Syun] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Hu, Wei-Syun] China Med Univ Hosp, Div Cardiovasc Med, Dept Med, Taichung, Taiwan; [Rajendran, Peramaiyan; Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Yeh, Yu-Lan] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Yeh, Yu-Lan] Jen Teh Jr Coll Med Nursing & Management, Miaoli, Taiwan; [Shen, Chia-Yao] Mei Ho Univ, Dept Nursing, Pingtung, Taiwan; [Chen, Ray-Jade] Taipei Med Univ, Dept Surg, Sch Med, Coll Med, Taipei, Taiwan; [Ho, Tsung-Jung; Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Padma, Viswanadha Vijaya] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India; [Chen, Yi-Hsing] GenMt Biotech Inc, Res & Dev Dept, Tainan, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University; Changhua Christian Hospital; Taipei Medical University; China Medical University Taiwan; Bharathiar University; Asia University Taiwan	Huang, CY (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.	cyhuang@mail.cmu.edu.tw	Rajendran, Peramaiyan/I-3877-2012; Rajendran, Peramaiyan/K-3287-2019; Chen, Ray/GRJ-6736-2022	Rajendran, Peramaiyan/0000-0001-6354-4388; Huang, Chih-Yang/0000-0003-2347-0411; Bor-Show, Tzang/0000-0003-0140-9943	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; GenMont Biotech Incorporation, Taiwan [1044EI]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; GenMont Biotech Incorporation, Taiwan	This work is supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019) and GenMont Biotech Incorporation, Taiwan. (1044EI). The funding organization provided support in the form of salaries for Y-H.C. and research materials (L. paracasei GMNL-32), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work is supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019) and GenMont Biotech Incorporation, Taiwan. (1044EI). The funding organization provided support in the form of salaries for authors [Y-H.C] and research materials (L. paracasei GMNL-32), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahi D, 2016, ACTA PHYSL OXF, V217, P300; Andrade S, 2009, J DAIRY RES, V76, P469, DOI 10.1017/S0022029909990173; ANSARI A, 1985, PROG CARDIOVASC DIS, V27, P421, DOI 10.1016/0033-0620(85)90003-9; Aoki-Yoshida A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158643; Ballocca F, 2015, EUR J PREV CARDIOL, V22, P1435, DOI 10.1177/2047487314546826; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Chuang L, 2007, J AGR FOOD CHEM, V55, P11080, DOI 10.1021/jf071786o; Ciou SY, 2014, BIOMEDICINE-TAIWAN, V4, P7, DOI 10.7603/s40681-014-0017-y; Cojocaru Manole, 2011, Maedica (Bucur), V6, P330; Collins FL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153180; Dawood MAO, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/514196; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Ettinger G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168622; Fak F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046837; Gao G, 2015, MBIO, V6; Gao K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28332; Haque S, 2005, NAT CLIN PRACT CARD, V2, P423, DOI 10.1038/ncpcardio0270; He BK, 2017, J EXP MED, V214, P107, DOI 10.1084/jem.20160961; Huang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127440; Huang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170109; Iyer C, 2008, CELL MICROBIOL, V10, P1442, DOI 10.1111/j.1462-5822.2008.01137.x; Jahns R, 2008, AUTOIMMUNITY, V41, P454, DOI 10.1080/08916930802031603; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kosiewicz MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00180; Kumar Manish, 2016, Nutr Healthy Aging, V4, P3, DOI 10.3233/NHA-150002; Lee J, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0686-7; Liao PH, 2016, INT J MED SCI, V13, P569, DOI 10.7150/ijms.15597; MacGregor G, 2002, POSTGRAD MED J, V78, P366, DOI 10.1136/pmj.78.920.366; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; McMahon M, 2011, EXPERT REV CLIN IMMU, V7, P227, DOI [10.1586/eci.10.98, 10.1586/ECI.10.98]; Mortaz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136455; Paiva AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048313; Phatharajaree W, 2007, CAN J CARDIOL, V23, P727, DOI 10.1016/S0828-282X(07)70818-8; Portugal LR, 2006, BRAZ J MED BIOL RES, V39, P629, DOI 10.1590/S0100-879X2006000500010; Sun J, 2016, NUTRITION, V32, P265, DOI 10.1016/j.nut.2015.08.020; Sydora BC, 2010, CLIN EXP IMMUNOL, V161, P187, DOI 10.1111/j.1365-2249.2010.04140.x; Szkaradkiewicz AK, 2014, ARCH IMMUNOL THER EX, V62, P495, DOI 10.1007/s00005-014-0277-y; Takeuchi K, 2006, FEBS J, V273, P3743, DOI 10.1111/j.1742-4658.2006.05377.x; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Tincani A, 2006, RHEUMATOLOGY, V45, P8, DOI 10.1093/rheumatology/kel308; Ting WJ, 2015, INT J MOL SCI, V16, P25881, DOI 10.3390/ijms161025881; Ting WJ, 2015, BRIT J NUTR, V114, P706, DOI 10.1017/S0007114515002469; Toshimitsu T, 2016, J DAIRY SCI, V99, P933, DOI 10.3168/jds.2015-9916; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Tzang BS, 2011, MOL IMMUNOL, V48, P1518, DOI 10.1016/j.molimm.2011.04.013; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Wagner RD, 2000, J FOOD PROTECT, V63, P638, DOI 10.4315/0362-028X-63.5.638; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wegielska I, 2016, ACTA SCI POLON-TECHN, V15, P201, DOI 10.17306/J.AFS.2016.2.20; WINSLOW TM, 1993, AM HEART J, V125, P1117, DOI 10.1016/0002-8703(93)90123-Q; Wutzke KD, 2008, EUR J CLIN NUTR, V62, P197, DOI 10.1038/sj.ejcn.1602716; Xu RY, 2012, J CLIN BIOCHEM NUTR, V50, P72, DOI 10.3164/jcbn.11-38; Zeller CB, 2008, CURR CARDIOL REV, V4, P116, DOI 10.2174/157340308784245775; Zhao P, 2009, FRONT BIOSCI-LANDMRK, V14, P1708, DOI 10.2741/3334	56	10	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185098	10.1371/journal.pone.0185098	http://dx.doi.org/10.1371/journal.pone.0185098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934296	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900087
J	Soldevilla, MM; Hervas, S; Villanueva, H; Lozano, T; Rabal, O; Oyarzabal, J; Lasarte, JJ; Bendandi, M; Inoges, S; de Cerio, ALD; Pastor, F				Martinez Soldevilla, Mario; Hervas, Sandra; Villanueva, Helena; Lozano, Teresa; Rabal, Obdulia; Oyarzabal, Julen; Jose Lasarte, Juan; Bendandi, Maurizio; Inoges, Susana; Lopez-Diaz de Cerio, Ascension; Pastor, Fernando			Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)	PLOS ONE			English	Article							OLIGONUCLEOTIDE APTAMER; MOLECULES; SELECTION; LIGANDS; PROTEIN	LAG3 receptor belongs to a family of immune-checkpoints expressed in T lymphocytes and other cells of the immune system. It plays an important role as a rheostat of the immune response. Focus on this receptor as a potential therapeutic target in cancer immunotherapy has been underscored after the success of other immune-checkpoint blockade strategies in clinical trials. LAG3 showcases the interest in the field of autoimmunity as several studies show that LAG3-targeting antibodies can also be used for the treatment of autoimmune diseases. In this work we describe the identification of a high-affinity LAG3 aptamer by High Throughput Sequencing SELEX in combination with a study of potential conserved binding modes according to sequence conservation by using 2D-structure prediction and 3D-RNA modeling using Rosetta. The aptamer with the highest accumulation of these conserved sequence motifs displays the highest affinity to LAG3 recombinant soluble proteins and binds to LAG3-expressing lymphocytes. The aptamer described herein has the potential to be used as a therapeutic agent, as it enhances the threshold of T-cell activation. Nonetheless, in future applications, it could also be engineered for treatment of autoimmune diseases by target depletion of LAG3-effector T lymphocytes.	[Martinez Soldevilla, Mario; Villanueva, Helena; Pastor, Fernando] Ctr Appl Med Res, Mol Therapeut Program, Aptamer Platform, CIMA, Pamplona, Spain; [Martinez Soldevilla, Mario; Hervas, Sandra; Villanueva, Helena; Lozano, Teresa; Jose Lasarte, Juan; Inoges, Susana; Lopez-Diaz de Cerio, Ascension; Pastor, Fernando] Recinto Complejo Hosp Navarra, Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain; [Hervas, Sandra; Lozano, Teresa; Jose Lasarte, Juan] Univ Navarra, CIMA, Ctr Appl Med Res, Program Immunol & Immunotherapy, Pamplona, Spain; [Rabal, Obdulia; Oyarzabal, Julen] Ctr Appl Med Res CIMA, Mol Therapeut Program, Small Mol Discovery Platform, Pamplona, Spain; [Bendandi, Maurizio] Wake Forest Univ, Baptist Healthcare Ctr, Dept Internal Med, Sect Hematol Oncol,Comprehens Canc Ctr, Winston Salem, NC USA; [Bendandi, Maurizio] WG Hefner VA Med Ctr, Dept Internal Med, Sect Hematol Oncol, Salisbury, NC USA; [Bendandi, Maurizio] WG Hefner VA Med Ctr, Dept Internal Med, Sect Hematol Oncol, Charlotte, NC USA; [Inoges, Susana; Lopez-Diaz de Cerio, Ascension] Univ Clin Navarra, Dept Immunol & Immunotherapy, Pamplona, Spain	University of Navarra; Wake Forest University; University of Navarra	Pastor, F (corresponding author), Ctr Appl Med Res, Mol Therapeut Program, Aptamer Platform, CIMA, Pamplona, Spain.; Pastor, F (corresponding author), Recinto Complejo Hosp Navarra, Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain.	fpasrodri@unav.es	Lasarte, Juan José/AAN-6548-2020; Villanueva, Helena/AAB-7911-2019; Inogés, Susana/AAW-6785-2021; Pastor, Fernando/T-6239-2017; Oyarzabal, Julen/K-7393-2017	Lasarte, Juan José/0000-0003-1641-3881; Pastor, Fernando/0000-0003-0432-3133; Oyarzabal, Julen/0000-0003-1941-7255; Lozano, Teresa/0000-0001-7122-5475	Instituto de Salud Carlos III FIS I+D [PI14/01611, PI11/02854]; Ramon y Cajal [RYC-2012-10699]; Melanoma Research Alliance [509510]	Instituto de Salud Carlos III FIS I+D; Ramon y Cajal(Spanish Government); Melanoma Research Alliance	This research is supported by Instituto de Salud Carlos III FIS I+D [(PI14/01611) and (PI11/02854) (http://www.isciii.es)] and Ramon y Cajal (RYC-2012-10699) (http://www.idi.mineco.gob.es) and Melanoma Research Alliance (509510) (http://www.curemelanoma.org) to FP.	Alam KK, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.4; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Brignone C, 2009, CLIN CANCER RES, V15, P6225, DOI 10.1158/1078-0432.CCR-09-0068; Cheng CY, 2015, METHOD ENZYMOL, V553, P35, DOI 10.1016/bs.mie.2014.10.051; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gefen T, 2017, MOL THER; Gilboa E, 2013, CLIN CANCER RES, V19, P1054, DOI 10.1158/1078-0432.CCR-12-2067; Goldberg MV, 2011, CURR TOP MICROBIOL, V344, P269, DOI 10.1007/82_2010_114; Gutierrez AA, 2015, ANTILAG 3 ANTIBODIES; Hervas-Stubbs S, 2016, ONCOTARGET, V7, P4522, DOI 10.18632/oncotarget.6608; Huang RY, 2015, ONCOTARGET, V6, P27359, DOI 10.18632/oncotarget.4751; HUARD B, 1994, IMMUNOGENETICS, V39, P213; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li B, 2008, CLIN CANCER RES, V14, P3545, DOI 10.1158/1078-0432.CCR-07-5200; Lozano T, 2016, BIOMATERIALS, V91, P73, DOI 10.1016/j.biomaterials.2016.03.007; Soldevilla MM, 2015, BIOMATERIALS, V67, P274, DOI 10.1016/j.biomaterials.2015.07.020; Miyakawa S, 2008, RNA, V14, P1154, DOI 10.1261/rna.1005808; Miyazaki T, 1996, INT IMMUNOL, V8, P725, DOI 10.1093/intimm/8.5.725; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Nozari A, 2017, MOL THER-NUCL ACIDS, V6, P29, DOI 10.1016/j.omtn.2016.12.002; Pastor F, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040064; Pastor F, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.26; Poirier N, 2011, CLIN EXP IMMUNOL, V164, P265, DOI 10.1111/j.1365-2249.2011.04329.x; Rabal Obdulia, 2016, Mol Ther Nucleic Acids, V5, pe376, DOI 10.1038/mtna.2016.84; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Zhang QX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah4569; Zhou J., 2016, NAT REV DRUG DISCOV	31	19	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185169	10.1371/journal.pone.0185169	http://dx.doi.org/10.1371/journal.pone.0185169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934318	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900110
J	Szczygielski, T; Surmik, D; Kapuscinska, A; Rothschild, BM				Szczygielski, Tomasz; Surmik, Dawid; Kapuscinska, Agnieszka; Rothschild, Bruce M.			The oldest record of aquatic amniote congenital scoliosis	PLOS ONE			English	Article							MESOSAURUS-TENUIDENS	We report the first occurrence of congenital scoliosis in an early Permian aquatic parareptile, Stereosternum tumidum from Parana A state, Brazil. The spine malformation is caused by a congenital hemivertebra. These observations give insight into the biomechanical aspects of underwater locomotion in an axial skeleton-compromised aquatic amniote. This is the oldest record of a hemivertebra in an aquatic animal.	[Szczygielski, Tomasz; Kapuscinska, Agnieszka] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Surmik, Dawid] Pk Sci & Human Evolut, Krasiejow, Poland; [Surmik, Dawid] Univ Silesia, Fac Earth Sci, Sosnowiec, Poland; [Rothschild, Bruce M.] Carnegie Museum, Pittsburgh, PA USA; [Rothschild, Bruce M.] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; University of Silesia in Katowice; West Virginia University	Szczygielski, T (corresponding author), Polish Acad Sci, Inst Paleobiol, Warsaw, Poland.	t.szczygielski@twarda.pan.pl	Szczygielski, Tomasz/L-8363-2017; Szczygielski, Tomasz/O-1827-2019	Szczygielski, Tomasz/0000-0001-5108-8493; Kapuscinska, Agnieszka/0000-0002-8050-2582; Surmik, Dawid/0000-0003-0121-9592	National Science Center, Poland [2011/01/N/ST10/06989]	National Science Center, Poland(National Science Centre, Poland)	This research was supported by the National Science Center (Narodowe Centrum Nauki, www.ncn.gov.pl), Poland, project no. 2011/01/N/ST10/06989 granted to D. Surmik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Baur G., 1889, AM J SCI, V37, P310, DOI 10.2475/ajs.s3-37.220.310; Braun J., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P307; Cope ED, 1886, P AM PHILOS SOC, V23, P1; da Silva RC, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00022; DONE SH, 1975, VET REC, V96, P313, DOI 10.1136/vr.96.14.313; Eckalbar WL, 2012, WIRES DEV BIOL, V1, P401, DOI 10.1002/wdev.34; Garcia ARR, 2015, DIETA MESOSAURIDAE A; Gervais P., 1865, ACAD SCI LETT MONTPE, P169; Holterhoff PF, 2013, US B N M M, V60, P109; Huene F. F.von., 1941, Palaeontographica Stuttgart A, V92, P45; Johnson G. D., 1988, J VERT PALEONTOL S, V8, p19A; Kaplan Kevin M, 2005, Spine J, V5, P564, DOI 10.1016/j.spinee.2004.10.044; Kapuscinska A, 1999, THESIS; Karl Hans-Volker, 2007, Clausthaler Geowissenschaften, V6, P63; Modesto SP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1912; Modesto Sean Patrick, 1999, Palaeontologia Africana, V35, P7; Modesto SP, 2010, J VERTEBR PALEONTOL, V30, P1378, DOI 10.1080/02724634.2010.501443; OELOFSEN BW, 1987, S AFR J SCI, V83, P370; Olson Everett Claire, 1947, FIELDIANA GEOL, V11, P1; Pineiro G, 2016, PEERJ, V4, DOI 10.7717/peerj.2036; Pineiro G, 2012, ACTA PALAEONTOL POL, V57, P299, DOI 10.4202/app.2010.0113; Rossmann Torsten, 2000, Senckenbergiana Lethaea, V80, P13; Rossmann Torsten, 1999, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V39, P69; Rothschild Bruce M., 2012, P1, DOI 10.1007/978-1-4614-0824-6_1; Santos RV, 2006, GONDWANA RES, V9, P456, DOI 10.1016/j.gr.2005.12.001; Schlensker E, 2013, EUR J COMP ANIM PRAC, V23, P119; Seeley H. G., 1892, Quarterly Journal of the Geological Society, Vxlviii, P586; Shawen Scott B, 2002, Spine (Phila Pa 1976), V27, pE539; SHIKAMA TOKIO, 1966, TRANS PROC PALAEONTOL SOC JAP NEW SER, V64, P351; Silva RR, 2017, FRONT EARTH SC-SWITZ, V5, DOI 10.3389/feart.2017.00023; Soares M. B., 2003, Geologica Acta, V1, P349; Song YQ, 2016, TAIWAN J OBSTET GYNE, V55, P112, DOI 10.1016/j.tjog.2015.05.004; Sumida SS, 2001, AM ZOOL, V41, P586, DOI 10.1668/0003-1569(2001)041[0586:APPOLS]2.0.CO;2; Tsuji LA, 2009, FOSS REC, V12, P71, DOI 10.1002/mmng.200800011; Villamil J, 2015, HIST BIOL, V28, P1; Witzmann F, 2014, ANAT HISTOL EMBRYOL, V43, P90, DOI 10.1111/ahe.12050; Woodward AS, 1897, GEOL MAG LONDON, V4, P145	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							E0185338	10.1371/journal.pone.0185338	http://dx.doi.org/10.1371/journal.pone.0185338			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934336	gold, Green Published			2022-12-27	WOS:000411339900148
J	Ekblad, B; Nissen-Meyer, J; Kristensen, T				Ekblad, Bie; Nissen-Meyer, Jon; Kristensen, Tom			Whole-genome sequencing of mutants with increased resistance against the two-peptide bacteriocin plantaricin JK reveals a putative receptor and potential docking site	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; AMINO-ACID TRANSPORTER; CLASS-II BACTERIOCINS; LACTOBACILLUS-PLANTARUM; PROTEIN-STRUCTURE; SENSITIVITY; COMPLEMENTARY; ANTIBIOTICS; RECOGNITION; PREDICTION	By whole-genome sequencing of resistant mutants, a putative receptor for plantaricin JK, a two-peptide bacteriocin produced by some Lactobacillus plantarum strains, was identified in Lactobacillus plantarum NCFB 965 and Weissella viridescens NCFB 1655. The receptors of the two species had 66% identical amino acid sequences and belong to the amino acid-poly-amine-organocation (APC) transporter protein family. The resistant mutants contained point mutations in the protein-encoding gene resulting in either premature stop codons, leading to truncated versions of the protein, or single amino acid substitutions. The secondary structure of the W. viridescens protein was predicted to contain 12 transmembrane (TM) helices, a core structure shared by most members of the APC protein family. The single amino acid substitutions that resulted in resistant strains were located in a confined region of the protein that consists of TM helix 10, which is predicted to be part of an inner membrane pore, and an extracellular loop between TM helix 11 and 12. By use of template-based modeling a 3D structure model of the protein was obtained, which visualizes this mutational hotspot region and further strengthen the hypothesis that it represents a docking site for plantaricin JK.	[Ekblad, Bie; Nissen-Meyer, Jon; Kristensen, Tom] Univ Oslo, Sect Biochem & Mol Biol, Dept Biosci, Oslo, Norway	University of Oslo	Ekblad, B; Kristensen, T (corresponding author), Univ Oslo, Sect Biochem & Mol Biol, Dept Biosci, Oslo, Norway.	bie.ekblad@ibv.uio.no; tom.kristensen@ibv.uio.no	Kristensen, Tom/C-5873-2019; Nissen-Meyer, Jon/Y-8727-2019	Kristensen, Tom/0000-0002-2131-4469	Molecular Life Science initiative at the University of Oslo	Molecular Life Science initiative at the University of Oslo	This work was supported by the Molecular Life Science initiative at the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Arthur TD, 2014, FUTURE MICROBIOL, V9, P235, DOI 10.2217/fmb.13.148; Cavera VL, 2015, INT J ANTIMICROB AG, V46, P494, DOI 10.1016/j.ijantimicag.2015.07.011; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Field D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01363; Gabrielsen C, 2012, ANTIMICROB AGENTS CH, V56, P2908, DOI 10.1128/AAC.00314-12; Galvez A., 2014, FOOD BIOPRESERVATION, P15; Hauge HH, 1999, J BACTERIOL, V181, P740, DOI 10.1128/JB.181.3.740-747.1999; Hechard Y, 2002, BIOCHIMIE, V84, P545, DOI 10.1016/S0300-9084(02)01417-7; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JIMENEZDIAZ R, 1995, APPL ENVIRON MICROB, V61, P4459; Kamboj K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01204; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kjos M, 2011, MICROBIOL-SGM, V157, P3256, DOI 10.1099/mic.0.052571-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Moll GN, 1999, J BACTERIOL, V181, P4848, DOI 10.1128/JB.181.16.4848-4852.1999; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Oppegard C, 2016, MICROBIOLOGYOPEN, V5, P700, DOI 10.1002/mbo3.363; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Ramnath M, 2000, APPL ENVIRON MICROB, V66, P3098, DOI 10.1128/AEM.66.7.3098-3101.2000; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seddik HA, 2017, PROBIOTICS ANTIMICRO, V9, P111, DOI 10.1007/s12602-017-9264-z; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Uzelac G, 2013, J BACTERIOL, V195, P5614, DOI 10.1128/JB.00859-13; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	31	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185279	10.1371/journal.pone.0185279	http://dx.doi.org/10.1371/journal.pone.0185279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931059	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700081
J	Singh, V; Ahmed, S; Dreyfuss, ML; Kiran, U; Chaudhery, DN; Srivastava, VK; Ahuja, RC; Baqui, AH; Darmstadt, GL; Santosham, M; West, KP				Singh, Veena; Ahmed, Saifuddin; Dreyfuss, Michele L.; Kiran, Usha; Chaudhery, Deepika N.; Srivastava, Vinod K.; Ahuja, Ramesh C.; Baqui, Abdullah H.; Darmstadt, Gary L.; Santosham, Mathuram; West, Keith P., Jr.			An integrated nutrition and health program package on IYCN improves breastfeeding but not complementary feeding and nutritional status in rural northern India: A quasiexperimental randomized longitudinal study	PLOS ONE			English	Article							CHILD UNDERNUTRITION; EDUCATIONAL INTERVENTION; YOUNG-CHILDREN; GROWTH; INFANTS; IMPACT	Background Undernutrition below two years of age remains a major public health problem in India. We conducted an evaluation of an integrated nutrition and health program that aimed to improve nutritional status of young children by improving breast and complementary feeding practices over that offered by the Government of India's standard nutrition and health care program. Methods In Uttar Pradesh state, through multi-stage cluster random sampling, 81 villages in an intervention district and 84 villages in a comparison district were selected. A cohort of 957 third trimester pregnant women identified during house-to-house surveys was enrolled and, following childbirth, mother-child dyads were followed every three months from birth to 18 months of age. The primary outcomes were improvements in weight-for-age and length-forage z scores, with improved breastfeeding and complementary feeding practices as intermediate outcomes. Findings Optimal breastfeeding practices were higher among women in intervention than comparison areas, including initiating breastfeeding within one hour of delivery (17.4% vs. 2.7%, p< 0.001), feeding colostrum (34.7% vs. 8.4%, p< 0.001), avoiding pre-lacteals (19.6% vs. 2.1%, p< 0.001) and exclusively breastfeeding up to 6 months (24.1% vs. 15.3%, p = 0.001). However, differences were few and mixed between study arms with respect to complementary feeding practices. The mean weight-for-age z-score was higher at 9 months (-2.1 vs. -2.4, p = 0.0026) and the prevalence of underweight status was lower at 12 months (58.5% vs. 69.3%, p = 0.047) among intervention children. The prevalence of stunting was similar between study arms at all ages. Coefficients to show the differences between the intervention and comparison districts (0.13 cm/mo) suggested significant faster linear growth among intervention district infants at earlier ages (0 - 5 months). Interpretation Mothers participating in the intervention district were more likely to follow optimal breast, although not complementary feeding practices. The program modestly improved linear growth in earlier age and weight gain in late infancy. Comprehensive nutrition and health interventions are complex; the implementation strategies need careful examination to improve feeding practices and thus impact growth.	[Singh, Veena; West, Keith P., Jr.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA; [Ahmed, Saifuddin; Dreyfuss, Michele L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth, Baltimore, MD USA; [Kiran, Usha; Chaudhery, Deepika N.] CARE India, New Delhi, India; [Srivastava, Vinod K.; Ahuja, Ramesh C.] King George Med Univ, Lucknow, Uttar Pradesh, India; [Baqui, Abdullah H.; Darmstadt, Gary L.; Santosham, Mathuram] Johns Hopkins Bloomberg Sch Publ Hlth, Hlth Syst Div, Dept Int Hlth, Baltimore, MD USA; [Kiran, Usha] Bill & Melinda Gates Fdn, Global Hlth Program, New Delhi, India; [Chaudhery, Deepika N.] World Bank, Hlth Nutr & Populat Global Practice, New Delhi, India; [Srivastava, Vinod K.] Hind Inst Med Sci, Sitapur, Uttar Pradesh, India; [Darmstadt, Gary L.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; King George's Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; The World Bank; Stanford University	Singh, V (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA.	veena.singh@gmail.com	Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824; Singh, Veena/0000-0002-6296-3318	USAID, India Mission, through Global Research Activity [HRN-A-00-96-90006-00];  [GH 614]	USAID, India Mission, through Global Research Activity(United States Agency for International Development (USAID)); 	The study was funded by USAID, India Mission, through Global Research Activity Award # HRN-A-00-96-90006-00 to the Johns Hopkins Bloomberg School of Public Health. VS was supported during analysis and reporting through Gates Grant GH 614 and the George G. Graham Professorship Endowment at Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, 3200506 NFHS; Avula R, 2011, J NUTR, V141, P680, DOI 10.3945/jn.109.116954; Behrman J, 2001, 104 IFPRI; Bhandari N, 2004, J NUTR, V134, P2342; Bhandari N, 2001, J NUTR, V131, P1946, DOI 10.1093/jn/131.7.1946; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BROWN LV, 1992, AM J CLIN NUTR, V56, P994, DOI 10.1093/ajcn/56.6.994; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Census of India, 2009, WELC WEBS CENS IND; Dubowitz T, 2007, FOOD NUTR BULL, V28, P266, DOI 10.1177/156482650702800302; Guldan GS, 2000, J NUTR, V130, P1204, DOI 10.1093/jn/130.5.1204; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Onis M. de, 2006, Acta Paediatrica, V95, P76; Penny ME, 2005, LANCET, V365, P1863, DOI 10.1016/S0140-6736(05)66426-4; Vazir S, 2013, MATERN CHILD NUTR, V9, P99, DOI 10.1111/j.1740-8709.2012.00413.x; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; *WHO UNICEF, 2002, GLOB STRAT INF YOUNG	18	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185030	10.1371/journal.pone.0185030	http://dx.doi.org/10.1371/journal.pone.0185030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931088	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700062
J	Wang, ZQ; Zhang, MY; Deng, ML; Weng, NQ; Wang, HY; Wu, SX				Wang, Zhi-Qiang; Zhang, Mei-Yin; Deng, Mei-Ling; Weng, Nuo-Qing; Wang, Hui-Yun; Wu, Shao-Xiong			Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; EXPRESSION; MICRORNA; CANCER; TUMOR; BIOMARKERS; RADIOTHERAPY; CONCOMITANT	MicroRNAs (miRNAs) are short noncoding RNAs that play critical roles in human malignancies and can be used as biomarkers for cancer. Until now, a number of biomarkers for prognosis of glioblastoma (GBM) have been reported in tumor tissues but only a few biomarkers in circulating fluid. Using a custom microarray, we previously identified 19 differentially expressed miRNAs in serum of patients with GBM. In this study, we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM. We first validated the serum levels of 3 candidate miRNAs in an independent cohort of 24 GBM patients and 12 healthy volunteers by real-time quantitative reverse transcription PCR (qRT-PCR), and then evaluated the prognostic value of these miRNAs in a total of 36 GBM patients. The results show that the serum levels of the 3 miRNAs (miR-451a, miR-485-3p and miR-4298) determined by qRT-PCR are significantly different between 24 GBM patients and 12 healthy volunteers (all P <0.05) and are in concordance with the results of microarray analysis. High serum level of miR-451a is correlated with positive tumor O(6)-methylguanine-DNA methyltransferase (MGMT) expression (P = 0.040). Survival analysis showed that low serum miR-485-3p level is associated with poor progression-free survival (PFS) (P < 0.004) and overall survival (OS) (P < 0.023). Furthermore, univariate and multivariate Cox analyses demonstrated that that serum miR-485-3p expression is a significant independent prognostic factor for PFS and OS in GBM patients. In conclusion, serum miR-485-3p level is reduced and might be a potential prognostic biomarker in GBM patients.	[Wang, Zhi-Qiang; Deng, Mei-Ling; Wu, Shao-Xiong] Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Zhi-Qiang; Zhang, Mei-Yin; Deng, Mei-Ling; Weng, Nuo-Qing; Wang, Hui-Yun; Wu, Shao-Xiong] Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Zhi-Qiang; Zhang, Mei-Yin; Deng, Mei-Ling; Weng, Nuo-Qing; Wang, Hui-Yun; Wu, Shao-Xiong] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Wu, SX (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China.; Wang, HY; Wu, SX (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China.; Wang, HY; Wu, SX (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	wanghyun@mail.sysu.edu.cn; wushx@sysucc.org.cn			National Natural Science Foundation of China [81372564]; The Research Fund of the State Key Laboratory of Oncology in South China [010811]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Research Fund of the State Key Laboratory of Oncology in South China	This project is supported by the National Natural Science Foundation of China (Grant No: 81372564 to Hui-Yun Wang) and by The Research Fund of the State Key Laboratory of Oncology in South China (Grant No: 010811 to Hui-Yun Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya-Ruiz M, 2013, ASIAN PAC J CANCER P, V14, P3757, DOI 10.7314/APJCP.2013.14.6.3757; Avet-Loiseau H, 2002, BLOOD, V99, P2185, DOI 10.1182/blood.V99.6.2185; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CF, 2011, MOL PHARMACOL, V79, P735, DOI 10.1124/mol.110.069633; Chen T, 2010, J ENVIRON SCI HEAL C, V28, P89, DOI 10.1080/10590501.2010.481477; De Mattos-Arruda L, 2014, ANN ONCOL, V25, P1729, DOI 10.1093/annonc/mdu239; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; Garcia-Romero N, 2017, ONCOTARGET, V8, P1416, DOI 10.18632/oncotarget.13635; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Karsy M, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14755; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Lou C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.27; Lucotti S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-52; Ma RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038096; Mizoguchi M, 2008, NEUROL SURG TOKYO, V36, P83; Roth P, 2011, J NEUROCHEM, V118, P449, DOI 10.1111/j.1471-4159.2011.07307.x; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; SUZUKI T, 1989, CANCER RES, V49, P1095; Tang HL, 2015, J CANCER RES THER, V11, P630, DOI 10.4103/0973-1482.146121; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang Q, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-97; Wang Z-Q, 2015, PRACT J CANC, V30, P4; Wang ZX, 2011, J SURG ONCOL, V104, P847, DOI 10.1002/jso.22008; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Xiong D, 2016, ONCOTARGET; Yang CH, 2013, INT J CANCER, V132, P116, DOI 10.1002/ijc.27657; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861; Yue X, 2016, J NEUROSURG, V124, P122, DOI 10.3171/2015.1.JNS141577; Zhao SG, 2013, NEURO-ONCOLOGY, V15, P707, DOI 10.1093/neuonc/not001	37	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184969	10.1371/journal.pone.0184969	http://dx.doi.org/10.1371/journal.pone.0184969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931080	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700050
J	Yacoub, R; Nugent, M; Cai, WJ; Nadkarni, GN; Chaves, LD; Abyad, S; Honan, AM; Thomas, SA; Zheng, W; Valiyaparambil, SA; Bryniarski, MA; Sun, YJ; Buck, M; Genco, RJ; Quigg, RJ; He, JC; Uribarri, J				Yacoub, Rabi; Nugent, Melinda; Cai, Weijin; Nadkarni, Girish N.; Chaves, Lee D.; Abyad, Sham; Honan, Amanda M.; Thomas, Shruthi A.; Zheng, Wei; Valiyaparambil, Sujith A.; Bryniarski, Mark A.; Sun, Yijun; Buck, Michael; Genco, Robert J.; Quigg, Richard J.; He, John C.; Uribarri, Jaime			Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; RENAL-FAILURE; GLYCOTOXINS; GLYCOXIDATION; ACCUMULATION; ENDPRODUCTS; OBESITY; INFLAMMATION; DIVERSITY; PRECEDES	The modern Western diet is rich in advanced glycation end products (AGEs). We have previously shown an association between dietary AGEs and markers of inflammation and oxidative stress in a population of end stage renal disease (ESRD) patients undergoing peritoneal dialysis (PD). In the current pilot study we explored the effects of dietary AGEs on the gut bacterial microbiota composition in similar patients. AGEs play an important role in the development and progression of cardiovascular (CVD) disease. Plasma concentrations of different bacterial products have been shown to predict the risk of incident major adverse CVD events independently of traditional CVD risk factors, and experimental animal models indicates a possible role AGEs might have on the gut microbiota population. In this pilot randomized open label controlled trial, twenty PD patients habitually consuming a high AGE diet were recruited and randomized into either continuing the same diet (HAGE, n = 10) or a one-month dietary AGE restriction (LAGE, n = 10). Blood and stool samples were collected at baseline and after intervention. Variable regions V3-V4 of 16s rDNA were sequenced and taxa was identified on the phyla, genus, and species levels. Dietary AGE restriction resulted in a significant decrease in serum N-epsilon-(carboxymethyl) lysine (CML) and methylglyoxal-derivatives (MG). At baseline, our total cohort exhibited a lower relative abundance of Bacteroides and Alistipes genus and a higher abundance of Prevotella genus when compared to the published data of healthy population. Dietary AGE restriction altered the bacterial gut microbiota with a significant reduction in Prevotella copri and Bifidobacterium animalis relative abundance and increased Alistipes indistinctus, Clostridium citroniae, Clostridium hathewayi, and Ruminococcus gauvreauii relative abundance. We show in this pilot study significant microbiota differences in peritoneal dialysis patients' population, as well as the effects of dietary AGEs on gut microbiota, which might play a role in the increased cardiovascular events in this population and warrants further studies.	[Yacoub, Rabi; Chaves, Lee D.; Abyad, Sham; Honan, Amanda M.; Thomas, Shruthi A.; Quigg, Richard J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Internal Med, Buffalo, NY 14260 USA; [Nugent, Melinda; Cai, Weijin; Nadkarni, Girish N.; He, John C.; Uribarri, Jaime] Icahn Sch Med Mt Sinai, Dept Internal Med, New York, NY 10029 USA; [Zheng, Wei] SUNY Buffalo, Dept Comp Sci & Engn, Buffalo, NY USA; [Valiyaparambil, Sujith A.; Buck, Michael] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY USA; [Bryniarski, Mark A.] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Phamaceut Sci, Buffalo, NY USA; [Sun, Yijun] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY USA; [Genco, Robert J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Oral Biol, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yacoub, R (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Internal Med, Buffalo, NY 14260 USA.	rabiyaco@buffalo.edu			National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001412]; NIH; University at Buffalo Genome, Environment and Microbiome (GEM); department fund; Innovative Micro-Programs Accelerating Collaboration in Themes (IMPACT); National Institute of Diabetes and Digestive and Kidney Diseases [K23DK107908-01A1]; NIH [R01A1125982, R01DE024523];  [101BX000345];  [R01DK078897]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125982] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University at Buffalo Genome, Environment and Microbiome (GEM); department fund; Innovative Micro-Programs Accelerating Collaboration in Themes (IMPACT); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo and by the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This was also supported by University at Buffalo Genome, Environment and Microbiome (GEM), and department fund for RY and LC. Innovative Micro-Programs Accelerating Collaboration in Themes (IMPACT) for RY. GNK is supported by National Institute of Diabetes and Digestive and Kidney Diseases, K23DK107908-01A1. YS is supported by NIH R01A1125982, R01DE024523. JCH is supported by 101BX000345, R01DK078897.	Ahmad S, 2014, GLYCOBIOLOGY, V24, P979, DOI 10.1093/glycob/cwu057; Aikawa E, 2016, STEM CELLS DEV, V25, P1721, DOI 10.1089/scd.2016.0067; Ames JM, 1999, BRIT J NUTR, V82, P489, DOI 10.1017/S0007114599001749; Baig MH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06067-5; Baothman OA, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0278-4; BEISSWENGER PJ, 1995, DIABETES, V44, P824, DOI 10.2337/diabetes.44.7.824; Bohlender JM, 2005, AM J PHYSIOL-RENAL, V289, pF645, DOI 10.1152/ajprenal.00398.2004; Borrelli RC, 2005, MOL NUTR FOOD RES, V49, P673, DOI 10.1002/mnfr.200500011; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Busch M, 2010, EUR J CLIN INVEST, V40, P742, DOI 10.1111/j.1365-2362.2010.02317.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YP, 2016, J ETHNOPHARMACOL, V194, P850, DOI 10.1016/j.jep.2016.10.079; Cho Y, 2013, NEPHROL DIAL TRANSPL, V28, P1899, DOI 10.1093/ndt/gft050; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Cullis B, 2014, PERITON DIALYSIS INT, V34, P494, DOI 10.3747/pdi.2013.00222; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eid HM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00387; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Ghazalpour A, 2016, CURR OPIN LIPIDOL, V27, P141, DOI 10.1097/MOL.0000000000000278; Gkogkolou P, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.22028; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Hartog JWL, 2005, ANN NY ACAD SCI, V1043, P299, DOI 10.1196/annals.1333.037; He CJ, 1999, DIABETES, V48, P1308, DOI 10.2337/diabetes.48.6.1308; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Henle T, 2003, KIDNEY INT, V63, pS145, DOI 10.1046/j.1523-1755.63.s84.16.x; Kellow NJ, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-55; Kim D, 2016, ARTHRITIS RHEUMATOL, V68, P2565, DOI 10.1002/art.39807; Knip M, 2016, NAT REV ENDOCRINOL, V12, P154, DOI 10.1038/nrendo.2015.218; KORBET SM, 1993, AM J KIDNEY DIS, V22, P588, DOI 10.1016/S0272-6386(12)80933-4; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Lan PG, 2014, CLIN J AM SOC NEPHRO, V9, P1091, DOI 10.2215/CJN.09730913; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; MAKITA Z, 1994, LANCET, V343, P1519, DOI 10.1016/S0140-6736(94)92935-1; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McNally L, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2015.16, 10.1038/NMICROBIOL.2015.16]; Meerwaldt R, 2005, DIABETOLOGIA, V48, P1637, DOI 10.1007/s00125-005-1828-x; Moschen AR, 2016, CELL HOST MICROBE, V19, P455, DOI 10.1016/j.chom.2016.03.007; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nara N, 2013, CLIN IMMUNOL, V146, P112, DOI 10.1016/j.clim.2012.12.001; Noordzij MJ, 2008, J REN CARE, V34, P207, DOI 10.1111/j.1755-6686.2008.00038.x; OBRIEN J, 1989, CRIT REV FOOD SCI, V28, P211, DOI 10.1080/10408398909527499; Ottum MS, 2015, J CLIN BIOCHEM NUTR, V57, P1, DOI 10.3164/jcbn.15-3; Peppa M, 2008, CURR DIABETES REV, V4, P92, DOI 10.2174/157339908784220732; Prasad A, 2012, CARDIOL REV, V20, P177, DOI 10.1097/CRD.0b013e318244e57c; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rosenbaum JT, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0614-8; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sanders ME, 2006, J CLIN GASTROENTEROL, V40, P776, DOI 10.1097/01.mcg.0000225576.73385.f0; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Shekhtman A., 2016, EXPERT REV PROTEOMIC, P1; Singh VP, 2014, KOREAN J PHYSIOL PHA, V18, P1, DOI 10.4196/kjpp.2014.18.1.1; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Uribarri J, 2003, J AM SOC NEPHROL, V14, P728, DOI 10.1097/01.ASN.0000051593.41395.B9; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vlassara H, 2004, REV ENDOCR METAB DIS, V5, P181, DOI 10.1023/B:REMD.0000032406.84813.f6; Woting A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040202; Yu T, 2017, EXP MOL PATHOL, V102, P7, DOI 10.1016/j.yexmp.2016.12.002; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	68	70	71	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184789	10.1371/journal.pone.0184789	http://dx.doi.org/10.1371/journal.pone.0184789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931089	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700036
J	Hara, K; Hamada, C; Wakabayashi, K; Kanda, R; Kaneko, K; Horikoshi, S; Tomino, Y; Suzuki, Y				Hara, Kazuaki; Hamada, Chieko; Wakabayashi, Keiichi; Kanda, Reo; Kaneko, Kayo; Horikoshi, Satoshi; Tomino, Yasuhiko; Suzuki, Yusuke			Scavenging of reactive oxygen species by astaxanthin inhibits epithelial-mesenchymal transition in high glucose-stimulated mesothelial cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; PERITONEAL-DIALYSIS; TRANSGENIC RATS; FACTOR-BETA; IN-VITRO; INFLAMMATION; MEMBRANE; ESTABLISHMENT	Background High glucose concentrations influence the functional and structural development of the peritoneal membrane. We previously reported that the oral administration of astaxanthin (AST) suppressed peritoneal fibrosis (PF) as well as inhibited oxidative stress, inflammation, and epithelial-mesenchymal transition (EMT) of peritoneal mesothelial cells (PMCs) in a chlorhexidine-induced PF rat model. This suggests that oxidative stress induction of EMT is a key event during peritoneal damage. The present study evaluated the therapeutic effect of AST in suppressing EMT, in response to glucose-induced oxidative stress. Methods Temperature-sensitive mesothelial cells (TSMCs) were cultured in the presence or absence of AST and then treated with 140 mM glucose for 3 or 12 hours. Expression levels of TNF-alpha, TGF-alpha, and VEGF were determined at the mRNA and protein levels, and nuclear factor kappa B (NF-kappa B) activity was evaluated. We measured NO2-/NO3- concentrations in cellular supernatants and determined 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels in mitochondrial and nuclear DNA. The expressions of E-cadherin and alpha-smooth muscle actin (alpha-SMA) were evaluated by double immunofluorescence and protein levels. Results High glucose concentrations induced overproduction of reactive oxidative species (ROS), increasing 8-OHdG mitochondrial DNA and cytokine levels. The NF-kappa B pathway was activated in response to high glucose concentrations, whereas de novo a-SMA expression was observed with decreased E-cadherin expression. AST treatment attenuated ROS production, inflammatory cytokine production, NF-kappa B activation, and EMT. Conclusion The findings of the present study indicate that AST may have an anti-EMT effect due to anti-oxidative and anti-inflammatory activities by scavenging glucose-induced ROS from mitochondria in PMCs. AST may be an efficacious treatment for PF.	[Hara, Kazuaki; Hamada, Chieko; Wakabayashi, Keiichi; Kanda, Reo; Kaneko, Kayo; Horikoshi, Satoshi; Tomino, Yasuhiko; Suzuki, Yusuke] Juntendo Univ, Fac Med, Dept Nephrol, Bunkyo Ku, Tokyo, Japan; [Kanda, Reo; Tomino, Yasuhiko] Ikegami Gen Hosp, Tokyo, Japan	Juntendo University	Hamada, C (corresponding author), Juntendo Univ, Fac Med, Dept Nephrol, Bunkyo Ku, Tokyo, Japan.	chieko@juntendo.ac.jp			Japan Society for Promotion of Science KAKENHI [26461260]; Medical Corporation SHOWAKAI	Japan Society for Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Corporation SHOWAKAI	This work was supported by the Japan Society for Promotion of Science KAKENHI (Grant Number 26461260). Medical Corporation SHOWAKAI provided support in the form of salaries for authors RK and YT. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Bhuvaneswari S, 2014, CELL STRESS CHAPERON, V19, P183, DOI 10.1007/s12192-013-0443-x; Byun J, 1999, FEBS LETT, V455, P243, DOI 10.1016/S0014-5793(99)00893-5; Ciszewicz M, 2011, INT J ARTIF ORGANS, V34, P489, DOI 10.5301/IJAO.2011.8467; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Ding Y, 2007, J LEUKOCYTE BIOL, V81, P520, DOI 10.1189/jlb.0406262; Fassett RG, 2011, MAR DRUGS, V9, P447, DOI 10.3390/md9030447; Ferrier ML, 2001, KIDNEY INT, V60, P2343, DOI 10.1046/j.1523-1755.2001.00050.x; Fukawa T, 2012, EXP CELL RES, V318, P1926, DOI 10.1016/j.yexcr.2012.05.023; Guerra BA, 2012, DIABETES RES CLIN PR, V98, P108, DOI 10.1016/j.diabres.2012.07.004; Ha H, 2005, NEPHROLOGY, V10, pS7, DOI 10.1111/j.1440-1797.2005.00448.x; Hamada C, 2015, J ARTIF ORGANS, V18, P243, DOI 10.1007/s10047-015-0822-4; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho MY, 2012, MOL CANCER RES, V10, P1109, DOI 10.1158/1541-7786.MCR-12-0160; Hotta Y, 2010, NEPHROL DIAL TRANSPL, V25, P1825, DOI 10.1093/ndt/gfp742; Hsu CC, 2005, J DIABETES COMPLICAT, V19, P96, DOI 10.1016/j.jdiacomp.2004.06.004; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; JIALAL I, 1990, ATHEROSCLEROSIS, V82, P185, DOI 10.1016/0021-9150(90)90039-L; Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588; Kanda R, 2014, NEPHROL DIAL TRANSPL, V29, P289, DOI 10.1093/ndt/gft397; Kim YJ, 2009, J AGR FOOD CHEM, V57, P8793, DOI 10.1021/jf9019745; Kishimoto Y, 2010, EUR J NUTR, V49, P119, DOI 10.1007/s00394-009-0056-4; Kozuki Y, 2000, CANCER LETT, V151, P111, DOI 10.1016/S0304-3835(99)00418-8; Krstic J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/654594; Liu XX, 2014, CHIN J INTEGR MED, V20, P667, DOI 10.1007/s11655-012-1176-x; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; MIKI W, 1991, PURE APPL CHEM, V63, P141, DOI 10.1351/pac199163010141; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P2694, DOI 10.1167/iovs.02-0822; Pashkow FJ, 2008, AM J CARDIOL, V101, p58D, DOI 10.1016/j.amjcard.2008.02.010; Sagun KC, 2005, FASEB J, V19, P1657, DOI 10.1096/fj.05-4107com; Satoh A, 2009, J CLIN BIOCHEM NUTR, V44, P280, DOI 10.3164/jcbn.08-238; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwenger V, 2006, J AM SOC NEPHROL, V17, P199, DOI 10.1681/ASN.2005020155; Seo MJ, 2001, PERITON DIALYSIS INT, V21, pS35; Szeto CC, 2002, PERITON DIALYSIS INT, V22, P265; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Takahashi R, 1999, EXP ANIM TOKYO, V48, P255, DOI 10.1538/expanim.48.255; Uchiyama K, 2002, REDOX REP, V7, P290, DOI 10.1179/135100002125000811; Wakabayashi K, 2015, PERITON DIALYSIS INT, V35, P506, DOI 10.3747/pdi.2013.00317; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; ZEMEL D, 1994, KIDNEY INT, V46, P1422, DOI 10.1038/ki.1994.414; Zweers MM, 1999, J LAB CLIN MED, V134, P124, DOI 10.1016/S0022-2143(99)90116-6	42	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184332	10.1371/journal.pone.0184332	http://dx.doi.org/10.1371/journal.pone.0184332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926603	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600015
J	Khatami, F; Larijani, B; Heshmat, R; Keshtkar, A; Mohammadamoli, M; Teimoori-Toolabi, L; Nasiri, S; Tavangar, SM				Khatami, Fatemeh; Larijani, Bagher; Heshmat, Ramin; Keshtkar, Abbasali; Mohammadamoli, Mahsa; Teimoori-Toolabi, Ladan; Nasiri, Shirzad; Tavangar, Seyed Mohammad			Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer	PLOS ONE			English	Article							SODIUM/IODIDE SYMPORTER NIS; BRAF MUTATION; E-CADHERIN; IODIDE TRANSPORTER; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; IMMUNOHISTOCHEMICAL ANALYSIS; PROTEIN EXPRESSION; CLINICAL-TRIALS; BETA-CATENIN; PAPILLARY	Promoter methylation in a number of tumor-suppressor genes (TSGs) can play crucial roles in the development of thyroid carcinogenesis. The focus of the current meta-analysis was to determine the impact of promoter methylation of eight selected candidate TSGs on thyroid cancer and to identify the most important molecules in this carcinogenesis pathway. A comprehensive search was performed using Pub Med, Scopus, and ISI Web of Knowledge databases, and eligible studies were included. The methodological quality of the included studies was evaluated according to the Newcastle Ottawa scale table and pooled odds ratios (ORs); 95% confidence intervals (CIs) were used to estimate the strength of the associations with Stata 12.0 software. Egger's and Begg's tests were applied to detect publication bias, in addition to the "Metatrim" method. A total of 55 articles were selected, and 135 genes with altered promoter methylation were found. Finally, we included eight TSGs that were found in more than four studies (RASSF1, TSHR, PTEN, SLC5A, DAPK, P16, RAR beta 2, and CDH1). The order of the pooled ORs for these eight TSGs from more to less significant was CDH1 (OR = 6.73), SLC5 (OR = 6.15), RASSF1 (OR = 4.16), PTEN (OR = 3.61), DAPK (OR = 3.51), P16 (OR = 3.31), TSHR (OR = 2.93), and RAR beta 2 (OR = 1.50). Analyses of publication bias and sensitivity confirmed that there was very little bias. Thus, our findings showed that CDH1 and SCL5A8 genes were associated with the risk of thyroid tumor genesis.	[Khatami, Fatemeh; Heshmat, Ramin] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Chron Dis Res Ctr, Tehran, Iran; [Larijani, Bagher; Mohammadamoli, Mahsa] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran; [Keshtkar, Abbasali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Sci Educ Dev, Tehran, Iran; [Teimoori-Toolabi, Ladan] Pasteur Inst Iran, Mol Med Dept, Tehran, Iran; [Nasiri, Shirzad] Univ Tehran Med Sci, Shariati Hosp, Dept Surg, Tehran, Iran; [Tavangar, Seyed Mohammad] Univ Tehran Med Sci, Dr Shariati Hosp, Dept Pathol, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Tavangar, SM (corresponding author), Univ Tehran Med Sci, Dr Shariati Hosp, Dept Pathol, Tehran, Iran.	Tavangar@ams.ac.ir	Khatami, Fatemeh/AAQ-3091-2021; larijani, Bagher/ABE-3315-2020; Teimoori-Toolabi, Ladan/J-5547-2018; Heshmat, Ramin/S-7435-2017; Khatami, Fatemeh/M-1772-2017	larijani, Bagher/0000-0001-5386-7597; Teimoori-Toolabi, Ladan/0000-0002-6588-9774; nasiri, shirzad/0000-0001-7267-9890; Khatami, Fatemeh/0000-0002-6311-1336				Abubaker J, 2008, J CLIN ENDOCR METAB, V93, P611, DOI 10.1210/jc.2007-1717; Ai LB, 2003, MODERN PATHOL, V16, P944, DOI 10.1097/01.MP.0000085760.74313.DD; Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Alsina J, 2017, MOL IMAGING RADIONUC, V26, P102, DOI 10.4274/2017.26.suppl.12; Alvarez-Nunez F, 2006, THYROID, V16, P17, DOI 10.1089/thy.2006.16.17; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Boltze C, 2003, PATHOL RES PRACT, V199, P399, DOI 10.1078/0344-0338-00436; Brait M, 2012, EPIGENETICS-US, V7, P710, DOI 10.4161/epi.20524; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Chang H, 2015, CYTOPATHOLOGY; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Ciampi R, 2017, J ENDOCRINOL INVEST, V40, P55, DOI 10.1007/s40618-016-0526-5; Czarnecka Karolina, 2011, Front Biosci (Elite Ed), V3, P137, DOI 10.2741/e228; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Garcia-Rostan G, 1999, CANCER RES, V59, P1811; Garcia-Rostan G, 2001, AM J PATHOL, V158, P987, DOI 10.1016/S0002-9440(10)64045-X; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Gopal E, 2004, J BIOL CHEM, V279, P44522, DOI 10.1074/jbc.M405365200; Guerra A, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S44; Haghpanah V, 2006, Indian J Cancer, V43, P80; Haghpanah V, 2006, APPL IMMUNOHISTO M M, V14, P422, DOI 10.1097/01.pai.0000213100.88074.b8; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong CB, 2005, CANCER RES, V65, P3617, DOI 10.1158/0008-5472.CAN-05-0048; Hoque MO, 2005, J CLIN ENDOCR METAB, V90, P4011, DOI 10.1210/jc.2005-0313; Hou P, 2008, CANCER, V113, P2440, DOI 10.1002/cncr.23869; Hou P, 2011, ENDOCR-RELAT CANCER, V18, P687, DOI 10.1530/ERC-11-0212; Howell GM, 2013, ONCOLOGIST, V18, P926, DOI 10.1634/theoncologist.2013-0072; Howlader N, 2012, SEER CANC STAT REV 1; Hu SY, 2006, INT J CANCER, V119, P2322, DOI 10.1002/ijc.22110; Ishida E, 2007, PATHOBIOLOGY, V74, P344, DOI 10.1159/000110028; Ivanovska J, 2014, APOPTOSIS, V19, P329, DOI 10.1007/s10495-013-0916-5; Jensen K, 2010, EXP THER MED, V1, P457, DOI 10.3892/etm_00000071; Jiang JL, 2015, EXP THER MED, V10, P1549, DOI 10.3892/etm.2015.2656; Kartal K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1861-1; Khaled H, 2016, J ADV RES, V7, P565, DOI 10.1016/j.jare.2016.02.007; Khatami Fatemeh, 2017, Asian Pac J Cancer Prev, V18, P293; Khatami Fatemeh, 2017, Acta Med Iran, V55, P175; Kiseljak-Vassiliades Katja, 2011, Front Endocrinol (Lausanne), V2, P99, DOI 10.3389/fendo.2011.00099; Kogai T, 2006, ENDOCR-RELAT CANCER, V13, P797, DOI 10.1677/erc.1.01143; Kogai T, 2012, PHARMACOL THERAPEUT, V135, P355, DOI 10.1016/j.pharmthera.2012.06.007; Kondo T, 2007, CANCER RES, V67, P5461, DOI 10.1158/0008-5472.CAN-06-4477; Lacroix L, 2004, J CLIN ENDOCR METAB, V89, P1423, DOI 10.1210/jc.2003-030542; Lam AKY, 2007, ANN SURG ONCOL, V14, P1772, DOI 10.1245/s10434-006-9280-9; Larijani B, 2004, Asian Pac J Cancer Prev, V5, P36; Larijani B, 2005, IRAN J PUBLIC HEALTH, V34, P1; Lee JJ, 2008, INT J ONCOL, V33, P861, DOI 10.3892/ijo_00000074; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Makhlouf A.M., 2016, ONCOTARGET; Migdalska-Sek M, 2011, WSPOLCZESNA ONKOL, V15, P191, DOI 10.5114/wo.201124312; Mohammadi-Asl J, 2009, J APPL SCI, V9, P3593; Mohammadi-asl J, 2011, MED ONCOL, V28, P1123, DOI 10.1007/s12032-010-9587-z; Murugan AK, 2011, CANCER RES, V71, P4403, DOI 10.1158/0008-5472.CAN-10-4041; Murugan AK, 2011, ENDOCR PATHOL, V22, P97, DOI 10.1007/s12022-011-9155-x; Murugan AK, 2010, BIOCHEM BIOPH RES CO, V393, P555, DOI 10.1016/j.bbrc.2010.02.095; Nakamura N, 2005, LAB INVEST, V85, P1065, DOI 10.1038/labinvest.3700306; Ng K, 2014, ONCOTARGETS THERAPY; Nozhat Z, 2016, MOL DIAGN THER, V20, P13, DOI 10.1007/s40291-015-0175-y; Perland E, 2017, TRENDS PHARMACOL SCI, V38, P305, DOI 10.1016/j.tips.2016.11.008; Porra V, 2005, J CLIN ENDOCR METAB, V90, P3028, DOI 10.1210/jc.2004-1394; QU F, 2012, J NANTONG U MED SCI, V6; Ravera S, 2017, ANNU REV PHYSIOL, V79, P261, DOI 10.1146/annurev-physiol-022516-034125; Rocha AS, 2001, J PATHOL, V194, P358, DOI 10.1002/path.905; Rodriguez AM, 2002, J CLIN ENDOCR METAB, V87, P3500, DOI 10.1210/jc.87.7.3500; Rodriguez-Roder S, 2017, ENDOCRINOLOGIA DIABE; Sanii S, 2012, ASIAN PAC J CANCER P, V13, P2175, DOI 10.7314/APJCP.2012.13.5.2175; Schagdarsurengin U, 2002, CANCER RES, V62, P3698; Schagdarsurengin U, 2006, THYROID, V16, P633, DOI 10.1089/thy.2006.16.633; Schneider-Stock R, 2005, INT J BIOCHEM CELL B, V37, P1763, DOI 10.1016/j.biocel.2005.02.019; Shirazi Hasti Atashi, 2012, Indian J Hum Genet, V18, P340, DOI 10.4103/0971-6866.107989; Shou FY, 2017, ONCOTARGETS THER, V10, P247, DOI 10.2147/OTT.S124417; Smith JA, 2007, ARCH OTOLARYNGOL, V133, P1006, DOI 10.1001/archotol.133.10.1006; St Bernard R, 2005, ENDOCRINOLOGY, V146, P1145, DOI 10.1210/en.2004-1134; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sun WH, 2016, INT J CLIN EXP PATHO, V9, P8373; Tabriz HM, 2009, PATHOL RES PRACT, V205, P83, DOI 10.1016/j.prp.2008.08.007; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Trovisco V, 2005, VIRCHOWS ARCH, V446, P589, DOI 10.1007/s00428-005-1236-0; Wang D, 2014, AM J CANCER RES, V4, P725; White MG, 2016, ANN SURG ONCOL, V23, P2302, DOI 10.1245/s10434-016-5185-4; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2007, ENDOCRINOLOGY, V148, P948, DOI 10.1210/en.2006-0927; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Xing MZ, 2003, CANCER RES, V63, P2316; Xing MZ, 2004, CANCER RES, V64, P1664, DOI 10.1158/0008-5472.CAN-03-3242; Yu W, 2017, HUMAN MOL GENETICS; Zane M, 2013, BIOMED PHARMACOTHER, V67, P723, DOI 10.1016/j.biopha.2013.06.007; Zhang BF, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-45	97	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184892	10.1371/journal.pone.0184892	http://dx.doi.org/10.1371/journal.pone.0184892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926589	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600049
J	Di, XQ; Li, JQ; Qi, H; Cong, LG; Yang, HM				Di, Xiaoqiang; Li, Jinqing; Qi, Hui; Cong, Ligang; Yang, Huamin			A semi-symmetric image encryption scheme based on the function projective synchronization of two hyperchaotic systems	PLOS ONE			English	Article							CHAOTIC SYSTEM; ALGORITHM; PERMUTATION; MAP; ROBUST; CODE	Both symmetric and asymmetric color image encryption have advantages and disadvantages. In order to combine their advantages and try to overcome their disadvantages, chaos synchronization is used to avoid the key transmission for the proposed semi-symmetric image encryption scheme. Our scheme is a hybrid chaotic encryption algorithm, and it consists of a scrambling stage and a diffusion stage. The control law and the update rule of function projective synchronization between the 3-cell quantum cellular neural networks (QCNN) response system and the 6th-order cellular neural network (CNN) drive system are formulated. Since the function projective synchronization is used to synchronize the response system and drive system, Alice and Bob got the key by two different chaotic systems independently and avoid the key transmission by some extra security links, which prevents security key leakage during the transmission. Both numerical simulations and security analyses such as information entropy analysis, differential attack are conducted to verify the feasibility, security, and efficiency of the proposed scheme.	[Di, Xiaoqiang; Li, Jinqing; Qi, Hui; Cong, Ligang; Yang, Huamin] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Jilin, Peoples R China	Changchun University of Science & Technology	Di, XQ (corresponding author), Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Jilin, Peoples R China.	dixiaoqiang@cust.edu.cn			Industrial Innovation Project of Jilin Province [2016C087]; Science and Technology Project of Jilin Province [20150312030ZX]	Industrial Innovation Project of Jilin Province; Science and Technology Project of Jilin Province	This research is partially supported by Industrial Innovation Project of Jilin Province (2016C087, http://jldrc.gov.cn) and Science and Technology Project of Jilin Province (20150312030ZX, http://www.jlkjt.gov.cn/bsfw/kjjhxmsb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research is partially supported by Industrial Innovation Project of Jilin Province (2016C087, http://jldrc.gov.cn) and Science and Technology Project of Jilin Province (20150312030ZX, http://www.jlkjt.gov.cn/bsfw/kjjhxmsb/).	Abdullah AH, 2012, AEU-INT J ELECTRON C, V66, P806, DOI 10.1016/j.aeue.2012.01.015; Al-Mashhadi H.M., 2017, 2017 INT C CURR RES; Belazi A, 2017, NONLINEAR DYNAM, V87, P337, DOI 10.1007/s11071-016-3046-0; Belazi A, 2017, OPT LASER ENG, V88, P37, DOI 10.1016/j.optlaseng.2016.07.010; Belazi A, 2016, SIGNAL PROCESS, V128, P155, DOI 10.1016/j.sigpro.2016.03.021; Bernhard MA, 1992, INTRO CHAOTIC DYNAMI; Carroll TL, 1995, PATENT APPL DEP NAVY; Cheng CJ, 2013, COMMUN NONLINEAR SCI, V18, P2825, DOI 10.1016/j.cnsns.2013.02.011; El-Latif A.A.A., 2013, SIGNAL PROCESS, V93, P2986, DOI DOI 10.1016/J.SIGPR0.2013.03.031; Elashry IF, 2012, INF SECUR J, V21, P193, DOI 10.1080/19393555.2011.654319; Fortuna L, 2004, INT J BIFURCAT CHAOS, V14, P1085, DOI 10.1142/S0218127404009624; Fu C, 2011, OPT COMMUN, V284, P5415, DOI 10.1016/j.optcom.2011.08.013; Gagunashvili ND, 2012, COMPUT PHYS COMMUN, V183, P418, DOI 10.1016/j.cpc.2011.10.009; Gagunashvili ND, 2012, COMPUT PHYS COMMUN, V183, P193, DOI 10.1016/j.cpc.2011.08.014; Guesmi R, 2016, MULTIMED TOOLS APPL, V75, P4753, DOI 10.1007/s11042-015-2501-0; Hsiao HI, 2015, SIGNAL PROCESS, V113, P169, DOI 10.1016/j.sigpro.2015.01.024; Hua ZY, 2015, INFORM SCIENCES, V297, P80, DOI 10.1016/j.ins.2014.11.018; IEEE Standard for Floating-Point Arithmetic, 2019, 7542019 IEEE; Li JQ, 2013, J ELECTRON IMAGING, V22, DOI 10.1117/1.JEI.22.1.013036; Liu HJ, 2015, OPT COMMUN, V338, P340, DOI 10.1016/j.optcom.2014.10.021; Liu HJ, 2010, COMPUT MATH APPL, V59, P3320, DOI 10.1016/j.camwa.2010.03.017; Liu LL, 2012, COMPUT ELECTR ENG, V38, P1240, DOI 10.1016/j.compeleceng.2012.02.007; Matthews RAJ, 1989, CRYPTOLOGIA, VXIII, P29, DOI [10.1080/0161-118991863745, DOI 10.1080/0161-118991863745]; Mirzaei O, 2012, NONLINEAR DYNAM, V67, P557, DOI 10.1007/s11071-011-0006-6; Pareschi F, 2012, IEEE T INF FOREN SEC, V7, P491, DOI 10.1109/TIFS.2012.2185227; Patidar V, 2011, OPT COMMUN, V284, P4331, DOI 10.1016/j.optcom.2011.05.028; Rehman AU, 2015, MULTIMED TOOLS APPL, V74, P4655, DOI 10.1007/s11042-013-1828-7; Rhouma R, 2009, CHAOS SOLITON FRACT, V40, P309, DOI 10.1016/j.chaos.2007.07.083; Seyedzadeh SM, 2012, SIGNAL PROCESS, V92, P1202, DOI 10.1016/j.sigpro.2011.11.004; Stinson D.R., 2006, CRYPTOGRAPHY THEORY; Sudheer KS, 2009, PHYS LETT A, V373, P1847, DOI 10.1016/j.physleta.2009.03.052; Tong XJ, 2013, COMMUN NONLINEAR SCI, V18, P1725, DOI 10.1016/j.cnsns.2012.11.002; Toth G, 2000, SUPERLATTICE MICROST, V20, P473; Volos CK, 2013, SIGNAL PROCESS, V93, P1328, DOI 10.1016/j.sigpro.2012.11.008; Wang XY, 2010, COMMUN NONLINEAR SCI, V15, P2479, DOI 10.1016/j.cnsns.2009.10.001; Wang XY, 2015, OPT LASER ENG, V66, P10, DOI 10.1016/j.optlaseng.2014.08.005; Wang XY, 2013, COMMUN NONLINEAR SCI, V18, P3075, DOI 10.1016/j.cnsns.2013.04.008; Wang XY, 2012, SIGNAL PROCESS, V92, P1101, DOI 10.1016/j.sigpro.2011.10.023; Wang XY, 2012, OPT COMMUN, V285, P562, DOI 10.1016/j.optcom.2011.10.098; Wang XY, 2012, NONLINEAR DYNAM, V67, P365, DOI 10.1007/s11071-011-9984-7; Wang XY, 2010, COMMUN NONLINEAR SCI, V15, P124, DOI 10.1016/j.cnsns.2009.03.035; Wu XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119660; Ye GD, 2012, NONLINEAR DYNAM, V69, P2079, DOI 10.1007/s11071-012-0409-z; Ye GD, 2010, PATTERN RECOGN LETT, V31, P347, DOI 10.1016/j.patrec.2009.11.008; Ye RS, 2011, OPT COMMUN, V284, P5290, DOI 10.1016/j.optcom.2011.07.070; Yoon JW, 2010, COMMUN NONLINEAR SCI, V15, P3998, DOI 10.1016/j.cnsns.2010.01.041; Zhang Q, 2010, MATH COMPUT MODEL, V52, P2028, DOI 10.1016/j.mcm.2010.06.005; Zhang YQ, 2014, INFORM SCIENCES, V273, P329, DOI 10.1016/j.ins.2014.02.156; Zhang YS, 2014, COMMUN NONLINEAR SCI, V19, P74, DOI 10.1016/j.cnsns.2013.06.031; Zhou YC, 2014, SIGNAL PROCESS, V100, P197, DOI 10.1016/j.sigpro.2014.01.020	50	10	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184586	10.1371/journal.pone.0184586	http://dx.doi.org/10.1371/journal.pone.0184586			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910349	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200065
J	Khan, WS; Hamadneh, NN; Khan, WA				Khan, Waseem S.; Hamadneh, Nawaf N.; Khan, Waqar A.			Prediction of thermal conductivity of polyvinylpyrrolidone (PVP) electrospun nanocomposite fibers using artificial neural network and prey-predator algorithm	PLOS ONE			English	Article							OPTIMIZATION; ERROR; DYES	In this study, multilayer perception neural network (MLPNN) was employed to predict thermal conductivity of PVP electrospun nanocomposite fibers with multiwalled carbon nanotubes (MWCNTs) and Nickel Zinc ferrites [(Ni0.6Zn0.4) Fe2O4]. This is the second attempt on the application of MLPNN with prey predator algorithm for the prediction of thermal conductivity of PVP electrospun nanocomposite fibers. The prey predator algorithm was used to train the neural networks to find the best models. The best models have the minimal of sum squared error between the experimental testing data and the corresponding models results. The minimal error was found to be 0.0028 for MWCNTs model and 0.00199 for Ni-Zn ferrites model. The predicted artificial neural networks (ANNs) responses were analyzed statistically using z-test, correlation coefficient, and the error functions for both inclusions. The predicted ANN responses for PVP electrospun nanocomposite fibers were compared with the experimental data and were found in good agreement.	[Khan, Waseem S.; Khan, Waqar A.] Majmaah Univ, Coll Engn, Dept Mech & Ind Engn, Majmaah, Saudi Arabia; [Hamadneh, Nawaf N.] Saudi Elect Univ, Coll Sci & Theoret Studies, Dept Basic Sci, Riyadh, Saudi Arabia	Majmaah University; Saudi Electronic University	Khan, WA (corresponding author), Majmaah Univ, Coll Engn, Dept Mech & Ind Engn, Majmaah, Saudi Arabia.	wkhan1956@gmail.com	HAMADNEH, NAWAF N./Y-7759-2019; Khan, Waqar/H-3886-2013; Hamadneh, Nawaf N./AAW-7128-2021	HAMADNEH, NAWAF N./0000-0002-2170-2074; Khan, Waqar/0000-0002-8328-850X; Hamadneh, Nawaf N./0000-0002-2170-2074				AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212; Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872; Caizer C, 2001, J OPTOELECTRON ADV M, V3, P919; Chan LS, 2012, CHINESE J CHEM ENG, V20, P535, DOI 10.1016/S1004-9541(11)60216-4; Dev VRG, 2009, J APPL POLYM SCI, V113, P3397, DOI 10.1002/app.30059; Donadio D, 2016, LECT NOTES PHYS, V921, P275, DOI 10.1007/978-3-319-29261-8_7; Flaifel MH, 2013, COMPOS PART B-ENG, V52, P334, DOI 10.1016/j.compositesb.2013.04.021; Gojny FH, 2006, POLYMER, V47, P2036, DOI 10.1016/j.polymer.2006.01.029; Hamadneh Nawaf, 2012, Journal of Applied Sciences, V12, P840, DOI 10.3923/jas.2012.840.847; Hamadneh N, 2013, RES J APPL SCI, V8, P383; HANSEN D, 1965, J POLYM SCI PART A, V3, P659, DOI 10.1002/pol.1965.100030222; Harris PJ, 2004, CARBON NANOTUBES REL; Kapoor A., 1989, GAS SEP PURIF, V3, P187, DOI DOI 10.1016/0950-4214(89)80004-0; Karimzadeh F, 2006, MAT SCI ENG A-STRUCT, V432, P184, DOI 10.1016/j.msea.2006.05.141; Khan W., 2016, POLYM NANOCOMPOSITES; Khan W, 2012, NI J NANOTECHNOLOGY, V2012; Khan WS, 2013, INT J THERM SCI, V71, P74, DOI 10.1016/j.ijthermalsci.2013.03.006; Khan W. S., 2010, Journal of Nanotechnology in Engineering and Medicine, V1, DOI 10.1115/1.4002533; Khanlou HM, 2014, NEURAL COMPUT APPL, V25, P767, DOI 10.1007/s00521-014-1554-8; Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p; Norkhairunnisa M, 2012, J COMPOS MATER, V46, P903, DOI 10.1177/0021998311412985; O'Connell MJ, 2006, CARBON NANOTUBES PRO; Porter JF, 1999, CHEM ENG SCI, V54, P5863, DOI 10.1016/S0009-2509(99)00178-5; Slade P. E., 1970, THERMAL CHARACTERIZA; Tilahun SL, 2017, ADV HOSP TOUR SERV, P400, DOI 10.4018/978-1-5225-1054-3.ch019; Tilahun SL, 2015, INT J INF TECH DECIS, V14, P1331, DOI 10.1142/S021962201450031X; Triola MF, 2014, ELEMENTARY STAT USIN; Yadoji P, 2003, MAT SCI ENG B-SOLID, V98, P269, DOI 10.1016/S0921-5107(03)00063-1; Yeung DS, 2016, IEEE T NEUR NET LEAR, V27, P978, DOI 10.1109/TNNLS.2015.2431251; Zhang D, 2009, POLYMER, V50, P4189, DOI 10.1016/j.polymer.2009.06.062	30	17	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183920	10.1371/journal.pone.0183920	http://dx.doi.org/10.1371/journal.pone.0183920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934220	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900014
J	Pietz, G; De, R; Hedberg, M; Sjoberg, V; Sandstrom, O; Hernell, O; Hammarstrom, S; Hammarstrom, ML				Pietz, Grzegorz; De, Rituparna; Hedberg, Maria; Sjoberg, Veronika; Sandstrom, Olof; Hernell, Olle; Hammarstrom, Sten; Hammarstrom, Marie-Louise			Immunopathology of childhood celiac disease-Key role of intestinal epithelial cells	PLOS ONE			English	Article							T-CELLS; GENE-EXPRESSION; INNATE IMMUNITY; SP NOV.; GLIADIN; IDENTIFICATION; MUCOSA; INTERLEUKIN-18; INFLAMMASOME; LYMPHOCYTES	Background & Aims Celiac disease is a chronic inflammatory disease of the small intestine mucosa due to permanent intolerance to dietary gluten. The aim was to elucidate the role of small intestinal epithelial cells in the immunopathology of celiac disease in particular the influence of celiac disease-associated bacteria. Methods Duodenal biopsies were collected from children with active celiac disease, treated celiac disease, and clinical controls. Intestinal epithelial cells were purified and analyzed for gene expression changes at the mRNA and protein levels. Two in vitro models for human intestinal epithelium, small intestinal enteroids and polarized tight monolayers, were utilized to assess how interferon-gamma, interleukin- 17A, celiac disease-associated bacteria and gluten influence intestinal epithelial cells. Results More than 25 defense-related genes, including IRF1, SPINK4, ITLN1, OAS2, CIITA, HLA-DMB, HLA-DOB, PSMB9, TAP1, BTN3A1, and CX3CL1, were significantly upregulated in intestinal epithelial cells at active celiac disease. Of these genes, 70% were upregulated by interferon-gamma via the IRF1 pathway. Most interestingly, IRF1 was also upregulated by celiac disease-associated bacteria. The NLRP6/8 inflammasome yielding CASP1 and biologically active interleukin-18, which induces interferon-gamma in intraepithelial lymphocytes, was expressed in intestinal epithelial cells. Conclusion A key factor in the epithelial reaction in celiac disease appears to be over-expression of IRF1 that could be inherent and/or due to presence of undesirable microbes that act directly on IRF1. Dual activation of IRF1 and IRF1-regulated genes, both directly and via the interleukin-18 dependent inflammasome would drastically enhance the inflammatory response and lead to the pathological situation seen in active celiac disease.	[Pietz, Grzegorz; De, Rituparna; Hedberg, Maria; Sjoberg, Veronika; Hammarstrom, Sten; Hammarstrom, Marie-Louise] Umea Univ, Dept Clin Microbiol, Immunol, Umea, Sweden; [Sandstrom, Olof; Hernell, Olle] Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden	Umea University; Umea University	Hammarstrom, ML (corresponding author), Umea Univ, Dept Clin Microbiol, Immunol, Umea, Sweden.	marie-louise.hammarstrom@umu.se		De, Dr.Rituparna/0000-0002-8573-7276; Hammarstrom, Marie-Louise/0000-0001-6182-4423; Sandstrom, Olof/0000-0003-0899-0531	Swedish Research Council-Natural Sciences and Engineering Sciences [2010-5669, 2013-4522]; Kempe Foundations [SMK-1134]; TORNADO-Project within 7th EU framework program [222720-2]; Fund for Biotechnology-oriented Basic Science at Umea University; Council of the County of Vasterbotten; Swedish Society for Celiac Disease	Swedish Research Council-Natural Sciences and Engineering Sciences(Swedish Research Council); Kempe Foundations; TORNADO-Project within 7th EU framework program; Fund for Biotechnology-oriented Basic Science at Umea University; Council of the County of Vasterbotten; Swedish Society for Celiac Disease	Funding was provided by the Swedish Research Council-Natural Sciences and Engineering Sciences no. 2010-5669 and 2013-4522 (to M-LH and SH); The Kempe Foundations no. SMK-1134 (to M-LH); The TORNADO-Project within the 7th EU framework program theme, grant agreement no. 222720-2 (to M-LH and OH); The Fund for Biotechnology-oriented Basic Science at Umea University (to M-LH); The Council of the County of Vasterbotten (to M-LH and OS); The Swedish Society for Celiac Disease (to M-LH and OS); Donations to the Medical Faculty, Umea University to M-LH, the Medical Faculty, Umea University, grants including PhD-scholarships for GP and VS to M-LH. The funding agencies had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bondar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089068; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Cenit MC, 2015, NUTRIENTS, V7, P6900, DOI 10.3390/nu7085314; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dunne MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076008; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Forsberg G, 2007, INT IMMUNOL, V19, P993, DOI 10.1093/intimm/dxm077; Gianfrani C, 2003, J IMMUNOL, V170, P2719, DOI 10.4049/jimmunol.170.5.2719; Girbovan A, 2017, MED MICROBIOL IMMUN, V206, P83, DOI 10.1007/s00430-017-0496-z; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hedberg ME, 2013, INT J SYST EVOL MICR, V63, P4218, DOI 10.1099/ijs.0.052647-0; Hedberg ME, 2012, INT J SYST EVOL MICR, V62, P2685, DOI 10.1099/ijs.0.033613-0; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Kneepkens CMF, 2012, EUR J PEDIATR, V171, P1011, DOI 10.1007/s00431-012-1714-8; Kondrashova A, 2008, ANN MED, V40, P223, DOI 10.1080/07853890701678689; Leon AJ, 2006, CLIN EXP IMMUNOL, V146, P479, DOI 10.1111/j.1365-2249.2006.03239.x; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; LUNDQVIST C, 1992, J IMMUNOL METHODS, V152, P253, DOI 10.1016/0022-1759(92)90147-L; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; Mellins ED, 2014, CURR OPIN IMMUNOL, V26, P115, DOI 10.1016/j.coi.2013.11.005; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; Meresse B, 2015, DIGEST DIS, V33, P122, DOI 10.1159/000369521; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Nerdal PT, 2016, J IMMUNOL, V197, P3059, DOI 10.4049/jimmunol.1600913; Oberg ANV, 2004, INT J CANCER, V111, P101, DOI 10.1002/ijc.20231; Olsson C, 2008, PEDIATRICS, V122, P528, DOI 10.1542/peds.2007-2989; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; Ou GW, 2009, AM J GASTROENTEROL, V104, P3058, DOI 10.1038/ajg.2009.524; Rhodes DA, 2016, ANNU REV IMMUNOL, V34, P151, DOI 10.1146/annurev-immunol-041015-055435; Salvati VM, 2003, PEDIATR RES, V54, P312, DOI 10.1203/01.PDR.0000079184.70237.9C; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sjoberg V, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.9; Sjoberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053414; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Sollid LM, 2011, J INTERN MED, V269, P604, DOI 10.1111/j.1365-2796.2011.02376.x; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Veeraraghavan G, 2015, EXPERT REV GASTROENT, V9, P913, DOI 10.1586/17474124.2015.1033399; Vitale Serena, 2016, Mol Cell Pediatr, V3, P20, DOI 10.1186/s40348-016-0048-4; Wapenaar MC, 2007, IMMUNOGENETICS, V59, P349, DOI 10.1007/s00251-007-0199-5; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026	50	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185025	10.1371/journal.pone.0185025	http://dx.doi.org/10.1371/journal.pone.0185025			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934294	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900076
J	Zheng, XL; Wang, XM; Teng, D; Mao, RY; Hao, Y; Yang, N; Zong, LF; Wang, JH				Zheng, Xueling; Wang, Xiumin; Teng, Da; Mao, Ruoyu; Hao, Ya; Yang, Na; Zong, Lifen; Wang, Jianhua			Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; SALMONELLA-ENTERITIDIS; STAPHYLOCOCCUS-AUREUS; IN-VITRO; RESISTANCE; EXPRESSION; MECHANISM; MEMBRANE; DEFENSIN; DESIGN	NZ2114 and MP1102 are novel plectasin-derived peptides with potent activity against Gram-positive bacteria. The antibacterial characteristics and mechanism of NZ2114 and MP1102 against gas gangrene-associated Clostridium perfringens were studied for the first time. The minimal inhibitory concentration and minimal bactericidal concentration of NZ2114 and MP1102 against resistant C. perfringens type A strain CVCC 46 were 0.91 mu M. Based on the fractional inhibitory concentration index (FICI) result, an additive or synergic effect was observed between NZ2114 (FICI = 0.5 similar to 0.75) or MP1102 (FICI = 0.375 similar to 1.0) and antibiotics. The flow cytometry, scanning and transmission electron microscopy analysis showed that both NZ2114 and MP1102 induced obviously membrane damage, such as the leakage of cellular materials, partial disappearance of the cell membrane and membrane peeling, as well as retracting cytoplasm and ghost cell. The gel retardation and circular dichroism (CD) detection showed that NZ2114 and MP1102 could bind to C. perfringens genomic DNA and change the DNA conformation. Moreover, NZ2114 also interfered with the double helix and unwind the genomic DNA. The cell cycle analysis showed that C. perfringens CVCC 46 cells exposed to NZ2114 and MP1102 were arrested at the phase I. These data indicated that both NZ2114 and MP1102 have potential as new antimicrobial agents for gas gangrene infection resulting from resistant C. perfringens.	[Zheng, Xueling; Wang, Xiumin; Teng, Da; Mao, Ruoyu; Hao, Ya; Yang, Na; Zong, Lifen; Wang, Jianhua] Minist Agr, Key Lab Feed Biotechnol, Beijing, Peoples R China; [Zheng, Xueling; Wang, Xiumin; Teng, Da; Mao, Ruoyu; Hao, Ya; Yang, Na; Zong, Lifen; Wang, Jianhua] Chinese Acad Agr Sci, Gene Engn Lab, Feed Res Inst, Beijing, Peoples R China	Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS	Teng, D; Wang, JH (corresponding author), Minist Agr, Key Lab Feed Biotechnol, Beijing, Peoples R China.; Teng, D; Wang, JH (corresponding author), Chinese Acad Agr Sci, Gene Engn Lab, Feed Res Inst, Beijing, Peoples R China.	tengda@caas.cn; wangjianhua@caas.cn	Wang, Xiumin/AAB-3981-2022; Mao, Ruoyu/HDO-7383-2022		National Natural Science Foundation of China [31572445, 31372346, 31572444, 31672456, 31601968]; National Support Program for Science and Technology in China [2013BAD10602]; AMP Direction of National Innovation Program of Agricultural Science and Technology in CAAS [CAAS-ASTIP-2013-FRI-02, 2013-2017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Support Program for Science and Technology in China; AMP Direction of National Innovation Program of Agricultural Science and Technology in CAAS	This study was supported by the National Natural Science Foundation of China (No. 31572445, 31372346, No.31572444, No.31672456, and No.31601968), the Project of the National Support Program for Science and Technology in China (No. 2013BAD10602), and the AMP Direction of National Innovation Program of Agricultural Science and Technology in CAAS (CAAS-ASTIP-2013-FRI-02, 2013-2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No. 31572445, 31372346, No.31572444, No.31672456, and No.31601968), the Project of the National Support Program for Science and Technology in China (No. 2013BAD10B02), and the AMP Direction of National Innovation Program of Agricultural Science and Technology in CAAS (CAAS-ASTIP-2013-FRI-02, 2013-2017).	Adams V, 2015, PLASMID, V80, P90, DOI 10.1016/j.plasmid.2015.04.004; Andes D, 2009, ANTIMICROB AGENTS CH, V53, P3003, DOI 10.1128/AAC.01584-08; ARANYI C, 1970, APPL MICROBIOL, V20, P633, DOI 10.1128/AEM.20.4.633-637.1970; Brandenburg LO, 2012, POLYMERS-BASEL, V4, P539, DOI 10.3390/polym4010539; Bryant Amy E, 2010, Curr Infect Dis Rep, V12, P383, DOI 10.1007/s11908-010-0127-y; Caly DL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01336; Candido ED, 2014, PEPTIDES, V55, P65, DOI 10.1016/j.peptides.2014.02.003; Cao XT, 2015, APPL MICROBIOL BIOT, V99, P2649, DOI 10.1007/s00253-014-6077-9; Chen Y, 2015, J BIOL CHEM, V280, P12316; Dempsey CE, 2010, PROTEIN PEPTIDE LETT, V17, P1334; Gholamiandehkordi A, 2009, VET RES COMMUN, V33, P1031, DOI 10.1007/s11259-009-9306-4; Giguere S, 2012, VET MICROBIOL, V160, P207, DOI 10.1016/j.vetmic.2012.05.031; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Han XY, 2015, ANTIMICROB AGENTS CH, V59, P6855, DOI 10.1128/AAC.01643-15; Hao Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep44278; Hara S, 2008, BIOCHEM BIOPH RES CO, V374, P709, DOI 10.1016/j.bbrc.2008.07.093; Jiao J, 2015, PROCESS BIOCHEM, V50, P253, DOI 10.1016/j.procbio.2014.12.019; Joshi S, 2010, BBA-BIOMEMBRANES, V1798, P1864, DOI 10.1016/j.bbamem.2010.06.016; Kuwano K, 2005, INT J ANTIMICROB AG, V26, P396, DOI 10.1016/j.ijantimicag.2005.08.010; Lee DG, 2002, BBA-PROTEINS PROTEOM, V1598, P185, DOI 10.1016/S0167-4838(02)00373-4; Lee TH, 2016, CURR TOP MED CHEM, V16, P25, DOI 10.2174/1568026615666150703121700; Li JH, 2013, MICROBIOL MOL BIOL R, V77, P208, DOI 10.1128/MMBR.00062-12; Li L, 2011, CHINESE J STRUC CHEM, V30, P563; Li LR, 2013, APPL MICROBIOL BIOT, V97, P1711, DOI 10.1007/s00253-012-4352-1; Li WY, 2014, AMINO ACIDS, V46, P2287, DOI 10.1007/s00726-014-1820-1; Ma ML, 2014, INFECT IMMUN, V82, P2958, DOI 10.1128/IAI.01848-14; Mihajlovic M, 2010, BBA-BIOMEMBRANES, V1798, P1494, DOI 10.1016/j.bbamem.2010.02.023; Millet S, 2011, VET J, V187, P143, DOI 10.1016/j.tvjl.2010.05.001; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Osman KM, 2013, REV SCI TECH OIE, V32, P841; Park M, 2010, ARCH MICROBIOL, V192, P803, DOI 10.1007/s00203-010-0605-5; Saravanan R, 2012, BBA-BIOMEMBRANES, V1818, P1613, DOI 10.1016/j.bbamem.2012.03.015; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Soge OO, 2009, J APPL MICROBIOL, V106, P34, DOI 10.1111/j.1365-2672.2008.03960.x; Songer JG, 1998, SWINE HEALTH PROD, V6, P223; Teng D, 2014, APPL MICROBIOL BIOT, V98, P8313, DOI 10.1007/s00253-014-5898-x; Tsuji BT, 2006, DIAGN MICR INFEC DIS, V54, P73, DOI 10.1016/j.diagmicrobio.2005.08.014; Uzal FA, 2009, INFECT IMMUN, V77, P5291, DOI 10.1128/IAI.00825-09; van Dijk A, 2007, ANTIMICROB AGENTS CH, V51, P912, DOI 10.1128/AAC.00568-06; Wang XM, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01056-16, 10.1128/aac.01056-16]; Xi D, 2013, PROCESS BIOCHEM, V48, P453, DOI 10.1016/j.procbio.2013.01.008; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021; Zhang J, 2011, PROTEIN EXPRES PURIF, V78, P189, DOI 10.1016/j.pep.2011.04.014; Zhang Y, 2015, APPL MICROBIOL BIOT, V99, P6255, DOI 10.1007/s00253-015-6394-7; Zhang Y, 2014, APPL MICROBIOL BIOT, V98, P681, DOI 10.1007/s00253-013-4881-2; Zong LF, 2016, APPL MICROBIOL BIOT, V100, P5045, DOI 10.1007/s00253-016-7387-x	46	16	18	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185215	10.1371/journal.pone.0185215	http://dx.doi.org/10.1371/journal.pone.0185215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934314	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900127
J	Ayyagari, VN; Diaz-Sylvester, PL; Hsieh, THJ; Brard, L				Ayyagari, Vijayalakshmi N.; Diaz-Sylvester, Paula L.; Hsieh, Tsung-han Jeff; Brard, Laurent			Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines	PLOS ONE			English	Article							IN-VITRO; APOPTOSIS; CISPLATIN; EXPRESSION; AUTOTAXIN; P53; DOXORUBICIN; SENSITIVITY; GENERATION; RESISTANCE	Previously, Bithionol (BT) was shown to enhance the chemosensitivity of ovarian cancer cell lines to cisplatin treatment. In the present study, we focused on the anti-tumor potential of the BT-paclitaxel combination when added to a panel of ovarian cancer cell lines. This in vitro study aimed to 1) determine the optimum schedule for combination of BT and paclitaxel and 2) assess the nature and mechanism(s) underlying BT-paclitaxel interactions. The cytotoxic effects of both drugs either alone or in combination were assessed by presto-blue cell viability assay using six human ovarian cancer cell lines. Inhibitory concentrations to achieve 50% cell death (IC50) were determined for BT and paclitaxel in each cell line. Changes in levels of cleaved PARP, XIAP, bcl-2, bcl-xL, p21 and p27 were determined via immunoblot. Luminescent and colorimetric assays were used to determine caspases 3/7 and autotaxin (ATX) activity. Cellular reactive oxygen species (ROS) were measured by flow cytometry. Our results show that the efficacy of the BT-paclitaxel combination depends upon the concentrations and sequence of addition of paclitaxel and BT. Pretreatment with BT followed by paclitaxel resulted in antagonistic interactions whereas synergistic interactions were observed when both drugs were added simultaneously or when cells were pretreated with paclitaxel followed by BT. Synergistic interactions between BT and paclitaxel were attributed to increased ROS generation and enhanced apoptosis. Decreased expression of pro-survival factors (XIAP, bcl-2, bcl-xL) and increased expression of pro-apoptotic factors (caspases 3/7, PARP cleavage) was observed. Additionally, increased expression of key cell cycle regulators p21 and p27 was observed. These results show that BT and paclitaxel interacted synergistically at most drug ratios which, however, was highly dependent on the sequence of the addition of drugs. Our results suggest that BT-paclitaxel combination therapy may be effective in sensitizing ovarian cancer cells to paclitaxel treatment, thus mitigating some of the toxic effects associated with high doses of paclitaxel.	[Ayyagari, Vijayalakshmi N.; Diaz-Sylvester, Paula L.; Hsieh, Tsung-han Jeff; Brard, Laurent] Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA; [Diaz-Sylvester, Paula L.] Southern Illinois Univ, Sch Med, Ctr Clin Res, Springfield, IL USA; [Brard, Laurent] Southern Illinois Univ, Sch Med, Simmons Canc Inst SIU, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Brard, L (corresponding author), Southern Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA.; Brard, L (corresponding author), Southern Illinois Univ, Sch Med, Simmons Canc Inst SIU, Springfield, IL 62702 USA.	lbrard@siumed.edu		Ayyagari, Vijayalakshmi/0000-0003-1001-7044; Diaz-Sylvester, Paula/0000-0002-1531-1958	National Cancer Institute (NCI) of the National Institutes of Health (NIH) [P20CA192987]	National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this manuscript was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under award number P20CA192987 (LB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Ayyagari VN, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-3034-2; Ayyagari VN, 2016, ANTI-CANCER DRUG, V27, P547, DOI 10.1097/CAD.0000000000000364; Ayyagari VN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-61; BACQ Y, 1991, HEPATOLOGY, V14, P1066, DOI 10.1002/hep.1840140620; Band Horwitz S., TRENDS PHARM SCI, V13, P134; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Braddock D, 2009, Application, Patent No. [WO2009151644 A2, 2009151644]; CHEN HW, 1995, CARCINOGENESIS, V16, P1963, DOI 10.1093/carcin/16.8.1963; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cristea Mihaela, 2010, Ther Adv Med Oncol, V2, P175, DOI 10.1177/1758834010361333; ELIOPOULOS AG, 1995, ONCOGENE, V11, P1217; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Hadzic T, 2010, FREE RADICAL BIO MED, V48, P1024, DOI 10.1016/j.freeradbiomed.2010.01.018; He G, 2006, BRIT J CANCER, V95, P1514, DOI 10.1038/sj.bjc.6603448; Herod JJO, 1996, CANCER RES, V56, P2178; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Kampan NC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/413076; Kasibhatla S., 2006, CSH PROTOC, V2006; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kaufmann SH, 2000, BIOESSAYS, V22, P1007, DOI 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.3.CO;2-W; Kikuchi Y, 2001, Hum Cell, V14, P115; Kim JS, 2008, INT J CANCER, V122, P672, DOI 10.1002/ijc.23158; Kim KK, 2011, GYNECOL ONCOL, V122, P183, DOI 10.1016/j.ygyno.2011.03.035; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; Lambert HE, 2004, INT J GYNECOL CANCER, V14, P772, DOI 10.1111/j.1048-891X.2004.014507.x; Leitao MM, 2003, GYNECOL ONCOL, V91, P123, DOI 10.1016/S0090-8258(03)00464-5; LIPTON RB, 1989, NEUROLOGY, V39, P368, DOI 10.1212/WNL.39.3.368; Mansat-De Mas V, 1999, MOL PHARMACOL, V56, P867, DOI 10.1124/mol.56.5.867; Marx D, 2000, METH MOLEC MED, V39, P687; Meshkini A, 2012, EXP TOXICOL PATHOL, V64, P357, DOI 10.1016/j.etp.2010.09.010; Mitsuuchi Y, 2000, CANCER RES, V60, P5390; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Nam SW, 2001, CANCER RES, V61, P6938; Naumann RW, 2011, DRUGS, V71, P1397, DOI 10.2165/11591720-000000000-00000; Ott I, 2007, ARCH PHARM, V340, P117, DOI 10.1002/ardp.200600151; Pace A, 1997, ITAL J NEUROL SCI, V18, P73, DOI 10.1007/BF01999566; Park YD, 2016, MBIO, V7, DOI 10.1128/mBio.01073-16; Piccart MJ, 2000, J CLIN ONCOL, V18, P1193, DOI 10.1200/JCO.2000.18.6.1193; Pinato DJ, 2013, CANCER TREAT REV, V39, P153, DOI 10.1016/j.ctrv.2012.04.004; Rakovitch E, 1999, INT J RADIAT ONCOL, V44, P1119, DOI 10.1016/S0360-3016(99)00109-1; Rosenberg P, 2002, ACTA ONCOL, V41, P418, DOI 10.1080/028418602320404998; Rowinsky E K, 1993, J Natl Cancer Inst Monogr, P107; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Sevko A, 2012, J IMMUNOTOXICOL, V9, P275, DOI 10.3109/1547691X.2012.655343; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Sui MH, 2006, CANCER BIOL THER, V5, P1015, DOI 10.4161/cbt.5.8.2909; Torchilin VP, 2007, AAPS J, V9, pE128, DOI 10.1208/aapsj0902015; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsai-Turton M, 2007, TOXICOL SCI, V98, P216, DOI 10.1093/toxsci/kfm087; Witham J, 2007, CLIN CANCER RES, V13, P7191, DOI 10.1158/1078-0432.CCR-07-0362; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zeng S, 2000, CLIN CANCER RES, V6, P3766; Zhang DS, 2014, DRUG DES DEV THER, V8, P279, DOI 10.2147/DDDT.S56801	60	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185111	10.1371/journal.pone.0185111	http://dx.doi.org/10.1371/journal.pone.0185111			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931042	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700071
J	Salerno, JM; Bottoms, BL; Peter-Hagene, LC				Salerno, Jessica M.; Bottoms, Bette L.; Peter-Hagene, Liana C.			Individual versus group decision making: Jurors' reliance on central and peripheral information to evaluate expert testimony	PLOS ONE			English	Article							DEVIANCE; STEREOTYPES; JUDGMENTS	To investigate dual-process persuasion theories in the context of group decision making, we studied low and high need-for-cognition (NFC) participants within a mock trial study. Participants considered plaintiff and defense expert scientific testimony that varied in argument strength. All participants heard a cross-examination of the experts focusing on peripheral information (e.g., credentials) about the expert, but half were randomly assigned to also hear central information highlighting flaws in the expert's message (e.g., quality of the research presented by the expert). Participants rendered pre- and post-group-deliberation verdicts, which were considered "scientifically accurate" if the verdicts reflected the strong (versus weak) expert message, and "scientifically inaccurate" if they reflected the weak (versus strong) expert message. For individual participants, we replicated studies testing classic persuasion theories: Factors promoting reliance on central information (i.e., central cross-examination, high NFC) improved verdict accuracy because they sensitized individual participants to the quality discrepancy between the experts' messages. Interestingly, however, at the group level, the more that scientifically accurate mock jurors discussed peripheral (versus central) information about the experts, the more likely their group was to reach the scientifically accurate verdict. When participants were arguing for the scientifically accurate verdict consistent with the strong expert message, peripheral comments increased their persuasiveness, which made the group more likely to reach the more scientifically accurate verdict.	[Salerno, Jessica M.] Arizona State Univ, Sch Social & Behav Sci, Glendale, AZ 85281 USA; [Bottoms, Bette L.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [Peter-Hagene, Liana C.] Southern Illinois Univ, Dept Psychol, Carbondale, IL 62901 USA	Arizona State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Southern Illinois University System; Southern Illinois University	Salerno, JM (corresponding author), Arizona State Univ, Sch Social & Behav Sci, Glendale, AZ 85281 USA.	jessica.salerno@asu.edu			American Psychology-Law Society; Psi Chi	American Psychology-Law Society; Psi Chi	This project was funded by the American Psychology-Law Society (www.apadivisions.org/division-41) and Psi Chi (https://www.psichi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Michael Slepian, Daniel Wisneski, James Larson, Linda J. Skitka, Shari Diamond, and Michelle McCauley for helpful comments on earlier forms of this manuscript. The authors wish to thank Shari S. Diamond, Evan McKenzie, and David Stoioff for their consultation regarding legal issues and the ecological validity of our materials. The authors would also like to thank Michael Lombardo, E. Samuel Winer, G. Scott Morgan, Jeff Nibert, and Brad Lytle for lending their voices to the audiotape. The authors also wish to thank Maria Vargas, Robert Vaca, Jr., Amber Gaffney, and Kristen Roy for their invaluable research assistance. This research was supported by grants from Psi Chi and the American Psychology-Law Society.	Axsom D, 1987, J PERSONALITY SOCIAL; Bennett M, 2007, DEALING STATES EXPER; Bornstein BH, 2017, MOCK JUROR SAMPLING; Bottoms BL, 1994, J APPL SOCIAL PSYCHO; Bottoms BL, 2014, BEHAV SCI LAW; Burnstein E, 1977, J EXPT SOCIAL PSYCHO; Cacioppo JT, 1982, J PERSONALITY SOCIAL; CHAIKEN S, 1989, P212; Chaiken S, 1994, J PERSONALITY SOCIAL; Chaiken S, 1980, J PERSONALITY SOCIAL; Cooper J, 1996, LAW HUMAN BEHAV; Cooper J, 2000, LAW HUMAN BEHAV; Devine DJ, 2014, PSYCHOL PUBLIC POL L, V20, P109, DOI 10.1037/law0000006; Diamond SS, 2005, ANNU REV LAW SOC SCI, V1, P255, DOI 10.1146/annurev.lawsocsci.1.041604.120002; Diamond SS, 1996, J CRIMINAL LAW CRIMI; Fabrigar LR, 1999, PERSONALITY SOCIAL P; Freckelton IR, 2016, EXPERT EVIDENCE CRIM; Greene E, 1995, LAW HUMAN BEHAV; Haegerich TM, 2013, PSYCHOL PUBLIC POL L, V19, P81, DOI 10.1037/a0027808; Isenberg Daniel J, 1986, J PERSONALITY SOCIAL; Kahneman D., 2011, THINKING FAST SLOW; Kaplan MF, 1983, BASIC GROUP PROCESSE, P65; Kaplan MF, 1987, J PERSONALITY SOCIAL; Kassin SM, 1979, J PERSONALITY SOCIAL; Kerr NL, 1996, PSYCHOL REV; Kerr NL, 2000, GROUP PROCESSES INTE; Kovera MB, 1999, J APPL PSYCHOL; Kovera MB, 2002, PSYCHOL PUBLIC POLIC; Krauss DA, 2001, PSYCHOL PUBLIC POLIC; Levett LM, 2008, LAW HUMAN BEHAV, V32, P363, DOI 10.1007/s10979-007-9113-9; Lieberman JD, 2008, PSYCHOL PUBLIC POL L, V14, P27, DOI 10.1037/1076-8971.14.1.27; Maheswaran D, 1992, J CONSUMER PSYCHOL; Maheswaran D, 1991, J PERSONALITY SOCIAL; McAuliff BD, 2008, J APPL SOCIAL PSYCHO; McCabe JG, 2010, BEHAV SCI LAW; McCabe JG, 2011, BEHAV SCI LAW, V29, P331, DOI 10.1002/bsl.990; McKimmie BM, 2004, GROUP PROCESS INTERG, V7, P131, DOI 10.1177/1368430204043724; Miller M, 2014, CRIM JUSTICE BEHAV, V41, P732, DOI 10.1177/0093854813509369; Nemeth CJ, 1986, PSYCHOL REV; Opfer JE, 2011, BEHAV BRAIN SCI, V34, P85, DOI 10.1017/S0140525X10002943; Pennebaker JW, 2007, LINGUISTIC INQUIRY W; Petty R. E., 1981, J PERSONALITY SOCIAL; Petty R.T., 1994, PERSUASION PSYCHOL I, P113; Petty RE, 1983, J PERSONALITY SOCIAL; Petty RE, 1984, J PERSONALITY SOCIAL; Petty RE, 1986, ADV EXPT SOCIAL PSYC, P19; Petty RE, 1984, J PERSONALITY ASSESS; Ratneshwar S, 1991, J CONSUMER RES; Rijnbout JS, 2014, J APPL SOC PSYCHOL, V44, P455, DOI 10.1111/jasp.12238; Rijnbout JS, 2012, EUR J SOC PSYCHOL, V42, P915, DOI 10.1002/ejsp.1917; Rijnbout JS, 2012, GROUP PROCESS INTERG, V15, P813, DOI 10.1177/1368430212447136; Salerno JM, 2013, PSYCHOL SCI, V24, P2069, DOI 10.1177/0956797613486988; Salerno JM, 2009, AM J FORENSIC PSYCHO; Salerno JM, 2010, PSYCHONOMIC B REV; Schaeffer E, 2006, ILLINOIS TRIAL PRACT; Selig JP, MONTE CARLO METHOD A; Shestowsky D, 2004, LAW HUMAN BEHAV; Smith SM, 1996, PERSONALITY SOCIAL P; Sommers SR, 2006, J PERS SOC PSYCHOL, V90, P597, DOI 10.1037/0022-3514.90.4.597; STANOVICH K. E., 2000, BEHAV BRAIN SCI; Tormala ZL, 2006, J EXP SOC PSYCHOL, V42, P684, DOI 10.1016/j.jesp.2005.10.005; Vidmar N., 2000, BROOKLYN LAW REV, V66, P1121; Vidmar Neil, 2003, ARIZ L REV, V45, P1; Wegner DM, 1992, PERSONALITY SOCIAL P; Wright EF, 1990, J PERSONALITY SOCIAL; Zhang Y, 1999, J ADVERTISING	66	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0183580	10.1371/journal.pone.0183580	http://dx.doi.org/10.1371/journal.pone.0183580			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931011	gold, Green Submitted, Green Published			2022-12-27	WOS:000411314700011
J	Dorofejeva, O; Barr, AJ				Dorofejeva, Olga; Barr, Alastair J.			Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin	PLOS ONE			English	Article							FLUORESCENCE COMPLEMENTATION BIFC; ENDOTHELIAL-CELL JUNCTIONS; ENDOPLASMIC-RETICULUM; LIVING CELLS; CD148; PTP; ACTIVATION; PHOSPHORYLATION; DIMERIZATION; SIGMA	Receptor-type protein tyrosine phosphatases (RPTPs) of the R3 subgroup play key roles in the immune, vascular and nervous systems. They are characterised by a large ectodomain comprising multiple FNIII-like repeats, a transmembrane domain, and a single intracellular phosphatase domain. The functional role of the extracellular region has not been clearly defined and potential roles in ligand interaction, dimerization, and regulation of cell-cell contacts have been reported. Here bimolecular fluorescence complementation (BiFC) in live cells was used to examine the molecular basis for the interaction of VE-PTP with VE-cadherin, two proteins involved in endothelial cell contact and maintenance of vascular integrity. The potential of other R3-PTPs to interact with VE-cadherin was also explored using this method. Quantitative BiFC analysis, using a VE-PTP construct expressing only the ectodomain and transmembrane domain, revealed a specific interaction with VE-cadherin, when compared with controls. Controls were sialophorin, an unrelated membrane protein with a large ectodomain, and a membrane anchored C-terminal Venus-YFP fragment, lacking both ectodomain and transmembrane domains. Truncation of the first 16 FNIII-like repeats from the ectodomain of VE-PTP indicated that removal of this region is not sufficient to disrupt the interaction with VE-cadherin, although it occurs predominantly in an intracellular location. A construct with a deletion of only the 17th domain of VE-PTP was, in contrast to previous studies, still able to interact with VE-cadherin, although this also was predominantly intracellular. Other members of the R3-PTP family (DEP-1, GLEPP1 and SAP-1) also exhibited the potential to interact with VE-cadherin. The direct interaction of DEP-1 with VE-cadherin is likely to be of physiological relevance since both proteins are expressed in endothelial cells. Together the data presented in the study suggest a role for both the ectodomain and transmembrane domain of R3-PTPs in interaction with VE-cadherin.	[Dorofejeva, Olga; Barr, Alastair J.] Univ Westminster, Fac Sci & Technol, Dept Biomed Sci, London, England	University of Westminster	Barr, AJ (corresponding author), Univ Westminster, Fac Sci & Technol, Dept Biomed Sci, London, England.	a.barr1@westminster.ac.uk		Barr, Alastair/0000-0001-7738-8419	University of Westminster	University of Westminster	This study was supported by a scholarship from the University of Westminster.; We thank Prof Yotis Senis for use of lab facilities, Nahla Idris for technical support and Prof A. Weiss for the DEP-1 expression construct. OD is a recipient of a University of Westminster scholarship.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; CHEN YT, 1993, P NATL ACAD SCI USA, V90, P6508, DOI 10.1073/pnas.90.14.6508; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Cordoba SP, 2013, BLOOD, V121, P4295, DOI 10.1182/blood-2012-07-442251; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; den Hertog J, 2008, FEBS J, V275, P831, DOI 10.1111/j.1742-4658.2008.06247.x; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Haider AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025818; Hay DL, 2016, ANNU REV PHARMACOL, V56, P469, DOI 10.1146/annurev-pharmtox-010715-103120; Hendriks WJAJ, 2013, FEBS J, V280, P708, DOI 10.1111/febs.12000; Horstman A, 2014, INT J MOL SCI, V15, P9628, DOI 10.3390/ijms15069628; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kronstein R, 2012, CARDIOVASC RES, V93, P130, DOI 10.1093/cvr/cvr256; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Mohebiany AN, 2013, FEBS J, V280, P388, DOI 10.1111/j.1742-4658.2012.08653.x; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Rollin J, 2012, BLOOD, V120, P1309, DOI 10.1182/blood-2012-04-424044; Sallee JL, 2009, J BIOL CHEM, V284, P14997, DOI 10.1074/jbc.M901901200; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Spring K, 2012, BLOOD, V120, P2745, DOI 10.1182/blood-2011-12-398040; Strous GJ, 2002, FEBS LETT, V529, P102, DOI 10.1016/S0014-5793(02)03187-3; Takahashi K, 2012, P NATL ACAD SCI USA, V109, P1985, DOI 10.1073/pnas.1106171109; Takahashi T, 1999, J AM SOC NEPHROL, V10, P2135; Takahashi T, 2006, BLOOD, V108, P1234, DOI 10.1182/blood-2005-10-4296; Tangye SG, 1998, J IMMUNOL, V161, P3249; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Tertoolen LGJ, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-8; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Walchli S, 2005, BIOCHEM BIOPH RES CO, V331, P497, DOI 10.1016/j.bbrc.2005.03.196; Whiteford JR, 2011, MOL BIOL CELL, V22, P3609, DOI 10.1091/mbc.E11-02-0099; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357	49	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184574	10.1371/journal.pone.0184574	http://dx.doi.org/10.1371/journal.pone.0184574			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926625	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000411166600024
J	Hablot, J; Peyrin-Biroulet, L; Kokten, T; El Omar, R; Netter, P; Bastien, C; Jouzeau, JY; Sokol, H; Moulin, D				Hablot, Julie; Peyrin-Biroulet, Laurent; Kokten, Tunay; El Omar, Reine; Netter, Patrick; Bastien, Claire; Jouzeau, Jean-Yves; Sokol, Harry; Moulin, David			Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXTRAINTESTINAL MANIFESTATIONS; ANKYLOSING-SPONDYLITIS; GUT MICROBIOTA; DYSBIOSIS; SPONDYLOARTHRITIS; MANAGEMENT; IMMUNITY; FLORA	Amongst extraintestinal manifestations (EIM) occurring in IBD patients, rheumatologic manifestations are the most frequent. Understanding the relationships between arthritis and colitis is a prerequisite to improving the management of these patients. Microbiota of patients with IBD or rheumatologic diseases, like spondyloarthritis (SpA) is modified compared to healthy individual. Thus, we have evaluated the impact of colitis in the development of arthritis in mice and we have analyzed microbiota changes. Collagen-induced arthritis (CIA) was induced at day 0 in DBA1 mice exposed or not to Dextran Sodium Sulfate (DSS) to induce colitis between day 14 and day 21. Animals were monitored regularly for arthritis and colitis severity (clinical score, hindpaw edema). Fecal microbiota was studied by 16S rRNA deep sequencing at critical time points (D14, D14, D21 & D41). At day 41, histological scoring of the intestines and ankles were performed at the end of experiment. Induction of colitis slightly delayed arthritis onset (2 +/- 1 days of delay) and reduced its severity (5.75 +/- 1.62 in arthritis only group vs 4.00 +/- 1.48 in arthritis + colitis group (p = 0.02 at day 28) macroscopically and histologically. In contrast, colitis severity was not influenced by arthritis development. Induction of colitis promoted a modification of microbiota composition and a decrease of a-diversity. Fecal microbiota composition was different between "colitis" and "arthritis + colitis groups during colitis development. Interestingly a milder decrease of bacterial diversity in the +/- arthritis+ colitis group was observed. Concomitant experimental colitis protects mice against collagen-induced arthritis and this is associated with changes in gut microbiome composition.	[Hablot, Julie; El Omar, Reine; Netter, Patrick; Jouzeau, Jean-Yves; Moulin, David] Univ Lorraine, CNRS, IMoPA, UMR7365, Vandoeuvre Les Nancy, France; [Peyrin-Biroulet, Laurent; Kokten, Tunay] Univ Lorraine, UMR 5954, INSERM, NGERE, Vandoeuvre Les Nancy, France; [Peyrin-Biroulet, Laurent] CHRU Nancy, Serv Hepatogastroenterol, Vandoeuvre Les Nancy, France; [Bastien, Claire] CHRU Nancy, Serv Anatomopathol, Vandoeuvre Les Nancy, France; [Sokol, Harry] St Antoine Hosp, Dept Gastroenterol, Paris, France; [Sokol, Harry] UPMC Univ Paris 06, Sorbonne Univ, INSERM ERL 1157,St Antoine Hosp,AP HP, Avenir Team Gut Microbiota & Immun,UMR CNRS 7203, Paris, France; [Sokol, Harry] Univ Paris Saclay, AgroParisTech, UMR INRA, Micalis Inst, Jouy En Josas, France; [Moulin, David] CHRU Nancy, Contrat Interface, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CHU de Nancy	Moulin, D (corresponding author), Univ Lorraine, CNRS, IMoPA, UMR7365, Vandoeuvre Les Nancy, France.; Moulin, D (corresponding author), CHRU Nancy, Contrat Interface, Vandoeuvre Les Nancy, France.	david.moulin@univ-lorraine.fr	sokol, harry/ABA-8991-2020; MOULIN, David/J-3849-2014; Sokol, Harry/E-2290-2019	sokol, harry/0000-0002-2914-1822; MOULIN, David/0000-0001-6619-5769; Sokol, Harry/0000-0002-2914-1822; peyrin-biroulet, laurent/0000-0003-2536-6618; El Omar, Reine/0000-0002-8984-2022	Fondation Arthritis Courtin; Region Grand Est; Societe Frangaise de Rhumatologie	Fondation Arthritis Courtin; Region Grand Est; Societe Frangaise de Rhumatologie	This work has been partly funded by Fondation Arthritis Courtin, Societe Frangaise de Rhumatologie and Region Grand Est.	Ahl D, 2016, ACTA PHYSIOL, V217, P300, DOI 10.1111/apha.12695; [Anonymous], 2017, ROLE GUT INFLAMMATIO, V63, P1099; [Anonymous], 2017, FAECAL MICROBIOTA ST, V76, P1614; [Anonymous], 2014, TARGETING TH17 CELLS, V35, P493; Ardizzone S, 2008, DIGEST LIVER DIS, V40, pS253, DOI 10.1016/S1590-8658(08)60534-4; Asquith MJ, 2016, ARTHRITIS RHEUMATOL, V68, P2151, DOI 10.1002/art.39681; Barrie A, 2007, INFLAMM BOWEL DIS, V13, P1424, DOI 10.1002/ibd.20196; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Brusca SB, 2014, CURR OPIN RHEUMATOL, V26, P101, DOI 10.1097/BOR.0000000000000008; Chen LL, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/909514; Costello ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/art.38967; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Dorozynska I, 2014, PHARMACOL REP, V66, P250, DOI 10.1016/j.pharep.2013.09.007; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gill T, 2015, CURR OPIN RHEUMATOL, V27, P319, DOI 10.1097/BOR.0000000000000187; Gionchetti P, 2015, J RHEUMATOL, V42, P21, DOI 10.3899/jrheum.150628; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Koboziev I, 2014, FREE RADICAL BIO MED, V68, P122, DOI 10.1016/j.freeradbiomed.2013.11.008; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Liu XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30594; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MONSEN U, 1990, AM J GASTROENTEROL, V85, P711; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Munyaka PM, 2016, J BASIC MICROB, V56, P986, DOI 10.1002/jobm.201500726; Nagalingam NA, 2011, INFLAMM BOWEL DIS, V17, P917, DOI 10.1002/ibd.21462; Orchard TR, 1998, GUT, V42, P387, DOI 10.1136/gut.42.3.387; Peluso R, 2015, THER ADV CHRONIC DIS, V6, P65, DOI 10.1177/2040622314563929; Peluso R, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/631408; Petersen C, 2014, CELL MICROBIOL, V16, P1024, DOI 10.1111/cmi.12308; SCHER JU, 2015, ARTHRITIS RHEUMA S10, V67; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2016, GUT; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stebbings S, 2002, RHEUMATOLOGY, V41, P1395, DOI 10.1093/rheumatology/41.12.1395; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1982, DOI 10.1097/MIB.0000000000000392; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343; Veloso FT, 2011, WORLD J GASTROENTERO, V17, P2702, DOI 10.3748/wjg.v17.i22.2702; Vieira-Sousa E, 2015, ARTHRITIS RHEUMATOL, V67, P2813, DOI 10.1002/art.39282; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; Yeom Y, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1456-7; Zheng B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095441	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184624	10.1371/journal.pone.0184624	http://dx.doi.org/10.1371/journal.pone.0184624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926599	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600026
J	Pereira, S; Robinson, JO; Peoples, HA; Gutierrez, AM; Majumder, MA; McGuire, AL; Rothstein, MA				Pereira, Stacey; Robinson, Jill Oliver; Peoples, Hayley A.; Gutierrez, Amanda M.; Majumder, Mary A.; McGuire, Amy L.; Rothstein, Mark A.			Do privacy and security regulations need a status update? Perspectives from an intergenerational survey	PLOS ONE			English	Article							MECHANICAL TURK	Background The importance of health privacy protections in the era of the "Facebook Generation" has been called into question. The ease with which younger people share personal information about themselves has led to the assumption that they are less concerned than older generations about the privacy of their information, including health information. We explored whether survey respondents' views toward health privacy suggest that efforts to strengthen privacy protections as health information is moved online are unnecessary. Methods Using Amazon's Mechanical Turk (MTurk), which is well-known for recruitment for survey research, we distributed a 45-item survey to individuals in the U.S. to assess their perspectives toward privacy and security of online and health information, social media behaviors, use of health and fitness devices, and demographic information. Results 1310 participants (mean age: 36 years, 50% female, 78% non-Hispanic white, 54% college graduates or higher) were categorized by generations: Millennials, Generation X, and Baby Boomers. In multivariate regression models, we found that generational cohort was an independent predictor of level of concern about privacy and security of both online and health information. Younger generations were significantly less likely to be concerned than older generations (all P < 0.05). Time spent online and social media use were not predictors of level of concern about privacy or security of online or health information (all P > 0.05). Limitations This study is limited by the non-representativeness of our sample. Conclusions Though Millennials reported lower levels of concern about privacy and security, this was not related to internet or social media behaviors, and majorities within all generations reported concern about both the privacy and security of their health information. Thus, there is no intergenerational imperative to relax privacy and security standards, and it would be advisable to take privacy and security of health information more seriously.	[Pereira, Stacey; Robinson, Jill Oliver; Peoples, Hayley A.; Gutierrez, Amanda M.; Majumder, Mary A.; McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Rothstein, Mark A.] Univ Louisville, Sch Med, Inst Bioeth Hlth Policy & Law, Louisville, KY 40292 USA	Baylor College of Medicine; University of Louisville	Rothstein, MA (corresponding author), Univ Louisville, Sch Med, Inst Bioeth Hlth Policy & Law, Louisville, KY 40292 USA.	mark.rothstein@lousville.edu	Pereira, Stacey/ABB-8280-2021	Pereira, Stacey/0000-0001-6541-3904; Peoples, Hayley/0000-0002-9529-4720; Gutierrez, Amanda/0000-0002-4496-5328	Baylor College of Medicine; University of Louisville School of Medicine	Baylor College of Medicine; University of Louisville School of Medicine	Funding for this study was provided by the Baylor College of Medicine and the University of Louisville School of Medicine.; We thank Devan Petersen for her assistance with the data analysis for this paper. Funding for this study was provided by the Baylor College of Medicine and the University of Louisville School of Medicine.	Accenture, 2016, ACC 2016 CONS SURV P; Ancker JS, 2013, J AM MED INFORM ASSN, V20, P152, DOI 10.1136/amiajnl-2012-001062; [Anonymous], 2016, WIRED MAGAZINE; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Dimitropoulos Linda, 2011, Am J Manag Care, V17, pSP111; Howden LM, 2011, C2010BR03 US CENS BU; Johnson B., 2010, GUARDIAN; Kang Ruogu, 2014, S US PRIV SEC SOUPS; Madden M., 2014, PUBLIC PERCEPTIONS P; Meertens RM, 2008, J APPL SOC PSYCHOL, V38, P1506, DOI 10.1111/j.1559-1816.2008.00357.x; National Partnership for Women and Families, 2012, MAK IT MEAN CONS VAL; Nixson L, 2010, C2010BR05 US CENS BU; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Peer E, 2014, BEHAV RES METHODS, V46, P1023, DOI 10.3758/s13428-013-0434-y; Perrin A., 2015, SOCIAL NETWORKING US; Perrin A., 2015, ONE 5 AM REPORT GOIN; Regan PM, 2013, INNOVATION-ABINGDON, V26, P81, DOI 10.1080/13511610.2013.747650; Rothstein MA, 2009, HASTINGS CTR BIOETHI; Ryan CL, 2016, P20578 US CENS BUR, P20; Simons DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051876	20	11	11	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184525	10.1371/journal.pone.0184525	http://dx.doi.org/10.1371/journal.pone.0184525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH4XT	28926626	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600021
J	Kosonogov, V; De Zorzi, L; Honore, J; Martinez-Velazquez, ES; Nandrino, JL; Martinez-Selva, JM; Sequeira, H				Kosonogov, Vladimir; De Zorzi, Lucas; Honore, Jacques; Martinez-Velazquez, Eduardo S.; Nandrino, Jean-Louis; Martinez-Selva, Jose M.; Sequeira, Henrique			Facial thermal variations: A new marker of emotional arousal	PLOS ONE			English	Article							SKIN; TEMPERATURE; INNERVATION; SIGNATURES	Functional infrared thermal imaging (fITI) is considered a promising method to measure emotional autonomic responses through facial cutaneous thermal variations. However, the facial thermal response to emotions still needs to be investigated within the framework of the dimensional approach to emotions. The main aim of this study was to assess how the facial thermal variations index the emotional arousal and valence dimensions of visual stimuli. Twenty-four participants were presented with three groups of standardized emotional pictures (unpleasant, neutral and pleasant) from the International Affective Picture System. Facial temperature was recorded at the nose tip, an important region of interest for facial thermal variations, and compared to electrodermal responses, a robust index of emotional arousal. Both types of responses were also compared to subjective ratings of pictures. An emotional arousal effect was found on the amplitude and latency of thermal responses and on the amplitude and frequency of electrodermal responses. The participants showed greater thermal and dermal responses to emotional than to neutral pictures with no difference between pleasant and unpleasant ones. Thermal responses correlated and the dermal ones tended to correlate with subjective ratings. Finally, in the emotional conditions compared to the neutral one, the frequency of simultaneous thermal and dermal responses increased while both thermal or dermal isolated responses decreased. Overall, this study brings convergent arguments to consider fITI as a promising method reflecting the arousal dimension of emotional stimulation and, consequently, as a credible alternative to the classical recording of electrodermal activity. The present research provides an original way to unveil autonomic implication in emotional processes and opens new perspectives to measure them in touchless conditions.	[Kosonogov, Vladimir; Nandrino, Jean-Louis] Univ Murcia, Sch Psychol, Murcia, Spain; [Kosonogov, Vladimir] Southern Fed Univ, Acad Psychol & Educ Sci, Rostov Na Donu, Russia; [De Zorzi, Lucas; Honore, Jacques; Nandrino, Jean-Louis; Sequeira, Henrique] CNRS, UMR 9193, SCALab, Lille, France; [De Zorzi, Lucas; Honore, Jacques; Nandrino, Jean-Louis; Sequeira, Henrique] Univ Lille, Lille, France; [Martinez-Velazquez, Eduardo S.] Univ Guadalajara, Inst Neurosci, Guadalajara, Mexico; [Martinez-Velazquez, Eduardo S.] Meritorious Autonomous Univ Puebla, Fac Psicol, Puebla, Mexico; [Martinez-Selva, Jose M.] Murcia Inst Biomed Res IMIB Arrixaca, Murcia, Spain	University of Murcia; Southern Federal University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universidad de Guadalajara; Benemerita Universidad Autonoma de Puebla	Sequeira, H (corresponding author), CNRS, UMR 9193, SCALab, Lille, France.; Sequeira, H (corresponding author), Univ Lille, Lille, France.	Henrique.Sequeira@univ-lille1.fr	Kosonogov, Vladimir/R-8117-2016; , Jose/AAA-6330-2019; Dezorzi, Lucas/ABL-2745-2022; Nandrino, Jean-Louis/O-8900-2017	Kosonogov, Vladimir/0000-0002-0469-4818; Dezorzi, Lucas/0000-0002-0531-7942; Nandrino, Jean-Louis/0000-0003-2339-9432	Universidad de Murcia, Spain; Ministere de la Recherche, France; Conacyt, Mexico; CNRS; Ministere de la Recherche; University of Lille, France; program "Investissements d'Avenir" from the Ministere de la Recherche, France [ANR-11-EQPX-0023]	Universidad de Murcia, Spain; Ministere de la Recherche, France(Ministry of Research, France); Conacyt, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); University of Lille, France; program "Investissements d'Avenir" from the Ministere de la Recherche, France(French National Research Agency (ANR))	This work was supported by grants from the Universidad de Murcia, Spain (VK, JMM-S), the Ministere de la Recherche, France (LDZ), Conacyt, Mexico (ESM-V), the CNRS, the Ministere de la Recherche and the University of Lille, France (HS, JH, J-LN, group's grant). Technical apparatus was funded by the program "Investissements d'Avenir" (ANR-11-EQPX-0023) from the Ministere de la Recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armony J, 2013, CAMBRIDGE HDB HUMAN; Bar K.-J., 2015, AUTON NEUROSCI-BASIC, V192, DOI [10.1016/j.autneu.2015.07.282, DOI 10.1016/J.AUTNEU.2015.07.282]; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cacioppo J.T., 2000, HDB EMOTIONS, P173, DOI DOI 10.1017/CBO9780511546396.025; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Coli M, 2007, P S CO 2007 VEN PAD, P116; Cruz-Albarran IA, 2017, INFRARED PHYS TECHN, V81, P250, DOI 10.1016/j.infrared.2017.01.002; D'Hondt F, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00033; Davidson RJ, 2003, BRAIN COGNITION, V52, P129, DOI 10.1016/S0278-2626(03)00015-0; Di Giacinto A, 2014, NEUROSCIENCE, V266, P216, DOI 10.1016/j.neuroscience.2014.02.009; Donadio V, 2006, ANN NEUROL, V59, P376, DOI 10.1002/ana.20769; Engert V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090782; Gross JJ, 2011, EMOT REV, V3, P8, DOI 10.1177/1754073910380974; GULYAEV YV, 1995, IEEE ENG MED BIOL, V14, P766, DOI 10.1109/51.473272; Hahn AC, 2012, BIOL LETTERS, V8, P864, DOI 10.1098/rsbl.2012.0338; Hicks T, 2007, GUIDE MANAGING WORKP; Hot P, 2006, BRAIN RES, V1122, P171, DOI 10.1016/j.brainres.2006.09.020; Ioannou S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162749; Ioannou S, 2014, PSYCHOPHYSIOLOGY, V51, P951, DOI 10.1111/psyp.12243; Ioannou S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00845; Ioannou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079440; Johnson JM, 2014, CUTANEOUS VASODILATO; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 2008, A8 IAPS; Barbara M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00299; Martinez-Velazquez ES, 2016, INT J PSYCHOPHYSIOL, V108, P164, DOI 10.1016/j.ijpsycho.2016.07.470; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Merla A, 2007, P ANN INT IEEE EMBS, P247, DOI 10.1109/IEMBS.2007.4352270; Nakanishi R, 2008, INFANT BEHAV DEV, V31, P137, DOI 10.1016/j.infbeh.2007.09.001; Nakayama K, 2005, PHYSIOL BEHAV, V84, P783, DOI 10.1016/j.physbeh.2005.03.009; Nhan BR, 2010, IEEE T BIO-MED ENG, V57, P979, DOI 10.1109/TBME.2009.2035926; Nozawa A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/01/P01007; Panasiti MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep35174; Panksepp J., 2004, AFFECTIVE NEUROSCIEN; Pavlidis I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00305; Pavlidis I, 2000, IEEE WORKSHOP ON COMPUTER VISION BEYOND THE VISIBLE SPECTRUM: METHODS AND APPLICATIONS, PROCEEDINGS, P104, DOI 10.1109/CVBVS.2000.855255; Roy J-C, 1993, PROGR ELECTRODERMAL, P73; ROY JC, 1977, ARCH ITAL BIOL, V115, P171; Salazar-Lopez E, 2015, CONSCIOUS COGN, V34, P149, DOI 10.1016/j.concog.2015.04.003; SEQUEIRA H, 1993, NATO ADV SCI INST SE, V249, P93; Sequeira H, 2009, INT J PSYCHOPHYSIOL, V71, P50, DOI 10.1016/j.ijpsycho.2008.07.009; Silvert L, 2004, INT J PSYCHOPHYSIOL, V53, P135, DOI 10.1016/j.ijpsycho.2004.03.005; STEKETEE J, 1973, PHYS MED BIOL, V18, P686, DOI 10.1088/0031-9155/18/5/307; Venables Peter H, 1980, TECHNIQUES PSYCHOPHY, V54, P3; Vianna EPM, 2006, INT J PSYCHOPHYSIOL, V61, P70, DOI 10.1016/j.ijpsycho.2005.10.019; Walloe Lars, 2016, Temperature (Austin), V3, P92, DOI 10.1080/23328940.2015.1088502; Westcott EB, 2013, MICROCIRCULATION, V20, P217, DOI 10.1111/micc.12035; WINTON WM, 1984, J EXP SOC PSYCHOL, V20, P195, DOI 10.1016/0022-1031(84)90047-7	52	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183592	10.1371/journal.pone.0183592	http://dx.doi.org/10.1371/journal.pone.0183592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922392	gold, Green Published, Green Submitted			2022-12-27	WOS:000411059300005
J	Rahman, A; Lamberty, Y; Schenker, E; Cella, M; Languille, S; Bordet, R; Richardson, J; Pifferi, F; Aujard, F				Rahman, Anisur; Lamberty, Yves; Schenker, Esther; Cella, Massimo; Languille, Solene; Bordet, Regis; Richardson, Jill; Pifferi, Fabien; Aujard, Fabienne			Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus)	PLOS ONE			English	Article							LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; ANTAGONIST MEMANTINE; WORKING-MEMORY; MODEL; MODERATE; BRAIN; PERFORMANCE; IMPAIRMENT	The development of novel therapeutics to prevent cognitive decline of Alzheimer's disease (AD) is facing paramount difficulties since the translational efficacy of rodent models did not resulted in better clinical results. Currently approved treatments, including the acetylcholinesterase inhibitor donepezil (DON) and the N-methyl-D-aspartate antagonist memantine (MEM) provide marginal therapeutic benefits to AD patients. There is an urgent need to develop a predictive animal model that is phylogenetically proximal to humans to achieve better translation. The non-human primate grey mouse lemur (Microcebus murinus) is increasingly used in aging research, but there is no published results related to the impact of known pharmacological treatments on age-related cognitive impairment observed in this primate. In the present study we investigated the effects of DON and MEM on sleep-deprivation (SD)-induced memory impairment in young and aged male mouse lemurs. In particular, spatial memory impairment was evaluated using a circular platform task after 8 h of total SD. Acute single doses of DON or MEM (0.1 and 1mg/kg) or vehicle were administered intraperitoneally 3 h before the cognitive task during the SD procedure. Results indicated that both doses of DON were able to prevent the SD-induced deficits in retrieval of spatial memory as compared to vehicle-treated animals, both in young and aged animals Likewise, MEM show a similar profile at 1 mg/kg but not at 0.1mg/kg. Taken together, these results indicate that two widely used drugs for mitigating cognitive deficits in AD were partially effective in sleep deprived mouse lemurs, which further support the translational potential of this animal model. Our findings demonstrate the utility of this primate model for further testing cognitive enhancing drugs in development for AD or other neuropsychiatric conditions.	[Rahman, Anisur; Languille, Solene; Pifferi, Fabien; Aujard, Fabienne] Museum Natl Hist Nat, Ctr Natl Rech Sci, UMR 7179, Brunoy, France; [Lamberty, Yves] UCB Pharma Sa, Neurosci Therapeut Area, Braine Lalleud, Belgium; [Schenker, Esther] Inst Rech Serv, Croissy Sur Seine, France; [Cella, Massimo] Chiesi Farmaceut, Global Clin Dev, Dept Clin Pharmacol, Parma, Italy; [Bordet, Regis] Univ Lille Nord France, Dept Pharmacol Med, UDSL, Fac Med,CHU, Lille, France; [Richardson, Jill] GlaxoSmithKline, Neurosci Therapeut Unit, Stevenage, Herts, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UCB Pharma SA; Chiesi Pharmaceuticals Inc; Universite de Lille - ISITE; CHU Lille; Universite de Lille; GlaxoSmithKline	Aujard, F (corresponding author), Museum Natl Hist Nat, Ctr Natl Rech Sci, UMR 7179, Brunoy, France.	fabienne.aujard@mnhn.fr	Cella, Massimo/K-8375-2019	Pifferi, Fabien/0000-0001-9316-1935	Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative [115009]	Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative	This work was financially supported as part of the Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative under Grant Agreement no. 115009. For further information please refer to www.pharmacog.org. The funder provided support in the form of salaries for authors YL, ES, MC and JR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was financially supported as part of the Pharma-Cog consortium by the European Community's Seventh Framework Programme for the Innovative Medicine Initiative under Grant Agreement no. 115009. For further information please refer to http://www.pharmacog.org.	Alzoubi KH, 2012, BEHAV BRAIN RES, V226, P205, DOI 10.1016/j.bbr.2011.09.017; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Bakchine S, 2007, J ALZHEIMERS DIS, V11, P471; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bons N, 2006, GENES BRAIN BEHAV, V5, P120, DOI 10.1111/j.1601-183X.2005.00149.x; Boonstra TW, 2007, CELL MOL LIFE SCI, V64, P934, DOI 10.1007/s00018-007-6457-8; Braida D, 1996, EUR J PHARMACOL, V302, P13, DOI 10.1016/0014-2999(96)00072-6; Burns A, 1999, DEMENT GERIATR COGN, V10, P237, DOI 10.1159/000017126; Chen Z, 2002, ACTA PHARMACOL SIN, V23, P355; Chuah LYM, 2008, J NEUROSCI, V28, P11369, DOI 10.1523/JNEUROSCI.4045-08.2008; Chuah LYM, 2009, SLEEP, V32, P999, DOI 10.1093/sleep/32.8.999; Colavito V, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00106; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Creeley C, 2006, J NEUROSCI, V26, P3923, DOI 10.1523/JNEUROSCI.4883-05.2006; DAVIES P, 1987, J CLIN PSYCHIAT, V48, P23; DAVIES P, 1976, LANCET, V2, P1403; DAWSON GR, 1993, BEHAV BRAIN RES, V57, P143, DOI 10.1016/0166-4328(93)90130-I; Easton A, 2013, PSYCHOPHARMACOLOGY, V230, P279, DOI 10.1007/s00213-013-3152-3; FLOOD JF, 1981, BRAIN RES, V215, P177, DOI 10.1016/0006-8993(81)90500-X; FRANCIS PT, 1993, ANN NY ACAD SCI, V695, P19, DOI 10.1111/j.1749-6632.1993.tb23021.x; FRS. D, 2006, US NONH PRIM RES; Gauthier S, 2008, INT J GERIATR PSYCH, V23, P537, DOI 10.1002/gps.1949; Geldmacher David S., 2003, Prim Care Companion J Clin Psychiatry, V5, P251; Gomolin IH, 2010, J AM GERIATR SOC, V58, P1812, DOI 10.1111/j.1532-5415.2010.03048.x; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hagewoud R, 2010, SLEEP, V33, P1465, DOI 10.1093/sleep/33.11.1465; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ihalainen J, 2011, NEUROPHARMACOLOGY, V61, P891, DOI 10.1016/j.neuropharm.2011.06.008; Kim EY, 2005, NEUROSCI LETT, V388, P163, DOI 10.1016/j.neulet.2005.06.057; Korostenskaja M, 2007, BRAIN RES BULL, V72, P275, DOI 10.1016/j.brainresbull.2007.01.007; Kurz A, 2014, EXPERT OPIN PHARMACO, V15, P1955, DOI 10.1517/14656566.2014.945907; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lanctot K. L., 2003, CMAJ, V169; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Languille S, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00446; Laurijssens Bart, 2013, Drug Discov Today Technol, V10, pe319, DOI 10.1016/j.ddtec.2012.04.001; Lenz RA, 2012, PSYCHOPHARMACOLOGY, V220, P97, DOI 10.1007/s00213-011-2456-4; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li Q, 2012, MOL MED REP, V6, P1450, DOI 10.3892/mmr.2012.1102; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Minkeviciene R, 2004, J PHARMACOL EXP THER, V311, P677, DOI 10.1124/jpet.104.071027; Nagakura A, 2013, EUR J PHARMACOL, V703, P53, DOI 10.1016/j.ejphar.2012.12.023; Ogura H, 2000, METHOD FIND EXP CLIN, V22, P89, DOI 10.1358/mf.2000.22.2.796070; Periclou A, 2006, CLIN PHARMACOL THER, V79, P134, DOI 10.1016/j.clpt.2005.10.005; Picq JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146238; Picq JL, 2012, NEUROBIOL AGING, V33, P1096, DOI 10.1016/j.neurobiolaging.2010.09.009; Pifferi F, 2012, CHRONOBIOL INT, V29, P261, DOI 10.3109/07420528.2011.654019; Prvulovic D, 2014, EXPERT OPIN DRUG MET, V10, P1039, DOI 10.1517/17425255.2014.915028; Rahman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064493; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Rammsayer TH, 2001, LEARN MEMORY, V8, P20, DOI 10.1101/lm.33701; Reisberg B, 2006, ARCH NEUROL-CHICAGO, V63, P49, DOI 10.1001/archneur.63.1.49; Repantis D, 2010, PHARMACOL RES, V61, P473, DOI 10.1016/j.phrs.2010.02.009; Schneider JS, 2013, NEUROBIOL AGING, V34, P1126, DOI 10.1016/j.neurobiolaging.2012.10.020; Scholtzova H., 2008, J NEUROSCI RES, V224, P57; Schugens MM, 1997, NEUROSCI LETT, V224, P57, DOI 10.1016/S0304-3940(97)13452-8; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah RS, 2008, BIOMED PHARMACOTHER, V62, P199, DOI 10.1016/j.biopha.2008.02.005; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Strong R, 1998, GERIATRICS, V53, pS9; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Tarragon E, 2014, NEUROPHARMACOLOGY, V85, P206, DOI 10.1016/j.neuropharm.2014.05.023; TOBLER I, 1990, BEHAV BRAIN RES, V36, P73, DOI 10.1016/0166-4328(90)90161-7; Umukoro S, 2014, Drug Res (Stuttg), V64, P236, DOI 10.1055/s-0033-1357126; Van Dam D, 2006, EUR NEUROPSYCHOPHARM, V16, P59, DOI 10.1016/j.euroneuro.2005.06.005; Volteau C., 2011, J ALZHEIMERS DIS, V23, P749; Windisch M, 2014, NEURODEGENER DIS, V13, P147, DOI 10.1159/000357568; Xia ZM, 2012, BRAIN RES, V1441, P27, DOI 10.1016/j.brainres.2012.01.008; Xie ML, 2015, BEHAV BRAIN RES, V286, P64, DOI 10.1016/j.bbr.2015.02.040	76	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184822	10.1371/journal.pone.0184822	http://dx.doi.org/10.1371/journal.pone.0184822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922421	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300031
J	Lei, ZQ; Zhu, Z; Wang, BMC; Mei, H; Li, H; Ga, DZG; Jie, G; Chi, MMB; Zhang, S; Ma, CF; Xu, WB				Lei, Zhenqiang; Zhu, Zhen; Wang, Bai Ma Ci; Mei, Hong; Li, Hong; Ga, Dan Zeng Gong; Jie, Guo; Chi, Mi Ma Bu; Zhang, Sheng; Ma, Chaofeng; Xu, Wenbo			Outbreaks of epidemic keratoconjunctivitis caused by human adenovirus type 8 in the Tibet Autonomous Region of China in 2016	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISEASE; HEMAGGLUTINATION; CONJUNCTIVITIS; SEROTYPE; JAPAN; PCR	From April to November 2016, two outbreaks of epidemic keratoconjunctivitis (EKC) occurred successively at primary and middle schools in the Tibet Autonomous Region of China, and a total of 197 clinically diagnosed cases were reported. Real-time PCR analyses confirmed that human adenovirus (HAdV) infection was related to these outbreaks. Further studies involving sequence determination and phylogenetic analysis based on the penton base, hexon, and fiber genes indicated that human adenovirus type 8 (HAdV-8), belonging to species D, was responsible for the outbreaks. This is the first report of a HAdV-8 associated EKC outbreak in mainland of China, and the results of this study are expected to provide support for future research into HAdV-8 in China.	[Lei, Zhenqiang; Ma, Chaofeng] Shaanxi Univ Chinese Med, Sch Publ Hlth, Xianyang City, Shaanxi, Peoples R China; [Zhu, Zhen; Zhang, Sheng; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Rubella Lab, Beijing, Peoples R China; [Zhu, Zhen; Zhang, Sheng; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China; [Wang, Bai Ma Ci; Ga, Dan Zeng Gong] Tibet Ctr Dis Control & Prevent, Dept Infect Dis, Lhasa City, Tibet Autonomou, Peoples R China; [Mei, Hong] Tibet Ctr Dis Control & Prevent, Dept Hlth Inspect, Lhasa City, Tibet Autonomou, Peoples R China; [Li, Hong; Xu, Wenbo] Anhui Univ Sci & Technol, Med Sch, Dept Pathogen Biol, Huainan City, Anhui, Peoples R China; [Jie, Guo] Gongbujiangda Cty Ctr Dis Control & Prevent, Linzhi City, Tibet Autonomou, Peoples R China; [Chi, Mi Ma Bu] Rikaze Prefecture Ctr Dis Control & Prevent, Dept Infect Dis, Rikaze City, Tibet Autonomou, Peoples R China; [Ma, Chaofeng] Xian Ctr Dis Control & Prevent, Xian, Shaanxi, Peoples R China	Shaanxi University of Chinese Medicine; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Anhui University of Science & Technology	Ma, CF (corresponding author), Shaanxi Univ Chinese Med, Sch Publ Hlth, Xianyang City, Shaanxi, Peoples R China.; Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Rubella Lab, Beijing, Peoples R China.; Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China.; Xu, WB (corresponding author), Anhui Univ Sci & Technol, Med Sch, Dept Pathogen Biol, Huainan City, Anhui, Peoples R China.; Ma, CF (corresponding author), Xian Ctr Dis Control & Prevent, Xian, Shaanxi, Peoples R China.	mark7447@xiancdc.cn; wenbo_xu1@aliyun.com			National Key Research and Development Project [2016YFC1200905]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004202, 2012ZX10004201-003]	National Key Research and Development Project; Key Technologies R&D Program of National Ministry of Science	This work was supported by the National Key Research and Development Project (2016YFC1200905), and Key Technologies R&D Program of National Ministry of Science (2013ZX10004202,2012ZX10004201-003).	Adhikary AK, 2012, J MED MICROBIOL, V61, P1491, DOI 10.1099/jmm.0.044172-0; Adhikary AK, 2014, J CLIN VIROL, V61, P477, DOI 10.1016/j.jcv.2014.10.015; Aoki Koki, 2002, International Ophthalmology Clinics, V42, P49; Chang CH, 2003, GRAEF ARCH CLIN EXP, V241, P554, DOI 10.1007/s00417-003-0680-2; CHATTERJEE S, 1970, BRIT J OPHTHALMOL, V54, P628, DOI 10.1136/bjo.54.9.628; Cui AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061451; Fujimoto T, 2012, JPN J INFECT DIS, V65, P260, DOI 10.7883/yoken.65.260; GORDON YJ, 1993, OPHTHALMOLOGY, V100, P1835; Hamada N, 2008, J HOSP INFECT, V68, P262, DOI 10.1016/j.jhin.2007.12.012; Hiroi S, 2013, JPN J INFECT DIS, V66, P436, DOI 10.7883/yoken.66.436; Huang GH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110781, 10.137]; Ishiko H, 2008, J CLIN MICROBIOL, V46, P2002, DOI 10.1128/JCM.01835-07; Ishiko H, 2009, J CLIN MICROBIOL, V47, P2678, DOI 10.1128/JCM.r00313-09; Jin XH, 2011, MOL VIS, V17, P336; Kajon AE, 2013, J CLIN VIROL, V58, P4, DOI 10.1016/j.jcv.2013.06.030; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; Matsushima Y, 2013, GENOME ANNOUNC, V1, P1; Nanmoku K, 2016, TRANSPL INFECT DIS, V18, P234, DOI 10.1111/tid.12519; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Sarantis H, 2004, J CLIN MICROBIOL, V42, P3963, DOI 10.1128/JCM.42.9.3963-3969.2004; Sundaramoorthy R, 2016, J INFECT DEV COUNTR, V10, P449, DOI 10.3855/jidc.7225; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thygeson P., 1987, EPIDEMIOL REV, V33, P1187; Viney KA, 2008, EPIDEMIOL INFECT, V136, P1197, DOI 10.1017/S0950268807009843; WADELL G, 1969, P SOC EXP BIOL MED, V132, P413; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Wold W. S. M., 2013, FIELDS VIROLOGY, P1732; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	29	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0185048	10.1371/journal.pone.0185048	http://dx.doi.org/10.1371/journal.pone.0185048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915257	Green Published, Green Submitted, gold			2022-12-27	WOS:000410861600031
J	Chen, P; Du, Q; Liu, XM; Zhou, L; Hussain, S; Lei, L; Song, C; Wang, XC; Liu, WG; Yang, F; Shu, K; Liu, J; Du, JB; Yang, WY; Yong, TW				Chen, Ping; Du, Qing; Liu, Xiaoming; Zhou, Li; Hussain, Sajad; Lei, Lu; Song, Chun; Wang, Xiaochun; Liu, Weiguo; Yang, Feng; Shu, Kai; Liu, Jiang; Du, Junbo; Yang, Wenyu; Yong, Taiwen			Effects of reduced nitrogen inputs on crop yield and nitrogen use efficiency in a long-term maize-soybean relay strip intercropping system	PLOS ONE			English	Article							INTERSPECIFIC INTERACTIONS; PHOSPHORUS APPLICATION; FOOD SECURITY; N-2 FIXATION; ROOT LENGTH; SOIL N; WHEAT; COMPETITION; GROWTH; PEA	The blind pursuit of high yields via increased fertilizer inputs increases the environmental costs. Relay intercropping has advantages for yield, but a strategy for N management is urgently required to decrease N inputs without yield loss in maize-soybean relay intercropping systems (IMS). Experiments were conducted with three levels of N and three planting patterns, and dry matter accumulation, nitrogen uptake, nitrogen use efficiency (NUE), competition ratio (CR), system productivity index (SPI), land equivalent ratio (LER), and crop root distribution were investigated. Our results showed that the CR of soybean was greater than 1, and that the change in root distribution in space and time resulted in an interspecific facilitation in IMS. The maximum yield of maize under monoculture maize (MM) occurred with conventional nitrogen (CN), whereas under IMS, the maximum yield occurred with reduced nitrogen (RN). The yield of monoculture soybean (MS) and of soybean in IMS both reached a maximum under RN. The LER of IMS varied from 1.85 to 2.36, and the SPI peaked under RN. Additionally, the NUE of IMS increased by 103.7% under RN compared with that under CN. In conclusion, the separation of the root ecological niche contributed to a positive interspecific facilitation, which increased the land productivity. Thus, maize-soybean relay intercropping with reduced N input provides a very useful approach to increase land productivity and avert environmental pollution.	[Chen, Ping; Du, Qing; Liu, Xiaoming; Zhou, Li; Hussain, Sajad; Wang, Xiaochun; Liu, Weiguo; Yang, Feng; Shu, Kai; Liu, Jiang; Du, Junbo; Yang, Wenyu; Yong, Taiwen] Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China; [Chen, Ping; Du, Qing; Liu, Xiaoming; Zhou, Li; Hussain, Sajad; Song, Chun; Wang, Xiaochun; Liu, Weiguo; Yang, Feng; Shu, Kai; Liu, Jiang; Du, Junbo; Yang, Wenyu; Yong, Taiwen] Sichuan Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Sichuan Engn Res Ctr Crop Strip Intercropping Sys, Chengdu, Sichuan, Peoples R China; [Lei, Lu] Renshou Weather Bur, Meishan, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Yang, WY; Yong, TW (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China.; Yang, WY; Yong, TW (corresponding author), Sichuan Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Sichuan Engn Res Ctr Crop Strip Intercropping Sys, Chengdu, Sichuan, Peoples R China.	mssiyangwy@sicau.edu.cn; yongtaiwen@sicau.edu.cn	Hussain, Sajad/GZL-5573-2022; Song, Chun/B-8298-2019; Hussain, Sajad/S-4261-2019	Song, Chun/0000-0001-9927-2599; Hussain, Sajad/0000-0001-9100-360X; Chen, Ping/0000-0002-9940-4528	National Key Research and Development Program of China [2016YFD0300202]; National Natural Science Foundation of China [31271669, 31671625]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Key Research and Development Program of China (grant numbers 2016YFD0300202), the National Natural Science Foundation of China (grant numbers 31271669, 31671625).	Amosse C, 2014, NUTR CYCL AGROECOSYS, V98, P1, DOI 10.1007/s10705-013-9591-8; BELCHER JW, 1995, J ECOL, V83, P673, DOI 10.2307/2261635; CHAN LM, 1980, AGRON J, V72, P35, DOI 10.2134/agronj1980.00021962007200010008x; Corre-Hellou G, 2006, PLANT SOIL, V282, P195, DOI 10.1007/s11104-005-5777-4; D'Amico EJ, 2001, BEHAV RES METH INS C, V33, P479, DOI 10.3758/BF03195405; Duan YH, 2014, FIELD CROP RES, V157, P47, DOI 10.1016/j.fcr.2013.12.012; Erisman JW, 2007, ENVIRON POLLUT, V150, P140, DOI 10.1016/j.envpol.2007.06.033; Fan FL, 2006, PLANT SOIL, V283, P275, DOI 10.1007/s11104-006-0019-y; FEHR W. R., 1971, Crop science, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fleischer, 2014, PLANT BIOTECHNOLOGY, P181, DOI [10.1007/978-3-319-06892-3, DOI 10.1007/978-3-319-06892-3]; Gan YB, 2002, NUTR CYCL AGROECOSYS, V62, P163, DOI 10.1023/A:1015528132642; Gandhi VP, 2014, FOOD RES INT, V63, P108, DOI 10.1016/j.foodres.2014.03.015; Gao Y, 2010, AGR WATER MANAGE, V98, P199, DOI 10.1016/j.agwat.2010.08.021; Garnett T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00936; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hauggaard-Nielsen H, 2001, FIELD CROP RES, V72, P185, DOI 10.1016/S0378-4290(01)00176-9; Li B, 2016, P NATL ACAD SCI USA, V113, P6496, DOI 10.1073/pnas.1523580113; Li L, 2006, OECOLOGIA, V147, P280, DOI 10.1007/s00442-005-0256-4; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Li L, 2014, NEW PHYTOL, V203, P63, DOI 10.1111/nph.12778; Lithourgidis AS, 2011, EUR J AGRON, V34, P287, DOI 10.1016/j.eja.2011.02.007; Liu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169218; Lv Y, 2014, CROP SCI, V54, P914, DOI 10.2135/cropsci2013.06.0403; Ma L, 2010, J ENVIRON QUAL, V39, P1279, DOI 10.2134/jeq2009.0403; Neugschwandtner RW, 2015, FIELD CROP RES, V179, P113, DOI 10.1016/j.fcr.2015.04.018; Norse D, 2015, AGR ECOSYST ENVIRON, V209, P5, DOI 10.1016/j.agee.2015.02.014; Wang DJ, 2004, ENVIRON GEOCHEM HLTH, V26, P221, DOI 10.1023/B:EGAH.0000039584.35434.e0; Wang XC, 2017, FIELD CROP RES, V204, P12, DOI 10.1016/j.fcr.2016.12.020; Westerman R.L., 1990, SOIL TESTING PLANT A, Vthird, DOI [10.1097/00010694-198811000-00013, DOI 10.1097/00010694-198811000-00013]; Wu YS, 2016, PLANT PROD SCI, V19, P206, DOI 10.1080/1343943X.2015.1128095; Xia HY, 2013, FIELD CROP RES, V154, P53, DOI 10.1016/j.fcr.2013.07.011; Xia HY, 2013, FIELD CROP RES, V150, P52, DOI 10.1016/j.fcr.2013.05.027; Xiao YB, 2004, PLANT SOIL, V262, P45, DOI 10.1023/B:PLSO.0000037019.34719.0d; Yamane K, 2016, PLANT PROD SCI, V19, P449, DOI 10.1080/1343943X.2016.1164574; Yang F, 2017, PLANT PROD SCI, V20, P1, DOI 10.1080/1343943X.2016.1224553; Yang F, 2017, FIELD CROP RES, V203, P16, DOI 10.1016/j.fcr.2016.12.007; Yang F, 2015, AGRON J, V107, P296, DOI 10.2134/agronj14.0263; Yang F, 2014, FIELD CROP RES, V155, P245, DOI 10.1016/j.fcr.2013.08.011; Yang JY, 2010, AGR ECOSYST ENVIRON, V137, P192, DOI 10.1016/j.agee.2010.02.004; Yang WT, 2013, FIELD CROP RES, V146, P44, DOI 10.1016/j.fcr.2013.03.008; Yong TW, 2015, PLANT PROD SCI, V18, P388, DOI 10.1626/pps.18.388; Zhang GG, 2011, FIELD CROP RES, V124, P66, DOI 10.1016/j.fcr.2011.06.006; Zhang L, 2007, FIELD CROP RES, V103, P178, DOI 10.1016/j.fcr.2007.06.002; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; Zhao X, 2012, AGR ECOSYST ENVIRON, V156, P1, DOI 10.1016/j.agee.2012.04.024; Zuo YM, 2015, FRONT AGRIC SCI ENG, V2, P134, DOI 10.15302/J-FASE-2015069	47	61	70	14	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184503	10.1371/journal.pone.0184503	http://dx.doi.org/10.1371/journal.pone.0184503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910355	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200053
J	Feng, L; Wei, DM; Lin, ST; Maddison, R; Mhurchu, CN; Jiang, YN; Gao, Y; Wang, HJ				Feng, Lin; Wei, Dong-Mei; Lin, Shen-Ting; Maddison, Ralph; Mhurchu, Cliona Ni; Jiang, Yannan; Gao, Yang; Wang, Hai-Jun			Systematic review and meta-analysis of school-based obesity interventions in mainland China	PLOS ONE			English	Review							BODY-MASS INDEX; PHYSICAL-ACTIVITY INTERVENTIONS; CHILDHOOD OBESITY; PREVENTION PROGRAMS; HEALTH; CHILDREN; OVERWEIGHT; WEIGHT	Background Numerous school-based interventions for childhood obesity have been emerging in mainland China in recent decades, but little is known about the effectiveness of such interventions. This study aims to assess the effectiveness of school-based interventions for childhood obesity conducted in mainland China. Methods A systematic search was undertaken in eight databases to identify both randomized and non-randomized controlled trials from January 1990 to December 2015 examining the effectiveness of school-based obesity interventions. A random effects meta-analysis was conducted assessing the impact of included interventions on (body mass index) BMI. The quality of each included studies were assessed using Effective Public Health Practice Project Quality Assessment Tool. A P value <0.05 (two-sided) was considered statistically significant. Result Of the seventy-six included studies, we found physical activity and health education were the two most common components of interventions. More treatment studies were effective compared with prevention studies (85.0% vs. 58.3%). Comprehensive interventions involving physical activity and health education appeared more effective than the physical activity only interventions in both obesity treatment and prevention studies. The meta-analyses showed comprehensive interventions involving physical activity and health education had larger effect on the change of BMI than physical activity only interventions (treatment studies: -1.80 kg/m(2) (95% CI: -2.15,-1.44) vs. -0.91 kg/m(2) (95% CI: -1.15,-0.67); prevention studies: -0.19 kg/m(2) (95% CI: -0.27,-0.11) vs. +0.05 kg/m(2) (95% CI: -0.04, +0.15)). Conclusions Comprehensive school-based interventions may assist in tackling the rising prevalence of childhood obesity in mainland China.	[Feng, Lin] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China; [Wei, Dong-Mei; Lin, Shen-Ting; Wang, Hai-Jun] Peking Univ, Inst Child & Adolescent Hlth, Sch Publ Hlth, Dept Child Adolescent & Womens Hlth, Beijing, Peoples R China; [Lin, Shen-Ting] Hlth & Family Planning Bur Nanshan Dist, Shenzhen, Peoples R China; [Maddison, Ralph; Mhurchu, Cliona Ni; Jiang, Yannan] Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand; [Maddison, Ralph] Deakin Univ, Inst Phys Act & Nutr, Geelong, Vic, Australia; [Gao, Yang] Hong Kong Baptist Univ, Dept Phys Educ, Hong Kong, Hong Kong, Peoples R China; [Wang, Hai-Jun] Peking Univ, Inst Child & Adolescent Hlth, Dept Child Adolescent & Womens Hlth, Sch Publ Hlth,Hlth Sci Ctr, Beijing, Peoples R China	Peking University; Peking University; University of Auckland; Deakin University; Hong Kong Baptist University; Peking University	Wang, HJ (corresponding author), Peking Univ, Inst Child & Adolescent Hlth, Sch Publ Hlth, Dept Child Adolescent & Womens Hlth, Beijing, Peoples R China.; Wang, HJ (corresponding author), Peking Univ, Inst Child & Adolescent Hlth, Dept Child Adolescent & Womens Hlth, Sch Publ Hlth,Hlth Sci Ctr, Beijing, Peoples R China.	whjun1@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021; Maddison, Ralph/K-3418-2019	Wang, Haijun/0000-0003-0849-2903; Maddison, Ralph/0000-0001-8564-5518; Feng, Lin/0000-0002-6134-4937; Gao, Yang (Gemma)/0000-0003-0439-4804	Chinese Medical Board [11-064]	Chinese Medical Board	This study was funded by a grant from Chinese Medical Board (project no.11-064), http://www.chinamedicalboard.org/. HW received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Beibei W., 2005, INFLUENCE EXERCISE B; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Cao ZJ, 2015, AM J PREV MED, V48, P552, DOI 10.1016/j.amepre.2014.12.014; da Silveira JAC, 2013, PREV MED, V56, P237, DOI 10.1016/j.ypmed.2013.01.011; Chang Gai, 2009, Chinese Journal of Prevention and Control of Chronic Diseases, V17, P505; Chen J., 2006, STRAIT J PREV MED, P8; Cheng TO, 2012, INT J CARDIOL, V154, P233, DOI 10.1016/j.ijcard.2011.12.023; Chengqiang J., 2013, STUDY SELF CONSCIOUS; Cui Xin-yue, 2015, Beijing Da Xue Xue Bao Yi Xue Ban, V47, P400; Dai J., 2006, J CLIN REHABIL TIS E, V10, P20; Dajiang L, 2011, CHINESE J SCH HLTH, P1338; Dali X., 2013, EFFECTS SPOTS HLTH E; Dan W., 2014, EXPT STUDY MARTIAL A; Daying S, 2006, CHINESE J SCH DOCTOR, V20, P361; Duan JL, 2008, CHINESE J SCH HLTH, V29, P404; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Fang H, 2006, CHIN J MATERNAL CHIL, V17, P255; Fuyan W., 2009, CHINA PRACTICAL PREV, V16, P1809; Gao A, 2008, CHINESE J SCH HLTH, V29, P978; Gao Y, 2008, J PUBLIC HEALTH-UK, V30, P436, DOI 10.1093/pubmed/fdm057; Gong LY, 2014, J PEDIATR-US, V164, P795, DOI 10.1016/j.jpeds.2013.12.004; Gonzalez-Suarez C, 2009, AM J PREV MED, V37, P418, DOI 10.1016/j.amepre.2009.07.012; Guo HT, 2015, OBES RES CLIN PRACT, V9, P357, DOI 10.1016/j.orcp.2014.11.006; Hainan J., 2009, INFLUENCE ENDURANCE; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Han X, 2008, SHANGHAI J PREVENTIV, V20, P193; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Jiang H, 2007, P INT FOR PUBL HLTH; Jiang J, 2007, CHILD CARE HLTH DEV, V33, P641, DOI 10.1111/j.1365-2214.2007.00738.x; Jiang JX, 2002, CHINESE J CHILD HLTH, P364; Jingxiong J, 1997, CHINESE MENTAL HLTH; Jingyan H., 2014, COORDINATION LATE AD; JPHaS Green, 2011, COCHRANE HDB SYSTEMA; Jun-Qing B., 1997, CHINESE J SCH HLTH, P305; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Katz DL, 2008, INT J OBESITY, V32, P1780, DOI 10.1038/ijo.2008.158; Kun Z., 2013, KNOWLEDGE ATTITUDE B; Laiqiang L, 2007, J HARBIN I PHYS ED, P132; Lan S, 2005, CHINESE J PUBLIC HLT, P14; Lavelle HV, 2012, J PUBLIC HEALTH-UK, V34, P360, DOI 10.1093/pubmed/fdr116; Li H, 2004, CHINESE J HLTH ED, P19; Li M, 2008, OBES REV, V9, P548, DOI 10.1111/j.1467-789X.2008.00495.x; Li M., 2006, CHINESE J CLIN REHAB, V10, P44; Li M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-792; Li W, 2007, CHINA PRACTICAL PREV, V28, P796; Li XH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1282; Li YP, 2010, BIOMED ENVIRON SCI, V23, P180, DOI 10.1016/S0895-3988(10)60050-5; Li-hua L., 2013, CHINA SCH PHYS ED, P129; Liangmei X, 2015, CHINESE J SCH HLTH, P51; Lili H., 2011, EFFECT DIETARY BASED; Liu AL, 2007, BIOMED ENVIRON SCI, V20, P19; Liu J, 2012, J HYGIENE RES, P866; Liu SQ, 2005, CHINESE J SCH DOCTOR, V19, P115; Ma Jun, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P776; Martin A, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009728.pub2, 10.1002/14651858.CD010971.pub2]; Mei H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2829-z; Meng LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075481; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Peisheng T, 2006, CHINESE J SCH HLTH; Ping L, 1999, CHINESE J BEHAV MED, P43; Project EPHP, 2010, QUAL ASS TOOL QUANT; [荣湘江 RONG Xiangjiang], 2007, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V22, P702; Ruifang X., 2009, STUDY HLTH PROMOTION; Sheng-Li X., 2007, MATERN CHILD HLTH J, P2935; Shi J, 2004, CHINESE J HLTH ED, P14; Shuiping H, 2005, CHINESE J SCH HLTH, P12; Sobol-Goldberg S, 2013, OBESITY, V21, P2422, DOI 10.1002/oby.20515; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; Sun G, 2005, STUDY SCH LUNCH INTE; Tan H, 2002, PRACTICAL PREVENTIVE, P78; Tian BC, 2006, CHIN J SCH HLTH, V27, P869; UK CFPH and UK NCCF, 2006, OB PREV ID ASS MAN O; Wang JJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2535-2; Wang Y, 2015, OBES REV, V16, P547, DOI 10.1111/obr.12277; Wang Z., 2016, STUD CLIN MED ENG, V23, P935; Waters E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub3; Weichan C, 2010, INT J NURSING, V29, P1491; Wen L, 2008, CHINESE J SPORTS MED, P329; Wenjing L., 2014, STUDY MONITORING PHY; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Xia-xia J, 2010, CHINESE J SCH HLTH, V31, P265; Xia-xia J, 2010, CHINESE J SCH HLTH, V31, p[265, 9]; Xiao-Lin Y., 2010, J APPL CLIN PEDIAT, P1447; Xiaoqian Z., 2013, STUDY SPORTS INTERVE; Xihai Z., 2015, EXPT RES IMPACT 24 S; Xingmin G., 2014, RES MOTION BASED INT; Xiu-Lian Z., 2005, CHINESE J CLIN REHAB, P166; Xiujuan W, 2010, MODERN PREVENTIVE ME; Xu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141421; Yang C., 2014, ZHEJIANG SPORT SCI, V36, P101; Yang C., 2014, ZHEJIANG SPORT SCI, V36, P101; Yang Fan, 2013, Journal of Environmental & Occupational Medicine, V30, P333; Yanjun Z., 2015, STUDY EFFECT EXTRACU; Yanping T, 2015, SPORTS FORUM, P71; Yanying G., 2011, RES INFLUENCE EXERCI; Youlan C, 2010, CHINESE J HLTH ED, P756; Zhao P., 2013, EXPT STUDY OBESE PUP; Zhao WeiMing, 2011, Maternal and Child Health Care of China, V26, P1780; Zhao-Mei L., 2015, MATERN CHILD HLTH J, P1393; Zhaoyuan H., 2011, SPORT; Zhen L., 2010, EFFECT EXERCISE BASE; Zheng JQ, 2010, J CHILD HEALTH CARE, V18, P206; Zhiqin W, 2013, CHINESE J WOMEN CHIL	105	31	34	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184704	10.1371/journal.pone.0184704	http://dx.doi.org/10.1371/journal.pone.0184704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910362	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200081
J	van Buel, EM; Sigrist, H; Seifritz, E; Fikse, L; Bosker, FJ; Schoevers, RA; Klein, HC; Pryce, CR; Eisel, ULM				van Buel, Erin M.; Sigrist, Hannes; Seifritz, Erich; Fikse, Lianne; Bosker, Fokko J.; Schoevers, Robert A.; Klein, Hans C.; Pryce, Christopher R.; Eisel, Ulrich L. M.			Mouse repeated electroconvulsive seizure (ECS) does not reverse social stress effects but does induce behavioral and hippocampal changes relevant to electroconvulsive therapy (ECT) side-effects in the treatment of depression	PLOS ONE			English	Article							NEUROTROPHIC FACTOR PROTEIN; NG2-EXPRESSING GLIAL-CELLS; INDUCED MEMORY IMPAIRMENT; RAT MODEL; ACETYLCHOLINESTERASE ACTIVITY; SYNAPTIC PLASTICITY; GENE-EXPRESSION; MESSENGER-RNA; GROWTH-FACTOR; RODENT BRAIN	Electroconvulsive therapy (ECT) is an effective treatment for depression, but can have negative side effects including amnesia. The mechanisms of action underlying both the antidepressant and side effects of ECT are not well understood. An equivalent manipulation that is conducted in experimental animals is electroconvulsive seizure (ECS). Rodent studies have provided valuable insights into potential mechanisms underlying the antidepressant and side effects of ECT. However, relatively few studies have investigated the effects of ECS in animal models with a depression-relevant manipulation such as chronic stress. In the present study, mice were first exposed to chronic social stress (CSS) or a control procedure for 15 days followed by ECS or a sham procedure for 10 days. Behavioral effects were investigated using an auditory fear conditioning (learning) and expression (memory) test and a treadmill-running fatigue test. Thereafter, immunohistochemistry was conducted on brain material using the microglial marker Iba-1 and the cholinergic fibre marker ChAT. CSS did not increase fear learning and memory in the present experimental design; in both the control and CSS mice ECS reduced fear learning and fear memory expression. CSS induced the expected fatigue-like effect in the treadmill-running test; ECS induced increased fatigue in CSS and control mice. In CSS and control mice ECS induced inflammation in hippocampus in terms of increased expression of Iba-1 in radiatum of CA1 and CA3. CSS and ECS both reduced acetylcholine function in hippocampus as indicated by decreased expression of ChAT in several hippocampal sub-regions. Therefore, CSS increased fatigue and reduced hippocampal ChAT activity and, rather than reversing these effects, a repeated ECS regimen resulted in impaired fear learning-memory, increased fatigue, increased hippocampal Iba-1 expression, and decreased hippocampal ChAT expression. As such, the current model does not provide insights into the mechanism of ECT antidepressant function but does provide evidence for pathophysiological mechanisms that might contribute to important ECT side-effects.	[van Buel, Erin M.; Fikse, Lianne; Eisel, Ulrich L. M.] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands; [van Buel, Erin M.; Bosker, Fokko J.; Klein, Hans C.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [van Buel, Erin M.; Schoevers, Robert A.; Eisel, Ulrich L. M.] Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands; [Sigrist, Hannes; Seifritz, Erich; Pryce, Christopher R.] Univ Zurich, Psychiat Hosp, Preclin Lab Translat Res Affect Disorders PLaTRAD, Zurich, Switzerland; [Bosker, Fokko J.; Schoevers, Robert A.; Klein, Hans C.; Eisel, Ulrich L. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Zurich; University of Groningen	Eisel, ULM (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands.; Eisel, ULM (corresponding author), Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands.; Eisel, ULM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.	u.l.m.eisel@rug.nl		Klein, Hans/0000-0001-9429-828X; Schoevers, Robert A/0000-0003-0760-9866; van Buel, Erin/0000-0003-2031-3226; Eisel, Ulrich/0000-0003-4178-0384	Dutch ministry of Economic Affairs [PID_09_02/120329]; Swiss National Science Foundation [31003A-141137]; Boehringer Ingelheim Fonds Travel grant	Dutch ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Boehringer Ingelheim Fonds Travel grant(Boehringer Ingelheim)	This research was funded by a grant from the Dutch ministry of Economic Affairs (registered under grant number PID_09_02/120329), a grant from the Swiss National Science Foundation (31003A-141137 to CRP and ES), and a Boehringer Ingelheim Fonds Travel grant (to EMB).	Abbott CC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.124; Altar CA, 2003, BIOL PSYCHIAT, V54, P703, DOI 10.1016/S0006-3223(03)00073-8; Andrade C, 2002, J ECT, V18, P197, DOI 10.1097/00124509-200212000-00006; Andrade C, 2012, J NEURAL TRANSM, V119, P337, DOI 10.1007/s00702-011-0712-8; Angelucci F, 2002, J ECT, V18, P138, DOI 10.1097/00124509-200209000-00005; Anuradha H, 2010, PHARM BIOL, V48, P499, DOI 10.3109/13880200903188534; Azzinnari D, 2014, NEUROPHARMACOLOGY, V85, P328, DOI 10.1016/j.neuropharm.2014.05.039; Bergamini G, 2016, NEUROPHARMACOLOGY, V109, P306, DOI 10.1016/j.neuropharm.2016.03.048; Bocchio-Chiavetto L, 2006, EUR NEUROPSYCHOPHARM, V16, P620, DOI 10.1016/j.euroneuro.2006.04.010; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Carney S, 2003, LANCET, V361, P799; Cathomas F, 2015, BRAIN BEHAV IMMUN, V50, P125, DOI 10.1016/j.bbi.2015.06.184; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Dagyte G, 2011, BEHAV BRAIN RES, V221, P574, DOI 10.1016/j.bbr.2010.02.023; Dang HX, 2009, EXP BIOL MED, V234, P785, DOI 10.3181/0812-RM-354; Das A, 2005, LIFE SCI, V77, P2299, DOI 10.1016/j.lfs.2005.02.020; de Kloet ER, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6503162; Dougherty JP, 2016, JOVE-J VIS EXP, DOI 10.3791/54052; Duman RS, 1998, J ECT, V14, P181; Farzan F, 2014, J ECT, V30, P98, DOI 10.1097/YCT.0000000000000144; Fink M, 2014, J ECT, V30, P5, DOI 10.1097/YCT.0b013e3182a6ad0d; Fuertig R, 2016, BRAIN BEHAV IMMUN, V54, P59, DOI 10.1016/j.bbi.2015.12.020; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Grandjean J, 2016, NEUROIMAGE, V142, P544, DOI 10.1016/j.neuroimage.2016.08.013; Gregory-Roberts EM, 2010, J AFFECT DISORDERS, V126, P39, DOI 10.1016/j.jad.2009.11.018; Heijnen WT, 2010, J CLIN PSYCHOPHARM, V30, P616, DOI 10.1097/JCP.0b013e3181ee0f5f; Hidaka N, 2013, EPILEPSY RES, V104, P181, DOI 10.1016/j.eplepsyres.2012.09.017; Hovens IB., 2014, NEUROIMMUNOL NEUROIN, V1, P82, DOI [10.4103/2347-8659.139719, DOI 10.4103/2347-8659.139719]; Hu YD, 2010, J ECT, V26, P121, DOI 10.1097/YCT.0b013e3181c18bbf; Husain MM, 2004, J CLIN PSYCHIAT, V65, P485; Jansson L, 2009, PROG NEURO-PSYCHOPH, V33, P1119, DOI 10.1016/j.pnpbp.2009.06.007; Jimenez-Vasquez PA, 2007, EUR NEUROPSYCHOPHARM, V17, P298, DOI 10.1016/j.euroneuro.2006.06.011; Jinno S, 2008, EXP NEUROL, V212, P440, DOI 10.1016/j.expneurol.2008.04.028; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Kyeremanteng C, 2014, PROG NEURO-PSYCHOPH, V54, P170, DOI 10.1016/j.pnpbp.2014.05.012; Kyeremanteng C, 2012, PHARMACOPSYCHIATRY, V45, P244, DOI 10.1055/s-0032-1306278; Li BJ, 2007, LIFE SCI, V80, P1539, DOI 10.1016/j.lfs.2007.01.032; Luo J, 2014, NEUROPSYCH DIS TREAT, V10, P1847, DOI 10.2147/NDT.S67108; Luo J, 2012, PSYCHIAT RES, V198, P300, DOI 10.1016/j.psychres.2011.09.010; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Marano CM, 2007, J CLIN PSYCHIAT, V68, P512, DOI 10.4088/JCP.v68n0404; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; McDaniel WW, 2006, J ECT, V22, P103, DOI 10.1097/00124509-200606000-00005; Minelli A, 2011, PROG NEURO-PSYCHOPH, V35, P1322, DOI 10.1016/j.pnpbp.2011.04.013; Mongiat LA, 2014, SCIENCE, V344, P594, DOI 10.1126/science.1254236; Nakagawa Y, 2015, PHARMACOL THERAPEUT, V154, P21, DOI 10.1016/j.pharmthera.2015.06.010; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Nissen C, 2010, BIOL PSYCHIAT, V68, P544, DOI 10.1016/j.biopsych.2010.05.026; Nordanskog P, 2010, J ECT, V26, P62, DOI 10.1097/YCT.0b013e3181a95da8; O'Donovan S, 2014, INT J NEUROPSYCHOPH, V17, P1477, DOI 10.1017/S1461145714000200; O'Donovan S, 2012, PROG NEURO-PSYCHOPH, V37, P147, DOI 10.1016/j.pnpbp.2011.12.012; Payne NA, 2009, J PSYCHIATR PRACT, V15, P346, DOI 10.1097/01.pra.0000361277.65468.ef; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Piccinni A, 2009, EUR NEUROPSYCHOPHARM, V19, P349, DOI 10.1016/j.euroneuro.2009.01.002; Pigot M, 2008, J ECT, V24, P57, DOI 10.1097/YCT.0b013e3181616c14; Pryce CR, 2012, NEUROPHARMACOLOGY, V62, P358, DOI 10.1016/j.neuropharm.2011.08.012; Reid IC, 1997, SEIZURE, V6, P351, DOI 10.1016/S1059-1311(97)80034-9; Reti IM, 2000, NEUROPSYCHOPHARMACOL, V23, P439, DOI 10.1016/S0893-133X(00)00120-2; Sakaida M, 2013, J PSYCHOPHARMACOL, V27, P1058, DOI 10.1177/0269881113497612; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Shapira B, 2000, J ECT, V16, P97, DOI 10.1097/00124509-200006000-00002; Srikumar BN, 2006, NEUROSCIENCE, V143, P679, DOI 10.1016/j.neuroscience.2006.08.041; Steward O, 1997, EXP NEUROL, V148, P100, DOI 10.1006/exnr.1997.6613; STEWART C, 1994, NEUROREPORT, V5, P1041, DOI 10.1097/00001756-199405000-00006; STEWART C, 1993, BRAIN RES, V620, P139, DOI 10.1016/0006-8993(93)90280-Z; STEWART CA, 1994, NEUROSCI LETT, V178, P11, DOI 10.1016/0304-3940(94)90277-1; Stryjer R, 2012, CLIN NEUROPHARMACOL, V35, P161, DOI 10.1097/WNF.0b013e31825e7945; Sunanda, 2000, NEUROCHEM RES, V25, P1547, DOI 10.1023/A:1026606201069; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; van Buel EM, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.100; Wennstrom M, 2006, BIOL PSYCHIAT, V59, P178, DOI 10.1016/j.biopsych.2005.08.032; Wennstrom M, 2004, BIOL PSYCHIAT, V55, P464, DOI 10.1016/j.biopsych.2003.11.011; Wennstrom M, 2003, BIOL PSYCHIAT, V54, P1015, DOI 10.1016/S0006-3223(03)00693-0; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Willner P, 2017, NEUROBIOL STRESS, V6, P78, DOI 10.1016/j.ynstr.2016.08.002; Yao Z, 2010, NEUROSCIENCE, V168, P405, DOI 10.1016/j.neuroscience.2010.03.060; Yoosefi A, 2014, J ECT, V30, P15, DOI 10.1097/YCT.0b013e3182a4b4c6; Zhu XL, 2015, NEUROSCI LETT, V599, P32, DOI 10.1016/j.neulet.2015.05.022; Zyss T, 1997, BIOL PSYCHIAT, V42, P920, DOI 10.1016/S0006-3223(96)00518-5	80	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184603	10.1371/journal.pone.0184603	http://dx.doi.org/10.1371/journal.pone.0184603			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910337	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200067
J	Dalton, HA; Wood, BJ; Widowski, TM; Guerin, MT; Torrey, S				Dalton, Hillary A.; Wood, Benjamin J.; Widowski, Tina M.; Guerin, Michele T.; Torrey, Stephanie			An analysis of beak shape variation in two ages of domestic turkeys (Meleagris gallopavo) using landmark-based geometric morphometrics	PLOS ONE			English	Article							INJURIOUS PECKING; BILL SIZE; ENVIRONMENTAL ENRICHMENT; LIGHT-INTENSITY; MARSH SPARROWS; WILD TURKEYS; FLOOR SPACE; DIMORPHISM; BEHAVIOR; GROWTH	The objective of this study was to assess beak shape variation in domestic turkeys (Meleagris gallopavo) and determine the effects of age, sex, and beak size on beak shape variation using geometric morphometrics. Dorsal and right lateral images were taken of 2442 turkeys at 6 and 18.5 weeks of age. Landmarks were digitized in tpsDig in three analyses of the dorsal upper mandible, lateral upper mandible, and lateral lower mandible shape of each turkey at both ages. The coordinate data were then subjected to a principal components analysis (PCA), multivariate regression, and a canonical variates analysis (CVA) with a Procrustes ANOVA in MorphoJ. For the dorsal images, three principal components (PCs) showed beak shape variation ranged from long, narrow, and pointed to short, wide, and blunt upper mandibles at both ages (6 weeks: 95.36%, 18.5 weeks: 92.21%). Three PCs showed the lateral upper mandible shape variation ranged from long, wide beaks with long, curved beak tips to short, narrow beaks with short, pointed beak tips at both ages (6 weeks: 94.91%, 18.5 weeks: 94.33%). Three PCs also explained 97.80% (6 weeks) and 97.11% (18.5 weeks) of the lateral lower mandible shape variation ranging from wide and round to narrow and thin lower mandibles with superior/inferior beak tip shifts. Beak size accounted for varying proportions of the beak shape variation (0.96-54.76%; P < 0.0001) in the three analyses of each age group. For all the analyses, the CVA showed sexual dimorphism in beak shape (P < 0.0001) with female upper mandibles appearing wider and blunter dorsally with long, curved beak tips laterally. Whereas male turkey upper mandibles had a narrow, pointed dorsal appearance and short, pointed beak tips laterally. Future applications of beak shape variability could have a genetic and welfare value by incorporating beak shape variation to select for specific turkey beak phenotypes as an alternative to beak treatment.	[Dalton, Hillary A.; Wood, Benjamin J.; Widowski, Tina M.; Torrey, Stephanie] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada; [Dalton, Hillary A.; Widowski, Tina M.; Torrey, Stephanie] Univ Guelph, Campbell Ctr Study Anim Welf, Guelph, ON, Canada; [Wood, Benjamin J.] Hybrid Turkeys, Kitchener, ON, Canada; [Guerin, Michele T.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Dalton, HA (corresponding author), Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada.; Dalton, HA (corresponding author), Univ Guelph, Campbell Ctr Study Anim Welf, Guelph, ON, Canada.	hdalton@ualberta.ca	Wood, Benjamin/AAN-4266-2020	Wood, Benjamin/0000-0003-4977-3410; Torrey, Stephanie/0000-0002-8157-9207	Campbell Centre for the Study of Animal Welfare [2014-1]; Canadian Poultry Research Council [1154]; Hybrid Turkeys; Ontario Ministry of Agriculture, Food, and Rural Affairs [299278]; Poultry Industry Council [317]	Campbell Centre for the Study of Animal Welfare; Canadian Poultry Research Council; Hybrid Turkeys; Ontario Ministry of Agriculture, Food, and Rural Affairs; Poultry Industry Council	The authors would like to thank the following organizations for financial support: The Campbell Centre for the Study of Animal Welfare (project #2014-1, HAD); Canadian Poultry Research Council (project #1154, ST); Hybrid Turkeys (in-kind support, BJW), Ontario Ministry of Agriculture, Food, and Rural Affairs (HQP project #299278, HAD); and the Poultry Industry Council (project #317, ST). These funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hybrid Turkeys provided support in the form of research materials and author salaries (BJW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Babbitt GA, 2007, WATERBIRDS, V30, P199, DOI 10.1675/1524-4695(2007)30[199:SFSBDI]2.0.CO;2; Berns CM, 2010, AUK, V127, P626, DOI 10.1525/auk.2010.09213; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bright JA, 2016, P NATL ACAD SCI USA, V113, P5352, DOI 10.1073/pnas.1602683113; Buchholz R, 1997, J AVIAN BIOL, V28, P223, DOI 10.2307/3676973; Buchholz R, 1996, AUK, V113, P310, DOI 10.2307/4088897; Buchwalder T, 2004, APPL ANIM BEHAV SCI, V89, P207, DOI 10.1016/j.applanim.2004.07.001; Buchwalder T, 2003, APPL ANIM BEHAV SCI, V84, P75, DOI 10.1016/S0168-1591(03)00149-7; CAMPBELL NA, 1981, SYST ZOOL, V30, P268, DOI 10.2307/2413249; Canadian Council on Animal Care, 2009, CCAC GUID CAR US FAR; Carruthers C, 2012, J APPL POULTRY RES, V21, P645, DOI 10.3382/japr.2011-00433; CRAIG JV, 1992, POULTRY SCI, V71, P1830, DOI 10.3382/ps.0711830; Dalton HA, 2013, WORLD POULTRY SCI J, V69, P865, DOI 10.1017/S004393391300086X; Dennis RL, 2009, POULTRY SCI, V88, P38, DOI 10.3382/ps.2008-00227; Dryden IL, 1998, STAT ANAL SHAPE; Duggan G, 2014, J APPL POULTRY RES, V23, P280, DOI 10.3382/japr.2013-00860; DURELL SEALD, 1993, J ANIM ECOL, V62, P205, DOI 10.2307/5495; Fahey AG, 2007, POULTRY SCI, V86, P1312, DOI 10.1093/ps/86.7.1312; Fiks-van Niekerk T.G., 2007, LOHMANN INF, V42, P35; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; FREEMAN BM, 1987, WORLD POULTRY SCI J, V43, P15, DOI 10.1079/WPS19870002; Gentle MJ, 2007, VET REC, V160, P145, DOI 10.1136/vr.160.5.145; GILL DJ, 1984, POULTRY SCI, V63, P1314, DOI 10.3382/ps.0631314; Greenberg R, 2013, ECOL EVOL, V3, P389, DOI 10.1002/ece3.474; Greenberg R, 2012, ECOGRAPHY, V35, P146, DOI 10.1111/j.1600-0587.2011.07002.x; Greenberg R, 2010, ECOLOGY, V91, P2428, DOI 10.1890/09-1136.1; GRIGOR PN, 1995, VET REC, V136, P257, DOI 10.1136/vr.136.11.257; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; HOCKING P, 1993, P 4 EUR S POULTR WEL, P125; Hybrid Turkeys, 2016, COMM MAN GUID; KENDALL DG, 1977, ADV APPL PROBAB, V9, P428, DOI 10.2307/1426091; Kimball RT, 1996, ETHOLOGY, V102, P639; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Krautwald-Junghanns ME, 2011, BERL MUNCH TIERARZTL, V124, P8, DOI 10.2376/0005-9366-124-8; Kulemeyer C, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-2; KUO FL, 1991, POULTRY SCI, V70, P1057, DOI 10.3382/ps.0701057; LEIGHTON AT, 1985, POULTRY SCI, V64, P440, DOI 10.3382/ps.0640440; Lewis PD, 1998, ANIM SCI, V66, P759, DOI 10.1017/S1357729800009358; Marchant-Forde RM, 2008, POULTRY SCI, V87, P1474, DOI 10.3382/ps.2006-00360; Marchant-Forde RM, 2010, POULTRY SCI, V89, P2559, DOI 10.3382/ps.2010-00890; Marcus LF, 1996, NATO ASI SERIES A; Martrenchar A, 2001, BRIT POULTRY SCI, V42, P161, DOI 10.1080/00071660120048393; McKeegan DEF, 2012, ANIM WELFARE, V21, P207, DOI 10.7120/09627286.21.2.207; Moinard C, 2001, ANIM WELFARE, V10, P131; PRICE TD, 1984, AM NAT, V123, P500, DOI 10.1086/284219; Rico-Guevara A, 2015, BEHAV ECOL, V26, P21, DOI 10.1093/beheco/aru182; Rohlf F.J., TPSDIG DIGITIZE LAND; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Shao SM, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0162-0; Sherwin CM, 1999, BRIT POULTRY SCI, V40, P592, DOI 10.1080/00071669986954; Sievwright H, 2011, ORNITHOL SCI, V10, P131, DOI 10.2326/osj.10.131; Tattersall GJ, 2009, SCIENCE, V325, P468, DOI 10.1126/science.1175553; Temeles EJ, 2010, PHILOS T R SOC B, V365, P1053, DOI 10.1098/rstb.2009.0284; WATTS CR, 1971, SCI AM, V224, P112; Willems OW, 2014, BRIT POULTRY SCI, V55, P715, DOI 10.1080/00071668.2014.966058; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	60	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185159	10.1371/journal.pone.0185159	http://dx.doi.org/10.1371/journal.pone.0185159			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934330	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900108
J	Dolka, B; Chrobak-Chmiel, D; Czopowicz, M; Szeleszczuk, P				Dolka, Beata; Chrobak-Chmiel, Dorota; Czopowicz, Michal; Szeleszczuk, Piotr			Characterization of pathogenic Enterococcus cecorum from different poultry groups: Broiler chickens, layers, turkeys, and waterfowl	PLOS ONE			English	Article							VIRULENCE DETERMINANTS; MOLECULAR EPIDEMIOLOGY; STREPTOCOCCAL FLORA; MULTIPLEX PCR; SPONDYLITIS; IDENTIFICATION; OSTEOMYELITIS; INFECTION; STRAINS; INTESTINES	Enterococcus cecorum (EC) is known as a commensal in the intestines of mammals and birds. However, it has been described as an emerging pathogen in poultry industry worldwide. The aim of this study was to analyze and compare EC isolated from clinical material collected from poultry groups with different production purposes. The genetic diversity among pathogenic EC in relation to each specific poultry type was examined. In total, 148 isolates from independent infection outbreaks (2011 - 2016) were used: 76 broiler chickens (CB), 37 broiler breeders (BB), 23 layers (CL), 7 waterfowl (W) and 5 turkey (T) flocks (1 iso-late/1 flock). We provided age ranges at diagnosis of EC-infection for 5 poultry groups. Isolates obtained from CB were significantly more frequently retrieved from bone marrow, joints, spine, and contrary to BB, CL less frequently retrieved from respiratory system. The study showed differences between EC of various poultry types in relation to 10/32 (31.3%) biochemical parameters. EC isolates from CB were significantly more often positive for beta GAL, beta NAG, MLZ, and less often positive for PAL and beta MAN than isolates from other poultry types. However, BB and W isolates showed higher ability to metabolise mannitol than CB, CL, and T. CB isolates showed lower ability to survive at 60 degrees C. Only chicken EC-isolates harbored virulence genes: CB (8.1%) > BB (3.4%) > CL (2%). No specific pulsotype of EC was associated with a specific poultry. One or several various (up to 6) genetic types of EC may be involved in outbreaks in CB flocks within one year in one region. Outbreaks reported in following years in the same region were usually caused by a distinct set of EC-genetic types. PFGE results indicated at the genetic heterogeneity among pathogenic isolates involved in outbreaks in relation to each poultry type. To our best knowledge, this is the first study which provides a comparison between clinical EC from 5 poultry groups. The study provides a new insight into EC as pathogen of different bird species. The obtained data may be useful in further studies on EC-infections more focused on a specific type of poultry.	[Dolka, Beata; Szeleszczuk, Piotr] Warsaw Univ Life Sci, SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland; [Chrobak-Chmiel, Dorota] Warsaw Univ Life Sci, SGGW, Fac Vet Med, Dept Preclin Sci, Warsaw, Poland; [Czopowicz, Michal] Warsaw Univ Life Sci, SGGW, Fac Vet Med, Lab Vet Epidemiol & Econ, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Dolka, B (corresponding author), Warsaw Univ Life Sci, SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland.	beata_dolka@sggw.pl	Czopowicz, Michał/U-5452-2018	Czopowicz, Michał/0000-0002-4238-8360; /0000-0001-8836-5351; Szeleszczuk, Piotr/0000-0003-1830-4232; Chrobak-Chmiel, Dorota/0000-0002-0554-6921	KNOW (Leading National Research Centre) Scientific Consortium [05-1/KNOW2/2015]	KNOW (Leading National Research Centre) Scientific Consortium	The costs of manuscript publication were funded by KNOW (Leading National Research Centre) Scientific Consortium 'Healthy Animal Safe Food,' decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison H, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.1077; Armour N.K., 2011, POULT INF PROF, V117, P1; Aziz T., 2007, World Poultry, V23, P44; Baele M, 2002, J APPL MICROBIOL, V92, P348, DOI 10.1046/j.1365-2672.2002.01537.x; Boerlin P, 2012, VET MICROBIOL, V157, P405, DOI 10.1016/j.vetmic.2012.01.001; Borst LB, 2017, VET PATHOL, V54, P61, DOI 10.1177/0300985816658098; Borst LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121294; Borst LB, 2014, AVIAN DIS, V58, P244, DOI 10.1637/10687-101113-Reg.1; Borst LB, 2012, AVIAN PATHOL, V41, P479, DOI 10.1080/03079457.2012.718070; Brash M, 2011, AHL NEWSLETTER, V15, P5; Daud N.H, 2015, P 2 WORLD VET POULTR, P77; De Herdt P, 2009, VLAAMS DIERGEN TIJDS, V78, P44; DEVRIESE LA, 1991, LETT APPL MICROBIOL, V12, P137, DOI 10.1111/j.1472-765X.1991.tb00524.x; DEVRIESE LA, 1992, J APPL BACTERIOL, V73, P421, DOI 10.1111/j.1365-2672.1992.tb04998.x; DEVRIESE LA, 1991, J APPL BACTERIOL, V71, P46; DEVRIESE LA, 1983, INT J SYST BACTERIOL, V33, P772, DOI 10.1099/00207713-33-4-772; Devriese LA, 2002, VLAAMS DIERGEN TIJDS, V71, P219; Dolka B, 2017, MED WETER, V73, P193; Dolka B, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0761-1; Jackson CR, 2015, LETT APPL MICROBIOL, V60, P111, DOI 10.1111/lam.12374; Jackson CR, 2004, J CLIN MICROBIOL, V42, P3558, DOI 10.1128/JCM.42.8.3558-3565.2004; Jung A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0949-y; Jung A, 2014, BMC VET RES, V10; Jung A, 2014, AVIAN DIS, V58, P654, DOI 10.1637/10834-040114-Case.1; Jung A, 2013, AVIAN PATHOL, V42, P552, DOI 10.1080/03079457.2013.850151; Kense MJ, 2011, AVIAN PATHOL, V40, P603, DOI 10.1080/03079457.2011.619165; Kizerwetter-Swida M, 2008, J ANIM FEED SCI, V17, P224, DOI 10.22358/jafs/66602/2008; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Makrai L, 2011, ACTA VET HUNG, V59, P11, DOI 10.1556/AVet.59.2011.1.2; Manero A, 1999, APPL ENVIRON MICROB, V65, P4425; Markowski EP, 2009, DECIS SCI-J INNOV ED, V7, P59, DOI 10.1111/j.1540-4609.2008.00202.x; Martin-Platero AM, 2009, INT J FOOD MICROBIOL, V132, P24, DOI 10.1016/j.ijfoodmicro.2009.03.010; Robbins KM, 2012, AVIAN DIS, V56, P768, DOI 10.1637/10253-052412-Case.1; Scupham AJ, 2008, MICROB ECOL, V56, P322, DOI 10.1007/s00248-007-9349-4; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; Stepien-Pysniak D, 2016, ACTA VET HUNG, V64, P148, DOI 10.1556/004.2016.016; Szeleszczuk P, 2013, MED WETER, V69, P298; Talebi A, 2016, VET RES FORUM, V7, P353; van den Braak N, 1998, J CLIN MICROBIOL, V36, P1927, DOI 10.1128/JCM.36.7.1927-1932.1998; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Wijetunge DS, 2012, J VET DIAGN INVEST, V24, P1166, DOI 10.1177/1040638712463563; Wood AM, 2002, VET REC, V150, P27	42	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185199	10.1371/journal.pone.0185199	http://dx.doi.org/10.1371/journal.pone.0185199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934313	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900119
J	Park, NJ; Chang, YF; Bender, C; Conley, Y; Chlebowski, RT; van Londen, GJ; Foraker, R; Wassertheil-Smoller, S; Stefanick, ML; Kuller, LH				Park, Na-Jin; Chang, Yuefang; Bender, Catherine; Conley, Yvette; Chlebowski, Rowan T.; van Londen, G. J.; Foraker, Randi; Wassertheil-Smoller, Sylvia; Stefanick, Marcia L.; Kuller, Lewis H.			Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative	PLOS ONE			English	Article							LONG-TERM SURVIVORS; HEART-DISEASE; OLDER WOMEN; GYNECOLOGIC CANCERS; PHYSICAL-ACTIVITY; CARDIAC TOXICITY; RISK-FACTORS; ADJUVANT; THERAPY; DEATH	Background Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among older postmenopausal women. The impact of postmenopausal breast cancer on CVD for older women is uncertain. We hypothesized that older postmenopausal women with breast cancer would be at a higher risk of CVD than similar aged women without breast cancer and that CVD would be a major contributor to the subsequent morbidity and mortality. Methods In a prospective Women's Health Initiative study, incident CVD events and total and cause-specific death rates were compared between postmenopausal women with (n = 4,340) and without (n = 97,576) incident invasive breast cancer over 10 years post-diagnosis, stratified by 3 age groups (50-59, 60-69, and 70-79). Results Postmenopausal women, regardless of breast cancer diagnosis, had similar and high levels of CVD risk factors (e.g., smoking and hypertension) at baseline prior to breast cancer, which were strong predictors of CVD and total mortality over time. CVD affected mostly women age 70-79 with localized breast cancer (79% of breast cancer cases in 70-79 age group): only 17% died from breast cancer and CVD was the leading cause of death (22%) over the average 10 years follow up. Compared to age-matched women without breast cancer, women age 70-79 at diagnosis of localized breast cancer had a similar multivariate-adjusted hazard ratio (HR) of 1.01 (95% confidence interval [CI]: 0.76-1.33) for coronary heart disease, a lower risk of composite CVD ( HR = 0.84, 95% CI: 0.70-1.00), and a higher risk of total mortality (HR = 1.20, 95% CI: 1.04-1.39). Conclusion CVD was a major contributor to mortality in women with localized breast cancer at age 70-79. Further studies are needed to evaluate both screening and treatment of localized breast cancer tailored to the specific health issues of older women.	[Park, Na-Jin; Bender, Catherine; Conley, Yvette] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Chang, Yuefang] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [van Londen, G. J.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Foraker, Randi] Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH 43210 USA; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Stefanick, Marcia L.] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Kuller, Lewis H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; Yeshiva University; Albert Einstein College of Medicine; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Park, NJ (corresponding author), Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA.	parknj@pitt.edu		Park, Na-Jin/0000-0002-2602-2027; Conley, Yvette/0000-0002-1784-6067	National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; National Institutes of Health [KL2TR000146]; NATIONAL INSTITUTE ON AGING [P30AG024827, T32AG021885] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. Preparation of this manuscript was supported by the National Institutes of Health through grant number KL2TR000146 (N. Park). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Qadir H, 2017, JAMA CARDIOL, V2, P88, DOI 10.1001/jamacardio.2016.3841; Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; American Cancer Society, 2016, CANC TREATM SURV FAC; Amir E, 2011, JNCI-J NATL CANCER I, V103, P1; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Barac A, 2015, J AM COLL CARDIOL, V65, P2739, DOI 10.1016/j.jacc.2015.04.059; Bardia A, 2012, BREAST CANCER RES TR, V131, P907, DOI 10.1007/s10549-011-1843-1; Biganzoli L, 2012, LANCET ONCOL, V13, pE148, DOI 10.1016/S1470-2045(11)70383-7; Bowles EJA, 2012, JNCI-J NATL CANCER I, V104, P1293, DOI 10.1093/jnci/djs317; Chapman JAW, 2008, JNCI-J NATL CANCER I, V100, P252, DOI 10.1093/jnci/djn014; Chlebowski RT, 2015, BREAST CANCER RES TR, V154, P609, DOI 10.1007/s10549-015-3647-1; Chlebowski RT, 2015, J NATL COMPR CANC NE, V13, P917, DOI 10.6004/jnccn.2015.0106; Chlebowski RT, 2015, THER ADV DRUG SAF, V6, P45, DOI 10.1177/2042098614568300; Colzani E, 2011, J CLIN ONCOL, V29, P4014, DOI 10.1200/JCO.2010.32.6462; Cuppone F, 2008, CANCER-AM CANCER SOC, V112, P260, DOI 10.1002/cncr.23171; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Du XL, 2009, CANCER-AM CANCER SOC, V115, P5296, DOI 10.1002/cncr.24621; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Giordano SH, 2005, J CLIN ONCOL, V23, P783, DOI 10.1200/JCO.2005.04.175; Hague R, 2014, AM J MANAG CARE, V20, P86; Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Heron M, 2016, NATL VITAL STAT REP, V65, P5; Hildebrand JS, 2013, CANCER EPIDEM BIOMAR, V22, P1906, DOI 10.1158/1055-9965.EPI-13-0407; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Hozumi Y, 2011, ANN ONCOL, V22, P1777, DOI 10.1093/annonc/mdq707; Jackson JM, 2013, J CLIN EPIDEMIOL, V66, P349, DOI 10.1016/j.jclinepi.2012.01.013; Khouri MG, 2012, CIRCULATION, V126, P2749, DOI 10.1161/CIRCULATIONAHA.112.100560; Knobf MT, 2011, CURR CARDIOL REV, V7, P250, DOI 10.2174/157340311799960627; Kuller LH, 2016, J AM COLL CARDIOL, V67, P1013, DOI 10.1016/j.jacc.2015.12.034; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Mariotto AB, 2017, CANCER EPIDEM BIOMAR, V26, P809, DOI [10.1158/1055-9965.EPI-16-0889, 10.1158/1055-9965.epi-16-0889]; McTigue KM, 2014, OBESITY, V22, P801, DOI 10.1002/oby.20224; Montazeri K, 2014, CIRCULATION, V130, pE157, DOI 10.1161/CIRCULATIONAHA.114.008820; Nichols HB, 2009, CANCER EPIDEM BIOMAR, V18, P1403, DOI 10.1158/1055-9965.EPI-08-1094; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Ortman JM, 2014, AGING NATION OLDER P; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Reddigan JI, 2011, AM J CARDIOL, V108, P1426, DOI 10.1016/j.amjcard.2011.07.005; Richardson LC, 2016, MMWR MORB MORTAL WKL, V26; Simon MS, 2014, BREAST CANCER RES TR, V148, P187, DOI 10.1007/s10549-014-3114-4; Singla A, 2012, CURR OPIN CARDIOL, V27, P515, DOI 10.1097/HCO.0b013e3283570040; Weaver KE, 2014, J ONCOL PRACT, V10, pE231, DOI 10.1200/JOP.2013.001175; Weaver KE, 2013, J CANCER SURVIV, V7, P253, DOI 10.1007/s11764-013-0267-9; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	51	47	49	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184174	10.1371/journal.pone.0184174	http://dx.doi.org/10.1371/journal.pone.0184174			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934233	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900022
J	Chiang, BJ; Liao, CH; Lin, YH				Chiang, Bing-Juin; Liao, Chun-Hou; Lin, Yu-Hua			The efficacy of extracorporeal shockwave lithotripsy for symptomatic ureteral stones: Predictors of treatment failure without the assistance of computed tomography	PLOS ONE			English	Article							WAVE LITHOTRIPSY; HOUNSFIELD UNITS; STRICTURE FORMATION; URINARY CALCULI; DISTANCE; DISINTEGRATION; DENSITY; SUCCESS	Objectives Non-contrast computed tomography (NCCT) is not always performed clinically if the diagnosis of ureteral calculi has been confirmed using other radiographic imaging modalities. The aim of this study was to identify predictors of successful extracorporeal shockwave lithotripsy (ESWL) without assistance of NCCT. Methods We retrospectively reviewed the medical records of patients with symptomatic solitary ureteral stones who underwent ESWL between November 2015 and January 2016. Abdominal plain radiography or intravenous urography were performed before ESWL for localization. The exclusion criteria were repeated sessions of ESWL for the target stone and congenital genitourinary tract anomalies. The demographic characteristics, clinical history, medical charges, or imaging features of the stones were recorded. Successful treatment was defined as no fragments detected on radiography or ultrasonography in 4 weeks. For radiolucent calculi, successful treatment was regarded as cases without hydronephrosis, symptoms, or hematuria. Patients experiencing intractable pain and undergoing subsequent auxiliary surgeries were regarded as having ESWL treatment failure. Results Age (odds ratio [OR], 1.042; 95% confidence interval [CI], 1.007-1.078), history of ipsilateral renal or ureteral calculi episodes (OR, 2.669; 95% CI, 1.281-5.687), stone burden (OR, 3.499; 95% CI, 1.284-9.530), and radiopaque stone (OR, 2.351; 95% CI, 1.049-5.267) were significant predictors of ESWL failure in all patients. Conclusions For treating symptomatic ureteral stones, those with smaller size, radiolucency, and without a history of ipsilateral renal or ureteral calculi could be considered for first-line therapy with ESWL.	[Chiang, Bing-Juin] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chiang, Bing-Juin; Liao, Chun-Hou; Lin, Yu-Hua] Cardinal Tien Hosp, Dept Surg, Div Urol, New Taipei, Taiwan; [Chiang, Bing-Juin; Liao, Chun-Hou] Fu Jen Catholic Univ, Sch Med, Dept Urol, New Taipei, Taiwan; [Lin, Yu-Hua] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan	National Taiwan Normal University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Lin, YH (corresponding author), Cardinal Tien Hosp, Dept Surg, Div Urol, New Taipei, Taiwan.; Lin, YH (corresponding author), Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan.	jorgesuperowl@gmail.com						AMAR AD, 1981, J UROLOGY, V125, P416, DOI 10.1016/S0022-5347(17)55057-0; [Anonymous], 2007, RAD TRCO AC ONS FLAN; Cho KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144912; Chua ME, 2012, INT UROL NEPHROL, V44, P1349, DOI 10.1007/s11255-012-0189-x; Cimentepe E, 2003, J ENDOUROL, V17, P863, DOI 10.1089/089277903772036154; Delvecchio FC, 2003, UROLOGY, V61, P518, DOI 10.1016/S0090-4295(02)02433-0; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; ERTURK E, 1993, J UROLOGY, V149, P1425, DOI 10.1016/S0022-5347(17)36405-4; Gupta NP, 2005, BJU INT, V95, P1285, DOI 10.1111/j.1464-410X.2005.05520.x; Hall TC, 2015, CLIN RADIOL, V70, P243, DOI 10.1016/j.crad.2014.10.013; Jacobs BL, 2008, J ENDOUROL, V22, P1623, DOI 10.1089/end.2008.0169; Kanao K, 2006, J UROL 1, V176, P6; Kanao K, 2006, J UROLOGY, V176, P1453, DOI 10.1016/j.juro.2006.06.089; Malkawi IM, 2016, J ENDOUROL; Matlaga BR, 2012, J UROLOGY, V188, P130, DOI 10.1016/j.juro.2012.02.2569; Ng CF, 2009, J UROLOGY, V181, P1151, DOI 10.1016/j.juro.2008.10.161; Ouzaid I, 2012, BJU INT, V110, pE438, DOI 10.1111/j.1464-410X.2012.10964.x; Pareek G, 2005, UROLOGY, V66, P941, DOI 10.1016/j.urology.2005.05.011; Pareek G, 2003, J UROLOGY, V169, P1679, DOI 10.1097/01.ju.0000055608.92069.3a; Park BH, 2012, KOREAN J UROL, V53, P40, DOI 10.4111/kju.2012.53.1.40; Roberts WW, 1998, J UROLOGY, V159, P723, DOI 10.1016/S0022-5347(01)63711-X; Schoenfeld EM, 2015, WEST J EMERG MED, V16, P269, DOI 10.5811/westjem.2015.1.23272; Seitz C, 2006, EUR UROL, V49, P1099, DOI 10.1016/j.eururo.2005.12.003; Smith-Bindman R, 2014, NEW ENGL J MED, V371, P1100, DOI 10.1056/NEJMoa1404446; STEIN J, 1962, J UROLOGY, V87, P33, DOI 10.1016/S0022-5347(17)64902-4; Tamm EP, 2003, RADIOLOGY, V228, P319, DOI 10.1148/radiol.2282011726; Thomson J M, 2001, Australas Radiol, V45, P291, DOI 10.1046/j.1440-1673.2001.00923.x; Wiesenthal JD, 2011, J UROLOGY, V186, P556, DOI 10.1016/j.juro.2011.03.109; Wiesenthal JD, 2010, UROL RES, V38, P307, DOI 10.1007/s00240-010-0295-0; Yang TK, 2013, J FORMOS MED ASSOC, V112, P421, DOI 10.1016/j.jfma.2012.02.004; Yoshida S, 2006, UROLOGY, V68, P33, DOI 10.1016/j.urology.2006.01.052	31	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184855	10.1371/journal.pone.0184855	http://dx.doi.org/10.1371/journal.pone.0184855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931028	Green Submitted, gold, Green Published			2022-12-27	WOS:000411314700039
J	Vander Roost, J; Thorseth, IH; Dahle, H				Vander Roost, Jan; Thorseth, Ingunn Hindenes; Dahle, Hakon			Microbial analysis of Zetaproteobacteria and co-colonizers of iron mats in the Troll Wall Vent Field, Arctic Mid-Ocean Ridge	PLOS ONE			English	Article							LOIHI SEAMOUNT; HYDROTHERMAL FIELDS; OXIDIZING BACTERIA; FRESH-WATER; SEA; DIVERSITY; COMMUNITIES; FE; DEPOSITS; PHYSIOLOGY	Over the last decade it has become increasingly clear that Zetaproteobacteria are widespread in hydrothermal systems and that they contribute to the biogeochemical cycling of iron in these environments. However, how chemical factors control the distribution of Zetaproteobacteria and their co-occurring taxa remains elusive. Here we analysed iron mats from the Troll Wall Vent Field (TWVF) located at the Arctic Mid-Ocean Ridge (AMOR) in the Norwegian-Greenland Sea. The samples were taken at increasing distances from high-temperature venting chimneys towards areas with ultraslow low-temperature venting, encompassing a large variety in geochemical settings. Electron microscopy revealed the presence of biogenic iron stalks in all samples. Using 16S rRNA gene sequence profiling we found that relative abundances of Zetaproteobacteria in the iron mats varied from 0.2 to 37.9%. Biogeographic analyses of Zetaproteobacteria, using the ZetaHunter software, revealed the presence of ZetaOtus 1, 2 and 9, supporting the view that they are cosmopolitan. Relative abundances of co-occurring taxa, including Thaumarchaeota, Euryarchaeota and Proteobacteria, also varied substantially. From our results, combined with results from previous microbiological and geochemical analyses of the TWVF, we infer that the distribution of Zetaproteobacteria is connected to fluid-flow patterns and, ultimately, variations in chemical energy landscapes. Moreover, we provide evidence for iron-oxidizing members of Gallionellaceae being widespread in TWVF iron mats, albeit at low relative abundances.	[Vander Roost, Jan; Thorseth, Ingunn Hindenes; Dahle, Hakon] Univ Bergen, Ctr Geobiol, Bergen, Norway; [Vander Roost, Jan; Dahle, Hakon] Univ Bergen, Dept Biol, Bergen, Norway; [Thorseth, Ingunn Hindenes] Univ Bergen, Dept Earth Sci, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen	Dahle, H (corresponding author), Univ Bergen, Ctr Geobiol, Bergen, Norway.; Dahle, H (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	Hakon.Dahle@uib.no			Reseach Council of Norway [179560]	Reseach Council of Norway	This project was funded by The Reseach Council of Norway (http://www.forskningsradet.no/ en/Home_page/1177315753906) through Grant Number: 179560. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT JC, 1988, MAR GEOL, V81, P227, DOI 10.1016/0025-3227(88)90029-1; Amend JP, 2011, GEOCHIM COSMOCHIM AC, V75, P5736, DOI 10.1016/j.gca.2011.07.041; Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x; Baumberger T., 2012, THESIS; Chan CS, 2004, SCIENCE, V303, P1656, DOI 10.1126/science.1092098; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dahle H, 2015, ISME J, V9, P1593, DOI 10.1038/ismej.2014.247; Davis RE, 2009, GEOMICROBIOL J, V26, P570, DOI 10.1080/01490450902889080; Davis RE, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005413; Dekov VM, 2010, CHEM GEOL, V278, P186, DOI 10.1016/j.chemgeo.2010.09.012; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; Edgar R.C., 2011, BIOINFORMATICS; Edwards KJ, 2011, ISME J, V5, P1748, DOI 10.1038/ismej.2011.48; Emerson D, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01502; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Field EK, 2015, ISME J, V9, P857, DOI 10.1038/ismej.2014.183; Fleming EJ, 2013, FEMS MICROBIOL ECOL, V85, P116, DOI 10.1111/1574-6941.12104; Fullerton H, 2017, ISME J, V11, P1900, DOI 10.1038/ismej.2017.40; German CR, 2015, EARTH PLANET SC LETT, V419, P143, DOI 10.1016/j.epsl.2015.03.012; Hodges TW, 2009, APPL ENVIRON MICROB, V75, P1650, DOI 10.1128/AEM.01835-08; Hoshino T, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01554; Ishibashi J. I, 2015, SUBSEAFLOOR BIOSPHER, P301, DOI [10.1007/978-4-431-54865-2, DOI 10.1007/978-4-431-54865-2]; Jesser KJ, 2015, APPL ENVIRON MICROB, V81, P2976, DOI 10.1128/AEM.03608-14; Johannessen KC, 2017, GEOCHIM COSMOCHIM AC, V202, P101, DOI 10.1016/j.gca.2016.12.016; JUNIPER SK, 1988, CAN MINERAL, V26, P859; Kato S, 2009, ENVIRON MICROBIOL, V11, P3210, DOI 10.1111/j.1462-2920.2009.02031.x; Kato S, 2009, ENVIRON MICROBIOL, V11, P2094, DOI 10.1111/j.1462-2920.2009.01930.x; Kennedy CB, 2003, GEOMICROBIOL J, V20, P199, DOI 10.1080/01490450303873; Kopylova E, 2012, BIOINFORMATICS; Li JT, 2012, FEMS MICROBIOL ECOL, V81, P205, DOI 10.1111/j.1574-6941.2012.01367.x; Li JW, 2013, J GEOPHYS RES-BIOGEO, V118, P665, DOI 10.1002/jgrg.20057; Makita H, 2017, ARCH MICROBIOL, V199, P335, DOI 10.1007/s00203-016-1307-4; McAllister SM, 2011, APPL ENVIRON MICROB, V77, P5445, DOI 10.1128/AEM.00533-11; McBeth JM, 2013, ENV MICROBIOL REP, V5, P453, DOI 10.1111/1758-2229.12033; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; Moeller K, 2014, GEOCHIM COSMOCHIM AC, V126, P422, DOI 10.1016/j.gca.2013.11.018; Moyer CL, 1998, DEEP-SEA RES PT II, V45, P303, DOI 10.1016/S0967-0645(97)00081-7; MOYER CL, 1995, APPL ENVIRON MICROB, V61, P1555, DOI 10.1128/AEM.61.4.1555-1562.1995; Pedersen RB, 2010, GEOPHYS MONOGR SER, V188, P67, DOI 10.1029/2008GM000783; Peng XT, 2015, GEOCHIM COSMOCHIM AC, V169, P200, DOI 10.1016/j.gca.2015.09.011; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raiswell R, 2012, GEOCHEM PERSPECT, V1, P1, DOI 10.7185/geochempersp.1.1; Ramirez Gustavo A, 2016, Front Microbiol, V7, P1679; Resing JA, 2015, NATURE, V523, P200, DOI 10.1038/nature14577; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rubin-Blum M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091456; Schander C, 2010, MAR BIOL RES, V6, P155, DOI 10.1080/17451000903147450; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott JJ, 2017, ENVIRON MICROBIOL, V19, P301, DOI 10.1111/1462-2920.13607; Scott JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119284; Singer E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01409; Singer E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00052; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Sylvan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00279-11; Tischler JS, 2013, J MICROBIOL METH, V95, P138, DOI 10.1016/j.mimet.2013.07.027; Toner BM, 2009, GEOCHIM COSMOCHIM AC, V73, P388, DOI 10.1016/j.gca.2008.09.035; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Urich T, 2014, ENVIRON MICROBIOL, V16, P2699, DOI 10.1111/1462-2920.12283; Warnes GR, 2013, GPLOTS VARIOUS R PRO	63	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185008	10.1371/journal.pone.0185008	http://dx.doi.org/10.1371/journal.pone.0185008			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931087	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700057
J	Yi, L; Hu, N; Yin, J; Sun, J; Mu, HX; Dai, KR; Ding, DX				Yi, Lan; Hu, Nan; Yin, Jie; Sun, Jing; Mu, Hongxiang; Dai, Keren; Ding, Dexin			Up-regulation of calreticulin in mouse liver tissues after long-term irradiation with low-dose-rate gamma rays	PLOS ONE			English	Article							IONIZING-RADIATION; PROTEOMIC ANALYSIS; BLADDER-CANCER; IN-VIVO; MICE; EXPOSURE; GROWTH; RISK	The biological effects of low-dose or low-dose-rate ionizing radiation on normal tissues has attracted attention. Based on previous research, we observed the morphology of liver tissues of C57BL/6J mice that received <50, 50-500, and 500-1000 mu Gy/h of Cs-137 radiation for 180 d. We found that the pathological changes in liver tissues were more obvious as the irradiation dose rates increased. Additionally, differential protein expression in liver tissues was analyzed using a proteomics approach. Compared with the matched group in the 2D gel analysis of the irradiated groups, 69 proteins had >= 1.5-fold changes in expression. Twenty-three proteins were selected based on >= 2.5-fold change in expression, and 22 of them were meaningful for bioinformatics and protein fingerprinting analysis. These molecules were relevant to cytoskeleton processes, cell metabolism, biological defense, mitochondrial damage, detoxification and tumorigenesis. The results from real-time PCR and western blot (WB) analyses showed that calreticulin (CRT) was up-regulated in the irradiated groups, which indicates that CRT may be relevant to stress reactions when mouse livers are exposed to low-dose irradiation and that low-dose-rate ionizing radiation may pose a cancer risk. The CRT protein can be a potential candidate for low-dose or low-dose-rate ionizing radiation early-warning biomarkers. However, the underlying mechanism requires further investigation.	[Yi, Lan; Hu, Nan; Yin, Jie; Ding, Dexin] Univ South China, Key Discipline Lab Natl Def Biotechnol Uranium Mi, Hengyang, Hunan, Peoples R China; [Yi, Lan; Yin, Jie; Sun, Jing; Mu, Hongxiang; Dai, Keren] Univ South China, Coll Pharm & Biol Sci, Hengyang, Hunan, Peoples R China	University of South China; University of South China	Ding, DX (corresponding author), Univ South China, Key Discipline Lab Natl Def Biotechnol Uranium Mi, Hengyang, Hunan, Peoples R China.	dingdxzzz@163.com			Defense Industrial Technology Development Program [JCKY2016403C001]; Key Project of National Defense Basic Research [B3720132001]; National Natural Science Foundation of China [U1401231]; China Postdoctoral Science Foundation [2014M562115]; National Natural Scientific Foundation of China [81400117]; Hunan Provincial Postgraduate Students Scientific Research Innovation Project [CX2016B473]; University of South China [2014XQD46]	Defense Industrial Technology Development Program; Key Project of National Defense Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Postgraduate Students Scientific Research Innovation Project; University of South China	This project was sponsored by the following: Defense Industrial Technology Development Program (No. JCKY2016403C001) (Dr Dexin Ding) had a role in study design and decision to publish. Key Project of National Defense Basic Research (B3720132001) (Dr Dexin Ding) had a role in data collection and analysis. National Natural Science Foundation of China (U1401231) (Dr Lan Yi) had a role in study design and preparation of the manuscript. China Postdoctoral Science Foundation (2014M562115) (Dr Lan Yi) had a role in preparation of the manuscript. National Natural Scientific Foundation of China (81400117) (Dr Lan Yi) had a role in data collection and analysis. Hunan Provincial Postgraduate Students Scientific Research Innovation Project (CX2016B473) (Miss Jing Sun) had a role in data collection and analysis. Research Initiation Funding of University of South China for the Returned Scholars from Abroad (2014XQD46) (Dr Lan Yi) had a role in preparation of the manuscript.	Alfonso P, 2005, PROTEOMICS, V5, P2602, DOI 10.1002/pmic.200401196; Chen QF, 2015, BIOMED PHARMACOTHER, V73, P109, DOI 10.1016/j.biopha.2015.05.017; Chiang WF, 2013, ORAL ONCOL, V49, P534, DOI 10.1016/j.oraloncology.2013.01.003; Ciplys E, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0356-8; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Fuller N, 2015, AQUAT TOXICOL, V167, P55, DOI 10.1016/j.aquatox.2015.07.013; Kageyama S, 2004, CLIN CHEM, V50, P857, DOI 10.1373/clinchem.2003.027425; Khong P-L., 2013, Annals of the ICRP, V42, P9, DOI 10.1016/j.icrp.2012.10.001; Kron T, 2016, PHYS MED BIOL, V61, pR167, DOI 10.1088/0031-9155/61/14/R167; Lian YL, 2015, OCCUP ENVIRON MED, V72, P640, DOI 10.1136/oemed-2014-102772; Lu YC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/526524; Lu YC, 2011, AM J PATHOL, V179, P1425, DOI 10.1016/j.ajpath.2011.05.015; Mancuso M, 2015, ONCOTARGET, V6, P31263, DOI 10.18632/oncotarget.5075; Mitchel R. E. J., 2006, Dose-Response, V4, P75, DOI 10.2203/dose-response.04-002.Mitchel; Nenoi M, 2015, HUM EXP TOXICOL, V34, P272, DOI 10.1177/0960327114537537; Oujifard A, 2015, AQUAT TOXICOL, V165, P259, DOI 10.1016/j.aquatox.2015.06.010; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Pernemalm M, 2013, J PROTEOME RES, V12, P3934, DOI 10.1021/pr4002096; Rednam S, 2013, PEDIATR BLOOD CANCER, V60, P593, DOI 10.1002/pbc.24366; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Rosenstierne MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100813; Rybkina V. L., 2016, Radiatsionnaya Biologiya Radioekologiya, V56, P44, DOI 10.7868/S0869803116010136; Sasaki MS, 2014, J RADIAT RES, V55, P391, DOI 10.1093/jrr/rrt133; Schuler E, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-29; Sheng WW, 2014, J CELL PHYSIOL, V229, P887, DOI 10.1002/jcp.24519; Sun C, 2015, LEUKEMIA LYMPHOMA, V56, P1593, DOI 10.3109/10428194.2014.953153; Taki K, 2009, J RADIAT RES, V50, P241, DOI 10.1269/jrr.09011; Tatsukawa Y, 2013, INT J OBESITY, V37, P1123, DOI 10.1038/ijo.2012.193; Tatsukawa Y, 2013, J RADIOL PROT, V33, P281, DOI 10.1088/0952-4746/33/2/281; Uehara Y, 2010, RADIAT RES, V174, P611, DOI 10.1667/RR2195.1; UNSCEAR Publication, 2013, BIOL MECH RAD ACT LO; Xiao X, 2015, STEM CELLS DEV, V24, P1342, DOI 10.1089/scd.2014.0402; Yamashita S, 2016, RADIAT PROT DOSIM, V171, P41, DOI 10.1093/rpd/ncw189; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Yi L, 2016, ONCOL LETT, V12, P1861, DOI 10.3892/ol.2016.4850; Yi L, 2016, ENVIRON SCI POLLUT R, V23, P2549, DOI 10.1007/s11356-015-5494-3; Zamanian M, 2013, PATHOL ONCOL RES, V19, P149, DOI 10.1007/s12253-012-9600-2	37	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0182671	10.1371/journal.pone.0182671	http://dx.doi.org/10.1371/journal.pone.0182671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931006	Green Submitted, gold, Green Published			2022-12-27	WOS:000411314700005
J	Senghore, M; Otu, J; Witney, A; Gehre, F; Doughty, EL; Kaye, GL; Butcher, P; Salako, K; Kehinde, A; Onyejepu, N; Idigbe, E; Corrah, T; de Jong, B; Pollee, MJ; Antonio, M				Senghore, Madikay; Otu, Jacob; Witney, Adam; Gehre, Florian; Doughty, Emma L.; Kaye, Gemma L.; Butcher, Phillip; Salako, Kayode; Kehinde, Aderemi; Onyejepu, Nneka; Idigbe, Emmanuel; Corrah, Tumani; de Jong, Bouke; Pollee, Mark J.; Antonio, Martin			Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; TRANSMISSION; DIVERSITY; CAMEROON; COMPLEX; WORLD; TOOL	Nigeria has an emerging problem with multidrug-resistant tuberculosis (MDR-TB). Whole-genome sequencing was used to understand the epidemiology of tuberculosis and genetics of multi-drug resistance among patients from two tertiary referral centers in Southwest Nigeria. In line with previous molecular epidemiology studies, most isolates of Mycobacterium tuberculosis from this dataset belonged to the Cameroon clade within the Euro-American lineage. Phylogenetic analysis showed this clade was undergoing clonal expansion in this region, and suggests that it was involved in community transmission of sensitive and multidrug-resistant tuberculosis. Five patients enrolled for retreatment were infected with pre-extensively drug resistant (pre-XDR) due to fluoroquinolone resistance in isolates from the Cameroon clade. In all five cases resistance was conferred through a mutation in the gyrA gene. In some patients, genomic changes occurred in bacterial isolates during the course of treatment that potentially led to decreased drug susceptibility. We conclude that inter-patient transmission of resistant isolates, principally from the Cameroon clade, contributes to the spread of MDR-TB in this setting, underscoring the urgent need to curb the spread of multidrug resistance in this region.	[Senghore, Madikay; Otu, Jacob; Gehre, Florian; Corrah, Tumani; Antonio, Martin] Med Res Council Unit Gambia, Vaccines & Immun Theme, Fajara, Gambia; [Senghore, Madikay; Doughty, Emma L.; Kaye, Gemma L.; Pollee, Mark J.; Antonio, Martin] Univ Warwick, Microbiol & Infect Unit, Coventry, W Midlands, England; [Witney, Adam; Butcher, Phillip] St Georges Univ London, Inst Infect & Immun, London, England; [Gehre, Florian; de Jong, Bouke] Inst Trop Med, Antwerp, Belgium; [Salako, Kayode; Kehinde, Aderemi] Univ Coll Hosp, Dept Med Microbiol & Parasitol, Ibadan, Nigeria; [Onyejepu, Nneka; Idigbe, Emmanuel] Nigeria Inst Med Res, Natl TB Reference Lab, Lagos, Nigeria; [Pollee, Mark J.] Quadram Inst, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England; [Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Warwick; St Georges University London; Institute of Tropical Medicine (ITM); University of Ibadan; University College Hospital, Ibadan; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of London; London School of Hygiene & Tropical Medicine	Antonio, M (corresponding author), Med Res Council Unit Gambia, Vaccines & Immun Theme, Fajara, Gambia.; Antonio, M (corresponding author), Univ Warwick, Microbiol & Infect Unit, Coventry, W Midlands, England.; Antonio, M (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	mantionio@mrc.gm	Doughty, Emma/AAA-7416-2021; de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675; Kay, Gemma/0000-0002-1176-8459; Butcher, Philip/0000-0003-1223-9097; Pallen, Mark/0000-0003-1807-3657; Witney, Adam/0000-0003-4561-7170	EDCTP-WANETAM [CB. 2007. 41700.007]; MRC [MR/L015080/1] Funding Source: UKRI; Medical Research Council [MR/L015080/1] Funding Source: researchfish	EDCTP-WANETAM; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the EDCTP-WANETAM grant No: CB. 2007. 41700.007. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurrahman ST, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.277.3906; Ani A, 2015, AFR J MICROBIOL RES, V9, P960; [Anonymous], 2013, EUROPEAN COMMUNICABL, V18; Ardito F, 2001, J CLIN MICROBIOL, V39, P4440, DOI 10.1128/JCM.39.12.4440-4444.2001; Barrera L, 2008, WHO GUIDELINES APPRO; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Drobniewski F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-190; Falzon D, 2015, EUR RESPIR J, V45, P150, DOI 10.1183/09031936.00101814; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Gagneux S, 2014, CURR TOP MICROBIOL, V374, P1, DOI 10.1007/82_2013_329; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Gehre F, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0704-5; Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; IBRAHIM LM, 2014, PAN AFR MED J, V17, P33095; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Kay GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7717; Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12; Lawson L, 2010, ANN AFR MED, V9, P184, DOI 10.4103/1596-3519.68355; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Lee RS, 2015, J INFECT DIS, V211, P1905, DOI 10.1093/infdis/jiv011; Musa BM, 2015, ANN THORAC MED, V10, P185, DOI 10.4103/1817-1737.160838; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Somerville W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steiner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-881; Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Walker TM, 2015, LANCET INFECT DIS; Witney AA, 2015, J CLIN MICROBIOL, V53, P1473, DOI 10.1128/JCM.02993-14; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2015, GLOB TUB REP 2015; Yeboah-Manu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161892; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906	46	16	18	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184510	10.1371/journal.pone.0184510	http://dx.doi.org/10.1371/journal.pone.0184510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926571	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600020
J	Spiegler, V; Hensel, A; Seggewiss, J; Lubisch, M; Liebau, E				Spiegler, Verena; Hensel, Andreas; Seggewiss, Jochen; Lubisch, Milena; Liebau, Eva			Transcriptome analysis reveals molecular anthelmintic effects of procyanidins in C. elegans	PLOS ONE			English	Article							CONDENSED TANNINS; HAEMONCHUS-CONTORTUS; GASTROINTESTINAL NEMATODES; CAENORHABDITIS-ELEGANS; PARASITIC NEMATODES; PLANT POLYPHENOLS; MEDICINAL-PLANTS; HELMINTH CONTROL; PRIMER DESIGN; FLAVONOIDS	Worldwide, more than 1 billion people are affected by infestations with soil-transmitted helminths and also in veterinary medicine helminthiases are a severe threat to livestock due to emerging resistances against the common anthelmintics. Proanthocyanidins have been increasingly investigated for their anthelmintic properties, however, except for an interaction with certain proteins of the nematodes, not much is known about their mode of action. To investigate the anthelmintic activity on a molecular level, a transcriptome analysis was performed in Caenorhabditis elegans after treatment with purified and fully characterized oligomeric procyanidins (OPC). The OPCs had previously been obtained from a hydro-ethanolic (1:1) extract from the leaves of Combretum mucronatum, a plant which is traditionally used in West Africa for the treatment of helminthiasis, therefore, also the crude extract was included in the study. Significant changes in differential gene expression were observed mainly for proteins related to the intestine, many of which were located extracellularly or within cellular membranes. Among the up-regulated genes, several hitherto undescribed orthologues of structural proteins in humans were identified, but also genes that are potentially involved in the worms' defense against tannins. For example, T22D1.2, an orthologue of human basic salivary proline-rich protein (PRB) 2, and numr-1 (nuclear localized metal responsive) were found to be strongly up-regulated. Down-regulated genes were mainly associated with lysosomal activity, glycoside hydrolysis or the worms' innate immune response. No major differences were found between the groups treated with purified OPCs versus the crude extract. Investigations using GFP reporter gene constructs of T22D1.2 and numr-1 corroborated the intestine as the predominant site of the anthelmintic activity. The current findings support previous hypotheses of OPCs interacting with intestinal surface proteins and provide the first insights into the nematode's response to OPCs on a molecular level as a base for the identification of future drug targets.	[Spiegler, Verena; Hensel, Andreas] Univ Munster, Inst Pharmaceut Biol & Phytochem, Munster, Germany; [Seggewiss, Jochen] Univ Hosp Munster, Inst Human Genet, Munster, Germany; [Lubisch, Milena; Liebau, Eva] Inst Anim Physiol, Dept Mol Physiol, Munster, Germany	University of Munster; University of Munster	Spiegler, V (corresponding author), Univ Munster, Inst Pharmaceut Biol & Phytochem, Munster, Germany.	verena.spiegler@uni-muenster.de			University of Munster	University of Munster	This work was supported by no external funding, only intramural grants from the University of Munster.	Agyare C, 2014, J ETHNOPHARMACOL, V158, P255, DOI 10.1016/j.jep.2014.10.029; [Anonymous], 2000, NEMATODE PARASITES V; Athanasiadou S, 2007, ANIMAL, V1, P1392, DOI 10.1017/S1751731107000730; Ayers S, 2008, PHYTOCHEMISTRY, V69, P541, DOI 10.1016/j.phytochem.2007.08.003; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Barrau E, 2005, PARASITOLOGY, V131, P531, DOI 10.1017/S0031182005008024; Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; Berkowitz LA, 2008, J VIS EXP, P835; Berninsone P. M., 2006, WORMBOOK, DOI [10.1895/wormbook.1.125.1, DOI 10.1895/WORMBOOK.1.125.1]; Botura MB, 2013, VET PARASITOL, V192, P211, DOI 10.1016/j.vetpar.2012.10.012; BRENNER S, 1974, GENETICS, V77, P71; Brunet S, 2011, PARASITOL INT, V60, P419, DOI 10.1016/j.parint.2010.09.011; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Chan-Perez JI, 2016, VET PARASITOL, V217, P53, DOI 10.1016/j.vetpar.2015.11.001; D'Almeida RE, 2015, ACTA PARASITOL, V60, P164, DOI 10.1515/ap-2015-0023; da Silva VC, 2008, REV BRAS FARMACOGN, V18, P573, DOI 10.1590/S0102-695X2008000400013; Desrues O, 2016, PARASITOLOGY, V143, P444, DOI 10.1017/S0031182015001912; Ding YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067158; Duenas M, 2013, PHARMACOL RES, V76, P41, DOI 10.1016/j.phrs.2013.07.001; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Engels C, 2009, J AGR FOOD CHEM, V57, P7712, DOI 10.1021/jf901621m; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; FETTERER RH, 1993, VET PARASITOL, V46, P103, DOI 10.1016/0304-4017(93)90051-N; Ghafouri S, 2007, NEMATOLOGY, V9, P87, DOI 10.1163/156854107779969718; Hagerman A. E., 1989, CHEM SIGNIFICANCE CO, P323, DOI DOI 10.1007/978-1-4684-7511-1_20; HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P2590, DOI 10.1021/jf971097k; Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hoste H, 2015, VET PARASITOL, V212, P5, DOI 10.1016/j.vetpar.2015.06.026; Hoste H, 2012, VET PARASITOL, V186, P18, DOI 10.1016/j.vetpar.2011.11.042; Hoste H, 2006, TRENDS PARASITOL, V22, P253, DOI 10.1016/j.pt.2006.04.004; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kaplan RM, 2012, VET PARASITOL, V186, P70, DOI 10.1016/j.vetpar.2011.11.048; Karamac M, 2009, INT J MOL SCI, V10, P5485, DOI 10.3390/ijms10125485; Ketzis JK, 2006, VET PARASITOL, V139, P321, DOI 10.1016/j.vetpar.2006.04.022; Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kozan E, 2013, EXP PARASITOL, V134, P299, DOI 10.1016/j.exppara.2013.03.018; Lu Y, 1998, ARCH ORAL BIOL, V43, P717, DOI 10.1016/S0003-9969(98)00040-5; Luersen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060731; Malesev D, 2007, J SERB CHEM SOC, V72, P921, DOI 10.2298/JSC0710921M; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Martinez-Ortiz-de-Montellano C, 2013, EXP PARASITOL, V133, P281, DOI 10.1016/j.exppara.2012.11.024; McDonald M, 1996, J AGR FOOD CHEM, V44, P599, DOI 10.1021/jf950459q; McElwee MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-698; MEHANSHO H, 1983, P NATL ACAD SCI-BIOL, V80, P3948, DOI 10.1073/pnas.80.13.3948; MEHANSHO H, 1987, ANNU REV NUTR, V7, P423, DOI 10.1146/annurev.nu.07.070187.002231; Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463; Mori T, 2000, J PESTIC SCI, V25, P405; Nguyen TM, 2005, ANIM FEED SCI TECH, V121, P77, DOI 10.1016/j.anifeedsci.2005.02.013; Nieuwhof GJ, 2005, ANIM SCI, V81, P23, DOI 10.1079/ASC41010023; Novobilsky A, 2011, VET PARASITOL, V182, P213, DOI 10.1016/j.vetpar.2011.06.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pietsch Kerstin, 2012, Frontiers in Genetics, V3, P48, DOI 10.3389/fgene.2012.00048; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Ropiak HM, 2016, J AGR FOOD CHEM, V64, P8795, DOI 10.1021/acs.jafc.6b03842; ROUX DG, 1972, PHYTOCHEMISTRY, V11, P1219, DOI 10.1016/S0031-9422(00)90068-2; Shimada T, 2006, J CHEM ECOL, V32, P1149, DOI 10.1007/s10886-006-9077-0; SPENCER CM, 1988, PHYTOCHEMISTRY, V27, P2397, DOI 10.1016/0031-9422(88)87004-3; Spiegler V, 2017, NAT PROD REP, V34, P627, DOI 10.1039/c6np00126b; Spiegler V, 2015, MOLECULES, V20, P14810, DOI 10.3390/molecules200814810; Stiernagle Theresa, 2006, WormBook, P1; Sweeney T, 2016, PARASITE IMMUNOL, V38, P569, DOI 10.1111/pim.12347; Tamhane AC, 2000, STAT DATA ANAL ELEME; Tamura T, 2016, CURR MICROBIOL, V73, P115, DOI 10.1007/s00284-016-1032-x; Thompson David P., 1995, P203, DOI 10.1016/B978-012473345-9/50013-1; Tvermoes BE, 2010, J CELL SCI, V123, P2123, DOI 10.1242/jcs.065433; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; van den Enden E, 2009, EXPERT OPIN PHARMACO, V10, P435, DOI [10.1517/14656560902722463, 10.1517/14656560902722463 ]; Waller PJ, 2006, VET PARASITOL, V139, P1, DOI 10.1016/j.vetpar.2006.02.036; WHITE T., 1957, Journal of the Science of Food and Agriculture, V8, P377, DOI 10.1002/jsfa.2740080702; Williams AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0518-2; Williams AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097053; YAN QY, 1995, BIOCHEM J, V311, P341, DOI 10.1042/bj3110341; Yoneda S, 1998, J WOOD CHEM TECHNOL, V18, P193, DOI 10.1080/02773819809349576; Yoon YA, 2006, ARCH PHARM RES, V29, P582, DOI 10.1007/BF02969269; Yoshihara E, 2013, SEMIN-CIENC AGRAR, V34, P3935, DOI 10.5433/1679-0359.2013v34n6Supl2p3935	82	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e018465	10.1371/journal.pone.0184656	http://dx.doi.org/10.1371/journal.pone.0184656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926584	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600029
J	Sugimoto, K; Nakazato, K; Sato, A; Suzuki, S; Yoshihisa, A; Machida, T; Saitohl, S; Sekine, H; Takeishi, Y				Sugimoto, Koichi; Nakazato, Kazuhiko; Sato, Akihiko; Suzuki, Satoshi; Yoshihisa, Akiomi; Machida, Takeshi; Saitohl, Shu-ichi; Sekine, Hideharu; Takeishi, Yasuchika			Autoimmune disease mouse model exhibits pulmonary arterial hypertension	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; SURVIVIN; INHIBITION; DEFICIENCY; EXPRESSION; RESISTANCE; APOPTOSIS; THERAPY; LESIONS; AXIS	Background Pulmonary arterial hypertension is often associated with connective tissue disease. Although there are some animal models of pulmonary hypertension, an autoimmune disease-based model has not yet been reported. MRL/lpr mice, which have hypergammaglobulinemia, produce various autoimmune antibodies, and develop vasculitis and nephritis spontaneously. However, little is known about pulmonary circulation in these mice. In the present study, we examined the pulmonary arterial pressure in MRL/lpr mice. Methods and results We used female MRL/lpr mice aged between 12 and 14 weeks. Fluorescent immunostaining showed that there was no deposition of immunoglobulin or C3 in the lung tissue of the MRL/lpr mice. Elevation of interferon-gamma and interleukin-6 was recognized in the lung tissue of the MRL/lpr mice. Right ventricular systolic pressure, Fulton index and the ratio of right ventricular weight to body weight in the MRL/lpr mice were significantly higher than those in wild type mice with same background (C57BL/6). The medial smooth muscle area and the proportion of muscularized vessels in the lung tissue of the MRL/lpr mice were larger than those of the C57BL/6 mice. Western blot analysis demonstrated markedly elevated levels of prepro-endothelin-1 and survivin as well as decreased endothelial nitric oxide synthase phosphorylation in the lung tissue of the MRL/lpr mice. Terminal deoxynucleotidyl-transferase-mediated dUTP nick end-labeling assay showed the resistance against apoptosis of pulmonary arterial smooth muscle cells in the MRL/lpr mice. Conclusion We showed that MRL/lpr mice were complicated with pulmonary hypertension. MRL/lpr mice appeared to be a useful model for studying the mechanism of pulmonary hypertension associated with connective tissue diseases.	[Sugimoto, Koichi; Nakazato, Kazuhiko; Sato, Akihiko; Suzuki, Satoshi; Yoshihisa, Akiomi; Saitohl, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan; [Sugimoto, Koichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Pulm Hypertens, Fukushima, Japan; [Machida, Takeshi; Sekine, Hideharu] Fukushima Med Univ, Dept Immunol, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Sugimoto, K (corresponding author), Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan.; Sugimoto, K (corresponding author), Fukushima Med Univ, Dept Pulm Hypertens, Fukushima, Japan.	ksugi@fmu.ac.jp			Acterion Pharmaceuticals Japan	Acterion Pharmaceuticals Japan	Koichi Sugimoto belongs to endowed department sponsored by Acterion Pharmaceuticals Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors have not received any research funds for this research.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Chung L, 2010, CHEST, V138, P1383, DOI 10.1378/chest.10-0260; Dolff S, 2011, CLIN IMMUNOL, V141, P197, DOI 10.1016/j.clim.2011.08.005; Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862; Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, pE2677, DOI 10.1073/pnas.1424774112; Horowitz JC, 2012, INT J BIOCHEM CELL B, V44, P158, DOI 10.1016/j.biocel.2011.10.011; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Miyamichi-Yamamoto S, 2011, CIRC J, V75, P2668, DOI 10.1253/circj.CJ-11-0473; Mouraret N, 2015, CIRCULATION, V131, P742, DOI 10.1161/CIRCULATIONAHA.114.013258; Nakanishi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12417; Nandi M, 2005, CIRCULATION, V111, P2086, DOI 10.1161/01.CIR.0000163268.32638.F4; Sakamoto T, 2005, ARTERIOSCL THROM VAS, V25, P2005, DOI 10.1161/01.ATV.0000178171.61754.cd; Sekine H, 2011, ARTHRITIS RHEUM-US, V63, P1076, DOI 10.1002/art.30222; Shinohara T, 2015, AM J PHYSIOL-LUNG C, V308, pL523, DOI 10.1152/ajplung.00129.2014; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Skovsted GF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174119; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Sun XT, 2014, AM J RESP CELL MOL, V50, P1084, DOI 10.1165/rcmb.2013-0187OC; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Watanabe R, 2014, INTERNAL MED, V53, P627, DOI 10.2169/internalmedicine.53.0514; Yamauchi H, 2016, FREE RADICAL BIO MED, V94, P66, DOI 10.1016/j.freeradbiomed.2016.02.020; Zhang S, 2016, MOL MED REP, V13, P3415, DOI 10.3892/mmr.2016.4977	23	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184990	10.1371/journal.pone.0184990	http://dx.doi.org/10.1371/journal.pone.0184990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926602	Green Published, gold			2022-12-27	WOS:000411166600059
J	Fraiberk, M; Hajkova, M; Krulova, M; Kojzarova, M; Moravkova, AD; Psikal, I; Forstova, J				Fraiberk, Martin; Hajkova, Michaela; Krulova, Magdalena; Kojzarova, Martina; Moravkova, Alena Drda; Psikal, Ivan; Forstova, Jitka			Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; MULTISYSTEMIC WASTING SYNDROME; MAJOR CAPSID PROTEIN; RESPIRATORY SYNDROME VIRUS; HUMORAL IMMUNE-RESPONSES; TYPE-2 PCV2; EXPERIMENTAL REPRODUCTION; STRUCTURAL PROTEINS; EGFP-PSEUDOCAPSIDS; CONVENTIONAL PIGS	The aim of this study was to develop a suitable vaccine antigen against porcine circovirus 2 (PCV2), the causative agent of post-weaning multi-systemic wasting syndrome, which causes significant economic losses in swine breeding. Chimeric antigens containing PCV2b Cap protein sequences based on the mouse polyomavirus (MPyV) nanostructures were developed. First, universal vectors for baculovirus-directed production of chimeric MPyV VLPs or pentamers of the major capsid protein, VP1, were designed for their exploitation as vaccines against other pathogens. Various strategies were employed based on: A) exposure of selected immunogenic epitopes on the surface of MPyV VLPs by insertion into a surface loop of the VP1 protein, B) insertion of foreign protein molecules inside the VLPs, or C) fusion of a foreign protein or its part with the C-terminus of VP1 protein, to form giant pentamers of a chimeric protein. We evaluated these strategies by developing a recombinant vaccine against porcine circovirus 2. All candidate vaccines induced the production of antibodies against the capsid protein of porcine circovirus after immunization of mice. The candidate vaccine, Var C, based on fusion of mouse polyomavirus and porcine circovirus capsid proteins, could induce the production of antibodies with the highest PCV2 neutralizing capacity. Its ability to induce the production of neutralization antibodies was verified after immunization of pigs. The advantage of this vaccine, apart from its efficient production in insect cells and easy purification, is that it represents a DIVA (differentiating infected from vaccinated animals) vaccine, which also induces an immune response against the mouse polyoma VP1 protein and is thus able to distinguish between vaccinated and naturally infected animals.	[Fraiberk, Martin; Hajkova, Michaela; Krulova, Magdalena; Kojzarova, Martina; Moravkova, Alena Drda; Forstova, Jitka] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Psikal, Ivan] Dyntec Spol Sro, Terezin, Czech Republic	Charles University Prague	Forstova, J (corresponding author), Charles Univ Prague, Fac Sci, Prague, Czech Republic.	jitkaf@natur.cuni.cz	Hajkova, Michaela/U-8924-2017; Krulova, Magdalena/A-6255-2012	Hajkova, Michaela/0000-0003-1922-4891; Krulova, Magdalena/0000-0003-3622-376X	Technology Agency of the Czech Republic, TACR [TA03010700]; Specific University Research Grant of the Ministry of Education, Youth and Sports of CR [SVV-2017-260426]; National Sustainability Program II (Project BIOCEV-FAR); project "BIOCEV" the Ministry of Education, Youth and Sports of CR [LQ1604, CZ.1.05/1.1.00/02.0109]; Dyntec spol. s r.o.; Ministry of Education, Youth and Sports of CR within the National Sustainability Program II (Project BIOCEV-FAR) [LQ1604, CZ.1.05/1.1.00/02.0109]	Technology Agency of the Czech Republic, TACR; Specific University Research Grant of the Ministry of Education, Youth and Sports of CR; National Sustainability Program II (Project BIOCEV-FAR); project "BIOCEV" the Ministry of Education, Youth and Sports of CR; Dyntec spol. s r.o.; Ministry of Education, Youth and Sports of CR within the National Sustainability Program II (Project BIOCEV-FAR)	This work was supported by Technology Agency of the Czech Republic, TACR, project no. TA03010700, www.tacr.cz (MF, JF, ADM, IP); Specific University Research Grant of the Ministry of Education, Youth and Sports of CR, project no. SVV-2017-260426, www.msmt.cz (MF); National Sustainability Program II (Project BIOCEV-FAR) and by the project "BIOCEV" the Ministry of Education, Youth and Sports of CR, project no. LQ1604 and CZ.1.05/1.1.00/02.0109, www.msmt.cz (MF, JF); and Dyntec spol. s r.o., www.dyntec.cz (IP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IP is an employee of Dyntec spol s r.o. Dyntec spol. s r.o. provided support in the form of salary for IP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions section".; Acknowledgment is made to Karel Harant from the Mass Spectrometry and Proteomics Service Laboratory of Charles University, Faculty of Science, Biological Section, where the proteomic and mass spectrometric part of this work was done. This work was supported by the Technology Agency of the Czech Republic, TACR, project no. TA03010700, Specific University Research Grant of the Ministry of Education, Youth and Sports of CR, project no. SVV-2017-260426 and by the Ministry of Education, Youth and Sports of CR within the National Sustainability Program II (Project BIOCEV-FAR) LQ1604 and by the project "BIOCEV" (CZ.1.05/1.1.00/02.0109)."	Adeyemi OO, 2017, J VIROL, V91, DOI 10.1128/JVI.01586-16; Allan GM, 1999, J COMP PATHOL, V121, P1, DOI 10.1053/jcpa.1998.0295; Allan GM, 2000, ARCH VIROL, V145, P2421, DOI 10.1007/s007050070031; Alsharifi M, 2006, J IMMUNOL, V177, P3235, DOI 10.4049/jimmunol.177.5.3235; [Anonymous], 2015, VIRAL NANOTECHNOLOGY, DOI DOI 10.1201/B18596; Boura E, 2005, FEBS LETT, V579, P6549, DOI 10.1016/j.febslet.2005.10.062; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunborg IM, 2004, J VIROL METHODS, V122, P171, DOI 10.1016/j.jviromet.2004.08.014; Bucarey SA, 2009, VACCINE, V27, P5781, DOI 10.1016/j.vaccine.2009.07.061; CHANG DC, 1993, J VIROL, V67, P6327, DOI 10.1128/JVI.67.10.6327-6331.1993; CHANG DC, 1992, VIROLOGY, V189, P821, DOI 10.1016/0042-6822(92)90615-V; Cortey M, 2011, VET MICROBIOL, V149, P522, DOI 10.1016/j.vetmic.2010.11.009; Crisci E, 2012, VET IMMUNOL IMMUNOP, V148, P211, DOI 10.1016/j.vetimm.2012.04.026; Dalton JAR, 2007, BIOINFORMATICS, V23, P1901, DOI 10.1093/bioinformatics/btm262; Dupont K, 2008, VET MICROBIOL, V128, P56, DOI 10.1016/j.vetmic.2007.09.016; Ellis JA, 2008, AM J VET RES, V69, P1608, DOI 10.2460/ajvr.69.12.1608; Finsterbusch T, 2009, VIRUS RES, V143, P177, DOI 10.1016/j.virusres.2009.02.009; FORSTOVA J, 1993, J VIROL, V67, P1405; FORSTOVA J, 1995, HUM GENE THER, V6, P297, DOI 10.1089/hum.1995.6.3-297; Fort M, 2007, VET MICROBIOL, V125, P244, DOI 10.1016/j.vetmic.2007.06.004; Franzo G, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0361-x; Franzo G, 2015, VET MICROBIOL, V178, P158, DOI 10.1016/j.vetmic.2015.05.003; Fric J, 2008, VACCINE, V26, P3242, DOI 10.1016/j.vaccine.2008.04.006; Gao ZZ, 2014, VIRUS RES, V183, P56, DOI 10.1016/j.virusres.2014.01.024; Garcia ML, 2000, VIROLOGY, V272, P293, DOI 10.1006/viro.2000.0351; Gedvilaite A, 2004, VIRAL IMMUNOL, V17, P51, DOI 10.1089/088282404322875458; Grasland B, 2005, VET RES, V36, P685, DOI 10.1051/vetres:2005024; Guo LJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-273; Harms PA, 2001, VET PATHOL, V38, P528, DOI 10.1354/vp.38-5-528; Hines RK, PORCINE CIRCOVIRUS S; Hornikova L, 2011, J VIROL METHODS, V178, P229, DOI 10.1016/j.jviromet.2011.08.019; Hruskova V, 2009, INT J ONCOL, V35, P1247, DOI 10.3892/ijo_00000441; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Karuppannan AK, 2010, VIROLOGY, V398, P1, DOI 10.1016/j.virol.2009.11.028; Kennedy S, 2000, J COMP PATHOL, V122, P9, DOI 10.1053/jcpa.1999.0337; Khayat R, 2011, J VIROL, V85, P7856, DOI 10.1128/JVI.00737-11; Krakowka S, 2001, VET PATHOL, V38, P31, DOI 10.1354/vp.38-1-31; KRAUZEWICZ N, 1990, J VIROL, V64, P4414, DOI 10.1128/JVI.64.9.4414-4420.1990; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EY, 2016, MICROBIOL IMMUNOL, V60, P846, DOI 10.1111/1348-0421.12458; Lefebvre DJ, 2008, J GEN VIROL, V89, P177, DOI 10.1099/vir.0.83280-0; Lekcharoensuk P, 2004, J VIROL, V78, P8135, DOI 10.1128/JVI.78.15.8135-8145.2004; Liu J, 2006, J VIROL, V80, P5065, DOI 10.1128/JVI.80.10.5065-5073.2006; Liu YK, 2015, BIOTECHNOL LETT, V37, P1765, DOI 10.1007/s10529-015-1856-7; Lopez-Vidal J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140039; Mahe D, 2000, J GEN VIROL, V81, P1815, DOI 10.1099/0022-1317-81-7-1815; Marcekova Z, 2009, J VIROL METHODS, V162, P133, DOI 10.1016/j.jviromet.2009.07.028; Meehan BM, 1998, J GEN VIROL, V79, P2171, DOI 10.1099/0022-1317-79-9-2171; Meerts Peter, 2006, BMC Vet Res, V2, P6, DOI 10.1186/1746-6148-2-6; Meshram CD, 2016, J VIROL; MONTROSS L, 1991, J VIROL, V65, P4991, DOI 10.1128/JVI.65.9.4991-4998.1991; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Nielsen SD, 1998, CLIN EXP IMMUNOL, V114, P66; Opriessnig T, 2004, VET PATHOL, V41, P624, DOI 10.1354/vp.41-6-624; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Rovira A, 2002, J VIROL, V76, P3232, DOI 10.1128/JVI.76.7.3232-3239.2002; Rueda P, 2000, VACCINE, V19, P726, DOI 10.1016/S0264-410X(00)00259-0; Saha D, 2012, J GEN VIROL, V93, P1548, DOI 10.1099/vir.0.042085-0; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Shang SB, 2009, MOL IMMUNOL, V46, P327, DOI 10.1016/j.molimm.2008.10.028; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stehle T, 1993, STRUCT LOND ENGL, V4; Stokrova J, 1999, FEBS LETT, V445, P119, DOI 10.1016/S0014-5793(99)00003-4; Swanson PA, 2009, SEMIN CANCER BIOL, V19, P244, DOI 10.1016/j.semcancer.2009.02.003; Tegerstedt K, 2005, CANCER RES, V65, P5953, DOI 10.1158/0008-5472.CAN-05-0335; Teunissen EA, 2013, J CONTROL RELEASE, V172, P305, DOI 10.1016/j.jconrel.2013.08.026; TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0; Trible BR, 2012, VIRUS RES, V164, P68, DOI 10.1016/j.virusres.2011.11.018; Wu PC, 2012, APPL MICROBIOL BIOT, V95, P1501, DOI 10.1007/s00253-012-4015-2; Xiao CT, 2015, J GEN VIROL, V96, P1830, DOI 10.1099/vir.0.000100	74	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184870	10.1371/journal.pone.0184870	http://dx.doi.org/10.1371/journal.pone.0184870			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922413	gold, Green Published, Green Submitted			2022-12-27	WOS:000411059300038
J	Liu, WY; Nanetti, A; Cheong, SA				Liu, Wenyuan; Nanetti, Andrea; Cheong, Siew Ann			Knowledge evolution in physics research: An analysis of bibliographic coupling networks	PLOS ONE			English	Article							BOSE-EINSTEIN CONDENSATION	Even as we advance the frontiers of physics knowledge, our understanding of how this knowledge evolves remains at the descriptive levels of Popper and Kuhn. Using the American Physical Society (APS) publications data sets, we ask in this paper how new knowledge is built upon old knowledge. We do so by constructing year-to-year bibliographic coupling networks, and identify in them validated communities that represent different research fields. We then visualize their evolutionary relationships in the form of alluvial diagrams, and show how they remain intact through APS journal splits. Quantitatively, we see that most fields undergo weak Popperian mixing, and it is rare for a field to remain isolated/undergo strong mixing. The sizes of fields obey a simple linear growth with recombination. We can also reliably predict the merging between two fields, but not for the considerably more complex splitting. Finally, we report a case study of two fields that underwent repeated merging and splitting around 1995, and how these Kuhnian events are correlated with breakthroughs on Bose-Einstein condensation (BEC), quantum teleportation, and slow light. This impact showed up quantitatively in the citations of the BEC field as a larger proportion of references from during and shortly after these events.	[Liu, Wenyuan; Cheong, Siew Ann] Nanyang Technol Univ, Sch Phys & Math Sci, 21 Nanyang Link, Singapore 637371, Singapore; [Nanetti, Andrea] Nanyang Technol Univ, Sch Art Design & Media, 81 Nanyang Dr, Singapore 637458, Singapore; [Liu, Wenyuan; Nanetti, Andrea; Cheong, Siew Ann] Nanyang Technol Univ, Complex Inst, 18 Nanyang Dr, Singapore 637723, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cheong, SA (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, 21 Nanyang Link, Singapore 637371, Singapore.; Cheong, SA (corresponding author), Nanyang Technol Univ, Complex Inst, 18 Nanyang Dr, Singapore 637723, Singapore.	cheongsa@ntu.edu.sg	Nanetti, Andrea/F-4655-2016; liu, wen/HGE-3071-2022; Cheong, Siew Ann/B-6991-2011	Nanetti, Andrea/0000-0002-3846-1254; Cheong, Siew Ann/0000-0002-8589-6699				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; [Anonymous], J STAT MECH THEORY E; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Chavalarias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054847; Chen P, 2010, J INFORMETR, V4, P278, DOI 10.1016/j.joi.2010.01.001; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Huang MH, 2003, SCIENTOMETRICS, V58, P489, DOI 10.1023/B:SCIE.0000006876.29052.bf; Jia T, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0078; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Ke Q, 2015, P NATL ACAD SCI USA, V2015, P40; KESSLER MM, 1963, IEEE T INFORM THEORY, V9, P49, DOI 10.1109/TIT.1963.1057800; Kuhn T, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041036; Kuhn TS, 1962, STRUCTURE SCI REVOLU, V31; Popper K., 2013, ALL LIFE IS PROBLEM; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Sienkiewicz J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160140; Wootton D., 2015, INVENTION SCI NEW HI; Yan EJ, 2012, J AM SOC INF SCI TEC, V63, P1313, DOI 10.1002/asi.22680	20	11	12	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184821	10.1371/journal.pone.0184821	http://dx.doi.org/10.1371/journal.pone.0184821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922427	gold, Green Published, Green Submitted			2022-12-27	WOS:000411059300030
J	Zhan, ZZ; Verberne, CJ; van den Heuvel, ER; Grossmann, I; Ranchor, AV; Wiggers, T; de Bock, GH				Zhan, Zhuozhao; Verberne, Charlotte J.; van den Heuvel, Edwin R.; Grossmann, Irene; Ranchor, Adelita V.; Wiggers, Theo; de Bock, Geertruida H.			Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for colorectal cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; TUMOR-MARKERS; CEA	Background The aim of the study was to evaluate psychological effects of the state-of-art intensified follow-up protocol for colorectal cancer patients in the CEAwatch trial. Method At two time points during the CEAwatch trial questionnaires regarding patients' attitude towards follow-up, patients' psychological functioning and patients' experiences and expectations were sent to participants by post. Linear mixed models were fitted to assess the influences and secular trends of the intensified follow-up on patients' attitude towards follow-up and psychological functioning. As secondary outcome, odds ratios were calculated using ordinal logistic mixed model to compare patients' experiences to their expectations, as well as their experiences at two different time points. Results No statistical significant effects of the intensified follow-up were found on patients' attitude towards the follow-up and psychological functioning variables. Patients had high expectations of the intensified follow-up and their experiences at the second time point were more positive compared to the scores at the first time point. Conclusion The intensified follow-up protocol posed no adverse effects on patients' attitude towards follow-up and psychological functioning. In general, patients were more nervous and anxious at the start of the new follow-up protocol, had high expectations of the new follow-up protocol and were troubled by the nuisances of the blood sample testing. As they spent more time in the follow-up and became more adapted to it, the nervousness and anxiety decreased and the preference for the frequent blood test became high in replacement of conversations with the doctors.	[Zhan, Zhuozhao; van den Heuvel, Edwin R.; de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Verberne, Charlotte J.; Grossmann, Irene; Wiggers, Theo] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [van den Heuvel, Edwin R.] Eindhoven Univ Technol, Dept Math & Comp Sci, Eindhoven, Netherlands; [Grossmann, Irene] Aarhus Univ Hosp, Dept Surg Afd P, Aarhus, Denmark; [Ranchor, Adelita V.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands	University of Groningen; University of Groningen; Eindhoven University of Technology; Aarhus University; University of Groningen	de Bock, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	g.h.de.bock@umcg.nl	Ranchor, Adelita/X-5725-2019; de Bock, Geertruida H./F-6529-2014	Ranchor, Adelita/0000-0001-7048-3771; de Bock, Geertruida H./0000-0003-3104-4471	ZonMW [171002209, 171002211]; China Scholarship Council	ZonMW(Netherlands Organization for Health Research and Development); China Scholarship Council(China Scholarship Council)	This work was supported by ZonMW, http://www.zonmw.nl/nl/, project number: 171002209 and 171002211; China Scholarship Council, http://en.csc.edu.cn/, project number: N/A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleiker EM a, 2008, 19 ANN C INT SOC QUA, V21, P1; Custers J a E, 2013, CANC NURS, P1; de Bock GH, 2004, BRIT J CANCER, V90, P1144, DOI 10.1038/sj.bjc.6601655; Duffy MJ, 2014, INT J CANCER, V134, P2513, DOI 10.1002/ijc.28384; Figueredo A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-26; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hemming K, 2015, STAT MED, V34, P181, DOI 10.1002/sim.6325; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Jeffery M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002200.pub2; Kjeldsen BJ, 1999, SCAND J GASTROENTERO, V34, P509, DOI 10.1080/003655299750026254; Li GW, 2017, INT J EPIDEMIOL, V46, P746, DOI 10.1093/ije/dyw320; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Pita-Fernandez S, 2014, ANN ONCOL, P941; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; Renehan AG, 2002, BRIT MED J, V324, P1; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stiggelbout AM, 1997, BRIT J CANCER, V75, P914, DOI 10.1038/bjc.1997.161; Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1783, DOI 10.1007/s10350-007-9030-5; Verberne CJ, 2015, EJSO-EUR J SURG ONC, V41, P1188, DOI 10.1016/j.ejso.2015.06.008; Verberne CJ, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-14; Watson M, 1998, J MED GENET, V35, P731, DOI 10.1136/jmg.35.9.731; Zhan Z, 2014, J CLIN EPIDEMIOL	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184740	10.1371/journal.pone.0184740	http://dx.doi.org/10.1371/journal.pone.0184740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922422	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300027
J	Zuiderbaan, W; Harvey, BM; Dumoulin, SO				Zuiderbaan, Wietske; Harvey, Ben M.; Dumoulin, Serge O.			Image identification from brain activity using the population receptive field model	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; NATURAL IMAGES; CEREBRAL-CORTEX; FMRI; AREAS; RESPONSES; PATTERNS; CONTRAST; STRIATE; MAPS	A goal of computational models is not only to explain experimental data but also to make new predictions. A current focus of computational neuroimaging is to predict features of the presented stimulus from measured brain signals. These computational neuroimaging approaches may be agnostic about the underlying neural processes or may be biologically inspired. Here, we use the biologically inspired population receptive field (pRF) approach to identify presented images from fMRI recordings of the visual cortex, using an explicit model of the underlying neural response selectivity. The advantage of the pRF-model is its simplicity: it is defined by a handful of parameters, which can be estimated from fMRI data that was collected within half an hour. Using 7T MRI, we measured responses elicited by different visual stimuli: (i) conventional pRF mapping stimuli, (ii) semi-random synthetic images and (iii) natural images. The pRF mapping stimuli were used to estimate the pRF-properties of each cortical location in early visual cortex. Next, we used these pRFs to identify which synthetic or natural images was presented to the subject from the fMRI responses. We show that image identification using V1 responses is far above chance, both for the synthetic and natural images. Thus, we can identify visual images, including natural images, using the most fundamental low-parameter pRF model estimated from conventional pRF mapping stimuli. This allows broader application of image identification.	[Zuiderbaan, Wietske; Harvey, Ben M.; Dumoulin, Serge O.] Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands; [Dumoulin, Serge O.] Spinoza Ctr Neuroimaging, Amsterdam, Netherlands	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Spinoza Centre for Neuroimaging (KNAW)	Zuiderbaan, W (corresponding author), Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands.	wietske.zuiderbaan@gmail.com			Netherlands Organization for Scientific Research (NWO) [452-08-008]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research (NWO) Vidi Grant 452-08-008 to SD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2017, J NEUROSCI, V37, P1546, DOI 10.1523/JNEUROSCI.3620-15.2016; Baseler HA, 2011, NAT NEUROSCI, V14, P649, DOI 10.1038/nn.2793; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brewer AA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00074; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; De Valois RL, 1988, SPATIAL VISION, Vviii; DeSimone K, 2015, J NEUROSCI, V35, P9836, DOI 10.1523/JNEUROSCI.3840-14.2015; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dumoulin SO, 2008, NEUROIMAGE, V42, P890, DOI 10.1016/j.neuroimage.2008.04.266; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Freeman J, 2011, J NEUROSCI, V31, P4792, DOI 10.1523/JNEUROSCI.5160-10.2011; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Harvey BM, 2011, J NEUROSCI, V31, P13604, DOI 10.1523/JNEUROSCI.2572-11.2011; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; He DJ, 2015, EXP BRAIN RES, V233, P3535, DOI 10.1007/s00221-015-4425-3; Henriksson L, 2008, J VISION, V8, DOI 10.1167/8.10.5; Hoffmann MB, 2012, NEURON, V75, P393, DOI 10.1016/j.neuron.2012.05.026; Horikawa T, 2013, SCIENCE, V340, P639, DOI 10.1126/science.1234330; HUBEL DH, 1982, NATURE, V299, P515, DOI 10.1038/299515a0; Hummer A, 2016, NEUROIMAGE, V142, P201, DOI 10.1016/j.neuroimage.2016.07.003; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kayser C, 2004, CURR OPIN NEUROBIOL, V14, P468, DOI 10.1016/j.conb.2004.06.002; Kok P, 2016, CURR BIOL, V26, P371, DOI 10.1016/j.cub.2015.12.038; Kok P, 2014, CURR BIOL, V24, P1531, DOI 10.1016/j.cub.2014.05.042; Kriegeskorte N, 2015, ANNU REV VIS SCI, V1, P417, DOI 10.1146/annurev-vision-082114-035447; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Mante V, 2005, J NEUROPHYSIOL, V94, P788, DOI 10.1152/jn.01094.2004; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Olman CA, 2004, VISION RES, V44, P669, DOI 10.1016/j.visres.2003.10.022; Papanikolaou A, 2014, P NATL ACAD SCI USA, V111, pE1656, DOI 10.1073/pnas.1317074111; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petro LS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01223; Schwarzkopf DS, 2014, J NEUROSCI, V34, P2713, DOI 10.1523/JNEUROSCI.4416-13.2014; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Thomas JM, 2015, NEUROIMAGE, V105, P428, DOI 10.1016/j.neuroimage.2014.10.060; Tong F, 2012, ANNU REV PSYCHOL, V63, P483, DOI 10.1146/annurev-psych-120710-100412; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zuiderbaan W, 2012, J VISION, V12, DOI 10.1167/12.3.10	61	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183295	10.1371/journal.pone.0183295	http://dx.doi.org/10.1371/journal.pone.0183295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922355	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300003
J	Igarashi, R; Ochiai, S; Sakaue, Y; Suetake, A; Iikawa, R; Togano, T; Miyamoto, F; Miyamoto, D; Fukuchi, T				Igarashi, Ryoko; Ochiai, Shun; Sakaue, Yuta; Suetake, Aki; Iikawa, Ryu; Togano, Testuya; Miyamoto, Fuuko; Miyamoto, Daiki; Fukuchi, Takeo			Optical coherence tomography angiography of the peripapillary capillaries in primary open-angle and normal-tension glaucoma	PLOS ONE			English	Article							VISUAL-FIELD DEFECTS; VESSEL DENSITY; OCT ANGIOGRAPHY; DISC PERFUSION; SUSPECT; RETINA; EYES	Objectives To evaluate the vascular architecture of the radial peripapillary capillaries (RPCs) and its relation with visual function in patients with open-angle glaucoma (OAG) and normal-tension glaucoma using spectral-domain optical coherence tomography (SD-OCT) angiography. Subjects and methods Clear OCT angiography images of blood vessels in the optic disc and peripapillary retina were obtained from 52 patients (52 eyes) aged 55.42 +/- 10.64 (range 28-72) years with primary OAG. The mean spherical equivalent was -3.19 +/- 2.31 diopters, and the mean deviation (MD) of the central 24/30-2 threshold test using the Humphrey Field Analyzer (HFA) was -10.47 +/- 7.99 dB. The correlations between the disappearance angle of the RPCs on OTC images, flow density (FD) and the circumpapillary retinal nerve fiber layer (cpRNFL) thickness, the angle of retinal nerve fiber layer (RNFL) defect, the MD and pattern standard deviation (PSD) values of the HFA central 24/30-2 threshold test using the Swedish interactive thresholding algorithm, the sensitivity threshold, age, corneal thickness, and refractive value were analyzed. In addition, the correlation between FD and the cpRNFL thickness was analyzed at FD measurement points. Results FD was significantly correlated with cpRNFL thickness, PSD value, MD value, and sensitivity threshold, whereas the disappearance angle of the RPCs was significantly correlated with the angle of the RNFL defect (P < 0.001), MD value (P < 0.01), and sensitivity threshold (P < 0.01). There was a negative correlation between FD and age (P < 0.05). The Pearson correlation coefficient of FD and cpRNFL thickness in the area surrounding the optic disc revealed the most significant correlation in the inferior visual field (r = 0.851, P < 0.001), followed by the superior visual field (r = 0.803, P < 0.001) and then the temporal visual field (r = 0.653, P < 0.001). Conclusion SD-OCT angiography enabled thorough observation of the RPCs. FD and the disappearance angle of the RPCs were significantly and independently correlated with glaucomarelated functional and morphological changes in the optic nerve, suggesting that these two factors are novel functional and morphological indicators of visual defects due to glaucoma.	[Igarashi, Ryoko; Ochiai, Shun; Sakaue, Yuta; Suetake, Aki; Iikawa, Ryu; Togano, Testuya; Miyamoto, Fuuko; Miyamoto, Daiki; Fukuchi, Takeo] Niigata Univ, Grad Sch Med & Dent Sci, Div Ophthalmol & Visual Sci, Niigata, Japan	Niigata University	Igarashi, R (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Ophthalmol & Visual Sci, Niigata, Japan.	iryoko@med.niigata-u.ac.jp		Togano, Tetsuya/0000-0003-2853-1308				Akagi T, 2016, AM J OPHTHALMOL, V168, P237, DOI 10.1016/j.ajo.2016.06.009; Anderson D., 1999, AUTOMATED STATIC PER, V2nd, P121; Araie Makoto, 2012, Nippon Ganka Gakkai Zasshi, V116; Bojikian KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154691; Chen CL, 2016, QUANT IMAG MED SURG, V6, P125, DOI 10.21037/qims.2016.03.05; Fukuchi T, 2010, CLIN OPHTHALMOL, V4, P1315, DOI 10.2147/OPTH.S13101; Hollo G, 2016, EUR J OPHTHALMOL, V26, pE42, DOI 10.5301/ejo.5000717; Iwata K., 1990, THERAPEUTIC RES, V11, P3369; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Lee EJ, 2016, INVEST OPHTH VIS SCI, V57, P6265, DOI 10.1167/iovs.16-20287; Leveque PM, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6956717; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Mammo Z, 2016, AM J OPHTHALMOL, V170, P41, DOI 10.1016/j.ajo.2016.07.015; Mo S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169385; Ojima T, 2007, JPN J OPHTHALMOL, V51, P197, DOI 10.1007/s10384-006-0433-y; Scripsema Nicole K, 2016, Invest Ophthalmol Vis Sci, V57, pOCT611, DOI 10.1167/iovs.15-18945; Spaeth GL, 1977, PATHOGENESIS NERVE D, P79; Srinivasan VJ, 2012, BIOMED OPT EXPRESS, V3, P612, DOI 10.1364/BOE.3.000612; Sugiyama T, 2012, ATARASHII GANKA, V29, P984; Tamura Akiko, 2013, Nippon Ganka Gakkai Zasshi, V117, P110; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Yamashita T, 2009, ATARASHII GANKA, V26, P997; Yamazaki S, 1996, BRIT J OPHTHALMOL, V80, P812, DOI 10.1136/bjo.80.9.812; Yarmohammadi A, 2017, OPHTHALMOLOGY, V124, P709, DOI 10.1016/j.ophtha.2017.01.004; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944	26	26	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184301	10.1371/journal.pone.0184301	http://dx.doi.org/10.1371/journal.pone.0184301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915256	Green Published, Green Submitted, gold			2022-12-27	WOS:000410861600009
J	Fecchio, M; Pigorini, A; Comanducci, A; Sarasso, S; Casarotto, S; Premoli, I; Derchi, CC; Mazza, A; Russo, S; Resta, F; Ferrarelli, F; Mariotti, M; Ziemann, U; Massimini, M; Rosanova, M				Fecchio, Matteo; Pigorini, Andrea; Comanducci, Angela; Sarasso, Simone; Casarotto, Silvia; Premoli, Isabella; Derchi, Chiara-Camilla; Mazza, Alice; Russo, Simone; Resta, Federico; Ferrarelli, Fabio; Mariotti, Maurizio; Ziemann, Ulf; Massimini, Marcello; Rosanova, Mario			The spectral features of EEG responses to transcranial magnetic stimulation of the primary motor cortex depend on the amplitude of the motor evoked potentials	PLOS ONE			English	Article							CORTICAL EFFECTIVE CONNECTIVITY; TMS-EEG; ELECTRICAL-STIMULATION; NATURAL FREQUENCIES; NEURONAL-ACTIVITY; SENSORY FEEDBACK; BRAIN RESPONSES; EXCITABILITY; HUMANS; AREAS	Transcranial magnetic stimulation (TMS) of the primary motor cortex (M1) can excite both cortico-cortical and cortico-spinal axons resulting in TMS-evoked potentials (TEPs) and motor-evoked potentials (MEPs), respectively. Despite this remarkable difference with other cortical areas, the influence of motor output and its amplitude on TEPs is largely unknown. Here we studied TEPs resulting from M1 stimulation and assessed whether their waveform and spectral features depend on the MEP amplitude. To this aim, we performed two separate experiments. In experiment 1, single-pulse TMS was applied at the same supra-threshold intensity on primary motor, prefrontal, premotor and parietal cortices and the corresponding TEPs were compared by means of local mean field power and time-frequency spectral analysis. In experiment 2 we stimulated M1 at resting motor threshold in order to elicit MEPs characterized by a wide range of amplitudes. TEPs computed from high-MEP and low-MEP trials were then compared using the same methods applied in experiment 1. In line with previous studies, TMS of M1 produced larger TEPs compared to other cortical stimulations. Notably, we found that only TEPs produced by M1 stimulation were accompanied by a late event-related desynchronization (ERD-peaking at similar to 300 ms after TMS), whose magnitude was strongly dependent on the amplitude of MEPs. Overall, these results suggest that M1 produces peculiar responses to TMS possibly reflecting specific anatomo-functional properties, such as the re-entry of proprioceptive feedback associated with target muscle activation.	[Fecchio, Matteo; Pigorini, Andrea; Comanducci, Angela; Sarasso, Simone; Casarotto, Silvia; Derchi, Chiara-Camilla; Mazza, Alice; Russo, Simone; Mariotti, Maurizio; Massimini, Marcello; Rosanova, Mario] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Premoli, Isabella] Kings Coll London, Dept Basic & Clin Neurosci, IoPPN, London, England; [Premoli, Isabella; Ziemann, Ulf] Univ Tubingen, Dept Neurol & Stroke, Tubingen, Germany; [Premoli, Isabella; Ziemann, Ulf] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Resta, Federico] Hosp Luigi Sacco, Div Radiol, Milan, Italy; [Ferrarelli, Fabio] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; [Massimini, Marcello] IRCCS Fdn Don Gnocchi Onlus, Milan, Italy; [Rosanova, Mario] Fdn Europea Ric Biomed Onlus, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of London; King's College London; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Milan; Luigi Sacco Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rosanova, M (corresponding author), Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy.; Rosanova, M (corresponding author), Fdn Europea Ric Biomed Onlus, Milan, Italy.	mario.rosanova@unimi.it	Ferrarelli, Fabio/D-3219-2019; Comanducci, Angela/AAB-9917-2019; Mazza, Alice/AAJ-8244-2021; Russo, Simone/Z-6077-2019; Derchi, Chiara Camilla/AAJ-1183-2021; Casarotto, Silvia/Q-9402-2019; Ziemann, Ulf/AAY-9125-2020; Sarasso, Simone/C-7817-2012; Rosanova, Mario/S-8440-2017; Pigorini, Andrea/ABC-8351-2021; Fecchio, Matteo/X-8209-2019; Massimini, Marcello/T-8115-2017	Ferrarelli, Fabio/0000-0003-0560-0227; Russo, Simone/0000-0002-7762-1900; Casarotto, Silvia/0000-0002-7548-7664; Sarasso, Simone/0000-0001-9984-4710; Rosanova, Mario/0000-0001-7486-7617; Pigorini, Andrea/0000-0002-1856-3413; Fecchio, Matteo/0000-0002-0347-8531; DERCHI, CHIARA CAMILLA/0000-0003-4573-2240; Mazza, Alice/0000-0002-5219-9846; Massimini, Marcello/0000-0003-2271-957X; Comanducci, Angela/0000-0001-6084-019X; Premoli, Isabella/0000-0002-2508-6440	LUMINOUS; European Union's Horizon Research and Innovation Programme [686764, 720270]; Swiss National Science Foundation [CRSII3_160803/1]; James S. McDonnell Foundation; Italian Ministry of Health [GR-2011-02352031]	LUMINOUS; European Union's Horizon Research and Innovation Programme; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); James S. McDonnell Foundation; Italian Ministry of Health(Ministry of Health, Italy)	This work has been partially funded by the LUMINOUS Project. This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme H2020-FETOPEN-2014-2015-RIA under agreement No. 686764. This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 720270 (HBP SGA1). This study has been partially funded by the grant "Sinergia" CRSII3_160803/1 by the Swiss National Science Foundation, the James S. McDonnell Foundation Scholar Award 2013, and the Grant "Giovani Ricercatori" GR-2011-02352031 from the Italian Ministry of Health (to MR).	Bohning DE, 1999, BIOL PSYCHIAT, V45, P385, DOI 10.1016/S0006-3223(98)00368-0; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; Bonmassar G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1914; Boroojerdi B, 2002, CLIN NEUROPHYSIOL, V113, P1501, DOI 10.1016/S1388-2457(02)00198-0; Canali P, 2015, J AFFECT DISORDERS, V184, P111, DOI 10.1016/j.jad.2015.05.043; Casali AG, 2010, NEUROIMAGE, V49, P1459, DOI 10.1016/j.neuroimage.2009.09.026; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Casarotto S, 2013, BRAIN TOPOGR, V26, P326, DOI 10.1007/s10548-012-0256-8; Casarotto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010281; Casula EP, 2016, SCI REP-UK, V6, DOI 10.1038/srep36191; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; CRACCO RQ, 1989, ELECTROEN CLIN NEURO, V74, P417, DOI 10.1016/0168-5597(89)90030-0; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; Ellaway PH, 2004, J PHYSIOL-LONDON, V556, P651, DOI 10.1113/jphysiol.2003.060483; Farzan F, 2013, NEUROIMAGE, V83, P120, DOI 10.1016/j.neuroimage.2013.06.059; Ferrarelli F, 2012, ARCH GEN PSYCHIAT, V69, P766, DOI 10.1001/archgenpsychiatry.2012.147; Ferreri F, 2017, NEUROSCI LETT, V647, P141, DOI 10.1016/j.neulet.2017.03.021; Ferreri F, 2013, REV NEUROSCIENCE, V24, P431, DOI 10.1515/revneuro-2013-0019; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Giambattistelli F, 2014, HUM BRAIN MAPP, V35, P1740, DOI 10.1002/hbm.22288; Gosseries O, 2015, BRAIN STIMUL, V8, P142, DOI 10.1016/j.brs.2014.10.008; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Harquel S, 2016, NEUROIMAGE, V135, P115, DOI 10.1016/j.neuroimage.2016.05.009; Herring JD, 2015, J NEUROSCI, V35, P14435, DOI 10.1523/JNEUROSCI.1833-15.2015; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Julkunen P, 2012, BRAIN STIMUL, V5, P526, DOI 10.1016/j.brs.2011.07.006; Kahkonen S, 2005, PSYCHOPHARMACOLOGY, V181, P16, DOI 10.1007/s00213-005-2197-3; Kahkonen S, 2004, CLIN NEUROPHYSIOL, V115, P583, DOI 10.1016/j.clinph.2003.10.032; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2002, CLIN NEUROPHYSIOL, V113, P175, DOI 10.1016/S1388-2457(01)00721-0; KUHLMAN WN, 1978, ELECTROEN CLIN NEURO, V44, P83, DOI 10.1016/0013-4694(78)90107-4; Libet B, 1982, Hum Neurobiol, V1, P235; Maier MA, 2002, CEREB CORTEX, V12, P281, DOI 10.1093/cercor/12.3.281; Maki H, 2010, NEUROSCI LETT, V478, P24, DOI 10.1016/j.neulet.2010.04.059; Maki H, 2010, CLIN NEUROPHYSIOL, V121, P492, DOI 10.1016/j.clinph.2009.11.078; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Mattavelli G, 2013, NEUROIMAGE, V76, P24, DOI 10.1016/j.neuroimage.2013.03.020; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Muller GR, 2003, NEUROSCI LETT, V340, P143, DOI 10.1016/S0304-3940(03)00019-3; Paus T, 2001, J NEUROPHYSIOL, V86, P1983, DOI 10.1152/jn.2001.86.4.1983; Pellicciari MC, 2016, CLIN NEUROPHYSIOL, V127, P621, DOI 10.1016/j.clinph.2015.03.002; Petrichella S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174879; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Pfurtscheller G, 1999, NEUROSCI LETT, V269, P153, DOI 10.1016/S0304-3940(99)00452-8; Premoli I, 2014, J NEUROSCI, V34, P5603, DOI 10.1523/JNEUROSCI.5089-13.2014; Preston D, 2012, ELECTROMYOGRAPHY NEU, P1320; Romei V, 2007, J NEUROSCI, V27, P11465, DOI 10.1523/JNEUROSCI.2827-07.2007; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Rossi S, 1998, NEUROIMAGE, V8, P163, DOI 10.1006/nimg.1998.0352; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Sejnowski TJ, 2014, NAT NEUROSCI, V17, P1440, DOI 10.1038/nn.3839; Shitara H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00554; Siebner HR, 2009, CORTEX, V45, P1035, DOI 10.1016/j.cortex.2009.02.007; Stancak A, 2006, PROG BRAIN RES, V159, P237, DOI 10.1016/S0079-6123(06)59016-8; Taylor PCJ, 2010, HUM BRAIN MAPP, V31, P1408, DOI 10.1002/hbm.20941; ter Braack EM, 2015, BRAIN TOPOGR, V28, P520, DOI 10.1007/s10548-013-0312-z; Van der Werf YD, 2006, EXP BRAIN RES, V175, P231, DOI 10.1007/s00221-006-0551-2; Virtanen J, 1999, MED BIOL ENG COMPUT, V37, P322, DOI 10.1007/BF02513307; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	65	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184910	10.1371/journal.pone.0184910	http://dx.doi.org/10.1371/journal.pone.0184910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910407	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200117
J	Peri, E; Ambrosini, E; Colombo, VM; van de Ruit, M; Grey, MJ; Monticone, M; Ferriero, G; Pedrocchi, A; Ferrigno, G; Ferrante, S				Peri, Elisabetta; Ambrosini, Emilia; Colombo, Vera Maria; van de Ruit, Mark; Grey, Michael J.; Monticone, Marco; Ferriero, Giorgio; Pedrocchi, Alessandra; Ferrigno, Giancarlo; Ferrante, Simona			Intra and inter-session reliability of rapid Transcranial Magnetic Stimulation stimulus-response curves of tibialis anterior muscle in healthy older adults	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; NONINVASIVE BRAIN-STIMULATION; INPUT-OUTPUT PROPERTIES; ELECTRICAL-STIMULATION; CORTICOSPINAL PATHWAY; CORTICAL EXCITABILITY; CHRONIC STROKE; PLASTICITY; TMS; NEUROPLASTICITY	Objective The clinical use of Transcranial Magnetic Stimulation (TMS) as a technique to assess corticospinal excitability is limited by the time for data acquisition and the measurement variability. This study aimed at evaluating the reliability of Stimulus-Response (SR) curves acquired with a recently proposed rapid protocol on tibialis anterior muscle of healthy older adults. Methods Twenty-four neurologically-intact adults (age: 55-75 years) were recruited for this test-retest study. During each session, six SR curves, 3 at rest and 3 during isometric muscle contractions at 5% of maximum voluntary contraction (MVC), were acquired. Motor Evoked Potentials (MEPs) were normalized to the maximum peripherally evoked response; the coil position and orientation were monitored with an optical tracking system. Intra-and inter-session reliability of motor threshold (MT), area under the curve (AURC), MEPmax, stimulation intensity at which the MEP is mid-way between MEPmax and MEPmin (I50), slope in I50, MEP latency, and silent period (SP) were assessed in terms of Standard Error of Measurement (SEM), relative SEM, Minimum Detectable Change (MDC), and Intraclass Correlation Coefficient (ICC). Results The relative SEM was <= 10% for MT, I50, latency and SP both at rest and 5% MVC, while it ranged between 11% and 37% for AURC, MEPmax, and slope. MDC values were overall quite large; e.g., MT required a change of 12% MSO at rest and 10% MSO at 5% MVC to be considered a real change. Inter-sessions ICC were >0.6 for all measures but slope at rest and MEPmax and latency at 5% MVC. Conclusions Measures derived from SR curves acquired in <4 minutes are affected by similar measurement errors to those found with long-lasting protocols, suggesting that the rapid method is at least as reliable as the traditional methods. As specifically designed to include older adults, this study provides normative data for future studies involving older neurological patients (e.g. stroke survivors).	[Peri, Elisabetta; Ambrosini, Emilia; Colombo, Vera Maria; Pedrocchi, Alessandra; Ferrigno, Giancarlo; Ferrante, Simona] Politecn Milan, Dept Elect Informat & Bioengn, NearLab, Milan, Italy; [Ambrosini, Emilia; Monticone, Marco; Ferriero, Giorgio] Ist Clin Sci Maugeri, Sci Inst Lissone IRCCS, Dept Phys & Rehabilitat Med, Lissone, MB, Italy; [van de Ruit, Mark] Delft Univ Technol, Dept Biomech Engn, Fac Mech Maritime & Mat Engn, Delft, Netherlands; [Grey, Michael J.] Univ East Anglia, Sch Hlth Sci, Acquired Brain Injury Rehabil Alliance, Norwich, Norfolk, England; [Monticone, Marco] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy	Polytechnic University of Milan; Istituti Clinici Scientifici Maugeri IRCCS; Delft University of Technology; University of East Anglia; University of Cagliari	Peri, E (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, NearLab, Milan, Italy.	elisabetta.peri@polimi.it	Monticone, Marco/AAC-4494-2022; van de Ruit, Mark/X-4872-2019; Ferriero, Giorgio/K-4217-2018; Pedrocchi, Alessandra/AAF-2655-2019; Colombo, Vera/R-3715-2019; , Giorgio/AAA-3522-2021; Ambrosini, Emilia/R-1371-2016	van de Ruit, Mark/0000-0003-3806-2031; Ferriero, Giorgio/0000-0002-7873-6777; Pedrocchi, Alessandra/0000-0001-9957-2786; Colombo, Vera/0000-0001-6648-1917; , Giorgio/0000-0002-7873-6777; Ambrosini, Emilia/0000-0002-6527-0779	Italian Ministry of Healthy [GR-2010-2312228]	Italian Ministry of Healthy(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Healthy (grant no.: GR-2010-2312228, project title "Fall prevention and locomotion recovery in post-stroke patients: a multimodal training towards a more autonomous daily life" (http://www.salute.gov.it/imos/C_17_pagineAree_4517_listaFile_itemName_7_file.pdt). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1939, J PHYSIOL-LONDON, V97, P153, DOI 10.1113/jphysiol.1939.sp003798; Ambrosini E, 2015, 7 IEEE EMBS C NEUR E; [Anonymous], 2015, NEUROSCI, V9, P335; Beaulieu LD, 2017, BRAIN STIMUL, V10, P196, DOI 10.1016/j.brs.2016.12.008; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; Cacchio A, 2011, J NEUROL SCI, V303, P90, DOI 10.1016/j.jns.2011.01.004; Cacchio A, 2009, CLIN NEUROPHYSIOL, V120, P414, DOI 10.1016/j.clinph.2008.11.019; Carroll TJ, 2001, J NEUROSCI METH, V112, P193, DOI 10.1016/S0165-0270(01)00468-X; Carson RG, 2013, BRAIN STIMUL, V6, P760, DOI 10.1016/j.brs.2013.01.016; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cortes M, 2012, NEUROMODULATION, V15, P316, DOI 10.1111/j.1525-1403.2012.00459.x; DAY BL, 1987, BRAIN, V110, P1191, DOI 10.1093/brain/110.5.1191; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Di Lazzaro V, 2012, BRAIN STIMUL, V5, P512, DOI 10.1016/j.brs.2011.07.008; Everaert DG, 2010, NEUROREHAB NEURAL RE, V24, P168, DOI 10.1177/1545968309349939; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; Kamke MR, 2012, J NEUROSCI, V32, P7001, DOI 10.1523/JNEUROSCI.1028-12.2012; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Liu H, 2014, J NEUROL SCI, V341, P105, DOI 10.1016/j.jns.2014.04.012; Mathias JP, 2014, BRAIN STIMUL, V7, P59, DOI 10.1016/j.brs.2013.08.003; Meaney A, 2015, J CLIN NEUROSCI, V22, P1434, DOI 10.1016/j.jocn.2015.02.034; Peri E, 2016, IFMBE PROC, V57, P1069, DOI 10.1007/978-3-319-32703-7_211; Pitcher JB, 2003, J PHYSIOL-LONDON, V546, P605, DOI 10.1113/jphysiol.2002.029454; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rossini PM, 2013, CURR PHARM DESIGN, V19, P6426, DOI 10.2174/1381612811319360004; Rothwell J., 2005, MAGNETIC STIMULATION, V2nd ed., P43, DOI [10.1016/B978-0-7506-7373-0.50007-9, DOI 10.1016/B978-0-7506-7373-0.50007-9]; Sale MV, 2008, J NEUROSCI, V28, P8285, DOI 10.1523/JNEUROSCI.1963-08.2008; Schmidt S, 2015, HUM BRAIN MAPP, V36, P40, DOI 10.1002/hbm.22611; Smith AE, 2011, J APPL PHYSIOL, V110, P206, DOI 10.1152/japplphysiol.00403.2010; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Takechi U, 2014, CLIN NEUROPHYSIOL, V125, P2055, DOI 10.1016/j.clinph.2014.01.034; Tallent J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035930; Troni W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155268; van de Ruit M, 26 ANN M SOC NEUR CO; van Hedel HJA, 2007, J NEUROL, V254, P1089, DOI 10.1007/s00415-006-0493-4; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; Xu Y, 2015, NEURAL REGEN RES, V10, P2072, DOI 10.4103/1673-5374.172329	49	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184828	10.1371/journal.pone.0184828	http://dx.doi.org/10.1371/journal.pone.0184828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910370	Green Published, gold, Green Accepted			2022-12-27	WOS:000410859200100
J	Rollo, F; Latini, A; Pichi, B; Colafigli, M; Benevolo, M; Sinopoli, I; Sperduti, I; Laquintana, V; Fabbri, G; Frasca, M; Cristaudo, A; Giuliani, M; Dona, MG				Rollo, Francesca; Latini, Alessandra; Pichi, Barbara; Colafigli, Manuela; Benevolo, Maria; Sinopoli, Ilenia; Sperduti, Isabella; Laquintana, Valentina; Fabbri, Giulia; Frasca, Mirko; Cristaudo, Antonio; Giuliani, Massimo; Dona, Maria Gabriella			Prevalence and determinants of oral infection by Human Papillomavirus in HIV-infected and uninfected men who have sex with men	PLOS ONE			English	Article							HPV INFECTION; RISK-FACTORS; OROPHARYNGEAL CANCER; UNITED-STATES; POPULATION; NECK; HEAD; WOMEN; COHORT; HEALTH	Background Oral Human Papillomavirus (HPV) infection is rare in the general population but common in high-risk individuals. Recent data indicate that oral HPV is associated with the development of head and neck carcinomas. HPV16 infection, in particular, increases the risk of oropharyngeal cancer. Methods We evaluated oral HPV prevalence and determinants of infection in cancer-free HIVinfected and uninfected men who have sex with men (MSM) recruited among attendees of an STI/HIV centre. Oral rinse and gargles were collected using a mouthwash and analyzed with the Linear Array HPV Genotyping Test. Socio-demographic and behavioral data were collected through face-to-face interviews. Results Overall, 170 MSM participated: 98 HIV-uninfected and 72 HIV-infected (91.7% under cART). Oral HPV was detected in 17.3% and 27.8% of the subjects, respectively (p = 0.13). Non-carcinogenic HPVs were significantly more common among HIV-infected MSM (18.1% vs. 5.1%, p = 0.01). Prevalence of the HPV types included in the quadrivalent HPV vaccine was similar (6.1% vs. 8.3% for the HIV-negative and positive MSM, respectively, p = 0.76). HPV16 was the most frequent type in HIV-negative (5.1%), and HIV-positive individuals, in the latter group together with HPV18, 72 and 84 (4.2% each). Older age at first sex (AOR: 4.02, 95% CI: 1.17-13.86 for those older than 18 years of age at first intercourse, p = 0.027) and a higher lifetime number of receptive oral sex partners (AOR: 9.14, 95% CI: 2.49-33.62 for those with >50 compared to <= 50 partners, p<0.001) were determinants of oral HPV among HIV-infected MSM. Conclusion Oral HPV infection among MSM attending an urban STI center is very frequent compared to the general population. Sexual behavior appears to be the major determinant of infection among the HIV-infected individuals.	[Rollo, Francesca; Benevolo, Maria; Laquintana, Valentina; Fabbri, Giulia] IRCCS, IFO, Regina Elena Natl Canc Inst, Pathol Dept, Rome, Italy; [Latini, Alessandra; Colafigli, Manuela; Frasca, Mirko; Cristaudo, Antonio; Giuliani, Massimo; Dona, Maria Gabriella] IRCCS, IFO, San Gallicano Dermatol Inst, STI HIV Unit, Rome, Italy; [Pichi, Barbara; Sinopoli, Ilenia] IRCCS, IFO, Regina Elena Natl Canc Inst, Otolaryngol Head Neck Surg Dept, Rome, Italy; [Sperduti, Isabella] IRCCS, IFO, Regina Elena Natl Canc Inst, Biostat Unit, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Istituti Fisioterapici Ospitalieri (IFO)	Dona, MG (corresponding author), IRCCS, IFO, San Gallicano Dermatol Inst, STI HIV Unit, Rome, Italy.	mariagabriella.dona@ifo.gov.it	Benevolo, Maria/J-8491-2018; Dona', Maria Gabriella/J-7336-2018; Colafigli, Manuela/K-5167-2018; latini, alessandra/J-8186-2018; Giuliani, Massimo/J-2788-2018; Rollo, Francesca/I-5249-2018; Laquintana, Valentina/U-7577-2017; Rollo, Francesca/AAC-2775-2021; Sperduti, Isabella/K-8902-2016	Benevolo, Maria/0000-0003-1994-0935; Dona', Maria Gabriella/0000-0003-3250-1726; Colafigli, Manuela/0000-0003-1610-6347; Giuliani, Massimo/0000-0002-4523-8261; Rollo, Francesca/0000-0003-2724-872X; Laquintana, Valentina/0000-0002-7374-5279; Rollo, Francesca/0000-0003-2724-872X; Sperduti, Isabella/0000-0001-5115-3099; pichi, barbara/0000-0003-0955-4563; Latini, Alessandra/0000-0002-9421-6560	Italian Ministry of Health [GR-2011-02349732]	Italian Ministry of Health(Ministry of Health, Italy)	The work was funded by the Italian Ministry of Health (GR-2011-02349732 to MGD).	Agalliu I, 2016, JAMA ONCOL; Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Carlander ALF, 2017, EUR J CANCER, V70, P75, DOI 10.1016/j.ejca.2016.10.015; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Colon-Lopez V, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-7; D'Souza G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086023; Darwich L, 2014, CLIN MICROBIOL INFEC, V20, pO585, DOI 10.1111/1469-0691.12523; Del Mistro A, 2012, SEX TRANSM DIS, V39, P894, DOI 10.1097/OLQ.0b013e31826ef2da; Divaris K, 2010, CANCER CAUSE CONTROL, V21, P567, DOI 10.1007/s10552-009-9486-9; Dona MG, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.08.011; Eliot MN, 2013, CANCER CAUSE CONTROL, V24, P1315, DOI 10.1007/s10552-013-0209-x; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Gaester K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06592; Garcia-Cuyas F, 2013, SEX TRANSM DIS, V40, P3; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Hang D, 2014, CANCER EPIDEM BIOMAR, V23, P2101, DOI 10.1158/1055-9965.EPI-14-0084; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; IARC, 2011, IARC MON EV CARC RIS, V100; King EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157976; King EM, 2015, SEX TRANSM INFECT, V91, P284, DOI 10.1136/sextrans-2014-051955; Lupato V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170091; Mazul AL, 2017, CANCER-AM CANCER SOC, V123, P71, DOI 10.1002/cncr.30312; Mooij SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098955; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Ong JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102138; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Read TRH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049324; Sammarco ML, 2016, J MED VIROL, V88, P911, DOI 10.1002/jmv.24406; Shiboski CH, 2016, AIDS, V30, P1573, DOI 10.1097/QAD.0000000000001072; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Bui TC, 2013, CANCER PREV RES, V6, P917, DOI 10.1158/1940-6207.CAPR-13-0081; Tinhofer I, 2015, EUR J CANCER, V51, P514, DOI 10.1016/j.ejca.2014.12.018; van Aar F, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0668-z; van Rijn VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092208	41	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184623	10.1371/journal.pone.0184623	http://dx.doi.org/10.1371/journal.pone.0184623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910359	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200070
J	Wangchuk, S; Matsumoto, T; Iha, H; Ahmed, K				Wangchuk, Sonam; Matsumoto, Takashi; Iha, Hidekatsu; Ahmed, Kamruddin			Surveillance of norovirus among children with diarrhea in four major hospitals in Bhutan: Replacement of GII. 21 by GII. 3 as a dominant genotype	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GASTROENTERITIS; PREVALENCE; INFECTION; COUNTRIES; THAILAND; IMMUNITY	Background Diarrhea is a major cause of morbidity and mortality among Bhutanese children. The etiology of diarrhea is not well known due to the challenges of conducting routine surveillance with Bhutan's modest research facilities. Establishing an etiology is crucial toward generating evidence that will contribute to policy discussions on a diarrheal disease control program. Our previous study, during 2010-2012, revealed that norovirus (NoV) is an important cause of diarrhea among Bhutanese children, and that GII. 21 was the major genotype circulating at that time. In other countries, GII. 4 is the major genotype responsible for NoV infections. In this update report, we provide new prevalence data to describe the progression of the transformation and distribution of the NoV genotype among Bhutanese children. Methods From June 2013 through May 2014, diarrheal stool samples were collected at one national referral hospital in Thimphu, two regional referral hospitals in the eastern and central regions, and one general hospital in the western region of Bhutan. NoV was detected by reverse transcription-polymerase chain reaction (RT-PCR), by amplifying the capsid gene. The RT-PCR results were confirmed by nucleotide sequencing of the amplicons. Results The proportion of NoV-positive stool samples was 23.6% (147/623), of which 76.9% were NoV GII and the remainders were NoV GI. The median age of infected children was 15.5 months, with a fairly balanced female: male ratio. NoV GII was most prevalent in the colder months (late November-mid April) and NoV GI had the highest prevalence in the summer (mid April-late September). Nucleotide sequencing was successful in 99 samples of GII strains. The most common genotypes were GII. 3 (42.6%), GII. 4 Sydney 2012 (15.8%), and GII. 4 unassigned (11.9%). No GII. 21 was found in any child in the present study. Phylogenetic analysis showed that GII. 3 strains in the present study belonged to an independent cluster in lineage B. These strains shared an ancestor with those from different countries and Bhutanese strains circulating during 2010. Conclusion NoV remains an important cause of diarrhea among Bhutanese children. Genotype GII. 3 from a single ancestor strain has spread, replacing the previously circulating GII. 21. Current NoV genotypes are similar to the strains circulating worldwide but are primarily related to those in neighboring countries. NoV GII is prevalent during the cold season, while GI is prevalent during the summer. To develop a NoV infection control policy, further studies are needed.	[Wangchuk, Sonam; Matsumoto, Takashi; Iha, Hidekatsu] Oita Univ, Dept Microbiol, Fac Med, Yufu, Japan; [Wangchuk, Sonam] Royal Govt Bhutan, Royal Ctr Dis Control, Minist Hlth, Thimphu, Bhutan; [Ahmed, Kamruddin] Univ Malaysia Sabah, Dept Pathobiol & Med Diagnost, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia	Oita University; Universiti Malaysia Sabah	Ahmed, K (corresponding author), Univ Malaysia Sabah, Dept Pathobiol & Med Diagnost, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia.	ahmed@ums.edu.my	Ahmed, Kamruddin/I-6423-2016	Ahmed, Kamruddin/0000-0002-1869-3701; Iha, Hidekatsu/0000-0002-0999-5636	Japan Society for the Promotion of Sciences [R11524]	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A grant (R11524) was obtained from Japan Society for the Promotion of Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sonam Wangchuk (ID R11524) was supported by RONPAKU program (April 2015 to March 2018) from the Japan Society for the Promotion of Sciences. We thank Dr. Mimi Lhamu Mynak, Head of the Department of Pediatric, Jigme Wangchuk National Referral Hospital, Dr. Purushotam Bhandari, Pediatrician, Gelephu Regional Referral Hospital, Dr. Tulsiram Ram Sharma, Pediatrician from Mongar Regional Referral Hospital for case enrollment. We also thank Tshering Dorji, Tsheten, Kinley Gyem, Dorji Tshering, Pema Gyeltshen from Enteric Disease Laboratory, Royal Centre for Disease Control, Ministry of Health for sample collection, storage and shipment.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Ayouni S, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.015; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bucardo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098201; Cannon JL, 2009, J VIROL, V83, P5363, DOI 10.1128/JVI.02518-08; Chan MCW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10061; de Graaf M, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.26.21178; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Franck KT, 2015, J INFECT DIS, V212, P881, DOI 10.1093/infdis/jiv105; Thanh HD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154284; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Karst SM, 2015, J VIROL, V89, P5756, DOI 10.1128/JVI.03063-14; Kim JS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/468304; Kittigul L, 2010, J MED VIROL, V82, P854, DOI 10.1002/jmv.21746; Kumazaki M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142568; Lee CC, 2015, CLIN INFECT DIS, V61, P1762, DOI 10.1093/cid/civ647; Lu J, 2015, EMERG INFECT DIS, V21, P1240, DOI 10.3201/eid2107.150226; Mans J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146280; Matsushima Y, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.26.21173; Nordgren J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005385; Parra GI, 2015, EMERG INFECT DIS, V21, P1477, DOI 10.3201/eid2108.150652; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phumpholsup T, 2015, ARCH VIROL, V160, P2603, DOI 10.1007/s00705-015-2545-5; Pires SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142927; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Rahman M, 2016, J MED VIROL, V88, P1742, DOI 10.1002/jmv.24530; Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754; Rouhani S, 2016, CLIN INFECT DIS, V62, P1210, DOI 10.1093/cid/ciw072; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Wangchuk Sonam, 2015, Trop Med Health, V43, P63, DOI 10.2149/tmh.2014-22; Wangchuk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110795; Yahiro T, 2015, EMERG INFECT DIS, V21, P732, DOI 10.3201/eid2104.141856; Zeng M, 2012, J MED VIROL, V84, P145, DOI 10.1002/jmv.22248; Zhirakovskaia EV, 2015, J MED VIROL, V87, P740, DOI 10.1002/jmv.24068	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184826	10.1371/journal.pone.0184826	http://dx.doi.org/10.1371/journal.pone.0184826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910371	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200099
J	Affram, K; Udofot, O; Singh, M; Krishnan, S; Reams, R; Rosenberg, J; Agyare, E				Affram, Kevin; Udofot, Ofonime; Singh, Mandip; Krishnan, Sunil; Reams, Renee; Rosenberg, Jens; Agyare, Edward			Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging	PLOS ONE			English	Article							TEMPERATURE-SENSITIVE LIPOSOME; PANCREATIC-CANCER; CONTRAST AGENTS; DRUG-DELIVERY; GEMCITABINE; EFFICACY; PHARMACOKINETICS; HYPERTHERMIA; RELEASE; MODEL	In numerous studies, liposomes have been used to deliver anticancer drugs such as doxorubicin to local heat-triggered tumor. Here, we investigate: (i) the ability of thermosensitive liposomal nanoparticle (TSLnp) as a delivery system to deliver poorly membrane-permeable anticancer drug, gemcitabine (Gem) to solid pancreatic tumor with the aid of local mild hyperthermia and, (ii) the possibility of using gadolinium (Magnevist (R)) loaded-TSLnps (Gd-TSLnps) to increase magnetic resonance imaging (MRI) contrast in solid tumor. In this study, we developed and tested gemcitabine-loaded thermosensitive liposomal nanoparticles (Gem-TSLnps) and gadolinium-loaded thermosensitive liposomal nanoparticles (Gd-TSLnps) both in in-vitro and in-vivo. The TSLnps exhibited temperature-dependent release of Gem, at 40-42 degrees C, 65% of Gem was released within 10 min, whereas <23% Gem leakage occurred at 37 degrees C after a period of 2 h. The pharmacokinetic parameters and tissue distribution of both Gem-TSLnps and Gd-TSLnps were significantly greater compared with free Gem and Gd, while Gem-TSLnps plasma clearance was reduced by 17-fold and that of Gd-TSLpns was decreased by 2-fold. Area under the plasma concentration time curve (AUC) of Gem-TSLnps (35.17 +/- 0.04 mu ghr/mL) was significantly higher than that of free Gem (2.09 +/- 0.01 mu ghr/mL) whereas, AUC of Gd-TSLnps was higher than free Gd by 3.9 fold high. TSLnps showed significant Gem accumulation in heated tumor relative to free Gem. Similar trend of increased Gd-TSLnps accumulation was observed in non-heated tumor compared to that of free Gd; however, no significant difference in MRI contrast enhancement between free Gd and Gd-TSLnps ex-vivo tumor images was observed. Despite Gem-TSLnps dose being half of free Gem dose, antitumor efficacy of Gem-TSLnps was comparable to that of free Gem(Gem-TSLnps 10 mg Gem/kg compared with free Gem 20 mg/kg). Overall, the findings suggest that TSLnps may be used to improve Gem delivery and enhance its antitumor activity. However, the formulation of Gd-TSLnp needs to be fully optimized to significantly enhance MRI contrast in tumor.	[Affram, Kevin; Udofot, Ofonime; Singh, Mandip; Reams, Renee; Agyare, Edward] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Krishnan, Sunil] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Rosenberg, Jens] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Udofot, Ofonime] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	State University System of Florida; Florida A&M University; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; Florida State University; University of Iowa	Agyare, E (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	edward.agyare@famu.edu		Sachdeva, Mandip/0000-0001-9192-8143; Agyare, Edward/0000-0002-6905-5136	NIH/RCMI [5G12MD007582-32]; NIH/NCI [5P20CA192990-03]; NATIONAL CANCER INSTITUTE [P20CA192990] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007582] Funding Source: NIH RePORTER	NIH/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH/RCMI #5G12MD007582-32 and NIH/NCI #5P20CA192990-03.; The authors acknowledge the financial assistance provided by the NIH/RCMI #5G12MD00758232 and NIH/NCI #5P20CA192990-03. The authors would like to thank Anna Cat for her assistance in designing the graphical abstract.	Affram Kevin, 2015, Integr Cancer Sci Ther, V2, P133; Agyare EK, 2014, J CONTROL RELEASE, V185, P121, DOI 10.1016/j.jconrel.2014.04.010; Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102; Allen Y DaC, 2015, THERMOSENSITIVE LIPO; Apparaju SK, 2008, CANCER CHEMOTH PHARM, V61, P223, DOI 10.1007/s00280-007-0464-1; Arpicco S, 2013, EUR J PHARM BIOPHARM, V85, P373, DOI 10.1016/j.ejpb.2013.06.003; Aydin RST, 2012, J NANOMATER, V2012, DOI 10.1155/2012/313961; Brusa P, 2007, ANTICANCER RES, V27, P195; Ciccolini J, 2016, CANCER CHEMOTH PHARM, V78, P1, DOI 10.1007/s00280-016-3003-0; Cosco D, 2012, INT J NANOMED, V7, P2535, DOI [10.2147/IJN.S28114, 10.2147/IJN.S34025]; Dash S, 2010, ACTA POL PHARM, V67, P217; de Smet M, 2013, INVEST RADIOL, V48, P395, DOI 10.1097/RLI.0b013e3182806940; de Smet M, 2010, J CONTROL RELEASE, V143, P120, DOI 10.1016/j.jconrel.2009.12.002; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dumstrei K, 2016, ONCOTARGET, V7, P11151, DOI 10.18632/oncotarget.7098; Ernsting MJ, 2013, J CONTROL RELEASE, V172, P782, DOI 10.1016/j.jconrel.2013.09.013; Fox RG, 2016, NATURE, V534, P407, DOI 10.1038/nature17988; Fu R, 2005, J MAGN RESON, V177, P1, DOI 10.1016/j.jmr.2005.07.013; Ghaghada K, 2008, ACAD RADIOL, V15, P1259, DOI 10.1016/j.acra.2008.04.018; Ghaghada KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007628; Hanada K, 2015, J GASTROENTEROL, V50, P147, DOI 10.1007/s00535-014-1026-z; Humbert M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009430; Hylander BL, 2015, J CONTROL RELEASE, V217, P160, DOI 10.1016/j.jconrel.2015.08.047; Immordino ML, 2004, J CONTROL RELEASE, V100, P331, DOI 10.1016/j.jconrel.2004.09.001; Ji TJ, 2016, ACS APPL MATER INTER, V8, P3438, DOI 10.1021/acsami.5b11619; Kaasgaard T, 2003, BIOPHYS J, V85, P350, DOI 10.1016/S0006-3495(03)74479-8; Ketan B, 2009, PLOS ONE, V4, P1; Kong G, 2000, CANCER RES, V60, P6950; Lanz C, 2007, J SEP SCI, V30, P1811, DOI 10.1002/jssc.200600534; Li L, 2013, J CONTROL RELEASE, V167, P130, DOI 10.1016/j.jconrel.2013.01.026; Liu XS, 2016, ACS NANO, V10, P2702, DOI 10.1021/acsnano.5b07781; Liu YJ, 2015, FOOD RES INT, V74, P97, DOI 10.1016/j.foodres.2015.04.024; Lokling KE, 2001, MAGN RESON IMAGING, V19, P731, DOI 10.1016/S0730-725X(01)00380-0; Luedke E, 2012, J IMMUNOTHER, V35, P367, DOI 10.1097/CJI.0b013e3182562d76; Luo H, 2016, CLIN CANC RES OFFICI; Mondal G, 2016, BIOMACROMOLECULES, V17, P301, DOI 10.1021/acs.biomac.5b01419; Nakamura H, 2015, J CONTROL RELEASE, V220, P406, DOI 10.1016/j.jconrel.2015.11.002; Needham D, 2000, CANCER RES, V60, P1197; Needham D, 2013, FARADAY DISCUSS, V161, P515, DOI 10.1039/c2fd20111a; Paolino D, 2010, J CONTROL RELEASE, V144, P144, DOI 10.1016/j.jconrel.2010.02.021; Qi H, 2016, J PHARM SCI; Rao M. A., 2014, FLOW FUNCTIONAL MODE, P27, DOI DOI 10.1007/978-1-4614-9230-6_2; Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051; SONG CW, 1984, CANCER RES, V44, P4721; Steffe JF, 1996, BIOPROCESSING PIPELI; Ta T, 2013, J CONTROL RELEASE, V169, P112, DOI 10.1016/j.jconrel.2013.03.036; Tagami T, 2011, BIOMATERIALS, V32, P6570, DOI 10.1016/j.biomaterials.2011.05.029; Tangutoori S, 2016, NANOMED-NANOTECHNOL, V12, P223, DOI 10.1016/j.nano.2015.08.007; Wang THM, 2010, IFMBE P, V25, P3; Xu HT, 2015, PHARM RES-DORDR, V32, P2428, DOI 10.1007/s11095-015-1635-0	50	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185116	10.1371/journal.pone.0185116	http://dx.doi.org/10.1371/journal.pone.0185116			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934281	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900094
J	Ellsworth, SG; Rabatic, BM; Chen, J; Zhao, J; Campbell, J; Wang, WL; Pi, WH; Stanton, P; Matuszak, M; Jolly, S; Miller, A; Kong, FM				Ellsworth, Susannah G.; Rabatic, Bryan M.; Chen, Jie; Zhao, Jing; Campbell, Jeffrey; Wang, Weili; Pi, Wenhu; Stanton, Paul; Matuszak, Martha; Jolly, Shruti; Miller, Amy; Kong, Feng-Ming			Principal component analysis identifies patterns of cytokine expression in non-small cell lung cancer patients undergoing definitive radiation therapy	PLOS ONE			English	Article							SOLUBLE CD40 LIGAND; DISEASES	Background/Purpose Radiation treatment (RT) stimulates the release of many immunohumoral factors, complicating the identification of clinically significant cytokine expression patterns. This study used principal component analysis (PCA) to analyze cytokines in non-small cell lung cancer (NSCLC) patients undergoing RT and explore differences in changes after hypofractionated stereotactic body radiation therapy (SBRT) and conventionally fractionated RT (CFRT) without or with chemotherapy. Methods The dataset included 141 NSCLC patients treated on prospective clinical protocols; PCA was based on the 128 patients who had complete CK values at baseline and during treatment. Patients underwent SBRT (n = 16), CFRT (n = 18), or CFRT (n = 107) with concurrent chemotherapy (ChRT). Levels of 30 cytokines were measured from prospectively collected platelet-poor plasma samples at baseline, during RT, and after RT. PCA was used to study variations in cytokine levels in patients at each time point. Results Median patient age was 66, and 22.7% of patients were female. PCA showed that sCD40l, fractalkine/C3, IP10, VEGF, IL-1a, IL-10, and GMCSF were responsible for most variability in baseline cytokine levels. During treatment, sCD40l, IP10, MIP-1b, fractalkine, IFN-r, and VEGF accounted for most changes in cytokine levels. In SBRT patients, the most important players were sCD40l, IP10, and MIP-1b, whereas fractalkine exhibited greater variability in CFRT alone patients. ChRT patients exhibited variability in IFN-gamma and VEGF in addition to IP10, MIP-1b, and sCD40l. Conclusions PCA can identify potentially significant patterns of cytokine expression after fractionated RT. Our PCA showed that inflammatory cytokines dominate post-treatment cytokine profiles, and the changes differ after SBRT versus CFRT, with vs without chemotherapy. Further studies are planned to validate these findings and determine the clinical significance of the cytokine profiles identified by PCA.	[Ellsworth, Susannah G.; Wang, Weili; Pi, Wenhu; Miller, Amy; Kong, Feng-Ming] Indiana Univ Sch Med, Dept Radiat Oncol, Indianapolis, IN 46202 USA; [Rabatic, Bryan M.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA; [Chen, Jie] Augusta Univ, Dept Biostat & Epidemiol, Augusta, GA USA; [Zhao, Jing; Campbell, Jeffrey; Stanton, Paul] Augusta Univ, Dept Radiat Oncol, Augusta, GA USA; [Matuszak, Martha; Jolly, Shruti] Univ Michigan, Dept Radiat Oncol, Sch Med, Ann Arbor, MI 48109 USA	Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Michigan System; University of Michigan	Kong, FM (corresponding author), Indiana Univ Sch Med, Dept Radiat Oncol, Indianapolis, IN 46202 USA.	fskong@iupui.edu	Chen, Jie/S-1161-2019; Kong, Feng-Ming/Y-2825-2019; Wang, Weili/A-5336-2013	Chen, Jie/0000-0003-2151-5276; Kong, Feng-Ming/0000-0003-2652-098X; Wang, Weili/0000-0002-1627-3025	National Cancer Institute, National Institutes of Health [R01CM 42840]; NATIONAL CANCER INSTITUTE [P01CA059827, R01CA142840] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, National Institutes of Health, no. R01CM 42840, https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci. The funding source had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloui C, 2014, INT J MOL SCI, V15, P22342, DOI 10.3390/ijms151222342; Anscher MS, 1998, LUNG CANCER-J IASLC, V19, P109, DOI 10.1016/S0169-5002(97)00076-7; Antonelli A, 2014, AUTOIMMUN REV, V13, P272, DOI 10.1016/j.autrev.2013.10.010; Caggiari Laura, 2007, Infect Agent Cancer, V2, P5, DOI 10.1186/1750-9378-2-5; Easton R, 2014, INJURY, V45, P934, DOI 10.1016/j.injury.2013.12.002; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Ferroni P, 2007, CURR MED CHEM, V14, P2170; Huang JP, 2012, BLOOD, V120, P3030, DOI 10.1182/blood-2012-05-427799; Jones BA, 2010, MOL INTERV, V10, P263, DOI 10.1124/mi.10.5.3; Kong FM, 2015, SEMIN RADIAT ONCOL, V25, P100, DOI 10.1016/j.semradonc.2014.12.003; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Mauri FA, 2012, ONCOL REP, V28, P647, DOI 10.3892/or.2012.1818; Roselli M, 2004, CLIN CANCER RES, V10, P610, DOI 10.1158/1078-0432.CCR-0348-03; Sainani KL, 2014, PM&R, V6, P275, DOI 10.1016/j.pmrj.2014.02.001; Siebert JC, 2014, BIOANALYSIS, V6, P209, DOI [10.4155/BIO.13.309, 10.4155/bio.13.309]; Siva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109560; Wang SL, 2015, INT J RADIAT ONCOL, V93, pS153, DOI 10.1016/j.ijrobp.2015.07.363	18	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183239	10.1371/journal.pone.0183239	http://dx.doi.org/10.1371/journal.pone.0183239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934231	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900009
J	Kawano, T; Imada, M; Chamavit, P; Kobayashi, S; Hashimoto, T; Nozaki, T				Kawano, Tetsuro; Imada, Mihoko; Chamavit, Pennapa; Kobayashi, Seiki; Hashimoto, Tetsuo; Nozaki, Tomoyoshi			Genetic diversity of Entamoeba: Novel ribosomal lineages from cockroaches	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; HISTOLYTICA; PATTERNS; REVEALS; TOOL	Our current taxonomic perspective on Entamoeba is largely based on small-subunit ribosomal RNA genes (SSU rDNA) from Entamoeba species identified in vertebrate hosts with minor exceptions such as E. moshkovskii from sewage water and E. marina from marine sediment. Other Entamoeba species have also been morphologically identified and described from non-vertebrate species such as insects; however, their genetic diversity remains unknown. In order to further disclose the diversity of the genus, we investigated Entamoeba spp. in the intestines of three cockroach species: Periplaneta americana, Blaptica dubia, and Gromphadorhina oblongonota. We obtained 134 Entamoeba SSU rDNA sequences from 186 cockroaches by direct nested PCR using the DNA extracts of intestines from cockroaches, followed by scrutinized BLASTn screening and phylogenetic analyses. All the sequences identified in this study were distinct from those reported from known Entamoeba species, and considered as novel Entamoeba ribosomal lineages. Furthermore, they were positioned at the base of the clade of known Entamoeba species and displayed remarkable degree of genetic diversity comprising nine major groups in the three cockroach species. This is the first report of the diversity of SSU rDNA sequences from Entamoeba in non-vertebrate host species, and should help to understand the genetic diversity of the genus Entamoeba.	[Kawano, Tetsuro; Hashimoto, Tetsuo; Nozaki, Tomoyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kawano, Tetsuro; Imada, Mihoko; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo, Japan; [Kawano, Tetsuro; Nozaki, Tomoyoshi] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Imada, Mihoko; Kobayashi, Seiki] Keio Univ, Sch Med, Dept Infect Dis, Shinjuku Ku, Tokyo, Japan; [Chamavit, Pennapa] Hauchiew Univ, Fac Med Technol, Bangplee, Samutprakarn, Thailand; [Hashimoto, Tetsuo] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Institute of Infectious Diseases (NIID); University of Tokyo; Keio University; University of Tsukuba	Nozaki, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Nozaki, T (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo, Japan.; Nozaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo, Japan.	nozaki@m.u-tokyo.ac.jp		Kawano-Sugaya, Tetsuro/0000-0001-5401-4414	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23117001, 23117005, 23390099, 26111524]; Japan Agency for Medical Research and Development (AMED); AMED; Japan International Cooperation Agency (JICA);  [15H05231]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED; Japan International Cooperation Agency (JICA); 	This work was supported in part by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (23117001, 23117005, 23390099, 26111524) to T.N. and 15H05231 to T.H., a grant for research on emerging and re-emerging infectious diseases from Japan Agency for Medical Research and Development (AMED) to T.N., and a grant for Science and Technology Research Partnership for Sustainable Development (SATREPS) from AMED and Japan International Cooperation Agency (JICA) to T.N.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali IKM, 2005, J CLIN MICROBIOL, V43, P5842, DOI 10.1128/JCM.43.12.5842-5847.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BISHOP ANN, 1932, PARASITOLOGY, V24, P225; CARINI A., 1933, ANN PARASITOL HUMAINE ET COMP, V11, P297; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clark CG, 2006, MOL BIOCHEM PARASIT, V146, P24, DOI 10.1016/j.molbiopara.2005.10.013; Das K, 2014, PARASITOL INT, V63, P308, DOI 10.1016/j.parint.2013.11.014; Escueta-de Cadiz A, 2010, PARASITOL INT, V59, P75, DOI 10.1016/j.parint.2009.10.010; Fantham H, 1911, P ZOOL SOC LOND, P625; Global Health Estimates, 2016, GLOB HLTH EST 2015 B; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kay MW, 1940, SAY AM MIDL NAT, P724; KIDDER GEORGE W., 1937, PARASITOLOGY, V29, P163; Marsh TL, 1998, WATER SCI TECHNOL, V37, P455, DOI 10.2166/wst.1998.0693; Shiratori T, 2016, J EUKARYOT MICROBIOL, V63, P280, DOI 10.1111/jeu.12276; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stensvold CR, 2011, PROTIST, V162, P525, DOI 10.1016/j.protis.2010.11.002; Tawari B, 2008, MOL BIOL EVOL, V25, P187, DOI 10.1093/molbev/msm238; Zaki M, 2002, J CLIN MICROBIOL, V40, P1271, DOI 10.1128/JCM.40.4.1271-1276.2002; Zaki M, 2001, J CLIN MICROBIOL, V39, P897, DOI 10.1128/JCM.39.3.897-905.2001	21	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185233	10.1371/journal.pone.0185233	http://dx.doi.org/10.1371/journal.pone.0185233			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934335	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900129
J	Luque, MA; Beltran-Matas, P; Marin, MC; Torres, B; Herrero, L				Angeles Luque, M.; Beltran-Matas, Pablo; Carmen Marin, M.; Torres, Blas; Herrero, Luis			Excitability is increased in hippocampal CA1 pyramidal cells of Fmr1 knockout mice	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MOUSE MODEL; NEURONAL EXCITABILITY; AFTER-HYPERPOLARIZATION; SYNAPTIC PLASTICITY; POTASSIUM CHANNELS; FMR1(-/Y) MOUSE; MESSENGER-RNAS; I-H	Fragile X syndrome (FXS) is caused by a failure of neuronal cells to express the gene encoding the fragile mental retardation protein (FMRP). Clinical features of the syndrome include intellectual disability, learning impairment, hyperactivity, seizures and anxiety. Fmr1 knockout (KO) mice do not express FMRP and, as a result, reproduce some FXS behavioral abnormalities. While intrinsic and synaptic properties of excitatory cells in various part of the brain have been studied in Fmr1 KO mice, a thorough analysis of action potential characteristics and input-output function of CA1 pyramidal cells in this model is lacking. With a view to determining the effects of the absence of FMRP on cell excitability, we studied rheobase, action potential duration, firing frequency-current intensity relationship and action potential after-hyperpolarization (AHP) in CA1 pyramidal cells of the hippocampus of wild type (WT) and Fmr1 KO male mice. Brain slices were prepared from 8-to 12-week-old mice and the electrophysiological properties of cells recorded. Cells from both groups had similar resting membrane potentials. In the absence of FMRP expression, cells had a significantly higher input resistance, while voltage threshold and depolarization voltage were similar in WT and Fmr1 KO cell groups. No changes were observed in rheobase. The action potential duration was longer in the Fmr1 KO cell group, and the action potential firing frequency evoked by current steps of the same intensity was higher. Moreover, the gain (slope) of the relationship between firing frequency and injected current was 1.25-fold higher in the Fmr1 KO cell group. Finally, AHP amplitude was significantly reduced in the Fmr1 KO cell group. According to these data, FMRP absence increases excitability in hippocampal CA1 pyramidal cells.	[Angeles Luque, M.; Beltran-Matas, Pablo; Carmen Marin, M.; Torres, Blas; Herrero, Luis] Univ Seville, Dept Physiol, Seville, Spain	University of Sevilla	Herrero, L (corresponding author), Univ Seville, Dept Physiol, Seville, Spain.	lherrero@us.es	Herrero, Luis/B-9959-2015	Herrero, Luis/0000-0002-4311-8792; Beltran Matas, Pablo/0000-0003-3817-5095				Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Bianchi R, 2009, J NEUROSCI, V29, P3497, DOI 10.1523/JNEUROSCI.5447-08.2009; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brager DH, 2014, BRAIN RES BULL, V103, P11, DOI 10.1016/j.brainresbull.2014.01.002; Brager DH, 2012, CELL REP, V1, P225, DOI 10.1016/j.celrep.2012.02.002; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; Chen S, 2014, J NEUROSCI, V34, P8219, DOI 10.1523/JNEUROSCI.0936-14.2014; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Contractor A, 2015, NEURON, V87, P699, DOI 10.1016/j.neuron.2015.06.017; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng PY, 2016, CELL REP, V16, P3157, DOI 10.1016/j.celrep.2016.08.046; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Ferron L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4628; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; Gross C, 2011, J NEUROSCI, V31, P5693, DOI 10.1523/JNEUROSCI.6661-10.2011; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Gu N, 2008, J NEUROPHYSIOL, V100, P2589, DOI 10.1152/jn.90433.2008; Honigsperger C, 2015, J PHYSIOL-LONDON, V593, DOI 10.1113/jphysiol.2014.280826; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kalmbach BE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0114-15.2015; Lee HY, 2011, NEURON, V72, P630, DOI 10.1016/j.neuron.2011.09.033; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Myrick LK, 2015, P NATL ACAD SCI USA, V112, P949, DOI 10.1073/pnas.1423094112; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Paxinos G. F, MOUSE BRAIN STEREOTA; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Routh BN, 2017, J PHYSIOL-LONDON, V595, P4431, DOI 10.1113/JP274258; Santos AR, 2014, LEARN MEMORY, V21, P543, DOI 10.1101/lm.035956.114; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Tang AH, 2015, J NEUROSCI, V35, P3938, DOI 10.1523/JNEUROSCI.4499-14.2015; Wahlstrom-Helgren S, 2015, J PHYSIOL-LONDON, V593, P5009, DOI 10.1113/JP271190; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Zhang LM, 2016, EXP NEUROL, V280, P60, DOI 10.1016/j.expneurol.2016.03.025; Zhang LH, 2010, J NEUROSCI, V30, P5724, DOI 10.1523/JNEUROSCI.0795-10.2010; Zhang YL, 2012, J NEUROSCI, V32, P15318, DOI 10.1523/JNEUROSCI.2162-12.2012; Zhang Y, 2014, NAT NEUROSCI, V17, P1701, DOI 10.1038/nn.3864; Zhao WF, 2011, J NEUROSCI, V31, P725, DOI 10.1523/JNEUROSCI.2915-10.2011	48	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185067	10.1371/journal.pone.0185067	http://dx.doi.org/10.1371/journal.pone.0185067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931075	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700067
J	Gehle, P; Goergen, B; Pilger, D; Ruokonen, P; Robinson, PN; Salchow, DJ				Gehle, Petra; Goergen, Barbara; Pilger, Daniel; Ruokonen, Peter; Robinson, Peter N.; Salchow, Daniel J.			Biometric and structural ocular manifestations of Marfan syndrome	PLOS ONE			English	Article							REVISED GHENT NOSOLOGY; RETINAL-DETACHMENT; ECTOPIA LENTIS; FIBRILLIN GENE; MUTATIONS; PREVALENCE; ADULTS	Background To study biometric and structural ocular manifestations of Marfan syndrome (MFS). Methods Observational, retrospective, comparative cohort study in a tertiary referral center on 285 MFS patients and 267 controls. Structural and biometric ocular characteristic were compared. Results MFS eyes were longer (axial length 24.25 +/- 1.74 mm versus 23.89 +/- 1.31 mm, p < 0.001) and had a flatter cornea than control eyes (mean keratometry 41.78 +/- 1.80 diopters (D) versus 43.05 +/- 1.51 D, p < 0.001). Corneal astigmatism was greater and the central cornea was thinner in MFS eyes (530.14 +/- 41.31 mu m versus 547.02 +/- 39.18 mu m, p < 0.001). MFS eyes were more myopic than control eyes (spherical equivalent -2.16 +/- 3.75 D versus -1.17 +/- 2.58 D, p < 0.001). Visual acuity was reduced (0.13 +/- 0.25 logMAR versus 0.05 +/- 0.18 logMAR, p < 0.001) and intraocular pressure was lower in MFS eyes (14.6 +/- 3.4 mmHg versus 15.1 +/- 3.2 mmHg, p = 0.01). Iris transillumination defects (ITD) were significantly more common in MFS eyes (odds ratio for MFS in the presence of ITD, 3.7). Ectopia lentis (EL) was only present in MFS eyes (33.4%). History of retinal detachment was significantly more common in MFS eyes. Glaucoma was equally common in both groups. Conclusions ITD and EL are most characteristic findings in MFS. ITD and corneal curvature should be studied as diagnostic criteria for MFS. Visual acuity is reduced in MFS. MFS patients need regular eye exams to identify serious ocular complications.	[Gehle, Petra] Charite Univ Med Berlin, Dept Cardiol, Augustenburger Pl 1, Berlin, Germany; [Goergen, Barbara; Pilger, Daniel; Salchow, Daniel J.] Charite Univ Med Berlin, Dept Ophthalmol, Augustenburger Pl 1, Berlin, Germany; [Ruokonen, Peter] Private Practice Zehlendorf, Berlin, Germany; [Robinson, Peter N.] Jackson Lab Genom Med, Farmington, CT USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jackson Laboratory	Salchow, DJ (corresponding author), Charite Univ Med Berlin, Dept Ophthalmol, Augustenburger Pl 1, Berlin, Germany.	daniel.salchow@charite.de		Salchow, Daniel/0000-0003-3678-6183; Gehle, Petra/0000-0002-0652-8098				Chandra A, 2015, CLIN GENET, V87, P284, DOI 10.1111/cge.12358; Chandra A, 2014, ACTA OPHTHALMOL, V92, pE82, DOI 10.1111/aos.12175; CROSS HE, 1973, AM J OPHTHALMOL, V75, P405, DOI 10.1016/0002-9394(73)91149-5; DIETZ HC, 1991, GENOMICS, V9, P355, DOI 10.1016/0888-7543(91)90264-F; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dotrelova D, 1997, RETINA-J RET VIT DIS, V17, P390; Drolsum L, 2015, ACTA OPHTHALMOL, V93, P46, DOI 10.1111/aos.12448; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Foster PJ, 2014, EYE, V28, P202, DOI 10.1038/eye.2013.280; Fotedar R, 2010, OPHTHALMOLOGY, V117, P417, DOI 10.1016/j.ophtha.2009.07.028; Fuchs J, 1997, ACTA PAEDIATR, V86, P947, DOI 10.1111/j.1651-2227.1997.tb15176.x; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785; Hashemi H, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-50; Hayward C, 1997, HUM MUTAT, V10, P415, DOI 10.1002/(SICI)1098-1004(1997)10:6<415::AID-HUMU1>3.3.CO;2-2; Heur M, 2008, AM J OPHTHALMOL, V145, P997, DOI 10.1016/j.ajo.2008.01.028; Izquierdo N J, 1992, Trans Am Ophthalmol Soc, V90, P111; Jobke S, 2008, CLIN OPHTHALMOL, V2, P601; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; Kara N, 2012, J CATARACT REFR SURG, V38, P309, DOI 10.1016/j.jcrs.2011.08.036; Kinori M, 2017, AM J OPHTHALMOL; Konradsen TR, 2013, ACTA OPHTHALMOL, V91, P751, DOI 10.1111/aos.12068; Konradsen TR, 2012, ACTA OPHTHALMOL, V90, P375, DOI 10.1111/j.1755-3768.2010.01996.x; Konradsen TR, 2009, OPHTHALMOLOGY, V116, P1343, DOI 10.1016/j.ophtha.2009.01.023; Lee SY, 2003, RETINA-J RET VIT DIS, V23, P24, DOI 10.1097/00006982-200302000-00004; Loewenstein A, 2000, RETINA-J RET VIT DIS, V20, P358, DOI 10.1097/00006982-200007000-00006; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Maumenee I H, 1981, Trans Am Ophthalmol Soc, V79, P684; Remulla JF, 2001, INT OPHTHALMOL CLIN, V41, P235, DOI 10.1097/00004397-200110000-00021; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SETALA K, 1988, ACTA OPHTHALMOL, V66, P334; Sharma T, 2002, RETINA-J RET VIT DIS, V22, P423, DOI 10.1097/00006982-200208000-00005; Sultan G, 2002, INVEST OPHTH VIS SCI, V43, P1757; Traboulsi E I, 2000, Ophthalmic Genet, V21, P9, DOI 10.1076/1381-6810(200003)21:1;1-I;FT009; WHEATLEY HM, 1995, ARCH OPHTHALMOL-CHIC, V113, P103, DOI 10.1001/archopht.1995.01100010105028	35	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0183370	10.1371/journal.pone.0183370	http://dx.doi.org/10.1371/journal.pone.0183370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931008	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700009
J	Igawa, M; Kato, M				Igawa, Momoko; Kato, Makoto			A new species of hermit crab, Diogenes heteropsammicola (Crustacea, Decapoda, Anomura, Diogenidae), replaces a mutualistic sipunculan in a walking coral symbiosis	PLOS ONE			English	Article							OBLIGATE POLLINATION MUTUALISM; EUPHORBIACEAE; PAGUROIDEA; CHINA	Symbiont shift is rare in obligate mutualisms because both the partners are reciprocally dependent on and specialized to each other. In the obligate accommodation-transportation mutualism between walking corals and sipunculans, however, an unusual saltatory symbiont shift was discovered. In shallow waters of southern Japan, an undescribed hermit crab species was found living in corallums of solitary scleractinian corals of the genera Heterocyathus and Heteropsammia, replacing the usual sipunculan symbiont. We described the hermit crab as a new species Diogenes heteropsammicola (Decapoda, Anomura, Diogenidae), and explored its association with the walking corals. This hermit crab species obligately inhabits the coiled cavity of the corals, and was easily distinguished from other congeneric species by the exceedingly slender chelipeds and ambulatory legs, and the symmetrical telson. Observations of behavior in aquaria showed that the new hermit crab, like the sipunculan, carries the host coral and prevents the coral from being buried. This is an interesting case in which an organism phylogenetically distant from Sipuncula takes over the symbiotic role in association with a walking coral. The hermit crab species is unique in that its lodging is a living solitary coral that grows with the hermit crab in an accommodation-transportation mutualism.	[Igawa, Momoko; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Kyoto University	Igawa, M (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan.	momoko.igawa.43e@gmail.com			Ministry of Education, Culture, Sports, Science and Technology [22247003, 15H02420]; Grants-in-Aid for Scientific Research [15H02420] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/) given to MK (22247003, 15H02420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura Akira, 2010, V14, P133; Bouvier E. L., 1895, ANN SCI NAT ZOOL, V20, P1; Bouvier EL, 1894, ANN MAG NAT HIST SER, V14, P312; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Dana J. D., 1851, P ACAD NAT SCI PHILA, V5, P267, DOI DOI 10.2307/20021092; Fujii T., 2016, HETEROPSAMMIA COCHLE, P1; GILL GA, 1977, LETHAIA, V10, P119, DOI 10.1111/j.1502-3931.1977.tb00601.x; GOREAU TF, 1968, NATURE, V217, P421, DOI 10.1038/217421a0; HICKSON SJ, 1924, INTRO STUDY RECENT C; HOEKSEMA B W, 1991, Zoologische Mededelingen (Leiden), V65, P221; Igawa M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169825; Kato M, 2003, P NATL ACAD SCI USA, V100, P5264, DOI 10.1073/pnas.0837153100; Kawakita A, 2004, EVOLUTION, V58, P2201; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Komai T, 2013, ZOOTAXA, V3613, P380, DOI 10.11646/zootaxa.3613.4.5; Komai T, 2012, J NAT HIST, V46, P1219, DOI 10.1080/00222933.2011.654279; Macdonald JD, 1862, NAT HIST REV LOND, V1862, P78; McLaughlin PA, 2005, J CRUSTACEAN BIOL, V25, P598, DOI 10.1651/C-2598.1; McLaughlin PA, 2007, CATALOG HERMIT CRABS; McLaughlin PA, 2010, RAFFLES B ZOOL, P5; Neelakantan B, 1985, THE INDIAN ZOOLOGIST, V9, P15; Rahayu D.L., 2012, CRUSTACEANA MONOGRAP, P263, DOI DOI 10.1163/9789004202894_022; Rahayu DL, 2015, RAFFLES B ZOOL, P182; RICE M E, 1976, Micronesica, V12, P119; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Schindewolf OH, AKAD WISSENSCHAFTEN; Sluiter GP, 1902, MONOGRAPH, V25, P1; Stolarski J, 2001, ACTA PALAEONTOL POL, V46, P309; Trivedi JN, 2016, ZOOTAXA, V509, P4208; Xiao LC, 2015, CRUSTACEANA, V88, P1439, DOI 10.1163/15685403-00003497; Yonge C.M., 1975, P305	31	10	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184311	10.1371/journal.pone.0184311	http://dx.doi.org/10.1371/journal.pone.0184311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931020	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700019
J	Wiese, AV; Ender, F; Quell, KM; Antoniou, K; Vollbrandt, T; Konig, P; Kohl, J; Laumonnier, Y				Wiese, Anna V.; Ender, Fanny; Quell, Katharina M.; Antoniou, Konstantina; Vollbrandt, Tillman; Koenig, Peter; Koehl, Joerg; Laumonnier, Yves			The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells	PLOS ONE			English	Article							COMPLEMENT FACTORS C3A; DENDRITIC CELLS; EFFECTOR FUNCTIONS; HUMAN EOSINOPHILS; C5A; MACROPHAGES; ANAPHYLATOXINS; INDUCTION; DISEASE; GENE	C5a regulates the development of maladaptive immune responses in allergic asthma mainly through the activation of C5a receptor 1 (C5aR1). Yet, the cell types and the mechanisms underlying this regulation are ill-defined. Recently, we described increased C5aR1 expression in lung tissue eosinophils but decreased expression in airway and pulmonary macrophages as well as in pulmonary CD11b(+) conventional dendritic cells (cDCs) and monocyte-derived DCs (moDCs) during the allergic effector phase using a floxed green fluorescent protein (GFP)-C5aR1 knock-in mouse. Here, we determined the role of C5aR1 signaling in neutrophils, moDCs and macrophages for the pulmonary recruitment of such cells and the importance of C5aR1-mediated activation of LysM-expressing cells for the development of allergic asthma. We used LysM-C5aR1 KO mice with a specific deletion of C5aR1 in LysMCre-expressing cells and confirmed the specific deletion of C5aR1 in neutrophils, macrophages and moDCs in the airways and/or the lung tissue. We found that alveolar macrophage numbers were significantly increased in LysM-C5aR1 KO mice. Induction of ovalbumin (OVA)-driven experimental allergic asthma in GFP-C5aR1(fl/fl) and LysM-C5aR1 KO mice resulted in strong but similar airway resistance, mucus production and Th2/Th17 cytokine production. In contrast, the number of airway but not of pulmonary neutrophils was lower in LysM-C5aR1 KO as compared with GFP-C5aR1(fl/fl) mice. The recruitment of macrophages, cDCs, moDCs, T cells and type 2 innate lymphoid cells was not altered in LysM-C5aR1 KO mice. Our findings demonstrate that C5aR1 is critical for steady state control of alveolar macrophage numbers and the transition of neutrophils from the lung into the airways in OVA-driven allergic asthma. However, C5aR1 activation of LysM-expressing cells plays a surprisingly minor role in the recruitment and activation of such cells and the development of the allergic phenotype in OVA-driven experimental allergic asthma.	[Wiese, Anna V.; Ender, Fanny; Quell, Katharina M.; Antoniou, Konstantina; Koehl, Joerg; Laumonnier, Yves] Univ Lubeck, Inst System Inflammat Res, Lubeck, Germany; [Vollbrandt, Tillman] Univ Lubeck, Cell Anal Core, Lubeck, Germany; [Koenig, Peter] Univ Lubeck, Inst Anat, Lubeck, Germany; [Koehl, Joerg] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Koehl, Joerg] Univ Cincinnati, Coll Med, Cincinnati, OH 45220 USA	University of Lubeck; University of Lubeck; University of Lubeck; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Kohl, J; Laumonnier, Y (corresponding author), Univ Lubeck, Inst System Inflammat Res, Lubeck, Germany.; Kohl, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Kohl, J (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45220 USA.	joerg.koehl@uksh.de; yves.laumonnier@uksh.de	Laumonnier, yves/F-6348-2018; König, Peter/AAK-2021-2020; Koehl, Joerg/C-8531-2011	Koehl, Joerg/0000-0003-1121-3178	Deutsch Forschungsgemeinschaft [IRTG1911A1, IRTG1911A2, KO 1245/3-1]	Deutsch Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsch Forschungsgemeinschaft Grants IRTG1911A1 to Y.L and J.K, IRTG1911A2 to P.K., KO 1245/3-1 to J.K. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Doyle AD, 2013, J LEUKOCYTE BIOL, V94, P17, DOI 10.1189/jlb.0213089; Elsner J, 1996, EUR J IMMUNOL, V26, P1560, DOI 10.1002/eji.1830260723; Ender F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172446; Engelke C, 2014, J IMMUNOL, V193, P5387, DOI 10.4049/jimmunol.1400080; Fujiu T, 2002, ANN ALLERG ASTHMA IM, V89, P90, DOI 10.1016/S1081-1206(10)61917-5; GOETZL EJ, 1976, AM J PATHOL, V85, P419; Haggadone MD, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1340156; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.274; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Krug N, 2001, AM J RESP CRIT CARE, V164, P1841, DOI 10.1164/ajrccm.164.10.2010096; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Marc MM, 2004, AM J RESP CELL MOL, V31, P216, DOI 10.1165/rcmb.2003-0394OC; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Nieuwenhuizen NE, 2012, J ALLERGY CLIN IMMUN, V130, P743, DOI 10.1016/j.jaci.2012.03.011; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Quell KM, 2017, J IMMUNOL, V199, P688, DOI 10.4049/jimmunol.1700318; Schmudde I, 2013, MUCOSAL IMMUNOL, V6, P807, DOI 10.1038/mi.2012.119; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Staab EB, 2014, INT IMMUNOPHARMACOL, V21, P293, DOI 10.1016/j.intimp.2014.05.008; Stiehm M, 2013, CLIN EXP ALLERGY, V43, P785, DOI 10.1111/cea.12116; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Verschoor A, 2016, IMMUNOL REV, V274, P112, DOI 10.1111/imr.12473; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Yves L, 2017, MOL IMMUNOL, V84, P51, DOI 10.1016/j.molimm.2016.11.013; Zhang X, 2010, J IMMUNOL, V185, P6741, DOI 10.4049/jimmunol.1000892; Zhang X, 2009, J IMMUNOL, V182, P5123, DOI 10.4049/jimmunol.0804276	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184956	10.1371/journal.pone.0184956	http://dx.doi.org/10.1371/journal.pone.0184956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931049	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700046
J	Huang, LH; Lin, PH; Tsai, KW; Wang, LJ; Huang, YH; Kuo, HC; Li, SC				Huang, Lien-Hung; Lin, Pei-Hsien; Tsai, Kuo-Wang; Wang, Liang-Jen; Huang, Ying-Hsien; Kuo, Ho-Chang; Li, Sung-Chou			The effects of storage temperature and duration of blood samples on DNA and RNA qualities	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENE-EXPRESSION; MESSENGER-RNA; STABILITY; BIOMARKER; MICRORNA; CXCL10; CELLS; HEPATITIS; DISEASE	DNA and RNA samples from blood are the common examination target for non-invasive physical tests and/or biomedical studies. Since high-quality DNA and RNA samples guarantee the correctness of these tests and/or studies, we investigated the effects of storage temperature and storage duration of whole blood on DNA and RNA qualities. Subjects were enrolled to donate blood samples which were stored for different durations and at different temperatures, followed by the examinations on RNA quality, qPCR, DNA quality and DNA methylation. For RNA, we observed obvious quality decline with storage duration longer than 24 hours. Storage at low temperature does not keep RNA samples from degradation. And, storing whole blood samples in freezer dramatically damage RNA. For DNA, quality decline was not observed even with storage duration for 15 days. However, DNA methylation significantly altered with storage duration longer than three days. Storage duration within 24 hours is critical for collecting high-quality RNA samples for next-generation sequencing (NGS) assays (RIN >= 8). If microarray assays are expected (RIN >= 7), storage duration within 32 hours is acceptable. Although DNA is resistant within 15 days when kept in whole blood, DNA quantity dramatically decreases owing to WBC lysis. In addition, duration for more than three days significantly alter DNA methylation status, globally and locally. Our result provides a reference for dealing with blood samples.	[Huang, Lien-Hung; Li, Sung-Chou] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan; [Huang, Lien-Hung; Wang, Liang-Jen; Huang, Ying-Hsien; Kuo, Ho-Chang; Li, Sung-Chou] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lin, Pei-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Tsai, Kuo-Wang] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Wang, Liang-Jen] Kaohsiung Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan; [Huang, Ying-Hsien; Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Huang, Ying-Hsien; Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Huang, Ying-Hsien] Chiayi Chang Gung Mem Hosp, Dept Pediat, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Li, SC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan.; Kuo, HC; Li, SC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan.; Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	erickuo48@yahoo.com.tw; raymond.pinus@gmail.com	Wang, Liang-Jen/AAR-1089-2020; Kuo, Ho-Chang/AAQ-6644-2020; Li, Sung-Chou/AGZ-8626-2022	Wang, Liang-Jen/0000-0002-5320-1151; Kuo, Ho-Chang/0000-0002-3295-2984; Li, Sung-Chou/0000-0002-3016-9718; Huang, Lien-Hung/0000-0001-8641-9897; Tsai, Kuo-Wang/0000-0002-9028-9834	Ministry of Science and Technology, Taiwan [MOST 106-2311-B-182A-002]; Chang Gung Memorial Hospital [CMRPG8F0591, CLRPG8D0113]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This article was funded by the grants from the Ministry of Science and Technology, Taiwan (MOST 106-2311-B-182A-002) and from Chang Gung Memorial Hospital (CMRPG8F0591 and CLRPG8D0113).	Antonelli A, 2014, CYTOKINE GROWTH F R, V25, P57, DOI 10.1016/j.cytogfr.2014.01.006; Antonelli A, 2014, AUTOIMMUN REV, V13, P272, DOI 10.1016/j.autrev.2013.10.010; BEUTLER E, 1990, BIOTECHNIQUES, V9, P166; Chou NH, 2016, ANTICANCER RES, V36, P3983; Cuhadar S, 2012, BIOCHEM MEDICA, V22, P202; Ferrari SM, 2015, ADV MED SCI-POLAND, V60, P349, DOI 10.1016/j.advms.2015.07.011; Gislefoss RE, 2009, CLIN CHEM LAB MED, V47, P596, DOI 10.1515/CCLM.2009.121; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Hrustincova A, 2015, FOLIA BIOL-PRAGUE, V61, P203; Ivanova NV, 2013, MOL ECOL RESOUR, V13, P890, DOI 10.1111/1755-0998.12134; Jaeger T, 2016, THROMB RES, V144, P215, DOI 10.1016/j.thromres.2016.06.034; KARAKURUM M, 1994, J CLIN INVEST, V93, P1564, DOI 10.1172/JCI117135; Kremlev SG, 2007, J NEUROSCI RES, V85, P2450, DOI 10.1002/jnr.21380; Kuo HC, 2016, J ALLERGY CLIN IMMUN, V138, P1227, DOI 10.1016/j.jaci.2016.04.050; Kuo HC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154943; Lee EY, 2013, AUTOIMMUN REV, V12, P554, DOI 10.1016/j.autrev.2012.10.001; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Li SC, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0197-2; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Lv YH, 2014, J FORENSIC SCI, V59, P1286, DOI 10.1111/1556-4029.12447; Margaritelis NV, 2015, BIOMARKERS, V20, P97, DOI 10.3109/1354750X.2014.1002807; STORCH GA, 1994, J CLIN MICROBIOL, V32, P2581, DOI 10.1128/JCM.32.10.2581-2583.1994; Tang SC, 2015, J NEUROL SCI, V348, P174, DOI 10.1016/j.jns.2014.11.035; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; van den Borne P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/893106; Vilahur N, 2013, EPIGENOMICS-UK, V5, P341, DOI [10.2217/EPI.13.29, 10.2217/epi.13.29]; WANG JT, 1992, J CLIN MICROBIOL, V30, P750, DOI 10.1128/JCM.30.3.750-753.1992; Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586; Yang CM, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0291-5; Yang YL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010192	31	53	54	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184692	10.1371/journal.pone.0184692	http://dx.doi.org/10.1371/journal.pone.0184692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926588	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600035
J	Blanco, MJ; Rodriguez-Martin, I; Learte, AIR; Clemente, C; Montalvo, MG; Seiki, M; Arroyo, AG; Sanchez-Camacho, C				Jose Blanco, Maria; Rodriguez-Martin, Ivan; Learte, Ana I. R.; Clemente, Cristina; Gregoria Montalvo, Maria; Seiki, Motoharu; Arroyo, Alicia G.; Sanchez-Camacho, Cristina			Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo	PLOS ONE			English	Article							SOMITE-DERIVED ANGIOBLASTS; OSTEOPONTIN MESSENGER-RNA; DEVELOPING RAT-BRAIN; MATRIX METALLOPROTEINASES; PROTEOLYTIC ACTIVITY; SONIC-HEDGEHOG; AXON GUIDANCE; IN-VIVO; LIMB; CANCER	Matrix metalloproteinases (MMPs) constitute a large group of endoproteases that play important functions during embryonic development, tumor metastasis and angiogenesis by degrading components of the extracellular matrix. Within this family, we focused our study on Mt4-mmp (also called Mmp17) that belongs to a distinct subset that is anchored to the cell surface via a glycosylphosphatidylinositol (GPI) moiety and with the catalytic site exposed to the extracellular space. Information about its function and substrates is very limited to date, and little has been reported on its role in the developing embryo. Here, we report a detailed expression analysis of Mt4-mmp during mouse embryonic development by using a LacZ reporter transgenic mouse line. We showed that Mt4-mmp is detected from early stages of development to postnatal stages following a dynamic and restricted pattern of expression. Mt4-mmp was first detected at E8.5 limited to the intersomitic vascularization, the endocardial endothelium and the dorsal aorta. Mt4-mmp(LacZ/+) cells were also observed in the neural crest cells, somites, floor plate and notochord at early stages. From E10.5, expression localized in the limb buds and persists during limb development. A strong expression in the brain begins at E12.5 and continues to postnatal stages. Specifically, staining was observed in the olfactory bulb, cerebral cortex, hippocampus, striatum, septum, dorsal thalamus and the spinal cord. In addition, LacZ-positive cells were also detected during eye development, initially at the hyaloid artery and later on located in the lens and the neural retina. Mt4-mmp expression was confirmed by quantitative RT-PCR and western blot analysis in some embryonic tissues. Our data point to distinct functions for this metalloproteinase during embryonic development, particularly during brain formation, angiogenesis and limb development.	[Jose Blanco, Maria; Rodriguez-Martin, Ivan; Learte, Ana I. R.] Univ Europea Madrid, Basic Biomed Sci Dept, Madrid, Spain; [Clemente, Cristina; Arroyo, Alicia G.; Sanchez-Camacho, Cristina] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Gregoria Montalvo, Maria; Sanchez-Camacho, Cristina] Univ Europea Madrid, Doctoral Studies & Res Sch, Madrid, Spain; [Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan	European University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); European University of Madrid; University of Tokyo	Sanchez-Camacho, C (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.; Sanchez-Camacho, C (corresponding author), Univ Europea Madrid, Doctoral Studies & Res Sch, Madrid, Spain.	cristina.sanchez-camacho@universidadeuropea.es	Clemente, Cristina/Q-3523-2019; Arroyo, Alicia G./L-2796-2014; Arroyo, Alicia G/M-2507-2018; Sanchez-Camacho, Cristina/K-6871-2014	Clemente, Cristina/0000-0002-5831-9132; Arroyo, Alicia G./0000-0002-1536-3846; Arroyo, Alicia G/0000-0002-1536-3846; Sanchez-Camacho, Cristina/0000-0001-7756-0426	Universidad Europea de Madrid [2016UEM04]; Ministry of Economy, Industry and Competitiveness (MIEC) [SAF2014-20520R]; MIEC; Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence [SEV-2015-0505]	Universidad Europea de Madrid; Ministry of Economy, Industry and Competitiveness (MIEC); MIEC; Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence	This work was supported by a grant from the Universidad Europea de Madrid (2016UEM04) to C.S.C. and grant SAF2014-20520R from the Ministry of Economy, Industry and Competitiveness (MIEC) to A.G.A. The CNIC is supported by the MIEC and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Ambler CA, 2001, DEV BIOL, V234, P352, DOI 10.1006/dbio.2001.0267; Arroyo AG, 2007, CURR PHARM DESIGN, V13, P1787, DOI 10.2174/138161207780831284; Chabottaux V, 2007, CLIN EXP METASTAS, V24, P647, DOI 10.1007/s10585-007-9113-7; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Choi JS, 2004, EXP BRAIN RES, V154, P275, DOI 10.1007/s00221-003-1657-4; Clements KM, 2011, ANN RHEUM DIS, V70, P683, DOI 10.1136/ard.2010.130757; CURRY T E JR, 1989, Steroids, V54, P501, DOI 10.1016/0039-128X(89)90044-5; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Eshkar-Oren I, 2009, DEVELOPMENT, V136, P1263, DOI 10.1242/dev.034199; Fortunato SJ, 2002, J ASSIST REPROD GEN, V19, P483, DOI 10.1023/A:1020362519981; Funatsu N, 2004, CEREB CORTEX, V14, P1031, DOI 10.1093/cercor/bhh063; Giachelli CM, 1998, AM J PATHOL, V152, P353; Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573; Hehr CL, 2005, DEVELOPMENT, V132, P3371, DOI 10.1242/dev.01908; Host L, 2012, INT J CANCER, V131, P1537, DOI 10.1002/ijc.27436; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hu JKH, 2012, GENE DEV, V26, P2088, DOI 10.1101/gad.187385.112; Huang AH, 2015, J ORTHOP RES, V33, P800, DOI 10.1002/jor.22834; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Janssens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052915; Kajita M, 1999, FEBS LETT, V457, P353, DOI 10.1016/S0014-5793(99)01065-0; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kolkenbrock H, 1999, BIOL CHEM, V380, P1103, DOI 10.1515/BC.1999.137; Lee MY, 2001, CELL TISSUE RES, V306, P179, DOI 10.1007/s004410100456; Leigh NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076484; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Martin-Alonso M, 2015, CIRC RES, V117, pE13, DOI 10.1161/CIRCRESAHA.117.305108; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; McFarlane S, 2003, NEURON, V37, P559, DOI 10.1016/S0896-6273(03)00089-8; Mittal R, 2016, J CELL PHYSIOL, V231, P2599, DOI 10.1002/jcp.25430; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Paye A, 2014, CANCER RES, V74, P6758, DOI 10.1158/0008-5472.CAN-13-2994; Puente XS, 1996, CANCER RES, V56, P944; Rikimaru A, 2007, GENES CELLS, V12, P1091, DOI 10.1111/j.1365-2443.2007.01110.x; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rychter Z., 1972, FOLIA MORPHOL WARSZ, V20; Sanchez-Camacho C, 2011, DEV NEUROBIOL, V71, P337, DOI 10.1002/dneu.20865; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sounni NE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00111; Srichai MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017099; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Watson SS, 2009, DEV DYNAM, V238, P693, DOI 10.1002/dvdy.21866; Webber CA, 2002, J NEUROSCI, V22, P8091; Yamamoto M, 2012, BIOL OPEN, V1, P458, DOI 10.1242/bio.2012638; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yvernogeau L, 2012, DEVELOPMENT, V139, P277, DOI 10.1242/dev.067678; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	53	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184767	10.1371/journal.pone.0184767	http://dx.doi.org/10.1371/journal.pone.0184767			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926609	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600038
J	de Morais, MSM; do Nascimento, RA; Vieira, MCA; Moreira, MA; da Camara, SMA; Maciel, ACC; Almeida, MD				Medeiros de Morais, Maria Socorro; do Nascimento, Rafaela Andrade; Apolinario Vieira, Mariana Carmem; Moreira, Mayle Andrade; Aires da Camara, Saionara Maria; Cavalcanti Maciel, Alvaro Campos; Almeida, Maria das Graces			Does body image perception relate to quality of life in middle-aged women?	PLOS ONE			English	Article							DISSATISFACTION; ASSOCIATION; ADULTS; SELF; MASS	Objective In Brazil, information about the influence of body image on the various life domains of women in menopausal transition is scarce. Thus, the objective of the study was to analyze the relationship between body image and quality of life in middle-aged Brazilian women. Methods This was a cross-sectional study of 250 women between 40 and 65 years old, living in Parnamirim/RN, Brazil, who were evaluated in relation to body image and quality of life. For body image, women were classified as: dissatisfied due to low weight, satisfied (with their body weight) and dissatisfied due to being overweight. Quality of life was assessed through a questionnaire in which higher values indicate higher quality of life. Multiple linear regression was performed to analyze the relationship between body image and quality of life, adjusted for covariates that presented p<0.20 in the bivariate analysis. Results The average age was 52.1 (+/- 5.6) years, 82% of the women reported being dissatisfied due to being overweight, and 4.4% were dissatisfied due to having low weight. After multiple linear regression analyzes, body image remained associated with health (p<0.001), emotional (p = 0.016), and sexual (p = 0.048) domains of quality of life, as well as total score of the questionnaire (p<0.001). Conclusion Women who reported being dissatisfied with their body image due to having low weight or overweight had worse quality of life in comparison to those who were satisfied (with their body weight).	[Medeiros de Morais, Maria Socorro; Almeida, Maria das Graces] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Natal, RN, Brazil; [do Nascimento, Rafaela Andrade; Apolinario Vieira, Mariana Carmem; Cavalcanti Maciel, Alvaro Campos] Univ Fed Rio Grande do Norte, Physiotherapy Dept, Natal, RN, Brazil; [Moreira, Mayle Andrade] Univ Fed Ceara, Physiotherapy Dept, Fortaleza, Ceara, Brazil; [Aires da Camara, Saionara Maria] Univ Fed Rio Grande do Norte, Physiotherapy Dept, Santa Cruz, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte	do Nascimento, RA (corresponding author), Univ Fed Rio Grande do Norte, Physiotherapy Dept, Natal, RN, Brazil.	rafinha_andrade357@hotmail.com	Maciel, Alvaro ACCM/M-4003-2017; Almeida, Maria das Graças/O-6579-2018; Camara, S MA/M-7513-2015; Maciel, Álvaro Campos Cavalcanti/AAM-8606-2020; morais, maria/O-6225-2015	Maciel, Alvaro ACCM/0000-0002-8913-7868; Almeida, Maria das Graças/0000-0002-5587-0922; Camara, S MA/0000-0002-3054-7213; Maciel, Álvaro Campos Cavalcanti/0000-0002-8913-7868; Andrade do Nascimento, Rafaela/0000-0002-3765-0408; morais, maria/0000-0002-2338-003X				Camara SMA, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0214-1; Alipour B, 2015, EAT WEIGHT DISORD-ST, V20, P465, DOI 10.1007/s40519-015-0184-1; Bachmann GA, 2012, FEMALE PATIENT, V37; Scagliusi FB, 2006, APPETITE, V47, P77, DOI 10.1016/j.appet.2006.02.010; Bea JW, 2011, MENOPAUSE, V18, P44, DOI 10.1097/gme.0b013e3181e3aab1; Benkeser R M, 2012, Ghana Med J, V46, P66; Butler L, 2011, STEROIDS, V76, P627, DOI 10.1016/j.steroids.2011.02.026; Caluete EM, 2015, REV BRAS GERIATR GER; Camara SMA, 2015, PLOS ONE, V10; Sousa ACPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102299; Donaghue N, 2009, BODY IMAGE, V6, P37, DOI 10.1016/j.bodyim.2008.08.002; Ejike CE, 2015, J EPIDEMIOLOGY GLOBA, V5, P19; Ferrucci L, 1995, WOMENS HLTH AGING ST; Flynn KE, 2016, J SEXUAL MED; Fu X, 2011, OSTEOPOROSIS INT, V22, P113, DOI 10.1007/s00198-010-1210-9; Gallon CW, 2012, REV BRAS GINECOL OBS, V34, P175, DOI 10.1590/S0100-72032012000400007; Gomes CD, 2014, ARCH GERONTOL GERIAT, V58, P214, DOI 10.1016/j.archger.2013.10.009; Hrabosky JI, 2009, BODY IMAGE, V6, P155, DOI 10.1016/j.bodyim.2009.03.001; Jafary F, 2011, AGING MENTAL HLTH, V5; Lisboa LL, 2015, REV BRAS GINECOL OBS; McKinley NM, 2008, BODY IMAGE, V5, P375, DOI 10.1016/j.bodyim.2008.07.001; Messier V, 2011, MATURITAS, V68, P331, DOI 10.1016/j.maturitas.2011.01.014; Mintem GC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1579-7; Mond J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-920; Moreira MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2667-4; Nayir T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163290; Pearce G, 2013, HLTH PSYCHOL REV; Peat CM, 2008, J GEN PSYCHOL, V135, P343, DOI 10.3200/GENP.135.4.343-358; Pelegrini A, 2014, CIENC SAUDE COLETIVA, V19, P1201, DOI 10.1590/1413-81232014194.09092012; Pirkle CM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-293; Polivy J, 2013, HLTH PSYCHOL REV; Richard A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3497-8; Rubinstein HR, 2013, J HEALTH PSYCHOL, V18, P292, DOI 10.1177/1359105312454040; Runfola CD, 2013, EUR EAT DISORD REV, V21, P52, DOI 10.1002/erv.2201; Sarabia Cobo Carmen María, 2012, Gerokomos, V23, P15, DOI 10.4321/s1134-928x2012000100003; Amaral ACS, 2017, BODY IMAGE, V22, P32, DOI 10.1016/j.bodyim.2017.04.006; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Vilaca KHC, 2012, REV BRAS CI E MOV, V20, P5; Yazdandoost RY, 2016, WORLD J PLASTIC SURG	39	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184031	10.1371/journal.pone.0184031	http://dx.doi.org/10.1371/journal.pone.0184031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926575	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600007
J	Hermansyah, A; Sainsbury, E; Krass, I				Hermansyah, Andi; Sainsbury, Erica; Krass, Ines			The operation of a Research and Development (R&D) program and its significance for practice change in community pharmacy	PLOS ONE			English	Article							MEDICATION ASSISTANCE SERVICE; AUSTRALIAN PHARMACISTS; DISEASE MANAGEMENT; CARE-PROGRAM; HEALTH-CARE; IMPLEMENTATION; FRAMEWORK; POLICY; PARIHS; MODEL	Background Community pharmacy practice in Australia is changing and Research and Development (R&D) in community pharmacy plays an important role in contributing to the changes. A range of Cognitive Pharmacy Services (CPS) were developed from R&D programs, yet their implementation has been minimal indicating slow practice change within community pharmacy. Given the vital role of R&D, little is known about the operation and the extent to which it has been effective in supporting practice change in community pharmacy. Methods In depth, semi-structured interviews were conducted with 27 key stakeholders in the pharmacy and healthcare system in Australia. All interviews were audio-recorded, transcribed ad verbatim and analysed using an inductive approach. Results Participants perceived that the R&D program has played an important role in the advent of CPS. Furthermore, they considered that evidence generated by the R&D projects is a critical influence on policy formulation, funding and implementation of CPS into practice. However, policy decisions and subsequent implementation are also influenced by other factors associated with context and facilitation which in turn foster or inhibit effective Knowledge Translation (KT) in the community pharmacy sector. Conclusion While R&D programs have been viewed as essential for supporting changes in community pharmacy practice through development and funding of CPS, the overall impact has been small, as contemporary practice continues to be predominantly a dispensing model. Given the complexity and dynamic nature of the community pharmacy system, stakeholders must take into account the inter-relationship between context, evidence and facilitation for successful KT in community pharmacy practice.	[Hermansyah, Andi; Sainsbury, Erica; Krass, Ines] Univ Sydney, Fac Pharm, Sydney, NSW, Australia; [Hermansyah, Andi] Airlangga Univ, Fac Pharm, Surabaya, Indonesia	University of Sydney; Airlangga University	Hermansyah, A (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW, Australia.; Hermansyah, A (corresponding author), Airlangga Univ, Fac Pharm, Surabaya, Indonesia.	andi.hermansyah@sydney.edu.au	Hermansyah, Andi/AAC-1494-2020	Hermansyah, Andi/0000-0002-9716-3126				Almarsdottir AB, 2014, RES SOC ADMIN PHARM, V10, P252, DOI 10.1016/j.sapharm.2013.04.002; [Anonymous], BR MED J, DOI DOI 10.1136/BMJ.C2298; Armour C, 2007, THORAX, V62, P496, DOI 10.1136/thx.2006.064709; Australian National Audit Office, 2015, ADM 5 COMM PHARM AGR; Brooks JM, 2008, INQUIRY-J HEALTH CAR, V45, P75, DOI 10.5034/inquiryjrnl_45.01.75; Calder R, 2006, EVALUATION 3 COMMUNI; Carter SR, 2012, CONSUMERS WILLINGNES; Chapman C, 2011, AUST PRESCR, V34, P34; Department of Health and Ageing, 2010, DIAB PIL PROGR DIAB; Dobrow MJ, 2004, SOC SCI MED, V58, P207, DOI 10.1016/S0277-9536(03)00166-7; Ellen ME, 2012, KNOWLEDGE TRANSLATIO; Emmerton LM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-164; Feletto E, 2010, PHARM WORLD SCI, V32, P130, DOI 10.1007/s11096-009-9355-3; Ferguson O., 2000, PHARM J, V264, P27; Gilbert A, 2013, J PHARM PRACT RES, V43, P4, DOI 10.1002/j.2055-2335.2013; GILBERT AL, 2014, J PHARM PRACT RES, V44, P9; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Gowan J., 2006, J COMPLEMENT MED, V5, P30; Hales J, 2010, EVALUATION DIABETES; Harvey G, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0398-2; Hermansyah A., 2016, RES SOCIAL ADM PHARM; Hilmer S, 2010, DRUG BURDEN INDEX PO; Kitson A, 1998, QUAL HEALTH CARE, V7, P149, DOI 10.1136/qshc.7.3.149; Krass I, 2007, DIABETIC MED, V24, P677, DOI 10.1111/j.1464-5491.2007.02143.x; Krass I, 2011, DIABETIC MED, V28, P987, DOI 10.1111/j.1464-5491.2011.03296.x; Krass I., 2005, PHARM DIABETES CARE; KRASS I, 2010, AUST J PHARM, V91, P39; Lounsbery JL, 2009, J AM PHARM ASS, V49; Maher JH, 2014, RES SOC ADMIN PHARM, V10, P633, DOI 10.1016/j.sapharm.2013.09.002; McMillan SS, 2013, RES SOC ADMIN PHARM, V9, P863, DOI 10.1016/j.sapharm.2012.11.003; Mitchell B, 2011, PATIENT EDUC COUNS, V83, P288, DOI 10.1016/j.pec.2011.04.027; Mossialos E, 2015, HEALTH POLICY, V119, P628, DOI 10.1016/j.healthpol.2015.02.007; Mossialos E, 2013, HEALTH POLICY, V111, P135, DOI 10.1016/j.healthpol.2013.04.003; Moullin JC, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0005-z; Noyce PR, 2007, ANN PHARMACOTHER, V41, P861, DOI 10.1345/aph.1K015; Patwardhan PD, 2014, RES SOC ADMIN PHARM, V10, P475, DOI 10.1016/j.sapharm.2013.07.005; Peterson GM, 2009, J CLIN PHARM THER, V34, P397, DOI 10.1111/j.1365-2710.2008.01020.x; Pharmacy Guild of Australia, 2010, 4 COMM PHARM AGR RES; PricewaterhouseCoopers, 2015, COMB REV 5 COMM PHAR; Roberts Alison S, 2005, Res Social Adm Pharm, V1, P546, DOI 10.1016/j.sapharm.2005.09.003; Roughead EE, 2003, DRUG AGING, V20, P643, DOI 10.2165/00002512-200320090-00002; Rycroft-Malone J, 2004, J NURS CARE QUAL, V19, P297, DOI 10.1097/00001786-200410000-00002; Saini B, 2004, ANN PHARMACOTHER, V38, P1954, DOI 10.1345/aph.1E045; Saini B, 2011, PATIENT EDUC COUNS, V83, P295, DOI 10.1016/j.pec.2011.05.001; Scahill S, 2010, NZ MED J, P6; Singleton JA, 2014, RES SOC ADMIN PHARM, V10, P459, DOI 10.1016/j.sapharm.2013.05.010; Stafford A, 2009, EC VALUE HOME MED RE; Strand MA, 2014, J AM PHARM ASSOC, V54, P193, DOI 10.1331/JAPhA.2014.13145; Tenni P., 2011, AUST PHARM, V30, P596; The Pharmaceutical Society of Australia, 2012, GUID PHARM PROV MED; Ullrich PM, 2014, WORLDV EVID-BASED NU, V11, P26, DOI 10.1111/wvn.12016; Wallace A, 2010, EVALUATION ASTHMA PI; Zellmer W A, 2001, Pharm Hist, V43, P75	53	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184954	10.1371/journal.pone.0184954	http://dx.doi.org/10.1371/journal.pone.0184954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922381	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300050
J	Kong, HS; Lee, J; Youm, HW; Kim, SK; Lee, JR; Suh, CS; Kim, SH				Kong, Hyun Sun; Lee, Jaewang; Youm, Hye Won; Kim, Seul Ki; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun			Effect of treatment with angiopoietin-2 and vascular endothelial growth factor on the quality of xenografted bovine ovarian tissue in mice	PLOS ONE			English	Article							FOLLICULAR SURVIVAL; POSTNATAL NEOVASCULARIZATION; DIFFERENT CRYOPROTECTANTS; STRUCTURAL PRESERVATION; SCID MICE; TRANSPLANTATION; ANGIOGENESIS; CRYOPRESERVATION; VEGF; VITRIFICATION	Cryopreservation and transplantation of ovarian tissue (OT) represents a method for fertility preservation. However, as the transplantation is performed without vessel anastomosis, unavoidable ischemic damage occurs. To reduce this ischemic damage and improve outcomes after transplantation, we used two kind of angiogenic factors, angiopoietin-2 (ang-2) and vascular endothelial growth factor (VEGF). Fresh or vitrified-warmed bovine OTs were prepared for xenotransplantation (XT). Fresh OTs were immediately xenografted into nude mice (XT-Fresh). Vitrified-warmed OTs were xenografted into four subgroups of mice, which were injected intraperitoneally before XT with saline (XT-Vitri), Ang-2 (XT-Ang-2), VEGF (XT-VEGF), and a combination of Ang-2 and VEGF (XT-Combined). Seven or 28 days post-grafting, grafted OTs and blood samples were collected for evaluation. Follicle normality was higher in the angiogenic factor-treated groups than in the XT-Vitri group. The XT-VEGF and the XT-Combined showed higher (P<0.05) follicular density than the XT-Vitri group. The highest apoptotic follicle ratio was observed in the XT-Vitri group on day 7; this was decreased (P<0.05) in the XT-Combined group. Microvessel densities were higher in the angiogenic factor-treated groups than in the XT-Vitri group. The largest fibrotic area was showed in the XT-Vitri group on day 28, and it was decreased (P<0.05) in the XT-combined group. Based on these results, administration of Ang-2 and VEGF to recipients prior to XT appeared to alleviate ischemic damage by enhancing angiogenesis, which resulted in the maintenance of follicle integrity and density, and reduced follicle apoptosis and OT fibrosis.	[Kong, Hyun Sun; Lee, Jaewang; Youm, Hye Won; Kim, Seul Ki; Lee, Jung Ryeol] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea; [Kong, Hyun Sun; Kim, Seul Ki; Lee, Jung Ryeol; Suh, Chang Suk; Kim, Seok Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Suh, Chang Suk] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Jaewang] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Northwestern University; Feinberg School of Medicine	Lee, JR (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea.; Lee, JR; Suh, CS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.; Suh, CS (corresponding author), Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea.	leejrmd@snu.ac.kr; suhcs@snu.ac.kr		Lee, Jung Ryeol/0000-0003-3743-2934; Lee, Jaewang/0000-0001-6801-7149	Korea Healthcare Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [HI12C0055]; National Research Foundation of Korea [NRF-2017R1C1B2003897]; Seoul National University Bundang Hospital Research Fund [02-2014-013]; Seoul National University Bundang Hospital Research Fund	Korea Healthcare Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea); Seoul National University Bundang Hospital Research Fund; Seoul National University Bundang Hospital Research Fund	This work was supported by the Korea Healthcare Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [grant number HI12C0055], National Research Foundation of Korea [grant number NRF-2017R1C1B2003897] and Seoul National University Bundang Hospital Research Fund [grant number 02-2014-013]. Ministry of Health and Welfare: http://www.mohw.go.kr/eng/index.jsp, Seoul National University Bundang Hospital Research Fund: https://www.snubh.org/dh/en/, National Research Foundation of Korea: http://www.nrf.re.kr/eng/main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves KA, 2017, REPROD FERT DEVELOP, V29, P867, DOI 10.1071/RD15402; Amorim CA, 2013, HUM REPROD, V28, P2146, DOI 10.1093/humrep/det103; Amorim CA, 2011, REPROD BIOMED ONLINE, V23, P160, DOI 10.1016/j.rbmo.2011.04.005; [Anonymous], NON TRADITIONAL REF; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; BAMBANG LS, 1995, J THORAC CARDIOV SUR, V110, P998, DOI 10.1016/S0022-5223(05)80167-9; Borges EN, 2009, CRYOBIOLOGY, V59, P195, DOI 10.1016/j.cryobiol.2009.07.003; Damous LL, 2016, REPROD SCI, V23, P803, DOI 10.1177/1933719115620493; Dath C, 2010, HUM REPROD, V25, P1734, DOI 10.1093/humrep/deq131; DISSEN GA, 1994, ENDOCRINOLOGY, V134, P1146, DOI 10.1210/en.134.3.1146; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fransolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091073; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gavish Z, 2014, HUM REPROD, V29, P989, DOI 10.1093/humrep/deu015; GOSDEN RG, 1994, J REPROD FERTIL, V101, P619, DOI 10.1530/jrf.0.1010619; Hernandez-Fonseca H, 2004, FERTIL STERIL, V81, P888, DOI 10.1016/j.fertnstert.2003.10.017; Herraiz S, 2014, FERTIL STERIL, V101, P775, DOI 10.1016/j.fertnstert.2013.11.016; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Isidori AM, 2016, J ENDOCRINOL INVEST, V39, P1235, DOI 10.1007/s40618-016-0502-0; Jensen AK, 2017, J ASSIST REPROD GEN, V34, P324, DOI 10.1007/s10815-016-0843-9; Kang BJ, 2016, J ASSIST REPROD GEN, V33, P281, DOI 10.1007/s10815-015-0628-6; Kong HS, 2016, REPROD SCI, V23, P51, DOI 10.1177/1933719115594021; Labied S, 2013, TRANSPLANTATION, V95, P426, DOI 10.1097/TP.0b013e318279965c; Langbeen A, 2016, ANIM REPROD SCI, V168, P73, DOI 10.1016/j.anireprosci.2016.02.029; Lee J.H., 2015, BIOMED RES INT, V2015, P10, DOI DOI 10.1155/2015/137020; Lee J, 2016, HUM REPROD, V31, P1827, DOI 10.1093/humrep/dew144; Lee J, 2015, THERIOGENOLOGY, V83, P285, DOI 10.1016/j.theriogenology.2014.09.027; Lee JR, 2014, EUR J OBSTET GYN R B, V178, P16, DOI 10.1016/j.ejogrb.2014.04.040; Li S, 2009, REPROD DOMEST ANIM, V44, P764, DOI 10.1111/j.1439-0531.2008.01069.x; Li SH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081237; Liu J, 2002, HUM REPROD, V17, P605, DOI 10.1093/humrep/17.3.605; Lucci CM, 2004, THERIOGENOLOGY, V61, P1101, DOI 10.1016/j.theriogenology.2003.06.004; Lundy T, 1999, J REPROD FERTIL, V115, P251, DOI 10.1530/jrf.0.1150251; Mahmoodi M, 2014, REPRODUCTION, V147, P733, DOI 10.1530/REP-13-0379; Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3; Schmidt KT, 2010, BJOG-INT J OBSTET GY, V117, P163, DOI 10.1111/j.1471-0528.2009.02408.x; Schubert B, 2008, FERTIL STERIL, V89, P1787, DOI 10.1016/j.fertnstert.2007.03.101; Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.TEA.2011.0204, 10.1089/ten.tea.2011.0204]; Teitelbaum AA, 2013, EUROINTERVENTION, V8, P1081, DOI 10.4244/EIJV8I9A165; Torrents E, 2003, HUM REPROD UPDATE, V9, P471, DOI 10.1093/humupd/dmg036; Van Eyck AS, 2009, FERTIL STERIL, V92, P374, DOI 10.1016/j.fertnstert.2008.05.012; Wang L, 2013, J ASSIST REPROD GEN, V30, P1301, DOI 10.1007/s10815-013-0043-9; Wang YR, 2012, REPROD BIOMED ONLINE, V24, P646, DOI 10.1016/j.rbmo.2012.02.025; Wu DD, 2010, ANAT REC, V293, P2154, DOI 10.1002/ar.21228; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Youm HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166782; Youm HW, 2014, HUM REPROD, V29, P720, DOI 10.1093/humrep/det449	50	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184546	10.1371/journal.pone.0184546	http://dx.doi.org/10.1371/journal.pone.0184546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915249	Green Published, gold, Green Submitted			2022-12-27	WOS:000410861600011
J	Mueller, C; Limacher, A; Mean, M; Rodondi, N; Aujesky, D				Mueller, Carolin; Limacher, Andreas; Mean, Marie; Rodondi, Nicolas; Aujesky, Drahomir			Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+cohort study	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; RISK-FACTORS; 1ST EPISODE; PREDICTORS; WEIGHT; THROMBOPHILIA; COHORT	Background Whether obesity is associated with recurrent venous thromboembolism (VTE) in elderly patients is unknown. Objectives To examine the association between two obesity measures, the body mass index (BMI) and the waist circumference (WC), and recurrent VTE in elderly patients. Patients/Methods We studied 986 patients aged >= 65 years with an acute VTE from a prospective multicenter cohort study (09/2009-12/2013). The BMI was determined and categorized as <25, 25 to <30, or >= 30 kg/m(2). The WC was categorized as <80 cm in women (w)/<94 cm in men (m), 80 to <88 cm (w)/94 to <102 cm (m), or >= 88 cm (w)/>= 102 cm (m). We examined the association between the BMI and the WC and the time to a first symptomatic recurrent VTE using competing risk regression, adjusting for known risk factors of VTE recurrence and periods of anticoagulation. Results The mean follow-up was 28 months. The 3-year cumulative incidence of recurrent VTE did not vary by BMI and was 17.6% for a BMI <25 kg/m(2), 11.5% for a BMI 25 to <30 kg/m(2), and 16.9% for a BMI >= 30 kg/m(2) (P = 0.09). The 3-year cumulative incidence of recurrent VTE did not vary by WC. After adjustment, neither the BMI (sub-hazard ratio [SHR] 1.02, 95% confidence interval [CI 0.98-1.05]) nor the WC (SHR 1.01, 95% CI 0.99-1.02) was associated with recurrent VTE. Conclusions Measures of body weight were not associated with recurrent VTE in our cohort. Obesity does not appear to be a predictor of recurrent VTE in the elderly.	[Mueller, Carolin; Mean, Marie; Rodondi, Nicolas; Aujesky, Drahomir] Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Bern, Switzerland; [Limacher, Andreas] Univ Bern, CTU Bern, Dept Clin Res, Bern, Switzerland; [Limacher, Andreas] Univ Bern, ISPM, Bern, Switzerland; [Mean, Marie] Lausanne Univ Hosp, Dept Gen Internal Med, Lausanne, Switzerland; [Rodondi, Nicolas] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern	Mueller, C (corresponding author), Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Bern, Switzerland.	Carolin.mueller2@insel.ch		Mean, Marie/0000-0003-0477-7899; Rodondi, Nicolas/0000-0001-9083-6896	Swiss National Science Foundation [33CSCO-122659/139470]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant of the Swiss National Science Foundation (no. 33CSCO-122659/139470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi M, 2003, THROMB HAEMOSTASIS, V89, P493, DOI 10.1055/s-0037-1613379; Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Baglin T, 2004, J THROMB HAEMOST, V2, P2152, DOI 10.1111/j.1538-7836.2004.01050.x; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Borch KH, 2009, J THROMB HAEMOST, V7, P739, DOI 10.1111/j.1538-7836.2008.03234.x; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Dey DK, 1999, EUR J CLIN NUTR, V53, P905, DOI 10.1038/sj.ejcn.1600852; Douketis J, 2010, ANN INTERN MED, V153, P523, DOI 10.7326/0003-4819-153-8-201010190-00009; Eichinger S, 2008, ARCH INTERN MED, V168, P1678, DOI 10.1001/archinte.168.15.1678; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Garcia-Fuster MJ, 2005, PATHOPHYSIOL HAEMO T, V34, P6, DOI 10.1159/000088541; Han TS, 2011, BRIT MED BULL, V97, P169, DOI 10.1093/bmb/ldr002; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Huang W, 2016, J THROMB THROMBOLYS, V41, P525, DOI 10.1007/s11239-015-1301-8; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lopez-Jimenez L, 2006, HAEMATOLOGICA, V91, P1046; Lutsey PL, 2010, AM J PUBLIC HEALTH, V100, P1506, DOI 10.2105/AJPH.2008.157776; Mean M, 2013, J THROMB THROMBOLYS, V36, P475, DOI 10.1007/s11239-013-0875-2; Novacek G, 2010, GASTROENTEROLOGY, V139, P779, DOI 10.1053/j.gastro.2010.05.026; Olie V, 2012, THROMB RES, V130, P16, DOI 10.1016/j.thromres.2011.10.026; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Severinsen MT, 2009, CIRCULATION, V120, P1850, DOI 10.1161/CIRCULATIONAHA.109.863241; Spencer FA, 2008, THROMB HAEMOSTASIS, V100, P780, DOI 10.1160/TH08-04-0255; Sundquist K, 2015, J THROMB HAEMOST, V13, P2180, DOI 10.1111/jth.13154	31	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184868	10.1371/journal.pone.0184868	http://dx.doi.org/10.1371/journal.pone.0184868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915260	Green Published, gold, Green Submitted			2022-12-27	WOS:000410861600018
J	Brown, HE; Desai, T; Murphy, AJ; Pancholi, H; Schmidt, ZW; Swahn, H; Liebl, EC				Brown, Hannah E.; Desai, Trishna; Murphy, Allison J.; Pancholi, Harshida; Schmidt, Zachary W.; Swahn, Hannah; Liebl, Eric C.			The function of Drosophila larval class IV dendritic arborization sensory neurons in the larval-pupal transition is separable from their function in mechanical nociception responses	PLOS ONE			English	Article							BODY-SIZE; BEHAVIOR; PICKPOCKET1; PROTEIN; GENES	The sensory and physiological inputs which govern the larval-pupal transition in Drosophila, and the neuronal circuity that integrates them, are complex. Previous work from our laboratory identified a dosage-sensitive genetic interaction between the genes encoding the Rho-GEF Trio and the zinc-finger transcription factor Sequoia that interfered with the larval-pupal transition. Specifically, we reported heterozygous mutations in sequoia (seq) dominantly exacerbated the trio mutant phenotype, and this seq-enhanced trio mutant genotype blocked the transition of third instar larvae from foragers to wanderers, a requisite behavioral transition prior to pupation. In this work, we use the GAL4-UAS system to rescue this phenotype by tissue-specific trio expression. We find that expressing trio in the class IV dendritic arborization (da) sensory neurons rescues the larval-pupal transition, demonstrating the reliance of the larval-pupal transition on the integrity of these sensory neurons. As nociceptive responses also rely on the functionality of the class IV da neurons, we test mechanical nociceptive responses in our mutant and rescued larvae and find that mechanical nociception is separable from the ability to undergo the larval-pupal transition. This demonstrates for the first time that the roles of the class IV da neurons in governing two critical larval behaviors, the larval-pupal transition and mechanical nociception, are functionally separable from each other.	[Brown, Hannah E.; Desai, Trishna; Murphy, Allison J.; Pancholi, Harshida; Schmidt, Zachary W.; Swahn, Hannah; Liebl, Eric C.] Denison Univ, Dept Biol, Granville, OH 43023 USA; [Brown, Hannah E.] Duke Univ, Sch Med, Dept Mol Genet, Durham, NC USA; [Brown, Hannah E.] Duke Univ, Sch Med, Dept Microbiol, Durham, NC USA; [Desai, Trishna] Cleveland Fdn, Cleveland, OH USA; [Murphy, Allison J.] Univ Rochester, Sch Med & Dent, Neurosci Grad Program, Rochester, NY USA; [Pancholi, Harshida] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53233 USA; [Swahn, Hannah] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Denison University; Duke University; Duke University; University of Rochester; Marquette University; Case Western Reserve University	Liebl, EC (corresponding author), Denison Univ, Dept Biol, Granville, OH 43023 USA.	liebl@denison.edu		Pancholi, Harshida/0000-0003-4375-6919; Murphy, Allison/0000-0002-9097-3687; Schmidt, Zachary/0000-0003-0824-6315; Brown, Hannah/0000-0002-9175-8209	Denison's Department of Biology, Leon & Grace Greene Academic Venture Fund; Lisska Center for Scholarly Engagement, Office of the Provost and R.C; Ohio State Campus Microscopy and Imaging Facility [P30 CA016058]	Denison's Department of Biology, Leon & Grace Greene Academic Venture Fund; Lisska Center for Scholarly Engagement, Office of the Provost and R.C; Ohio State Campus Microscopy and Imaging Facility	TD and ZWS were supported by Denison's J. Reid and Polly Anderson Endowed Fund and the Laurie Bukovac and David Hodgson Endowed Fund during the summer of 2016. Denison's Department of Biology, Leon & Grace Greene Academic Venture Fund, Lisska Center for Scholarly Engagement, Office of the Provost and R.C. Good Faculty Fellowship provided funding for this work. The Ohio State Campus Microscopy and Imaging Facility is supported in part by grant P30 CA016058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; Deak P, 1997, GENETICS, V147, P1697; Dean KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084149; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Iyer SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033634; Jayakumar S, 2016, ELIFE, V5, DOI 10.7554/eLife.17495; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth CK, 2014, P NATL ACAD SCI USA, V111, P7018, DOI 10.1073/pnas.1313058111; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Pahi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142226; Robertson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078704; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shivalkar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033737; SOKOLOWSKI MB, 1984, ANIM BEHAV, V32, P645, DOI 10.1016/S0003-3472(84)80139-6; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Valzania L, 2016, DEV BIOL, V410, P14, DOI 10.1016/j.ydbio.2015.12.021; Vandersmissen HP, 2014, GEN COMP ENDOCR, V209, P135, DOI 10.1016/j.ygcen.2014.08.006; Wegman LJ, 2010, DEV BIOL, V345, P170, DOI 10.1016/j.ydbio.2010.07.004; Weiner AT, 2016, CYTOSKELETON, V73, P35, DOI 10.1002/cm.21270; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xie XJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002207; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184950	10.1371/journal.pone.0184950	http://dx.doi.org/10.1371/journal.pone.0184950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910410	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200123
J	de Souza, MF; Kuasne, H; Barros, MD; Ciliao, HL; Marchi, FA; Fuganti, PE; Paschoal, AR; Rogatto, SR; Colus, IMD				de Souza, Marilesia Ferreira; Kuasne, Hellen; Barros-Filho, Mateus de Camargo; Ciliao, Heloisa Lizotti; Marchi, Fabio Albuquerque; Fuganti, Paulo Emilio; Paschoal, Alexandre Rossi; Rogatto, Silvia Regina; de Syllos Colus, Ilce Mara			Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; FREE NUCLEIC-ACIDS; CELL-PROLIFERATION; DOWN-REGULATION; BIOMARKERS; EXPRESSION; PLASMA; GENE; MICRORNAS; MIR-375	Circulating nucleic acids are found in free form in body fluids and may serve as minimally invasive tools for cancer diagnosis and prognosis. Only a few studies have investigated the potential application of circulating mRNAs and microRNAs (miRNAs) in prostate cancer (PCa). The Cancer Genome Atlas (TCGA) database was used for an in silico analysis to identify circulating mRNA and miRNA as potential markers of PCa. A total of 2,267 genes and 49 miRNAs were differentially expressed between normal and tumor samples. The prediction analyses of target genes and integrative analysis of mRNA and miRNA expression revealed eleven genes and eight miRNAs which were validated by RT-qPCR in plasma samples from 102 untreated PCa patients and 50 cancer-free individuals. Two genes, OR51E2 and SIM2, and two miRNAs, miR-200c and miR-200b, showed significant association with PCa. Expression levels of these transcripts distinguished PCa patients from controls (67% sensitivity and 75% specificity). PCa patients and controls with prostate-specific antigen (PSA) <= 4.0 ng/mL were discriminated based on OR51E2 and SIM2 expression levels. The miR-200c expression showed association with Gleason score and miR-200b, with bone metastasis, bilateral tumor, and PSA > 10.0 ng/mL. The combination of circulating mRNA and miRNA was useful for the diagnosis and prognosis of PCa.	[de Souza, Marilesia Ferreira; Ciliao, Heloisa Lizotti; de Syllos Colus, Ilce Mara] Univ Estadual Londrina, Gen Biol Dept, Londrina, Parana, Brazil; [Kuasne, Hellen; Barros-Filho, Mateus de Camargo; Marchi, Fabio Albuquerque; Rogatto, Silvia Regina] CIPE, AC Camargo Canc Ctr, Sao Paulo, Sao Paulo, Brazil; [Fuganti, Paulo Emilio] Londrina Canc Hosp, Londrina, Parana, Brazil; [Paschoal, Alexandre Rossi] Univ Tecnol Fed Parana, UTFPR, Dept Comp, Comelio Procopio, Parana, Brazil; [Rogatto, Silvia Regina] Univ Southern Denmark, Dept Clin Genet, Vejle Hosp, Vejle, Denmark; [Rogatto, Silvia Regina] Univ Southern Denmark, Inst Reg Hlth Res, Vejle, Denmark	Universidade Estadual de Londrina; A.C.Camargo Cancer Center; Universidade Tecnologica Federal do Parana; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark	Colus, IMD (corresponding author), Univ Estadual Londrina, Gen Biol Dept, Londrina, Parana, Brazil.	ilcecolus@gmail.com	Marchi, Fabio A/N-9288-2018; Paschoal, Alexandre Rossi Rossi/I-4074-2013; Rogatto, Silvia R/E-6535-2012; Filho, Mateus C Barros/J-1544-2015; Cólus, Ilce Mara/A-3071-2019	Marchi, Fabio A/0000-0001-5815-8423; Paschoal, Alexandre Rossi Rossi/0000-0002-8887-0582; Filho, Mateus C Barros/0000-0003-3893-5269; Souza, Marilesia/0000-0002-1556-3178; Lizotti Ciliao, Heloisa/0000-0001-7602-7160; Rogatto, Silvia/0000-0003-4637-5687	Araucaria Foundation of Support for the Scientific and Technological of Parana [185/2014]; National Institute of Science and Technology in Oncogenomics (Sao Paulo Research Foundation FAPESP) [2008/57887-9]; National Institute of Science and Technology in Oncogenomics (Brazilian National Council for Scientific and Technological Development CNPq) [573589/08-9]; Coordination for the Improvement of Higher Education Personnel Brazil (CAPES), Brazil; Vejle Hospital, Institute of Regional Health Research, Vejle, Denmark [K16-04V]	Araucaria Foundation of Support for the Scientific and Technological of Parana; National Institute of Science and Technology in Oncogenomics (Sao Paulo Research Foundation FAPESP); National Institute of Science and Technology in Oncogenomics (Brazilian National Council for Scientific and Technological Development CNPq); Coordination for the Improvement of Higher Education Personnel Brazil (CAPES), Brazil; Vejle Hospital, Institute of Regional Health Research, Vejle, Denmark	This study was supported by grants from the Araucaria Foundation of Support for the Scientific and Technological of Parana (185/2014), National Institute of Science and Technology in Oncogenomics (Sao Paulo Research Foundation FAPESP 2008/57887-9 and Brazilian National Council for Scientific and Technological Development CNPq 573589/08-9), Coordination for the Improvement of Higher Education Personnel Brazil (CAPES), Brazil and Vejle Hospital, Institute of Regional Health Research, Vejle, Denmark (K16-04V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Balzano F, 2015, MOLECULES, V20, P19030, DOI 10.3390/molecules201019030; Belchior M, CARACTERISTICAS ETNI; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao WQ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1921-6; CARRANO AV, 1988, MUTAT RES, V204, P379, DOI 10.1016/0165-1218(88)90036-5; Cheng GF, 2015, ADV DRUG DELIVER REV, V81, P75, DOI 10.1016/j.addr.2014.09.001; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069239; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Dasi F, 2001, LAB INVEST, V81, P767, DOI 10.1038/labinvest.3780285; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Deligezer U, 2010, CLIN CHIM ACTA, V411, P1452, DOI 10.1016/j.cca.2010.05.040; DeYoung MP, 2003, P NATL ACAD SCI USA, V100, P4760, DOI 10.1073/pnas.0831000100; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Endzelins E, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0523-5; Erdmann K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-82; Fabris L, 2016, EUR UROL, V70, P312, DOI 10.1016/j.eururo.2015.12.054; Filella X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111784; Gulati R, 2014, CANCER-AM CANCER SOC, V120, P3519, DOI 10.1002/cncr.28932; He MY, 2013, PROSTATE, V73, P1048, DOI 10.1002/pros.22652; Huang XY, 2015, EUR UROL, V67, P33, DOI 10.1016/j.eururo.2014.07.035; Instituto Nacional de Cancer Jose A Alencar Gomes da Silva. INCA D Instituto Nacional de Cancer, 2016, EST 2016; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kachakova D, 2015, DNA CELL BIOL, V34, P189, DOI 10.1089/dna.2014.2663; Katz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113700; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Klotz L, 2013, CURR TREAT OPTION ON, V14, P97, DOI 10.1007/s11864-012-0221-5; Kotb S, 2014, TUMOR BIOL, V35, P12613, DOI 10.1007/s13277-014-2584-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028837; March-Villalba JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043470; Mihelich BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124245; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Puhr M, 2012, AM J PATHOL, V181, P2188, DOI 10.1016/j.ajpath.2012.08.011; Rapisuwon S, 2016, COMPUT STRUCT BIOTEC, V14, P211, DOI 10.1016/j.csbj.2016.05.004; Rigau M, 2010, PROSTATE, V70, P1760, DOI 10.1002/pros.21211; Rodriguez M, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.29; Salami SS, 2013, UROL ONCOL-SEMIN ORI, V31, P566, DOI 10.1016/j.urolonc.2011.04.001; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sequeiros T, 2015, PROSTATE, V75, P1102, DOI 10.1002/pros.22995; Shen J, 2012, PROSTATE, V72, P1469, DOI 10.1002/pros.22499; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Simon R, 2007, CANCER INFORM, V3, P11; Strope SA, 2010, NAT REV UROL, V7, P487, DOI 10.1038/nrurol.2010.120; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wach S, 2015, INT J CANCER, V137, P1406, DOI 10.1002/ijc.29505; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Walter SD, 2017, BRIT J CANCER, V116, P141, DOI 10.1038/bjc.2016.378; Wang JQ, 2017, THERANOSTICS, V7, P1407, DOI 10.7150/thno.18262; Wang JQ, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0285-6; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Wu JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128642; Xu LL, 2000, CANCER RES, V60, P6568; Yu JJ, 2014, ONCOL REP, V31, P910, DOI 10.3892/or.2013.2897; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8; Zheng GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083025	67	61	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184094	10.1371/journal.pone.0184094	http://dx.doi.org/10.1371/journal.pone.0184094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910345	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200030
J	Ruff, CA; Faulkner, SD; Rumajogee, P; Beldick, S; Foltz, W; Corrigan, J; Basilious, A; Jiang, SJ; Thiyagalingam, S; Yager, JY; Fehlings, MG				Ruff, Crystal A.; Faulkner, Stuart D.; Rumajogee, Prakasham; Beldick, Stephanie; Foltz, Warren; Corrigan, Jennifer; Basilious, Alfred; Jiang, Shangjun; Thiyagalingam, Shanojan; Yager, Jerome Y.; Fehlings, Michael G.			The extent of intrauterine growth restriction determines the severity of cerebral injury and neurobehavioural deficits in rodents	PLOS ONE			English	Article							WHITE-MATTER INJURY; LATE OLIGODENDROCYTE PROGENITORS; BRAIN-INJURY; SPINAL-CORD; MAGNETIZATION-TRANSFER; PRENATAL ISCHEMIA; PREMATURE-INFANTS; HYPOXIA-ISCHEMIA; MOTOR IMPAIRMENT; CORPUS-CALLOSUM	Background Cerebral Palsy (CP) is the most common physical pediatric neurodevelopmental disorder and spastic diplegic injury is its most frequent subtype. CP results in substantial neuromotor and cognitive impairments that have significant socioeconomic impact. Despite this, its underlying pathophysiological mechanisms and etiology remain incompletely understood. Furthermore, there is a need for clinically relevant injury models, which a) reflect the heterogeneity of the condition and b) can be used to evaluate new translational therapies. To address these key knowledge gaps, we characterized a chronic placental insufficiency (PI) model, using bilateral uterine artery ligation (BUAL) of dams. This injury model results in intrauterine growth restriction (IUGR) in pups, and animals recapitulate the human phenotype both in terms of neurobehavioural and anatomical deficits. Methods Effects of BUAL were studied using luxol fast blue (LFB)/hematoxylin & eosin (H&E) staining, immunohistochemistry, quantitative Magnetic Resonance Imaging (MRI), and Catwalk neurobehavioural tests. Results Neuroanatomical analysis revealed regional ventricular enlargement and corpus callosum thinning in IUGR animals, which was correlated with the extent of growth restriction. Olig2 staining revealed reductions in oligodendrocyte density in white and grey matter structures, including the corpus callosum, optic chiasm, and nucleus accumbens. The caudate nucleus, along with other brain structures such as the optic chiasm, internal capsule, septofimbrial and lateral septal nuclei, exhibited reduced size in animals with IUGR. The size of the pretectal nucleus was reduced only in moderately injured animals. MAG/NF200 staining demonstrated reduced myelination and axonal counts in the corpus callosum of IUGR animals. NeuN staining revealed changes in neuronal density in the hippocampus and in the thickness of hippocampal CA2 and CA3 regions. Diffusion weighted imaging (DWI) revealed regional white and grey matter changes at 3 weeks of age. Furthermore, neurobehavioural testing demonstrated neuromotor impairments in animals with IUGR in paw intensities, swing speed, relative print positions, and phase dispersions. Conclusions We have characterized a rodent model of IUGR and have demonstrated that the neuroanatomical and neurobehavioural deficits mirror the severity of the IUGR injury. This model has the potential to be applied to examine the pathobiology of and potential therapeutic strategies for IUGR-related brain injury. Thus, this work has potential translational relevance for the study of CP.	[Ruff, Crystal A.; Faulkner, Stuart D.; Rumajogee, Prakasham; Beldick, Stephanie; Basilious, Alfred; Jiang, Shangjun; Thiyagalingam, Shanojan; Fehlings, Michael G.] Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Ruff, Crystal A.; Faulkner, Stuart D.; Rumajogee, Prakasham; Beldick, Stephanie; Basilious, Alfred; Jiang, Shangjun; Thiyagalingam, Shanojan; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Ruff, Crystal A.; Faulkner, Stuart D.; Rumajogee, Prakasham; Beldick, Stephanie; Basilious, Alfred; Jiang, Shangjun; Thiyagalingam, Shanojan; Fehlings, Michael G.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Foltz, Warren] STARR facil, Toronto Med Discovery Tower, Toronto, ON, Canada; [Corrigan, Jennifer; Yager, Jerome Y.] Univ Alberta, Sect Pediat Neurosci, Dept Pediat, Edmonton, AB, Canada; [Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Alberta; University of Toronto	Fehlings, MG (corresponding author), Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Div Neurosurg, Toronto, ON, Canada.	michael.fehlings@uhn.on.ca		Beldick, Stephanie/0000-0002-5349-0352; Fehlings, Michael/0000-0002-5722-6364	Kids Brain Health Network; Ontario Brain Institute; Jeremy and Judith Freedman Family Foundation; Ontario Stem Cell Initiative; Halbert Chair in Neural Repair and Regeneration	Kids Brain Health Network; Ontario Brain Institute; Jeremy and Judith Freedman Family Foundation; Ontario Stem Cell Initiative; Halbert Chair in Neural Repair and Regeneration	This project received financial support from the Kids Brain Health Network as well as the Ontario Brain Institute. C.A.R. was supported by postdoctoral research grants from the Jeremy and Judith Freedman Family Foundation and the Ontario Stem Cell Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Kids Brain Health Network as well as the Ontario Brain Institute for project support. C.A.R. was supported by postdoctoral research grants from the Jeremy and Judith Freedman Family Foundation and the Ontario Stem Cell Initiative. The authors wish to also thank Mr. E. Armstrong, Ms. X. Y. S. Fan, Ms. S. Altamentova for technical support and collaboration, as well as Dr. M. O'Higgins for editorial support. Dr. M. G. Fehlings acknowledges support from the Halbert Chair in Neural Repair and Regeneration.	Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 2014, ANN NEUROL, V75, P469, DOI 10.1002/ana.24132; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; Basilious A, 2015, DEV MED CHILD NEUROL, V57, P420, DOI 10.1111/dmcn.12599; Bihel E, 2011, STROKE, V42, P1412, DOI 10.1161/STROKEAHA.110.596650; Black AM, 2015, BEHAV BRAIN RES, V291, P289, DOI 10.1016/j.bbr.2015.05.033; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Cao Y, 2017, NEUROCHEM INT, V107, P198, DOI 10.1016/j.neuint.2016.10.014; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Constantinou Janet C, 2005, J Perinatol, V25, P788, DOI 10.1038/sj.jp.7211403; Coq JO, 2016, DEV MED CHILD NEUROL, V58, P7, DOI 10.1111/dmcn.13040; Dahlseng MO, 2014, DEV MED CHILD NEUROL, V56, P53, DOI 10.1111/dmcn.12293; Delcour M, 2012, BEHAV BRAIN RES, V232, P233, DOI 10.1016/j.bbr.2012.03.029; Delcour M, 2012, BRAIN PATHOL, V22, P1, DOI 10.1111/j.1750-3639.2011.00504.x; Drobyshevsky A, 2007, ANN NEUROL, V61, P307, DOI 10.1002/ana.21095; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Faulkner SD, 2013, SEMIN PEDIATR NEUROL, V20, P146, DOI 10.1016/j.spen.2013.06.002; French HM, 2009, J NEUROSCI RES, V87, P3076, DOI 10.1002/jnr.22139; Fung C, 2012, PEDIATR RES, V72, P2, DOI 10.1038/pr.2012.32; Graham HK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.82; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Jantzie LL, 2015, DEV NEUROSCI-BASEL, V37, P277, DOI 10.1159/000371721; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Koman L Andrew, 2003, Paediatr Drugs, V5, P11, DOI 10.2165/00128072-200305010-00002; Kruse M, 2009, DEV MED CHILD NEUROL, V51, P622, DOI 10.1111/j.1469-8749.2008.03190.x; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Levesque IR, 2010, MAGN RESON MED, V63, P633, DOI 10.1002/mrm.22244; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Logitharajah P, 2009, PEDIATR RES, V66, P222, DOI 10.1203/PDR.0b013e3181a9ef34; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mallard EC, 1999, SCHIZOPHR RES, V40, P11, DOI 10.1016/S0920-9964(99)00041-9; Mukhopadhyay K, 2010, INDIAN J PEDIATR, V77, P963, DOI 10.1007/s12098-010-0149-3; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; NITSOS I, 1990, INT J DEV NEUROSCI, V8, P233, DOI 10.1016/0736-5748(90)90029-2; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Ohshima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39377; Olivier P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007128; Padilla N, 2014, BRAIN RES, V1545, P1, DOI 10.1016/j.brainres.2013.12.007; Panigrahy A, 2005, PEDIATR RADIOL, V35, P1199, DOI 10.1007/s00247-005-1577-5; Reid MV, 2012, J NEUROPATH EXP NEUR, V71, P640, DOI 10.1097/NEN.0b013e31825cfa81; Ruff CA, 2013, J NEUROSCI, V33, P11899, DOI 10.1523/JNEUROSCI.1131-13.2013; Ruff CA, 2013, DEV MED CHILD NEUROL, V55, P689, DOI 10.1111/dmcn.12166; Rumajogee P, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00057; Salewski RP, 2015, STEM CELL TRANSL MED, V4, P743, DOI 10.5966/sctm.2014-0236; Schober ME, 2009, AM J PHYSIOL-REG I, V296, pR681, DOI 10.1152/ajpregu.90396.2008; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shevell MI, 2009, DEV MED CHILD NEUROL, V51, P872, DOI 10.1111/j.1469-8749.2009.03269.x; Stoinska B, 2011, J PERINATOL, V31, P137, DOI 10.1038/jp.2010.75; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Surman G, 2009, PAEDIATR PERINAT EP, V23, P513, DOI 10.1111/j.1365-3016.2009.01060.x; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Tolcos M, 2017, PROG NEUROBIOL, V154, P62, DOI 10.1016/j.pneurobio.2017.03.009; Tolcos M, 2011, EXP NEUROL, V232, P53, DOI 10.1016/j.expneurol.2011.08.002; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Towsley K, 2011, EUR J PAEDIATR NEURO, V15, P29, DOI 10.1016/j.ejpn.2010.07.005; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wren TAL, 2005, J PEDIATR ORTHOPED, V25, P79, DOI 10.1097/00004694-200501000-00018; Xie M, 2011, NEUROSCIENCE, V197, P339, DOI 10.1016/j.neuroscience.2011.09.042; Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3	68	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184653	10.1371/journal.pone.0184653	http://dx.doi.org/10.1371/journal.pone.0184653			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934247	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900037
J	Schmoll, M; Unger, E; Bijak, M; Stoiber, M; Lanmuller, H; Jarvis, JC				Schmoll, Martin; Unger, Ewald; Bijak, Manfred; Stoiber, Martin; Lanmueller, Hermann; Jarvis, Jonathan Charles			A novel miniature in-line load-cell to measure in-situ tensile forces in the tibialis anterior tendon of rats	PLOS ONE			English	Article							VIVO MUSCLE FORCE; SKELETAL-MUSCLE; CONTRACTILE PROPERTIES; OPTIC FIBER; LOCOMOTION; GASTROCNEMIUS; TRANSDUCER; EXERCISE; BEHAVIOR	Direct measurements of muscular forces usually require a substantial rearrangement of the biomechanical system. To circumvent this problem, various indirect techniques have been used in the past. We introduce a novel direct method, using a lightweight (similar to 0.5 g) miniature (3 x 3 x 7 mm) in-line load-cell to measure tension in the tibialis anterior tendon of rats. A linear motor was used to produce force-profiles to assess linearity, step-response, hysteresis and frequency behavior under controlled conditions. Sensor responses to a series of rectangular force-pulses correlated linearly (R-2 = 0.999) within the range of 0-20 N. The maximal relative error at full scale (20 N) was 0.07% of the average measured signal. The standard deviation of the mean response to repeated 20 N force pulses was +/- 0.04% of the mean response. The step-response of the load-cell showed the behavior of a PD2T2-element in control-engineering terminology. The maximal hysteretic error was 5.4% of the full-scale signal. Sinusoidal signals were attenuated maximally (-4 dB) at 200 Hz, within a measured range of 0.01-200 Hz. When measuring muscular forces this should be of minor concern as the fusion-frequency of muscles is generally much lower. The newly developed load-cell measured tensile forces of up to 20 N, without inelastic deformation of the sensor. It qualifies for various applications in which it is of interest directly to measure forces within a particular tendon causing only minimal disturbance to the biomechanical system.	[Schmoll, Martin; Unger, Ewald; Bijak, Manfred; Stoiber, Martin; Lanmueller, Hermann] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Waehringer Guertel, Vienna, Austria; [Schmoll, Martin; Jarvis, Jonathan Charles] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England	Medical University of Vienna; Liverpool John Moores University	Schmoll, M (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Waehringer Guertel, Vienna, Austria.; Schmoll, M; Jarvis, JC (corresponding author), Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool, Merseyside, England.	martin.schmoll@meduniwien.ac.at; J.C.Jarvis@ljmu.ac.uk	Bijak, Manfred/I-4448-2019	Stoiber, Martin/0000-0003-1174-987X; Unger, Ewald/0000-0003-0275-9988; Schmoll, Martin/0000-0001-6354-3879	MED-EL GmbH (Innsbruck, Austria)	MED-EL GmbH (Innsbruck, Austria)	This work is the outcome of a collaboration between the Medical University of Vienna and Liverpool John Moores University. This project was supported by MED-EL GmbH (Innsbruck, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is the outcome of a collaboration between the Medical University of Vienna and Liverpool John Moores University. This project was supported by MED-EL GmbH (Innsbruck, Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding does not alter our adherence to PLOS ONE policies on sharing data and materials.	Arndt AN, 1998, CLIN BIOMECH, V13, P532, DOI 10.1016/S0268-0033(98)00032-1; BIEWENER AA, 1988, J EXP BIOL, V137, P191; Biewener AA, 1998, J EXP BIOL, V201, P1681; BIEWENER AA, 1995, J EXP BIOL, V198, P1829; Biewener AA, 1998, AM ZOOL, V38, P703; Daley MA, 2003, J EXP BIOL, V206, P2941, DOI 10.1242/jeb.00503; DEKONING JJ, 1987, J MORPHOL, V194, P75, DOI 10.1002/jmor.1051940107; Duncan ND, 1998, EUR J APPL PHYSIOL O, V77, P372, DOI 10.1007/s004210050347; Finni T, 1998, EUR J APPL PHYSIOL O, V77, P289, DOI 10.1007/s004210050335; Genovese A, 2007, MACROMOL MATER ENG, V292, P184, DOI 10.1002/mame.200600346; GLOS DL, 1993, J BIOMECH ENG-T ASME, V115, P335, DOI 10.1115/1.2895495; GONYEA W, 1978, EXP NEUROL, V59, P75, DOI 10.1016/0014-4886(78)90202-9; JARVIS JC, 1991, J APPL PHYSIOL, V70, P938, DOI 10.1152/jappl.1991.70.2.938; Komi PV, 1996, EUR J APPL PHYSIOL, V72, P278, DOI 10.1007/BF00838652; Ling X, 2007, INT J PRES VES PIP, V84, P304, DOI 10.1016/j.ijpvp.2006.11.003; Marsh DR, 1998, MUSCLE NERVE, V21, P1265, DOI 10.1002/(SICI)1097-4598(199810)21:10<1265::AID-MUS4>3.0.CO;2-9; Plaut Ronald Lesley, 2007, Mat. Res., V10, P453; Ramirez A, 2010, J THEOR BIOL, V267, P546, DOI 10.1016/j.jtbi.2010.09.018; Schmoll M, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13245; Shin RH, 2008, MICROSURG, V28, P452, DOI 10.1002/micr.20520; SIMARD CP, 1982, EXP NEUROL, V77, P467, DOI 10.1016/0014-4886(82)90221-7; SPYROPOULOS BP, 1994, J NEUROSCI METH, V53, P95, DOI 10.1016/0165-0270(94)90149-X; Sutherland H, 2003, NEUROMODULATION, V6, P176, DOI 10.1046/j.1525-1403.2003.03025.x; van Bolhuis AI, 2001, J NEUROSCI METH, V107, P87, DOI 10.1016/S0165-0270(01)00355-7; Vickerton P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0786; WALMSLEY B, 1978, J NEUROPHYSIOL, V41, P1203, DOI 10.1152/jn.1978.41.5.1203; Weinmann A., 2013, REGELUNGEN ANAL TECH, V1; WINIARSKI AM, 1987, EXP NEUROL, V96, P650, DOI 10.1016/0014-4886(87)90226-3	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185209	10.1371/journal.pone.0185209	http://dx.doi.org/10.1371/journal.pone.0185209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934327	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000411339900124
J	Toyonaga, T; Kobayashi, T; Nakano, M; Saito, E; Umeda, S; Okabayashi, S; Ozaki, R; Hibi, T				Toyonaga, Takahiko; Kobayashi, Taku; Nakano, Masaru; Saito, Eiko; Umeda, Satoko; Okabayashi, Shinji; Ozaki, Ryo; Hibi, Toshifumi			Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CLINICAL-TRIALS; THERAPY; MULTICENTER; VARIABILITY; S100A12; MARKERS; KINASE	Background Fecal calprotectin (FC) is well accepted as a non-invasive biomarker which objectively reflects colonic inflammation in ulcerative colitis (UC). However, its value as a marker of response during the early phase of remission induction treatment has not been well studied. The aim of this study is to evaluate the significance of FC for predicting the short-term outcomes of remission induction treatment in patients with UC. Methods A prospective observational study was conducted among 31 patients with active UC. FC was monitored with two-item patient-reported outcome (PRO2), partial Mayo score (PMS), and Lichtiger clinical activity index (CAI) during the first 4 weeks of remission induction treatment. Clinical response was defined as a decrease in CAI of 3 or more points below baseline. Mucosal healing (MH) was defined as Mayo endoscopic subscore 0 or 1. Within-day and within-stool variability of FC were assessed during the first week of treatment. Results In week 4-clinical responders, PRO2, PMS, and CAI significantly decreased from day 3, however, FC did not show significant reduction until week 2. Among all markers, the decrease in PRO2 at week 4 most accurately predicted MH at week 12. Within-day variability of FC was remarkably wide even at the first week in clinical responders. Within-stool variability was extremely small. Conclusions PRO2 predicted the short-term outcomes of remission induction treatment earlier than FC possibly because of the wide within-day variability of FC in active UC.	[Toyonaga, Takahiko; Kobayashi, Taku; Saito, Eiko; Okabayashi, Shinji; Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Minato Ku, Tokyo, Japan; [Toyonaga, Takahiko; Nakano, Masaru; Umeda, Satoko; Ozaki, Ryo] Kitasato Univ, Kitasato Inst Hosp, Dept Gastroenterol, Minato Ku, Tokyo, Japan	Kitasato University; Kitasato University	Kobayashi, T (corresponding author), Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Minato Ku, Tokyo, Japan.	kobataku@insti.kitasato-u.ac.jp	Kobayashi, Taku/AAO-6437-2020	Kobayashi, Taku/0000-0002-2073-4234; Okabayashi, Shinji/0000-0003-2683-9018	Thermo Fisher Scientific Inc.	Thermo Fisher Scientific Inc.	This work was in part supported by Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc. helped data collection by measuring fecal calprotectin. There was no additional external funding received for this study.	Calafat M, 2015, INFLAMM BOWEL DIS, V21, P1072, DOI 10.1097/MIB.0000000000000349; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; De Vos M, 2012, J CROHNS COLITIS, V6, P557, DOI 10.1016/j.crohns.2011.11.002; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Du L, 2016, J CLIN GASTROENTEROL; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Ho GT, 2009, AM J GASTROENTEROL, V104, P673, DOI 10.1038/ajg.2008.119; Jairath V, 2015, ALIMENT PHARM THER, V42, P1200, DOI 10.1111/apt.13408; Kaiser T, 2007, GUT, V56, P1706, DOI 10.1136/gut.2006.113431; Kato K, 2014, ALIMENT PHARM THER, V39, P949, DOI 10.1111/apt.12688; Lasson A, 2015, J CROHNS COLITIS, V9, P26, DOI 10.1016/j.crohns.2014.06.002; Molander P, 2015, J CROHNS COLITIS, V9, P33, DOI 10.1016/j.crohns.2014.06.012; Musci JOD, 2016, J GASTROENTEROL, V51, P531, DOI 10.1007/s00535-016-1191-3; Nakase H, 2016, INTEST RES, V14, P231, DOI 10.5217/ir.2016.14.3.231; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Sandborn WJ, 2016, GASTROENTEROLOGY, V150, P96, DOI 10.1053/j.gastro.2015.09.001; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Takashima S, 2015, AM J GASTROENTEROL, V110, P873, DOI 10.1038/ajg.2015.66; Theede K, 2014, SCAND J GASTROENTERO, V49, P418, DOI 10.3109/00365521.2014.883427; Turner D, 2010, GUT, V59, P1207, DOI 10.1136/gut.2010.211755; Williet N, 2014, CLIN GASTROENTEROL H, V12, P1246, DOI 10.1016/j.cgh.2014.02.016	21	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185131	10.1371/journal.pone.0185131	http://dx.doi.org/10.1371/journal.pone.0185131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934315	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900099
J	Chung, HS; Kim, JS; Lee, SM; Park, SJ				Chung, Hye-Shin; Kim, Ji-Sun; Lee, Sang Mee; Park, Soon Jae			Role of the P2 residue of human alpha 1-antitrypsin in determining target protease specificity	PLOS ONE			English	Article							ALPHA-1-PROTEINASE INHIBITOR; SERINE PROTEINASES; SERPIN STRUCTURE; FACTOR-XII; ELASTASE; SUPERFAMILY; KALLIKREIN; MECHANISM; COMPLEX; SITE	Alpha 1-antitrypsin (A1AT) is a serine protease inhibitor that mainly inhibits neutrophil elastase in the lungs. A variant of A1AT at the P1 position with methionine 358 to arginine (A1AT-Pittsburgh) is a rapid inhibitor of thrombin with greatly diminished anti-elastase activity. The P2 residue (position 357) of A1AT-Pittsburgh has been shown to play an important role in interactions with thrombin and kallikrein, but the role of P2 residue in wild-type A1AT has largely been unraveled. Here, we investigated the effects of P2 proline substitutions in wild-type A1AT on interactions with porcine pancreatic elastase (PPE) and human neutrophil elastase (HNE). The mutant A1AT proteins (P357A, P357D, P357K, P357L, P357N, P357S, and P357W) were less efficient than the wild-type A1AT at inhibiting PPE and HNE. Among the mutants, P357D did not form a complex with PPE, whereas P357L, P357N, and P357W showed significantly reduced complex formation with PPE. Surprisingly, mass spectrometry analysis revealed that P357D had two cleavage sites after the P9 alanine and the P3 isoleucine residues. Our results indicate that the size and negative charge of the R group of the P2 residue influence the interaction with elastases. Specifically, the negative charge at the P2 residue is disfavored and the resulting conformational changes in the reactive center loop upon interaction with PPE lead to cleavage at new sites. Overall, the results of this study demonstrate a previously unknown role for P2 residue in determining inhibitory specificity of A1AT.	[Chung, Hye-Shin; Kim, Ji-Sun; Lee, Sang Mee; Park, Soon Jae] Alteogen Inc, Daejeon, South Korea; [Chung, Hye-Shin] Hannam Univ, Dept Biol Sci & Biotechnol, Daejeon, South Korea	Hannam University	Park, SJ (corresponding author), Alteogen Inc, Daejeon, South Korea.	park@alteogen.com			Alteogen Inc.	Alteogen Inc.	Alteogen Inc. provided support in the form of salaries for authors [H-SC, J-SK, SML, and SJP] and research materials/instruments but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ARDELT W, 1985, BIOCHEMISTRY-US, V24, P5313, DOI 10.1021/bi00341a007; BEATTY K, 1980, J BIOL CHEM, V255, P3931; Berg J. M., 2015, BIOCHEMISTRY; BLOW AMJ, 1977, BIOCHEM J, V161, P13, DOI 10.1042/bj1610013; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BRANTLY M, 1988, AM J MED, V84, P13; Chen VC, 2000, J BIOL CHEM, V275, P38457, DOI 10.1074/jbc.M005605200; Chung HS, 2016, GLYCOCONJUGATE J, V33, P201, DOI 10.1007/s10719-016-9657-3; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Djie MZ, 1996, BIOCHEMISTRY-US, V35, P11461, DOI 10.1021/bi952717i; FAGERHOL MK, 1967, CLIN CHIM ACTA, V16, P199, DOI 10.1016/0009-8981(67)90181-7; Gettins PGW, 2016, BIOCHEM J, V473, P2273, DOI 10.1042/BCJ20160014; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; HEEB MJ, 1990, J BIOL CHEM, V265, P2365; HOPKINS PCR, 1995, J BIOL CHEM, V270, P11866, DOI 10.1074/jbc.270.20.11866; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Kim SJ, 2001, J MOL BIOL, V306, P109, DOI 10.1006/jmbi.2000.4357; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lee KJ, 2013, GLYCOCONJUGATE J, V30, P537, DOI 10.1007/s10719-012-9453-7; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHAPIRA M, 1987, J CLIN INVEST, V80, P582, DOI 10.1172/JCI113108; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCOTT CF, 1986, J CLIN INVEST, V77, P631, DOI 10.1172/JCI112346; SHOTTON D M, 1970, Nature (London), V225, P802, DOI 10.1038/225802a0; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; SINHA S, 1987, P NATL ACAD SCI USA, V84, P2228, DOI 10.1073/pnas.84.8.2228; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185074	10.1371/journal.pone.0185074	http://dx.doi.org/10.1371/journal.pone.0185074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922398	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300056
J	Garrett, RK; Weeks, BE				Garrett, R. Kelly; Weeks, Brian E.			Epistemic beliefs' role in promoting misperceptions and conspiracist ideation	PLOS ONE			English	Article							CONTINUED INFLUENCE; MISINFORMATION; FACT; SCIENCE; ONLINE; BIAS	Widespread misperceptions undermine citizens' decision-making ability. Conclusions based on falsehoods and conspiracy theories are by definition flawed. This article demonstrates that individuals' epistemic beliefs-beliefs about the nature of knowledge and how one comes to know-have important implications for perception accuracy. The present study uses a series of large, nationally representative surveys of the U.S. population to produce valid and reliable measures of three aspects of epistemic beliefs: reliance on intuition for factual beliefs (Faith in Intuition for facts), importance of consistency between empirical evidence and beliefs (Need for evidence), and conviction that "facts" are politically constructed (Truth is political). Analyses confirm that these factors complement established predictors of misperception, substantively increasing our ability to explain both individuals' propensity to engage in conspiracist ideation, and their willingness to embrace falsehoods about high-profile scientific and political issues. Individuals who view reality as a political construct are significantly more likely to embrace falsehoods, whereas those who believe that their conclusions must hew to available evidence tend to hold more accurate beliefs. Confidence in the ability to intuitively recognize truth is a uniquely important predictor of conspiracist ideation. Results suggest that efforts to counter misperceptions may be helped by promoting epistemic beliefs emphasizing the importance of evidence, cautious use of feelings, and trust that rigorous assessment by knowledgeable specialists is an effective guard against political manipulation.	[Garrett, R. Kelly] Ohio State Univ, Sch Commun, Columbus, OH 43210 USA; [Weeks, Brian E.] Univ Michigan, Dept Commun Studies, Ann Arbor, MI 48109 USA; [Weeks, Brian E.] Univ Michigan, Ctr Polit Studies, Ann Arbor, MI 48109 USA	University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Garrett, RK (corresponding author), Ohio State Univ, Sch Commun, Columbus, OH 43210 USA.	garrett.258@osu.edu	Weeks, Brian/AHB-0858-2022; Garrett, R. Kelly/E-8690-2010	Weeks, Brian/0000-0003-2355-2302; Garrett, R. Kelly/0000-0001-7022-7452	National Science Foundation [IIS-1149599]; Div Of Information & Intelligent Systems [1149599] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This material is based in part upon work supported by the National Science Foundation under Grant Numbers IIS-1149599 (KG). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. This material also relies on data collected through the Omnibus survey for the School of Communication at the Ohio State University in both 2015 and 2016 (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baym, 2010, CRONKITE COLBERT EVO; Boghossian P., 2006, FEAR KNOWLEDGE RELAT; Brotherton R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124125; Brotherton R, 2015, PERS INDIV DIFFER, V80, P1, DOI 10.1016/j.paid.2015.02.011; Dagnall N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00206; Damasio AR., 2005, DESCARTES ERROR EMOT; Enders C. K., 2010, APPL MISSING DATA AN; Epstein S, 1996, J PERS SOC PSYCHOL, V71, P390, DOI 10.1037/0022-3514.71.2.390; Feinberg M, 2013, PSYCHOL SCI, V24, P56, DOI 10.1177/0956797612449177; Feldman L, 2017, PUBLIC UNDERST SCI, V26, P481, DOI 10.1177/0963662515595348; Garrett RK, 2016, J COMPUT-MEDIAT COMM, V21, P331, DOI 10.1111/jcc4.12164; Harding P, 2000, J RES SCI TEACH, V37, P225, DOI 10.1002/(SICI)1098-2736(200003)37:3<225::AID-TEA1>3.0.CO;2-G; Hemingway M., 2011, WEEKLY STANDARD, V17; Hinkin TR, 1998, ORGAN RES METHODS, V1, P104, DOI 10.1177/109442819800100106; Hofer BK, 2001, EDUC PSYCHOL REV, V13, P353, DOI 10.1023/A:1011965830686; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jamieson KH, 2015, P AM PHILOS SOC, V159, P66; Jasanoff S, 1996, SOC STUD SCI, V26, P393, DOI 10.1177/030631296026002008; Jerit J, 2012, J POLIT, V74, P672, DOI 10.1017/S0022381612000187; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Kahan DM, 2015, POLIT PSYCHOL, V36, P1, DOI 10.1111/pops.12244; Kahan DM, 2013, JUDGM DECIS MAK, V8, P407; Kahneman D., 2011, THINKING FAST SLOW; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Kuklinski JH, 2000, J POLIT, V62, P790, DOI 10.1111/0022-3816.00033; Kuklinski JH, 1998, ANN AM ACAD POLIT SS, V560, P143, DOI 10.1177/0002716298560001011; Latour B, 2004, CRIT INQUIRY, V30, P225, DOI 10.1086/421123; Latour Bruno., 1986, LAB LIFE SOCIAL CONS; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Lodge M., 2013, RATIONALIZING VOTER; Miller JM, 2016, AM J POLIT SCI, V60, P824, DOI 10.1111/ajps.12234; Mundfrom DJ, 2005, INT J TEST, V5, P159, DOI 10.1207/s15327574ijt0502_4; Murphy K.R., 2005, PSYCHOL TESTING PRIN; Newman E, 2012, PSYCHONOMIC B REV, P1; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; Oliver JE, 2014, AM J POLIT SCI, V58, P952, DOI 10.1111/ajps.12084; Oreskes N., 2010, MERCHANTS DOUBT; Pasek J, 2015, ELECT STUD, V40, P482, DOI 10.1016/j.electstud.2014.09.009; Prior M, 2015, Q J POLIT SCI, V10, P489, DOI 10.1561/100.00014127; SCHOMMER M, 1990, J EDUC PSYCHOL, V82, P498, DOI 10.1037/0022-0663.82.3.498; Schwarz N, 2007, SOCIAL PSYCHOL HDB B, V2, P385, DOI DOI 10.1023/A:1021223113233; Schwarz N, 2007, ADV EXP SOC PSYCHOL, V39, P127, DOI 10.1016/S0065-2601(06)39003-X; Seifert CM, 2002, PSYCHOL LEARN MOTIV, V41, P265, DOI 10.1016/S0079-7421(02)80009-3; Shibutani T., 1966, IMPROVISED NEWS SOCI; Sokal A., 2008, HOAX SCI PHILOS CULT; Swami V, 2014, COGNITION, V133, P572, DOI 10.1016/j.cognition.2014.08.006; Uscinski JE, 2016, POLIT RES QUART, V69, P57, DOI 10.1177/1065912915621621; Uscinski JE, 2013, CRIT REV, V25, P162, DOI 10.1080/08913811.2013.843872; Whitson JA, 2008, SCIENCE, V322, P115, DOI 10.1126/science.1159845; World Public Opinion, 2006, PERC AM BEL IR HAD W	53	52	52	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184733	10.1371/journal.pone.0184733	http://dx.doi.org/10.1371/journal.pone.0184733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FH3OQ	28922387	gold, Green Submitted, Green Published			2022-12-27	WOS:000411059300026
J	Ugwu, DI; Okoro, UC; Ahmad, H				Ugwu, David Izuchukwu; Okoro, Uchechukwu Chris; Ahmad, Hilal			New carboxamide derivatives bearing benzenesulphonamide as a selective COX-II inhibitor: Design, synthesis and structureactivity relationship	PLOS ONE			English	Article								Sixteen new carboxamide derivatives bearing substituted benzenesulphonamide moiety (7a-p) were synthesized by boric acid mediated amidation of appropriate benzenesulphonamide with 2-amino-4-picoline and tested for anti-inflammatory activity. One compound 7c showed more potent anti-inflammatory activity than celecoxib at 3 h in carrageenan-induced rat paw edema bioassay. Compounds 7g and 7k also showed good anti-inflammatory activity comparable to celecoxib. Compound 7c appeared selectivity index (COX-2/COX-1) better than celecoxib. Compound 7k appeared selectivity index (COX-2/COX-1) a little higher than the half of celecoxib while compound 7g is non-selective for COX-2. The LD50 of compounds 7c, 7g and 7k were comparable to celecoxib.	[Ugwu, David Izuchukwu; Okoro, Uchechukwu Chris] Univ Nigeria, Dept Pure & Ind Chem, Nsukka, Nigeria; [Ugwu, David Izuchukwu; Ahmad, Hilal] Indian Inst Technol, Dept Chem, Kanpur, Uttar Pradesh, India	University of Nigeria; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Ugwu, DI (corresponding author), Univ Nigeria, Dept Pure & Ind Chem, Nsukka, Nigeria.; Ugwu, DI (corresponding author), Indian Inst Technol, Dept Chem, Kanpur, Uttar Pradesh, India.	izuchukwu.ugwu@unn.edu.ng	Ugwu, David Izuchukwu/AAV-8960-2020	Ugwu, David Izuchukwu/0000-0002-2370-6191				Abdel-Aziz HA, 2014, EUR J MED CHEM, V80, P416, DOI 10.1016/j.ejmech.2014.04.065; Aissaoui H, 2008, BIOORG MED CHEM LETT, V18, P5729, DOI 10.1016/j.bmcl.2008.09.079; ANANTHANARAYANAN VS, 1993, J MED CHEM, V36, P1324, DOI 10.1021/jm00062a004; Bano S, 2011, EUR J MED CHEM, V46, P5763, DOI 10.1016/j.ejmech.2011.08.015; Bashir R, 2011, BIOORG MED CHEM LETT, V21, P4301, DOI 10.1016/j.bmcl.2011.05.061; Bhat M. A., 2006, Indian Journal of Pharmaceutical Sciences, V68, P120; Cairns JA, 2007, CANADIAN J CARDIOLOG, V23, P131; DEGASPARO M, 1995, REGUL PEPTIDES, V59, P303, DOI 10.1016/0167-0115(95)00085-P; Ghorab MM, 2014, ACTA PHARM, V64, P431; Ghosh MN, 1984, FUNDAMENTALS EXPT PH, P153; Graul A, 1997, DRUGS FUTURE, V22, P968, DOI DOI 10.1358/D0F.1997.022.09.423212; Hogan BL, 2000, J PHARMACEUT BIOMED, V23, P637, DOI 10.1016/S0731-7085(00)00342-3; Jainswal M., 2004, BIOORG MED CHEM LETT, V14, P5666, DOI [DOI 10.1016/J.BMCL.2004.08.051, 10.1016/j.bmcl.2004.08.051]; Jallow S, 2009, J CLIN MICROBIOL, V47, P2200, DOI 10.1128/JCM.01654-08; Kalgutkar AS, 1999, EXPERT OPIN THER PAT, V9, P831, DOI 10.1517/13543776.9.7.831; Lee SH, 2004, BIOL PHARM BULL, V27, P786, DOI 10.1248/bpb.27.786; Mistry BD, 2015, INDIAN J CHEM B, V54, P128; Montalbetti CAGN, 2005, TETRAHEDRON, V61, P10827, DOI 10.1016/j.tet.2005.08.031; Nakayama T, 2005, ANTICANCER RES, V25, P157; Nouraddin H, 2013, IRAN J PHARM RES, V12, P330; Pasinetti GM, 1998, J NEUROSCI RES, V54, P1; PATCHETT AA, 1993, J MED CHEM, V36, P2051, DOI 10.1021/jm00067a001; Roskoski R, 2003, BIOCHEM BIOPH RES CO, V309, P709, DOI 10.1016/j.bbrc.2003.08.055; Shet P., 2013, RES J CHEM SCI, V3, P15; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Talley JJ, 1999, PROGR MED CHEM, V36, P201, DOI 10.1016/S0079-6468(08)70048-1; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vane JR, 1971, NATURE, V231, P235; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0183807	10.1371/journal.pone.0183807	http://dx.doi.org/10.1371/journal.pone.0183807			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922386	gold, Green Published, Green Submitted			2022-12-27	WOS:000411059300007
J	Chen, Y; Meyer, JN; Hill, HZ; Lange, G; Condon, MR; Klein, JC; Ndirangu, D; Falvo, MJ				Chen, Yang; Meyer, Joel N.; Hill, Helene Z.; Lange, Gudrun; Condon, Michael R.; Klein, Jacquelyn C.; Ndirangu, Duncan; Falvo, Michael J.			Role of mitochondrial DNA damage and dysfunction in veterans with Gulf War Illness	PLOS ONE			English	Article							MUSCLE INSULIN-RESISTANCE; POPULATION-BASED SURVEY; HUMAN SKELETAL-MUSCLE; DEET N,N-DIETHYL-M-TOLUAMIDE; PARKINSONS-DISEASE; COMBINED EXPOSURE; OXIDATIVE STRESS; HEALTH; SYMPTOMS; RECOVERY	Gulf War Illness (GWI) is a chronic multi-symptom illness not currently diagnosed by standard medical or laboratory test that affects 30% of veterans who served during the 1990-1991 Gulf War. The clinical presentation of GWI is comparable to that of patients with certain mitochondrial disorders-i.e., clinically heterogeneous multisystem symptoms. Therefore, we hypothesized that mitochondrial dysfunction may contribute to both the symptoms of GWI as well as its persistence over time. We recruited 21 cases of GWI (CDC and Kansas criteria) and 7 controls to participate in this study. Peripheral blood samples were obtained in all participants and a quantitative polymerase chain reaction (QPCR) based assay was performed to quantify mitochondrial and nuclear DNA lesion frequency and mitochondrial DNA (mtDNA) copy number (mtDNAcn) from peripheral blood mononuclear cells. Samples were also used to analyze nuclear DNA lesion frequency and enzyme activity for mitochondrial complexes I and IV. Both mtDNA lesion frequency (p = 0.015, d = 1.13) and mtDNAcn (p = 0.001; d = 1.69) were elevated in veterans with GWI relative to controls. Nuclear DNA lesion frequency was also elevated in veterans with GWI (p = 0.344; d = 1.41), but did not reach statistical significance. Complex I and IV activity (p > 0.05) were similar between groups and greater mtDNA lesion frequency was associated with reduced complex I (r(2) = -0.35, p = 0.007) and IV (r(2) = -0.28, p < 0.01) enzyme activity. In conclusion, veterans with GWI exhibit greater mtDNA damage which is consistent with mitochondrial dysfunction.	[Chen, Yang; Klein, Jacquelyn C.; Ndirangu, Duncan; Falvo, Michael J.] Vet Affairs New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, E Orange, NJ 07018 USA; [Chen, Yang; Hill, Helene Z.; Condon, Michael R.; Falvo, Michael J.] Univ Med & Dent New Jersey, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Lange, Gudrun] Beth Israel Deaconess Med Ctr, Pain & Fatigue Study Ctr, New York, NY 10003 USA; [Lange, Gudrun] Albert Einstein Med Ctr, New York, NY USA; [Condon, Michael R.] Vet Affairs New Jersey Hlth Care Syst, Surg Serv, E Orange, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Duke University; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Falvo, MJ (corresponding author), Vet Affairs New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, E Orange, NJ 07018 USA.; Falvo, MJ (corresponding author), Univ Med & Dent New Jersey, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA.	Michael.Falvo@va.gov	Meyer, Joel/G-9836-2017	Meyer, Joel/0000-0003-1219-0983; Falvo, Michael/0000-0001-9348-6676				Abdullah L, 2016, TOXICOLOGY, V372, P22, DOI 10.1016/j.tox.2016.10.012; Abu-Qare A, 2000, TOXICOL LETT, V117, P151, DOI 10.1016/S0378-4274(00)00257-5; Abu-Qare AW, 2001, J TOXICOL ENV HEAL A, V63, P243, DOI 10.1080/15287390151143640; Abu-Qare AW, 2001, TOXICOL LETT, V123, P51, DOI 10.1016/S0378-4274(01)00380-0; Aguer C, 2015, FASEB J, V29, P336, DOI 10.1096/fj.14-255901; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; BACKER JM, 1982, CANCER RES, V42, P2764; Ballinger SW, 1996, CANCER RES, V56, P5692; Binns J., 2014, GULF WAR ILLNESS HLT; Binns JH, 2008, GULF WAR ILLNESS HLT; Budnik LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064413; Byun HM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-18; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; Cohen BH, 2010, DEV DISABIL RES REV, V16, P189, DOI 10.1002/ddrr.106; Croteau DL, 2012, AGING CELL, V11, P456, DOI 10.1111/j.1474-9726.2012.00803.x; Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3; Doebbeling BN, 2000, AM J MED, V108, P695, DOI 10.1016/S0002-9343(00)00405-8; Engelbrecht JP, 2009, INHAL TOXICOL, V21, P297, DOI [10.1080/08958370802464273, 10.1080/08958370802464273 ]; Falvo MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1124; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Genter MB, 2006, BIOCHEM BIOPH RES CO, V342, P1375, DOI 10.1016/j.bbrc.2006.02.121; Golomb BA, 2002, MITOCHONDRIAL FUNCTI; Golomb BA, 2014, NEURAL COMPUT, V26, P2594, DOI 10.1162/NECO_a_00659; Golomb BA, 2008, P NATL ACAD SCI USA, V105, P4295, DOI 10.1073/pnas.0711986105; Gonzalez-Hunt Claudia P, 2016, Curr Protoc Toxicol, V67, DOI 10.1002/0471140856.tx2011s67; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; KEMP GJ, 1993, NMR BIOMED, V6, P66, DOI 10.1002/nbm.1940060111; Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001; Koslik HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092887; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Li L, 2001, TOXICOL APPL PHARM, V177, P17, DOI 10.1006/taap.2001.9283; Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x; Luz AL, 2017, TOXICOLOGY, V387, P81, DOI 10.1016/j.tox.2017.05.018; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Medicine Io, 2014, CHR MULT ILL GULF WA; Meyer J.N, 2017, TOXICOLOGY; Meyer JN, 2013, TOXICOLOGICAL SCI; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4; Omura T, 2006, CHEM-BIOL INTERACT, V163, P86, DOI 10.1016/j.cbi.2006.06.008; Rose MR, 2004, NEUROLOGY, V63, P1681, DOI 10.1212/01.WNL.0000142600.17167.0E; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Sim KG, 2002, METABOLISM, V51, P366, DOI 10.1053/meta.2002.30521; Soltaninejad K, 2009, MED SCI MONITOR, V15, pRA75; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Wittkopp S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064444; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zhong J, 2016, CIRCULATION, V133, P378, DOI 10.1161/CIRCULATIONAHA.115.018802	60	34	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184832	10.1371/journal.pone.0184832	http://dx.doi.org/10.1371/journal.pone.0184832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910366	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200101
J	Jegousse, C; Yang, YD; Zhan, J; Wang, JH; Zhou, YQ				Jegousse, Clara; Yang, Yuedong; Zhan, Jian; Wang, Jihua; Zhou, Yaoqi			Structural signatures of thermal adaptation of bacterial ribosomal RNA, transfer RNA, and messenger RNA	PLOS ONE			English	Article							OPTIMAL-GROWTH TEMPERATURE; SYNONYMOUS CODON USAGE; GENOMIC G+C CONTENT; PROTEIN; STABILITY; SEQUENCES; MECHANISM; ELUCIDATION; PROKARYOTES; PREDICTION	Temperature adaptation of bacterial RNAs is a subject of both fundamental and practical interest because it will allow a better understanding of molecular mechanism of RNA folding with potential industrial application of functional thermophilic or psychrophilic RNAs. Here, we performed a comprehensive study of rRNA, tRNA, and mRNA of more than 200 bacterial species with optimal growth temperatures (OGT) ranging from 4 degrees C to 95 degrees C. We investigated temperature adaptation at primary, secondary and tertiary structure levels. We showed that unlike mRNA, tRNA and rRNA were optimized for their structures at compositional levels with significant tertiary structural features even for their corresponding randomly permutated sequences. tRNA and rRNA are more exposed to solvent but remain structured for hyperthermophiles with nearly OGT-independent fluctuation of solvent accessible surface area within a single RNA chain. mRNA in hyperthermophiles is essentially the same as random sequences without tertiary structures although many mRNA in mesophiles and psychrophiles have well-defined tertiary structures based on their low overall solvent exposure with clear separation of deeply buried from partly exposed bases as in tRNA and rRNA. These results provide new insight into temperature adaptation of different RNAs.	[Jegousse, Clara] Univ Nantes, UFR Sci & Tech, 2 Rue Houssiniere, Nantes, France; [Jegousse, Clara; Yang, Yuedong; Zhan, Jian; Zhou, Yaoqi] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Jegousse, Clara; Yang, Yuedong; Zhan, Jian; Zhou, Yaoqi] Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Qld, Australia; [Wang, Jihua; Zhou, Yaoqi] Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Biophys, Dezhou, Peoples R China	Nantes Universite; Griffith University; Griffith University; Dezhou University	Zhou, YQ (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.; Zhou, YQ (corresponding author), Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Qld, Australia.; Zhou, YQ (corresponding author), Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Biophys, Dezhou, Peoples R China.	yaoqi.zhou@griffith.edu.au	Jian, Zhan/AAM-2759-2021; Zhou, Yaoqi/B-3284-2009; Yang, Yuedong/C-9394-2009	Jian, Zhan/0000-0003-0856-2385; Zhou, Yaoqi/0000-0002-9958-5699; Yang, Yuedong/0000-0002-6782-2813; Jegousse, Clara/0000-0003-3213-2510	National Natural Science Foundation of China [61671107, 61540025]; Taishan Scholars Program of Shandong province of China; National Health and Medical Research Council [1059775, 1083450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong province of China; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Natural Science Foundation of China (61671107) to YY and JW, by the Taishan Scholars Program of Shandong province of China, National Natural Science Foundation of China (61540025), and National Health and Medical Research Council (1059775 and 1083450) of Australia to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by National Natural Science Foundation of China (61671107) to YY and JW, by the Taishan Scholars Program of Shandong province of China, National Natural Science Foundation of China (61540025), and National Health and Medical Research Council (1059775 and 1083450) of Australia to YZ. We also gratefully acknowledge the use of the High Performance Computing Cluster "Gowonda" to complete this research. This research/project has also been undertaken with the aid of the research cloud resources provided by the Queensland Cyber Infrastructure Foundation (QCIF).	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Bouzas TD, 2006, PROTEIN PEPTIDE LETT, V13, P645, DOI 10.2174/092986606777790548; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chakravarty S, 2000, FEBS LETT, V470, P65, DOI 10.1016/S0014-5793(00)01267-9; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Chattopadhyay MK, 2006, J BIOSCIENCES, V31, P157, DOI 10.1007/BF02705244; Daniel RM, 2000, CELL MOL LIFE SCI, V57, P250, DOI 10.1007/PL00000688; Dutta A, 2010, FEMS MICROBIOL LETT, V305, P100, DOI 10.1111/j.1574-6968.2010.01922.x; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Furtig B, 2010, ACS CHEM BIOL, V5, P753, DOI 10.1021/cb100025a; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Grogan DW, 1998, MOL MICROBIOL, V28, P1043, DOI 10.1046/j.1365-2958.1998.00853.x; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Herschlag D, 2015, CURR OPIN STRUC BIOL, V30, P125, DOI 10.1016/j.sbi.2015.02.006; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; HURLEY TD, 1992, J MOL BIOL, V227, P1255, DOI 10.1016/0022-2836(92)90536-S; Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; Koonin EV, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-27; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lambros RJ, 2003, EXTREMOPHILES, V7, P443, DOI 10.1007/s00792-003-0353-4; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lobry JR, 2006, GENE, V385, P128, DOI 10.1016/j.gene.2006.05.033; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; Mallik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069898; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Miao ZC, 2015, RNA, V21, P1066, DOI 10.1261/rna.049502.114; Nakashima H, 2003, J BIOCHEM, V133, P507, DOI 10.1093/jb/mvg067; Paz A, 2004, P NATL ACAD SCI USA, V101, P2951, DOI 10.1073/pnas.0308594100; Puton T, 2014, NUCLEIC ACIDS RES, V42, P5403, DOI 10.1093/nar/gku208; Querol E, 1996, PROTEIN ENG, V9, P265, DOI 10.1093/protein/9.3.265; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Rozov A, 2016, NUCLEIC ACIDS RES, V44, P6434, DOI 10.1093/nar/gkw431; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Schwartzman DW, 2004, BIOCHEM SOC T, V32, P168, DOI 10.1042/BST0320168; Seetin Matthew G, 2012, Methods Mol Biol, V905, P99, DOI 10.1007/978-1-61779-949-5_8; Siddiqui KS, 2015, BIOTECHNOL ADV, V33, P1912, DOI 10.1016/j.biotechadv.2015.11.001; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Sohngen C, 2016, NUCLEIC ACIDS RES, V44, pD581, DOI 10.1093/nar/gkv983; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tatusova T, 2014, NUCLEIC ACIDS RES, V42, pD553, DOI 10.1093/nar/gkt1274; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang HC, 2006, BIOCHEM BIOPH RES CO, V342, P681, DOI 10.1016/j.bbrc.2006.02.037; Wang HC, 2006, J MOL EVOL, V63, P120, DOI 10.1007/s00239-005-0255-4; Workman C, 1999, NUCLEIC ACIDS RES, V27, P4816, DOI 10.1093/nar/27.24.4816; Xu Xiaojun, 2015, Biophys Rep, V1, P2; Yang YD, 2017, RNA, V23, P14, DOI 10.1261/rna.057364.116; Yano JK, 2003, CURR OPIN BIOTECH, V14, P360, DOI 10.1016/S0958-1669(03)00075-2; Zhao HY, 2014, PROTEINS, V82, P640, DOI 10.1002/prot.24441; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	55	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184722	10.1371/journal.pone.0184722	http://dx.doi.org/10.1371/journal.pone.0184722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910383	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200085
J	Ortega, MT; Foote, DJ; Nees, N; Erdmann, JC; Bangs, CD; Rosenfeld, CS				Ortega, Madison T.; Foote, Dustin J.; Nees, Nicholas; Erdmann, Jason C.; Bangs, Charles D.; Rosenfeld, Cheryl S.			Karyotype analysis and sex determination in Australian Brush-turkeys (Alectura lathami)	PLOS ONE			English	Article							TOKUDAIA-TOKUNOSHIMENSIS; MATERNAL CONDITION; RATIO; BIRDS; CHROMOSOME; ALLOCATION; GALLIFORMES; AVES; INVESTMENT; OSIMENSIS	Sexual differentiation across taxa may be due to genetic sex determination (GSD) and/or temperature sex determination (TSD). In many mammals, males are heterogametic (XY); whereas females are homogametic (XX). In most birds, the opposite is the case with females being heterogametic (ZW) and males the homogametic sex (ZZ). Many reptile species lack sex chromosomes, and instead, sexual differentiation is influenced by temperature with specific temperatures promoting males or females varying across species possessing this form of sexual differentiation, although TSD has recently been shown to override GSD in Australian central beaded dragons (Pogona vitticeps). There has been speculation that Australian Brush-turkeys (Alectura lathami) exhibit TSD alone and/or in combination with GSD. Thus, we sought to determine if this species possesses sex chromosomes. Blood was collected from one sexually mature female and two sexually mature males residing at Sylvan Heights Bird Park (SHBP) and shipped for karyotype analysis. Karyotype analysis revealed that contrary to speculation, Australian Brush-turkeys possess the classic avian ZW/ZZ sex chromosomes. It remains a possibility that a biased primary sex ratio of Australian Brush-turkeys might be influenced by maternal condition prior to ovulation that result in her laying predominantly Z- or W-bearing eggs and/or sex-biased mortality due to higher sensitivity of one sex in environmental conditions. A better understanding of how maternal and extrinsic factors might differentially modulate ovulation of Z- or W-bearing eggs and hatching of developing chicks possessing ZW or ZZ sex chromosomes could be essential in conservation strategies used to save endangered members of Megapodiidae.	[Ortega, Madison T.; Rosenfeld, Cheryl S.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Ortega, Madison T.; Rosenfeld, Cheryl S.] Univ Missouri, Biomed Sci, Columbia, MO 65211 USA; [Foote, Dustin J.; Nees, Nicholas] Sylvan Hts Bird Pk, Scotland Neck, NC USA; [Foote, Dustin J.] East Carolina Univ, Dept Biol, Greenville, NC USA; [Erdmann, Jason C.; Bangs, Charles D.] Stanford Hlth Care, Cytogenet Lab, Palo Alto, CA USA; [Rosenfeld, Cheryl S.] Univ Missouri, Thompson Ctr Autism & Neurobehav Disorders, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of North Carolina; East Carolina University; Stanford University; University of Missouri System; University of Missouri Columbia	Rosenfeld, CS (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.; Rosenfeld, CS (corresponding author), Univ Missouri, Biomed Sci, Columbia, MO 65211 USA.; Rosenfeld, CS (corresponding author), Univ Missouri, Thompson Ctr Autism & Neurobehav Disorders, Columbia, MO 65211 USA.	rosenfeldc@missouri.edu		Rosenfeld, Cheryl/0000-0002-4137-3933	National Institute of General Medical Science (NIGMS), a component of the National Institutes of Health (NIH) [R25GM056901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056901] Funding Source: NIH RePORTER	National Institute of General Medical Science (NIGMS), a component of the National Institutes of Health (NIH); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Madison T. Ortega was supported by the IMSD EXPRESS Fellows Program (via grant number R25GM056901 from the National Institute of General Medical Science (NIGMS), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGHI FE, 1971, CYTOGENETICS, V10, P81, DOI 10.1159/000130130; Baeta R, 2012, BIOL LETTERS, V8, P401, DOI 10.1098/rsbl.2011.1009; BELTERMAN RHR, 1984, GENETICA, V65, P39, DOI 10.1007/BF00056765; Bowers EK, 2017, EVOL BIOL, V44, P11, DOI 10.1007/s11692-016-9380-9; CRACRAFT J, 1981, AUK, V98, P681; DEBOER LEM, 1981, GENETICA, V54, P225, DOI 10.1007/BF00135038; Deveson IW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700731; Douhard M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0510; Dowling DK, 2006, J EVOLUTION BIOL, V19, P440, DOI 10.1111/j.1420-9101.2005.01017.x; DUTRILLAUX B, 1975, HUMANGENETIK, V28, P113, DOI 10.1007/BF00735743; Eiby YA, 2008, P ROY SOC B-BIOL SCI, V275, P2703, DOI 10.1098/rspb.2008.0954; Eiby YA, 2009, J COMP PHYSIOL B, V179, P875, DOI 10.1007/s00360-009-0370-4; Elliott A., 1992, HDB BIRDS WORLD ALIV; Goerlich VC, 2010, PHYSIOL BIOCHEM ZOOL, V83, P490, DOI 10.1086/651315; Goerlich-Jansson VC, 2013, INTEGR COMP BIOL, V53, P902, DOI 10.1093/icb/ict056; Goth A, 2008, GEN COMP ENDOCR, V155, P742, DOI 10.1016/j.ygcen.2007.11.004; Goth A, 2005, BIOL LETTERS, V1, P31, DOI 10.1098/rsbl.2004.0247; Goth A, 2007, AUSTRAL ECOL, V32, P378, DOI 10.1111/j.1442-9993.2007.01709.x; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Harrison GJ, 2006, CLIN AVIAN MED; Henderson LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110858; Houck ML, 2017, ANIMAL CYTOGENETICS; HUNGERFORD DA, 1965, STAIN TECHNOL, V40, P333, DOI 10.3109/10520296509116440; Kan XZ, 2010, GENET MOL RES, V9, P1625, DOI 10.4238/vol9-3gmr898; Kuroiwa A, 2011, CHROMOSOME RES, V19, P635, DOI 10.1007/s10577-011-9223-6; Ladjali-Mohammedi K, 1999, CYTOGENET CELL GENET, V86, P271, DOI 10.1159/000015318; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nakamura T, 2007, CHROMOSOME RES, V15, P799, DOI 10.1007/s10577-007-1163-9; Pereira SL, 2006, MOL PHYLOGENET EVOL, V38, P499, DOI 10.1016/j.ympev.2005.07.007; Prior GL, 2011, BIOL LETTERS, V7, P958, DOI 10.1098/rsbl.2011.0264; Pryke SR, 2011, EVOLUTION, V65, P2792, DOI 10.1111/j.1558-5646.2011.01391.x; Robertson BC, 2006, BIOL LETTERS, V2, P229, DOI 10.1098/rsbl.2005.0430; Rosenfeld CS, 2012, REPROD FERT DEVELOP, V24, P45, DOI 10.1071/RD11906; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Rubenstein DR, 2007, AM NAT, V170, P155, DOI 10.1086/518671; Ryan CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111052; Schindler S, 2015, NATURE, V526, P249, DOI 10.1038/nature14968; SEABRIGH.M, 1971, LANCET, V2, P971; STOCK AD, 1982, CYTOGENET CELL GENET, V34, P136, DOI 10.1159/000131802; Yamauchi Y, 2016, SCIENCE, V351, P514, DOI 10.1126/science.aad1795	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0185014	10.1371/journal.pone.0185014	http://dx.doi.org/10.1371/journal.pone.0185014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910392	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200127
J	Takahashi, A; Suzuki, S; Aoyama, Y; Umezu, M; Iwasaki, K				Takahashi, Azuma; Suzuki, Sara; Aoyama, Yusuke; Umezu, Mitsuo; Iwasaki, Kiyotaka			A three-dimensional strain measurement method in elastic transparent materials using tomographic particle image velocimetry	PLOS ONE			English	Article							DIGITAL VOLUME CORRELATION; FINITE-ELEMENT-ANALYSIS; BONE; VALIDATION; VIVO	Background The mechanical interaction between blood vessels and medical devices can induce strains in these vessels. Measuring and understanding these strains is necessary to identify the causes of vascular complications. This study develops a method to measure the threedimensional (3D) distribution of strain using tomographic particle image velocimetry (Tomo-PIV) and compares the measurement accuracy with the gauge strain in tensile tests. Methods and findings The test system for measuring 3D strain distribution consists of two cameras, a laser, a universal testing machine, an acrylic chamber with a glycerol water solution for adjusting the refractive index with the silicone, and dumbbell-shaped specimens mixed with fluorescent tracer particles. 3D images of the particles were reconstructed from 2D images using a multiplicative algebraic reconstruction technique (MART) and motion tracking enhancement. Distributions of the 3D displacements were calculated using a digital volume correlation. To evaluate the accuracy of the measurement method in terms of particle density and interrogation voxel size, the gauge strain and one of the two cameras for Tomo-PIV were used as a video-extensometer in the tensile test. The results show that the optimal particle density and interrogation voxel size are 0.014 particles per pixel and 40 x 40 x 40 voxels with a 75% overlap. The maximum measurement error was maintained at less than 2.5% in the 4-mmwide region of the specimen. Conclusions We successfully developed a method to experimentally measure 3D strain distribution in an elastic silicone material using Tomo-PIV and fluorescent particles. To the best of our knowledge, this is the first report that applies Tomo-PIV to investigate 3D strain measurements in elastic materials with large deformation and validates the measurement accuracy.	[Takahashi, Azuma; Aoyama, Yusuke; Umezu, Mitsuo; Iwasaki, Kiyotaka] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Integrat Biosci & Biomed Engn, Shinjuku Ku, Tokyo, Japan; [Suzuki, Sara; Umezu, Mitsuo] Waseda Univ, Grad Sch Creat Sci & Engn, Dept Modern Mech Engn, Shinjuku Ku, Tokyo, Japan; [Iwasaki, Kiyotaka] Waseda Univ, Cooperat Major Adv Biomed Sci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Iwasaki, Kiyotaka] Waseda Univ, Cooperat Major Adv Biomed Sci, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan	Waseda University; Waseda University; Waseda University; Waseda University	Iwasaki, K (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Integrat Biosci & Biomed Engn, Shinjuku Ku, Tokyo, Japan.; Iwasaki, K (corresponding author), Waseda Univ, Cooperat Major Adv Biomed Sci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan.; Iwasaki, K (corresponding author), Waseda Univ, Cooperat Major Adv Biomed Sci, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan.	iwasaki@waseda.jp			Research on Regulatory Science of Pharmaceuticals and Medical Devices from Japan Agency for Medical Research and development, AMED [16mk0102042h0002]; Japan Society for Promotion of Science [15J07145]	Research on Regulatory Science of Pharmaceuticals and Medical Devices from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partially supported by the Research on Regulatory Science of Pharmaceuticals and Medical Devices from Japan Agency for Medical Research and development, AMED (http://www.amed.go.jp/en/) (No. 16mk0102042h0002) and Japan Society for Promotion of Science (https://www.jsps.go.jp/english/) (15J07145).	Altnji HE, 2015, MED ENG PHYS, V37, P23, DOI 10.1016/j.medengphy.2014.09.017; Anderson PSL, 2012, J R SOC INTERFACE, V9, P1846, DOI 10.1098/rsif.2012.0043; Auricchio F, 2014, COMPUT METHOD BIOMEC, V17, P1; Benoit A, 2009, J BIOMECH, V42, P2381, DOI 10.1016/j.jbiomech.2009.06.034; Bright JA, 2011, J ANAT, V219, P456, DOI 10.1111/j.1469-7580.2011.01408.x; Buchmann NA, 2011, EXP FLUIDS, V50, P1131, DOI 10.1007/s00348-011-1042-1; Demanget N, 2012, ANN BIOMED ENG, V40, P2674, DOI 10.1007/s10439-012-0618-0; Elsinga GE, 2006, EXP FLUIDS, V41, P933, DOI 10.1007/s00348-006-0212-z; Elsinga GE, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/8/084004; Gahagnon S, 2012, J BIOMECH, V45, P2860, DOI 10.1016/j.jbiomech.2012.08.032; Gillard F, 2014, J MECH BEHAV BIOMED, V29, P480, DOI 10.1016/j.jmbbm.2013.09.014; GUTOWSKI V, 1993, CONSTR BUILD MATER, V7, P19; Herman G T, 1976, Comput Biol Med, V6, P273, DOI 10.1016/0010-4825(76)90066-4; Hussein AI, 2012, PROC IUTAM, V4, P116, DOI 10.1016/j.piutam.2012.05.013; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Madi K, 2013, MED ENG PHYS, V35, P1298, DOI 10.1016/j.medengphy.2013.02.001; Martin D, 2013, INT J NUMER METH BIO, V29, P1161, DOI 10.1002/cnm.2557; Novara M, 2012, EXP FLUIDS, V52, P1027, DOI 10.1007/s00348-011-1187-y; Novara M, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/3/035401; Pakanca M, 2015, J BIOM ENG, V137, P1; Roberts BC, 2014, J BIOMECH, V47, P923, DOI 10.1016/j.jbiomech.2014.01.001; Scarano F, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/1/012001; Scarano F, 2009, EXP FLUIDS, V47, P69, DOI 10.1007/s00348-009-0629-2; Verhulp E, 2004, J BIOMECH, V37, P1313, DOI 10.1016/j.jbiomech.2003.12.036; Wang Q, 2015, BIOMECH MODEL MECHAN, V14, P29, DOI 10.1007/s10237-014-0583-7; Wang YL, 2007, J APPL POLYM SCI, V103, P3143, DOI 10.1002/app.24598; Wells PNT, 2011, J R SOC INTERFACE, V8, P1521, DOI 10.1098/rsif.2011.0054; Wieneke B, 2008, EXP FLUIDS, V45, P549, DOI 10.1007/s00348-008-0521-5; Zauel R, 2006, J BIOMECH ENG-T ASME, V128, P1, DOI 10.1115/1.2146001	29	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184782	10.1371/journal.pone.0184782	http://dx.doi.org/10.1371/journal.pone.0184782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910397	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200094
J	Tug, S; Tross, AK; Hegen, P; Neuberger, EWI; Helmig, S; Schollhorn, W; Simon, P				Tug, Suzan; Tross, Anna-Katharina; Hegen, Patrick; Neuberger, Elmo Wanja Immanuel; Helmig, Susanne; Schoellhorn, Wolfgang; Simon, Perikles			Acute effects of strength exercises and effects of regular strength training on cell free DNA concentrations in blood plasma	PLOS ONE			English	Article							INFLAMMATION; MARKERS; TRAPS	Creatine kinase (CK) is a marker for muscle cell damage with limited potential as marker for training load in strength training. Recent exercise studies identified cell free DNA (cfDNA) as a marker for aseptic inflammation and cell damage. Here we overserved in a pilot study the acute effects during strength exercise and chronic effects of regular strength training on cfDNA concentrations over a period of four weeks in three training groups applying conservation training (CT) at 60% of the 1 repetition maximum, high intensity-low repetition training (HT) at 90% of the 1 repetition maximum and differential training (DT) at 60% of the 1 repetition maximum. EDTA-plasma samples were collected before every training session, and on the first and last training day repeatedly after every set of exercises. CfDNA increased significantly by 1.62-fold (mean (+/- SD) before first exercise: 8.31 (2.84) ng/ml, after last exercise 13.48 (4.12) ng/ml) across all groups within a single training session (p < 0.001). The increase was 1.77-fold higher (mean (+/- SD) before first exercise: 12.23 (6.29) ng/ml, after last exercise 17.73 (11.24) ng/ml) in HT compared to CT (mean (+/- SD) before first exercise: 6.79 (1.28) ng/ml, after last exercise 10.05 (2.89) ng/ml) (p = 0.01). DNA size analysis suggested predominant release of short, mononucleosomal DNA-fragments in the acute exercise setting, while we detected an increase of mostly longer, polynucleosomal cfDNA-fragments at rest before the training session only at day two with a subsequent return to baseline (p < 0.001). In contrast, training procedures did not cause any alterations in CK. Our results suggest that during strength exercise short-fragmented cfDNA is released, reflecting a fast, aseptic inflammatory response, while elevation of longer fragments at baseline on day two seemed to reflect mild cellular damage due to a novel training regime. We critically discuss the implications of our findings for future evaluations of cfDNA as a marker for training load in strength training.	[Tug, Suzan; Tross, Anna-Katharina; Neuberger, Elmo Wanja Immanuel; Helmig, Susanne; Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Dis Prevent & Rehabil, Mainz, Germany; [Hegen, Patrick; Schoellhorn, Wolfgang] Johannes Gutenberg Univ Mainz, Inst Training & Movement Sci, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Simon, P (corresponding author), Johannes Gutenberg Univ Mainz, Dept Sports Med Dis Prevent & Rehabil, Mainz, Germany.	simonpe@uni-mainz.de	Schoellhorn, Wolfgang/AGY-7067-2022; Simon, Perikles D/B-2293-2013	Schoellhorn, Wolfgang/0000-0002-4558-1991; Simon, Perikles D/0000-0002-7996-4034				ARMSTRONG RB, 1990, MED SCI SPORT EXER, V22, P429; Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Atamaniuk J, 2008, EUR J APPL PHYSIOL, V104, P711, DOI 10.1007/s00421-008-0827-2; Atamaniuk J, 2010, EUR J APPL PHYSIOL, V110, P695, DOI 10.1007/s00421-010-1532-5; Baechle TR, 2008, ESSENTIALS STRENGTH; Beiter T, 2015, SPORTS MED, V45, P625, DOI 10.1007/s40279-014-0296-1; Beiter T, 2014, J APPL PHYSIOL, V117, P325, DOI 10.1152/japplphysiol.00173.2014; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; BRAITH RW, 1993, MED SCI SPORT EXER, V25, P132, DOI 10.1249/00005768-199301000-00018; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Breitbach S, 2014, J APPL PHYSIOL, V117, P119, DOI 10.1152/japplphysiol.00002.2014; Breitbach S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087838; CHOUDHURY NA, 1991, J SURG RES, V51, P392, DOI 10.1016/0022-4804(91)90139-D; Fatouros IG, 2006, CLIN CHEM, V52, P1820, DOI 10.1373/clinchem.2006.070417; Fatouros IG, 2010, CLIN BIOCHEM, V43, P1368, DOI 10.1016/j.clinbiochem.2010.08.020; Fisher-wellman K, 2009, ACUTE EXERCISE OXIDA, V25, P1; Hegen P, 2015, EUR COLLAGE SPORT SC, V20; MAYHEW JL, 1991, J SPORT MED PHYS FIT, V31, P135; Peake J, 2005, EXERC IMMUNOL REV, V11, P64; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Reis E, 1995, INT J SPORTS MED, V16, P545, DOI 10.1055/s-2007-973052; Schollhorn WI, 2000, ACTA ACAD OLYMPIQUAE; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Tug S, 2016, INT J SPORT PHYSIOL, P1; URHAUSEN A, 1995, SPORTS MED, V20, P251, DOI 10.2165/00007256-199520040-00004; Velders M, 2014, CLIN BIOCHEM, V47, P471, DOI 10.1016/j.clinbiochem.2013.12.017; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95	27	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184668	10.1371/journal.pone.0184668	http://dx.doi.org/10.1371/journal.pone.0184668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910365	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200075
J	Dong, JJ; Zhai, B; Sun, WH; Hu, FL; Cheng, H; Xu, J				Dong, Jiejie; Zhai, Bo; Sun, Weihua; Hu, Fengli; Cheng, Hao; Xu, Jun			Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; DRUG-RESISTANCE; EXPRESSION; SNAIL; INVASION; CHEMORESISTANCE; INHIBITION; INDUCTION; AUTOPHAGY; REVERSES	Sorafenib, an orally available kinase inhibitor, is the standard first-line systemic drug for advanced hepatocellular carcinoma (HCC), and it exerts potent inhibitory activity against epithelial-mesenchymal transition (EMT) and multidrug resistance (MDR) by inhibiting mitogen-activated protein kinase (MAPK) signaling in HCC. However, after long-term exposure to sorafenib, HCC cells exhibit EMT and resistance to sorafenib. The activation of AKT by sorafenib is thought to be responsible for the development of these characteristics. The present study aims to examine the underlying mechanism and seek potential strategies to reverse this resistance and the progression to EMT. Sorafenib-resistant cells showed increased metastatic and invasive ability, with a higher expression of P-glycoprotein (P-gp), compared with the parental cells. This phenomenon was at least partially due to EMT and the appearance of MDR in sorafenib-resistant HCC cells. Moreover, MDR was a downstream molecular event of EMT. Silencing Snail with siRNA blocked EMT and partially reversed the MDR, thereby markedly abolishing invasion and metastasis in sorafenib-resistant HCC cells, but silencing of MDR1 had no effect on the EMT phenotype. Additionally, HCC parental cells that were stably transfected with pCDNA3.1-Snail exhibited EMT and MDR. Two sorafenib-resistant HCC cell lines, established from human HCC HepG2 and Huh7 cells, were refractory to sorafenib-induced growth inhibition but were sensitive to MK-2206, a novel allosteric AKT inhibitor. Thus, the combination of sorafenib and MK-2206 led to significant reversion of the EMT phenotype and P-gp-mediated MDR by downregulating phosphorylated AKT. These findings underscore the significance of EMT, MDR and enhanced PI3K/AKT signaling in sorafenib-resistant HCC cells.	[Dong, Jiejie; Cheng, Hao; Xu, Jun] Harbin Med Univ, Dept Gen Surg, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China; [Dong, Jiejie] Yuncheng Cent Hosp, Dept Hepatobiliary Surg, Yuncheng, Shanxi, Peoples R China; [Zhai, Bo; Hu, Fengli] Harbin Med Univ, Dept Gen Surg, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China; [Zhai, Bo; Hu, Fengli; Xu, Jun] Heilongjiang Med Sci Inst, Harbin, Heilongjiang, Peoples R China; [Sun, Weihua] Jinzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Jinzhou, Liaoning, Peoples R China	Harbin Medical University; Shanxi Medical University; Harbin Medical University; Jinzhou Medical University	Xu, J (corresponding author), Harbin Med Univ, Dept Gen Surg, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China.; Xu, J (corresponding author), Heilongjiang Med Sci Inst, Harbin, Heilongjiang, Peoples R China.	medxujun@163.com			National Natural Science Foundation of China [81401975]; Heilongjiang Medical Science Institute [201502, 201504]; China Postdoctoral Science Foundation [2016M591564]; Heilongjiang Postdoctoral Fund [LBH-Z14219, LBH-Z16191]; Heilongjiang Province Health Bureau, China [2014-399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Medical Science Institute; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Fund; Heilongjiang Province Health Bureau, China	This work was supported in part by grants from the National Natural Science Foundation of China (81401975), Scientific Research Project of Heilongjiang Medical Science Institute (201502, 201504), China Postdoctoral Science Foundation (2016M591564), Heilongjiang Postdoctoral Fund (LBH-Z14219, LBH-Z16191), and Heilongjiang Province Health Bureau (2014-399), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Borght SV, 2008, LIVER INT, V28, P1370, DOI 10.1111/j.1478-3231.2008.01889.x; Chen J, 2015, CANCER LETT, V367, P1, DOI 10.1016/j.canlet.2015.06.019; Chen JS, 2014, MOL CELL BIOCHEM, V393, P283, DOI 10.1007/s11010-014-2071-x; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Chen SY, 2014, ONCOL LETT, V8, P2333, DOI 10.3892/ol.2014.2521; Chen XL, 2011, J HEPATOL, V55, P838, DOI 10.1016/j.jhep.2010.12.043; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cheng L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.450; Chow AKM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078675; Gedaly R, 2010, ANTICANCER RES, V30, P4951; He CJ, 2015, ONCOTARGET, V6, P28867, DOI 10.18632/oncotarget.4814; Jiao M, 2012, INT J ONCOL, V40, P461, DOI 10.3892/ijo.2011.1197; Jin X, 2016, TUMOR BIOL, V37, P2683, DOI 10.1007/s13277-015-4068-9; Jou J, 2010, J CLIN INVEST, V120, P1031, DOI 10.1172/JCI42615; Kong LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11747; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Li WT, 2011, ASIAN PAC J CANCER P, V12, P2575; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma JL, 2016, TUMOR BIOL, V37, P6177, DOI 10.1007/s13277-015-4458-z; Mallini P, 2014, CANCER TREAT REV, V40, P341, DOI 10.1016/j.ctrv.2013.09.008; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meng FD, 2015, INT J CLIN EXP PATHO, V8, P6157; Miyoshi A, 2005, BRIT J CANCER, V92, P252, DOI 10.1038/sj.bjc.6602266; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Smith BN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104987; Tabrizi M, 2015, ARCH IRAN MED, V18, P173, DOI 0151803/AIM.007; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsou SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116747; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Wang HB, 2015, MOL MED REP, V12, P3902, DOI 10.3892/mmr.2015.3871; Wang L, 2014, TUMOR BIOL, V35, P9, DOI 10.1007/s13277-013-1141-0; Wu Q, 2014, CANCER LETT, V347, P159, DOI 10.1016/j.canlet.2014.03.013; Yamada S, 2014, ANN SURG ONCOL, V21, P3882, DOI 10.1245/s10434-014-3779-2; Zhai B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138485; Zhai B, 2015, TUMOR BIOL, V36, P2323, DOI 10.1007/s13277-014-2839-3; Zhai B, 2014, MOL CANCER THER, V13, P1589, DOI 10.1158/1535-7163.MCT-13-1043; Zhao DL, 2014, CELL SIGNAL, V26, P1030, DOI 10.1016/j.cellsig.2014.01.026; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhou SL, 2015, CANCER LETT, V358, P124, DOI 10.1016/j.canlet.2014.11.044; Zucchini-Pascal N, 2013, INT J MOL SCI, V14, P20768, DOI 10.3390/ijms141020768	43	75	83	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185088	10.1371/journal.pone.0185088	http://dx.doi.org/10.1371/journal.pone.0185088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934275	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900085
J	Thoms, R; Kohler, M; Gessler, A; Gleixner, G				Thoms, Ronny; Koehler, Michael; Gessler, Arthur; Gleixner, Gerd			Above and below ground carbohydrate allocation differs between ash (Fraxinus excelsior L.) and beech (Fagus sylvatica L.)	PLOS ONE			English	Article							CARBON ALLOCATION; PHOTOSYNTHETIC CARBON; RESIDENCE TIMES; TREE DIVERSITY; PLANT CARBON; SOIL; PHLOEM; TRANSLOCATION; FOREST; RESPIRATION	We investigated soluble carbohydrate transport in trees that differed in their phloem loading strategies in order to better understand the transport of photosynthetic products into the roots and the rhizosphere as this knowledge is needed to better understand the respiratory processes in the rhizosphere. We compared beech, which is suggested to use mainly passive loading of transport sugars along a concentration gradient into the phloem, with ash that uses active loading and polymer trapping of raffinose family oligosaccharides (RFOs). We pulse-labeled 20 four-year old European beech and 20 four-year old ash trees with (CO2)-C-13 and tracked the fate of the label within different plant compartments. We extracted soluble carbohydrates from leaves, bark of stems and branches, and fine roots, measured their amount and isotopic content and calculated their turnover times. In beech one part of the sucrose was rapidly transported into sink tissues without major exchange with storage pools whereas another part of sucrose was strongly exchanged with unlabeled possibly stored sucrose. In contrast the storage and allocation patterns in ash depended on the identity of the transported sugars. RFO were the most important transport sugars that had highest turnover in all shoot compartments. However, the turnover of RFOs in the roots was uncoupled from the shoot. The only significant relation between sugars in the stem base and in the roots of ash was found for the amount (r(2) = 0.50; p = 0.001) and isotopic content (r(2) = 0.47; p = 0.01) of sucrose. The negative relation of the amounts suggested an active transport of sucrose into the roots of ash. Sucrose concentration in the root also best explained the concentration of RFOs in the roots suggesting that RFO in the roots of ash may be resynthesized from sucrose. Our results interestingly suggest that in both tree species only sucrose directly entered the fine root system and that in ash RFOs are transported indirectly into the fine roots only. The direct transport of sucrose might be passive in beech but active in ash (sustained active up-and unloading to co-cells), which would correspond to the phloem loading strategies. Our results give first hints that the transport of carbohydrates between shoot and root is not necessarily continuous and involves passive (beech) and active (ash) transport processes, which may be controlled by the phloem unloading.	[Thoms, Ronny; Gleixner, Gerd] Max Planck Inst Biogeochem, Jena, Germany; [Koehler, Michael] Burckhardt Inst, Trop Silviculture & Forest Ecol, Gottingen, Germany; [Gessler, Arthur] Eidg Forsch Sanstalt WSL, Birmensdorf, Switzerland	Max Planck Society	Gleixner, G (corresponding author), Max Planck Inst Biogeochem, Jena, Germany.	gerd.gleixner@bgc-jena.mpg.de	Gleixner, Gerd/M-8519-2017; Gessler, Arthur/C-7121-2008; Gleixner, Gerd/O-4215-2019	Gleixner, Gerd/0000-0002-4616-0953; Gessler, Arthur/0000-0002-1910-9589; Gleixner, Gerd/0000-0002-4616-0953	Deutsche Forschungsgemeinschaft (DFG) within the Graduiertenkolleg 1086 "The role of biodiversity for biochemical cycles and biotic interactions in a temperate deciduous forest"	Deutsche Forschungsgemeinschaft (DFG) within the Graduiertenkolleg 1086 "The role of biodiversity for biochemical cycles and biotic interactions in a temperate deciduous forest"(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) within the Graduiertenkolleg 1086 "The role of biodiversity for biochemical cycles and biotic interactions in a temperate deciduous forest". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was funded by the Deutsche Forschungsgemeinschaft (DFG) within the Graduiertenkolleg 1086 "The role of biodiversity for biochemical cycles and biotic interactions in a temperate deciduous forest". Furthermore, we thank Steffen Ruhlow for technical support, Janine Sommer, Michaela Rath, and Sarah Zieger for collaborations in the field.	Ainsworth EA, 2011, PLANT PHYSIOL, V155, P64, DOI 10.1104/pp.110.167684; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; BACHMANN M, 1994, PLANT PHYSIOL, V105, P1335, DOI 10.1104/pp.105.4.1335; BRUGGEMANN N, 2011, BIOGEOSCIENCES, V8, P3457, DOI DOI 10.5194/bg-8-3457-2011; Carbone MS, 2007, GLOBAL CHANGE BIOL, V13, P466, DOI 10.1111/j.1365-2486.2006.01300.x; Cesarz S, 2013, SOIL BIOL BIOCHEM, V61, P23, DOI 10.1016/j.soilbio.2013.02.003; De Deyn GB, 2011, BIOGEOSCIENCES, V8, P1131, DOI 10.5194/bg-8-1131-2011; Dobrowolska D, 2011, FORESTRY, V84, P133, DOI 10.1093/forestry/cpr001; Epron D, 2012, TREE PHYSIOL, V32, P776, DOI 10.1093/treephys/tps057; FERRIER JM, 1976, CAN J BOT, V54, P2130, DOI 10.1139/b76-229; Fuchslueger L, 2014, NEW PHYTOL, V201, P916, DOI 10.1111/nph.12569; Gaudinski JB, 2000, BIOGEOCHEMISTRY, V51, P33, DOI 10.1023/A:1006301010014; Gessler A, 2007, FUNCT PLANT BIOL, V34, P692, DOI 10.1071/FP07064; Gould N, 2004, FUNCT PLANT BIOL, V31, P987, DOI 10.1071/FP04058; Guckland A, 2009, J PLANT NUTR SOIL SC, V172, P500, DOI 10.1002/jpln.200800072; HINESLEY LE, 1992, J AM SOC HORTIC SCI, V117, P852, DOI 10.21273/JASHS.117.5.852; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Holtta T, 2005, TREES-STRUCT FUNCT, V20, P67; HORWATH WR, 1994, TREE PHYSIOL, V14, P1163, DOI 10.1093/treephys/14.10.1163; Jahnke S, 1998, BOT ACTA, V111, P307, DOI 10.1111/j.1438-8677.1998.tb00714.x; KALTTORRES W, 1987, PLANT PHYSIOL, V83, P283, DOI 10.1104/pp.83.2.283; Keel SG, 2012, NEW PHYTOL, V194, P972, DOI 10.1111/j.1469-8137.2012.04120.x; KELLER F, 1989, NEW PHYTOL, V113, P291, DOI 10.1111/j.1469-8137.1989.tb02406.x; Korner C, 2015, CURR OPIN PLANT BIOL, V25, P107, DOI 10.1016/j.pbi.2015.05.003; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Kuzyakov Y, 2001, SOIL BIOL BIOCHEM, V33, P1915, DOI 10.1016/S0038-0717(01)00117-1; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Lang C, 2011, TREE PHYSIOL, V31, P531, DOI 10.1093/treephys/tpr042; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Liesche J., 2013, SYMPLASMIC TRANSPORT, P133; Liesche J, 2012, PLANT PHYSIOL, V159, P355, DOI 10.1104/pp.112.195115; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Mencuccini M, 2010, NEW PHYTOL, V185, P189, DOI 10.1111/j.1469-8137.2009.03050.x; Merchant A, 2011, PLANT CELL ENVIRON, V34, P1599, DOI 10.1111/j.1365-3040.2011.02359.x; Minchin PEH, 1996, J EXP BOT, V47, P1293, DOI 10.1093/jxb/47.Special_Issue.1293; Muench E, 1930, DIE STOFFBEWEGUNGEN, P4; Oner-Sieben S, 2014, J EXP BOT, V65, P1905, DOI 10.1093/jxb/eru066; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191; Plain C, 2009, TREE PHYSIOL, V29, P1433, DOI 10.1093/treephys/tpp072; Poschet G, 2010, PLANT CELL PHYSIOL, V51, P1571, DOI 10.1093/pcp/pcq100; Rennie EA, 2009, P NATL ACAD SCI USA, V106, P14162, DOI 10.1073/pnas.0902279106; Richter A, 2009, RAPID COMMUN MASS SP, V23, P2476, DOI 10.1002/rcm.4088; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; Sampson DA, 2007, GLOBAL CHANGE BIOL, V13, P2008, DOI 10.1111/j.1365-2486.2007.01414.x; Slewinski TL, 2010, PLANT SCI, V178, P341, DOI 10.1016/j.plantsci.2010.01.010; Thompson MV, 2003, PLANT CELL ENVIRON, V26, P1561, DOI 10.1046/j.1365-3040.2003.01080.x; THOMPSON RG, 1979, CAN J BOT, V57, P845, DOI 10.1139/b79-106; Thoms C, 2010, SOIL BIOL BIOCHEM, V42, P1558, DOI 10.1016/j.soilbio.2010.05.030; Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x; Wertin TM, 2008, TREE PHYSIOL, V28, P1831, DOI 10.1093/treephys/28.12.1831; WIEMKEN V, 1993, PLANTA, V190, P387, DOI 10.1007/BF00196968; Wingate L, 2010, NEW PHYTOL, V188, P576, DOI 10.1111/j.1469-8137.2010.03384.x; ZIMMERMA.MH, 1969, PLANTA, V84, P272, DOI 10.1007/BF00388113; ZIMMERMANN MH, 1957, PLANT PHYSIOL, V32, P288, DOI 10.1104/pp.32.4.288	56	5	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184247	10.1371/journal.pone.0184247	http://dx.doi.org/10.1371/journal.pone.0184247			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934229	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900024
J	Yuan, WZ; Chen, JH; Shu, Y; Liu, SG; Wu, L; Ji, JT; Liu, ZY; Tang, Q; Zhou, ZL; Cheng, YF; Jiang, B; Shu, XG				Yuan, Wenzheng; Chen, Jinhuang; Shu, Yan; Liu, Sanguang; Wu, Liang; Ji, Jintong; Liu, Zhengyi; Tang, Qiang; Zhou, Zili; Cheng, Yifeng; Jiang, Bin; Shu, Xiaogang			Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis	PLOS ONE			English	Review							MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; KINASE PROMOTER HYPERMETHYLATION; CPG ISLAND HYPERMETHYLATION; TUMOR-SUPPRESSOR GENES; GASTRIC-CANCER; COLORECTAL-CANCER; MULTIPLE GENES; ESOPHAGEAL ADENOCARCINOMA; ABERRANT METHYLATION; DNA METHYLATION	Objective One of the critical mechanisms of gastrointestinal cancer pathogenesis is the silencing of death associated protein kinase 1 (DAPK1), which could be caused by aberrant methylation of the promoter. However, the relationship between DAPK1 methylation and the risk of gastrointestinal cancer is still controversial. Hence, we conducted this study to determine the potential correlation. Methods Eligible publications were searched in the Pubmed, Embase, and Cochrane Library through November 2016 according to the inclusion criteria and exclusion criteria. Revman 5.3 and Stata 12.0 software were used to analyze the relevant data regarding the association between the frequency of DAPK1 methylation and gastrointestinal cancer. Results A total of 22 studies with 2406 patients were included in this meta analysis. Methylation of DAPK1 was positively related with the risk of gastrointestinal cancer (odds ratio [OR] = 5.35, 95% confidence interval [CI]: 2.76-10.38, P < 0.00001, random effects model). The source of heterogeneity was analyzed by sensitivity analysis and subgroup analysis. After omitting one heterogeneous study, the I 2 decreased and the OR increased in pooled analysis. Also, the heterogeneity decreased most significantly in the subgroup of studies that had a sample size of less than 60 cases. Then, the correlations between DAPK1 methylation and clinicopathological features of gastrointestinal cancer were assessed. DAPK1 methylation was positively correlated with the lymph node (N) stage (positive vs. negative, OR = 1.45, 95% CI: 1.01-2.06, P = 0.04, fixed effects model) and poor differentiation (OR = 1.55, 95% CI:1.02-2.35, P = 0.04, fixed effects model) in gastric cancer, and the association was significant among Asian patients. However, among cases of gastrointestinal cancer, the association between DAPK1 methylation and tumor (T) stage, N stage, distant metastasis (M) stage, and cancer differentiation were not statistically significant. Conclusions DAPK1 methylation is a potential biomarker for the early diagnosis of gastrointestinal cancer. Further analysis of the clinicopathological features indicated that aberrant methylation of DAPK1 is positively associated with the tumorigenesis of gastrointestinal cancer, and metastasis of gastric cancer.	[Yuan, Wenzheng; Wu, Liang; Ji, Jintong; Liu, Zhengyi; Tang, Qiang; Zhou, Zili; Cheng, Yifeng; Shu, Xiaogang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan, Hubei, Peoples R China; [Chen, Jinhuang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Emergency Surg, Wuhan, Hubei, Peoples R China; [Shu, Yan] Hubei Univ Sci & Technol, Coll Clin Med, Xianning, Peoples R China; [Liu, Sanguang] Hebei Med Univ, Hosp 2, Dept Hepatobiliary Surg, Shijiazhuang, Hebei, Peoples R China; [Jiang, Bin] Huazhong Univ Sci & Technol, Tongji Med Coll, TongJi Hosp, Dept Breast & Thyroid Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hubei University of Science & Technology; Hebei Medical University; Huazhong University of Science & Technology	Shu, XG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan, Hubei, Peoples R China.	sxg678@yahoo.com			National Nature Science Foundation of China [81470789, 81271199]; Public welfare in Health Industry [201402015]; Health and Family Plan Committee of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public welfare in Health Industry; Health and Family Plan Committee of China	This study was supported by the National Nature Science Foundation of China (No. 81470789 and 81271199) (http://www.nsfc.gov.cn/), and Research Fund of Public welfare in Health Industry (No. 201402015), Health and Family Plan Committee of China, 2014 (http://www.nhfpc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Nature Science Foundation of China (No. 81470789 and 81271199)(http://www.nsfc.gov.cn/), and Research Fund of Public welfare in Health Industry (No.201402015), Health and Family Plan Committee of China, 2014 (http://www.nhfpc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agodi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135078; Almeida FGO, 2015, BIOL RES, V48, DOI [10.1186/s40659-015-0042-7, 10.1186/S40659-015-0042-7]; Anacleto C, 2005, NEOPLASIA, V7, P331, DOI 10.1593/neo.04502; Bagci B, 2016, CANCER BIOMARK, V17, P133, DOI 10.3233/CBM-160624; Brock MV, 2003, CLIN CANCER RES, V9, P2912; Catto JWF, 2005, J CLIN ONCOL, V23, P2903, DOI 10.1200/JCO.2005.03.163; Celik S, 2015, ONCOL LETT, V9, P399, DOI 10.3892/ol.2014.2677; Chan AWH, 2005, ONCOL REP, V13, P937; Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116549; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Fackler MJ, 2004, CANCER RES, V64, P4442, DOI 10.1158/0008-5472.CAN-03-3341; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gonzalez-Gomez P, 2003, ONCOL REP, V10, P1031; Harden SV, 2003, CLIN CANCER RES, V9, P1370; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu SL, 2010, TUMORI J, V96, P726, DOI 10.1177/030089161009600515; Hu SY, 2006, INT J CANCER, V119, P2322, DOI 10.1002/ijc.22110; Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306; Jia WZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005040; Jiang B, 2016, J HUAZHONG U SCI-MED, V36, P278, DOI 10.1007/s11596-016-1580-0; Kato K, 2008, INT J CANCER, V122, P603, DOI 10.1002/ijc.23143; Ksiaa F, 2009, CLIN CHIM ACTA, V404, P128, DOI 10.1016/j.cca.2009.03.044; Kuester D, 2007, NEOPLASIA, V9, P236, DOI 10.1593/neo.06802; KUPCINSKAITENOREIK, 2013, MED LITH, V49, P361; Laskar RS, 2015, MOL CARCINOGEN, V54, P1786, DOI 10.1002/mc.22250; Lee BB, 2009, CLIN CANCER RES, V15, P6185, DOI 10.1158/1078-0432.CCR-09-0111; Lee S, 2004, LAB INVEST, V84, P884, DOI 10.1038/labinvest.3700108; Li B, 2011, EPIGENETICS-US, V6, P307, DOI 10.4161/epi.6.3.14182; Li Y K, 2015, J APPL MATH, V2015, DOI DOI 10.1145/2801040.2801062; Mittag F, 2006, CANCER LETT, V240, P69, DOI 10.1016/j.canlet.2005.08.034; Nomura T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-1; Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Qin Y, 2014, INT J CLIN EXP PATHO, V7, P7536; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Sabbioni Silvia, 2003, Mol Diagn, V7, P201, DOI 10.2165/00066982-200307030-00010; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; Schildhaus HU, 2005, INT J ONCOL, V26, P1493; Schneider-Stock R, 2014, APOPTOSIS, V19, P285, DOI 10.1007/s10495-013-0932-5; Singh P, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00046; Stevens C, 2009, J BIOL CHEM, V284, P334, DOI 10.1074/jbc.M805165200; Tahara T, 2015, EPIGENOMICS-UK, V7, P475, DOI 10.2217/epi.15.4; Tahara T, 2010, DIGESTION, V82, P27, DOI 10.1159/000252766; To KF, 2002, INT J CANCER, V102, P623, DOI 10.1002/ijc.10783; Waki T, 2003, CANCER SCI, V94, P360, DOI 10.1111/j.1349-7006.2003.tb01447.x; Xiong JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107272; Xu XL, 2004, WORLD J GASTROENTERO, V10, P3441; Yamaguchi S, 2003, CANCER LETT, V194, P99, DOI 10.1016/S0304-3835(03)00055-7; Ye M, 2012, EUR J CANCER PREV, V21, P241, DOI 10.1097/CEJ.0b013e32834c9caa; Zhai JW, 2013, EXP THER MED, V5, P972, DOI 10.3892/etm.2013.916; Zhao JB, 2016, IEEE T SMART GRID, V7, P6, DOI 10.1109/TSG.2015.2490603; Zou XP, 2009, HUM PATHOL, V40, P1534, DOI 10.1016/j.humpath.2009.01.029	52	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184959	10.1371/journal.pone.0184959	http://dx.doi.org/10.1371/journal.pone.0184959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934284	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900065
J	Zajenkowski, M				Zajenkowski, Marcin			Hostile and energetic: Anger is predicted by low agreeableness and high energetic arousal	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; PERSONALITY; AGGRESSION; PERFORMANCE; EMOTION; STATE; TRAIT	A hypothesis that anger is related to high energetic arousal (EA), but only at a low level of agreeableness was tested. In the first two studies, the association between trait anger, agreeableness, and EA was explored. In the next two studies, the interactions of agreeableness with constructs conceptually and empirically close to EA, in predicting anger were tested. Study 3 revealed that anger was predicted by a low level of agreeableness and a high level of positive affect. In study 4 task engagement (construct containing an energetic component) was included in the context of cognitive performance. At a high level of agreeableness the association between anger and task engagement was negative, whereas among individuals with low agreeableness this relation was not significant.	[Zajenkowski, Marcin] Univ Warsaw, Fac Psychol, Warsaw, Poland	University of Warsaw	Zajenkowski, M (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	zajenkowski@psych.uw.edu.pl		Zajenkowski, Marcin/0000-0001-8669-4231	National Science Centre in Poland [2014/13/B/HS6/04083]	National Science Centre in Poland(National Science Centre, Poland)	The work was supported by a grant 2014/13/B/HS6/04083 funded by the National Science Centre in Poland.	[Anonymous], 2016, POLSKIE FORUM PSYCHO, V21, P93; [Anonymous], 1983, MANUAL RAVENS PROGR; [Anonymous], 2014, ROCZNIKI PSYCHOL, V17, P327; Austin EJ, 2002, PERS INDIV DIFFER, V32, P1391, DOI 10.1016/S0191-8869(01)00129-5; Berkowitz L., 1993, AGGRESSION ITS CAUSE, DOI 3.0.CO;2-9; Bettencourt BA, 2006, PSYCHOL BULL, V132, P751, DOI 10.1037/0033-2909.132.5.751; Bresin K, 2012, J RES PERS, V46, P79, DOI 10.1016/j.jrp.2011.12.007; Brzozowski P, 2010, SKALA UCZUC POZYTYWN; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Costa PT, 2007, REVISED NEO PERSONAL; DEFFENBACHER JL, 1992, ADV PERS AS, V9, P177; Finley A, 2016, J PERS; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Harmon-Jones E, 2010, J RES PERS, V44, P120, DOI 10.1016/j.jrp.2009.09.001; Harmon-Jones E, 2009, EMOTION, V9, P183, DOI 10.1037/a0014959; Hayes AF, 2015, MULTIVAR BEHAV RES, V50, P1, DOI 10.1080/00273171.2014.962683; Hindmarch I., 1988, PSYCHOPHARMACOLOGY R; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; MATTHEWS G, 1990, BRIT J PSYCHOL, V81, P17, DOI 10.1111/j.2044-8295.1990.tb02343.x; Matthews G., 2009, PERSONALITY TRAITS; Matthews G., 2000, HDB SELF REGULATION, P171, DOI [10.1016/B978-012109890-2/50035-4, DOI 10.1016/B978-012109890-2/50035-4]; Matthews G, 2012, PERS INDIV DIFFER, V53, P574, DOI 10.1016/j.paid.2012.04.034; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; Matthews G, 2010, SPRINGER SER HUM EXC, P205, DOI 10.1007/978-1-4419-1210-7_13; Meier BP, 2004, PERS SOC PSYCHOL B, V30, P856, DOI 10.1177/0146167204264764; Meier BP, 2006, PSYCHOL SCI, V17, P136, DOI 10.1111/j.1467-9280.2006.01676.x; Ode S, 2008, J RES PERS, V42, P295, DOI 10.1016/j.jrp.2007.05.007; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Smith TW, 2004, J PERS, V72, P1217, DOI 10.1111/j.1467-6494.2004.00296.x; Spielberger C.D., 1999, STAXI 2 STATE TRAIT; Thayer R. E, 1990, BIOPSYCHOLOGY MOOD A; Tobin RM, 2000, J PERS SOC PSYCHOL, V79, P656, DOI 10.1037//0022-3514.79.4.656; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D., 2000, MOOD TEMPERAMENT; Wilkowski BM, 2010, J PERS, V78, P9, DOI 10.1111/j.1467-6494.2009.00607.x; Zajenkowski M, 2016, INTELLIGENCE, V58, P1, DOI 10.1016/j.intell.2016.06.002; Zajenkowski M, 2015, PERS INDIV DIFFER, V81, P23, DOI 10.1016/j.paid.2014.12.062; Zajenkowski M, 2012, PERS INDIV DIFFER, V52, P858, DOI 10.1016/j.paid.2012.01.007; Zawadzki B, INWENTARZ NEO FFI CO	40	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184919	10.1371/journal.pone.0184919	http://dx.doi.org/10.1371/journal.pone.0184919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931038	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700043
J	Briggs, JW; Ren, L; Chakrabarti, KR; Tsai, YC; Weissman, AM; Hansen, RJ; Gustafson, DL; Khan, YA; Dinman, JD; Khanna, C				Briggs, Joseph W.; Ren, Ling; Chakrabarti, Kristi R.; Tsai, Yien Che; Weissman, Allan M.; Hansen, Ryan J.; Gustafson, Daniel L.; Khan, Yousuf A.; Dinman, Jonathan D.; Khanna, Chand			Activation of the unfolded protein response in sarcoma cells treated with rapamycin or temsirolimus	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; STRESSED ENDOPLASMIC-RETICULUM; INDUCED GENE-EXPRESSION; P70 S6 KINASE; RIBOSOMAL-SUBUNIT; MAMMALIAN TARGET; BINDING PARTNER; TRANSLOCON PORE; CANCER-THERAPY; ER STRESS	Activation of the unfolded protein response (UPR) in eukaryotic cells represents an evolutionarily conserved response to physiological stress. Here, we report that the mTOR inhibitors rapamycin (sirolimus) and structurally related temsirolimus are capable of inducing UPR in sarcoma cells. However, this effect appears to be distinct from the classical role for these drugs as mTOR inhibitors. Instead, we detected these compounds to be associated with ribosomes isolated from treated cells. Specifically, temsirolimus treatment resulted in protection from chemical modification of several rRNA residues previously shown to bind rapamycin in prokaryotic cells. As an application for these findings, we demonstrate maximum tumor cell growth inhibition occurring only at doses which induce UPR and which have been shown to be safely achieved in human patients. These results are significant because they challenge the paradigm for the use of these drugs as anticancer agents and reveal a connection to UPR, a conserved biological response that has been implicated in tumor growth and response to therapy. As a result, eIF2 alpha phosphorylation and Xbp-1 splicing may serve as useful biomarkers of treatment response in future clinical trials using rapamycin and rapalogs.	[Briggs, Joseph W.; Ren, Ling; Chakrabarti, Kristi R.; Khanna, Chand] NCI, Tumor Metastasis Biol Sect, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Tsai, Yien Che; Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Ctr Canc Res, NIH, Frederick, MD 20892 USA; [Hansen, Ryan J.; Gustafson, Daniel L.] Colorado State Univ, Flint Anim Canc Ctr, Ft Collins, CO 80523 USA; [Briggs, Joseph W.; Khan, Yousuf A.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Chakrabarti, Kristi R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Khanna, Chand] Ethos Vet Hlth, Woburn, MA USA; [Hansen, Ryan J.] Sierra Oncol, Vancouver, BC, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Colorado State University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Briggs, JW (corresponding author), NCI, Tumor Metastasis Biol Sect, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA.; Briggs, JW (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	briggsjw@umd.edu		Tsai, Yien Che/0000-0001-9624-1092; Khan, Yousuf/0000-0003-0201-2796; Briggs, Joseph/0000-0001-6375-6348	Intramural Research Program of the National Institutes of Health; National Cancer Institute, Center for Cancer Research (CK) [5R01HL119439-03]; National Heart, Lung and Blood Institute, National Institutes of Health (JDD) [3R01HL119439-03S1]; National Heart, Lung and Blood Institute, National Institutes of Health (JDD, JWB); Howard Hughes Medical Institute/University of Maryland College Park (YAK); NATIONAL CANCER INSTITUTE [F30CA196075, ZIABC009392, P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117177] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research (CK); National Heart, Lung and Blood Institute, National Institutes of Health (JDD); National Heart, Lung and Blood Institute, National Institutes of Health (JDD, JWB); Howard Hughes Medical Institute/University of Maryland College Park (YAK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research (CK) 5R01HL119439-03 National Heart, Lung and Blood Institute, National Institutes of Health (JDD) 3R01HL119439-03S1 National Heart, Lung and Blood Institute, National Institutes of Health (JDD, JWB), and partly supported by an undergraduate fellowship from the Howard Hughes Medical Institute/University of Maryland College Park (YAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERS MW, 1993, ANN NY ACAD SCI, V696, P54; Amit M, 2005, FEBS LETT, V579, P3207, DOI 10.1016/j.febslet.2005.03.023; [Anonymous], [No title captured]; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boni J, 2007, J CLIN PHARMACOL, V47, P1430, DOI 10.1177/0091270007306957; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; BROSTROM MA, 1995, J BIOL CHEM, V270, P4127, DOI 10.1074/jbc.270.8.4127; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gingras AC, 2001, GENE DEV, V15, P2852; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Jenni S, 2003, CURR OPIN STRUC BIOL, V13, P212, DOI 10.1016/S0959-440X(03)00034-4; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Larsson SL, 2001, BIOCHEMISTRY-US, V40, P3222, DOI 10.1021/bi002286q; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lin PJ, 2011, J CELL BIOL, V195, P55, DOI 10.1083/jcb.201103118; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; McConkey DJ, 2017, BIOCHEM BIOPH RES CO, V482, P450, DOI 10.1016/j.bbrc.2016.11.047; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Niwa M, 2005, GENOME BIOL, V6; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Raymond E, 2004, J CLIN ONCOL, V22, P2336, DOI 10.1200/JCO.2004.08.116; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shor B, 2008, CANCER RES, V68, P2934, DOI 10.1158/0008-5472.CAN-07-6487; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; STADE K, 1994, NUCLEIC ACIDS RES, V22, P1394, DOI 10.1093/nar/22.8.1394; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	66	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185089	10.1371/journal.pone.0185089	http://dx.doi.org/10.1371/journal.pone.0185089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926611	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600068
J	DeVallance, E; Riggs, D; Jackson, B; Parkulo, T; Zaslau, S; Chantler, PD; Olfertl, IM; Bryner, RW				DeVallance, Evan; Riggs, Dale; Jackson, Barbara; Parkulo, Travis; Zaslau, Stanley; Chantler, Paul D.; Olfertl, I. Mark; Bryner, Randy W.			Effect of chronic stress on running wheel activity in mice	PLOS ONE			English	Article							CHRONIC MILD STRESS; DIABETIC FATTY RAT; PHYSICAL-ACTIVITY; RESTRAINT STRESS; FOOD-INTAKE; MODEL; DEPRESSION; BEHAVIOR; RESPONSIVENESS; NEUROENDOCRINE	Acute and chronic stress have been reported to have differing effects on physical activity in rodents, but no study has examined a chronic stress protocol that incorporates stressors often experienced by rodents throughout a day. To examine this, the effects of the Unpredictable Chronic Mild Stress (UCMS) protocol on voluntary running wheel activity at multiple time points, and/or in response to acute removal of chronic stress was determined. Twenty male Balb/c mice were given access and accustomed to running wheels for 4 weeks, after which they were randomized into 2 groups; exercise (EX, n = 10) and exercise with chronic stress using a modified UCMS protocol for 7 hours/day (8: 00 a.m.-3: 00p.m.), 5 days/week for 8 weeks (EXS, n = 10). All mice were given access to running wheels from approximately 3: 30 p.m. to 7: 30 a. m. during the weekday, however during weekends mice had full-time access to running wheels (a time period of no stress for the EXS group). Daily wheel running distance and time were recorded. The average running distance, running time, and work each weekday was significantly lower in EXS compared to EX mice, however, the largest effect was seen during week one. Voluntary wheel running deceased in all mice with increasing age; the pattern of decline appeared to be similar between groups. During the weekend (when no stress was applied), EXS maintained higher distance compared to EX, as well as higher daily distance, time, and work compared to their weekday values. These results indicate that mild chronic stress reduces total spontaneous wheel running in mice during the first week of the daily stress induction and maintains this reduced level for up to 8 consecutive weeks. However, following five days of UCMS, voluntary running wheel activity rebounds within 2-3 days.	[DeVallance, Evan; Parkulo, Travis; Chantler, Paul D.; Olfertl, I. Mark; Bryner, Randy W.] WVU Sch Med, Div Exercise Physiol, Morgantown, WV 26506 USA; [Riggs, Dale; Jackson, Barbara; Zaslau, Stanley] WVU Sch Med, Dept Surg, Morgantown, WV USA	West Virginia University; West Virginia University	Bryner, RW (corresponding author), WVU Sch Med, Div Exercise Physiol, Morgantown, WV 26506 USA.	rbryner@hsc.ovve.edu			West Virginia University [3-R-046R]	West Virginia University	This work was supported by West Virginia University through the James & Emily LaRosa Urology Research Fund (fund number 3-R-046R).; This project was supported by funding from West Virginia University through the James & Emily LaRosa Urology Research Fund (fund number 3-R-046R).	Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; Bates HE, 2008, ENDOCRINOLOGY, V149, P2990, DOI 10.1210/en.2007-1473; Bates HE, 2007, METABOLISM, V56, P1065, DOI 10.1016/j.metabol.2007.03.015; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Chang CH, 2014, BIOL PSYCHIAT, V76, P223, DOI 10.1016/j.biopsych.2013.09.020; DALLMAN MF, 1993, TRENDS ENDOCRIN MET, V4, P62, DOI 10.1016/S1043-2760(05)80017-7; Demirtas T, 2014, INFLAMMATION, V37, P1432, DOI 10.1007/s10753-014-9867-4; Di Chiara G, 1999, BIOL PSYCHIAT, V46, P1624, DOI 10.1016/S0006-3223(99)00236-X; Ducottet C, 2005, BEHAV BRAIN RES, V156, P153, DOI 10.1016/j.bbr.2004.05.018; Gavrilovic L, 2012, J BIOL REG HOMEOS AG, V26, P367; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; GRIFFITHS J, 1992, PHARMACOL BIOCHEM BE, V42, P219, DOI 10.1016/0091-3057(92)90519-L; Grippo AJ, 2005, PHYSIOL BEHAV, V84, P697, DOI 10.1016/j.physbeh.2005.02.011; Grippo AJ, 2005, PSYCHOPHARMACOLOGY, V179, P769, DOI 10.1007/s00213-004-2103-4; Grippo AJ, 2003, PHYSIOL BEHAV, V78, P703, DOI 10.1016/S0031-9384(03)00050-7; Gurfein BT, 2012, MOL MED, V18, P606, DOI 10.2119/molmed.2012.00053; Hill MN, 2012, NEUROSCI BIOBEHAV R, V36, P2085, DOI 10.1016/j.neubiorev.2012.07.001; Hruschka DJ, 2005, PSYCHONEUROENDOCRINO, V30, P698, DOI 10.1016/j.psyneuen.2005.03.002; Javelot H, 2014, BEHAV BRAIN RES, V261, P8, DOI 10.1016/j.bbr.2013.11.047; Kyrou L, 2008, HORM-INT J ENDOCRINO, V7, P287, DOI 10.14310/horm.2002.1209; Li S, 2007, LIFE SCI, V80, P1373, DOI 10.1016/j.lfs.2006.12.027; Malisch JL, 2008, GEN COMP ENDOCR, V156, P210, DOI 10.1016/j.ygcen.2008.01.020; Malisch JL, 2016, PHYSIOL BIOCHEM ZOOL, V89, P546, DOI 10.1086/688660; Malisch JL, 2009, BEHAV GENET, V39, P192, DOI 10.1007/s10519-008-9246-8; Mann EA, 2015, PHYSIOL BEHAV, V150, P83, DOI 10.1016/j.physbeh.2015.02.021; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Pan Y, 2013, PSYCHONEUROENDOCRINO, V38, P122, DOI 10.1016/j.psyneuen.2012.05.007; Papp M, 1996, EUR J PHARMACOL, V296, P129, DOI 10.1016/0014-2999(95)00697-4; Parker KJ, 2003, HORM BEHAV, V43, P60, DOI 10.1016/S0018-506X(02)00016-8; Popescu S, 2016, CLIN INTERV AGING, V11, P313, DOI 10.2147/CIA.S97295; PRZEGALINSKI E, 1995, NEUROPHARMACOLOGY, V34, P1305, DOI 10.1016/0028-3908(95)00102-C; Rogoz Z, 2012, PHARMACOL REP, V64, P1391, DOI 10.1016/S1734-1140(12)70936-2; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Song L, 2006, PHARMACOL BIOCHEM BE, V83, P186, DOI 10.1016/j.pbb.2006.01.004; Swallow JG, 1998, J APPL PHYSIOL, V84, P69, DOI 10.1152/jappl.1998.84.1.69; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Willner P, 1996, PHYSIOL BEHAV, V60, P129, DOI 10.1016/0031-9384(95)02256-2; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Zhang X, 2007, CHIN J INTEGR MED, V13, P46, DOI 10.1007/s11655-007-0046-4; Zhu SW, 2006, BEHAV BRAIN RES, V167, P1, DOI 10.1016/j.bbr.2005.02.038	42	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184829	10.1371/journal.pone.0184829	http://dx.doi.org/10.1371/journal.pone.0184829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926614	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600044
J	Kim, SW; Shin, HJ; Hwang, JH; Shin, JS; Park, SK; Kim, JY; Kim, KJ; Kay, CS; Kang, YN				Kim, Shin-Wook; Shin, Hun-Joo; Hwang, Jin-Ho; Shin, Jin-Sol; Park, Sung-Kwang; Kim, Jin-Young; Kim, Ki-Jun; Kay, Chul-Seung; Kang, Young-Nam			Image similarity evaluation of the bulk-density-assigned synthetic CT derived from MRI of intracranial regions for radiation treatment	PLOS ONE			English	Article							RADIOTHERAPY; SIMULATION	Objective Various methods for radiation-dose calculation have been investigated over previous decades, focusing on the use of magnetic resonance imaging (MRI) only. The bulk-densityassignment method based on manual segmentation has exhibited promising results compared to dose-calculation with computed tomography (CT). However, this method cannot be easily implemented in clinical practice due to its time-consuming nature. Therefore, we investigated an automatic anatomy segmentation method with the intention of providing the proper methodology to evaluate synthetic CT images for a radiation-dose calculation based on MR images. Methods CT images of 20 brain cancer patients were selected, and their MR images including T1-weighted, T2-weighted, and PETRA were retrospectively collected. Eight anatomies of the patients, such as the body, air, eyeball, lens, cavity, ventricle, brainstem, and bone, were segmented for bulk-density-assigned CT image (BCT) generation. In addition, water-equivalent CT images (WCT) with only two anatomies D body and air D were generated for a comparison with BCT. Histogram comparison and gamma analysis were performed by comparison with the original CT images, after the evaluation of automatic segmentation performance with the dice similarity coefficient (DSC), false negative dice (FND) coefficient, and false positive dice (FPD) coefficient. Results The highest DSC value was 99.34 for air segmentation, and the lowest DSC value was 73.50 for bone segmentation. For lens segmentation, relatively high FND and FPD values were measured. The cavity and bone were measured as over-segmented anatomies having higher FPD values than FND. The measured histogram comparison results of BCT were better than those of WCT in all cases. In gamma analysis, the averaged improvement of BCT compared to WCT was measured. All the measured results of BCT were better than those of WCT. Therefore, the results of this study show that the introduced methods, such as histogram comparison and gamma analysis, are valid for the evaluation of the synthetic CT generation from MR images. Conclusions The image similarity results showed that BCT has superior results compared to WCT for all measurements performed in this study. Consequently, more accurate radiation treatment for the intracranial regions can be expected when the proper image similarity evaluation introduced in this study is performed.	[Kim, Shin-Wook; Shin, Hun-Joo; Kay, Chul-Seung] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Hwang, Jin-Ho; Shin, Jin-Sol] Catholic Univ Korea, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Park, Sung-Kwang] Inje Univ, Busan Paik Hosp, Dept Radiat Oncol, Busan, South Korea; [Kim, Jin-Young] Inje Univ, Haeundae Paik Hosp, Dept Radiat Oncol, Busan, South Korea; [Kim, Ki-Jun] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Kang, Young-Nam] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Inje University; Inje University; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Kang, YN (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	ynkang33@gmail.com						[Anonymous], 2011, R OPENCV 2 COMPUTER; Chen L, 2004, PHYS MED BIOL, V49, P5157, DOI 10.1088/0031-9155/49/22/010; Dean CJ, 2012, BRIT J RADIOL, V85, P61, DOI 10.1259/bjr/11855927; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dowling JA, 2012, INT J RADIAT ONCOL, V83, pE5, DOI 10.1016/j.ijrobp.2011.11.056; Eilertsen K, 2008, ACTA ONCOL, V47, P1294, DOI 10.1080/02841860802256426; Evans PM, 2008, PHYS MED BIOL, V53, pR151, DOI 10.1088/0031-9155/53/12/R01; Johansson A, 2012, MED PHYS, V39, P3283, DOI 10.1118/1.4711807; Johansson A, 2011, MED PHYS, V38, P2708, DOI 10.1118/1.3578928; Jonsson JH, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-62; Kapanen M, 2013, MAGN RESON MED, V70, P127, DOI 10.1002/mrm.24459; Karlsson M, 2009, INT J RADIAT ONCOL, V74, P644, DOI 10.1016/j.ijrobp.2009.01.065; Korhonen J, 2014, MED PHYS, V41, DOI 10.1118/1.4842575; Korsholm ME, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-16; Lambert J, 2011, RADIOTHER ONCOL, V98, P330, DOI 10.1016/j.radonc.2011.01.012; Lee YK, 2003, RADIOTHER ONCOL, V66, P203, DOI 10.1016/S0167-8140(02)00440-1; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Njeh CF, 2008, J MED PHYS, V33, P136, DOI 10.4103/0971-6203.44472; Nyholm T, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-54; Paulson ES, 2015, MED PHYS, V42, P28, DOI 10.1118/1.4896096; Pereira GC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231090; Roberson PL, 2005, MED PHYS, V32, P473, DOI 10.1118/1.1851920; Saito AI, 2009, J APPL CLIN MED PHYS, V10, P92, DOI 10.1120/jacmp.v10i2.2847; Schmidt MA, 2015, PHYS MED BIOL, V60, pR323, DOI 10.1088/0031-9155/60/22/R323; Stanescu T, 2008, PHYS MED BIOL, V53, P3579, DOI 10.1088/0031-9155/53/13/013; Uha J, 2014, MED PHYS, V41, DOI 10.1118/1.4873315; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185082	10.1371/journal.pone.0185082	http://dx.doi.org/10.1371/journal.pone.0185082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926610	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600067
J	Kydd, E; Padalino, B; Henshall, C; McGreevy, P				Kydd, Erin; Padalino, Barbara; Henshall, Cathrynne; McGreevy, Paul			An analysis of equine round pen training videos posted online: Differences between amateur and professional trainers	PLOS ONE			English	Article							EQUUS-CABALLUS; HORSES; BEHAVIOR; EQUITATION; ATTENTION; RESPONSES; ROLES; STATE	Natural Horsemanship is popular among many amateur and professional trainers and as such, has been the subject of recent scientific enquiry. One method commonly adopted by Natural Horsemanship (NH) trainers is that of round pen training (RPT). RPT sessions are usually split into a series of bouts; each including two phases: chasing/flight and chasing off-set/flight offset. However, NH training styles are heterogeneous. This study investigated online videos of RPT to explore the characteristics of RPT sessions and test for differences in techniques and outcomes between amateurs and professionals (the latter being defined as those with accompanying online materials that promote clinics, merchandise or a service to the public). From more than 300 candidate videos, we selected sample files for individual amateur (n = 24) and professional (n = 21) trainers. Inclusion criteria were: training at liberty in a Round Pen; more than one bout and good quality video. Sessions or portions of sessions were excluded if the trainer attached equipment, such as a lunge line, directly to the horse or the horse was saddled, mounted or ridden. The number of bouts and duration of each chasing and non-chasing phase were recorded, and the duration of each RPT session was calculated. General weighted regression analysis revealed that, when compared with amateurs, professionals showed fewer arm movements per bout (p<0.05). Poisson regression analysis showed that professionals spent more time looking up at their horses, when transitioning between gaits, than amateurs did (p<0.05). The probability of horses following the trainer was not significantly associated with amount of chasing, regardless of category. Given that, according to some practitioners, the following response is a goal of RPT, this result may prompt caution in those inclined to give chase. The horses handled by professionals showed fewer conflict behaviours (e.g. kicking, biting, stomping, head-tossing, defecating, bucking and attempting to escape), and fewer oral and head movements (e.g. head-lowering, licking and chewing) than those horses handled by amateurs Overall, these findings highlight the need for selectivity when using the internet as an educational source and the importance of trainer skill and excellent timing when using negative reinforcement in horse training.	[Kydd, Erin; Padalino, Barbara; McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW, Australia; [Padalino, Barbara] Univ Bari, Dept Vet Med, Bari, Italy; [Padalino, Barbara] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga, NSW, Australia; [Henshall, Cathrynne] Hillydale Equine, Inverary Rd, Bungonia, NSW, Australia	University of Sydney; Universita degli Studi di Bari Aldo Moro; Charles Sturt University	Kydd, E (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW, Australia.	erin.kydd@students.mq.edu.au	Padalino, Barbara/AAJ-7498-2020	McGreevy, Paul/0000-0001-7220-8378; PADALINO, BARBARA/0000-0002-7630-8285				Anderson C., 2010, LESSONS WELL LEARNED; Anderson C, 2004, C ANDERSONS DOWNUNDE; Baragli P, 2011, J VET BEHAV, V6, P31, DOI 10.1016/j.jveb.2010.08.020; Birke L, 2011, APPL ANIM BEHAV SCI, V134, P56, DOI 10.1016/j.applanim.2011.06.002; Bourjade M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126344; Brannaman B, 2001, FARAWAY HORSES ADVEN; Domjan MP, 2014, PRINCIPLES LEARNING; Dorrance T, 2010, TRUE UNITY WILLING C; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Fowler V, 2012, ANTHROZOOS, V25, P301, DOI 10.2752/175303712X13403555186217; Fureix C, 2009, BEHAV PROCESS, V82, P359, DOI 10.1016/j.beproc.2009.08.007; Hall C, 2008, J APPL ANIM WELF SCI, V11, P249, DOI 10.1080/10888700802101130; Henshall C, 2014, APPL ANIM BEHAV SCI, V155, P1, DOI 10.1016/j.applanim.2014.03.004; Hunt R., 1978, THINK HARMONY HORSES; Kedzierski W, 2012, J EQUINE VET SCI, V32, P752, DOI 10.1016/j.jevs.2012.03.002; Krueger K, 2007, APPL ANIM BEHAV SCI, V104, P162, DOI 10.1016/j.applanim.2006.04.021; Krueger K, 2011, ANIM COGN, V14, P187, DOI 10.1007/s10071-010-0352-7; Lieberman DA, 2000, LEARNING BEHAV COGNI; Linklater WL, 2000, BIOL REV, V75, P1, DOI 10.1017/S0006323199005411; Loftus L, 2016, ANIMALS, V6, DOI 10.3390/ani6090055; Lyons J, 1991, LYONS HORSES J LYONS; Maros K, 2010, INTERACT STUD, V11, P410, DOI 10.1075/is.11.3.05mar; McDonnell S, 2005, LICKING CHEWING LEAR; McDonnell S.M., 2003, PRACTICAL FIELD GUID; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; McGreevy P, 2006, 2 INT EQ SCI S MIL I; McGreevy P., 2010, EQUITATION SCI, V1st ed.; McGreevy PD, 2009, VET J, V181, P12, DOI 10.1016/j.tvjl.2009.03.005; McGreevy Paul, 2007, CARROTS STICKS PRINC; McGreevy PD, 2007, J VET BEHAV, V2, P108, DOI 10.1016/j.jveb.2007.05.003; McGreevy PD, 2014, J VET BEHAV, V9, P382, DOI 10.1016/j.jveb.2014.06.006; McGreevy PD, 2009, J VET BEHAV, V4, P193, DOI 10.1016/j.jveb.2008.08.001; Muller P, 2016, PSYCHOLOGY, V7, P480; Nicholls L, 2014, EFFECT MANE PULLING; Parelli P., 1993, NATURAL HORSE MAN SH; Payne E, 2015, VET J, V204, P247, DOI 10.1016/j.tvjl.2015.04.004; Proops L, 2010, ANIM COGN, V13, P197, DOI 10.1007/s10071-009-0257-5; Roberts M, 1997, MAN WHO LISTENS HORS; Seaman SC, 2002, APPL ANIM BEHAV SCI, V78, P175, DOI 10.1016/S0168-1591(02)00095-3; Sighieri C, 2003, ANIM WELFARE, V12, P705; Starling Melissa J., 2013, Animals, V3, P300, DOI 10.3390/ani3020300; Vervill S, 2008, J EQUINE VET SCI, V28, P309, DOI 10.1016/j.jevs.2008.03.006; Visser EK, 2009, VET J, V181, P48, DOI 10.1016/j.tvjl.2009.03.009; Waran N, 2002, ANIMAL WEL, V1, P151; Waring G.H., 2003, HORSE BEHAV, V2; Warren-Smith AK, 2008, J APPL ANIM WELF SCI, V11, P285, DOI 10.1080/10888700802101304; Wilk I, 2015, J VET BEHAV, V10, P231, DOI 10.1016/j.jveb.2015.01.001; Wilson A, 2004, TOP HORSE TRAINING M	48	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184851	10.1371/journal.pone.0184851	http://dx.doi.org/10.1371/journal.pone.0184851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922395	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300035
J	Liu, MY; Pan, YS; Zhou, LC; Wang, YJ				Liu, Mingyong; Pan, Yuesong; Zhou, Lichun; Wang, Yongjun			Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; INTRAVENOUS THROMBOLYSIS; ALTEPLASE 3; RISK; THERAPY; AGE; IMPLEMENTATION; OUTCOMES; SCALE	Background and purpose Predictors of symptomatic intracranial hemorrhage (sICH) in Chinese patients with acute ischemic stroke treated with recombinant tissue plasminogen activator remain unclear. Methods Data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China) study were assessed to explore risk factors for symptomatic intracranial hemorrhage after intravenous thrombolysis. Three candidate sICH definitions were analyzed. Results Among 1128 patients with acute ischemic stroke treated with intravenous rtPA within 4.5 hours of symptom onset, 23 (2.0%), 44(3.9%) and 61 (5.4%) experienced modified mSITS-MOST, ECASS II, and NINDS defined sICH, respectively. Multivariate logistic regression revealed independent risk factors for sICH were age. 70 years-old(sICH per NINDS, adjusted OR = 1.73[95% CI1.02-2.95], p = 0.04), diabetes(sICH per SITS-MOST, adjusted OR = 3.50 [95% CI1.34-9.16], p = 0.01), serum glucose on admission >9.0mmol/L(sICH per ECASS II, adjusted OR = 2.84[95% CI1.48-5.46], p = 0.002), NIHSS on admission>20(sICH per SITS-MOST, adjusted OR = 5.06[95% CI1.68-15.20], p = 0.004 or sICH per NINDS, adjusted OR 2.81[95% CI1.42-5.57], p = 0.003) and cardioembolism(sICH per SITS-MOST, adjusted OR = 7.09[95% CI2.41-20.87], p<0.001 or sICH per ECASS II, adjusted OR = 4.99 [95% CI2.53-9.84], p<0.001) or sICH per NINDS, adjusted OR = 2.47[95% CI1.39-4.39], p = 0.002). Conclusion Cardioembolism, NIHSS on admission higher than 20, serum glucose on admission higher than 9.0 mmol/L and age >= 70 years were independent risk factors for symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke treated with recombinant tissue plasminogen activator.	[Liu, Mingyong; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Ctr Stroke, Beijing, Peoples R China; [Liu, Mingyong; Wang, Yongjun] Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Liu, Mingyong; Wang, Yongjun] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Liu, Mingyong; Wang, Yongjun] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Liu, Mingyong; Zhou, Lichun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China; [Pan, Yuesong] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Pan, Yuesong] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Ctr Stroke, Beijing, Peoples R China.; Wang, YJ (corresponding author), Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Wang, YJ (corresponding author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.; Wang, YJ (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.; Zhou, LC (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	13701279076@163.com; yongjunwang1962@gmail.com	Pan, Yuesong/AAI-6303-2020; Mingyong, Liu/D-1500-2014	Pan, Yuesong/0000-0003-3082-6789; Mingyong, Liu/0000-0001-6187-8587	National Science and Technology Major Project of China [2011BA108602]; State Key Development Program of Basic Research of China [2009CB521905]	National Science and Technology Major Project of China; State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China)	This study was funded by the National Science and Technology Major Project of China (2011BA108602) and the State Key Development Program of Basic Research of China (2009CB521905) to YW.	Al-Khaled M, 2014, J STROKE CEREBROVASC, V23, P7, DOI 10.1016/j.jstrokecerebrovasdis.2012.04.004; Anderson CS, 2016, NEW ENGL J MED, V374, P2313, DOI 10.1056/NEJMoa1515510; Brown DL, 2005, ANN EMERG MED, V46, P56, DOI 10.1016/j.annemergmed.2004.12.025; Costello CA, 2012, J CLIN NEUROSCI, V19, P360, DOI 10.1016/j.jocn.2011.08.014; Cronin CA, 2012, STROKE, V43, P1684, DOI 10.1161/STROKEAHA.112.656587; Cucchiara Brett, 2008, J Stroke Cerebrovasc Dis, V17, P331, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.012; Dharmasaroja PA, 2013, J STROKE CEREBROVASC, V22, P227, DOI 10.1016/j.jstrokecerebrovasdis.2011.08.001; Dharmasaroja PA, 2012, J CLIN NEUROSCI, V19, P799, DOI 10.1016/j.jocn.2011.08.035; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Ginsberg MD, 2015, INT J STROKE, V10, P494, DOI 10.1111/ijs.12476; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Kono S, 2013, J STROKE CEREBROVASC, V22, P190, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.016; Lee HJ, 2017, J STROKE, V19, P229, DOI 10.5853/jos.2016.01109; Liao XL, 2013, CNS NEUROSCI THER, V19, P43, DOI 10.1111/cns.12031; Liao XL, 2014, STROKE, V45, P2354, DOI 10.1161/STROKEAHA.114.005989; Lin QQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153486; Lindley RI, 2015, STROKE, V46, P746, DOI 10.1161/STROKEAHA.114.006573; Lou M, 2008, NEUROLOGY, V71, P1417, DOI 10.1212/01.wnl.0000330297.58334.dd; Matsuo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110444; Matute MC, 2012, CEREBROVASC DIS, V33, P231, DOI 10.1159/000334662; Mazya M, 2012, STROKE, V43, P1524, DOI 10.1161/STROKEAHA.111.644815; Menon BK, 2012, STROKE, V43, P2293, DOI 10.1161/STROKEAHA.112.660415; Mosimann PJ, 2013, STROKE, V44, P806, DOI 10.1161/STROKEAHA.112.675678; Muengtaweepongsa S, 2015, ANN INDIAN ACAD NEUR, V18, P181, DOI 10.4103/0972-2327.150592; National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]; Orlando A, 2016, J STROKE CEREBROVASC, V25, P969, DOI 10.1016/j.jstrokecerebrovasdis.2016.01.003; Saposnik G, 2013, NEUROLOGY, V80, P21, DOI 10.1212/WNL.0b013e31827b1ace; Seet RCS, 2012, CEREBROVASC DIS, V34, P106, DOI 10.1159/000339675; Strbian D, 2011, Neurology, V77, P341, DOI 10.1212/WNL.0b013e3182267b8c; Strbian D, 2014, STROKE, V45, P752, DOI 10.1161/STROKEAHA.113.003806; Strbian D, 2012, ANN NEUROL, V71, P634, DOI 10.1002/ana.23546; Sung SF, 2013, STROKE, V44, P1561, DOI 10.1161/STROKEAHA.111.000651; Tong X, 2014, INT J STROKE, V9, P728, DOI 10.1111/ijs.12155; Ueshima S, 2002, THROMB HAEMOSTASIS, V87, P544, DOI 10.1055/s-0037-1613042; Urra X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059420; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Xian Y, 2012, JAMA-J AM MED ASSOC, V307, P2600, DOI 10.1001/jama.2012.6756	37	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184646	10.1371/journal.pone.0184646	http://dx.doi.org/10.1371/journal.pone.0184646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922363	Green Submitted, gold, Green Published			2022-12-27	WOS:000411059300020
J	Weaver, SR; Prichard, AS; Maerz, NL; Prichard, AP; Endres, EL; Hernandez-Castellano, LE; Akins, MS; Bruckmaier, RM; Hernandez, LL				Weaver, Samantha R.; Prichard, Allan S.; Maerz, Noah L.; Prichard, Austin P.; Endres, Elizabeth L.; Hernandez-Castellano, Lorenzo E.; Akins, Matthew S.; Bruckmaier, Rupert M.; Hernandez, Laura L.			Elevating serotonin pre-partum alters the Holstein dairy cow hepatic adaptation to lactation	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR CANCER; LIVER-REGENERATION; CIRCULATING SEROTONIN; HEPATOCYTE APOPTOSIS; PERIPHERAL SEROTONIN; SUBCLINICAL KETOSIS; PARTIAL-HEPATECTOMY; TRANSITION PERIOD; ENERGY-BALANCE; PREGNANCY	Serotonin is known to regulate energy and calcium homeostasis in several mammalian species. The objective of this study was to determine if pre-partum infusions of 5-hydroxytryptophan (5-HTP), the immediate precursor to serotonin synthesis, could modulate energy homeostasis at the level of the hepatocyte in post-partum Holstein and Jersey dairy cows. Twelve multiparous Holstein cows and twelve multiparous Jersey cows were intravenously infused daily for approximately 7 d pre-partum with either saline or 1 mg/kg bodyweight of 5-HTP. Blood was collected for 14 d post-partum and on d30 post-partum. Liver biopsies were taken on d1 and d7 post-partum. There were no changes in the circulating concentrations of glucose, insulin, glucagon, non-esterified fatty acids, or urea nitrogen in response to treatment, although there were decreased beta-hydroxybutyrate concentrations with 5-HTP treatment around d6 to d10 post-partum, particularly in Jersey cows. Cows infused with 5-HTP had increased hepatic serotonin content and increased mRNA expression of the serotonin 2B receptor on d1 and d7 post-partum. Minimal changes were seen in the hepatic mRNA expression of various gluconeogenic enzymes. There were no changes in the mRNA expression profile of cell-cycle progression marker cyclin-dependent kinase 4 or apoptotic marker caspase 3, although proliferating cell nuclear antigen expression tended to be increased in Holstein cows infused with 5-HTP on d1 post-partum. Immunofluorescence assays showed an increased number of CASP3-and Ki67-positive cells in Holstein cows infused with 5-HTP on d1 post-partum. Given the elevated hepatic serotonin content and increased mRNA abundance of 5HTR2B, 5-HTP infusions may be stimulating an autocrine-paracrine adaptation to lactation in the Holstein cow liver.	[Weaver, Samantha R.; Prichard, Allan S.; Maerz, Noah L.; Prichard, Austin P.; Endres, Elizabeth L.; Hernandez, Laura L.] Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA; [Hernandez-Castellano, Lorenzo E.; Bruckmaier, Rupert M.] Univ Bern, Vetsuisse Fac, Vet Physiol, Bern, Switzerland; [Akins, Matthew S.] Univ Wisconsin Marshfield, Dept Dairy Sci, Marshfield, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Bern	Hernandez, LL (corresponding author), Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA.	llhernandez@wisc.edu	Castellano, Lorenzo E. Hernández/T-1034-2016	Castellano, Lorenzo E. Hernández/0000-0003-2729-0434; Hernandez, Laura/0000-0001-7591-5203	USDA-HATCH Formula Fund [142-PRJ74RD]; USDA-Hatch funding [WIS01732]; Wisconsin Consortium for Extension and Research in Agriculture and Natural Resources (CERANR); University of Wisconsin Madison; National Science Foundation Graduate Research Fellowship Program [DGE-1256259]	USDA-HATCH Formula Fund; USDA-Hatch funding; Wisconsin Consortium for Extension and Research in Agriculture and Natural Resources (CERANR); University of Wisconsin Madison; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	The reported study was supported by the USDA-HATCH Formula Fund, grant 142-PRJ74RD and USDA-Hatch funding #WIS01732, as well as funding provided by the Wisconsin Consortium for Extension and Research in Agriculture and Natural Resources (CERANR) and Graduate School funding provided by the University of Wisconsin Madison. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1256259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuyi AA, 2005, VET QUART, V27, P117, DOI 10.1080/01652176.2005.9695192; Al-Trad B, 2010, J ANIM SCI, V88, P2998, DOI 10.2527/jas.2009-2463; Albrecht JH, 1999, CELL GROWTH DIFFER, V10, P397; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Balasubramanian S, 1998, HEPATOLOGY, V27, P62, DOI 10.1002/hep.510270111; Baldwin RL, 2004, J DAIRY SCI, V87, P2977, DOI 10.3168/jds.S0022-0302(04)73429-3; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Collier RJ, 2012, ANIMAL, V6, P403, DOI 10.1017/S1751731111002461; DONKIN SS, 1995, J ANIM SCI, V73, P546; Donovan MH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00036; El-Merahbi R, 2015, FEBS LETT, V589, P1728, DOI 10.1016/j.febslet.2015.05.054; French PD, 2006, J DAIRY SCI, V89, P1057, DOI 10.3168/jds.S0022-0302(06)72173-7; Hauso O, 2007, REGUL PEPTIDES, V143, P39, DOI 10.1016/j.regpep.2007.02.009; KARKALAS J, 1985, J SCI FOOD AGR, V36, P1019, DOI 10.1002/jsfa.2740361018; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003; Laporta J, 2015, DOMEST ANIM ENDOCRIN, V51, P65, DOI 10.1016/j.domaniend.2014.11.005; Laporta J, 2013, DOMEST ANIM ENDOCRIN, V44, P176, DOI 10.1016/j.domaniend.2013.01.005; Laporta J, 2015, J ENDOCRINOL, V226, P43, DOI 10.1530/JOE-14-0693; Laporta J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110190; Laubenthal L, 2016, J DAIRY SCI, V99, P1571, DOI 10.3168/jds.2015-9847; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Lesurtel M, 2014, HEPATOLOGY, V60, P30, DOI 10.1002/hep.27067; Li Y, 2016, J ANIM PHYSIOL AN N, V100, P844, DOI 10.1111/jpn.12454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; Martinez N, 2012, J DAIRY SCI, V95, P7158, DOI 10.3168/jds.2012-5812; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; McLeod KR, 2000, J ANIM SCI, V78, P760; Merens W, 2007, J AFFECT DISORDERS, V103, P43, DOI 10.1016/j.jad.2007.01.032; Moore SAE, 2015, J DAIRY SCI, V98, P3754, DOI 10.3168/jds.2014-8841; Oh CM, 2016, DIABETES METAB J, V40, P89, DOI 10.4093/dmj.2016.40.2.89; Oh CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7794; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Olson KM, 2011, J DAIRY SCI, V94, P507, DOI 10.3168/jds.2010-3433; Papadimas GK, 2006, LIVER INT, V26, P352, DOI 10.1111/j.1478-3231.2005.01230.x; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; SMITH NE, 1974, J DAIRY SCI, V57, P1055, DOI 10.3168/jds.S0022-0302(74)85008-3; Soll C, 2012, CLIN CANCER RES, V18, P5902, DOI 10.1158/1078-0432.CCR-11-1813; Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441; Starlinger P, 2014, HEPATOLOGY, V60, P257, DOI 10.1002/hep.26950; Sumara G, 2012, CELL METAB, V16, P588, DOI 10.1016/j.cmet.2012.09.014; Tharwat M, 2012, CAN J VET RES, V76, P241; Tharwat M, 2012, RES VET SCI, V93, P1281, DOI 10.1016/j.rvsc.2012.03.011; Tzirogiannis KN, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0201-2; Vicari T, 2008, DOMEST ANIM ENDOCRIN, V34, P74, DOI 10.1016/j.domaniend.2006.11.002; Walsh RB, 2007, J DAIRY SCI, V90, P2788, DOI 10.3168/jds.2006-560; Watanabe H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088058; Weaver SR, 2016, J DAIRY SCI, V99, P842, DOI 10.3168/jds.2015-9828; Weaver SR, 2016, J ENDOCRINOL, V230, P105, DOI 10.1530/JOE-16-0038; White HM, 2016, J DAIRY SCI, V99, P812, DOI 10.3168/jds.2015-9953; White HM, 2015, ANIMALS BASEL, V18, P793; Wylie ARG, 2008, J DAIRY SCI, V91, P577, DOI 10.3168/jds.2007-0388; Zhang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08098	55	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184939	10.1371/journal.pone.0184939	http://dx.doi.org/10.1371/journal.pone.0184939			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922379	Green Published, gold, Green Submitted			2022-12-27	WOS:000411059300048
J	Kiso, K; Yoshifuji, H; Oku, T; Hikida, M; Kitagori, K; Hirayama, Y; Nakajima, T; Haga, H; Tsuruyama, T; Miyagawa-Hayashino, A				Kiso, Kaori; Yoshifuji, Hajime; Oku, Takuma; Hikida, Masaki; Kitagori, Koji; Hirayama, Yoshitaka; Nakajima, Toshiki; Haga, Hironori; Tsuruyama, Tatsuaki; Miyagawa-Hayashino, Aya			Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients	PLOS ONE			English	Article							ACTIN CYTOSKELETON; RECEPTOR; CANCER; CALCINEURIN; LYMPHOMA; PROTEINS; TAGLN2; LINES; NFAT	Transgelin-2 (TAGLN2) is an actin-binding protein that controls actin stability and promotes T cell activation. TAGLN2 is also expressed on B-cells but its function in B-cells is unknown. We found that TAGLN2-expressing B-cells were localized in the germinal center (GC) of secondary lymphoid tissues and TAGLN2 mRNA was significantly upregulated after IgM +IgG stimulation in primary human B-cells, suggesting that TAGLN2 was upregulated upon B-cell activation. In support of this, lymph nodes (LNs) from patients with systemic lupus erythematosus (SLE), in which the intense GC activity have been recognized, showed increased TAGLN2 expression in B-cells compared to control LNs. Moreover, TAGLN2(+)B-cells were distributed widely not only in the GC but also in the perifollicular areas in SLE LNs. In contrast, CD19(+) B-cells and CD19(+)CD27(+) memory-B cells in peripheral blood of SLE patients showed no increase in TAGLN2 mRNA. Two-photon excitation microscopy of Raji cells demonstrated that TAGLN2 colocalized with F-actin and moved together to the periphery upon stimulation. TAGLN2-knockdown in Raji cells resulted in impaired phosphorylation of PLC gamma 2 leading to inhibition of cell migration. Microarray analysis of TAGLN2-knockdown Raji cells showed decreased expression of the genes associated with immune function including CCR6 and as well as of those associated with regulation of the actin cytoskeleton including ABI2, compared to controls. These results suggest that TAGLN2 might regulate activation and migration of B-cells, in particular, the entry of activated B-cells into the follicle. We also suggest that TAGLN2 could be used as a marker for activated B-cells.	[Kiso, Kaori; Tsuruyama, Tatsuaki] Kyoto Univ, Grad Sch Med, Ctr Anat Pathol & Forens Med Res, Kyoto, Japan; [Yoshifuji, Hajime; Kitagori, Koji; Nakajima, Toshiki] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Oku, Takuma; Hikida, Masaki; Kitagori, Koji; Hirayama, Yoshitaka; Miyagawa-Hayashino, Aya] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Oku, Takuma; Hirayama, Yoshitaka] Astellas Pharma Inc, Res Portfolio & Sci, Drug Discovery Res, Tsukuba, Ibaraki, Japan; [Hikida, Masaki] Akita Univ, Dept Life Sci, Lab Mol Cell Physiol, Akita, Japan; [Haga, Hironori; Miyagawa-Hayashino, Aya] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto, Japan; [Miyagawa-Hayashino, Aya] Kansai Med Univ, Dept Clin Pathol, Osaka, Japan	Kyoto University; Kyoto University; Kyoto University; Astellas Pharmaceuticals; Akita University; Kyoto University; Kansai Medical University	Miyagawa-Hayashino, A (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan.; Miyagawa-Hayashino, A (corresponding author), Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto, Japan.; Miyagawa-Hayashino, A (corresponding author), Kansai Med Univ, Dept Clin Pathol, Osaka, Japan.	ayam@kuhp.kyoto-u.ac.jp	Yoshifuji, Hajime/AAZ-1657-2020	Haga, Hironori/0000-0003-4322-9561; Farne, Kaori/0000-0002-2589-4659	Japanese Government; Astellas Pharma Inc.; Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Astellas Pharma Inc	Japanese Government; Astellas Pharma Inc.(Astellas Pharmaceuticals); Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Astellas Pharma Inc(Astellas Pharmaceuticals)	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology of the Japanese Government to AMH and in part by Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program grants from the Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Publication of this article was approved by an intellectual property committee composed of representatives from Kyoto University and Astellas Pharma. Takuma Oku and Yoshitaka Hirayama are employed by Astellas Pharma Inc. Astellas Pharma Inc provided support in the form of salaries for authors TO and YH, and approved publication of this article, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Choi J, 2012, CURR OPIN IMMUNOL, V24, P651, DOI 10.1016/j.coi.2012.10.004; Dorner T, 2011, J IMMUNOL METHODS, V363, P187, DOI 10.1016/j.jim.2010.06.009; Dvorakova M, 2014, EXPERT REV PROTEOMIC, V11, P149, DOI 10.1586/14789450.2014.860358; Ek S, 2005, LEUKEMIA RES, V29, P205, DOI 10.1016/j.leukres.2004.06.009; Elgueta R, 2015, J IMMUNOL, V194, P505, DOI 10.4049/jimmunol.1401553; Elsner M, 2012, J PROTEOMICS, V75, P4693, DOI 10.1016/j.jprot.2012.02.012; Fleischer SJ, 2016, ARTHRITIS RHEUMATOL, V68, P1210, DOI 10.1002/art.39559; Frances R, 2006, MOL IMMUNOL, V43, P2124, DOI 10.1016/j.molimm.2005.12.011; Gez S, 2007, BBA-PROTEINS PROTEOM, V1774, P1173, DOI 10.1016/j.bbapap.2007.06.011; Hannah J, 2016, AUTOIMMUN REV, V15, P93, DOI 10.1016/j.autrev.2015.09.006; Hao SL, 2003, EMBO J, V22, P4166, DOI 10.1093/emboj/cdg401; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jang SH, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0070-9; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kojima M, 2000, PATHOL INT, V50, P304, DOI 10.1046/j.1440-1827.2000.01052.x; Markopoulou A, 2013, CLIN IMMUNOL, V148, P359, DOI 10.1016/j.clim.2012.09.009; Na BR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156429; Na BR, 2015, J CELL BIOL, V209, P143, DOI 10.1083/jcb.201407130; Reimer D, 2017, IMMUNOL CELL BIOL, V95, P33, DOI 10.1038/icb.2016.68; Rho JH, 2009, J PROTEOME RES, V8, P5610, DOI 10.1021/pr900705r; Song WX, 2014, BBA-BIOMEMBRANES, V1838, P569, DOI 10.1016/j.bbamem.2013.07.016; Song WX, 2013, IMMUNOL REV, V256, P177, DOI 10.1111/imr.12113; Stanton RJ, 2014, CELL HOST MICROBE, V16, P201, DOI 10.1016/j.chom.2014.07.005; Wiede F, 2013, IMMUNOL CELL BIOL, V91, P335, DOI 10.1038/icb.2013.14; Wong CK, 2009, J CLIN IMMUNOL, V29, P738, DOI 10.1007/s10875-009-9318-4; Xiao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046510; Yu Y, 2013, J CELL SCI, V126, P1049, DOI 10.1242/jcs.098210; Zhang YB, 2010, CANCER SCI, V101, P523, DOI 10.1111/j.1349-7006.2009.01424.x; Zheng XW, 2015, CANCER BIOL THER, V16, P1407, DOI 10.1080/15384047.2015.1070990; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184738	10.1371/journal.pone.0184738	http://dx.doi.org/10.1371/journal.pone.0184738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910360	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200088
J	Merrill, NM; Schipper, JL; Karnes, JB; Kauffman, AL; Martin, KR; MacKeigan, JP				Merrill, Nathan M.; Schipper, Joshua L.; Karnes, Jonathan B.; Kauffman, Audra L.; Martin, Katie R.; MacKeigan, Jeffrey P.			PI3K-C2 alpha knockdown decreases autophagy and maturation of endocytic vesicles	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; CLATHRIN; PROTEIN; PHOSPHATIDYLINOSITOL; TRAFFICKING; ULK1; ATG9; BECLIN-1; PI3K; PHOSPHORYLATION	Phosphoinositide 3-kinase (PI3K) family members are involved in diverse cellular fates including cell growth, proliferation, and survival. While many molecular details are known about the Class I and III PI3Ks, less is known about the Class II PI3Ks. To explore the function of all eight PI3K isoforms in autophagy, we knock down each gene individually and measure autophagy. We find a significant decrease in autophagy following siRNA-mediated PIK3C2A (encoding the Class 2 PI3K, PI3K-C2 alpha) knockdown. This defective autophagy is rescued by exogenous PI3K-C2 alpha, but not kinase-dead PI3K-C2 alpha. Using confocal microscopy, we probe for markers of endocytosis and autophagy, revealing that PI3K-C2 alpha colocalizes with markers of endocytosis. Though endocytic uptake is intact, as demonstrated by transferrin labeling, PIK3C2A knockdown results in vesicle accumulation at the recycling endosome. We isolate distinct membrane sources and observe that PI3K-C2 alpha interacts with markers of endocytosis and autophagy, notably ATG9. Knockdown of either PIK3C2A or ATG9A/B, but not PI3KC3, results in an accumulation of transferrin-positive clathrin coated vesicles and RAB11-positive vesicles at the recycling endosome. Taken together, these results support a role for PI3K-C2 alpha in the proper maturation of endosomes, and suggest that PI3K-C2 alpha may be a critical node connecting the endocytic and autophagic pathways.	[Merrill, Nathan M.; Karnes, Jonathan B.; MacKeigan, Jeffrey P.] Van Andel Inst, Grad Sch, Grand Rapids, MI 49503 USA; [Merrill, Nathan M.; Schipper, Joshua L.; Karnes, Jonathan B.; Kauffman, Audra L.; Martin, Katie R.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Ctr Canc Cell Biol, Grand Rapids, MI 49503 USA; [MacKeigan, Jeffrey P.] Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA	Van Andel Institute; Van Andel Institute; Michigan State University; Michigan State University College of Human Medicine	MacKeigan, JP (corresponding author), Van Andel Inst, Grad Sch, Grand Rapids, MI 49503 USA.; MacKeigan, JP (corresponding author), Van Andel Res Inst, Ctr Canc Cell Biol, Grand Rapids, MI 49503 USA.; MacKeigan, JP (corresponding author), Michigan State Univ, Coll Human Med, Grand Rapids, MI 49503 USA.	mackeig1@msu.edu		MacKeigan, Jeffrey/0000-0002-0198-5679; Martin, Katie/0000-0002-3689-4814; Merrill, Nathan/0000-0003-0757-3680	Van Andel Institute; National Cancer Institute [R01CA197398]	Van Andel Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Van Andel Institute Graduate School fellowship to N.M. M., and award number R01CA197398 from the National Cancer Institute to J.P.M. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Aki S, 2015, J BIOL CHEM, V290, P6086, DOI 10.1074/jbc.M114.601484; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; BEAULATION J, 1977, J MORPHOL, V154, P39, DOI 10.1002/jmor.1051540104; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Campa CC, 2015, FEBS LETT, V589, P1552, DOI 10.1016/j.febslet.2015.05.001; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Devereaux K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076405; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Elis W, 2008, MOL CANCER RES, V6, P614, DOI 10.1158/1541-7786.MCR-07-0262; ERICSSON JL, 1969, EXP CELL RES, V56, P393, DOI 10.1016/0014-4827(69)90030-5; Franco I, 2014, DEV CELL, V28, P647, DOI 10.1016/j.devcel.2014.01.022; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gallagher LE, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020024; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Ge L, 2013, ELIFE, V2, DOI 10.7554/eLife.00947; Goodall ML, 2014, AUTOPHAGY, V10, P1120, DOI 10.4161/auto.28594; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; He CC, 2009, AUTOPHAGY, V5, P385, DOI 10.4161/auto.5.3.7699; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Imai K, 2016, J CELL SCI, V129, P3781, DOI 10.1242/jcs.196196; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kiel JAKW, 1999, YEAST, V15, P741, DOI 10.1002/(SICI)1097-0061(19990630)15:9<741::AID-YEA416>3.0.CO;2-O; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2014, AUTOPHAGY, V10, P549, DOI 10.4161/auto.28448; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knaevelsrud H, 2013, J CELL BIOL, V202, P331, DOI 10.1083/jcb.201205129; Krag C, 2010, J CELL SCI, V123, P4240, DOI 10.1242/jcs.071712; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lee YK, 2016, BMB REP, V49, P424, DOI 10.5483/BMBRep.2016.49.8.081; Leibiger B, 2015, CELL REP, V13, P15, DOI 10.1016/j.celrep.2015.08.058; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Marat AL, 2017, SCIENCE, V356, P968, DOI 10.1126/science.aaf8310; Martin KR, 2013, AUTOPHAGY, V9, P74, DOI 10.4161/auto.22532; Martin KR, 2011, J CELL SCI, V124, P812, DOI 10.1242/jcs.080341; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moreau K, 2015, METHODS, V75, P19, DOI 10.1016/j.ymeth.2014.11.005; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; NOVIKOFF AB, 1962, J CELL BIOL, V15, P140, DOI 10.1083/jcb.15.1.140; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Pavel M, 2017, FEBS J, V284, P672, DOI 10.1111/febs.13931; Popovic D, 2014, EMBO REP, V15, P392, DOI 10.1002/embr.201337995; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Prior I A, 1999, Mol Cell Biol Res Commun, V1, P162, DOI 10.1006/mcbr.1999.0126; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Takahashi Y, 2016, ONCOTARGET, V7, P20855, DOI 10.18632/oncotarget.8028; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang B, 2017, CURR OPIN CELL BIOL, V45, P47, DOI 10.1016/j.ceb.2017.02.011; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yu XL, 2015, AUTOPHAGY, V11, P1711, DOI 10.1080/15548627.2015.1043076; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098067; Zhao YQ, 2007, J BIOL CHEM, V282, P1249, DOI 10.1074/jbc.M606998200; Zhou C, 2017, APPL MICROBIOL BIOT, V9, P1; Zhou CQ, 2017, CELL RES, V27, P184, DOI 10.1038/cr.2016.146	86	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184909	10.1371/journal.pone.0184909	http://dx.doi.org/10.1371/journal.pone.0184909			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910396	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200116
J	Katsanos, K; Kitrou, P; Spiliopoulos, S; Maroulis, I; Petsas, T; Karnabatidis, D				Katsanos, Konstantinos; Kitrou, Panagiotis; Spiliopoulos, Stavros; Maroulis, Ioannis; Petsas, Theodore; Karnabatidis, Dimitris			Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; PERCUTANEOUS ETHANOL INJECTION; DOXORUBICIN-ELUTING BEADS; DECISION-MAKING; LIPIODOL CHEMOEMBOLIZATION; SYMPTOMATIC TREATMENT; PHASE-III; CONVENTIONAL CHEMOEMBOLIZATION; CLINICAL-PRACTICE; LIVER-TUMORS	Background The optimal transcatheter embolization strategy for patients with unresectable hepatocellular carcinoma (HCC) remains elusive. We conducted a systematic review and network meta-analysis (NMA) of different embolization options for unresectable HCC. Methods Medical databases were searched for randomized controlled trials evaluating bland transarterial embolization (TAE), conventional TACE, drug-eluting bead chemoembolization (DEB-TACE), or transarterial radioembolization (TARE), either alone or combined with adjuvant chemotherapy, or local liver ablation, or external radiotherapy for unresectable HCC up to June 2017. Random effects Bayesian models with a binomial and normal likelihood were fitted (WinBUGS). Primary endpoint was patient survival expressed as hazard ratios (HR) and 95% credible intervals. An exponential model was used to fit patient survival curves. Safety and objective response were calculated as odds ratios (OR) and accompanying 95% credible intervals. Competing treatments were ranked with the SUCRA statistic. Heterogeneity-adjusted effective sample sizes were calculated to evaluate information size for each comparison. Quality of evidence (QoE) was assessed with the GRADE system adapted for NMA reports. All analyses complied with the ISPOR-AMCP-NCP Task Force Report for good practice in NMA. Findings The network of evidence included 55 RCTs (12 direct comparisons) with 5,763 patients with preserved liver function and unresectable HCC (intermediate to advanced stage). All embolization strategies achieved a significant survival gain over control treatment (HR range, 0.42-0.76; very low-to-moderate QoE). However, TACE, DEB-TACE, TARE and adjuvant systemic agents did not confer any survival benefit over bland TAE alone (moderate QoE, except low in case of TARE). There was moderate QoE that TACE combined with external radiation or liver ablation achieved the best patient survival (SUCRA 86% and 96%, respectively). Estimated median survival was 13.9 months in control, 18.1 months in TACE, 20.6 months with DEB-TACE, 20.8 months with bland TAE, 30.1 months in TACE plus external radiotherapy, and 33.3 months in TACE plus liver ablation. TARE was the safest treatment (SUCRA 77%), however, all examined therapies were associated with a significantly higher risk of toxicity over control (OR range, 6.35 to 68.5). TACE, DEB-TACE, TARE and adjuvant systemic agents did not improve objective response over bland embolization alone (OR range, 0.85 to 1.65). There was clinical diversity among included randomized controlled trials, but statistical heterogeneity was low. Conclusions Chemo-and radio-embolization for unresectable hepatocellular carcinoma may improve tumour objective response and patient survival, but are not more effective than bland particle embolization. Chemoembolization combined with external radiotherapy or local liver ablation may significantly improve tumour response and patient survival rates over embolization monotherapies. Quality of evidence remains mostly low to moderate because of clinical diversity.	[Katsanos, Konstantinos; Kitrou, Panagiotis; Petsas, Theodore; Karnabatidis, Dimitris] Patras Univ Hosp, Sch Med, Dept Intervent Radiol, Rion, Greece; [Katsanos, Konstantinos] Guys & St Thomas Hosp, Dept Intervent Radiol, Kings Hlth Partners, NHS Fdn Trust, London, England; [Spiliopoulos, Stavros] Attikon Univ Hosp, Sch Med, Dept Intervent Radiol, Athens, Greece; [Maroulis, Ioannis] Patras Univ Hosp, Sch Med, Dept Liver Surg, Rion, Greece	University of Patras; Guy's & St Thomas' NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of London; King's College London; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; University of Patras	Katsanos, K (corresponding author), Patras Univ Hosp, Sch Med, Dept Intervent Radiol, Rion, Greece.; Katsanos, K (corresponding author), Guys & St Thomas Hosp, Dept Intervent Radiol, Kings Hlth Partners, NHS Fdn Trust, London, England.	katsanos@med.upatras.gr	Spiliopoulos, Stavros/I-9280-2019	Spiliopoulos, Stavros/0000-0003-1860-0568				Achana FA, 2013, STAT MED, V32, P752, DOI 10.1002/sim.5539; BARTOLOZZI C, 1995, RADIOLOGY, V197, P812, DOI 10.1148/radiology.197.3.7480761; Becker G, 2005, WORLD J GASTROENTERO, V11, P6104, DOI 10.3748/wjg.v11.i39.6104; Bhardwaj N, 2010, SURG ENDOSC, V24, P254, DOI 10.1007/s00464-009-0590-4; Boily G, 2015, HPB, V17, P52, DOI 10.1111/hpb.12273; Britten CD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-16; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Brown KT, 2016, J CLIN ONCOLOGY OFFI; Brown S, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-110; Bruix J, 1998, HEPATOLOGY, V27, P1578, DOI 10.1002/hep.510270617; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Cabibbo G, 2010, HEPATOLOGY, V51, P1274, DOI 10.1002/hep.23485; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; CHANG JM, 1994, CANCER, V74, P2449, DOI 10.1002/1097-0142(19941101)74:9<2449::AID-CNCR2820740910>3.0.CO;2-4; de Baere T, 2016, CARDIOVASC INTER RAD, V39, P334, DOI 10.1007/s00270-015-1208-y; Delicque J, 2016, CLIN RES HEPATOLOGY; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Doffoel M, 2008, EUR J CANCER, V44, P528, DOI 10.1016/j.ejca.2008.01.004; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Facciorusso A, 2016, INT J HYPERTHER, P1; Facciorusso A, 2017, UNITED EUR GASTROENT, V5, P511, DOI 10.1177/2050640616673516; Facciorusso A, 2016, DIGEST LIVER DIS, V48, P571, DOI 10.1016/j.dld.2016.02.005; Forner A, 2012, J HEPATOL, V56, P984, DOI 10.1016/j.jhep.2011.08.017; Fu Y, 2015, INT J CLIN EXP MED, V8, P10388; Gaba RC, 2016, J VASC INTERV RADIOL, V27, P457, DOI 10.1016/j.jvir.2015.12.752; Gao S, 2013, HEPATO-GASTROENTEROL, V60, P813, DOI 10.5754/hge121025; Golfieri R, 2014, BRIT J CANCER, V111, P255, DOI 10.1038/bjc.2014.199; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Han SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102686; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; HIGUCHI T, 1994, CANCER, V73, P2259, DOI 10.1002/1097-0142(19940501)73:9<2259::AID-CNCR2820730905>3.0.CO;2-P; Hirooka T, 2009, METHOD INFORM MED, V48, P104, DOI 10.3414/ME0535; Huang C, 2016, J CANCER RES THER, V12, pC148, DOI 10.4103/0973-1482.200605; Huang KJ, 2014, J GASTROEN HEPATOL, V29, P920, DOI 10.1111/jgh.12439; Huo YR, 2015, JAMA ONCOL, V1, P756, DOI 10.1001/jamaoncol.2015.2189; Inaba Y, 2013, EUR J CANCER, V49, P2832, DOI 10.1016/j.ejca.2013.05.011; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Jansen MC, 2005, EJSO-EUR J SURG ONC, V31, P331, DOI 10.1016/j.ejso.2004.10.011; Kallini JR, 2016, ADV THER, V33, P699, DOI 10.1007/s12325-016-0324-7; Katsanos K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135692; Katsanos K, 2014, J VASC SURG, V59, P1123, DOI 10.1016/j.jvs.2014.01.041; KAWAI S, 1992, CANCER CHEMOTH PHARM, V31, pS1, DOI 10.1007/BF00687096; Kolligs FT, 2015, LIVER INT, V35, P1715, DOI 10.1111/liv.12750; Kudo M, 2014, HEPATOLOGY, V60, P1697, DOI 10.1002/hep.27290; Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007; Kwan SW, 2012, LIVER TRANSPLANT, V18, P727, DOI 10.1002/lt.23413; Lammer Johannes, 2010, Cardiovasc Intervent Radiol, V33, P41, DOI 10.1007/s00270-009-9711-7; Lan T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003185; Lencioni R, 2016, HEPATOLOGY, V64, P106, DOI 10.1002/hep.28453; Lencioni R, 2016, J HEPATOL, V64, P1090, DOI 10.1016/j.jhep.2016.01.012; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Leng ZQ, 2000, CHIN J RAD ONCOL, V9, P99, DOI DOI 10.3760/J.ISSN:1004-4221.2000.02.007; Li L, 2016, TUMORI J, V102, P301, DOI 10.5301/tj.5000491; Li MQ, 2009, J GASTROEN HEPATOL, V24, P1437, DOI 10.1111/j.1440-1746.2009.05863.x; [李玉 Li Yu], 2003, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V12, P30; Liao MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068453; [廖小方 Liao Xiaofang], 2010, [实用肿瘤杂志, Journal of Practical Oncology], V25, P681; LIN DY, 1988, GASTROENTEROLOGY, V94, P453, DOI 10.1016/0016-5085(88)90436-2; Liu DX, 2009, J INTERVENT RADIOL, V18, P389; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091124; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Mabed M, 2009, EUR J CANCER CARE, V18, P492, DOI 10.1111/j.1365-2354.2008.00984.x; MADDEN MV, 1993, GUT, V34, P1598, DOI 10.1136/gut.34.11.1598; Malagari K, 2010, CARDIOVASC INTER RAD, V33, P541, DOI 10.1007/s00270-009-9750-0; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; Marrero JA, 2016, J HEPATOL, V65, P1140, DOI 10.1016/j.jhep.2016.07.020; Mathurin P, 1998, ALIMENT PHARM THERAP, V12, P111; Meng MB, 2009, RADIOTHER ONCOL, V92, P184, DOI 10.1016/j.radonc.2008.11.002; Meyer T, 2013, BRIT J CANCER, V108, P1252, DOI 10.1038/bjc.2013.85; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Ni JY, 2014, WORLD J GASTROENTERO, V20, P17206, DOI 10.3748/wjg.v20.i45.17206; Ni JY, 2013, J CANCER RES CLIN, V139, P653, DOI 10.1007/s00432-012-1369-x; OBERTI F, 1995, NEW ENGL J MED, V332, P1256; Oliveri RS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004787.pub2; Organization W.H, 1979, WHO HDB REP RES CANC; Park YN, 1998, AM J SURG PATHOL, V22, P656, DOI 10.1097/00000478-199806000-00002; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; PELLETIER G, 1990, J HEPATOL, V11, P181, DOI 10.1016/0168-8278(90)90110-D; Pelletier G, 1998, J HEPATOL, V29, P129, DOI 10.1016/S0168-8278(98)80187-6; Peng KG, 2000, CHIN J RAD ONCOL, V9, P11, DOI DOI 10.3760/J.ISSN:1004-4221.2000.01.003; Pinter M, 2015, RADIOLOGY, V277, P903, DOI 10.1148/radiol.2015142140; Pitton MB, 2015, CARDIOVASC INTER RAD, V38, P352, DOI 10.1007/s00270-014-1012-0; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Qi XS, 2016, ONCOTARGET, V7, P34703, DOI 10.18632/oncotarget.9157; Rammohan A, 2012, WORLD J RADIOL, V4, P405, DOI 10.4329/wjr.v4.i9.405; RAOUL JL, 1994, J NUCL MED, V35, P1782; Raoul JL, 1997, HEPATOLOGY, V26, P1156; Ray CE, 2015, AM J ROENTGENOL, V204, P440, DOI 10.2214/AJR.14.12844; Sacco R, 2011, J VASC INTERV RADIOL, V22, P1545, DOI 10.1016/j.jvir.2011.07.002; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salem R, 2016, GASTROENTEROLOGY, V151, P1155, DOI 10.1053/j.gastro.2016.08.029; Salem R, 2013, HEPATOLOGY, V58, P2188, DOI 10.1002/hep.26382; Sansonno D, 2012, ONCOLOGIST, V17, P359, DOI 10.1634/theoncologist.2011-0313; Shang Y, 2007, SHIJIE HUAREN XIAOHU, V15, P3140, DOI DOI 10.3969/J.ISSN.1009-3079.2007.29.016; Thorlund K, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-41; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; US Department Of Health nd Human Services National Institutes of Health National Cancer Institute, 2010, COMM TERM CRIT ADV E; van Malenstein H, 2011, ONKOLOGIE, V34, P368, DOI 10.1159/000329602; Vente MAD, 2009, EUR RADIOL, V19, P951, DOI 10.1007/s00330-008-1211-7; Verslype C, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds225; Wang G, 2000, J CLIN ONCOL, V5, P380, DOI [10.1007/PL00012067, DOI 10.1007/PL00012067, 10.1007/PL0001206]; Wang H, 2015, CANCER-AM CANCER SOC, V121, P2917, DOI 10.1002/cncr.29456; Wang XH, 2006, SHAXI YIXUE ZAZHI, V35, P461, DOI DOI 10.3969/J.ISSN.1000-7377.2006.04.030; Wang YB, 2007, QUAL LIFE RES, V16, P389, DOI 10.1007/s11136-006-9133-9; Wen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23269; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Woods BS, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-54; Wu Peihong, 1998, Zhonghua Zhongliu Zazhi, V20, P391; [肖泽民 XIAO Zemin], 2008, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V35, P18; Xie ZB, 2015, HEPATOL RES, V45, P190, DOI 10.1111/hepr.12450; [许国辉 Xu Guohui], 2002, [临床放射学杂志, Journal of Clinical Radiology], V21, P66; Xue HZ, 1995, CHIN J RAD ONCOL, V4, P84; Yamamoto K, 1997, SEMINARS ONCOLOGY S6, V24; Yang M, 2014, MOL BIOL REP, V41, P6575, DOI 10.1007/s11033-014-3541-7; Yang P, 2008, ADV THER, V25, P787, DOI 10.1007/s12325-008-0079-x; Yu SCH, 2014, RADIOLOGY, V270, P607, DOI 10.1148/radiol.13130498; Zhang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100305; [张志良 Zhang Zhiliang], 2012, [介入放射学杂志, Journal of Interventional Radiology], V21, P596; Zhao MH, 2006, ZHONGHUA FANGSHE CHO, V15, P39, DOI DOI 10.3760/J.ISSN:1004-4221.2006.01.010; Zhao Ming, 2011, Zhonghua Yi Xue Za Zhi, V91, P1167; Zou LQ, 2014, WORLD J GASTROENTERO, V20, P17227, DOI 10.3748/wjg.v20.i45.17227	130	62	69	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184597	10.1371/journal.pone.0184597	http://dx.doi.org/10.1371/journal.pone.0184597			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934265	Green Submitted, gold, Green Published			2022-12-27	WOS:000411339900034
J	Li, XT; Yuan, JL; Yang, L; Qin, W; Yang, SN; Li, Y; Fan, HM; Hu, WL				Li, Xuanting; Yuan, Junliang; Yang, Lei; Qin, Wei; Yang, Shuna; Li, Yue; Fan, Huimin; Hu, Wenli			The significant effects of cerebral microbleeds on cognitive dysfunction: An updated metaanalysis	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; ALZHEIMER-DISEASE; CEREBROVASCULAR-DISEASE; NEUROLOGICAL DISORDER; BRAIN MICROBLEEDS; BLOOD-FLOW; ASSOCIATION; DEMENTIA; DECLINE; MEMORY	Objective Accumulated data suggests that cerebral microbleeds (CMBs) play an important role in the decline of cognitive function, but the results remain inconsistent. In the current study, we aimed to investigate the association between CMBs and cognitive function, as well as the various effects of CMBs on different domains of cognition. Methods We searched through the databases of PubMed, Embase, Cochrane Library, and ScienceDirect. After a consistency test, the publication bias was evaluated and a sensitivity analysis was performed with combined odds ratios (OR) and standardized mean difference (SMD) of CMBs. Results A meta-analysis of 25 studies with 9343 participants total was conducted. Patients with CMBs had higher incidence of cognitive impairment (OR: 3.5410; 95% confidence interval [CI] [2.2979, 5.4567], p< 0.05) and lower scores of cognitive functions (SMD: -0.2700 [-0.4267, -0.1133], p< 0.05 in Mini-Mental State Examination [MMSE] group and -0.4869 [-0.8902, -0.0818], p< 0.05 in Montreal Cognitive Assessment [MoCA] group). Our results also indicated that patients with CMBs had obvious decline in cognitive functions, for instance, orientation (SMD: -0.9565 [-1.7260, -0.1869], p< 0.05), attention and calculation (SMD: -1.1518 [-1.9553, -0.3484], p< 0.05) and delayed recall (SMD: -0.5527 [-1.1043, -0.0011], p = 0.05). Conclusions Our data suggested that CMBs might be an important risk factor for cognitive dysfunction, especially in the domains of orientation, attention and calculation and delayed recall functions. Prospective cohort studies with further investigations will be needed in larger samples.	[Li, Xuanting; Yuan, Junliang; Yang, Lei; Qin, Wei; Yang, Shuna; Li, Yue; Fan, Huimin; Hu, Wenli] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Hu, WL (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	huwenli@sina.com			National Natural Science Foundation of China [81271309, 81301016]; Beijing Municipal Administration of Hospitals' Youth Programme [QM L20150303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals' Youth Programme	This work was supported by National Natural Science Foundation of China (81271309, 81301016) and Beijing Municipal Administration of Hospitals' Youth Programme (QM L20150303).	Akoudad S, 2016, JAMA NEUROL, V73, P934, DOI 10.1001/jamaneurol.2016.1017; Benedictus MR, 2015, JAMA NEUROL, V72, P539, DOI 10.1001/jamaneurol.2015.14; Brundel M, 2014, CEREBROVASC DIS, V37, P195, DOI 10.1159/000358119; Chai C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002974; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; Ding J, 2017, NEUROLOGY, V88, P2089, DOI 10.1212/WNL.0000000000003983; Doi H, 2015, INTERNAL MED, V54, P1027, DOI 10.2169/internalmedicine.54.3747; Fang M, 2013, INT J MED SCI, V10, P1307, DOI 10.7150/ijms.6430; Goos JDC, 2010, NEUROLOGY, V74, P1954, DOI 10.1212/WNL.0b013e3181e396ea; Goos JDC, 2009, STROKE, V40, P3455, DOI 10.1161/STROKEAHA.109.558197; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregg NM, 2015, JAMA NEUROL, V72, P1021, DOI 10.1001/jamaneurol.2015.1359; Gregoire SM, 2012, CEREBROVASC DIS, V33, P430, DOI 10.1159/000336237; Gustavsson AM, 2015, CEREBROVASC DIS EXTR, V5, P41, DOI 10.1159/000377710; Heringa SM, 2014, J ALZHEIMERS DIS, V38, P211, DOI 10.3233/JAD-130542; Lei CY, 2013, J NEUROL NEUROSUR PS, V84, P693, DOI 10.1136/jnnp-2012-303948; Miwa K, 2014, NEUROLOGY, V83, P646, DOI 10.1212/WNL.0000000000000692; Nakata-Kudo Y, 2006, DEMENT GERIATR COGN, V22, P8, DOI 10.1159/000092958; Nardone R, 2011, J NEURAL TRANSM, V118, P1349, DOI 10.1007/s00702-011-0650-5; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Poels MMF, 2011, STROKE, V42, P656, DOI 10.1161/STROKEAHA.110.607184; Prince M, 2015, WORLD ALZHEIMERS REP; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Qiu C, 2010, NEUROLOGY, V75, P2221, DOI 10.1212/WNL.0b013e3182020349; Trzepacz PT, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0103-3; Ueda Y, 2016, J ALZHEIMERS DIS, V53, P315, DOI 10.3233/JAD-151008; Valenti R, 2016, J NEUROL SCI, V368, P195, DOI 10.1016/j.jns.2016.07.018; van der Vlies AE, 2012, NEUROLOGY, V79, P763, DOI 10.1212/WNL.0b013e3182661f91; van Es ACGM, 2011, NEUROLOGY, V77, P1446, DOI 10.1212/WNL.0b013e318232ab1d; van Norden AGW, 2011, STROKE, V42, P3382, DOI 10.1161/STROKEAHA.111.629634; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Wu RH, 2014, MED SCI MONITOR, V20, P2189, DOI 10.12659/MSM.891004; Xu X, 2017, J NEUROL NEUROSUR PS, V88, P7, DOI 10.1136/jnnp-2016-313271; Xu X, 2015, STROKE, V46, P2808, DOI 10.1161/STROKEAHA.115.010700; Yakushiji Y, 2012, STROKE, V43, P1800, DOI 10.1161/STROKEAHA.111.647065; Yakushiji Y, 2008, STROKE, V39, P3323, DOI 10.1161/STROKEAHA.108.516112; Yamashiro K, 2014, CEREBROVASC DIS EXTR, V4, P212, DOI 10.1159/000369294; Zhang AJ, 2010, NEUROSCI BULL, V26, P257, DOI 10.1007/s12264-010-1210-y; Zhang M, 2013, J INT MED RES, V41, P347, DOI 10.1177/0300060513476448	40	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185145	10.1371/journal.pone.0185145	http://dx.doi.org/10.1371/journal.pone.0185145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934304	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900104
J	Ohno, T; Yamamoto, G; Hayashi, J; Nishida, E; Goto, H; Sasaki, Y; Kikuchi, T; Fukuda, M; Hasegawa, Y; Mogi, M; Mitani, A				Ohno, Tasuku; Yamamoto, Genta; Hayashi, Jun-ichiro; Nishida, Eisaku; Goto, Hisashi; Sasaki, Yasuyuki; Kikuchi, Takeshi; Fukuda, Mitsuo; Hasegawa, Yoshiaki; Mogi, Makio; Mitani, Akio			Angiopoietin-like protein 2 regulates Porphyromonas gingivalis lipopolysaccharide-induced inflammatory response in human gingival epithelial cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; PERIODONTAL-DISEASE; CREVICULAR FLUID; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; FACTOR-ALPHA; EXPRESSION; ASSOCIATION; ANGPTL2; RISK	Angiopoietin-like protein 2 (ANGPTL2) maintains tissue homeostasis by inducing inflammation and angiogenesis. It is produced in infiltrating immune cells or resident cells, such as adipocytes, vascular endothelial cells, and tumor cells. We hypothesized that ANGPTL2 might play an important role as a unique mediator in both systemic and periodontal disease. We demonstrated an increased ANGPTL2 concentration in gingival crevicular fluid from chronic periodontitis patients. Porphyromonas gingivalis lipopolysaccharide (LPS) treatment strongly induced ANGPTL2 mRNA and protein levels in Ca9-22 human gingival epithelial cells. Recombinant human ANGPTL2 increased interleukin 1 beta (IL-1 beta), IL-8, and tumor necrosis factor-a (TNF-alpha) mRNA and protein levels in Ca9-22 cells. Small-interfering (si) RNA-mediated ANGPTL2 knockdown in Ca9-22 cells reduced IL-1 beta, IL-8 and TNF-a mRNA and protein levels compared with control siRNA (p<0.01) in P. gingivalis LPS-stimulated Ca9-22 cells. Antibodies against integrin alpha 5 beta 1, an ANGPTL receptor, blocked induction of these inflammatory cytokines in P. gingivalis LPS-treated Ca9-22 cells, suggesting that secreted ANGPTL induces inflammatory cytokines in gingival epithelial cells via an autocrine loop. The classic sequential cascade of P. gingivalis LPS! inflammatory cytokine induction is well established. However, in the current study, we reveal a novel cascade comprising sequential P. gingivalis LPS! ANGPTL2! integrin alpha 5 beta inflammatory cytokine induction, which might be responsible for inducing potent periodontal disorganization activity in gingival epithelial cells. Via this pathway, ANGPTL2 functions in the pathogenesis of periodontitis and contributes to prolonging chronic inflammation in patients with systemic disease.	[Ohno, Tasuku; Yamamoto, Genta; Hayashi, Jun-ichiro; Nishida, Eisaku; Goto, Hisashi; Sasaki, Yasuyuki; Kikuchi, Takeshi; Fukuda, Mitsuo; Mitani, Akio] Aichi Gakuin Univ, Dept Periodontol, Sch Dent, Chikusa Ku, Nagoya, Aichi, Japan; [Hasegawa, Yoshiaki] Aichi Gakuin Univ, Dept Microbiol, Sch Dent, Chikusa Ku, Nagoya, Aichi, Japan; [Mogi, Makio] Aichi Gakuin Univ, Dept Integrat Educ Pharm, Sch Pharm, Chikusa Ku, Nagoya, Aichi, Japan	Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University	Yamamoto, G (corresponding author), Aichi Gakuin Univ, Dept Periodontol, Sch Dent, Chikusa Ku, Nagoya, Aichi, Japan.	genta@dpc.agu.ac.jp		Kikuchi, Takeshi/0000-0003-0310-5302; OHNO, TASUKU/0000-0003-4718-5340	Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan) [24593134, 16K11571]; Grants-in-Aid for Scientific Research [26463149] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan) grant no. 24593134 (A.M.) grant no. 16K11571 (M.M.) https://www.jsps.go.jp/j-grantsinaid/.; This work was supported by a Grant-in-Aid for Scientific Research (C) (grant no. 24593134 and 16K11571) from the Ministry of Education, Culture, Sports, Science, and Technology (Tokyo, Japan). The authors report no conflicts of interest related to this study.	Arbes SJ, 1999, J DENT RES, V78, P1777, DOI 10.1177/00220345990780120301; Armitage GC, 2004, PERIODONTOL 2000, V34, P109, DOI 10.1046/j.0906-6713.2002.003427.x; Champagne CME, 2003, PERIODONTOL 2000, V31, P167, DOI 10.1034/j.1600-0757.2003.03110.x; Chapple ILC, 2013, J CLIN PERIODONTOL, V40, pS106, DOI [10.1111/jcpe.12077, 10.1902/jop.2013.1340011]; Chaves ES, 2000, J CLIN PERIODONTOL, V27, P897, DOI 10.1034/j.1600-051x.2000.027012897.x; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Deng M, 2014, BLOOD, V124, P924, DOI 10.1182/blood-2014-01-549162; Dutzan N, 2009, J CLIN PERIODONTOL, V36, P396, DOI 10.1111/j.1600-051X.2009.01390.x; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Erdemir Ebru Olgun, 2008, Eur J Dent, V2, P102; Fujimura T, 2014, LASER MED SCI, V29, P987, DOI 10.1007/s10103-013-1439-6; Goto H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140942; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; GRENIER D, 1995, ORAL MICROBIOL IMMUN, V10, P319, DOI 10.1111/j.1399-302X.1995.tb00161.x; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Iwata T, 2005, CLIN EXP IMMUNOL, V141, P261, DOI 10.1111/j.1365-2249.2005.02836.x; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kanda A, 2012, LAB INVEST, V92, P1553, DOI 10.1038/labinvest.2012.111; Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523; Knight ET, 2016, PERIODONTOL 2000, V71, P22, DOI 10.1111/prd.12110; Kubota Y, 2005, P NATL ACAD SCI USA, V102, P13502, DOI 10.1073/pnas.0501902102; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Mitani A, 2015, J PERIODONTOL, V86, P301, DOI 10.1902/jop.2014.140293; Mogi M, 1999, ARCH ORAL BIOL, V44, P535, DOI 10.1016/S0003-9969(99)00020-5; Mogi M, 2004, J DENT RES, V83, P166, DOI 10.1177/154405910408300216; Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Santulli G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00004; Sato R, 2015, ONCOL REP, V33, P58, DOI 10.3892/or.2014.3586; Singhal S, 2016, J ORAL SCI, V58, P547, DOI 10.2334/josnusd.16-0017; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Uehara A, 2002, J MED MICROBIOL, V51, P626, DOI 10.1099/0022-1317-51-8-626; Umikawa M, 2015, BIOCHEM BIOPH RES CO, V467, P235, DOI 10.1016/j.bbrc.2015.09.183	41	20	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184825	10.1371/journal.pone.0184825	http://dx.doi.org/10.1371/journal.pone.0184825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934245	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900048
J	Saghapour, E; Kermani, S; Sehhati, M				Saghapour, Ehsan; Kermani, Saeed; Sehhati, Mohammadreza			A novel feature ranking method for prediction of cancer stages using proteomics data	PLOS ONE			English	Article							MULTI-LABEL CLASSIFIER; FEATURE-SELECTION; PROGNOSTIC-FACTOR; PROTEINS; IDENTIFICATION; EXPRESSION; SITES; ATTRIBUTES; RECURRENCE; DIAGNOSIS	Proteomic analysis of cancers' stages has provided new opportunities for the development of novel, highly sensitive diagnostic tools which helps early detection of cancer. This paper introduces a new feature ranking approach called FRMT. FRMT is based on the Technique for Order of Preference by Similarity to Ideal Solution method (TOPSIS) which select the most discriminative proteins from proteomics data for cancer staging. In this approach, outcomes of 10 feature selection techniques were combined by TOPSIS method, to select the final discriminative proteins from seven different proteomic databases of protein expression profiles. In the proposed workflow, feature selection methods and protein expressions have been considered as criteria and alternatives in TOPSIS, respectively. The proposed method is tested on seven various classifier models in a 10-fold cross validation procedure that repeated 30 times on the seven cancer datasets. The obtained results proved the higher stability and superior classification performance of method in comparison with other methods, and it is less sensitive to the applied classifier. Moreover, the final introduced proteins are informative and have the potential for application in the real medical practice.	[Saghapour, Ehsan; Kermani, Saeed; Sehhati, Mohammadreza] Isfahan Univ Med Sci, Sch Adv Technol Med, Dept Biomed Engn, Esfahan, Iran	Isfahan University Medical Science	Kermani, S (corresponding author), Isfahan Univ Med Sci, Sch Adv Technol Med, Dept Biomed Engn, Esfahan, Iran.	kermani@med.mui.ac.ir	Sehhati, Mohammadreza/U-6753-2017; Kermani, Saeed/V-3925-2017	Sehhati, Mohammadreza/0000-0002-7316-5645; Kermani, Saeed/0000-0003-3339-9532	Isfahan University of Medical Sciences, Isfahan, Iran [395775]	Isfahan University of Medical Sciences, Isfahan, Iran	This research was financially supported by the Isfahan University of Medical Sciences, Isfahan, Iran (Grant no.395775).r This research was financially supported by the Isfahan University of Medical Sciences, Isfahan, Iran (Grant no.395775). The authors would like to acknowledge the products and services provided by Isfahan University of Medical Sciences. The results published here are in whole or part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/; for this reason, the authors would like to greatly acknowledge the TCGA Research Network. Also, we wish to acknowledge MS Solutions LLC members for supplying us with editing, proofreading, and high-quality research publication support services.	ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; Azodi MZ, 2012, J PARAMEDICAL SCI, V4; Behbahani M, 2016, J THEOR BIOL, V411, P1, DOI 10.1016/j.jtbi.2016.09.001; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown G, 2012, J MACH LEARN RES, V13, P27; Cai YD, 2005, J THEOR BIOL, V234, P145, DOI 10.1016/j.jtbi.2004.11.017; Chen XX, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1654623; Cheng X, 2017, ONCOTARGET; Cheng X, 2017, BIOINFORMATICS, V33, P341, DOI 10.1093/bioinformatics/btw644; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Ding CB, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-015-0280-0; Ding CB, 2015, INT J CLIN EXP PATHO, V8, P2779; Ding H, 2016, VIROL SIN, V31, P350, DOI 10.1007/s12250-016-3740-6; Ding H, 2016, COMPUT BIOL MED, V71, P156, DOI 10.1016/j.compbiomed.2016.02.012; Ding H, 2015, AMINO ACIDS, V47, P329, DOI 10.1007/s00726-014-1862-4; Ding H, 2014, INTERDISCIP SCI, V6, P235, DOI 10.1007/s12539-013-0205-6; Ding H, 2014, MOL BIOSYST, V10, P2229, DOI 10.1039/c4mb00316k; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Duckworth C, 2015, ONCOGENE; Duda R.O., 2000, PATTERN CLASSIFICATI; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Fleuren EDG, 2010, INT J CANCER, V127, P1486, DOI 10.1002/ijc.25172; Garcia-Carracedo D, 2016, ONCOTARGET, V7, P29780, DOI 10.18632/oncotarget.8957; Han J, 2012, MOR KAUF D, P1; Hanash S, 2010, NAT REV CANCER, V10, P652, DOI 10.1038/nrc2918; Hanyuda A, 2016, ANN SURG ONCOL, V23, P908, DOI 10.1245/s10434-015-4967-4; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Ho TK, 1995, P 3 INT C DOC AN REC; Honda K, 2012, JAPANESE J CLIN ONCO; Jia JH, 2016, ONCOTARGET, V7, P34558, DOI 10.18632/oncotarget.9148; Jia JH, 2016, J THEOR BIOL, V394, P223, DOI 10.1016/j.jtbi.2016.01.020; Kaddi C, 2015, MODELS PREDICTING ST; Karnik NN, 1999, IEEE T FUZZY SYST, V7, P643, DOI 10.1109/91.811231; Khatib H, 2013, IRAN J CANCER PREV, V6, P30; Klir G.J., 1995, FUZZY SETS FUZZY LOG, DOI 10.1109/9780470544341.ch11; Lai HY, 2017, ONCOTARGET, V8, P28169, DOI 10.18632/oncotarget.15963; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2014, NUCLEIC ACIDS RES, V42, P12961, DOI 10.1093/nar/gku1019; Lin H, 2012, J BIOMOL STRUCT DYN, V29, P643, DOI 10.1080/07391102.2011.672628; Lin H, 2011, THEOR BIOSCI, V130, P91, DOI 10.1007/s12064-010-0114-8; Lin H, 2010, MOL DIVERS, V14, P667, DOI 10.1007/s11030-009-9205-1; Lin H, 2011, J MICROBIOL METH, V84, P67, DOI 10.1016/j.mimet.2010.10.013; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu L, 2017, MED CHEM SHARIQAH UN; Lu J-W, 2016, CANC METASTASIS; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mazumder A, 2008, EXPERT REV MOL DIAGN, V8, P125, DOI 10.1586/14737159.8.2.125; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Meher PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep42362; Nanni L, 2016, PATTERN RECOGN LETT, V84, P259, DOI 10.1016/j.patrec.2016.10.010; Nanni L, 2014, J THEOR BIOL, V360, P109, DOI 10.1016/j.jtbi.2014.07.003; Pelletier F.J., 2020, B SYMB LOG, V63, P342, DOI [10.28933/rjcms-2018-04-0501, DOI 10.28933/RJCMS-2018-04-0501]; Poincloux L, 2009, SURG ONCOL, V18, P357, DOI 10.1016/j.suronc.2008.09.003; Qiu W.R., 2017, ONCOTARGET; Qiu WR, 2016, BIOINFORMATICS, V32, P3116, DOI 10.1093/bioinformatics/btw380; QUINLAN JR, 1987, INT J MAN MACH STUD, V27, P221, DOI 10.1016/S0020-7373(87)80053-6; Rezaie-Tavirani M, 2013, GASTROENTEROLOGY HEP, V6; Saghapour E, 2017, J THEORETICAL BIOL; Scholkopft B., 1999, NEURAL NETW SIGNAL P, V1, P1; Sehhati M, 2015, IEEE ACM T COMPUT BI, V12, P1440, DOI 10.1109/TCBB.2015.2407407; Sonntag J., 2014, TRANSL PROTEOMICS, V2, P52, DOI DOI 10.1016/j.trprot.2014.02.001; Stafford P, 2014, P NATL ACAD SCI USA, V111, pE3072, DOI 10.1073/pnas.1409432111; Tang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30529; Tang H, 2016, BIOCHEM BIOPH RES CO, V477, P150, DOI 10.1016/j.bbrc.2016.06.035; Nguyen T, 2016, IEEE T FUZZY SYST, V24, P273, DOI 10.1109/TFUZZ.2015.2453153; Nguyen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120364; Tripathi P, 2017, J THEOR BIOL, V424, P49, DOI 10.1016/j.jtbi.2017.04.027; Tzeng GH, 2011, MULTIPLE ATTRIBUTE DECISION MAKING: METHODS AND APPLICATIONS, P1; Wei LY, 2019, IEEE ACM T COMPUT BI, V16, P1264, DOI 10.1109/TCBB.2017.2670558; Xiao X, 2013, ANAL BIOCHEM, V436, P168, DOI 10.1016/j.ab.2013.01.019; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xiao X, 2009, J APPL CRYSTALLOGR, V42, P169, DOI 10.1107/S0021889809002751; Xu Y, 2017, MED CHEM SHARIQAH UN; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105018; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Xu Y, 2013, PEERJ, V1, DOI 10.7717/peerj.171; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yang H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5413903; Yuan LF, 2013, TOXICOL IN VITRO, V27, P852, DOI 10.1016/j.tiv.2012.12.024; Zali H, 2011, GASTROENTEROLOGY HEP, V4; Zhang P., 2015, J SENSORS, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0133137; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890	90	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184203	10.1371/journal.pone.0184203	http://dx.doi.org/10.1371/journal.pone.0184203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934234	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900023
J	Reis, ZSN; Vitral, GLN; de Souza, IMF; Rego, MAS; Guimaraes, RN				Nogueira Reis, Zilma Silveira; Nogueira Vitral, Gabriela Luiza; Fonseca de Souza, Ingrid Michelle; Santiago Rego, Maria Albertina; Guimaraes, Rodney Nascimento			Newborn skin reflection: Proof of concept for a new approach for predicting gestational age at birth. A cross-sectional study	PLOS ONE			English	Article							FETAL SKIN; THICKNESS; INFANTS; NM	Background Current methods to assess the gestational age during prenatal care or at birth are a global challenge. Disadvantages, such as low accessibility, high costs, and imprecision of clinical tests and ultrasonography measurements, may compromise health decisions at birth, based on the gestational age. Newborns' organs and tissues can indirectly indicate their physical maturity, and we hypothesized that evolutionary changes in their skin, detected using an optoelectronic device meter, may aid in estimating the gestational age. This study analyzed the feasibility of using newborn skin reflectance to estimate the gestational age at birth noninvasively. Methods and findings A cross-sectional study evaluated the skin reflectance of selected infants, preferably premature, at birth. The first-trimester ultrasound was the reference for gestational age. A prototype of a new noninvasive optoelectronic device measured the backscattering of light from the skin, using a light emitting diode at wavelengths of 470 nm, 575 nm, and 630 nm. Univariate and multivariate regression analysis models were employed to predict gestational age, combining skin reflectance with clinical variables for gestational age estimation. The gestational age at birth of 115 newborns from 24.1 to 41.8 weeks of gestation correlated with the light at 630 nm wavelength reflectance 3.3 mm/6.5 mm ratio distant of the sensor, at the forearm and sole (Pearson's correlation = 0.505, P < 0.001 and 0.710, P < 0.001, respectively). The best-combined variables to predict the gold standard gestational age at birth was the skin reflectance at wavelengths of 630 nm and 470 nm in combination with birth weight, phototherapy, and adjusted to include incubator stay, and sex (R-2 = 0.828, P < 0.001). The main limitation of the study is that it was very specific to the premature population we studied and needs to be studied in a broader spectrum of newborns. Conclusions A novel automated skin reflectometer device, in combination with clinical variables, was able to predict the gestational age and could be useful when the information is in doubt or is unknown. Multivariable predictive models associated the skin reflectance with easy to obtain clinical parameters, at the birth scenario. External validation needs to be proven in an actual population with the real incidence of premature infants.	[Nogueira Reis, Zilma Silveira; Fonseca de Souza, Ingrid Michelle] Univ Fed Minas Gerais, Fac Med, Ctr Hlth Informat, Belo Horizonte, MG, Brazil; [Nogueira Reis, Zilma Silveira; Nogueira Vitral, Gabriela Luiza; Guimaraes, Rodney Nascimento] Univ Fed Minas Gerais, Fac Med, Postgrad Program Womens Hlth, Belo Horizonte, MG, Brazil; [Nogueira Reis, Zilma Silveira] Univ Fed Minas Gerais, Fac Med, Dept Gynecol & Obstet, Belo Horizonte, MG, Brazil; [Santiago Rego, Maria Albertina] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Nogueira Reis, Zilma Silveira; Nogueira Vitral, Gabriela Luiza; Fonseca de Souza, Ingrid Michelle; Santiago Rego, Maria Albertina; Guimaraes, Rodney Nascimento] Univ Fed Minas Gerais, Fac Med, Ave Prof Alfredo Balena, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Ctr Hlth Informat, Belo Horizonte, MG, Brazil.; Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Postgrad Program Womens Hlth, Belo Horizonte, MG, Brazil.; Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Gynecol & Obstet, Belo Horizonte, MG, Brazil.; Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Ave Prof Alfredo Balena, Belo Horizonte, MG, Brazil.	zilma@medicina.ufmg.br	Reis, Zilma/H-8105-2013	Reis, Zilma/0000-0001-6374-9295	Bill & Melinda Gates Foundation [OPP1128907]; Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1128907] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative	This research was supported by the Grand Challenges Exploration from the Bill & Melinda Gates Foundation (Grant number OPP1128907, Contract), http://www.gatesfoundation.org/, and Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil, http://www.fapemig.br/en/. Revision in manuscript written in English was supported by Pro-Reitoria de Pesquisa of Universidade Federal de Minas Gerais, Brazil PRPq Call number 02/2017, http://www.ufmg.br/prpq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Beydoun H, 2011, REPROD BIOMED ONLINE, V22, P321, DOI 10.1016/j.rbmo.2010.12.003; Coolen NA, 2010, ARCH DERMATOL RES, V302, P47, DOI 10.1007/s00403-009-0989-8; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Ersch J, 1999, OBSTET GYNECOL, V94, P753, DOI 10.1016/S0029-7844(99)00379-8; Fenton TR, 2013, BMC PEDIATR, V13, P1, DOI DOI 10.1186/1471-2431-13-1; FRIEHE CA, 1975, J OPT SOC AM, V65, P1502, DOI 10.1364/JOSA.65.001502; HALL MH, 1985, BRIT J OBSTET GYNAEC, V92, P445, DOI 10.1111/j.1471-0528.1985.tb01347.x; Hardman MJ, 1999, J INVEST DERMATOL, V113, P1106, DOI 10.1046/j.1523-1747.1999.00800.x; Ho DS, 2007, J KOREAN PHYS SOC, V51, P1663, DOI 10.3938/jkps.51.1663; Karl S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124286; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lister T., 2012, J BIOMEDICAL OPTICS, V17; LYNN CJ, 1993, BIOL NEONATE, V64, P69; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; MOLL I, 1986, J INVEST DERMATOL, V87, P779, DOI 10.1111/1523-1747.ep12458993; Pereira Ana Paula Esteves, 2013, BMC Res Notes, V6, P60, DOI 10.1186/1756-0500-6-60; POST PW, 1976, HUM BIOL, V48, P541; Reis ZSN, 2016, INVENTORSDISPOSITIVO; Robertson K, 2010, ACTA DERM-VENEREOL, V90, P368, DOI 10.2340/00015555-0875; SAIDI IS, 1995, APPL OPTICS, V34, P7410, DOI 10.1364/AO.34.007410; Telofski LS, 2012, DERMATOLOGY RES PRAC, V2012; Wingate MS, 2007, ANN EPIDEMIOL, V17, P425, DOI 10.1016/j.annepidem.2007.01.035; Yudovsky D, 2010, APPL OPTICS, V49, P1707, DOI 10.1364/AO.49.001707; 2003, INT J GYNAECOL OBSTE, V82, P127	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184734	10.1371/journal.pone.0184734	http://dx.doi.org/10.1371/journal.pone.0184734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931040	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700031
J	Rodriguez-Fanjul, J; Fernandez-Feijoo, CD; Lopez-Abad, M; Ramos, MGL; Caballe, RB; Alcantara-Horillo, S; Camprubi, MC				Rodriguez-Fanjul, Javier; Duran Fernandez-Feijoo, Cristina; Lopez-Abad, Miriam; Lopez Ramos, Maria Goretti; Balada Caballe, Rafael; Alcantara-Horillo, Soledad; Camprubi Camprubi, Marta			Neuroprotection with hypothermia and allopurinol in an animal model of hypoxic-ischemic injury: Is it a gender question?	PLOS ONE			English	Article							BRAIN-INJURY; SEX-DIFFERENCES; NEONATAL BRAIN; RAT MODEL; MATERNAL ALLOPURINOL; REPERFUSION INJURY; NEURONAL DEATH; FETAL HYPOXIA; BLOOD-LEVELS; ENCEPHALOPATHY	Background Hypoxic-ischemic encephalopathy (HIE) is one of the most important causes of neonatal brain injury. Therapeutic hypothermia (TH) is the standard treatment for term newborns after perinatal hypoxic ischemic injury (HI). Despite this, TH does not provide complete neuroprotection. Allopurinol seems to be a good neuroprotector in several animal studies, but it has never been tested in combination with hypothermia. Clinical findings show that male infants with (HI) fare more poorly than matched females in cognitive outcomes. However, there are few studies about neuroprotection taking gender into account in the results. T The aim of the present study was to evaluate the potential additive neuroprotective effect of allopurinol when administrated in association with TH in a rodent model of moderate HI. Gender differences in neuroprotection were also evaluated. Methods P10 male and female rat pups were subjected to HI (Vannucci model) and randomized into five groups: sham intervention (Control), no treatment (HI), hypothermia (HIH), allopurinol (HIA), and dual therapy (hypothermia and allopurinol) (HIHA). To evaluate a treatment's neuroprotective efficiency, 24 hours after the HI event caspase3 activation was measured. Damaged area and hippocampal volume were also measured 72 hours after the HI event. Negative geotaxis test was performed to evaluate early neurobehavioral reflexes. Learning and spatial memory were assessed via Morris Water Maze (MWM) test at 25 days of life. Results Damaged area and hippocampal volume were different among treatment groups (p = 0.001). The largest tissue lesion was observed in the HI group, followed by HIA. There were no differences between control, HIH, and HIHA. When learning process was analyzed, no differences were found. Females from the HIA group had similar results to the HIH and HIHA groups. Cleaved caspase 3 expression was increased in both HI and HIA. Despite this, in females cleaved caspase-3 was only differently increased in the HI group. All treated animals present an improvement in short-term (Negative geotaxis) and long-term (WMT) functional tests. Despite this, treated females present better long-term outcome. In short-term outcome no sex differences were observed. Conclusions Our results suggest that dual therapy confers great neuroprotection after an HI event. There were functional, histological, and molecular improvements in all treated groups. These differences were more important in females than in males. No statistically significant differences were found between HIHA and HIH; both of them present a great improvement. Our results support the idea of different regulation mechanisms and pathways of cell death, depending on gender.	[Rodriguez-Fanjul, Javier; Lopez-Abad, Miriam; Lopez Ramos, Maria Goretti; Camprubi Camprubi, Marta] Sant Joan de Deu Hosp Clin, Dept Neonatol, BCNatal, Barcelona, Spain; [Duran Fernandez-Feijoo, Cristina] Hosp Alvaro Cunqueiro, Dept Neonatol, EOXI, Vigo, Spain; [Balada Caballe, Rafael; Alcantara-Horillo, Soledad] Univ Barcelona, Fac Med & Biomed Sci, Dept Pathol & Expt Therapeut, Bellvitge Campus, Barcelona, Spain	University of Barcelona	Camprubi, MC (corresponding author), Sant Joan de Deu Hosp Clin, Dept Neonatol, BCNatal, Barcelona, Spain.	mcamprubic@hsjdbcn.org	Alcantara, Soledad/K-3648-2014	Alcantara, Soledad/0000-0003-3313-2715; Duran Fernandez-Feijoo, Cristina/0000-0002-0807-8393	Spanish Ministerio de Economia y Competitividad [BFU2014-55373-R]; Generalitat de Catalunya [SGR 1178]; Bebedue	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Bebedue	This work was supported by Bebedue to MC and by grants from the Spanish Ministerio de Economia y Competitividad [BFU2014-55373-R] and from the Generalitat de Catalunya [2014 SGR 1178] to SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Bebedue to MC and by grants from the Spanish Ministerio de Economia y Competitividad [BFU2014-55373-R] and from the Generalitat de Catalunya [2014 SGR 1178] to SA.	ASPBERG A, 1992, DEV BRAIN RES, V66, P55, DOI 10.1016/0165-3806(92)90139-N; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Benders MJNL, 2006, ARCH DIS CHILD-FETAL, V91, pF163, DOI 10.1136/adc.2005.086652; Boda D, 1999, PRENAT NEONAT MED, V4, P130; Chaudhari T, 2008, COCHRANE DB SYST REV, V16; Chaudhari T, 2012, COCHRANE DB SYST REV, V7; Chavez-Valdez R, 2014, NEUROSCIENCE, V260, P106, DOI 10.1016/j.neuroscience.2013.12.023; Chun PT, 2015, DEV NEUROSCI-BASEL, V37, P161, DOI 10.1159/000370147; Descloux C, 2015, INT J DEV NEUROSCI, V45, P75, DOI 10.1016/j.ijdevneu.2015.06.008; Drury PP, 2014, CLIN PERINATOL, V41, P161, DOI 10.1016/j.clp.2013.10.005; Fan XY, 2013, PEDIATR RES, V73, P18, DOI 10.1038/pr.2012.139; Fang AY, 2013, PEDIATR RES, V73, P12, DOI 10.1038/pr.2012.138; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Garberg HT, 2016, PEDIATR RES, V80, P710, DOI 10.1038/pr.2016.149; Glass Hannah C, 2007, Curr Treat Options Neurol, V9, P414, DOI 10.1007/s11940-007-0043-0; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunes T, 2007, PEDIATR NEUROL, V36, P17, DOI 10.1016/j.pediatrneurol.2006.08.005; Hassell KJ, 2015, ARCH DIS CHILD-FETAL, V100, pF541, DOI 10.1136/archdischild-2014-306284; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Huang HZ, 2016, INT J NEUROSCI, V126, P647, DOI 10.3109/00207454.2015.1047016; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kaandorp JJ, 2015, ARCH DIS CHILD-FETAL, V100, pF216, DOI 10.1136/archdischild-2014-306769; Kaandorp JJ, 2012, ARCH DIS CHILD-FETAL, V97, pF162, DOI 10.1136/archdischild-2011-300356; Kaandorp JJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-8; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lai YC, 2011, CIRC RES, V109, P1375, DOI 10.1161/CIRCRESAHA.111.256479; Lee JK, 2016, DEV NEUROSCI-BASEL, V38, P277, DOI 10.1159/000448585; Li YC, 2016, MOLECULES, V21, DOI 10.3390/molecules21101341; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Marro PJ, 2006, BRAIN RES, P1073; Mayoral SR, 2009, PEDIATR RES, V66, P248, DOI 10.1203/PDR.0b013e3181b1bc34; Morken TS, 2014, STROKE, V45, P2777, DOI 10.1161/STROKEAHA.114.005341; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Netto CA, 2017, J NEUROSCI RES, V95, P409, DOI 10.1002/jnr.23828; Nie XJ, 2016, NEUROSCI RES, V108, P24, DOI 10.1016/j.neures.2016.01.008; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; PALMER C, 1990, PEDIATR RES, V27, P332, DOI 10.1203/00006450-199004000-00003; PALMER C, 1993, PEDIATR RES, V33, P405; Peeters C, 2001, BIOL NEONATE, V79, P274; Peeters-Scholte C, 2003, PEDIATR RES, V54, P516, DOI 10.1203/01.PDR.0000081297.53793.C6; Perlman JM, 2007, J PERINATOL, V27, pS39, DOI 10.1038/sj.jp.7211716; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P83, DOI 10.3109/14767058.2012.663168; Roux C, 2015, EXP NEUROL, V267, P177, DOI 10.1016/j.expneurol.2015.02.037; Sabir H, 2014, PLOS ONE, V6, P9; Sanders SA, 1999, ANTIOXID REDOX SIGN, V1, P371, DOI 10.1089/ars.1999.1.3-371; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sharma J, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-9; Sheldon RA, 2004, PEDIATR RES, V56, P656, DOI 10.1203/01.PDR.0000139413.27864.50; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Smit E, 2015, RESUSCITATION, V96, P214, DOI 10.1016/j.resuscitation.2015.07.050; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Smith J, 2000, BRIT J OBSTET GYNAEC, V107, P461, DOI 10.1111/j.1471-0528.2000.tb13262.x; Sosunov SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120456; Torrance HL, 2009, PEDIATRICS, V124, P350, DOI 10.1542/peds.2008-2228; Van Bel F, 1998, PEDIATRICS, V101, P185, DOI 10.1542/peds.101.2.185; Wang XY, 2001, BIOL NEONATE, V79, P172; YAGER J, 1993, PEDIATR RES, V34, P525, DOI 10.1203/00006450-199310000-00029; Yamaguchi M, 2015, PLOS ONE, V10; Zhang Q, 2015, BRAIN RES, V1622, P361, DOI 10.1016/j.brainres.2015.07.010; Zhang Z, 1998, FREE RADICAL RES, V28, P151, DOI 10.3109/10715769809065801; Zhao P, 2015, NEUROCHEM INT, V89, P17, DOI 10.1016/j.neuint.2015.06.008; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	64	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184643	10.1371/journal.pone.0184643	http://dx.doi.org/10.1371/journal.pone.0184643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931035	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700026
J	Herold, M; Breuer, J; Hucke, S; Knolle, P; Schwab, N; Wiendl, H; Klotz, L				Herold, Martin; Breuer, Johanna; Hucke, Stephanie; Knolle, Percy; Schwab, Nicholas; Wiendl, Heinz; Klotz, Luisa			Liver X receptor activation promotes differentiation of regulatory T cells	PLOS ONE			English	Article							NERVOUS-SYSTEM AUTOIMMUNITY; TRYPTOPHAN CATABOLISM; NUCLEAR RECEPTORS; IMMUNE TOLERANCE; LIPID-METABOLISM; RETINOIC ACID; LXR-ALPHA; EXPRESSION; INFLAMMATION; COLITIS	The nuclear receptor Liver X Receptor (LXR) is a ligand-activated transcription factor that has been implicated in control of chronic inflammation by downregulating pro-inflammatory T cell responses. An impaired function of regulatory T cells, a subset of CD4+ T cells with a crucial role in maintaining lymphocytes homeostasis and immune regulation, is frequently observed in chronic inflammatory diseases. We observed that pharmacological activation of LXR in T cells not only resulted in a thorough suppression of Th1 and Th17 polarization in vitro, but also significantly induced regulatory T cells (Treg) cell differentiation in a receptor-specific fashion. In line with this, systemic LXR activation by oral treatment of mice with the LXR agonist GW3965 induced gut-associated regulatory T cells in vivo. Importantly, such LXR-activated Tregs had a higher suppressive capacity in functional in vitro coculture assays with effector T cells. Our data thus point towards a dual role of LXR-mediated control of inflammation by suppression of pro-inflammatory T cells and reciprocal induction of regulatory T cells.	[Herold, Martin; Breuer, Johanna; Hucke, Stephanie; Schwab, Nicholas; Wiendl, Heinz; Klotz, Luisa] Univ Munster, Dept Neurol, Albert Schweitzer Campus 1, Munster, Germany; [Knolle, Percy] Tech Univ Munich, Inst Mol Immunol & Expt Oncol, Munich, Germany	University of Munster; Technical University of Munich	Klotz, L (corresponding author), Univ Munster, Dept Neurol, Albert Schweitzer Campus 1, Munster, Germany.	Luisa.klotz@ukmuenster.de	Klotz, Luisa/HCI-7635-2022; Wiendl, Heinz/AAX-6041-2021	Knolle, Percy A./0000-0003-2983-0414; Schwab, Nicholas/0000-0001-5494-9885; Wiendl, Heinz/0000-0003-4310-3432	German Research Foundation [CRC 128 A8, 704]; Interdisciplinary center for clinical research (IZKF) [KI2/015/14]	German Research Foundation(German Research Foundation (DFG)); Interdisciplinary center for clinical research (IZKF)	This study was supported by the German Research Foundation Grant Number CRC 128 A8 and 704 to LK (http://www.stbtr128.de/; www.limes-institut-bonn.de/forschung/forschungsverbuende/sfb-704/) and the Interdisciplinary center for clinical research (IZKF) Grant Number KI2/015/14 to LK (https://campus. uni-muerster.de/izkf.html).	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Barreto M, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-5; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bereshchenko O, 2014, CELL REP, V7, P464, DOI 10.1016/j.celrep.2014.03.004; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Breuer J, 2014, ANN NEUROL, V75, P739, DOI 10.1002/ana.24165; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen X, 2011, INT IMMUNOPHARMACOL, V11, P1489, DOI 10.1016/j.intimp.2011.05.018; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Dunn SE, 2010, J EXP MED, V207, P1599, DOI 10.1084/jem.20091663; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; Jakobsson T, 2014, MUCOSAL IMMUNOL, V7, P1416, DOI 10.1038/mi.2014.31; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lin L, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-016-0187-3; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Menning A, 2010, EUR J IMMUNOL, V40, P2539, DOI 10.1002/eji.200939938; Mohinta S, 2015, TOXICOL SCI, V145, P233, DOI 10.1093/toxsci/kfv046; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nomura T, 2005, CURR TOP MICROBIOL, V293, P287, DOI 10.1007/3-540-27702-1_13; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Scheffold A, 2005, EUR J IMMUNOL, V35, P1336, DOI 10.1002/eji.200425887; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; SHINAR DM, 1994, GENE, V147, P273, DOI 10.1016/0378-1119(94)90080-9; Sidhu-Varma M, 2016, INFLAMM BOWEL DIS, V22, P548, DOI 10.1097/MIB.0000000000000653; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Walcher D, 2006, ARTERIOSCL THROM VAS, V26, P1022, DOI 10.1161/01.ATV.0000210278.67076.8f; Wang Y, 2014, GUT MICROBES, V5, P552, DOI 10.4161/gmic.29797; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600	55	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184985	10.1371/journal.pone.0184985	http://dx.doi.org/10.1371/journal.pone.0184985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926619	Green Submitted, gold, Green Published			2022-12-27	WOS:000411166600058
J	Ly, HJ; Lokugamage, N; Nishiyama, S; Ikegami, T				Ly, Hoai J.; Lokugamage, Nandadeva; Nishiyama, Shoko; Ikegami, Tetsuro			Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain	PLOS ONE			English	Article							GENUS PHLEBOVIRUS; HEMORRHAGIC-FEVER; GENETIC DIVERSITY; VIRUS; TRANSMISSION; RNA; TRANSCRIPTION; EPIDEMIOLOGY; EVOLUTIONARY; OUTBREAKS	Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to Africa and the Arabian Peninsula. The causative agent, Rift Valley fever phlebovirus (RVFV), belongs to the genus Phlebovirus in the family Phenuiviridae and causes high rates of abortions in ruminants, and hemorrhagic fever, encephalitis, or blindness in humans. Viral maintenance by mosquito vectors has led to sporadic RVF outbreaks in ruminants and humans in endemic countries, and effective vaccination of animals and humans may minimize the impact of this disease. A live-attenuated MP-12 vaccine strain is one of the best characterized RVFV strains, and was conditionally approved as a veterinary vaccine in the U.S. Live-attenuated RVF vaccines including MP-12 strain may form reassortant strains with other bunyavirus species. This study thus aimed to characterize the occurrence of genetic reassortment between the MP-12 strain and bunyavirus species closely related to RVFV. The Arumowot virus (AMTV) and Gouleako goukovirus (GOLV), are transmitted by mosquitoes in Africa. The results of this study showed that GOLV does not form detectable reassortant strains with the MP-12 strain in co-infected C6/36 cells. The AMTV also did not form any reassortant strains with MP-12 strain in co-infected C6/36 cells, due to the incompatibility among N, L, and Gn/Gc proteins. A lack of reassortant formation could be due to a functional incompatibility of N and L proteins derived from heterologous species, and due to a lack of packaging via heterologous Gn/Gc proteins. The MP-12 strain did, however, randomly exchange L-, M-, and S-segments with a genetic variant strain, rMP12-GM50, in culture cells. The MP-12 strain is thus unlikely to form any reassortant strains with AMTV or GOLV in nature.	[Ly, Hoai J.; Lokugamage, Nandadeva; Nishiyama, Shoko; Ikegami, Tetsuro] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Ikegami, Tetsuro] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Ikegami, Tetsuro] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA; [Nishiyama, Shoko] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Hokkaido University	Ikegami, T (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Ikegami, T (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; Ikegami, T (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.	teikegam@utmb.edu	Ikegami, Tetsuro/H-1329-2013	Ikegami, Tetsuro/0000-0001-8318-2783	American people through the United States Agency for International Development (USAID) [26-3002-6062, AID-OAA-A-13-00084]; Kansas Bioscience Authority [S13027]; NIH/NIAID [R01 AI08764301-A1]; Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston; James W. McLaughlin Postdoctoral Fellowship at UTMB	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Kansas Bioscience Authority; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston; James W. McLaughlin Postdoctoral Fellowship at UTMB	This study was made possible by the generous support of the subcontract 26-3002-6062 from the American people through the United States Agency for International Development (USAID, AID-OAA-A-13-00084, http://research.utep.edu/Default.aspx?alias=research.utep.edu/riftvalleyfeverinnovationlab). The study was also partially supported by the Kansas Bioscience Authority (http://www.kansasbioauthority.org/) grant subcontract S13027, the NIH/NIAID (https://www.niaid.nih.gov/) grant R01 AI08764301-A1, and the funding from the Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston (https://www.utmb.edu/scvd/). SN was supported by the James W. McLaughlin Postdoctoral Fellowship at UTMB (https://www.utmb.edu/mclaughlin/index.htm). The contents do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi L, 2001, J GEN VIROL, V82, P781, DOI 10.1099/0022-1317-82-4-781; Alkan C, 2013, ANTIVIR RES, V100, P54, DOI 10.1016/j.antiviral.2013.07.005; Berger S, 2016, RIFT VALLEY FEVER GL; Berthet N, 2016, VECTOR-BORNE ZOONOT, V16, P139, DOI 10.1089/vbz.2015.1830; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Bowen MD, 2001, VIROLOGY, V291, P185, DOI 10.1006/viro.2001.1201; Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05; Chung HC, 2014, EMERG INFECT DIS, V20, P2072, DOI 10.3201/eid2012.131742; Freire CCM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11353; GAD AM, 1987, T ROY SOC TROP MED H, V81, P694, DOI 10.1016/0035-9203(87)90460-3; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; GONZALEZ JP, 1992, T ROY SOC TROP MED H, V86, P680, DOI 10.1016/0035-9203(92)90190-N; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2015, J VIROL, V89, P7262, DOI 10.1128/JVI.00135-15; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613, DOI 10.1111/j.1348-0421.2003.tb03424.x; Junglen S, 2015, EMERG INFECT DIS, V21, P2190, DOI 10.3201/eid2112.141840; Kalveram B, 2011, JOVE-J VIS EXP, DOI 10.3791/3400; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Ly HJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0573-8; Marklewitz M, 2011, J VIROL, V85, P9227, DOI 10.1128/JVI.00230-11; Marklewitz Marco, 2015, Proc Natl Acad Sci U S A, V112, P7536, DOI 10.1073/pnas.1502036112; Miller MM, 2015, CLIN VACCINE IMMUNOL, V22, P930, DOI 10.1128/CVI.00114-15; Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032; Muga GO, 2015, AM J TROP MED HYG, V92, P730, DOI 10.4269/ajtmh.14-0363; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Seufi AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-65; SWANEPOEL R, 1986, J HYG-CAMBRIDGE, V97, P331, DOI 10.1017/S0022172400065426; Swanepoel R., 2004, INFECT DIS LIVESTOCK, V2, P1037; TESH RB, 1988, ANNU REV ENTOMOL, V33, P169, DOI 10.1146/annurev.en.33.010188.001125; TURELL MJ, 1991, AM J TROP MED HYG, V44, P278, DOI 10.4269/ajtmh.1991.44.278; Wuerth JD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060174	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185194	10.1371/journal.pone.0185194	http://dx.doi.org/10.1371/journal.pone.0185194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926632	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600076
J	Westfall, DA; Krishnamoorthy, G; Wolloscheck, D; Sarkar, R; Zgurskaya, HI; Rybenkov, VV				Westfall, David A.; Krishnamoorthy, Ganesh; Wolloscheck, David; Sarkar, Rupa; Zgurskaya, Helen I.; Rybenkov, Valentin V.			Bifurcation kinetics of drug uptake by Gram-negative bacteria	PLOS ONE			English	Article							MULTIDRUG TRANSPORTER LMRP; ESCHERICHIA-COLI; OUTER-MEMBRANE; P-GLYCOPROTEIN; PSEUDOMONAS-AERUGINOSA; PERMEABILITY BARRIER; EFFLUX PUMPS; BETA-LACTAMS; ACRAB-TOLC; RESISTANCE	Cell envelopes of many bacteria consist of two membranes studded with efflux transporters. Such organization protects bacteria from the environment and gives rise to multidrug resistance. We report a kinetic model that accurately describes the permeation properties of this system. The model predicts complex non-linear patterns of drug uptake complete with a bifurcation, which recapitulate the known experimental anomalies. We introduce two kinetic parameters, the efflux and barrier constants, which replace those of Michaelis and Menten for trans-envelope transport. Both compound permeation and efflux display transitions, which delineate regimes of efficient and inefficient efflux. The first transition is related to saturation of the transporter by the compound and the second one behaves as a bifurcation and involves saturation of the outer membrane barrier. The bifurcation was experimentally observed in live bacteria. We further found that active efflux of a drug can be orders of magnitude faster than its diffusion into a cell and that the efficacy of a drug depends both on its transport properties and therapeutic potency. This analysis reveals novel physical principles in the behavior of the cellular envelope, creates a framework for quantification of small molecule permeation into bacteria, and should invigorate structure-activity studies of novel antibiotics.	[Westfall, David A.; Krishnamoorthy, Ganesh; Wolloscheck, David; Sarkar, Rupa; Zgurskaya, Helen I.; Rybenkov, Valentin V.] Univ Oklahoma, Dept Chem & Biochem, Stephenson Pkwy, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Zgurskaya, HI; Rybenkov, VV (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Stephenson Pkwy, Norman, OK 73019 USA.	elenaz@ou.edu; valya@ou.edu		Zgurskaya, Helen/0000-0001-8929-4727	Department of the Defense, Defense Threat Reduction Agency [HDTRA1-14-1-0019]	Department of the Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the award HDTRA1-14-1-0019 from the Department of the Defense, Defense Threat Reduction Agency to HIZ and WR. The content of the information does not necessarily reflect the position or the policy of the federal government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASUQUO AE, 1993, J ANTIMICROB CHEMOTH, V31, P865, DOI 10.1093/jac/31.6.865; Bauer WR, 2006, P NATL ACAD SCI USA, V103, P11446, DOI 10.1073/pnas.0601769103; Bezrukov SM, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2766720; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; CHEN AY, 1993, CANCER RES, V53, P1332; Coldham NG, 2010, J ANTIMICROB CHEMOTH, V65, P1655, DOI 10.1093/jac/dkq169; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daury L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10731; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Eren E, 2013, J BIOL CHEM, V288, P12042, DOI 10.1074/jbc.M113.463570; Gutfreund H., 1975, Ontario Field Biologist, V29, P161; Hajjar E, 2010, BIOCHEMISTRY-US, V49, P6928, DOI 10.1021/bi100845x; Kojima S, 2013, P NATL ACAD SCI USA, V110, pE2629, DOI 10.1073/pnas.1310333110; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Krishnamoorthy G, 2016, ANTIMICROB AGENTS CH, V60, P7372, DOI 10.1128/AAC.01882-16; Lewinson O, 2003, P NATL ACAD SCI USA, V100, P1667, DOI 10.1073/pnas.0435544100; Lewis K, 2012, NATURE, V485, P439, DOI 10.1038/485439a; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lim SP, 2010, ANTIMICROB AGENTS CH, V54, P1800, DOI 10.1128/AAC.01714-09; Lomovskaya O, 2008, METHODS PRINCIPLES M, V33; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; Lu PH, 2001, EUR J BIOCHEM, V268, P1687, DOI 10.1046/j.1432-1033.2001.02041.x; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; Mohammad MM, 2011, J BIOL CHEM, V286, P8000, DOI 10.1074/jbc.M110.197723; Muller H, 2007, BIOORGAN MED CHEM, V15, P7470, DOI 10.1016/j.bmc.2007.07.024; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Nakae T, 1982, Tokai J Exp Clin Med, V7 Suppl, P141; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, V1; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Ohki S, 2004, STRUCTURE BIOL MEMBR; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Petrushenko ZM, 2011, MOL MICROBIOL, V81, P881, DOI 10.1111/j.1365-2958.2011.07763.x; PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x; Pothula KR, 2016, BBA-BIOMEMBRANES, V1858, P1760, DOI 10.1016/j.bbamem.2015.12.020; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Ricci V, 2003, J ANTIMICROB CHEMOTH, V52, P605, DOI 10.1093/jac/dkg418; Rice LB, 2012, MAYO CLIN PROC, V87, P198, DOI 10.1016/j.mayocp.2011.12.003; Richmond GE, 2013, J ANTIMICROB CHEMOTH, V68, P1594, DOI 10.1093/jac/dkt052; Ruggerone P, 2013, CURR TOP MED CHEM, V13, P3079, DOI 10.2174/15680266113136660220; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Silver LL, 2016, BIOORGAN MED CHEM, V24, P6379, DOI 10.1016/j.bmc.2016.06.044; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; THANASSI DG, 1995, J BACTERIOL, V177, P998, DOI 10.1128/jb.177.4.998-1007.1995; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Trusts PC, 2016, SCI ROADM ANT DISC S; Zgurskaya HI, 2015, ACS INFECT DIS, V1, P512, DOI 10.1021/acsinfecdis.5b00097; Zgurskaya HI, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00100; Zhou Y, 2015, ANAL CHEM, V87, P3579, DOI 10.1021/ac504880r	52	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184671	10.1371/journal.pone.0184671	http://dx.doi.org/10.1371/journal.pone.0184671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926596	gold, Green Submitted, Green Published			2022-12-27	WOS:000411166600031
J	Murai, T; Takebe, N; Nagasawa, K; Todate, Y; Nakagawa, R; Nakano, R; Hangai, M; Hasegawa, Y; Takahashi, Y; Yoshioka, K; Ishigaki, Y				Murai, Tomomi; Takebe, Noriko; Nagasawa, Kan; Todate, Yusuke; Nakagawa, Riyuki; Nakano, Rieko; Hangai, Mari; Hasegawa, Yutaka; Takahashi, Yoshihiko; Yoshioka, Kunihiro; Ishigaki, Yasushi			Association of epicardial adipose tissue with serum level of cystatin C in type 2 diabetes	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; GLOMERULAR-FILTRATION-RATE; VISCERAL ABDOMINAL FAT; COMPUTED-TOMOGRAPHY; PERICARDIAL FAT; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; HEART-DISEASE; CALCIFICATION	Objective Accumulation of epicardial adipose tissue (EAT) is considered to be a cardiovascular risk factor independent from visceral adiposity, obesity, hypertension and diabetes. We explored the parameters related to EAT accumulation, aiming to clarify the novel pathophysiological roles of EAT in subjects with type 2 diabetes (T2DM). Methods We examined the laboratory values, including cystatinC, and surrogate markers used for evaluating atherosclerosis. EAT was measured as the sum of the adipose tissue area, obtained by plain computed tomography scans in 208 subjects with T2DM but no history of coronary artery disease. Results EAT correlated positively with age, body mass index (BMI), visceral fat area, leptin, cystatin C and C-peptide, while correlating negatively with adiponectin, estimated glomerular filteration rate (eGFR) and the liver-to-spleen ratio. Multiple linear regression analysis revealed serum cystatin C (beta = 0.175), leptin (beta = 0.536), BMI (beta = 0.393) and age (beta = 0.269) to be the only parameters showing independent statistically significant associations with EAT. When cystatin C was replaced with eGFR, eGFR showed no significant correlation with EAT. In reverse analysis, serum cystatin C was significantly associated with EAT after adjustment in multivariate analysis. Discussion EAT accumulation and elevated cystatin C have been independently regarded as risk factors influencing atherosclerosis. The strong association between EAT and cystatin C demonstrated herein indicates that EAT accumulation may play an important role in Cystatin C secretion, possibly contributing to cardiometabolic risk in T2DM patients.	[Murai, Tomomi; Takebe, Noriko; Nagasawa, Kan; Todate, Yusuke; Nakagawa, Riyuki; Nakano, Rieko; Hangai, Mari; Hasegawa, Yutaka; Takahashi, Yoshihiko; Ishigaki, Yasushi] Iwate Med Univ, Div Diabet & Metab, Dept Internal Med, Morioka, Iwate, Japan; [Yoshioka, Kunihiro] Iwate Med Univ, Div Cardiovasc Radiol, Dept Radiol, Morioka, Iwate, Japan	Iwate Medical University; Iwate Medical University	Ishigaki, Y (corresponding author), Iwate Med Univ, Div Diabet & Metab, Dept Internal Med, Morioka, Iwate, Japan.	ishigaki@iwate-med.ac.jp			Japan Society for the Promotion of Science [15K09416]; Ministry of Education, Culture, Sports, Science and Technology of Japan [S1491001, 2014-2018]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in Aid for Scientific Research (15K09416) to Y.I., from the Japan Society for the Promotion of Science and a Grant-in-Aid for Strategic Medical Science Research (S1491001, 2014-2018) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ABRAHAMSON M, 1990, BIOCHEM J, V268, P287, DOI 10.1042/bj2680287; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Aulinas A, 2016, CLIN ENDOCRINOL OXF; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Bertaso AG, 2013, ARQ BRAS CARDIOL, V101, pE18, DOI 10.5935/abc.20130138; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Cheng VY, 2010, JACC-CARDIOVASC IMAG, V3, P352, DOI 10.1016/j.jcmg.2009.12.013; Chun H, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0210-7; Dandana A, 2014, J CLIN LAB ANAL, V28, P191, DOI 10.1002/jcla.21665; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Elkeles RS, 2010, ATHEROSCLEROSIS, V210, P331, DOI 10.1016/j.atherosclerosis.2009.11.026; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; Fluchter S, 2007, OBESITY, V15, P870, DOI 10.1038/oby.2007.591; Fracanzani AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162473; Gorter PM, 2008, ATHEROSCLEROSIS, V197, P896, DOI 10.1016/j.atherosclerosis.2007.08.016; Hangai M, 2016, J ATHEROSCLER THROMB, V23, P1178, DOI 10.5551/jat.30155; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Iacobellis G, 2015, NAT REV ENDOCRINOL, V11, P363, DOI 10.1038/nrendo.2015.58; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jeong JW, 2007, CIRC J, V71, P536, DOI 10.1253/circj.71.536; Kaikita K., 2016, J ATHEROSCLEROSIS TH; Kerr JD, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-26; Kremen J, 2006, J CLIN ENDOCR METAB, V91, P4620, DOI 10.1210/jc.2006-1044; Lafarge JC, 2010, BIOCHIMIE, V92, P1580, DOI 10.1016/j.biochi.2010.04.011; Luc G, 2006, ATHEROSCLEROSIS, V185, P375, DOI 10.1016/j.atherosclerosis.2005.06.017; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; MARCHINGTON JM, 1989, COMP BIOCHEM PHYS B, V94, P225, DOI 10.1016/0305-0491(89)90337-4; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Nakano NT, 2017, OBESITY SCI PRACTIC; Naour N, 2009, OBESITY, V17, P2121, DOI 10.1038/oby.2009.96; Natale F, 2009, EUR J ECHOCARDIOGR, V10, P549, DOI 10.1093/ejechocard/jep002; Niccoli G, 2008, ATHEROSCLEROSIS, V198, P373, DOI 10.1016/j.atherosclerosis.2007.09.022; Nichols John H, 2008, J Cardiovasc Comput Tomogr, V2, P288, DOI 10.1016/j.jcct.2008.08.008; Ono M, 2014, INTERNAL MED, V53, P391, DOI 10.2169/internalmedicine.53.9549; Puri R, 2015, J AM COLL CARDIOL, V65, P1273, DOI 10.1016/j.jacc.2015.01.036; Ristiniemi N, 2012, CLIN BIOCHEM, V45, P535, DOI 10.1016/j.clinbiochem.2012.02.012; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Salgado-Somoza A, 2010, AM J PHYSIOL-HEART C, V299, pH202, DOI 10.1152/ajpheart.00120.2010; Shimabukuro M, 2013, ARTERIOSCL THROM VAS, V33, P1077, DOI 10.1161/ATVBAHA.112.300829; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Silva D, 2012, AM J CARDIOL, V109, P1431, DOI 10.1016/j.amjcard.2012.01.356; Singh D, 2007, NEPHROL DIAL TRANSPL, V22, P1087, DOI 10.1093/ndt/gfl744; Tanami Y, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002676; Ueno K, 2009, CIRC J, V73, P1927, DOI 10.1253/circj.CJ-09-0266; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138; Xu Y, 2012, CORONARY ARTERY DIS, V23, P227, DOI 10.1097/MCA.0b013e328351ab2c	47	16	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184723	10.1371/journal.pone.0184723	http://dx.doi.org/10.1371/journal.pone.0184723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922364	Green Submitted, Green Published, gold			2022-12-27	WOS:000411059300025
J	Thuy, DB; Campbell, J; Hoang, NVM; Trinh, TTT; Duong, HTH; Hieu, NC; Duy, NHA; Hao, NV; Baker, S; Thwaites, GE; Chau, NVV; Thwaites, CL				Duong Bich Thuy; James Campbell; Nguyen Van Minh Hoang; Truong Thi Thuy Trinh; Ha Thi Hai Duong; Nguyen Chi Hieu; Nguyen Hoang Anh Duy; Nguyen Van Hao; Stephen Baker; Thwaites, Guy E.; Nguyen Van Vinh Chau; Louise Thwaites, C.			A one-year prospective study of colonization with antimicrobial-resistant organisms on admission to a Vietnamese intensive care unit	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; NASAL CARRIAGE; BACTERIA; EPIDEMIOLOGY; PREVALENCE; INFECTION	There is a paucity of data regarding initial bacterial colonization on admission to Intensive Care Units (ICUs) in low and middle-income countries (LMICs). Patients admitted to ICUs in LMICs are at high-risk of subsequent infection with antimicrobial-resistant organisms (AROs). We conducted a prospective, observational study at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam from November 2014 to January 2016 to assess the colonization and antimicrobial susceptibility of Staphylococcus aureus, Escherichia coli, Klebsiella spp., Pseudomonas spp. and Acinetobacter spp. among adult patients within 48 hours of ICU admission. We found the admission colonization prevalence (with at least one of the identified organisms) was 93.7% (785/838) and that of AROs was 63.1% (529/838). The colonization frequency with AROs among patients admitted from the community was comparable to those transferred from other hospitals (62.2% vs 63.8%). Staphylococcus aureus was the most commonly isolated bacteria from nasal swabs (13.1%, 110/838) and the methicillin-resistant Staphylococcus aureus nasal colonization prevalence was 8.6% (72/838). We isolated Escherichia coli from rectal swabs from almost all enrolled patients (88.3%, 740/838) and 52.1% (437/838) of patients were colonized by extended spectrum beta-lactamase producing Escherichia coli. Notably, Klebsiella pneumoniae was the most frequently isolated bacteria from the tracheal swabs (11.8%, 18/153). Vietnamese ICU patients have a high rate of colonization with AROs and are thus at risk of subsequent infections with these organisms if good infection control practices are not in place.	[Duong Bich Thuy; James Campbell; Nguyen Van Minh Hoang; Stephen Baker; Thwaites, Guy E.; Louise Thwaites, C.] OUCRU, Wellcome Trust Major Overseas Programmes, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Duong Bich Thuy; Truong Thi Thuy Trinh; Ha Thi Hai Duong; Nguyen Chi Hieu; Nguyen Hoang Anh Duy; Nguyen Van Hao] Hosp Trop Dis, Adult Intens Care Unit, Ho Chi Minh City, Vietnam; [James Campbell; Stephen Baker; Thwaites, Guy E.; Louise Thwaites, C.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Nguyen Van Hao] Univ Med & Pharm, Dept Infect Dis, Ho Chi Minh City, Vietnam; [Stephen Baker] Univ Cambridge, Dept Med, Cambridge, England; [Nguyen Van Vinh Chau] Hosp Trop Dis, Board Directors, Ho Chi Minh City, Vietnam	University of Oxford; Hochiminh City University of Medicine & Pharmacy; University of Cambridge	Thuy, DB (corresponding author), OUCRU, Wellcome Trust Major Overseas Programmes, Hosp Trop Dis, Ho Chi Minh City, Vietnam.; Thuy, DB (corresponding author), Hosp Trop Dis, Adult Intens Care Unit, Ho Chi Minh City, Vietnam.	duongthuyicu@gmail.com	Thwaites, Guy E/R-4993-2019	Thwaites, Guy E/0000-0002-2858-2087; Baker, Stephen/0000-0003-1308-5755	Oxford University Clinical Research Unit based in Vietnam (OUCRU-VN)	Oxford University Clinical Research Unit based in Vietnam (OUCRU-VN)	This study is funded by Oxford University Clinical Research Unit based in Vietnam (OUCRU-VN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, COLONIZATION INFECT, P568; Bonten MJM, 1996, INFECT CONT HOSP EP, V17, P193; Boyce JM, 1996, INFECT CONT HOSP EP, V17, P256; Cole AM, 2001, CLIN DIAGN LAB IMMUN, V8, P1064, DOI 10.1128/CDLI.8.6.1064-1069.2001; Durmaz G, 2016, J INFECT DEV CTRIES, V10; Erdenizmenli M, 2004, JPN J INFECT DIS, V57, P172; Galoisy-Guibal L, 2006, INFECT CONT HOSP EP, V27, P1233, DOI 10.1086/507277; Gamblin J, 2013, J MED MICROBIOL, V62, P437, DOI 10.1099/jmm.0.051854-0; George K, 2016, J CLIN DIAGN RES, V10, pDC11, DOI 10.7860/JCDR/2016/18259.7262; Greene JN, 1996, INFECT CONT HOSP EP, V17, P114; Haverkate MR, 2014, INTENS CARE MED, V40, P564, DOI 10.1007/s00134-014-3225-8; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P47; Nguyen KV, 2014, T ROY SOC TROP MED H, V108, P783, DOI 10.1093/trstmh/tru132; Mainous AG, 2006, ANN FAM MED, V4, P132, DOI 10.1370/afm.526; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; Ren YG, 2015, CELL BIOCHEM BIOPHYS, V71, P1235, DOI 10.1007/s12013-014-0333-6; Schultsz C, 2013, INTENS CARE MED, V39, P661, DOI 10.1007/s00134-012-2771-1; Tan RM, 2014, J MICROBIOL IMMUNOL, V47, P87, DOI 10.1016/j.jmii.2012.11.006; Tom Frieden, 2013, CDC, P22; Thu TA, 2012, AM J INFECT CONTROL, V40, P840, DOI 10.1016/j.ajic.2011.10.020; Yan X, 2015, CLIN MICROBIOL INFEC, V21, P157, DOI 10.1016/j.cmi.2014.08.023; Yesilbag Z, 2015, MIKROBIYOL BUL, V49, P327	22	7	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184847	10.1371/journal.pone.0184847	http://dx.doi.org/10.1371/journal.pone.0184847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910379	Green Published, gold			2022-12-27	WOS:000410859200106
J	Kowalczyk, M; Sawulski, S; Dabrowski, W; Grzycka-Kowalczyk, L; Kotlinska-Hasiec, E; Wronska-Sewruk, A; Florek, A; Rutyna, R				Kowalczyk, Michal; Sawulski, Slawomir; Dabrowski, Wojciech; Grzycka-Kowalczyk, Luiza; Kotlinska-Hasiec, Edyta; Wronska-Sewruk, Agnieszka; Florek, Artur; Rutyna, Rafal			Successful 1: 1 proportion ventilation with a unique device for independent lung ventilation using a double-lumen tube without complications in the supine and lateral decubitus positions. A pilot study	PLOS ONE			English	Article							HYPOXIC PULMONARY VASOCONSTRICTION; DIFFERENTIAL VENTILATION; SHUNT FRACTION; AIRWAY-CLOSURE; SELECTIVE PEEP; ANESTHESIA; ATELECTASIS; OXYGENATION; ISOFLURANE; PERFUSION	Introduction Adequate blood oxygenation and ventilation/perfusion matching should be main goal of anaesthetic and intensive care management. At present, one of the methods of improving gas exchange restricted by ventilation/perfusion mismatching is independent ventilation with two ventilators. Recently, however, a unique device has been developed, enabling ventilation of independent lungs in 1: 1, 2: 1, 3: 1, and 5: 1 proportions. The main goal of the study was to evaluate the device's utility, precision and impact on pulmonary mechanics. Secondly- to measure the gas distribution in supine and lateral decubitus position. Materials and methods 69 patients who underwent elective thoracic surgery were eligible for the study. During general anaesthesia, after double lumen tube intubation, the aforementioned control system was placed between the anaesthetic machine and the patient. In the supine and lateral decubitus (left/right) positions, measurements of conventional and independent (1: 1 proportion) ventilation were performed separately for each lung, including the following: tidal volume, peak pressure and dynamic compliance. Results Our results show that conventional ventilation using Robertshaw tube in the supine position directs 47% of the tidal volume to the left lung and 53% to the right lung. Furthermore, in the left lateral position, 44% is directed to the dependent lung and 56% to the non-dependent lung. In the right lateral position, 49% is directed to the dependent lung and 51% to the non-dependent lung. The control system positively affected non-dependent and dependent lung ventilation by delivering equal tidal volumes into both lungs with no adverse effects, regardless of patient's position. Conclusions We report that gas distribution is uneven during conventional ventilation using Robertshaw tube in the supine and lateral decubitus positions. However, this recently released control system enables precise and safe independent ventilation in the supine and the left and right lateral decubitus positions.	[Kowalczyk, Michal; Sawulski, Slawomir; Dabrowski, Wojciech; Kotlinska-Hasiec, Edyta; Wronska-Sewruk, Agnieszka; Florek, Artur; Rutyna, Rafal] Med Univ Lublin, Dept Anaesthesiol & Intens Care 1, Lublin, Poland; [Grzycka-Kowalczyk, Luiza] Med Univ Lublin, Dept Radiol & Nucl Med 1, Lublin, Poland	Medical University of Lublin; Medical University of Lublin	Kowalczyk, M (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Care 1, Lublin, Poland.	michalkowalczyk@vp.pl	Dabrowski, Wojciech/AAN-8425-2020; Kowalczyk, Michał/AAN-1914-2021; Rutyna, Rafał/AAU-4585-2020	Dabrowski, Wojciech/0000-0003-0449-2375; Kowalczyk, Michał/0000-0002-1991-190X; Rutyna, Rafał/0000-0003-0769-719X				Abe K, 1998, ANESTH ANALG, V87, P1164; BAEHRENDTZ S, 1983, ACTA ANAESTH SCAND, V27, P311, DOI 10.1111/j.1399-6576.1983.tb01958.x; BAEHRENDTZ S, 1984, ANESTHESIOLOGY, V61, P511, DOI 10.1097/00000542-198411000-00006; BAEHRENDTZ S, 1984, ACTA ANAESTH SCAND, V28, P252, DOI 10.1111/j.1399-6576.1984.tb02054.x; BAEHRENDTZ S, 1983, ACTA ANAESTH SCAND, V27, P270, DOI 10.1111/j.1399-6576.1983.tb01950.x; BINDSLEV L, 1981, ACTA ANAESTH SCAND, V25, P297, DOI 10.1111/j.1399-6576.1981.tb01655.x; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bruells CS, 2011, EUR J ANAESTH, V28, P570, DOI 10.1097/EJA.0b013e32834942a3; CARLON GC, 1978, CRIT CARE MED, V6, P380, DOI 10.1097/00003246-197811000-00009; Chang H, 2002, J APPL PHYSIOL, V92, P745, DOI 10.1152/japplphysiol.00377.2001; Choi YS, 2007, J THORAC CARDIOV SUR, V134, P613, DOI 10.1016/j.jtcvs.2007.05.018; Darowski Marek, 2000, Frontiers of Medical and Biological Engineering, V10, P177, DOI 10.1163/15685570052062576; Futier E, 2014, MINERVA ANESTESIOL, V80, P726; Glapinski J, 2006, PROCEEDINGS OF THE 5TH WORLD CONGRESS OF BIOMECHANICS, P299; HEDENSTIERNA G, 1981, J APPL PHYSIOL, V50, P55, DOI 10.1152/jappl.1981.50.1.55; Hedenstierna G, 2012, MINERVA ANESTESIOL, V78, P1193; Karzai W, 2009, ANESTHESIOLOGY, V110, P1402, DOI 10.1097/ALN.0b013e31819fb15d; Lennon PF, 1996, ANESTHESIOLOGY, V84, P404, DOI 10.1097/00000542-199602000-00020; Nagendran J, 2006, CURR OPIN ANESTHESIO, V19, P34, DOI 10.1097/01.aco.0000192777.09527.9e; PICK RA, 1982, CHEST, V82, P345, DOI 10.1378/chest.82.3.345; Pilcher DV, 2007, J THORAC CARDIOV SUR, V133, P1071, DOI 10.1016/j.jtcvs.2006.10.028; Sankar A, 2014, BRIT J ANAESTH, V113, P424, DOI 10.1093/bja/aeu100; Sawulski Slawomir, 2010, Anestezjol Intens Ter, V42, P6; STRANDBERG A, 1986, ACTA ANAESTH SCAND, V30, P154, DOI 10.1111/j.1399-6576.1986.tb02387.x; Tokics L, 1996, J APPL PHYSIOL, V81, P1822, DOI 10.1152/jappl.1996.81.4.1822; TUXEN DV, 1987, AM REV RESPIR DIS, V136, P872, DOI 10.1164/ajrccm/136.4.872; WAHBA RWM, 1991, CAN J ANAESTH, V38, P384, DOI 10.1007/BF03007630; WEST JB, 1964, J APPL PHYSIOL, V19, P713, DOI 10.1152/jappl.1964.19.4.713	28	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184537	10.1371/journal.pone.0184537	http://dx.doi.org/10.1371/journal.pone.0184537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910340	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200057
J	Su, SF; Bao, H; Wang, XY; Wang, ZQ; Li, X; Zhang, MQ; Wang, JY; Jiang, H; Wang, WJ; Qu, SY; Liu, MN				Su, Shaofei; Bao, Han; Wang, Xinyu; Wang, Zhiqiang; Li, Xi; Zhang, Meiqi; Wang, Jiaying; Jiang, Hao; Wang, Wenji; Qu, Siyang; Liu, Meina			The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study	PLOS ONE			English	Article							UNIVERSAL HEALTH-INSURANCE; SOCIOECONOMIC-STATUS; CONSERVING SURGERY; CHINESE WOMEN; MASTECTOMY; RACE/ETHNICITY; PERFORMANCE; DISPARITIES; INDICATORS; THERAPY	Though evidence-based treatments have been recommended for breast cancer, underuse of the treatments was still observed. To certain extent, patients' access to care, which can be enhanced by increasing the coverage of health insurance, could account for the current underuse in recommended care. This study aimed to examine the association between different proportions of reimbursement and quality of recommended breast cancer care, as well as length of hospital stay. In this retrospective study, 3669 patients diagnosed with invasive breast cancer between 1 June, 2011 and 30 June, 2013 were recruited. Seven quality indicators from preoperative diagnosis procedures to adjuvant therapy and one composite indicator were selected as dependent variables. Logistic regression and generalized linear models were used to explore the association between quality of care and length of hospital stay with different reimbursement rates. Compared with UEBMI (urban employment basic medical insurance), which represented high level reimbursement rate, patients with lower rates of reimbursement were less likely to receive core biopsy, HER-2 (human epidermal growth factor receptor-2) testing, BCS (breast conserving surgery), SLNB (sentinel lymph nodes biopsy), adjuvant therapy and hormonal treatment. No significant difference in preoperative length of hospital stay was observed among the three insurance schemes, however URBMI (urban resident basic medical insurance) insured patients stayed longer for total length of hospital stay. Significant disparities in utilization of evidence-based breast cancer care among patients with different proportions of reimbursement were observed. Patients with lower rate of reimbursement were less likely to receive recommended care. Our findings could provide important support for further healthcare reform and quality improvement in breast cancer care.	[Su, Shaofei; Wang, Xinyu; Li, Xi; Zhang, Meiqi; Wang, Jiaying; Jiang, Hao; Wang, Wenji; Qu, Siyang; Liu, Meina] Harbin Med Univ, Dept Biostat, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China; [Bao, Han] Inner Mongolia Med Univ, Dept Biostat, Publ Hlth Coll, Hohhot, Peoples R China; [Wang, Zhiqiang] Univ Queensland, Sch Med, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	Harbin Medical University; Inner Mongolia Medical University; Royal Brisbane & Women's Hospital; University of Queensland	Liu, MN (corresponding author), Harbin Med Univ, Dept Biostat, Publ Hlth Coll, Harbin, Heilongjiang, Peoples R China.	liumeina369@163.com	Wang, Zhiqiang/A-5835-2010	Wang, Zhiqiang/0000-0002-5839-743X; Wang, Xinyu/0000-0001-5377-0816	National Natural Science Foundation of China [81273183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (grant number 81273183), http://www.nsfe.gov.cni/.; This study was funded by National Natural Science Foundation of China (grant number 81273183).	[Anonymous], 2013, NATL EC SOCIAL DEV S; Badakhshi H, 2013, CANCER MED-US, V2, P712, DOI 10.1002/cam4.114; Bao H, 2016, J CANCER RES CLIN, V142, P1079, DOI 10.1007/s00432-015-2106-z; Bao H, 2015, INT J QUAL HEALTH C, V27, P291, DOI 10.1093/intqhc/mzv042; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Coburn N, 2008, BREAST J, V14, P128, DOI 10.1111/j.1524-4741.2007.00542.x; Eberth JM, 2014, J CLIN ONCOL, V32, P2206, DOI 10.1200/JCO.2013.52.8257; Freedman RA, 2011, CANCER-AM CANCER SOC, V117, P180, DOI 10.1002/cncr.25542; Fung KW, 2001, ANZ J SURG, V71, P202, DOI 10.1046/j.1440-1622.2001.02094.x; Gomez SL, 2004, ETHNIC DIS, V14, P134; Gray JE, 2011, J ONCOL PRACT, V7, P247, DOI 10.1200/JOP.2010.000174; Halpern MT, 2007, CANCER, V110, P403, DOI 10.1002/cncr.22786; Hargraves JL, 2003, HEALTH SERV RES, V38, P809, DOI 10.1111/1475-6773.00148; Hu RW, 2014, J IMMIGR MINOR HEALT, V16, P565, DOI 10.1007/s10903-013-9966-6; Jiong TU, 2014, 18 ISA WORLD C SOC; Jubelirer S J, 2001, W V Med J, V97, P144; Kimmick GG, 2015, J ONCOL PRACT, V11, pE9, DOI 10.1200/JOP.2014.001397; Lam WW, 2005, PSYCHO-ONCOLOGY, V14, P585, DOI 10.1002/pon.877; Lee MC, 2009, BREAST J, V15, P34, DOI 10.1111/j.1524-4741.2008.00668.x; Li C, 2011, SOC SCI MED, V73, P359, DOI 10.1016/j.socscimed.2011.06.002; Malin JL, 2006, J CLIN ONCOL, V24, P626, DOI 10.1200/JCO.2005.03.3365; Malin JL, 2002, J CLIN ONCOL, V20, P4381, DOI 10.1200/JCO.2002.04.020; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Moreland Amber, 2009, Am J Surg, V198, P787, DOI 10.1016/j.amjsurg.2009.05.031; Niu XL, 2013, CANCER MED-US, V2, P403, DOI 10.1002/cam4.84; Pan Y, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0102-4; Richardson LC, 2006, AM J PUBLIC HEALTH, V96, P160, DOI 10.2105/AJPH.2004.053579; Shi RH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1228-7; Stenehjem DD, 2014, BREAST CANCER-TARGET, V6, P169, DOI 10.2147/BCTT.S69416; Temple WJ, 2006, J CLIN ONCOL, V24, P3367, DOI 10.1200/JCO.2005.02.7771; Thompson B, 2008, ANN SURG ONCOL, V15, P443, DOI 10.1245/s10434-007-9584-4; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Wu XC, 2012, J CLIN ONCOL, V30, P142, DOI 10.1200/JCO.2011.36.8399; Yu H, 2015, HEALTH POLICY, V119, P1145, DOI 10.1016/j.healthpol.2015.07.008; Zhang L, 2012, PSYCHO-ONCOLOGY, V21, P488, DOI 10.1002/pon.1922	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184866	10.1371/journal.pone.0184866	http://dx.doi.org/10.1371/journal.pone.0184866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910357	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200111
J	Arfken, A; Song, B; Bowman, JS; Piehler, M				Arfken, Ann; Song, Bongkeun; Bowman, Jeff S.; Piehler, Michael			Denitrification potential of the eastern oyster microbiome using a 16S rRNA gene based metabolic inference approach	PLOS ONE			English	Article							NITROUS-OXIDE REDUCTASE; BACTERIAL COMMUNITIES; CRASSOSTREA-GIGAS; PACIFIC OYSTER; SEDIMENT; DIVERSITY; NITRIFICATION; EMISSION; GUT; BAY	The eastern oyster (Crassostrea virginica) is a foundation species providing significant ecosystem services. However, the roles of oyster microbiomes have not been integrated into any of the services, particularly nitrogen removal through denitrification. We investigated the composition and denitrification potential of oyster microbiomes with an approach that combined 16S rRNA gene analysis, metabolic inference, qPCR of the nitrous oxide reductase gene (nosZ), and N-2 flux measurements. Microbiomes of the oyster digestive gland, the oyster shell, and sediments adjacent to the oyster reef were examined based on next generation sequencing (NGS) of 16S rRNA gene amplicons. Denitrification potentials of the microbiomes were determined by metabolic inferences using a customized denitrification gene and genome database with the paprica (PAthway PRediction by phylogenetIC plAcement) bioinformatics pipeline. Denitrification genes examined included nitrite reductase (nirS and nirK) and nitrous oxide reductase (nosZ), which was further subdivided by genotype into clade I (nosZI) or clade II (nosZII). Continuous flow through experiments measuring N-2 fluxes were conducted with the oysters, shells, and sediments to compare denitrification activities. Paprica properly classified the composition of microbiomes, showing similar classification results from Silva, Greengenes and RDP databases. Microbiomes of the oyster digestive glands and shells were quite different from each other and from the sediments. The relative abundance of denitrifying bacteria inferred by paprica was higher in oysters and shells than in sediments suggesting that oysters act as hotspots for denitrification in the marine environment. Similarly, the inferred nosZI gene abundances were also higher in the oyster and shell microbiomes than in the sediment microbiome. Gene abundances for nosZI were verified with qPCR of nosZI genes, which showed a significant positive correlation (F-1,F-7 = 14.7, p = 6.0x10(-3), R-2 = 0.68). N-2 flux rates were significantly higher in the oyster (364.4 +/- 23.5 mu mol N-N-2 m(-2) h(-1)) and oyster shell (355.3 +/- 6.4 mu mol N-N-2 m(-2) h(-1)) compared to the sediment (270.5 +/- 20.1 mu mol N-N-2 m(-2) h(-1)). Thus, bacteria carrying nosZI genes were found to be an important denitrifier, facilitating nitrogen removal in oyster reefs. In addition, this is the first study to validate the use of 16S gene based metabolic inference as a method for determining microbiome function, such as denitrification, by comparing inference results with qPCR gene quantification and rate measurements.	[Arfken, Ann; Song, Bongkeun] Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA; [Bowman, Jeff S.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, San Diego, CA 92103 USA; [Piehler, Michael] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA	William & Mary; Virginia Institute of Marine Science; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of North Carolina; University of North Carolina Chapel Hill	Arfken, A (corresponding author), Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA.	amarfken@vims.edu		Piehler, Michael/0000-0003-3881-4862; Bowman, Jeff/0000-0002-8811-6280	National Science Foundation Division of Biological Oceanography [1321373, 11696, 1233327]; National Science Foundation Division of Polar Programs [1641019]; National Science Foundation; Commonwealth of Virginia Equipment Trust Fund; Office of Naval Research	National Science Foundation Division of Biological Oceanography(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); National Science Foundation Division of Polar Programs(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Commonwealth of Virginia Equipment Trust Fund; Office of Naval Research(Office of Naval Research)	Funding was provided by the National Science Foundation Division of Biological Oceanography, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=11696, grant number 1321373 to BS; National Science Foundation Division of Biological Oceanography, https://www.nstgovifunding/pgm_summ.jsp?pims_id=11696, grant number 1233327 to MP; National Science Foundation Division of Polar Programs, https://www.nsf.gov/div/index.jsp?div=PLR, grant number 1641019 to JSB; as well as contributions from the National Science Foundation, the Commonwealth of Virginia Equipment Trust Fund and the Office of Naval Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bowman JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135868; Caffrey JM, 2016, MAR POLLUT BULL, V112, P86, DOI 10.1016/j.marpolbul.2016.08.038; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cerco CF, 2007, ESTUAR COAST, V30, P331, DOI 10.1007/BF02700175; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Cleary DFR, 2015, MICROB ECOL, V70, P889, DOI 10.1007/s00248-015-0632-5; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Depkat-Jakob PS, 2010, APPL ENVIRON MICROB, V76, P6205, DOI 10.1128/AEM.01373-10; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desnues C, 2007, WATER RES, V41, P3407, DOI 10.1016/j.watres.2007.04.018; Domeignoz-Horta LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00971; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ensign SH, 2008, BIOGEOCHEMISTRY, V91, P133, DOI 10.1007/s10533-008-9265-9; Fernandez-Piquer J, 2012, J APPL MICROBIOL, V112, P1134, DOI 10.1111/j.1365-2672.2012.05287.x; Giles H, 2006, AQUACULTURE, V261, P125, DOI 10.1016/j.aquaculture.2006.06.048; Glibert PM, 2014, ESTUAR COAST, V37, pS128, DOI 10.1007/s12237-013-9630-3; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Green TJ, 2010, J APPL MICROBIOL, V109, P613, DOI 10.1111/j.1365-2672.2010.04687.x; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Hernandez-Zarate G, 2006, J APPL MICROBIOL, V100, P664, DOI 10.1111/j.1365-2672.2005.02800.x; Hoellein TJ, 2015, BIOGEOCHEMISTRY, V122, P113, DOI 10.1007/s10533-014-0034-7; Humphries AT, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00074; JENKINS MC, 1984, LIMNOL OCEANOGR, V29, P609, DOI 10.4319/lo.1984.29.3.0609; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Kellogg ML, 2014, ESTUAR COAST SHELF S, V151, P156, DOI 10.1016/j.ecss.2014.09.025; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; King GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051475; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lokmer A, 2016, ENVIRON MICROBIOL, V18, P970, DOI 10.1111/1462-2920.13163; Lokmer A, 2015, ISME J, V9, P670, DOI 10.1038/ismej.2014.160; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mosier AC, 2010, ENV MICROBIOL REP, V2, P667, DOI 10.1111/j.1758-2229.2010.00156.x; Newell RIE, 2005, NATO SCI S SS IV EAR, V47, P93; Newell RIE, 2002, LIMNOL OCEANOGR, V47, P1367, DOI 10.4319/lo.2002.47.5.1367; Ngugi DK, 2012, ENVIRON MICROBIOL, V14, P860, DOI 10.1111/j.1462-2920.2011.02648.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orellana LH, 2014, MBIO, V5, DOI 10.1128/mBio.01193-14; Pfister CA, 2014, PEERJ, V2, DOI 10.7717/peerj.631; Piehler MF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00082.1; Polymenakou PN, 2005, MICROB ECOL, V49, P367, DOI 10.1007/s00248-004-0274-5; Rothig T, 2016, MOL ECOL, V25, P1308, DOI 10.1111/mec.13567; Romero J, 2002, MICROBIAL ECOL, V44, P365, DOI 10.1007/s00248-002-1063-7; Rubin BER, 2014, MICROBIOLOGYOPEN, V3, P910, DOI 10.1002/mbo3.216; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Smith CJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00542; Smyth AR, 2016, MAR ECOL PROG SER, V560, P173, DOI 10.3354/meps11922; Smyth AR, 2013, MAR ECOL PROG SER, V493, P23, DOI 10.3354/meps10516; Stief P, 2009, P NATL ACAD SCI USA, V106, P4296, DOI 10.1073/pnas.0808228106; Sun MY, 2013, ENVIRON MICROBIOL, V15, P2517, DOI 10.1111/1462-2920.12133; Svenningsen NB, 2012, APPL ENVIRON MICROB, V78, P4505, DOI 10.1128/AEM.00401-12; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Fernandez NT, 2014, FEMS MICROBIOL ECOL, V88, P69, DOI 10.1111/1574-6941.12270; Trabal N, 2012, MICROB ECOL, V64, P555, DOI 10.1007/s00248-012-0039-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wegner KM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-252; Wust PK, 2009, APPL ENVIRON MICROB, V75, P3430, DOI 10.1128/AEM.00304-09; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zurel D, 2011, ENVIRON MICROBIOL, V13, P1467, DOI 10.1111/j.1462-2920.2011.02448.x	66	48	49	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185071	10.1371/journal.pone.0185071	http://dx.doi.org/10.1371/journal.pone.0185071			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934286	Green Published, gold			2022-12-27	WOS:000411339900083
J	Cabanas, M; Bassil, F; Mons, N; Garret, M; Cho, YH				Cabanas, Magali; Bassil, Fares; Mons, Nicole; Garret, Maurice; Cho, Yoon H.			Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; IMMEDIATE-EARLY GENES; TRANSGENIC MICE; SYNAPTIC PLASTICITY; PROJECTION NEURONS; INDIRECT PATHWAYS; PREFERENTIAL LOSS; SPINY NEURONS; ABNORMALITIES; ACTIVATION	Hereditary Huntington's disease (HD) is associated with progressive motor, cognitive and psychiatric symptoms. A primary consequence of the HD mutation is the preferential loss of medium spiny projection cells with relative sparing of local interneurons in the striatum. In addition, among GABAergic striatal projection cells, indirect pathway cells expressing D2 dopamine receptors are lost earlier than direct pathway cells expressing D1 receptors. To test in vivo the functional integrity of direct and indirect pathways as well as interneurons in the striatum of male R6/1 transgenic mice, we assessed their c-Fos expression levels induced by a striatal-dependent cognitive task and compared them with age-matched wildtype littermates. We found a significant increase of c-Fos+ nuclei in the dorsomedial striatum, and this only at 2 months, when our HD mouse model is still pre-motor symptomatic, the increase disappearing with symptom manifestation. Contrary to our expectation, the indirect pathway projection neurons did not undergo any severer changes of c-Fos expression regardless of age in R6/1 mice. We also found a decreased activation of interneurons that express parvalbumin in the dorsomedial striatum at both presymptomatic and symptomatic ages. Finally, analysis of c-Fos expression in extended brain regions involved in the cognitive learning used in our study, demonstrates, throughout ages studied, changes in the functional connectivity between regions in the transgenic mice. Further analysis of the cellular and molecular changes underlying the transient striatal hyperactivity in the HD mice may help to understand the mechanisms involved in the disease onset.	[Cabanas, Magali; Bassil, Fares; Mons, Nicole; Garret, Maurice; Cho, Yoon H.] CNRS, UMR 5287, Inst Neurosci Cognit & Integrat Aquitaine, Pessac, France; [Cabanas, Magali; Bassil, Fares; Mons, Nicole; Garret, Maurice; Cho, Yoon H.] Univ Bordeaux, Bordeaux, France; [Bassil, Fares] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Pennsylvania; Pennsylvania Medicine	Garret, M; Cho, YH (corresponding author), CNRS, UMR 5287, Inst Neurosci Cognit & Integrat Aquitaine, Pessac, France.; Garret, M; Cho, YH (corresponding author), Univ Bordeaux, Bordeaux, France.	maurice.garret@u-bordeaux.fr; yoon.cho@u-bordeaux.fr	Bassil, Fares/H-7073-2018; Mons, Nicole/AAD-5541-2019; Bassil, Fares/F-4227-2018		University of Bordeaux, France; Hereditary Disease Foundation, USA	University of Bordeaux, France; Hereditary Disease Foundation, USA	Our work was funded by the University of Bordeaux, France (to MC) and the Hereditary Disease Foundation, USA (to YHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1992, ANN NEUROL, V31, P425, DOI 10.1002/ana.410310412; Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Cayzac S, 2011, P NATL ACAD SCI USA, V108, P9280, DOI 10.1073/pnas.1016190108; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Cepeda C, 2013, J NEUROSCI, V33, P7393, DOI 10.1523/JNEUROSCI.2137-12.2013; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; Cicchetti F, 1996, MOVEMENT DISORD, V11, P619, DOI 10.1002/mds.870110605; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Cummings DM, 2007, BRAIN RES BULL, V72, P103, DOI 10.1016/j.brainresbull.2006.10.016; Deng YP, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00198; Du ZW, 2016, NEUROSCIENCE, V329, P363, DOI 10.1016/j.neuroscience.2016.05.027; FERRANTE RJ, 1987, BRAIN RES, V411, P162, DOI 10.1016/0006-8993(87)90694-9; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00124; Giampa C, 2009, EUR J NEUROSCI, V29, P902, DOI 10.1111/j.1460-9568.2009.06649.x; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Harrington DL, 2015, BRAIN, V138, P2332, DOI 10.1093/brain/awv145; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hohn S, 2011, J NEUROSCI, V31, P8986, DOI 10.1523/JNEUROSCI.1238-11.2011; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Kloppel S, 2015, EBIOMEDICINE, V2, P1420, DOI 10.1016/j.ebiom.2015.08.002; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; Lebreton F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126972; Li JY, 2003, TRENDS MOL MED, V9, P414, DOI 10.1016/j.molmed.2003.08.006; Lobo MK, 2013, J NEUROSCI, V33, P18381, DOI 10.1523/JNEUROSCI.1875-13.2013; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Moratalla R, 1996, NEUROREPORT, V8, P1, DOI 10.1097/00001756-199612200-00001; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Murphy KP, 2000, J NEUROSCIENCE OFFIC, P20; Naver B, 2003, NEUROSCIENCE, V122, P1049, DOI 10.1016/j.neuroscience.2003.08.053; Nithianantharajah J, 2013, NEUROSCIENCE, V251, P66, DOI 10.1016/j.neuroscience.2012.05.043; Petersen A, 2002, NEUROBIOL DIS, V11, P134, DOI 10.1006/nbdi.2002.0534; Picconi B, 2006, NEUROBIOL DIS, V22, P143, DOI 10.1016/j.nbd.2005.10.009; Pietropaolo S, 2015, NEUROPHARMACOLOGY, V89, P368, DOI 10.1016/j.neuropharm.2014.07.021; Pignatelli M, 2012, NEUROBIOL DIS, V48, P409, DOI 10.1016/j.nbd.2012.07.015; Poudel GR, 2015, BRAIN STRUCT FUNCT, V220, P501, DOI 10.1007/s00429-013-0670-z; Quarantelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072159; Rebec GV, 2006, NEUROSCIENCE, V137, P327, DOI 10.1016/j.neuroscience.2005.08.062; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Reiner A, 2013, MOVEMENT DISORD, V28, P1691, DOI 10.1002/mds.25624; Richfield EK, 1995, ANN NEUROL, V38, P852, DOI 10.1002/ana.410380605; Spektor BS, 2002, MOL BRAIN RES, V102, P118, DOI 10.1016/S0169-328X(02)00216-4; Stalnaker TA, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00012; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Werme M, 2002, J NEUROSCI, V22, P8133; Werner CJ, 2014, HUM BRAIN MAPP, V35, P2582, DOI 10.1002/hbm.22351; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184580	10.1371/journal.pone.0184580	http://dx.doi.org/10.1371/journal.pone.0184580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934250	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900032
J	Simic, M; Stephansson, O; Petersson, G; Cnattingius, S; Wikstrom, AK				Simic, Marija; Stephansson, Olof; Petersson, Gunnar; Cnattingius, Sven; Wikstrom, Anna-Karin			Slow fetal growth between first and early second trimester ultrasound scans and risk of small for gestational age (SGA) birth	PLOS ONE			English	Article							LAST MENSTRUAL PERIOD; BIPARIETAL DIAMETER; PREDICTION; RESTRICTION; 1ST-TRIMESTER; PREGNANCY; PREECLAMPSIA; DELIVERY; DOPPLER; INSULIN	Objectives To investigate the association between fetal growth between first and early second trimester ultrasound scan and the risk of severe small for gestational age (SGA) birth. Methods This cohort study included 69 550 singleton pregnancies with first trimester dating and an early second trimester growth scan in Stockholm and Gotland Counties, Sweden between 2008 and 2014. Exposure was difference in biparietal diameter growth between observed and expected at the second trimester scan, calculated by z-scores. Risk of birth of a severe SGA infant (birth weight for gestational age by fetal sex less than the 3 rd centile) was calculated using multivariable logistic regression analysis and presented as adjusted odds ratio (aOR). Results Parietal growth less than 2.5 percentile between first and second trimester ultrasound examination was associated with elevated risk of being born severe SGA. (aOR 1.67; 95% Confidence Interval 1.28-2.18). The risks of preterm severe SGA (birth before 37 weeks) and term severe SGA (birth 37 weeks or later) were at similar levels, and risk of severe SGA were also elevated in the absence of preeclampsia, hypertensive diseases or gestational diabetes. Conclusions Fetuses with slow growth of biparietal diameter at ultrasound examination in early second trimester exhibit increased risk of being born SGA independent of gestational age at birth and presence of maternal hypertensive diseases or diabetes mellitus.	[Simic, Marija; Stephansson, Olof; Petersson, Gunnar; Cnattingius, Sven; Wikstrom, Anna-Karin] Karolinska Univ Hosp & Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Stephansson, Olof] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Simic, Marija] Karolinska Univ Hosp Solna, Clin Epidemiol Unit, T2, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; University of California System; University of California Berkeley; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Simic, M (corresponding author), Karolinska Univ Hosp & Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden.; Simic, M (corresponding author), Karolinska Univ Hosp Solna, Clin Epidemiol Unit, T2, Stockholm, Sweden.	marija.simic@ki.se		Simic, Marija/0000-0002-1804-4015; Stephansson, Olof/0000-0003-1528-4563	Swedish research council [2013-2429, 2014-3561]	Swedish research council(Swedish Research CouncilEuropean Commission)	This study was supported by grant from the Swedish research council, project No. 2013-2429 (OS) and 2014-3561(to AKW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2008, ULTRASOUND OBST GYN, V32, P732, DOI 10.1002/uog.6244; ALFIREVIC Z, 1995, AM J OBSTET GYNECOL, V172, P1379, DOI 10.1016/0002-9378(95)90466-2; Baschat AA, 2010, J PERINAT MED, V38, P239, DOI [10.1515/JPM.2010.041, 10.1515/jpm.2010.041]; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Brodsky Dara, 2004, J Intensive Care Med, V19, P307, DOI 10.1177/0885066604269663; Bukowski R, 2007, BMJ-BRIT MED J, V334, P836, DOI 10.1136/bmj.39129.637917.AE; Hiden U, 2012, J CLIN ENDOCR METAB, V97, P3613, DOI 10.1210/jc.2012-1212; Hiden U, 2009, CURR VASC PHARMACOL, V7, P460, DOI 10.2174/157016109789043973; Kady SM, 2004, BEST PRACT RES CL OB, V18, P397, DOI 10.1016/j.bpobgyn.2004.02.009; Kallen K, 2004, ULTRASOUND OBST GYN, V24, P30, DOI 10.1002/uog.1085; Kovo M, 2015, REPROD SCI, V22, P316, DOI 10.1177/1933719114542024; Larsen T, 2000, BRIT J OBSTET GYNAEC, V107, P238, DOI 10.1111/j.1471-0528.2000.tb11695.x; Lesmes C, 2015, ULTRASOUND OBST GYN, V46, P341, DOI 10.1002/uog.14899; Lesmes C, 2015, ULTRASOUND OBST GYN, V46, P198, DOI 10.1002/uog.14826; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Nakling J, 2002, ACTA OBSTET GYN SCAN, V81, P846, DOI 10.1034/j.1600-0412.2002.810908.x; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Papageorghiou AT, 2001, ULTRASOUND OBST GYN, V18, P441, DOI 10.1046/j.0960-7692.2001.00572.x; Pedersen NG, 2008, ULTRASOUND OBST GYN, V32, P147, DOI 10.1002/uog.6109; Pedersen NG, 2013, EUR J OBSTET GYN R B, V168, P20, DOI 10.1016/j.ejogrb.2012.12.006; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Schwartz N, 2011, J ULTRAS MED, V30, P55, DOI 10.7863/jum.2011.30.1.55; SELBING A, 1985, ACTA OBSTET GYN SCAN, V64, P593, DOI 10.3109/00016348509156368; Simic M, 2014, J PERINAT MED, V42, P247, DOI 10.1515/jpm-2013-0061; Smith GCS, 2004, JAMA-J AM MED ASSOC, V292, P2249, DOI 10.1001/jama.292.18.2249; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Smith-Bindman R, 2002, RADIOLOGY, V223, P153, DOI 10.1148/radiol.2231010876; Thorsell M, 2008, BJOG-INT J OBSTET GY, V115, P585, DOI 10.1111/j.1471-0528.2008.01678.x; Tunon K, 1999, ULTRASOUND OBST GYN, V14, P17, DOI 10.1046/j.1469-0705.1999.14010017.x; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Vintzileos AM, 2014, SEMIN PERINATOL, V38, P159, DOI 10.1053/j.semperi.2014.03.006; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]	35	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184853	10.1371/journal.pone.0184853	http://dx.doi.org/10.1371/journal.pone.0184853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934257	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900051
J	Wang, JZ; Tiyip, T; Ding, JL; Zhang, D; Liu, W; Wang, F; Tashpolat, N				Wang, Jingzhe; Tiyip, Tashpolat; Ding, Jianli; Zhang, Dong; Liu, Wei; Wang, Fei; Tashpolat, Nigara			Desert soil clay content estimation using reflectance spectroscopy preprocessed by fractional derivative	PLOS ONE			English	Article							ORGANIC-MATTER; SALT CRUST; CALIBRATION; CARBON; PREDICTION; MOISTURE; LIBRARY; PLAYA; BASIN; DUST	Effective pretreatment of spectral reflectance is vital to model accuracy in soil parameter estimation. However, the classic integer derivative has some disadvantages, including spectral information loss and the introduction of high-frequency noise. In this paper, the fractional order derivative algorithm was applied to the pretreatment and partial least squares regression (PLSR) was used to assess the clay content of desert soils. Overall, 103 soil samples were collected from the Ebinur Lake basin in the Xinjiang Uighur Autonomous Region of China, and used as data sets for calibration and validation. Following laboratory measurements of spectral reflectance and clay content, the raw spectral reflectance and absorbance data were treated using the fractional derivative order from the 0.0 to the 2.0 order (order interval: 0.2). The ratio of performance to deviation (RPD), determinant coefficients of calibration (R-c(2)), root mean square errors of calibration (RMSEC), determinant coefficients of prediction (R-p(2)), and root mean square errors of prediction (RMSEP) were applied to assess the performance of predicting models. The results showed that models built on the fractional derivative order performed better than when using the classic integer derivative. Comparison of the predictive effects of 22 models for estimating clay content, calibrated by PLSR, showed that those models based on the fractional derivative 1.8 order of spectral reflectance (R-c(2) = 0.907, RMSEC = 0.425%, Rp(2) = 0.916, RMSEP = 0.364%, and RPD = 2.484 >= 2.000) and absorbance (R-c(2) = 0.888, RMSEC = 0.446%, R-p(2)= 0.918, RMSEP = 0.383% and RPD = 2.511 >= 2.000) were most effective. Furthermore, they performed well in quantitative estimations of the clay content of soils in the study area.	[Wang, Jingzhe; Tiyip, Tashpolat; Ding, Jianli; Zhang, Dong; Liu, Wei; Wang, Fei; Tashpolat, Nigara] Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Xinjiang, Peoples R China; [Wang, Jingzhe; Tiyip, Tashpolat; Ding, Jianli; Zhang, Dong; Liu, Wei; Wang, Fei; Tashpolat, Nigara] Xinjiang Univ, Key Lab Oasis Ecol, Urumqi, Xinjiang, Peoples R China	Xinjiang University; Xinjiang University	Tiyip, T (corresponding author), Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Xinjiang, Peoples R China.; Tiyip, T (corresponding author), Xinjiang Univ, Key Lab Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	tash_xju@163.com	Wang, Jingzhe/Q-4555-2019	Wang, Jingzhe/0000-0001-8332-7997	National Natural Science Foundation of China [41130531, 41661046]; National Plan on Key Technology Research and Development Program of China [2014BAC151301]; China Postdoctoral Science Foundation [2016M602909]; Scientific Research Foundation for Doctors of Xinjiang University [BS150246]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Plan on Key Technology Research and Development Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific Research Foundation for Doctors of Xinjiang University	This study was supported by the National Natural Science Foundation of China (41130531 and 41661046), National Plan on Key Technology Research and Development Program of China (2014BAC151301), China Postdoctoral Science Foundation (2016M602909) and Scientific Research Foundation for Doctors of Xinjiang University (BS150246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (41130531 and 41661046), National Plan on Key Technology Research and Development Program of China (2014BAC15B01), China Postdoctoral Science Foundation (2016M602909) and Scientific Research Foundation for Doctors of Xinjiang University (BS150246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are especially grateful to the reviewers and editors for appraising our manuscript and for offering instructive suggestions. Finally, Jingzhe Wang wants to thank, in particular, the ongoing and unwavering support received from MSc Yao Mu over years. Will you spend the rest of your life with me?	Abuduwailil J, 2015, ENVIRON SCI POLLUT R, V22, P14018, DOI 10.1007/s11356-015-4625-1; Ackerson JP, 2015, GEODERMA, V259, P196, DOI 10.1016/j.geoderma.2015.06.002; Adeline KRM, 2017, GEODERMA, V288, P143, DOI 10.1016/j.geoderma.2016.11.010; Arikoglu A, 2014, RHEOL ACTA, V53, P219, DOI 10.1007/s00397-014-0758-2; Baldock JA, 2013, SOIL RES, V51, P577, DOI 10.1071/SR13077; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; BENDOR E, 1995, SOIL SCI SOC AM J, V59, P364, DOI 10.2136/sssaj1995.03615995005900020014x; Bilgili AV, 2010, J ARID ENVIRON, V74, P229, DOI 10.1016/j.jaridenv.2009.08.011; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Dixon J. B., 1991, Applied Clay Science, V5, P489, DOI 10.1016/0169-1317(91)90019-6; Fujimaki H, 2006, VADOSE ZONE J, V5, P1246, DOI 10.2136/vzj2005.0144; Galvao RKH, 2005, TALANTA, V67, P736, DOI 10.1016/j.talanta.2005.03.025; Garg V, 2012, INT J ADV COMPUT SC, V3, P130; Ge YX, 2016, ATMOS RES, V178, P196, DOI 10.1016/j.atmosres.2016.04.002; Gomez C, 2015, REMOTE SENS ENVIRON, V156, P58, DOI 10.1016/j.rse.2014.09.032; Han WX, 2014, EARTH SURF PROC LAND, V39, P779, DOI 10.1002/esp.3483; He XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137827; Heymans N, 2006, RHEOL ACTA, V45, P765, DOI 10.1007/s00397-005-0043-5; Hilfer R, 2000, J PHYS CHEM B, V104, P3914, DOI 10.1021/jp9936289; Insausti M, 2013, MICROCHEM J, V108, P32, DOI 10.1016/j.microc.2012.12.007; Islam K, 2003, AUST J SOIL RES, V41, P1101, DOI 10.1071/SR02137; Jackson M.L, 1973, SOIL CHEM ANAL; Ji WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105708; Jin XL, 2016, AGR FOREST METEOROL, V218, P250, DOI 10.1016/j.agrformet.2015.12.062; Kuldeep B, 2015, ISA T, V54, P101, DOI 10.1016/j.isatra.2014.06.005; LI B, 2015, COMPUT ELECTR ENG, V45, P324, DOI DOI 10.1016/J.C0MPELECENG.2015.02.013; Liu DW, 2011, WATER AIR SOIL POLL, V218, P175, DOI 10.1007/s11270-010-0633-4; Liu HJ, 2009, PEDOSPHERE, V19, P532, DOI 10.1016/S1002-0160(09)60146-6; Liu WD, 2002, REMOTE SENS ENVIRON, V81, P238, DOI 10.1016/S0034-4257(01)00347-9; Machado JT, 2011, COMMUN NONLINEAR SCI, V16, P1140, DOI 10.1016/j.cnsns.2010.05.027; Nawar S, 2016, SOIL TILL RES, V155, P510, DOI 10.1016/j.still.2015.07.021; Peng XT, 2014, REMOTE SENS-BASEL, V6, P2699, DOI 10.3390/rs6042699; Peng Y, 2014, SOIL SCI, V179, P325, DOI 10.1097/SS.0000000000000074; Ramasamy V, 2008, SPECTROCHIM ACTA A, V70, P25, DOI 10.1016/j.saa.2007.07.008; Rinnan A, 2009, TRAC-TREND ANAL CHEM, V28, P1201, DOI 10.1016/j.trac.2009.07.007; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Saadatmandi A, 2010, COMPUT MATH APPL, V59, P1326, DOI 10.1016/j.camwa.2009.07.006; Sankey JB, 2008, GEODERMA, V148, P149, DOI 10.1016/j.geoderma.2008.09.019; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schjonning P, 2017, GEODERMA, V286, P83, DOI 10.1016/j.geoderma.2016.10.020; Schmitt JM, 1998, APPL SPECTROSC, V52, P840, DOI 10.1366/0003702981944580; Shen ZQ, 2013, PEDOSPHERE, V23, P305, DOI 10.1016/S1002-0160(13)60020-X; Shi TZ, 2014, J HAZARD MATER, V265, P166, DOI 10.1016/j.jhazmat.2013.11.059; Shi Z, 2014, SCI CHINA EARTH SCI, V57, P1671, DOI 10.1007/s11430-013-4808-x; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Tan C, 2008, ANAL BIOANAL CHEM, V392, P515, DOI 10.1007/s00216-008-2280-9; Tseng CC, 2012, SIGNAL PROCESS, V92, P1317, DOI 10.1016/j.sigpro.2011.11.030; Waiser TH, 2007, SOIL SCI SOC AM J, V71, P389, DOI 10.2136/sssaj2006.0211; Wang JZ, 2017, J SPECTROSC, V2017, DOI 10.1155/2017/1375158; Wetterlind J, 2008, PLANT SOIL, V302, P317, DOI 10.1007/s11104-007-9489-9; Yao JQ, 2015, J MT SCI-ENGL, V12, P358, DOI 10.1007/s11629-014-3087-0; Zhang D, 2016, J SPECTROSC, V2016, DOI 10.1155/2016/1081674; Zhang JP, 2015, J COMPUT PHYS, V293, P442, DOI 10.1016/j.jcp.2015.02.021	54	15	20	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184836	10.1371/journal.pone.0184836	http://dx.doi.org/10.1371/journal.pone.0184836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934274	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900049
J	Boissiere, L; Perotin-Collard, JM; Bertin, E; Gaubil, I; Cives, AD; Barbe, C; Dury, S; Nardi, J; Lebargy, F; Deslee, G; Launois, C				Boissiere, Louis; Perotin-Collard, Jeanne-Marie; Bertin, Eric; Gaubil, Isabelle; Cives, Ana Diaz; Barbe, Coralie; Dury, Sandra; Nardi, Julie; Lebargy, Francois; Deslee, Gaetan; Launois, Claire			Improvement of dyspnea after bariatric surgery is associated with increased Expiratory Reserve Volume: A prospective follow-up study of 45 patients	PLOS ONE			English	Article							SWEDISH OBESE SUBJECTS; INDUCED WEIGHT-LOSS; PULMONARY-FUNCTION; RESPIRATORY-FUNCTION; MORBID-OBESITY; GASTRIC BYPASS; LUNG-VOLUMES; GAS-EXCHANGE; STANDARDIZATION; INTERVENTION	Objectives To assess the effects of bariatric surgery in patients with obesity on dyspnea and to analyze the relationships between improvement of dyspnea after bariatric surgery and changes in pulmonary function, especially Expiratory Reserve Volume (ERV) which is the lung volume abnormality most frequently associated with obesity. Methods Forty-five patients (5 males/40 females, mean Body Mass Index = 46.2 +/- 6.8 kg/m(2)) were evaluated before and 6 to 12 months after bariatric surgery. Dyspnea was assessed by the modified Medical Research Council (mMRC) scale. Pulmonary function tests, arterial blood gases and six-minute walk test were performed. Laboratory parameters including C-Reactive Protein (CRP) were analyzed. Results Ninety percent of patients were dyspneic before surgery (mMRC scale-1) versus 59% after surgery (p< 0.001). Mean mMRC score improved after bariatric surgery (1.5 +/- 0.9 vs 0.7 +/- 0.7, p< 0.0001). Among patients with dyspnea before surgery (n = 38), a more marked increase in ERV after surgery was observed in patients with improvement of dyspnea compared to patients with no improvement of dyspnea (+ 0.17 +/- 0.32 L vs + 0.49 +/- 0.35 L, p = 0.01). Multivariate analysis including age, variation of BMI, variation of CRP, variation of Total Lung Capacity and variation of ERV demonstraded that ERV was the only variable associated with improvement of the mMRc score after bariatric surgery (p = 0.04). Conclusion Weight loss associated with bariatric surgery improves dyspnea in daily living. This improvement could be partly related to increased ERV.	[Boissiere, Louis; Perotin-Collard, Jeanne-Marie; Dury, Sandra; Nardi, Julie; Lebargy, Francois; Deslee, Gaetan; Launois, Claire] Reims Univ Hosp, Dept Resp Dis, Reims, France; [Perotin-Collard, Jeanne-Marie; Deslee, Gaetan] Reims Univ Hosp, INSERM, UMRS 903, Reims, France; [Bertin, Eric; Gaubil, Isabelle] Reims Univ Hosp, Dept Nutr, Reims, France; [Cives, Ana Diaz] Reims Univ Hosp, Dept Gastroenterol Surg, Reims, France; [Barbe, Coralie] Reims Univ Hosp, Clin Res Unit, Reims, France; [Dury, Sandra] Univ Reims, EA 4683, Reims, France	CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; CHU de Reims; CHU de Reims; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Launois, C (corresponding author), Reims Univ Hosp, Dept Resp Dis, Reims, France.	claunois@chu-reims.fr	DESLEE, Gaetan/G-2625-2013	DESLEE, Gaetan/0000-0002-4919-5916				Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Albanopoulos K, 2016, SURG ENDOSC, V30, P699, DOI 10.1007/s00464-015-4262-2; Babb TG, 2008, AM J RESP CRIT CARE, V178, P116, DOI 10.1164/rccm.200706-875OC; Biring MS, 1999, AM J MED SCI, V318, P293, DOI 10.1097/00000441-199911000-00002; Brazzale DJ, 2015, RESPIROLOGY, V20, P715, DOI 10.1111/resp.12563; Collet F, 2007, INT J OBESITY, V31, P700, DOI 10.1038/sj.ijo.0803460; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; De Lorenzo A, 1999, RESPIRATION, V66, P407, DOI 10.1159/000029423; DeLorey DS, 2005, INT J OBESITY, V29, P1039, DOI 10.1038/sj.ijo.0803003; El-Gamal H, 2005, CHEST, V128, P3870, DOI 10.1378/chest.128.6.3870; de Souza SAF, 2009, SURG OBES RELAT DIS, V5, P540, DOI 10.1016/j.soard.2009.05.003; Gabrielsen AM, 2013, CLIN OBES, V3, P117, DOI 10.1111/cob.12024; Gerlach Y, 2013, INT J OBESITY, V37, P341, DOI 10.1038/ijo.2012.49; HAKALA K, 1995, INT J OBESITY, V19, P343; Hayen A, 2013, MATURITAS, V76, P45, DOI 10.1016/j.maturitas.2013.06.005; HOLLEY HS, 1967, J CLIN INVEST, V46, P475, DOI 10.1172/JCI105549; Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827; Karason K, 2000, ARCH INTERN MED, V160, P1797, DOI 10.1001/archinte.160.12.1797; Launois C, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-61; Littleton SW, 2012, RESPIROLOGY, V17, P43, DOI 10.1111/j.1440-1843.2011.02096.x; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; REFSUM HE, 1990, INT J OBESITY, V14, P175; Saydain G, 2004, CHEST, V125, P446, DOI 10.1378/chest.125.2.446; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Solway S, 2001, CHEST, V119, P256, DOI 10.1378/chest.119.1.256; Sutherland TJT, 2008, EUR RESP J; THOMAS PS, 1989, THORAX, V44, P382, DOI 10.1136/thx.44.5.382; Vargas CB, 2013, OBES SURG, V23, P1590, DOI 10.1007/s11695-013-0924-0; WADSTROM C, 1991, ACTA CHIR-EUR J SURG, V157, P341; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wei YF, 2011, SURG OBES RELAT DIS, V7, P599, DOI 10.1016/j.soard.2011.04.221; Zavorsky GS, 2007, CHEST, V131, P362, DOI 10.1378/chest.06-1513	34	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185058	10.1371/journal.pone.0185058	http://dx.doi.org/10.1371/journal.pone.0185058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931052	Green Published, Green Submitted, gold			2022-12-27	WOS:000411314700065
J	Christopher, PP; Appelbaum, PS; Truong, D; Albert, K; Maranda, L; Lidz, C				Christopher, Paul P.; Appelbaum, Paul S.; Truong, Debbie; Albert, Karen; Maranda, Louise; Lidz, Charles			Reducing therapeutic misconception: A randomized intervention trial in hypothetical clinical trials	PLOS ONE			English	Article							INFORMED-CONSENT	Background Participants in clinical trials frequently fail to appreciate key differences between research and clinical care. This phenomenon, known as therapeutic misconception, undermines informed consent to clinical research, but to date there have been no effective interventions to reduce it and concerns have been expressed that to do so might impede recruitment. We determined whether a scientific reframing intervention reduces therapeutic misconception without significantly reducing willingness to participate in hypothetical clinical trials. Methods This prospective randomized trial was conducted from 2015 to 2016 to test the efficacy of an informed consent intervention based on scientific reframing compared to a traditional informed consent procedure (control) in reducing therapeutic misconception among patients considering enrollment in hypothetical clinical trials modeled on real-world studies for one of five disease categories. Patients with diabetes mellitus, hypertension, coronary artery disease, head/neck cancer, breast cancer, and major depression were recruited from medical clinics and a clinical research volunteer database. The primary outcomes were therapeutic misconception, as measured by a validated, ten-item Therapeutic Misconception Scale (range = 10-50), and willingness to participate in the clinical trial. Results 154 participants completed the study (age range, 23-87 years; 92.3% white, 56.5% female); 74 (48.1%) had been randomized to receive the experimental intervention. Therapeutic misconception was significantly lower (p = 0.004) in the scientific reframing group (26.4, 95% CI [23.7 to 29.1] compared to the control group (30.9, 95% CI [28.4 to 33.5], and remained so after controlling for education (p = 0.017). Willingness to participate in the hypothetical trial was not significantly different (p = 0.603) between intervention (52.1%, 95% CI [40.2% to 62.4%]) and control (56.3%, 95% CI [45.3% to 66.6%] groups. Conclusions An enhanced educational intervention augmenting traditional informed consent led to a meaningful reduction in therapeutic misconception without a statistically significant change in willingness to enroll in hypothetical clinical trials. Additional study of this intervention is required in real-world clinical trials.	[Christopher, Paul P.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [Appelbaum, Paul S.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, Div Law Eth & Psychiat, New York, NY USA; [Truong, Debbie; Albert, Karen; Lidz, Charles] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA	Brown University; Columbia University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Christopher, PP (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA.	paul_christopher@brown.edu	Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; Christopher, Paul/0000-0001-5055-5379	National Institute for Complementary and Integrative Health, U.S. National Institutes of Health [R21AT008648]; National Center for Complementary & Integrative Health [R21AT008648] Funding Source: NIH RePORTER	National Institute for Complementary and Integrative Health, U.S. National Institutes of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institute for Complementary and Integrative Health, part of the U.S. National Institutes of Health (R21AT008648). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht TL, 1999, J CLIN ONCOL, V17, P3324, DOI 10.1200/JCO.1999.17.10.3324; Appelbaum PS, 2006, KENNEDY INST ETHIC J, V16, P367, DOI 10.1353/ken.2006.0021; Appelbaum Paul S, 2004, IRB, V26, P1, DOI 10.2307/3564231; Appelbaum PS, 2012, CLIN TRIALS, V9, P748, DOI 10.1177/1740774512456455; Appelbaum PS, 2008, OXFORD TXB CLIN RES; Brown RF, 2004, SOC SCI MED, V58, P379, DOI 10.1016/S0277-9536(03)00204-1; Brown RF, 2011, HEALTH EXPECT, V14, P29, DOI 10.1111/j.1369-7625.2010.00613.x; Dunn LB, 2006, AM J PSYCHIAT, V163, P500, DOI 10.1176/appi.ajp.163.3.500; Henderson GE, 2006, SOC SCI MED, V62, P239, DOI 10.1016/j.socscimed.2005.05.022; Henderson GE, 2007, PLOS MED, V3, P14; Lidz CW, 2015, CAMB Q HEALTHC ETHIC, V24, P231, DOI 10.1017/S096318011400053X; Lidz CW, 2004, SOC SCI MED, V58, P1689, DOI 10.1016/S0277-9536(03)00338-1; Miller FG, 2003, HASTINGS CENT REP, V33, P19, DOI 10.2307/3528434; Miller FG, 2006, KENNEDY INST ETHIC J, V16, P353, DOI 10.1353/ken.2006.0025; Sreenivasan G, 2003, LANCET, V362, P2016, DOI 10.1016/S0140-6736(03)15025-8; Synnot A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003717.pub3; Treweek S, 2010, COCHRANE DATABASE SY	17	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184224	10.1371/journal.pone.0184224	http://dx.doi.org/10.1371/journal.pone.0184224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931031	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700016
J	Smith, JA; Bar-Peled, M				Smith, James Amor; Bar-Peled, Maor			Synthesis of UDP-apiose in Bacteria: The marine phototroph Geminicoccus roseus and the plant pathogen Xanthomonas pisi	PLOS ONE			English	Article							D-XYLOSE SYNTHASE; BETA-D-XYLOSYLTRANSFERASE; ESCHERICHIA-COLI; GLUCURONIC ACID; PSEUDOMONAS-AERUGINOSA; RHAMNOSE BIOSYNTHESIS; EMBL-EBI; IDENTIFICATION; CLONING; POLYSACCHARIDE	The branched-chain sugar apiose was widely assumed to be synthesized only by plant species. In plants, apiose-containing polysaccharides are found in vascularized plant cell walls as the pectic polymers rhamnogalacturonan II and apiogalacturonan. Apiosylated secondary metabolites are also common in many plant species including ancestral avascular bryophytes and green algae. Apiosyl-residues have not been documented in bacteria. In a screen for new bacterial glycan structures, we detected small amounts of apiose in methanolic extracts of the aerobic phototroph Geminicoccus roseus and the pathogenic soil-dwelling bacteria Xanthomonas pisi. Apiose was also present in the cell pellet of X. pisi. Examination of these bacterial genomes uncovered genes with relatively low protein homology to plant UDP-apiose/UDP-xylose synthase (UAS). Phylogenetic analysis revealed that these bacterial UAS-like homologs belong in a clade distinct to UAS and separated from other nucleotide sugar biosynthetic enzymes. Recombinant expression of three bacterial UAS-like proteins demonstrates that they actively convert UDP-glucuronic acid to UDP-apiose and UDP-xylose. Both UDP-apiose and UDP-xylose were detectable in cell cultures of G. roseus and X. pisi. We could not, however, definitively identify the apiosides made by these bacteria, but the detection of apiosides coupled with the in vivo transcription of bUAS and production of UDP-apiose clearly demonstrate that these microbes have evolved the ability to incorporate apiose into glycans during their life-cycles. While this is the first report to describe enzymes for the formation of activated apiose in bacteria, the advantage of synthesizing apiose-containing glycans in bacteria remains unknown. The characteristics of bUAS and its products are discussed.	[Smith, James Amor; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Smith, James Amor; Bar-Peled, Maor] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.; Bar-Peled, M (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Bar-Peled, M (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	peled@ccrc.uga.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-12ER16324]; U.S. Department of Energy [DE-FG02-93ER20097]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	The authors acknowledge the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through Grant DE-FG02-12ER16324 (M.A.O and M.B-P.) for funding studies of Apiose synthesis. We also acknowledge the U.S. Department of Energy-funded Center for Plant and Microbial Complex Carbohydrates (Grant DE-FG02-93ER20097) for equipment support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beck E., 1990, Methods in Plant Biochemistry, Vol. 2: Carbohydrates., P235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Broach B, 2012, FEBS J, V279, P100, DOI 10.1111/j.1742-4658.2011.08402.x; Bystrova OV, 2006, FEMS IMMUNOL MED MIC, V46, P85, DOI 10.1111/j.1574-695X.2005.00004.x; Choi SH, 2012, J AM CHEM SOC, V134, P13946, DOI 10.1021/ja305322x; Coyne MJ, 2011, J BACTERIOL, V193, P5252, DOI 10.1128/JB.05337-11; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; Fletcher CM, 2007, P NATL ACAD SCI USA, V104, P2413, DOI 10.1073/pnas.0608797104; Foesel BU, 2007, SYST APPL MICROBIOL, V30, P581, DOI 10.1016/j.syapm.2007.05.005; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; GRISEBACH H, 1964, BIOCHEM BIOPH RES CO, V17, P737, DOI 10.1016/0006-291X(64)90423-1; Gu XG, 2011, MICROBIOL-SGM, V157, P260, DOI 10.1099/mic.0.040758-0; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; ISOGAI E, 1986, ZBL BAKT-INT J MED M, V261, P53, DOI 10.1016/S0176-6724(86)80062-1; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KNIREL YA, 1990, CRIT REV MICROBIOL, V17, P273, DOI 10.3109/10408419009105729; Kobayashi M, 2002, PLANT CELL PHYSIOL, V43, P1259, DOI 10.1093/pcp/pcf157; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Li Z, 2016, J BIOL CHEM, V291, P19051, DOI 10.1074/jbc.M116.724708; MACPHERSON DF, 1994, MOL MICROBIOL, V11, P281, DOI 10.1111/j.1365-2958.1994.tb00308.x; MAROLDA CL, 1995, J BACTERIOL, V177, P5539, DOI 10.1128/jb.177.19.5539-5546.1995; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; ONeill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI [DOI 10.1016/B978-0-12-461012-5.50018-5, 10.1016/b978-0-12-461012-5.50018-5]; ORTMANN R, 1972, BIOCHIM BIOPHYS ACTA, V289, P293, DOI 10.1016/0005-2744(72)90080-0; Picmanova M, 2016, GLYCOBIOLOGY, V26, P430, DOI 10.1093/glycob/cww012; Polizzi SJ, 2012, BIOCHEMISTRY-US, V51, P8844, DOI 10.1021/bi301135b; Rezanka T, 2000, PHYTOCHEMISTRY, V54, P635, DOI 10.1016/S0031-9422(00)00147-3; Rezanka T, 2013, PHYTOCHEMISTRY, V88, P34, DOI 10.1016/j.phytochem.2013.01.003; ROBERTSON BD, 1994, J BACTERIOL, V176, P6915, DOI 10.1128/JB.176.22.6915-6920.1994; SANDERMA.H, 1968, BIOCHIM BIOPHYS ACTA, V165, P552, DOI 10.1016/0304-4165(68)90239-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Smith J, 2016, J BIOL CHEM, V291, P21434, DOI 10.1074/jbc.M116.749069; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Watson R R, 1975, Adv Carbohydr Chem Biochem, V31, P135; Yang T, 2012, ANAL BIOCHEM, V421, P691, DOI 10.1016/j.ab.2011.12.028; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; Yin S, 2016, PLANT CELL REP, V35, P2403, DOI 10.1007/s00299-016-2044-5; Yin YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027995; Zheng SZ, 1998, INDIAN J CHEM B, V37, P825	47	5	5	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184953	10.1371/journal.pone.0184953	http://dx.doi.org/10.1371/journal.pone.0184953			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931093	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700045
J	Catozzi, C; Bonastre, AS; Francino, O; Lecchi, C; De Carlo, E; Vecchio, D; Martucciello, A; Fraulo, P; Bronzo, V; Cusco, A; D'Andreano, S; Ceciliani, F				Catozzi, Carlotta; Sanchez Bonastre, Armand; Francino, Olga; Lecchi, Cristina; De Carlo, Esterina; Vecchio, Domenico; Martucciello, Alessandra; Fraulo, Pasquale; Bronzo, Valerio; Cusco, Anna; D'Andreano, Sara; Ceciliani, Fabrizio			The microbiota of water buffalo milk during mastitis	PLOS ONE			English	Article							SOMATIC-CELL COUNT; BOVINE CLINICAL MASTITIS; INTRAMAMMARY INFECTION; DAIRY; CATTLE; IDENTIFICATION; RAW; MANAGEMENT; LACTATION; SEQUENCES	The aim of this study was to define the microbiota of water buffalo milk during sub-clinical and clinical mastitis, as compared to healthy status, by using high-throughput sequencing of the 16S rRNA gene. A total of 137 quarter samples were included in the experimental design: 27 samples derived from healthy, culture negative quarters, with a Somatic Cell Count (SCC) of less than 200,000 cells/ml; 27 samples from quarters with clinical mastitis; 83 samples were collected from quarters with subclinical mastitis, with a SCC number greater of 200,000 cells/ml and/or culture positive for udder pathogens, without clinical signs of mastitis. Bacterial DNA was purified and the 16S rRNA genes were individually amplified and sequenced. Significant differences were found in milk samples from healthy quarters and those with sub-clinical and clinical mastitis. The microbiota diversity of milk from healthy quarters was richer as compared to samples with sub-clinical mastitis, whose microbiota diversity was in turn richer as compared to those from clinical mastitis. The core microbiota of water buffalo milk, defined as the asset of microorganisms shared by all healthy milk samples, includes 15 genera, namely Micrococcus, Propionibacterium, 5-7N15, Solibacillus, Staphylococcus, Aerococcus, Facklamia, Trichococcus, Turicibacter, 02d06, SMB53, Clostridium, Acinetobacter, Psychrobacter and Pseudomonas. Only two genera (Acinetobacter and Pseudomonas) were present in all the samples from sub-clinical mastitis, and no genus was shared across all in clinical mastitis milk samples. The presence of mastitis was found to be related to the change in the relative abundance of genera, such as Psychrobacter, whose relative abundance decreased from 16.26% in the milk samples from healthy quarters to 3.2% in clinical mastitis. Other genera, such as SMB53 and Solibacillus, were decreased as well. Discriminant analysis presents the evidence that the microbial community of healthy and clinical mastitis could be discriminated on the background of their microbiota profiles.	[Catozzi, Carlotta; Lecchi, Cristina; Bronzo, Valerio; Ceciliani, Fabrizio] Univ Milan, Dipartimento Med Vet, Via Celoria 10, Milan, Italy; [Sanchez Bonastre, Armand; Francino, Olga] Univ Autonoma Barcelona, Vet Sch, Mol Genet Vet Serv SVGM, Barcelona, Spain; [De Carlo, Esterina; Vecchio, Domenico; Martucciello, Alessandra; Fraulo, Pasquale] Natl Reference Ctr Hyg & Technol Water Buffalo Fa, Ist Zooprofilatt Sperimentale Mezzogiorno, Via Calabrie, Salerno, Italy; [Cusco, Anna; D'Andreano, Sara] Vetgen Eureka PRUAB, Campus UAB, Barcelona, Spain	University of Milan; Autonomous University of Barcelona; IZS del Mezzogiorno; Autonomous University of Barcelona	Ceciliani, F (corresponding author), Univ Milan, Dipartimento Med Vet, Via Celoria 10, Milan, Italy.	fabrizio.ceciliani@unimi.it	Cusco, Anna/GRY-5131-2022; Ceciliani, Fabrizio/Q-6551-2017; Cusco, Anna/F-6262-2019; Vecchio, Domenico/I-4102-2013; Francino, Olga/K-5683-2017; Catozzi, Carlotta/AAC-1785-2019; De Carlo, Esterina/Q-1309-2016; Lecchi, Cristina/K-8729-2016	Cusco, Anna/0000-0002-9574-5755; Ceciliani, Fabrizio/0000-0002-9199-5757; Vecchio, Domenico/0000-0002-8766-7224; Francino, Olga/0000-0002-9022-3835; Catozzi, Carlotta/0000-0002-1028-1489; De Carlo, Esterina/0000-0001-7883-1283; Lecchi, Cristina/0000-0002-7262-1696	Ricerca Corrente MIUR [IZS ME 10/13 RC]	Ricerca Corrente MIUR	The present investigation was entirely carried out with the financial support of Grant IZS ME 10/13 RC - Ricerca Corrente 2013 MIUR. There was no additional external funding received for this study.; We thank Prof Paolo Moroni for the critical reading of the manuscript. We are also indebted to Mrs Chiara Gini for graphical editing of figures, and Dr Andrea Talenti for the support in statistical analysis. The present investigation was carried out with the financial support of Grant IZS ME 10/13 RC-Ricerca Corrente 2013 (AM) MIUR. There was no additional external funding received for this study.	Addis MF, 2016, MOL BIOSYST, V12, P2359, DOI 10.1039/c6mb00217j; Ali MA, 2011, J ANIM PLANT SCI-PAK, V21, P477; [Anonymous], 2016, FAO REPORT; Bhatt VD, 2012, J APPL MICROBIOL, V112, P639, DOI 10.1111/j.1365-2672.2012.05244.x; Braem G, 2014, J APPL MICROBIOL, V116, P1084, DOI 10.1111/jam.12447; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Capra E, 2014, LETT APPL MICROBIOL, V59, P642, DOI 10.1111/lam.12326; Cisak E, 2017, FOODBORNE PATHOG DIS, V14, P189, DOI 10.1089/fpd.2016.2203; De Carlo E, 2013, BUFFALO BULL, V32, P1066; De Filippis F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089680; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ercolini D, 2012, APPL ENVIRON MICROB, V78, P8142, DOI 10.1128/AEM.02218-12; Fagiolo A, 2007, ITAL J ANIM SCI, V6, P200; Falentin H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00480; Faye B, 2012, INT DAIRY J, V24, P50, DOI 10.1016/j.idairyj.2011.12.011; Guccione J, 2016, J DAIRY SCI, V99, P2945, DOI 10.3168/jds.2015-10291; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hertl JA, 2011, J DAIRY SCI, V94, P4863, DOI 10.3168/jds.2010-4000; Hiitio H, 2016, J DAIRY SCI, V99, P6532, DOI 10.3168/jds.2015-10811; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jeon SJ, 2015, APPL ENVIRON MICROB, V81, P6324, DOI 10.1128/AEM.01753-15; Jiao JZ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01364; Kivaria FM, 2007, VET J, V173, P617, DOI 10.1016/j.tvjl.2006.01.008; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; Kumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00078; Li L, 2016, J DAIRY SCI, V99, P7016, DOI 10.3168/jds.2016-11041; Lima SF, 2017, J DAIRY SCI, V100, P3031, DOI 10.3168/jds.2016-11604; Locatelli C, 2013, J DAIRY SCI, V96, P3799, DOI 10.3168/jds.2012-6275; Machado VS, 2012, VET MICROBIOL, V159, P460, DOI 10.1016/j.vetmic.2012.04.033; MADSEN M, 1992, VET MICROBIOL, V32, P81, DOI 10.1016/0378-1135(92)90009-I; Mao SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-237; Moroni P, 2006, J DAIRY SCI, V89, P998, DOI 10.3168/jds.S0022-0302(06)72165-8; Myer PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129174; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; NMC, 2017, LAB HDB BOVINE MASTI; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Papa R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01333; PYORALA S, 1992, BRIT VET J, V148, P54, DOI 10.1016/0007-1935(92)90067-B; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Rainard P, 2017, VET RES, V48, DOI 10.1186/s13567-017-0429-2; Rodrigues NF, 2015, GENET MOL RES, V14, P6518, DOI 10.4238/2015.June.12.4; Rogers GB, 2013, TRENDS MICROBIOL, V21, P271, DOI 10.1016/j.tim.2013.03.004; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sahin A, 2016, BUFFALO BULL, V35, P573; Sahin A, 2017, INDIAN J ANIM RES, V51, P35, DOI 10.18805/ijar.1146r; Sahin A, 2016, PAK J ZOOL, V48, P325; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Santos TMA, 2011, J DAIRY SCI, V94, P291, DOI 10.3168/jds.2010-3668; Santos Thiago M A, 2012, PLoS One, V7, pe53048, DOI 10.1371/journal.pone.0053048; Scaccabarozzi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142973; Sharma A, 2007, ITAL J ANIM SCI, V6, P965; Stubbendieck RM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01234; Taponen S, 2009, J DAIRY SCI, V92, P2610, DOI 10.3168/jds.2008-1729; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Vayssier-Taussat M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00029; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00296; Wright EA, 2015, VET MICROBIOL, V175, P105, DOI 10.1016/j.vetmic.2014.11.011	64	40	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184710	10.1371/journal.pone.0184710	http://dx.doi.org/10.1371/journal.pone.0184710			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926595	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600036
J	Hall, M; Caton, S				Hall, Margeret; Caton, Simon			Am I who I say I am? Unobtrusive self-representation and personality recognition on Facebook	PLOS ONE			English	Article							LANGUAGE USE; WORDS; INFORMATION; REGRESSION; DIVERSITY; DYNAMICS; WORLD; STYLE; NEED; BIAS	Across social media platforms users (sub) consciously represent themselves in a way which is appropriate for their intended audience. This has unknown impacts on studies with unobtrusive designs based on digital (social) platforms, and studies of contemporary social phenomena in online settings. A lack of appropriate methods to identify, control for, and mitigate the effects of self-representation, the propensity to express socially responding characteristics or self-censorship in digital settings, hinders the ability of researchers to confidently interpret and generalize their findings. This article proposes applying boosted regression modelling to fill this research gap. A case study of paid Amazon Mechanical Turk workers (n = 509) is presented where workers completed psychometric surveys and provided anonymized access to their Facebook timelines. Our research finds indicators of self-representation on Facebook, facilitating suggestions for its mitigation. We validate the use of LIWC for Facebook personality studies, as well as find discrepancies with extant literature about the use of LIWC-only approaches in unobtrusive designs. Using survey data and LIWC sentiment categories as predictors, the boosted regression model classified the Five Factor personality model with an average accuracy of 74.6%. The contribution of this work is an accurate prediction of psychometric information based on short, informal text.	[Hall, Margeret] Univ Nebraska, Sch Interdisciplinary Informat, Omaha, NE 68182 USA; [Caton, Simon] Natl Coll Ireland, Sch Comp, Dublin, Ireland	University of Nebraska System; National College of Ireland	Hall, M (corresponding author), Univ Nebraska, Sch Interdisciplinary Informat, Omaha, NE 68182 USA.	mahall@unomaha.edu	Caton, Simon/ABC-1531-2020; Hall, Margeret/AAI-4181-2020	Caton, Simon/0000-0001-9379-3879; Hall, Margeret/0000-0003-1049-3040				[Anonymous], P ACM WEBSCI 15; [Anonymous], 2011, ASS ADVANCEMENT ARTI, DOI DOI 10.1007/S00247-002-0848-7; [Anonymous], 2015, CHI 15, DOI DOI 10.1145/2702613.2732787; Araujo M, 2014, INT WORLD WID WEB C; Back MD, 2010, PSYCHOL SCI, V21, P372, DOI 10.1177/0956797609360756; Balahur A, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P1207; Bazarova N, 2012, J LANG SOC PSYCHOL; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bollen J, 2011, ARTIF LIFE, V17, P237, DOI 10.1162/artl_a_00034; Bosnjak M, 2001, J COMPUT COMMUN, V6, P14; Boyd D, 2004, CSCW04, V6, P6; Boyd RL, 2017, CURR OPIN BEHAV SCI, V18, P63, DOI 10.1016/j.cobeha.2017.07.017; Buhlmann P, 2006, ANN STAT, V34, P559, DOI 10.1214/009053606000000092; Campbell RS, 2003, PSYCHOL SCI, V14, P60, DOI 10.1111/1467-9280.01419; Caton S, 2015, BIG DATA SOC, V2, DOI 10.1177/2053951715612822; Chung C.K., 2014, SOCIAL COGNITION COM, P25; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Clifford S., 2015, RES POLITICS, V2, DOI [10.1177/2053168015622072, DOI 10.1177/2053168015622072]; Cook RD, 1982, RESIDUALS INFLUENCE; Das S., 2013, P INT AAAI C WEB SOC, V7, P120; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; Duggan M, 2014, PEW SOCIAL MEDIA REP; Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; Ewig C., 2011, SOCIAL MEDIA THEORIE; Farnadi G, 2013, P INT AAAI C WEB SOC, V7, P14; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; FOWLER RL, 1987, APPL PSYCH MEAS, V11, P419, DOI 10.1177/014662168701100407; Galesic M, 2009, PUBLIC OPIN QUART, V73, P349, DOI 10.1093/poq/nfp031; Goffman Erving, 1959, MISE SCENE VIE QUOTI; Goncalves P., 2013, P 1 ACM C ONL OSC NE, P27; Gonzales AL, 2010, COMMUN RES, V37, P3, DOI 10.1177/0093650209351468; Gonzalez-Bailon S, 2014, SOC NETWORKS, V38, P16, DOI 10.1016/j.socnet.2014.01.004; Gosling SD, 2015, ANNU REV PSYCHOL, V66, P877, DOI 10.1146/annurev-psych-010814-015321; Groom CJ, 2002, J RES PERS, V36, P615, DOI 10.1016/S0092-6566(02)00512-3; Hall M, 2013, 2013 IEEE THIRD INTERNATIONAL CONFERENCE ON CLOUD AND GREEN COMPUTING (CGC 2013), P277, DOI 10.1109/CGC.2013.51; Halldorsson M. M., 2012, PROC FOMC, P1; Han Lin, 2013, Cross-Cultural Design. Cultural Differences in Everyday Life. 5th International Conference, CCD 2013. Held as Part of HCI International 2013. Proceedings: LNCS 8024, P432, DOI 10.1007/978-3-642-39137-8_48; Hilsen AI, 2014, AI SOC, V29, P3, DOI 10.1007/s00146-012-0426-y; Hoever A., 2010, STRATEGIEN KONZEPTE; Hogan Bernie., 2010, B SCI TECHNOL SOC, V30, P377, DOI [10.1177/0270467610385893, DOI 10.1177/0270467610385893]; Huppert FA, 2013, SOC INDIC RES, V110, P837, DOI 10.1007/s11205-011-9966-7; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; iall M., 2013, P 15 INT C HUM COMP, P13; IBM, 2011, IBM SPSS ADV STAT 22; IBM, 2011, IBM SPSS REGR 22; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; John OP, 1991, BIG 5 INVENTORY D VE; Jungherr A, 2012, SOC SCI COMPUT REV, V30, P229, DOI 10.1177/0894439311404119; Komisin M., 2012, P 25 INT FLOR ART IN, P232; Kramer A.D., 2012, P SIGCHI C HUMAN FAC, P767, DOI DOI 10.1145/2207676.2207787; Kramer ADI, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P287; Lambiotte R, 2014, P IEEE, V102, P1934, DOI 10.1109/JPROC.2014.2359054; Lawson HM, 2006, SOC SCI COMPUT REV, V24, P189, DOI 10.1177/0894439305283402; Lease M, 2013, SOC SCI RES NETWORK, V15; Li Q, 2004, STAT SINICA, V14, P485; Lingel J., 2014, P 17 ACM C COMPUTER, P1502; Lopez-Lopez E, 2014, J INF SCI, V1, P1; Mahmud J., 2015, IBM WATSON PERSONALI; Mahmud J, 2014, PREDICTION INFLUENCE, P603; Markovikj D, 2013, MINING FACEBOOK DATA, P23; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Mehra A, 2001, ADMIN SCI QUART, V46, P121, DOI 10.2307/2667127; Newman ML, 2003, PERS SOC PSYCHOL B, V29, P665, DOI 10.1177/0146167203029005010; Ott M., 2011, P 49 ANN M ASS COMP, V1, P309, DOI DOI 10.1145/2567948.2577293; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Park G, 2015, J PERS SOC PSYCHOL, V108, P934, DOI 10.1037/pspp0000020; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Pennebaker JW, 1999, J PERS SOC PSYCHOL, V77, P1296, DOI 10.1037/0022-3514.77.6.1296; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Purdie-Vaughns V, 2008, J PERS SOC PSYCHOL, V94, P615, DOI 10.1037/0022-3514.94.4.615; Qiu L, 2012, CYBERPSYCH BEH SOC N, V15, P569, DOI 10.1089/cyber.2012.0200; Ross J., 2010, C HUM FACT COMP SYST, P2863, DOI [DOI 10.5888/PCD14.170066, DOI 10.1145/1753846.1753873]; Rost M., 2013, P 2013 C COMP SUPP C, P357, DOI [10.1145/2441776.2441817, DOI 10.1145/2441776.2441817]; Schapire RE, 2003, LECT NOTES STAT, V171, P149, DOI 10.1007/978-0-387-21579-2_9; Schonlau M, 2005, STATA J, V5, P330, DOI 10.1177/1536867X0500500304; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Tamir DI, 2012, P NATL ACAD SCI USA, V109, P8038, DOI 10.1073/pnas.1202129109; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Tulyakov S, 2007, REV CLASSIF COMB MET, V90, P361; Utz S, 2012, CYBERPSYCH BEH SOC N, V15, P37, DOI 10.1089/cyber.2010.0651; van Dijck J, 2013, MEDIA CULT SOC, V35, P199, DOI 10.1177/0163443712468605; Wang N, 2010, CAN HAPPINESS BE MEA; Warshaw J, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P797, DOI 10.1145/2702123.2702274; Wilson RE, 2012, PERSPECT PSYCHOL SCI, V7, P203, DOI 10.1177/1745691612442904; Yang H, 2013, MULTIPLE LINEAR REGR, V39, P27; Yarkoni T, 2010, J RES PERS, V44, P363, DOI 10.1016/j.jrp.2010.04.001; Yearwood MH, 2015, PERS INDIV DIFFER, V87, P224, DOI 10.1016/j.paid.2015.07.040; Youyou W, 2015, P NATL ACAD SCI; Zhao SY, 2008, COMPUT HUM BEHAV, V24, P1816, DOI 10.1016/j.chb.2008.02.012; Zimmer M, 2010, ETHICS INF TECHNOL, V12, P313, DOI 10.1007/s10676-010-9227-5	94	17	18	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184417	10.1371/journal.pone.0184417	http://dx.doi.org/10.1371/journal.pone.0184417			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH4XT	28926569	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000411166600017
J	Stanisavljevic, D; Petrovic, I; Vukovic, V; Schwirtlich, M; Gredic, M; Stevanovic, M; Popovic, J				Stanisavljevic, Danijela; Petrovic, Isidore; Vukovic, Vladanka; Schwirtlich, Marija; Gredic, Marija; Stevanovic, Milena; Popovic, Jelena			SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; DNA-DAMAGE; GENES; TRANSCRIPTION; PROMOTES; DEGRADATION; BINDING; DIFFERENTIATION; INHIBITION; EXPRESSION	SOX14 is a member of the SOX family of transcription factors mainly involved in the regulation of neural development. Recently, it became evident that SOX14 is one of four hyper-methylated genes in cervical carcinoma, considered as a tumor suppressor candidate in this type of malignancy. In this paper we elucidated the role of SOX14 in the regulation of malignant properties of cervical carcinoma cells in vitro. Functional analysis performed in HeLa cells revealed that SOX14 overexpression decreased viability and promoted apoptosis through altering the expression of apoptosis related genes. Our results demonstrated that overexpression of SOX14 initiated accumulation of p53, demonstrating potential cross-talk between SOX14 and the p53 signaling pathway. Further analysis unambiguously showed that SOX14 triggered posttranslational modification of p53 protein, as detected by the significantly increased level of phospho-p53 (Ser-15) in SOX14-overexpressing HeLa cells. Moreover, the obtained results revealed that SOX14 activated p53 protein, which was confirmed by elevated p21 Waf1/Cip1, a well known target gene of p53. This study advances our understanding about the role of SOX14 and might explain the molecular mechanism by which this transcription factor could exert tumor suppressor properties in cervical carcinoma.	[Stanisavljevic, Danijela; Petrovic, Isidore; Vukovic, Vladanka; Schwirtlich, Marija; Gredic, Marija; Stevanovic, Milena; Popovic, Jelena] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Stevanovic, Milena] Univ Belgrade, Fac Biol, Belgrade, Serbia; [Stevanovic, Milena] Serbian Acad Arts & Sci, Belgrade, Serbia; [Gredic, Marija] UGMLC, JLUG, Excellence Cluster Cardiopulmonary Syst ECCPS, Giessen, Germany; [Gredic, Marija] German Ctr Lung Res DZL, Giessen, Germany	University of Belgrade; University of Belgrade; Serbian Academy of Sciences & Arts	Popovic, J (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia.	jpopovic@imgge.bg.ac.rs	Popovic, Jelena/S-6304-2017	Popovic, Jelena/0000-0001-8565-1555; Schwirtlich, Marija/0000-0002-2183-0164; Gredic, Marija/0000-0001-6008-171X; Stevanovic, Milena/0000-0003-4286-7334; Petrovic, Isidora/0000-0002-9816-2184; Stanisavljevic Ninkovic, Danijela/0000-0003-0481-4004	Ministry of Education, Science and Technological Development, Republic of Serbia [173051]; Serbian Academy of Sciences and Arts (Project: "Studying the molecular mechanisms involved in maintaining pluripotency and differentiation of stem cells" [F 24]; Northwestern University RHLCCC Flow Cytometry Facility; Cancer Center Support Grant [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	Ministry of Education, Science and Technological Development, Republic of Serbia; Serbian Academy of Sciences and Arts (Project: "Studying the molecular mechanisms involved in maintaining pluripotency and differentiation of stem cells"; Northwestern University RHLCCC Flow Cytometry Facility; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No. 173051) and by the Serbian Academy of Sciences and Arts (Project: "Studying the molecular mechanisms involved in maintaining pluripotency and differentiation of stem cells", No F 24).; Flow cytometry analysis was supported by the Northwestern University RHLCCC Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). We thank Paul Mehl for flow cytometry data analysis and Dr Snezana Kojic for the CDKN1A/ p21<SUP>Waf1/Cip1</SUP> promoter and p53 expression constructs.	Ajay AK, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-2; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Arsic N, 1998, CYTOGENET CELL GENET, V83, P139, DOI 10.1159/000015149; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Barrionuevo F, 2010, INT J BIOCHEM CELL B, V42, P433, DOI 10.1016/j.biocel.2009.07.015; DEFFIE A, 1993, MOL CELL BIOL, V13, P3415, DOI 10.1128/MCB.13.6.3415; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hainaut P, 2000, ADV CANCER RES, V77, P81; Han F, 2015, ONCOGENE, V34, P4391, DOI 10.1038/onc.2014.370; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; HARPER JW, 1993, CELL, V75, P805; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li F, 2015, INT J CLIN EXP PATHO, V8, P1698; Luo QY, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020066; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; MIYASHITA T, 1995, CELL, V80, P293; Mowat MRA, 1998, ADV CANCER RES, V74, P25, DOI 10.1016/S0065-230X(08)60764-2; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Petrovic I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143591; Popovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091852; Popovic J, 2009, J GENET, V88, P15, DOI 10.1007/s12041-009-0003-4; Prior HM, 1996, MOL MED, V2, P405, DOI 10.1007/BF03401900; Prives C, 1999, J PATHOL, V187, P112; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Senchenko VN, 2013, EPIGENETICS-US, V8, P409, DOI 10.4161/epi.24233; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Tong Wei-Gang, 2010, Epigenetics, V5, P499; TUCK SP, 1989, MOL CELL BIOL, V9, P2163, DOI 10.1128/MCB.9.5.2163; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Wang J, 2016, ONCOGENE, V35, P1692, DOI 10.1038/onc.2015.234; Wang R, 2016, ONCOTARGET; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhu YZ, 2012, INT J MOL SCI, V13, P15767, DOI 10.3390/ijms131215767	47	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184686	10.1371/journal.pone.0184686	http://dx.doi.org/10.1371/journal.pone.0184686			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926586	gold, Green Submitted, Green Published			2022-12-27	WOS:000411166600034
J	Sutton, BC; Birse, RT; Maggert, K; Ray, T; Hobbs, J; Ezenekwe, A; Kazmierczak, J; Mosko, M; Kish, J; Bullock, A; Shi, ZG; Stack, MS; Irwin, D				Sutton, Bobbie C.; Birse, Ryan T.; Maggert, Kevin; Ray, Tammy; Hobbs, Jessica; Ezenekwe, Amobi; Kazmierczak, Jason; Mosko, Michael; Kish, Joan; Bullock, Andrew; Shi, Zonggao; Stack, M. Sharon; Irwin, Darryl			Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX (R) HS, a new highly sensitive assay for the MassARRAY (R) System	PLOS ONE			English	Article							LUNG-CANCER	Increased early detection and personalized therapy for lung cancer have coincided with greater use of minimally invasive sampling techniques such as endobronchial ultrasound-guided biopsy (EBUS), endoscopic ultrasound-guided biopsy (EUS), and navigational biopsy, as well as thin needle core biopsies. As many lung cancer patients have late stage disease and other comorbidities that make open surgical procedures hazardous, the least invasive biopsy technique with the highest potential specimen yield is now the preferred first diagnostic study. However, use of these less invasive procedures generates significant analytical challenges for the laboratory, such as a requirement for robust detection of low level somatic mutations, particularly when the starting sample is very small or demonstrates few intact tumor cells. In this study, we assessed 179 clinical cases of non-small cell lung carcinoma (NSCLC) that had been previously tested for EGFR, KRAS, NRAS, and BRAF mutations using a novel multiplexed analytic approach that reduces wild-type signal and allows for detection of low mutation load approaching 1%, iPLEX (R) HS panel for the MassARRAY (R) System (Agena Bioscience, San Diego, CA). This highly sensitive system identified approximately 10% more KRAS, NRAS, EGFR and BRAF mutations than were detected by the original test platform, which had a sensitivity range of 5-10% variant allele frequency (VAF).	[Sutton, Bobbie C.; Maggert, Kevin; Ray, Tammy; Hobbs, Jessica; Ezenekwe, Amobi; Kish, Joan] South Bend Med Fdn, Pathol Dept, South Bend, IN USA; [Birse, Ryan T.; Kazmierczak, Jason; Mosko, Michael; Irwin, Darryl] Agena Biosci, San Diego, CA 92121 USA; [Bullock, Andrew; Shi, Zonggao; Stack, M. Sharon] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA; [Sutton, Bobbie C.] True Hlth, Dept Womans Hlth, Frisco, TX USA	University of Notre Dame	Birse, RT; Irwin, D (corresponding author), Agena Biosci, San Diego, CA 92121 USA.	ryan.birse@agenabio.com; darry.irwin@agenabio.com			Agena Bioscience; Walther Cancer Foundation	Agena Bioscience; Walther Cancer Foundation	Agena Bioscience provided support in the form of salaries for authors RTB, JK, MM, DI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MSS was partially supported by grant funding from The Walther Cancer Foundation. Furthermore, the iPLEX (R) HS chemistry stated in this manuscript was developed and launched by Agena Bioscience as a commercial product in 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; [Anonymous], 2014, WORLD CANC REPORT; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Chen GL, 2015, HUM PATHOL, V46, P113, DOI 10.1016/j.humpath.2014.09.014; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Henschke CI, 2008, ONCOLOGIST, V13, P65, DOI 10.1634/theoncologist.2007-0153; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; National Comprehensive Cancer Network, 2017, NAT COMPR CANC NETW, V4; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tol J, 2010, J CELL MOL MED, V14, P2122, DOI 10.1111/j.1582-4934.2009.00788.x	11	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0183715	10.1371/journal.pone.0183715	http://dx.doi.org/10.1371/journal.pone.0183715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926605	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600005
J	Pyne, R; Honig, J; Vaiciunas, J; Koroch, A; Wyenandt, C; Bonos, S; Simon, J				Pyne, Robert; Honig, Josh; Vaiciunas, Jennifer; Koroch, Adolfina; Wyenandt, Christian; Bonos, Stacy; Simon, James			A first linkage map and downy mildew resistance QTL discovery for sweet basil (Ocimum basilicum) facilitated by double digestion restriction site associated DNA sequencing (ddRADseq)	PLOS ONE			English	Article							PERONOSPORA-BELBAHRII; LACTUCA-SALIGNA; GENUS OCIMUM; L.; LETTUCE; GENOME; CONSTRUCTION; SEGREGATION; INHERITANCE; PATHOGEN	Limited understanding of sweet basil (Ocimum basilicum L.) genetics and genome structure has reduced efficiency of breeding strategies. This is evidenced by the rapid, worldwide dissemination of basil downy mildew (Peronospora belbahrii) in the absence of resistant cultivars. In an effort to improve available genetic resources, expressed sequence tag simple sequence repeat (EST-SSR) and single nucleotide polymorphism (SNP) markers were developed and used to genotype the MRI x SB22 F-2 mapping population, which segregates for response to downy mildew. SNP markers were generated from genomic sequences derived from double digestion restriction site associated DNA sequencing (ddRADseq). Disomic segregation was observed in both SNP and EST-SSR markers providing evidence of an O. basilicum allotetraploid genome structure and allowing for subsequent analysis of the mapping population as a diploid intercross. A dense linkage map was constructed using 42 EST-SSR and 1,847 SNP markers spanning 3,030.9 cM. Multiple quantitative trait loci (QTL) model (MQM) analysis identified three QTL that explained 37-55% of phenotypic variance associated with downy mildew response across three environments. A single major QTL, dm11.1 explained 21-28% of phenotypic variance and demonstrated dominant gene action. Two minor QTL dm9.1 and dm14.1 explained 5-16% and 4-18% of phenotypic variance, respectively. Evidence is provided for an additive effect between the two minor QTL and the major QTL dm11.1 increasing downy mildew susceptibility. Results indicate that ddRADseq-facilitated SNP and SSR marker genotyping is an effective approach for mapping the sweet basil genome.	[Pyne, Robert; Honig, Josh; Vaiciunas, Jennifer; Wyenandt, Christian; Bonos, Stacy; Simon, James] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA; [Koroch, Adolfina] CUNY, Dept Sci, Borough Manhattan Community Coll, New York, NY 10021 USA	Rutgers State University New Brunswick; City University of New York (CUNY) System	Simon, J (corresponding author), Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ 08901 USA.	jimsimon@rutgers.edu			United States United Department of Agriculture (USDA) Special Crops Research Initiative [2011-51181-30646]; USDA National Institute of Food and Agriculture [2016-68004-24931]; Binational Agricultural Research & Development (BARD) [US-4947-16R]; New Jersey Agricultural Experiment Station; New Use Agriculture and Natural Plant Products Program; Rutgers Cooperative Extension Service (NIFA HATCH) [NJAES 12131, 1005685]	United States United Department of Agriculture (USDA) Special Crops Research Initiative; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Binational Agricultural Research & Development (BARD); New Jersey Agricultural Experiment Station; New Use Agriculture and Natural Plant Products Program; Rutgers Cooperative Extension Service (NIFA HATCH)	Funds for this research and in support of a graduate assistantship/doctoral degree for RMP were provided by United States United Department of Agriculture (USDA) Special Crops Research Initiative Award No. 2011-51181-30646. Additional funds were provided by USDA National Institute of Food and Agriculture Award No. 2016-68004-24931, and the Binational Agricultural Research & Development (BARD) Award No. US-4947-16R. We thank the New Jersey Agricultural Experiment Station, the New Use Agriculture and Natural Plant Products Program and the Rutgers Cooperative Extension Service for also providing funds in support of this work (NIFA HATCH project reports NJAES 12131 and 1005685).; Funds for this research and in support of a graduate assistantship/doctoral degree for RMP were provided by United States United Department of Agriculture (USDA) Special Crops Research Initiative Award No.2011-51181-30646. Additional funds were provided by USDA National Institute of Food and Agriculture Award No. 2016-68004-24931, and the Binational Agricultural Research & Development (BARD) Award No. US-4947-16R. We thank the New Jersey Agricultural Experiment Station, the New Use Agriculture and Natural Plant Products Program and the Rutgers Cooperative Extension Service for also providing funds in support of this work (NIFA HATCH project reports NJAES 12131 and 1005685). We thank Dr. Todd Wehner (North Carolina State University) for his advice throughout the course of this project. We thank Mark Peacos, and Ed Dager for their assistance with greenhouse and field work.	Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; [Anonymous], 2006, JOINMAP SOFTWARE CAL; Ates D, 2016, PLOS ONE, V11, Patent No. 26978666; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Belbahri L, 2005, MYCOL RES, V109, P1276, DOI 10.1017/S0953756205003928; Bellin D, 2009, THEOR APPL GENET, V120, P163, DOI 10.1007/s00122-009-1167-2; Ben-Naim Y, 2015, PHYTOPATHOLOGY, V2710, Patent No. 25844828; Bielenberg DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139406; Blomquist CL, 2009, PLANT DIS, V93, P968, DOI 10.1094/PDIS-93-9-0968A; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, 2001, LAB ANIMAL, V30, P44; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chaimovitsh D., 1983, PHYTOPATHOLOGY, V90, P58; Christensen KA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-325; Chu ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116197; Clevenger J, 2015, MOL PLANT, V8, P831, DOI 10.1016/j.molp.2015.02.002; Cohen Y, 2013, PLANT DIS, V97, P692, DOI 10.1094/PDIS-12-12-1126-PDN; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; den Boer E, 2014, THEOR APPL GENET, V127, P1805, DOI 10.1007/s00122-014-2342-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Farahani-Kofoet RD, 2012, MYCOL PROG, V11, P961, DOI 10.1007/s11557-012-0816-z; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Gang DR, 2001, PLANT PHYSIOL, V125, P539, DOI 10.1104/pp.125.2.539; Garibaldi A, 2004, PLANT DIS, V88, P312, DOI 10.1094/PDIS.2004.88.3.312A; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gonzalo MJ, 2005, THEOR APPL GENET, V110, P802, DOI 10.1007/s00122-004-1814-6; Guo L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00925; Henning JA, 2016, EUPHYTICA, V208, P545, DOI 10.1007/s10681-015-1600-3; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Irish BM, 2008, PHYTOPATHOLOGY, V98, P894, DOI 10.1094/PHYTO-98-8-0894; Isobe SN, 2013, DNA RES, V20, P79, DOI 10.1093/dnares/dss035; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Jeuken M, 2002, THEOR APPL GENET, V105, P384, DOI 10.1007/s00122-002-0943-z; Kanetis L, 2014, PLANT DIS, V98, P283, DOI 10.1094/PDIS-07-13-0759-PDN; KHOSLA MK, 1985, CYTOLOGIA, V50, P253, DOI 10.1508/cytologia.50.253; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kong XY, 2015, PLANT DIS, V99, P1642, DOI 10.1094/PDIS-01-15-0077-PDN; Koroch AR, 2010, ISR J PLANT SCI, V58, P183, DOI 10.1560/IJPS.59.3-4.183; Li HT, 2013, THEOR APPL GENET, V126, P937, DOI 10.1007/s00122-012-2027-z; Logan-Young CJ, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400077; Manrique-Carpintero NC, 2016, G3-GENES GENOM GENET, V6, P2617, DOI 10.1534/g3.116.030031; McLeod A, 2006, PLANT DIS, V90, P1115, DOI 10.1094/PD-90-1115A; Nagy G, 2011, PLANT DIS, V95, P1034, DOI 10.1094/PDIS-04-11-0329; NATION RG, 1992, HORTSCIENCE, V27, P1221, DOI 10.21273/HORTSCI.27.11.1221; Olczak-Woltman H, 2011, J APPL GENET, V52, P249, DOI 10.1007/s13353-011-0030-8; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Phippen WB, 2000, J HERED, V91, P289, DOI 10.1093/jhered/91.4.289; Pintore I, 2016, PHYTOPARASITICA; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; PUSHPANGADAN P, 1982, CYTOLOGIA, V47, P575, DOI 10.1508/cytologia.47.575; Pyne RM, 2015, J AM SOC HORTIC SCI, V140, P396, DOI 10.21273/JASHS.140.5.396; Pyne RM, 2014, HORTSCIENCE, V49, P1041, DOI 10.21273/HORTSCI.49.8.1041; Rastogi S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1640-z; Reflinur, 2014, RICE, V7, DOI 10.1186/s12284-014-0003-8; Roberts PD, 2009, PLANT DIS, V93, P199, DOI 10.1094/PDIS-93-2-0199B; Rozen S, 2000, Methods Mol Biol, V132, P365; Saude C, 2013, PLANT DIS, V97, P1248, DOI 10.1094/PDIS-01-13-0026-PDN; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Selvarajah D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138224; Simko I, 2013, SCI REP-UK, V3, DOI 10.1038/srep02875; SIMON JE, 1990, ADVANCES IN NEW CROPS, P484; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; USDA, US DEP AGR CENS AGR; van Dijk T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-25; Vicente JG, 2012, PLANT PATHOL, V61, P600, DOI 10.1111/j.1365-3059.2011.02539.x; Wang Y, 2016, THEOR APPL GENET, V7120; Wu K, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0274-7, 10.1186/s12870-014-0277-4]; Wyenandt CA, 2015, PHYTOPATHOLOGY, V105, P885, DOI 10.1094/PHYTO-02-15-0032-FI; Wyenandt CA, 2010, HORTSCIENCE, V45, P1416, DOI 10.21273/HORTSCI.45.9.1416; Zhang NW, 2009, PLANT PATHOL, V58, P923, DOI 10.1111/j.1365-3059.2009.02066.x; Zhou XJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-351	74	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184319	10.1371/journal.pone.0184319	http://dx.doi.org/10.1371/journal.pone.0184319			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922359	Green Published, gold			2022-12-27	WOS:000411059300015
J	Maheshwari, Y; Selvaraj, V; Hajeri, S; Yokomi, R				Maheshwari, Yogita; Selvaraj, Vijayanandraj; Hajeri, Subhas; Yokomi, Raymond			Application of droplet digital PCR for quantitative detection of Spiroplasma citri in comparison with real time PCR	PLOS ONE			English	Article							DNA COPY NUMBER; STUBBORN DISEASE; QUANTIFICATION; NAVEL	Droplet digital polymerase chain reaction (ddPCR) is a method for performing digital PCR that is based on water-oil emulsion droplet technology. It is a unique approach to measure the absolute copy number of nucleic acid targets without the need of external standards. This study evaluated the applicability of ddPCR as a quantitative detection tool for the Spiroplasma citri, causal agent of citrus stubborn disease (CSD) in citrus. Two sets of primers, SP1, based on the spiral in housekeeping gene, and a multicopy prophage gene, SpV1 ORF1, were used to evaluate ddPCR in comparison with real time (quantitative) PCR (qPCR) for S. citri detection in citrus tissues. Standard curve analyses on tenfold dilution series showed that both ddPCR and qPCR exhibited good linearity and efficiency. However, ddPCR had a tenfold greater sensitivity than qPCR and accurately quantified up to one copy of spiralin gene. Receiver operating characteristic analysis indicated that the ddPCR methodology was more robust for diagnosis of CSD and the area under the curve was significantly broader compared to qPCR. Field samples were used to validate ddPCR efficacy and demonstrated that it was equal or better than qPCR to detect S. citri infection in fruit columella due to a higher pathogen titer. The ddPCR assay detected both the S. citri spiralin and the SpV1 ORF1 targets quantitatively with high precision and accuracy compared to qPCR assay. The ddPCR was highly reproducible and repeatable for both the targets and showed higher resilience to PCR inhibitors in citrus tissue extract for the quantification of S. citri compare to qPCR.	[Maheshwari, Yogita; Selvaraj, Vijayanandraj; Yokomi, Raymond] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA 93648 USA; [Hajeri, Subhas] Cent Calif Tristeza Eradicat Agcy, Citrus Pest Detect Program, Tulare, CA USA	United States Department of Agriculture (USDA)	Yokomi, R (corresponding author), USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA 93648 USA.	ray.yokomi@ars.usda.gov	Hajeri, Subhas/E-8180-2018	Hajeri, Subhas/0000-0002-5993-118X; Maheshwari, Yogita/0000-0003-1781-4572; selvaraj, vijayanandraj/0000-0002-0544-3009; Yokomi, Raymond/0000-0002-5658-2279	California Citrus Research Board [5300-138, 5300-166]; Tulare County Pest Control District	California Citrus Research Board; Tulare County Pest Control District	This work was supported by the California Citrus Research Board (5300-138 and 5300-166) and the Tulare County Pest Control District. The funders of this research (California Citrus Research Board and the Tulare County Pest Control District) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MOL TECHNIQUES TAXON; Bove J. M., 2000, COMPENDIUM CITRUS DI, P48; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; FLETCHER J, 1981, PHYTOPATHOLOGY, V71, P874; FOS A, 1986, ANN INST PASTEUR MIC, V137A, P97, DOI 10.1016/S0769-2609(86)80009-6; Gumpf DJ, 1981, MYCOPLASMA DISEASES, P97; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Kim TG, 2013, J ENVIRON SCI HEAL A, V48, P417, DOI 10.1080/10934529.2013.728915; Kiselinova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085999; Kyriakou A, 1996, J HORTIC SCI, V71, P461, DOI 10.1080/14620316.1996.11515427; LEE IM, 1984, PHYTOPATHOLOGY, V74, P84, DOI 10.1094/Phyto-74-84; Lee IM, 2006, PLANT DIS, V90, P989, DOI 10.1094/PD-90-0989; LIU HY, 1983, PHYTOPATHOLOGY, V73, P582, DOI 10.1094/Phyto-73-582; Mello AFS, 2010, J PLANT PATHOL, V92, P429; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; OLDFIELD GN, 1976, CALIF AGR, V30, P15; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Racki N, 2014, ANAL BIOANAL CHEM, V406, P661, DOI 10.1007/s00216-013-7476-y; SAGLIO P, 1973, INT J SYST BACTERIOL, V23, P191, DOI 10.1099/00207713-23-3-191; Sanders R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075296; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Wang XF, 2015, PLANT DIS, V99, P149, DOI 10.1094/PDIS-06-14-0572-RE; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; Yokomi RK, 2008, PLANT DIS, V92, P253, DOI 10.1094/PDIS-92-2-0253; Yokomi RK, 2011, P 18 C ORG CITR VIR	28	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184751	10.1371/journal.pone.0184751	http://dx.doi.org/10.1371/journal.pone.0184751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910375	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200090
J	Wang, K; Melki, R; Kabani, M				Wang, Kai; Melki, Ronald; Kabani, Mehdi			A prolonged chronological lifespan is an unexpected benefit of the [PSI+] prion in yeast	PLOS ONE			English	Article							GENETIC-VARIATION; PROPAGATION; INHERITANCE; LEISHMANIASIS; DETERMINANT; HYPOTHESIS; MECHANISM; SEVERITY; SUP35P	Self-replicating 'proteinaceous infectious particles' or prions are responsible for complex heritable traits in the yeast Saccharomyces cerevisiae. Our current understanding of the biology of yeast prions stems from studies mostly done in the context of actively dividing cells in optimal laboratory growth conditions. Evidence suggest that fungal prions exist in the wild where most cells are in a non-dividing quiescent state, because of imperfect growth conditions, scarcity of nutrients and competition. We know little about the faithful transmission of yeast prions in such conditions and their physiological consequences throughout the lifespan of yeast cells. We addressed this issue for the [PSI+] prion that results from the self-assembly of the translation release factor Sup35p into insoluble fibrillar aggregates. [PSI+] leads to increased nonsense suppression and confers phenotypic plasticity in response to environmental fluctuations. Here, we report that while [PSI+] had little to no effect on growth per se, it dramatically improved the survival of yeast cells in stationary phase. Remarkably, prolonged chronological lifespan persisted even after [PSI+] was cured from the cells, suggesting that prions may facilitate the acquisition of complex new traits. Such an important selective advantage may contribute to the evolutionary conservation of the prion-forming ability of Sup35p orthologues in distantly related yeast species.	[Wang, Kai; Melki, Ronald; Kabani, Mehdi] Univ Paris Saclay, Paris Saclay Inst Neurosci, CNRS, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Melki, R; Kabani, M (corresponding author), Univ Paris Saclay, Paris Saclay Inst Neurosci, CNRS, Gif Sur Yvette, France.	Ronald.Melki@cnrs.fr; Mehdi.Kabani@cnrs.fr	Kabani, Mehdi/G-7456-2012	Kabani, Mehdi/0000-0001-7440-6394	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche [ANR-12-13508-0013-02]; French Ministry of National Education, Research and Technology	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of National Education, Research and Technology	M.K. and R.M. are supported by the Centre National de la Recherche Scientifique (CNRS) and the Agence Nationale de la Recherche (ANR-12-13508-0013-02). K.W. was the beneficiary of a doctoral grant from the French Ministry of National Education, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Chih-Yen King for the generous gift of yeast strains and Tracy Bellande for excellent technical assistance. M.K. and R.M. are supported by the Centre National de la Recherche Scientifique (CNRS) and the Agence Nationale de la Recherche (ANR-12-B508-0013-02). K. W. was the beneficiary of a doctoral grant from the French Ministry of National Education, Research and Technology.	Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Baudin-Baillieu A, 2014, CELL REP, V8, P438, DOI 10.1016/j.celrep.2014.06.036; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Daignan-Fornier B, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-20; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Garcia DM, 2014, FEMS YEAST RES, V14, P136, DOI 10.1111/1567-1364.12116; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Harrison LB, 2007, J MOL BIOL, V368, P273, DOI 10.1016/j.jmb.2007.01.070; JULIANI MH, 1973, BIOCHEM BIOPH RES CO, V53, P531, DOI 10.1016/0006-291X(73)90694-3; Kabani M, 2014, MOL MICROBIOL, V92, P507, DOI 10.1111/mmi.12572; Kabani M, 2011, PRION, V5, P277, DOI [10.4161/pri.5.4.18070, 10.4161/pri.18070]; Kabani M, 2011, MOL MICROBIOL, V81, P640, DOI 10.1111/j.1365-2958.2011.07719.x; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Longo VD, 2012, SUBCELL BIOCHEM, V57, P101, DOI 10.1007/978-94-007-2561-4_5; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; O'Farrell PH, 2011, PHILOS T R SOC B, V366, P3498, DOI 10.1098/rstb.2011.0079; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Speldewinde SH, 2017, MICROB CELL, V4, P127, DOI 10.15698/mic2017.04.568; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2016, CELL, V167, P300, DOI 10.1016/j.cell.2016.09.036; Tuite MF, 2015, SEMIN CELL DEV BIOL, V44, P51, DOI 10.1016/j.semcdb.2015.08.016; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Wickner RB, 2015, MICROBIOL MOL BIOL R, V79, P1, DOI 10.1128/MMBR.00041-14; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]	32	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184905	10.1371/journal.pone.0184905	http://dx.doi.org/10.1371/journal.pone.0184905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910422	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200114
J	Wilson, N; Kvizhinadze, G; Pega, F; Nair, N; Blakely, T				Wilson, Nick; Kvizhinadze, Giorgi; Pega, Frank; Nair, Nisha; Blakely, Tony			Home modification to reduce falls at a health district level: Modeling health gain, health inequalities and health costs	PLOS ONE			English	Article							RISK-FACTORS; OLDER; PREVENTION; EXERCISE	Background There is some evidence that home safety assessment and modification (HSAM) is effective in reducing falls in older people. But there are various knowledge gaps, including around cost-effectiveness and also the impacts at a health district-level. Methods and findings A previously established Markov macro-simulation model built for the whole New Zealand (NZ) population (Pega et al 2016, Injury Prevention) was enhanced and adapted to a health district level. This district was Counties Manukau District Health Board, which hosts 42,000 people aged 65+ years. A health system perspective was taken and a discount rate of 3% was used for both health gain and costs. Intervention effectiveness estimates came from a systematic review, and NZ-specific intervention costs were extracted from a randomized controlled trial. In the 65+ age-group in this health district, the HSAM program was estimated to achieve health gains of 2800 quality-adjusted life-years (QALYs; 95% uncertainty interval [UI]: 547 to 5280). The net health system cost was estimated at NZ$8.44 million (95% UI: $663 to $14.3 million). The incremental cost-effectiveness ratio (ICER) was estimated at NZ$5480 suggesting HSAM is cost-effective (95% UI: cost saving to NZ$15,300 [equivalent to US $10,300]). Targeting HSAM only to people age 65+ or 75+ with previous injurious falls was estimated to be particularly cost-effective (ICERs: $700 and $832, respectively) with the latter intervention being cost-saving. There was no evidence for differential cost-effectiveness by sex or by ethnicity: Maori (Indigenous population) vs non-Maori. Conclusions This modeling study suggests that a HSAM program could produce considerable health gain and be cost-effective for older people at a health district level. Nevertheless, comparisons may be desirable with other falls prevention interventions such as group exercise programs, which also provide social contact and may prevent various chronic diseases.	[Wilson, Nick; Kvizhinadze, Giorgi; Pega, Frank; Nair, Nisha; Blakely, Tony] Univ Otago, Dept Publ Hlth, Programme BODE3, Wellington, New Zealand	University of Otago	Wilson, N (corresponding author), Univ Otago, Dept Publ Hlth, Programme BODE3, Wellington, New Zealand.	nick.wilson@otago.ac.nz		Blakely, Tony/0000-0002-6995-4369	Ministry of Business, Innovation and Employment (MBIE) [UOOX1406]; Health Research Council of New Zealand [10/248]	Ministry of Business, Innovation and Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Health Research Council of New Zealand(Health Research Council of New Zealand)	The authors thank the Ministry of Business, Innovation and Employment (MBIE) for funding this work (grant number UOOX1406). The Health Research Council of New Zealand (grant no: 10/248) is also owed thanks for funding earlier model development work.r The authors thank CMDHB staff for collaborating on this study and Ministry of Business, Innovation and Employment (MBIE) for funding this work (grant number UOOX1406). The Health Research Council of New Zealand (grant no: 10/248) is also owed thanks for funding earlier model development work. The Ministry of Health kindly provided access to anonymized official health data (HealthTracker) and the Accident Compensation Corporation (ACC) for aggregated claims data. We also thank Associate Professor Michael Keall and an anonymous reviewer for helpful comments. Nevertheless, any views/conclusions in this publication are those of the authors and may not reflect the position of any of the agencies that have provided support for this study. Frank Pega is a Technical Officer at the World Health Organization, but at the time of writing of this paper was a Postdoctoral Fellow at the University of Otago.	Bennett Julie, 2016, Aust N Z J Public Health, V40, P405, DOI 10.1111/1753-6405.12519; Blakely T, 2012, 3 U OT DEP PUBL HLTH; Blakely T, 2015, NEW ZEAL MED J, V128, P13; Chase CA, 2012, AM J OCCUP THER, V66, P284, DOI 10.5014/ajot.2012.005017; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Huang ZG, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013661; Karlsson MK, 2013, SCAND J PUBLIC HEALT, V41, P442, DOI 10.1177/1403494813483215; Keall MD, 2017, INJURY PREV, V23, P22, DOI 10.1136/injuryprev-2015-041947; Keall MD, 2015, LANCET, V385, P231, DOI 10.1016/S0140-6736(14)61006-0; Kumar A, 2016, AGE AGEING, V45, P345, DOI 10.1093/ageing/afw036; Kvizhinadze G, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0052-2; Litmus & Massey University & Sapere Research Group, 2015, INT EV REP BOW SCREE; McLeod M, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-15; Ministry of Health, 2016, REP NZ BURD DIS INJ; OECD, 2013, NEW INT COMP GDP CON; Pega F, 2016, INJURY PREV, V22, P420, DOI 10.1136/injuryprev-2016-041999; Pega F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151812; Robertson M, 2012, FALLING COSTS CASE I; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schwenk M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-50; Shen C, 2016, AM J EPIDEMIOL, V183, P36, DOI 10.1093/aje/kwv142; Stel VS, 2004, AGE AGEING, V33, P58, DOI 10.1093/ageing/afh028; Vieira ER, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1419; Woodward A, 2015, THE HEALTHY COUNTRY	25	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184538	10.1371/journal.pone.0184538	http://dx.doi.org/10.1371/journal.pone.0184538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910342	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200058
J	Arca-Suarez, J; Galan-Sanchez, F; Marin-Casanova, P; Rodriguez-Iglesias, MA				Arca-Suarez, Jorge; Galan-Sanchez, Fatima; Marin-Casanova, Pilar; Rodriguez-Iglesias, Manuel A.			Direct identification of microorganisms from thioglycolate broth by MALDI-TOF MS	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DESORPTION IONIZATION-TIME; POSITIVE BLOOD CULTURES; MICROBIOLOGY; PERFORMANCE; INFECTIONS; BACTERIA; PATHOGEN	We developed an easy MALDI-TOF MS-based assay to identify microorganisms directly from thioglycolate broth. A total of 101 positive thioglycolate broths inoculated with 15 different kinds of samples were evaluated. In 91 samples (90.1%), direct MALDI-TOF MS identifications were the same as those obtained after conventional laboratory procedures including subcultures. In 10 samples misidentified by direct processing, yeasts or mixed cultures grew in the thioglycolate subcultures, or high cellular debris hampered a correct analysis. This rapid method can provide a fast, clinically-relevant species-level identification without disturbing the daily workflow in clinical microbiology laboratories.	[Arca-Suarez, Jorge; Galan-Sanchez, Fatima; Marin-Casanova, Pilar; Rodriguez-Iglesias, Manuel A.] Hosp Univ Puerta Mar, Lab Microbiol, Cadiz, Spain; [Galan-Sanchez, Fatima; Rodriguez-Iglesias, Manuel A.] Univ Cadiz, Area Microbiol, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz	Galan-Sanchez, F (corresponding author), Hosp Univ Puerta Mar, Lab Microbiol, Cadiz, Spain.; Galan-Sanchez, F (corresponding author), Univ Cadiz, Area Microbiol, Cadiz, Spain.	fatima.galan@uca.es	Arca-Suárez, Jorge/ABG-5575-2021; Galán-Sánchez, Fátima/AAT-1475-2021	Galán-Sánchez, Fátima/0000-0003-0101-6701; Arca-Suarez, Jorge/0000-0002-4248-503X				Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Barlam TF, 2016, CLIN INFECT DIS, V62, P1197, DOI 10.1093/cid/ciw217; Buchan BW, 2013, J CLIN MICROBIOL, V51, P1359, DOI 10.1128/JCM.03105-12; Chen JHK, 2013, J CLIN MICROBIOL, V51, P1733, DOI 10.1128/JCM.03259-12; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; CLAROS MC, 1995, J CLIN MICROBIOL, V33, P2505, DOI 10.1128/JCM.33.9.2505-2507.1995; Dhiman N, 2011, J CLIN MICROBIOL, V49, P1614, DOI 10.1128/JCM.02381-10; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P546, DOI 10.1111/j.1469-0691.2010.03257.x; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Lagace-Wiens PRS, 2012, J CLIN MICROBIOL, V50, P3324, DOI 10.1128/JCM.01479-12; Lallemand E, 2016, EUR J CLIN MICROBIOL, V35, P857, DOI 10.1007/s10096-016-2608-x; Martinez RM, 2014, J CLIN MICROBIOL, V52, P2521, DOI 10.1128/JCM.00529-14; Moussaoui W, 2010, CLIN MICROBIOL INFEC, V16, P1631, DOI 10.1111/j.1469-0691.2010.03356.x; Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Segawa S, 2014, CLIN CHIM ACTA, V435, P59, DOI 10.1016/j.cca.2014.04.024; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589	19	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185229	10.1371/journal.pone.0185229	http://dx.doi.org/10.1371/journal.pone.0185229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934331	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900128
J	Chapman, PB; Liu, NJ; Zhou, Q; Iasonos, A; Hanley, S; Bosl, GJ; Spriggs, DR				Chapman, Paul B.; Liu, Nathan J.; Zhou, Qin; Iasonos, Alexia; Hanley, Sara; Bosl, George J.; Spriggs, David R.			Time to publication of oncology trials and why some trials are never published	PLOS ONE			English	Article							POSITIVE-OUTCOME BIAS; CLINICAL-TRIALS; SUBSEQUENT PUBLICATION; RANDOMIZED-TRIALS	Background Very little is known about the proportion of oncology trials that get published, the time it takes to publish them, or the reasons why oncology trials do not get published. Methods We analyzed all clinical trials that closed to accrual at our cancer center between 2009-2013. Trials were categorized by study purpose (therapeutic vs. diagnostic), phase (pilot, phase I, II, or III), and sponsor (industrial, cooperative group, institutional, or peer-reviewed). Final publications were identified in MEDLINE and EMBASE by NCT numbers, or by querying the principal investigator. For trials not published, we surveyed the principal investigators to identify the reason for non-publication. Findings 469 of 809 protocols (58%) had been published by November 2016. The calculated probability of publication 7 years after completing accrual was 70.4%; the calculated median time to publication was 47 months. Only 18.8% of protocols overall were estimated to be published within 2 years from completing accrual. The calculated probability of publication was higher for therapeutic trials than non-therapeutic trials, but there was no difference based on phase or sponsor. Among protocols not published, 45.3% had completed accrual, and among these, a majority had a manuscript in preparation or review, or the trial was still collecting data. Failure to publish due to a pharmaceutical sponsor was rare. 30.6% of unpublished trials had closed for various reasons before completing accrual, usually due to poor accrual or pharmaceutical sponsor issues. Interpretation Almost 30% of trials were calculated to be unpublished by 7 years after closing to accrual at our institution. Failure to reach accrual goals was an important factor in non-publication. We have devised new institutional policies that identify trials likely not to meet accrual goals and require early closure. We should be able to shorten the time from accrual completion to publication, especially for pilot and phase I trials for which long follow up is not needed.	[Chapman, Paul B.; Hanley, Sara; Bosl, George J.; Spriggs, David R.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Chapman, Paul B.; Liu, Nathan J.; Bosl, George J.; Spriggs, David R.] Weill Cornell Med Coll, New York, NY USA; [Zhou, Qin; Iasonos, Alexia] Mem Sloan Kettering Canc Ctr, Epidemiol Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Chapman, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA.; Chapman, PB (corresponding author), Weill Cornell Med Coll, New York, NY USA.	chapmanp@mskcc.org			NCI Cancer Center Support Grant (CCSG) [P30 CA08748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work received funding from a NCI Cancer Center Support Grant (CCSG, P30 CA08748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P254, DOI 10.1001/jama.280.3.254; Camacho LH, 2005, CANCER, V104, P1497, DOI 10.1002/cncr.21337; Chen RJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i637; Chen YP, 2016, EUR J CANCER, V66, P17, DOI 10.1016/j.ejca.2016.06.010; Davis FG, 1999, CANCER, V85, P485, DOI 10.1002/(SICI)1097-0142(19990115)85:2<485::AID-CNCR29>3.3.CO;2-C; DEBELLEFEUILLE C, 1992, ANN ONCOL, V3, P187, DOI 10.1093/oxfordjournals.annonc.a058147; Elzinga KE, 2016, CLIN TRIALS, V13, P574, DOI 10.1177/1740774516665597; Emerson GB, 2010, ARCH INTERN MED, V170, P1934, DOI 10.1001/archinternmed.2010.406; Hoeg RT, 2009, AM J CLIN ONCOL-CANC, V32, P253, DOI 10.1097/COC.0b013e3181845544; Iasonos A, 2016, CLIN CANCER RES, V22, P2114, DOI 10.1158/1078-0432.CCR-15-2517; Johnson RT, 2007, NAT CLIN PRACT NEURO, V3, P590, DOI 10.1038/ncpneuro0618; Kasenda B, 2014, JAMA-J AM MED ASSOC, V311, P1045, DOI 10.1001/jama.2014.1361; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Massey PR, 2016, ONCOLOGIST, V21, P261, DOI 10.1634/theoncologist.2015-0516; Ross JA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000391; Ross JS, 2013, JAMA INTERN MED, V173, P825, DOI 10.1001/jamainternmed.2013.136; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Saito H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101826; Schandelmaier S, 2015, ANN ONCOL, V26, P1966, DOI 10.1093/annonc/mdv283; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Smithy JW, 2014, JAMA INTERN MED, V174, P1518, DOI 10.1001/jamainternmed.2014.3438; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785	22	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184025	10.1371/journal.pone.0184025	http://dx.doi.org/10.1371/journal.pone.0184025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934243	Green Submitted, gold, Green Published			2022-12-27	WOS:000411339900017
J	Khayer, N; Marashi, SA; Mirzaie, M; Goshadrou, F				Khayer, Nasibeh; Marashi, Sayed-Amir; Mirzaie, Mehdi; Goshadrou, Fatemeh			Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic mice	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; COLONY-STIMULATING FACTOR; AMYLOID-BETA-PEPTIDE; MAST-CELLS; MICROARRAY DATA; UP-REGULATION; COEXPRESSION ANALYSIS; COGNITIVE IMPAIRMENT; RHEUMATOID-ARTHRITIS; REGULATORY NETWORKS	Alzheimer's disease (AD) is the most common cause for dementia in human. Currently, more than 46 million people in the world suffer from AD and it is estimated that by 2050 this number increases to more than 131 million. AD is considered as a complex disease. Therefore, understanding the mechanism of AD is a universal challenge. Nowadays, a huge number of disease-related high-throughput "omics" datasets are freely available. Such datasets contain valuable information about disease-related pathways and their corresponding gene interactions. In the present work, a three-way interaction model is used as a novel approach to understand AD-related mechanisms. This model can trace the dynamic nature of co-expression relationship between two genes by introducing their link to a third gene. Apparently, such relationships cannot be traced by the classical two-way interaction model. Liquid association method was applied to capture the statistically significant triplets which are involved in three-way interaction. Subsequently, gene set enrichment analysis (GSEA) and gene regulatory network (GRN) inference were applied to analyze the biological relevance of the statistically significant triplets. The results of this study suggest that the innate immunity processes are important in AD. Specifically, our results suggest that H2-Ob as the switching gene and the gene pair {Csf1r, Milr1} form a statistically significant and biologically relevant triplet, which may play an important role in AD. We propose that the homeostasis-related link between mast cells and microglia is presumably controlled with H2-Ob expression levels as a switching gene.	[Khayer, Nasibeh; Goshadrou, Fatemeh] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Dept Basic Sci, Tehran, Iran; [Marashi, Sayed-Amir] Univ Tehran, Dept Biotechnol, Coll Sci, Tehran, Iran; [Marashi, Sayed-Amir] Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran; [Mirzaie, Mehdi] Tarbiat Modares Univ, Fac Math Sci, Dept Appl Math, Tehran, Iran	Shahid Beheshti University Medical Sciences; University of Tehran; Tarbiat Modares University	Marashi, SA (corresponding author), Univ Tehran, Dept Biotechnol, Coll Sci, Tehran, Iran.; Marashi, SA (corresponding author), Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran.	marashi@ut.ac.ir	Marashi, Sayed-Amir/A-5384-2008; Goshadrou, Fatemeh/AAU-1568-2021	Marashi, Sayed-Amir/0000-0001-9801-7449; Mirzaie, Mehdi/0000-0003-4434-5118; Khayer, Nasibeh/0000-0002-3524-8589				Adamec E, 2000, NEUROSCIENCE, V100, P663, DOI 10.1016/S0306-4522(00)00281-5; AKIYAMA H, 1994, BRAIN RES, V639, P171, DOI 10.1016/0006-8993(94)91779-5; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alcolea D, 2015, NEUROLOGY, V85, P626, DOI 10.1212/WNL.0000000000001859; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Cerrato S, 2010, VET IMMUNOL IMMUNOP, V133, P9, DOI 10.1016/j.vetimm.2009.06.011; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Ciaramella A, 2010, J ALZHEIMERS DIS, V19, P559, DOI 10.3233/JAD-2010-1257; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Dong HQ, 2014, MOL NEUROBIOL, V49, P1487, DOI 10.1007/s12035-014-8697-6; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FACCI L, 1995, P NATL ACAD SCI USA, V92, P3376, DOI 10.1073/pnas.92.8.3376; Fernandez-Botran R, 2011, PARKINSONISM RELAT D, V17, P683, DOI 10.1016/j.parkreldis.2011.06.007; Fernandez-Flores A, 2016, J AM ACAD DERMATOL, V74, P536, DOI 10.1016/j.jaad.2015.09.038; Ferrer I, 2001, BRAIN PATHOL, V11, P144; Garcia I, 2011, MOL DIVERS, V15, P561, DOI 10.1007/s11030-010-9280-3; Gentleman R., 2015, GENEFILTER METHODS F; GEULA C, 1995, ALZ DIS ASSOC DIS, V9, P23, DOI 10.1097/00002093-199501002-00005; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gunderson T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0371-5; Harcha PA, 2015, J NEUROSCI, V35, P9526, DOI 10.1523/JNEUROSCI.3686-14.2015; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hilla AM, 2017, J NEUROSCI, V37, P6113, DOI 10.1523/JNEUROSCI.0584-17.2017; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; Ho YY, 2011, BIOMETRICS, V67, P133, DOI 10.1111/j.1541-0420.2010.01440.x; Jiang X, 2016, RHEUMATOLOGY, V55, P149, DOI 10.1093/rheumatology/kev285; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang YJ, 2013, BRIT J HAEMATOL, V163, P343, DOI 10.1111/bjh.12544; Kayano M, 2009, BIOINFORMATICS, V25, P2735, DOI 10.1093/bioinformatics/btp531; Korolainen MA, 2010, J NEUROCHEM, V112, P1386, DOI 10.1111/j.1471-4159.2009.06558.x; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li KC, 2002, P NATL ACAD SCI USA, V99, P16875, DOI 10.1073/pnas.252466999; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; Liu ZP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S11; Lopez-Gonzalez I, 2015, J NEUROPATH EXP NEUR, V74, P319, DOI 10.1097/NEN.0000000000000176; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Mirza Z, 2014, CNS NEUROL DISORD-DR, V13, P501, DOI 10.2174/18715273113126660154; Muccioli GG, 2008, NEUROPHARMACOLOGY, V54, P16, DOI 10.1016/j.neuropharm.2007.05.015; Murphy GM, 2000, AM J PATHOL, V157, P895, DOI 10.1016/S0002-9440(10)64603-2; MYLLYKANGASLUOSUJARVI R, 1994, BRIT J RHEUMATOL, V33, P501; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076160; Niederhoffer N, 2009, INT J IMMUNOPATH PH, V22, P473, DOI 10.1177/039463200902200224; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Qiu YH, 2015, HUM IMMUNOL, V76, P753, DOI 10.1016/j.humimm.2015.09.033; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Ray M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r148; Ray M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-136; Remo A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0492-2; Rentzos M, 2012, ACTA NEUROL SCAND, V125, P77, DOI 10.1111/j.1600-0404.2011.01524.x; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Sanmartin C, 2011, CURR MED CHEM, V18, P4635, DOI 10.2174/092986711797379249; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shendre A, 2014, GENES IMMUN, V15, P534, DOI 10.1038/gene.2014.47; Souwer Y, 2009, BRIT J HAEMATOL, V145, P334, DOI 10.1111/j.1365-2141.2009.07625.x; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Wes PD, 2016, GLIA, V64, P1710, DOI 10.1002/glia.22988; Willse JT, 2014, PACKAGE CTT; Wirz KTS, 2014, J ALZHEIMERS DIS, V38, P719, DOI 10.3233/JAD-130920; Xu ZP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03766; Yuan HB, 2010, J NEUROSCI RES, V88, P1348, DOI 10.1002/jnr.22304; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang JX, 2007, BIOINFORMATICS, V23, P2903, DOI 10.1093/bioinformatics/btm482; Zhang S, 2012, CELL PHYSIOL BIOCHEM, V29, P931, DOI 10.1159/000171029; Zhang X, 2016, CELL PHYSIOL BIOCHEM, V38, P1520, DOI 10.1159/000443093; Zhang ZC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122851; Zhou XHJ, 2005, NAT BIOTECHNOL, V23, P238, DOI 10.1038/nbt1058	88	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184697	10.1371/journal.pone.0184697	http://dx.doi.org/10.1371/journal.pone.0184697			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934252	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900039
J	Lundgren, H; Martinsson, K; Cederbrant, K; Jirholt, J; Mucs, D; Madeyski-Bengtson, K; Havarinasab, S; Hultman, P				Lundgren, Hanna; Martinsson, Klara; Cederbrant, Karin; Jirholt, Johan; Mucs, Daniel; Madeyski-Bengtson, Katja; Havarinasab, Said; Hultman, Per			HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity	PLOS ONE			English	Article							INDUCED LIVER-INJURY; HLA CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; NONVALVULAR ATRIAL-FIBRILLATION; DIRECT THROMBIN INHIBITOR; DRUG HYPERSENSITIVITY; STROKE PREVENTION; PEPTIDE REPERTOIRE; RISK-FACTORS; GENOME-WIDE	The oral thrombin inhibitor ximelagatran was withdrawn in the late clinical trial phase because it adversely affected the liver. In approximately 8% of treated patients, drug-induced liver injury (DILI) was expressed as transient alanine transaminase (ALT) elevations. No evidence of DILI had been revealed in the pre-clinical in vivo studies. A whole genome scan study performed on the clinical study material identified a strong genetic association between the major histocompatibility complex alleles for human leucocyte antigens (HLA) (HLA-DR7 and HLA-DQ2) and elevated ALT levels in treated patients. An immunemediated pathogenesis was suggested. Here, we evaluated whether HLA transgenic mice models could be used to investigate whether the expression of relevant HLA molecules was enough to reproduce the DILI effects in humans. In silico modelling performed in this study revealed association of both ximelagatran (pro-drug) and melagatran (active drug) to the antigen-presenting groove of the homology modelled HLA-DR7 molecule suggesting "altered repertoire" as a key initiating event driving development of DILI in humans. Transgenic mouse strains (tgms) expressing HLA of serotype HLA-DR7 (HLA-DRB1*0701, -DRA*0102), and HLA-DQ2 (HLA-DQB1*0202, -DQA1*0201) were created. These two lines were crossed with a human (h) CD4 transgenic line, generating the two tgms DR7xhCD4 and DQ2xhCD4. To investigate whether the DILI effects observed in humans could be reproduced in tgms, the mice were treated for 28 days with ximelagatran. Results revealed no signs of DILI when biomarkers for liver toxicity were measured and histopathology was evaluated. In the ximelagatran case, presence of relevant HLA-expression in a preclinical model did not fulfil the prerequisite for reproducing DILI observed in patients. Nonetheless, for the first time an HLA-transgenic mouse model has been investigated for use in HLA-associated DILI induced by a low molecular weight compound. This study shows that mimicking of genetic susceptibility, expressed as DILI-associated HLA-types in mice, is not sufficient for reproducing the complex pathogenesis leading to DILI in man.	[Lundgren, Hanna; Cederbrant, Karin; Havarinasab, Said; Hultman, Per] Linkoping Univ, Div Mol & Immunol Pathol, Dept Clin & Expt Med, Fac Hlth Sci,Ostergotland Cty Council, Linkoping, Sweden; [Martinsson, Klara] Linkoping Univ, AIR Rheumatol Unit, Dept Clin & Expt Med, Fac Hlth Sci,Ostergotland Cty Council, Linkoping, Sweden; [Cederbrant, Karin; Mucs, Daniel] Karolinska Inst, Swetox, Unit Toxicol Sci, Sodertalje, Sweden; [Jirholt, Johan; Madeyski-Bengtson, Katja] AstraZeneca R&D, Transgen Ctr, Molndal, Sweden	City Council Ostergotland; Linkoping University; City Council Ostergotland; Linkoping University; Karolinska Institutet; AstraZeneca	Cederbrant, K (corresponding author), Linkoping Univ, Div Mol & Immunol Pathol, Dept Clin & Expt Med, Fac Hlth Sci,Ostergotland Cty Council, Linkoping, Sweden.; Cederbrant, K (corresponding author), Karolinska Inst, Swetox, Unit Toxicol Sci, Sodertalje, Sweden.	Karin.Cederbrant@swetox.se		Mucs, Daniel/0000-0002-7370-926X	AstraZeneca; AstraZeneca R&D as part of safety problem-solving activities initiated for ximelagatran (Exanta(R))	AstraZeneca(AstraZeneca); AstraZeneca R&D as part of safety problem-solving activities initiated for ximelagatran (Exanta(R))(AstraZeneca)	The funder of this study AstraZeneca provided support in the form of salaries for authors (HL, KC, KM, JJ, KMB) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; This work was financed by AstraZeneca R&D as part of the safety problem-solving activities initiated for ximelagatran (Exanta (R)). The plasmid Pdoi5 was a kind gift from Dr C. Benoist. The pathology readings were kindly carried out by pathologist Frank Seeliger at AstraZeneca Safety Assessment (Sweden) and all the blood and tissue samplings were carried out by the staff from the AstraZeneca animal department (Sodertalje, Sweden).	Agnelli G, 2009, THROMB RES, V123, P488, DOI 10.1016/j.thromres.2008.02.017; Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Alfirevic A, 2012, GENOME MED, V4, DOI 10.1186/gm350; ALTMANN DM, 1995, J EXP MED, V181, P867, DOI 10.1084/jem.181.3.867; Andersson U, 2009, BIOMARKERS, V14, P572, DOI 10.3109/13547500903261354; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bharadwaj M, 2012, ANNU REV PHARMACOL, V52, P401, DOI 10.1146/annurev-pharmtox-010611-134701; Chakraborty M, 2015, HEPATOLOGY, V62, P546, DOI 10.1002/hep.27764; Chen Z, 2006, TISSUE ANTIGENS, V68, P210, DOI 10.1111/j.1399-0039.2006.00656.x; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Cullberg M, 2005, CLIN PHARMACOL THER, V77, P279, DOI 10.1016/j.clpt.2004.11.001; Daly AK, 2009, SEMIN LIVER DIS, V29, P400, DOI 10.1055/s-0029-1240009; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Eriksson BI, 2003, J THROMB HAEMOST, V1, P2490, DOI 10.1111/j.1538-7836.2003.00494.x; Eriksson UG, 2003, DRUG METAB DISPOS, V31, P294, DOI 10.1124/dmd.31.3.294; Ford GA, 2007, STROKE, V38, P2965, DOI 10.1161/STROKEAHA.107.488007; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Harper AR, 2012, NAT BIOTECHNOL, V30, P1117, DOI 10.1038/nbt.2424; Hughes CA, 2008, ANN PHARMACOTHER, V42, P387, DOI 10.1345/aph.1K522; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Karlin E, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0418-0; Keisu M, 2010, Handb Exp Pharmacol, P407, DOI 10.1007/978-3-642-00663-0_13; Kenne K, 2008, TOXICOL IN VITRO, V22, P730, DOI 10.1016/j.tiv.2007.11.014; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Klitz W, 2003, TISSUE ANTIGENS, V62, P296, DOI 10.1034/j.1399-0039.2003.00103.x; KOUSKOFF V, 1993, J IMMUNOL METHODS, V166, P287, DOI 10.1016/0022-1759(93)90370-M; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Lee WM, 2005, DRUG SAFETY, V28, P351, DOI 10.2165/00002018-200528040-00006; Luckey D, 2011, J AUTOIMMUN, V37, P122, DOI 10.1016/j.jaut.2011.05.001; MADDON PJ, 1987, P NATL ACAD SCI USA, V84, P9155, DOI 10.1073/pnas.84.24.9155; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mangalam AK, 2008, ADV IMMUNOL, V97, P65, DOI 10.1016/S0065-2776(08)00002-3; Martin-Murphy BV, 2010, TOXICOL LETT, V192, P387, DOI 10.1016/j.toxlet.2009.11.016; Metushi IG, 2015, HEPATOLOGY, V61, P1332, DOI 10.1002/hep.27549; Monshi MM, 2013, HEPATOLOGY, V57, P727, DOI 10.1002/hep.26077; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; PANINABORDIGNON P, 1992, J EXP MED, V176, P1779, DOI 10.1084/jem.176.6.1779; Pavlos R, 2012, PHARMACOGENOMICS, V13, P1285, DOI [10.2217/PGS.12.108, 10.2217/pgs.12.108]; Petersen P, 2003, J AM COLL CARDIOL, V41, P1445, DOI 10.1016/S0735-1097(03)00255-9; Robles-Diaz M, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00267; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632; Sonderstrup G, 1999, IMMUNOL REV, V172, P335, DOI 10.1111/j.1600-065X.1999.tb01377.x; Southworth H, 2014, STAT MED, V33, P2914, DOI 10.1002/sim.6142; Spraggs CF, 2012, CLIN PHARMACOL THER, V91, P647, DOI 10.1038/clpt.2011.277; Taneja V, 2010, IMMUNOL REV, V233, P62, DOI 10.1111/j.0105-2896.2009.00858.x; Ulrich RG, 2007, ANNU REV MED, V58, P17, DOI 10.1146/annurev.med.58.072905.160823; YAMAMOTO K, 1994, J EXP MED, V180, P165, DOI 10.1084/jem.180.1.165; YEUNG RSM, 1994, J EXP MED, V180, P1911, DOI 10.1084/jem.180.5.1911; Yip VLM, 2015, CLIN REV ALLERG IMMU, V48, P165, DOI 10.1007/s12016-014-8418-y; Zhou RR, 2012, EXP MOL PATHOL, V93, P213, DOI 10.1016/j.yexmp.2012.05.006	56	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184744	10.1371/journal.pone.0184744	http://dx.doi.org/10.1371/journal.pone.0184744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934241	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900042
J	Ortega, A; Tarazon, E; Gil-Cayuela, C; Garcia-Manzanares, M; Martinez-Dolz, L; Lago, F; Gonzalez-Juanatey, JR; Cinca, J; Jorge, E; Portoles, M; Rosello-Lleti, E; Rivera, M				Ortega, Ana; Tarazon, Estefania; Gil-Cayuela, Carolina; Garcia-Manzanares, Maria; Martinez-Dolz, Luis; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Cinca, Juan; Jorge, Esther; Portoles, Manuel; Rosello-Lleti, Esther; Rivera, Miguel			Intercalated disc in failing hearts from patients with dilated cardiomyopathy: Its role in the depressed left ventricular function	PLOS ONE			English	Article							ALPHA-T-CATENIN; GENE-EXPRESSION DATA; ELECTRON-MICROSCOPY; GAP-JUNCTIONS; FAILURE; CONDUCTION; MUTATIONS; QUANTIFICATION; HYPERTROPHY; GUIDELINES	Alterations in myocardial structure and reduced cardiomyocyte adhesions have been previously described in dilated cardiomyopathy (DCM). We studied the transcriptome of cell adhesion molecules in these patients and their relationships with left ventricular (LV) function decay. We also visualized the intercalated disc (ID) structure and organization. The transcriptomic profile of 23 explanted LV samples was analyzed using RNA-sequencing (13 DCM, 10 control [CNT]), focusing on cell adhesion genes. Electron microscopy analysis to visualize ID structural differences and immunohistochemistry experiments of ID proteins was also performed. RT-qPCR and western blot experiments were carried out on ID components. We found 29 differentially expressed genes, most of all, constituents of the ID structure. We found that the expression of GJA3, DSP and CTNNA3 was directly associated with LV ejection fraction (r = 0.741, P = 0.004; r = 0.674, P = 0.011 and r = 0.565, P = 0.044, respectively), LV systolic (P = 0.003, P = 0.003, P = 0.028, respectively) and diastolic dimensions (P = 0.006, P = 0.001, P = 0.025, respectively). Electron microscopy micrographs showed a reduced ID convolution index and immunogold labeling of connexin 46 (GJA gene), desmoplakin (DSP gene) and catenin alpha-3 (CTNNA3 gene) proteins in DCM patients. Moreover, we observed that protein and mRNA levels analyzed by RT-qPCR of these ID components were diminished in DCM group. In conclusion, we report significant gene and protein expression changes and found that the ID components GJA3, DSP and CTNNA3 were highly related to LV function. Microscopic observations indicated that ID is structurally compromised in these patients. These findings give new data for understanding the ventricular depression that characterizes DCM, opening new therapeutic perspectives for these critically diseased patients.	[Ortega, Ana; Tarazon, Estefania; Gil-Cayuela, Carolina; Garcia-Manzanares, Maria; Portoles, Manuel; Rosello-Lleti, Esther; Rivera, Miguel] Hlth Res Inst La Fe, Cardiocirculatory Unit, Valencia, Spain; [Ortega, Ana; Tarazon, Estefania; Gil-Cayuela, Carolina; Garcia-Manzanares, Maria; Martinez-Dolz, Luis; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Cinca, Juan; Jorge, Esther; Portoles, Manuel; Rosello-Lleti, Esther; Rivera, Miguel] Ctr Biomed Res Network Cardiovasc Dis CIBERCV, Madrid, Spain; [Martinez-Dolz, Luis] Univ & Polytech La Fe Hosp, Heart Failure & Transplantat Unit, Cardiol Dept, Valencia, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Cellular & Mol Cardiol Res Unit, Dept Cardiol, Santiago De Compostela, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain; [Cinca, Juan; Jorge, Esther] Santa Creu & St Pau Hosp, Cardiol Serv, Barcelona, Spain	Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Rivera, M (corresponding author), Hlth Res Inst La Fe, Cardiocirculatory Unit, Valencia, Spain.; Rivera, M (corresponding author), Ctr Biomed Res Network Cardiovasc Dis CIBERCV, Madrid, Spain.	miguelrivera492@gmail.com	Ortega, Ana AO/D-3027-2017; Ortega, Ana/AAG-5941-2020; Dolz, Luis Martinez/X-4627-2018; PORTOLES, MANUEL/B-4789-2009; Tarazón, Estefanía/D-6950-2017; Roselló Lletí, Esther/ABG-8503-2020; jorge, esther/D-4206-2014	Ortega, Ana AO/0000-0002-9763-0505; Ortega, Ana/0000-0002-9763-0505; Dolz, Luis Martinez/0000-0001-5145-8191; PORTOLES, MANUEL/0000-0002-4415-7160; Tarazón, Estefanía/0000-0003-3466-2558; Roselló Lletí, Esther/0000-0003-2627-6104; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; jorge, esther/0000-0002-2777-0000	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" [PI13/00100, PI14/01506]; CIBERCV [CB16/11/00261]; European Regional Development Fund (FEDER); RETICS [12/0042/0003]	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III"; CIBERCV; European Regional Development Fund (FEDER)(European Commission); RETICS	This work was supported by the National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" [PI13/00100; PI14/01506], CIBERCV [CB16/11/00261], the European Regional Development Fund (FEDER), and RETICS [12/0042/0003]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Basso C, 2006, EUR HEART J, V27, P1847, DOI 10.1093/eurheartj/ehl095; Bauce B, 2005, EUR HEART J, V26, P1666, DOI 10.1093/eurheartj/ehi341; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chi NC, 2010, P NATL ACAD SCI USA, V107, P14662, DOI 10.1073/pnas.0909432107; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fry CH, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1198, DOI 10.1161/CIRCEP.114.001471; Garcia-Pavia P, 2011, HEART, V97, P1744, DOI 10.1136/hrt.2011.227967; Goossens S, 2007, J CELL SCI, V120, P2126, DOI 10.1242/jcs.004713; Herrer I, 2014, LAB INVEST, V94, P645, DOI 10.1038/labinvest.2014.54; Hesketh GG, 2010, CIRC RES, V106, P1153, DOI 10.1161/CIRCRESAHA.108.182147; Janssens B, 2003, HUM GENET, V112, P227, DOI 10.1007/s00439-002-0857-5; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kanno S, 2001, CARDIOVASC PATHOL, V10, P169, DOI 10.1016/S1054-8807(01)00078-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucocq J, 2008, METHOD CELL BIOL, V88, P59, DOI 10.1016/S0091-679X(08)00404-4; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Ortega A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160168; Ortega A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107635; Pinto YM, 2016, EUR HEART J, V37, P1850, DOI 10.1093/eurheartj/ehv727; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosello-Lleti E, 2015, J CELL MOL MED, V19, P442, DOI 10.1111/jcmm.12477; Severs NJ, 2002, J CARD FAIL, V8, pS293, DOI 10.1054/jcaf.2002.129255; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Tomas M, 2002, J NEUROCHEM, V83, P601, DOI 10.1046/j.1471-4159.2002.01167.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vermij SH, 2017, CARDIOVASC RES, V113, P259, DOI 10.1093/cvr/cvw259; Wang XJ, 1999, J MOL CELL CARDIOL, V31, P333, DOI 10.1006/jmcc.1998.0886; Wilson A, 2014, CELL MOL LIFE SCI, V71, P165, DOI 10.1007/s00018-013-1374-5; Yamada KA, 2003, J CARDIOVASC ELECTR, V14, P1205, DOI 10.1046/j.1540-8167.2003.03276.x; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6	39	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185062	10.1371/journal.pone.0185062	http://dx.doi.org/10.1371/journal.pone.0185062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934278	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900082
J	Sabry, AH; Hasan, WZW; Kadir, MZAA; Radzi, MAM; Shafie, S				Sabry, Ahmad H.; Hasan, W. Z. W.; Kadir, M. Z. A. Ab.; Radzi, M. A. M.; Shafie, S.			DC-based smart PV-powered home energy management system based on voltage matching and RF module	PLOS ONE			English	Article							BIDIRECTIONAL INVERTER; APPLIANCES	The main tool for measuring system efficiency in homes and offices is the energy monitoring of the household appliances' consumption. With the help of GUI through a PC or smart phone, there are various applications that can be developed for energy saving. This work describes the design and prototype implementation of a wireless PV-powered home energy management system under a DC-distribution environment, which allows remote monitoring of appliances' energy consumptions and power rate quality. The system can be managed by a central computer, which obtains the energy data based on XBee RF modules that access the sensor measurements of system components. The proposed integrated prototype framework is characterized by low power consumption due to the lack of components and consists of three layers: XBee-based circuit for processing and communication architecture, solar charge controller, and solar-battery-load matching layers. Six precise analogue channels for data monitoring are considered to cover the energy measurements. Voltage, current and temperature analogue signals were accessed directly from the remote XBee node to be sent in real time with a sampling frequency of 11-123 Hz to capture the possible surge power. The performance shows that the developed prototype proves the DC voltage matching concept and is able to provide accurate and precise results.	[Sabry, Ahmad H.] Univ Putra Malaysia, Fac Engn, Control & Automat, Serdang, Malaysia; [Hasan, W. Z. W.; Kadir, M. Z. A. Ab.; Radzi, M. A. M.; Shafie, S.] Univ Putra Malaysia, Fac Engn, Serdang, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Sabry, AH (corresponding author), Univ Putra Malaysia, Fac Engn, Control & Automat, Serdang, Malaysia.; Hasan, WZW (corresponding author), Univ Putra Malaysia, Fac Engn, Serdang, Malaysia.	ahs4771384@gmail.com; wanzuha@upm.edu.my	Hassan, Wan Zuha Wan/AAD-8694-2020; Kadir, Zainal/B-6629-2009; Radzi, Mohd Amran Mohd/I-7637-2013; Sabry, Ahmad H./ACN-4519-2022	Hassan, Wan Zuha Wan/0000-0003-4691-066X; Kadir, Zainal/0000-0001-7263-2953; Radzi, Mohd Amran Mohd/0000-0003-3785-1573; Sabry, Ahmad H./0000-0002-2736-5582; Shafie, Suhaidi/0000-0002-8867-2754	GERAN PUTRA University Putra Malaysia [9399822/ 12000RM]	GERAN PUTRA University Putra Malaysia	This work was supported by the GERAN PUTRA University Putra Malaysia [grant number 9399822/ 12000RM]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MA, 2015, ENERGIES, V8, P8716, DOI 10.3390/en8088716; Bai YW, 2008, P INT S CONS EL; Bian D, 2014, 2014 IEEE PES INNOVATIVE SMART GRID TECHNOLOGIES CONFERENCE (ISGT); Chobot E., 2013, IJESA, V3, P1; Ciabattoni L, 2015, NEUROCOMPUTING, V170, P296, DOI 10.1016/j.neucom.2015.01.086; Erol-Kantarci M, 2011, IEEE T SMART GRID, V2, P314, DOI 10.1109/TSG.2011.2114678; Gholase V, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P696, DOI 10.1109/ICIT.2015.7125179; Gudi N, 2012, INT J ELEC POWER, V43, P185, DOI 10.1016/j.ijepes.2012.05.023; Han J, 2009, IEEE INT C CONS EL; Jiang BN, 2015, IEEE T SMART GRID, V6, P3, DOI 10.1109/TSG.2014.2347043; Lien CH, 2007, IEEE T CONSUM ELECTR, V53, P1634, DOI 10.1109/TCE.2007.4429263; Lien CH, 2008, IEEE IMTC P, P2179, DOI 10.1109/IMTC.2008.4547409; Lobaccaro G, 2016, ENERGIES, V9, DOI 10.3390/en9050348; Lucia O, 2013, IEEE J EM SEL TOP P, V1, P315, DOI 10.1109/JESTPE.2013.2283224; Nazabal JA, 2013, C EXH 2013 INT C NEW; OEM RF Modules, 2005, MAXSTREAM, P1; Sabry Ahmad H., 2015, Applied Mechanics and Materials, V785, P225, DOI 10.4028/www.scientific.net/AMM.785.225; Sabry A. H., 2015, J APPL MECH MAT, V785, P156; Sabry AH, 2015, ARPN J ENG APPL SCI, V10, P6424; Serra H, 2005, 2005 IEEE International Workshop on Intelligent Signal Processing (WISP), P128; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; Whaite S, 2015, ENERGIES, V8, P4378, DOI 10.3390/en8054378; Wu TF, 2013, IEEE T POWER ELECTR, V28, P5098, DOI 10.1109/TPEL.2013.2245681; Wu TF, 2013, IEEE T POWER ELECTR, V28, P1890, DOI 10.1109/TPEL.2012.2206057; Wu TF, 2010, IEEE T POWER ELECTR, V25, P1915, DOI 10.1109/TPEL.2010.2043542; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157	26	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185012	10.1371/journal.pone.0185012	http://dx.doi.org/10.1371/journal.pone.0185012			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934271	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000411339900075
J	Sim, WJ; Ang, AS; Tan, MC; Xiang, WW; Foo, D; Loh, KK; Jafary, FH; Watson, TJ; Ong, PJL; Ho, HH				Sim, Wen Jun; Ang, An Shing; Tan, Mae Chyi; Xiang, Wen Wei; Foo, David; Loh, Kwok Kong; Jafary, Fahim Haider; Watson, Timothy James; Ong, Paul Jau Lueng; Ho, Hee Hwa			Causes of delay in door-to-balloon time in south-east Asian patients undergoing primary percutaneous coronary intervention	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; PRIMARY PCI; MORTALITY; ANGIOPLASTY; STRATEGIES	Objective To evaluate causes and impact of delay in the door-to-balloon (D2B) time for patients undergoing primary percutaneous coronary intervention (PPCI). Subjects and methods From January 2009 to December 2012, 1268 patients (86% male, mean age of 58 +/- 12 years) presented to our hospital for ST-elevation myocardial infarction (STEMI) and underwent PPCI. They were divided into two groups: Non-delay defined as D2B time <= 90 mins and delay group defined as D2B time > 90 mins. Data were collected retrospectively on baseline clinical characteristics, mode of presentation, angiographic findings, therapeutic modality and inhospital outcome. Results 202 patients had delay in D2B time. There were more female patients in the delay group. They were older and tend to self-present to hospital. They were less likely to be smokers and have a higher prevalence of prior MI. The incidence of posterior MI was higher in the delay group. They also had a higher incidence of triple vessel disease. The 3 most common reasons for D2B delay was delay in the emergency department (39%), atypical clinical presentation (37.6%) and unstable medical condition requiring stabilisation/ computed tomographic imaging (26.7%). The inhospital mortality was numerically higher in the delay group (7.4% versus 4.8%, p = 0.12). Conclusions Delay in D2B occurred in 16% of our patients undergoing PPCI. Several key factors for delay were identified and warrant further intervention.	[Sim, Wen Jun; Ang, An Shing; Tan, Mae Chyi; Foo, David; Loh, Kwok Kong; Jafary, Fahim Haider; Watson, Timothy James; Ong, Paul Jau Lueng; Ho, Hee Hwa] Tan Tock Seng Hosp, Dept Cardiol, Singapore, Singapore; [Xiang, Wen Wei] Tan Tock Seng Hosp, Clin Res & Innovat Off, Singapore, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital	Ho, HH (corresponding author), Tan Tock Seng Hosp, Dept Cardiol, Singapore, Singapore.	hokai_wah@yahoo.com						Angeja BG, 2002, AM J CARDIOL, V89, P1156, DOI 10.1016/S0002-9149(02)02296-8; Bates ER, 2013, NEW ENGL J MED, V369, P889, DOI 10.1056/NEJMp1308772; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Bhatia Lovleen C, 2013, J Cardiovasc Dis Res, V4, P107, DOI 10.1016/j.jcdr.2012.07.003; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Gregoratos G, 2001, Am J Geriatr Cardiol, V10, P345, DOI 10.1111/j.1076-7460.2001.00641.x; Keeley EC, 2007, NEW ENGL J MED, V356, P47, DOI 10.1056/NEJMct063503; Levine GN, 2016, J AM COLL CARDIOL, V67, P1235, DOI 10.1016/j.jacc.2015.10.005; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Miedema MD, 2011, CIRCULATION, V124, P1636, DOI 10.1161/CIRCULATIONAHA.111.033118; Parikh SV, 2008, AM HEART J, V155, P290, DOI 10.1016/j.ahj.2007.10.021; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Ricci B, 2016, CURR PHARM DESIGN, V22, P3877, DOI 10.2174/1381612822666160309115125; RICH MW, 1989, CHEST, V96, P489, DOI 10.1378/chest.96.3.489; Swaminathan RV, 2013, J AM COLL CARDIOL, V61, P1688, DOI 10.1016/j.jacc.2012.11.073; Wu EB, 2008, CATHETER CARDIO INTE, V71, P152, DOI 10.1002/ccd.21315	19	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185186	10.1371/journal.pone.0185186	http://dx.doi.org/10.1371/journal.pone.0185186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934306	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900114
J	Sullivan, S; Northstone, K; Gadd, C; Walker, J; Margelyte, R; Richards, A; Whiting, P				Sullivan, Sarah; Northstone, Kate; Gadd, Caroline; Walker, Julian; Margelyte, Ruta; Richards, Alison; Whiting, Penny			Models to predict relapse in psychosis: A systematic review	PLOS ONE			English	Review							1ST EPISODE; SCHIZOPHRENIA; METAANALYSIS; COST	Background There is little evidence on the accuracy of psychosis relapse prediction models. Our objective was to undertake a systematic review of relapse prediction models in psychosis. Method We conducted a literature search including studies that developed and/or validated psychosis relapse prediction models, with or without external model validation. Models had to target people with psychosis and predict relapse. The key databases searched were; Embase, Medline, Medline In-Process Citations & Daily Update, PsychINFO, BIOSIS Citation Index, CINAHL, and Science Citation Index, from inception to September 2016. Prediction modelling studies were assessed for risk of bias and applicability using the PROBAST tool. Results There were two eligible studies, which included 33,088 participants. One developed a model using prodromal symptoms and illness-related variables, which explained 14% of relapse variance but was at high risk of bias. The second developed a model using administrative data which was moderately discriminative (C = 0.631) and associated with relapse (OR 1.11 95% CI 1.10, 1.12) and achieved moderately discriminative capacity when validated (C = 0.630). The risk of bias was low. Conclusions Due to a lack of high quality evidence it is not possible to make any specific recommendations about the predictors that should be included in a prognostic model for relapse. For instance, it is unclear whether prodromal symptoms are useful for predicting relapse. The use of routine data to develop prediction models may be a more promising approach, although we could not empirically compare the two included studies.	[Sullivan, Sarah; Northstone, Kate; Margelyte, Ruta; Richards, Alison; Whiting, Penny] United Hosp Bristol NHS Fdn Trust, NIHR CLAHRC West, Bristol, Avon, England; [Sullivan, Sarah; Northstone, Kate] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Gadd, Caroline] Otsuka Pharmaceut Europe Ltd, Otsuka Hlth Solut, Slough, Berks, England; [Walker, Julian] Avon & Wiltshire Mental Hlth NHS Trust, Jenner House, Chippenham, Wilts, England	University of Bristol	Sullivan, S (corresponding author), United Hosp Bristol NHS Fdn Trust, NIHR CLAHRC West, Bristol, Avon, England.; Sullivan, S (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	sarah.sullivan@bristol.ac.uk	Northstone, Kate/A-8165-2011	Northstone, Kate/0000-0002-0602-1983; Walker, Julian/0000-0002-8104-4683; Whiting, Penny/0000-0003-1138-5682; /0000-0002-7914-8037; Sullivan, Sarah/0000-0002-1446-8478	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust; Otsuka Health Solutions Ltd.	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust; Otsuka Health Solutions Ltd.(Otsuka Pharmaceutical)	The research is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust and Otsuka Health Solutions Ltd. Otsuka Health Solutions Ltd commissioned this review. The refinement of the research question was the result of a consensus between NIHR CLAHRC West and Otsuka Health Solutions Ltd. Otsuka Health Solutions Ltd did not influence the study design, data collection, analysis or decision to publish. Ms Caroline Gadd is a coauthor of this paper and therefore has commented on drafts of the paper and therefore has had a role in the preparation of this manuscript.; The research is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Alvarez-Jimenez M, 2012, SCHIZOPHR RES, V139, P116, DOI 10.1016/j.schres.2012.05.007; Ben-Zeev R., SMART PHONE APP KEEP; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Centre for Reviews Dissemination, SYSTEMATIC REV CRDS, V009; Collaboration. C, 2016, COCHR METH PROGN TRU; Davis UC., 2015, APP AIMS PREVENT REL; Dawson M., 2013, PREVENTING RELAPSE S; Dobson R, SLEEP SENSORS PREVEN; Eisner E, 2013, CLIN PSYCHOL REV, V33, P637, DOI 10.1016/j.cpr.2013.04.001; Gaebel W, 2007, SCHIZOPHR RES, V95, P19, DOI 10.1016/j.schres.2007.06.016; Geersing GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032844; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hong JY, 2009, PROG NEURO-PSYCHOPH, V33, P835, DOI 10.1016/j.pnpbp.2009.03.034; Kishimoto T, 2013, MOL PSYCHIATR, V18, P53, DOI 10.1038/mp.2011.143; Lahti AC, PREDICTION RELAPSE S; Leucht S, 2003, AM J PSYCHIAT, V160, P1209, DOI 10.1176/appi.ajp.160.7.1209; Moons KG, 2014, PLOS ONE, V11; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Rooke O, 1998, BRIT J CLIN PSYCHOL, V37, P259, DOI 10.1111/j.2044-8260.1998.tb01384.x; Schizophrenia Commission, 2012, AB ILLN; Tarrier N., 1991, INNOVATIONS PSYCHOL; Vigod SN, 2015, J PSYCHIATR RES, V61, P205, DOI 10.1016/j.jpsychires.2014.12.003; Vigod SN, 2013, BRIT J PSYCHIAT, V202, P187, DOI 10.1192/bjp.bp.112.115030; WEIDEN PJ, 1995, SCHIZOPHRENIA BULL, V21, P419, DOI 10.1093/schbul/21.3.419; Wiersma D, 1998, SCHIZOPHRENIA BULL, V24, P75, DOI 10.1093/oxfordjournals.schbul.a033315; Wiersma D, 2000, EUR PSYCHIAT, V15, p292S, DOI 10.1016/S0924-9338(00)94276-7; Wolff R, PROBAST 2015	27	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183998	10.1371/journal.pone.0183998	http://dx.doi.org/10.1371/journal.pone.0183998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934214	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900016
J	Wang, YC; Wang, CW; Lin, WC; Tsai, YJ; Chang, CP; Lee, YJ; Lin, MJ; Li, C				Wang, Yi-Chun; Wang, Chien-Wen; Lin, Wen-Chang; Tsai, Yun-Jung; Chang, Chien-Ping; Lee, Yu-Jen; Lin, Min-Jon; Li, Chuan			Identification, chromosomal arrangements and expression analyses of the evolutionarily conserved prmt1 gene in chicken in comparison with its vertebrate paralogue prmt8	PLOS ONE			English	Article							PROTEIN ARGININE METHYLTRANSFERASE; SUBCELLULAR-LOCALIZATION; SUBSTRATE-SPECIFICITY; N-METHYLTRANSFERASE; GENOME SIZE; HISTONE H4; METHYLATION; DIFFERENTIATION; INSIGHTS; RECEPTOR	Nine protein arginine methyltransferases (PRMTs) are conserved in mammals and fish. Among these, PRMT1 is the major type I PRMT for asymmetric dimethylarginine (ADMA) formation and is the most conserved and widely distributed one. Two chicken prmt1 splicing variants were assembled and confirmed by RT-PCR experiments. However, only two scaffolds containing single separate prmt1 exon with high GC contents are present in the current chicken genome assembly. Besides, prmt1 exons are scattered in separate small scaffolds in most avian species. Complete prmt1 gene has only been predicted from two falcon species with few neighboring genes. Crocodilians are considered close to the common ancestor shared by crocodilians and birds. The gene arrangements around prmt1 in American alligator are different from that in birds but are largely conserved in human. Orthologues of genes in a large segment of human chromosomal 19 around PRMT1 are missing or not assigned to the current chicken chromosomes. In comparison, prmt8, the prmt1 paralogue, is on chicken chromosome 1 with the gene arrangements downstream of prmt8 highly conserved in birds, crocodilians, and human. However, the ones upstream vary greatly in birds. Biochemically, we found that though prmt1 transcripts were detected, limited or none PRMT1 protein was present in chicken tissues. Moreover, a much higher level of PRMT8 protein was detected in chicken brain than in mouse brain. While PRMT8 is brain specific in other vertebrate species studied, low level of PRMT8 was present in chicken but not mouse liver and muscle. We also showed that the ADMA level in chicken was similar to that in mouse. This study provides the critical information of chicken PRMT1 and PRMT8 for future analyses of the function of protein arginine methyltransferases in birds.	[Wang, Yi-Chun; Wang, Chien-Wen; Tsai, Yun-Jung; Chang, Chien-Ping; Lee, Yu-Jen; Lin, Min-Jon; Li, Chuan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Wang, Yi-Chun; Lin, Min-Jon; Li, Chuan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Wen-Chang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Academia Sinica - Taiwan	Li, C (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan.; Li, C (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	cli@csmu.edu.tw	Lin, Wen-chang/B-3100-2011; Lin, Wen-chang/ABH-7976-2020	Lin, Wen-chang/0000-0003-0194-1745; Lin, Wen-chang/0000-0003-0194-1745	Ministry of Science and Technology, Taiwan, ROC [MOST 103-2320-B-040-022-MY3, MOST 103-2320-B-040 -022-MY3]	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	The study was supported by MOST 103-2320-B-040-022-MY3 from Ministry of Science and Technology, Taiwan, ROC to CL.; The study was supported by MOST 103-2320-B-040 -022-MY3 from Ministry of Science and Technology, Taiwan, ROC to CL. We thank Su-Fong Ye for helping the in vitro methylation reaction.	BALDWIN GS, 1971, SCIENCE, V171, P579, DOI 10.1126/science.171.3971.579; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Denyer MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150988; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hron T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0724-z; Hughes AL, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-12; Hughes AL, 2008, MOL BIOL EVOL, V25, P2681, DOI 10.1093/molbev/msn207; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; Kim JD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500615; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee PKM, 2017, J NEUROCHEM, V140, P613, DOI 10.1111/jnc.13921; Lee YJ, 2012, J CELL BIOCHEM, V113, P2721, DOI 10.1002/jcb.24151; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Lin CH, 2002, J PROTEIN CHEM, V21, P447, DOI 10.1023/A:1021394903025; Lin Ying-Chi, 2013, ScientificWorldJournal, V2013, P736386, DOI 10.1155/2013/736386; Lovell PV, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0565-1; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pawlak MR, 2002, J CELL BIOCHEM, V87, P394, DOI 10.1002/jcb.10307; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Simandi Z, 2015, STEM CELLS, V33, P726, DOI 10.1002/stem.1894; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tsai YJ, 2011, FEBS J, V278, P905, DOI 10.1111/j.1742-4658.2011.08006.x; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Warren WC, 2017, G3-GENES GENOM GENET, V7, P109, DOI 10.1534/g3.116.035923; Wei HM, 2014, FEBS LETT, V588, P1542, DOI 10.1016/j.febslet.2014.03.052; Weng MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036708; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	40	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185042	10.1371/journal.pone.0185042	http://dx.doi.org/10.1371/journal.pone.0185042			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934323	Green Submitted, gold, Green Published			2022-12-27	WOS:000411339900079
J	Xu, QH; Shi, WZ; Xie, YH; Wang, ZF; Li, XS; Tong, CX				Xu, Qinghai; Shi, Wanzhong; Xie, Yuhong; Wang, Zhenfeng; Li, Xusheng; Tong, Chuanxin			Identification of low-overpressure interval and its implication to hydrocarbon migration: Case study in the Yanan sag of the Qiongdongnan Basin, South China Sea	PLOS ONE			English	Article							KRISHNA-GODAVARI BASIN; ORGANIC-MATTER MATURATION; PORE-PRESSURE PREDICTION; GEOPRESSURE PREDICTION; SEISMIC DATA; WELL LOGS; INDIA; YINGGEHAI; GENERATION; SYSTEMS	The Qiongdongnan Basin is a strongly overpressured basin with the maximum pressure coefficient (the ratio of the actual pore pressure versus hydrostatic pressure at the same depth) over 2.27. However, there exists a widespread low-overpressure interval between the strong overpressure intervals in the Yanan Sag of western basin. The mechanisms of the low-overpressure interval are not well understood. Three main approaches, pore pressure test data and well-log analysis, pressure prediction based on the relationship between the deviation of the velocity and the pressure coefficients, and numerical modeling, were employed to illustrate the distribution and evolution of the low-overpressure interval. And we analyzed and explained the phenomenon of the low-overpressure interval that is both underlain and overlain by high overpressure internal. The low-overpressure interval between the strong overpressure intervals can be identified and modelled by drilling data of P-wave sonic and the mud weight, and the numerical modeling using the PetroMod software. Results show that the low-overpressure interval is mainly composed of sandstone sediments. The porosities of sandstone in the low-overpressure interval primarily range from 15%-20%, and the permeabilities range from 10-100 md. Analysis of the geochemical parameters of C1, iC4/nC4, Delta R3, and numerical modeling shows that oil and gas migrated upward into the sandstone in the low-overpressure interval, and then migrated along the sandstone of low-overpressure interval into the Yacheng uplift. The low-overpressure both underlain and overlain by overpressure resulted from the fluids migrating along the sand-stones in the low-overpressure interval into the Yacheng uplift since 1.9Ma. The mudstone in the strong overpressure interval is good cap overlain the sandstone of low-overpressure interval, therefore up-dip pinchouts or isolated sandstone in the low-overpressure interval locating the migration path of oil and gas are good plays for hydrocarbon exploration.	[Xu, Qinghai; Shi, Wanzhong] China Univ Geosci, Minist Educ, Key Lab Tecton & Petr Resources, Wuhan, Hubei, Peoples R China; [Xu, Qinghai; Shi, Wanzhong] China Univ Geosci, Fac Earth Resources, Wuhan, Hubei, Peoples R China; [Xie, Yuhong; Wang, Zhenfeng; Li, Xusheng; Tong, Chuanxin] CNOOC, Zhanjiang Co, Beijing, Peoples R China	China University of Geosciences; China University of Geosciences; China National Offshore Oil Corporation (CNOOC)	Shi, WZ (corresponding author), China Univ Geosci, Minist Educ, Key Lab Tecton & Petr Resources, Wuhan, Hubei, Peoples R China.; Shi, WZ (corresponding author), China Univ Geosci, Fac Earth Resources, Wuhan, Hubei, Peoples R China.	shiwz@cug.edu.cn			Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan); Ministry of Science and Technology of China [2011ZX05023-004-010]	Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan)(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was jointly supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan), and the 12th "five-year" plan of the Ministry of Science and Technology of China (2011ZX05023-004-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was jointly supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan), and the 12th "five-year" plan of the Ministry of Science and Technology of China (2011ZX05023-004-010). The authors would like to express their sincere appreciations to Keyu Liu of Commonwealth Scientific and Industrial Research Organization (CSIRO) Australia for his valuable suggestions. We also thank the Editor Iratxe Puebla and two reviewers who give helpful comments and suggestions.	Belotti P., 1978, J OIL GAS, V21, P76; Carcione JM, 2003, GEOPHYSICS, V68, P1569, DOI 10.1190/1.1620631; Chatterjee R, 2011, NAT HAZARDS, V57, P121, DOI 10.1007/s11069-010-9659-6; Chen HH, 1998, AAPG BULL, V82, P757; Chen HH, 2003, GEOFLUIDS, V3, P177, DOI 10.1046/j.1468-8123.2003.00061.x; Das B, 2017, INT J ROCK MECH MIN, V93, P30, DOI 10.1016/j.ijrmms.2016.12.018; Dasgupta S, 2016, AAPG BULL, V100, P1833, DOI 10.1306/05131615170; Dasgupta S, 2016, MAR PETROL GEOL, V78, P493, DOI 10.1016/j.marpetgeo.2016.10.004; [杜学斌 Du Xuebin], 2010, [大地构造与成矿学, Geotectonica et Metallogenia], V34, P554; Dutta NC, 2002, GEOPHYSICS, V67, P2012, DOI 10.1190/1.1527101; Eaton B. A, 1972, WORLD OIL, V185, P51; Fu N., 2005, PETROLEUM EXPLORATIO, V32, P34; Guo XW, 2010, AAPG BULL, V94, P1859, DOI 10.1306/05191009179; HAO F, 1995, AAPG BULL, V79, P551; Hao F, 1998, J PETROL GEOL, V21, P427, DOI 10.1111/j.1747-5457.1998.tb00794.x; Hao F., 2001, SCI CHINA SER D, V31, P471; Hermanrud C, 1998, AAPG MEMOIR, V70, P65; Kan TK, 2001, GEOPHYSICS, V66, P1937, DOI 10.1190/1.1487135; [李纯泉 Li Chunquan], 2002, [新疆石油地质, Xinjiang Petroleum Geology], V23, P389; [李绪深 Li Xushen], 2005, [地质科技情报, Geological Science and Techology Information], V24, P70; [李宗亮 LI Zongliang], 2008, [新疆石油地质, Xinjiang Petroleum Geology], V29, P753; Muggeridge A, 2005, AAPG BULL, V89, P61, DOI 10.1306/07300403002; Pennebaker E. S, 1968, WORLD OIL, V166, P73; Sayers CM, 2002, GEOPHYSICS, V67, P1286, DOI 10.1190/1.1500391; Shi WZ, 2013, J ASIAN EARTH SCI, V66, P150, DOI 10.1016/j.jseaes.2012.12.037; Singha DK, 2014, GEOCHEM GEOPHY GEOSY, V15, P1009, DOI 10.1002/2013GC005162; Tingay MRP, 2009, AAPG BULL, V93, P51, DOI 10.1306/08080808016; Wilkinson M, 2006, AAPG BULL, V90, P1945, DOI 10.1306/06270605178; Xiao J., 2007, J OIL GAS TECHNOLOGY, V29, P7; Xiao XM, 2006, ORG GEOCHEM, V37, P990, DOI 10.1016/j.orggeochem.2006.06.001; Xie X. N., 1999, SCI CHINA SER D, V29, P247; [谢玉洪 Xie Yuhong], 2011, [天然气工业, Natural Gas Industry], V31, P21; Yuan Y, 2009, MAR PETROL GEOL, V26, P1152, DOI 10.1016/j.marpetgeo.2008.08.008; Zhang T., 1999, ACTA SEDIMENTOL SINI, V17, P627; Zhu G. H., 2000, CHINA OFFSHORE OIL G, V14, P29; [祝建军 ZHU Jianjun], 2011, [天然气地球科学, Natural Gas Geoscience], V22, P324; Zhu W. L, 2007, PETROLEUM PRINT, P145; 杨计海, 1999, [天然气工业, Natural Gas Industry], V19, P39	38	3	3	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183676	10.1371/journal.pone.0183676	http://dx.doi.org/10.1371/journal.pone.0183676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934237	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900013
J	Barington, M; Brorson, MM; Hofman-Bang, J; Rasmussen, SK; Holst, B; Feldt-Rasmussen, U				Barington, Maria; Brorson, Marianne Moller; Hofman-Bang, Jacob; Rasmussen, Se Krogh; Holst, Birgitte; Feldt-Rasmussen, Ulla			Ghrelin-mediated inhibition of the TSH-stimulated function of differentiated human thyrocytes ex vivo	PLOS ONE			English	Article							PITUITARY-THYROID AXIS; AGOUTI-RELATED PROTEIN; BODY-MASS INDEX; METABOLIC PARAMETERS; CIRCULATING GHRELIN; PLASMA GHRELIN; NEUROPEPTIDE-Y; MESSENGER-RNA; FOOD-INTAKE; ENERGY HOMEOSTASIS	Ghrelin is a peptide hormone produced mainly in the gastrointestinal tract known to regulate several physiological functions including gut motility, adipose tissue accumulation and hunger sensation leading to increased bodyweight. Studies have found a correlation between the plasma levels of thyroid hormones and ghrelin, but an effect of ghrelin on the human thyroid has never been investigated even though ghrelin receptors are present in the thyroid. The present study shows a ghrelin-induced decrease in the thyroid-stimulating hormone (TSH)-induced production of thyroglobulin and mRNA expression of thyroperoxidase in a primary culture of human thyroid cells obtained from paranodular tissue. Accordingly, a trend was noted for an inhibition of TSH-stimulated expression of the sodium-iodine symporter and the TSH-receptor. Thus, this study suggests an effect of ghrelin on human thyrocytes and thereby emphasizes the relevance of examining whether ghrelin also influences the metabolic homeostasis through altered thyroid hormone production.	[Barington, Maria; Brorson, Marianne Moller; Hofman-Bang, Jacob; Rasmussen, Se Krogh; Feldt-Rasmussen, Ulla] Univ Copenhagen Hosp, Dept Med Endocrinol, Rigshosp, Copenhagen, Denmark; [Holst, Birgitte] Univ Copenhagen, Inst Pharmacol, Dept Neurosci & Pharmacol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Feldt-Rasmussen, U (corresponding author), Univ Copenhagen Hosp, Dept Med Endocrinol, Rigshosp, Copenhagen, Denmark.	ufeldt@rh.dk	Feldt-Rasmussen, Ulla/AAB-9218-2021	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Holst, Birgitte/0000-0001-7432-097X				Abd El Gawad SS, 2012, ENDOCR PRACT, V18, P376, DOI 10.4158/EP11130.OR; Altinova AE, 2006, THYROID, V16, P1259, DOI 10.1089/thy.2006.16.1259; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; BELLUR S, 1990, ENDOCRINOLOGY, V127, P1526, DOI 10.1210/endo-127-3-1526; Biyikli HH, 2014, ENDOCR PRACT, V20, P818, DOI 10.4158/EP13469.OR; Braclik M, 2008, THYROID, V18, P545, DOI 10.1089/thy.2007.0300; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Cassoni P, 2000, J ENDOCRINOL, V165, P139, DOI 10.1677/joe.0.1650139; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Emami A, 2014, REGUL PEPTIDES, V189, P17, DOI 10.1016/j.regpep.2014.01.001; Fekete C, 2006, ENDOCRINOLOGY, V147, P520, DOI 10.1210/en.2005-0956; Fekete C, 2004, ENDOCRINOLOGY, V145, P4816, DOI 10.1210/en.2004-0476; Fekete C, 2002, ENDOCRINOLOGY, V143, P3846, DOI 10.1210/en.2002-220338; Fekete C, 2001, ENDOCRINOLOGY, V142, P2606, DOI 10.1210/en.142.6.2606; Fusco A, 2007, J ENDOCRINOL INVEST, V30, P948, DOI 10.1007/BF03349243; Gimenez-Palop O, 2005, EUR J ENDOCRINOL, V153, P73, DOI 10.1530/eje.1.01934; Gjedde S, 2008, J CLIN ENDOCR METAB, V93, P2277, DOI 10.1210/jc.2007-2619; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gurgul E, 2012, ENDOKRYNOL POL, V63, P456; Haqq AM, 2003, J CLIN ENDOCR METAB, V88, P174, DOI 10.1210/jc.2002-021052; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kluge M, 2013, J PSYCHIATR RES, V47, P1236, DOI 10.1016/j.jpsychires.2013.05.010; Kluge M, 2010, EUR J ENDOCRINOL, V162, P1059, DOI 10.1530/EJE-10-0094; Kokkinos A, 2007, ENDOCRINE, V32, P30, DOI 10.1007/s12020-007-9002-5; Konturek PC, 2004, J PHYSIOL PHARMACOL, V55, P325; Kordi F, 2015, INT J ENDOCRINOL MET, V13, DOI 10.5812/ijem.17988; Kosowicz J, 2011, HORM METAB RES, V43, P121, DOI 10.1055/s-0030-1269853; Kronborg TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179858; Kuroda K, 2015, ENDOCRINOLOGY, V156, P4437, DOI 10.1210/en.2015-1561; MADSEN SN, 1976, ACTA ENDOCRINOL-COP, V81, P208, DOI 10.1530/acta.0.0810208; Mahmoudi F, 2011, IRAN J PHARM RES, V10, P627; Malandrino N, 2014, EXP CLIN ENDOCR DIAB, V122, P540, DOI 10.1055/s-0034-1376965; Marzullo P, 2004, J CLIN ENDOCR METAB, V89, P936, DOI 10.1210/jc.2003-031328; Morillo-Bernal J, 2011, PEPTIDES, V32, P2333, DOI 10.1016/j.peptides.2011.09.013; Otto B, 2001, EUR J ENDOCRINOL, V145, pR5; Park YJ, 2008, MOL CELL ENDOCRINOL, V285, P19, DOI 10.1016/j.mce.2008.01.003; Pazos Y, 2008, VITAM HORM, V77, P89, DOI 10.1016/S0083-6729(06)77005-4; Pekary AE, 2012, PEPTIDES, V36, P157, DOI 10.1016/j.peptides.2012.04.021; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P173, DOI 10.1016/0303-7207(95)03712-8; Reichenbach A, 2012, ENDOCRINOLOGY, V153, P5452, DOI 10.1210/en.2012-1622; Riis ALD, 2003, J CLIN ENDOCR METAB, V88, P853, DOI 10.1210/jc.2002-021302; ROGER P, 1988, J CLIN ENDOCR METAB, V66, P1158, DOI 10.1210/jcem-66-6-1158; Ruchala M, 2014, PEPTIDES, V51, P31, DOI 10.1016/j.peptides.2013.10.018; Sawicka B, 2010, J PEDIATR ENDOCR MET, V23, P345, DOI 10.1515/jpem.2010.055; Sawicka Beata, 2009, Pediatr Endocrinol Diabetes Metab, V15, P20; Schussler P, 2012, OBESITY, V20, P1212, DOI 10.1038/oby.2011.385; Sivertsen B, 2013, BRIT J PHARMACOL, V170, P1349, DOI 10.1111/bph.12361; Sosic-Jurjevic B, 2009, NEUROENDOCRINOLOGY, V89, P327, DOI 10.1159/000188603; Tanda ML, 2009, J ENDOCRINOL INVEST, V32, P74, DOI 10.1007/BF03345683; Tang-Christensen M, 2004, ENDOCRINOLOGY, V145, P4645, DOI 10.1210/en.2004-0529; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yin Y, 2014, INT J MOL SCI, V15, P4837, DOI 10.3390/ijms15034837; Yu HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143001; Zhu Y, 2014, PHYSIOL BEHAV, V135, P135, DOI 10.1016/j.physbeh.2014.06.009; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zimmermann-Belsing T, 1998, SCAND J CLIN LAB INV, V58, P529, DOI 10.1080/00365519850186148	61	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184992	10.1371/journal.pone.0184992	http://dx.doi.org/10.1371/journal.pone.0184992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931076	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700052
J	Rosinska, M; Parda, N; Kolakowska, A; Godzik, P; Zakrzewska, K; Madalinski, K; Zielinski, A; Boguradzka, A; Gierczynski, R; Stepien, M				Rosinska, Magdalena; Parda, Natalia; Kolakowska, Agnieszka; Godzik, Paulina; Zakrzewska, Karolina; Madalinski, Kazimierz; Zielinski, Andrzej; Boguradzka, Anna; Gierczynski, Rafal; Stepien, Malgorzata			Factors associated with hepatitis C prevalence differ by the stage of liver fibrosis: A cross-sectional study in the general population in Poland, 2012-2016	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; VIRUS-INFECTION; DISEASE BURDEN; HIV-INFECTION; UNITED-STATES; RISK-FACTORS; B-VIRUS; HCV; CIRRHOSIS; TRANSMISSION	Background & aims There is a considerable burden of hepatitis C in Europe related to the lack of prompt diagnosis. We aimed to estimate the prevalence and related risk factors of HCV infections by the stages of liver fibrosis, using non-invasive methods, to understand testing needs in Poland. Methods A cross-sectional study was conducted in 2012-2016 adopting a stratified random sampling of primary health care units followed by systematic sampling of patients within each unit. Study participants filled a questionnaire and donated blood for laboratory HCV testing. Additionally, the results of liver function tests and platelet count were collected to calculate APRI and FIB-4 scores. Cases were classified according to the level of fibrosis: 'significant fibrosis' (APRI >= 0.7 or FIB4 >= 1.45) and 'no significant fibrosis' (APRI< 0.7 and FIB4< 1.45). Results Of 21 875 study participants, 102 were HCV-RNA positive. Prevalence of HCV infections and significant fibrosis was estimated at 0.47% (95% CI 0.38% -0.57%) and 0.12% (0.08% -0.17%), respectively. Cases with significant fibrosis accounted for 51.6% (33.4%-69.9%) in men and 34.4% (17.3%-51.4%) in women. There was no correlation between the HCV prevalence and age. Blood transfusion prior to 1992 strongly predicted significant fibrosis as did the history of injecting drug use (IDU) and ever having an HCV-infected sexual partner in men and caesarean sections in women. Factors associated with HCV infection without significant fibrosis were tattooing in men and younger age in women. We acknowledge limited possibility to study the associations between IDU and ever having HCV-infected sexual partner, given small sample sizes for these exposures. Conclusions As no clear birth cohort affected by HCV could be identified, risk factor-based screening in the general population should be considered, taking into account the association between the increased risk of liver fibrosis and the history of transfusion prior to 1992 and caesarean sections.	[Rosinska, Magdalena; Parda, Natalia; Zakrzewska, Karolina; Zielinski, Andrzej; Stepien, Malgorzata] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Epidemiol, Warsaw, Poland; [Kolakowska, Agnieszka; Godzik, Paulina; Zakrzewska, Karolina; Madalinski, Kazimierz] Natl Inst Hyg, Dept Virol, Natl Inst Publ Hlth, Warsaw, Poland; [Boguradzka, Anna] Ctr Postgrad Med Educ, Dept Family Practice, Warsaw, Poland; [Gierczynski, Rafal] Natl Inst Hyg, Dept Bacteriol, Natl Inst Publ Hlth, Warsaw, Poland	National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); Centre of Postgraduate Medical Education - Poland; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH)	Rosinska, M (corresponding author), Natl Inst Hyg, Natl Inst Publ Hlth, Dept Epidemiol, Warsaw, Poland.	mrosinska@pzh.gov.pl	Stępień, Małgorzata/AAV-4282-2020; Zielinski, Andrzej/ABA-2921-2020; Rosińska, Magdalena/K-5857-2019; Rosińska, Magdalena/Q-2068-2018	Stępień, Małgorzata/0000-0002-4640-7290; Rosińska, Magdalena/0000-0002-6256-7809; Rosińska, Magdalena/0000-0002-6256-7809; Zakrzewska, Karolina/0000-0003-4131-4738	Switzerland through the Swiss Contribution to the enlarged European Union [KIK 35]; Minister of Health of the Republic of Poland	Switzerland through the Swiss Contribution to the enlarged European Union; Minister of Health of the Republic of Poland	This study was supported by a grant number KIK 35 Prevention of HCV infections from Switzerland through the Swiss Contribution to the enlarged European Union (https://www.programszwajcarski.gov.pl/) and the Minister of Health of the Republic of Poland (http://www.mz.gov.pl/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspinall EJ, 2015, EUR J EPIDEMIOL, V30, P115, DOI 10.1007/s10654-014-9958-4; Bailey H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2089-7; Brouard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126920; Carney K, 2013, HEPATOLOGY, V57, P2117, DOI 10.1002/hep.26245; Coward S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011821; Cullen BL, 2012, J PUBLIC HEALTH-UK, V34, P14, DOI 10.1093/pubmed/fdr097; European Association for the Study of the Liver, 2016, J HEPATOL; Fierer DS, 2016, J INFECT DIS, V214, P1134, DOI 10.1093/infdis/jiw336; Flisiak R, 2011, EUR J GASTROEN HEPAT, V23, P1213, DOI 10.1097/MEG.0b013e32834d173c; Foster GR, 2016, J HEPATOL, V64, P1224, DOI 10.1016/j.jhep.2016.01.029; Godzik Paulina, 2012, Przegl Epidemiol, V66, P575; Green L, 2016, BJOG-INT J OBSTET GY, V123, P2164, DOI 10.1111/1471-0528.13831; Hager RME, 2004, AM J OBSTET GYNECOL, V190, P428, DOI 10.1016/j.ajog.2003.08.037; Hahne A SJ, 2013, BMC INFECT DIS, P13; Hartleb M, 2012, EUR J GASTROEN HEPAT, V24, P1288, DOI 10.1097/MEG.0b013e328357632a; Hatzakis A, 2015, J VIRAL HEPATITIS, V22, P26, DOI 10.1111/jvh.12351; Hope VD, 2014, EPIDEMIOL INFECT, V142, P270, DOI 10.1017/S0950268813000940; Indolfi G, 2013, J MED VIROL, V85, P608, DOI 10.1002/jmv.23522; Jewett A, 2015, HEALTH PROMOT PRACT, V16, P256, DOI 10.1177/1524839914532291; Klevens RM, 2016, CLIN INFECT DIS, V63, P1049, DOI 10.1093/cid/ciw468; Leznicka M, 2014, MED PR, V65, P633, DOI 10.13075/mp.5893.00083; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Little R.J.A., 2002, STAT ANAL MISSING DA; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; Parda N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013359; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Rosinska M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0828-9; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sulkowski MS, 2016, GASTROENTEROLOGY, V150, P419, DOI 10.1053/j.gastro.2015.10.013; Tohme RA, 2012, CLIN INFECT DIS, V54, P1167, DOI 10.1093/cid/cir991; Udompap P, 2016, J HEPATOL, V64, P1027, DOI 10.1016/j.jhep.2016.01.009; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249; Xu FJ, 2016, CLIN INFECT DIS, V62, P289, DOI 10.1093/cid/civ860; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566; Zuure FR, 2014, BMC PUBLIC HEALTH, P14	38	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185055	10.1371/journal.pone.0185055	http://dx.doi.org/10.1371/journal.pone.0185055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931062	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700064
J	Toyota, T; Shiomi, H; Morimoto, T; Natsuaki, M; Kimura, T				Toyota, Toshiaki; Shiomi, Hiroki; Morimoto, Takeshi; Natsuaki, Masahiro; Kimura, Takeshi			Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration	PLOS ONE			English	Article							DRUG-ELUTING STENTS; METAANALYSIS; INTERVENTION; REGISTRY	Aims The Dual Antiplatelet Therapy (DAPT) study demonstrated that DAPT beyond 1-year after drug-eluting stent (DES) implantation, as compared with aspirin therapy alone, significantly reduced the risk of major cardiovascular and cerebrovascular events, which was mainly driven by the large risk reduction for myocardial infarction (MI). We sought to compare the largest DAPT study with other trials evaluating DAPT durations after DES implantation. Methods and results By a systematic literature search, we identified 9 trials comparing prolonged-versus short-DAPT in addition to the DAPT study. The result from the DAPT study (N = 9961) with public-private collaboration was different from the pooled result of the 9 other investigator-driven trials (N = 22174) in terms of the effect of prolonged-DAPT on MI (odds ratio [OR] 0.48 [95% CI 0.38-0.62] versus pooled OR 0.88 [95% CI 0.67-1.15]: P = 0.001 for difference), while the trends for excess risk of prolonged-DAPT relative to short-DAPT for all-cause death (OR 1.31 [95% CI 0.97-1.78] versus pooled OR 1.16 [95% CI 0.92-1.45]: P = 0.53 for difference), and bleeding (OR 1.62 [95% CI 1.21-2.17] versus pooled OR 2.08 [95% CI 1.51-2.84]: P = 0.25 for difference) were consistently seen in both the DAPT and other trials. The annual rate of MI during aspirin mono-therapy in the DAPT study was much higher than that those in the other trials (2.7% versus 0.6-1.6%). Conclusions Given the difference between the DAPT study and other trials, future studies should focus on certain subgroups of patients that are more or less likely to benefit from longer duration DAPT.	[Toyota, Toshiaki; Shiomi, Hiroki; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Kyoto, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan; [Natsuaki, Masahiro] Saiseikai Fukuoka Gen Hosp, Div Cardiol, Fukuoka, Fukuoka, Japan	Kyoto University; Hyogo College of Medicine	Kimura, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Kyoto, Japan.	taketaka@kuhp.kyoto-u.ac.jp	Toyota, Toshiaki/AAF-9494-2021; Shiomi, Hiroki/ADJ-9510-2022	Toyota, Toshiaki/0000-0002-7214-2265; Shiomi, Hiroki/0000-0001-7234-023X				Abo-salem E, 2015, CARDIOVASC THER, V33, P253, DOI 10.1111/1755-5922.12137; Cassese S, 2015, CLIN RES CARDIOL, V104, P887, DOI 10.1007/s00392-015-0860-1; Elmariah S, 2015, LANCET, V385, P792, DOI 10.1016/S0140-6736(14)62052-3; Giustino G, 2015, J AM COLL CARDIOL, V65, P1298, DOI 10.1016/j.jacc.2015.01.039; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kaul S, 2010, J AM COLL CARDIOL, V55, P415, DOI 10.1016/j.jacc.2009.06.065; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Natsuaki M, 2014, CIRC-CARDIOVASC INTE, V7, P168, DOI 10.1161/CIRCINTERVENTIONS.113.000987; Navarese EP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1618; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X; Spencer FA, 2015, ANN INTERN MED, V163, P118, DOI 10.7326/M15-0083; Stefanini GG, 2014, J AM COLL CARDIOL, V64, P953, DOI 10.1016/j.jacc.2014.06.1158; Tada T, 2013, JACC-CARDIOVASC INTE, V6, P1267, DOI 10.1016/j.jcin.2013.06.015; US Food and Drug Administration, 2015, FDA DRUG SAF COMM FD; Verdoia M, 2016, ANGIOLOGY, V67, P224, DOI 10.1177/0003319715586500; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]	18	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0174502	10.1371/journal.pone.0174502	http://dx.doi.org/10.1371/journal.pone.0174502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931015	gold, Green Published, Green Submitted			2022-12-27	WOS:000411314700001
J	Gao, Y; Wang, YR; Zhai, X; He, YF; Chen, R; Zhou, JJ; Li, M; Wang, QJ				Gao, Ye; Wang, Yiran; Zhai, Xiao; He, Yifei; Chen, Rong; Zhou, Jingjing; Li, Ming; Wang, Qijin			Publication trends of research on diabetes mellitus and T cells (1997-2016): A 20-year bibliometric study	PLOS ONE			English	Article							PATHOGENESIS; RESPONSES; ARTICLES; CHINA	Introduction Diabetes Mellitus (DM) is a huge burden for human health. Recent studies show the close relationship between DM and T cells. We investigated the trend in DM and T cells research. Methods Using the Web of Science database, we searched the publications on DM and T cells in 1997-2016, and studied the source data using bibliometric methodology. Excel 2016, GraphPad Prism 5, and VOSviewer software were used to analyze the publication trend in DM and T cells research. Results We found a total of 1077 publications with 38109 citations up to January 23, 2017. The highest contribution came from the United States, with 48.38% of the publications, 61.44% of the citations and the highest H-index (74). China had the 5th place for total publications, but ranked 11th both for citation frequency (604) and H-index (13). The inflection point of the global DM and T cells publications was in 2000. Journal of Immunology published the most related articles (164). Santamaria P. was the leading scholar in this field with the most publications (35). The keywords "regulatory T cell" and "autoimmune diabetes" were mentioned more than 300 times. Furthermore, type 2 (T2) DM, T cell immunoglobulin and mucin domain (TIM) and obesity are becoming popular research topics in this field. Conclusion The quantity of publications on DM and T cells grew rapidly around year 2000, but has relatively decreased recently. The United States had the leading position in global research. There was a discrepancy between productivity and quality of publications from China. Latest progress is most likely first published by the Journal of Immunology. Santamaria P.,Roep B. O. and Peakman M. were the pioneer scholars in this field. Most researchers have focused on "regulatory T cell" and "autoimmune diabetes" research. In future, T2DM, TIM and obesity may be the popular areas.	[Gao, Ye; Wang, Yiran] Second Mil Med Univ, Changhai Hosp, Grad Management Unit, Shanghai, Peoples R China; [Wang, Yiran] Second Mil Med Univ, Changhai Hosp, Dept Oncol, Shanghai, Peoples R China; [Zhai, Xiao; Li, Ming] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China; [He, Yifei; Chen, Rong; Zhou, Jingjing; Wang, Qijin] Second Mil Med Univ, Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Wang, QJ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China.	wangqijin8668601@163.com	Wang, Yijun/GXW-1763-2022; Wang, Yin/HCI-9352-2022; wang, yixuan/GXW-2866-2022; wang, yi/GVT-8516-2022; Wang, Yixuan/GZK-6559-2022	Gao, Ye/0000-0002-6338-9602	National Natural Science Foundation of China [81670741]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81670741). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2016, J THORAC ONCOL, V11, P1040, DOI 10.1016/j.jtho.2016.03.010; Anderson DE, 2007, EXPERT OPIN THER TAR, V11, P1005, DOI 10.1517/14728222.11.8.1005; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Ekinci S, 2015, WORLD NEUROSURG, V84, P2072, DOI 10.1016/j.wneu.2014.12.003; Frankl JA, 2016, DIABETES-METAB RES, V32, P297, DOI 10.1002/dmrr.2720; Geaney F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133009; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Li T, 2008, NEUROSCI LETT, V441, P248, DOI 10.1016/j.neulet.2008.06.044; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lyu QJ, 2017, SCIENTOMETRICS, V110, P105, DOI 10.1007/s11192-016-2179-8; Narotsky D, 2012, EUR J GASTROEN HEPAT, V24, P1071, DOI 10.1097/MEG.0b013e328355a4ab; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Seriwala HM, 2015, EXPERT REV RESP MED, V9, P817, DOI 10.1586/17476348.2015.1103649; Shuaib W, 2015, AM J CARDIOL, V115, P972, DOI 10.1016/j.amjcard.2015.01.029; Skyler JS, 2017, DIABETES, V66, P241, DOI 10.2337/db16-0806; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tang W, 2013, CELL PHYSIOL BIOCHEM, V32, P827, DOI 10.1159/000354485; Wang QJ, 2015, APMIS, V123, P146, DOI 10.1111/apm.12330; Wong FS, 1997, RES IMMUNOL, V148, P327, DOI 10.1016/S0923-2494(97)87242-2; Yang TT, 2015, EUR REV MED PHARMACO, V19, P2010; Yates T, 2016, NAT REV ENDOCRINOL, V12, P377, DOI 10.1038/nrendo.2016.74; Zetterqvist AV, 2013, PLOS ONE, V8, P14; Zhai X, 2016, LANCET, V387, P1722, DOI 10.1016/S0140-6736(16)30261-6; Zhang N, 2016, AUTOIMMUNITY, V49, P405, DOI 10.1080/08916934.2016.1196677; Zhao PQ, 2016, J DIABETES, V8, P199, DOI 10.1111/1753-0407.12276	28	49	51	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184869	10.1371/journal.pone.0184869	http://dx.doi.org/10.1371/journal.pone.0184869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926600	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600046
J	Bai, YR; Qiao, L; Xie, N; Shi, YQ; Liu, N; Wang, JH				Bai, Yuru; Qiao, Lu; Xie, Ning; Shi, Yongquan; Liu, Na; Wang, Jinhai			Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers	PLOS ONE			English	Article							MESSENGER-RNA DEADENYLATION; BREAST-CANCER; LUNG ADENOCARCINOMA; GASTRIC-CANCER; CELL-PROLIFERATION; PROSTATE-CANCER; DOWN-REGULATION; TOB; METHYLATION; CARCINOMA	Background Despite advances in early diagnosis and treatment, cancer remains the major cause of mortality in the world. The Tob/BTG antiproliferative (APRO) protein family is reported to participate in diverse human diseases. However, there's little known about their expression and prognostic values in most human cancers. Methods We performed a detailed cancer vs. normal analysis. The mRNA expression levels of APRO family in various cancers were analyzed via the Oncomine database. Moreover, the Kaplan-Meier Plotter and PrognScan databases were used to evaluate the prognostic values. Results We observed that the mRNA expression levels of TOB1-2 and BTG2 were decreased in most cancers compared with normal tissues, while BTG3 was upregulated in most cancers. In survival analyses based on Kaplan-Meier Plotter, TOB1, BTG1 and BTG4 showed significant associations with survival outcome of different subtypes of breast cancer. Decreased BTG2 was related with poor relapse free survival (RFS) in all subtypes of breast cancer. Especially, besides RFS, reduced BTG2 also indicated worse overall survival and distant metastasis free survival in breast cancer patients who were classified as luminal A. Significant prognostic effects of the whole APRO family were also found in lung adenocarcinoma, but not in squamous cell lung carcinoma. In addition, potential correlations between some APRO family members and survival outcomes were also observed in ovarian, colorectal and brain cancer. Conclusions Some members of APRO family showed significant expression differences between cancer and normal tissues, and could be prognostic biomarkers for defined cancer types.	[Bai, Yuru; Qiao, Lu; Xie, Ning; Liu, Na; Wang, Jinhai] Xi An Jiao Tong Univ, Dept Gastroenterol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China; [Shi, Yongquan] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Shi, Yongquan; Liu, Na] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Air Force Military Medical University	Liu, N; Wang, JH (corresponding author), Xi An Jiao Tong Univ, Dept Gastroenterol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China.; Liu, N (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China.	liunafmmu@163.com; jinhaiwang@hotmail.com	liu, na/W-7939-2019; Shi, Yongquan/AAE-3954-2020		National Natural Science Foundation of China [81370484]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant number 81370484 (Na Liu). The funder had been greatly helpful in study design, decision to publish, and modification of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Helms MW, 2009, CANCER RES, V69, P5049, DOI 10.1158/0008-5472.CAN-08-4154; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Ito Y, 2005, CANCER LETT, V220, P237, DOI 10.1016/j.canlet.2004.08.017; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Lee JC, 2015, CANCER LETT, V360, P310, DOI 10.1016/j.canlet.2015.02.034; Li BS, 2015, ONCOGENE, V34, P2556, DOI 10.1038/onc.2014.214; Ma LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070716; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Nahta R, 2006, MOL CANCER THER, V5, P1593, DOI 10.1158/1535-7163.MCT-06-0133; O'Malley S, 2009, INT J CANCER, V125, P1805, DOI 10.1002/ijc.24490; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ren XL, 2015, J CANCER RES CLIN, V141, P397, DOI 10.1007/s00432-014-1826-9; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Takahashi F, 2011, ONCOGENE, V30, P3084, DOI 10.1038/onc.2011.24; Talbot SG, 2005, CANCER RES, V65, P3063, DOI 10.1158/0008-5472.CAN-04-1985; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Tzachanis D, 2009, CELL CYCLE, V8, P1019, DOI 10.4161/cc.8.7.8033; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Yu JW, 2008, GENE EXPRESSION, V14, P173; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zheng HC, 2015, ONCOTARGET, V6, P19685, DOI 10.18632/oncotarget.4081	42	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184902	10.1371/journal.pone.0184902	http://dx.doi.org/10.1371/journal.pone.0184902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922388	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300041
J	Chiu, APY; Lin, QY; He, DH				Chiu, Alice P. Y.; Lin, Qianying; He, Daihai			News trends and web search query of HIV/AIDS in Hong Kong	PLOS ONE			English	Article							ONLINE INFORMATION-SEEKING; PUBLIC-HEALTH; SURVEILLANCE; COVERAGE; HIV; COMPLEMENTARITY; IMPACT; MEDIA; MEN; SEX	Background The HIV epidemic in Hong Kong has worsened in recent years, with major contributions from high-risk subgroup of men who have sex with men (MSM). Internet use is prevalent among the majority of the local population, where they sought health information online. This study examines the impacts of HIV/AIDS and MSM news coverage on web search query in Hong Kong. Methods Relevant news coverage about HIV/AIDS and MSM from January 1st, 2004 to December 31st, 2014 was obtained from the WiseNews databse. News trends were created by computing the number of relevant articles by type, topic, place of origin and sub-populations. We then obtained relevant search volumes from Google and analysed causality between news trends and Google Trends using Granger Causality test and orthogonal impulse function. Results We found that editorial news has an impact on "HIV" Google searches on HIV, with the search term popularity peaking at an average of two weeks after the news are published. Similarly, editorial news has an impact on the frequency of "AIDS" searches two weeks after. MSM-related news trends have a more fluctuating impact on "MSM" Google searches, although the time lag varies anywhere from one week later to ten weeks later. Conclusions This infodemiological study shows that there is a positive impact of news trends on the online search behavior of HIV/AIDS or MSM-related issues for up to ten weeks after. Health promotional professionals could make use of this brief time window to tailor the timing of HIV awareness campaigns and public health interventions to maximise its reach and effectiveness.	[Chiu, Alice P. Y.; Lin, Qianying; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University	He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China.	daihai.he@polyu.edu.hk	Lin, Qianying/ABD-8415-2021; He, Daihai/AAT-8735-2021	He, Daihai/0000-0003-3253-654X	Hong Kong Polytechnic University; AIDS Trust Fund Hong Kong [MSS 236 R]	Hong Kong Polytechnic University(Hong Kong Polytechnic University); AIDS Trust Fund Hong Kong	DH was supported by Start-up grant for new recruits of Hong Kong Polytechnic University and AIDS Trust Fund Hong Kong (MSS 236 R). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2016, LANCET, V388, P198, DOI 10.1016/S0140-6736(16)30781-4; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Census and Statistics Department Hong Kong, 2013, 62 CENS STAT DEP; Chan K, 2016, HIV SURVEILLANCE REP; DeVilbiss EA, 2014, J AUTISM DEV DISORD, V44, P3271, DOI 10.1007/s10803-014-2160-4; Dutta-Bergman MJ, 2004, NEW MEDIA SOC, V6, P659, DOI 10.1177/146144804047086; Dutta-Bergman MJ, 2004, J BROADCAST ELECTRON, V48, P41, DOI 10.1207/s15506878jobem4801_3; Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Fleiss J.L., 2013, STAT METHODS RATES P; Gabarron E, 2016, STUD HEALTH TECHNOL, V228, P778, DOI 10.3233/978-1-61499-678-1-778; Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECONOMETRICS, V14, P227, DOI 10.1016/0304-4076(80)90092-5; Jo CL, 2015, TOB CONTROL, V24, P395, DOI 10.1136/tobaccocontrol-2013-051261; KALICHMAN SC, 1994, AIDS EDUC PREV, V6, P542; Kerber KA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00050; Ling Rebecca, 2016, JMIR Public Health Surveill, V2, pe156, DOI 10.2196/publichealth.6504; Linkov F, 2014, SURG OBES RELAT DIS, V10, P533, DOI 10.1016/j.soard.2013.10.007; M. Eichler, 2012, CAUSALITY STAT PERSP, P327, DOI [DOI 10.1002/9781119945710.CH22, 10.1002/9781119945710.ch22]; Niederdeppe J, 2008, J HEALTH COMMUN, V13, P181, DOI 10.1080/10810730701854110; Noar Seth M., 2013, Journal of the National Cancer Institute Monographs, P188, DOI 10.1093/jncimonographs/lgt017; Simmering JE, 2014, RES SOC ADMIN PHARM, V10, P896, DOI 10.1016/j.sapharm.2014.01.003; Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415; StatCounter Global Stats, SEARCH ENG MARK SHAR; Thompson LH, 2014, EPIDEMIOL INFECT, V142, P2397, DOI 10.1017/S0950268813003464; Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179; Weeks BE, 2012, HEALTH COMMUN, V27, P158, DOI 10.1080/10410236.2011.571757; Yan YY, 2010, J MED SYST, V34, P147, DOI 10.1007/s10916-008-9226-9; Zheluk A, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2936	31	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0185004	10.1371/journal.pone.0185004	http://dx.doi.org/10.1371/journal.pone.0185004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH3OQ	28922376	Green Submitted, gold, Green Published			2022-12-27	WOS:000411059300052
J	Antoniou, S; Lambropoulou, S				Antoniou, Stathis; Lambropoulou, Sofia			Extending topological surgery to natural processes and dynamical systems	PLOS ONE			English	Article							MAGNETIC-FLUX TUBES; MASS-ACTION; MODEL	Topological surgery is a mathematical technique used for creating new manifolds out of known ones. We observe that it occurs in natural phenomena where a sphere of dimension 0 or 1 is selected, forces are applied and the manifold in which they occur changes type. For example, 1-dimensional surgery happens during chromosomal crossover, DNA recombination and when cosmic magnetic lines reconnect, while 2-dimensional surgery happens in the formation of tornadoes, in the phenomenon of Falaco solitons, in drop coalescence and in the cell mitosis. Inspired by such phenomena, we introduce new theoretical concepts which enhance topological surgery with the observed forces and dynamics. To do this, we first extend the formal definition to a continuous process caused by local forces. Next, for modeling phenomena which do not happen on arcs or surfaces but are 2-dimensional or 3-dimensional, we fill in the interior space by defining the notion of solid topological surgery. We further introduce the notion of embedded surgery in S-3 for modeling phenomena which involve more intrinsically the ambient space, such as the appearance of knotting in DNA and phenomena where the causes and effect of the process lies beyond the initial manifold, such as the formation of black holes. Finally, we connect these new theoretical concepts with a dynamical system and we present it as a model for both 2-dimensional 0-surgery and natural phenomena exhibiting a 'hole drilling' behavior. We hope that through this study, topology and dynamics of many natural phenomena, as well as topological surgery itself, will be better understood.	[Antoniou, Stathis; Lambropoulou, Sofia] Natl Tech Univ Athens, Dept Math, Athens, Greece	National Technical University of Athens	Antoniou, S (corresponding author), Natl Tech Univ Athens, Dept Math, Athens, Greece.	santoniou@math.ntua.gr		Antoniou, Stathis/0000-0002-0668-1180	European Union (European Social Fund - ESF); Greek national funds through the Operational Program; THALES [MIS 380154]	European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program; THALES(Thales Group)	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES: Reinforcement of the interdisciplinary and/or inter-institutional research and innovation. In particular, this research is a result of the research program THALES "Algebraic Modeling of Topological and Computational Structures", MIS 380154. Professor Sofia Lambropoulou was the Scientific Administrator of this program.	Adams C, 2004, WHY KNOT INTRO MATH; Antoniou S, 2005, THESIS; Antoniou S, SPRINGER P MATH STAT; DAHLBURG RB, 1995, J GEOPHYS RES-SPACE, V100, P16991, DOI 10.1029/95JA01613; GLATZMAIER GA, 1995, NATURE, V377, P203, DOI 10.1038/377203a0; Hartwell LH, 2000, GENETICS GENES GENOM, P486; Johnson AB, 2002, GARLAND SCI; Johnson N, VISUALIZATION HOPF F; Jones VFR, 1986, NOT AM MATH SOC, V33; Keeton WT, 1983, ELEMENTS BIOL SCI, P395; Kerr RM, 2013, P IUTAM, P57; Kiehn RM, 2001, FALACO SOLITONS COSM; Kiehn RM, 2004, NONEQUILIBRIUM SYSTE, V1, p[147, 150]; Knots Rolfsen D., 2003, KNOTS LINKS; Kondrashov D, 1999, ASTROPHYS J, V519, P884, DOI 10.1086/307383; Laing CE, 2014, SCI REPORTS, V5; Lambropoulou S, 2014, MATH FORSCH OB WORKS; Lambropoulou S, 2008, DYNAMICAL SYSTEMS TO; Lambropoulou S, 2017, J KNOT THEOR RAMIF, V26, DOI 10.1142/S0218216517430027; Langford LD, 1983, REV INTERACTIONS HOP, P215; Lotka AJ, 1920, J AM CHEM SOC, V42, P1595, DOI 10.1021/ja01453a010; Milnor J, 1963, MORESE THEORY; Ott CD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.161103; Prasolov V., 1995, INTUITIVE TOPOLOGY, V4; Prasolov V.V., 1997, AMS TRANSLATIONS MAT, V154; Pujari S, 2015, USEFUL NOTES MECH CR; Ranicki Andrew, 2002, OXFORD MATH MONOGRAP; SAMARDZIJA N, 1992, P ROY SOC LOND A MAT, V439, P637, DOI 10.1098/rspa.1992.0173; SAMARDZIJA N, 1988, B MATH BIOL, V50, P465, DOI 10.1007/BF02458847; Sumners D, 1995, NOTICES AMS, V42, P528; Volterra V, 1931, LECONS THEORIE MATH; WASSERMAN SA, 1985, SCIENCE, V229, P171, DOI 10.1126/science.2990045; Zhigilei LV, 2010, LECT NOTES	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0183993	10.1371/journal.pone.0183993	http://dx.doi.org/10.1371/journal.pone.0183993			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915271	gold, Green Published, Green Submitted			2022-12-27	WOS:000410861600007
J	Canakci, S; Toy, MF; Inci, AF; Liu, X; Kuzum, D				Canakci, Sadullah; Toy, Muhammed Faruk; Inci, Ahmet Fatih; Liu, Xin; Kuzum, Duygu			Computational analysis of network activity and spatial reach of sharp wave-ripples	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; FIELD POTENTIALS; INTERNEURONS; HIPPOCAMPUS; ORIGIN; MEMORY; MODEL; EEG	Network oscillations of different frequencies, durations and amplitudes are hypothesized to coordinate information processing and transfer across brain areas. Among these oscillations, hippocampal sharp wave-ripple complexes (SPW-Rs) are one of the most prominent. SPW-Rs occurring in the hippocampus are suggested to play essential roles in memory consolidation as well as information transfer to the neocortex. To-date, most of the knowledge about SPW-Rs comes from experimental studies averaging responses from neuronal populations monitored by conventional microelectrodes. In this work, we investigate spatiotemporal characteristics of SPW-Rs and how microelectrode size and distance influence SPWR recordings using a biophysical model of hippocampus. We also explore contributions from neuronal spikes and synaptic potentials to SPW-Rs based on two different types of network activity. Our study suggests that neuronal spikes from pyramidal cells contribute significantly to ripples while high amplitude sharp waves mainly arise from synaptic activity. Our simulations on spatial reach of SPW-Rs show that the amplitudes of sharp waves and ripples exhibit a steep decrease with distance from the network and this effect is more prominent for smaller area electrodes. Furthermore, the amplitude of the signal decreases strongly with increasing electrode surface area as a result of averaging. The relative decrease is more pronounced when the recording electrode is closer to the source of the activity. Through simulations of field potentials across a high-density microelectrode array, we demonstrate the importance of finding the ideal spatial resolution for capturing SPW-Rs with great sensitivity. Our work provides insights on contributions from spikes and synaptic potentials to SPWRs and describes the effect of measurement configuration on LFPs to guide experimental studies towards improved SPW-R recordings.	[Canakci, Sadullah] Boston Univ, Elect & Comp Engn Dept, Boston, MA 02215 USA; [Toy, Muhammed Faruk; Liu, Xin; Kuzum, Duygu] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Toy, Muhammed Faruk] Middle East Tech Univ, Elect & Elect Engn, Ankara, Turkey; [Inci, Ahmet Fatih] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Boston University; University of California System; University of California San Diego; Middle East Technical University; Sabanci University	Kuzum, D (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	dkuzum@eng.ucsd.edu	Inci, Ahmet/ABA-8606-2020; Liu, Xin/Q-5024-2019	Liu, Xin/0000-0003-3993-3505	Office of Naval Research Young Investigator Award; UC San Diego Frontiers of Innovation Scholars Program; UCSD Center for Multiscale Imaging of Brain Function	Office of Naval Research Young Investigator Award(Office of Naval Research); UC San Diego Frontiers of Innovation Scholars Program; UCSD Center for Multiscale Imaging of Brain Function	We would like to acknowledge Office of Naval Research Young Investigator Award and UC San Diego Frontiers of Innovation Scholars Program for funding this research. We also acknowledge UCSD Center for Multiscale Imaging of Brain Function for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Office of Naval Research Young Investigator Award and UC San Diego Frontiers of Innovation Scholars Program for funding this research. We also acknowledge UCSD Center for Multiscale Imaging of Brain Function for research support.	Barbier D, 2008, IEEE T; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Bedard C, 2014, J ELECTROMAGN ANAL A, V6, P296, DOI DOI 10.4236/JEMAA.2014.610029; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Brunel N, 2003, J NEUROPHYSIOL; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chatillon CE, 2013, CLIN NEUROPHYSIOL, V124, P1541, DOI 10.1016/j.clinph.2013.02.113; Csicsvari J, 2000, NEURON; de la Prida LM, 2015, J CLIN NEUROPHYSIOL, V32, P207, DOI 10.1097/WNP.0000000000000150; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Draguhn A, 2002, P PHYSL; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; Fink CG, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0024-15.2015; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hajos N, 2013, J NEUROSCI, V33, P11677, DOI 10.1523/JNEUROSCI.5729-12.2013; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lempka SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059839; Leski S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003137; Linden H., 2014, FRONT NEUROINFORM, V7, P41, DOI DOI 10.3389/fninf.2013.00041; Malerba P, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004880; Malmivuo J, 1995, BIOELECTROMAGNETISM; Moffitt M, 2005, CLIN NEUROPHYSIOL; Nelson MJ, 2010, J NEUROPHYSIOL, V103, P2315, DOI 10.1152/jn.00157.2010; Ness TV, 2015, NEUROINFORMATICS, V13, P403, DOI 10.1007/s12021-015-9265-6; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Patel J, 2013, J NEUROSCI, V 33, P17029, DOI 10.1523/JNEUROSCI.2036-13.2013; Pettersen KH, 2008, BIOPHYS J, V94, P784, DOI 10.1529/biophysj.107.111179; Schlingloff D, 2014, J NEUROSCI, V34, P11385, DOI 10.1523/JNEUROSCI.0867-14.2014; Stacey WC, 2009, J NEUROPHYSIOL, V102, P2342, DOI 10.1152/jn.00397.2009; Stark E, 2014, NEURON; Sullivan D, 2011, RELATIONSHIPS HIPPOC; Taxidis J, 2013, FRONT COMPUT NEUROSC, V7; Taxidis J, 2015, NEURON, V87, P590, DOI 10.1016/j.neuron.2015.07.014; Taxidis J, 2012, HIPPOCAMPUS, V22, P995, DOI 10.1002/hipo.20930; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Traub R, 2000, J NEUROSCI; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; Traub RD, 2012, EUR J NEUROSCI, V36, P2650, DOI 10.1111/j.1460-9568.2012.08184.x; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Van Quyen ML, 2008, CELL TYPE SPECIFIC F; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Worrell G, 2008, BRAIN; YLINEN A, 1995, J NEUROSCI, V15, P30; Zelmann R, 2012, CLIN NEUROPHYSIOL, V123, P106, DOI [10.1016/j.clinph.2011.06.006, 10.1016/j.clinph.2011.02.022]	56	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184542	10.1371/journal.pone.0184542	http://dx.doi.org/10.1371/journal.pone.0184542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915251	Green Published, gold, Green Submitted			2022-12-27	WOS:000410861600010
J	Onodera, S; Saito, A; Hasegawa, D; Morita, N; Watanabe, K; Nomura, T; Shibahara, T; Ohba, S; Yamaguchi, A; Azuma, T				Onodera, Shoko; Saito, Akiko; Hasegawa, Daigo; Morita, Nana; Watanabe, Katsuhito; Nomura, Takeshi; Shibahara, Takahiko; Ohba, Shinsuke; Yamaguchi, Akira; Azuma, Toshifumi			Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; SONIC HEDGEHOG; PTCH2; EXPRESSION; PATHWAY; BOC; MORPHOGENESIS; ACTIVATION; PROTEINS; RECEPTOR	Gorlin syndrome is a genetic disorder of autosomal dominant inheritance that predisposes the affected individual to a variety of disorders that are attributed largely to heterozygous germline patched1 (PTCH1) mutations. PTCH1 is a hedgehog (Hh) receptor as well as a repressor, mutation of which leads to constitutive activation of Hh pathway. Hh pathway encompasses a wide variety of cellular signaling cascades, which involve several molecules; however, no associated genotype-phenotype correlations have been reported. Recently, mutations in Suppressor of fused homolog (SUFU) or PTCH2 were reported in patients with Gorlin syndrome. These facts suggest that multi-layered mutations in Hh pathway may contribute to the development of Gorlin syndrome. We demonstrated multiple mutations of Hh-related genes in addition to PTCH1, which possibly act in an additive or multiplicative manner and lead to Gorlin syndrome. High-throughput sequencing was performed to analyze exome sequences in four unrelated Gorlin syndrome patient genomes. Mutations in PTCH1 gene were detected in all four patients. Specific nucleotide variations or frameshift variations of PTCH1 were identified along with the inferred amino acid changes in all patients. We further filtered 84 different genes which are closely related to Hh signaling. Fifty three of these had enough coverage of over x30. The sequencing results were filtered and compared to reduce the number of sequence variants identified in each of the affected individuals. We discovered three genes, PTCH2, BOC, and WNT9b, with mutations with a predicted functional impact assessed by MutationTaster2 or PolyPhen-2 (Polymorphism Phenotyping v2) analysis. It is noticeable that PTCH2 and BOC are Hh receptor molecules. No significant mutations were observed in SUFU. Multi-layered mutations in Hh pathway may change the activation level of the Hh signals, which may explain the wide phenotypic variability of Gorlin syndrome.	[Onodera, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo, Japan; [Onodera, Shoko; Ohba, Shinsuke] Univ Tokyo, Grad Sch Med, Div Clin Biotechnol, Bunkyo Ku, Tokyo, Japan; [Onodera, Shoko; Ohba, Shinsuke] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Hasegawa, Daigo; Watanabe, Katsuhito; Shibahara, Takahiko] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Morita, Nana; Nomura, Takeshi] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, Chiba, Japan; [Yamaguchi, Akira; Azuma, Toshifumi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Dental College; University of Tokyo; University of Tokyo; Tokyo Dental College; Tokyo Dental College; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Dent Coll, Dept Biochem, Tokyo, Japan.; Azuma, T (corresponding author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan.	tazuma@tdc.ac.jp	Yamaguchi, Akira/AAX-9286-2020	Ohba, Shinsuke/0000-0002-6874-8539; Onodera, Shoko/0000-0003-0673-3400	Japan Society for the Promotion of Science [16K20427, 16K20428, 16K15791]; Tokyo Dental College President's Encouragement Research Grant [31580]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Dental College President's Encouragement Research Grant	This study was supported by Japan Society for the Promotion of Science: 16K20427, 16K20428, 16K15791; and Tokyo Dental College President's Encouragement Research Grant: 31580. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alfaro AC, 2014, DEVELOPMENT, V141, P3331, DOI 10.1242/dev.110056; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Fan Z, 2008, J MED GENET, V45, P303, DOI 10.1136/jmg.2007.055343; Fujii K, 2014, PEDIATR INT, V56, P667, DOI 10.1111/ped.12461; Fujii K, 2013, FAM CANCER, V12, P611, DOI 10.1007/s10689-013-9623-1; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Holtz AM, 2013, DEVELOPMENT, V140, P3423, DOI 10.1242/dev.095083; Ishiuchi T, 2009, J CELL BIOL, V185, P959, DOI 10.1083/jcb.200811030; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jin YR, 2012, DEVELOPMENT, V139, P1821, DOI 10.1242/dev.075796; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kameda T, 1999, GENES CELLS, V4, P175, DOI 10.1046/j.1365-2443.1999.00250.x; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Klein RD, 2005, GENET MED, V7, P611, DOI 10.1097/01.gim.0000182879.57182.b4; Lan Y, 2006, DEV DYNAM, V235, P1448, DOI 10.1002/dvdy.20723; Morita K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140480; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nieuwenhuis E, 2006, MOL CELL BIOL, V26, P6609, DOI 10.1128/MCB.00295-06; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Pastorino L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/ajmg.a.32944; Rabbani B, 2012, J HUM GENET, V57, P621, DOI 10.1038/jhg.2012.91; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Regard JB, 2013, NAT MED, V19, P1505, DOI 10.1038/nm.3314; Robinson PN, 2011, CLIN GENET, V80, P127, DOI 10.1111/j.1399-0004.2011.01713.x; Schneeberger K, 2014, NAT REV GENET, V15, P662, DOI 10.1038/nrg3745; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070995; Soufir N, 2006, BRIT J CANCER, V95, P548, DOI 10.1038/sj.bjc.6603303; Tang HM, 2016, GENETICS, V203, P635, DOI 10.1534/genetics.116.190033; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Wicking C, 1997, AM J HUM GENET, V60, P21; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05; Zheng X, 2013, ONCOL REP, V30, P2020, DOI 10.3892/or.2013.2690; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239; Zhu XJ, 2016, DEV DYNAM, V245, P414, DOI 10.1002/dvdy.24376	47	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184702	10.1371/journal.pone.0184702	http://dx.doi.org/10.1371/journal.pone.0184702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915250	gold, Green Submitted, Green Published			2022-12-27	WOS:000410861600015
J	Zhou, AY; Baruch, M; Ajo-Franklin, CM; Maharbiz, MM				Zhou, Alyssa Y.; Baruch, Moshe; Ajo-Franklin, Caroline M.; Maharbiz, Michel M.			A portable bioelectronic sensing system (BESSY) for environmental deployment incorporating differential microbial sensing in miniaturized reactors	PLOS ONE			English	Article							SHEWANELLA-ONEIDENSIS; BACTERIAL RESPIRATION; ESCHERICHIA-COLI; OUTER-MEMBRANE; BIOSENSORS; SENSOR; MR-1; REDUCTION; NANOWIRES; PROTEIN	Current technologies are lacking in the area of deployable, in situ monitoring of complex chemicals in environmental applications. Microorganisms metabolize various chemical compounds and can be engineered to be analyte-specific making them naturally suited for robust chemical sensing. However, current electrochemical microbial biosensors use large and expensive electrochemistry equipment not suitable for on-site, real-time environmental analysis. Here we demonstrate a miniaturized, autonomous bioelectronic sensing system (BESSY) suitable for deployment for instantaneous and continuous sensing applications. We developed a 2x2 cm footprint, low power, two-channel, three-electrode electrochemical potentiostat which wirelessly transmits data for on-site microbial sensing. Furthermore, we designed a new way of fabricating self-contained, submersible, miniaturized reactors (m-reactors) to encapsulate the bacteria, working, and counter electrodes. We have validated the BESSY's ability to specifically detect a chemical amongst environmental perturbations using differential current measurements. This work paves the way for in situ microbial sensing outside of a controlled laboratory environment.	[Zhou, Alyssa Y.; Maharbiz, Michel M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Zhou, Alyssa Y.; Baruch, Moshe; Ajo-Franklin, Caroline M.] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA USA; [Ajo-Franklin, Caroline M.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA USA; [Maharbiz, Michel M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Maharbiz, Michel M.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Maharbiz, MM (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.; Maharbiz, MM (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Maharbiz, MM (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	maharbiz@berkeley.edu	Ajo-Franklin, Caroline M/F-3405-2016		Office of Naval Research [N000141310551]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-ACO2-05CH11231]	Office of Naval Research(Office of Naval Research); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the Office of Naval Research (N000141310551) and performed at the Molecular Foundry and UC Berkeley. Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-ACO2-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIKAWA Y, 1998, METH BIOTEC, V6, P225; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Chua EJ, 2016, FRONT MAR SCI FRONTI, V3, P1; Coursolle D, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00056; D'Souza SF, 2001, BIOSENS BIOELECTRON, V16, P337, DOI 10.1016/S0956-5663(01)00125-7; Di Lorenzo M, 2009, WATER RES, V43, P3145, DOI 10.1016/j.watres.2009.01.005; Fonseca BM, 2013, BIOCHEM J, V449, P101, DOI 10.1042/BJ20121467; Friedman ES, 2012, BIOSENS BIOELECTRON, V32, P309, DOI 10.1016/j.bios.2011.12.013; Goldbeck CP, 2013, ACS SYNTH BIOL, V2, P150, DOI 10.1021/sb300119v; Golitsch F, 2013, BIOSENS BIOELECTRON, V47, P285, DOI 10.1016/j.bios.2013.03.010; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Grieshaber D, 2008, SENSORS-BASEL, V8, P1400, DOI 10.3390/s8031400; Hanrahan G, 2004, J ENVIRON MONITOR, V6, P657, DOI 10.1039/b403975k; Jensen HM, 2016, ACS SYNTH BIOL, V5, P679, DOI 10.1021/acssynbio.5b00279; Jensen HM, 2010, P NATL ACAD SCI USA, V107, P19213, DOI 10.1073/pnas.1009645107; Justino CIL, 2015, TRENDS ENVIRON ANAL, V6-7, P21, DOI 10.1016/j.teac.2015.02.001; Kotloski NJ, 2013, AM SOC MICROBIOLOGY, V4; Kroger S, 2005, BIOSENS BIOELECTRON, V20, P1903, DOI 10.1016/j.bios.2004.08.036; Larsen LH, 1997, ANAL CHEM, V69, P3527, DOI 10.1021/ac9700890; Lei Y, 2006, ANAL CHIM ACTA, V568, P200, DOI 10.1016/j.aca.2005.11.065; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Mills G, 2012, SENSOR REV, V32, P17, DOI 10.1108/02602281211197116; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; Peixoto L, 2011, BIOELECTROCHEMISTRY, V81, P99, DOI 10.1016/j.bioelechem.2011.02.002; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Ross DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016649; Rundel PW, 2009, NEW PHYTOL, V182, P589, DOI 10.1111/j.1469-8137.2009.02811.x; Schuetz B, 2009, APPL ENVIRON MICROB, V75, P7789, DOI 10.1128/AEM.01834-09; Shin HJ, 2011, APPL MICROBIOL BIOT, V89, P867, DOI 10.1007/s00253-010-2990-8; Simonian A.L., 1998, METH BIOTEC, P237; Stretton S, 1998, APPL ENVIRON MICROB, V64, P2554; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; TerAvest MA, 2016, BIOTECHNOL BIOENG, V113, P687, DOI 10.1002/bit.25723; TerAvest MA, 2014, CHEMELECTROCHEM, V1, P1874, DOI 10.1002/celc.201402194; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Wang HM, 2013, BIOTECHNOL ADV, V31, P1796, DOI 10.1016/j.biotechadv.2013.10.001; Webster DP, 2014, BIOSENS BIOELECTRON, V62, P320, DOI 10.1016/j.bios.2014.07.003; Yang XP, 2002, SENSORS-BASEL, V2, P455, DOI 10.3390/s21100455; Zhang FZ, 2011, TRENDS MICROBIOL, V19, P323, DOI 10.1016/j.tim.2011.05.003; Zhang YF, 2012, BIOSENS BIOELECTRON, V38, P189, DOI 10.1016/j.bios.2012.05.032; Zhang YF, 2011, BIOTECHNOL BIOENG, V108, P2339, DOI 10.1002/bit.23204; Zhou AY, 2015, IEEE ENG MED BIO, P7518, DOI 10.1109/EMBC.2015.7320131	45	16	16	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184994	10.1371/journal.pone.0184994	http://dx.doi.org/10.1371/journal.pone.0184994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915277	Green Published, gold			2022-12-27	WOS:000410861600025
J	Bloch, JS; Ruetz, M; Krautler, B; Locher, KP				Bloch, Joeel S.; Ruetz, Markus; Kraeutler, Bernhard; Locher, Kaspar P.			Structure of the human transcobalamin beta domain in four distinct states	PLOS ONE			English	Article							VITAMIN-B-12 TRANSPORT; INTRINSIC-FACTOR; COBALAMIN; BINDING; PROTEIN; ASSIMILATION; RECOGNITION; MECHANISMS; COBINAMIDE; ANALOGS	Vitamin B12 (cyanocobalamin, CNCbl) is an essential cofactor-precursor for two biochemical reactions in humans. When ingested, cobalamins (Cbl) are transported via a multistep transport system into the bloodstream, where the soluble protein transcobalamin (TC) binds Cbl and the complex is taken up into the cells via receptor mediated endocytosis. Crystal structures of TC in complex with CNCbl have been solved previously. However, the initial steps of holo-TC assembly have remained elusive. Here, we present four crystal structures of the beta domain of human TC (TC-beta) in different substrate-bound states. These include the apo and CNCbl-bound states, providing insight into the early steps of holo-TC assembly. We found that in vitro assembly of TC-alpha and TC-beta to a complex was Cbldependent. We also determined the structure of TC-beta in complex with cobinamide (Cbi), an alternative substrate, shedding light on the specificity of TC. We finally determined the structure of TC-beta in complex with an inhibitory antivitamin B12 (anti-B12). We used this structure to model the binding of anti-B12 into full-length holo-TC and could rule out that the inhibitory function of anti-B12 was based on an inability to form a functional complex with TC.	[Bloch, Joeel S.; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, Dept Biol, Zurich, Switzerland; [Ruetz, Markus; Kraeutler, Bernhard] Univ Innsbruck, Inst Organ Chem, Innsbruck, Austria; [Ruetz, Markus; Kraeutler, Bernhard] Univ Innsbruck, Ctr Mol Biosci, Innsbruck, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Innsbruck; University of Innsbruck	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, Dept Biol, Zurich, Switzerland.	locher@mol.biol.ethz.ch	Bloch, Joël/ABA-2181-2020	Bloch, Joël/0000-0002-5786-0488	Swiss National Science Foundation [SNF 310030B_166672]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the beamline staff at the Swiss Light Source at the Paul Scherrer Institute in Villigen for great assistance with the data collection. This work was supported by the Swiss National Science Foundation (SNF 310030B_166672 to K.P.L.). The PDB accession codes are 5N00 (apo TC-beta), 5NP4 (CNCb1-bound TC-beta), 5NRP (Cbi-bound TC-beta), 5NSA (F2PhE-tyCbl-bound TC-beta).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12100; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; CANNATA JJB, 1965, J BIOL CHEM, V240, P3249; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2004, BIOCHEMISTRY-US, V43, P15095, DOI 10.1021/bi048924c; Fedosov SN, 1995, BIOCHEMISTRY-US, V34, P16082, DOI 10.1021/bi00049a023; Fedosov SN, 2002, J BIOL CHEM, V277, P9989, DOI 10.1074/jbc.M111399200; FLODH H, 1968, INT J CANCER, V3, P694, DOI 10.1002/ijc.2910030518; Furger E, 2013, J BIOL CHEM, V288, P25466, DOI 10.1074/jbc.M113.483271; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KOLHOUSE JF, 1977, J CLIN INVEST, V60, P1381, DOI 10.1172/JCI108899; Krautler B, 2015, CHEM-EUR J, V21, P11280, DOI 10.1002/chem.201502072; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lildballe DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046657; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Matthews RG, 2008, CURR OPIN STRUC BIOL, V18, P658, DOI 10.1016/j.sbi.2008.11.005; Mireku SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41575; Mutti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075312; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; RAPPAZZO ME, 1970, BRIT J HAEMATOL, V18, P425, DOI 10.1111/j.1365-2141.1970.tb01456.x; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Ruetz M., 2013, ANGEW CHEM, V125, P11617; Ruetz M, 2017, ANGEW CHEM INT EDIT, V56, P7387, DOI 10.1002/anie.201701583; Ruetz M, 2013, ANGEW CHEM INT EDIT, V52, P2606, DOI 10.1002/anie.201209651; TAYLOR RT, 1967, J BIOL CHEM, V242, P1509; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103	32	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184932	10.1371/journal.pone.0184932	http://dx.doi.org/10.1371/journal.pone.0184932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910388	Green Published, gold			2022-12-27	WOS:000410859200121
J	Schlinzig, T; Johansson, S; Stephansson, O; Hammarstrom, L; Zetterstrom, RH; von Dobeln, U; Cnattingius, S; Norman, M				Schlinzig, Titus; Johansson, Stefan; Stephansson, Olof; Hammarstrom, Lennart; Zetterstrom, Rolf H.; von Dobeln, Ulrika; Cnattingius, Sven; Norman, Mikael			Surge of immune cell formation at birth differs by mode of delivery and infant characteristics-A population-based cohort study	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; CESAREAN-SECTION; NEONATAL-MORTALITY; CHILDHOOD ASTHMA; NEWBORN-INFANT; RISK-FACTORS; DISEASES; GROWTH; AGE; ASSOCIATION	Background Birth by cesarean section is associated with increased risks of immune disorders. We tested whether establishment of immune function at birth relates to mode of delivery, taking other maternal and infant characteristics into account. Methods and findings Using a prospectively collected database, we retrieved information on maternal and infant characteristics of 6,014 singleton infants delivered from February to April 2014 in Stockholm, Sweden, with gestational age >= 35 weeks, Apgar scores >= 7, and without congenital malformations or any neonatal morbidity. We linked our data to blood levels of T-cell receptor excision circles (TREC) and.-deleting recombination excision circles (KREC), determined as part of a neonatal screening program for immune-deficiencies, and representing quantities of newly formed T-and B-lymphocytes. Multivariate logistic regression was used to calculate odds ratios (OR) with 95% confidence intervals (CI) for participants having TREC and KREC levels in the lowest quintile. Multivariate models were adjusted for postnatal age at blood sampling, and included perinatal (mode of delivery, infant sex, gestational age, and birth weight for gestational age), and maternal characteristics (age, parity, BMI, smoking, diabetes, and hypertensive disease). Low TREC was associated with cesarean section before labor (adjusted OR:1.32 [95% CI 1.08-1.62]), male infant sex (aOR:1.60 [1.41-1.83]), preterm birth at 35-36 weeks of gestation (aOR:1.89 [1.21-2.96]) and small for gestational age (aOR:1.67 [1.00-2.79]). Low KREC was associated with male sex (aOR:1.32 [1.15-1.50]), postterm birth at >= 42 weeks (aOR:1.43 [1.13-1.82]) and small for gestational age (aOR:2.89 [1.78-4.69]). Maternal characteristics showed no consistent associations with neonatal levels of either TREC or KREC. Conclusion Cesarean section before labor was associated with lower T-lymphocyte formation, irrespective of maternal characteristics, pregnancy, and neonatal risk factors. The significance of a reduced birth-related surge in lymphocyte formation for future immune function and health remains to be investigated.	[Schlinzig, Titus; Norman, Mikael] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Schlinzig, Titus] Karolinska Univ Hosp, Dept Pediat Perioperat Med & Intens Care, Stockholm, Sweden; [Johansson, Stefan] Sodersjukhuset Karolinska Inst SOS, Dept Clin Sci & Educ, Stockholm, Sweden; [Johansson, Stefan; Stephansson, Olof; Cnattingius, Sven] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Stephansson, Olof] Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Hammarstrom, Lennart] Karolinska Inst, Div Clin Immunol, Dept Lab Med, Stockholm, Sweden; [Zetterstrom, Rolf H.; von Dobeln, Ulrika] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden; [Zetterstrom, Rolf H.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [von Dobeln, Ulrika] Karolinska Inst, Div Mol Metab, Dept Med Biochem & Biophys, Stockholm, Sweden; [Norman, Mikael] Karolinska Univ Hosp, Dept Neonatal Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Schlinzig, T (corresponding author), Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.; Schlinzig, T (corresponding author), Karolinska Univ Hosp, Dept Pediat Perioperat Med & Intens Care, Stockholm, Sweden.	titus.schlinzig@karolinska.se		Johansson, Stefan/0000-0001-8832-6918; Norman, Mikael/0000-0003-4191-3781; Stephansson, Olof/0000-0003-1528-4563; Zetterstrom, Rolf/0000-0002-3016-0019; Hammarstrom, Lennart/0000-0002-8635-9609	Stockholm County Council; Karolinska Institutet; Swedish Order of Freemasons' Foundation for Children's Welfare; Swedish Research Council [2013-2429]; Epidemiology at Karolinska Institutet	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Order of Freemasons' Foundation for Children's Welfare; Swedish Research Council(Swedish Research CouncilEuropean Commission); Epidemiology at Karolinska Institutet	This project was supported by a regional agreement on clinical research between Stockholm County Council and Karolinska Institutet, and by the Swedish Order of Freemasons' Foundation for Children's Welfare. OS was supported by unrestricted grants from the Swedish Research Council (2013-2429) and the Strategic Research Program in Epidemiology at Karolinska Institutet. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.014; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Bager P, 2012, INFLAMM BOWEL DIS, V18, P857, DOI 10.1002/ibd.21805; Barbera M., 2016, J CLIN IMMUNOL, P1; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Blustein J, 2013, INT J OBESITY, V37, P900, DOI 10.1038/ijo.2013.49; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Cho CE, 2013, AM J OBSTET GYNECOL, V208, P249, DOI 10.1016/j.ajog.2012.08.009; CNATTINGIUS S, 1995, CANCER EPIDEM BIOMAR, V4, P441; Cook MB, 2008, INT J CANCER, V122, P2600, DOI 10.1002/ijc.23424; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Fischer J, 2015, INFECTION, V43, P399, DOI 10.1007/s15010-015-0791-9; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; GASPARONI A, 1992, BIOL NEONATE, V61, P137; Gitau R, 2001, EUR J OBSTET GYN R B, V98, P14, DOI 10.1016/S0301-2115(01)00298-6; Hakansson S, 2003, CLIN EXP ALLERGY, V33, P757, DOI 10.1046/j.1365-2222.2003.01667.x; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; HERSON VC, 1992, AM J PERINAT, V9, P285, DOI 10.1055/s-2007-994791; Johansson S, 2005, CIRCULATION, V112, P3430, DOI 10.1161/CIRCULATIONAHA.105.540906; Klein SL, 2016, SEX DIFFERENCES IMMU; Koenig JM, 2005, PEDIATR RES, V57, P424, DOI 10.1203/01.PDR.0000153945.49022.96; Kolokotroni O, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-179; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; LAGERCRANTZ H, 1977, PEDIATR RES, V11, P889, DOI 10.1203/00006450-197708000-00007; Laitinen J, 2004, EUR J CLIN NUTR, V58, P180, DOI 10.1038/sj.ejcn.1601765; Lee BW, 1996, CYTOMETRY, V26, P8, DOI 10.1002/(SICI)1097-0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E; Lee HS, 2016, CIRCULATION S1, V133, pAP186; Lisse IM, 1997, J PEDIATR-US, V130, P77, DOI 10.1016/S0022-3476(97)70313-5; Lynch CD, 2013, AM J OBSTET GYNECOL, V208, P247, DOI 10.1016/j.ajog.2012.12.027; Malamitsi-Puchner A, 2005, EARLY HUM DEV, V81, P387, DOI 10.1016/j.earlhumdev.2004.10.017; Marchini G, 2000, ACTA PAEDIATR, V89, P1082, DOI 10.1080/713794557; Marild K, 2012, GASTROENTEROLOGY, V142, P39, DOI 10.1053/j.gastro.2011.09.047; McLaughlin CC, 2009, CANCER CAUSE CONTROL, V20, P289, DOI 10.1007/s10552-008-9243-5; Menacker F, 2006, SEMIN PERINATOL, V30, P235, DOI 10.1053/j.semperi.2006.07.002; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; Olearo E, 2012, PRENATAL DIAG, V32, P662, DOI 10.1002/pd.3883; POCIOT F, 1993, DIABETOLOGIA, V36, P870, DOI 10.1007/BF00400364; Romero R, 2013, AM J OBSTET GYNECOL, V208, P243, DOI 10.1016/j.ajog.2012.12.026; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Steinborn A, 1999, CLIN EXP IMMUNOL, V117, P147; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; Wirbelauer J, 2010, AM J PERINAT, V27, P819, DOI 10.1055/s-0030-1254547; Ye J, 2015, BJOG INT J OBSTET GY; Yektaei-Karin E, 2007, PEDIAT ALLERG IMM-UK, V18, P643, DOI 10.1111/j.1399-3038.2007.00578.x	53	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184748	10.1371/journal.pone.0184748	http://dx.doi.org/10.1371/journal.pone.0184748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910364	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200089
J	Yang, ZY; Zhang, YL; Jiang, YY; Zhu, FJ; Zeng, LG; Wang, YL; Lei, XQ; Yao, Y; Hou, YJ; Xu, LQ; Xiong, CX; Yang, XL; Hu, K				Yang, Zongying; Zhang, Yiliu; Jiang, Yingying; Zhu, Fengjiao; Zeng, Liugen; Wang, Yulan; Lei, Xiaoqing; Yao, Yi; Hou, Yujie; Xu, Liangqing; Xiong, Chunxian; Yang, Xianle; Hu, Kun			Transcriptional responses in the hepatopancreas of Eriocheir sinensis exposed to deltamethrin	PLOS ONE			English	Article							CHINESE MITTEN CRAB; MONOSEX NILE TILAPIA; PYRETHROID INSECTICIDES; OREOCHROMIS-NILOTICUS; RAINBOW-TROUT; ACETYLCHOLINESTERASE ACTIVITY; SPIROPLASMA-ERIOCHEIRIS; OXIDATIVE STRESS; PROTECTIVE ROLE; GENE DISCOVERY	Deltamethrin is an important pesticide widely used against ectoparasites. Deltamethrin contamination has resulted in a threat to the healthy breeding of the Chinese mitten crab, Eriocheir sinensis. In this study, we investigated transcriptional responses in the hepatopancreas of E. sinensis exposed to deltamethrin. We obtained 99,087,448, 89,086,478, and 100,117,958 raw sequence reads from control 1, control 2, and control 3 groups, and 92,094,972, 92,883,894, and 92,500,828 raw sequence reads from test 1, test 2, and test 3 groups, respectively. After filtering and quality checking of the raw sequence reads, our analysis yielded 79,228,354, 72,336,470, 81,859,826, 77,649,400, 77,194,276, and 75,697,016 clean reads with a mean length of 150 bp from the control and test groups. After deltamethrin treatment, a total of 160 and 167 genes were significantly upregulated and downregulated, respectively. Gene ontology terms "biological process," "cellular component, " and "molecular function" were enriched with respect to cell killing, cellular process, other organism part, cell part, binding, and catalytic. Pathway analysis using the Kyoto Encyclopedia of Genes and Genomes showed that the metabolic pathways were significantly enriched. We found that the CYP450 enzyme system, carboxylesterase, glutathioneS- transferase, and material (including carbohydrate, lipid, protein, and other substances) metabolism played important roles in the metabolism of deltamethrin in the hepatopancreas of E. sinensis. This study revealed differentially expressed genes related to insecticide metabolism and detoxification in E. sinensis for the first time and will help in understanding the toxicity and molecular metabolic mechanisms of deltamethrin in E. sinensis.	[Yang, Zongying; Zhang, Yiliu; Jiang, Yingying; Zhu, Fengjiao; Yang, Xianle; Hu, Kun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China; [Yang, Zongying; Zeng, Liugen; Wang, Yulan; Lei, Xiaoqing; Yao, Yi; Hou, Yujie; Xu, Liangqing; Xiong, Chunxian] Nanchang Acad Agr Sci, Nanchang, Jiangxi, Peoples R China	Shanghai Ocean University	Hu, K (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	khu@shou.edu.cn	Yang, Xian/GVU-9087-2022		National 863 Program of China [2011AA10A216]; Special Fund for Agro-scientific Research in the Public Interest [201203085]; National Natural Resources Platform; Shanghai University Knowledge Service Platform	National 863 Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest; National Natural Resources Platform; Shanghai University Knowledge Service Platform	XLY received the National 863 Program of China [grant number 2011AA10A216], the Special Fund for Agro-scientific Research in the Public Interest [grant number 201203085], and Kun Hu received the National Natural Resources Platform, and the Shanghai University Knowledge Service Platform funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABALIS IM, 1986, J TOXICOL ENV HEALTH, V18, P13, DOI 10.1080/15287398609530844; Abdel-Daim MM, 2015, ECOTOXICOLOGY ENV SA, V111, P46; Abdel-Daim MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072991; ADRIAN RH, 1976, J PHYSIOL-LONDON, V258, P125, DOI 10.1113/jphysiol.1976.sp011410; Amin KA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-45; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Banka L, 1997, J ENVIRON SCI HEAL B, V32, P789, DOI 10.1080/03601239709373113; BLOOMQUIST JR, 1986, NEUROTOXICOLOGY, V7, P11; Bohne VJB, 2007, FOOD CHEM TOXICOL, V45, P733, DOI 10.1016/j.fct.2006.10.020; BRADBURY SP, 1989, REV ENVIRON CONTAM T, V108, P133; Carcamo JG, 2017, COMP BIOCHEM PHYS C, V191, P129, DOI 10.1016/j.cbpc.2016.10.004; CASIDA JE, 1983, ANNU REV PHARMACOL, V23, P413, DOI 10.1146/annurev.pa.23.040183.002213; Cengiz EI, 2012, ECOTOX ENVIRON SAFE, V80, P381, DOI 10.1016/j.ecoenv.2012.04.012; Ceyhun SB, 2010, COMP BIOCHEM PHYS C, V152, P215, DOI 10.1016/j.cbpc.2010.04.008; Chavez-Mardones J, 2014, AQUACULTURE, V433, P421, DOI 10.1016/j.aquaculture.2014.06.017; CLARK JR, 1989, ENVIRON TOXICOL CHEM, V8, P393, DOI [10.1897/1552-8618(1989)8[393:TOPTMI]2.0.CO;2, 10.1002/etc.5620080505]; Dinu D, 2010, ARCH ENVIRON CON TOX, V58, P757, DOI 10.1007/s00244-009-9401-0; Djami-Tchatchou AT, 2012, J PHYTOPATHOL, V160, P449, DOI 10.1111/j.1439-0434.2012.01925.x; EDWARDS R, 1986, TOXICOL APPL PHARM, V84, P512, DOI 10.1016/0041-008X(86)90256-5; El-Sayed YS, 2007, ENVIRON TOXICOL PHAR, V24, P212, DOI 10.1016/j.etap.2007.05.006; El-Sayed YS, 2008, BASIC CLIN PHARMACOL, V102, P293, DOI 10.1111/j.1742-7843.2007.00157.x; Ensibi C, 2013, ENVIRON TOXICOL PHAR, V36, P384, DOI 10.1016/j.etap.2013.04.019; Erdogan O, 2011, GENE, V484, P13, DOI 10.1016/j.gene.2011.05.026; Feld M, 2005, BEHAV BRAIN RES, V158, P251, DOI 10.1016/j.bbr.2004.09.005; FORSHAW PJ, 1990, NEUROPHARMACOLOGY, V29, P75, DOI 10.1016/0028-3908(90)90086-7; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gavery MR, 2012, COMP BIOCHEM PHYS D, V7, P94, DOI 10.1016/j.cbd.2011.12.003; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Guardiola FA, 2014, FISH SHELLFISH IMMUN, V36, P120, DOI 10.1016/j.fsi.2013.10.020; HAYA K, 1989, ENVIRON TOXICOL CHEM, V8, P381, DOI 10.1002/etc.5620080504; He L, 2012, PLOS ONE, V7; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Huang SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09116; Tu HT, 2012, CHEMOSPHERE, V86, P83, DOI 10.1016/j.chemosphere.2011.09.022; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Kan Y, 2012, ENVIRON TOXICOL PHAR, V34, P170, DOI 10.1016/j.etap.2012.03.009; L'Hotellier M., 1986, 1986 British Crop Protection Conference. Pests and diseases. Proceedings of a conference held at Brighton Metropole, England, November 17-20, 1986. Vol. 3., P1109; LAWRENCE LJ, 1985, NEUROTOXICOLOGY, V6, P87; Li XD, 2007, AQUACULTURE, V272, P361, DOI 10.1016/j.aquaculture.2007.08.029; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Lin MC, 2012, PEPTIDES, V38, P197, DOI 10.1016/j.peptides.2012.10.003; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028516; [马阿妮 Ma Ani], 2010, [生命科学, Chinese Bulletin of Life Sciences], V22, P978; Manunza B, 1997, CARBOHYD RES, V300, P89, DOI 10.1016/S0008-6215(97)00028-1; Meng QG, 2014, FISH SHELLFISH IMMUN, V40, P182, DOI 10.1016/j.fsi.2014.06.029; Milam CD, 2000, ARCH ENVIRON CON TOX, V39, P324, DOI 10.1007/s002440010111; Olsvik PA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-48; Olsvik PA, 2014, COMP BIOCHEM PHYS C, V162, P23, DOI 10.1016/j.cbpc.2014.03.005; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Parvez S, 2006, CHEMOSPHERE, V62, P1324, DOI 10.1016/j.chemosphere.2005.07.025; Paul EA, 2006, B ENVIRON CONTAM TOX, V76, P614, DOI 10.1007/s00128-006-0964-4; Prasanthi K, 2005, FOOD CHEM TOXICOL, V43, P299, DOI 10.1016/j.fct.2004.10.005; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; Ray DE, 2006, PHARMACOL THERAPEUT, V111, P174, DOI 10.1016/j.pharmthera.2005.10.003; Ried C, 1996, J BIOL CHEM, V271, P28120, DOI 10.1074/jbc.271.45.28120; Roux MM, 2002, J VIROL, V76, P7140, DOI 10.1128/JVI.76.14.7140-7149.2002; Sakin F, 2011, FRESEN ENVIRON BULL, V20, P2806; SMITH TM, 1986, RESIDUE REV, V97, P93; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; Song LS, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0112-y; TALESA V, 1992, COMP BIOCHEM PHYS C, V101, P499, DOI 10.1016/0742-8413(92)90077-K; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tu HT, 2009, ECOTOX ENVIRON SAFE, V72, P1463, DOI 10.1016/j.ecoenv.2009.04.008; Velisek J, 2007, ENVIRON TOXICOL PHAR, V23, P297, DOI 10.1016/j.etap.2006.11.006; Villarini M, 1998, TOXICOLOGY, V130, P129, DOI 10.1016/S0300-483X(98)00097-3; Wheelock CE, 2006, ENVIRON TOXICOL CHEM, V25, P973, DOI 10.1897/05-334R.1; World Health Organization (WHO), 1990, DEL ENV HLTH CRIT; Yonar ME, 2011, PESTIC BIOCHEM PHYS, V99, P226, DOI 10.1016/j.pestbp.2010.12.008; Zhu FJ, 2017, CAN J FISH AQUAT SCI, V74, P435, DOI 10.1139/cjfas-2016-0041	74	12	13	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184581	10.1371/journal.pone.0184581	http://dx.doi.org/10.1371/journal.pone.0184581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910412	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200064
J	Huggins, LG; Michaels, CJ; Cruickshank, SM; Preziosi, RF; Else, KJ				Huggins, Lucas G.; Michaels, Christopher J.; Cruickshank, Sheena M.; Preziosi, Richard F.; Else, Kathryn J.			A novel copro-diagnostic molecular method for qualitative detection and identification of parasitic nematodes in amphibians and reptiles	PLOS ONE			English	Article							6TH MASS EXTINCTION; N. SP; ASPICULURIS-TETRAPTERA; PCR PRIMERS; DNA; TOOLS; PHARYNGODONIDAE; COMMUNITIES; INFECTIONS; DIVERSITY	Anthropogenic disturbance via resource acquisition, habitat fragmentation and climate change, amongst other factors, has led to catastrophic global biodiversity losses and species extinctions at an accelerating rate. Amphibians are currently one of the worst affected classes with at least a third of species categorised as being threatened with extinction. At the same time, they are also critically important for many habitats and provide man with a powerful proxy for ecosystem health by acting as a bioindicator group. Whilst the causes of synchronised amphibian losses are varied recent research has begun to highlight a growing role that macroparasites are playing in amphibian declines. However, diagnosing parasite infection in the field can be problematic, principally relying on collection and euthanasia of hosts, followed by necropsy and morphological identification of parasites in situ. The current study developed a non-invasive PCR-based methodology for sensitive detection and identification of parasitic nematode DNA released in the faeces of infected amphibians as egg or tissue fragments (environmental DNA). A DNA extraction protocol optimised for liberation of DNA from resilient parasite eggs was developed alongside the design of a novel, nematode universal, degenerate primer pair, thus avoiding the difficulties of using species specific primers in situations where common parasite species are unknown. Used in conjunction this protocol and primer pair was tested on a wide range of faecal samples from captive and wild amphibians. The primers and protocol were validated and detected infections, including a Railletnema nematode infection in poison dart frogs from ZSL London Zoo and Mantella cowani frogs in the wild. Furthermore, we demonstrate the efficacy of our PCR-based protocol for detecting nematode infection in other hosts, such as the presence of pinworm (Aspiculuris) in two tortoise species and whipworm (Trichuris muris) in mice. Our environmental DNA approach mitigates problems associated with microscopic identification and can be applied to detect nematode parasitoses in wild and captive hosts for infection surveillance and maintenance of healthy populations.	[Huggins, Lucas G.; Cruickshank, Sheena M.; Else, Kathryn J.] Univ Manchester, MAHSC, Fac Biol Med & Hlth, Manchester, Lancs, England; [Michaels, Christopher J.] ZSL London Zoo, Herpetol Sect, London, England; [Preziosi, Richard F.] Manchester Metropolitan Univ, Fac Sci & Engn, Manchester, Lancs, England	University of Manchester; Manchester Metropolitan University	Huggins, LG (corresponding author), Univ Manchester, MAHSC, Fac Biol Med & Hlth, Manchester, Lancs, England.	lucas-g-h@hotmail.com	Huggins, Lucas/AAJ-7346-2021; Preziosi, Richard F/A-8626-2010	Huggins, Lucas/0000-0002-1384-2886; Preziosi, Richard F/0000-0003-0468-6655; Cruickshank, Sheena/0000-0002-3047-5475				Baille D, 2008, MOL ECOL, V17, P1523, DOI 10.1111/j.1365-294X.2008.03697.x; BAKER MR, 1985, P HELM SOC WASH, V52, P76; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001; Bhadury P, 2006, AQUAT MICROB ECOL, V44, P97, DOI 10.3354/ame044097; Bhadury P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026445; Bhadury P, 2010, HYDROBIOLOGIA, V641, P245, DOI 10.1007/s10750-009-0088-z; Blackwood CB, 2005, APPL ENVIRON MICROB, V71, P6193, DOI 10.1128/AEM.71.10.6193-6198.2005; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Bouamer S, 2005, ZOOSYSTEMA, V27, P193; Bouamer S, 2003, CAN J ZOOL, V81, P1885, DOI [10.1139/z03-166, 10.1139/Z03-166]; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Budischak SA, 2015, MOL ECOL RESOUR, V15, P1112, DOI 10.1111/1755-0998.12382; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Bursey CR, 2006, COMP PARASITOL, V73, P193, DOI 10.1654/4181.1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Costa FO, 2010, THEOR BIOSCI, V129, P149, DOI 10.1007/s12064-010-0091-y; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Cutillas C, 2002, PARASITOL RES, V88, P574, DOI 10.1007/s00436-002-0596-5; Demeler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061285; Dorris M, 1999, PARASITOL TODAY, V15, P188, DOI 10.1016/S0169-4758(99)01439-8; Eckert J, 2003, ACTA TROP, V85, P157, DOI 10.1016/S0001-706X(02)00216-4; Eisenberg Tobias, 2009, Salamandra, V45, P91; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; Giangaspero A, 2004, IPPOLOGIA, V15, P11; Gobert GN, 2005, MOL CELL PROBE, V19, P250, DOI 10.1016/j.mcp.2005.01.006; Golab E, 2009, J MICROBIOL METH, V78, P213, DOI 10.1016/j.mimet.2009.05.019; Gomez Andres, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P222, DOI 10.1016/j.ijppaw.2013.07.002; Goswami U, 2015, ACTA PARASITOL, V60, P553, DOI 10.1515/ap-2015-0079; Hong RL, 2005, J EXP ZOOL PART A, V303A, P742, DOI 10.1002/jez.a.200; Hunt DJ, 2002, NEMATOLOGY, V4, P803, DOI 10.1163/156854102760402595; Huver JR, 2015, ECOL APPL, V25, P991, DOI 10.1890/14-1530.1; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; Johnson PTJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P124; Johnson Pieter T. J., 2009, P249, DOI 10.1007/978-0-387-09577-6_11; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Kenney SJ, 2006, INT J FOOD MICROBIOL, V106, P61, DOI 10.1016/j.ijfoodmicro.2005.05.011; Koprivnikar J, 2012, ECOHEALTH, V9, P342, DOI 10.1007/s10393-012-0785-3; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Malysheva SV, 2016, J HELMINTHOL, V90, P186, DOI 10.1017/S0022149X15000061; Malysheva SV, 2015, ZOOTAXA, V3926, P100, DOI 10.11646/zootaxa.3926.1.4; McNally J, 2013, VET PARASITOL, V198, P325, DOI 10.1016/j.vetpar.2013.09.014; Nilsson RH, 2016, FUNG BIOL-US, P47, DOI 10.1007/978-3-319-29137-6_4; Oldekop JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038922; Pan F, 2015, J SOIL SCI PLANT NUT, V15, P129, DOI 10.4067/S0718-95162015005000011; Pessier AP, 2014, ZOO BIOL, V33, P516, DOI 10.1002/zoo.21166; Rahman L, 2014, SOIL RES, V52, P604, DOI 10.1071/SR14041; Renco M, 2012, J NEMATOL, V44, P329; da Silva NRR, 2010, NEMATOLOGY, V12, P661, DOI 10.1163/138855410X500073; Roedder Dennis, 2009, Diversity, V1, P52; Romansic JM, 2011, OECOLOGIA, V166, P1029, DOI 10.1007/s00442-011-1932-1; Schar F, 2014, PARASITOL INT, V63, P597, DOI 10.1016/j.parint.2014.03.007; Shah AA, 2015, J NEMATOL, V47, P153; Shen YY, 2013, PLOS ONE, V8, P5; Steel H, 2012, APPL SOIL ECOL, V61, P100, DOI 10.1016/j.apsoil.2012.05.004; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taniuchi M, 2011, AM J TROP MED HYG, V84, P332, DOI 10.4269/ajtmh.2011.10-0461; Tinsley RC, 1995, PARASITOLOGY, V111, pS153, DOI 10.1017/S0031182000075879; Tkach V. V., 2010, Vestnik Zoologii, V44, P3, DOI 10.2478/v10058-010-0001-2; Traub RJ, 2008, VET PARASITOL, V155, P67, DOI 10.1016/j.vetpar.2008.05.001; Van Steenkiste N, 2015, MOL ECOL RESOUR, V15, P945, DOI 10.1111/1755-0998.12358; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; WAKELIN D, 1976, PARASITOLOGY, V72, P173, DOI 10.1017/S0031182000048472; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; Wang CR, 2016, GENE, V585, P71, DOI 10.1016/j.gene.2016.03.037; Wright K, 2001, AMPHIBIANS MED CAPTI, P193	68	3	4	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185151	10.1371/journal.pone.0185151	http://dx.doi.org/10.1371/journal.pone.0185151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934299	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900106
J	Isaiah, A; Hoffmann, AR; Kelley, R; Mundell, P; Steiner, JM; Suchodolski, JS				Isaiah, Anitha; Hoffmann, Aline Rodrigues; Kelley, Russ; Mundell, Paul; Steiner, Jorg M.; Suchodolski, Jan S.			Characterization of the nasal and oral microbiota of detection dogs	PLOS ONE			English	Article							SKIN MICROBIOTA; GUT MICROBIOME; HEALTH	Little is known about physiological factors that affect the sense of olfaction in dogs. The objectives of this study were to describe the canine nasal and oral microbiota in detection dogs. We sought to determine the bacterial composition of the nasal and oral microbiota of a diverse population of detection canines. Nasal and oral swabs were collected from healthy dogs (n = 81) from four locations-Alabama, Georgia, California, and Texas. Nasal and oral swabs were also collected from a second cohort of detection canines belonging to three different detection job categories: explosive detection dogs (SP-E; n = 22), patrol and narcotics detection dogs (P-NDD; n = 15), and vapor wake dogs (VWD-E; n = 9). To understand if the nasal and oral microbiota of detection canines were variable, sample collection was repeated after 7 weeks in a subset of dogs. DNA was extracted from the swabs and used for 454-pyrosequencing of the16S rRNA genes. Nasal samples had a significantly lower diversity than oral samples (P<0.01). Actinobacteria and Proteobacteria were higher in nasal samples, while Bacteroidetes, Firmicutes, Fusobacteria, and Tenericutes were higher in oral samples. Bacterial diversity was not significantly different based on the detection job. No significant difference in beta diversity was observed in the nasal samples based on the detection job. In oral samples, however, ANOSIM suggested a significant difference in bacterial communities based on job category albeit with a small effect size (R = 0.1079, P = 0.02). Analysis of the composition of bacterial communities using LEfSe showed that within the nasal samples, Cardiobacterium and Riemerella were higher in VWD-E dogs, and Sphingobacterium was higher in the P-NDD group. In the oral samples Enterococcus and Capnocytophaga were higher in the P-NDD group. Gemella and Aggregatibacter were higher in S-PE, and Pigmentiphaga, Chryseobacterium, Parabacteroides amongst others were higher within the VWD-E group. Our initial data also shows that there is a temporal variation in alpha diversity in nasal samples in detection canines.	[Isaiah, Anitha; Steiner, Jorg M.; Suchodolski, Jan S.] Texas A&M Univ, Dept Small Anim Clin Sci, Coll Vet Med & Biomed Sci, Gastrointestinal Lab, College Stn, TX 77843 USA; [Hoffmann, Aline Rodrigues] Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, Dermatopathol Specialty Serv, College Stn, TX USA; [Mundell, Paul] Canine Compan Independence, Santa Rosa, CA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Suchodolski, JS (corresponding author), Texas A&M Univ, Dept Small Anim Clin Sci, Coll Vet Med & Biomed Sci, Gastrointestinal Lab, College Stn, TX 77843 USA.	jsuchodolski@cvm.tamu.edu			Office of Naval Research [N000141410256]	Office of Naval Research(Office of Naval Research)	This study was supported by a grant from the Office of Naval Research, grant # N000141410256, http://www.onr.navy.mil/.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Butler T, 2015, EUR J CLIN MICROBIOL, V34, P1271, DOI 10.1007/s10096-015-2360-7; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cenit MC, 2014, BBA-MOL BASIS DIS, V1842, P1981, DOI 10.1016/j.bbadis.2014.05.023; Cheng YY, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0143-0; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Craven BA, 2010, J R SOC INTERFACE, V7, P933, DOI 10.1098/rsif.2009.0490; Cusco A, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00006; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elliott DR, 2005, J CLIN MICROBIOL, V43, P5470, DOI 10.1128/JCM.43.11.5470-5476.2005; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154646; Francois A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24687; Garza DR, 2015, CELL MOL LIFE SCI, V72, P4287, DOI 10.1007/s00018-015-2004-1; Hackner K, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa78fd; Magnusson KR, 2015, NEUROSCIENCE, V300, P128, DOI 10.1016/j.neuroscience.2015.05.016; Meason-Smith C, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv139; Misic AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0052-7; Newman MM, 2016, SCI TOTAL ENVIRON, V543, P155, DOI 10.1016/j.scitotenv.2015.11.008; Oh C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131468; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Riggio MP, 2011, VET MICROBIOL, V150, P394, DOI 10.1016/j.vetmic.2011.03.001; RODRIGUESHOFFMA.A, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.003197; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Theis KR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00615; Tress B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176736; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Weese JS, 2013, VET DERMATOL, V24; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zarco MF, 2012, ORAL DIS, V18, P109, DOI 10.1111/j.1601-0825.2011.01851.x; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14	37	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184899	10.1371/journal.pone.0184899	http://dx.doi.org/10.1371/journal.pone.0184899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934260	gold, Green Submitted, Green Published			2022-12-27	WOS:000411339900059
J	Jones, SC; Hall, S; Kypri, K				Jones, Sandra C.; Hall, Sabine; Kypri, Kypros			Should I drink responsibly, safely or properly? Confusing messages about reducing alcohol-related harm	PLOS ONE			English	Article							ADOLESCENT; TOBACCO	'Responsible drinking' campaigns emerged in the early 1970s as a means of addressing hazardous drinking and its related consequences. While these were initially the product of public health agencies and health-related NGOs, they are increasingly being developed and disseminated by the alcohol industry. There is considerable debate as to whether industry-generated campaigns are designed to reduce hazardous drinking and related problems (as argued by their developers) or are designed to avoid government regulation or even to increase sales. The aim of the present study was to explore the way that recent industry-developed responsible drinking campaigns are perceived and interpreted by the general public. That is, do they promote low-risk drinking, promote risky drinking, or just muddy the waters. Two sub-studies were conducted. The first, a mall intercept study with 180 adults in two Australian shopping districts, explored participants' understanding of slogans/taglines. The second, an online survey with 480 Australian adults, explored understandings and interpretations of television/online commercials. The results of the two studies revealed diversity in participants' interpretation of the 'responsible drinking' advertisements. Terminology utilised in industry-developed advertisements was found to be ambiguous; for example, what age group was being referred to in the tagline 'Kids and alcohol don't mix', and whether 'Drink Properly' meant not drinking to excess or drinking in a way that made you look more sophisticated. In Study Two, the government-developed campaign ('Know when to say when') was clearly interpreted as warning against risky consumption of alcohol; whereas the industry-developed campaigns ('How to drink properly', 'Kids absorb your drinking', 'Friends are waiting') were interpreted to have a range of different meanings, including some seemingly unrelated to alcohol. These findings are consistent with the literature evaluating anti-smoking campaigns developed by the tobacco industry, and previous research showing that industry communications serve to soften public opinion and create the impression of a 'socially responsible' industry but are likely to be less effective than initiatives focused on the availability and promotion of alcohol.	[Jones, Sandra C.; Hall, Sabine] Australian Catholic Univ, Ctr Hlth & Social Res, Melbourne, Vic, Australia; [Kypri, Kypros] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Sch Med & Publ Hlth, Callaghan, NSW, Australia	Australian Catholic University; University of Newcastle	Jones, SC (corresponding author), Australian Catholic Univ, Ctr Hlth & Social Res, Melbourne, Vic, Australia.	Sandra.Jones@acu.edu.au			Australian Research Council [FT120100932]	Australian Research Council(Australian Research Council)	The first author is supported by an Australian Research Council Future Fellowship (FT120100932). The authors received no specific funding for this work.	Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Australian Bureau of Statistics, 2015, APP CONS ALC AUSTR 2; Australian Media Association (AMA), 2012, ALC MARK YOUNG PEOPL; Barry A., 2007, HLTH ED MONOGRAPH SE, V24, P1, DOI DOI 10.3109/14992027.2016.1143980; Biener L, 2002, TOB CONTROL, V11, pII43; Bond L, 2010, AUSTRALAS MED J, V3, P325, DOI 10.4066/AMJ.2010.363; Bond L, 2009, AUSTRALAS MED J, V2, DOI 10.4066/AMJ.2009.43; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Education Commission of the States, 1977, TASK FORC RESP DEC A, V1; Ellickson PL, 2005, ADDICTION, V100, P235, DOI 10.1111/j.1360-0443.2005.00974.x; Hall WD, 2006, MED J AUSTRALIA, V185, P635, DOI 10.5694/j.1326-5377.2006.tb00736.x; Henriksen L, 2006, TOB CONTROL, V15, P13, DOI 10.1136/tc.2003.006361; Jones SC, 2007, J PUBLIC AFF, V7, P148, DOI 10.1002/pa.256; Jones SC, 2015, SOC MAR Q; Jones SC, 2013, EVID BASE, V2, P1; Lavrakas PJ, 2008, ENCY SURVEY RES METH, DOI DOI 10.1371/journal.pone.0073008; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P845, DOI 10.1016/j.jclinepi.2014.03.002; McCambridge J, 2014, ADDICTION, V109, P519, DOI 10.1111/add.12356; McCusker Centre for Action on Alcohol and Youth (MCAAY), ALC IND PEAK BOD REP; Miller PG, 2011, ADDICTION, V106, P1560, DOI 10.1111/j.1360-0443.2011.03499.x; NHMRC, 2009, AUSTR GUID RED HLTH; Pettigrew S, 2016, ADDICTION, V111, P1107, DOI 10.1111/add.13296; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51; Smith SW, 2006, HEALTH COMMUN, V20, P1, DOI 10.1207/s15327027hc2001_1; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Wakefield M, 2006, AM J PUBLIC HEALTH, V96, P2154, DOI 10.2105/AJPH.2005.083352; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Williams M, 1981, ALCOHOL HEALTH RES W, V6, P2	29	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184705	10.1371/journal.pone.0184705	http://dx.doi.org/10.1371/journal.pone.0184705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934269	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900041
J	Wu, JH; Liu, X; Nayak, SG; Pitarresi, JR; Cuitino, MC; Yu, LB; Hildreth, BE; Thies, KA; Schilling, DJ; Fernandez, SA; Leone, G; Ostrowski, MC				Wu, Jinghai; Liu, Xin; Nayak, Sunayana G.; Pitarresi, Jason R.; Cuitino, Maria C.; Yu, Lianbo; Hildreth, Blake E., III; Thies, Katie A.; Schilling, Daniel J.; Fernandez, Soledad A.; Leone, Gustavo; Ostrowski, Michael C.			Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele	PLOS ONE			English	Article							MOUSE MODELS; DUCTAL ADENOCARCINOMA; GENE; SYSTEM; MICE	The contribution of the tumor microenvironment to the development of pancreatic adenocarcinoma ( PDAC) is unclear. The LSL-Kras(G12D/+); LSL-p53(R172H/+); Pdx-1-Cre(KPC) tumor model, which is widely utilized to faithfully recapitulate human pancreatic cancer, depends on Cre-mediated recombination in the epithelial lineage to drive tumorigenesis. Therefore, specific Cre-loxP recombination in stromal cells cannot be applied in this model, limiting the in vivo investigation of stromal genetics in tumor initiation and progression. To address this issue, we generated a new Pdx1FlpO knock-in mouse line, which represents the first mouse model to physiologically express FlpO recombinase in pancreatic epithelial cells. This mouse specifically recombines Frt loci in pancreatic epithelial cells, including acinar, ductal, and islet cells. When combined with the Frt-STOP-Frt Kras(G12D) and p53(Frt) mouse lines, simultaneous Pdx1FlpO activation of mutant Kras and deletion of p53 results in the spectrum of pathologic changes seen in PDAC, including PanIN lesions and ductal carcinoma. Combination of this KPF mouse model with any stroma-specific Cre can be used to conditionally modify target genes of interest. This will provide an excellent in vivo tool to study the roles of genes in different cell types and multiple cell compartments within the pancreatic tumor microenvironment.	[Wu, Jinghai; Liu, Xin; Nayak, Sunayana G.; Pitarresi, Jason R.; Cuitino, Maria C.; Schilling, Daniel J.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Wu, Jinghai; Liu, Xin; Nayak, Sunayana G.; Pitarresi, Jason R.; Cuitino, Maria C.; Schilling, Daniel J.] Ohio State Univ, Canc Biol & Genet Dept, Columbus, OH 43210 USA; [Yu, Lianbo; Fernandez, Soledad A.] Ohio State Univ, Ctr Biostat, Dept Biomed Informat, Columbus, OH 43210 USA; [Hildreth, Blake E., III; Thies, Katie A.; Leone, Gustavo; Ostrowski, Michael C.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Hildreth, Blake E., III; Thies, Katie A.; Leone, Gustavo; Ostrowski, Michael C.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Medical University of South Carolina; Medical University of South Carolina	Wu, JH (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.; Wu, JH (corresponding author), Ohio State Univ, Canc Biol & Genet Dept, Columbus, OH 43210 USA.; Ostrowski, MC (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.; Ostrowski, MC (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	Jinghai.Wu@osumc.edu; ostrowsk@musc.edu	Ostrowski, Michael C/H-3108-2011; yu, lianbo/B-3472-2010; Hildreth, Eason/W-8186-2019	Hildreth, Eason/0000-0002-4631-1117; Nayak, Sunayana/0000-0003-3935-7501	NIH [PO1CA097189]; NATIONAL CANCER INSTITUTE [P01CA097189, P30CA138313] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH (PO1CA097189, MCO and GL); https://www.nih.gov/. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; The authors thank Dr. Tyler Jacks (Massachusetts Institute of Technology), Dr. David Kirsch (Duke University) for providing transgenic animals; Dr. Mark Magnuson (Vanderbilt University) for providing Pdx1CFP vector [10]; Dr. A. Francis Stewart for providing pCAGGs-FlpO vector [2]; Dr. V. Coppola (Genetically Engineered Mouse Modeling facility of The Ohio State University James Comprehensive Cancer Center) for helping mouse targeting; Shannon K. Halloran, and Maokun Li for helping mouse housing and genotyping. This study was supported by NIH PO1 CA097189 (M.C.O. and G.L.).	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; CASEY G, 1993, CANCER LETT, V69, P151, DOI 10.1016/0304-3835(93)90168-9; Doyle A, 2012, TRANSGENIC RES, V21, P327, DOI 10.1007/s11248-011-9537-3; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Howlader N, 2013, SEER CANC STAT REV 1; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Mazur PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013578; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ostapoff, 2013, EXPT METASTASIS MODE, P57; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Potter LA, 2012, GENESIS, V50, P384, DOI 10.1002/dvg.20804; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066	26	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184984	10.1371/journal.pone.0184984	http://dx.doi.org/10.1371/journal.pone.0184984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934293	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900072
J	Ahmad, MS; Kimhofer, T; Ahmad, S; AlAma, MN; Mosli, HH; Hindawi, SI; Mook-Kanamori, DO; Sebekova, K; Damanhouri, ZA; Holmes, E				Ahmad, Muhammad Saeed; Kimhofer, Torben; Ahmad, Sultan; AlAma, Mohammed Nabil; Mosli, Hala Hisham; Hindawi, Salwa Ibrahim; Mook-Kanamori, Dennis O.; Sebekova, Katarina; Damanhouri, Zoheir Abdullah; Holmes, Elaine			Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INTIMA MEDIA THICKNESS; HEMODIALYSIS-PATIENTS; REFERENCE VALUES; FLUORESCENCE; ACCUMULATION; POPULATION; MORTALITY; STRESS; FOOD	Skin auto fluorescence (SAF) is used as a proxy for the accumulation of advanced glycation end products (AGEs) and has been proposed to stratify patients into cardiovascular disease (CVD) and diabetes mellitus (DM) risk groups. This study evaluates the effects of seven different ethnicities (Arab, Central-East African, Eastern Mediterranean, European, North African, South Asian and Southeast Asian) and gender on SAF as well as validating SAF assessment as a risk estimation tool for CVD and DM in an Arabian cohort. SAF data from self-reported healthy 2,780 individuals, collated from three independent studies, has been linear modelled using age and gender as a covariate. A cross-study harmonized effect size (Cohens'd) is provided for each ethnicity. Furthermore, new data has been collected from a clinically well-defined patient group of 235 individuals, to evaluate SAF as a clinical tool for DM and CVD-risk estimation in an Arab cohort. In an Arab population, SAF-based CVD and/or DM risk-estimation can be improved by referencing to ethnicity and gender-specific SAF values. Highest SAF values were observed for the North African population, followed by East Mediterranean, Arab, South Asian and European populations. The South Asian population had a slightly steeper slope in SAF values with age compared to other ethnic groups. All ethnic groups except Europeans showed a significant gender effect. When compared with a European group, effect size was highest for Eastern Mediterranean group and lowest for South Asian group. The Central-East African and Southeast Asian ethnicity matched closest to the Arab and Eastern Mediterranean ethnicities, respectively. Ethnic and gender-specific data improves performance in SAF-based CVD and DM risk estimation. The provided harmonized effect size allows a direct comparison of SAF in different ethnicities. For the first time, gender differences in SAF are described for North African and East Mediterranean populations.	[Ahmad, Muhammad Saeed; Ahmad, Sultan; Damanhouri, Zoheir Abdullah; Holmes, Elaine] King Abdulaziz Univ, King Fahad Med Res Ctr, Drug Metab Unit, Jeddah, Saudi Arabia; [Ahmad, Muhammad Saeed; Kimhofer, Torben; Holmes, Elaine] Imperial Coll London, Fac Med, Dept Surg & Canc, Biomol Med, London, England; [AlAma, Mohammed Nabil] King Abdulaziz Univ Hosp, Dept Med, Cardiol Unit, Jeddah, Saudi Arabia; [Mosli, Hala Hisham] King Abdulaziz Univ, Fac Med, Dept Med, Jeddah, Saudi Arabia; [Hindawi, Salwa Ibrahim] King Abdulaziz Univ, Fac Med, Dept Haematol, Jeddah, Saudi Arabia; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Primary Care Publ Hlth & Clin Epidemiol, Leiden, Netherlands; [Sebekova, Katarina] Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia; [Damanhouri, Zoheir Abdullah] King Abdulaziz Univ, Fac Med, Dept Pharmacol, Jeddah, Saudi Arabia	King Abdulaziz University; Imperial College London; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh; King Abdulaziz University; King Abdulaziz University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Comenius University Bratislava; King Abdulaziz University	Ahmad, MS (corresponding author), King Abdulaziz Univ, King Fahad Med Res Ctr, Drug Metab Unit, Jeddah, Saudi Arabia.; Ahmad, MS; Kimhofer, T (corresponding author), Imperial Coll London, Fac Med, Dept Surg & Canc, Biomol Med, London, England.	maahmad2@kau.edu.sa; t.kimhofer12@imperial.ac.uk	Ahmad, Muhammad S/L-5322-2013; Damanhouri, Zoheir/ABI-6203-2020; Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020; Sebekova, Katarina/GSD-7056-2022; Sebekova, Katarina/H-4906-2016	Ahmad, Muhammad S/0000-0003-1945-2739; Holmes, Elaine/0000-0002-0556-8389; Sebekova, Katarina/0000-0002-9641-9265; Sebekova, Katarina/0000-0002-9641-9265; HINDAWI, SALWA/0000-0003-3804-5434	Deanship of Scientific Research (DSR), King Abdulaziz University [2-141-35-HiCi]; Stratified Medicine Graduate Training Programme in Systems Medicine and Spectroscopic Profiling (STRATiGRAD); Dutch Science Organization (ZonMW-VENI Grant) [916.14.023]; Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University; Stratified Medicine Graduate Training Programme in Systems Medicine and Spectroscopic Profiling (STRATiGRAD); Dutch Science Organization (ZonMW-VENI Grant); Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, under grant no. (2-141-35-HiCi). T Kimhofer was supported by Stratified Medicine Graduate Training Programme in Systems Medicine and Spectroscopic Profiling (STRATiGRAD). Dennis Mook-Kanamori is supported by Dutch Science Organization (ZonMW-VENI Grant 916.14.023).; The authors thank all participants of this study. This article was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Ahmad MS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10198; Barat P, 2011, DIABETES CARE, V35, pe1; Conway B, 2010, DIABETES TECHNOL THE, V12, P339, DOI 10.1089/dia.2009.0152; de Vos LC, 2015, ARTERIOSCL THROM VAS, V35, P1532, DOI 10.1161/ATVBAHA.115.305407; Eny KM, 2015, DIABETES TECHNOL THE, V17, P726, DOI 10.1089/dia.2015.0017; Eny KM, 2014, DIABETOLOGIA, V57, P1623, DOI 10.1007/s00125-014-3286-9; Hangai M, 2016, J ATHEROSCLER THROMB; Hartog JWL, 2007, EUR J HEART FAIL, V9, P1146, DOI 10.1016/j.ejheart.2007.09.009; Hashimoto K, 2016, J DIABETES COMPLICAT; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Jochemsen BM, 2009, J FOOD NUTR RES-SLOV, V48, P51; Kessel L, 2002, DIABETOLOGIA, V45, P1457, DOI 10.1007/s00125-002-0925-3; Klenovics KS, 2014, DIABETIC MED, V31, P581, DOI 10.1111/dme.12326; Knowles JW, 2015, J CLIN INVEST, V125, P1739, DOI [10.1172/JCI74692, 10.1172/JCI74592]; Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113; Krul-Poel YHM, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0250-z; Lutgers HL, 2009, DIABETOLOGIA, V52, P789, DOI 10.1007/s00125-009-1308-9; Lutgers HL, 2010, EUR J CLIN INVEST, V40, P812, DOI 10.1111/j.1365-2362.2010.02329.x; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meerwaldt R, 2007, DIABETES CARE, V30, P107, DOI 10.2337/dc06-1391; Mook-Kanamori MJ, 2013, DERM-ENDOCRINOL, V5, P325, DOI 10.4161/derm.26046; Nongnuch A, 2015, BRIT J NUTR, V113, P1040, DOI 10.1017/S0007114515000379; Podgorna E, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0543-6; R Core Team, R LANG ENV STAT COMP; Rajaobelina K, 2016, DIABETES-METAB RES; Sugisawa E, 2013, DIABETES CARE, V36, P2339, DOI 10.2337/dc12-1077; van Waateringe RP, 2016, EUR J CLIN INVEST, V46, P481, DOI 10.1111/eci.12627; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Vouillarmet J, 2013, DIABETES TECHNOL THE, V15, P601, DOI 10.1089/dia.2013.0009; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yamanaka M, 2016, J CLIN BIOCHEM NUTR, V58, P135, DOI 10.3164/jcbn.15-132; Yue X, 2011, DIABETIC MED, V28, P818, DOI 10.1111/j.1464-5491.2010.03217.x	33	12	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185175	10.1371/journal.pone.0185175	http://dx.doi.org/10.1371/journal.pone.0185175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931094	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700077
J	Foteinopoulos, P; Mulder, BM				Foteinopoulos, Panayiotis; Mulder, Bela M.			A microtubule-based minimal model for spontaneous and persistent spherical cell polarity	PLOS ONE			English	Article							END-TRACKING PROTEINS; YEAST; MEMBRANE; DYNAMICS; CYTOSKELETON; MECHANISMS	We propose a minimal model for the spontaneous and persistent generation of polarity in a spherical cell based on dynamic microtubules and a single mobile molecular component. This component, dubbed the polarity factor, binds to microtubules nucleated from a centrosome located in the center of the cell, is subsequently delivered to the cell membrane, where it diffuses until it unbinds. The only feedback mechanism we impose is that the residence time of the microtubules at the membrane increases with the local density of the polarity factor. We show analytically that this system supports a stable unipolar symmetry-broken state for a wide range of parameters. We validate the predictions of the model by 2D particle-based simulations. Our model provides a route towards the creation of polarity in a minimal cell-like environment using a biochemical reconstitution approach.	[Foteinopoulos, Panayiotis; Mulder, Bela M.] Inst AMOLF, Syst Biophys Dept, Amsterdam, Netherlands	AMOLF	Mulder, BM (corresponding author), Inst AMOLF, Syst Biophys Dept, Amsterdam, Netherlands.	mulder@amolf.nl			Foundation for Fundamental Research on Matter (FOM); Netherlands Organisation for Scientific Research (NWO)	Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work of BMM was supported by the research programme of the Foundation for Fundamental Research on Matter (FOM,www.fom.nl), which is part of the Netherlands Organisation for Scientific Research (NWO,www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Bressloff PC, 2015, SIAM J APPL MATH, V75, P652, DOI 10.1137/140990358; Bruce A, 2002, MOL BIOL CELL; BUENDIA B, 1992, J CELL BIOL, V116, P1431, DOI 10.1083/jcb.116.6.1431; Calvez V, 2012, SIAM J APPL MATH, V72, P594, DOI 10.1137/11083486X; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; Freisinger T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2795; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Good MC, 2013, SCIENCE, V342, P856, DOI 10.1126/science.1243147; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Hawkins RJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.040903; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002271; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Klunder B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003396; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Li Jian-Ming, 2012, Int J Mol Imaging, V2012, P253475, DOI 10.1155/2012/253475; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Milani M, 1998, P SOC PHOTO-OPT INS, V3256, P195, DOI 10.1117/12.307071; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Recouvreux P, 2016, P NATL ACAD SCI USA, V113, P1811, DOI 10.1073/pnas.1419248113; Schmidt N, 2012, J CELL BIOL, V198, P421, DOI 10.1083/jcb.201111130; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Su XL, 2013, NAT CELL BIOL, V15, P948, DOI 10.1038/ncb2801; Taberner N, 2015, METHOD CELL BIOL, V128, P1, DOI 10.1016/bs.mcb.2015.02.008; Taberner N, 2014, METHOD CELL BIOL, V120, P69, DOI 10.1016/B978-0-12-417136-7.00005-7; Thompson BJ, 2013, DEVELOPMENT, V140, P13, DOI 10.1242/dev.083634; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wu CF, 2015, ELIFE, V4, DOI 10.7554/eLife.11611	38	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184706	10.1371/journal.pone.0184706	http://dx.doi.org/10.1371/journal.pone.0184706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931032	gold, Green Published, Green Submitted			2022-12-27	WOS:000411314700028
J	Lambert, A; Jarlier, M; Bourgade, SG; Conroy, T				Lambert, Aurelien; Jarlier, Marta; Bourgade, Sophie Gourgou; Conroy, Thierry			Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ACCORD 11 randomized trial	PLOS ONE			English	Article							GEMCITABINE	Background Hohla et al. suggested that female gender could positively predict response to FOLFIRINOX in patients with advanced pancreatic cancer. In this study, we explored the response to the FOLFIRINOX regimen by gender within the trial PRODIGE4/ACCORD 11. Patients and methods Data were described by gender, both in FOLFIRINOX group and in the intention-to-treat population of the trial. The relative effect of gender (females in comparison to males) on overall survival (OS) and progression-free survival was estimated by using a Cox proportional hazard model and was presented with the Hazard Ratio and their 95% confidence interval. The analysis of prognostic factors of OS included also: age (older than 65 years), ECOG performance status, primary tumor location, synchronous metastases, number of metastatic sites, hepatic metastasis, pulmonary metastases, lymph node metastases, level of Albumin and level of serum carbohydrate antigen 19-9 and three domains from the EORTC Quality of Life QLQC-30 questionnaire. Results The FOLFIRINOX group (N = 171 patients) included 106 women (62%) and 65 men. No significant differences were observed between genders regarding demographic and clinical parameters, excepted for lymph nodes metastasis (17% and 35% in women and men respectively; p = 0.012). Median OS was longer for females as compared to males in FOLFIRINOX group (13.1 versus 10.3 months respectively; HR = 0.73; 95% CI, 0.51-1.06). Similarly, median PFS was superior (7.2 versus 5.9 months; HR = 0.79; 95% CI, 0.57-1.10). Nevertheless, in both cases, the differences were not statistically significant (p = 0.10 et p = 0.169, respectively). Conclusions In this study, the overall survival and progression-free survival rates were not significantly higher for females than for males in FOLFIRINOX group (HR = 0.73; 95% CI, 0.51-1.06 and HR = 0.79; 95% CI, 0.57-1.10 respectively). Even if the percentage of patients with lymph node metastasis is higher for males than for females, the interaction between gender and lymph node metastasis was non-significant. Our exploratory analysis did not permit to definitively conclude about a possible effect of gender on the prognosis of patients under FOLFIRINOX. This subject deserves further evaluation.	[Lambert, Aurelien; Conroy, Thierry] Inst Cancerol Lorraine, Dept Med Oncol, Vandoeuvre Les Nancy, France; [Jarlier, Marta; Bourgade, Sophie Gourgou] Inst Reg Canc Montpellier, Biostat Unit, Parc Euromed, Montpellier, France	UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Lambert, A (corresponding author), Inst Cancerol Lorraine, Dept Med Oncol, Vandoeuvre Les Nancy, France.	a.lambert@nancy.unicancer.fr	Conroy, Thierry/X-8127-2019	Lambert, Aurelien/0000-0001-9990-1201				Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Gourgou-Bourgade S, 2013, J CLIN ONCOL, V31, P23, DOI 10.1200/JCO.2012.44.4869; Hidalgo M, 2014, ANN ONCOL         S2, V25; Hohla F, 2014, INT J ONCOL, V44, P319, DOI 10.3892/ijo.2013.2176	4	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0183288	10.1371/journal.pone.0183288	http://dx.doi.org/10.1371/journal.pone.0183288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931010	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700008
J	Ryskov, AP; Osipov, FA; Omelchenko, AV; Semyenova, SK; Girnyk, AE; Korchagin, VI; Vergun, AA; Murphy, RW				Ryskov, Alexey P.; Osipov, Fedor A.; Omelchenko, Andrey V.; Semyenova, Seraphima K.; Girnyk, Anastasiya E.; Korchagin, Vitaly I.; Vergun, Andrey A.; Murphy, Robert W.			The origin of multiple clones in the parthenogenetic lizard species Darevskia rostombekowi	PLOS ONE			English	Article							CAUCASIAN ROCK LIZARD; HETERONOTIA-BINOEI GEKKONIDAE; CYTOCHROME-B GENE; MICROSATELLITE LOCI; ALLELIC VARIANTS; LACERTA; DIVERSITY; EVOLUTION; COMPLEX; SAURIA	The all-female Caucasian rock lizard Darevskia rostombekowi and other unisexual species of this genus reproduce normally via true parthenogenesis. Typically, diploid parthenogenetic reptiles exhibit some amount of clonal diversity. However, allozyme data from D.rostombekowi have suggested that this species consists of a single clone. Herein, we test this hypothesis by evaluating variation at three variable microsatellite loci for 42 specimens of D. rostombekowi from four populations in Armenia. Analyses based on single nucleotide polymorphisms of each locus reveal five genotypes or presumptive clones in this species. All individuals are heterozygous at the loci. The major clone occurs in 24 individuals and involves three populations. Four rare clones involve one or several individuals from one or two populations. Most variation owes to parent-specific single nucleotide polymorphisms, which occur as heterozygotes. This result fails to reject the hypothesis of a single hybridization founder event that resulted in the initial formation of one major clone. The other clones appear to have originated via post-formation microsatellite mutations of the major clone.	[Ryskov, Alexey P.; Osipov, Fedor A.; Semyenova, Seraphima K.; Girnyk, Anastasiya E.; Korchagin, Vitaly I.; Vergun, Andrey A.] Russian Acad Sci, Inst Gene Biol, Lab Genome Org, Moscow, Russia; [Osipov, Fedor A.; Vergun, Andrey A.] Moscow State Pedag Univ, Dept Biochem Mol Biol & Genet, Moscow, Russia; [Omelchenko, Andrey V.] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Grp Bioinformat & Modeling Biol Proc, Moscow, Russia; [Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON, Canada	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Moscow State University of Education; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Royal Ontario Museum	Ryskov, AP (corresponding author), Russian Acad Sci, Inst Gene Biol, Lab Genome Org, Moscow, Russia.	ryskov@mail.ru	Osipov, Fedor/AAC-2363-2022; Girnyk, Anastasiya/U-7872-2018; Omelchenko, Andrey V/E-8887-2014; Vergun, Andrey/I-4829-2016; Korchagin, Vitaly/B-8635-2011; Ryskov, Alexey/F-1179-2016	Osipov, Fedor/0000-0002-0904-1752; Girnyk, Anastasiya/0000-0001-9199-1281; Omelchenko, Andrey V/0000-0003-4512-4413; Vergun, Andrey/0000-0001-5255-7802; Korchagin, Vitaly/0000-0003-2264-6294; Ryskov, Alexey/0000-0002-4159-0671	Russian Science Foundation [14-14-00832]; Russian Foundation of Scientific Researches [17-04-00396]; RAS Program "Molecular and Cell Biology"	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation of Scientific Researches; RAS Program "Molecular and Cell Biology"	The work on DNA sequencing was supported by the Russian Science Foundation No 14-14-00832 (http://rscf.ru/en). The work on genotype revealing and characterization was supported by the Russian Foundation of Scientific Researches (grant No 17-04-00396) by the RAS Program "Molecular and Cell Biology" (http://rscf.ru/en). The work was conducted on the base of the Center for Collective Use, Institute of Gene Biology, Russian Academy of Sciences (GK-02.451.11.7060) (http://www.genebiology.ru/en/).; The work on DNA sequencing was supported by the Russian Science Foundation No 14-14-00832. The work on genotype revealing and characterization was supported by the Russian Foundation of Scientific Researches (grant No 17-04-00396) and by the RAS Program "Molecular and Cell Biology". The work was conducted on the base of the Center for Collective Use, Institute of Gene Biology, Russian Academy of Sciences (GK-02.451.11.7060). Authors thank to Felix Danielyan for help in field and for providing biological materials.	Abdala CS, 2016, COPEIA, V104, P487, DOI 10.1643/CH-15-381; Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Avise J., 2008, CLONALITY GENETICS E; Badaeva TN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002730; Booth W, 2016, BIOL J LINN SOC, V118, P172, DOI 10.1111/bij.12744; Cole CJ, 1988, AM MUS NOVIT, V2905, P1; Darevsky I., 1967, ROCK LIZARDS CAUCASU; Darevsky I.S., 1985, Biology of Reptilia, V15, P411; Darevsky I. S., 1993, SOVREMENNYE PROBLEMY, P89; DAREVSKY IS, 1958, DOKL AKAD NAUK SSSR+, V122, P730; Deakin JE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2774-3; DENSMORE LD, 1989, EVOLUTION, V43, P969, DOI 10.1111/j.1558-5646.1989.tb02543.x; Dessauer Herbert C., 1989, New York State Museum Bulletin, V466, P49; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freitas S, 2016, MOL PHYLOGENET EVOL, V102, P117, DOI 10.1016/j.ympev.2016.05.035; Freitas S, 2016, SYST BIODIVERS, V14, P184, DOI 10.1080/14772000.2015.1111267; Fu JZ, 2000, COPEIA, P432, DOI 10.1643/0045-8511(2000)000[0432:DOTCBG]2.0.CO;2; Fu JZ, 1998, J MOL EVOL, V46, P127, DOI 10.1007/PL00013146; Fu JZ, 2000, AMPHIBIA-REPTILIA, V21, P83, DOI 10.1163/156853800507291; Fu JZ, 1999, GENETICA, V105, P227, DOI 10.1023/A:1003865227108; Fujita MK, 2009, CYTOGENET GENOME RES, V127, P261, DOI 10.1159/000295177; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hedges S. Blair, 2014, Caribbean Herpetology, V49; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jancuchova-Laskova J, 2015, CURR ZOOL, V61, P155; Janko K, 2008, EVOLUTION, V62, P1264, DOI 10.1111/j.1558-5646.2008.00359.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kearney M, 2008, MOL ECOL, V17, P5257, DOI 10.1111/j.1365-294X.2008.03991.x; Korchagin VI, 2007, GENE, V392, P126, DOI 10.1016/j.gene.2006.11.020; Kupriyanova LA, 1999, CYTOLOGIA, V21, P1038; Kupriyanova LA, 1989, EVOLUTION ECOLOGY UN, V466, P289; Lutes AA, 2010, NATURE, V464, P283, DOI 10.1038/nature08818; MacCulloch RD, 1997, BIOCHEM SYST ECOL, V25, P33, DOI 10.1016/S0305-1978(96)00085-3; Macculloch Ross D., 1995, Amphibia-Reptilia, V16, P331, DOI 10.1163/156853895X00415; Malysheva D N, 2006, Dokl Biochem Biophys, V410, P304, DOI 10.1134/S1607672906050140; Manriquez-Moran NL, 2014, ZOOL SCI, V31, P14, DOI 10.2108/zsj.31.14; Martirosyan IA, 2002, RUSS J GENET+, V38, P691, DOI 10.1023/A:1016000219576; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1992, GENETICA, V87, P53, DOI 10.1007/BF00128773; MORITZ C, 1991, GENETICS, V129, P211; Murphy RW, 1997, GENETICA, V101, P125, DOI 10.1023/A:1018392603062; Murphy RW, 2000, ZOOL J LINN SOC-LOND, V130, P527, DOI 10.1006/zjls.1999.0241; Murphy RW, 1999, AMPHIBIA-REPTILIA, V20, P225; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Osipov FA, 2016, MOL GENET MICROBIOL+, V31, P69, DOI 10.3103/S0891416816020075; Parker E. Davis Jr, 1989, New York State Museum Bulletin, V466, P72; PARKER ED, 1979, EVOLUTION, V33, P1150, DOI 10.1111/j.1558-5646.1979.tb04769.x; PARKER ED, 1984, HERPETOLOGICA, V40, P245; PARKER ED, 1979, AM ZOOL, V19, P753; Pellegrino KCM, 2003, J HERPETOL, V37, P197, DOI 10.1670/0022-1511(2003)037[0197:TKOLPS]2.0.CO;2; Ryskov AR, 2008, INT REV CEL MOL BIO, V270, P319, DOI 10.1016/S1937-6448(08)01407-X; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarkhnishvili D, 2010, BIOL J LINN SOC, V101, P447, DOI 10.1111/j.1095-8312.2010.01498.x; Uetz P., 2021, REPTILE DATABASE; UZZELL T, 1975, COPEIA, P204; Vergun AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091674; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Vrijenhoek Robert C., 1989, New York State Museum Bulletin, V466, P19; VYAS DK, 1990, EVOLUTION, V44, P922, DOI 10.1111/j.1558-5646.1990.tb03814.x	61	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185161	10.1371/journal.pone.0185161	http://dx.doi.org/10.1371/journal.pone.0185161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931071	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700074
J	Zhao, X; Ouyang, WW; Chester, C; Long, SQ; Wang, NX; He, ZX				Zhao, Xing; Ouyang, Weiwei; Chester, Cariad; Long, Shiqi; Wang, Nianxue; He, Zhixu			Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus	PLOS ONE			English	Article							T-CELLS; IN-VIVO; VIRUS; IMMUNOTHERAPY; CANCER; TRIAL; CHEMOTHERAPY; COMBINATION; CARCINOMA; THERAPY	Oncolytic viruses (OV) have recently emerged as a promising therapeutic modality in cancer treatment. OV selectively infect and kill tumor cells, while sparing untransformed cells. The direct cytotoxic effects combined with the capacity to trigger an immune response make OV an appealing combination partner in the burgeoning field of cancer immunotherapy. One of the leading OV therapeutic candidates is the double-stranded RNA virus reovirus. In order to improve the oncolytic activity of reovirus and allow for systemic administration despite the prevalence of neutralizing antibodies, cytokine-induced killer (CIK) cells were explored as cell carriers for reovirus delivery. In this study, CIK cells were successfully loaded with reovirus ex vivo, and viral replication was limited in CIK cells. Confocal microscopy and flow cytometry demonstrated that CIK cells retained reovirus on the surface. Moreover, CIK cells could promote reovirus infection of tumor cells in the presence of neutralizing antibodies; meanwhile, cytotoxicity of CIK cells was increased after loading with reovirus. These findings support further investigation of reovirus and CIK combination for antitumor therapy.	[Zhao, Xing; He, Zhixu] Guizhou Med Univ, Stem Cell & Tissue Engn Res Ctr, Guiyang, Guizhou, Peoples R China; [Zhao, Xing; Long, Shiqi; Wang, Nianxue] Guizhou Med Univ, Dept Immunol, Guiyang, Guizhou, Peoples R China; [Ouyang, Weiwei] Guizhou Med Univ, Affiliated Hosp, Dept Thorac Oncol, Guiyang, Guizhou, Peoples R China; [Ouyang, Weiwei] Guizhou Canc Hosp, Guiyang, Guizhou, Peoples R China; [Chester, Cariad] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA	Guizhou Medical University; Guizhou Medical University; Guizhou Medical University; Stanford University	He, ZX (corresponding author), Guizhou Med Univ, Stem Cell & Tissue Engn Res Ctr, Guiyang, Guizhou, Peoples R China.	hzx@gmc.edu.cn			National Natural Science Foundation of China [81360346]; Social Developmental Research Foundation of Guizhou Province [SY (2012)3094]; Guizhou Province's Science and Technology Major Project, Qian-J-Zhong [[2015]2003]; National Natural Science Foundation of China (NSFC) [81360346]; Guizhou Province's Science and Technology Major Project [Qian-J-Zhong[2015]2003]; NICHD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Developmental Research Foundation of Guizhou Province; Guizhou Province's Science and Technology Major Project, Qian-J-Zhong; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guizhou Province's Science and Technology Major Project; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from National Natural Science Foundation of China (grant number 81360346, http://www.nsfc.gov.cn/); The Social Developmental Research Foundation of Guizhou Province [grant number SY (2012)3094, http://www.gzpopss.gov.cn/]; and Guizhou Province's Science and Technology Major Project, Qian-J-Zhong (grant number [2015]2003, http://kjzdzx.gzste.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project is supported by the National Natural Science Foundation of China (NSFC, No. 81360346), Social Developmental Research Foundation of Guizhou Province [No. SY (2012)3094] and Guizhou Province's Science and Technology Major Project, Qian-J-Zhong[2015]2003. Anti-reovirus-sigma 3 primary antibody (deposited to the DSHB by Dermody, T.S.) was obtained from the Developmental Studies Hybridoma Bank (DSHB) developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Adair RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003578; Bhat R, 2011, INT J CANCER, V128, P908, DOI 10.1002/ijc.25415; Chakrabarty R, 2015, INVEST NEW DRUG, V33, P761, DOI 10.1007/s10637-015-0216-8; Clements D, 2014, ONCOLYTIC VIROTHER, V3, P69, DOI 10.2147/OV.S51321; El-Sherbiny YM, 2015, CLIN EXP IMMUNOL, V180, P98, DOI 10.1111/cei.12562; Gujar SA, 2011, MOL THER, V19, P797, DOI 10.1038/mt.2010.297; Harrington KJ, 2010, CLIN CANCER RES, V16, P3067, DOI 10.1158/1078-0432.CCR-10-0054; Ilett EJ, 2011, CLIN CANCER RES, V17, P2767, DOI 10.1158/1078-0432.CCR-10-3266; Jakel CE, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/897214; Jennings VA, 2014, INT J CANCER, V134, P1091, DOI 10.1002/ijc.28450; Karapanagiotou EM, 2012, CLIN CANCER RES, V18, P2080, DOI 10.1158/1078-0432.CCR-11-2181; Kaufman HL, 2015, NAT REV DRUG DISCOV, V14, P642, DOI 10.1038/nrd4663; Li JJ, 2012, J IMMUNOTHER, V35, P189, DOI 10.1097/CJI.0b013e318241d9de; Liu L, 2012, CLIN CANCER RES, V18, P1751, DOI 10.1158/1078-0432.CCR-11-2442; LU PH, 1994, J IMMUNOL, V153, P1687; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Olioso P, 2009, HEMATOL ONCOL, V27, P130, DOI 10.1002/hon.886; Pievani A, 2011, BLOOD, V117, P510, DOI 10.1182/blood-2010-06-290858; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sborov DW, 2014, CLIN CANCER RES, V20, P5946, DOI 10.1158/1078-0432.CCR-14-1404; Steele L, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-20; Thorne SH, 2006, SCIENCE, V311, P1780, DOI 10.1126/science.1121411; Weng DS, 2008, J IMMUNOTHER, V31, P63, DOI 10.1097/CJI.0b013e31815a121b; White CL, 2008, GENE THER, V15, P911, DOI 10.1038/gt.2008.21; Zhao X, 2016, MOL CANCER THER, V15, P767, DOI 10.1158/1535-7163.MCT-15-0695	26	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184816	10.1371/journal.pone.0184816	http://dx.doi.org/10.1371/journal.pone.0184816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922411	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300029
J	Lueders, I; Young, D; Maree, L; van der Horst, G; Luther, I; Botha, S; Tindall, B; Fosgate, G; Ganswindt, A; Bertschinger, HJ				Lueders, Imke; Young, Debbie; Maree, Liana; van der Horst, Gerhard; Luther, Ilse; Botha, Stephan; Tindall, Brendan; Fosgate, Geoffrey; Ganswindt, Andre; Bertschinger, Henk J.			Effects of GnRH vaccination in wild and captive African Elephant bulls (Loxodonta africana) on reproductive organs and semen quality	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; WHITE-TAILED DEER; TESTICULAR FUNCTION; AGGRESSIVE-BEHAVIOR; FEEDLOT PERFORMANCE; ACTIVE IMMUNIZATION; ENDOCRINE FUNCTION; FIELD CONDITIONS; SEXUAL-BEHAVIOR; MALE PIGS	Objectives Although the African elephant (Loxodonta africana) is classified as endangered by the International Union for Conservation of Nature (IUCN), in some isolated habitats in southern Africa, contraception is of major interest due to local overpopulation. GnRH vaccination has been promoted as a non-invasive contraceptive measure for population management of overabundant wildlife. We tested the efficacy of this treatment for fertility control in elephant bulls. Methods In total, 17 male African elephants that were treated with a GnRH vaccine were examined in two groups. In the prospective study group 1 (n = 11 bulls, ages: 8-36 years), semen quality, the testes, seminal vesicles, ampullae and prostate, which were all measured by means of transrectal ultrasound, and faecal androgen metabolite concentrations were monitored over a three-year period. Each bull in the prospective study received 5 ml of Improvac (R) (1000 mu g GnRH conjugate) intramuscularly after the first examination, followed by a booster six weeks later and thereafter every 5-7 months. In a retrospective study group (group 2, n = 6, ages: 19-33 years), one examination was performed on bulls which had been treated with GnRH vaccine for 5-11 years. Results In all bulls of group 1, testicular and accessory sex gland sizes decreased significantly after the third vaccination. In six males examined prior to vaccination and again after more than five vaccinations, the testis size was reduced by 57.5%. Mean testicular height and length decreased from 13.3 +/- 2.6 cm x 15.2 +/- 2.8 cm at the beginning to 7.6 +/- 2.1 cm x 10.2 +/- 1.8 cm at the end of the study. Post pubertal bulls (> 9 years, n = 6) examined prior to vaccination produced ejaculates with viable spermatozoa (volume: 8-175 ml, sperm concentration: 410-4000x10(6)/ml, total motility: 0-90%), while after 5-8 injections, only 50% of these bulls produced ejaculates with a small number of immotile spermatozoa. The ejaculates of group 2 bulls (vaccinated > 8 times) were devoid of spermatozoa. Faecal androgen metabolite concentrations measured in captive males decreased significantly after the fourth vaccination. None of the males entered musth during the treatment period. Conclusions Our results showed a marked decrease in semen quality, testicle and secondary sex gland sizes following repeated GnRH vaccinations. After 2-4 years of continuous treatment every 5-7 months, the effects were similar to surgical castration.	[Lueders, Imke] GEOlifes Anim Fertil & Reprod Res, Frohmestr 7, Hamburg, Germany; [Lueders, Imke; Ganswindt, Andre] Univ Pretoria, Fac Vet Sci, Dept Anat & Physiol, Endocrine Res Lab, Onderstepoort, South Africa; [Young, Debbie] African Elephant Res Unit, Plettenberg Bay, South Africa; [Maree, Liana; van der Horst, Gerhard; Luther, Ilse] Univ Western Cape, Dept Med Biosci, Bellville, South Africa; [Maree, Liana; van der Horst, Gerhard; Luther, Ilse] Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa; [Botha, Stephan] African Lion Safari, Cambridge, ON, Canada; [Tindall, Brendan] Robberg Vet Clin, 56 Longships, Plettenberg Bay, South Africa; [Fosgate, Geoffrey; Bertschinger, Henk J.] Univ Pretoria, Dept Prod Anim Studies, Fac Vet Sci, Onderstepoort, South Africa	University of Pretoria; University of the Western Cape; National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of Pretoria	Lueders, I (corresponding author), GEOlifes Anim Fertil & Reprod Res, Frohmestr 7, Hamburg, Germany.; Lueders, I (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Anat & Physiol, Endocrine Res Lab, Onderstepoort, South Africa.	imke.lueders@geolifes.com	Fosgate, Geoffrey T/N-8700-2014; Ganswindt, Andre/G-9856-2014; Van+der+Horst, Gerhard/AAB-7489-2020	Fosgate, Geoffrey T/0000-0002-9432-0042; Ganswindt, Andre/0000-0002-1474-7602; 	U.S. Fish and Wildlife Service [AFE 0705]; German Academic Exchange Service (DAAD) [D/11/45084]; International Elephant Foundation; Birmingham Zoo, USA; Technology Innovation Agency (Pretoria, South Africa)	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); International Elephant Foundation; Birmingham Zoo, USA; Technology Innovation Agency (Pretoria, South Africa)	I. Lueders and GvDH received a grant from the U.S. Fish and Wildlife Service- African elephant Fund #AFE 0705; I. Lueders received funding through the German Academic Exchange Service (DAAD) within the Postdoctoral Fellowship Program, Grant #D/11/45084; I. Lueders received project funding through the International Elephant Foundation and the Birmingham Zoo, USA; HJB received additional funding through the Technology Innovation Agency (Pretoria, South Africa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balet L, 2014, J DAIRY SCI, V97, P2193, DOI 10.3168/jds.2013-7602; Barth A. D., 1989, ABNORMAL MORPHOLOGY; Bertschinger Henk, 2008, P257; Bertschinger HJ, 2013, CONTRACEPTIVE APPL G; Boedeker NC, 2012, J ZOO WILDLIFE MED, V43, P603, DOI 10.1638/2011-0270.1; Botha AE, 2008, WILDLIFE RES, V35, P548, DOI 10.1071/WR07136; BROWN JL, 1993, J REPROD FERTIL, V99, P627, DOI 10.1530/jrf.0.0990627; CAMPBELL R. C., 1956, Journal of Agricultural Science, V48, P1, DOI 10.1017/S002185960003029X; Chiyo PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031382; Cook RB, 2000, J ANIM SCI, V78, P2778; Curtis Paul D., 2008, Human-Wildlife Conflicts, V2, P68; De Nys HM, 2010, J S AFR VET ASSOC, V81, P8; de Oliveira CA, 2004, J ZOO WILDLIFE MED, V35, P70, DOI 10.1638/02-091; Dowsett KF, 1996, AUST VET J, V74, P228, DOI 10.1111/j.1751-0813.1996.tb15410.x; Ferro VA, 2004, VET IMMUNOL IMMUNOP, V101, P73, DOI 10.1016/j.vetimm.2004.03.011; GABRILOVE JL, 1987, J CLIN ENDOCR METAB, V64, P1331, DOI 10.1210/jcem-64-6-1331; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Ghosal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084787; Gobello C, 2006, THERIOGENOLOGY, V66, P1560, DOI 10.1016/j.theriogenology.2006.02.005; Hermes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057616; Hildebrandt TB, 2000, ZOO BIOL, V19, P333, DOI 10.1002/1098-2361(2000)19:5&lt;333::AID-ZOO5&gt;3.0.CO;2-A; Hildebrandt TB, 1998, J ZOO WILDLIFE MED, V29, P114; HOWARD JG, 1984, J REPROD FERTIL, V72, P187, DOI 10.1530/jrf.0.0720187; Janett F, 2009, ANIM REPROD SCI, V115, P88, DOI 10.1016/j.anireprosci.2008.11.011; Jaros P, 2005, LIVEST PROD SCI, V92, P31, DOI 10.1016/j.livprodsci.2004.07.011; Johnson O. W., 1965, Journal of Mammalogy, V46, P373, DOI 10.2307/1377621; Karaconji B, 2015, AUST VET J, V93, P121, DOI 10.1111/avj.12307; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Kiyma Z, 2000, J ANIM SCI, V78, P2237; Laws R.M., 1975, ELEPHANTS THEIR HABI; Lincoln GA, 1996, J REPROD FERTIL, V108, P107, DOI 10.1530/jrf.0.1080107; Luders I, 2016, VET J, V209, P190, DOI 10.1016/j.tvjl.2015.07.014; Lueders I, 2014, J ZOO WILDLIFE MED, V45, P611, DOI 10.1638/2013-0233R.1; Malmgren L, 2001, EQUINE VET J, V33, P75, DOI 10.2746/042516401776767340; Marais HJ, 2013, J ZOO WILDLIFE MED, V44, pS18, DOI 10.1638/1042-7260-44.4S.S18; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; Miller LA, 2004, J WILDLIFE DIS, V40, P725, DOI 10.7589/0090-3558-40.4.725; Miller LA, 2000, AM J REPROD IMMUNOL, V44, P266, DOI 10.1111/j.8755-8920.2000.440503.x; Mohle U, 2002, GEN COMP ENDOCR, V129, P135, DOI 10.1016/S0016-6480(02)00525-7; Mutinda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091749; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Poole JH, 1994, DIFFERENCES SEXES, P331; Portas TJ, 2007, AUST VET J, V85, P425, DOI 10.1111/j.1751-0813.2007.00207.x; Quy RJ, 2014, WILDLIFE RES, V41, P185, DOI 10.1071/WR14035; Rajapaska RC, 2010, EU AS LINK PROJ S MA; Saragusty J, 2009, ANIM REPROD SCI, V115, P247, DOI 10.1016/j.anireprosci.2008.10.019; Schmitt DL, 1998, ANIM REPROD SCI, V53, P309, DOI 10.1016/S0378-4320(98)00120-1; Simms MS, 2000, BRIT J CANCER, V83, P443, DOI 10.1054/bjoc.2000.1315; Somgird C, 2016, ANIM REPROD SCI, V164, P111, DOI 10.1016/j.anireprosci.2015.11.019; van der Horst G, 2009, BIOTECH HISTOCHEM, V84, P299, DOI 10.3109/10520290902984274	51	17	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0178270	10.1371/journal.pone.0178270	http://dx.doi.org/10.1371/journal.pone.0178270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915245	Green Submitted, Green Published, gold			2022-12-27	WOS:000410861600002
J	Gluck, JM; Herren, AW; Yechikov, S; Kao, HKJ; Khan, A; Phinney, BS; Chiamvimonvat, N; Chan, JW; Lieu, DK				Gluck, Jessica M.; Herren, Anthony W.; Yechikov, Sergey; Kao, Hillary K. J.; Khan, Ambereen; Phinney, Brett S.; Chiamvimonvat, Nipavan; Chan, James W.; Lieu, Deborah K.			Biochemical and biomechanical properties of the pacemaking sinoatrial node extracellular matrix are distinct from contractile left ventricular matrix	PLOS ONE			English	Article							SINUS NODE; GROWTH; COLLAGEN; ELASTIN	Extracellular matrix plays a role in differentiation and phenotype development of its resident cells. Although cardiac extracellular matrix from the contractile tissues has been studied and utilized in tissue engineering, extracellular matrix properties of the pacemaking sinoatrial node are largely unknown. In this study, the biomechanical properties and biochemical composition and distribution of extracellular matrix in the sinoatrial node were investigated relative to the left ventricle. Extracellular matrix of the sinoatrial node was found to be overall stiffer than that of the left ventricle and highly heterogeneous with interstitial regions composed of predominantly fibrillar collagens and rich in elastin. The extracellular matrix protein distribution suggests that resident pacemaking cardiomyocytes are enclosed in fibrillar collagens that can withstand greater tensile strength while the surrounding elastin-rich regions may undergo deformation to reduce the mechanical strain in these cells. Moreover, basement membrane-associated adhesion proteins that are ligands for integrins were of low abundance in the sinoatrial node, which may decrease force transduction in the pacemaking cardiomyocytes. In contrast to extracellular matrix of the left ventricle, extracellular matrix of the sinoatrial node may reduce mechanical strain and force transduction in pacemaking cardiomyocytes. These findings provide the criteria for a suitable matrix scaffold for engineering biopacemakers.	[Gluck, Jessica M.; Yechikov, Sergey; Kao, Hillary K. J.; Khan, Ambereen; Chiamvimonvat, Nipavan; Lieu, Deborah K.] Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Herren, Anthony W.; Phinney, Brett S.] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Kao, Hillary K. J.; Khan, Ambereen] Calif State Univ Sacramento, Bridges Stem Cell Res Program, Sacramento, CA 95819 USA; [Chiamvimonvat, Nipavan] Northern Calif Hlth Care Syst, Dept Vet Affairs, Mather, CA USA; [Chan, James W.] Univ Calif Davis, Ctr Biophoton, Sacramento, CA 95817 USA; [Chan, James W.] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA; [Chan, James W.] Univ Calif Davis, Lab Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; California State University System; California State University Sacramento; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Lieu, DK (corresponding author), Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA.	dklieu@ucdavis.edu	Phinney, Brett/S-6404-2016	Phinney, Brett/0000-0003-3870-3302; Chiamvimonvat, Nipavan/0000-0001-9499-8817; Lieu, Deborah/0000-0002-3765-3203; Gluck, Jessica/0000-0002-6908-0809	California Institute for Regenerative Medicine (CIRM) Basic Biology Grant [RB4-05764]; UC Davis Academic Federation Innovative Development Award; National Institutes of Health (NIH) [R01 HL085727, R01 HL085844, TG2-01163]; Merit Review Award from the United States Department of Veteran Affairs Biomedical Laboratory Research &Development (BLRD) Service [I01 BX000576]; CIRM Postdoctoral Training Fellowship [TG2-01163]; NIH T32 Training Program in Basic and Translation Cardiovascular Science [NIH T32 HL086350]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085727, T32HL086350, R01HL085844, R01HL137228] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000576, I01CX001490] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) Basic Biology Grant; UC Davis Academic Federation Innovative Development Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Award from the United States Department of Veteran Affairs Biomedical Laboratory Research &Development (BLRD) Service; CIRM Postdoctoral Training Fellowship; NIH T32 Training Program in Basic and Translation Cardiovascular Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by California Institute for Regenerative Medicine (CIRM, https://www.cirm.ca.gov) Basic Biology Grant (RB4-05764) and UC Davis Academic Federation Innovative Development Award to DKL, National Institutes of Health (NIH, https://www.nih.gov) R01 HL085727, National Institutes of Health (NIH, https://www.nih.gov) R01 HL085844, and Merit Review Award (I01 BX000576) from the United States Department of Veteran Affairs Biomedical Laboratory Research &Development (BLRD, https://www.research.va.gov/services/blrd/) Service to NC. JMG has been supported by a CIRM (https://www.cirm.ca.gov) Postdoctoral Training Fellowship (TG2-01163) and a Postdoctoral Training Fellowship from National Institutes of Health (NIH, https://www.nih.gov) T32 Training Program in Basic and Translation Cardiovascular Science (NIH T32 HL086350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by California Institute for Regenerative Medicine (CIRM) Basic Biology Grant (RB4-05764) and UC Davis Academic Federation Innovative Development Award to DKL, NIH R01 HL085727, NIH R01 HL085844, and Merit Review Award (I01 BX000576) from the United States Department of Veteran Affairs Biomedical Laboratory Research & Development (BLRD) Service to NC. JMG has been supported by a CIRM Postdoctoral Training Fellowship (TG2-01163) and a Postdoctoral Training Fellowship from NIH T32 Training Program in Basic and Translation Cardiovascular Science (NIH T32 HL086350).	Ambrosi CM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.071309; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Barallobre-Barreiro Javier, 2013, Methods Mol Biol, V1005, P215, DOI 10.1007/978-1-62703-386-2_17; Barallobre-Barreiro J, 2012, CIRCULATION, V125, P789, DOI 10.1161/CIRCULATIONAHA.111.056952; BASHEY RI, 1992, CIRC RES, V70, P1006, DOI 10.1161/01.RES.70.5.1006; Billiar KL, 2011, STUD MECHANOBIOL TIS, V4, P201, DOI 10.1007/8415_2010_30; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Csepe TA, 2016, PROG BIOPHYS MOL BIO, V120, P164, DOI 10.1016/j.pbiomolbio.2015.12.011; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Fedorov VV, 2010, J AM COLL CARDIOL, V56, P1386, DOI 10.1016/j.jacc.2010.03.098; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Fratzl P, 2008, COLLAGEN STRUCTURE M, pxviii, DOI DOI 10.1007/978-0-387-73906-9_1; Fujii T, 2000, J ORTHOP RES, V18, P87, DOI 10.1002/jor.1100180113; Gaetani R, 2015, CELL TRANSPLANT; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Herum KM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050053; Johnson TD, 2014, BIOMATER SCI-UK, V2, P735, DOI 10.1039/c3bm60283d; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Liu F, 2011, JOVE-J VIS EXP, DOI 10.3791/2911; Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nabipour A, 2012, TURK J VET ANIM SCI, V36, P463, DOI 10.3906/vet-0807-2; Oberwallner B, 2013, J BIOMEDICAL MAT R A; Oberwallner B, 2015, EUR J CARDIO-THORAC, V47, P416, DOI 10.1093/ejcts/ezu163; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Purslow P. P., 2008, P325, DOI 10.1007/978-0-387-73906-9_12; Rienks M, 2014, CIRC RES, V114, P872, DOI 10.1161/CIRCRESAHA.114.302533; RODEHEFFER RJ, 1984, CIRCULATION, V69, P203, DOI 10.1161/01.CIR.69.2.203; Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHIRAISHI I, 1992, CIRCULATION, V85, P2176, DOI 10.1161/01.CIR.85.6.2176; Silver FH, 2001, CRIT REV BIOMED ENG, V29, P279, DOI 10.1615/CritRevBiomedEng.v29.i3.10; Silver Frederick H., 2006; van Essen GJ, 2009, J ANIM SCI, V87, P1991, DOI 10.2527/jas.2009-1860; van Putten S, 2016, J MOL CELL CARDIOL, V93, P133, DOI 10.1016/j.yjmcc.2015.11.025; Yanni J, 2010, J MOL CELL CARDIOL, V48, P653, DOI 10.1016/j.yjmcc.2009.08.023; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhu YX, 2011, J BIOMECH, V44, P2356, DOI 10.1016/j.jbiomech.2011.07.010	41	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185125	10.1371/journal.pone.0185125	http://dx.doi.org/10.1371/journal.pone.0185125			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934329	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900098
J	Mauriello, G; De Prisco, A; Di Prisco, G; La Storia, A; Caprio, E				Mauriello, Gianluigi; De Prisco, Annachiara; Di Prisco, Gennaro; La Storia, Antonietta; Caprio, Emilio			Microbial characterization of bee pollen from the Vesuvius area collected by using three different traps	PLOS ONE			English	Article							TAXONOMY; SPP.	Flower pollen is collected by honeybee foragers, adhered on their rear legs and transported into the hives in the form of pellets. Once in the hives, bee pollen is moisturised with nectar and bee mouth secretions and due to enzymatically modifications it becomes the so-called bee-bread, the protein reservoir of young bees. Bee pollen can be artificially removed from bee legs and collected by using specific systems, the bee pollen traps. Bee pollen is commercialized for human consumption as fresh product and after freezing or drying. Although bee pollen is nowadays largely consumed in developed countries, as food or food supplement according to local legislation, little is known on its safety related to microbiological hazards. In this work, we aimed to characterize for the first time the microbiological profile of Italian bee pollen in fresh, frozen and dried form collected along an entire harvesting season. Moreover, monthly microbiological analyses were performed on frozen (storage at -18 degrees C) and dried (storage at room temperature) bee pollen over a 4 months period. Further aim of this work was the evaluation of the possible impact on production level of three different traps used for pollen collection. Our results on microbial contamination of fresh and frozen bee pollen show that a more comprehensive microbiological risk assessment of bee pollen is required. On the other side, dried pollen showed very low microbial contamination and no pathogen survived after the drying process and during storage.	[Mauriello, Gianluigi; De Prisco, Annachiara; Di Prisco, Gennaro; La Storia, Antonietta; Caprio, Emilio] Univ Naples Federico II, Dept Agr Sci, Portici, Italy	University of Naples Federico II	Mauriello, G (corresponding author), Univ Naples Federico II, Dept Agr Sci, Portici, Italy.	giamauri@unina.it	De Prisco, Annachiara/GQI-2376-2022; De Prisco, Annachiara/GZL-8784-2022; Di Prisco, Gennaro/AGY-3511-2022; Mauriello, Gianluigi/D-2939-2016	Mauriello, Gianluigi/0000-0002-6876-6235				Almeida-Muradian LB, 2005, J FOOD COMPOS ANAL, V18, P105, DOI 10.1016/j.jfca.2003.10.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson KE, 2014, MOL ECOL, V23, P5904, DOI 10.1111/mec.12966; Belhadj H., 2012, ADV ENVIRON BIOL, V6, P1415; Blaiotta G, 2004, SYST APPL MICROBIOL, V27, P696, DOI 10.1078/0723202042369901; Brindza J., 2010, ACTA CHIM SLOVACA, V3, P95; Cabrera C, 2013, CIENC INVESTIG AGRAR, V40, P223, DOI 10.4067/S0718-16202013000100020; Campos MGR, 2008, J APICULT RES, V47, P154, DOI 10.3896/IBRA.1.47.2.12; Canale A, 2016, MATERIALS, P9; COLLIN S, 1995, J AGR FOOD CHEM, V43, P444, DOI 10.1021/jf00050a035; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; De Filippis F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089680; De-Melo AAM, 2015, LETT APPL MICROBIOL, V61, P477, DOI 10.1111/lam.12480; DeGrandi-Hoffman G, 2013, APIDOLOGIE, V44, P52, DOI 10.1007/s13592-012-0154-9; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Dimou M, 2006, J APICULT RES, V45, P42, DOI 10.1080/00218839.2006.11101312; Ercolini D, 2012, APPL ENVIRON MICROB, V78, P8142, DOI 10.1128/AEM.02218-12; Estevinho LM, 2012, INT J FOOD SCI TECH, V47, P429, DOI 10.1111/j.1365-2621.2011.02859.x; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3594; Feas X, 2012, MOLECULES, V17, P8359, DOI 10.3390/molecules17078359; Hervatin H, 2012, J FOOD PROT S, V75, pP3; Kacaniova M, 2011, J ENVIRON SCI HEAL B, V46, P623, DOI 10.1080/03601234.2011.589322; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Medina A, 2004, SYST APPL MICROBIOL, V27, P261, DOI 10.1078/072320204322881880; Metri BC, 2013, UROL ANNALS, V5, P312, DOI 10.4103/0974-7796.120295; Nardoni S, 2016, ANN AGR ENV MED, V23, P103, DOI 10.5604/12321966.1196862; Nogueira C, 2012, INT J MOL SCI, V13, P11173, DOI 10.3390/ijms130911173; Pidek I.A., 2004, ANN U M CURIESKLOD B, V49, P143; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Raja S., 2010, HALTERES, V1, P1; Seng P, 2016, INT J INFECT DIS, V45, P65, DOI 10.1016/j.ijid.2016.02.014; de Arruda VAS, 2013, FOOD CHEM TOXICOL, V51, P143, DOI 10.1016/j.fct.2012.09.019; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	33	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0183208	10.1371/journal.pone.0183208	http://dx.doi.org/10.1371/journal.pone.0183208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934240	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900008
J	Rosso, M; Majem, B; Devis, L; Lapyckyj, L; Besso, MJ; Llaurado, M; Abascal, MF; Matos, ML; Lanau, L; Castellvi, J; Sanchez, JL; Benavente, AP; Gil-Moreno, A; Reventos, J; Margalef, AS; Rigau, M; Vazquez-Levin, MH				Rosso, Marina; Majem, Blanca; Devis, Laura; Lapyckyj, Lara; Besso, Maria Jose; Llaurado, Marta; Florencia Abascal, Maria; Laura Matos, Maria; Lanau, Lucia; Castellvi, Josep; Luis Sanchez, Jose; Perez Benavente, Asuncion; Gil-Moreno, Antonio; Reventos, Jaume; Santamaria Margalef, Anna; Rigau, Marina; Hebe Vazquez-Levin, Monica			E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness	PLOS ONE			English	Article							CELL-ADHESION; MESENCHYMAL TRANSITION; TUMOR PROGRESSION; CARCINOMA; EXPRESSION; METASTASIS; SPHEROIDS; PHENOTYPE; CHEMORESISTANCE; EPITHELIUM	Ovarian cancer (OC) is the fifth cancer death cause in women worldwide. The malignant nature of this disease stems from its unique dissemination pattern. Epithelial-to-mesenchymal transition (EMT) has been reported in OC and downregulation of Epithelial cadherin (E-cadherin) is a hallmark of this process. However, findings on the relationship between E-cadherin levels and OC progression, dissemination and aggressiveness are controversial. In this study, the evaluation of E-cadherin expression in an OC tissue microarray revealed its prognostic value to discriminate between advanced-and early-stage tumors, as well as serous tumors from other histologies. Moreover, E-cadherin, Neural cadherin (N-cadherin), cytokeratins and vimentin expression was assessed in TOV-112, SKOV-3, OAW-42 and OV-90 OC cell lines grown in monolayers and under anchorage-independent conditions to mimic ovarian tumor cell dissemination, and results were associated with cell aggressiveness. According to these EMT-related markers, cell lines were classified as mesenchymal (M; TOV-112), intermediate mesenchymal (IM; SKOV-3), intermediate epithelial (IE; OAW-42) and epithelial (E; OV-90). M-and IM-cells depicted the highest migration capacity when grown in monolayers, and aggregates derived from M-and IM-cell lines showed lower cell death, higher adhesion to extracellular matrices and higher invasion capacity than E- antigen 125 levels more than 500 U/mL and platinum-free intervals less than 6 months. Altogether, E-cadherin expression levels were found relevant for the assessment of OC progression and aggressiveness.and IE-aggregates. The analysis of E-cadherin, N-cadherin, cytokeratin 19 and vimentin mRNA levels in 20 advanced-stage high-grade serous human OC ascites showed an IM phenotype in all cases, characterized by higher proportions of N-to E-cadherin and vimentin to cytokeratin 19. In particular, higher E-cadherin mRNA levels were associated with cancer antigen 125 levels more than 500 U/mL and platinum-free intervals less than 6 months. Altogether, E-cadherin expression levels were found relevant for the assessment of OC progression and aggressiveness.	[Rosso, Marina; Lapyckyj, Lara; Besso, Maria Jose; Florencia Abascal, Maria; Laura Matos, Maria; Hebe Vazquez-Levin, Monica] CONICET FIBYME, Lab Estudios Interacc Celular Reprod & Canc, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina; [Majem, Blanca; Devis, Laura; Llaurado, Marta; Lanau, Lucia; Gil-Moreno, Antonio; Reventos, Jaume; Santamaria Margalef, Anna; Rigau, Marina] Vall Hebron Res Inst, Biomed Res Unit Gynecol, Barcelona, Spain; [Majem, Blanca; Devis, Laura; Llaurado, Marta; Lanau, Lucia; Gil-Moreno, Antonio; Reventos, Jaume; Santamaria Margalef, Anna; Rigau, Marina] Univ Hosp, Barcelona, Spain; [Castellvi, Josep] Vall Hebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Luis Sanchez, Jose; Perez Benavente, Asuncion; Gil-Moreno, Antonio] Vall Hebron Univ Hosp, Dept Gynecol Oncol, Barcelona, Spain; [Llaurado, Marta] Univ British Columbia, Ovarian Canc Res Team OvCaRe, Dept Obstet & Gynecol ( OBGYN), Vancouver, BC, Canada; [Reventos, Jaume] Generalitat Catalunya, Dept Hlth, Barcelona, Spain; [Rigau, Marina] Biomed Res Inst Bellvitge IDIBELL, Barcelona, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; University of British Columbia; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Vazquez-Levin, MH (corresponding author), CONICET FIBYME, Lab Estudios Interacc Celular Reprod & Canc, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina.	mhvazl@gmail.com	BENAVENTE, ASUNCION PEREZ/C-5116-2014; Castellvi, Josep/C-5092-2014; Majem, Blanca/AAN-6687-2021; Jauregui, Laura Devis/ABH-5740-2020; Rosso, Marina/A-7886-2018; PEREZ BENAVENTE, ASUNCION/J-8272-2016; Gil-Moreno, Antonio/C-1122-2016	Castellvi, Josep/0000-0001-5745-9996; Rosso, Marina/0000-0002-1077-3088; PEREZ BENAVENTE, ASUNCION/0000-0003-1872-9003; Devis-Jauregui, Laura/0000-0003-3736-3983; Gil-Moreno, Antonio/0000-0003-1106-5590	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICTSU1072]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (Argentina) [PIP740]; Institute Nacional del Cancer (Argentina) [INC 2014-2015, INC 2016-2017]; Red Tematica de Investigacion Contra el Cancer Ministerio de Ciencia e Innovacion Espanol (RTICC) [RD12/0036/0035]; SGR Departament d'Univeristats, Recerca i Societat de la Informacio de la Generalitat de Catalunya [SGR1330]; IRSES (International Research Staff Exchange Scheme) [269285]	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Institute Nacional del Cancer (Argentina); Red Tematica de Investigacion Contra el Cancer Ministerio de Ciencia e Innovacion Espanol (RTICC); SGR Departament d'Univeristats, Recerca i Societat de la Informacio de la Generalitat de Catalunya(Generalitat de Catalunya); IRSES (International Research Staff Exchange Scheme)	Studies were supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica; http://www.agencia.mincyt.gob.ar/) (Argentina) (Grant PICTSU1072), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); http://www.conicet.gov.ar/) (Argentina) (Grant PIP740) and Institute Nacional del Cancer (http://www.msal.gov.ar/inc/) (Argentina) (Grant INC 2014-2015 and INC 2016-2017) to MHVL; Red Tematica de Investigacion Contra el Cancer Ministerio de Ciencia e Innovacion Espanol (http://www.rticc.org/) (RTICC; RD12/0036/0035), SGR Departament d'Univeristats, Recerca i Societat de la Informacio de la Generalitat de Catalunya: 2014 (http://web.gencat.cat/ca/inici/) (SGR1330) to JR, and IRSES (International Research Staff Exchange Scheme; http://ec.europa/eu/research/ mariecurieactions/funded-projects/international-research-staff-exchange-scheme) (Ref. 269285) to JR and MHVL.	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Alshenawy HA, 2010, ANN DIAGN PATHOL, V14, P387, DOI 10.1016/j.anndiagpath.2010.05.005; Amadori D., 1997, Frontiers in Bioscience (online), V2, pG8; Angst BD, 2001, J CELL SCI, V114, P629; Bacic B, 2013, ARCH GYNECOL OBSTET, V287, P1219, DOI 10.1007/s00404-012-2684-9; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Davidson B, 2000, J PATHOL, V192, P460; Davidson B, 2015, HUM PATHOL, V46, P1, DOI 10.1016/j.humpath.2014.10.004; ElMasri WM, 2009, CANCER TREAT RES, V149, P297, DOI 10.1007/978-0-387-98094-2_14; Ferlay J, 2013, IARC CANCERBASE; Gheldof A, 2013, PROG MOL BIOL TRANSL, V116, P317, DOI 10.1016/B978-0-12-394311-8.00014-5; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jin MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103965; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lapyckyj L, 2010, J CELL PHYSIOL, V222, P596, DOI 10.1002/jcp.21974; Matos ML, 2017, J CELL PHYSIOL, V232, P1368, DOI 10.1002/jcp.25622; Liew PL, 2015, INT J CLIN EXP PATHO, V8, P5642; Llaurado M, 2012, INT J CANCER, V130, P1532, DOI 10.1002/ijc.26148; Nuti SV, 2014, ONCOTARGET, V5, P7260, DOI 10.18632/oncotarget.2428; Osman N, 2008, Ir Med J, V101, P245; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Pease JC, 2012, BIOL OPEN, V1, P622, DOI 10.1242/bio.2012653; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323; Roggiani F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091387; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schneider MR, 2015, BIOESSAYS, V37, P294, DOI 10.1002/bies.201400141; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Su YJ, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.17; Suidan RS, 2014, GYNECOL ONCOL, V134, P455, DOI 10.1016/j.ygyno.2014.07.002; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; Zhu JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131782	46	49	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184439	10.1371/journal.pone.0184439	http://dx.doi.org/10.1371/journal.pone.0184439			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934230	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900029
J	Toyoshima, K; Nakamura, M; Adachi, Y; Imaizumi, A; Hakamada, T; Abe, Y; Kaneko, E; Takahashi, S; Shimokado, K				Toyoshima, Kenji; Nakamura, Marie; Adachi, Yusuke; Imaizumi, Akira; Hakamada, Tomomi; Abe, Yasuko; Kaneko, Eiji; Takahashi, Soiciro; Shimokado, Kentaro			Increased plasma proline concentrations are associated with sarcopenia in the elderly	PLOS ONE			English	Article							AMINO-ACID PROFILE; SKELETAL-MUSCLE; METABOLISM; HEALTHY; EPIDEMIOLOGY; BIOMARKERS; DISEASE; PROTEIN; MEAT; MASS	Background and purpose Metabolome analyses have shown that plasma amino acid profiles reflect various pathological conditions, such as cancer and diabetes mellitus. It remains unclear, however, whether plasma amino acid profiles change in patients with sarcopenia. This study therefore aimed to investigate whether sarcopenia-specific changes occur in plasma amino acid profiles. Methods A total of 153 community-dwelling and seven institutionalized elderly individuals (56 men, 104 women; mean age, 77.7 +/- 7.0 years) were recruited for this cross-sectional analysis. We performed a comprehensive geriatric assessment, which included an evaluation of hand grip strength, gait speed, muscle mass and blood chemistry, including the concentration of 18 amino acids. Results Twenty-eight of the 160 participants met the criteria for sarcopenia established by the Asian Working Group on Sarcopenia in Older People. Univariate analysis revealed associations between the presence of sarcopenia and a higher plasma concentration of proline and glutamine, lower concentrations of histidine and tryptophan. Multivariable analysis revealed that a higher concentration of proline was the only variable independently associated with sarcopenia. Conclusions The plasma concentration of proline may be useful for understanding the underlying pathophysiology of sarcopenia.	[Toyoshima, Kenji; Nakamura, Marie; Hakamada, Tomomi; Abe, Yasuko; Kaneko, Eiji; Shimokado, Kentaro] Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Grad Sch, Tokyo, Japan; [Adachi, Yusuke; Imaizumi, Akira] Corartion Incprporated, Inst Innovat, Ajinomoto, Kawasaki, Kanagawa, Japan; [Takahashi, Soiciro] Mituke Municipal Hosp, Mistuke, Niigata, Japan	Tokyo Medical & Dental University (TMDU); Ajinomoto Co Inc	Toyoshima, K (corresponding author), Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Grad Sch, Tokyo, Japan.	k.toyoshima.vasc@tmd.ac.jp		Imaizumi, Akira/0000-0002-8615-1007; toyoshima, kenji/0000-0002-1220-273X	 [1714]		This work was supported by University research fund #1714 to KS.	Altorf-van der Kuil W, 2013, BRIT J NUTR, V110, P810, DOI 10.1017/S0007114512005788; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Collino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056564; Delwing D, 2007, LIFE SCI, V81, P1645, DOI 10.1016/j.lfs.2007.09.031; Ferreira AGK, 2014, INT J BIOCHEM CELL B, V54, P20, DOI 10.1016/j.biocel.2014.05.027; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164877; Fukutake N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132223; Gu Y, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0408-1; He QH, 2011, FRONT BIOSCI-LANDMRK, V16, P2451, DOI 10.2741/3865; Hellmuth C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2108909; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Ilaiwy A, 2016, INT J BIOCHEM CELL B, V79, P80, DOI 10.1016/j.biocel.2016.08.012; Kinny-Koster B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159205; Lai HS, 2005, SEMIN CANCER BIOL, V15, P267, DOI 10.1016/j.semcancer.2005.04.003; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lustgarten MS, 2014, J GERONTOL A-BIOL, V69, P717, DOI 10.1093/gerona/glt152; MAHONEY F I, 1965, Md State Med J, V14, P61; Melton LJ, 2000, J AM GERIATR SOC, V48, P625; Meynial-Denis D, 2016, NUTR REV, V74, P225, DOI 10.1093/nutrit/nuv052; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; Moaddel R, 2016, J GERONTOL A; Montoliu I, 2014, AGING-US, V6, P9, DOI 10.18632/aging.100630; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Nakamura H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.32; Nakamura H, 2016, AM J HUM BIOL, V28, P236, DOI 10.1002/ajhb.22787; Ogawa S, 2014, J CLIN PSYCHIAT, V75, pE906, DOI 10.4088/JCP.13r08908; Ribel-Madsen A, 2016, PHYSL REPORTS, V4; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Schmidt JA, 2016, EUR J CLIN NUTR, V70, P306, DOI 10.1038/ejcn.2015.144; Shimbo K, 2010, BIOMED CHROMATOGR, V24, P683, DOI 10.1002/bmc.1346; Smolenska Z, 2016, BIOMARKERS, V21, P218, DOI 10.3109/1354750X.2015.1130746; Takashina C, 2016, NUTR METAB, V13, DOI 10.1186/s12986-015-0059-5; Toshima T, 2015, HEPATOL RES, V45, P1170, DOI 10.1111/hepr.12484; Wang G, 2014, J PROTEOME RES, V13, P2649, DOI 10.1021/pr5000895; Wang LL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40146; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	40	33	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185206	10.1371/journal.pone.0185206	http://dx.doi.org/10.1371/journal.pone.0185206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934309	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900122
J	Zhang, DZ; He, RZ; Li, SY; Wang, ZW				Zhang, Dezhi; He, Runzhong; Li, Shuangyan; Wang, Zhongwei			A multimodal logistics service network design with time windows and environmental concerns	PLOS ONE			English	Article							ROUTING PROBLEM; PROGRAMMING APPROACH; HUB LOCATION; OPTIMIZATION; MULTICOMMODITY; TRANSPORTATION; ALGORITHM; UNCERTAINTY; OPERATIONS; ALLOCATION	The design of a multimodal logistics service network with customer service time windows and environmental costs is an important and challenging issue. Accordingly, this work established a model to minimize the total cost of multimodal logistics service network design with time windows and environmental concerns. The proposed model incorporates CO2 emission costs to determine the optimal transportation mode combinations and investment selections for transfer nodes, which consider transport cost, transport time, carbon emission, and logistics service time window constraints. Furthermore, genetic and heuristic algorithms are proposed to set up the abovementioned optimal model. A numerical example is provided to validate the model and the abovementioned two algorithms. Then, comparisons of the performance of the two algorithms are provided. Finally, this work investigates the effects of the logistics service time windows and CO2 emission taxes on the optimal solution. Several important management insights are obtained.	[Zhang, Dezhi; He, Runzhong] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Li, Shuangyan; Wang, Zhongwei] Cent South Univ Forestry & Technol, Sch Transportat & Logist, Changsha, Hunan, Peoples R China	Central South University; Central South University of Forestry & Technology	Li, SY (corresponding author), Cent South Univ Forestry & Technol, Sch Transportat & Logist, Changsha, Hunan, Peoples R China.	lishuangyan585@163.com			Central South University Teacher Research Fund [2015JSJJ001]; Hunan Province Science and Technology Development Funds [2015RS4045]; Excellent youth project of Hunan Provincial Department of Education [15B261]; National Natural Science Foundation of China [71672193]	Central South University Teacher Research Fund; Hunan Province Science and Technology Development Funds; Excellent youth project of Hunan Provincial Department of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work that is described in this paper was supported by Central South University Teacher Research Fund (NO. 2015JSJJ001, DZZ receives funding), Hunan Province Science and Technology Development Funds (NO. 2015RS4045, SYL receives funding), Excellent youth project of Hunan Provincial Department of Education (NO. 15B261, SYL receives funding) and National Natural Science Foundation of China (NO. 71672193, DZZ receives funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the academic editor and two anonymous reviewers provided many comments that improved a previous version of this manuscript. The work that is described in this paper was supported by Central South University Teacher Research Fund (NO. 2015JSJJ001, DZZ receives funding), Hunan Province Science and Technology Development Funds (NO. 2015RS4045, SYL receives funding), Excellent youth project of Hunan Provincial Department of Education (NO. 15B261, SYL receives funding) and National Natural Science Foundation of China (NO. 71672193, DZZ receives funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alumur SA, 2012, OMEGA-INT J MANAGE S, V40, P927, DOI 10.1016/j.omega.2012.02.005; Aronsson H., 2006, International Journal of Logistics Management, V17, P394, DOI 10.1108/09574090610717545; Asgari N, 2013, TRANSPORT RES A-POL, V48, P1, DOI 10.1016/j.tra.2012.10.020; Bock S, 2010, EUR J OPER RES, V200, P733, DOI 10.1016/j.ejor.2009.01.046; Chang TS, 2008, COMPUT OPER RES, V35, P2877, DOI 10.1016/j.cor.2006.12.025; Dekker R, 2012, EUR J OPER RES, V219, P671, DOI 10.1016/j.ejor.2011.11.010; Ehmke JF, 2016, COMPUT OPER RES, V67, P34, DOI 10.1016/j.cor.2015.08.013; Elhedhli S, 2012, TRANSPORT RES D-TR E, V17, P370, DOI 10.1016/j.trd.2012.02.002; Fukasawa R, 2016, TRANSPORT RES B-METH, V94, P61, DOI 10.1016/j.trb.2016.09.006; Ganesh K, 2005, INT J ADV MANUF TECH, V26, P148, DOI [10.1007/s00170-003-1976-4, 10.1007/s00170-003-19764]; Haghani A, 1996, TRANSPORT RES A-POL, V30, P231, DOI 10.1016/0965-8564(95)00020-8; Harris I, 2014, TRANSPORT RES E-LOG, V66, P1, DOI 10.1016/j.tre.2014.01.010; Harris I, 2011, INT J PROD ECON, V131, P313, DOI 10.1016/j.ijpe.2010.03.005; He Q, 2014, INT J HYBRID INFORM, V7, P235; Huang YX, 2010, TRANSPORT RES E-LOG, V46, P820, DOI 10.1016/j.tre.2010.03.002; Ishfaq R, 2011, EUR J OPER RES, V210, P213, DOI 10.1016/j.ejor.2010.09.017; Jansen B, 2004, EUR J OPER RES, V156, P41, DOI 10.1016/j.ejor.2003.02.001; Jindal A., 2016, ANN OPER RES, P1; Kim D, 1997, COMPUT IND ENG, V33, P685, DOI 10.1016/S0360-8352(97)00222-2; Liotta G, 2015, INT J PROD ECON, V164, P351, DOI 10.1016/j.ijpe.2014.12.016; Lopes RB, 2016, COMPUT OPER RES, V70, P155, DOI 10.1016/j.cor.2016.01.006; McKinnon A., 2012, GREEN LOGISTICS IMPR; Moccia L, 2011, NETWORKS, V57, P53, DOI 10.1002/net.20383; Mohammadi M, 2017, EUR J OPER RES, V257, P792, DOI 10.1016/j.ejor.2016.07.054; Paraskevopoulos DC, 2016, TRANSPORT RES E-LOG, V85, P166, DOI 10.1016/j.tre.2015.10.007; Piecyk MI, 2010, INT J PROD ECON, V128, P31, DOI 10.1016/j.ijpe.2009.08.027; Qu Y, 2016, NETW SPAT ECON, V16, P303, DOI 10.1007/s11067-014-9227-9; Santoso T, 2005, EUR J OPER RES, V167, P96, DOI 10.1016/j.ejor.2004.01.046; Shaw K, 2016, COMPUT IND ENG, V98, P483, DOI 10.1016/j.cie.2016.06.011; SteadieSeifi M, 2014, EUR J OPER RES, V233, P1, DOI 10.1016/j.ejor.2013.06.055; Tyan JC, 2003, OMEGA-INT J MANAGE S, V31, P55, DOI 10.1016/S0305-0483(02)00094-4; Wang F, 2011, DECIS SUPPORT SYST, V51, P262, DOI 10.1016/j.dss.2010.11.020; Wang Y, 2013, J IND ENG MANAGEMENT, V6, P79; Wang Y, 2017, APPL SOFT COMPUT, V56, P143, DOI 10.1016/j.asoc.2017.02.025; Wang Y, 2015, EXPERT SYST APPL, V42, P5019, DOI 10.1016/j.eswa.2015.02.058; Wang Y, 2014, EXPERT SYST APPL, V41, P521, DOI 10.1016/j.eswa.2013.07.078; Wang ZT, 2015, EUR J OPER RES, V241, P478, DOI 10.1016/j.ejor.2014.09.012; Yang JH, 2016, J CLEAN PROD, V119, P223, DOI 10.1016/j.jclepro.2013.11.011; Zhang D, 2015, OPTIMAL LOCATION SIZ; Zhang Dezhi, 2016, TRANSPORTATION RES D; Zhang SZ, 2014, TRANSPORT RES D-TR E, V31, P85, DOI 10.1016/j.trd.2014.05.015	41	26	28	9	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185001	10.1371/journal.pone.0185001	http://dx.doi.org/10.1371/journal.pone.0185001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934272	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900074
J	Borkum, MS; Heckmann, JM; Manning, K; Dave, JA; Levitt, NS; Rayner, BL; Wearne, N				Borkum, M. S.; Heckmann, J. M.; Manning, K.; Dave, J. A.; Levitt, N. S.; Rayner, B. L.; Wearne, N.			High prevalence of "non-dipping" blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals	PLOS ONE			English	Article							NEUROPATHY; THERAPY; DISEASE; RISK; DYSFUNCTION; BIOMARKERS; MARKERS	Background HIV-infected individuals are at increased risk of tissue inflammation and accelerated vascular aging ('inflamm-aging'). Abnormal diurnal blood pressure (BP) rhythms such as non-dipping may contribute to an increased risk of cardiovascular and cerebrovascular events in HIV infected individuals. However, little data exists on ambulatory blood pressure (ABP) and measures of vascular stiffness in the black African HIV infected population. Methods This is a cross-sectional analysis of otherwise well, HIV infected outpatients on ART for >5 years. Study assessments included: 24hr ABP monitoring, pulse wave velocity (PWV) and central aortic systolic pressure (CASP) using a AtCor Medical Sphygmocor device, fasting lipogram, oral glucose tolerance test, high-sensitivity C-reactive protein (hsCRP) and anthropometric data. Patients completed a questionnaire of autonomic symptoms. CD4+ counts and viral loads were obtained from the National Laboratory results system. Results Sixty seven black participants were included in the analysis of whom 91% (n = 61) were female with a mean age of 42.2 +/- 8.6 years. The median duration on ART was 7.5 years (IQR = 6-10), 84% were virally supressed and the median CD4 count was 529.5cells/mm(3) (IQR = 372.0-686.5). The majority (67%) were classified as overweight and 76% had an increased waist circumference, yet only 88% of participants were normotensive. A hsCRP level in the high cardiovascular risk category was found in 68% of participants. The prevalence of non-dipping BP was 65%. Interestingly, there was no association on multivariable analysis between dipping status and traditional risk factors for non-dipping BP, such as: obesity, autonomic dysfunction and older age. Conclusion This relatively young cross-sectional sample of predominantly normotensive, but overweight black women on effective ART >5 years showed: a high prevalence of non-dipping BP, inflammation and vascular stiffness. Causality cannot be inferred but cardiovascular risk reduction should be emphasized in these patients.	[Borkum, M. S.; Rayner, B. L.; Wearne, N.] Univ Cape Town, Groote Schuur Hosp, Dept Nephrol & Hypertens, Cape Town, South Africa; [Heckmann, J. M.] Univ Cape Town, Groote Schuur Hosp, Dept Med, Div Neurol, Cape Town, South Africa; [Manning, K.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Dave, J. A.; Levitt, N. S.] Univ Cape Town, Groote Schuur Hosp, Dept Endocrinol & Metab, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Borkum, MS (corresponding author), Univ Cape Town, Groote Schuur Hosp, Dept Nephrol & Hypertens, Cape Town, South Africa.	mborkum@gmail.com	Rayner, Brian/AAA-3174-2021	Dave, joel/0000-0003-3084-7408; Levitt, Naomi/0000-0001-6480-8066	Medical Research Council of South Africa; Astra Zeneca	Medical Research Council of South Africa(South African Medical Research Council); Astra Zeneca(AstraZeneca)	This study was supported by Medical Research Council of South Africa (NW, JH), Astra Zeneca (MB). Some research funding awarded from a commercial source: Astra Zeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Drs Cali Dogon and Simthandile Mazondwa for their invaluable assistance in the clinical testing. Medical Research Council of South Africa (NW and JMH) and Astra Zeneca (MB) research grants that made this study possible. Ms Noluthando Mgwayi, our fieldworker, for patient recruitment and language translation.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2016, J CLIN CELL IMMUNOL, V7; Bhatia M S, 2014, J Clin Diagn Res, V8, pWC01, DOI 10.7860/JCDR/2014/7725.4927; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Borkum M, 2014, CARDIOVASC J AFR, V25, P153, DOI 10.5830/CVJA-2014-029; Centner CM, 2017, MUSCLE NERVE; Dave JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151911; Deeks SG, 2011, HIV INFECT INFLAMMAT, V20; Dolan E, 2005, HYPERTENSION, V46; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Echeverria P, 2014, JAIDS-J ACQ IMM DEF, V65, P50, DOI 10.1097/QAI.0b013e3182a97c17; Fourie CMT, 2011, CARDIOVASC J AFR, V22, P117; Hypertension guideline working group, 2014, Cardiovasc J Afr, V25, P288, DOI 10.5830/CVJA-2014-062; Isiguzo G, 2016, NIGER J CARDIOL, V13, P33; Kent ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148920; Kent ST, 2017, J AM SOC HYPERTENS; Kilic H, 2013, BLOOD PRESSURE, V22, P45, DOI 10.3109/08037051.2012.694255; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; La De, 2013, BMC INFECT DIS, V13, P1471; Lazar JM, 2009, AIDS RES HUM RETROV, V25, P877, DOI 10.1089/aid.2008.0269; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maritz J, 2010, MUSCLE NERVE, V41, P599, DOI 10.1002/mus.21535; Morar N, 1998, J Cardiovasc Risk, V5, P313, DOI 10.1097/00043798-199810000-00005; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Profant J, 1999, HYPERTENSION, V33, P1099, DOI 10.1161/01.HYP.33.5.1099; Rider OJ, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0057-1; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Schattenkerk DWE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160243; Shiburi CP, 2006, AM J HYPERTENS, V19, P40, DOI 10.1016/j.amjhyper.2005.06.018; Stranieri A, 2013, ARTIF INTELL MED, V58, P185, DOI 10.1016/j.artmed.2013.04.007; van der Hoeven M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-31; Van der Watt JJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-71; Vishwanath Arun, 2016, Indian J Sex Transm Dis AIDS, V37, P123; Wearne N, 2016, CLIN NEPHROL, V86, pS41, DOI 10.5414/CNP86S117; World Health Organization, 2006, NIT DIAGN DIAB MELL; Yehia BR, 2012, JAMA-J AM MED ASSOC, V308, P339, DOI 10.1001/jama.2012.5927; Zanni MV, 2014, NAT REV CARDIOL, V11, P728, DOI 10.1038/nrcardio.2014.167; Zilliox L, 2011, NEUROLOGY, V76, P1099, DOI 10.1212/WNL.0b013e3182120147	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185003	10.1371/journal.pone.0185003	http://dx.doi.org/10.1371/journal.pone.0185003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931072	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700055
J	Darling, NJ; Balmanno, K; Cook, SJ				Darling, Nicola J.; Balmanno, Kathryn; Cook, Simon J.			ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death	PLOS ONE			English	Article							HUMAN-MELANOMA CELLS; ER STRESS; TRANSCRIPTION FACTOR; BH3-ONLY PROTEIN; MESSENGER-RNAS; UP-REGULATION; IN-VIVO; ACTIVATION; EXPRESSION; PHOSPHORYLATION	Disruption of protein folding in the endoplasmic reticulum (ER) causes ER stress. Activation of the unfolded protein response (UPR) acts to restore protein homeostasis or, if ER stress is severe or persistent, drive apoptosis, which is thought to proceed through the cell intrinsic, mitochondrial pathway. Indeed, cells that lack the key executioner proteins BAX and BAK are protected from ER stress-induced apoptosis. Here we show that chronic ER stress causes the progressive inhibition of the extracellular signal-regulated kinase (ERK1/2) signalling pathway. This is causally related to ER stress since reactivation of ERK1/2 can protect cells from ER stress-induced apoptosis whilst ERK1/2 pathway inhibition sensitises cells to ER stress. Furthermore, cancer cell lines harbouring constitutively active BRAF(V600E) are addicted to ERK1/2 signalling for protection against ER stress-induced cell death. ERK1/2 signalling normally represses the pro-death proteins BIM, BMF and PUMA and it has been proposed that ER stress induces BIM-dependent cell death. We found no evidence that ER stress increased the expression of these proteins; furthermore, BIM was not required for ER stress-induced death. Rather, ER stress caused the PERK-dependent inhibition of cap-dependent mRNA translation and the progressive loss of pro-survival proteins including BCL2, BCLXL and MCL1. Despite these observations, neither ERK1/2 activation nor loss of BAX/BAK could confer long-term clonogenic survival to cells exposed to ER stress. Thus, ER stress induces cell death by at least two biochemically and genetically distinct pathways: a classical BAX/BAK-dependent apoptotic response that can be inhibited by ERK1/2 signalling and an alternative ERK1/2- and BAX/BAK-independent cell death pathway.	[Darling, Nicola J.; Balmanno, Kathryn; Cook, Simon J.] Babraham Inst, Signalling Lab, Babraham Res Campus, Cambridge CB22 3AT, England; [Darling, Nicola J.] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Dundee	Darling, NJ; Cook, SJ (corresponding author), Babraham Inst, Signalling Lab, Babraham Res Campus, Cambridge CB22 3AT, England.; Darling, NJ (corresponding author), Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland.	n.j.darling@dundee.ac.uk; simon.cook@babraham.ac.uk		Cook, Simon/0000-0001-9087-1616; Balmanno, Kathryn/0000-0002-6417-3889; Darling, Nicola/0000-0001-7278-6012	Biotechnology and Biological Sciences Research Council PhD studentship (NJD); BBSRC Institute Strategic Programme Grant [BB/F015852/1, BBS/E/B/00000417, BBS/E/B/000C0413, BB/J004456/1, BB/P013384/1]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0413, BBS/E/B/000C0417, BB/E02162X/1, BBS/E/B/000C0419, 981749, BBS/E/B/000C0433, BBS/E/B/0000H151, BBS/E/B/000C0432] Funding Source: researchfish; Cancer Research UK [14867] Funding Source: researchfish; BBSRC [BBS/E/B/000C0413, BBS/E/B/000C0417, BBS/E/B/000C0419, BBS/E/B/000C0433, BB/E02162X/1, BBS/E/B/000C0432] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council PhD studentship (NJD)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a Biotechnology and Biological Sciences Research Council PhD studentship (NJD) and by a BBSRC Institute Strategic Programme Grant (KB & SJC); Grant numbers: BB/F015852/1, BBS/E/B/00000417, BBS/E/B/000C0413, BB/J004456/1, BB/P013384/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to members of the Cook laboratory for advice and discussions; Dr Paul Smith (AstraZeneca) for provision of selumetinib and AZD8055 and Prof Noboru Mizushima (Tokyo Medical and Dental University, Tokyo, Japan) for providing immortalised WT and Atg5<SUP>-/-</SUP> MEFs. This study was supported by a Biotechnology and Biological Sciences Research Council PhD studentship (NJD) and by a BBSRC Institute Strategic Programme Grant (KB & SJC).	Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Cai B, 1998, J CELL PHYSIOL, V177, P282, DOI 10.1002/(SICI)1097-4652(199811)177:2<282::AID-JCP10>3.0.CO;2-C; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Cook SJS, 2017, FEBS J; Cope CL, 2014, J CELL SCI, V127, P788, DOI 10.1242/jcs.137588; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Ghosh AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039586; Gupta S, 2012, FEBS LETT, V586, P4023, DOI 10.1016/j.febslet.2012.10.002; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Hiramatsu N, 2014, MOL BIOL CELL, V25, P1411, DOI 10.1091/mbc.E13-11-0664; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Janssen K, 2009, J CELL SCI, V122, P4481, DOI 10.1242/jcs.055772; Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li SN, 2002, MOL CELL BIOL, V22, P2853, DOI 10.1128/MCB.22.8.2853-2861.2002; LITTLE AS, 2011, SCI SIGNAL, V4, DOI DOI 10.1126/scisignal.2001752; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mahadevan NR, 2010, J INFLAMM RES, V3, P99, DOI 10.2147/JIR.S11190; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sale MJ, 2013, BIOCHEM J, V450, P285, DOI 10.1042/BJ20121212; Sandow JJ, 2014, CELL DEATH DIFFER, V21, P475, DOI 10.1038/cdd.2013.168; Saveljeva S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.548; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takayanagi S, 2013, CELL STRESS CHAPERON, V18, P11, DOI 10.1007/s12192-012-0351-5; Todd DE, 2004, ONCOGENE, V23, P3284, DOI 10.1038/sj.onc.1207467; Townsend KJ, 1999, J BIOL CHEM, V274, P1801, DOI 10.1074/jbc.274.3.1801; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Verfaillie T, 2013, BIOCHEM BIOPH RES CO, V438, P500, DOI 10.1016/j.bbrc.2013.07.107; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Weston CR, 2003, ONCOGENE, V22, P1281, DOI 10.1038/sj.onc.1206261; Wheeler MC, 2008, J IMMUNOL, V181, P256, DOI 10.4049/jimmunol.181.1.256; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	66	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184907	10.1371/journal.pone.0184907	http://dx.doi.org/10.1371/journal.pone.0184907			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931068	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700042
J	Desmet, C; van der Wiel, A; Brass, M				Desmet, Charlotte; van der Wiel, Alko; Brass, Marcel			Brain regions involved in observing and trying to interpret dog behaviour	PLOS ONE			English	Article							TEMPORO-PARIETAL JUNCTION; MENTAL STATES; MIND; ATTRIBUTION; METAANALYSIS; PERCEPTION; THINKING; PROMPTS; WALKING; PEOPLE	Humans and dogs have interacted for millennia. As a result, humans (and especially dog owners) sometimes try to interpret dog behaviour. While there is extensive research on the brain regions that are involved in mentalizing about other peoples' behaviour, surprisingly little is known of whether we use these same brain regions to mentalize about animal behaviour. In this fMRI study we investigate whether brain regions involved in mentalizing about human behaviour are also engaged when observing dog behaviour. Here we show that these brain regions are more engaged when observing dog behaviour that is difficult to interpret compared to dog behaviour that is easy to interpret. Interestingly, these results were not only obtained when participants were instructed to infer reasons for the behaviour but also when they passively viewed the behaviour, indicating that these brain regions are activated by spontaneous mentalizing processes.	[Desmet, Charlotte; van der Wiel, Alko; Brass, Marcel] Univ Ghent, Dept Expt Psychol, Ghent, Belgium; [Desmet, Charlotte; van der Wiel, Alko; Brass, Marcel] Univ Ghent, Ghent Inst Funct & Metab Imaging brain, Ghent, Belgium; [van der Wiel, Alko] Katholieke Univ Leuven, Dept Work & Org Studies, Fac Econ & Business, Louvain, Belgium	Ghent University; Ghent University; KU Leuven	Brass, M (corresponding author), Univ Ghent, Dept Expt Psychol, Ghent, Belgium.; Brass, M (corresponding author), Univ Ghent, Ghent Inst Funct & Metab Imaging brain, Ghent, Belgium.	marcel.brass@ugent.be	Brass, Marcel/J-7082-2012	Brass, Marcel/0000-0002-3364-4019	Research Council of Ghent University [B/13089]	Research Council of Ghent University(Ghent University)	This work was supported by the Research Council of Ghent University under grant number B/13089 received by Charlotte Desmet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Research Council of Ghent University under grant number B/13089.	Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Desmet C, 2015, NEUROIMAGE, V122, P195, DOI 10.1016/j.neuroimage.2015.08.018; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Horowitz A, 2009, BEHAV PROCESS, V81, P447, DOI 10.1016/j.beproc.2009.03.014; Horowitz AC, 2007, ANTHROZOOS, V20, P23, DOI 10.2752/089279307780216650; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Kujala MV, 2012, PLOS ONE, P7; Lakestani N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134319; Liew SL, 2011, HUM BRAIN MAPP, V32, P1986, DOI 10.1002/hbm.21164; Mar RA, 2007, SOC COGN AFFECT NEUR, V2, P199, DOI 10.1093/scan/nsm011; Marsh LE, 2014, NEUROIMAGE, V103, P81, DOI 10.1016/j.neuroimage.2014.09.020; Meyer I, 2014, ANTHROZOOS, V27, P127, DOI 10.2752/175303714X13837396326576; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Prguda E, 2014, BEHAV PROCESS, V108, P80, DOI 10.1016/j.beproc.2014.09.012; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schirmer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074591; Schultz J, 2004, J COGNITIVE NEUROSCI, V16, P1695, DOI 10.1162/0898929042947874; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Urquiza-Haas EG, 2015, ANIM BEHAV, V109, P167, DOI 10.1016/j.anbehav.2015.08.011; Utz RL, 2014, SOC INDIC RES, V116, P327, DOI 10.1007/s11205-013-0299-6; van der Meer L, 2011, NEUROIMAGE, V56, P2364, DOI 10.1016/j.neuroimage.2011.03.053; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Wan M, 2012, PLOS ONE, V7	38	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0182721	10.1371/journal.pone.0182721	http://dx.doi.org/10.1371/journal.pone.0182721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH6UK	28931030	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700006
J	Tammana, D; Tammana, TVS				Tammana, Damayanti; Tammana, Trinadh Venkata Satish			Chlamydomonas FAP265 is a tubulin polymerization promoting protein, essential for flagellar reassembly and hatching of daughter cells from the sporangium	PLOS ONE			English	Article							ALPHA-TUBULIN; PROTEOMIC ANALYSIS; TPPP/P25; CILIUM; MICROTUBULES; REINHARDTII; BRAIN; P25; SYNUCLEINOPATHIES; DIFFERENTIATION	Tubulin polymerization promoting proteins (TPPPs) belong to a family of neomorphic moon lighting proteins, involved in various physiological and pathological conditions. In physiological conditions, TPPPs play an important role in microtubule dynamics regulating mitotic spindle assembly and in turn cell proliferation. In pathological situations, TPPPs interact with a-synuclein and beta-amyloid and promote their aggregation leading to Parkinson's disease and multiple system atrophy. Orthologs of TPPP family proteins were identified in ciliary proteomes from various organisms including Chlamydomonas but their role in ciliogenesis was not known. Here we showed that Flagellar Associated Protein, FAP265, a Chlamydomonas homologue of TPPP family proteins, localizes in the cytosol, at the basal bodies and in the flagella of vegetative Chlamydomonas cells. During cell division, the protein was found as a distinct spot in the nucleus and at the cleavage furrow which forms between the daughter cells. Further null mutants of Chlamydomonas FAP265 protein, fap265, showed severe defects in hatching from the mother sporangium. Daughter cells of fap265 were significantly larger in size compared with wild type cells. Moreover, the daughter cells present within the mother sporangium failed to form flagella before hatching. They reassembled their flagella only after hatching from the sporangium suggesting that FAP265 plays an important role in flagellar reassembly after cell division.	[Tammana, Damayanti; Tammana, Trinadh Venkata Satish] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India		Tammana, D; Tammana, TVS (corresponding author), Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India.	damayantitammana@gmail.com; tambiologicals@gmail.com	Tammana, T V Satish/ABF-2357-2021	Tammana, T V Satish/0000-0001-8366-5355; TAMMANA, DAMAYANTI/0000-0003-1678-6864	Science and Engineering Research Board, Department of Science and Technology, India [SBNS/LS-59/2014]; Department of Science and Technology, India [IFA12/LSBM39]	Science and Engineering Research Board, Department of Science and Technology, India; Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by the Science and Engineering Research Board, Department of Science and Technology, India, No. SBNS/LS-59/2014 to Dr. Damayanti Tammana and Department of Science and Technology, India No.: IFA12/LSBM39 to Dr. Trinadh Venkata Satish Tammana and the Dept. of IT, BT and S&T, GoK for infrastructural support provided to IBAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaiz Olivier, 2014, Cilia, V3, P9, DOI 10.1186/2046-2530-3-9; CAVALIER.T, 1974, J CELL SCI, V16, P529; Craige B, 2013, CURR PROTOC CELL BIO; Geremek M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088216; Gradilone SA, 2013, CANCER RES, V73, P2259, DOI 10.1158/0008-5472.CAN-12-2938; Harris EH, 1989, COMPREHENSIVE GUIDE, Vxiv; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Huang KY, 2004, MOL BIOL CELL, V15, P3605, DOI 10.1091/mbc.E04-01-0010; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; Kubo T, 2009, PLANT CELL PHYSIOL, V50, P572, DOI 10.1093/pcp/pcp016; Kurien BT, 2009, METHODS MOL BIOL, V536, P201, DOI 10.1007/978-1-59745-542-8_22; Lake V, 2003, PHOTOSYNTH RES, V77, P69, DOI 10.1023/A:1024955916194; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; LHERNAULT SW, 1983, J CELL BIOL, V97, P258, DOI 10.1083/jcb.97.1.258; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; NEWMAN SM, 1990, GENETICS, V126, P875; Olah J, 2013, CYTOSKELETON, V70, P677, DOI 10.1002/cm.21137; Olah J, 2014, BIOCHEM SOC T, V42, P1762, DOI 10.1042/BST20140257; Orosz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049276; Orosz F, 2009, INFECT GENET EVOL, V9, P1275, DOI 10.1016/j.meegid.2009.09.001; Orosz F, 2008, FEBS LETT, V582, P3757, DOI 10.1016/j.febslet.2008.10.011; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Ran J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12917; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Staverosky JA, 2009, DEV DYNAM, V238, P685, DOI 10.1002/dvdy.21865; TAKAHASHI M, 1993, J NEUROCHEM, V60, P228, DOI 10.1111/j.1471-4159.1993.tb05842.x; TAKAHASHI M, 1991, FEBS LETT, V289, P37, DOI 10.1016/0014-5793(91)80903-G; Tammana TVS, 2008, MOL MICROBIOL, V70, P837, DOI 10.1111/j.1365-2958.2008.06448.x; Tammana TVS, 2013, J CELL SCI, V126, P5018, DOI 10.1242/jcs.133439; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2014, BBA-MOL BASIS DIS, V1842, P547, DOI 10.1016/j.bbadis.2014.01.009; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wood CR, 2013, CURR BIOL, V23, P906, DOI 10.1016/j.cub.2013.04.019; Zhou WB, 2010, MOL CELL BIOCHEM, V343, P231, DOI 10.1007/s11010-010-0518-2; Zhou WB, 2010, MOL CELL BIOCHEM, V333, P91, DOI 10.1007/s11010-009-0208-0	45	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185108	10.1371/journal.pone.0185108	http://dx.doi.org/10.1371/journal.pone.0185108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931065	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700070
J	Kadoda, K; Moriwaki, T; Tsuda, M; Sasanuma, H; Ishiai, M; Takata, M; Ide, H; Masunaga, S; Takeda, S; Tano, K				Kadoda, Kei; Moriwaki, Takahito; Tsuda, Masataka; Sasanuma, Hiroyuki; Ishiai, Masamichi; Takata, Minoru; Ide, Hiroshi; Masunaga, Shin-ichiro; Takeda, Shunichi; Tano, Keizo			Selective cytotoxicity of the anti-diabetic drug, metformin, in glucose-deprived chicken DT40 cells	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; DIABETES-MELLITUS; VERTEBRATE CELLS; REPAIR PATHWAY; FORMALDEHYDE; DEPRIVATION; INVOLVEMENT; TARGET; ALDH2	Metformin is a biguanide drug that is widely used in the treatment of diabetes. Epidemiological studies have indicated that metformin exhibits anti-cancer activity. However, the molecular mechanisms underlying this activity currently remain unclear. We hypothesized that metformin is cytotoxic in a tumor-specific environment such as glucose deprivation and/or low oxygen (O-2) tension. We herein demonstrated that metformin was highly cytotoxic under glucose-depleted, but not hypoxic (2% O-2) conditions. In order to elucidate the underlying mechanisms of this selective cytotoxicity, we treated exposed DNA repair-deficient chicken DT40 cells with metformin under glucose-depleted conditions and measured cellular sensitivity. Under glucose-depleted conditions, metformin specifically killed fancc and fancl cells that were deficient in FANCC and FANCL proteins, respectively, which are involved in DNA interstrand cross-link repair. An analysis of chromosomal aberrations in mitotic chromosome spreads revealed that a clinically relevant concentration of metformin induced DNA double-strand breaks (DSBs) in fancc and fancl cells under glucose-depleted conditions. In summary, metformin induced DNA damage under glucose-depleted conditions and selectively killed cells. This metformin-mediated selective toxicity may suppress the growth of malignant tumors that are intrinsically deprived of glucose.	[Kadoda, Kei; Moriwaki, Takahito; Masunaga, Shin-ichiro; Tano, Keizo] Kyoto Univ, Res Reactor Inst, Div Radiat Life Sci, Kumatori, Osaka, Japan; [Tsuda, Masataka; Sasanuma, Hiroyuki; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto, Japan; [Ishiai, Masamichi; Takata, Minoru] Kyoto Univ, Radiat Biol Ctr, Dept Late Effects Studies, Kyoto, Japan; [Ide, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Japan; [Moriwaki, Takahito] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Hiroshima University; Kyoto University	Tano, K (corresponding author), Kyoto Univ, Res Reactor Inst, Div Radiat Life Sci, Kumatori, Osaka, Japan.	tano@rri.kyoto-u.ac.jp	Takata, Minoru/K-3772-2019; Ide, Hiroshi/G-9042-2019; Tsuda, Masataka/G-2505-2019	Tsuda, Masataka/0000-0002-1267-3777; Takeda, Shunichi/0000-0002-7924-7991; Takata, Minoru/0000-0002-4926-3675	JSPS KEKENHI [15K00537, 15H04295]	JSPS KEKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KEKENHI grant number 15K00537 to KT, http://www.jsps.go.jp/english/e-grants/index.html; and JSPS KEKENHI grant number 15H04295 to SM, http://www.jsps.go.jp/english/e-grants/index.html.	Amador RR, 2012, GENET MOL BIOL, V35, P153, DOI 10.1590/S1415-47572011005000060; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Couve-Privat S, 2007, NUCLEIC ACIDS RES, V35, P5672, DOI 10.1093/nar/gkm592; Das BB, 2014, NUCLEIC ACIDS RES, V42, P4435, DOI 10.1093/nar/gku088; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Frid A, 2010, DIABETES CARE, V33, P1291, DOI 10.2337/dc09-1284; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Hira A, 2013, BLOOD, V122, P3206, DOI 10.1182/blood-2013-06-507962; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Janjetovic K, 2011, EUR J PHARMACOL, V651, P41, DOI 10.1016/j.ejphar.2010.11.005; Kizaka-Kondoh S, 2003, CANCER SCI, V94, P1021, DOI 10.1111/j.1349-7006.2003.tb01395.x; McNeill DR, 2013, J BIOL CHEM, V288, P12426, DOI 10.1074/jbc.M113.456087; Moriwaki T, 2017, CHEM RES TOXICOL, V30, P699, DOI 10.1021/acs.chemrestox.6b00417; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; PERRIELLO G, 1994, DIABETES, V43, P920, DOI 10.2337/diabetes.43.7.920; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Pontel LB, 2015, MOL CELL, V60, P177, DOI 10.1016/j.molcel.2015.08.020; Qi XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep35788; Ritz C, 2005, J STAT SOFTW, V12, P1; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Sui XB, 2015, MOL PHARMACEUT, V12, P3783, DOI 10.1021/acs.molpharmaceut.5b00577; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Yabe M, 2016, BRIT J HAEMATOL, V175, P457, DOI 10.1111/bjh.14243; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Zhang QS, 2016, BLOOD, V128, P2774, DOI 10.1182/blood-2015-11-683490; Zhu Y, 2013, ONCOGENE, V32, P2058, DOI 10.1038/onc.2012.223	31	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185141	10.1371/journal.pone.0185141	http://dx.doi.org/10.1371/journal.pone.0185141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926637	Green Published, Green Submitted, gold			2022-12-27	WOS:000411166600074
J	McAnally, KI; Morris, AP; Best, C				McAnally, Ken I.; Morris, Adam P.; Best, Christopher			Metacognitive monitoring and control in visual change detection: Implications for situation awareness and cognitive control	PLOS ONE			English	Article							CHANGE BLINDNESS BLINDNESS; CONFIDENCE; DISCRIMINATION; CALIBRATION; MEMORY; INFORMATION; EXPERIENCE; ALLOCATION; JUDGMENTS; BELIEFS	Metacognitive monitoring and control of situation awareness (SA) are important for a range of safety-critical roles (e.g., air traffic control, military command and control). We examined the factors affecting these processes using a visual change detection task that included representative tactical displays. SA was assessed by asking novice observers to detect changes to a tactical display. Metacognitive monitoring was assessed by asking observers to estimate the probability that they would correctly detect a change, either after study of the display and before the change (judgement of learning; JOL) or after the change and detection response (judgement of performance; JOP). In Experiment 1, observers failed to detect some changes to the display, indicating imperfect SA, but JOPs were reasonably well calibrated to objective performance. Experiment 2 examined JOLs and JOPs in two task contexts: with study-time limits imposed by the task or with self-pacing to meet specified performance targets. JOPs were well calibrated in both conditions as were JOLs for high performance targets. In summary, observers had limited SA, but good insight about their performance and learning for high performance targets and allocated study time appropriately.	[McAnally, Ken I.; Best, Christopher] Def Sci & Technol Grp, Aerosp Div, Fishermans Bend, Vic, Australia; [McAnally, Ken I.] Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia; [Morris, Adam P.] Monash Univ, Dept Physiol, Neurosci Program, Biomed Discovery Inst, Clayton, Vic, Australia	Defence Science & Technology; University of Melbourne; Monash University	McAnally, KI (corresponding author), Def Sci & Technol Grp, Aerosp Div, Fishermans Bend, Vic, Australia.; McAnally, KI (corresponding author), Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia.	mcanally@unimelb.edu.au		McAnally, Ken/0000-0003-1787-0750; Morris, Adam/0000-0002-2281-5775	Defence Science and Technology Organisation	Defence Science and Technology Organisation	The Defence Science and Technology Organisation paid the salaries of the authors, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. Release of the manuscript for publication was approved by the Chief of Aerospace Division. The specific roles of the authors are articulated in the 'author contributions' section.	[Anonymous], 2007, NAT STAT ETH COND HU; Ariel R, 2009, J EXP PSYCHOL GEN, V138, P432, DOI 10.1037/a0015928; BARANSKI JV, 1994, PERCEPT PSYCHOPHYS, V55, P412, DOI 10.3758/BF03205299; BARANSKI JV, 1995, CAN J EXP PSYCHOL, V49, P397, DOI 10.1037/1196-1961.49.3.397; Beck MR, 2007, CONSCIOUS COGN, V16, P58, DOI 10.1016/j.concog.2006.05.003; Beck MR, 2007, CONSCIOUS COGN, V16, P31, DOI 10.1016/j.concog.2006.01.003; BJORKMAN M, 1993, PERCEPT PSYCHOPHYS, V54, P75, DOI 10.3758/BF03206939; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; CLARKE FR, 1959, J ACOUST SOC AM, V31, P629, DOI 10.1121/1.1907764; Cohen MS, 1996, HUM FACTORS, V38, P206, DOI 10.1518/001872096779048020; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; DiVita J, 2004, HUM FACTORS, V46, P205, DOI 10.1518/hfes.46.2.205.37340; ENDSLEY M, 1990, SITUATIONAL AWARENES, V9; Endsley MR, 1998, HUM FAC ERG SOC P, P82; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; Flavell J.H., 1976, NATURE INTELLIGENCE, P231, DOI DOI 10.1038/HDY.1976.85; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Harvey N, 1997, TRENDS COGN SCI, V1, P78, DOI 10.1016/S1364-6613(97)01014-0; Hoffrage U, 2004, COGNITIVE ILLUSIONS: A HANDBOOK ON FALLACIES AND BIASES IN THINKING, JUDGEMENT AND MEMORY, P235; Howe PDL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084490; HUTCHINS E, 1995, COGNITIVE SCI, V19, P265, DOI 10.1207/s15516709cog1903_1; Joint military symbology, 2014, MILSTD2525D DEP DEF; Koriat A, 2006, J EXP PSYCHOL GEN, V135, P36, DOI 10.1037/0096-3445.135.1.36; Koriat A, 2000, CONSCIOUS COGN, V9, P149, DOI 10.1006/ccog.2000.0433; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; Levin DT, 2012, CONSCIOUS COGN, V21, P875, DOI 10.1016/j.concog.2012.02.011; Levin DT, 2000, VIS COGN, V7, P397, DOI 10.1080/135062800394865; Lichtenstein S., 1982, JUDGMENT UNCERTAINTY, P306, DOI [DOI 10.1017/CBO9780511809477, DOI 10.1017/CBO9780511809477.023]; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Mitroff SR, 2004, PERCEPT PSYCHOPHYS, V66, P1268, DOI 10.3758/BF03194997; NELSON TO, 1988, J EXP PSYCHOL LEARN, V14, P676, DOI 10.1037/0278-7393.14.4.676; Rensink RA, 2000, VIS COGN, V7, P17, DOI 10.1080/135062800394667; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Rensink RA, 2000, VIS COGN, V7, P345, DOI 10.1080/135062800394847; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Soderstrom NC, 2015, J EXP PSYCHOL LEARN, V41, P553, DOI 10.1037/a0038388; Son L.K., 2002, APPL METACOGNITION, P15, DOI [10.1017/CBO9780511489976.003, DOI 10.1017/CBO9780511489976.003]; Stone ER, 2000, ORGAN BEHAV HUM DEC, V83, P282, DOI 10.1006/obhd.2000.2910; Taylor R., 1990, AER MED PAN S 2 6 OC, V3, P1; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Yates J.F., 1990, JUDGMENT DECISION MA	43	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0176032	10.1371/journal.pone.0176032	http://dx.doi.org/10.1371/journal.pone.0176032			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0WP	28915244	Green Published, gold			2022-12-27	WOS:000410861600001
J	Zhong, ZJ; Tian, YN; Li, W; Huang, XM; Deng, L; Cao, SZ; Geng, Y; Fu, HL; Shen, LH; Liu, HF; Peng, GN				Zhong, Zhijun; Tian, Yinan; Li, Wei; Huang, Xiangming; Deng, Lei; Cao, Suizhong; Geng, Yi; Fu, Hualin; Shen, Liuhong; Liu, Haifeng; Peng, Guangneng			Multilocus genotyping of Giardia duodenalis in captive non-human primates in Sichuan and Guizhou provinces, Southwestern China	PLOS ONE			English	Article							CRYPTOSPORIDIUM SPP.; MOLECULAR CHARACTERIZATION; ENTEROCYTOZOON-BIENEUSI; ASSEMBLAGE B; PREVALENCE; CHILDREN; ZOO	Giardia duodenalis is a common human and animal pathogen. It has been increasingly reported in wild and captive non-human primates (NHPs) in recent years. However, multilocus genotyping information for G. duodenalis infecting NHPs in southwestern China is limited. In the present study, the prevalence and multilocus genotypes (MLGs) of G. duodenalis in captive NHPs in southwestern China were determined. We examined 207 fecal samples from NHPs in Sichuan and Guizhou provinces, and 16 specimens were positive for G. duodenalis. The overall infection rate was 7.7%, and only assemblage B was identified. G. duodenalis was detect positive in northern white-cheeked gibbon (14/36, 38.9%), crab-eating macaque (1/60, 1.7%) and rhesus macaques (1/101, 0.9%). Multilocus sequence typing based on beta-giardin (bg), triose phosphate isomerase (tpi) and glutamate dehydrogenase (gdh) revealed nine different assemblage B MLGs (five known genotypes and four novel genotypes). Based on a phylogenetic analysis, one potentially zoonotic genotype of MLG SW7 was identified in a northern white-cheeked gibbon. A high degree of genetic diversity within assemblage B was observed in captive northern white-cheeked gibbons in Southwestern China, including a potentially zoonotic genotype, MLG SW7. To the best of our knowledge, this is the first report using a MLGs approach to identify G. duodenalis in captive NHPs in Southwestern China.	[Zhong, Zhijun; Tian, Yinan; Li, Wei; Deng, Lei; Cao, Suizhong; Geng, Yi; Fu, Hualin; Shen, Liuhong; Liu, Haifeng; Peng, Guangneng] Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Coll Vet Med, Chengdu, Sichuan, Peoples R China; [Huang, Xiangming] Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu Res Base Giant Panda Breeding, Chengdu, Sichuan, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Coll Vet Med, Chengdu, Sichuan, Peoples R China.	pgn.sicau@163.com	Deng, Lei/AAB-5622-2020	Deng, Lei/0000-0003-0391-6180	National Key Research and Development Program of China [2016YFD0501009]; National Natural Science Foundation of China [31272620]; Chengdu Giant Panda Breeding Research Foundation [CPF2015-4]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chengdu Giant Panda Breeding Research Foundation	This work was supported by the National Key Research and Development Program of China (2016YFD0501009); the National Natural Science Foundation of China (31272620); and the Chengdu Giant Panda Breeding Research Foundation (CPF2015-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2012, PARASITOL RES, V110, P1025, DOI 10.1007/s00436-011-2564-4; Beck R, 2011, VET PARASITOL, V175, P40, DOI 10.1016/j.vetpar.2010.09.026; Berrilli F, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-199; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Du SZ, 2015, KOREAN J PARASITOL, V53, P395, DOI 10.3347/kjp.2015.53.4.395; Durigan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115489; Ehsan AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118239; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Huey CS, 2013, INFECT GENET EVOL, V17, P269, DOI 10.1016/j.meegid.2013.04.013; Jenkins EJ, 2013, ADV PARASIT, V82, P33, DOI 10.1016/B978-0-12-407706-5.00002-2; Johnston AR, 2012, PLOS NEGL TROP DIS, V6; Karim MR, 2015, INFECT GENET EVOL, V30, P82, DOI 10.1016/j.meegid.2014.12.013; Karim MR, 2014, INT J PARASITOL, V44, P1039, DOI 10.1016/j.ijpara.2014.07.006; Lebbad M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001262; Lee MF, 2016, PARASITOL RES, V116, P1; Levecke B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/j.ijpara.2009.05.013; Li JQ, 2017, INT J PARASITOL-PAR, V6, P8, DOI 10.1016/j.ijppaw.2016.12.003; Li JQ, 2015, J EUKARYOT MICROBIOL, V62, P833, DOI 10.1111/jeu.12269; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2015, CHINESE VET SCI, P156; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Souza SLP, 2007, VET PARASITOL, V149, P258, DOI 10.1016/j.vetpar.2007.08.019; Sricharern W, 2016, INFECT GENET EVOL, V40, P310, DOI 10.1016/j.meegid.2016.02.004; Takumi K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-168; THOMPSON SC, 1994, J PAEDIATR CHILD H, V30, P202, DOI 10.1111/j.1440-1754.1994.tb00620.x; Wegayehu T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0706-7; Ye J, 2013, CHINA PARASITOL INT, V63, P132; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653	28	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184913	10.1371/journal.pone.0184913	http://dx.doi.org/10.1371/journal.pone.0184913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910395	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200119
J	Bi, YH; Fan, B; Wu, FC				Bi, Yanhong; Fan, Bin; Wu, Fuchao			Multiple Cayley-Klein metric learning	PLOS ONE			English	Article								As a specific kind of non-Euclidean metric lies in projective space, Cayley-Klein metric has been recently introduced in metric learning to deal with the complex data distributions in computer vision tasks. In this paper, we extend the original Cayley-Klein metric to the multiple Cayley-Klein metric, which is defined as a linear combination of several Cayley-Klein metrics. Since Cayley-Klein is a kind of non-linear metric, its combination could model the data space better, thus lead to an improved performance. We show how to learn a multiple Cayley-Klein metric by iterative optimization over single Cayley-Klein metric and their combination coefficients under the objective to maximize the performance on separating interclass instances and gathering intra-class instances. Our experiments on several benchmarks are quite encouraging.	[Bi, Yanhong; Fan, Bin; Wu, Fuchao] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Bi, Yanhong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fan, B (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China.	bfan@nlpr.ia.ac.cn	Fan, Bin/AAD-8307-2019		National Natural Science Foundation of China [61375043, 61472119, 61672032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 61375043, 61472119 and 61672032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NEURAL INF PROCESS S; [Anonymous], 2013, 30 INT C MACH LEARN; Bi YH, 2015, PROC CVPR IEEE, P2339, DOI 10.1109/CVPR.2015.7298847; Borsuk K., 1960, FDNS GEOMETRY; Cayley A., 1859, PHILOS T ROY SOC LON, V149, P61; Chechik G, 2010, J MACH LEARN RES, V11, P1109; Chunhua Shen, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2601, DOI 10.1109/CVPR.2011.5995447; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Coxeter HSM., 1957, NONEUCLIDEAN GEOMETR; Davis J. V., 2007, P 24 INT C MACH LEAR, P209, DOI DOI 10.1145/1273496.1273523; Domeniconi C, 2002, ADV NEUR IN, V14, P665; Frome A, 2007, IEEE I CONF COMP VIS, P94; Globerson A., 2005, NIPS; Goldberger J., 2004, ADV NEURAL INF PROCE, P1; Guillaumin M, 2009, IEEE I CONF COMP VIS, P498, DOI 10.1109/ICCV.2009.5459197; Han XF, 2015, PROC CVPR IEEE, P3279, DOI 10.1109/CVPR.2015.7298948; Hastie T, 1996, IEEE T PATTERN ANAL, V18, P607, DOI 10.1109/34.506411; Hu JL, 2014, PROC CVPR IEEE, P1875, DOI 10.1109/CVPR.2014.242; Huang ZW, 2014, PROC CVPR IEEE, P1677, DOI 10.1109/CVPR.2014.217; Klein F, 1928, VORLESUNGEN NICHT EU; Klein F., 1873, MATH ANN, V6, P112; Klein F., 1871, MATH ANN, V4, P573, DOI [10.1007/BF02100583, DOI 10.1007/BF02100583]; Kumar N, 2009, IEEE I CONF COMP VIS, P365, DOI 10.1109/ICCV.2009.5459250; Law MT, 2014, PROC CVPR IEEE, P1051, DOI 10.1109/CVPR.2014.138; Li Z., 2012, CVPR WORKSH, P45; Lu JW, 2014, IEEE T PATTERN ANAL, V36, P331, DOI 10.1109/TPAMI.2013.134; Lu ZY, 2013, INT CONF MACH LEARN, P583, DOI 10.1109/ICMLC.2013.6890359; MacQueen J. B., 1965, ANN MATH STAT; Noh Yung-kyun, 2010, ADV NEURAL INFORM PR, V23, P1822; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Peng J, 2002, INT C PATT RECOG, P33, DOI 10.1109/ICPR.2002.1047788; Semerci Murat, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference (ECML PKDD 2013). Proceedings: LNCS 8189, P675, DOI 10.1007/978-3-642-40991-2_43; Shen C., 2009, P 23 ANN C NEUR INF, P1007; Shi Y, 2014, AAAI CONF ARTIF INTE, P2078; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang J., 2012, NIPS, V25, P1610; Wang QL, 2014, LECT NOTES COMPUT SC, V8695, P456, DOI 10.1007/978-3-319-10584-0_30; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Xing E., 2002, ADV NEURAL INFORM PR, V15, P505, DOI DOI 10.5555/2968618.2968683; Xiong C, 2012, P 18 ACM SIGKDD INT, P958, DOI [10.1145/2339530.2339680, DOI 10.1145/2339530.2339680]; Yeung DY, 2007, IEEE T NEURAL NETWOR, V18, P141, DOI 10.1109/TNN.2006.883723; Yinjie Huang, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2013. Proceedings: LNCS 8190, P224, DOI 10.1007/978-3-642-40994-3_15	43	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184865	10.1371/journal.pone.0184865	http://dx.doi.org/10.1371/journal.pone.0184865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934244	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900053
J	Hopkins, MJ; Chen, FY; Hu, SX; Zhang, ZF				Hopkins, Melanie J.; Chen, Feiyang; Hu, Shixue; Zhang, Zhifei			The oldest known digestive system consisting of both paired digestive glands and a crop from exceptionally preserved trilobites of the Guanshan Biota (Early Cambrian, China)	PLOS ONE			English	Article							ORDOVICIAN TRILOBITE; KAILI-BIOTA; BURGESS; FOSSILIZATION; LAGERSTATTE; ANATOMY; GUIZHOU	The early Cambrian Guanshan biota of eastern Yunnan, China, contains exceptionally preserved animals and algae. Most diverse and abundant are the arthropods, of which there are at least 11 species of trilobites represented by numerous specimens. Many trilobite specimens show soft-body preservation via iron oxide pseudomorphs of pyrite replacement. Here we describe digestive structures from two species of trilobite, Palaeolenus lantenoisi and Redlichia mansuyi. Multiple specimens of both species contain the preserved remains of an expanded stomach region (a "crop") under the glabella, a structure which has not been observed in trilobites this old, despite numerous examples of trilobite gut traces from other Cambrian Lagerstatten. In addition, at least one specimen of Palaeolenus lantenoisi shows the preservation of an unusual combination of digestive structures: a crop and paired digestive glands along the alimentary tract. This combination of digestive structures has also never been observed in trilobites this old, and is rare in general, with prior evidence of it from one juvenile trilobite specimen from the late Cambrian Orsten fauna of Sweden and possibly one adult trilobite specimen from the Early Ordovician Fezouata Lagerstatte. The variation in the fidelity of preservation of digestive structures within and across different Lagerstatten may be due to variation in the type, quality, and point of digestion of food among specimens in addition to differences in mode of preservation. The presence and combination of these digestive features in the Guanshan trilobites contradicts current models of how the trilobite digestive system was structured and evolved over time. Most notably, the crop is not a derived structure as previously proposed, although it is possible that the relative size of the crop increased over the evolutionary history of the clade.	[Hopkins, Melanie J.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Chen, Feiyang; Zhang, Zhifei] Northwest Univ, Early Life Inst, State Key Lab Continental Dynam, Xian, Shaanxi, Peoples R China; [Chen, Feiyang; Zhang, Zhifei] Northwest Univ, Dept Geol, Xian, Shaanxi, Peoples R China; [Hu, Shixue] Chengdu Inst Geol & Mineral Resources, Chengdu, Sichuan, Peoples R China	American Museum of Natural History (AMNH); Northwest University Xi'an; Northwest University Xi'an	Hopkins, MJ (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.; Zhang, ZF (corresponding author), Northwest Univ, Early Life Inst, State Key Lab Continental Dynam, Xian, Shaanxi, Peoples R China.; Zhang, ZF (corresponding author), Northwest Univ, Dept Geol, Xian, Shaanxi, Peoples R China.	mhopkins@amnh.org; elizf@nwu.edu.cn	chen, feiyang/HDL-7230-2022	zhang, zhifei/0000-0003-0325-5116	National 973 Program [2013CB835002]; 111 Project of China [P201102007]; National Natural Science Foundation of China (NSFC) [41425008, 41621003]	National 973 Program(National Basic Research Program of China); 111 Project of China(Ministry of Education, China - 111 Project); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Fossil collection was partly financed by the National 973 Program (2013CB835002) and 111 Project of China (P201102007). This work represents a contribution to the research programmes from the National Natural Science Foundation of China (NSFC 41425008 and 41621003 to ZZ). The funders had no role in the study design, data collections and analysis, decision to publish, or preparation of the manuscript.r Thank you to J.-P Zhai and Z.-L Zhang for fossil preparation, and to Dr. H.-J. Gong for help with the scanning electron microscopy. Thank you to T.-Y. Park and an anonymous reviewer for comments that improved this manuscript, and to S. Kiel for editorial assistance. This study was financially supported by the National Natural Science Foundation of China (NSFC 41425008 and 41621003 to Z. Zhang and ELI group). Fossil collection was partly financed by the National 973 Program (2013CB835002) and 111 Project of China (P201102007).	Alberti Mirco, 2009, Mainzer Geowissenschaftliche Mitteilungen, V37, P23; Babcock Loren E., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P401; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P537, DOI 10.1111/j.1475-4983.2007.00656.x; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; CHATTERTON BDE, 1994, J PALEONTOL, V68, P294, DOI 10.1017/S0022336000022897; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Cisne J. L., 1981, PALAEONTOGRAPHICA AM, V9, P95; Corbacho Joan, 2011, Batalleria, V16, P16; Daley AC, 2016, ARTHROPOD STRUCT DEV, V45, P71, DOI 10.1016/j.asd.2015.09.004; Degan Shu, 1995, Beringeria Special Issue, V2, P203; Ebbestad JOR, 2013, GFF, V135, P18, DOI 10.1080/11035897.2012.737365; English Adam M., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P537; Eriksson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035625; Fatka O, 2015, EST J EARTH SCI, V64, P255, DOI 10.3176/earth.2015.32; Fatka O, 2013, B GEOSCI, V88, P95, DOI 10.3140/bull.geosci.1329; Fatka Oldrich, 2008, Cuadernos del Museo Geominero, V9, P117; Forchielli A, 2014, PALAEOGEOGR PALAEOCL, V398, P59, DOI 10.1016/j.palaeo.2013.08.001; Forchielli A, 2012, B GEOSCI, V87, P133, DOI 10.3140/bull.geosci.1225; Gabbott SE, 2004, GEOLOGY, V32, P901, DOI 10.1130/G20640.1; Gaines R.R., 2014, PALEONTOL SOC PAP, V20, P123, DOI DOI 10.1017/S1089332600002837; Gaines RR, 2008, GEOLOGY, V36, P755, DOI 10.1130/G24961A.1; Gutierrez-Marco JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep39728; Hou XG, 2008, EARTH ENV SCI T R SO, V99, P213, DOI 10.1017/S1755691009008093; Hu S.X., 2013, THE GUANSHAN BIOTA; Hu SX, 2010, SCI CHINA EARTH SCI, V53, P1765, DOI 10.1007/s11430-010-4086-9; Hu SX, 2010, ACTA PALAEONTOL POL, V55, P495, DOI 10.4202/app.2009.1106; Ivantsov AY, 2000, PALEONTOL ZH, P50; Kordule Vratislav, 2006, Bulletin of Geosciences, V81, P277, DOI 10.3140/bull.geosci.2006.04.277; Lerosey-Aubril R, 2017, GONDWANA RES, V42, P264, DOI 10.1016/j.gr.2016.10.013; Lerosey-Aubril R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032934; Lerosey-Aubril R, 2011, LETHAIA, V44, P166, DOI 10.1111/j.1502-3931.2010.00233.x; Lin Jih-Pai, 2007, Memoir of the Association of Australasian Palaeontologists, V33, P179; Lin JP, 2006, PALAIOS, V21, P15, DOI 10.2110/palo.2004.p04-83; LUO H., 1999, EARLY CAMBRIAN CHENG; Luo H., 2008, EARLY CAMBRIAN MALON; Ortega-Hernandez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052623; Peteya JA, 2013, THESIS; Raymond P. E., 1920, MEM CONN ACAD ARTS S, V7, P1; Snajdr Milan, 1987, Casopis Narodniho Muzea v Praze Rada Prirodovedna, V156, P8; Sturmer W., 1973, Palaeontologische Z, V47, P104; Vannier J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4641; Volborth A, 1963, SERIE, V6, P1; Walcott CD, 1881, B MUS COMP ZOOL HARV, V8, P191; Whiteley T.E., 2002, TRILOBITES NEW YORK; Whittington H.B., 1980, Palaeontology (Oxford), V23, P171; WHITTINGTON HB, 1993, PHILOS T ROY SOC B, V339, P109, DOI 10.1098/rstb.1993.0008; Yuan J. L., 2002, TRILOBITE FAUNA KAIL; Zhang XL, 2003, PALAEONTOLOGY, V46, P447, DOI 10.1111/1475-4983.00307; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhao YL, 2005, ACTA GEOL SIN-ENGL, V79, P751; Zhu MY, 2005, PALAEOGEOGR PALAEOCL, V220, P31, DOI 10.1016/j.palaeo.2003.03.001; Zhu XJ, 2014, LETHAIA, V47, P66, DOI 10.1111/let.12041	53	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184982	10.1371/journal.pone.0184982	http://dx.doi.org/10.1371/journal.pone.0184982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934290	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900071
J	Hung, CI; Liu, CY; Yang, CH				Hung, Ching-I; Liu, Chia-Yih; Yang, Ching-Hui			Untreated duration predicted the severity of depression at the two-year follow-up point	PLOS ONE			English	Article							ANTIDEPRESSANT TREATMENT; MAJOR DEPRESSION; ILLNESS; DISORDER; OUTCOMES; ANXIETY; MATTER	Background No study has investigated the impact of the duration of untreated depression (DUD) on the severity of depression at the two-year follow-up point in patients with major depressive disorder (MDD) who discontinued pharmacotherapy. This study aimed to investigate this issue. Methods This study enrolled 155 subjects with MDD at baseline, and 101 subjects who had discontinued pharmacotherapy for 17.1 +/- 5.8 months were assessed at the two-year follow-up point. DUD was defined as the interval between the onset of the index major depressive episode and the start of pharmacotherapy. The 17-item Hamilton Depression Rating Scale (HAMD) was used to evaluate depression. Multiple linear regressions were used to examine the impacts of DUD on the severity and improvement percentage (IP) of depression at follow-up. Results A longer DUD was significantly associated with a greater severity and a lower IP of depression at follow-up. After controlling for confounding factors, DUD was the most significant factor predicting the severity and IP of depression at follow-up. DUD was more strongly associated with the prognosis of depression at follow-up than depression and anxiety severities at baseline. Conclusions The DUD at baseline independently predicted the severity of depression at the two-year follow-up point. Although the patients had discontinued pharmacotherapy for nearly 1.5 years, the impact of the DUD on the severity of depression persisted at follow-up. The DUD was an important index that predicted the severity of depression at the two-year follow-up point.	[Hung, Ching-I; Liu, Chia-Yih] Linkou & Chang Gung Univ, Chang Gung Mem Hosp, Dept Psychiat, Tao Yuan, Taiwan; [Yang, Ching-Hui] Chang Gung Univ Sci & Technol, Dept Nursing, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Hung, CI (corresponding author), Linkou & Chang Gung Univ, Chang Gung Mem Hosp, Dept Psychiat, Tao Yuan, Taiwan.	a36250@cgmh.org.tw			National Science Council of Taiwan [NSC 95-2314-B-182A-188-MY2]; Chang Gung Memorial Hospital [CMRPG3E0991, CMRPG 3E2141]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported in part by grants from the National Science Council of Taiwan (NSC 95-2314-B-182A-188-MY2) and Chang Gung Memorial Hospital Research Programs (CMRPG3E0991 and CMRPG 3E2141); the two funding Sources had no further role in study design; in the collection, analysis or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Altamura AC, 2007, INT J CLIN PRACT, V61, P1697, DOI 10.1111/j.1742-1241.2007.01450.x; Altamura AC, 2008, EUR PSYCHIAT, V23, P92, DOI 10.1016/j.eurpsy.2007.11.004; Altamura AC, 2010, INT CLIN PSYCHOPHARM, V25, P172, DOI 10.1097/YIC.0b013e3283384c74; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnone D, 2013, MOL PSYCHIATR, V18, P1265, DOI 10.1038/mp.2012.150; Bukh JD, 2013, J AFFECT DISORDERS, V145, P42, DOI 10.1016/j.jad.2012.07.008; Chan SWY, 2016, J AFFECT DISORDERS, V189, P199, DOI 10.1016/j.jad.2015.09.021; de Diego-Adelino J, 2010, J AFFECT DISORDERS, V120, P221, DOI 10.1016/j.jad.2009.03.012; First MB, 2002, STRUCTURED CLIN INTE; Friedman ES, 2012, EUR NEUROPSYCHOPHARM, V22, P183, DOI 10.1016/j.euroneuro.2011.07.010; Furukawa TA, 2000, BRIT J PSYCHIAT, V177, P331, DOI 10.1192/bjp.177.4.331; Ghio L, 2015, J AFFECT DISORDERS, V175, P224, DOI 10.1016/j.jad.2015.01.014; Ghio L, 2014, J AFFECT DISORDERS, V152, P45, DOI 10.1016/j.jad.2013.10.002; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hung CI, 2015, NEUROPSYCH DIS TREAT, V11, P2245, DOI 10.2147/NDT.S89498; Hung CI, 2014, CURR OPIN PSYCHIATR, V27, P344, DOI 10.1097/YCO.0000000000000086; Hung CI, 2012, INT J PSYCHIAT CLIN, V16, P33, DOI 10.3109/13651501.2011.617456; Kim HK, 2016, PROG NEURO-PSYCHOPH, V67, P51, DOI 10.1016/j.pnpbp.2016.01.008; Lai CH, 2014, J AFFECT DISORDERS, V160, P74, DOI 10.1016/j.jad.2013.12.036; Okuda A, 2010, PSYCHIAT CLIN NEUROS, V64, P268, DOI 10.1111/j.1440-1819.2010.02091.x; Posternak MA, 2006, J NERV MENT DIS, V194, P324, DOI 10.1097/01.nmd.0000217820.33841.53; Rogers MA, 2016, J PSYCHOPHYSIOL, V30, P1, DOI 10.1027/0269-8803/a000148; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28	24	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185119	10.1371/journal.pone.0185119	http://dx.doi.org/10.1371/journal.pone.0185119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934289	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900095
J	Fujise, K; Kikuchi, Y; Kokubu, E; Okamoto-Shibayama, K; Ishihara, K				Fujise, Kazutaka; Kikuchi, Yuichiro; Kokubu, Eitoyo; Okamoto-Shibayama, Kazuko; Ishihara, Kazuyuki			Effect of extracytoplasmic function sigma factors on autoaggregation, hemagglutination, and cell surface properties of Porphyromonas gingivalis	PLOS ONE			English	Article							ESCHERICHIA-COLI; PUTATIVE GLYCOSYLTRANSFERASE; OBLIGATE ANAEROBE; BIOFILM FORMATION; SECRETION SYSTEM; GENOME SEQUENCE; GENE-EXPRESSION; PROTEIN; VIRULENCE; CONSTRUCTION	Porphyromonas gingivalis is a bacterium frequently isolated from chronic periodontal lesions and is involved in the development of chronic periodontitis. To colonize the gingival crevice, P. gingivalis has to adapt to environmental stresses. Microbial gene expression is regulated by transcription factors such as those in two-component systems and extracytoplasmic function (ECF) sigma factors. ECF sigma factors are involved in the regulation of environmental stress response genes; however, the roles of individual ECF sigma factors are largely unknown. The purpose of this study was to investigate the functions, including autoaggregation, hemagglutination, gingipain activity, susceptibility to antimicrobial agents, and surface structure formation, of P. gingivalis ECF sigma factors encoded by SigP (PGN_0274), SigCH (PGN_0319), PGN_ 0450, PGN_ 0970, and SigH (PGN_1740). Various physiological aspects of the sigP mutant were affected; autoaggregation was significantly decreased at 60 min (p < 0.001), hemagglutination activity was markedly reduced, and enzymatic activities of Kgp and Rgps were significantly decreased (p < 0.001). The other mutants also showed approximately 50% reduction in Rgps activity. Kgp activity was significantly reduced in the sigH mutant (p < 0.001). No significant differences in susceptibilities to tetracycline and ofloxacin were observed in the mutants compared to those of the wild-type strain. However, the sigP mutant displayed an increased susceptibility to ampicillin, whereas the PGN_0450 and sigH mutants showed reduced susceptibility. Transmission electron microscopy images revealed increased levels of outer membrane vesicles formed at the cell surfaces of the sigP mutant. These results indicate that SigP is important for bacterial surface- associated activities, including gingipain activity, autoaggregation, hemagglutination, vesicle formation, and antimicrobial susceptibility.	[Fujise, Kazutaka; Kikuchi, Yuichiro; Kokubu, Eitoyo; Okamoto-Shibayama, Kazuko; Ishihara, Kazuyuki] Tokyo Dent Coll, Dept Microbiol, Chiyoda Ku, Tokyo, Japan; [Kikuchi, Yuichiro; Kokubu, Eitoyo; Ishihara, Kazuyuki] Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiyoda Ku, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College	Kikuchi, Y (corresponding author), Tokyo Dent Coll, Dept Microbiol, Chiyoda Ku, Tokyo, Japan.; Kikuchi, Y (corresponding author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiyoda Ku, Tokyo, Japan.	yukikuchi@tdc.ac.jp		Ishihara, Kazuyuki/0000-0002-6567-807X; KIKUCHI, YUICHIRO/0000-0001-7232-837X	Ministry of Education, Culture, Sports, Science and Technology of Japan [JP24592778, JP16K11461, JP26463171]; Tokyo Dental College; Grants-in-Aid for Scientific Research [15K11023] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Dental College; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant JP24592778 (to KI), JP16K11461 (to EK) and JP26463171 (to YK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and research funds from Tokyo Dental College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 1999, J CLIN MICROBIOL, V37, P1426, DOI 10.1128/JCM.37.5.1426-1430.1999; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; Curtis MA, 2002, INFECT IMMUN, V70, P6968, DOI 10.1128/IAI.70.12.6968-6975.2002; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; Dou Y, 2016, MOL ORAL MICROBIOL, V31, P270, DOI 10.1111/omi.12122; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Ebersole J L, 1995, Oral Dis, V1, P115; Eisenstark A, 1996, FREE RADICAL BIO MED, V21, P975, DOI 10.1016/S0891-5849(96)00154-2; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Gerits E, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1300366; Gicquel G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080407; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gui MJ, 2016, MOL ORAL MICROBIOL, V31, P365, DOI 10.1111/omi.12134; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huett A, 2009, J IMMUNOL, V182, P4917, DOI 10.4049/jimmunol.0803050; Ikeda T, 2002, ANTIMICROB AGENTS CH, V46, P3257, DOI 10.1128/AAC.46.10.3257-3260.2002; Inoue T, 2015, NEW MICROBIOL, V38, P101; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Kikuchi Y, 2005, MICROBIOL-SGM, V151, P841, DOI 10.1099/mic.0.27589-0; Kikuchi Y, 2009, ORAL MICROBIOL IMMUN, V24, P377, DOI 10.1111/j.1399-302X.2009.00526.x; Kondo Y, 2010, INFECT IMMUN, V78, P2846, DOI 10.1128/IAI.01448-09; Krute CN, 2015, MICROBIOL-SGM, V161, P1136, DOI 10.1099/mic.0.000065; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; Mascher T, 2013, CURR OPIN MICROBIOL, V16, P148, DOI 10.1016/j.mib.2013.02.001; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Muller C, 2011, ANTIMICROB AGENTS CH, V55, P1211, DOI 10.1128/AAC.01252-10; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; NAITO Y, 1993, ORAL MICROBIOL IMMUN, V8, P195, DOI 10.1111/j.1399-302X.1993.tb00559.x; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Onozawa S, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-4; Osbourne DO, 2010, MICROBIOL-SGM, V156, P2180, DOI 10.1099/mic.0.038331-0; Ota K, 2017, ANAEROBE, V43, P82, DOI 10.1016/j.anaerobe.2016.12.006; Saito A, 2009, MICROB PATHOGENESIS, V47, P329, DOI 10.1016/j.micpath.2009.09.012; Sakai E, 2007, J BACTERIOL, V189, P3977, DOI 10.1128/JB.01691-06; Salje J, 2014, MICROBIOLOGYOPEN, V3, P426, DOI 10.1002/mbo3.176; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Taguchi Y, 2016, INFECT IMMUN, V84, P230, DOI 10.1128/IAI.01308-15; Tokuda M, 1996, INFECT IMMUN, V64, P4067, DOI 10.1128/IAI.64.10.4067-4073.1996; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; WENSINK J, 1981, EUR J BIOCHEM, V116, P331, DOI 10.1111/j.1432-1033.1981.tb05338.x; Xie H, 2012, INFECT IMMUN, V80, P3471, DOI 10.1128/IAI.00680-12; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yanamandra SS, 2012, MOL ORAL MICROBIOL, V27, P202, DOI 10.1111/j.2041-1014.2012.00643.x	55	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185027	10.1371/journal.pone.0185027	http://dx.doi.org/10.1371/journal.pone.0185027			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931045	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700060
J	Kelen, D; Andorka, C; Szabo, M; Alafuzoff, A; Kaila, K; Summanen, M				Kelen, Dorottya; Andorka, Csilla; Szabo, Mikloa; Alafuzoff, Aleksander; Kaila, Kai; Summanen, Milla			Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; PLASMA COPEPTIN; HYPOTHERMIA; VASOPRESSIN; BIOMARKERS; INFANTS; S100B; ASPHYXIA	The objective of this study was to evaluate the early changes in serial serum levels of copeptin and neuron-specific enolase (NSE) in neonates diagnosed with birth asphyxia, and to determine whether these biomarkers measured in the first 168 hours after birth are predictive of long-term neurodevelopmental outcome. Copeptin and NSE levels were measured from serum samples collected 6, 12, 24, 48, 72, and 168 hours after birth from 75 term neonates diagnosed with hypoxic-ischemic encephalopathy (HIE) and treated with therapeutic hypothermia for 72 hours. In addition, serum copeptin levels after birth were measured from 10 HIE diagnosed neonates, who were randomized to the normothermic arm of the TOBY cohort. All neonates underwent neurodevelopmental assessment using the Bayley Scales of Infant and Toddler Development-II at two years of age. Copeptin levels were highest at 6 hours after birth and steadily decreased, whereas the highest NSE levels were measured at 24 hours after birth. The biomarker levels correlated with blood-gas parameters (base excess, pH and lactate) at 6 and 12 hours after birth. Copeptin and NSE levels in the early postnatal period were significantly higher in neonates with poor outcome compared to those with favorable outcome at two years of age. Furthermore, in the TOBY cohort, copeptin levels were significantly lower in hypothermic compared to normothermic neonates. To conclude, copeptin and NSE measured in the early postnatal period are potential prognostic biomarkers of long-term neurodevelopmental outcome in term neonates diagnosed with HIE and treated with therapeutic hypothermia.	[Kelen, Dorottya; Andorka, Csilla; Szabo, Mikloa] Semmelweis Univ, Dept Pediat 1, Budapest, Hungary; [Alafuzoff, Aleksander; Kaila, Kai; Summanen, Milla] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Alafuzoff, Aleksander; Kaila, Kai; Summanen, Milla] Univ Helsinki, Neurosci Ctr, Helsinki, Finland	Semmelweis University; University of Helsinki; University of Helsinki	Kaila, K (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.; Kaila, K (corresponding author), Univ Helsinki, Neurosci Ctr, Helsinki, Finland.	kai.kaila@helsinki.fi	Kaila, Kai K/R-8528-2016	Kaila, Kai K/0000-0003-0668-5955; Summanen, Milla/0000-0003-3843-2741	European Research Council [ERC-2013-AdG 341116]	European Research Council(European Research Council (ERC)European Commission)	Funding of work and materials for serum biomarker analyses was provided by the European Research Council (https://erc.europa.eu/) grant number ERC-2013-AdG 341116 (KK).	Ahearne Caroline E, 2016, World J Clin Pediatr, V5, P67, DOI 10.5409/wjcp.v5.i1.67; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bailey, 1969, MANUAL BAYLEY SCALES; Bennet L, 2010, SEMIN FETAL NEONAT M, V15, P253, DOI 10.1016/j.siny.2010.05.007; Benzing J, 2011, J CLIN ENDOCR METAB, V96, pE982, DOI 10.1210/jc.2010-2858; Celtik C, 2004, BRAIN DEV-JPN, V26, P398, DOI 10.1016/j.braindev.2003.12.007; Davidson JO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00198; Evers KS, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00075; GIBBS DM, 1985, ENDOCRINOLOGY, V116, P723, DOI 10.1210/endo-116-2-723; Giuseppe D, 2009, CURR NEUROVASC RES, V6, P110, DOI 10.2174/156720209788185614; Katan M, 2010, SWISS MED WKLY, V140, P11, DOI 10.4414/smw.2010.13101; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; L'Abate P, 2013, RESP PHYSIOL NEUROBI, V185, P222, DOI 10.1016/j.resp.2012.10.011; Lagercrantz H., 1998, FETAL NEONATAL PHYSL, P220; Lv HY, 2015, CLIN CHIM ACTA, V450, P282, DOI 10.1016/j.cca.2015.08.021; Maravic-Stojkovic V, 2014, ANGIOLOGY, V65, P122, DOI 10.1177/0003319712473637; Massaro AN, 2014, PEDIATR CRIT CARE ME, V15, P615, DOI 10.1097/PCC.0000000000000155; Merchant N, 2015, DEV MED CHILD NEUROL, V57, P8, DOI 10.1111/dmcn.12726; Miller SP, 2005, J PEDIATR-US, V146, P453, DOI 10.1016/j.jpeds.2004.12.026; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Nagdyman N, 2003, PEDIATR RES, V54, P270, DOI 10.1203/01.PDR.0000072518.98189.A0; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Pittman QJ, 1998, PROG BRAIN RES, V119, P383; Roka A, 2008, PEDIATRICS, V121, pE844, DOI 10.1542/peds.2007-1987; Roka A, 2007, ACTA PAEDIATR, V96, P1118, DOI 10.1111/j.1651-2227.2007.00361.x; Roka A, 2012, ACTA PAEDIATR, V101, P319, DOI 10.1111/j.1651-2227.2011.02480.x; Schlapbach LJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-38; Sharif-Naeini R, 2008, NEURON, V58, P179, DOI 10.1016/j.neuron.2008.02.013; Summanen M, 2017, NEONATOLOGY, V112, P60, DOI 10.1159/000456063; Wellmann S, 2016, OBSTET GYNECOL; Wellmann S, 2010, J CLIN ENDOCR METAB, V95, P5091, DOI 10.1210/jc.2010-1331	31	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184593	10.1371/journal.pone.0184593	http://dx.doi.org/10.1371/journal.pone.0184593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931055	gold, Green Submitted, Green Published			2022-12-27	WOS:000411314700024
J	Neu, J; Dziunycz, PJ; Dzung, A; Lefort, K; Falke, M; Denzler, R; Freiberger, SN; Iotzova-Weiss, G; Kuzmanov, A; Levesque, MP; Dotto, GP; Hofbauer, GFL				Neu, Johannes; Dziunycz, Piotr Jan; Dzung, Andreas; Lefort, Karine; Falke, Martin; Denzler, Remy; Freiberger, Sandra Nicole; Iotzova-Weiss, Guergana; Kuzmanov, Aleksandar; Levesque, Mitchell Paul; Dotto, Gian-Paolo; Hofbauer, Guenther Franz L.			miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS	PLOS ONE			English	Article							POTENTIAL TUMOR-SUPPRESSOR; SKIN-CANCER; KERATINOCYTE; MICRORNAS; DIFFERENTIATION; EXPRESSION; RESISTANCE; MUTATIONS	Cutaneous squamous cell carcinoma (SCC) is the second most common human skin cancer with a rapidly increasing incidence among the Caucasian population. Among the many regulators, responsible for cancer progression and growth, microRNAs (miRNA) are generally accepted as key players by now. In our current study we found that microRNA-181a (miR-181a) shows low abundance in SCC compared to normal epidermal skin. In vitro, miRNA downregulation in normal primary keratinocytes induced increased proliferation, while in vivo miR-181a downregulation in HaCaT normal keratinocytes showed tumor-like growth increase up to 50%. Inversely, upregulation of these miRNAs in cancer cells lead to reduced cellular proliferation and induction of apoptosis in vitro. An in vivo therapeutic model with induced miR-181a expression in SCC13 cancer cells reduced tumor formation in mice by 80%. Modulation of miR-181a levels showed an inverse correlation with the proto-oncogene KRAS both on mRNA and protein level by direct interaction. Knockdown of KRAS mimicked the anti-proliferative effects of miR-181a overexpression in patient-derived SCC cells and abolished the enhanced viability of HaCaT cells following miR-181a knockdown. Furthermore, phospho-ERK levels correlated with KRAS levels, suggesting that the observed effects were mediated via the MAPK signaling pathway. miR-181a seemed regulated during keratinocyte differentiation probably in order to amplify the tumor suppressive character of differentiation. Taken together, miR-181a plays a crucial tumor suppressive role in SCC by targeting KRAS and could be a promising candidate for a miRNA based therapy.	[Neu, Johannes; Dziunycz, Piotr Jan; Dzung, Andreas; Freiberger, Sandra Nicole; Iotzova-Weiss, Guergana; Kuzmanov, Aleksandar; Levesque, Mitchell Paul; Hofbauer, Guenther Franz L.] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland; [Lefort, Karine; Dotto, Gian-Paolo] Univ Lausanne, Dept Biochem, Epalinges, Switzerland; [Falke, Martin] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Denzler, Remy] ETH, Dept Biol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Lausanne; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Neu, J (corresponding author), Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland.	johannes.neu@usz.ch	Hofbauer, Gunther/B-2671-2010; Freiberger, Sandra/AAT-5527-2020	Hofbauer, Gunther/0000-0003-0542-7989; Dzung, Andreas/0000-0002-1776-1928	European Skin Research Foundation ESRF	European Skin Research Foundation ESRF	This work was supported by Hartmann Muller-Stiftung #1688, http://www.hartmannmuellerstiftung.ch/home (GH) and European Skin Research Foundation ESRF, http://www.euroskinresearch.org/ (PD GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelio I, 2012, J CELL BIOL, V199, P347, DOI 10.1083/jcb.201203134; Barbollat-Boutrand L, 2016, EXPT DERMATOLOGY; Barde Isabelle, 2010, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s53; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Candi E, 2015, CELL DEATH DIFFER, V22, P12, DOI 10.1038/cdd.2014.113; Chang YS, 2010, CLIN BIOCHEM, V43, P296, DOI 10.1016/j.clinbiochem.2009.10.007; Chen G, 2013, APJCP, V14; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Fei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032834; Freiberger SN, 2015, MOL CANCER THER, V14, P2132, DOI 10.1158/1535-7163.MCT-15-0023-T; He QT, 2013, BBA-GEN SUBJECTS, V1830, P5258, DOI 10.1016/j.bbagen.2013.07.028; Hildebrand J, 2011, J INVEST DERMATOL, V131, P20, DOI 10.1038/jid.2010.268; Hiraki M, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.5; Hofbauer G, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14026; Hofbauer GFL, 2010, EXP DERMATOL, V19, P473, DOI 10.1111/j.1600-0625.2010.01086.x; Huang X., 2016, ONCOTARGET; Kim M, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0084-2; Korhan P, 2014, BIOCHEM BIOPH RES CO, V450, P1304, DOI 10.1016/j.bbrc.2014.06.142; Kozloski GA, 2016, BLOOD, V127, P2856, DOI 10.1182/blood-2015-11-680462; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li L, 2016, EUR REV MED PHARMACO, V20, P2004; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Ma ZL, 2015, ACTA BIOCH BIOPH SIN, V47, P630, DOI 10.1093/abbs/gmv054; Parikh A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3977; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Schneider MR, 2012, BRIT J DERMATOL, V166, P22, DOI 10.1111/j.1365-2133.2011.10568.x; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Shin KH, 2011, BIOCHEM BIOPH RES CO, V404, P896, DOI 10.1016/j.bbrc.2010.12.055; Sholl Lynette M, 2016, Surg Pathol Clin, V9, P353, DOI 10.1016/j.path.2016.04.003; Siddiqui AD, 2010, ANN SURG ONCOL, V17, P1168, DOI 10.1245/s10434-009-0811-z; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Tsang WP, 2009, CARCINOGENESIS, V30, P953, DOI 10.1093/carcin/bgp094; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zou CC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-97	45	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185028	10.1371/journal.pone.0185028	http://dx.doi.org/10.1371/journal.pone.0185028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931048	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000411314700061
J	Robinson, KP; Sim, TMC; Culloch, RM; Bean, TS; Aguilar, IC; Eisfeld, SM; Filan, M; Haskins, GN; Williams, G; Pierce, GJ				Robinson, Kevin P.; Sim, Texa M. C.; Culloch, Ross M.; Bean, Thomas S.; Aguilar, Isabel Cordoba; Eisfeld, Sonja M.; Filan, Miranda; Haskins, Gary N.; Williams, Genevieve; Pierce, Graham J.			Female reproductive success and calf survival in a North Sea coastal bottlenose dolphin (Tursiops truncatus) population	PLOS ONE			English	Article							ASSOCIATION PATTERNS; ANTHROPOID PRIMATES; MATERNAL SIZE; MORAY FIRTH; CONSEQUENCES; EXPOSURE; FITNESS; PARAMETERS; EXPRESSION; MANAGEMENT	Between-female variation in reproductive output provides a strong measure of individual fitness and a quantifiable measure of the health of a population which may be highly informative to management. In the present study, we examined reproductive traits in female bottlenose dolphins from the east coast of Scotland using longitudinal sightings data collected over twenty years. From a total of 102 females identified between 1997 and 2016, 74 mothers produced a collective total of 193 calves. Females gave birth from 6 to 13 years of age with a mean age of 8. Calves were produced during all study months, May to October inclusive, but showed a seasonal birth pulse corresponding to the regional peak in summer water temperatures. Approximately 83% (n = 116) of the calves of established fate were successfully raised to year 2-3. Of the known mortalities, similar to 45% were first-born calves. Calf survival rates were also lower in multiparous females who had previously lost calves. A mean interbirth interval (IBI) of 3.80 years (n = 110) and mean fecundity of 0.16 was estimated for the population. Calf loss resulted in shortened IBIs, whilst longer IBIs were observed in females assumed to be approaching reproductive senescence. Maternal age and size, breeding experience, dominance, individual associations, group size and other social factors, were all concluded to influence reproductive success (RS) in this population. Some females are likely more important than others for the future viability of the population. Consequently, a better knowledge of the demographic groups containing those females showing higher reproductive success would be highly desirable for conservation efforts aimed at their protection.	[Robinson, Kevin P.; Sim, Texa M. C.; Culloch, Ross M.; Bean, Thomas S.; Aguilar, Isabel Cordoba; Eisfeld, Sonja M.; Filan, Miranda; Haskins, Gary N.; Williams, Genevieve] CRRU, Banff, Scotland; [Sim, Texa M. C.; Pierce, Graham J.] Univ Aberdeen, Oceanlab, Newburgh, Scotland; [Pierce, Graham J.] Univ Aveiro, CESAM, Aveiro, Portugal; [Pierce, Graham J.] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Pierce, Graham J.] CSIC, Inst Invest Marinas, Vigo, Spain; [Culloch, Ross M.] Queens Univ Belfast, Sch Nat & Built Environm, Queens Univ, Marine Lab, Portaferry, North Ireland; [Eisfeld, Sonja M.] WDC, Chippenham, England; [Williams, Genevieve] James Cook Univ, Townsville, Qld, Australia	University of Aberdeen; Universidade de Aveiro; Universidade de Aveiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Queens University Belfast; James Cook University	Robinson, KP (corresponding author), CRRU, Banff, Scotland.	kev.robinson@crru.org.uk	Robinson, Kevin/H-3866-2019; Pierce, Graham/A-5404-2018	Pierce, Graham/0000-0002-4744-4501; Robinson, Kevin/0000-0001-8085-9752	Born Free Foundation	Born Free Foundation	We would like to thank our CRRU colleagues, volunteers, supporters and funders who have made this long-term monitoring study possible. There are too many individuals to list here, but we would very much like to thank the following past and present co-workers for field and logistical support: Michael Tetley, Marina Costa, Alessandro Ponzo, Joanne Weare, Nina Baumgartner, Benjamin Williams, Kathryn Dick, Konstantinos Margaris, Jamie Vaughan, Lilian Lieber, Helen Mitcheson, Nick Duthie, Connor Bamford, Andreas Fahlman, Elizabeth Pelonzi, Allan Whaley, Jenny Armstrong, Livia Zapponi. Jenny Spinou, Jack Borrett, Alejandro Herreo Palacio, Rebecca Hall, Grace Russell, Theofilos Sidiropoulos and Beatriz Gimenez-Reguera. We also acknowledge the Born Free Foundation (formerly Care for the Wild International) for their ongoing support, and our co-workers and colleagues at Aberdeen University, the Sea Mammal Research Unit, Scottish Agricultural College, Hebridean Whale & Dolphin Trust and Whale & Dolphin Conservation. The present examination forms part of a wider, long-term monitoring project of the coastally-occurring cetacean species in northeast Scotland. All survey work was carried-out under licence from Scottish Natural Heritage.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bansal R, 2005, DEV BRAIN RES, V156, P13, DOI 10.1016/j.devbrainres.2005.01.007; Brough TE, 2016, ENDANGER SPECIES RES, V29, P255, DOI 10.3354/esr00715; Cheney B, 2015, 21 BIENN C BIOL MAR; Cheney B, 2014, GLOB ECOL CONSERV, V2, P118, DOI 10.1016/j.gecco.2014.08.010; Cheney B, 2013, MAMMAL REV, V43, P71, DOI 10.1111/j.1365-2907.2011.00208.x; CHENEY D, 1986, SCIENCE, V234, P1361, DOI 10.1126/science.3538419; Civil MA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1796; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Culloch RM, 2008, J MAR BIOL ASSOC UK, V88, P1237, DOI 10.1017/S0025315408000210; Currey RJC, 2009, AQUAT CONSERV, V19, P658, DOI 10.1002/aqc.1015; Eisfeld S., 2003, THESIS; Eisfeld S. M., 2004, EUROPEAN RES CETACEA, V18, P60; FEDIGAN LM, 1995, AM J PRIMATOL, V37, P9, DOI 10.1002/ajp.1350370103; Filan M., 2015, THESIS; Frere CH, 2010, P NATL ACAD SCI USA, V107, P19949, DOI 10.1073/pnas.1007997107; Frere CH, 2010, P ROY SOC B-BIOL SCI, V277, P2667, DOI 10.1098/rspb.2010.0039; Fruet PF, 2015, MAR BIOL, V162, P661, DOI 10.1007/s00227-015-2613-0; Gero S., 2012, THESIS; Grasman KA, 2001, J TOXICOL ENV HEAL A, V62, P191, DOI 10.1080/009841001458307; Grellier K, 2003, CAN J ZOOL, V81, P1421, DOI 10.1139/Z03-132; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P60, DOI 10.1289/ehp.8053; Henderson SD, 2014, MAR MAMMAL SCI, V30, P1067, DOI 10.1111/mms.12109; IVERSON SJ, 1993, PHYSIOL ZOOL, V66, P61, DOI 10.1086/physzool.66.1.30158287; Kogi K, 2004, MAR MAMMAL SCI, V20, P510, DOI 10.1111/j.1748-7692.2004.tb01176.x; Krutzen M, 2004, MOL ECOL, V13, P1975, DOI 10.1111/j.1365-294X.2004.02192.x; Lande R., 2003, OXFORD SERIES ECOLOG; LUNN NJ, 1994, J ANIM ECOL, V63, P827, DOI 10.2307/5260; Magrath RD, 1997, BEHAV ECOL SOCIOBIOL, V41, P185, DOI 10.1007/s002650050378; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mitani JC, 1997, BEHAV ECOL SOCIOBIOL, V40, P213, DOI 10.1007/s002650050335; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; Moller Luciana M., 2008, Research Letters in Ecology, V2008, P1, DOI 10.1155/2008/498390; Murphy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131085; Pomeroy PP, 1999, J ANIM ECOL, V68, P235, DOI 10.1046/j.1365-2656.1999.00281.x; Proaktor G, 2008, ECOLOGY, V89, P2604, DOI 10.1890/07-0833.1; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; PUSEY AE, 1990, BEHAVIOUR, V115, P203, DOI 10.1163/156853990X00581; Quick N, 2014, 14D086 UK DEP EN CLI; Robinson Kevin P., 2007, Lutra, V50, P19; Robinson KP, 2014, MAR MAMMAL SCI, V30, P381, DOI 10.1111/mms.12023; Robinson Kevin P., 2012, Journal of Cetacean Research and Management, V12, P365; Ross C, 2000, FOLIA PRIMATOL, V71, P93, DOI 10.1159/000021733; Samuels A, 1997, MAR MAMMAL SCI, V13, P70, DOI 10.1111/j.1748-7692.1997.tb00613.x; Scott M.D., 1990, P235; SHINE R, 1988, AM NAT, V131, P124, DOI 10.1086/284778; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Sim TMC, 2015, THESIS; Steiner Aude, 2008, Aquatic Mammals, V34, P84, DOI 10.1578/AM.34.1.2008.84; Stockin KA, 2006, J MAR BIOL ASSOC UK, V86, P201, DOI 10.1017/S002531540601304X; THOMAS CD, 1990, CONSERV BIOL, V4, P324, DOI 10.1111/j.1523-1739.1990.tb00295.x; Thompson PM, 2011, 354 SNH SCOTT GOV; Urian KW, 1996, J MAMMAL, V77, P394, DOI 10.2307/1382814; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells R.S., 1987, Current Mammalogy, V1, P247; Whitehead H, 2000, CETACEAN SOCIETIES, P219; Willsteed E, 2017, SCI TOTAL ENVIRON, V577, P19, DOI 10.1016/j.scitotenv.2016.10.152; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wilson B, 2004, ANIM CONSERV, V7, P331, DOI 10.1017/S1367943004001581; Wright AJ, 2015, CONSERV BIOL, V29, P333, DOI 10.1111/cobi.12425; Yang JH, 2003, MOL BRAIN RES, V111, P123, DOI 10.1016/S0169-328X(02)00697-6	64	20	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185000	10.1371/journal.pone.0185000	http://dx.doi.org/10.1371/journal.pone.0185000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931081	gold, Green Accepted, Green Published			2022-12-27	WOS:000411314700054
J	Song, WW; Wang, M; Su, W; Lu, QW; Xiao, XH; Cai, J; Zhang, Z; Li, SQ; Li, PT; Gong, JW; Gong, WK; Shang, HH; Liu, AY; Li, JW; Chen, TT; Ge, Q; Shi, YZ; Yuan, YL				Song, Weiwu; Wang, Mi; Su, Wei; Lu, Quanwei; Xiao, Xianghui; Cai, Juan; Zhang, Zhen; Li, Shaoqi; Li, Pengtao; Gong, Juwu; Gong, Wankui; Shang, Haihong; Liu, Aiying; Li, Junwen; Chen, Tingting; Ge, Qun; Shi, Yuzhen; Yuan, Youlu			Genetic and phenotypic effects of chromosome segments introgressed from Gossypium barbadense into Gossypium hirsutum	PLOS ONE			English	Article							FIBER QUALITY TRAITS; ORYZA-SATIVA L.; UPLAND COTTON; SUBSTITUTION LINES; QTL ANALYSIS; LOCI; MAP; POPULATIONS; ENVIRONMENT; COMPONENTS	MBI9915 is an introgression cotton line with excellent fiber quality. It was obtained by advanced backcrossing and continuous inbreeding from an interspecific cross between the upland cotton (Gossypium hirsutum) cultivar CCRI36 as the recurrent parent and the sea island cotton (G. barbadense) cultivar Hai1, as the donor parent. To study the genetic effects of the introgressed chromosome segments in G. hirsutum, an F-2 secondary segregating population of 1537 individuals was created by crossing MBI9915 and CCRI36, and an F-2:3 population was created by randomly selecting 347 individuals from the F-2 generation. Quantitative trait locus (QTL) mapping and interaction for fiber length and strength were identified using IciMapping software. The genotype analysis showed that the recovery rate for MBI9915 was 97.9%, with a total 6 heterozygous segments and 13 homozygous segments. A total of 18 QTLs for fiber quality and 6 QTLs for yield related traits were detected using the two segregating generations. These QTLs were distributed across 7 chromosomes and collectively explained 0.81%-9.51% of the observed phenotypic variations. Six QTLs were consistently detected in two generations and 6 QTLs were identified in previous studies. A total of 13 pairs of interaction for fiber length and 13 pairs of interaction for fiber strength were identified in two generations. Among them, 3 pairs of interaction for fiber length and 3 pairs of interaction for fiber strength could be identified in all generations; 4 pairs of interactions affected fiber length and fiber strength simultaneously. The results clearly showed that 5 chromosome segments (Seg-5-1, Seg-7-1, Seg-8-1, Seg-20-2 and Seg-20-3) have important effects on fiber yield and quality. This study provides the useful information for gene cloning and marker-assisted breeding for excellent fiber related quality.	[Song, Weiwu; Su, Wei; Lu, Quanwei; Xiao, Xianghui; Cai, Juan; Zhang, Zhen; Li, Shaoqi; Li, Pengtao; Gong, Juwu; Gong, Wankui; Shang, Haihong; Liu, Aiying; Li, Junwen; Chen, Tingting; Ge, Qun; Shi, Yuzhen; Yuan, Youlu] Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, State Key Lab Cotton Biol,Key Lab Biol & Genet Br, Anyang, Henan, Peoples R China; [Song, Weiwu; Cai, Juan] Enshi Acad Agr Sci, Enshi, Hubei, Peoples R China; [Wang, Mi] Yangtze Univ, Coll Agr, Jingzhou, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Yangtze University	Shi, YZ; Yuan, YL (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, State Key Lab Cotton Biol,Key Lab Biol & Genet Br, Anyang, Henan, Peoples R China.	shiyzmb@126.com; yylcri@126.com	Gǒng, Wànkuí/AAL-5622-2020	Gǒng, Wànkuí/0000-0002-8556-0669	National Natural Science Foundation of China [31101188]; National Key R & D Program for Crop Breeding [2016YFD0100300]; National Agricultural Science and technology innovation project for CAAS;  [161016201733]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R & D Program for Crop Breeding; National Agricultural Science and technology innovation project for CAAS; 	The "study design, data collection and analysis of the manuscript" were done in 2013 and 2014, and were funded by the National Natural Science Foundation of China (31101188) (Years of support: 2012.01-2014.12); the "decision to publish, or preparation of the manuscript" were funded by National Key R & D Program for Crop Breeding (2016YFD0100300) (Years of support: 2016.06-2020.12) and the National Agricultural Science and technology innovation project for CAAS and the project of Director (161016201733) (Years of support: 2017.01-2017.12).	Cao ZB, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0393-3; Clement JD, 2012, FIELD CROP RES, V128, P1, DOI 10.1016/j.fcr.2011.12.002; ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; Fang XM, 2017, THEOR APPL GENET, V130, P795, DOI 10.1007/s00122-017-2852-1; Guo LX, GENETIC ANAL FIBER Q; [贺道华 He Daohua], 2004, [棉花学报, Cotton Science], V16, P131; He R, 2014, EVALUATION IDENTIFYI, pS562; HUANG Z, 2003, GENETICS BREEDING CO; Jamshed M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2560-2; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Li AH, 2013, MOL BREEDING, V32, P1, DOI 10.1007/s11032-012-9807-7; Li BT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157978; Li M, 2011, THEOR APPL GENET, V123, P411, DOI 10.1007/s00122-011-1593-9; Liang Yan, 2010, Molecular Plant Breeding, V8, P221; Liao CY, 2001, THEOR APPL GENET, V103, P104, DOI 10.1007/s001220000528; [林忠旭 LIN Zhong-xu], 2009, [中国农业科学, Scientia Agricultura Sinica], V42, P3036; Liu DX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2605-6; Liu JY, 2000, ACTA BOT SIN, V42, P991; Liu SB, 2006, THEOR APPL GENET, V112, P1360, DOI 10.1007/s00122-006-0238-x; Liu TM, 2009, THEOR APPL GENET, V118, P1509, DOI 10.1007/s00122-009-0999-0; Luan M, 2009, PLANT BREEDING, V128, P671, DOI 10.1111/j.1439-0523.2009.01650.x; Ma LJ, EVALUATION QTL IDENT; [马麒 Ma Qi], 2014, [广东农业科学, Guangdong Agricultural Sciences], V41, P138; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2003, THEOR APPL GENET, V106, P384, DOI 10.1007/s00122-002-1025-y; Qian N., 2009, GENETIC DIVERSITY AS; REINISCH AJ, 1994, GENETICS, V138, P829; Said JI, 2015, MOL GENET GENOMICS, V290, P1003, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Shi YZ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3128-x; Shi YZ, 2015, J INTEGR PLANT BIOL, V57, P450, DOI 10.1111/jipb.12288; Smith CW, 1997, CROP SCI, V37, P1775, DOI 10.2135/cropsci1997.0011183X003700060019x; Stelly DM, 2005, CROP SCI, V45, P2663, DOI 10.2135/cropsci2004.0642; Szalma SJ, 2007, THEOR APPL GENET, V114, P1211, DOI 10.1007/s00122-007-0512-6; Tang SY, 2015, EUPHYTICA, V201, P195, DOI [10.1007/s10681-014-1189-y, 10.1007/s10681-]; Ujiie K, 2012, EUPHYTICA, V187, P325, DOI 10.1007/s10681-012-0660-x; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Wang FR, 2013, MOL BREEDING, V32, P547, DOI 10.1007/s11032-013-9888-y; Wang HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130742; Wang JK, 2006, GENET RES, V88, P93, DOI 10.1017/S0016672306008408; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; Wu Mao-Qing, 2003, Acta Genetica Sinica, V30, P443; Yang XL, 2015, EUPHYTICA, V201, P215, DOI 10.1007/s10681-014-1194-1; Zhai HC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159101; Zhang J, 2000, COTTON SCI, V12, P267, DOI DOI 10.3969/J.ISSN.1002-7807.2000.05.012; [张金凤 Zhang Jinfeng], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P773; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhang ZS, 2011, THEOR APPL GENET, V123, P1075, DOI 10.1007/s00122-011-1649-x; Zhu WY, 2009, PLANT MOL BIOL REP, V27, P126, DOI 10.1007/s11105-008-0054-3; Zhu YaJuan, 2010, Acta Agronomica Sinica, V36, P1318, DOI 10.3724/SP.J.1006.2010.01318; 王鹏, 2008, [科学通报, Chinese Science Bulletin], V53, P1065	52	17	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184882	10.1371/journal.pone.0184882	http://dx.doi.org/10.1371/journal.pone.0184882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931074	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700040
J	Jafamezhadgero, AA; Shad, MM; Majlesi, M; Granacher, U				Jafamezhadgero, Amir Ali; Shad, Morteza Madadi; Majlesi, Mandi; Granacher, Urs			A comparison of running kinetics in children with and without genu varus: A cross sectional study	PLOS ONE			English	Article							GROUND REACTION FORCE; KNEE OSTEOARTHRITIS; PATELLOFEMORAL PAIN; FRONTAL-PLANE; RISK-FACTORS; LOADING RATE; FREE MOMENT; WALKING; GAIT; KINEMATICS	Introduction Varus knee alignment has been identified as a risk factor for the progression of medial knee osteoarthritis. However, the underlying mechanisms have not been elucidated yet in children. Thus, the aims of the present study were to examine differences in ground reaction forces, loading rate, impulses, and free moment values during running in children with and without genu varus. Methods Thirty-six boys aged 9-14 volunteered to participate in this study. They were divided in two age-matched groups (genu varus versus healthy controls). Body weight adjusted three dimensional kinetic data (Fx, Fy, Fz) were collected during running at preferred speed using two Kistler force plates for the dominant and non-dominant limb. Results Individuals with knee genu varus produced significantly higher (p = .01; d = 1.09; 95%) body weight adjusted ground reaction forces in the lateral direction (Fx) of the dominant limb compared to controls. On the non-dominant limb, genu varus patients showed significantly higher body weight adjusted ground reaction forces values in the lateral (p = .01; d = 1.08; 86%) and medial (p < .001; d = 1.55; 102%) directions (Fx). Further, genu varus patients demonstrated 55% and 36% greater body weight adjusted loading rates in the dominant (p < .001; d = 2.09) and non-dominant (p < .001; d = 1.02) leg, respectively. No significant between-group differences were observed for adjusted free moment values (p>.05). Discussion Higher mediolateral ground reaction forces and vertical loading rate amplitudes in boys with genu varus during running at preferred running speed may accelerate the development of progressive joint degeneration in terms of the age at knee osteoarthritis onset. Therefore, practitioners and therapists are advised to conduct balance and strength training programs to improve lower limb alignment and mediolateral control during dynamic movements.	[Jafamezhadgero, Amir Ali; Shad, Morteza Madadi] Univ Mohaghegh Ardabili, Dept Phys Educ & Sport Sci, Ardebil, Iran; [Majlesi, Mandi] Islamic Azad Univ, Hamedan Branch, Dept Sport Biomech, Fac Humanities, Hamadan, Iran; [Granacher, Urs] Univ Potsdam, Div Training & Movement Sci, Res Focus Cognit Sci, Potsdam, Germany	University of Mohaghegh Ardabili; Islamic Azad University; University of Potsdam	Granacher, U (corresponding author), Univ Potsdam, Div Training & Movement Sci, Res Focus Cognit Sci, Potsdam, Germany.	urs.granacher@uni-potsdam.de	Granacher, Urs/T-9900-2017; Granacher, Urs/N-1963-2019; Granacher, Urs/GXM-3858-2022; Jafarnezhadgero, AmirAli/AAE-2249-2019	Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Jafarnezhadgero, AmirAli/0000-0002-2739-4340; Majlesi, Mahdi/0000-0003-2032-4937	Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of University of Potsdam; Open Access Publishing Fund of University of Potsdam, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of University of Potsdam; Open Access Publishing Fund of University of Potsdam, Germany	We acknowledge the support of the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of University of Potsdam. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully thank all children and their parents for their participation and cooperation in this study. We acknowledge the support of the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of University of Potsdam, Germany.	Ackerman IN, 2017, J ORTHOP SPORT PHYS, V47, P67, DOI 10.2519/jospt.2017.7286; Almosnino S., 2009, MED REHABIL, V1, P1, DOI DOI 10.1186/1758-2555-1-19; Anbarian M, 2015, GAIT POSTURE, V42, pS39; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Barrios JA, 2009, CLIN BIOMECH, V24, P850, DOI 10.1016/j.clinbiomech.2009.07.016; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; Brouwer GM, 2007, ARTHRITIS RHEUM, V56, P1204, DOI 10.1002/art.22515; Burr DB, 2003, RHEUM DIS CLIN N AM, V29, P675, DOI 10.1016/S0889-857X(03)00061-9; Butler RJ, 2011, PHYS THER, V91, P1235, DOI 10.2522/ptj.20100324; Caine D, 2006, BRIT J SPORT MED, V40, P749, DOI 10.1136/bjsm.2005.017822; Cheung RTH, 2011, J ORTHOP SPORT PHYS, V41, P914, DOI 10.2519/jospt.2011.3771; Chockalingam N., 2008, SCOLIOSIS, V3, P1, DOI DOI 10.1186/1748-7161-3-10); Cohen J.E., 1988, STAT POWER ANAL BEHA; Crowell HP, 2011, CLIN BIOMECH, V26, P78, DOI 10.1016/j.clinbiomech.2010.09.003; Damavandi M, 2012, HUM MOVEMENT SCI, V31, P182, DOI 10.1016/j.humov.2011.06.004; Davis IS, 2010, MED SCI SPORT EXER, V42, P682, DOI 10.1249/01.MSS.0000385903.65728.85; Flatters K, 2017, J SCI MED SPORT, V20, pe30; Fukaya T, 2015, KNEE, V22, P213, DOI 10.1016/j.knee.2015.02.012; Gatti AA, 2017, J BIOMECH; Gay RE, 2008, CLIN BIOMECH, V23, P1, DOI 10.1016/j.clinbiomech.2007.08.006; Gruber AH, 2014, J SPORT HEALTH SCI, V3, P113, DOI 10.1016/j.jshs.2014.03.004; HOLDEN JP, 1991, J BIOMECH, V24, P887, DOI 10.1016/0021-9290(91)90167-L; Hsue BJ, 2009, GAIT POSTURE, V29, P465, DOI 10.1016/j.gaitpost.2008.11.007; Jafarnezhadgero AA, 2017, GAIT POSTURE, V55, P75, DOI 10.1016/j.gaitpost.2017.04.011; Jafarnezhadgero AA, 2017, GAIT POSTURE, V53, P236, DOI 10.1016/j.gaitpost.2017.02.006; John CT, 2012, J BIOMECH, V45, P2438, DOI 10.1016/j.jbiomech.2012.06.037; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kubo M, 2006, GAIT POSTURE, V23, P512, DOI 10.1016/j.gaitpost.2005.06.007; Kuhman DJ, 2016, HUM MOVEMENT SCI, V47, P9, DOI 10.1016/j.humov.2016.01.013; LAFORTUNE MA, 1992, CLIN BIOMECH, V7, P181, DOI 10.1016/0268-0033(92)90034-2; Liikavainio T, 2010, KNEE, V17, P69, DOI 10.1016/j.knee.2009.05.003; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Lythgo N, 2009, GAIT POSTURE, V30, P502, DOI 10.1016/j.gaitpost.2009.07.119; MARKS R, 1994, J THEOR BIOL, V170, P283, DOI 10.1006/jtbi.1994.1189; Miller RH, 2015, GAIT POSTURE, V41, P326, DOI 10.1016/j.gaitpost.2014.10.009; Milner CE, 2006, J BIOMECH, V39, P2819, DOI 10.1016/j.jbiomech.2005.09.022; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745, DOI 10.2106/00004623-198769050-00016; Pamukoff DN, 2016, CLIN BIOMECH, V33, P61, DOI 10.1016/j.clinbiomech.2016.02.007; Pohl MB, 2009, CLIN J SPORT MED, V19, P372, DOI 10.1097/JSM.0b013e3181b8c270; Robertson G, 2013, RES METHODS BIOMECHA; Rodrigues P, 2013, J APPL BIOMECH, V29, P141, DOI 10.1123/jab.29.2.141; Sheerin KR, 2012, PHYS THER SPORT, V13, P250, DOI 10.1016/j.ptsp.2012.01.003; Silva DD, 2015, CLIN BIOMECH, V30, P971, DOI 10.1016/j.clinbiomech.2015.06.021; Specogna Adrian V, 2004, J Knee Surg, V17, P203; Stief F, 2014, KNEE, V21, P688, DOI 10.1016/j.knee.2014.03.004; Stief F, 2011, GAIT POSTURE, V33, P490, DOI 10.1016/j.gaitpost.2011.01.001; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Tweed JL, 2008, J AM PODIAT MED ASSN, V98, P436, DOI 10.7547/0980436; Willems TM, 2006, GAIT POSTURE, V23, P91, DOI 10.1016/j.gaitpost.2004.12.004; Willwacher S, 2016, FOOTWEAR SCI, V8, P1, DOI 10.1080/19424280.2015.1119890; Wolf S, 2008, GAIT POSTURE, V27, P51, DOI 10.1016/j.gaitpost.2007.01.005; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005	52	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185057	10.1371/journal.pone.0185057	http://dx.doi.org/10.1371/journal.pone.0185057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926635	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600065
J	Mei, YJ; Liu, H; Zhang, SX; Yang, M; Hu, C; Zhang, J; Shen, P; Chen, XD				Mei, Yunjun; Liu, Huan; Zhang, Shunxi; Yang, Ming; Hu, Chun; Zhang, Jian; Shen, Ping; Chen, Xiangdong			Effects of salinity on the cellular physiological responses of Natrinema sp.J7-2	PLOS ONE			English	Article							GENE-EXPRESSION DATA; HALOBACTERIUM-SALINARUM NRC-1; EXTREMELY HALOPHILIC BACTERIA; SALT STRESS; RNA-SEQ; ARCHAEA; OSMOADAPTATION; SPECTROSCOPY; ADAPTATION; SURVIVAL	The halophilic archaea (haloarchaea) live in hyersaline environments such as salt lakes, salt ponds and marine salterns. To cope with the salt stress conditions, haloarchaea have developed two fundamentally different strategies: the "salt-in" strategy and the "compatiblesolute" strategy. Although investigation of the molecular mechanisms underlying the tolerance to high salt concentrations has made outstanding achievements, experimental study from the aspect of transcription is rare. In the present study, we monitored cellular physiology of Natrinema sp.J7-2 cells incubated in different salinity media (15%, 25% and 30% NaCl) from several aspects, such as cellular morphology, growth, global transcriptome and the content of intracellular free amino acids. The results showed that the cells were polymorphic and fragile at a low salt concentration (15% NaCl) but had a long, slender rod shape at high salt concentrations (25% and 30% NaCl). The cells grew best in 25% NaCl, mediocre in 30% NaCl and struggled in 15% NaCl. An RNA-seq analysis revealed differentially expressed genes (DEGs) in various salinity media. A total of 1,148 genes were differentially expressed, consisting of 719 DEGs (348 up-regulated and 371 down-regulated genes) between cells in 15% vs 25% NaCl, and 733 DEGs (521 up-regulated and 212 down-regulated genes) between cells in 25% vs 30% NaCl. Moreover, 304 genes were commonly differentially expressed in both 15% vs 25% and 25% vs30% NaCl. The DEGs were enriched in different KEGG metabolic pathways, such as amino acids, glycerolipid, ribosome, nitrogen, protoporphyrin, porphyrin and porhiniods. The intracellular predominant free amino acids consisted of the glutamate family (Glu, Arg and Pro), aspartate family (Asp) and aromatic amino acids (Phe and Trp), especially Glu and Asp.	[Mei, Yunjun; Liu, Huan; Zhang, Shunxi; Yang, Ming; Hu, Chun; Zhang, Jian] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Hubei, Peoples R China; [Shen, Ping; Chen, Xiangdong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Wuhan Polytechnic University; Wuhan University	Mei, YJ (corresponding author), Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Hubei, Peoples R China.; Chen, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	meiyunjun_2000@163.com; xdchen@whu.edu.cn			National Natural Science Foundation of China [31270215, 31570174]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by grants from the National Natural Science Foundation of China (Grants No. 31270215 to Y. Mei and 31570174 to X. Chen), http.//www.nsfc.gov.cn/.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Calo D, 2011, MOL MICROBIOL, V81, P1166, DOI 10.1111/j.1365-2958.2011.07781.x; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Chen Y, 2001, AMINO ACIDS BIOTIC R, V23, P47; Coker James A, 2007, Saline Syst, V3, P6, DOI 10.1186/1746-1448-3-6; da Costa M. S., 1998, V61, P117; Dawson KS, 2012, ORG GEOCHEM, V48, P1, DOI 10.1016/j.orggeochem.2012.04.003; Disalvo EA, 2008, BBA-BIOMEMBRANES, V1778, P2655, DOI 10.1016/j.bbamem.2008.08.025; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Fang SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1287-9; Fendrihan S, 2012, GEOBIOLOGY, V10, P424, DOI 10.1111/j.1472-4669.2012.00337.x; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041621; Ferrer C, 1996, J BACTERIOL, V178, P309, DOI 10.1128/jb.178.1.309-313.1996; Galinski E A, 1995, Adv Microb Physiol, V37, P272, DOI 10.1016/S0065-2911(08)60148-4; Goldstein JI, 1981, SCANNING ELECTRON MI, P495; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Guerzoni ME, 2001, MICROBIOL-SGM, V147, P2255, DOI 10.1099/00221287-147-8-2255; IMHOFF JF, 1984, J BACTERIOL, V160, P478, DOI 10.1128/JB.160.1.478-479.1984; Jensen MW, 2015, EXTREMOPHILES, V19, P315, DOI 10.1007/s00792-014-0716-z; Joghee NN, 2014, BIOCHIMIE, V102, P102, DOI 10.1016/j.biochi.2014.02.015; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kellermann MY, 2016, BBA-BIOMEMBRANES, V1858, P2940, DOI 10.1016/j.bbamem.2016.08.010; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kokoeva MV, 2002, EMBO J, V21, P2312, DOI 10.1093/emboj/21.10.2312; Kurt-Kizildogan A, 2017, GENE, V601, P56, DOI 10.1016/j.gene.2016.11.042; KUSHWAHA SC, 1982, CAN J MICROBIOL, V28, P1365, DOI 10.1139/m82-203; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Leuko S, 2015, ASTROBIOLOGY, V15, P987, DOI 10.1089/ast.2015.1310; Leuko S, 2009, J PROTEOME RES, V8, P2218, DOI 10.1021/pr800663c; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Martin DD, 1999, APPL ENVIRON MICROB, V65, P1815; Mei YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123874; Moran-Reyna Coker JA, 2014, F1000RESEARCH, V3, P168; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Reina-Bueno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033587; ROBERTS MF, 1990, J BIOL CHEM, V265, P18207; Roberts MF, 2004, FRONT BIOSCI-LANDMRK, V9, P1999, DOI 10.2741/1366; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russell N. J., 1993, P163; RUSSELL NJ, 1989, J BIOENERG BIOMEMBR, V21, P93, DOI 10.1007/BF00762214; Shen P, 1994, Yi Chuan Xue Bao, V21, P409; STOECKENIUS W, 1967, J CELL BIOL, V34, P365, DOI 10.1083/jcb.34.1.365; Sun ZN, 2014, ANN APPL STAT, V8, P1022, DOI 10.1214/14-AOAS721; Vauclare P, 2015, EXTREMOPHILES, V19, P1099, DOI 10.1007/s00792-015-0782-x; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Woese CR., 1970, 20 S SOC GEN MICR, P39	50	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184974	10.1371/journal.pone.0184974	http://dx.doi.org/10.1371/journal.pone.0184974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926633	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600057
J	Wilms, T; Khan, G; Coates, PJ; Sgaramella, N; Fahraeus, R; Hassani, A; Philip, PS; Speak, LN; Califano, L; Colella, G; Olofsson, K; Loizou, C; Franco, R; Nylander, K				Wilms, Torben; Khan, Gulfaraz; Coates, Philip J.; Sgaramella, Nicola; Fahraeus, Robin; Hassani, Asma; Philip, Pretty S.; Speak, Lena Norberg; Califano, Luigi; Colella, Giuseppe; Olofsson, Katarina; Loizou, Christos; Franco, Renato; Nylander, Karin			No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue	PLOS ONE			English	Article							SUBTROPICAL ISLAND; SOUTHERN JAPAN; EXPRESSION; INFECTION; EBV; ASSOCIATION; PREVALENCE; PROTEIN; CANCER; HEAD	Squamous cell carcinoma of the head and neck (SCCHN) comprises a large group of cancers in the oral cavity and nasopharyngeal area that typically arise in older males in association with alcohol/tobacco usage. Within the oral cavity, the mobile tongue is the most common site for tumour development. The incidence of tongue squamous cell carcinoma (TSCC) is increasing in younger people, which has been suggested to associate with a viral aetiology. Two common human oncogenic viruses, human papilloma virus (HPV) and Epstein-Barr virus (EBV) are known causes of certain types of SCCHN, namely the oropharynx and nasopharynx, respectively. EBV infects most adults worldwide through oral transmission and establishes a latent infection, with sporadic productive viral replication and release of virus in the oral cavity throughout life. In view of the prevalence of EBV in the oral cavity and recent data indicating that it infects tongue epithelial cells and establishes latency, we examined 98 cases of primary squamous cell carcinoma of the mobile tongue and 15 cases of tonsillar squamous cell carcinoma for the presence of EBV-encoded RNAs (EBERs), EBV DNA and an EBV-encoded protein, EBNA-1. A commercially available in situ hybridisation kit targeting EBER transcripts (EBER-ISH) showed a positive signal in the cytoplasm and/or nuclei of tumour cells in 43% of TSCCs. However, application of control probes and RNase A digestion using in-house developed EBER-ISH showed identical EBER staining patterns, indicating non-specific signals. PCR analysis of the BamH1 W repeat sequences did not identify EBV genomes in tumour samples. Immunohistochemistry for EBNA-1 was also negative. These data exclude EBV as a potential player in TSCC in both old and young patients and highlight the importance of appropriate controls for EBER-ISH in investigating EBV in human diseases.	[Wilms, Torben; Speak, Lena Norberg; Olofsson, Katarina; Loizou, Christos] Umea Univ, Dept Clin Sci ENT, Umea, Sweden; [Khan, Gulfaraz; Hassani, Asma; Philip, Pretty S.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Med Microbiol & Immunol, Tawam Hosp Campus, Al Ain, U Arab Emirates; [Coates, Philip J.; Fahraeus, Robin] Masaryk Mem Canc Inst, RECAMO, Zluty Kopec 7, Brno, Czech Republic; [Sgaramella, Nicola; Fahraeus, Robin; Nylander, Karin] Umea Univ, Dept Med Biosci, Umea, Sweden; [Fahraeus, Robin] Univ Paris Diderot, INSERM, UMRS1162, 27 Rue Juliette Dodu, Paris, France; [Califano, Luigi] Univ Naples Federico II, Dept Neurosci Reprod & Dent Sci, Naples, Italy; [Colella, Giuseppe] Univ Naples 2, Multidisciplinary Dept Med Surg & Dent Specialtie, Naples, Italy; [Franco, Renato] Univ Naples 2, Dipartimento Univ Anat Patol, Naples, Italy	Umea University; United Arab Emirates University; Masaryk Memorial Cancer Institute; Umea University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Naples Federico II; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Wilms, T (corresponding author), Umea Univ, Dept Clin Sci ENT, Umea, Sweden.; Nylander, K (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	Torben.wilms@vll.se; karin.nylander@umu.se	Loizou, Christos/S-1657-2019; Khan, Gulfaraz/AAC-2859-2022; Coates, Philip J/H-6854-2019; fahraeus, robin/K-8726-2014	Loizou, Christos/0000-0003-1247-8573; Khan, Gulfaraz/0000-0001-6836-1783; Coates, Philip J/0000-0003-1518-6306; , robin/0000-0003-0402-8492; Hassani, Asma/0000-0001-7792-2140	Lion's Cancer Research Foundation; Swedish Cancer Society [160336]; Vasterbotten County Council; Umea University; GACR [P206/12/G151]; UAEU [31M263, 31R090];  [MEYS-NPSI-L01413]	Lion's Cancer Research Foundation; Swedish Cancer Society(Swedish Cancer Society); Vasterbotten County Council; Umea University; GACR(Grant Agency of the Czech Republic); UAEU; 	This work was supported by Lion's Cancer Research Foundation, Umea University; the Swedish Cancer Society Contract number 160336; Vasterbotten County Council; Umea University; MEYS-NPSI-L01413; GACR P206/12/G151; and UAEU grants 31M263 and 31R090.; This study was supported by grants from Lion's Cancer Research Foundation, Umea. University; the Swedish Cancer Society Contract number 160336; Vasterbotten County Council; Umea. University; MEYS-NPSI-L01413; GACR P206/12/G151; and UAEU grants 31M263 and 31R090 awarded to GK.	Acharya S, 2015, J ORAL PATHOL MED, V44, P252, DOI 10.1111/jop.12231; Ahmed W, 2014, REV MED VIROL, V24, P3, DOI 10.1002/rmv.1763; CHEUNG A, 1982, J VIROL, V44, P286, DOI 10.1128/JVI.44.1.286-294.1982; COATES PJ, 1991, J CLIN PATHOL, V44, P115, DOI 10.1136/jcp.44.2.115; Cruz I, 1997, ORAL ONCOL, V33, P182, DOI 10.1016/S0964-1955(96)00054-1; Cruz I, 2000, INT J CANCER, V86, P356, DOI 10.1002/(SICI)1097-0215(20000501)86:3&lt;356::AID-IJC9&gt;3.0.CO;2-W; Daskalogianni C, 2015, J PATHOL, V235, P334, DOI 10.1002/path.4431; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Gillison ML, 2015, J CLIN ONCOL, V33, P3235, DOI 10.1200/JCO.2015.61.6995; Gondivkar SM, 2012, ORAL ONCOL, V48, P195, DOI 10.1016/j.oraloncology.2011.10.007; Gonzalez-Moles MA, 2002, LARYNGOSCOPE, V112, P482, DOI 10.1097/00005537-200203000-00014; Hassani A, 2015, EXP MOL PATHOL, V99, P558, DOI 10.1016/j.yexmp.2015.09.013; Hermann R M, 2004, Cancer Radiother, V8, P262, DOI 10.1016/j.canrad.2004.06.003; Higa M, 2003, ORAL ONCOL, V39, P405, DOI 10.1016/S1368-8375(02)00164-1; Higa M, 2002, J CLIN PATHOL, V55, P414, DOI 10.1136/jcp.55.6.414; Hutt-Fletcher LM, 2017, J VIROL, V91, DOI 10.1128/JVI.01677-16; Jiang R, 2012, ORAL ONCOL, V48, P836, DOI 10.1016/j.oraloncology.2012.03.017; Khammissa RAG, 2016, INT J DENT, V2016, DOI 10.1155/2016/4941783; KHAN G, 1992, AM J PATHOL, V140, P757; KHAN G, 1992, J CLIN PATHOL, V45, P616, DOI 10.1136/jcp.45.7.616; Khan G, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0260-1; Khan Gulfaraz, 2009, V511, P311, DOI 10.1007/978-1-59745-447-6_13; Kikuchi K, 2016, TUMOR BIOL, V37, P3389, DOI 10.1007/s13277-015-4167-7; Kis A, 2009, EUR J ORAL SCI, V117, P536, DOI 10.1111/j.1600-0722.2009.00660.x; Kobayashi I, 1999, J PATHOL, V189, P34, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;34::AID-PATH391&gt;3.0.CO;2-4; Lee N, 2016, P NATL ACAD SCI USA, V113, P3221, DOI 10.1073/pnas.1601773113; Llewellyn CD, 2001, ORAL ONCOL, V37, P401, DOI 10.1016/S1368-8375(00)00135-4; Loizou C, 2015, ONCOL LETT, V10, P3565, DOI 10.3892/ol.2015.3775; Longnecker R, 2013, FIELDS VIROLOGY, V2, P1898; Metgud R, 2012, ONCOL REV, V6, P164, DOI 10.4081/oncol.2012.e21; Nawandar DM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005195; NIEDOBITEK G, 1991, J GEN VIROL, V72, P3035, DOI 10.1099/0022-1317-72-12-3035; Patel SC, 2011, J CLIN ONCOL, V29, P1488, DOI 10.1200/JCO.2010.31.7883; Prabhu SR, 2016, J CAN DENT ASSOC, V82; Sand L, 2014, MICROBES INFECT, V16, P371, DOI 10.1016/j.micinf.2014.02.009; Sgaramella N, 2015, BRIT J CANCER, V113, P321, DOI 10.1038/bjc.2015.207; Shamaa AA, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-45; Shimakage M, 2002, HUM PATHOL, V33, P608, DOI 10.1053/hupa.2002.129786; Tota JE, 2017, ORAL ONCOL, V67, P146, DOI 10.1016/j.oraloncology.2017.02.019; Tsao SW, 2015, J PATHOL, V235, P323, DOI 10.1002/path.4448; Vockerodt M, 2015, J PATHOL, V235, P312, DOI 10.1002/path.4459; Young LS, 2016, NAT REV CANCER, V16, P789, DOI 10.1038/nrc.2016.92; YOUNG LS, 1991, J VIROL, V65, P2868, DOI 10.1128/JVI.65.6.2868-2874.1991	43	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184201	10.1371/journal.pone.0184201	http://dx.doi.org/10.1371/journal.pone.0184201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926591	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600011
J	Entenmann, L; Pietzner, M; Artati, A; Hannemann, A; Henning, AK; Kastenmuller, G; Volzke, H; Nauck, M; Adamski, J; Wallaschofski, H; Friedrich, N				Entenmann, Lukas; Pietzner, Maik; Artati, Anna; Hannemann, Anke; Henning, Ann-Kristin; Kastenmueller, Gabi; Voelzke, Henry; Nauck, Matthias; Adamski, Jerzy; Wallaschofski, Henri; Friedrich, Nele			Comprehensive metabolic characterization of serum osteocalcin action in a large non-diabetic sample	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OSTEOBLAST-LIKE CELLS; BONE-MINERAL DENSITY; GENERAL-POPULATION; FUNCTIONAL-ROLE; INSULIN; EXPRESSION; FRACTURE; RECEPTOR; MASS	Recent research suggested a metabolic implication of osteocalcin (OCN) in e.g. insulin sensitivity or steroid production. We used an untargeted metabolomics approach by analyzing plasma and urine samples of 931 participants using mass spectrometry to reveal further metabolic actions of OCN. Several detected relations between OCN and metabolites were strongly linked to renal function, however, a number of associations remained significant after adjustment for renal function. Intermediates of proline catabolism were associated with OCN reflecting the implication in bone metabolism. The association to kynurenine points towards a pro-inflammatory state with increasing OCN. Inverse relations with intermediates of branch-chained amino acid metabolism suggest a link to energy metabolism. Finally, urinary surrogate markers of smoking highlight its adverse effect on OCN metabolism. In conclusion, the present study provides a read-out of metabolic actions of OCN. However, most of the associations were weak arguing for a limited role of OCN in whole-body metabolism.	[Entenmann, Lukas; Pietzner, Maik; Hannemann, Anke; Henning, Ann-Kristin; Nauck, Matthias; Wallaschofski, Henri; Friedrich, Nele] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Artati, Anna; Adamski, Jerzy] Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [Kastenmueller, Gabi] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Nauck, Matthias; Friedrich, Nele] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [Adamski, Jerzy] German Ctr Diabet Res DZD, Munich, Germany; [Wallaschofski, Henri] Schwerpunktpraxis Diabet & Hormonerkrankungen, Erfurt, Germany; [Friedrich, Nele] Res Ctr Prevent & Hlth, Glostrup, Denmark	Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; German Centre for Cardiovascular Research; Technical University of Munich	Friedrich, N (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.; Friedrich, N (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany.; Friedrich, N (corresponding author), Res Ctr Prevent & Hlth, Glostrup, Denmark.	nele.friedrich@uni-greifswald.de	Kastenmüller, Gabi/ABF-5987-2020	Kastenmuller, Gabi/0000-0002-2368-7322; Adamski, Jerzy/0000-0001-9259-0199; Pietzner, Maik/0000-0003-3437-9963	German Federal Ministry of Education and Research (BMBF) [01ZZ0403, 01ZZ0103, 01G10883, 031S2061B]; Ministry for Education, Research and Cultural Affairs; Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania [03152061A]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Research and Cultural Affairs; Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania	This work was funded by grants from the German Federal Ministry of Education and Research (BMBF, grants 01ZZ0403, 01ZZ0103, 01G10883, AtheroSysMed 031S2061B), the Ministry for Education, Research and Cultural Affairs, as well as the Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania. This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (03152061A).	Apalset EM, 2014, CLIN EXP IMMUNOL, V176, P452, DOI 10.1111/cei.12288; Bictash M, 2010, J CLIN EPIDEMIOL, V63, P970, DOI 10.1016/j.jclinepi.2009.10.001; Blum M, 2002, OSTEOPOROSIS INT, V13, P663, DOI 10.1007/s001980200090; Clemmensen C, 2014, BRIT J PHARMACOL, V171, P1129, DOI 10.1111/bph.12365; Colak O, 2002, CLIN BIOCHEM, V35, P247, DOI 10.1016/S0009-9120(02)00301-6; De Toni L, 2014, ENDOCRINOLOGY, V155, P4266, DOI 10.1210/en.2014-1283; El Refaey M, 2015, MOL CELL ENDOCRINOL, V410, P87, DOI 10.1016/j.mce.2015.01.034; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FARRUGIA W, 1991, J ENDOCRINOL, V130, P213, DOI 10.1677/joe.0.1300213; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gao JY, 2016, EUR J PHARMACOL, V777, P41, DOI 10.1016/j.ejphar.2016.02.060; Gu F, 2015, INT J EPIDEMIOL; Hallen A, 2013, AMINO ACIDS, V45, P1249, DOI 10.1007/s00726-013-1590-1; Hallstrom H, 2013, AM J EPIDEMIOL, V178, P898, DOI 10.1093/aje/kwt062; Hannemann A, 2013, ANDROLOGY-US, V1, P469, DOI 10.1111/j.2047-2927.2012.00044.x; Husek P, 2008, CLIN CHEM LAB MED, V46, P1391, DOI 10.1515/CCLM.2008.259; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Ivaska KK, 2004, J BIOL CHEM, V279, P18361, DOI 10.1074/jbc.M314324200; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Jegatheesan P, 2016, BRIT J NUTR, V116, P191, DOI 10.1017/S0007114516001793; Kalaiselvi VS, 2013, J CLIN DIAGN RES, V7, P814, DOI 10.7860/JCDR/2013/5370.2946; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Linhart I, 1996, TOXICOL APPL PHARM, V136, P155, DOI 10.1006/taap.1996.0019; MacPherson H, 1999, BONE, V24, P179, DOI 10.1016/S8756-3282(98)00173-2; Mochida T, 2011, MOL GENET METAB, V103, P406, DOI 10.1016/j.ymgme.2011.05.002; Pi M, 2016, ENDOCRINOLOGY, V157, P1866, DOI 10.1210/en.2015-2010; RIANCHO JA, 1995, J BONE MINER RES, V10, P439; Rothwell JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093474; Sailer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063950; Sekula P, 2016, J AM SOC NEPHROL, V27, P1175, DOI 10.1681/ASN.2014111099; Shu H, 2016, DIABETES METAB RES R; Singh S, 2015, J CLIN DIAGN RES, V9, pRC4, DOI 10.7860/JCDR/2015/14857.6318; Sprini D, 2014, CLIN CASES MINER BON, V11, P117, DOI 10.11138/ccmbm/2014.11.2.117; Szulc P, 2002, J CLIN ENDOCR METAB, V87, P666, DOI 10.1210/jc.87.2.666; Tomlinson RE, 2014, J APPL PHYSIOL, V116, P416, DOI 10.1152/japplphysiol.00957.2013; Torricelli P, 2002, BIOMED PHARMACOTHER, V56, P492, DOI 10.1016/S0753-3322(02)00287-1; Vidal C, 2015, STEM CELLS, V33, P111, DOI 10.1002/stem.1836; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Yazdanpanah N, 2007, BONE, V41, P987, DOI 10.1016/j.bone.2007.08.021; Yi JR, 2016, ARCH ORAL BIOL, V64, P51, DOI 10.1016/j.archoralbio.2015.12.009; Yoon V, 2012, OSTEOPOROSIS INT, V23, P2081, DOI 10.1007/s00198-012-1940-y; Yoshitomi H, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0706-4; Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046	45	1	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184721	10.1371/journal.pone.0184721	http://dx.doi.org/10.1371/journal.pone.0184721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922389	Green Submitted, Green Published, gold			2022-12-27	WOS:000411059300024
J	Jeeva, S; Pador, S; Voss, B; Ganaie, SS; Mir, MA				Jeeva, Subbiah; Pador, Sean; Voss, Brittany; Ganaie, Safder Saieed; Mir, Mohammad Ayoub			Crimean-Congo hemorrhagic fever virus nucleocapsid protein has dual RNA binding modes	PLOS ONE			English	Article							LA-CROSSE VIRUS; NUCLEOPROTEIN REVEALS; GLYCOPROTEINS GN; UUKUNIEMI VIRUS; TAIL DOMAINS; 5' TERMINUS; S-SEGMENT; CAP; REPLICATION; PANHANDLE	Crimean Congo hemorrhagic fever, a zoonotic viral disease, has high mortality rate in humans. There is currently no vaccine for Crimean Congo hemorrhagic fever virus (CCHFV) and chemical interventions are limited. The three negative sense genomic RNA segments of CCHFV are specifically encapsidated by the nucleocapsid protein into three ribonucleocapsids, which serve as templates for the viral RNA dependent RNA polymerase. Here we demonstrate that CCHFV nucleocapsid protein has two distinct binding modes for double and single strand RNA. In the double strand RNA binding mode, the nucleocapsid protein preferentially binds to the vRNA panhandle formed by the base pairing of complementary nucleotides at the 5' and 3' termini of viral genome. The CCHFV nucleocapsid protein does not have RNA helix unwinding activity and hence does not melt the duplex vRNA panhandle after binding. In the single strand RNA binding mode, the nucleocapsid protein does not discriminate between viral and non-viral RNA molecules. Binding of both vRNA panhandle and single strand RNA induce a conformational change in the nucleocapsid protein. Nucleocapsid protein remains in a unique conformational state due to simultaneously binding of structurally distinct vRNA panhandle and single strand RNA substrates. Although the role of dual RNA binding modes in the virus replication cycle is unknown, their involvement in the packaging of viral genome and regulation of CCHFV replication in conjunction with RdRp and host derived RNA regulators is highly likely.	[Jeeva, Subbiah; Pador, Sean; Voss, Brittany; Ganaie, Safder Saieed; Mir, Mohammad Ayoub] Western Univ Hlth Sci, Pomona, CA 91766 USA	Western University of Health Sciences	Mir, MA (corresponding author), Western Univ Hlth Sci, Pomona, CA 91766 USA.	mmir@westernu.edu	Ganaie, Safder/AAH-5010-2020; Ganaie, Safder/AAB-8857-2022		internal grant (WUCVMMIR) from the College of Veterinary Medicine, Western University of Health Sciences; College of Veterinary Medicine	internal grant (WUCVMMIR) from the College of Veterinary Medicine, Western University of Health Sciences; College of Veterinary Medicine	This work was supported by the internal grant (WUCVMMIR) from the College of Veterinary Medicine, Western University of Health Sciences.; This work was supported by the internal grant support from the College of Veterinary Medicine. The authors would like thank Dr. Griffon (Associate dean for research) for continuous support, especially for supporting the purchase of BLITZ instrument used in this work. All authors read the manuscript before submitting for publication.	Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12; Cheng E, 2014, J VIROL; Cheng E, 2012, J VIROL, V86, P10173, DOI 10.1128/JVI.05560-11; Cheng E, 2011, J BIOL CHEM, V286, P11814, DOI 10.1074/jbc.M110.210179; Elliot R.M., 2000, VIRUS TAXONOMY, P599; Flick R, 2002, J VIROL, V76, P10849, DOI 10.1128/JVI.76.21.10849-10860.2002; Ganaie SS, 2014, BIOCH J; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; GOTT P, 1993, VIROLOGY, V194, P332, DOI 10.1006/viro.1993.1263; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P19365, DOI 10.1073/pnas.1108515108; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Hepojoki J, 2010, J GEN VIROL, V91, P2341, DOI 10.1099/vir.0.021006-0; HEWLETT MJ, 1977, J VIROL, V21, P1085, DOI 10.1128/JVI.21.3.1085-1093.1977; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; Lakowitcz J.R, 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6_8; Macleod JML, 2015, J GEN VIROL, V96, P524, DOI 10.1099/vir.0.071332-0; Mir MA, 2006, J VIROL, V80, P6276, DOI 10.1128/JVI.00147-06; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; Mir MA, 2006, RNA, V12, P272, DOI 10.1261/rna.2101906; Mir MA, 2005, J VIROL, V79, P1824, DOI 10.1128/JVI.79.3.1824-1835.2005; Mir MA, 2001, BIOCHEMISTRY-US, V40, P11578, DOI 10.1021/bi010731r; Mir MA, 2010, J BIOL CHEM, V285, P11357, DOI 10.1074/jbc.M110.102459; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Mourya DT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001653; OBIJESKI JF, 1976, J VIROL, V19, P985, DOI 10.1128/JVI.19.3.985-997.1976; Osborne JC, 2000, J VIROL, V74, P9946, DOI 10.1128/JVI.74.21.9946-9952.2000; Palmenberg AC, 1997, SEMIN VIROL, V8, P231, DOI 10.1006/smvy.1997.0126; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; RAJU R, 1989, J VIROL, V63, P122, DOI 10.1128/JVI.63.1.122-128.1989; Ribeiro D, 2009, VIROLOGY, V383, P121, DOI 10.1016/j.virol.2008.09.028; Richmond KE, 1998, VIROLOGY, V248, P6, DOI 10.1006/viro.1998.9223; Salim NN, 2016, J BIOL CHEM, V291, P24702, DOI 10.1074/jbc.M116.750729; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; Severson W, 1999, J BIOL CHEM, V274, P33732, DOI 10.1074/jbc.274.47.33732; Severson WE, 2001, J VIROL, V75, P2646, DOI 10.1128/JVI.75.6.2646-2652.2001; Shi XH, 2007, J VIROL, V81, P10151, DOI 10.1128/JVI.00573-07; Stefan MI, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003106; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; Swanepoel R., 1994, INFECT DIS LIVESTOCK, P723; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Yu Guo WW, 2012, PNAS, V109, P5046	45	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184935	10.1371/journal.pone.0184935	http://dx.doi.org/10.1371/journal.pone.0184935			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922369	Green Submitted, gold, Green Published			2022-12-27	WOS:000411059300047
J	Kuehner, C; Welz, A; Reinhard, I; Alpers, GW				Kuehner, Christine; Welz, Annett; Reinhard, Iris; Alpers, Georg W.			Lab meets real life: A laboratory assessment of spontaneous thought and its ecological validity	PLOS ONE			English	Article							DOMAIN CRITERIA RDOC; WANDERING MIND; PERSEVERATIVE COGNITION; AMBULATORY ASSESSMENT; DEFAULT NETWORK; NEGATIVE AFFECT; GERMAN VERSION; RUMINATION; MINDFULNESS; DEPRESSION	People's minds frequently wander towards self-generated thoughts, which are unrelated to external stimuli or demands. These phenomena, referred to as "spontaneous thought" (ST) and "mind wandering" (MW), have previously been linked with both costs and benefits. Current assessments of ST and MW have predominantly been conducted in the laboratory, whereas studies on the ecological validity of such lab-related constructs and their interrelations are rare. The current study examined the stability of ST dimensions assessed in the lab and their predictive value with respect to MW, repetitive negative thought (uncontrollable rumination, RUM), and affect in daily life. Forty-three university students were assessed with the Amsterdam Resting State Questionnaire (2nd version) to assess ten ST dimensions during the resting state in two laboratory sessions, which were separated by five days of electronic ambulatory assessment (AA). During AA, individuals indicated the intensity of MW and RUM, as well as of positive and negative affect in daily life ten times a day. ST dimensions measured in the lab were moderately stable across one week. Five out of ten ST lab dimensions were predicted by mental health-related symptoms or by dispositional cognitive traits. Hierarchical linear models revealed that a number of ST lab dimensions predicted cognitive and affective states in daily life. Mediation analyses showed that RUM, but not MW per se, accounted for the relationship between specific ST lab dimensions and mood in daily life. By using a simple resting state task, we could demonstrate that a number of lab dimensions of spontaneous thought are moderately stable, are predicted by mental health symptoms and cognitive traits, and show plausible associations with categories of self-generated thought and mood in daily life.	[Kuehner, Christine; Welz, Annett] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Res Grp Longitudinal & Intervent Res,Dept Psychia, Mannheim, Germany; [Reinhard, Iris] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Biostat, Mannheim, Germany; [Alpers, Georg W.] Univ Mannheim, Dept Psychol, Sch Social Sci, Mannheim, Germany; [Alpers, Georg W.] Univ Mannheim, Otto Selz Inst, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Mannheim; University of Mannheim	Kuehner, C (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Res Grp Longitudinal & Intervent Res,Dept Psychia, Mannheim, Germany.	Christine.Kuehner@zi-mannheim.de		Kuehner, Christine/0000-0002-6185-5534; Alpers, Georg W./0000-0001-9896-5158	German Research Foundation [KU1464/4-1,2]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (KU1464/4-1,2).	Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Andrews-Hanna JR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00900; Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Braboszcz C, 2011, NEUROIMAGE, V54, P3040, DOI 10.1016/j.neuroimage.2010.10.008; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Bylsma LM, 2011, J ABNORM PSYCHOL, V120, P155, DOI 10.1037/a0021662; Carciofo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091285; Chiesa A, 2010, PSYCHOL MED, V40, P1239, DOI 10.1017/S0033291709991747; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cloninger CR, 2006, WORLD PSYCHIATRY, V5, P71; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Diaz BA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00492; Diaz BA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00271; Diaz B Alexander, 2013, Front Hum Neurosci, V7, P446, DOI 10.3389/fnhum.2013.00446; Gruberger M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00056; Hautzinger MB M, 2012, ALLGEMEINE DESPRESSI; Holmes EA, 2016, ANNU REV CLIN PSYCHO, V12, P249, DOI 10.1146/annurev-clinpsy-021815-092925; Huffziger S, 2013, PSYCHONEUROENDOCRINO, V38, P2258, DOI 10.1016/j.psyneuen.2013.04.014; Huffziger S, 2012, Z KL PSYCH PSYCHOTH, V41, P38, DOI 10.1026/1616-3443/a000118; Huffziger S, 2009, J ABNORM PSYCHOL, V118, P746, DOI 10.1037/a0016946; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Kane MJ, PSYCHOL SCI IN PRESS; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Konjedi S, 2017, COGN AFFECT BEHAV NE, V17, P697, DOI 10.3758/s13415-017-0506-z; Kragel PA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000106; Kuehner C, 2017, LANCET PSYCHIAT, V4, P146, DOI 10.1016/S2215-0366(16)30263-2; Laux L, 1981, THEORETISCHE GRUNDLA; Lyubomirsky S, 2015, ANNU REV CLIN PSYCHO, V11, P1, DOI 10.1146/annurev-clinpsy-032814-112733; Marchetti A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01855; Marchetti I, 2016, CLIN PSYCHOL SCI, V4, P835, DOI 10.1177/2167702615622383; Marchetti I, 2013, CLIN PSYCHOL SCI, V1, P443, DOI 10.1177/2167702613489668; Marchetti I, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00131; Marchetti I, 2012, CONSCIOUS COGN, V21, P1517, DOI 10.1016/j.concog.2012.05.013; Marcusson-Clavertz D, 2016, J EXP PSYCHOL LEARN, V42, P451, DOI 10.1037/xlm0000180; Mason MF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00477; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; McVay JC, 2009, PSYCHON B REV, V16, P857, DOI 10.3758/PBR.16.5.857; Michalak J, 2008, Z KL PSYCH PSYCHOTH, V37, P200, DOI 10.1026/1616-3443.37.3.200; Moberly NJ, 2008, J ABNORM PSYCHOL, V117, P314, DOI 10.1037/0021-843X.117.2.314; Mrazek MD, 2012, EMOTION, V12, P442, DOI 10.1037/a0026678; Nezlek JB, 2005, J PERS, V73, P1539, DOI 10.1111/j.1467-6494.2005.00358.x; Nolen-Hoeksema S, 2011, PERSPECT PSYCHOL SCI, V6, P589, DOI 10.1177/1745691611419672; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Ottaviani C, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00433; Ottaviani C, 2015, BIOL PSYCHOL, V107, P24, DOI 10.1016/j.biopsycho.2015.02.011; Ottaviani C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00524; Ottaviani C, 2013, BIOL PSYCHOL, V94, P38, DOI 10.1016/j.biopsycho.2013.05.003; Pipinis E, 2017, BRAIN TOPOGR, V30, P245, DOI 10.1007/s10548-016-0522-2; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raes F, 2008, COGNITIVE THER RES, V32, P526, DOI 10.1007/s10608-007-9137-y; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Ruby FJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077554; Seli P, 2016, TRENDS COGN SCI, V20, P605, DOI 10.1016/j.tics.2016.05.010; Seli P, 2016, PSYCHOL SCI, V27, P685, DOI 10.1177/0956797616634068; Smallwood J, 2004, CONSCIOUS COGN, V13, P789, DOI 10.1016/j.concog.2004.07.004; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2015, ANNU REV PSYCHOL, V66, P487, DOI 10.1146/annurev-psych-010814-015331; Smallwood J, 2013, PSYCHOL BULL, V139, P519, DOI 10.1037/a0030010; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; Stoffers D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142014; Timm C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178759; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Trull TJ, 2013, ANNU REV CLIN PSYCHO, V9, P151, DOI 10.1146/annurev-clinpsy-050212-185510; Tusche A, 2014, NEUROIMAGE, V97, P107, DOI 10.1016/j.neuroimage.2014.03.076; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weber R, 2012, COMMUN METHODS MEAS, V6, P190, DOI 10.1080/19312458.2012.703834; Woody ML, 2015, CURR OPIN PSYCHOL, V4, P6, DOI 10.1016/j.copsyc.2015.01.004; Zamoscik V, 2014, SOC COGN AFFECT NEUR, V9, P2034, DOI 10.1093/scan/nsu006	73	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184488	10.1371/journal.pone.0184488	http://dx.doi.org/10.1371/journal.pone.0184488			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910351	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200050
J	Lin, Q; Liang, JR; Huang, QQ; Luo, CS; Anderson, DM; Bowler, C; Chen, CP; Li, XS; Gao, YH				Lin, Qun; Liang, Jun-Rong; Huang, Qian-Qian; Luo, Chun-Shan; Anderson, Donald M.; Bowler, Chris; Chen, Chang-Ping; Li, Xue-Song; Gao, Ya-Hui			Differential cellular responses associated with oxidative stress and cell fate decision under nitrate and phosphate limitations in Thalassiosira pseudonana: Comparative proteomics	PLOS ONE			English	Article							MARINE DIATOM; PHOTOSYSTEM-II; HIGHER-PLANTS; DEATH; NITROGEN; PROTEIN; PHOSPHORUS; PHYTOPLANKTON; INSIGHTS; OXIDASE	Diatoms are important components of marine ecosystems and contribute greatly to the world's primary production. Despite their important roles in ecosystems, the molecular basis of how diatoms cope with oxidative stress caused by nutrient fluctuations remains largely unknown. Here, an isobaric tags for relative and absolute quantitation (iTRAQ) proteomic method was coupled with a series of physiological and biochemical techniques to explore oxidative stress- and cell fate decision-related cellular and metabolic responses of the diatom Thalassiosira pseudonana to nitrate (N) and inorganic phosphate (P) stresses. A total of 1151 proteins were detected; 122 and 56 were significantly differentially expressed from control under N- and P-limited conditions, respectively. In N- limited cells, responsive proteins were related to reactive oxygen species (ROS) accumulation, oxidative stress responses and cell death, corresponding to a significant decrease in photosynthetic efficiency, marked intracellular ROS accumulation, and caspase-mediated programmed cell death activation. None of these responses were identified in P-limited cells; however, a significant up-regulation of alkaline phosphatase proteins was observed, which could be the major contributor for P-limited cells to cope with ambient P deficiency. These findings demonstrate that fundamentally different metabolic responses and cellular regulations are employed by the diatom in response to different nutrient stresses and to keep the cells viable.	[Lin, Qun] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Peoples R China; [Lin, Qun; Liang, Jun-Rong; Huang, Qian-Qian; Luo, Chun-Shan; Chen, Chang-Ping; Li, Xue-Song; Gao, Ya-Hui] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Liang, Jun-Rong; Chen, Chang-Ping; Gao, Ya-Hui] Xiamen Univ, Minist Educ, Key Lab Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Anderson, Donald M.] Woods Hole Oceanog Inst, Biol Dept, Woods Hole, MA 02543 USA; [Bowler, Chris] CNRS, INSERM, Ecol & Evolutionary Biol Sect, Ecole Normale Super,UMR8197,U1024,IBENS, 46 Rue Ulm, Paris, France	Xiamen University; Xiamen University; Xiamen University; Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Liang, JR (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China.; Liang, JR (corresponding author), Xiamen Univ, Minist Educ, Key Lab Coastal & Wetland Ecosyst, Xiamen, Peoples R China.	sunljr@xmu.edu.cn	Bowler, Chris/AAC-6256-2019; Chen, Changping/AAU-4352-2020	Chen, Changping/0000-0002-3332-2458; Bowler, Chris/0000-0003-3835-6187	National Natural Science Foundation of China [41576138, 41076080]; Woods Hole Center for Oceans and Human Health, National Science Foundation [OCE-1314642]; National Institute of Environmental Health Sciences [1-P01-ES021923-01]; ERC; ANR project DiaDomOil; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021923] Funding Source: NIH RePORTER; Division Of Ocean Sciences [1314642] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Woods Hole Center for Oceans and Human Health, National Science Foundation; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ERC(European Research Council (ERC)European Commission); ANR project DiaDomOil(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded by the National Natural Science Foundation of China (41576138, 41076080, 41576138) to Dr. un-Rong Liang; the Woods Hole Center for Oceans and Human Health, National Science Foundation (OCE-1314642) to Dr. Donald M Anderson; the National Institute of Environmental Health Sciences (1-P01-ES021923-01) to Dr. Donald M Anderson; and the ERC Advanced Award Diatomite and ANR project DiaDomOil to Dr. Chris Bowler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Bidle KD, 2015, ANNU REV MAR SCI, V7, P341, DOI 10.1146/annurev-marine-010213-135014; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Brussaard CPD, 1997, J PHYCOL, V33, P980, DOI 10.1111/j.0022-3646.1997.00980.x; BRUSSAARD CPD, 1995, MAR ECOL PROG SER, V123, P259, DOI 10.3354/meps123259; Casotti R, 2005, J PHYCOL, V41, P7, DOI 10.1111/j.1529-8817.2005.04052.x; CEMBELLA AD, 1984, CRC CR REV MICROBIOL, V10, P317; Chung CC, 2005, APPL ENVIRON MICROB, V71, P8744, DOI 10.1128/AEM.71.12.8744-8751.2005; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; Cooper MS, 2010, J BIOSCI BIOENG, V109, P198, DOI 10.1016/j.jbiosc.2009.08.004; Cormann KU, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00157; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; de Carvalho MHC, 2016, NEW PHYTOL, V210, P497, DOI 10.1111/nph.13787; Ding D, 2007, BIOCHEM BIOPH RES CO, V361, P629, DOI 10.1016/j.bbrc.2007.07.072; Du C, 2014, J PROTEOME RES, V13, P720, DOI 10.1021/pr400803w; Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768; Feng HQ, 2013, ACTA BIOCH BIOPH SIN, V45, P985, DOI 10.1093/abbs/gmt094; GAGE MA, 1985, FRESHWATER BIOL, V15, P227, DOI 10.1111/j.1365-2427.1985.tb00195.x; Hirst J, 2005, BIOCHEM SOC T, V33, P525, DOI 10.1042/BST0330525; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Ivancic I, 2016, PROG OCEANOGR, V146, P175, DOI 10.1016/j.pocean.2016.07.003; JANSSON M, 1988, HYDROBIOLOGIA, V170, P157, DOI 10.1007/BF00024903; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Lauritano C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1574-5; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Li PF, 2013, NITRIC OXIDE-BIOL CH, V33, P88, DOI 10.1016/j.niox.2013.06.007; Li SJ, 2013, J BIOTECHNOL, V168, P1, DOI 10.1016/j.jbiotec.2013.08.003; Liang JR, 2013, J APPL PHYCOL, V25, P477, DOI 10.1007/s10811-012-9881-6; Liu HJ, 2011, P NATL ACAD SCI USA, V108, P18536, DOI 10.1073/pnas.1111597108; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Luo CS, 2014, J PROTEOME RES, V13, P5510, DOI 10.1021/pr5004664; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Meyer Y, 1999, TRENDS PLANT SCI, V4, P388, DOI 10.1016/S1360-1385(99)01475-2; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nedelcu AM, 2009, J MOL EVOL, V68, P256, DOI 10.1007/s00239-009-9201-1; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nunn BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075653; Orefice I, 2015, MAR GENOM, V24, P81, DOI 10.1016/j.margen.2015.06.008; Ou LJ, 2014, J SEA RES, V85, P499, DOI 10.1016/j.seares.2013.08.005; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Qiao JJ, 2012, J PROTEOME RES, V11, P5286, DOI 10.1021/pr300504w; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Rosenwasser S, 2014, P NATL ACAD SCI USA, V111, P2740, DOI 10.1073/pnas.1319773111; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Segovia M, 2003, PLANT PHYSIOL, V132, P99, DOI 10.1104/pp.102.017129; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Thamatrakoln K, 2012, ENVIRON MICROBIOL, V14, P67, DOI 10.1111/j.1462-2920.2011.02468.x; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Creveld SG, 2015, ISME J, V9, P385, DOI 10.1038/ismej.2014.136; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Wang HF, 2018, J X-RAY SCI TECHNOL, V26, P171, DOI 10.3233/XST-17302; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yang ZK, 2014, J APPL PHYCOL, V26, P73, DOI 10.1007/s10811-013-0050-3; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	75	13	14	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184849	10.1371/journal.pone.0184849	http://dx.doi.org/10.1371/journal.pone.0184849			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910417	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200107
J	Mogull, SA				Mogull, Scott A.			Accuracy of cited "facts" in medical research articles: A review of study methodology and recalculation of quotation error rate	PLOS ONE			English	Review							GOOGLE SCHOLAR; ORTHOPEDIC LITERATURE; LITERATURE SEARCHES; SURGICAL JOURNALS; SURGERY JOURNALS; REFERENCES; CITATION; AUTHORS; DERMATOLOGY	Previous reviews estimated that approximately 20 to 25% of assertions cited from original research articles, or "facts," are inaccurately quoted in the medical literature. These reviews noted that the original studies were dissimilar and only began to compare the methods of the original studies. The aim of this review is to examine the methods of the original studies and provide a more specific rate of incorrectly cited assertions, or quotation errors, in original research articles published in medical journals. Additionally, the estimate of quotation errors calculated here is based on the ratio of quotation errors to quotations examined (a percent) rather than the more prevalent and weighted metric of quotation errors to the references selected. Overall, this resulted in a lower estimate of the quotation error rate in original medical research articles. A total of 15 studies met the criteria for inclusion in the primary quantitative analysis. Quotation errors were divided into two categories: content ("factual") or source (improper indirect citation) errors. Content errors were further subdivided into major and minor errors depending on the degree that the assertion differed from the original source. The rate of quotation errors recalculated here is 14.5% (10.5% to 18.6% at a 95% confidence interval). These content errors are predominantly, 64.8% (56.1% to 73.5% at a 95% confidence interval), major errors or cited assertions in which the referenced source either fails to substantiate, is unrelated to, or contradicts the assertion. Minor errors, which are an oversimplification, overgeneralization, or trivial inaccuracies, are 35.2% (26.5% to 43.9% at a 95% confidence interval). Additionally, improper secondary (or indirect) citations, which are distinguished from calculations of quotation accuracy, occur at a rate of 10.4% (3.4% to 17.5% at a 95% confidence interval).	[Mogull, Scott A.] Texas State Univ, San Marcos, TX 78666 USA	Texas State University System; Texas State University San Marcos	Mogull, SA (corresponding author), Texas State Univ, San Marcos, TX 78666 USA.	mogull@txstate.edu		Mogull, Scott A./0000-0002-4758-0642				Al-Benna S, 2009, BURNS, V35, P677, DOI 10.1016/j.burns.2008.11.014; Anders ME, 2010, RESP CARE, V55, P578; Awrey J, 2011, WORLD J SURG, V35, P475, DOI 10.1007/s00268-010-0912-7; Buchan JC, 2005, AM J OPHTHALMOL, V140, P1146, DOI 10.1016/j.ajo.2005.07.018; Buijze GA, 2012, J BONE JOINT SURG BR, V94B, P276, DOI 10.1302/0301-620X.94B2.27618; CLARFIELD AM, 1989, CAN MED ASSOC J, V140, P844; Davids JR, 2010, J BONE JOINT SURG AM, V92A, P1155, DOI 10.2106/JBJS.I.00063; DELACEY G, 1985, BRIT MED J, V291, P884, DOI 10.1136/bmj.291.6499.884; EICHORN P, 1987, AM J PUBLIC HEALTH, V77, P1011, DOI 10.2105/AJPH.77.8.1011; EKLUND J, 1995, ACTA ANAESTH SCAND, V39, P575, DOI 10.1111/j.1399-6576.1995.tb04128.x; EVANS JT, 1990, JAMA-J AM MED ASSOC, V263, P1353, DOI 10.1001/jama.263.10.1353; Fenton JE, 2000, CLIN OTOLARYNGOL, V25, P40, DOI 10.1046/j.1365-2273.2000.00322.x; Gavras H, 2002, AM J HYPERTENS, V15, P831, DOI 10.1016/S0895-7061(02)02989-8; GEORGE PM, 1994, J AM ACAD DERMATOL, V31, P61, DOI 10.1016/S0190-9622(94)70136-9; GOLDBERG R, 1993, ANN EMERG MED, V22, P1450, DOI 10.1016/S0196-0644(05)81995-X; Gosling CM, 2004, MANUAL THER, V9, P36, DOI 10.1016/S1356-689X(03)00056-0; Granter SR, 2015, AM J CLIN PATHOL, V144, P427, DOI 10.1309/AJCPDMWVGKW9N1CU; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Gupta P, 2005, INDIAN PEDIATR, V42, P140; HANSEN ME, 1994, AM J ROENTGENOL, V163, P719, DOI 10.2214/ajr.163.3.8079876; HARTREE EF, 1976, PERSPECT BIOL MED, V20, P82, DOI 10.1353/pbm.1976.0032; HINCHCLIFF KW, 1993, J AM VET MED ASSOC, V202, P397; Hobma S O, 1992, Ned Tijdschr Geneeskd, V136, P637; Hol J, 2009, J ALLERGY CLIN IMMUN, V124, P1354, DOI 10.1016/j.jaci.2009.07.047; INGELFINGER FJ, 1976, NEW ENGL J MED, V295, P1075, DOI 10.1056/NEJM197611042951911; International Committee of Medical Journal Editors, 2016, REC COND REP ED PUBL; Jergas H, 2015, PEERJ, V3, DOI 10.7717/peerj.1364; Kolbitsch C, 1997, J NEUROSURG ANESTH, V9, P8, DOI 10.1097/00008506-199701000-00004; Lawson L, 1999, PSYCHIAT B, V23, P221, DOI [10.1192/pb.23.4.221, DOI 10.1192/PB.23.4.221]; Lee SY, 1999, INT J DERMATOL, V38, P357, DOI 10.1046/j.1365-4362.1999.00706.x; LOWRY SR, 1985, BRIT MED J, V291, P1421, DOI 10.1136/bmj.291.6506.1421; Luo M, 2013, FOOT ANKLE INT, V34, P949, DOI 10.1177/1071100713475354; Mertens S, 2011, DTSCH ARZTEBL INT, V108, P550, DOI 10.3238/arztebl.2011.0550; Mogull SA, SCI MED COMMUNICATIO; Neihouse PF, 1988, CLIN ANAT, V23, P594; Nourbakhsh E, 2012, HEALTH INFO LIBR J, V29, P214, DOI 10.1111/j.1471-1842.2012.00992.x; Perrott D, 2009, J ORAL MAXIL SURG, V67, P1356, DOI 10.1016/j.joms.2009.01.004; Pieters G, 2001, TIJDSCHR PSYCHIAT, V43, P349; Porrino JA, 2008, J HAND SURG-AM, V33A, P2, DOI 10.1016/j.jhsa.2007.10.007; PUDER KS, 1987, CLIN PHARMACOL THER, V42, P1, DOI 10.1038/clpt.1987.100; PUTTERMAN C, 1992, ISRAEL J MED SCI, V28, P465; Rama-Maceiras P, 2013, EUR J ANAESTH, V30, P129, DOI 10.1097/EJA.0b013e32835aa512; Rastegar DA, 2002, J FAM PRACTICE, V51, P168; Reddy MS, 2008, SURG-J R COLL SURG E, V6, P71, DOI 10.1016/S1479-666X(08)80067-4; Riesenberg LA, 2003, GUTHRIE J D GUTHRIE, V72, P80; Riesenberg LA, 2001, 4 INT C PEER REV BIO; RYAN AJ, 1975, JAMA-J AM MED ASSOC, V231, P1135, DOI 10.1001/jama.1975.03240230011006; Schulmeister L, 1998, Image J Nurs Sch, V30, P143; Shultz M, 2007, J MED LIBR ASSOC, V95, P442, DOI 10.3163/1536-5050.95.4.442; Simkin MV, 2007, J AM SOC INF SCI TEC, V58, P1661, DOI 10.1002/asi.20653; Simkin MV, 2005, SCIENTOMETRICS, V62, P367, DOI 10.1007/s11192-005-0028-2; Singh S, 2009, INDIAN J DERMATOL VE, V75, P488, DOI 10.4103/0378-6323.55392; STARK R, 1983, ARCH NEUROL-CHICAGO, V40, P658, DOI 10.1001/archneur.1983.04050090094019; Stather PW, 2014, EUR J VASC ENDOVASC, V47, P240, DOI 10.1016/j.ejvs.2013.11.007; Tfelt-Hansen P, 2015, HEADACHE, V55, P419, DOI 10.1111/head.12529; Wager E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000002.pub3; Warren KJ, 1997, 3 INT C PEER REV BIO; Yankauer A., 1990, CBE VIEWS, V13, P38; Zalcberg D, 2013, EUR J ANAESTH, V30, P129, DOI 10.1097/EJA.0b013e32835aa527	59	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184727	10.1371/journal.pone.0184727	http://dx.doi.org/10.1371/journal.pone.0184727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910404	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200086
J	Garcia-Alles, LF; Lesniewska, E; Root, K; Aubry, N; Pocholle, N; Mendoza, CI; Bourillot, E; Barylyuk, K; Pompon, D; Zenobi, R; Reguera, D; Truan, G				Garcia-Alles, Luis F.; Lesniewska, Eric; Root, Katharina; Aubry, Nathalie; Pocholle, Nicolas; Mendoza, Carlos I.; Bourillot, Eric; Barylyuk, Konstantin; Pompon, Denis; Zenobi, Renato; Reguera, David; Truan, Gilles			Spontaneous non-canonical assembly of CcmK hexameric components from beta-carboxysome shells of cyanobacteria	PLOS ONE			English	Article							BACTERIAL MICROCOMPARTMENT SHELLS; GAMMA-CARBONIC ANHYDRASE; STRUCTURAL INSIGHTS; PROTEIN; ORGANELLE; ENCAPSULATION; CONSTRUCTION; MECHANISMS; PRINCIPLES; ENZYME	CcmK proteins are major constituents of icosahedral shells of beta-carboxysomes, a bacterial microcompartment that plays a key role for CO2 fixation in nature. Supported by the characterization of bidimensional (2D) layers of packed CcmK hexamers in crystal and electron microscopy structures, CcmK are assumed to be the major components of icosahedral flat facets. Here, we reassessed the validity of this model by studying CcmK isoforms from Synechocystis sp. PCC6803. Native mass spectrometry studies confirmed that CcmK are hexamers in solution. Interestingly, potential pre-assembled intermediates were also detected with CcmK2. Atomic-force microscopy (AFM) imaging under quasi-physiological conditions confirmed the formation of canonical flat sheets with CcmK4. Conversely, CcmK2 formed both canonical and striped-patterned patches, while CcmK1 assembled into remarkable supra-hexameric curved honeycomb-like mosaics. Mutational studies ascribed the propensity of CcmK1 to form round assemblies to a combination of two features shared by at least one CcmK isoform in most beta-cyanobacteria: a displacement of an alpha helical portion towards the hexamer edge, where a potential phosphate binding funnel forms between packed hexamers, and the presence of a short C-terminal extension in CcmK1. All-atom molecular dynamics supported a contribution of phosphate molecules sandwiched between hexamers to bend CcmK1 assemblies. Formation of supra-hexameric curved structures could be reproduced in coarse-grained simulations, provided that adhesion forces to the support were weak. Apart from uncovering unprecedented CcmK self-assembly features, our data suggest the possibility that transitions between curved and flat assemblies, following cargo maturation, could be important for the biogenesis of beta-carboxysomes, possibly also of other BMC.	[Garcia-Alles, Luis F.; Aubry, Nathalie; Pompon, Denis; Truan, Gilles] Univ Toulouse, CNRS, INRA, LISBP,INSA, Toulouse, France; [Lesniewska, Eric; Pocholle, Nicolas; Bourillot, Eric] Univ Bourgogne Franche Comte, CNRS, UMR 6303, ICB, Dijon, France; [Root, Katharina; Barylyuk, Konstantin; Zenobi, Renato] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Zurich, Switzerland; [Mendoza, Carlos I.] Univ Barcelona, Dept Fis Mat Condensada, Barcelona, Spain; [Mendoza, Carlos I.] Univ Nacl Autonoma Mexico, Inst Invest Mat, Mexico City, DF, Mexico; Univ Cambridge, Dept Biochem, Cambridge, England	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Barcelona; Universidad Nacional Autonoma de Mexico; University of Cambridge	Garcia-Alles, LF; Truan, G (corresponding author), Univ Toulouse, CNRS, INRA, LISBP,INSA, Toulouse, France.	lgarciaa@insa-toulouse.fr; gilles.truan@insa-toulouse.fr	Reguera, David/L-8580-2014; Truan, Gilles/C-7044-2019; Mendoza, Carlos I/A-6576-2009; bourillot, eric/B-4081-2017; Lesniewska, Eric/B-6523-2015	Reguera, David/0000-0001-6395-6112; Truan, Gilles/0000-0002-3560-8302; bourillot, eric/0000-0002-2445-490X; Garcia-Alles, Luis/0000-0002-1141-0393; Barylyuk, Konstantin/0000-0002-3580-0345; Lesniewska, Eric/0000-0002-8027-7223	Swiss National Science Foundation (SNF) [200020_159929]; Toulouse White Biotechnology; DGAPA-UNAM; DGAPA [IN-110516]; Spanish government [FIS2015-67837-P]; Feder grants;  [ANR-15-IDEX-03 PIA2/iSite-BFC];  [ANR-15-CE09-0002-02]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Toulouse White Biotechnology; DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); DGAPA; Spanish government(Spanish GovernmentEuropean Commission); Feder grants; ; 	LFGA, NA, DP and GT work was financed in part within the CarboYeast precompetitive project by Toulouse White Biotechnology. AFM work by EL, NP and EB was founded by ANR-15-IDEX-03 PIA2/iSite-BFC, ANR-15-CE09-0002-02 and Feder grants. KR, KB and RZ acknowledge financial support for mass spectrometry studies by the Swiss National Science Foundation (SNF, grant number 200020_159929). CIM received financial support provided by DGAPA-UNAM through a Sabbatical Fellowship and by grant DGAPA IN-110516. DR acknowledges funding from the Spanish government through grant FIS2015-67837-P (MINECO/FEDER, UE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Carlos I. Mendoza (CIM) appreciates the hospitality of Prof. David Reguera (DR) and the Departament de Fisica de la Materia Condensada, Universitat de Barcelona, where part of the simulation work was carried out during a sabbatical leave. CIM also acknowledges support provided by DGAPA-UNAM through a Sabbatical Fellowship.	Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; Aznar M, 2016, J PHYS CHEM B, V120, P6147, DOI 10.1021/acs.jpcb.6b02150; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Cai F, 2015, ACS SYNTH BIOL, V4, P444, DOI 10.1021/sb500226j; Cai F, 2013, J BIOL CHEM, V288, P16055, DOI 10.1074/jbc.M113.456897; Cameron JC, 2013, CELL, V155, P1131, DOI 10.1016/j.cell.2013.10.044; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078285; Choudhary SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033210; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; de Araujo C, 2014, PHOTOSYNTH RES, V121, P135, DOI 10.1007/s11120-014-0018-4; Dryden KA, 2009, PROTEIN SCI, V18, P2629, DOI 10.1002/pro.272; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Faulkner M, 2017, NANOSCALE, V9, P10662, DOI 10.1039/c7nr02524f; Forouhar Farhad, 2007, Journal of Structural and Functional Genomics, V8, P37, DOI 10.1007/s10969-007-9018-3; Ganser BK, 2003, EMBO J, V22, P2886, DOI 10.1093/emboj/cdg276; Gomez-Garcia MR, 2013, J BACTERIOL, V195, P3309, DOI 10.1128/JB.00207-13; Grason GM, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4962629; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Kaneko Y, 2006, J BACTERIOL, V188, P805, DOI 10.1128/JB.188.2.805-808.2006; Keeling TJ, 2014, PHOTOSYNTH RES, V121, P125, DOI 10.1007/s11120-014-9973-z; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Lassila JK, 2014, J MOL BIOL, V426, P2217, DOI 10.1016/j.jmb.2014.02.025; Lawrence AD, 2014, ACS SYNTH BIOL, V3, P454, DOI 10.1021/sb4001118; Lidmar J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.051910; Lin MT, 2014, PLANT J, V79, P1, DOI 10.1111/tpj.12536; Mahalik JP, 2016, ACS NANO, V10, P5751, DOI 10.1021/acsnano.5b07805; Mallette E, 2017, J BIOL CHEM, V292, P1197, DOI 10.1074/jbc.M116.754093; Menon BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003570; Pang A, 2014, J BIOL CHEM, V289, P22377, DOI 10.1074/jbc.M114.569285; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Perlmutter JD, 2016, ELIFE, V5, DOI 10.7554/eLife.14078; Pitts AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048360; Ponstingl H, 2000, PROTEINS, V41, P47; Quin MB, 2016, APPL MICROBIOL BIOT, V100, P9187, DOI 10.1007/s00253-016-7737-8; Rae BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043871; Roberts EW, 2012, J BACTERIOL, V194, P787, DOI 10.1128/JB.06444-11; Rojas OJ, 2002, ADSORPTION POLYELECT; Samborska B, 2012, STRUCTURE, V20, P1353, DOI 10.1016/j.str.2012.05.013; San Martin C, 2002, NAT STRUCT BIOL, V9, P756, DOI 10.1038/nsb837; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sinha S, 2014, J MOL BIOL, V426, P2328, DOI 10.1016/j.jmb.2014.04.012; Sutter M, 2017, SCIENCE, V356, P1293, DOI 10.1126/science.aan3289; Sutter M, 2016, NANO LETT, V16, P1590, DOI 10.1021/acs.nanolett.5b04259; Takenoya M, 2010, J BACTERIOL, V192, P6056, DOI 10.1128/JB.00652-10; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tomchick DR, 1998, STRUCTURE, V6, P337, DOI 10.1016/S0969-2126(98)00036-7; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Uetrecht C, 2011, NAT CHEM, V3, P126, DOI 10.1038/NCHEM.947; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Zlotnick A, 2003, VIROLOGY, V315, P269, DOI 10.1016/S0042-6822(03)00586-5	64	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185109	10.1371/journal.pone.0185109	http://dx.doi.org/10.1371/journal.pone.0185109			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934279	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900092
J	Guo, YY; Zhou, JB; Wu, Y; Li, ZB				Guo, Yanyong; Zhou, Jibiao; Wu, Yao; Li, Zhibin			Identifying the factors affecting bike-sharing usage and degree of satisfaction in Ningbo, China	PLOS ONE			English	Article							ELECTRIC BIKES; BICYCLE SCHEME; SYSTEM; IMPACT	The boom in bike-sharing is receiving growing attention as societies become more aware of the importance of active non-motorized traffic modes. However, the low usage of this transport mode in China raises concerns. The primary objective of this study is to explore factors affecting bike-sharing usage and satisfaction degree of bike-sharing among the bike-sharing user population in China. Data were collected by a questionnaire survey in Ningbo. A bivariate ordered probit (BOP) model was developed to examine simultaneously those factors associated with both bike-sharing usage and satisfaction degree of bike-sharing among users. Marginal effects for contributory factors were calculated to quantify their impacts on the outcomes. The results showed that the BOP model can account for commonly shared unobserved characteristics within usage and satisfaction of bike-sharing. The BOP model results showed that the usage of bike-sharing was affected by gender, household bicycle/ebike ownership, trip model, travel time, bike-sharing stations location, and users' perception of bike-sharing. The satisfaction degree of bike-sharing was affected by household income, bike-sharing stations location, and users' perception of bike-sharing. It is also found that bike-sharing usage and satisfaction degree are strongly correlated and positive in direction. The results can enhance our comprehension of the factors that affect usage and satisfaction degree of bike-sharing. Based on the results, some suggestions regarding planning, engineering, and public advocacy were discussed to increase the usage of bike-sharing in Ningbo, China.	[Guo, Yanyong; Wu, Yao; Li, Zhibin] Southeast Univ, Jiangsu Key Lab Urban ITS, Nanjing, Jiangsu, Peoples R China; [Guo, Yanyong] Univ British Columbia, Dept Civil Engn, Vancouver, BC, Canada; [Zhou, Jibiao] Ningbo Univ Technol, Sch Civil & Transportat Engn, Ningbo, Zhejiang, Peoples R China	Southeast University - China; University of British Columbia; Ningbo University of Technology	Guo, YY (corresponding author), Southeast Univ, Jiangsu Key Lab Urban ITS, Nanjing, Jiangsu, Peoples R China.; Guo, YY (corresponding author), Univ British Columbia, Dept Civil Engn, Vancouver, BC, Canada.; Zhou, JB (corresponding author), Ningbo Univ Technol, Sch Civil & Transportat Engn, Ningbo, Zhejiang, Peoples R China.	guoyanyong.guo@ubc.ca; zhoujb2014@nbut.edu.cn	wu, yao/AAG-4373-2021; Guo, Yanyong/ABI-7924-2020	Guo, Yanyong/0000-0003-0367-2673; Zhou, Ji-biao/0000-0001-5396-6587	Public Technology Application Foundation of Zhejiang Province of China [2016C33256]; Social Science Foundation of Zhejiang Province of China [18NDJC107YB]; National Natural Science Foundation of China [71701046, 51508094]; China Postdoctoral Science Foundation [2017M571644]; Fundamental Research Funds for the Central Universities [YBJJ1458]; Scientific Innovation Research of College Graduates in Jiangsu Province [KYLX_0173]	Public Technology Application Foundation of Zhejiang Province of China; Social Science Foundation of Zhejiang Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Innovation Research of College Graduates in Jiangsu Province	The study was sponsored by The Public Technology Application Foundation of Zhejiang Province of China (No. 2016C33256), the Social Science Foundation of Zhejiang Province of China (No.18NDJC107YB), the National Natural Science Foundation of China (No. 71701046 & 51508094), the China Postdoctoral Science Foundation funded project (2017M571644), the Fundamental Research Funds for the Central Universities (No. YBJJ1458), the Scientific Innovation Research of College Graduates in Jiangsu Province (No. KYLX_0173).	Anastasopoulos PC, 2012, TRANSPORT RES REC, P12, DOI 10.3141/2279-02; Austwick MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074685; Bachand-Marleau J, 2012, TRANSPORT RES REC, P66, DOI 10.3141/2314-09; Campbell AA, 2016, TRANSPORT RES C-EMER, V67, P399, DOI 10.1016/j.trc.2016.03.004; Cao Y., 2015, XINGHUA NEWS    0725; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; Cherry CR, 2009, TRANSPORT RES D-TR E, V14, P281, DOI 10.1016/j.trd.2008.11.003; DeMaio P.J., 2009, J PUBLIC TRANSPORT, V12, P41, DOI [5038/2375-0901.12.410.5038/2375-0901.12.4.3, DOI 10.5038/2375-0901.12.4.3]; Faghih-Imani A, 2014, J TRANSP GEOGR, V41, P306, DOI 10.1016/j.jtrangeo.2014.01.013; Fishman E, 2016, TRANSPORT REV, V36, P92, DOI 10.1080/01441647.2015.1033036; Fishman E, 2014, TRANSPORT RES D-TR E, V31, P13, DOI 10.1016/j.trd.2014.05.013; Fishman E, 2012, TRANSPORT RES F-TRAF, V15, P686, DOI 10.1016/j.trf.2012.08.002; Greene H., 2003, ECONOMETRIC ANAL; Guangzhou Institute for Transportation and Development, 2016, BIK SHAR INF CHIN; Guo YY, 2014, TRANSPORT RES REC, P28, DOI 10.3141/2468-04; Hampshire R, 2015, EMPIRICAL ANAL BIKE; Hzsggzxc. com, HANGZH PUBL BIC STAT; Jensen P, 2010, TRANSPORT RES D-TR E, V15, P522, DOI 10.1016/j.trd.2010.07.002; Jurdak R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079396; Lathia N, 2012, TRANSPORT RES C-EMER, V22, P88, DOI 10.1016/j.trc.2011.12.004; LDA Consulting, 2015, 2014 CAP BIK MEMB SU; Li ZB, 2013, TRANSPORT RES A-POL, V47, P56, DOI 10.1016/j.tra.2012.10.017; Liu ZL, 2012, PROCD SOC BEHV, V43, P73, DOI 10.1016/j.sbspro.2012.04.079; Ma T, 2015, BICYCLE SHARING TRAN; Mei ZY, 2014, PROMET-ZAGREB, V26, P383, DOI 10.7307/ptt.v26i5.1343; Ningbo Municipal Statistics Bureau, 2014, 2014 NINGB STAT YB; O'Brien O, 2014, J TRANSP GEOGR, V34, P262, DOI 10.1016/j.jtrangeo.2013.06.007; Parkes SD, 2013, J TRANSP GEOGR, V31, P94, DOI 10.1016/j.jtrangeo.2013.06.003; Popham W. J., 1978, CRITERION REFERENCED; Rixey RA, 2013, TRANSPORT RES REC, P46, DOI 10.3141/2387-06; SHAFIZADEH K, 1997, TRANSPORTATION RES B, V1578, P84, DOI DOI 10.3141/1578-11; Shaheen SA, 2012, PUBLIC BIKESHARING N, P11; Shaheen SA, 2011, TRANSPORT RES REC, P33, DOI 10.3141/2247-05; Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20; Tang Y, 2013, EVOLUTION LESSONS CH; Wang XZ, 2016, J URBAN PLAN DEV, V142, DOI 10.1061/(ASCE)UP.1943-5444.0000273; Yang RF, 2014, CONSTRUCTION MANAGEM; Yang RF, 2012, SPECIAL PLANNING PUB; Yang T, 2011, BIKE SHARING SYSTEMS; Zhang SC, 2014, MONTHLY TRANSPORTATI; Zhao JB, 2014, TRANSPORT POLICY, V35, P253, DOI 10.1016/j.tranpol.2014.06.008; Zhou Dan, 2016, Journal of Traffic and Transportation Engineering, V16, P133; Zhou XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137922	43	88	90	31	200	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185100	10.1371/journal.pone.0185100	http://dx.doi.org/10.1371/journal.pone.0185100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934321	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900088
J	Macdonald, SE; Nolan, MJ; Harman, K; Boulton, K; Hume, DA; Tomley, FM; Stabler, RA; Blake, DP				Macdonald, Sarah E.; Nolan, Matthew J.; Harman, Kimberley; Boulton, Kay; Hume, David A.; Tomley, Fiona M.; Stabler, Richard A.; Blake, Damer P.			Effects of Eimeria tenella infection on chicken caecal microbiome diversity, exploring variation associated with severity of pathology	PLOS ONE			English	Article							ENTERITIS PREDISPOSING FACTORS; COMPETITIVE-EXCLUSION PRODUCT; IN-VITRO INHIBITION; NECROTIC ENTERITIS; ESCHERICHIA-COLI; IMMUNE-RESPONSE; GUT MICROBIOTA; AVIAN EIMERIA; BACTEROIDES; POULTRY	Eimeria species cause the intestinal disease coccidiosis, most notably in poultry. While the direct impact of coccidiosis on animal health and welfare is clear, its influence on the enteric microbiota and by-stander effects on chicken health and production remains largely unknown, with the possible exception of Clostridium perfringens (necrotic enteritis). This study evaluated the composition and structure of the caecal microbiome in the presence or absence of a defined Eimeria tenella challenge infection in Cobb500 broiler chickens using 16S rRNA amplicon sequencing. The severity of clinical coccidiosis in individual chickens was quantified by caecal lesion scoring and microbial changes associated with different lesion scores identified. Following E. tenella infection the diversity of taxa within the caecal microbiome remained largely stable. However, infection induced significant changes in the abundance of some microbial taxa. The greatest changes were detected in birds displaying severe caecal pathology; taxa belonging to the order Enterobacteriaceae were increased, while taxa from Bacillales and Lactobacillales were decreased with the changes correlated with lesion severity. Significantly different profiles were also detected in infected birds which remained asymptomatic (lesion score 0), with taxa belonging to the genera Bacteroides decreased and Lactobacillus increased. Many differential taxa from the order Clostridiales were identified, with some increasing and others decreasing in abundance in Eimeria-infected animals. The results support the view that caecal microbiome dysbiosis associated with Eimeria infection contributes to disease pathology, and could be a target for intervention to mitigate the impact of coccidiosis on poultry productivity and welfare. This work highlights that E. tenella infection has a significant impact on the abundance of some caecal bacteria with notable differences detected between lesion score categories emphasising the importance of accounting for differences in caecal lesions when investigating the relationship between E. tenella and the poultry intestinal microbiome.	[Macdonald, Sarah E.; Nolan, Matthew J.; Harman, Kimberley; Tomley, Fiona M.; Blake, Damer P.] Univ London, Royal Vet Coll, Dept Pathobiol & Populat Sci, Hatfield, Herts, England; [Boulton, Kay; Hume, David A.] Univ Edinburgh, Sch Vet Studies, Roslin Inst & Royal Dick, Edinburgh, Midlothian, Scotland; [Stabler, Richard A.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England	University of London; University of London Royal Veterinary College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Macdonald, SE; Blake, DP (corresponding author), Univ London, Royal Vet Coll, Dept Pathobiol & Populat Sci, Hatfield, Herts, England.	smacdonald@rvc.ac.uk; dblake@rvc.ac.uk	Tomley, Fiona/GWM-9070-2022; Hume, David/N-6702-2019	Tomley, Fiona/0000-0003-2188-8013; Stabler, Richard/0000-0002-2402-6630; Macdonald, Sarah/0000-0003-4710-0191; Blake, Damer/0000-0003-1077-2306; Hume, David/0000-0002-2615-1478	 [BB/L00478X];  [BB/L004046]; BBSRC [BB/L004046/1, BB/L00478X/1, BBS/E/D/20002173, BB/L004003/1, BBS/E/D/20320000] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20002173, BB/L00478X/1, BB/L004003/1, BBS/E/D/20320000, BB/L004046/1] Funding Source: researchfish	; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by BB/L00478X, BB/L004046. http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angelakis E, 2016, MICROB PATHOG; [Anonymous], BIOINFORMATICS; ARAKAWA A, 1981, POULTRY SCI, V60, P2203, DOI 10.3382/ps.0602203; BAMBA T, 1995, J GASTROENTEROL, V30, P45; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake DP, 2014, TRENDS PARASITOL, V30, P12, DOI 10.1016/j.pt.2013.10.003; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bolger AM, 2014, BIOINFORMATICS; Boulton K, 2017, RESISTANCE IN PRESS; Carter A, 2017, VET MICROBIOL, V199, P100, DOI 10.1016/j.vetmic.2016.12.029; Chen CY, 2012, POULTRY SCI, V91, P2139, DOI 10.3382/ps.2012-02237; Chen C-Y, 2016, J ANIMAL RES NUTR, V1; Choi KY, 2015, ASIAN AUSTRAL J ANIM, V28, P1217, DOI 10.5713/ajas.15.0026; Clark EL, 2017, TRENDS PARASITOL, V33, P231, DOI 10.1016/j.pt.2016.08.007; Clark EL, 2016, INT J PARASITOL, V46, P537, DOI 10.1016/j.ijpara.2016.05.006; Clarke L, 2014, MEAT SCI, V97, P358, DOI 10.1016/j.meatsci.2014.01.004; Cordoni G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3289-7; Dalloul RA, 2005, COMP IMMUNOL MICROB, V28, P351, DOI 10.1016/j.cimid.2005.09.001; Dalloul RA, 2003, POULTRY SCI, V82, P62, DOI 10.1093/ps/82.1.62; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giannenas I, 2012, VET PARASITOL, V188, P31, DOI 10.1016/j.vetpar.2012.02.017; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Guardia S, 2011, POULTRY SCI, V90, P1878, DOI 10.3382/ps.2010-01311; Gyorke A, 2013, PARASITE, V20, DOI 10.1051/parasite/2013052; Hessenberger S, 2016, VET PARASITOL, V229, P93, DOI 10.1016/j.vetpar.2016.10.001; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P209, DOI 10.1016/j.vetimm.2006.07.007; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Laurent F, 2001, INFECT IMMUN, V69, P2527, DOI 10.1128/IAI.69.4.2527-2534.2001; Lei F, 2012, APPL ENVIRON MICROB, V78, P5763, DOI 10.1128/AEM.00327-12; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Lynagh GR, 2000, VET IMMUNOL IMMUNOP, V76, P89, DOI 10.1016/S0165-2427(00)00203-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martynova-Van Kley M. A., 2012, International Journal of Poultry Science, V11, P747; Mcdougald LR, 1998, POULTRY SCI, V77, P1156, DOI 10.1093/ps/77.8.1156; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McReynolds J, 2009, POULTRY SCI, V88, P2075, DOI 10.3382/ps.2009-00106; Moore RJ, 2016, AVIAN PATHOL, V45, P275, DOI 10.1080/03079457.2016.1150587; Nakamura A, 2002, POULTRY SCI, V81, P1653, DOI 10.1093/ps/81.11.1653; NAMAVAR F, 1983, INFECT IMMUN, V40, P930, DOI 10.1128/IAI.40.3.930-935.1983; Nava G. M., 2005, Animal Health Research Reviews, V6, P105, DOI 10.1079/AHR2005103; Neuwirth E., 2014, RCOLORBREWER COLORBR; Nuotio L, 2013, POULTRY SCI, V92, P250, DOI 10.3382/ps.2012-02575; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Peek HW, 2011, VET QUART, V31, P143, DOI 10.1080/01652176.2011.605247; QIN ZR, 1995, POULTRY SCI, V74, P1, DOI 10.3382/ps.0740001; Reid AJ, 2014, GENOME RES, V24, P1676, DOI 10.1101/gr.168955.113; Ritzi MM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0397-y; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; ROTSTEIN OD, 1989, INFECT IMMUN, V57, P745, DOI 10.1128/IAI.57.3.745-753.1989; RStudio, 2015, RSTUDIO INT DEV R; Rubio LA, 2015, J ANIM PHYSIOL AN N, V99, P418, DOI 10.1111/jpn.12256; Schneitz C, 2016, POULTRY SCI, V95, P1125, DOI 10.3382/ps/pew020; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Stanley D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0388-6; Stanley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104739; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Sterzo EV, 2007, BRAZ J POULTRY SCI, V9, P69, DOI 10.1590/S1516-635X2007000100010; Tierney J, 2004, VET PARASITOL, V122, P171, DOI 10.1016/j.vetpar.2004.05.001; Uyeno Y, 2015, MICROBES ENVIRON, V30, P126, DOI 10.1264/jsme2.ME14176; Vasai F, 2014, POULTRY SCI, V93, P916, DOI 10.3382/ps.2013-03497; Verbeke W, 2007, ANAL CHIM ACTA, V586, P2, DOI 10.1016/j.aca.2006.07.065; Waite DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00673; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wu SB, 2014, VET MICROBIOL, V169, P188, DOI 10.1016/j.vetmic.2014.01.007; Wu ZG, 2016, DEV COMP IMMUNOL, V63, P206, DOI 10.1016/j.dci.2016.04.016; Yoon S.-H., 2016, INT J SYSTEMATIC EVO; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zhou ZY, 2017, EXP PARASITOL, V177, P73, DOI 10.1016/j.exppara.2017.04.007	80	61	64	18	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184890	10.1371/journal.pone.0184890	http://dx.doi.org/10.1371/journal.pone.0184890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934262	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900056
J	Chu, A; Varma, T; Petocz, P; Samman, S				Chu, Anna; Varma, Trishala; Petocz, Peter; Samman, Samir			Quantifiable effects of regular exercise on zinc status in a healthy population-A systematic review	PLOS ONE			English	Review							AEROBIC EXERCISE; FITNESS; MARKERS; COPPER	Zinc is an essential mineral of which its functions have potential implications on exercise performance and beneficial adaptations of physical activity. While the effects of aerobic exercise on zinc metabolism acutely have been well described, the effect of long-term exercise training on zinc status remains unclear. The present review aims to determine the effects of exercise training on markers of zinc status in an apparently healthy adult population. We conducted a systematic literature search on PubMed, Scopus, SPORTDiscus and Cochrane Library from inception to 28 January 2016 to identify interventional or cohort studies that investigated the effects of exercise training on indices of zinc status. Pairwise comparisons of mean differences in within-group change were calculated and summarised visually in forest plots. Six studies satisfied the inclusion criteria for the systematic review, of which 5 studies included data on changes in serum zinc concentrations and 3 studies provided changes in dietary zinc intake. Two comparisons showed significantly higher increase of serum zinc concentrations in the exercise group compared to control, while one comparison reported significantly lower change in serum zinc for the exercising group. The exercise groups consumed significantly higher dietary zinc compared to controls in two comparisons. The present review revealed an incomplete evidence base in evaluating the effect of long-term exercise training on markers of zinc status. Further well-designed investigations are required to elucidate the relationship for establishment of dietary recommendation in populations who are continuing exercise interventions.	[Chu, Anna; Varma, Trishala; Samman, Samir] Univ Otago, Dept Human Nutr, Dunedin, New Zealand; [Petocz, Peter] Macquarie Univ, Dept Stat, Sydney, NSW, Australia; [Samman, Samir] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	University of Otago; Macquarie University; University of Sydney	Samman, S (corresponding author), Univ Otago, Dept Human Nutr, Dunedin, New Zealand.; Samman, S (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	samir.samman@otago.ac.nz		Samman, Samir/0000-0001-6326-0481				[Anonymous], 2014, REV MAN REVMAN; Arikan S, 2008, CELL BIOCHEM FUNCT, V26, P655, DOI 10.1002/cbf.1480; Azizbeigi K, 2013, INT J SPORT NUTR EXE, V23, P230, DOI 10.1123/ijsnem.23.3.230; Beck FWJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE1002, DOI 10.1152/ajpendo.1997.272.6.E1002; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Chu A, 2015, HUMAN HLTH NUTR NEW, P17; Chu A, 2017, SPORTS MED, V47, P127, DOI 10.1007/s40279-016-0567-0; Chu A, 2016, MED SCI SPORT EXER, V48, P726, DOI 10.1249/MSS.0000000000000805; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10-9990]; Cordova A, 1998, ANN NUTR METAB, V42, P274, DOI 10.1159/000012744; Crespo R, 1995, J SPORT MED PHYS FIT, V35, P268; Diment BC, 2015, MED SCI SPORT EXER, V47, P1390, DOI 10.1249/MSS.0000000000000562; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; FOGELHOLM G M, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P99; FOGELHOLM M, 1992, ANN NUTR METAB, V36, P209, DOI 10.1159/000177720; Foster M, 2012, NUTRIENTS, V4, P676, DOI 10.3390/nu4070676; Foster M, 2010, ANTIOXID REDOX SIGN, V13, P1549, DOI 10.1089/ars.2010.3111; Ganapathy S, 1999, CRIT REV FOOD SCI, P37; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Haralambie G, 1981, INT J SPORT MED; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Jackson MJ, 1989, ZINC HUMAN BIOL, p1~14, DOI DOI 10.1007/978-1-4471-3879-2_1; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lowe NM, 2013, CRIT REV FOOD SCI, V53, P1110, DOI 10.1080/10408398.2012.742863; Lukaski HC, 2005, AM J CLIN NUTR, V81, P1045; LUKASKI HC, 1990, AM J CLIN NUTR, V51, P1093, DOI 10.1093/ajcn/51.6.1093; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Manore MM, 2015, SPORTS MED, V45, pS83, DOI 10.1007/s40279-015-0401-0; Margaritis I, 2008, NUTR RES REV, V21, P3, DOI 10.1017/S0954422408018076; National Health and Medical Research Council, 2006, NUTR REF VAL AUSTR N; Nikolaidis MG, 2009, ARCH BIOCHEM BIOPHYS, V490, P77, DOI 10.1016/j.abb.2009.08.015; Nuviala RJ, 1999, INT J SPORT NUTR, V9, P295, DOI 10.1123/ijsn.9.3.295; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Peake JM, 2003, INT J SPORTS MED, V24, P212, DOI 10.1055/s-2003-39094; Samman S, 2007, NUTR DIET, V64, pS131, DOI 10.1111/j.1747-0080.2007.00200.x; Smiles WJ, 2016, J EXP BIOL, V219, P214, DOI 10.1242/jeb.125104; Speich M, 2001, CLIN CHIM ACTA, V312, P1, DOI 10.1016/S0009-8981(01)00598-8; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184827	10.1371/journal.pone.0184827	http://dx.doi.org/10.1371/journal.pone.0184827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931036	gold, Green Published, Green Submitted			2022-12-27	WOS:000411314700037
J	Hu, CL; Luo, Y; Wang, H; Kuang, SN; Liang, GJ; Yang, Y; Mai, SS; Yang, JQ				Hu, Congli; Luo, Ying; Wang, Hong; Kuang, Shengnan; Liang, Guojuan; Yang, Yang; Mai, Shaoshan; Yang, Junqing			Re-evaluation of the interrelationships among the behavioral tests in rats exposed to chronic unpredictable mild stress	PLOS ONE			English	Article							ANIMAL-MODEL; DEPRESSION; ANTIDEPRESSANT; BRAIN; MICE; HIPPOCAMPUS; DYSFUNCTION; VALIDITY; PROTEIN	The chronic unpredictable mild stress model of depression has been widely used as an experimental tool to investigate human psychopathology. Our objective was to provide an update on the validity and reliability of the chronic unpredictable mild stress model, by analyzing the interrelationships among the indexes using stepwise discriminant analysis and Pearson correlation coefficient to examine the possible combinations. We evaluated the depressive rats in both the presence and the absence of chronic unpredictable mild stress, using weight change, percentage of sucrose preference, coat state, splash test, open-field test, elevated plus-maze test, forced swimming test, and Morris water maze test. The results showed that 6-week-long chronic unpredictable mild stress produces significant depression and anxiety-like behavior. The combination of body weight change, percentage of sucrose preference, coat state score, open-field score, grooming latency of splash test, immobility time in force swimming test, and platform crossing in the Morris water maze test can effectively discriminate between normal and chronic unpredictable mild stress rats. Strong interrelationships were noted among these indexes in both open-field test and elevated plusmaze test. In conclusion, there might be certain criteria for the combination of behavioral endpoints, which is advantageous to more effectively and reliably assess the chronic unpredictable mild stress induced depression model.	[Hu, Congli; Luo, Ying; Wang, Hong; Kuang, Shengnan; Liang, Guojuan; Yang, Yang; Mai, Shaoshan; Yang, Junqing] Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing, Peoples R China	Chongqing Medical University	Yang, JQ (corresponding author), Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing, Peoples R China.	cqyangjq@cqmu.edu.cn		Hu, Congli/0000-0002-3590-2739; Mai, shaoshan/0000-0001-8165-4580	Research Fund of Chongqing Science Technology Commission of China [cstc2012jjA0112]	Research Fund of Chongqing Science Technology Commission of China	This work was supported by the Research Fund of Chongqing Science Technology Commission of China (NO: cstc2012jjA0112). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was finished in the key laboratory of biological chemistry and molecular pharmacology (Chongqing Medical University, Chongqing, China). We thank professor Xiaoni Zhong for helpful suggestion, and Puqiao Lian, Lingtian Tan for technical assistance. This study was supported by Research Fund of Chongqing Science Technology Commission of China (NO: cstc2012jjA0112).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Burda K, 2011, PHARMACOL REP, V63, P898, DOI 10.1016/S1734-1140(11)70605-3; Carey G, MULTIVARIATE ANAL VA; Ciani E, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-71; Gonda X, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0068-9; Guo JY, 2015, BEHAV BRAIN RES, V286, P278, DOI 10.1016/j.bbr.2015.03.013; Jiang P, 2013, PSYCHONEUROENDOCRINO, V38, P2091, DOI 10.1016/j.psyneuen.2013.03.017; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; Kessler RC, 2010, PSYCHOL MED, V40, P225, DOI 10.1017/S0033291709990213; Lin YH, 2005, BEHAV BRAIN RES, V165, P63, DOI 10.1016/j.bbr.2005.06.034; Lino-De-Oliveira C, 2005, BEHAV BRAIN RES, V158, P243, DOI 10.1016/j.bbr.2004.09.004; Liu DX, 2014, PROG NEURO-PSYCHOPH, V49, P21, DOI 10.1016/j.pnpbp.2013.10.017; Luo DD, 2008, BRAIN RES BULL, V77, P8, DOI 10.1016/j.brainresbull.2008.05.010; Luo Y, 2017, ONCOTARGET, V8, P35558, DOI 10.18632/oncotarget.16009; Luo Y, 2016, PHYSIOL BEHAV, V167, P145, DOI 10.1016/j.physbeh.2016.09.010; MATTHEWS K, 1995, PHYSIOL BEHAV, V57, P241, DOI 10.1016/0031-9384(94)00286-E; Mehta V, 2017, PHYSIOL BEHAV, V171, P69, DOI 10.1016/j.physbeh.2017.01.006; Mutlu O, 2012, LIFE SCI, V91, P1252, DOI 10.1016/j.lfs.2012.09.023; NISHIMURA H, 1988, PHYSIOL BEHAV, V42, P93, DOI 10.1016/0031-9384(88)90266-1; Ortmann CF, 2016, NEUROTOX RES, V29, P469, DOI 10.1007/s12640-016-9596-6; Qi XL, 2006, BEHAV BRAIN RES, V175, P233, DOI 10.1016/j.bbr.2006.08.035; Slupski W, 2017, PHARMACOL REP, V69, P943, DOI 10.1016/j.pharep.2017.03.012; Surget A, 2009, EXPT ANIMAL MODELS N, P79; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Tondo L, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-013-0431-y; Vitale G, 2009, PSYCHOPHARMACOLOGY, V207, P173, DOI 10.1007/s00213-009-1646-9; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 1996, PHYSIOL BEHAV, V60, P129, DOI 10.1016/0031-9384(95)02256-2; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; WILLNER P, 1995, ADV BIOCHEM PSYCHOPH, V49, P19; Yalcin I, 2005, EUR J PHARMACOL, V514, P165, DOI 10.1016/j.ejphar.2005.03.029; Yiend J, 2009, J AFFECT DISORDERS, V118, P79, DOI 10.1016/j.jad.2009.01.026	35	72	82	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185129	10.1371/journal.pone.0185129	http://dx.doi.org/10.1371/journal.pone.0185129			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931086	gold, Green Submitted, Green Published			2022-12-27	WOS:000411314700072
J	Jardel, S; Fabien, N; Hot, A; Vukusic, S; Tebib, J; Cottin, V; Seve, P; Laville, M; Belot, A; Durieu, I; Garnier, L; Coutant, F; Reynaud, Q; Lega, JC				Jardel, Sabine; Fabien, Nicole; Hot, Arnaud; Vukusic, Sandra; Tebib, Jacques; Cottin, Vincent; Seve, Pascal; Laville, Maurice; Belot, Alexandre; Durieu, Isabelle; Garnier, Lorna; Coutant, Frederic; Reynaud, Quitterie; Lega, Jean Christophe			Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey	PLOS ONE			English	Article							CONNECTIVE-TISSUE DISEASES; CLASSIFICATION CRITERIA; SJOGRENS-SYNDROME; RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; ANTIBODIES; CONSENSUS	Objective To assess in clinical practice the frequency and diagnosis associated with the SS-B-positive/SS-A negative autoantibody profile. Methods We analyzed a one-year consecutive population of 624 patients referred by clinicians to the immunology laboratory to investigate anti-SS-A and/or anti-SS-B autoantibodies, who were detected using luminex technology. Data were analyzed for patients with isolated anti-SS-B autoantibodies. The clinical characteristics and diagnosis of connective tissue diseases (CTD) were retrieved according to the international criteria. Results Among 1173 sera positive for anti-SS-A and/or anti-SS-B autoantibodies from 624 patients, we identified 84 patients (13.5%) that had isolated anti-SS-B. Among the 75 patients positive for anti-SS-B with known clinical data, 15 were diagnosed with a CTD (20%) including 4 systemic lupus erythematosus (5%), 4 rheumatoid arthritis (5%), 2 idiopathic inflammatory myositis (3%), 1 primary Sjogren's syndrome pSS (1%), 1 systemic sclerosis (1%), 2 undefined CTD (3%), and 1 mixed CTD (1%). Among the 60 other patients, 18 had non-CTD autoimmune diseases and 42 had non-autoimmune diseases. Within the CTD population, the presence of isolated anti-SS-B was not significantly associated to characteristic indicating a specific syndrome. There was no association between diagnosis of CTD and level of anti-SS-B autoantibodies (p = 0.70). Arthralgia was the more frequent sign and encountered in 10 patients (67%), of whom 3 had arthritis. Conclusion The presence of anti-SS-B, without anti-SS-A autoantibodies using luminex technology, was not associated with CTD, especially pSS, in daily clinical practice. Our data suggests that the SS-B serological profile is not contributive for the classification criteria of pSS.	[Jardel, Sabine; Durieu, Isabelle; Reynaud, Quitterie; Lega, Jean Christophe] Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Internal & Vasc Med, Lyon, France; [Fabien, Nicole; Garnier, Lorna; Coutant, Frederic] Hosp Civils Lyon, Dept Immunol, Ctr Hosp Lyon Sud, Lyon, France; [Hot, Arnaud] Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Edouard Herriot, Dept Internal Med & Vasc Med, Lyon, France; [Vukusic, Sandra] Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Dept Neurol A, Lyon, France; [Tebib, Jacques] Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Rheumatol, Lyon, France; [Cottin, Vincent] Claude Bernard Univ Lyon 1, Natl Reference Ctr Rare Pulm Dis, Dept Resp Med, Louis Pradel Hosp,Hosp Civils Lyon,UMR 754, Lyon, France; [Seve, Pascal] Claude Bernard Univ Lyon 1, Hop Croix Rousse, Hosp Civils Lyon, Dept Internal Med, Lyon, France; [Laville, Maurice] Claude Bernard Univ Lyon 1, Dept Nephrol, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Lyon, France; [Belot, Alexandre] Claude Bernard Univ Lyon 1, Pediat Nephrol Rheumatol, Dermatol Unit, Hosp Civils Lyon,INSERM,U1111,Hop Femme Mere Enfa, Lyon, France; [Lega, Jean Christophe] Claude Bernard Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Jardel, S (corresponding author), Claude Bernard Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Internal & Vasc Med, Lyon, France.	sabinejardel@gmail.com	Belot, Alexandre/C-7378-2013; GARNIER, Lorna/ACB-8668-2022; Coutant, Frederic/J-6336-2019; Mainbourg, Sabine/V-1225-2019	Belot, Alexandre/0000-0003-4902-5332; Coutant, Frederic/0000-0003-2485-5284; Mainbourg, Sabine/0000-0003-4564-2931				Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Baer AN, 2015, ANN RHEUM DIS, V74, P1557, DOI 10.1136/annrheumdis-2014-206683; Cavazzana I, 2001, CLIN EXP RHEUMATOL, V19, P403; Davis JM, 2005, MEDICINE, V84, P208, DOI 10.1097/01.md.0000173181.87969.eb; Fauchais AL, 2010, AUTOIMMUN REV, V9, P595, DOI 10.1016/j.autrev.2010.05.004; Hoogendijk JE, 2003, 119 ENMC INT WORKSH, P337; Infantino M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/978202; Keech Catherine L., 1996, P789, DOI 10.1016/B978-044482383-0/50121-7; LOPEZLONGO FJ, 1994, J RHEUMATOL, V21, P1450; Mosca M, 1999, CLIN EXP RHEUMATOL, V17, P615; Peene I, 2002, ANN RHEUM DIS, V61, P1090, DOI 10.1136/ard.61.12.1090; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Quartuccio L, 2014, J AUTOIMMUN, V51, P75, DOI 10.1016/j.jaut.2013.10.002; Sharp GC, 1987, MIXED CONNECTIVE TIS, P23; Shiboski CH, 2017, ARTHRITIS RHEUMATOL, V69, P35, DOI 10.1002/art.39859; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; VENABLES PJW, 1989, CLIN EXP RHEUMATOL, V7, P181; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185104	10.1371/journal.pone.0185104	http://dx.doi.org/10.1371/journal.pone.0185104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931060	gold, Green Submitted, Green Published			2022-12-27	WOS:000411314700069
J	Price, SJ; Wadia, A; Wright, ON; Leung, WTM; Cunningham, AA; Lawson, B				Price, Stephen J.; Wadia, Alexandra; Wright, Owen N.; Leung, William T. M.; Cunningham, Andrew A.; Lawson, Becki			Screening of a long-term sample set reveals two Ranavirus lineages in British herpetofauna	PLOS ONE			English	Article							VIRUS 3-LIKE RANAVIRUS; MAJOR CAPSID PROTEIN; WORLD ORGANIZATION; SEQUENCE-ANALYSIS; ANIMAL HEALTH; IRIDOVIRUS; AMPHIBIANS; BULLFROGS; INFECTION; MORTALITY	Reports of severe disease outbreaks in amphibian communities in mainland Europe due to strains of the common midwife toad virus (CMTV)-like clade of Ranavirus are increasing and have created concern due to their considerable population impacts. In Great Britain, viruses in another clade of Ranavirus-frog virus 3 (FV3)-like-have caused marked declines of common frog (Rana temporaria) populations following likely recent virus introductions. The British public has been reporting mortality incidents to a citizen science project since 1992, with carcasses submitted for post-mortem examination, resulting in a long-term tissue archive spanning 25 years. We screened this archive for ranavirus (458 individuals from 228 incidents) using molecular methods and undertook preliminary genotyping of the ranaviruses detected. In total, ranavirus was detected in 90 individuals from 41 incidents focused in the north and south of England. The majority of detections involved common frogs (90%) but also another anuran, a caudate and a reptile. Most incidents were associated with FV3-like viruses but two, separated by 300 km and 16 years, involved CMTV-like viruses. These British CMTV-like viruses were more closely related to ranaviruses from mainland Europe than to each other and were estimated to have diverged at least 458 years ago. This evidence of a CMTV-like virus in Great Britain in 1995 represents the earliest confirmed case of a CMTV associated with amphibians and raises important questions about the history of ranavirus in Great Britain and the epidemiology of CMTV-like viruses. Despite biases present in the opportunistic sample used, this study also demonstrates the role of citizen science projects in generating resources for research and the value of maintaining long-term wildlife tissue archives.	[Price, Stephen J.] UCL Genet Inst, Gower St, London, England; [Price, Stephen J.; Wadia, Alexandra; Wright, Owen N.; Leung, William T. M.; Cunningham, Andrew A.; Lawson, Becki] ZSL, Inst Zool, Regents Pk, London, England; [Wadia, Alexandra] Univ York, York, N Yorkshire, England; [Wright, Owen N.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	University of London; University College London; University of York - UK; Cardiff University	Price, SJ (corresponding author), UCL Genet Inst, Gower St, London, England.; Price, SJ (corresponding author), ZSL, Inst Zool, Regents Pk, London, England.	s.price@ucl.ac.uk	Price, Stephen J./Q-1535-2019	Price, Stephen J./0000-0001-6983-6250; Wright, Owen/0000-0001-8983-4674; lawson, becki/0000-0003-1706-7140	Natural Environment Research Council [NE/M000338/1, NE/M000591/1, NE/M00080X/1]; European Research Council [260801-BIG-IDEA]; Department for Environment, Food Rural Affairs; Welsh Government through the Animal Plant & Health Agency's Diseases of Wildlife Scheme [ED 1600]; Esmee Fairbairn Foundation; Universities Federation for Animal Welfare; NERC [NE/M000338/1, NE/M000591/1, NE/M00080X/1]; ERC [260801-BIG-IDEA]; Defra	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Department for Environment, Food Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Welsh Government through the Animal Plant & Health Agency's Diseases of Wildlife Scheme; Esmee Fairbairn Foundation; Universities Federation for Animal Welfare; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC(European Research Council (ERC)European Commission); Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by Natural Environment Research Council (http://www.nerc.ac.uk) grants NE/M000338/1, NE/M000591/1 & NE/M00080X/1, and European Research Council (https://erc.europa.eu) grant 260801-BIG-IDEA. The Garden Wildlife Health project was funded by Department for Environment, Food & Rural Affairs (http://www.defra.gov.uk) and the Welsh Government through the Animal Plant & Health Agency's Diseases of Wildlife Scheme (Project ED 1600) within their Scanning Surveillance Programme; the Esmee Fairbairn Foundation (http://esmeefairbairn.org.uk/) and the Universities Federation for Animal Welfare (http://www.ufavf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NERC grants NE/M000338/1, NE/M000591/1 & NE/M00080X/1 and ERC grant 260801-BIG-IDEA. The Garden Wildlife Health project was funded by Defra (http://www.defra.gov.uk) and the Welsh Government through the Animal Plant & Health Agency's Diseases of Wildlife Scheme (Project ED 1600) within their Scanning Surveillance Programme; the Esmee Fairbairn Foundation (http://esmeefairbairn.org.uk/) and the Universities Federation for Animal Welfare (http://www.ufaw.org.uk).	Ariel E, 2009, DIS AQUAT ORGAN, V85, P7, DOI 10.3354/dao02060; Balseiro A, 2009, DIS AQUAT ORGAN, V84, P95, DOI 10.3354/dao02032; Black Y, 2017, J WILDLIFE DIS, V53, P509, DOI 10.7589/2016-08-176; Chen ZY, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-101; Cunningham A. A., 2001, INVESTIGATIONS MASS; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; Dong WZ, 2011, EMERG INFECT DIS, V17, P2388, DOI 10.3201/eid1712.101758; Duffus A. L. J., 2013, Herpetological Review, V44, P260; Duffus A. L. J., 2015, RANAVIRUSES LETHAL P, P9, DOI DOI 10.1007/978-3-319-13755-1; Duffus ALJ, 2017, J EMERG DIS VIROL, V3; Duffus Amanda L. J., 2014, Herpetological Review, V45, P608; Duffus ALJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00074.1; Duffus ALJ, 2013, J WILDLIFE DIS, V49, P464, DOI 10.7589/2012-05-147; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Griekspoor A, 2015, 4PEAKS; Holopainen R, 2009, DIS AQUAT ORGAN, V85, P81, DOI 10.3354/dao02074; Holopainen R, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01295-16; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyatt AD, 2000, ARCH VIROL, V145, P301, DOI 10.1007/s007050050025; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lawson B, 2015, ECOHEALTH, V12, P693, DOI 10.1007/s10393-015-1054-z; Leung WTM, 2017, J VIROL METHODS; Mao JH, 1997, VIROLOGY, V229, P212, DOI 10.1006/viro.1996.8435; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Marschang RE, 1999, ARCH VIROL, V144, P1909, DOI 10.1007/s007050050714; Mavian C, 2012, J VIROL, V86, P11413, DOI 10.1128/JVI.01967-12; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Miaud C, 2016, J WILDLIFE DIS, V52, P242, DOI 10.7589/2015-05-113; North AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127037; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price SJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0952; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; R Core Team, 2021, R LANGUAGE ENV STAT; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rijks JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157473; Rosa GM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43260; Schloegel LM, 2010, DIS AQUAT ORGAN, V92, P101, DOI 10.3354/dao02140; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Sharifian-Fard M, 2011, EMERG INFECT DIS, V17, P2371, DOI 10.3201/eid1712.110236; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stohr AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118633; Tapiovaara H, 1998, DIS AQUAT ORGAN, V32, P185, DOI 10.3354/dao032185; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; UK Data Service Census Support, 2015, UK DAT SERV CENS SUP; Une Y, 2009, EMERG INFECT DIS, V15, P1146, DOI 10.3201/eid1507.081636; van Beurden SJ, 2014, GENOME ANNOUNC, V2; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zhang QY, 2001, DIS AQUAT ORGAN, V48, P27, DOI 10.3354/dao048027	50	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184768	10.1371/journal.pone.0184768	http://dx.doi.org/10.1371/journal.pone.0184768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931029	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700035
J	Randhawa, AK; Parikh, JS; Kuk, JL				Randhawa, Arshdeep K.; Parikh, Jash S.; Kuk, Jennifer L.			Trends in medication use by body mass index and age between 1988 and 2012 in the United States	PLOS ONE			English	Article							DISEASE RISK-FACTORS; OBESITY PARADOX; DEPRESSION; ADULTS; PRESCRIPTION	Objective Whether the increase in prescription medication use over time differs by age and obesity status is unclear. Method National Health and Nutrition Examination Survey (NHANES) between 1988 and 2012 was analyzed (n = 57,543). Findings Increased medication use over time was seen in older individuals of all body mass index (BMI) classes, with the most prominent increase in those with obesity (p<0.001). For example, older men (>= 65y) with obesity took 3.1 more medications between 1988 and 2012 versus 1.5 for normal weight older men. There were minimal differences in medication use over time in younger individuals. In men, the odds of taking antihypertensives, lipid-lowering medication, antidiabetics, and antidepressants increased with age, time and BMI wherein the association between age and medication use was magnified over time (age*time, p<0.05). In women, older women with overweight or obesity had a greater increase in the likelihood of antihypertensives and antidiabetics medication over time (BMI*time, p>0.05). Conclusion Older individuals of all BMI classes may be driving the increase in medication use over time. However, the rise in the likelihood of taking cardiometabolic medications over time was generally not different between those with or without obesity in men with some increases seen in older women. Further research may be required to assess accessibility and barriers to medication use among certain demographics.	[Randhawa, Arshdeep K.; Parikh, Jash S.; Kuk, Jennifer L.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada	York University - Canada	Kuk, JL (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.	jennkuk@yorku.ca			Canadian Institute of Health Research [131594]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research -#131594, http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PREVENTION C DC DIAG; Bennett W, 2011, COMPARATIVE EFFECTIV, P1; Carney RM, 2003, BIOL PSYCHIAT, V54, P241, DOI 10.1016/S0006-3223(03)00111-2; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; CDC National Center for Health Statistics, 2016, MEAS OUTP ANT PRESCR; Center for Disease Control and Prevention, 2016, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC), 2012, NAT CTR HLTH STAT DA; Chang J, 2016, J RES PHARM PRACT, V5, P149, DOI 10.4103/2279-042X.185706; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ehrt U, 2006, INT J GERIATR PSYCH, V21, P252, DOI 10.1002/gps.1456; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Gu Q, 2014, NCHS DATA BRIEF, P1; Gu Q, 2007, NCHS DATA BRIEF, V2010, P1, DOI DOI 10.1037/E665492010-001); Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kit BK, 2012, ANN EPIDEMIOL, V22, P112, DOI 10.1016/j.annepidem.2011.10.010; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Molenaar EA, 2008, DIABETES CARE, V31, P1367, DOI 10.2337/dc07-2413; Murphy SL, 2013, NATL VITAL STAT REP, P61; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wee CC, 2005, AM J PUBLIC HEALTH, V95, P159, DOI 10.2105/AJPH.2003.027946	28	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184089	10.1371/journal.pone.0184089	http://dx.doi.org/10.1371/journal.pone.0184089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931017	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700015
J	He, L; Liu, Y; Yin, H; Zhang, JP; Zhang, J; Zhang, J				He, Ling; Liu, Yin; Yin, Heng; Zhang, Junpeng; Zhang, Jing; Zhang, Jiang			Automatic initial and final segmentation in cleft palate speech of Mandarin speakers	PLOS ONE			English	Article								The speech unit segmentation is an important pre-processing step in the analysis of cleft palate speech. In Mandarin, one syllable is composed of two parts: initial and final. In cleft palate speech, the resonance disorders occur at the finals and the voiced initials, while the articulation disorders occur at the unvoiced initials. Thus, the initials and finals are the minimum speech units, which could reflect the characteristics of cleft palate speech disorders. In this work, an automatic initial/final segmentation method is proposed. It is an important preprocessing step in cleft palate speech signal processing. The tested cleft palate speech utterances are collected from the Cleft Palate Speech Treatment Center in the Hospital of Stomatology, Sichuan University, which has the largest cleft palate patients in China. The cleft palate speech data includes 824 speech segments, and the control samples contain 228 speech segments. The syllables are extracted from the speech utterances firstly. The proposed syllable extraction method avoids the training stage, and achieves a good performance for both voiced and unvoiced speech. Then, the syllables are classified into with "quasi-unvoiced" or with "quasi-voiced" initials. Respective initial/final segmentation methods are proposed to these two types of syllables. Moreover, a two-step segmentation method is proposed. The rough locations of syllable and initial/final boundaries are refined in the second segmentation step, in order to improve the robustness of segmentation accuracy. The experiments show that the initial/final segmentation accuracies for syllables with quasi-unvoiced initials are higher than quasi-voiced initials. For the cleft palate speech, the mean time error is 4.4ms for syllables with quasi-unvoiced initials, and 25.7ms for syllables with quasi-voiced initials, and the correct segmentation accuracy P-30 for all the syllables is 91.69%. For the control samples, P-30 for all the syllables is 91.24%.	[He, Ling; Liu, Yin; Zhang, Junpeng; Zhang, Jing; Zhang, Jiang] Sichuan Univ, Sch Elect Engn & Informat, Chengdu, Sichuan, Peoples R China; [Yin, Heng] Sichuan Univ, Hosp Stomatol, Dept Cleft Lip & Palate, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zhang, J; Zhang, J (corresponding author), Sichuan Univ, Sch Elect Engn & Informat, Chengdu, Sichuan, Peoples R China.	zhangjing@scu.edu.cn; zhangjiang_@hotmail.com		zhang, jin/0000-0003-2663-053X	National Natural Science Foundation of China [61503264]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China 61503264. LH receives this funding. http://www.nsfc.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China 61503264.	BRUGNARA F, 1993, SPEECH COMMUN, V12, P357, DOI 10.1016/0167-6393(93)90083-W; Cairns DA, 1996, IEEE T BIO-MED ENG, V43, P35, DOI 10.1109/10.477699; Chen Bin, 2012, Acta Acustica, V37, P104; Chen TM, 2013, PSYCHON B REV, V20, P154, DOI 10.3758/s13423-012-0326-7; Cho JW, 2016, SIGNAL PROCESS, V120, P200, DOI 10.1016/j.sigpro.2015.09.002; Dai YH, 2009, COMMUNICATIONS TECHN, V42, P181; [丁慧 Ding Hui], 2004, [应用声学, Applied Acoustics], V23, P20; Dowling E., 1992, 1992 C 26 AS C, V2, P1105; El Ayadi M, 2017, SPEECH COMMUN, V92, P52, DOI 10.1016/j.specom.2017.05.005; Golding-Kushner K. J., 2001, THERAPY TECHNIQUES C, P19; Guo QY, 2010, INT CONF COMPUT AUTO, P123, DOI 10.1109/ICCAE.2010.5451414; Harding A, 1996, EUR J DISORDER COMM, V31, P331; Hsieh CT, 1999, J INF SCI ENG, V15, P615; Jia Z. B., 2006, THESIS; [李皓 Li Hao], 2012, [声学学报, Acta Acustica], V37, P339; Li J, 2016, INT C AS LANG PROC, P57; Li Jin, 2010, Proceedings of the 2010 International Conference on Intelligent Computation Technology and Automation (ICICTA 2010), P591, DOI 10.1109/ICICTA.2010.309; Li X, 2005, ACTA ACUSTICA; Li Y., 2015, ASSESSMENT TREATMENT; Lin X., 2013, LINGUISTICS PHONETIC, P35; Liu YJ, 2005, J GANSU SCI, V17, P90; Lu D, 2011, J GUILIN U ELECT TEC; Mporas I, 2011, SIGNAL PROCESS, V91, P2101, DOI 10.1016/j.sigpro.2011.03.020; Nakagawa S., 1988, 9th International Conference on Pattern Recognition (IEEE Cat. No.88CH2614-6), P960, DOI 10.1109/ICPR.1988.28414; Nieto R. G., 2014, 2014 19 S IM SIGN PR, P1; Noetzel A., 1991, Electro International. Conference Record, P580, DOI 10.1109/ELECTR.1991.718279; Rah DK, 2001, ANN BIOMED ENG, V29, P587, DOI 10.1114/1.1380422; Reichl W, 1993, EUROPEAN C SPEECH CO, V279-280, P277; SETHY A, 2002, INT C SPOK LANG PROC; Shastri L, 1999, P 14 INT C PHON SCI, V910, P1721; Sheng H., 1999, 9 NAT C SIGN PROC; Su Min, 2008, Audio Engineering, V32, P49; Takahashi N, 2002, INT C SPOK LANG PROC, V101, P13; Toledano DT, 2000, INT CONF ACOUST SPEE, P3438, DOI 10.1109/ICASSP.2000.860140; Triskova H, 2011, ARCH ORIENT, V79, P99; Vijayalakshmi P., 2009, TENCON 2009 2009 IEE, P1; Vijayalakshmi R, 2007, IEEE T BIO-MED ENG, V54, P621, DOI 10.1109/TBME.2006.889191; Wang Yan, 2011, Computer Engineering and Applications, V47, P134, DOI 10.3778/j.issn.1002-8331.2011.14.038; XIAO SC, 2004, AUDIO ENG, V6, P37, DOI DOI 10.1016/J.SIGPRO.2011.03.020; Zao L, 2014, IEEE SIGNAL PROC LET, V21, P620, DOI 10.1109/LSP.2014.2311435; Zhang Baoqi, 2010, Acta Acustica, V35, P701; Zhang T, 2013, 2013 3RD INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND NETWORK TECHNOLOGY (ICCSNT), P1050, DOI 10.1109/ICCSNT.2013.6967284; ZHANG X, 2007, NONINVASIVE ESTIMATI, P506; Zhao XF, 2008, CAN CON EL COMP EN, P139	44	1	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184267	10.1371/journal.pone.0184267	http://dx.doi.org/10.1371/journal.pone.0184267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926572	Green Submitted, gold, Green Published			2022-12-27	WOS:000411166600013
J	Duc, C; Pradal, M; Sanchez, I; Noble, J; Tesniere, C; Blondin, B				Duc, Camille; Pradal, Martine; Sanchez, Isabelle; Noble, Jessica; Tesniere, Catherine; Blondin, Bruno			A set of nutrient limitations trigger yeast cell death in a nitrogen-dependent manner during wine alcoholic fermentation	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; ASSIMILABLE NITROGEN; PANTOTHENIC-ACID; MICROARRAY DATA; METABOLISM; EXPRESSION; KINETICS; GLYCOGEN; GROWTH	Yeast cell death can occur during wine alcoholic fermentation. It is generally considered to result from ethanol stress that impacts membrane integrity. This cell death mainly occurs when grape musts processing reduces lipid availability, resulting in weaker membrane resistance to ethanol. However the mechanisms underlying cell death in these conditions remain unclear. We examined cell death occurrence considering yeast cells ability to elicit an appropriate response to a given nutrient limitation and thus survive starvation. We show here that a set of micronutrients (oleic acid, ergosterol, pantothenic acid and nicotinic acid) in low, growth-restricting concentrations trigger cell death in alcoholic fermentation when nitrogen level is high. We provide evidence that nitrogen signaling is involved in cell death and that either SCH9 deletion or Tor inhibition prevent cell death in several types of micronutrient limitation. Under such limitations, yeast cells fail to acquire any stress resistance and are unable to store glycogen. Unexpectedly, transcriptome analyses did not reveal any major changes in stress genes expression, suggesting that post-transcriptional events critical for stress response were not triggered by micronutrient starvation. Our data point to the fact that yeast cell death results from yeast inability to trigger an appropriate stress response under some conditions of nutrient limitations most likely not encountered by yeast in the wild. Our conclusions provide a novel frame for considering both cell death and the management of nutrients during alcoholic fermentation.	[Duc, Camille; Pradal, Martine; Sanchez, Isabelle; Tesniere, Catherine; Blondin, Bruno] Univ Montpellier, Montpellier SupAgro, INRA, UMR SPO, Montpellier, France; [Duc, Camille; Noble, Jessica] Lallemand SAS, Blagnac, France	INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Lallemand - France	Blondin, B (corresponding author), Univ Montpellier, Montpellier SupAgro, INRA, UMR SPO, Montpellier, France.	bruno.blondin@supagro.fr	Tesnière, Catherine/L-8771-2018	Tesnière, Catherine/0000-0003-4865-9229				Alexandre H, 1994, UNION OENOLOGUES FRA, V34, P11; Ambroset C, 2011, GENET, V1; [Anonymous], 2014, PLOS ONE, V9; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; BELY M, 1990, AM J ENOL VITICULT, V41, P319; Bisson LF, 1999, AM J ENOL VITIC, V50; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Carmona-Gutierrez D, 2012, CELL DEATH DIFFER, V19, P913, DOI 10.1038/cdd.2012.31; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delobel P, 2012, LETT APPL MICROBIOL, V55, P338, DOI 10.1111/j.1472-765X.2012.03301.x; Enjalbert B, 2000, MICROBIOL-SGM, V146, P2685, DOI 10.1099/00221287-146-10-2685; Fabrizio P, 2003, GENETICS, V163, P35; Guaragnella N, 2011, BIOCH SOC T, V39; Hagen KM, 2008, AM J ENOL VITICULT, V59, P432; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kitagaki H, 2007, ETHANOL INDUCED DEAT; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Landolfo S, 2008, BBA-GEN SUBJECTS, V1780, P892, DOI 10.1016/j.bbagen.2008.03.008; Leadsham JE, 2009, J CELL SCI, V122, P706, DOI 10.1242/jcs.042424; Li LH, 2013, MOL BIOL CELL, V24, P3697, DOI 10.1091/mbc.E13-05-0241; Lis P, 2016, ONCOTARGET, V7, P10153, DOI 10.18632/oncotarget.7174; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; NI HT, 1995, MOL MICROBIOL, V16, P1197, DOI 10.1111/j.1365-2958.1995.tb02342.x; Orozco H, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-104; Orozco H, 2012, MECH AGEING DEV, V133, P348, DOI 10.1016/j.mad.2012.03.013; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Quan ZZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005282; R Core Team, 2014, NO TITLE R A LANGUAG; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; SABLAYROLLES JM, 1989, BIOPROCESS ENG, V4, P139, DOI 10.1007/BF00369763; Sablayrolles JM, 1987, BIOTECHNOL TECH, V1; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tesniere C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061645; Tsang F, 2015, J BIOL CHEM, V290, P12753, DOI 10.1074/jbc.M115.644534; Wang XD, 2003, J APPL MICROBIOL, V94, P349, DOI 10.1046/j.1365-2672.2003.01827.x; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Zhang R, 2012, J CHROMATOGR SCI, V50, P598, DOI 10.1093/chromsci/bms035	44	29	29	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184838	10.1371/journal.pone.0184838	http://dx.doi.org/10.1371/journal.pone.0184838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922393	Green Submitted, gold, Green Published			2022-12-27	WOS:000411059300032
J	Okubo, T; Osaki, T; Nozaki, E; Uemura, A; Sakai, K; Matushita, M; Matsuo, J; Nakamura, S; Kamiya, S; Yamaguchi, H				Okubo, Torahiko; Osaki, Takako; Nozaki, Eriko; Uemura, Akira; Sakai, Kouhei; Matushita, Mizue; Matsuo, Junji; Nakamura, Shinji; Kamiya, Shigeru; Yamaguchi, Hiroyuki			Walker occupancy has an impact on changing airborne bacterial communities in an underground pedestrian space, as small-dust particles increased with raising both temperature and humidity	PLOS ONE			English	Article							INDOOR AIR; OUTDOOR AIR; RESPIRATORY HEALTH; EXPOSURE; RESUSPENSION; POLLUTANTS; DEPOSITION; DIVERSITY; POLLUTION; SYSTEM	Although human occupancy is a source of airborne bacteria, the role of walkers on bacterial communities in built environments is poorly understood. Therefore, we visualized the impact of walker occupancy combined with other factors (temperature, humidity, atmospheric pressure, dust particles) on airborne bacterial features in the Sapporo underground pedestrian space in Sapporo, Japan. Air samples (n = 18; 4,800L/each sample) were collected at 8: 00 h to 20: 00 h on 3 days (regular sampling) and at early morning/late night (5: 50 h to 7: 50 h/22: 15 h to 24: 45 h) on a day (baseline sampling), and the number of CFUs (colony forming units) OTUs (operational taxonomic units) and other factors were determined. The results revealed that temperature, humidity, and atmospheric pressure changed with weather. The number of walkers increased greatly in the morning and evening on each regular sampling day, although total walker numbers did not differ significantly among regular sampling days. A slight increase in small dust particles (0.3-0.5 mu m) was observed on the days with higher temperature regardless of regular or baseline sampling. At the period on regular sampling, CFU levels varied irregularly among days, and the OTUs of 22-phylum types were observed, with the majority being from Firmicutes or Proteobacteria (gamma-), including Staphylococcus sp. derived from human individuals. The data obtained from regular samplings reveled that although no direct interaction of walker occupancy and airborne CFU and OTU features was observed upon Pearson's correlation analysis, cluster analysis indicated an obvious lineage consisting of walker occupancy, CFU numbers, OTU types, small dust particles, and seasonal factors (including temperature and humidity). Meanwhile, at the period on baseline sampling both walker and CFU numbers were similarly minimal. Taken together, the results revealed a positive correlation of walker occupancy with airborne bacteria that increased with increases in temperature and humidity in the presence of airborne small particles. Moreover, the results indicated that small dust particles at high temperature and humidity may be a crucial factor responsible for stabilizing the bacteria released from walkers in built environments. The findings presented herein advance our knowledge and understanding of the relationship between humans and bacterial communities in built environments, and will help improve public health in urban communities.	[Okubo, Torahiko; Uemura, Akira; Sakai, Kouhei; Matushita, Mizue; Matsuo, Junji; Yamaguchi, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Osaki, Takako; Nozaki, Eriko; Kamiya, Shigeru] Kyorin Univ, Sch Med, Dept Infect Dis, Mitaka, Tokyo, Japan; [Nakamura, Shinji] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Bunkyo Ku, Tokyo, Japan	Hokkaido University; Kyorin University; Juntendo University	Yamaguchi, H (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Kita Ku, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp	Okubo, Torahiko/Q-1707-2019	Okubo, Torahiko/0000-0002-3194-5862	Management Expenses Grant for National University; Japan Society for the Promotion of Science in Japan [15K08471]; Grants-in-Aid for Scientific Research [15K08471] Funding Source: KAKEN	Management Expenses Grant for National University; Japan Society for the Promotion of Science in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Although this study was supported by the Management Expenses Grant for National University and the Japan Society for the Promotion of Science in Japan (15K08471), we declare that the funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript and except these, there was no additional external funding received for this study.	Adams RI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128022; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Bhangar S, 2014, INDOOR AIR, V24, P604, DOI 10.1111/ina.12111; Bouillard L, 2005, ANN AGR ENV MED, V12, P187; Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Dybwad M, 2014, APPL ENVIRON MICROB, V80, P257, DOI 10.1128/AEM.02849-13; Ferro AR, 2004, ENVIRON SCI TECHNOL, V38, P1759, DOI 10.1021/es0263893; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Ghosh B, 2015, ENVIRON INT, V85, P254, DOI 10.1016/j.envint.2015.09.018; Guo H, 2010, ENVIRON SCI POLLUT R, V17, P1268, DOI 10.1007/s11356-010-0306-2; Johnson L, 2010, J OCCUP ENVIRON HYG, V7, P585, DOI 10.1080/15459624.2010.508951; Karottki DG, 2015, INT J ENV RES PUB HE, V12, P1667, DOI 10.3390/ijerph120201667; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; LUCKEY TD, 1972, AM J CLIN NUTR, V25, P1292; Menetrez MY, 2001, J AIR WASTE MANAGE, V51, P1436, DOI 10.1080/10473289.2001.10464365; Nicolas M, 2009, ENVIRON SCI TECHNOL, V43, P7437, DOI 10.1021/es901569d; Ouidir M, 2015, ENVIRON INT, V84, P161, DOI 10.1016/j.envint.2015.07.021; Pantelic J, 2015, INDOOR AIR, V25, P683, DOI 10.1111/ina.12187; Pope CA, 1999, ENVIRON HEALTH PERSP, V107, P567, DOI 10.2307/3434399; Prussin AJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0144-z; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Qian J, 2008, AEROSOL SCI TECH, V42, P566, DOI 10.1080/02786820802220274; Rivas I, 2014, ENVIRON INT, V69, P200, DOI 10.1016/j.envint.2014.04.009; Rosenfelder M, 2016, INT J BIOMETEOROL, V60, P277, DOI 10.1007/s00484-015-1024-8; Sanchez-Soberon F, 2015, ENVIRON RES, V143, P10, DOI 10.1016/j.envres.2015.09.008; THATCHER TL, 1995, ATMOS ENVIRON, V29, P1487, DOI 10.1016/1352-2310(95)00016-R; Tischer C, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0042-y; Tschernig T, EXPT TOXICOLOGIC PAT, V65, P883; van Kampen V, 2014, ANN OCCUP HYG, V58, P693, DOI 10.1093/annhyg/meu026; Verschaeve L, 2009, MED HYPOTHESES, V73, P802, DOI 10.1016/j.mehy.2009.01.058; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang J, 2015, INDOOR AIR, V25, P176, DOI 10.1111/ina.12127; Yang W, 2011, J EXPO SCI ENV EPID, V21, P310, DOI 10.1038/jes.2010.23	36	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184980	10.1371/journal.pone.0184980	http://dx.doi.org/10.1371/journal.pone.0184980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922412	Green Submitted, Green Published, gold			2022-12-27	WOS:000411059300051
J	Yoon, JR; Lee, DH; Ko, SN; Shin, YS				Yoon, Jung-Ro; Lee, Dae-Hee; Ko, Seung-Nam; Shin, Young-Soo			Proprioception in patients with posterior cruciate ligament tears: A meta-analysis comparison of reconstructed and contralateral normal knees	PLOS ONE			English	Article							JOINT POSITION SENSE; REMNANT PRESERVATION; INJURY	Posterior cruciate ligament (PCL) reconstruction for patients with PCL insufficiency has been associated with postoperative improvements in proprioceptive function due to mechanoreceptor regeneration. However, it is unclear whether reconstructed PCL or contralateral normal knees have better proprioceptive function outcomes. This meta-analysis was designed to compare the proprioceptive function of reconstructed PCL or contralateral normal knees in patients with PCL insufficiency. All studies that compared proprioceptive function, as assessed with threshold to detect passive movement (TTDPM) or joint position sense (JPS) in PCL reconstructed or contralateral normal knees were included. JPS was calculated by reproducing passive positioning (RPP). Five studies met the inclusion/exclusion criteria for the meta-analysis. The proprioceptive function, defined as TTDPM (95% CI: 0.25 to 0.51 degrees; P<0.00001) and RPP (95% CI: 0.19 to 0.45 degrees; P<0.00001), was significantly different between the reconstructed PCL and contralateral normal knees. The mean difference in angle of error between the reconstructed PCL and contralateral normal knees was 0.06 degrees greater in TTDPM than by RPP. In addition, results from subgroup analyses, based on the starting angles and the moving directions of the knee, that evaluated TTDPM at 15 degrees flexion to 45 degrees extension, TTDPM at 45 degrees flexion to 110 degrees flexion, RPP in flexion, and RPP in extension demonstrated that mean angles of error were significantly greater, by 0.38 degrees (P = 0.0001), 0.36 degrees (P = 0.02), 0.36 degrees (P<0.00001), and 0.23 degrees (P = 0.04), respectively, in reconstructed PCL than in contralateral normal knees. The proprioceptive function of PCL reconstructed knees was decreased, compared with contralateral normal knees, as determined by both TTDPM and RPP. In addition, the amount of loss of proprioception was greater in TTDPM than in RPP, even with minute differences. Results from subgroup analysis, that evaluated the mean angles of error in moving directions through RPP, suggested that the moving direction of flexion has a significantly greater mean for angles of error than the moving direction of extension. Although the level of differences between various parameters were statistically significant, further studies are needed to determine whether the small differences (>1 degrees) of the loss of proprioception are clinically relevant.	[Yoon, Jung-Ro; Ko, Seung-Nam; Shin, Young-Soo] Vet Hlth Serv Med Ctr, Dept Orthoped Surg, Seoul, South Korea; [Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthoped Surg, Seoul, South Korea	Veterans Health Service Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Shin, YS (corresponding author), Vet Hlth Serv Med Ctr, Dept Orthoped Surg, Seoul, South Korea.	sysoo3180@naver.com	lee, dae hee/I-9390-2017					Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Adachi N, 2007, KNEE SURG SPORT TR A, V15, P2, DOI 10.1007/s00167-006-0127-5; Arockiaraj J, 2013, BONE JOINT J, V95B, P188, DOI 10.1302/0301-620X.95B2.30566; BARRACK RL, 1984, J SPORT MED PHYS FIT, V24, P18; Beynnon BD, 2000, PROPRIOCEPTION AND NEUROMUSCULAR CONTROL IN JOINT STABILITY, P127; Callaghan MJ, 2002, J ATHL TRAINING, V37, P19; Cash RM, 1996, CLIN ORTHOP RELAT R, P172; Chouteau J, 2012, KNEE SURG SPORT TR A, V20, P762, DOI 10.1007/s00167-012-1879-8; Clark P, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P225, DOI 10.1007/BF01567967; Eguchi A, 2014, ORTHOP TRAUMATOL-SUR, V100, P303, DOI 10.1016/j.otsr.2013.12.020; Friden T, 1997, J ORTHOP RES, V15, P637, DOI 10.1002/jor.1100150502; Grob KR, 2002, J BONE JOINT SURG BR, V84B, P614, DOI 10.1302/0301-620X.84B4.11241; Herrington L, 2005, J SPORT REHABIL, V14, P356, DOI 10.1123/jsr.14.4.356; Iwasa J, 2000, CLIN ORTHOP RELAT R, P168, DOI 10.1097/00003086-200012000-00020; Jung HJ, 2013, KNEE SURG SPORT TR A, V21, P1029, DOI 10.1007/s00167-012-2111-6; Katayama M, 2004, INT ORTHOP, V28, P278, DOI 10.1007/s00264-004-0583-9; KATONIS PG, 1991, ACTA ORTHOP SCAND, V62, P276, DOI 10.3109/17453679108993609; Kim YM, 2011, AM J SPORT MED, V39, P425, DOI 10.1177/0363546510374452; Lee DW, 2014, AM J SPORT MED, V42, P1822, DOI 10.1177/0363546514536680; Lee Dung Chul, 2013, Knee Surg Relat Res, V25, P126, DOI 10.5792/ksrr.2013.25.3.126; Lephart SM, 1997, AM J SPORT MED, V25, P130, DOI 10.1177/036354659702500126; Li J, PROSPECTIVE RANDOMIZ; Liabaud B, 2013, KNEE, V20, P412, DOI 10.1016/j.knee.2013.02.001; MATTHEWS PBC, 1988, CAN J PHYSIOL PHARM, V66, P430, DOI 10.1139/y88-073; Ogard WK, 2011, STRENGTH COND J, V33, P111, DOI 10.1519/SSC.0b013e31821bf3ae; Raunest J, 1998, ARCH ORTHOP TRAUM SU, V118, P159, DOI 10.1007/s004020050338; Ribot-Ciscar E, 1998, BRAIN RES, V791, P167, DOI 10.1016/S0006-8993(98)00092-4; Roberts D, 2000, J ORTHOPAED RES, V18, P565, DOI 10.1002/jor.1100180408; Safran MR, 1999, J SPORT REHABIL, V8, P304, DOI 10.1123/jsr.8.4.304; Wells G.A., NEWCASTLE OTTAWA SCA	30	3	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184812	10.1371/journal.pone.0184812	http://dx.doi.org/10.1371/journal.pone.0184812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922423	Green Submitted, Green Published, gold			2022-12-27	WOS:000411059300028
J	Ostermann, JK; Witt, CM; Reinhold, T				Ostermann, Julia K.; Witt, Claudia M.; Reinhold, Thomas			A retrospective cost-analysis of additional homeopathic treatment in Germany: Long-term economic outcomes	PLOS ONE			English	Article							DISORDERS; TRIAL; CARE	Objectives This study aimed to provide a long-term cost comparison of patients using additional homeopathic treatment (homeopathy group) with patients using usual care (control group) over an observation period of 33 months. Methods Health claims data from a large statutory health insurance company were analysed from both the societal perspective (primary outcome) and from the statutory health insurance perspective (secondary outcome). To compare costs between patient groups, homeopathy and control patients were matched in a 1: 1 ratio using propensity scores. Predictor variables for the propensity scores included health care costs and both medical and demographic variables. Health care costs were analysed using an analysis of covariance, adjusted for baseline costs, between groups both across diagnoses and for specific diagnoses over a period of 33 months. Specific diagnoses included depression, migraine, allergic rhinitis, asthma, atopic dermatitis, and headache. Results Data from 21,939 patients in the homeopathy group (67.4% females) and 21,861 patients in the control group (67.2% females) were analysed. Health care costs over the 33 months were 12,414 EUR [95% CI 12,022-12,805] in the homeopathy group and 10,428 EUR [95% CI 10,036-10,820] in the control group (p< 0.0001). The largest cost differences were attributed to productivity losses (homeopathy: EUR 6,289 [6,118-6,460]; control: EUR 5,498 [5,326-5,670], p< 0.0001) and outpatient costs (homeopathy: EUR 1,794 [1,770-1,818]; control: EUR 1,438 [1,414-1,462], p< 0.0001). Although the costs of the two groups converged over time, cost differences remained over the full 33 months. For all diagnoses, homeopathy patients generated higher costs than control patients. Conclusion The analysis showed that even when following-up over 33 months, there were still cost differences between groups, with higher costs in the homeopathy group.	[Ostermann, Julia K.; Witt, Claudia M.; Reinhold, Thomas] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Witt, Claudia M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Maryland; University of Maryland Baltimore	Ostermann, JK (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	julia.ostermann@charite.de	Witt, Claudia M./AAX-2370-2021	Witt, Claudia M./0000-0002-5440-7805; Reinhold, Thomas/0000-0001-5169-7029; Ostermann, Julia/0000-0002-0180-8752	statutory health insurance company Techniker Krankenkasse	statutory health insurance company Techniker Krankenkasse	This is an investigator initiated study that is co-sponsored by the statutory health insurance company Techniker Krankenkasse. The co-sponsor provided data, but was not involved in the main data analysis, data interpretation, writing, or decision to submit the manuscript. All authors had full access to the data and are responsible for the veracity and completeness of the data reported. All authors had full access to the data in the study and take final responsibility to submit for publication.	Anlauf M, 2015, GMS, P13; [Anonymous], 2014, R LANG ENV STAT COMP; Baars EW, 2014, BMJ OPEN, V4, DOI DOI 10.1136/BMJ0PEN-2014-005332; Brien S, 2011, RHEUMATOLOGY, V50, P1070, DOI 10.1093/rheumatology/keq234; DZVh&Auml;, 2012, SEL KLASS HOM BET KR; Friemel S, 2005, PSYCHIAT PRAX, V32, P113, DOI 10.1055/s-2004-834611; House of Commons Science and Technology Committee, 2010, EV CHECK 2 HOM; Insel TR, 2008, AM J PSYCHIAT, V165, P663, DOI 10.1176/appi.ajp.2008.08030366; Jain Asha, 2003, Homeopathy, V92, P71, DOI 10.1016/S1475-4916(03)00004-3; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Kliems H, 2011, J ALTERN COMPLEM MED, V17, P265, DOI 10.1089/acm.2010.0158; MADDOX J, 1988, NATURE, V334, P287, DOI 10.1038/334287a0; Marian F, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-52; Mathie RT, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-142; OPATHIE Keine Abrechnung zulasten der gesetzlichen Krankenversicherung, 2017, DTSCH ARZTEBL, V114; Ostermann JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134657; Roll S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054973; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; SIMON G, 1995, AM J PSYCHIAT, V152, P352; Smith K, 2012, BIOETHICS, V26, P398, DOI 10.1111/j.1467-8519.2010.01876.x; Statistisches Bundesamt, 2014, JAHR ARB; Studer HP, 2011, FORSCH KOMPLEMENTMED, V18, P315, DOI 10.1159/000334797; Thompson EA, 2011, HOMEOPATHY, V100, P122, DOI 10.1016/j.homp.2011.05.001; Viksveen P, 2014, EUR J HEALTH ECON, V15, P157, DOI 10.1007/s10198-013-0462-7; Witt C, 2005, COMPLEMENT THER MED, V13, P79, DOI 10.1016/j.ctim.2005.03.005; Witt CM, 2009, DERMATOLOGY, V219, P329, DOI 10.1159/000248854	27	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0182897	10.1371/journal.pone.0182897	http://dx.doi.org/10.1371/journal.pone.0182897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915242	Green Submitted, Green Published, gold			2022-12-27	WOS:000410861600003
J	Horemheb-Rubio, G; Ramos-Cervantes, P; Arroyo-Figueroa, H; Avila-Rios, S; Garcia-Morales, C; Reyes-Teran, G; Escobedo, G; Estrada, G; Garcia-Iglesias, T; Munoz-Saucedo, N; Kershenobich, D; Ostrosky-Wegman, P; Ruiz-Palacios, GM				Horemheb-Rubio, Gibran; Ramos-Cervantes, Pilar; Arroyo-Figueroa, Hugo; Avila-Rios, Santiago; Garcia-Morales, Claudia; Reyes-Teran, Gustavo; Escobedo, Galileo; Estrada, Gloria; Garcia-Iglesias, Trinidad; Munoz-Saucedo, Nayeli; Kershenobich, David; Ostrosky-Wegman, Patricia; Ruiz-Palacios, Guillermo M.			High HPgV replication is associated with improved surrogate markers of HIV progression	PLOS ONE			English	Article							GB-VIRUS-C; C/HEPATITIS-G-VIRUS; BLOOD-DONORS; PHYLOGENETIC ANALYSIS; DOWN-REGULATION; HIGH PREVALENCE; INFECTION; TRANSMISSION; RNA; RECOMBINATION	Background Human Pegivirus (HPgV) may have a beneficial effect on HIV disease progression in co-infected patients; however, the virologic characteristics of this infection are not well defined. In this study, we determined HPgV viremia prevalence in Mexico and provide new insights to understand HPgV infection and HPgV/HIV co-infection. Methods We analyzed and quantified 7,890 serum samples for HPgV viremia by One-Step RT-Real-Time PCR, 6,484 from healthy blood donors and 1,406 from HIV-infected patients. Data on HIV progression were obtained from patients' records. HPgV genotyping was performed in 445 samples by nested PCR of the 5'URT region. Finite Mixture Models were used to identify clustering patterns of HPgV viremia in blood donors and co-infected antiretroviral (ART)naive patients. Results HPgV was detected in 2.98% of blood donors and 33% of HIV patients, with a wide range of viral loads. The most prevalent genotypes were 3 (58.6%) and 2 (33.7%). HPgV viral loads from healthy blood donors and HPgV/HIV+ ART-naive co-infected patients were clustered into two component distributions, low and high, with a cut-off point of 5.07log(10) and 5.06log(10), respectively. High HPgV viremia was associated with improved surrogate markers of HIV infection, independent of the estimated duration of HIV infection or HIV treatment. Conclusions HPgV prevalence in Mexico was similar to that reported for other countries. The prevalent genotypes could be related to Mexico's geographic location and ethnicity, since genotype 2 is frequent in the United States and Europe and genotype 3 in Asia and Amerindian populations. HPgV viral load demonstrated two patterns of replication, low and high. The more pronounced beneficial response observed in co-infected patients with high HPgV viremia may explain discrepancies found between other studies. Mechanisms explaining high and low HPgV replication should be explored to determine whether the persistently elevated replication depends on host or viral factors.	[Horemheb-Rubio, Gibran; Ramos-Cervantes, Pilar; Arroyo-Figueroa, Hugo; Ruiz-Palacios, Guillermo M.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; [Avila-Rios, Santiago; Garcia-Morales, Claudia; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Infect Dis Res Ctr, Mexico City, DF, Mexico; [Escobedo, Galileo] Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Liver Pancreas & Intestinal Motil Lab, Mexico City, DF, Mexico; [Estrada, Gloria] Hosp Gen Mexico City, Blood Bank, Mexico City, DF, Mexico; [Garcia-Iglesias, Trinidad; Munoz-Saucedo, Nayeli] Univ Guadalajara, Ctr Univ Ciencias Salud, Immnuol Lab, Guadalajara, Jalisco, Mexico; [Kershenobich, David] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Ostrosky-Wegman, Patricia] Univ Nacl Autonoma Mexico, Biomed Res Inst, Mexico City, DF, Mexico; [Estrada, Gloria] Inst Nacl Transfus Sanguinea, Res & Normat, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Universidad de Guadalajara; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico	Ruiz-Palacios, GM (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico.	gmrps@unam.mx	Ruiz-Palacios, Guillermo/GYQ-5462-2022; Avila-Rios, Santiago/AAB-4383-2020	Reyes-Teran, Gustavo/0000-0002-4115-4888	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [323782]; CONACyT [323782]	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We did not receive any specific funding for this research work, except for a PhD scholarship from CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico), fellowship no. 323782, for the first author, Gibran Horemheb-Rubio, MD.; We thank Beatriz Remus, MD, for reviewing the manuscript and Gioconda Vallarta, MA, for design of the manuscript's diagrams. Gibran Horemheb Rubio Quintanares, MD, is a doctoral student from Programa de Doctorado de Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship No. 323782 from CONACyT.	AbuOdeh RO, 2015, J MED VIROL, V87, P2074, DOI 10.1002/jmv.24289; Alvarado-Mora MV, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-345; Anggorowati N, 2013, MICROBIOL IMMUNOL, V57, P298, DOI 10.1111/1348-0421.12033; [Anonymous], 2000, AIDS Res Hum Retroviruses, V16, P1123; Avila-Rios S, 2011, PLOS ONE, P6; Avila-Rios S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142604; Berzsenyi MD, 2011, J HEPATOL, V55, P536, DOI 10.1016/j.jhep.2010.12.021; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Biernacki C, 2003, COMPUT STAT DATA AN, V41, P561, DOI 10.1016/S0167-9473(02)00163-9; Bishop C.M., 2006, PATTERN RECOGN, P423; Bjorkman P, 2001, VOX SANG, V81, P148, DOI 10.1046/j.1423-0410.2001.00098.x; Bjorkman P, 2007, AIDS, V21, P1641, DOI 10.1097/QAD.0b013e32823bc9b7; Blackard JT, 2016, J GEN VIROL, V97, P1537, DOI 10.1099/jgv.0.000477; Blackard JT, 2017, J MED VIROL; Chang CM, 2014, CANCER RES, V74, P5553, DOI 10.1158/0008-5472.CAN-14-0209; Chivero ET, 2014, J GEN VIROL, V95, P1307, DOI 10.1099/vir.0.063016-0; Dmitriev P. N., 2010, Voprosy Virusologii, V55, P23; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Feng Y, 2011, CHINA PLOS ONE, P6; Feng Y, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.14169; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Handelsman E, 2007, HIV MED, V8, P561, DOI 10.1111/j.1468-1293.2007.00510.x; Kaye S, 2005, CLIN INFECT DIS, V40, P876, DOI 10.1086/428123; Keys JR, 2014, J MED VIROL, V86, P473, DOI 10.1002/jmv.23829; Keyvani H, 2012, HEPAT MON, V12, P38, DOI 10.5812/kowsar.1735143X.817; Krajden M, 2010, INT J CANCER, V126, P2885, DOI 10.1002/ijc.25035; Lanteri MC, 2015, J INFECT DIS, V211, P1585, DOI 10.1093/infdis/jiu660; Lauck M, 2015, J VIROL, V89, P2425, DOI 10.1128/JVI.02752-14; Liu P, 1997, TRANSFUSION, V37, P732, DOI 10.1046/j.1537-2995.1997.37797369450.x; Loureiro CL, 2002, J MED VIROL, V68, P357, DOI 10.1002/jmv.10211; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Muerhoff AS, 2005, J GEN VIROL, V86, P1729, DOI 10.1099/vir.0.80854-0; Muerhoff AS, 1996, J HEPATOL, V25, P379, DOI 10.1016/S0168-8278(96)80125-5; Naito H, 2001, J VIROL METHODS, V91, P3, DOI 10.1016/S0166-0934(00)00207-X; Neibecker M, 2011, J MED VIROL, V83, P685, DOI 10.1002/jmv.22029; Nerurkar VR, 1998, J MED VIROL, V56, P123, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;123::AID-JMV4&gt;3.0.CO;2-A; Oubina JR, 1999, VIRUS RES, V65, P121, DOI 10.1016/S0168-1702(99)00109-4; Patrikar Seema, 2014, Med J Armed Forces India, V70, P134, DOI 10.1016/j.mjafi.2013.08.005; Quiros E, 1998, EUR J EPIDEMIOL, V14, P617, DOI 10.1023/A:1007448501661; Re V, 2001, VOX SANG, V81, P54, DOI 10.1046/j.1423-0410.2001.00076.x; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Schleicher SB, 2003, J MED VIROL, V71, P226, DOI 10.1002/jmv.10474; Sentjens R, 2003, TRANSFUSION, V43, P1558, DOI 10.1046/j.1537-2995.2003.00561.x; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Stapleton JT, 2009, AIDS, V23, P605, DOI 10.1097/QAD.0b013e32831f1b00; Tamura K, MEGA6 MOL EVOLUTIONA; Tanaka Y, 1998, AM J TROP MED HYG, V59, P462, DOI 10.4269/ajtmh.1998.59.462; Vahidnia F, 2012, CLIN INFECT DIS, V55, P1012, DOI 10.1093/cid/cis589; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Young D, 2017, PACKAGE MIXTOOLS; Zanetti AR, 1998, J MED VIROL, V54, P107, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt;107::AID-JMV7&gt;3.0.CO;2-A; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x	53	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184494	10.1371/journal.pone.0184494	http://dx.doi.org/10.1371/journal.pone.0184494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910347	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200052
J	Woo, YC; Lee, CH; Fong, CHY; Tso, AWK; Cheung, BMY; Lam, KSL				Woo, Yu Cho; Lee, Chi Ho; Fong, Carol H. Y.; Tso, Annette W. K.; Cheung, Bernard M. Y.; Lam, Karen S. L.			Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population	PLOS ONE			English	Article							FOLLOW-UP; RISK; PREVALENCE; SCORE; CRITERIA	Aim Diabetes is a serious global health problem. A simple and effective screening tool should have substantial public health benefit. We investigated the performance of the latest American Diabetes Association diabetes screening methods in our aging Chinese population. Methods Subjects without diabetes who returned for the 4th Hong Kong Cardiovascular Risk Factors Prevalence Study in 2010-2012 were evaluated for the probability of having diabetes with reference to the age-and body mass index-based screening criteria (screening criteria) and the diabetes risk test (risk test), and the conclusion drawn was compared to their measured glycaemic status. Diabetes was defined by fasting glucose >= 7 mmol/L or 2-hour post oral glucose tolerance test glucose >= 11.1 mmol/L. Results 1415 subjects, aged 58.1 +/- 10.2, were evaluated. 95 (6.7%) had diabetes. The risk test showed good accuracy (area under the receiver operating curve 0.725) in screening for diabetes with an optimal cut-off score of five. Compared to the screening criteria, the risk test had significantly better specificity (0.57 vs. 0.41, p < 0.001), positive predictive value (0.12 vs. 0.09, p < 0.001) and positive diagnostic likelihood ratio (1.85 vs. 1.37, p < 0.001). To diagnose one case of diabetes, fewer subjects (11 vs. 18) needed to be tested for blood glucose if the risk test was adopted. Conclusion The risk test appears to be a more effective screening tool in our population. It is simple to use and can be adopted as a public health strategy for identifying people with undiagnosed diabetes for early intervention.	[Woo, Yu Cho; Lee, Chi Ho; Fong, Carol H. Y.; Tso, Annette W. K.; Cheung, Bernard M. Y.; Lam, Karen S. L.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lee, Chi Ho; Cheung, Bernard M. Y.; Lam, Karen S. L.] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Cheung, BMY; Lam, KSL (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.; Cheung, BMY; Lam, KSL (corresponding author), Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.	mycheung@hku.hk; ksllam@hku.hk	Lee, Chi HO/AAS-7948-2021; Lee, Paul Chi-Ho/GZG-6173-2022; /E-9829-2010	Lee, Chi-Ho/0000-0002-7569-409X; /0000-0001-9106-7363	Hong Kong Research Grants Council [GRF HKU/763312]; Ng Teng Fong Charitable Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Ng Teng Fong Charitable Foundation	This work was supported from the Hong Kong Research Grants Council (GRF HKU/763312) and Ng Teng Fong Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS75; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Census and Statistics Department HKSAR, 2016, WOM MEN HONG KONG KE; Cheung BMY, 2007, DIABETES CARE, V30, P1430, DOI 10.2337/dc06-1820; Christian Stock TH, 2014, DTCOMPAIR COMP BINAR; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gu W, 2009, BIOSTATISTICS, V10, P172, DOI 10.1093/biostatistics/kxn025; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Mason C, 2009, OBESITY, V17, P1789, DOI 10.1038/oby.2009.87; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Moskowitz CS, 2006, CLIN TRIALS, V3, P272, DOI 10.1191/1740774506cn147oa; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Rembold CM, 1998, BMJ-BRIT MED J, V317, P307, DOI 10.1136/bmj.317.7154.307; Tso AWK, 2006, DIABETOLOGIA, V49, P1806, DOI 10.1007/s00125-006-0324-2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang WQ, 1998, DIABETES RES CLIN PR, V39, P185, DOI 10.1016/S0168-8227(98)00002-3; Waugh NR, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17350; Woo YC, 2015, DIABETIC MED, V32, P1207, DOI 10.1111/dme.12691; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184840	10.1371/journal.pone.0184840	http://dx.doi.org/10.1371/journal.pone.0184840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910380	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200104
J	Belkaid, M; Cuperlier, N; Gaussier, P				Belkaid, Marwen; Cuperlier, Nicolas; Gaussier, Philippe			Emotional metacontrol of attention: Top-down modulation of sensorimotor processes in a robotic visual search task	PLOS ONE			English	Article							NOVELTY; SYSTEMS; BRAIN; MODEL	Emotions play a significant role in internal regulatory processes. In this paper, we advocate four key ideas. First, novelty detection can be grounded in the sensorimotor experience and allow higher order appraisal. Second, cognitive processes, such as those involved in self-assessment, influence emotional states by eliciting affects like boredom and frustration. Third, emotional processes such as those triggered by self-assessment influence attentional processes. Last, close emotion-cognition interactions implement an efficient feedback loop for the purpose of top-down behavior regulation. The latter is what we call 'Emotional Metacontrol'. We introduce a model based on artificial neural networks. This architecture is used to control a robotic system in a visual search task. The emotional metacontrol intervenes to bias the robot visual attention during active object recognition. Through a behavioral and statistical analysis, we show that this mechanism increases the robot performance and fosters the exploratory behavior to avoid deadlocks.	[Belkaid, Marwen; Cuperlier, Nicolas; Gaussier, Philippe] Univ Cergy Pontoise, ENSEA, CNRS, Univ Paris Seine,ETIS UMR 8051, Cergy Pontoise, France	Centre National de la Recherche Scientifique (CNRS); CY Cergy Paris Universite	Belkaid, M (corresponding author), Univ Cergy Pontoise, ENSEA, CNRS, Univ Paris Seine,ETIS UMR 8051, Cergy Pontoise, France.	marwen.belkaid@ensea.fr	Cuperlier, Nicolas/AAS-2637-2020; Belkaid, Marwen/AAF-7835-2021	Cuperlier, Nicolas/0000-0001-7610-3143; Belkaid, Marwen/0000-0003-2358-2560	MENESR (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche); Centre National de la Recherche Scientifique (CNRS); ANR DIRAC [ANR-13-ASTR-0018]; Ecole Doctorale "Science et Ingenierie" of the Universite de Cergy Pontoise	MENESR (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ANR DIRAC(French National Research Agency (ANR)); Ecole Doctorale "Science et Ingenierie" of the Universite de Cergy Pontoise	This research was supported by the MENESR (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche), the Centre National de la Recherche Scientifique (CNRS) and the ANR DIRAC ANR-13-ASTR-0018. MB was supported by The Ecole Doctorale "Science et Ingenierie" of the Universite de Cergy Pontoise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the reviewers for their comments, A. Jauffret for his contribution in previous works on the emotional metacontrol, R. Braud, A. Karaouzene and G. Mostafaoui for their advice regarding the visual processing system, and Nils and Orianne for providing the stuffed animals used in the experiment. This work was supported by ANR DIRAC ANR-13-ASTR-0018.	Arbib MA, 2004, TRENDS COGN SCI, V8, P554, DOI 10.1016/j.tics.2004.10.004; Arnold M.B., 1960, EMOTION PERSONALITY, V2; Balcetis E, 2009, PSYCHOL SCI; Belkaid M, P IEEE INT C INT ROB; Breazeal C, 2001, IEEE T SYST MAN CY A, V31, P443, DOI 10.1109/3468.952718; Brooks R. A., 1986, IEEE J ROBOTICS AUTO, V2; Canamero L., 2005, EMOTIONAL DEV; Coello Y, 2012, COGN PROCESS, V13, pS131, DOI 10.1007/s10339-012-0470-z; Csikszentmihalyi M., 1991, FLOW PSYCHOL OPTIMAL; Ethofer T, 2009, J COGNITIVE NEUROSCI, V21, P1255, DOI 10.1162/jocn.2009.21099; Fellous J.M., 2004, HUMAN EMOTIONS ROBOT, P39; Frings C, 2010, Q J EXP PSYCHOL, V63, P42, DOI 10.1080/17470210903156594; Gaussier P, 2004, LECT NOTES ARTIF INT, V3139, P243; Grandjean D, 2011, COGN TECHNOL, P441, DOI 10.1007/978-3-642-15184-2_23; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Hasson C., 2011, J BEHAV ROBOTICS, V2, P111, DOI DOI 10.2478/S13230-012-0005-4; Izard CE, 2010, EMOT REV, V2, P363, DOI 10.1177/1754073910374661; Jauffret A, 2013 IEEE 3 JOINT IN; Jauffret A, 2015, FRONT NEUROROBOTICS, V9, DOI 10.3389/fnbot.2015.00001; Jauffret A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00016; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Krichmar JL, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00001; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Lewis MD, 2005, BEHAV BRAIN SCI, V28, P169, DOI 10.1017/S0140525X0500004X; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Lones J, 2014 IEEE 4 JOINT IN; Lowe R, ROLE EMOTION ADAPTIV; Lowe R, 2007, LECT NOTES ARTIF INT, V4840, P1; Marsland S., 2003, NEURAL COMPUTING SUR, V3, P157; McGaugh JL, 2015, ANNU REV PSYCHOL, V66, P1, DOI 10.1146/annurev-psych-010814-014954; Morgado L, FLAIRS C, P245; Morgado L, 2007, LECT NOTES ARTIF INT, V4840, P59; Ognibene D, 2015, IEEE T AUTON MENT DE, V7, P3, DOI 10.1109/TAMD.2014.2341351; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ortony A., 1988, COGNITIVE STRUCTURE; Pessoa Luiz, 2010, Dialogues Clin Neurosci, V12, P433; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Scherer K.R., 2001, APPRAISAL PROCESSES, p92?120; SCHMIDHUBER J, 1991, IEEE IJCNN, P1458, DOI 10.1109/IJCNN.1991.170605; Tajadura-Jimenez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026083; Valdes-Conroy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049162; Wendt J, 2011, BIOL PSYCHOL, V86, P203, DOI 10.1016/j.biopsycho.2010.11.009; Widrow B, 1960, IRE WESCON, DOI DOI 10.21236/AD0241531; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	45	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184960	10.1371/journal.pone.0184960	http://dx.doi.org/10.1371/journal.pone.0184960			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7CN	28934291	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900066
J	Benabid, M; Ghrab, J; Rhim, A; Ben-Romdhane, R; Aoun, K; Bouratbine, A				Benabid, Meriem; Ghrab, Jamila; Rhim, Adel; Ben-romdhane, Rania; Aoun, Karim; Bouratbine, Aida			Temporal dynamics and Leishmania infantum infection prevalence of Phlebotomus perniciosus (Diptera, Phlebotominae) in highly endemic areas of visceral leishmaniasis in Tunisia	PLOS ONE			English	Article							BLOOD FEEDING PREFERENCES; TIME PCR ASSAY; MITOCHONDRIAL INTROGRESSION; CANINE LEISHMANIASIS; VECTORS; PSYCHODIDAE; FOCUS; REGION; DNA; IDENTIFICATION	Phlebotomus perniciosus is one of the major vectors of Leishmania infantum in the Mediterranean basin. The aim of this work was (i) to provide information about abundance and temporal dynamics of this Larroussius species in a hot spot area of visceral leishmaniasis in Tunisia, (ii) to detect L. infantum DNA in wild caught female sandflies and (iii) to measure Phlebotomus perniciosus infection rate throughout the active season. Sandflies were collected monthly during one year using CDC miniature light-traps in house and in animal shelters. Male specimens were identified at species level according to morphological characters. Female specimens were conserved individually for molecular study. Leishmania infection was tested by kinetoplast DNA real-time PCR and ITS-1 PCR-sequencing. Subsequent sandfly species identification of infected specimens was done by mitochondrial cytochrome b sequencing. In one year period, overall 4,441 specimens (2230 males and 2211 females) were collected. Sandfly activity started in end-April and ended in early-November. Mean sandfly density in house was significantly lower than in animal shelters (51 +/- 50 versus 504 +/- 460 sandflies/CDC night, p<0.05). However, a higher proportion of females was found in house (58.4% versus 49.2%, p<0.001). Based on species identification of male specimens, Phlebotomus perniciosus was the dominant species (56% of the whole male sandfly fauna, p<0.0001). It showed two peaks of density in the active season, a sharp one in early May and a higher long lasting one from end-July to end-September. DNA was extracted from 190 female specimens randomly sampled and corresponding to 96 specimens from house and 94 from animal shelters. Twenty four female sandfly were infected by Leishmania infantum. All infected specimens were recognized as Phlebotomus perniciosus. Leishmania infantum infection rate in female sandflies was 2.3 fold higher in house than in animal shelters (17.7% versus 7.4%, p<0.05). In house, estimated number of infected specimens was the highest at the end of the active season. Abundance, dynamics of density and Leishmania infantum infection prevalence of Phlebotomus perniciosus in Tunisian hot spot of visceral leishmaniasis highlight the major role of this Phlebotominae species in L. infantum transmission.	[Benabid, Meriem; Ghrab, Jamila; Rhim, Adel; Ben-romdhane, Rania; Aoun, Karim; Bouratbine, Aida] Univ Tunis El Manar, Pasteur Inst Tunis, Dept Parasitol, Res Lab LR 11 IPT 06, Tunis, Tunisia; [Ghrab, Jamila] Univ Carthage, Higher Inst Sci & Technol Environm Borj Cedria, Dept Biotechnol, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage	Bouratbine, A (corresponding author), Univ Tunis El Manar, Pasteur Inst Tunis, Dept Parasitol, Res Lab LR 11 IPT 06, Tunis, Tunisia.	aida.bouratbine@pasteur.rns.tn			Ministry of Higher Education and Scientific Research, Tunisia in the setting of the Research Laboratory Medical Parasitology, Biotechnologies and Biomolecules (PMBB), Institut Pasteur of Tunis, Tunisia [LR11-IPT06]	Ministry of Higher Education and Scientific Research, Tunisia in the setting of the Research Laboratory Medical Parasitology, Biotechnologies and Biomolecules (PMBB), Institut Pasteur of Tunis, Tunisia	This study was supported by the Ministry of Higher Education and Scientific Research, Tunisia in the setting of the Research Laboratory Medical Parasitology, Biotechnologies and Biomolecules (PMBB), Institut Pasteur of Tunis, Tunisia (LR11-IPT06). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc E., 1972, PHLEBOTOMES REGION E; Afshar AA, 2014, ASIAN PAC J TROP MED, V7, P93, DOI 10.1016/S1995-7645(14)60002-X; Alten B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004458; Amora SSA, 2009, NEOTROP ENTOMOL, V38, P303, DOI 10.1590/S1519-566X2009000300001; Aoun K, 2009, MED MALADIES INFECT, V39, P775, DOI 10.1016/j.medmal.2009.08.010; Barhoumi W, 2015, ACTA TROP, V141, P73, DOI 10.1016/j.actatropica.2014.10.008; Ben-Ahmed K, 2009, AM J TROP MED HYG, V81, P40; BETTINI S, 1986, T ROY SOC TROP MED H, V80, P458, DOI 10.1016/0035-9203(86)90344-5; Boudabous R, 2012, J MED ENTOMOL, V49, P787, DOI 10.1603/ME11110; Branco S, 2013, ACTA TROP, V125, P339, DOI 10.1016/j.actatropica.2012.12.008; Carrillo E, 2013, TRENDS PARASITOL, V29, P579, DOI 10.1016/j.pt.2013.10.007; Casanova C, 2001, MEM I OSWALDO CRUZ, V96, P273, DOI 10.1590/S0074-02762001000200023; Chargui N, 2013, J VECTOR ECOL, V38, P1, DOI 10.1111/j.1948-7134.2013.12000.x; Chelbi I, 2012, B SOC PATHOL EXOT, P1; CROSET H, 1970, Annales de Parasitologie Humaine et Comparee, V45, P863; Croset H, 1978, ANN PARASITOLOGIE HU; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dolmatova A, 1971, NA LES PHLEBOTOMES D; Esseghir S, 1997, INSECT MOL BIOL, V6, P211, DOI 10.1046/j.1365-2583.1997.00175.x; Galvez R, 2010, ACTA TROP, V115, P95, DOI 10.1016/j.actatropica.2010.02.009; Garcia N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/318254; Ghrab J, 2006, PARASITE, V13, P23, DOI 10.1051/parasite/2006131023; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Ivarez A, 2017, ACTA TROPICA; Izri M, 1990, ANN PARASITOLOGIE HU, V65, P150; Jimenez M, 2013, PARASITOL RES, V112, P2453, DOI 10.1007/s00436-013-3406-3; Karayiannis S, 2015, PARASITOLOGY, V142, P1574, DOI 10.1017/S0031182015001158; Killick-Kendrick R, 1984, B SOC PATHOLOGIE E 2, V78, P747; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lisi O, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0560-0; Maia C, 2013, MEM I OSWALDO CRUZ, V108, P481, DOI 10.1590/S0074-0276108042013014; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Morillas Marquez F., 1991, Parassitologia (Rome), V33, P437; Myskova J, 2008, J MED ENTOMOL, V45, P133, DOI 10.1603/0022-2585(2008)45[133:LISFCO]2.0.CO;2; Oliveira F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00375; Pesson B, 2004, MED VET ENTOMOL, V18, P25, DOI 10.1111/j.0269-283x.2004.0471.x; Peyrefitte CN, 2013, VECTOR-BORNE ZOONOT, V13, P630, DOI 10.1089/vbz.2012.1169; Prudhomme J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1250-2; Ranasinghe S, 2008, T ROY SOC TROP MED H, V102, P875, DOI 10.1016/j.trstmh.2008.04.003; READY PD, 1991, MEM I OSWALDO CRUZ, V86, P41, DOI 10.1590/S0074-02761991000100008; RIOUX J-A, 1967, Annales de Parasitologie Humaine et Comparee, V42, P665; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Rossi E, 2008, ACTA TROP, V105, P158, DOI 10.1016/j.actatropica.2007.10.005; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Talbi FZ, 2015, PATHOLOGY RES INT, V2015; Testa JM, 2002, ACTA TROP, V84, P205, DOI 10.1016/S0001-706X(02)00187-0; van der Auwera G, 2015, CLIN MICROBIOL REV, V28, P265, DOI 10.1128/CMR.00104-14; Zoghami Z, 2014, ACTA TROP, V139, P32, DOI 10.1016/j.actatropica.2014.06.012	48	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184700	10.1371/journal.pone.0184700	http://dx.doi.org/10.1371/journal.pone.0184700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934263	gold, Green Published, Green Submitted			2022-12-27	WOS:000411339900040
J	Cavalcanti, AD; Meohas, W; Ribeiro, GD; Lopes, ACD; Gholamin, S; Razavi, M; Brunswick, THK; Avan, A; Guimaraes, JAM; Duarte, MEL; Kahn, SA				Cavalcanti, Amanda dos Santos; Meohas, Walter; Ribeiro, Gabriele de Oliveira; de Sa Lopes, Ana Cristina; Gholamin, Sharareh; Razavi, Mostafa; Kasai Brunswick, Tais Hanae; Avan, Amir; Matheus Guimaraes, Joao Antonio; Leite Duarte, Maria Eugenia; Kahn, Suzana Assad			Patient-derived osteosarcoma cells are resistant to methotrexate	PLOS ONE			English	Article							CANCER-STEM-CELLS; SARCOMA; METASTASIS	Osteosarcoma is the most common primary bone tumor in children and young adults. The median survival of osteosarcoma patients has not significantly improved since 1990, despite administration of different classes of chemotherapy agents, such as methotrexate, cisplatin and doxorubicin. Cancer stem cells (CSCs) are responsible for the resistance of osteosarcoma to chemotherapy and OCT4, SOX2 and SSEA4 have been used to identify CSCs in osteosarcoma. Here, we used low-passage patient-derived osteosarcoma cells and osteosarcoma cells directly isolated from patients before and after chemotherapy treatments to evaluate the effects of chemotherapy on stem cell markers expression. We demonstrate that primary osteosarcoma cells are resistant to methotrexate treatment and sensitive to cisplatin and doxorubicin in vitro. We also verified that cisplatin and doxorubicin reduce the expression of SOX2 and OCT4 in primary osteosarcoma cells whereas methotrexate does not alter SOX2 and OCT4 expression, however it increases SSEA4 expression in primary osteosarcoma cells. Finally, we found that, although the combination treatment cisplatin plus doxorubicin inhibited the in vivo growth of osteosarcoma cells in NOD-SCID gamma mice subcutaneously injected with SaOs2, the combination treatment cisplatin plus doxorubicin plus methotrexate did not inhibit the in vivo growth of these cells. These observations may provide an explanation for the poor response of osteosarcomas to chemotherapy and point to the need of reevaluating the therapeutic strategies for human osteosarcomas.	[Cavalcanti, Amanda dos Santos; Meohas, Walter; Ribeiro, Gabriele de Oliveira; de Sa Lopes, Ana Cristina; Matheus Guimaraes, Joao Antonio; Leite Duarte, Maria Eugenia; Kahn, Suzana Assad] Natl Inst Traumatol & Orthopaed, Res Div, Rio De Janeiro, RJ, Brazil; [Gholamin, Sharareh; Razavi, Mostafa; Kahn, Suzana Assad] Stanford Univ, Stanford Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Kasai Brunswick, Tais Hanae] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, RJ, Brazil; [Kasai Brunswick, Tais Hanae] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil; [Avan, Amir] Mashhad Univ Med Sci, Sch Med, Dept Modern Sci & Technol, Mol Med Grp, Mashhad, Iran	Stanford University; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Mashhad University Medical Science	Kahn, SA (corresponding author), Natl Inst Traumatol & Orthopaed, Res Div, Rio De Janeiro, RJ, Brazil.; Kahn, SA (corresponding author), Stanford Univ, Stanford Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	kahns@stanford.edu	Kasai-Brunswick, Tais Hanae/AAK-9905-2020	Gholamin, Sharareh/0000-0001-7425-6074; Razavi, Seyed-Mostafa/0000-0003-0812-6540; Cavalcanti, Amanda/0000-0002-8792-7524; Kasai-Brunswick, Tais Hanae/0000-0002-6361-5980; naseri, shahrokh/0000-0001-8974-2120	Pew Charitable Trusts; PEW Latin American Fellowship	Pew Charitable Trusts; PEW Latin American Fellowship	This study was supported by the Pew Charitable Trusts.; The authors thank Caetano Altafin and the PEW Latin American Fellowship (SAK) for the financial support and Vivaldo Moura-Neto for the intellectual contribution.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Assad K. S., 2016, MOL MED, V8, P511, DOI [10.15252/emmm.20150542127138566, DOI 10.15252/EMMM, DOI 10.15252/EMMM.201505421]; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Choong PF, 2014, INT J MED SCI, V11, P1154, DOI 10.7150/ijms.8281; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Creusot RJ, 2008, CLIN IMMUNOL, V127, P176, DOI 10.1016/j.clim.2007.12.009; Depau L, 2017, ONCOTARGET; Di Fiore R, 2009, J CELL PHYSIOL, V219, P301, DOI 10.1002/jcp.21667; Fujii H, 2009, INT J ONCOL, V34, P1381, DOI 10.3892/ijo_00000265; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Guo W, 1999, CLIN CANCER RES, V5, P621; Harris MB, 1998, J CLIN ONCOL, V16, P3641, DOI 10.1200/JCO.1998.16.11.3641; He AN, 2015, J CELL BIOCHEM, V116, P1719, DOI 10.1002/jcb.25131; Kahn SA, 2012, CURR TOP MED CHEM, V12, P2082; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Pautke C, 2004, ANTICANCER RES, V24, P3743; Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Siclari VA, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-78; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang Y, 2016, EXP THER MED, V12, P81, DOI 10.3892/etm.2016.3303; Yang CL, 2014, INT J MOL SCI, V15, P423, DOI 10.3390/ijms15010423; Zhang HX, 2013, STEM CELLS, V31, P433, DOI 10.1002/stem.1298; Zhang WG, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/765362	36	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184891	10.1371/journal.pone.0184891	http://dx.doi.org/10.1371/journal.pone.0184891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934267	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900057
J	Dimitropoulos, K; Barmpoutis, P; Zioga, C; Kamas, A; Patsiaoura, K; Grammalidis, N				Dimitropoulos, Kosmas; Barmpoutis, Panagiotis; Zioga, Christina; Kamas, Athanasios; Patsiaoura, Kalliopi; Grammalidis, Nikos			Grading of invasive breast carcinoma through Grassmannian VLAD encoding	PLOS ONE			English	Article							TEXTURE CLASSIFICATION; IMAGE-ANALYSIS; CANCER; DIAGNOSIS; ALGORITHMS	In this paper we address the problem of automated grading of invasive breast carcinoma through the encoding of histological images as VLAD (Vector of Locally Aggregated Descriptors) representations on the Grassmann manifold. The proposed method considers each image as a set of multidimensional spatially-evolving signals that can be efficiently modeled through a higher-order linear dynamical systems analysis. Subsequently, each H&E (Hematoxylin and Eosin) stained breast cancer histological image is represented as a cloud of points on the Grassmann manifold, while a vector representation approach is applied aiming to aggregate the Grassmannian points based on a locality criterion on the manifold. To evaluate the efficiency of the proposed methodology, two datasets with different characteristics were used. More specifically, we created a new medium-sized dataset consisting of 300 annotated images (collected from 21 patients) of grades 1, 2 and 3, while we also provide experimental results using a large dataset, namely BreaKHis, containing 7,909 breast cancer histological images, collected from 82 patients, of both benign and malignant cases. Experimental results have shown that the proposed method outperforms a number of state of the art approaches providing average classification rates of 95.8% and 91.38% with our dataset and the BreaKHis dataset, respectively.	[Dimitropoulos, Kosmas; Barmpoutis, Panagiotis; Grammalidis, Nikos] Ctr Res & Technol Hellas, Informat Technol Inst, Thessaloniki, Greece; [Zioga, Christina; Kamas, Athanasios; Patsiaoura, Kalliopi] Agios Pavlos Gen Hosp, Dept Pathol, Thessaloniki, Greece	Centre for Research & Technology Hellas	Grammalidis, N (corresponding author), Ctr Res & Technol Hellas, Informat Technol Inst, Thessaloniki, Greece.	ngramm@iti.gr	Grammalidis, Nikos/U-9411-2019	Grammalidis, Nikos/0000-0001-8465-6258; Dimitropoulos, Kosmas/0000-0003-1584-7047				Arfken G, 1985, GRAM SCHMIDT ORTHOGO, P516; Axelrod DE, 2008, CANCER INFORM, V6, P99; Coelho LP, 2010, LECT N BIOINFORMAT, V6004, P23, DOI 10.1007/978-3-642-13131-8_4; Costantini R, 2008, IEEE T IMAGE PROCESS, V17, P42, DOI 10.1109/TIP.2007.910956; Cruz-Roa A, 2014, SPIE MED IMAGING, P9041; Dimitropoulos K, INT C COMP VIS THEOR; Dimitropoulos K, IEEE T CIRCUITS SYST; Dimitropoulos K, 2017, IEEE T CIRC SYST VID, V27, P1143, DOI 10.1109/TCSVT.2016.2527340; Dimitropoulos K, 2017, SIGNAL IMAGE VIDEO P, V11, P145, DOI 10.1007/s11760-016-0913-6; Dimitropoulos K, 2015, IEEE T CIRC SYST VID, V25, P339, DOI 10.1109/TCSVT.2014.2339592; Doretto G, 2003, INT J COMPUT VISION, V51, P91, DOI 10.1023/A:1021669406132; Doyle S, IEEE INT S BIOM IM M; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filipczuk P, 2013, IEEE T MED IMAGING, V32, P2169, DOI 10.1109/TMI.2013.2275151; George YM, 2014, IEEE SYST J, V8, P949, DOI 10.1109/JSYST.2013.2279415; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hu SQ, 2015, 2015 8TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP), P702, DOI 10.1109/CISP.2015.7407968; Jegou H., 2010, COMPUTER VISION PATT; Kantorov V, P IEEE C COMP VIS PA; KARCHER H, 1977, COMMUN PUR APPL MATH, V30, P509, DOI 10.1002/cpa.3160300502; Komaki Kansei, 2006, Breast Cancer, V13, P249, DOI 10.2325/jbcs.13.249; Kowal M, 2013, COMPUT BIOL MED, V43, P1563, DOI 10.1016/j.compbiomed.2013.08.003; Litjens G, 2016, NATURE SCI REPORTS, V6; Martin RJ, 2000, IEEE T SIGNAL PROCES, V48, P1164, DOI 10.1109/78.827549; Michail E, 2014, IEEE ENG MED BIOL SO; Naik S, IEEE INT S BIOM IM M; Niwas SI, IEEE INT C IM SYST T; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Ojansivu V, 2008, LECT NOTES COMPUT SC, V5099, P236, DOI 10.1007/978-3-540-69905-7_27; Paramanandam M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162053; Petushi Sokol, 2006, BMC Med Imaging, V6, P14, DOI 10.1186/1471-2342-6-14; Ravichandran A, 2013, IEEE T PATTERN ANAL, V35, P342, DOI 10.1109/TPAMI.2012.83; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Rublee E., IEEE INT C COMP VIS; Siddiqi S., 2007, ADV NEURAL INFORM PR; Spanhol FA, INT JOINT C NEUR NET; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; Sudbo J, 2000, ANAL CELL PATHOL, V21, P71, DOI 10.1155/2000/389361; Tozeren A, 2007, BMC MED IMAGING, V7; Turaga P, 2011, IEEE T PATTERN ANAL, V33, P2273, DOI 10.1109/TPAMI.2011.52; VANOVERSCHEE P, 1994, AUTOMATICA, V30, P75, DOI 10.1016/0005-1098(94)90230-5; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Zamri MIP, 2016, COMPUT ELECTRON AGR, V124, P227, DOI 10.1016/j.compag.2016.04.004; Zhang YG, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-17	46	52	52	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185110	10.1371/journal.pone.0185110	http://dx.doi.org/10.1371/journal.pone.0185110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934283	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900093
J	Han, F; Zhuang, TT; Chen, JJ; Zhu, XL; Cai, YF; Lu, YP				Han, Fei; Zhuang, Ting-Ting; Chen, Jing-Jing; Zhu, Xiu-Ling; Cai, Ya-Fei; Lu, Ya-Ping			Novel derivative of Paeonol, Paeononlsilatie sodium, alleviates behavioral damage and hippocampal dendritic injury in Alzheimer's disease concurrent with cofilin1/phosphorylated-cofilin1 and RAC1/CDC42 alterations in rats	PLOS ONE			English	Article							AMYLOID CASCADE HYPOTHESIS; E/AMYLOID-BETA INTERACTION; LONG-TERM POTENTIATION; WILD-TYPE TAU; A-BETA; SYNAPTIC PLASTICITY; D-GALACTOSE; COFILIN PHOSPHORYLATION; COGNITIVE IMPAIRMENT; TRANSGENIC MICE	Alzheimer's disease (AD) is a typical hippocampal amnesia and the most common senile dementia. Many studies suggest that cognitive impairments are more closely correlated with synaptic loss than the burden of amyloid deposits in AD progression. To date, there is no effective treatment for this disease. Paeonol has been widely employed in traditional Chinese medicine. This compound improves learning behavior in an animal model; however, the mechanism remains unclear. In this study, Paeononlsilatie sodium (Pa), a derivative of Paeonol, attenuated D-galactose (D-gal) and AlCl3-induced behavioral damages in rats based on evaluations of the open field test (OFT), elevated plus maze test (EPMT), and Morris water maze test (MWMT). Pa increased the dendritic complexity and the density of dendritic spines. Correlation analysis indicated that morphological changes in neuronal dendrites are closely correlated with behavioral changes. Pa treatment reduced the production of A beta, affected the phosphorylation and redistribution of cofilin1 and inhibited rod-like formation in hippocampal neurons. The induction of D-gal and AlCl3 promoted the expression of RAC1/CDC42 expression; however, the tendency of gene expression was inhibited by pretreatment with Pa. Taken together, our results suggest that Pa may represent a novel therapeutic agent for the improvement of cognitive and emotional behaviors and dendritic morphology in an AD animal model.	[Han, Fei; Zhuang, Ting-Ting; Chen, Jing-Jing; Zhu, Xiu-Ling; Cai, Ya-Fei; Lu, Ya-Ping] Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China; [Zhu, Xiu-Ling] Wannan Med Coll, Dept Anat, Wuhu, Peoples R China	Anhui Normal University; Wannan Medical College	Lu, YP (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Peoples R China.	yapinglu@ahnu.edu.cn	Cai, Yafei/S-7210-2019		National Natural Science Foundation of China [30470537]; Natural Science Foundation of Department of Education, Anhui Province [ZD2008006-1]; Innovation Team of Scientific Research Platform in Anhui Universities; Provincial Key Laboratory of Biotic Environment and Ecological Safety in Anhui	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Department of Education, Anhui Province; Innovation Team of Scientific Research Platform in Anhui Universities; Provincial Key Laboratory of Biotic Environment and Ecological Safety in Anhui	The present study was supported by National Natural Science Foundation of China (No. 30470537), Natural Science Foundation of Department of Education, Anhui Province (ZD2008006-1), Innovation Team of Scientific Research Platform in Anhui Universities, and Provincial Key Laboratory of Biotic Environment and Ecological Safety in Anhui. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Baj G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00018; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barone E, 2014, BBA-MOL BASIS DIS, V1842, P2500, DOI 10.1016/j.bbadis.2014.10.004; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Borbely E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/345305; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Bringas ME, 2013, NEUROSCIENCE, V241, P170, DOI 10.1016/j.neuroscience.2013.03.030; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Byrne KM, 2016, CELL SYST, V2, P38, DOI 10.1016/j.cels.2016.01.003; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dickstein DL, 2010, BRAIN STRUCT FUNCT, V214, P161, DOI 10.1007/s00429-010-0245-1; Ding Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154375; Du QA, 2010, CAN J PHYSIOL PHARM, V88, P1010, DOI [10.1139/Y10-077, 10.1139/y10-077]; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; EINSTEIN G, 1994, J NEUROSCI, V14, P5077; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Flores G, 2005, NEUROSCIENCE, V133, P463, DOI 10.1016/j.neuroscience.2005.02.021; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Goni F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013391; Guirado R, 2014, INT J NEUROPSYCHOPH, V17, P1635, DOI 10.1017/S1461145714000406; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Hsieh CL, 2006, J ETHNOPHARMACOL, V106, P208, DOI 10.1016/j.jep.2005.12.027; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu XY, 2003, ACTA NEUROPATHOL, V106, P213, DOI 10.1007/s00401-003-0720-3; Martinez-Tellez RI, 2009, SYNAPSE, V63, P794, DOI 10.1002/syn.20664; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jayant S, 2016, PHARMACOL BIOCHEM BE, V140, P39, DOI 10.1016/j.pbb.2015.11.006; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kim S, 2015, NEUROBIOL AGING, V36, P3239, DOI 10.1016/j.neurobiolaging.2015.09.007; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Kolb B, 1998, NEUROSCI BIOBEHAV R, V22, P143, DOI 10.1016/S0149-7634(97)00008-0; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lazcano Z, 2014, SYNAPSE; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Li HY, 2017, PHYTOTHER RES, V31, P284, DOI 10.1002/ptr.5747; Li HY, 2016, J ETHNOPHARMACOL, V179, P162, DOI 10.1016/j.jep.2015.12.020; Li H, 2016, SCI REP-UK, V6, DOI 10.1038/srep23693; Li ZQ, 2012, J ETHNOPHARMACOL, V144, P305, DOI 10.1016/j.jep.2012.09.013; Liu JP, 2013, NEUROSCI LETT, V549, P63, DOI 10.1016/j.neulet.2013.06.002; Liu MH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00440; Liu MH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/651890; Lu YP, 2003, EXP NEUROL, V183, P482, DOI 10.1016/S0014-4886(03)00205-X; Luo Y, 2009, MECH AGEING DEV, V130, P248, DOI 10.1016/j.mad.2008.12.005; Ma QL, 2008, J BIOL CHEM, V283, P14132, DOI 10.1074/jbc.M708034200; Maiti P, 2015, NEUROSCI BIOBEHAV R, V59, P208, DOI 10.1016/j.neubiorev.2015.09.020; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MASLIAH E, 1991, NEURON, V6, P729, DOI 10.1016/0896-6273(91)90170-5; Mavroudis IA, 2011, INT J NEUROSCI, V121, P347, DOI 10.3109/00207454.2011.553753; Mendoza-Naranjo A, 2012, J ALZHEIMERS DIS, V29, P63, DOI 10.3233/JAD-2012-101575; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Paxinos G, 2007, RAT BRAIN STEREOTAXI, V6; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Sarazin M, 2007, NEUROLOGY, V69, P1859, DOI 10.1212/01.wnl.0000279336.36610.f7; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Sun ZZ, 2009, AGE, V31, P277, DOI 10.1007/s11357-009-9099-y; Tackenberg C, 2009, J NEUROSCI, V29, P14439, DOI 10.1523/JNEUROSCI.3590-09.2009; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tania N, 2011, BIOPHYS J, V100, P1883, DOI 10.1016/j.bpj.2011.02.036; Tao WW, 2016, PSYCHIAT RES, V238, P116, DOI 10.1016/j.psychres.2016.02.033; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tseng YT, 2012, SHOCK, V37, P312, DOI 10.1097/SHK.0b013e31823fe939; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang Y, 2013, J NEUROSCI, V33, P6423, DOI 10.1523/JNEUROSCI.5107-12.2013; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Woo JA, 2012, CELL DEATH DIFFER, V19, P1413, DOI 10.1038/cdd.2012.14; Xiao F, 2011, NEUROSCI BULL, V27, P143, DOI 10.1007/s12264-011-1028-2; Xiao Q, 2017, NEUROSCIENCE, V355, P61, DOI 10.1016/j.neuroscience.2017.04.050; Yang J, 2011, J ALZHEIMERS DIS, V24, P269, DOI 10.3233/JAD-2011-101401; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Zhang Y, 2016, INT J BIOL MACROMOL, V92, P935, DOI 10.1016/j.ijbiomac.2016.08.008; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630; Zhao Y, 2014, BRAIN RES BULL, V109, P61, DOI 10.1016/j.brainresbull.2014.09.008; Zhou J, 2011, BRAIN RES, V1388, P141, DOI 10.1016/j.brainres.2011.02.064	124	18	19	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185102	10.1371/journal.pone.0185102	http://dx.doi.org/10.1371/journal.pone.0185102			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934273	Green Published, gold, Green Submitted			2022-12-27	WOS:000411339900090
J	Ilboudo, PG; Huang, XX; Ngwira, B; Mwanyungwe, A; Mogasale, V; Mengel, MA; Cavailler, P; Gessner, BD; Le Gargasson, JB				Ilboudo, Patrick G.; Huang, Xiao Xian; Ngwira, Bagrey; Mwanyungwe, Abel; Mogasale, Vittal; Mengel, Martin A.; Cavailler, Philippe; Gessner, Bradford D.; Le Gargasson, Jean-Bernard			Cost-of-illness of cholera to households and health facilities in rural Malawi	PLOS ONE			English	Article							ENDEMIC CHOLERA; VACCINES; SURVEILLANCE; MOZAMBIQUE; EPIDEMIC; HAITI	Cholera remains an important public health problem in many low- and middle-income countries. Vaccination has been recommended as a possible intervention for the prevention and control of cholera. Evidence, especially data on disease burden, cost-of-illness, delivery costs and cost-effectiveness to support a wider use of vaccine is still weak. This study aims at estimating the cost-of-illness of cholera to households and health facilities in Machinga and Zomba Districts, Malawi. A cross-sectional study using retrospectively collected cost data was undertaken in this investigation. One hundred patients were purposefully selected for the assessment of the household cost-of-illness and four cholera treatment centres and one health facility were selected for the assessment conducted in health facilities. Data collected for the assessment in households included direct and indirect costs borne by cholera patients and their families while only direct costs were considered for the assessment conducted in health facilities. Whenever possible, descriptive and regression analysis were used to assess difference in mean costs between groups of patients. The average costs to patients' households and health facilities for treating an episode of cholera amounted to US $65.6 and US$59.7 in 2016 for households and health facilities, respectively equivalent to international dollars (I$) 249.9 and 227.5 the same year. Costs incurred in treating a cholera episode were proportional to duration of hospital stay. Moreover, 52% of households used coping strategies to compensate for direct and indirect costs imposed by the disease. Both households and health facilities could avert significant treatment expenditures through a broader use of pre-emptive cholera vaccination. These findings have direct policy implications regarding priority investments for the prevention and control of cholera.	[Ilboudo, Patrick G.] Agence Med Prevent, Abidjan, Cote Ivoire; [Huang, Xiao Xian; Le Gargasson, Jean-Bernard] Agence Med Prevent, Ferney Voltaire, France; [Ngwira, Bagrey; Mwanyungwe, Abel] Polytech, Blantyre, Malawi; [Mogasale, Vittal] Int Vaccine Inst, Seoul, South Korea; [Mengel, Martin A.; Cavailler, Philippe; Gessner, Bradford D.] Agence Med Prevent, Paris, France	Agence de Medecine Preventive; International Vaccine Institute; Agence de Medecine Preventive	Ilboudo, PG (corresponding author), Agence Med Prevent, Abidjan, Cote Ivoire.	gilboudo@aamp.org	Mogasale, Vittal/C-7853-2011; Mogasale, Vittal/HCH-7125-2022	Mogasale, Vittal/0000-0003-0596-8072	Bill and Melinda Gates Foundation [1106078]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We would like to acknowledge the financial support provided by the Bill and Melinda Gates Foundation (website: http/Amy) gatesfoundation orgtfr) through the project Cholera Targeted Investments to Answer Endemic Use Questions [grant number 1106078] awarded to MAM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; [Anonymous], 2015, WEEKLY EPIDEMIOLOGIC; Barzilay EJ, 2013, NEW ENGL J MED, V368, P599, DOI 10.1056/NEJMoa1204927; Bekolo CE, 2016, B WORLD HEALTH ORGAN, V94, P667, DOI 10.2471/BLT.15.166892; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; Clemens J, 2014, CURR TOP MICROBIOL, V379, P231, DOI 10.1007/82_2013_353; Conteh L, 2004, HEALTH POLICY PLANN, V19, P127, DOI 10.1093/heapol/czh015; Deen JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000173; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Gujral L, 2013, J INFECT DIS, V208, pS107, DOI 10.1093/infdis/jit212; IMF, 2017, **NON-TRADITIONAL**; IMF, 2016, WORLD EC OUTL SUBD D; Jefferson T., 2000, COST OF ILLNESS STUD, V2nd ed., P17; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Khonje A, 2012, MALAWI MED J, V24, P29; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-8; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Luquero FJ, 2016, EMERG INFECT DIS, V22, P410, DOI 10.3201/eid2203.141970; Malawi National Statistical Office, 2016, GEOHIVE MAL POP STAT; Mogasale V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005124; Mogasale V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004072; Nations Unies, 2015, PROJ DOC SOMM NAT UN; Poulos C, 2012, EPIDEMIOL INFECT, V140, P500, DOI 10.1017/S0950268811000513; Sack DA, 2006, J HEALTH POPUL NUTR, V24, P1; Sardar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081231; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; Schaetti C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001844; Thiem VD, 2003, J HEALTH POPUL NUTR, V21, P304; von Seidlein L, 2013, J INFECT DIS, V208, pS8, DOI 10.1093/infdis/jit194; WHO, 2016, WEEKLY EPIDEMIOLOGIC, P433; WHO, 2016, WORLD HLTH STAT 2016; World Health Organization, 2016, WHO PREQ VACC	35	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185041	10.1371/journal.pone.0185041	http://dx.doi.org/10.1371/journal.pone.0185041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934285	Green Submitted, Green Published, gold			2022-12-27	WOS:000411339900078
J	Wang, ZN; Oppegard, SC; Eddington, DT; Cheng, J				Wang, Zhinan; Oppegard, Shawn C.; Eddington, David T.; Cheng, Jun			Effect of localized hypoxia on Drosophila embryo development	PLOS ONE			English	Article							OXYGEN-UPTAKE RATE; MELANOGASTER EMBRYOS; ENGRAILED PROTEIN; METABOLIC-RATE; CELL-CULTURE; GRADIENTS; RESPONSES; DEVICE; MICROFLUIDICS; AMPLIFICATION	Environmental stress, such as oxygen deprivation, affects various cellular activities and developmental processes. In this study, we directly investigated Drosophila embryo development in vivo while cultured on a microfluidic device, which imposed an oxygen gradient on the developing embryos. The designed microfluidic device enabled both temporal and spatial control of the local oxygen gradient applied to the live embryos. Time-lapse live cell imaging was used to monitor the morphology and cellular migration patterns as embryos were placed in various geometries relative to the oxygen gradient. Results show that pole cell movement and tail retraction during Drosophila embryogenesis are highly sensitive to oxygen concentrations. Through modeling, we also estimated the oxygen permeability across the Drosophila embryonic layers for the first time using parameters measured on our oxygen control device.	[Wang, Zhinan; Oppegard, Shawn C.; Eddington, David T.; Cheng, Jun] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cheng, J (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	juncheng@uic.edu			National Science Foundation, Div Of Biological Infrastructure [1253060]; Searle Funds at The Chicago Community Trust; NSF DBI [1253060]; Chicago Biomedical Consortium from The Searle Funds at The Chicago Community Trust	National Science Foundation, Div Of Biological Infrastructure(National Science Foundation (NSF)); Searle Funds at The Chicago Community Trust; NSF DBI(National Science Foundation (NSF)); Chicago Biomedical Consortium from The Searle Funds at The Chicago Community Trust	This work was supported by the National Science Foundation, Div Of Biological Infrastructure, NO.1253060 to DE (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1253060) and the Searle Funds at The Chicago Community Trust # N/A. to JC (http:cct.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NSF DBI 1253060 and partly funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust.	BOWNES M, 1975, J EMBRYOL EXP MORPH, V33, P789; Burggren W, 2017, BIOL OPEN, V6, P471, DOI 10.1242/bio.023994; Burke DT, 1997, GENOME RES, V7, P189, DOI 10.1101/gr.7.3.189; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; Camp JP, 2007, BIOTECHNOL PROGR, V23, P1485, DOI 10.1021/bp070308v; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Chang C, 2013, LAB CHIP, V13, P1817, DOI [10.1039/c3lc41418c, 10.1039/c3lc41418]; Chen YA, 2011, LAB CHIP, V11, P3626, DOI 10.1039/c1lc20325h; Cheng J, 1996, NUCLEIC ACIDS RES, V24, P380, DOI 10.1093/nar/24.2.380; Cohen CB, 1999, ANAL BIOCHEM, V273, P89, DOI 10.1006/abio.1999.4204; Costa M, 1993, DEV DROSOPHILA MELAN; Crowder RO, 1997, J MEMBRANE SCI, V134, P235, DOI 10.1016/S0376-7388(97)00112-9; DINARDO S, 1987, GENE DEV, V1, P1212, DOI 10.1101/gad.1.10.1212; DINARDO S, 1985, CELL, V43, P59, DOI 10.1016/0092-8674(85)90012-1; Douglas RM, 2005, AM J PHYSIOL-REG I, V288, pR511, DOI 10.1152/ajpregu.00520.2004; Douglas RM, 2001, AM J PHYSIOL-REG I, V280, pR1555, DOI 10.1152/ajpregu.2001.280.5.R1555; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; GROTE J, 1977, PFLUG ARCH EUR J PHY, V372, P37, DOI 10.1007/BF00582204; Hadd AG, 1997, ANAL CHEM, V69, P3407, DOI 10.1021/ac970192p; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; Heinrich EC, 2011, J EXP BIOL, V214, P1419, DOI 10.1242/jeb.051904; Jacobson SC, 1996, ANAL CHEM, V68, P720, DOI 10.1021/ac951230c; JAGLARZ MK, 1995, DEVELOPMENT, V121, P3495; Jiao Z, 1997, BIOTECHNOL TECH, V11, P755, DOI 10.1023/A:1018452603510; Just M. Vlak, 1996, INSECT CELL CULTURES; KARR TL, 1989, DEVELOPMENT, V105, P605; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kirby B., 2010, MICRO NANOSCALE FLUI; Kirk JE, 1955, J GERONTOL, V10, P288, DOI 10.1093/geronj/10.3.288; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; MAIORELLA B, 1988, BIO-TECHNOL, V6, P1406, DOI 10.1038/nbt1288-1406; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Oppegard SC, 2013, BIOMED MICRODEVICES, V15, P407, DOI 10.1007/s10544-013-9737-0; Oppegard SC, 2010, LAB CHIP, V10, P2366, DOI 10.1039/c004856a; Oppegard SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006891; Owerkowicz T, 2009, J EXP BIOL, V212, P1237, DOI 10.1242/jeb.023945; Rebollo E, 2004, PLOS BIOL, V2, P54, DOI 10.1371/journal.pbio.0020008; Rushlow CA, 2012, CURR OPIN GENET DEV, V22, P542, DOI 10.1016/j.gde.2012.08.005; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Tyler M.S., 2000, DEV BIOL GUIDE EXPT; Van Voorhies WA, 2009, J EXP BIOL, V212, P3132, DOI 10.1242/jeb.031179; Vigne Paul, 2010, BMC Physiology, V10, P8, DOI 10.1186/1472-6793-10-8; Wang L, 2013, LAB CHIP, V13, P695, DOI [10.1039/c2lc40661f, 10.1039/C2LC40661F]; WEIR MP, 1985, NATURE, V318, P433, DOI 10.1038/318433a0; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; WITTE L, 1977, J CHROMATOGR, V143, P329, DOI 10.1016/S0378-4347(00)80979-2; WONG TKK, 1994, CYTOTECHNOLOGY, V15, P157, DOI 10.1007/BF00762390; Zarndt R, 2015, AM J PHYSIOL-REG I, V309, pR1347, DOI 10.1152/ajpregu.00164.2015	52	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185267	10.1371/journal.pone.0185267	http://dx.doi.org/10.1371/journal.pone.0185267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934338	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900136
J	Chen, C; Li, LX; Peng, HP; Yang, YX				Chen, Chuan; Li, Lixiang; Peng, Haipeng; Yang, Yixian			Finite time synchronization of memristor-based Cohen-Grossberg neural networks with mixed delays	PLOS ONE			English	Article							EXPONENTIAL SYNCHRONIZATION; STABILITY	Finite time synchronization, which means synchronization can be achieved in a settling time, is desirable in some practical applications. However, most of the published results on finite time synchronization don't include delays or only include discrete delays. In view of the fact that distributed delays inevitably exist in neural networks, this paper aims to investigate the finite time synchronization of memristor-based Cohen-Grossberg neural networks (MCGNNs) with both discrete delay and distributed delay (mixed delays). By means of a simple feedback controller and novel finite time synchronization analysis methods, several new criteria are derived to ensure the finite time synchronization of MCGNNs with mixed delays. The obtained criteria are very concise and easy to verify. Numerical simulations are presented to demonstrate the effectiveness of our theoretical results.	[Chen, Chuan; Li, Lixiang; Peng, Haipeng; Yang, Yixian] Beijing Univ Posts & Telecommun, Informat Secur Ctr, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China; [Yang, Yixian] State Key Lab Publ Big Data, Guiyang 550025, Guizhou, Peoples R China	Beijing University of Posts & Telecommunications	Li, LX (corresponding author), Beijing Univ Posts & Telecommun, Informat Secur Ctr, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China.	li_lixiang2006@163.com	Li, lixiang/G-6222-2011	Li, lixiang/0000-0001-9949-8731; Li, Lixiang/0000-0001-8541-308X	National Key Research and Development Program [2016YFB0800602, 2016YFB0800604]; National Natural Science Foundation of China [61573067, 61771071, 61472045]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by the National Key Research and Development Program (Grant nos .2016YFB0800602 and 2016YFB0800604), and the National Natural Science Foundation of China (Grant Nos. 61573067, 61771071 and 61472045).	Abdurahman A, 2015, COGN NEURODYNAMICS, V9, P603, DOI 10.1007/s11571-015-9352-2; Aubin J.P., 1984, DIFFERENTIAL INCLUSI; Chen C., 2017, NEURAL PROCESSING LE; Chen CA, 2017, NEUROCOMPUTING, V235, P83, DOI 10.1016/j.neucom.2016.12.061; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Clarke FH, 1984, P INT C MATH ZUR 199, V5, P847; COHEN MA, 1983, IEEE T SYST MAN CYB, V13, P815, DOI 10.1109/TSMC.1983.6313075; Filippov A., 1988, DIFF EQUAT+; Han XM, 2016, NEUROCOMPUTING, V201, P40, DOI 10.1016/j.neucom.2015.11.103; Hu C, 2014, NEUROCOMPUTING, V143, P90, DOI 10.1016/j.neucom.2014.06.016; Itoh M, 2008, INT J BIFURCAT CHAOS, V18, P3183, DOI 10.1142/S0218127408022354; Jiao B, 2017, CHAOS, V27, DOI 10.1063/1.4978024; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Li LX, 2015, CHAOS SOLITON FRACT, V72, P20, DOI 10.1016/j.chaos.2015.01.005; Lin D, 2010, NEUROCOMPUTING, V73, P2873, DOI 10.1016/j.neucom.2010.08.008; Lin D, 2010, FUZZY SET SYST, V161, P2066, DOI 10.1016/j.fss.2010.03.006; Liu M, 2016, NEUROCOMPUTING, V194, P1, DOI 10.1016/j.neucom.2016.02.012; Liu QM, 2012, CHAOS, V22, DOI 10.1063/1.4745212; Mei GF, 2016, COMPLEXITY, V21, P417, DOI 10.1002/cplx.21755; Milanovic V, 1996, INT J BIFURCAT CHAOS, V6, P2571, DOI 10.1142/S0218127496001648; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Tan Z, 2001, INT J MOD PHYS C, V12, P19, DOI 10.1142/S0129183101001407; Tang Q, 2014, NEURAL COMPUT APPL, V24, P775, DOI 10.1007/s00521-012-1292-8; Tang Y, 1998, AUTOMATICA, V34, P51, DOI 10.1016/S0005-1098(97)00174-X; Tojtovska B, 2012, APPL MATH COMPUT, V219, P2289, DOI 10.1016/j.amc.2012.08.076; Wan Y, 2016, NEURAL NETWORKS, V73, P86, DOI 10.1016/j.neunet.2015.10.009; Wang CN, 2015, COMPLEXITY, V21, P370, DOI 10.1002/cplx.21572; Wang WP, 2014, NEURAL NETWORKS, V53, P8, DOI 10.1016/j.neunet.2014.01.010; Wang XY, 2007, CHAOS, V17, DOI 10.1063/1.2755420; Wang XY, 2009, COMMUN NONLINEAR SCI, V14, P3351, DOI 10.1016/j.cnsns.2009.01.010; Wang XY, 2008, PHYSICA A, V387, P3751, DOI 10.1016/j.physa.2008.02.020; Wang XY, 2008, PHYS LETT A, V372, P435, DOI 10.1016/j.physleta.2007.07.053; Wang ZD, 2006, IEEE T NEURAL NETWOR, V17, P814, DOI 10.1109/TNN.2006.872355; Wen SP, 2015, IEEE T NEUR NET LEAR, V26, P1493, DOI 10.1109/TNNLS.2014.2387355; Wu AL, 2012, NEURAL NETWORKS, V36, P1, DOI 10.1016/j.neunet.2012.08.009; Wu AL, 2013, COMMUN NONLINEAR SCI, V18, P373, DOI 10.1016/j.cnsns.2012.07.005; Xiao JY, 2017, NEUROCOMPUTING, V219, P431, DOI 10.1016/j.neucom.2016.09.049; Yang XS, 2016, IEEE T CYBERNETICS, V46, P3377, DOI 10.1109/TCYB.2015.2505903; Yang XS, 2015, IEEE T FUZZY SYST, V23, P2302, DOI 10.1109/TFUZZ.2015.2417973; Yang XS, 2015, J FRANKLIN I, V352, P4382, DOI 10.1016/j.jfranklin.2015.07.001; Yang XS, 2014, NEUROCOMPUTING, V143, P275, DOI 10.1016/j.neucom.2014.05.064; Yang XS, 2014, COGN NEURODYNAMICS, V8, P239, DOI 10.1007/s11571-013-9277-6; Yang XS, 2011, CHAOS SOLITON FRACT, V44, P817, DOI 10.1016/j.chaos.2011.06.006; Yu J, 2011, NEUROCOMPUTING, V74, P1776, DOI 10.1016/j.neucom.2011.02.015; Zhang H, 2017, IEEE T SYST MAN CY-S, V47, P885, DOI 10.1109/TSMC.2016.2523935; Zhang W, 2016, NEUROCOMPUTING, V173, P1066, DOI 10.1016/j.neucom.2015.08.063; Zheng CD, 2013, IEEE T NEUR NET LEAR, V24, P800, DOI 10.1109/TNNLS.2013.2244613; Zhu QX, 2012, FUZZY SET SYST, V203, P74, DOI 10.1016/j.fss.2012.01.005; Zhu QX, 2012, NONLINEAR DYNAM, V67, P829, DOI 10.1007/s11071-011-0029-z; Zhu QX, 2010, NONLINEAR DYNAM, V61, P517, DOI 10.1007/s11071-010-9668-8	50	8	8	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185007	10.1371/journal.pone.0185007	http://dx.doi.org/10.1371/journal.pone.0185007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931066	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700056
J	Chen, FY; Lee, A; Ge, SK; Nathan, S; Knox, SM; McNamara, NA				Chen, Feeling Y.; Lee, Albert; Ge, Shaokui; Nathan, Sara; Knox, Sarah M.; McNamara, Nancy A.			Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjogren's syndrome	PLOS ONE			English	Article							KERATINIZING SQUAMOUS METAPLASIA; PERIPHERAL NERVOUS-SYSTEM; DRY EYE; LYMPHOCYTIC INFILTRATION; OCULAR SURFACE; CELLS; INTERLEUKIN-1; NERVES; MANIFESTATIONS; INFLAMMATION	Sjogren's syndrome (SS) is a chronic, autoimmune exocrinopathy that leads to severe dryness of the mouth and eyes. Exocrine function is highly regulated by neuronal mechanisms but little is known about the link between chronic inflammation, innervation and altered exocrine function in the diseased eyes and exocrine glands of SS patients. To gain a better understanding of neuronal regulation in the immunopathogenesis of autoimmune exocrinopathy, we profiled a mouse model of spontaneous, autoimmune exocrinopathy that possess key characteristics of peripheral neuropathy experienced by SS patients. Mice deficient in the autoimmune regulator (Aire) gene developed spontaneous, CD4+ T cell-mediated exocrinopathy and aqueous-deficient dry eye that were associated with loss of nerves innervating the cornea and lacrimal gland. Changes in innervation and tear secretion were accompanied by increased proliferation of corneal epithelial basal cells, limbal expansion of KRT19-positive progenitor cells, increased vascularization of the peripheral cornea and reduced nerve function in the lacrimal gland. In addition, we found extensive loss of MIST1+ secretory acinar cells in the Aire -/- lacrimal gland suggesting that acinar cells are a primary target of the disease, Finally, topical application of ophthalmic steroid effectively restored corneal innervation in Aire -/- mice thereby functionally linking nerve loss with local inflammation in the aqueous-deficient dry eye. These data provide important insight regarding the relationship between chronic inflammation and neuropathic changes in autoimmune-mediated dry eye. Peripheral neuropathies characteristic of SS appear to be tightly linked with the underlying immunopathological mechanism and Aire -/- mice provide an excellent tool to explore the interplay between SS-associated immunopathology and peripheral neuropathy.	[Chen, Feeling Y.; Lee, Albert; Nathan, Sara; Knox, Sarah M.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Ge, Shaokui; McNamara, Nancy A.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Ge, Shaokui; McNamara, Nancy A.] Univ Calif Berkeley, Vis Sci Grad Program, Berkeley, CA 94720 USA; [McNamara, Nancy A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Knox, SM (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.; McNamara, NA (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.; McNamara, NA (corresponding author), Univ Calif Berkeley, Vis Sci Grad Program, Berkeley, CA 94720 USA.; McNamara, NA (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	sarah.knox@ucst.edu; nency.mcnamara@ucsf.edu	Knox, Sarah Monica/GNW-5445-2022		Allergan Foundation - American Optometric Foundation; National Eye Institute [R01-EY026492]; NATIONAL EYE INSTITUTE [R01EY026492, R01EY025980, P30EY002162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R35DE028255] Funding Source: NIH RePORTER	Allergan Foundation - American Optometric Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was funding by an Allergan Foundation Research Grant awarded by the American Optometric Foundation and National Eye Institute grant R01-EY026492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funding by an Allergan Foundation Research Grant awarded by the American Optometric Foundation and National Eye Institute grant R01-EY026492.	Alegria GC, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000179; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Birnbaum J, 2010, NEUROLOGIST, V16, P287, DOI 10.1097/NRL.0b013e3181ebe59f; Bougea A, 2015, INT J CHRONIC DIS, V2015; Bougea Anastasia, 2016, Int J Chronic Dis, V2016, P9854813, DOI 10.1155/2016/9854813; Chen YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077286; Chen YT, 2012, LAB INVEST, V92, P556, DOI 10.1038/labinvest.2011.189; Chen YT, 2010, AM J PATHOL, V177, P1333, DOI 10.2353/ajpath.2010.100227; Chen YT, 2009, MOL VIS, V15, P563; Chen YF, 2014, AM J PATHOL, V184, P1695, DOI 10.1016/j.ajpath.2014.02.024; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Deshmukh US, 2008, ARTHRITIS RHEUM-US, V58, P1318, DOI 10.1002/art.23368; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Eskandari F, 2003, ARTHRITIS RES THER, V5, P251, DOI 10.1186/ar1002; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Ferrari G, 2013, INVEST OPHTH VIS SCI, V54, P813, DOI 10.1167/iovs.11-8379; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Ghanem RC, 2011, CURR EYE RES, V36, P989, DOI 10.3109/02713683.2011.593730; Goules AV, 2016, AUTOIMMUN REV, V15, P695, DOI 10.1016/j.autrev.2016.03.004; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Knox SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2493; Lafitte C, 2001, J NEUROL, V248, P577, DOI 10.1007/s004150170135; Li S, 2008, INVEST OPHTH VIS SCI, V49, P34, DOI 10.1167/iovs.07-0685; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Meagher C, 2008, J IMMUNOL, V180, P7793, DOI 10.4049/jimmunol.180.12.7793; MELLGREN SI, 1989, NEUROLOGY, V39, P390, DOI 10.1212/WNL.39.3.390; Mori K, 2005, BRAIN, V128, P2518, DOI 10.1093/brain/awh605; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Namavari A, 2012, INVEST OPHTH VIS SCI, V53, P4575, DOI 10.1167/iovs.12-9760; Paranyuk Y, 2001, CURR EYE RES, V23, P199, DOI 10.1076/ceyr.23.3.199.5468; Patel R, 2014, CLIN EPIDEMIOL, V6, P247, DOI 10.2147/CLEP.S47399; Pavlakis PP, 2012, J AUTOIMMUN, V39, P27, DOI 10.1016/j.jaut.2012.01.003; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Rebustini IT, 2009, DEV CELL, V17, P482, DOI 10.1016/j.devcel.2009.07.016; Robinson CP, 1996, CLIN IMMUNOL IMMUNOP, V79, P50, DOI 10.1006/clin.1996.0050; Stepp M.A., 2016, GLIA; Tsai W-H., 1995, MOMENT PRESERVING TH, P44; Tuisku IS, 2008, EXP EYE RES, V86, P879, DOI 10.1016/j.exer.2008.03.002; Vijmasi T, 2014, INVEST OPHTH VIS SCI, V55, P5401, DOI 10.1167/iovs.14-13924; Vijmasi T, 2013, MOL VIS, V19, P1957; WILLIAMS RM, 1994, J AUTONOM NERV SYST, V47, P95, DOI 10.1016/0165-1838(94)90070-1; Yamaguchi T, 2016, CORNEA, V35, pS65, DOI 10.1097/ICO.0000000000000989; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; Zeng XPL, 2013, J IMMUNOL, V190, P3895, DOI 10.4049/jimmunol.1203001; Zhou DL, 2014, EXPERT REV CLIN IMMU, V10, P513, DOI 10.1586/1744666X.2014.900441	48	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184916	10.1371/journal.pone.0184916	http://dx.doi.org/10.1371/journal.pone.0184916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926640	Green Published, gold			2022-12-27	WOS:000411166600053
J	Cirkovic, I; Trajkovic, J; Hauschild, T; Andersen, PS; Shittu, A; Larsen, AR				Cirkovic, Ivana; Trajkovic, Jasmina; Hauschild, Tomasz; Andersen, Paal Skytt; Shittu, Adebayo; Larsen, Anders Rhod			Nasal and pharyngeal carriage of methicillinresistant Staphylococcus sciuri among hospitalised patients and healthcare workers in a Serbian university hospital	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; MOLECULAR CHARACTERIZATION; RESISTANCE; STRAINS; MEMBERS; AUREUS; MEC; GENES; IDENTIFICATION; EPIDEMIOLOGY	There has been a paucity of data on methicillin-resistant Staphylococcus sciuri (MRSS) epidemiology in European healthcare settings. The aim of the study was to determine the prevalence of nasal and pharyngeal carriage and diversity of MRSS among inpatients and healthcare workers (HCWs) in the largest healthcare centre in Serbia, and to assess performance of different methods for MRSS screening. Nasal and pharyngeal swabs were obtained from 195 patients and 105 HCWs in different departments. Each swab was inoculated directly onto MRSA-ID, oxacillin-resistance screening agar and mannitol salt agar (MSA) with 2 mg/L of oxacillin. After inoculation, each swab was dipped in Mueller-Hinton broth with 6.5% NaCl and after overnight incubation, subcultured onto oxacillin-MSA. Characterisation of isolated MRSS strains was determined by antimicrobial susceptibility testing, PFGE, SCCmec typing and antimicrobial resistance genes detection. MRSS nasal and pharyngeal carriage rate was high (5%) in our hospital and department-variable. PFGE revealed a possible cross-transmission of MRSS between a patient and an HCW, and dissemination across hospital wards. All analysed isolates were multidrug resistant. Fusidic acid resistance was discovered in 93.7% of isolates, but fusA mutations in EF-G and fusB/C genes were not detected. SCCmec regions of MRSS contained elements of classic methicillinresistant S. aureus type III. Broth enrichment prior to isolation on oxacillin-MSA was superior to direct cultivation on different media with a sensitivity/specificity of 100% and 88.5%, respectively. MRSS is a significant coloniser of patients and HCWs in the hospital. Further research is needed to investigate the clinical significance of the bacterium in our settings.	[Cirkovic, Ivana; Trajkovic, Jasmina] Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Hauschild, Tomasz] Univ Bialystok, Inst Biol, Dept Microbiol, Bialystok, Poland; [Andersen, Paal Skytt; Larsen, Anders Rhod] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Copenhagen, Denmark; [Shittu, Adebayo] Obafemi Awolowo Univ, Dept Microbiol, Ife, Nigeria	University of Belgrade; University of Bialystok; Statens Serum Institut; Obafemi Awolowo University	Cirkovic, I (corresponding author), Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia.	cirkoviciv@yahoo.com	Shittu, Adebayo Osagie/AGX-7853-2022; Andersen, Paal S/H-2087-2015	Shittu, Adebayo Osagie/0000-0003-3992-4123; Andersen, Paal S/0000-0001-5656-0427; Hauschild, Tomasz/0000-0002-1262-5548; Larsen, Anders Rhod/0000-0002-1713-8765; Cirkovic, Ivana/0000-0003-1515-1824	Ministry of Education, Science and Technological Development of Serbia [175039]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of Serbia, Grants No. 175039, http://www.mpn.gov.rs/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim ML, 2009, MICROB DRUG RESIST, V15, P19, DOI 10.1089/mdr.2009.0881; Becker K, 2006, J CLIN MICROBIOL, V44, P229, DOI 10.1128/JCM.44.1.229-231.2006; Bignardi GE, 1996, J ANTIMICROB CHEMOTH, V37, P53, DOI 10.1093/jac/37.1.53; Busscher JF, 2006, VET MICROBIOL, V113, P131, DOI 10.1016/j.vetmic.2005.10.028; Cirkovic I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127347; Couto I, 2000, J CLIN MICROBIOL, V38, P1136, DOI 10.1128/JCM.38.3.1136-1143.2000; Couto I, 2003, J BACTERIOL, V185, P645, DOI 10.1128/JB.185.2.645-653.2003; Dakic I, 2005, J CLIN MICROBIOL, V43, P2782, DOI 10.1128/JCM.43.6.2782-2785.2005; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Garcia MC, 2002, FOOD MICROBIOL, V19, P23, DOI 10.1006/fmic.2001.0457; Harrison EM, 2014, J ANTIMICROB CHEMOTH, V69, P911, DOI 10.1093/jac/dkt452; Hauschild T, 2003, J VET MED B, V50, P241, DOI 10.1046/j.1439-0450.2003.00662.x; Hauschild T, 2007, MICROB DRUG RESIST, V13, P77, DOI 10.1089/mdr.2007.713; Hauschild T, 2007, INT J ANTIMICROB AG, V29, P356, DOI 10.1016/j.ijantimicag.2006.10.002; Hauschild T, 2009, INT J ANTIMICROB AG, V33, P383, DOI 10.1016/j.ijantimicag.2008.09.020; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Katayama Y, 2001, ANTIMICROB AGENTS CH, V45, P1955, DOI 10.1128/AAC.45.7.1955-1963.2001; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; McLaws FB, 2011, ANTIMICROB AGENTS CH, V55, P1173, DOI 10.1128/AAC.00817-10; Machado ABP, 2007, J MED MICROBIOL, V56, P1328, DOI 10.1099/jmm.0.47294-0; Nemeghaire S, 2014, VET MICROBIOL, V171, P342, DOI 10.1016/j.vetmic.2014.02.005; Nemeghaire S, 2014, VET MICROBIOL, V171, P357, DOI 10.1016/j.vetmic.2014.01.041; Pan A, 2013, J HOSP INFECT, V83, P107, DOI 10.1016/j.jhin.2012.09.020; Schoenfelder SMK, 2017, VET MICROBIOL, V200, P79, DOI 10.1016/j.vetmic.2016.04.019; Severin JA, 2010, ANTIMICROB AGENTS CH, V54, P5413, DOI 10.1128/AAC.00426-10; Stepanovic S, 2006, J CLIN MICROBIOL, V44, P934, DOI 10.1128/JCM.44.3.934-937.2006; Stepanovic S, 2005, INT J STD AIDS, V16, P452, DOI 10.1258/0956462054093999; Stepanovic S, 2005, J CLIN MICROBIOL, V43, P956, DOI 10.1128/JCM.43.2.956-958.2005; Stepanovic S, 2006, MICROB DRUG RESIST, V12, P115, DOI 10.1089/mdr.2006.12.115; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tulinski P, 2012, APPL ENVIRON MICROB, V78, P299, DOI 10.1128/AEM.05594-11; Urushibara N, 2011, MICROB DRUG RESIST, V17, P291, DOI 10.1089/mdr.2010.0144; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zhou YJ, 2008, J BACTERIOL, V190, P508, DOI 10.1128/JB.01549-07	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0185181	10.1371/journal.pone.0185181	http://dx.doi.org/10.1371/journal.pone.0185181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926634	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600075
J	Herbert, RJH; Collins, K; Mallinson, J; Hall, AE; Pegg, J; Rosso, K; Clarke, L; Clements, T				Herbert, Roger J. H.; Collins, Ken; Mallinson, Jenny; Hall, Alice E.; Pegg, Josephine; Rosso, Kathryn; Clarke, Leo; Clements, Tom			Epibenthic and mobile species colonisation of a geotextile artificial surf reef on the south coast of England	PLOS ONE			English	Article							ROCKY INTERTIDAL COMMUNITY; UNDERWATER VIDEO STATIONS; STABLE-ISOTOPE ANALYSES; HABITAT COMPLEXITY; NATURAL REEFS; MARINE-INVERTEBRATES; BENTHIC ASSEMBLAGES; SUBTIDAL EPIBIOTA; ALGAL SUCCESSION; FISH ASSEMBLAGES	With increasing coastal infrastructure and use of novel materials there is a need to investigate the colonisation of assemblages associated with new structures, how these differ to natural and other artificial habitats and their potential impact on regional biodiversity. The colonisation of Europe's first artificial surf reef (ASR) was investigated at Boscombe on the south coast of England (2009-2014) and compared with assemblages on existing natural and artificial habitats. The ASR consists of geotextile bags filled with sand located 220m offshore on a sandy sea bed at a depth of 0-5m. Successional changes in epibiota were recorded annually on differently orientated surfaces and depths using SCUBA diving and photography. Mobile faunal assemblages were sampled using Baited Remote Underwater Video (BRUV). Distinct stages in colonisation were observed, commencing with bryozoans and green algae which were replaced by red algae, hydroids and ascidians, however there were significant differences in assemblage structure with depth and orientation. The reef is being utilised by migratory, spawning and juvenile life-history stages of fish and invertebrates. The number of non-native species was larger than on natural reefs and other artificial habitats and some occupied a significant proportion of the structure. The accumulation of 180 benthic and mobile taxa, recorded to date, appears to have arisen from a locally rich and mixed pool of native and non-native species. Provided no negative invasive impacts are detected on nearby protected reefs the creation of novel yet diverse habitats may be considered a beneficial outcome.	[Herbert, Roger J. H.; Hall, Alice E.; Clarke, Leo] Bournemouth Univ, Dept Life & Environm Sci, Fac Sci & Technol, Talbot Campus, Poole, Dorset, England; [Collins, Ken; Mallinson, Jenny; Clements, Tom] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, Waterfront Campus,European Way, Southampton, Hants, England; [Pegg, Josephine] Univ Ctr Sparsholt, Winchester, Hants, England; [Rosso, Kathryn] British Trust Ornithol, Thetford, Norfolk, England	Bournemouth University; NERC National Oceanography Centre; University of Southampton; British Trust for Ornithology	Herbert, RJH (corresponding author), Bournemouth Univ, Dept Life & Environm Sci, Fac Sci & Technol, Talbot Campus, Poole, Dorset, England.	rherbert@bournemouth.ac.uk	Clarke, Leo/P-7750-2019	Herbert, Roger/0000-0002-9854-3112; Pegg, Josephine/0000-0001-6364-4741	Esmee Fairbairn Foundation; Bournemouth Borough Council	Esmee Fairbairn Foundation; Bournemouth Borough Council	This work received support from the Esmee Fairbairn Foundation and Bournemouth Borough Council The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful for financial support from the Esmee Fairbairn Foundation and Bournemouth Borough Council. We thank Mike Markey, skipper of Peveril Myth, John Humphreys, skipper of Sea Rush and divers Nick Owen, Lin Baldock, Jane Maddocks, Lucy Martin, Matt Doggett, Kathryn Dawson, Steve Trewhella, Ralf Hubner, Sally Keith and others from SeaSearch. We also thank Ruth Throssel, Eleanor Stacy, Ross Wheeler and Wayne O'Brien who assisted with the fieldwork. We are grateful to Harry Manley for production of the map (Fig 1).	Adams TP, 2014, J APPL ECOL, V51, P330, DOI 10.1111/1365-2664.12207; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 2015, DIVERS DISTRIB, V21, P755, DOI 10.1111/ddi.12301; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; ANDERSON MJ, 1994, J EXP MAR BIOL ECOL, V184, P217, DOI 10.1016/0022-0981(94)90006-X; Antoniadou C, 2010, J EXP MAR BIOL ECOL, V382, P145, DOI 10.1016/j.jembe.2009.11.004; ARDIZZONE GD, 1989, B MAR SCI, V44, P592; Arenas F, 2006, J MAR BIOL ASSOC UK, V86, P1329, DOI 10.1017/S0025315406014354; Bacchiocchi F, 2003, ESTUAR COAST SHELF S, V56, P1157, DOI 10.1016/S0272-7714(02)00322-0; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Benedetti-Cecchi L, 2000, ECOL MONOGR, V70, P45, DOI 10.1890/0012-9615(2000)070[0045:PDAIID]2.0.CO;2; BOHNSACK JA, 1985, B MAR SCI, V37, P11; Borrero JC, 2003, P 3 INT SURF REEF S, P83; Bouchoucha M, 2016, MAR ECOL PROG SER, V547, P193, DOI 10.3354/meps11641; BREITBURG DL, 1985, OECOLOGIA, V65, P173, DOI 10.1007/BF00379215; Brown CJ, 2005, BIOFOULING, V21, P73, DOI 10.1080/08927010512331344197; Bulleri F, 2005, J APPL ECOL, V42, P1063, DOI 10.1111/j.1365-2664.2005.01096.x; Bulleri F, 2006, OECOLOGIA, V149, P482, DOI 10.1007/s00442-006-0459-3; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Caddy J. F., 2007, MARINE HABITAT COVER; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; CARTER JW, 1985, B MAR SCI, V37, P86; Carvalho S, 2013, MAR ENVIRON RES, V92, P170, DOI 10.1016/j.marenvres.2013.09.013; Chapman MG, 2002, J EXP MAR BIOL ECOL, V275, P95, DOI 10.1016/S0022-0981(02)00134-X; Charbonnel E, 2002, ICES J MAR SCI, V59, pS208, DOI 10.1006/jmsc.2002.1263; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clynick BG, 2008, MAR ENVIRON RES, V65, P18, DOI 10.1016/j.marenvres.2007.07.005; Collins KJ, 2012, UNDERWATER TECHNOL, V30, P183, DOI 10.3723/ut.30.183; Collins KJ, 1990, P ISLE WIGHT NATURAL, V9, P41; Connell J.H., 1985, P125; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Connell SD, 1999, MAR ENVIRON RES, V47, P373, DOI 10.1016/S0141-1136(98)00126-3; Cresson P, 2014, J EXP MAR BIOL ECOL, V452, P54, DOI 10.1016/j.jembe.2013.11.014; Dafforn KA, 2015, FRONT ECOL ENVIRON, V13, P82, DOI 10.1890/140050; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P249, DOI 10.1016/0022-0981(87)90057-8; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P195, DOI 10.1016/0022-0981(87)90055-4; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P217, DOI 10.1016/0022-0981(87)90056-6; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Edwards RA, 2005, MAR FRESHWATER RES, V56, P133, DOI 10.1071/MF04202; FAGER EW, 1971, LIMNOL OCEANOGR, V16, P241; Falace A, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P435; FARRELL TM, 1991, ECOL MONOGR, V61, P95, DOI 10.2307/1943001; Fletcher S, 2011, LAND USE POLICY, V28, P395, DOI 10.1016/j.landusepol.2010.08.002; Folpp H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063505; Froese R., 2015, FISHBASE; Gladstone W, 2012, J EXP MAR BIOL ECOL, V429, P28, DOI 10.1016/j.jembe.2012.06.013; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Glasby TM, 2000, J EXP MAR BIOL ECOL, V248, P177, DOI 10.1016/S0022-0981(00)00169-6; Glasby TM, 2001, MAR ECOL PROG SER, V214, P127, DOI 10.3354/meps214127; Glasby TM, 1999, ESTUAR COAST SHELF S, V48, P281, DOI 10.1006/ecss.1998.0417; Glasby TM, 1999, J EXP MAR BIOL ECOL, V234, P275, DOI 10.1016/S0022-0981(98)00156-7; Gonzalez-Gurriaran E, 2002, J CRUSTACEAN BIOL, V22, P91, DOI 10.1651/0278-0372(2002)022[0091:MPOFSC]2.0.CO;2; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Guidetti P, 2004, MAR ECOL PROG SER, V274, P57, DOI 10.3354/meps274057; Haggit T, 2014, BAITED REMOTE UNDERW; Harvey E. S., 2013, 2010002 FRDC; Hatcher AM, 1998, HYDROBIOLOGIA, V367, P153, DOI 10.1023/A:1003228100220; Hayward PJ, 1995, HDB MARINE FAUNA N W, pxi; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Herbert RJH, 2012, J BIOGEOGR, V39, P585, DOI 10.1111/j.1365-2699.2011.02626.x; Hunter WR, 2009, ICES J MAR SCI, V66, P691, DOI 10.1093/icesjms/fsp058; Irving AD, 2002, MAR ECOL PROG SER, V245, P83, DOI 10.3354/meps245083; Jacobi CM, 1996, J EXP MAR BIOL ECOL, V206, P39, DOI 10.1016/S0022-0981(96)02605-6; Jenkins S.R., 2010, BIOFOULING, V456, P60, DOI [10.1002/9781444315462.ch4, DOI 10.1002/9781444315462.CH4]; Jensen AC, 2000, ARTIFICIAL REEFS EUR; Knott NA, 2004, J MAR BIOL ASSOC UK, V84, P1117, DOI 10.1017/S0025315404010550h; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Mallinson J.J., 2000, Proceedings of the Dorset Natural History & Archaeological Society, V121, P113; MARKAGER S, 1992, MAR ECOL PROG SER, V88, P83, DOI 10.3354/meps088083; Mead S, 2010, P 32 C COAST ENG SHA; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; Mineur F, 2012, OCEANOGR MAR BIOL, V50, P189; Moura A, 2008, BIOFOULING, V24, P381, DOI 10.1080/08927010802256414; Noel LMLJ, 2009, ECOL STUD-ANAL SYNTH, V206, P213, DOI 10.1007/978-3-540-92704-4_15; Parsons DF, 2016, MAR ECOL PROG SER, V561, P155, DOI 10.3354/meps11927; Perkol-Finkel S, 2007, J EXP MAR BIOL ECOL, V340, P25, DOI 10.1016/j.jembe.2006.08.008; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Platt WJ, 2003, ECOL MONOGR, V73, P507, DOI 10.1890/01-0552; Ponti M, 2015, MAR ENVIRON RES, V104, P10, DOI 10.1016/j.marenvres.2014.12.004; Relini G, 2002, ICES J MAR SCI, V59, pS132, DOI 10.1006/jmsc.2002.1272; Rendle EJ, 2014, MAR POLICY, V45, P349, DOI 10.1016/j.marpol.2013.09.004; Rule MJ, 2005, MAR ECOL PROG SER, V290, P67, DOI 10.3354/meps290067; Russell B, 2014, IUCN RED LIST THREAT; Sampedro MP, 2004, J CRUSTACEAN BIOL, V24, P168, DOI 10.1651/C-2404; Schmid K, 2016, HYDROBIOLOGIA, V112, P75; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2009, BIOL BULL-US, V216, P373; Sherman RL, 2002, ICES J MAR SCI, V59, pS196, DOI 10.1006/jmsc.2001.1163; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; SOUSA WP, 1992, SYST ASSOC SPEC VOL, V46, P425; Stobart B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127559; Stoner AW, 2004, J FISH BIOL, V65, P1445, DOI 10.1111/j.0022-1112.2004.00593.x; THOMAS CJ, 1993, MAR ECOL PROG SER, V95, P19, DOI 10.3354/meps095019; TODD CD, 1988, J EXP MAR BIOL ECOL, V115, P113, DOI 10.1016/0022-0981(88)90097-4; Ushiama S, 2016, BIOFOULING, V32, P1049, DOI 10.1080/08927014.2016.1224860; Utne-Palm AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143487; VADAS RL, 1988, J PHYCOL, V24, P338; Vaz-Pinto F, 2014, MAR ENVIRON RES, V94, P72, DOI 10.1016/j.marenvres.2013.12.007; Vega Fernandez T, 2008, AQUAT BIOL, V1, P239, DOI 10.3354/ab00027; Walker SJ, 2014, BIODIVERS CONSERV, V23, P433, DOI 10.1007/s10531-013-0611-4; Wetzel MA, 2011, GEOTEXT GEOMEMBRANES, V29, P440, DOI 10.1016/j.geotexmem.2010.12.004; Wilding TA, 2007, J EXP MAR BIOL ECOL, V353, P279, DOI 10.1016/j.jembe.2007.10.001; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; Wootton JT, 2002, ECOL RES, V17, P249, DOI 10.1046/j.1440-1703.2002.00484.x; Wraith J, 2013, MAR ECOL PROG SER, V477, P189, DOI 10.3354/meps10137	110	14	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184100	10.1371/journal.pone.0184100	http://dx.doi.org/10.1371/journal.pone.0184100			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926608	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600009
J	Sbardella, A; Pugliese, E; Pietronero, L				Sbardella, Angelica; Pugliese, Emanuele; Pietronero, Luciano			Economic development and wage inequality: A complex system analysis	PLOS ONE			English	Article							INCOME INEQUALITY; GROWTH; TRENDS; US; INDUSTRIALIZATION	Adapting methods from complex system analysis, this paper analyzes the features of the complex relationship between wage inequality and the development and industrialization of a country. Development is understood as a combination of a monetary index, GDP per capita, and a recently introduced measure of a country's economic complexity: Fitness. Initially the paper looks at wage inequality on a global scale, over the time period 1990-2008. Our empirical results show that globally the movement of wage inequality along with the ongoing industrialization of countries has followed a longitudinally persistent pattern comparable to the one theorized by Kuznets in the fifties: countries with an average level of development suffer the highest levels of wage inequality. Next, the study narrows its focus on wage inequality within the United States. By using data on wages and employment in the approximately 3100 US counties over the time interval 1990-2014, it generalizes the Fitness-Complexity metric for geographic units and industrial sectors, and then investigates wage inequality between NAICS industries. The empirical time and scale dependencies are consistent with a relation between wage inequality and development driven by institutional factors comparing countries, and by change in the structural compositions of sectors in a homogeneous institutional environment, such as the counties of the United States.	[Sbardella, Angelica; Pietronero, Luciano] ISC CNR, Inst Complex Syst, Rome, Italy; [Pugliese, Emanuele; Pietronero, Luciano] Sapienza Univ Roma, Dept Phys, Rome, Italy; [Sbardella, Angelica] Univ Roma Tor Vergata, Fac Econ, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; University of Rome Tor Vergata	Pugliese, E (corresponding author), Sapienza Univ Roma, Dept Phys, Rome, Italy.	ernanuele.pugliese@gmail.com	Pietronero, Luciano/O-4473-2018	Pietronero, Luciano/0000-0001-6424-8863; Sbardella, Angelica/0000-0002-4462-6609	CNR Progetto di Interesse CRISIS LAB; EU [611272 GROWTHCOM]	CNR Progetto di Interesse CRISIS LAB; EU(European Commission)	The authors acknowledge funding from the "CNR Progetto di Interesse CRISIS LAB" (http://www.crisislab.it) and EU Project no. 611272 GROWTHCOM (http://www.growthcom.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D., 2000, TECHNICAL CHANGE INE; Acemoglu D., 2012, FOREIGN POLICY, P85; Acemoglu D., 1997, J ECON GROWTH, V2, P61, DOI DOI 10.1023/A:1009733730177; Acemoglu D, 2013, DEMOCRACY REDISTRIBU; Aghion P, 1998, REV ECON DYNAM, V1, P276, DOI 10.1006/redy.1997.0007; AHLUWALIA MS, 1976, AM ECON REV, V66, P128; Alderson AS, 2002, AM J SOCIOL, V107, P1244, DOI 10.1086/341329; ALESINA A, 1994, Q J ECON, V109, P465, DOI 10.2307/2118470; ANAND S, 1993, J DEV ECON, V40, P25, DOI 10.1016/0304-3878(93)90103-T; Autor David H., 2010, POLARIZATION JOB OPP; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Benabou R., 1996, NBER MACROECON ANNU, V11, P11, DOI [10.1086/654291, DOI 10.1086/654291]; BIRDSALL N, 1995, WORLD BANK ECON REV, V9, P477, DOI 10.1093/wber/9.3.477; Birdsall N, 1997, AM ECON REV, V87, P32; Blau FD, 1994, INT DIFFERENCES MALE; BLUESTONE B, 1988, AM ECON REV, V78, P124; Bluestone B, 1988, GREAT U TURN CORPORA; Bluestone Barry, 1982, DEINDUSTRIALIZATION; Conceicao P, 2000, 15 UTIP; CONCEICAO P, 2000, 14 UTIP; Conceicao P., 2001, INEQUALITY IND CHANG; Costanza R, 2009, THE PARDEE PAPERS; Cowell FA, 1996, ECONOMETRICA, V64, P77, DOI 10.2307/2171925; Cristelli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117174; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; David H, 1997, COMPUTING INEQUALITY; Deininger K, 1996, WORLD BANK ECON REV, V10, P565, DOI 10.1093/wber/10.3.565; Diener E, 1997, SOC INDIC RES, V40, P189, DOI 10.1023/A:1006859511756; Feenstra RC, 2015, AM ECON REV, V105, P3150, DOI 10.1257/aer.20130954; Forbes KJ, 2000, AM ECON REV, V90, P869, DOI 10.1257/aer.90.4.869; Galbraith J., 2015, WIDER WORKING PAPER; Galbraith JK, 2007, J POLICY MODEL, V29, P587, DOI 10.1016/j.jpolmod.2007.05.008; Galbraith JK, 2000, 17 UTIP; Galbraith JK, 2007, 43 UTIP; Galbraith JK., 2003, CESIFO ECON STUD, V49, P527, DOI DOI 10.1093/CESIF0/49.4.527; Galbraith JK., 1998, 259 LEVV EC I; Galor O, 1997, AM ECON REV, V87, P363; Galor O., 1997, J ECON GROWTH, V2, P93, DOI [10.1023/A:1009785714248, DOI 10.1023/A:1009785714248]; Goldin C., 2009, RACE ED TECHNOLOGY; Greenwood J, 1989, FINANCIAL DEV GROWTH; Hartmann D, 2017, WORLD DEV, V93, P75, DOI 10.1016/j.worlddev.2016.12.020; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; JUHN C, 1993, J POLIT ECON, V101, P410, DOI 10.1086/261881; Katz L.F., 1999, HDB LABOR EC, V3, P1463, DOI DOI 10.1016/S1573-4463(99)03007-2; Katz LF, 1991, CHANGES RELATIVE WAG; KIM S, 1995, Q J ECON, V110, P881, DOI 10.2307/2946643; Kuznets S, 1955, AM ECON REV, V45, P1; LEVY F, 1992, J ECON LIT, V30, P1333; Marx K., 1995, CAPITAL VOLUME I, VI; Moller S, 2009, AM J SOCIOL, V114, P1037, DOI 10.1086/595943; MURPHY KM, 1989, J POLIT ECON, V97, P1003, DOI 10.1086/261641; Nadaraya E.A., 1964, THEOR PROBAB APPL+, V9, P141, DOI [10.1137/1110024, DOI 10.1137/1109020]; Nelson R.R., 1994, IND CORP CHANG, V3, P47, DOI DOI 10.1093/ICC/3.1.47; Perotti Roberto, 1996, J ECON GROWTH, V1, P149, DOI DOI 10.1007/BF00138861; PERSSON T, 1994, AM ECON REV, V84, P600; Piketty T., 2014, CAPITAL 21 CENTURY; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Pugliese E., 2014, ARXIV14100249; Pugliese E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168540; Ram R, 1997, SOUTH ECON J, V64, P576, DOI 10.2307/1060869; Ravallion M, 1997, WORLD BANK ECON REV, V11, P357, DOI 10.1093/wber/11.2.357; ROBINSON S, 1976, AM ECON REV, V66, P437; Rosenstein-Rodan PN, 1943, ECON J, V53, P202, DOI 10.2307/2226317; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shapley LS, 2016, 17 VALUE N PERSON GA, V17, P307, DOI [10.1515/9781400881970-018, DOI 10.1515/9781400881970-018]; Smith A., 1776, ENCY BRITANNICA, V1; Stiglitz JE., 2010, REPORT COMMISSION ME; SUMMERS R, 1984, J POLICY MODEL, V6, P237, DOI 10.1016/0161-8938(84)90014-0; Tacchella A, 2013, J ECON DYN CONTROL, V37, P1683, DOI 10.1016/j.jedc.2013.04.006; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Theil H., 1967, STUDIES MATH MANAGER, P7; U S Bureau of Labor Statistics, 2015, Q CENS EMPL WAG QCEW; Williamson J. G., 1982, RES EC HIST, V7, P1; Zignago S., 2010, BACI INT TRADE DATAB	74	28	29	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0182774	10.1371/journal.pone.0182774	http://dx.doi.org/10.1371/journal.pone.0182774			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH4XT	28926577	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600003
J	Andruszkiewicz, EA; Sassoubre, LM; Boehm, AB				Andruszkiewicz, Elizabeth A.; Sassoubre, Lauren M.; Boehm, Alexandria B.			Persistence of marine fish environmental DNA and the influence of sunlight	PLOS ONE			English	Article							EDNA; BIODIVERSITY; CONSERVATION; DEGRADATION; ABUNDANCE; IMPACTS; QUANTIFICATION; TEMPERATURE; DIVERSITY; GENOMICS	Harnessing information encoded in environmental DNA (eDNA) in marine waters has the potential to revolutionize marine biomonitoring. Whether using organism-specific quantitative PCR assays or metabarcoding in conjunction with amplicon sequencing, scientists have illustrated that realistic organism censuses can be inferred from eDNA. The next step is establishing ways to link information obtained from eDNA analyses to actual organism abundance. This is only possible by understanding the processes that control eDNA concentrations. The present study uses mesocosm experiments to study the persistence of eDNA in marine waters and explore the role of sunlight in modulating eDNA persistence. We seeded solute-permeable dialysis bags with water containing indigenous eDNA and suspended them in a large tank containing seawater. Bags were subjected to two treatments: half the bags were suspended near the water surface where they received high doses of sunlight, and half at depth where they received lower doses of sunlight. Bags were destructively sampled over the course of 87 hours. eDNA was extracted from water samples and used as template for a Scomber japonicus qPCR assay and a marine fish-specific 12S rRNA PCR assay. The latter was subsequently sequenced using a metabarcoding approach. S. japonicus eDNA, as measured by qPCR, exhibited first order decay with a rate constant similar to 0.01 hr(-1) with no difference in decay rate constants between the two experimental treatments. eDNA metabarcoding identified 190 organizational taxonomic units (OTUs) assigned to varying taxonomic ranks. There was no difference in marine fish communities as measured by eDNA metabarcoding between the two experimental treatments, but there was an effect of time. Given the differences in UVA and UVB fluence received by the two experimental treatments, we conclude that sunlight is not the main driver of fish eDNA decay in the experiments. However, there are clearly temporal effects that need to be considered when interpreting information obtained using eDNA approaches.	[Andruszkiewicz, Elizabeth A.; Sassoubre, Lauren M.; Boehm, Alexandria B.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Sassoubre, Lauren M.] Univ Buffalo State Univ New York, Dept Civil Struct & Environm Engn, Buffalo, NY USA	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Boehm, AB (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	aboehm@stanford.edu	Allan, Elizabeth Andruszkiewicz/AAD-2255-2021	Boehm, Alexandria/0000-0002-8162-5090; Allan, Elizabeth Andruszkiewicz/0000-0002-9675-0003	U.S. Environmental Protection Agency (EPA) [F15E211913419]	U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	This work was supported by a gift from the Seaver Institute to Woods Institute for the Environment at Stanford University. This publication was developed under STAR Fellowship Assistance Agreement no. F15E211913419 awarded by the U.S. Environmental Protection Agency (EPA). It has not been formally reviewed by EPA. The views expressed in this publication are solely those of Elizabeth Andruszkiewicz and coauthors, and EPA does not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022985; Allard L, 2014, FISHERIES MANAG ECOL, V21, P234, DOI 10.1111/fme.12071; Andruszkiewicz EA, 2017, PLOS ONE, V12; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bourlat SJ, 2013, MAR POLLUT BULL, V74, P19, DOI 10.1016/j.marpolbul.2013.05.042; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cammen KM, 2016, J HERED, V107, P481, DOI 10.1093/jhered/esw044; Cao Y, 2012, J APPL MICROBIOL, V113, P66, DOI 10.1111/j.1365-2672.2012.05305.x; Carey VJ, 2015, GEE GEN ESTIMATION E; Chamberlain SA, 2013, TAXIZE TAXONOMIC SEA, P1; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Corlett RT, 2017, TRENDS BIOTECHNOL, V35, P55, DOI 10.1016/j.tibtech.2016.06.009; Creer S, 2017, MARINE ECOLOGY GENET, V1, P1; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Forsstrom T, 2016, MAR POLLUT BULL, V109, P350, DOI 10.1016/j.marpolbul.2016.05.054; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Guo ZW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013113; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hiddink JG, 2006, CAN J FISH AQUAT SCI, V63, P721, DOI 10.1139/F05-266; Hinlo R, 2017, MANAG BIOL INVASION, V8, P89, DOI 10.3391/mbi.2017.8.1.09; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2015, MOL ECOL RESOUR, V15, P461, DOI 10.1111/1755-0998.12377; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Kelley JL, 2016, NAT REV GENET, V17, P523, DOI 10.1038/nrg.2016.66; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Lacoursiere-Roussel A, 2016, J APPL ECOL, V53, P1148, DOI 10.1111/1365-2664.12598; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Maraccini PA, 2016, ENVIRON SCI TECHNOL, V50, P5068, DOI 10.1021/acs.est.6b00505; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Mattioli MC, 2017, WATER RES, V108, P106, DOI 10.1016/j.watres.2016.10.066; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; Merkes CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113346; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; O'Donnell JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148698; Oksanen J., 2020, COMMUNITY ECOL PACKA; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Radulovici Adriana E., 2010, Diversity, V2, P450; Ribeiro AM, 2017, MAR GENOM, V31, P1, DOI 10.1016/j.margen.2016.09.002; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Schratzberger M, 2002, MAR BIOL, V140, P83, DOI 10.1007/s002270100688; Shelton AO, 2016, FRAMEWORK INFERRING, P1; Shogren AJ, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0290; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Stoeckle MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175186; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Team R.C, R LANG ENV STAT COMP; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Turner CR, 2012, EVALUATING ENV DNA D, P1; Wang M., 2014, ADV STAT, V2014; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786; Yang W, 2013, PLOS ONE, V8; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	81	41	43	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0185043	10.1371/journal.pone.0185043	http://dx.doi.org/10.1371/journal.pone.0185043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915253	Green Published, Green Submitted, gold			2022-12-27	WOS:000410861600030
J	Huang, C; Yang, Y; Chen, XT; Wang, C; Li, Y; Zheng, CL; Wang, YH				Huang, Chao; Yang, Yang; Chen, Xuetong; Wang, Chao; Li, Yan; Zheng, Chunli; Wang, Yonghua			Large-scale cross-species chemogenomic platform proposes a new drug discovery strategy of veterinary drug from herbal medicines	PLOS ONE			English	Article							NATURAL-PRODUCTS; APOPTOSIS; PROTEIN; TARGET	Veterinary Herbal Medicine (VHM) is a comprehensive, current, and informative discipline on the utilization of herbs in veterinary practice. Driven by chemistry but progressively directed by pharmacology and the clinical sciences, drug research has contributed more to address the needs for innovative veterinary medicine for curing animal diseases. However, research into veterinary medicine of vegetal origin in the pharmaceutical industry has reduced, owing to questions such as the short of compatibility of traditional natural-product extract libraries with high-throughput screening. Here, we present a cross-species chemo-genomic screening platform to dissect the genetic basis of multifactorial diseases and to determine the most suitable points of attack for future veterinary medicines, thereby increasing the number of treatment options. First, based on critically examined pharmacology and text mining, we build a cross-species drug-likeness evaluation approach to screen the lead compounds in veterinary medicines. Second, a specific cross-species target prediction model is developed to infer drug-target connections, with the purpose of understanding how drugs work on the specific targets. Third, we focus on exploring the multiple targets interference effects of veterinary medicines by heterogeneous network convergence and modularization analysis. Finally, we manually integrate a disease pathway to test whether the cross-species chemo-genomic platform could uncover the active mechanism of veterinary medicine, which is exemplified by a specific network module. We believe the proposed cross-species chemo-genomic platform allows for the systematization of current and traditional knowledge of veterinary medicine and, importantly, for the application of this emerging body of knowledge to the development of new drugs for animal diseases.	[Huang, Chao; Chen, Xuetong; Wang, Yonghua] Northwest A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China; [Yang, Yang] Shihezi Univ, Sch Pharm, Shihezi, Peoples R China; [Wang, Chao] Dalian Ocean Univ, Coll Econ & Management, Dalian, Peoples R China; [Li, Yan] Dalian Univ Technol, Dept Mat Sci & Chem Engn, Dalian, Liaoning, Peoples R China; [Zheng, Chunli] Northwest Univ, Sch Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Shihezi University; Dalian Ocean University; Dalian University of Technology; Northwest University Xi'an	Wang, YH (corresponding author), Northwest A&F Univ, Coll Life Sci, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China.; Zheng, CL (corresponding author), Northwest Univ, Sch Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China.	chunlizheng@126.com; yh_wang@nwsuaf.edu.cn	li, yong/HDN-3885-2022; Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022		Northwest A & F University, National Natural Science Foundation of China [31170796, 81373892]; National Natural Science Foundation of China [U1603285]	Northwest A & F University, National Natural Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Northwest A & F University, National Natural Science Foundation of China (31170796 and 81373892) supported the study design. National Natural Science Foundation of China (31540008) supported the data collection and analysis. National Natural Science Foundation of China (U1603285) supported publishing and preparing the manuscript.	Adrian M, 1996, J AGR FOOD CHEM, V44, P1979, DOI 10.1021/jf950807o; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bhutani KK, 2010, INDIAN J EXP BIOL, V48, P199; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fang L, 2014, J SEP SCI, V37, P3245, DOI 10.1002/jssc.201400711; Fu Y, 2014, J TRADIT CHINESE MED, V1, P84, DOI [10.1016/j.jtcms.2014.09.006, DOI 10.1016/j.jtcms.2014.09.006]; Graziose Rocky, 2010, Curr Drug Discov Technol, V7, P2; Harvey AL, 1999, TRENDS PHARMACOL SCI, V20, P196, DOI 10.1016/S0165-6147(99)01346-2; Hecker N, 2012, NUCLEIC ACIDS RES, V40, pD1113, DOI 10.1093/nar/gkr912; Hodgins DC, 2002, POLYMICROBIAL DISEASES, P213; Hu SQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005367; Huang C, 2014, BRIEF BIOINFORM, V15, P710, DOI 10.1093/bib/bbt035; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Khandarkar K, 2013, UNIVERSAL J CHEM, V1, P38; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim HC, 2010, TUBERC RESPIR DIS, V68, P125, DOI 10.4046/trd.2010.68.3.125; Kim MJ, 2009, NUTR RES PRACT, V3, P180, DOI 10.4162/nrp.2009.3.3.180; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Laudato M., 2013, OA ALTERN MED, V1, P1; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Liu Z, 2016, SCI REP, P6; Maobe M A G, 2013, EUROP J APPL SCI, V5, P01; Marrassini C, 2011, J NAT PROD, V74, P1503, DOI 10.1021/np100937e; Mauri A, 2006, MATCH-COMMUN MATH CO, V56, P237; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Newman R, 1989, NUTR REPORTS INT US, V51, P851; Niu XF, 2015, CHEM-BIOL INTERACT, V239, P34, DOI 10.1016/j.cbi.2015.06.026; Petranovic D, 2010, FEMS YEAST RES, V10, P1046, DOI 10.1111/j.1567-1364.2010.00689.x; Qiu JZ, 2012, J INFECT DIS, V206, P292, DOI 10.1093/infdis/jis336; Qureshi MH, 2003, J IMMUNOL, V170, P1002, DOI 10.4049/jimmunol.170.2.1002; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Russo R, 2009, NAT PROD COMMUN, V4, P1777; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Sessa R, 2009, INT J IMMUNOPATH PH, V22, P659, DOI 10.1177/039463200902200311; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stogdale L., 2008, CAN VET J, V49, P802; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tian P, 2011, NATURE, V480, pS84, DOI 10.1038/480S84a; van der Greef J, 2005, NAT REV DRUG DISCOV, V4, P961, DOI 10.1038/nrd1904; van Laarhoven T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066952; Vandamme D, 2009, BBA-MOL CELL RES, V1793, P1259, DOI 10.1016/j.bbamcr.2009.04.004; Viegi L, 2003, J ETHNOPHARMACOL, V89, P221, DOI 10.1016/j.jep.2003.08.003; Vlasblom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-99; Volman JJ, 2008, PHYSIOL BEHAV, V94, P276, DOI 10.1016/j.physbeh.2007.11.045; Wang W, 2013, PAC S BIOC PAC S BIO; Wang XL, 2011, BIOCHEM J, V435, P285, DOI 10.1042/BJ20101864; Wang Y, 2015, SYSTEMS PHARM DISSEC; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zhang Z-B, 2007, PLANT PHYSIOL, V144, P942; Zheng C, 2015, SCI REPORTS, V5; Zheng CL, 2014, MOL DIVERS, V18, P621, DOI 10.1007/s11030-014-9521-y	58	6	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2017	12	9							e0184880	10.1371/journal.pone.0184880	http://dx.doi.org/10.1371/journal.pone.0184880			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0WP	28915268	Green Published, gold, Green Submitted			2022-12-27	WOS:000410861600019
J	Calvo-Martin, JM; Papaceit, M; Segarra, C				Calvo-Martin, Juan M.; Papaceit, Montserrat; Segarra, Carmen			Molecular population genetics of the Polycomb genes in Drosophila subobscura	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ADAPTIVE PROTEIN EVOLUTION; POSITIVE SELECTION DRIVES; NUCLEOTIDE VARIATION; HISTONE METHYLTRANSFERASE; SU(Z) 12; MELANOGASTER; POLYMORPHISM; CHROMOSOME; SUBUNIT	Polycomb group (PcG) proteins are important regulatory factors that modulate the chromatin state. They form protein complexes that repress gene expression by the introduction of posttranslational histone modifications. The study of PcG proteins divergence in Drosophila revealed signals of coevolution among them and an acceleration of the nonsynonymous evolutionary rate in the lineage ancestral to the obscura group species, mainly in subunits of the Pcl-PRC2 complex. Herein, we have studied the nucleotide polymorphism of PcG genes in a natural population of D. subobscura to detect whether natural selection has also modulated the evolution of these important regulatory genes in a more recent time scale. Results show that most genes are under the action of purifying selection and present a level and pattern of polymorphism consistent with predictions of the neutral model, the exceptions being Su(z)12 and Pho. MK tests indicate an accumulation of adaptive changes in the SU(Z)12 protein during the divergence of D. subobscura and D. guanche. In contrast, the HKA test shows a deficit of polymorphism at Pho. The most likely explanation for this reduced variation is the location of this gene in the dot-like chromosome and would indicate that this chromosome also has null or very low recombination in D. subobscura, as reported in D. melanogaster.	[Segarra, Carmen] Univ Barcelona, Dept Genet Microbiol & Estadist, Fac Biol, Barcelona, Spain; Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain	University of Barcelona; University of Barcelona	Segarra, C (corresponding author), Univ Barcelona, Dept Genet Microbiol & Estadist, Fac Biol, Barcelona, Spain.	csegarra@ub.edu		Segarra, Carmen/0000-0002-3201-5405	Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); Generalitat de Catalunya, Catalonia, Spain; Ministerio de Economia y Competitividad, Spain [BFU2012-35168, BFU2015-63732]; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Catalonia, Spain [2009SGR-1287, 2014SGR10555]	Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); Generalitat de Catalunya, Catalonia, Spain(Generalitat de Catalunya); Ministerio de Economia y Competitividad, Spain(Spanish Government); Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Catalonia, Spain(Generalitat de Catalunya)	This work was supported by a predoctoral fellowship from Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Catalonia, Spain, to JMCM.; and grants BFU2012-35168 and BFU2015-63732 from Ministerio de Economia y Competitividad, Spain, and 2009SGR-1287 and 2014SGR10555 from Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Catalonia, Spain, to Montserrat Aguade.	AKASHI H, 1995, GENETICS, V139, P1067; Alvarez-Ponce D, 2012, MOL BIOL EVOL, V29, P123, DOI 10.1093/molbev/msr160; Arguello JR, 2010, MOL BIOL EVOL, V27, P848, DOI 10.1093/molbev/msp291; Beck EA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17197; Beh LY, 2012, P NATL ACAD SCI USA, V109, pE1063, DOI 10.1073/pnas.1118678109; Betancourt AJ, 2009, CURR BIOL, V19, P655, DOI 10.1016/j.cub.2009.02.039; Burland T G, 2000, Methods Mol Biol, V132, P71; Calvo-Martin JM, 2016, HEREDITY, V116, P213, DOI 10.1038/hdy.2015.91; Calvo-Martin JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40536; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Clark NL, 2010, MOL BIOL EVOL, V27, P1152, DOI 10.1093/molbev/msp324; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; Eanes WF, 2011, J EXP BIOL, V214, P165, DOI 10.1242/jeb.046458; Findlay GD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004108; Flores HA, 2015, G3-GENES GENOM GENET, V5, P583, DOI 10.1534/g3.114.015875; FU YX, 1993, GENETICS, V133, P693; Gibert JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001280; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hochman B., 1976, GENET BIOL DROSOPHIL, V1b, P903; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Krimbas Costas B., 1992, P127; KUNZEMUHL E, 1958, CHROMOSOMA, V9, P559; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Leung W, 2010, GENETICS, V185, P1519, DOI 10.1534/genetics.110.116129; Levine MT, 2008, GENETICS, V179, P475, DOI 10.1534/genetics.107.085423; LEWONTIN RC, 1964, GENETICS, V49, P49; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOUKAS M, 1979, J HERED, V70, P17, DOI 10.1093/oxfordjournals.jhered.a109181; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Munte A, 2005, GENETICS, V169, P1573, DOI 10.1534/genetics.104.032748; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Nobrega C, 2008, MOL BIOL EVOL, V25, P1534, DOI 10.1093/molbev/msn100; Nowak AJ, 2011, J BIOL CHEM, V286, P23388, DOI 10.1074/jbc.M110.207407; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Papaceit M, 2006, EVOLUTION, V60, P768, DOI 10.1111/j.0014-3820.2006.tb01155.x; Papaceit M, 2013, EVOLUTION, V67, P66, DOI 10.1111/j.1558-5646.2012.01731.x; Podemski L, 2001, CHROMOSOMA, V110, P305, DOI 10.1007/s004120100151; Pratdesaba R, 2015, MOL ECOL, V24, P1729, DOI 10.1111/mec.13155; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; PREVOSTI A, 1964, GENET RES, V5, P27, DOI 10.1017/S0016672300001002; Rai AN, 2013, MOL CELL BIOL, V33, P4844, DOI 10.1128/MCB.00307-13; Ramos-Onsins SE, 2007, EVOL BIOINFORM, V3, P41; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Riley RM, 2003, MOL ECOL, V12, P1315, DOI 10.1046/j.1365-294X.2003.01741.x; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Voigt S, 2015, GENETICS, V200, P591, DOI 10.1534/genetics.115.177030; Wang RL, 1996, GENETICS, V144, P1113; Wang W, 2004, GENETICS, V166, P1783, DOI 10.1534/genetics.166.4.1783; Wang W, 2002, SCIENCE, V295, P134, DOI 10.1126/science.1064521; Wong A, 2008, MOL BIOL EVOL, V25, P497, DOI 10.1093/molbev/msm270; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	60	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0185005	10.1371/journal.pone.0185005	http://dx.doi.org/10.1371/journal.pone.0185005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910411	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200125
J	Lynch, CM; van Berkel, VH; Frieboes, HB				Lynch, Chip M.; van Berkel, Victor H.; Frieboes, Hermann B.			Application of unsupervised analysis techniques to lung cancer patient data	PLOS ONE			English	Article							SURVIVAL PREDICTION; WEB SERVER; EPIDEMIOLOGY; SURVEILLANCE; IDENTIFICATION; SELECTION; PROTEINS; OUTCOMES; TRENDS; RNA	This study applies unsupervised machine learning techniques for classification and clustering to a collection of descriptive variables from 10,442 lung cancer patient records in the Surveillance, Epidemiology, and End Results (SEER) program database. The goal is to automatically classify lung cancer patients into groups based on clinically measurable disease-specific variables in order to estimate survival. Variables selected as inputs for machine learning include Number of Primaries, Age, Grade, Tumor Size, Stage, and TNM, which are numeric or can readily be converted to numeric type. Minimal up-front processing of the data enables exploring the out-of-the-box capabilities of established unsupervised learning techniques, with little human intervention through the entire process. The output of the techniques is used to predict survival time, with the efficacy of the prediction representing a proxy for the usefulness of the classification. A basic single variable linear regression against each unsupervised output is applied, and the associated Root Mean Squared Error (RMSE) value is calculated as a metric to compare between the outputs. The results show that self-ordering maps exhibit the best performance, while k-Means performs the best of the simpler classification techniques. Predicting against the full data set, it is found that their respective RMSE values (15.591 for self-ordering maps and 16.193 for k-Means) are comparable to supervised regression techniques, such as Gradient Boosting Machine (RMSE of 15.048). We conclude that unsupervised data analysis techniques may be of use to classify patients by defining the classes as effective proxies for survival prediction.	[Lynch, Chip M.] Univ Louisville, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA; [van Berkel, Victor H.] Univ Louisville, Dept Cardiovasc & Thorac Surg, Louisville, KY 40292 USA; [Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Frieboes, HB (corresponding author), Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA.; Frieboes, HB (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	hbfrie01@louisville.edu	van Berkel, Victor/AAC-1956-2021	Frieboes, Hermann/0000-0001-5959-4286	National Cancer Institute [R15CA203605]; NATIONAL CANCER INSTITUTE [R15CA203605] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Cancer Institute, R15CA203605 to HBF. The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	Abreu PH, 2013, 13 MED C MED BIOL EN; Abreu PH, 2014, INT C HLTH INF; ACS, 2017, NONSM CELL LUNG CANC; Agrawal Ankit, 2011, International Journal of Knowledge Discovery in Bioinformatics, V2, P34, DOI 10.4018/jkdb.2011040103; Agrawal A, 2011, 11 INT C DAT MIN WOR; Agrawal A, 2011, P 10 INT WORKSH DAT; Agrawal A, 2012, SCI PROGRAMMING-NETH, V20, P29, DOI [10.1155/2012/920245, 10.3233/SPR-2012-0335]; [Anonymous], 2015, WHAT YOU NEED KNOW L; [Anonymous], AJCC CANC STAG; [Anonymous], RES DAT 1973 2009; [Anonymous], 2015, OV SEER PROGR SURV E; Bhaskarla A, 2010, J SURG RES, V162, P1, DOI 10.1016/j.jss.2009.12.030; Chen DC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/632786; Chen W, 2017, J BIOMOL STRUCT DYN, V35, P683, DOI 10.1080/07391102.2016.1157761; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dimitoglu G, 2012, J COMPUTING, V4, P1; Fradkin D., 2006, MACHINE LEARNING MET; Fraley C, 2003, J CLASSIF, V20, P263, DOI 10.1007/s00357-003-0015-3; Franceschi P, 2014, PROTEOMICS, V14, P853, DOI 10.1002/pmic.201300308; Fu JB, 2005, CHEST, V127, P768, DOI 10.1378/chest.127.3.768; Garcia-Laencina PJ, 2015, COMPUT BIOL MED, V59, P125, DOI 10.1016/j.compbiomed.2015.02.006; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; In H, 2015, J SURG ONCOL, V111, P657, DOI 10.1002/jso.23883; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kapadia NS, 2012, INT J RADIAT ONCOL, V84, pS545, DOI 10.1016/j.ijrobp.2012.07.1453; Krishnaiah V., 2013, INT J COMPUTER SCI I, V4, P39; Lally BE, 2009, LUNG CANCER, V64, P226, DOI 10.1016/j.lungcan.2008.08.010; Leslie Christina, 2002, Pac Symp Biocomput, P564; Liang ZY, 2017, BIOINFORMATICS, V33, P467, DOI 10.1093/bioinformatics/btw630; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Lin H, 2019, IEEE ACM T COMPUT BI, V16, P1316, DOI 10.1109/TCBB.2017.2666141; Lin H, 2011, J MICROBIOL METH, V84, P67, DOI 10.1016/j.mimet.2010.10.013; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu ZQ, 2010, ADV EXP MED BIOL, V680, P11, DOI 10.1007/978-1-4419-5913-3_2; Moorthy K, 2011, BIOINFORMATION, V7, P142; Owonikoko TK, 2007, J CLIN ONCOL, V25, P5570, DOI 10.1200/JCO.2007.12.5435; Ramalingam S, 1998, J CLIN ONCOL, V16, P651, DOI 10.1200/JCO.1998.16.2.651; Santos MS, 2015, J BIOMED INFORM, V58, P49, DOI 10.1016/j.jbi.2015.09.012; Skrypnyk I, 2012, MACH LEARN APPL ICML; Swan AL, 2013, OMICS, V17, P595, DOI 10.1089/omi.2013.0017; Tang H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3267325; Tang H, 2016, MOL BIOSYST, V12, P1269, DOI 10.1039/c5mb00883b; Team RC, 2015, LANG ENV STAT COMP V; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Wang Samuel J, 2007, Gastrointest Cancer Res, V1, P84; WEI LY, IEEE ACM TRANS COMPU, V16, P1264; Wu XC, 2004, CANCER EPIDEM BIOMAR, V13, P1215; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhang CJ, 2016, ONCOTARGET, V7, P69783, DOI 10.18632/oncotarget.11975; Zhang T, 2017, NUCLEIC ACIDS RES, V45, pD135, DOI 10.1093/nar/gkw728; Zhao YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34817	56	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184370	10.1371/journal.pone.0184370	http://dx.doi.org/10.1371/journal.pone.0184370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910336	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200043
J	Silva, P; Matos, AD; Martinez-Pecino, R				Silva, Patricia; Delerue Matos, Alice; Martinez-Pecino, Roberto			E-inclusion: Beyond individual socio-demographic characteristics	PLOS ONE			English	Article							DIGITAL DIVIDE; INFORMATION-TECHNOLOGY; INTERNET ADOPTION; SENIOR-CITIZENS; OLDER-ADULTS; ACCEPTANCE; AGE; EDUCATION; ACCESS; CITY	The changing demographic structure of the population, resulting in unparalleled growth of the elderly population, means that e-inclusion of this population group is considered to be a social and political priority in the context of the Information Society. Most research studies have only considered individual variables -such as age, gender, education, income and health-in the explanatory models of e-inclusion of senior citizens, while ignoring macro variables, such as the welfare systems and public policies in each country. Simultaneously, most studies focus on small-scale samples, lack international comparisons and do not consider the combined effect of several variables that influence Internet use. This study aims to analyse possible differences between two countries that have different welfare systems and public policies, after controlling for the effects of the individual variables that have been identified in the literature as relevant for Internet use. The study focuses on a sample of 8639 individuals, aged 50 years and over, residing in Portugal and Estonia, who participated in the SHARE project (Survey of Health, Ageing and Retirement in Europe). The results of the logistic regression analysis demonstrate that welfare systems and public policies have an impact on the likelihood of Internet use, thus reinforcing the importance of developing public policies to foster e-inclusion of senior citizens.	[Silva, Patricia] Univ Minho, Inst Social Sci, Commun & Soc Res Ctr, Braga, Portugal; [Delerue Matos, Alice] Univ Minho, Inst Social Sci, Dept Sociol & Commun, Braga, Portugal; [Delerue Matos, Alice] Univ Minho, Inst Social Sci, Soc Res Ctr, Braga, Portugal; [Martinez-Pecino, Roberto] Univ Seville, Dept Social Pyschol, Seville, Spain	Universidade do Minho; Universidade do Minho; Universidade do Minho; University of Sevilla	Silva, P (corresponding author), Univ Minho, Inst Social Sci, Commun & Soc Res Ctr, Braga, Portugal.	patriciasilva@ics.uminho.pt	Delerue Matos, Alice/AAC-3838-2020	Delerue Matos, Alice/0000-0002-2394-4077; Silva, Patricia/0000-0003-4074-5368	German Ministry of Education and Research; U.S. National Institute on Aging [U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064]; Foundation for Science and Technology (FCT) as a PhD individual scholarship of QREN - POPH - Typology 4.1 - Advanced Training - European Social Fund; MEC (Ministry of Education and Science); European Commission [QLK6-CT-2001-00360, SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812, 211909, 227822, 261982]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Foundation for Science and Technology (FCT) as a PhD individual scholarship of QREN - POPH - Typology 4.1 - Advanced Training - European Social Fund; MEC (Ministry of Education and Science)(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This paper uses data from SHARE Wave 4 (DOI: 10.6103/SHARE.w4.500), see Borsch-Supan et al. (2013) for methodological details.* The SHARE data collection has been primarily funded by the European Commission through FP5 (QLK6-CT-2001-00360), FP6 (SHARE-I3: RII-CT-2006-062193, COMPARE: CIT5-CT-2005-028857, SHARELIFE: CIT4-CT-2006-028812) and FP7 (SHARE-PREP: No211909, SHARE-LEAP: No227822, SHARE M4: No261982). Additional funding from the German Ministry of Education and Research, the U.S. National Institute on Aging (U01_AG09740-13S2, P01_AG005842, P01_AG08291, P30_AG12815, R21_AG025169, Y1-AG-4553-01, IAG_BSR06-11, OGHA_04-064) and from various national funding sources is gratefully acknowledged (see www.share-project.org)." For development of this paper we have received support from: The Foundation for Science and Technology (FCT) as a PhD individual scholarship of QREN - POPH - Typology 4.1 - Advanced Training, subsidised by the European Social Fund and by national funds from the MEC (Ministry of Education and Science).	Agudo S, 2012, COMUNICAR, V20, P193, DOI 10.3916/C39-2012-03-10; Ajam Van Deursen, 2014, INFORM COMMUN SOC, V18; Bimber B, 2000, SOC SCI Q, V81; Browne H., 2000, U MARY LAND, P1; Carpenter BD, 2007, COMPUT HUM BEHAV, V23, P3012, DOI 10.1016/j.chb.2006.08.015; Casado-Munoz R, 2015, COMUNICAR, V23, P37, DOI 10.3916/C45-2015-04; Choi NG, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2645; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colombo F, 2015, COMUNICAR, V23, P47, DOI 10.3916/C45-2015-05; Correa T, 2015, NEW MEDIA SOC, V17, P483, DOI 10.1177/1461444813506975; Demoussis M, 2006, ECON INNOV NEW TECH, V15, P235, DOI 10.1080/10438590500216016; Dias I., 2012, SOCIOL PROBL PRAT, V68, P51, DOI [10.7458/SPP201268693, DOI 10.7458/SPP201268693]; Dino MJS, 2015, EDUC GERONTOL, V41, P53, DOI 10.1080/03601277.2014.917236; Eastman JK, 2004, J CONSUM MARK, V21, P208, DOI 10.1108/07363760410534759; European Commission, 2007, COMM COMM EUR PARL C; European Parliament, 2015, EUR PARL RES 5 MAY 2; Fox S., 2004, OLDER AMERICANS INTE, P1; Friemel TN, 2016, NEW MEDIA SOC, V18, P313, DOI 10.1177/1461444814538648; Gell NM, 2013, GERONTOLOGIST, P1; GIDDENS A., 2001, SOCIOLOGIA; Gilleard C, 2015, SOCIOL RES ONLINE, V20, DOI 10.5153/sro.3552; Guillen MF, 2005, SOC FORCES, V84, P681, DOI 10.1353/sof.2006.0015; Hartog J, 2001, APPL ECON, V33, P1021, DOI 10.1080/000368401300182798; Heo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087819; Hill Rebecca, 2008, Information Technology & People, V21, P244, DOI 10.1108/09593840810896019; Horrigan JB, 2000, NEW INTERNET USERS W, P1; Jung Y, 2010, EDUC GERONTOL, V36, P193, DOI 10.1080/03601270903183313; Larsson E, 2013, EDUC GERONTOL, V39, P155, DOI 10.1080/03601277.2012.699833; Lee B, 2011, COMPUT HUM BEHAV, V27, P1231, DOI 10.1016/j.chb.2011.01.003; Lee CJ, 2009, J BROADCAST ELECTRON, V53, P365, DOI 10.1080/08838150903102758; Lenhart A, 2000, PEW INTERNET AM LIFE, P1; Lissitsa S, 2015, POETICS, V52, P44, DOI 10.1016/j.poetic.2015.06.002; Loges WE, 2001, COMMUN RES, V28, P536, DOI 10.1177/009365001028004007; Malter F., 2013, SHARE WAVE 4 INNOVAT; Martinez R, 2011, COMUNICAR, V19, P89, DOI 10.3916/C37-2011-02-09; Martinez-Pecino R, 2013, PORTUGUESE OLDER PEO, P331; Ministerio da T e ES, 2005, PROGR ACC INT PLAN T; Niehaves B, 2014, EUR J INFORM SYST, V23, P708, DOI 10.1057/ejis.2013.19; Ono H, 2007, SOC SCI RES, V36, P1135, DOI 10.1016/j.ssresearch.2006.09.001; Orviska M, 2009, INF ECON POLICY, V21, P279, DOI 10.1016/j.infoecopol.2009.06.002; Peacock SE, 2007, EUR J AGEING, V4, P191, DOI 10.1007/s10433-007-0067-z; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P330, DOI 10.1192/bjp.174.4.330; Quan-Haase A, 2016, INFORM COMMUN SOC, V19, P691, DOI 10.1080/1369118X.2016.1140217; Ramon-Jeronimo MA, 2013, SOC SCI COMPUT REV, V31, P389, DOI 10.1177/0894439312473421; Rosenthal RL, 2008, EDUC GERONTOL, V34, P610, DOI 10.1080/03601270801949427; Santoni G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120077; Selwyn N, 2003, AGEING SOC, V23, P561, DOI 10.1017/S0144686X03001302; Sourbati M, 2009, NEW MEDIA SOC, V11, P1083, DOI 10.1177/1461444809340786; Stoica V, 2015, REV CERCET INTERV SO, V51, P202; Tsai HYS, 2015, COMPUT HUM BEHAV, V51, P344, DOI 10.1016/j.chb.2015.04.022; van Deursen AJAM, 2011, POETICS, V39, P125, DOI 10.1016/j.poetic.2011.02.001; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Venkatesh V, 2012, MIS QUART, V36, P157; Wei L, 2012, J COMPUT-MEDIAT COMM, V17, P303, DOI 10.1111/j.1083-6101.2012.01578.x; Wilson KR, 2003, SOC SCI COMPUT REV, V21, P133, DOI [10.1177/0894439303021002001, 10.1177/0894439303251554]; Wong YC, 2014, AGEING INT, V39, P144, DOI 10.1007/s12126-013-9185-4; Yu RP, 2016, INFORM COMMUN SOC, V19, P1445, DOI 10.1080/1369118X.2015.1109695; Zhou R., 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089598	58	10	10	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184545	10.1371/journal.pone.0184545	http://dx.doi.org/10.1371/journal.pone.0184545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910358	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200060
J	Termini, JM; Gupta, S; Raffa, FN; Guirado, E; Fischl, MA; Niu, LG; Kanagavelu, S; Stone, GW				Termini, James M.; Gupta, Sachin; Raffa, Francesca N.; Guirado, Elizabeth; Fischl, Margaret A.; Niu, Liguo; Kanagavelu, Saravana; Stone, Geoffrey W.			Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion	PLOS ONE			English	Article							CLINICAL-TRIAL; KAPPA-B; VACCINE; IMMUNOTHERAPY; LMP1; ANTIGEN; CD40; PROSTAGLANDIN-E2; INTERLEUKIN-12; EXPRESSION	Dendritic cells (DC) are a promising cell type for cancer vaccines due to their high immunostimulatory capacity. However, improper maturation of DC prior to treatment may account for the limited efficacy of DC vaccine clinical trials. Latent Membrane Protein-1 (LMP1) of Epstein-Barr virus was examined for its ability to mature and activate DC as a gene-based molecular adjuvant for DC vaccines. DC were transduced with an adenovirus 5 vector (Ad5) expressing LMP1 under the control of a Tet-inducible promoter. Ad5-LMP1 was found to mature and activate both human and mouse DC. LMP1 enhanced in vitro migration of DC toward CCL19, as well as in vivo migration of DC to the inguinal lymph nodes of mice following intradermal injection. LMP1-transduced DC increased T cell proliferation in a Pmel-1 adoptive transfer model and enhanced survival in B16-F10 melanoma models. LMP1-DC also enhanced protection in a vaccinia-Gag viral challenge assay. LMP1 induced high levels of IL-12p70 secretion in mouse DC when compared to standard maturation protocols. Importantly, LMP1-transduced human DC retained the capacity to secrete IL-12p70 and TNF in response to DC restimulation. In contrast, DC matured with Monocyte Conditioned Media-Mimic cocktail (Mimic) were impaired in IL-12p70 secretion following restimulation. Overall, LMP1 matured and activated DC, induced migration to the lymph node, and generated high levels of IL-12p70 in a murine model. We propose LMP1 as a promising molecular adjuvant for DC vaccines.	[Termini, James M.; Gupta, Sachin; Raffa, Francesca N.; Guirado, Elizabeth; Niu, Liguo; Kanagavelu, Saravana; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA; [Termini, James M.; Gupta, Sachin; Raffa, Francesca N.; Guirado, Elizabeth; Niu, Liguo; Kanagavelu, Saravana; Stone, Geoffrey W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Fischl, Margaret A.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Fischl, Margaret A.] Univ Miami, Miller Sch Med, Miami Ctr AIDS Res, Miami, FL 33136 USA; [Kanagavelu, Saravana] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Stone, Geoffrey W.] NGM Biopharmaceut, San Francisco, CA 94080 USA	University of Miami; University of Miami; University of Miami; University of Miami; Cedars Sinai Medical Center	Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami Ctr AIDS Res, Miami, FL 33136 USA.; Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.; Stone, GW (corresponding author), NGM Biopharmaceut, San Francisco, CA 94080 USA.	drgeoffstone@gmail.com			National Institutes of Health, National Institute of Allergy and Infectious Diseases [R21AI093294, R21AI078834, P30AI073961]; Florida Department of Health [1BF02]	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Florida Department of Health	GWS was supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases grants R21AI093294 and R21AI078834, Florida Department of Health and Bankhead-Coley Cancer Research Program TTF award 1BF02, and National Institutes of Health, National Institute of Allergy and Infectious Diseases grant P30AI073961 to the Miami Center for AIDS Research (PI Savita Pahwa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcipowski KM, 2012, J IMMUNOL, V189, P5165, DOI 10.4049/jimmunol.1201821; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Baumforth KRN, 1999, J CLIN PATHOL-MOL PA, V52, P307; Benteyn D, 2014, METHODS MOL BIOL, V1139, P3, DOI 10.1007/978-1-4939-0345-0_1; Boudreau JE, 2011, MOL THER, V19, P841, DOI 10.1038/mt.2011.57; Butterfield LH, 2008, J IMMUNOTHER, V31, P294, DOI 10.1097/CJI.0b013e31816a8910; Carreno BM, 2013, J CLIN INVEST, V123, P3383, DOI 10.1172/JCI68395; Chia WK, 2012, ANN ONCOL, V23, P997, DOI 10.1093/annonc/mdr341; Chiappori AA, 2010, EXPERT OPIN BIOL TH, V10, P983, DOI 10.1517/14712598.2010.484801; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Fujiwara S, 2012, J IMMUNOTHER, V35, P513, DOI 10.1097/CJI.0b013e3182619cb4; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Gottschalk S, 2003, BLOOD, V101, P1905, DOI 10.1182/blood-2002-05-1514; Gupta S, 2011, J LEUKOCYTE BIOL, V90, P389, DOI 10.1189/jlb.0211068; Gupta S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-39; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Hatzivassiliou E, 1998, J IMMUNOL, V160, P1116; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kalinski P, 1998, J IMMUNOL, V161, P2804; Kalinski P, 2001, BLOOD, V97, P3466, DOI 10.1182/blood.V97.11.3466; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lesterhuis WJ, 2011, CLIN CANCER RES, V17, P5725, DOI 10.1158/1078-0432.CCR-11-1261; Luftig M, 2003, P NATL ACAD SCI USA, V100, P15595, DOI 10.1073/pnas.2136756100; Maes W, 2011, CANCER IMMUNOL IMMUN, V60, P153, DOI 10.1007/s00262-010-0946-6; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Maurais E, 2009, VIROLOGY, V385, P227, DOI 10.1016/j.virol.2008.11.033; McFarland EDC, 1999, ONCOGENE, V18, P6959, DOI 10.1038/sj.onc.1203217; Morelli AE, 2003, TRENDS IMMUNOL, V24, P108, DOI 10.1016/S1471-4906(03)00023-1; Murphy G, 1996, PROSTATE, V29, P371; Nair S, 2003, J IMMUNOL, V171, P6275, DOI 10.4049/jimmunol.171.11.6275; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 2003, CURRENT PROTOCOLS IM, p[20, 1]; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schuler G, 2010, EUR J IMMUNOL, V40, P2123, DOI 10.1002/eji.201040630; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Van Brussel I, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/690643; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Williams BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046981; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031	45	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184915	10.1371/journal.pone.0184915	http://dx.doi.org/10.1371/journal.pone.0184915			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910387	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200120
J	Gonzalez-Carranza, ZH; Zhang, XB; Peters, JL; Boltz, V; Szecsi, J; Bendahmane, M; Roberts, JA				Gonzalez-Carranza, Zinnia H.; Zhang, Xuebin; Peters, Janny L.; Boltz, Veronique; Szecsi, Judit; Bendahmane, Mohammed; Roberts, Jeremy A.			HAWAIIAN SKIRT controls size and floral organ number by modulating CUC1 and CUC2 expression	PLOS ONE			English	Article							CUP-SHAPED-COTYLEDON; EARLY FLOWER DEVELOPMENT; SHOOT APICAL MERISTEM; ARABIDOPSIS-THALIANA; MICRORNA REGULATION; GENES; BOUNDARY; GROWTH; SEPARATION; PLANTS	The Arabidopsis thaliana F-box gene HAWAIIAN SKIRT (HWS) affects organ growth and the timing of floral organ abscission. The loss-of-function hws-1 mutant exhibits fused sepals and increased organ size. To understand the molecular mechanisms of HWS during plant development, we mutagenized hws-1 seeds with ethylmethylsulphonate (EMS) and screened for mutations suppressing hws-1 associated phenotypes. We isolated the shs1/ hws-1 (suppressor of hws-1) mutant in which hws-1 sepal fusion phenotype was suppressed. The shs1/hws-1 mutant carries a G -> A nucleotide substitution in the MIR164 binding site of CUP-SHAPED COTYLEDON 1 (CUC1) mRNA. CUC1 and CUP-SHAPED COTYLEDON 2 (CUC2) transcript levels were altered in shs1, renamed cuc1-1D, and in hws-1 mutant. Genetic interaction analyses using single, double and triple mutants of cuc1-1D, cuc2-1D (a CUC2 mutant similar to cuc1-1D), and hws-1, demonstrate that HWS, CUC1 and CUC2 act together to control floral organ number. Loss of function of HWS is associated with larger petal size due to alterations in cell proliferation and mitotic growth, a role shared with the CUC1 gene.	[Gonzalez-Carranza, Zinnia H.; Zhang, Xuebin; Roberts, Jeremy A.] Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Sutton Bonington Campus, Loughborough, Leics, England; [Peters, Janny L.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Mol Plant Physiol, Nijmegen, Netherlands; [Boltz, Veronique; Szecsi, Judit; Bendahmane, Mohammed] Univ Lyon, Ecole Normale Super Lyon, Lab Reprod & Dev Plantes, Lyon, France; [Zhang, Xuebin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Roberts, Jeremy A.] Univ Plymouth, Fac Sci & Engn, Sch Biol & Marine Sci, Plymouth, Devon, England	University of Nottingham; Radboud University Nijmegen; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); United States Department of Energy (DOE); Brookhaven National Laboratory; University of Plymouth	Gonzalez-Carranza, ZH (corresponding author), Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Sutton Bonington Campus, Loughborough, Leics, England.	zinnia.gonzalez@nottingham.ac.uk	Peters, Janny L./K-7745-2013; Bendahmane, Mohammed/AAX-1296-2020	Peters, Janny L./0000-0002-1081-5209; Bendahmane, Mohammed/0000-0003-1661-1060; Gonzalez-Carranza, Zinnia Haydee/0000-0002-9127-3252	University of Nottingham; Radboud University Nijmegen; French "Agence Nationale de la Recherche" [ANR-09-BLAN-0006, ANR13-BSV7-0014]	University of Nottingham; Radboud University Nijmegen; French "Agence Nationale de la Recherche"(French National Research Agency (ANR))	This work was supported by funds from the University of Nottingham, Radboud University Nijmegen and the French "Agence Nationale de la Recherche" (grants ANR-09-BLAN-0006 and ANR13-BSV7-0014 to MB).	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Aida M, 1999, DEVELOPMENT, V126, P1563; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bogre L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-226; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Breuil-Broyer S, 2004, PLANT J, V38, P182, DOI 10.1111/j.1365-313X.2004.02026.x; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dash M, 2015, PLANT J, V84, P335, DOI 10.1111/tpj.13002; Dinh Thanh Theresa, 2014, Methods Mol Biol, V1110, P127, DOI 10.1007/978-1-4614-9408-9_6; Gaillochet C, 2015, CURR OPIN PLANT BIOL, V23, P91, DOI 10.1016/j.pbi.2014.11.002; Gazquez A, 2017, NEW PHYTOL, V215, P299, DOI 10.1111/nph.14573; Gonzalez-Carranza ZH, 2007, PLANT PHYSIOL, V144, P1370, DOI 10.1104/pp.106.092288; Hepworth J, 2014, CURR OPIN PLANT BIOL, V17, P36, DOI 10.1016/j.pbi.2013.11.005; Huang TB, 2012, DEVELOPMENT, V139, P2161, DOI 10.1242/dev.075069; Ishida T, 2000, PLANT CELL PHYSIOL, V41, P60, DOI 10.1093/pcp/41.1.60; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Katayama N, 2010, PLANT CELL, V22, P2131, DOI 10.1105/tpc.109.073189; Kim ES, 2016, PHYSIOL PLANTARUM, V157, P221, DOI 10.1111/ppl.12443; Krizek BA, 2006, PLANT J, V45, P369, DOI 10.1111/j.1365-313X.2005.02633.x; Lampugnani ER, 2013, DEVELOPMENT, V140, P185, DOI 10.1242/dev.084582; Lampugnani ER, 2012, PLANT J, V71, P724, DOI 10.1111/j.1365-313X.2012.05023.x; Landrein B, 2015, ELIFE, V4, DOI [10.7554/eLife.07811, 10.7554/eLife.07811.001]; Lang PLM, 2017, BIORXIV; Larue CT, 2009, PLANT J, V58, P450, DOI 10.1111/j.1365-313X.2009.03796.x; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Laufs P, 2003, DEVELOPMENT, V130, P785, DOI 10.1242/dev.00295; Levin JZ, 1998, GENETICS, V149, P579; Leyser HMO, 1992, ARABIDOPSIS COMPLEAT, P9; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Nahar MAU, 2012, PLANT CELL PHYSIOL, V53, P1134, DOI 10.1093/pcp/pcs057; Peters JL, 2003, TRENDS PLANT SCI, V8, P484, DOI 10.1016/j.tplants.2003.09.002; Powell AE, 2012, CURR BIOL, V22, pR360, DOI 10.1016/j.cub.2012.02.010; Rast MI, 2008, CURR OPIN GENET DEV, V18, P287, DOI 10.1016/j.gde.2008.05.005; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Spinelli SV, 2011, PLANT PHYSIOL, V156, P1894, DOI 10.1104/pp.111.177709; Szecsi Judit, 2014, Methods Mol Biol, V1110, P191, DOI 10.1007/978-1-4614-9408-9_8; Takada S, 2001, DEVELOPMENT, V128, P1127; Takada S, 2004, DEVELOPMENT, V132, P1555; Takeda S, 2011, PLANT J, V66, P1066, DOI 10.1111/j.1365-313X.2011.04571.x; Weigel D, 1995, ANNU REV GENET, V29, P19, DOI 10.1146/annurev.ge.29.120195.000315; Weigel D., 2002, ARABIDOPSIS LAB MANU; Yu HY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030317	47	19	21	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185106	10.1371/journal.pone.0185106	http://dx.doi.org/10.1371/journal.pone.0185106			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934292	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000411339900091
J	Laut, L; Martins, MVA; Frontalini, F; Ballalai, JM; Belart, P; Habib, R; Fontana, LF; Clemente, IMMM; Lorini, ML; Mendonca, JG; Laut, VM; Figueiredo, MDL				Laut, Lazaro; Alves Martins, Maria Virginia; Frontalini, Fabrizio; Ballalai, Joao M.; Belart, Pierre; Habib, Renan; Fontana, Luiz F.; Clemente, Iara M. M. M.; Lorini, Maria Lucia; Mendonca Filho, Joao G.; Laut, Vanessa M.; Lima Figueiredo, Marcos de Souza			Assessment of the trophic state of a hypersaline-carbonatic environment: Vermelha Lagoon (Brazil)	PLOS ONE			English	Article							PARTICULATE ORGANIC-MATTER; RIO-DE-JANEIRO; BIOCHEMICAL-COMPOSITION; SPATIAL INTERPOLATION; MICROBIAL MATS; GUANABARA BAY; FORAMINIFERAL ASSEMBLAGES; SURUI MANGROVE; SEDIMENTS; SEA	Vermelha Lagoon is a hypersaline shallow transitional ecosystem in the state of Rio de Janeiro (Brazil). This lagoon is located in the protected area of Massambaba, between the cities of Araruama and Saquarema (Brazil), and displays two quite uncommon particularities: it exhibits carbonate sedimentation and displays the development of Holocene stromatolites. Due to both particularities, the salt industry and property speculation have been, increasingly, generating anthropic pressures on this ecosystem. This study aims to apply a multiproxy approach to evaluate the trophic state of Vermelha Lagoon based on physicochemical parameters and geochemical data for the quantification and qualification of organic matter (OM), namely total organic carbon (TOC), total sulfur (TS), total phosphorus (TP) and biopolymeric carbon (BPC), including carbohydrates (CHO), lipids (LIP) and proteins (PTN). The CHO/TOC ratio values suggest that OM supplied to the sediment is of autochthonous origin and results, essentially, from microbial activity. The cluster analyses allowed the identification of four regions in Vermelha Lagoon. The Region I included stations located in shallow areas of the eastern sector of Vermelha lagoon affected by the impact of the artificial channel of connection with Araruama Lagoon. The Region II, under the influence of salt pans, is characterized by the highest values of BPC, namely CHO promoted by microbiological activity. The Region III include stations spread through the lagoon with high values of dissolved oxygen and lower values of TP. Stromatolites and microbial mattes growth was observed in some stations of this sector. Region IV, where the highest values of TOC and TS were found, represents depocenters of organic matter, located in general in depressed areas. Results of this work evidences that the Vermelha Lagoon is an eutrophic but alkaline and well oxygenated environment (at both water column and surface sediment) where the autotrophic activity is greater than heterotrophic one. These particular conditions make this a special and rare ecosystem.	[Laut, Lazaro; Ballalai, Joao M.; Belart, Pierre; Habib, Renan] Univ Fed Estado Rio de Janeiro UNIRIO, Lab Micropaleontol LabMicro, Rio De Janeiro, RJ, Brazil; [Alves Martins, Maria Virginia; Clemente, Iara M. M. M.] Univ Estado Rio De Janeiro, Dept Estratig & Paleontol, Rio De Janeiro, RJ, Brazil; [Alves Martins, Maria Virginia] Univ Aveiro, Unidade Invest GeoBioTec, Dept Geociencias, Aveiro, Portugal; [Frontalini, Fabrizio] Univ Urbino Carlo Bo, Dipartimento Sci Pure & Applicate DiSPeA, Urbino, Italy; [Fontana, Luiz F.; Mendonca Filho, Joao G.] Univ Fed Rio de Janeiro, Lab Palinofacies & Facies Organ LAFO, Rio de Janeiro, RJ, Brazil; [Lorini, Maria Lucia] Univ Fed Estado Rio de Janeiro UNIRIO, Dept Ciencias Nat, Rio De Janeiro, RJ, Brazil; [Laut, Vanessa M.] Univ Fed Fluminense, Programa Posgrad Biol Marinha & Ambientes Costeir, Inst Biol, Niteroi, RJ, Brazil; [Lima Figueiredo, Marcos de Souza] Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Biodiversidade Neotrop, Rio De Janeiro, RJ, Brazil	Universidade Federal do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade de Aveiro; University of Urbino; Universidade Federal do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal do Estado do Rio de Janeiro	Laut, L (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Lab Micropaleontol LabMicro, Rio De Janeiro, RJ, Brazil.	lazaro.laut@gmail.com	Frontalini, Fabrizio/C-4819-2008; Figueiredo, Marcos S. L./A-9720-2014; Martins, Maria Virginia Alves/O-2893-2013; Laut, Lazaro L.M./K-4782-2012; Belart, Pierre/ABB-4130-2021; Laut, Lazaro/O-4193-2019; Filho, João Graciano Mendonça/C-2098-2013; Alves Martins, Maria Virginia/AAD-3531-2021	Frontalini, Fabrizio/0000-0002-0425-9306; Figueiredo, Marcos S. L./0000-0003-0558-911X; Martins, Maria Virginia Alves/0000-0001-8348-8862; Laut, Lazaro L.M./0000-0002-5637-1930; Laut, Lazaro/0000-0002-5637-1930; Filho, João Graciano Mendonça/0000-0001-8997-0270; Alves Martins, Maria Virginia/0000-0001-8348-8862; Ballalai, Joao Marcelo/0000-0002-8896-6816; Lorini, MariaLucia/0000-0002-7783-093X; Dias, Pierre/0000-0003-1508-5564	National Council of Technological and Scientific Development - CNPq (Universal Project) [445830/2014-0]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ (Biota Project) [E26/11.399/2012]; CNPq	National Council of Technological and Scientific Development - CNPq (Universal Project)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ (Biota Project); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was financed by the National Council of Technological and Scientific Development - CNPq (Universal Project 445830/2014-0) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ (Biota Project E26/11.399/2012). The authors would like to thank CNPq for the Scientific Initiation Fellowships (PIBC Program) given to Joao M. Ballalai and Renan Habib. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N., 1974, GEOMORFOLOGIA, V43, P1; Martins MVA, 2016, MAR POLLUT BULL, V105, P161, DOI 10.1016/j.marpolbul.2016.02.032; ASPILA KI, 1976, ANALYST, V101, P187, DOI 10.1039/an9760100187; ASTM International, 2008, D4239 ASTM, V552, P6; Azpurua M, 2010, PROG ELECTROMA RES M, V14, P135, DOI 10.2528/PIERM10083103; Baptista Neto J. A., 2005, REV TAMOIOS, V2, P6; Barroso LV, 1987, B FUNDACAO BRASILEIR, P30; Borges AC, 2009, MAR POLLUT BULL, V58, P1750, DOI 10.1016/j.marpolbul.2009.07.025; Borja A, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 1: CLASSIFICATION OF ESTUARINE AND NEARSHORE COASTAL ECOSYSTEMS, P125; Borrego J, 1998, J COASTAL RES, V14, P1276; Cartes JE, 2002, PROG OCEANOGR, V53, P29, DOI 10.1016/S0079-6611(02)00023-X; Chai-Coetzer CL, 2011, THORAX, V66, P213, DOI 10.1136/thx.2010.152801; Coe HHG, 2010, 6 SEM LAT AM GEOGR F, P1; Coelho-Souza SA, 2012, BRAZ J OCEANOGR, V60, P353, DOI 10.1590/S1679-87592012000300008; Cotano U, 2006, MAR POLLUT BULL, V52, P404, DOI 10.1016/j.marpolbul.2005.09.027; da Silva FS, 2008, BRAZ J OCEANOGR, V56, P13, DOI 10.1590/S1679-87592008000100002; DANOVARO R, 1993, DEEP-SEA RES PT I, V40, P953, DOI 10.1016/0967-0637(93)90083-F; Danovaro R, 1997, ESTUAR COAST SHELF S, V44, P723, DOI 10.1006/ecss.1996.0135; Danovaro R, 1999, J SEA RES, V42, P117, DOI 10.1016/S1385-1101(99)00024-6; Datta DK, 1999, ORG GEOCHEM, V30, P75, DOI 10.1016/S0146-6380(98)00203-4; de la Lanza-Espino G., 2011, UNIV CIENC, V27, P145; Debenay JP, 2001, J FORAMIN RES, V31, P133, DOI 10.2113/0310133; Dell'Anno A, 2002, MAR POLLUT BULL, V44, P611, DOI 10.1016/S0025-326X(01)00302-2; Demergasso C, 2003, REV CHIL HIST NAT, V76, P485; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dugdale R. C., 1988, OCEANOL ACTA, V9, P178; FABIANO M, 1995, CONT SHELF RES, V15, P1453, DOI 10.1016/0278-4343(94)00088-5; FABIANO M, 1994, HYDROBIOLOGIA, V277, P71, DOI 10.1007/BF00016755; Fabiano M, 1999, SCI MAR, V63, P89, DOI 10.3989/scimar.1999.63s189; Fontana LF, 2010, AN ACAD BRAS CIENC, V82, P1013, DOI 10.1590/S0001-37652010000400022; Fontana LF, 2010, MAR POLLUT BULL, V60, P1674, DOI 10.1016/j.marpolbul.2010.06.049; Fritz S. C., 2010, The diatoms: applications for the environmental and earth sciences, P186; GERCHAKO.SM, 1972, LIMNOL OCEANOGR, V17, P938, DOI 10.4319/lo.1972.17.6.0938; Goovaerts P, 2000, J HYDROL, V228, P113, DOI 10.1016/S0022-1694(00)00144-X; Gremare A, 1997, MAR ECOL PROG SER, V150, P195, DOI 10.3354/meps150195; Gremare A, 2002, MAR ECOL PROG SER, V234, P85, DOI 10.3354/meps234085; Grotzinger J, 2013, UNDERSTANDING EARTH; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HENRICHS SM, 1995, MAR CHEM, V49, P127, DOI 10.1016/0304-4203(95)00012-G; Herminda L., 2005, AN I GEOCIENCIAS, V28, P59, DOI [10.11137/2005_2_59-70, DOI 10.11137/2005_2_59-70]; HOHN A, 1986, SCI TOTAL ENVIRON, V58, P175, DOI 10.1016/0048-9697(86)90086-0; Horodysky RJ, 1997, J SEDIMENT PETROL, V47, P680; Isla E, 2006, J MARINE SYST, V60, P255, DOI 10.1016/j.jmarsys.2006.01.006; Keblouti M, 2012, ENRGY PROCED, V18, P468, DOI 10.1016/j.egypro.2012.05.058; Koroleff F., 1976, METHODS SEAWATER ANA, P134; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; LOPES CEA, 1986, SCI TOTAL ENVIRON, V58, P55, DOI 10.1016/0048-9697(86)90075-6; Mansur KL, 2012, GEOPARQUES BRASIL PR, P687; MARSH JB, 1966, J LIPID RES, V7, P574; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Martins M. V., 2015, PLOS ONE; Clemente IMMM, 2015, J COASTAL RES, V31, P1190, DOI 10.2112/JCOASTRES-D-14-00104.1; Laut LLM, 2016, J SEDIMENT ENVIRON, V1, P297, DOI 10.12957/jse.2016.25903; Mendontha-Filho JG., 2003, ANUARIO I GEOCIENCIA, V26, P69, DOI 10.11137/2003_0_69-78; MWATHA WE, 1993, INT J SYST BACTERIOL, V43, P401, DOI 10.1099/00207713-43-3-401; Oliveira L., 1955, MEMORIAS I O CRUZ, V53, P171, DOI [10.1590/S0074-02761955000200004, DOI 10.1590/S0074-02761955000200004]; Paez-Osuna F, 1998, ENVIRON POLLUT, V102, P321, DOI 10.1016/S0269-7491(98)00045-1; PETRUCIO MM, 1998, ECOLOGIA LAGOAS COST, P135; Petrucio MM, 1998, ECOLOGIA LAGOAS COST, P2; Primo PBS., 2002, LAGOA ARARUAMA PERFI; Pusceddu A, 1999, HYDROBIOLOGIA, V397, P59, DOI 10.1023/A:1003690313842; RICE DL, 1982, MAR ECOL PROG SER, V9, P153, DOI 10.3354/meps009153; Silva FS, 2011, ANUARIO I GEOCIENCIA, V34, P52; Silva FS, 2010, ANU I GEOCIENCIAS, V33, P24; Silva FS, 2001, INTERACAO HOMEM MEIO, P85; Silva FS, 2011, ANU I GEOCIENCIAS, V34, P33; Silva L. H. Silva E., 2004, Revista Brasileira de Paleontologia, V7, P193; Siqueira GW., 2006, ARQ CIENCIAS MAR FOR, V39, P18; Stein R., 1991, ACCUMULATION ORGANIC; Teodoro AC, 2010, MAR POLLUT BULL, V60, P536, DOI 10.1016/j.marpolbul.2009.11.011; TERZOPOULOS D, 1988, IEEE T PATTERN ANAL, V10, P417, DOI 10.1109/34.3908; Tucker M. E., 1990, CARBONATE SEDIMENTOL, P164; Vasconcelos C, 2006, SEDIMENT GEOL, V185, P175, DOI 10.1016/j.sedgeo.2005.12.022; Vasconcelos C, 1997, J SEDIMENT RES, V67, P378; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504, DOI 10.1128/MMBR.62.2.504-544.1998	75	15	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0184819	10.1371/journal.pone.0184819	http://dx.doi.org/10.1371/journal.pone.0184819			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7CN	28934270	Green Published, Green Submitted, gold			2022-12-27	WOS:000411339900047
J	Axen, I; Kwak, L; Hagberg, J; Jensen, I				Axen, Iben; Kwak, Lydia; Hagberg, Jan; Jensen, Irene			Does physical activity buffer insomnia due to back and neck pain?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; SLEEP DISTURBANCE; HEALTH; QUALITY; DISABILITY; WORK; ACCELEROMETER; QUESTIONNAIRE; METAANALYSIS; PREDICTION	Introduction Musculoskeletal pain is highly prevalent and a burden to society, recurrent and persistent low back pain (LBP) and neck pain (NP) being the most common conditions. They are associated with other poor health outcomes such as sleep problems. Physical activity (PA) prevents LBP and NP, but the direct effect on sleep is unclear. This study explored the effect of pain on insomnia, and examined if adherence to moderate-to-high intensity levels of PA influenced this relationship. Methods In this prospective observational study, 1821 workers were followed over 3 years. Data included self-rated measures of LBP and NP, insomnia and level and amount of PA. Pain variables were used in a "risk profile" for future sick-listing, insomnia was categorized into those with and without such problems, and adherence to PA was defined as reporting moderate-to-high levels in two consecutive years. In Poisson regression models, individuals with pain risk profiles were analysed according to PA adherence for the outcome insomnia. Repeated measurements allowed control for prior pain. Results In this mainly male working population, individuals with a risk profile for LBP and NP had a significant increased risk (RR = 1.5) of developing insomnia one year later when not adhering to moderate-to-high levels of PA. Among those not reporting prior pain, the risk was even larger (RR = 2.5). Generalizability may be restricted to relatively healthy males. The individuals who reported a pain risk profile two consecutive years did not get the buffer effect from adhering to moderate-to-high levels of PA in terms of developing insomnia.	[Axen, Iben; Kwak, Lydia; Hagberg, Jan; Jensen, Irene] Karolinska Inst, Inst Environm Med, Unit Intervent & Implementat Worker Hlth, Nobels V 13, Stockholm, Sweden	Karolinska Institutet	Axen, I (corresponding author), Karolinska Inst, Inst Environm Med, Unit Intervent & Implementat Worker Hlth, Nobels V 13, Stockholm, Sweden.	iben.axen@ki.se	Jensen, Irene B/B-6012-2012; Axén, Iben/AAC-8638-2020	Jensen, Irene B/0000-0003-1745-866X; Axén, Iben/0000-0001-5251-5995; Kwak, Lydia/0000-0003-3117-6765				Alfoldi P, 2017, J REHABIL MED, V49, P63, DOI 10.2340/16501977-2162; [Anonymous], WHO GUID BAS TRAIN S; Axen I, 2016, CLIN J PAIN, V32, P254, DOI 10.1097/AJP.0000000000000249; Axen I, 2013, BEST PRACT RES CL RH, V27, P601, DOI 10.1016/j.berh.2013.10.004; Baker S, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0593-5; Benjaminsson A, 2007, J REHABIL MED, V39, P640, DOI 10.2340/16501977-0104; Bergstrom C, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-81; Bergstrom G, 2008, WORK, V31, P167; Bevan S, 2015, BEST PRACT RES CL RH, V29, P356, DOI 10.1016/j.berh.2015.08.002; Campbell P, 2013, SLEEP, V36, P1693, DOI 10.5665/sleep.3130; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Ekblom-Bak E, 2011, MOTIONSVANOR FYSISK; Ekman M, 2005, ACTA ORTHOP, V76, P275, DOI 10.1080/00016470510030698; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Hagstromer M, 2015, J SCI MED SPORT, V18, P553, DOI 10.1016/j.jsams.2014.07.012; Pueyo MJ, 2012, GAC SANIT, V26, P30, DOI 10.1016/j.gaceta.2011.03.008; Kanagasabai T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0227-z; Kovacs FM, 2005, SPINE, V30, P1786, DOI 10.1097/01.brs.0000172159.47152.dc; Kubo K, 2010, J STRENGTH COND RES, V24, P322, DOI 10.1519/JSC.0b013e3181c865e2; Leboeuf-Yde C, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-39; Lohela M, 2009, J OCCUP ENVIRON MED, V51, P195, DOI 10.1097/JOM.0b013e318192bd2c; March L, 2014, BEST PRACT RES CL RH, V28, P353, DOI 10.1016/j.berh.2014.08.002; National Sleep Foundation, WHAT IS INS; Nordin S, 2013, SCAND J PSYCHOL, V54, P112, DOI 10.1111/sjop.12029; Odegard SS, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-24; Picavet HSJ, 2011, MED SCI SPORT EXER, V43, P74, DOI 10.1249/MSS.0b013e3181e57a6a; Rubio-Arias JA, 2017, MATURITAS, V100, P49, DOI 10.1016/j.maturitas.2017.04.003; Saragiotto BT, 2016, BR J SPORTS MED; Schur EA, 2007, J GEN INTERN MED, V22, P818, DOI 10.1007/s11606-007-0140-5; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Tang NKY, 2015, SLEEP, V38, P1751, DOI 10.5665/sleep.5158; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van de Water ATM, 2011, MANUAL THER, V16, P550, DOI 10.1016/j.math.2011.05.004; Von Korff M, 1990, PAIN, V279, P91, DOI DOI 10.1016/0304-3959(90)91125-3; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wannstrom I, 2009, SCAND J PSYCHOL, V50, P231, DOI 10.1111/j.1467-9450.2008.00697.x; Yang H, 2016, SPINE	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0184288	10.1371/journal.pone.0184288	http://dx.doi.org/10.1371/journal.pone.0184288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931026	Green Published, gold, Green Submitted			2022-12-27	WOS:000411314700017
J	Zhu, RH; Zheng, ZC; Li, TX; Zhang, XZ; He, SQ; Wang, YD; Liu, T; Li, W				Zhu, Renhuan; Zheng, Zicheng; Li, Tingxuan; Zhang, Xizhou; He, Shuqin; Wang, Yongdong; Liu, Tao; Li, Wei			Dynamics of soil organic carbon mineralization in tea plantations converted from farmland at Western Sichuan, China	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; CO2 PRODUCTION; HILLY REGION; RESPIRATION; MOISTURE; DECOMPOSITION; RESPONSES; AVAILABILITY; FRACTIONS; BIOCHAR	Climate warming and land use change are some of the drivers affecting soil organic carbon (SOC) dynamics. The Grain for Green Project, local natural resources, and geographical conditions have resulted in farmland conversion into tea plantations in the hilly region of Western Sichuan. However, the effect of such land conversion on SOC mineralization remains unknown. In order to understand the temperature sensitivity of SOC decomposition in tea plantations converted from farmland, this study considered the different years (i.e., 2-3, 9-10, and 16-17 years) of tea plantations converted from farmland as the study site, and soil was incubated for 28 days at 15 degrees C, 25 degrees C, and 35 degrees C to measure the soil respiration rate, amount, and temperature coefficient (Q(10)). Temperature and land use type interactively affected the SOC mineralization rate, and the cumulative amount of SOC mineralization in all the plots was the largest at 35 degrees C. SOC mineralization was greater and more sensitive to temperature changes in the farmland than in the tea plantations. Compared with the control, tea plantation soils showed lower SOC mineralization rate and cumulative mineralization amount. The 16-17-year-old tea plantation with a low SOC mineralization amount and high SOC content revealed the benefits of carbon sequestration enhancement obtained by converting farmland into tea plantations. The first-order kinetic equation described SOC mineralization dynamics well. Farmland conversion into tea plantations appeared to reduce the potentially mineralizable carbon pool, and the age of tea plantations also had an effect on the SOC mineralization and sequestration. The relatively weak SOC mineralization temperature sensitivity of the tea plantation soils suggested that the SOC pool of the tea plantation soils was less vulnerable to warming than that of the control soils.	[Zhu, Renhuan; Zheng, Zicheng; Li, Tingxuan; Zhang, Xizhou; Wang, Yongdong; Liu, Tao; Li, Wei] Sichuan Agr Univ, Coll Resources Sci, Chengdu, Sichuan, Peoples R China; [He, Shuqin] Sichuan Agr Univ, Coll Forestry, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zheng, ZC (corresponding author), Sichuan Agr Univ, Coll Resources Sci, Chengdu, Sichuan, Peoples R China.	zichengzheng@126.com	Zheng, Zicheng/J-6463-2019	Zheng, zicheng/0000-0002-2743-9174	National Natural Science Foundation [41271307]; Science and Technology Support Program in Sichuan [2013NZ0044]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program in Sichuan	The work was supported by National Natural Science Foundation (no. 41271307), Science and Technology Support Program in Sichuan (no. 2013NZ0044).; The work was supported by National Natural Science Foundation (No. 41271307), Science and Technology Support Program in Sichuan (No. 2013NZ0044). The authors would like to thank Craig Stapleton who gives valuable suggestions on the manuscript.	Alvarez R, 2000, SOIL SCI SOC AM J, V64, P184, DOI 10.2136/sssaj2000.641184x; [Anonymous], 2013, ACTA PEDOLOGICA SINI; Arevalo CBM, 2012, SOIL SCI SOC AM J, V76, P241, DOI 10.2136/sssaj2011.0126; Bahn M, 2008, ECOSYSTEMS, V11, P1352, DOI 10.1007/s10021-008-9198-0; Canali S, 2004, BIOL FERT SOILS, V40, P206, DOI 10.1007/s00374-004-0759-x; Chang SX, 2016, BIOL FERT SOILS, V52, P629, DOI 10.1007/s00374-016-1104-x; Chen CP, 2016, BOT STUD, V57, DOI 10.1186/s40529-016-0147-5; Craine JM, 2013, BIOGEOCHEMISTRY, V113, P359, DOI 10.1007/s10533-012-9762-8; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Fan DM, 2017, J ZHEJIANG UNIV-SC B, V18, P99, DOI [10.1631/jzus.B1600044, 10.1631/jzus.b1600044]; Fang YY, 2014, AGR ECOSYST ENVIRON, V191, P158, DOI 10.1016/j.agee.2014.02.018; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Ghosh A, 2016, AGR ECOSYST ENVIRON, V233, P202, DOI 10.1016/j.agee.2016.09.010; Gillabel J, 2010, GLOBAL CHANGE BIOL, V16, P2789, DOI 10.1111/j.1365-2486.2009.02132.x; Grellier S, 2017, SCI TOTAL ENVIRON, V593, P654, DOI [10.1016/j.scitotenv2017.03.204, 10.1016/j.scitotenv.2017.03.204]; Haddix ML, 2011, SOIL SCI SOC AM J, V75, P56, DOI 10.2136/sssaj2010.0118; HOWARD DM, 1993, SOIL BIOL BIOCHEM, V25, P1537, DOI 10.1016/0038-0717(93)90008-Y; Jia Juan, 2015, Acta Ecologica Sinica - International Journal, V35, P1; Jin XB, 2008, AUST J SOIL RES, V46, P273, DOI 10.1071/SR07144; Kaschuk G, 2010, SOIL BIOL BIOCHEM, V42, P1, DOI 10.1016/j.soilbio.2009.08.020; Khan SH, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.706; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Leifeld J, 2005, BIOGEOCHEMISTRY, V75, P433, DOI 10.1007/s10533-005-2237-4; Li DJ, 2013, SOIL BIOL BIOCHEM, V67, P24, DOI 10.1016/j.soilbio.2013.07.008; Li Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep28235; [李玮 Li Wei], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1642; [刘合明 Liu Heming], 2008, [生态环境, Ecology and Environment], V17, P2046; Liu YQ, 2012, FOREST ECOL MANAG, V285, P77, DOI 10.1016/j.foreco.2012.08.019; Lu, 2000, SOIL ANAL METHODS AG; Lu SB, 2017, J SOIL SEDIMENT, V17, P985, DOI 10.1007/s11368-016-1602-3; Moscatelli MC, 2007, SOIL TILL RES, V97, P51, DOI 10.1016/j.still.2007.08.007; Munoz-Rojas M, 2015, AGR ECOSYST ENVIRON, V202, P8, DOI 10.1016/j.agee.2014.12.014; Qiu Xi, 2016, Chinese Journal of Plant Ecology, V40, P236; Shen JG, 1992, T CSAE, V8, P35; Sierra CA, 2015, J ADV MODEL EARTH SY, V7, P335, DOI 10.1002/2014MS000358; SPARLING GP, 1986, SOIL BIOL BIOCHEM, V18, P363, DOI 10.1016/0038-0717(86)90039-8; Sun JN, 2016, SCI TOTAL ENVIRON, V569, P390, DOI 10.1016/j.scitotenv.2016.06.082; Sun SH, 2013, PLANT SOIL, V372, P597, DOI 10.1007/s11104-013-1758-1; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Taylor PG, 2017, ECOL LETT, V20, P779, DOI 10.1111/ele.12765; Tian QX, 2017, SOIL BIOL BIOCHEM, V109, P135, DOI 10.1016/j.soilbio.2017.02.009; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Updegraff K, 2001, ECOL APPL, V11, P311; van Wesemael B, 2011, PLANT SOIL, V338, P247, DOI 10.1007/s11104-010-0567-z; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wang GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053914; Wang QK, 2016, ECOSYSTEMS, V19, P450, DOI 10.1007/s10021-015-9941-2; Wang SQ, 2016, ECOL ENG, V90, P113, DOI 10.1016/j.ecoleng.2016.01.046; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071986; [吴健利 Wu Jianli], 2016, [农业环境科学学报, Journal of Agro-Environment Science], V35, P1006; Yang L, 2007, J ENVIRON MANAGE, V85, P690, DOI 10.1016/j.jenvman.2006.09.011; Yang Y.J, 2004, TEA CULTIVATION CHIN; Zhang J, 2011, EUR J SOIL SCI, V62, P863, DOI 10.1111/j.1365-2389.2011.01394.x	54	10	12	7	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2017	12	9							e0185271	10.1371/journal.pone.0185271	http://dx.doi.org/10.1371/journal.pone.0185271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH6UK	28931064	Green Submitted, Green Published, gold			2022-12-27	WOS:000411314700080
J	Cartoni, R; Pekkurnaz, G; Wang, C; Schwarz, TL; He, ZG				Cartoni, Romain; Pekkurnaz, Gulcin; Wang, Chen; Schwarz, Thomas L.; He, Zhigang			A high mitochondrial transport rate characterizes CNS neurons with high axonal regeneration capacity	PLOS ONE			English	Article							MICROFLUIDIC CULTURE PLATFORM; GROWTH CONE; INJURY; MECHANISMS; MOTILITY; DEFICITS	Improving axonal transport in the injured and diseased central nervous system has been proposed as a promising strategy to improve neuronal repair. However, the contribution of each cargo to the repair mechanism is unknown. DRG neurons globally increase axonal transport during regeneration. Because the transport of specific cargos after axonal insult has not been examined systematically in a model of enhanced regenerative capacity, it is unknown whether the transport of all cargos would be modulated equally in injured central nervous system neurons. Here, using a microfluidic culture system we compared neurons co-deleted for PTEN and SOCS3, an established model of high axonal regeneration capacity, to control neurons. We measured the axonal transport of three cargos (mitochondria, synaptic vesicles and late endosomes) in regenerating axons and found that the transport of mitochondria, but not the other cargos, was increased in PTEN/SOCS3 co-deleted axons relative to controls. The results reported here suggest a pivotal role for this organelle during axonal regeneration.	[Cartoni, Romain; Pekkurnaz, Gulcin; Wang, Chen; Schwarz, Thomas L.; He, Zhigang] Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Cartoni, Romain; Pekkurnaz, Gulcin; Wang, Chen; Schwarz, Thomas L.; He, Zhigang] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Pekkurnaz, Gulcin; Schwarz, Thomas L.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Pekkurnaz, Gulcin] Univ Calif San Diego, Div Biol Sci, Sect Neurobiol, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Schwarz, TL; He, ZG (corresponding author), Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.; Schwarz, TL; He, ZG (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Schwarz, TL (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu; zhigang.he@childrens.harvard.edu		Pekkurnaz, Gulcin/0000-0002-7388-6178	International Foundation for Research in Paraplegia; Wings for Life Spinal Cord Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation [R01EY021242, R01GM069808]; NIH [R01GM069808, P30 HD018655, P30EY012196]; 3R Research Foundation Switzerland [129-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, U54HD090255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196, R01EY021242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069808] Funding Source: NIH RePORTER	International Foundation for Research in Paraplegia; Wings for Life Spinal Cord Research Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 3R Research Foundation Switzerland; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the International Foundation for Research in Paraplegia (http://www.irp.ch), Wings for Life Spinal Cord Research Foundation (http://www.wingsforlife. com) (R.C.); grant R01EY021242 from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (http://www.Ammadelsonfoundation.org) (Z. H.), NIH grant R01GM069808 (T.L.S.); and grant 129-11 from the 3R Research Foundation Switzerland (http://www.forschung3r.ch) (Z.H. and T.L.S.). Children's Hospital Boston Intellectual And Developmental Disabilities Research Center (IDDRC) and viral cores supported by NIH grants P30 HD018655 and P30EY012196 were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Anthony Hill from the IDDCR-Cellular imaging core of Boston Children's Hospital for technical assistance with live imaging and members of the Schwarz and He labs for technical advice and valuable input. This study was supported by the International Foundation for Research in Paraplegia, Wings for Life Spinal Cord Research Foundation (R.C.); grant R01EY021242 from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Z. H.), grant R01GM069808 (T.L.S.); and grant 129-11 from the 3R Research Foundation Switzerland (Z.H. and T.L.S.). IDDRC and viral cores supported by NIH grants P30 HD018655 and P30EY012196 were used for this study.	Belin S, 2015, NEURON, V86, P1000, DOI 10.1016/j.neuron.2015.03.060; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Cartoni R, 2016, NEURON, V92, P1294, DOI 10.1016/j.neuron.2016.10.060; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Han SM, 2016, NEURON, V92, P1308, DOI 10.1016/j.neuron.2016.11.025; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Mar FM, 2014, J NEUROSCI, V34, P5965, DOI 10.1523/JNEUROSCI.4680-13.2014; Melkov A, 2017, CELL MOL LIFE SCI, V39, P1169; Nawabi H, 2015, NEURON, V88, P704, DOI 10.1016/j.neuron.2015.10.005; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Pinto MJ, 2016, J NEUROCHEM, V139, P921, DOI 10.1111/jnc.13702; Schmieg N, 2014, SEMIN CELL DEV BIOL, V27, P32, DOI 10.1016/j.semcdb.2013.10.004; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sorbara CD, 2014, NEURON, V84, P1183, DOI 10.1016/j.neuron.2014.11.006; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101	25	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184672	10.1371/journal.pone.0184672	http://dx.doi.org/10.1371/journal.pone.0184672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926622	gold, Green Submitted, Green Published			2022-12-27	WOS:000411166600032
J	Chen, TC; Yeh, CY; Lin, CW; Yang, CM; Yang, CH; Lin, IH; Chen, PY; Cheng, JY; Hu, FR				Chen, Ta-Ching; Yeh, Chao-Yuan; Lin, Chao-Wen; Yang, Chung-May; Yang, Chang-Hao; Lin, I-Hung; Chen, Pao-Yang; Cheng, Jung-Yu; Hu, Fung-Rong			Vascular hypoperfusion in acute optic neuritis is a potentially new neurovascular model for demyelinating diseases	PLOS ONE			English	Article							PERIPAPILLARY CHOROIDAL THICKNESS; ENDOTHELIN-1 PLASMA-LEVELS; BLOOD-FLOW-VELOCITY; NERVE-FIBER LAYER; MULTIPLE-SCLEROSIS; WHITE-MATTER; CEREBRAL HYPOPERFUSION; COHERENCE TOMOGRAPHY; AXONAL DEGENERATION; ALZHEIMERS-DISEASE	Purpose Optic neuritis is highly correlated with multiple sclerosis and is a major cause of acute visual loss and long-term neuronal degeneration. Primary cerebral hypoperfusion has been reported in brain demyelinating diseases. This study investigated whether peripapillary perfusion is changed in patients with acute optic neuritis (AON). Methods This three-year cohort study was conducted from September 1 2012, to August 31, 2015. Two hundred and forty-one patients with non-glaucomatous acute optic neuropathy were screened, and 42 non-highly myopic patients who had suffered their first episode of unilaterally idiopathic AON were studied. All cases received spectral-domain optical coherence tomography (OCT) examination, general survey, and standard corticosteroid therapy. OCT images were analyzed using a customized MATLAB program for measuring peripapillary choroidal thickness (PCT). Multivariate regression models were constructed to identify factors that are significantly related to peripapillary perfusion. Results Decreased PCT was found in eyes experiencing AON combined with disc swelling (the ratio of lesion eye PCT/fellow eye PCT was 0.87 +/- 0.08; range, from 0.75 to 1.00). In comparison to the healthy fellow eyes, approximately every 26% increase in the thickness of the retinal nerve fiber layer due to axonal swelling was associated with a 10% decreased thickness of PCT. Thinner PCT is also correlated with poorer trough vision, which may lead to poorer final vision. These findings were obvious in patients with optic papillitis but not in patients with retrobulbar neuritis. Conclusions Peripapillary vascular hypoperfusion was found in patients experiencing AON combined with disc swelling. These findings are unlike those for other ocular inflammatory diseases but are consistent with cerebral hypoperfusion, which is found in brain demyelinating diseases; thus, these findings may represent a new neurovascular model in this field.	[Chen, Ta-Ching; Lin, Chao-Wen; Yang, Chung-May; Yang, Chang-Hao; Hu, Fung-Rong] Natl Taiwan Univ, Coll Med, Dept Ophthalmol, Taipei, Taiwan; [Chen, Ta-Ching] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Yeh, Chao-Yuan] Univ Southern Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Lin, I-Hung] Natl Taiwan Univ, Coll Med, Sch Med, Taipei, Taiwan; [Chen, Pao-Yang] Acad Sinica, Inst Plant & Microbial Biol, Taipei, Taiwan; [Cheng, Jung-Yu] Ming Chuan Univ, Dept Healthcare Informat & Management, Taoyuan, Taiwan	National Taiwan University; National Taiwan University; University of Southern California; National Taiwan University; Academia Sinica - Taiwan; Ming Chuan University	Hu, FR (corresponding author), Natl Taiwan Univ, Coll Med, Dept Ophthalmol, Taipei, Taiwan.	fungronghu@ntuh.gov.tw	Yang, Chang-Hao/AAR-3759-2021; Chen, Pao-Yang/ABG-9939-2020; Yang, Chung-May/AAV-3737-2020	Chen, Pao-Yang/0000-0002-7402-3075; Chen, Ta-Ching/0000-0003-4358-6585; YANG, CHUNG-MAY/0000-0003-4082-420X; Lin, I-Hung/0000-0003-4268-2540; YANG, CHANG-HAO/0000-0002-4328-8716; Yeh, Chao-Yuan/0000-0002-1947-1596; HU, FUNG-RONG/0000-0002-2102-5317				Adhya S, 2006, NEUROIMAGE, V33, P1029, DOI 10.1016/j.neuroimage.2006.08.008; Aktas O, 2016, CURRENT OPINION NEUR; Al-Louzi OA, 2015, MULTIPLE SCLEROSIS; Arora KS, 2012, INVEST OPHTH VIS SCI, V53, P6393, DOI 10.1167/iovs.12-10224; Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cai J., 2015, CURR EYE RES, P1; Cambron M, 2012, J CEREBR BLOOD F MET, V32, P413, DOI 10.1038/jcbfm.2011.193; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Cole SR, 2000, INVEST OPHTH VIS SCI, V41, P1017; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; D'haeseleer M, 2015, J CEREBR BLOOD F MET, V35, P1406, DOI 10.1038/jcbfm.2015.131; D'haeseleer M, 2013, P NATL ACAD SCI USA, V110, P5654, DOI 10.1073/pnas.1222560110; D'haeseleer M, 2011, LANCET NEUROL, V10, P657, DOI 10.1016/S1474-4422(11)70105-3; De Keyser J, 2008, J CEREBR BLOOD F MET, V28, P1645, DOI 10.1038/jcbfm.2008.72; Diem R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010956; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Fard MA, 2015, INVESTIGATIVE OPHTHA; Freitas-Neto CA, 2016, OPHTHALMOLOGY, V123, P222, DOI 10.1016/j.ophtha.2015.06.045; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Gabilondo I, 2015, ANN NEUROL, V77, P517, DOI 10.1002/ana.24351; Gupta P, 2015, INVEST OPHTH VIS SCI, V56, P1475, DOI 10.1167/iovs.14-15742; Harb E, 2015, AM J OPHTHALMOL, V160, P62, DOI 10.1016/j.ajo.2015.04.018; Haufschild T, 2001, J NEURO-OPHTHALMOL, V21, P37, DOI 10.1097/00041327-200103000-00011; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; Henderson APD, 2011, ANN NEUROL, V70, P955, DOI 10.1002/ana.22554; Hickman SJ, 2002, LANCET, V360, P1953, DOI 10.1016/S0140-6736(02)11919-2; Hirooka K, 2015, GRAEF ARCH CLIN EXP, V253, P609, DOI 10.1007/s00417-014-2927-5; Hsiang HW, 2008, AM J OPHTHALMOL, V146, P102, DOI 10.1016/j.ajo.2008.03.010; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Ishikawa S, 2014, BRIT J OPHTHALMOL, V98, P1508, DOI 10.1136/bjophthalmol-2014-305333; Jiang R, 2015, INVEST OPHTH VIS SCI, V56, P4045, DOI 10.1167/iovs.15-16521; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Kobelt G, 2006, NEUROLOGY, V66, P1696, DOI 10.1212/01.wnl.0000218309.01322.5c; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Lee S, 2014, INVEST OPHTH VIS SCI, V55, P4378, DOI 10.1167/iovs.14-14227; Linsenmeier RA, 2000, INVEST OPHTH VIS SCI, V41, P3117; Marshall O, 2014, JAMA NEUROL, V71, P1275, DOI 10.1001/jamaneurol.2014.1668; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; Mehta H, 2015, EYE, V29, P1060, DOI 10.1038/eye.2015.65; Metz I, 2007, BRAIN, V130, P1254, DOI 10.1093/brain/awl370; Moghimi S, 2016, INVEST OPHTH VIS SCI, V57, P1293, DOI 10.1167/iovs.15-18312; Nguyen AQ, 2014, EXP BIOL MED, V239, P1461, DOI 10.1177/1535370214523703; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Noseworthy JH, 2001, NEUROLOGY, V56, P1514, DOI 10.1212/WNL.56.11.1514; Novais EA, 2015, OSLI RETINA, V46, P920, DOI 10.3928/23258160-20151008-04; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Okamoto M, 2015, OSLI RETINA, V46, P25, DOI 10.3928/23258160-20150101-04; Pache M, 2003, EUR NEUROL, V49, P164, DOI 10.1159/000069085; Papadaki EZ, 2012, MAGN RESON MED, V68, P1932, DOI 10.1002/mrm.24194; Park HYL, 2014, J GLAUCOMA, V23, P225, DOI 10.1097/IJG.0000000000000045; Park HYL, 2013, OPHTHALMOLOGY, V120, P1292, DOI 10.1016/j.ophtha.2012.11.021; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Roed H, 2005, J NEUROIMMUNOL, V162, P165, DOI 10.1016/j.jneuroim.2005.02.002; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Saindane AM, 2007, AM J NEURORADIOL, V28, P767; Sanchez-Catasus CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066271; SODERSTROM M, 1993, NEUROLOGY, V43, P1215, DOI 10.1212/WNL.43.6.1215; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Tran JQ, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000018; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Tsakiri A, 2012, MULT SCLER J, V18, P72, DOI 10.1177/1352458511415452; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009; Yun C, 2016, GRAEFEARCH CLIN EX	70	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184927	10.1371/journal.pone.0184927	http://dx.doi.org/10.1371/journal.pone.0184927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926646	Green Published, gold, Green Submitted			2022-12-27	WOS:000411166600055
J	Miyamoto, K; Ohkawara, B; Ito, M; Masuda, A; Hirakawa, A; Sakai, T; Hiraiwa, H; Hamada, T; Ishiguro, N; Ohno, K				Miyamoto, Kentaro; Ohkawara, Bisei; Ito, Mikako; Masuda, Akio; Hirakawa, Akihiro; Sakai, Tadahiro; Hiraiwa, Hideki; Hamada, Takashi; Ishiguro, Naoki; Ohno, Kinji			Fluoxetine ameliorates cartilage degradation in osteoarthritis by inhibiting Wnt/beta-catenin signaling	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; ENDOCHONDRAL OSSIFICATION; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; HIP OSTEOARTHRITIS; CELL-LINE; WNT; MOUSE; MODEL	Abnormal activation of the Wnt/beta-catenin signaling is implicated in the osteoarthritis (OA) pathology. We searched for a pre-approved drug that suppresses abnormally activated Wnt/beta-catenin signaling and has a potency to reduce joint pathology in OA. We introduced the TOPFlash reporter plasmid into HCS-2/8 human chondrosarcoma cells to estimate the Wnt/beta-catenin activity in the presence of 10 mu M each compound in a panel of pre-approved drugs. We found that fluoxetine, an antidepressant in the class of selective serotonin reuptake inhibitors (SSRI), down-regulated Wnt/beta-catenin signaling in human chondrosarcoma cells. Fluoxetine inhibited both Wnt3A- and LiCl-induced loss of proteoglycans in chondrogenically differentiated ATDC5 cells. Fluoxetine increased expression of Sox9 (the chondrogenic master regulator), and decreased expressions of Axin2 (a marker for Wnt/beta-catenin signaling) and Mmp13 (matrix metalloproteinase 13). Fluoxetine suppressed a LiCl-induced increase of total beta-catenin and a LiCl-induced decrease of phosphorylated beta-catenin in a dose-dependent manner. An in vitro protein-binding assay showed that fluoxetine enhanced binding of beta-catenin with Axin1, which is a scaffold protein forming the degradation complex for beta-catenin. Fluoxetine suppressed LiCl-induced beta-catenin accumulation in human OA chondrocytes. Intraarticular injection of fluoxetine in a rat OA model ameliorated OA progression and suppressed beta-catenin accumulation.	[Miyamoto, Kentaro; Ohkawara, Bisei; Ito, Mikako; Masuda, Akio; Ohno, Kinji] Nagoya Univ, Div Neurogenet, Ctr Neurol Dis & Canc, Grad Sch Med, Nagoya, Aichi, Japan; [Miyamoto, Kentaro; Sakai, Tadahiro; Hiraiwa, Hideki; Hamada, Takashi; Ishiguro, Naoki] Nagoya Univ, Dept Orthopaed Surg, Grad Sch Med, Nagoya, Aichi, Japan; [Hirakawa, Akihiro] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University	Ohkawara, B (corresponding author), Nagoya Univ, Div Neurogenet, Ctr Neurol Dis & Canc, Grad Sch Med, Nagoya, Aichi, Japan.	biseiohkawara@med.nagoya-u.ac.jp	Ohno, Kinji/H-4020-2012; Ito, Mikako/I-1941-2012; Hirakawa, Akihiro/AAE-5936-2019; Ohno, Kinji/ABD-5787-2020	Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Ohkawara, Bisei/0000-0002-1987-458X	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labor and Welfare (MHLW); Japan Agency for Medical Research and Development (AMED); Hori Sciences & Arts foundation; 24th General Assembly of the Japanese Association of Medical Sciences; Grants-in-Aid for Scientific Research [16K15661, 15H04840] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Hori Sciences & Arts foundation; 24th General Assembly of the Japanese Association of Medical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Ministry of Health, Labor and Welfare (MHLW), the Japan Agency for Medical Research and Development (AMED), the Hori Sciences & Arts foundation, and the 24th General Assembly of the Japanese Association of Medical Sciences.; We would like to thank Dr. Masaharu Takigawa at Okayama University for providing HCS-2/8 cells. This work was supported by a grants-in-aid of the 24th General Assembly of the Japanese Association of Medical Sciences.	Alvarez-Garcia O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034788; Asai N, 2014, BIOCHEM BIOPH RES CO, V451, P302, DOI 10.1016/j.bbrc.2014.07.125; Blom AB, 2010, CURR DRUG TARGETS, V11, P620; Blom AB, 2009, ARTHRITIS RHEUM, V60, P501, DOI 10.1002/art.24247; Bouaziz W, 2016, P NATL ACAD SCI USA, V113, P5453, DOI 10.1073/pnas.1514854113; Chan HN, 2009, ANN ACAD MED SINGAP, V38, P974; Citrome L, 2012, INT J CLIN PRACT, V66, P431, DOI 10.1111/j.1742-1241.2012.02899.x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cucchiarini M, 2007, ARTHRITIS RHEUM, V56, P158, DOI 10.1002/art.22299; De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Kawaguchi H, 2008, MOL CELLS, V25, P1; Kozawa E, 2012, ARTHRITIS RHEUM-US, V64, P454, DOI 10.1002/art.33398; Lane NE, 2007, ARTHRITIS RHEUM-US, V56, P3319, DOI 10.1002/art.22867; Lin YN, 2016, SCI REP-UK, V6, DOI 10.1038/srep31986; Liu SS, 2016, MOL MED REP, V13, P1999, DOI 10.3892/mmr.2016.4798; Lodewyckx Liesbet, 2009, Curr Rheumatol Rep, V11, P23; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; Ma B, 2013, CALCIFIED TISSUE INT, V92, P399, DOI 10.1007/s00223-012-9675-5; Ma B, 2012, ARTHRITIS RHEUM-US, V64, P2589, DOI 10.1002/art.34425; Magni LR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004185.pub3; Manabe N, 1999, RHEUMATOLOGY, V38, P714, DOI 10.1093/rheumatology/38.8.714; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Matsushita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081569; Min JL, 2005, ARTHRITIS RHEUM-US, V52, P1077, DOI 10.1002/art.20993; Nakashima M, 2012, BIOCHEM BIOPH RES CO, V422, P508, DOI 10.1016/j.bbrc.2012.05.036; Nalesso G, 2016, ANN RHEUM DIS; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Papathanasiou I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3805; Papathanasiou I, 2010, J ORTHOP RES, V28, P348, DOI 10.1002/jor.20993; Rentsendorj O, 2005, BIOCHEM J, V389, P705, DOI 10.1042/BJ20050214; Sacre S, 2010, ARTHRITIS RHEUM-US, V62, P683, DOI 10.1002/art.27304; Staines KA, 2012, CELL BIOCHEM FUNCT, V30, P633, DOI 10.1002/cbf.2852; Takamatsu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092699; Takegami Y, 2016, BIOCHEM BIOPH RES CO, V473, P255, DOI 10.1016/j.bbrc.2016.03.089; TAKIGAWA M, 1989, CANCER RES, V49, P3996; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Wieland HA, 2005, NAT REV DRUG DISCOV, V4, P331, DOI 10.1038/nrd1693; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	47	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184388	10.1371/journal.pone.0184388	http://dx.doi.org/10.1371/journal.pone.0184388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	28926590	gold, Green Published, Green Submitted			2022-12-27	WOS:000411166600016
J	Poteat, T; Parke, C; Solares, D; Williams, JK; Wolf, RC; Metheny, N; Vazzano, A; Dent, J; Gibbs, A; Nonyane, BAS; Toiv, N				Poteat, Tonia; Parke, Chulwoo; Solares, Diego; Williams, John K.; Wolf, R. Cameron; Metheny, Noah; Vazzano, Andrea; Dent, Juan; Gibbs, Ashley; Nonyane, Bareng Aletta Sanny; Toiv, Nora			Changing hearts and minds: Results from a multi-country gender and sexual diversity training	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; HIV; MEN; ATTITUDES; EPIDEMICS; WORKERS	Engaging key populations, including gender and sexual minorities, is essential to meeting global targets for reducing new HIV infections and improving the HIV continuum of care. Negative attitudes toward gender and sexual minorities serve as a barrier to political will and effective programming for HIV health services. The President's Emergency Plan for AIDS Relief (PEPFAR), established in 2003, provided Gender and Sexual Diversity Trainings for 2,825 participants including PEPFAR staff and program implementers, U.S. government staff, and local stakeholders in 38 countries. The outcomes of these one-day trainings were evaluated among a subset of participants using a mixed methods pre- and post-training study design. Findings suggest that sustainable decreases in negative attitudes toward gender and sexual minorities are achievable with a one-day training.	[Poteat, Tonia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Parke, Chulwoo] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Solares, Diego; Vazzano, Andrea; Dent, Juan; Gibbs, Ashley] Palladium Grp, Hlth Policy Project, Washington, DC USA; [Williams, John K.] Ctr Dis Control & Prevent, Div Global HIV TB, Atlanta, GA USA; [Wolf, R. Cameron; Metheny, Noah] US Agcy Int Dev, Washington, DC 20523 USA; [Nonyane, Bareng Aletta Sanny] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Toiv, Nora] Off US Global AIDS Coordinator, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; United States Agency for International Development (USAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Poteat, T (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	tpoteat@jhu.edu	Nonyane, Bareng A.S./AAC-8118-2020; Park, Chulwoo/P-3710-2019	Nonyane, Bareng A.S./0000-0001-5633-7487; Park, Chulwoo/0000-0003-0667-6549; Poteat, Tonia/0000-0001-6541-3787	USAID; PEPFAR [AID-OAA-A-10-00067]; NIH [P30A1094189]; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; PEPFAR; NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER	USAID(United States Agency for International Development (USAID)); PEPFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; PEPFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This publication was made possible by support from USAID and PEPFAR to the Health Policy Project (HPP) under Agreement No. AID-OAA-A-10-00067 and with assistance from the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30A1094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.; The findings and conclusions in this article are based upon the Gender & Sexual Diversity Training which was developed by the USAID- and PEPFAR-funded Health Policy Project, in coordination with a U.S. government interagency team, including members of the PEPFAR Key Populations Technical Working Group and the PEPFAR Gender Technical Working Group. We are grateful to the dedicated staff who devoted countless hours to developing and implementing the GSD Training as well as the numerous training participants for their willingness to take part in this evaluation.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Bateman C, 2011, SAMJ S AFR MED J, V101, P91, DOI 10.7196/SAMJ.4735; Beyrer C, 2008, SEX TRANSM INFECT, V84, P410, DOI 10.1136/sti.2008.033290; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chan PA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-153; Cook T.D., 1978, ADV EXP SOC PSYCHOL, V11, P1, DOI [10.1016/S0065-2601(08)60004-0, DOI 10.1016/S0065-2601(08)60004-0]; Creswell J.W., 2007, DESIGNING CONDUCTING; Ellis SJ, 2002, J HOMOSEXUAL, V44, P121, DOI 10.1300/J082v44n01_07; Grosso A, 2015, GLOB PUBLIC HEALTH, V10, P1172, DOI 10.1080/17441692.2015.1043314; HADDOCK G, 1993, J PERS SOC PSYCHOL, V65, P1105, DOI 10.1037/0022-3514.65.6.1105; Hill DB, 2005, SEX ROLES, V53, P531, DOI 10.1007/s11199-005-7140-x; Horowitz JM, 2013, GLOBAL DIVIDE HOMOSE, P1; Hurtado SL, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1402-z; Huskinson TLH, 2006, SOC COGNITION, V24, P453, DOI 10.1521/soco.2006.24.4.453; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Levy ME, 2014, AIDS BEHAV, V18, P972, DOI 10.1007/s10461-014-0719-x; Mansh M, 2015, ACAD MED, V90, P574, DOI 10.1097/ACM.0000000000000656; O'Hanlan KA, J GAY LESBIAN MED AS, V1, P25; Poteat T, 2014, CURR OPIN HIV AIDS, V9, P168, DOI 10.1097/COH.0000000000000030; Prakashkumar M D, 2014, Indian J Lepr, V86, P99; Reynolds R, 2010, GLOBAL FORUM MSM HIV; Santos GM, 2013, JAIDS-J ACQ IMM DEF, V63, pE167, DOI 10.1097/QAI.0b013e318294de80; Sheehan KimBartel., 2001, J COMPUT-MEDIAT COMM, V6, pJCMC621, DOI [DOI 10.1111/J.1083-6101.2001.TB00117.X, 10.1111/j.1083-6101.2001.tb00117.x]; Soto RJ, 2007, JAIDS-J ACQ IMM DEF, V46, P101; Stahlman Shauna, 2017, JMIR Public Health Surveill, V3, pe23, DOI 10.2196/publichealth.7334; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; U.S. Department of State, 2014, PEPFAR 3 0 CONTR EP; UNAIDS, 2014, NAT COMM POL INSTR 2; UNAIDS, 2014, 90 90 90 AMB TREATM; Varas-Diaz N, 2016, AIDS CARE, V28, P376, DOI 10.1080/09540121.2015.1090537; Vincent M L, 1985, Fam Life Educ, V3, P23; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07; Wirtz AL, 2012, 19 INT AIDS C WASH D; World Health Organization, 2017, VIOL WOM HIV AIDS CR; Zanna M., 2008, ATTITUDES NEW LOOK O	38	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184484	10.1371/journal.pone.0184484	http://dx.doi.org/10.1371/journal.pone.0184484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH4XT	28926568	Green Submitted, Green Published, gold			2022-12-27	WOS:000411166600019
J	Kawakubo, M; Demehri, S; Manstein, D				Kawakubo, Masayoshi; Demehri, Shadmehr; Manstein, Dieter			Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response	PLOS ONE			English	Article							BASAL-CELL CARCINOMAS; REGULATORY T-CELLS; PHOTODYNAMIC THERAPY; SOLID STRESS; DELIVERY; BETA; IMMUNOSUPPRESSION; PHOTOTHERMOLYSIS; ADENOCARCINOMA; HYPERTHERMIA	Background Ablative fractional photothermolysis (aFP) using a CO2 laser generates multiple small diameter tissue lesions within the irradiation field. aFP is commonly used for a wide variety of dermatological indications, including treatment of photodamaged skin and dyschromia, drug delivery and modification of scars due to acne, surgical procedures and burns. In this study we explore the utility of aFP for treating oncological indications, including induction of local tumor regression and inducing anti-tumor immunity, which is in marked contrast to current indications of aFP. Methodology/Principal findings We used a fractional CO2 laser to treat a tumor established by BALB/c colon carcinoma cell line (CT26. CL25), which expressed a tumor antigen, beta-galactosidase (beta-gal). aFP treated tumors grew significantly slower as compared to untreated controls. Complete remission after a single aFP treatment was observed in 47% of the mice. All survival mice from the tumor inoculation rejected re-inoculation of the CT26. CL25 colon carcinoma cells and moreover 80% of the survival mice rejected CT26 wild type colon carcinoma cells, which are parental cells of CT26. CL25 cells. Histologic section of the FP-treated tumors showed infiltrating neutrophil in the tumor early after aFP treatment. Flow cytometric analysis of tumor-infiltrating lymphocytes showed aFP treatment abrogated the increase in regulatory T lymphocyte (Treg), which suppresses anti-tumor immunity and elicited the expansion of epitope-specific CD8(+) T lymphocytes, which were required to mediate the tumor-suppressing effect of aFP. Conclusion We have demonstrated that aFP is able to induce a systemic anti-tumor adaptive immunity preventing tumor recurrence in a murine colon carcinoma in a mouse model. This study demonstrates a potential role of aFP treatments in oncology and further studies should be performed.	[Kawakubo, Masayoshi; Demehri, Shadmehr; Manstein, Dieter] Massachusetts Gen Hosp, Res Inst, Cutaneous Biol Res Ctr, Dept Dermatol, Charlestown, MA 02114 USA; [Kawakubo, Masayoshi; Demehri, Shadmehr; Manstein, Dieter] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kawakubo, M (corresponding author), Massachusetts Gen Hosp, Res Inst, Cutaneous Biol Res Ctr, Dept Dermatol, Charlestown, MA 02114 USA.; Kawakubo, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mkawakubo@mgh.harvard.edu	Demehri, Shadmehr/N-5732-2019		NIH HHS [DP5 OD021353] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021353] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allemann IB, 2010, LASER MED SCI, V25, P137, DOI 10.1007/s10103-009-0734-8; BARKER DE, 1951, PLAST RECONSTR SURG, V7, P115, DOI 10.1097/00006534-195102000-00004; BODMER S, 1989, J IMMUNOL, V143, P3222; Chaput N, 2007, J IMMUNOL, V179, P4969, DOI 10.4049/jimmunol.179.8.4969; Chauhan VP, 2014, CANCER CELL, V26, P14, DOI 10.1016/j.ccr.2014.06.003; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Chen XY, 2014, J CONTROL RELEASE, V192, P310, DOI 10.1016/j.jconrel.2014.08.006; Chen XY, 2012, J CONTROL RELEASE, V159, P43, DOI 10.1016/j.jconrel.2012.01.002; COLOMBO MP, 1992, J IMMUNOL, V149, P113; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; GOMER CJ, 1984, PHOTOCHEM PHOTOBIOL, V40, P435, DOI 10.1111/j.1751-1097.1984.tb04614.x; Haak CS, 2015, BRIT J DERMATOL, V172, P215, DOI 10.1111/bjd.13166; Haedersdal M, 2014, LASER SURG MED, V46, P462, DOI 10.1002/lsm.22259; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Hantash BM, 2007, LASER SURG MED, V39, P87, DOI 10.1002/lsm.20405; HARRIS JW, 1976, CANCER RES, V36, P2733; Hazeldine J, 2016, BURNS TRAUMA, V4, DOI 10.1186/s41038-016-0059-3; HENDERSON BW, 1987, CANCER RES, V47, P3110; Huggett MT, 2014, BRIT J CANCER, V110, P1698, DOI 10.1038/bjc.2014.95; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jalian HR, 2014, LASER SURG MED, V46, P1, DOI 10.1002/lsm.22201; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Kato H, 2003, LUNG CANCER, V42, P103, DOI 10.1016/S0169-5002(03)00242-3; KELLER R, 1983, INVAS METAST, V3, P183; Khan MH, 2005, LASER SURG MED, V36, P270, DOI 10.1002/lsm.20142; Kim HW, 2014, DERMATOL SURG, V40, P1361, DOI 10.1097/DSS.0000000000000185; Kirkbride KC, 2003, EXPERT OPIN BIOL TH, V3, P251; Konnikov N, 2011, LASER SURG MED, V43, P72, DOI 10.1002/lsm.21035; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Li XS, 2011, PHOTOCH PHOTOBIO SCI, V10, P817, DOI 10.1039/c0pp00306a; Ma YG, 2016, CARDIOVASC RES, V110, P51, DOI 10.1093/cvr/cvw024; Manstein D, 2004, LASER SURG MED, V34, P426, DOI 10.1002/lsm.20048; Mishalian I, 2013, CANCER IMMUNOL IMMUN, V62, P1745, DOI 10.1007/s00262-013-1476-9; MOAN J, 1985, CANCER RES, V45, P1608; Mroz P, 2013, CANCER RES, V73, P6462, DOI 10.1158/0008-5472.CAN-11-2572; Mroz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015194; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nanashima A, 2012, ANTICANCER RES, V32, P4931; NEUMANN RA, 1991, J AM ACAD DERMATOL, V25, P991, DOI 10.1016/0190-9622(91)70296-E; Ortiz AE, 2015, LASER SURG MED, V47, P106, DOI 10.1002/lsm.22310; Park DH, 2014, EUR J CANCER, V50, P1259, DOI 10.1016/j.ejca.2014.01.008; Prignano F, 2009, DERMATOL THER, V22, pS8, DOI 10.1111/j.1529-8019.2009.01265.x; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Tierney EP, 2012, DERMATOL SURG, V38, P1777, DOI 10.1111/j.1524-4725.2012.02572.x; Tierney EP, 2009, DERMATOL SURG, V35, P1445, DOI 10.1111/j.1524-4725.2009.01258.x; Toraya-Brown S, 2014, INT J HYPERTHER, V30, P531, DOI 10.3109/02656736.2014.968640; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892; Trelles MA, 2010, J DRUGS DERMATOL, V9, P315; Usuda J, 2010, CLIN CANCER RES, V16, P2198, DOI 10.1158/1078-0432.CCR-09-2520; Weiss ET, 2013, J AM ACAD DERMATOL, V68, P98, DOI 10.1016/j.jaad.2012.05.033; Wislez M, 2003, CANCER RES, V63, P1405	53	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2017	12	9							e0184852	10.1371/journal.pone.0184852	http://dx.doi.org/10.1371/journal.pone.0184852			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH3OQ	28922374	Green Published, Green Submitted, gold			2022-12-27	WOS:000411059300036
J	Aldawsari, A; Khan, MA; Hameed, BH; Alqadami, AA; Siddiqui, MR; Alothman, ZA; Ahmed, AYBH				Aldawsari, Abdullah; Khan, Moonis Ali; Hameed, B. H.; Alqadami, Ayoub Abdullah; Siddiqui, Masoom Raza; Alothman, Zeid Abdullah; Ahmed, A. Yacine Badjah Hadj			Mercerized mesoporous date pit activated carbon - A novel adsorbent to sequester potentially toxic divalent heavy metals from water	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; ADSORPTION; REMOVAL; IONS; CADMIUM; COPPER; PALM; KINETICS; SORPTION; CD(II)	A substantive approach converting waste date pits to mercerized mesoporous date pit activated carbon (DPAC) and utilizing it in the removal of Cd(II), Cu(II), Pb(II), and Zn(II) was reported. In general, rapid heavy metals adsorption kinetics for Co range: 25-100 mg/L was observed, accomplishing 77-97% adsorption within 15 min, finally, attaining equilibrium in 360 min. Linear and non-linear isotherm studies revealed Langmuir model applicability for Cd(II) and Pb(II) adsorption, while Freundlich model was fitted to Zn(II) and Cu(II) adsorption. Maximum monolayer adsorption capacities (qm) for Cd(II), Pb(II), Cu(II), and Zn(II) obtained by non-linear isotherm model at 298 K were 212.1, 133.5, 194.4, and 111 mg/g, respectively. Kinetics modeling parameters showed the applicability of pseudo-secondorder model. The activation energy (Ea) magnitude revealed physical nature of adsorption. Maximum elution of Cu(II) (81.6%), Zn(II) (70.1%), Pb(II) (96%), and Cd(II) (78.2%) were observed with 0.1 M HCl. Thermogravimetric analysis of DPAC showed a total weight loss (in two-stages) of 28.3%. Infra-red spectral analysis showed the presence of carboxyl and hydroxyl groups over DPAC surface. The peaks at 820, 825, 845 and 885 cm(-1) attributed to Zn-O, Pb-O, Cd-O, and Cu-O appeared on heavy metals saturated DPAC, confirmed their binding on DPAC during the adsorption.	[Aldawsari, Abdullah; Khan, Moonis Ali; Alqadami, Ayoub Abdullah; Siddiqui, Masoom Raza; Alothman, Zeid Abdullah; Ahmed, A. Yacine Badjah Hadj] King Saud Univ, Coll Sci, Dept Chem, Riyadh, Saudi Arabia; [Hameed, B. H.] Univ Sains Malaysia, Sch Chem Engn, Engn Campus, Nibong Tebal, Penang, Malaysia	King Saud University; Universiti Sains Malaysia	Khan, MA (corresponding author), King Saud Univ, Coll Sci, Dept Chem, Riyadh, Saudi Arabia.	mokhan@ksu.edu.sa	Khan, Moonis Ali/C-6356-2011; Hameed, Bassim H./C-1270-2009; Siddiqui, Prof Masoom Raza/ABC-7839-2020; Aldawsari, Abdullah/GQH-3210-2022; ALOthman, Zeid A./E-7333-2014; Alqadami, Ayoub/D-9862-2017; Alqadami, Ayoub Abdullah/ABD-1898-2020	Khan, Moonis Ali/0000-0002-0548-8581; Hameed, Bassim H./0000-0001-5171-6189; ALOthman, Zeid A./0000-0001-9970-2480; Aldawsari, Abdullah/0000-0003-2709-9381; Alqadami, Ayoub/0000-0002-4527-0931	DSR at King Saud University [RG-1437-031]; Deanship of Scientific Research at King Saud University [RG-1437-031]	DSR at King Saud University(King Saud University); Deanship of Scientific Research at King Saud University(King Saud University)	This work has been funded by DSR at King Saud University through the Research group No. RG-1437-031. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the Research group No. RG-1437-031.	Ahmad T, 2012, ENVIRON SCI POLLUT R, V19, P1464, DOI 10.1007/s11356-011-0709-8; Ahmed MJ, 2016, PROCESS SAF ENVIRON, V102, P168, DOI 10.1016/j.psep.2016.03.010; Ajmal M, 2005, J HAZARD MATER, V122, P177, DOI 10.1016/j.jhazmat.2005.03.029; Ajmal M, 2006, J HAZARD MATER, V135, P242, DOI 10.1016/j.jhazmat.2005.11.054; Akasha I, 2016, FOOD CHEM, V197, P799, DOI 10.1016/j.foodchem.2015.11.046; Al-Farsi MA, 2011, NUTS AND SEEDS IN HEALTH AND DISEASE PREVENTION, P447, DOI 10.1016/B978-0-12-375688-6.10053-2; Al-Ghouti MA, 2010, J HAZARD MATER, V176, P510, DOI 10.1016/j.jhazmat.2009.11.059; Aldawsari A, 2017, DESALIN WATER TREAT, V62, P273, DOI 10.5004/dwt.2017.0529; Alqadami AA, 2017, J CLEAN PROD, V156, P426, DOI 10.1016/j.jclepro.2017.04.085; Alsohaimi IH, 2015, CHEM ENG J, V270, P9, DOI 10.1016/j.cej.2015.02.008; Amarasinghe BMWPK, 2007, CHEM ENG J, V132, P299, DOI 10.1016/j.cej.2007.01.016; Ameh P.O., 2013, INT J MODERN CHEM, V5, P136; Anirudhan TS, 2011, J ENVIRON SCI, V23, P1989, DOI 10.1016/S1001-0742(10)60515-3; Barneveld WH, 1993, FAO AGR SERVICES B, V101; Bhatnagar A, 2010, CHEM ENG J, V157, P277, DOI 10.1016/j.cej.2010.01.007; Chen XC, 2011, BIORESOURCE TECHNOL, V102, P8877, DOI 10.1016/j.biortech.2011.06.078; Danish M, 2011, J CHEM ENG DATA, V56, P3607, DOI 10.1021/je200460n; Dubinin M. M, 1947, PROC ACAD SCI USSR C, V55, P327, DOI DOI 10.4236/OJS.2014.41001; El-Hendawy ANA, 2009, J HAZARD MATER, V167, P260, DOI 10.1016/j.jhazmat.2008.12.118; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Grottrup J, 2017, CERAMICS INTER; Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8; Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141; Jain AK, 2003, J HAZARD MATER, V101, P31, DOI 10.1016/S0304-3894(03)00146-8; Khandanlou R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120264; Kula I, 2008, BIORESOURCE TECHNOL, V99, P492, DOI 10.1016/j.biortech.2007.01.015; Lagergren S.K., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Mohan D, 2002, WATER RES, V36, P2304, DOI 10.1016/S0043-1354(01)00447-X; Motsi T, 2009, INT J MINER PROCESS, V92, P42, DOI 10.1016/j.minpro.2009.02.005; Mouni L, 2010, DESALIN WATER TREAT, V16, P66, DOI 10.5004/dwt.2010.1106; Murugadoss G, 2016, J LUMIN, V170, P78, DOI 10.1016/j.jlumin.2015.10.034; Oubekka LD, 2016, REV ROUM CHIM, V61, P175; Rao RAK, 2010, J HAZARD MATER, V173, P273, DOI 10.1016/j.jhazmat.2009.08.080; SASO, 2009, 10252009 GSO; Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064; Tajar AF, 2009, J HAZARD MATER, V165, P1159, DOI 10.1016/j.jhazmat.2008.10.131; Tyagi A, 2016, RSC ADV, V6, P72423, DOI 10.1039/c6ra10488f; Wang FY, 2010, J HAZARD MATER, V177, P300, DOI 10.1016/j.jhazmat.2009.12.032; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072475; WHO, 2011, GUID DRINK WAT QUAL; ZOUBOULIS AI, 1992, SEPAR SCI TECHNOL, V27, P2143, DOI 10.1080/01496399208019471	42	33	34	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e014493	10.1371/journal.pone.0184493	http://dx.doi.org/10.1371/journal.pone.0184493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910368	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200051
J	Kumar, NP; Moideen, K; Viswanathan, V; Sivakumar, S; Menon, PA; Kornfeld, H; Babu, S				Kumar, Nathella Pavan; Moideen, Kadar; Viswanathan, Vijay; Sivakumar, Shanmugam; Menon, Pradeep A.; Kornfeld, Hardy; Babu, Subash			Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes comorbidity and reversal upon treatment	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ACTIVE PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; CATHELICIDIN LL-37; GRANULYSIN LEVELS; MELLITUS; CELLS; EXPRESSION; PLASMA; FLUID	Background The association of antimicrobial peptides (AMPs) with tuberculosis-diabetes comorbidity (PTB-DM) is not well understood. Methods To study the association of AMPs with PTB-DM, we examined the systemic levels of cathelicidin (LL37), human beta defensin-2 (HBD2), human neutrophil peptides 1-3, (HNP1-3) and granulysin in individuals with either PTB-DM, PTB, latent TB (LTB) or no TB infection (NTB). Results Circulating levels of cathelicidin and HBD2 were significantly higher and granulysin levels were significantly lower in PTB-DM compared to PTB, LTB or NTB, while the levels of HNP1-3 were significantly higher in PTB-DM compared to LTB or NTB individuals. Moreover, the levels of cathelicidin and/or HBD2 were significantly higher in PTB-DM or PTB individuals with bilateral and cavitary disease and also exhibited a significant positive relationship with bacterial burden. Cathelidin, HBD2 and HNP1-3 levels exhibited a positive relationship with HbA1c and/or fasting blood glucose levels. Finally, anti-tuberculosis therapy resulted in significantly diminished levels of cathelicidin, HBD2, granulysin and significantly enhanced levels of HNP1-3 and granulysin in PTB-DM and/or PTB individuals. Conclusion Therefore, our data demonstrate that PTB-DM is associated with markedly enhanced levels of AMPs and diminished levels of granulysin.	[Kumar, Nathella Pavan; Moideen, Kadar; Babu, Subash] Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Madras, Tamil Nadu, India; [Viswanathan, Vijay] Prof M Viswanathan Diabet Res Ctr, Madras, Tamil Nadu, India; [Sivakumar, Shanmugam; Menon, Pradeep A.] Natl Inst Res TB, Madras, Tamil Nadu, India; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Worcester, MA USA; [Babu, Subash] NIAID, LPD, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Madras, Tamil Nadu, India.; Babu, S (corresponding author), NIAID, LPD, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sbabu@mail.nih.gov	Kornfeld, Hardy/AAS-2903-2021; Babu, Subash/GXG-4746-2022; Kumar, Nathella Pavan/AAU-2328-2021		Indian Department of Biotechnology; Indian Council of Medical Research; National Institute for Allergy and Infectious Diseases, National Institutes of Health; CRDF Global [USB1-31149-XX-13]; Division of Intramural Research, NIAID, NIH	Indian Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); National Institute for Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CRDF Global; Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was jointly sponsored by the Indian Department of Biotechnology; the Indian Council of Medical Research; and the National Institute for Allergy and Infectious Diseases, National Institutes of Health, and administered by CRDF Global [grant USB1-31149-XX-13]. This work was also funded in part by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashitani J, 2002, CHEST, V121, P519, DOI 10.1378/chest.121.2.519; Bates M, 2015, COLD SPRING HARB PER; Bloom BR, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0006-2015; Cakir E, 2014, INT J TUBERC LUNG D, V18, P671, DOI 10.5588/ijtld.13.0831; Castaneda-Sanchez JI, 2013, PATHOGENS, V2, P13, DOI 10.3390/pathogens2010013; Di Liberto D, 2007, TUBERCULOSIS, V87, P322, DOI 10.1016/j.tube.2007.01.003; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Girardi E, 2017, INT J INFECT DIS; Gonzalez-Curiel I, 2011, HUM IMMUNOL, V72, P656, DOI 10.1016/j.humimm.2011.03.027; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2016, NAT REV IMMUNOL, V16, P321, DOI 10.1038/nri.2016.29; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Rivas-Santiago B, 2008, INFECT IMMUN, V76, P935, DOI 10.1128/IAI.01218-07; Rivas-Santiago B, 2009, INFECT IMMUN, V77, P4690, DOI 10.1128/IAI.01515-08; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P312, DOI 10.1016/j.tube.2007.01.002; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Silva JP, 2016, BIOTECHNOL ADV, V34, P924, DOI 10.1016/j.biotechadv.2016.05.007; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Verway M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003407; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; Yamshchikov AV, 2010, AM J CLIN NUTR, V92, P603, DOI 10.3945/ajcn.2010.29411; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zhan YF, 2015, EXP THER MED, V9, P11, DOI 10.3892/etm.2014.2042	33	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184753	10.1371/journal.pone.0184753	http://dx.doi.org/10.1371/journal.pone.0184753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910369	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000410859200091
J	Shen, ZL; Jiang, LL; Yang, SR; Ye, J; Dai, N; Liu, XY; Li, N; Lu, J; Liu, F; Lu, Y; Sun, XJ; Cheng, YQ; Xu, XF				Shen, Zonglin; Jiang, Linling; Yang, Shuran; Ye, Jing; Dai, Nan; Liu, Xiaoyan; Li, Na; Lu, Jin; Liu, Fang; Lu, Yi; Sun, Xuejin; Cheng, Yuqi; Xu, Xiufeng			Identify changes of brain regional homogeneity in early and later adult onset patients with first-episode depression using resting-state fMRI	PLOS ONE			English	Article							DEFAULT MODE NETWORK; CEREBRAL-BLOOD-FLOW; LATE-LIFE DEPRESSION; MAJOR DEPRESSION; FUNCTIONAL CONNECTIVITY; RECURRENT DEPRESSION; NAIVE DEPRESSION; SYMPTOM CLUSTERS; EMOTIONAL FACES; DISORDER	Objective Previous work exhibited different brain grey matter volume (GMV) changes between patients with early adult onset depression (EOD, age 18-29) and later adult onset depression (LOD, age 30-44) by using 30-year-old as the cut-off age. To identify whether regional homogeneity (ReHo) changes are also different between EOD and LOD by using same cutoff age, we used resting-state functional magnetic resonance imaging (fMRI) to detect the abnormal ReHo between patients with EOD and LOD in the present study. Methods Resting-state fMRI scans of 58 patients with EOD, 62 patients with LOD, 60 young healthy controls (HC), and 52 old HC were obtained. The ReHo approach was used to analyze the images. Results The ANOVA analysis revealed that the ReHo values in the frontoparietal, occipital, and cerebellar regions were significantly different among the four groups. Relative to patients with LOD, patients with EOD displayed significantly increased ReHo in the left precuneus, and decreased ReHo in the right fusiform. The ReHo values in the left precuneus and the right fusiform had no significant correlation with the score of the depression rating scale or illness duration in both patient subgroups. Compared to young HC, patients with EOD showed significantly increased ReHo in the right frontoparietal regions and the right calcarine. Furthermore, the increased ReHo in the right frontoparietal regions, right insula and left hippocampus, and decreased ReHo in the left inferior occipital gyrus, right middle occipital gyrus, left calcarine, and left supplementary motor area were observed in patients with LOD when compared to old HC. Conclusions The ReHo of brain areas that were related to mood regulation was changed in the first-episode, drug-naive adult patients with MDD. Adult patients with EOD and LOD exhibited different ReHo abnormalities relative to each age-matched comparison group, suggesting that depressed adult patients with different age-onset might have different pathological mechanism.	[Shen, Zonglin; Jiang, Linling; Yang, Shuran; Ye, Jing; Dai, Nan; Liu, Xiaoyan; Li, Na; Lu, Jin; Liu, Fang; Xu, Xiufeng] Kunming Med Univ, Dept Psychiat, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Lu, Yi; Sun, Xuejin] Kunming Med Univ, Dept Med Imaging, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Cheng, Yuqi] Mental Hlth Inst Yunnan Prov, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University	Xu, XF (corresponding author), Kunming Med Univ, Dept Psychiat, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China.	xfxu2004@sina.com		Shen, Zonglin/0000-0002-1015-4535	National Natural Science Foundation of China [81160171, 81660237]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Agreement Number 81160171, 81660237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany S, 2013, J AFFECT DISORDERS, V149, P175, DOI 10.1016/j.jad.2013.01.019; Bellgowan JF, 2015, J AM ACAD CHILD PSY, V54, P841, DOI 10.1016/j.jaac.2015.08.001; Buchanan A, 2014, J PSYCHIATR RES, V59, P38, DOI 10.1016/j.jpsychires.2014.09.002; Bukh Jens Drachmann, 2011, Clin Pract Epidemiol Ment Health, V7, P140, DOI 10.2174/1745017901107010140; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Charlton RA, 2013, INT J GERIATR PSYCH, V28, P1166, DOI 10.1002/gps.3939; Chen JD, 2012, J AFFECT DISORDERS, V143, P56, DOI 10.1016/j.jad.2012.05.025; Cheng YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112307; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Graff-Guerrero A, 2004, J AFFECT DISORDERS, V80, P55, DOI 10.1016/S0165-0327(03)00049-1; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; Grayson L, 2013, J AFFECT DISORDERS, V150, P161, DOI 10.1016/j.jad.2013.03.021; Guo WB, 2015, J AFFECT DISORDERS, V179, P31, DOI 10.1016/j.jad.2015.03.028; Guo WB, 2014, PROG NEURO-PSYCHOPH, V54, P1, DOI 10.1016/j.pnpbp.2014.05.008; Guo WB, 2013, J AFFECT DISORDERS, V151, P1097, DOI 10.1016/j.jad.2013.09.003; Harald B, 2012, J AFFECT DISORDERS, V139, P126, DOI 10.1016/j.jad.2011.07.015; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Ho TC, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00040; Janssen J, 2006, INT J GERIATR PSYCH, V21, P86, DOI 10.1002/gps.1428; Joormann J, 2007, J ABNORM PSYCHOL, V116, P135, DOI 10.1037/0021-843X.116.1.135; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Kendall MG, 1990, RANK CORRELATION MET, Vvii; Kendler KS, 2009, BIOL PSYCHIAT, V65, P808, DOI 10.1016/j.biopsych.2008.11.015; Korten NCM, 2012, J AFFECT DISORDERS, V138, P259, DOI 10.1016/j.jad.2012.01.042; Kujawa AJ, 2011, J ABNORM CHILD PSYCH, V39, P125, DOI 10.1007/s10802-010-9438-6; Lai CH, 2016, BRAIN IMAGING BEHAV, V10, P187, DOI 10.1007/s11682-015-9381-9; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lau WKW, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.55; Lemogne C, 2010, J AFFECT DISORDERS, V124, P196, DOI 10.1016/j.jad.2009.11.003; Liang MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079999; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Lyons MJ, 1998, ARCH GEN PSYCHIAT, V55, P468, DOI 10.1001/archpsyc.55.5.468; Park SC, 2014, YONSEI MED J, V55, P1712, DOI 10.3349/ymj.2014.55.6.1712; Parker G, 1999, J AFFECT DISORDERS, V52, P11, DOI 10.1016/S0165-0327(98)00084-6; Peng DH, 2011, CHINESE MED J-PEKING, V124, P369, DOI 10.3760/cma.j.issn.0366-6999.2011.03.009; Perico CAM, 2005, NEUROSCI LETT, V384, P265, DOI 10.1016/j.neulet.2005.04.088; Qin JL, 2014, MAGN RESON MED, V72, P1397, DOI 10.1002/mrm.25036; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Rush AJ, 2007, J CLIN PSYCHIAT, V68, P4; Schmaal L, 2016, MOL PSYCHIATR, V21, P806, DOI 10.1038/mp.2015.69; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shen ZL, 2016, NEUROIMAGE-CLIN, V12, P492, DOI 10.1016/j.nicl.2016.08.016; Tononi G, 1998, NEUROIMAGE, V7, P133, DOI 10.1006/nimg.1997.0313; Tozzi F, 2008, PSYCHOL MED, V38, P641, DOI 10.1017/S0033291707002681; Vasic N, 2015, J PSYCHIATR NEUROSCI, V40, P412, DOI 10.1503/jpn.140246; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Xue S, 2016, BEHAV BRAIN RES, V306, P13, DOI 10.1016/j.bbr.2016.03.012; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang X, 2015, NEUROPSYCH DIS TREAT, V11, P2415, DOI 10.2147/NDT.S93055; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhong X, 2016, J AFFECT DISORDERS, V206, P280, DOI 10.1016/j.jad.2016.09.005; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	58	20	21	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184712	10.1371/journal.pone.0184712	http://dx.doi.org/10.1371/journal.pone.0184712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910390	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200082
